>OBAHECAF_00001 hypothetical protein
MLSIPVEKFPLRGSKPQGIISIFEHSYRTKWNVFFLSIKRNSLVFIFLKNSQLTSSTCPN
IPEFVLGNREARLEFHPFIFTYELPFNRFVFKVFQRFIHQPVIKSPREKHTFTTHKTEIS
TNSIIQNSIFVFILVKERLCRAINIDQHFVSDRHGSRQNTFSLFGLYYFTIVNNRKIIPI
>OBAHECAF_00002 Lipopolysaccharide export system protein LptA
MIKYICLIVSFLVTTFSLFAQQEEGKKRRIEIVYGGEFTIDHVKYPGATIFKSDGKRVQF
HHQGLDVWCDLAVLYEARNEVIAYGDVLLQQGDTLQMNSKYISYNGNLKTAVAKEEVVLK
NETMTLETEELFLDRNAQVAYYNNFGKITDIENELTSKVGKYFIETKKNQFTNAVKIVNK
DFTVDSQVLDYFHNTGNAYFYGATTIVGKDYKTYSEKGFYDTRREEGYFKQNAKIDYDLK
TIKGDSLYFDKKRQFASATNNIIILDSLNKTTVKGHYGEVHKAKDSMFITKKPLIITLVE
RDSMYMHGKKILVTGKEGKRNIRVFHDARIYKTDLQAKCDSIHSNEENGLTQLIGNPVAW
TGESQITGENIHLIADKRTQQMDSLKVFNNALVVEKDSLGDGYNQVKGRVLYGKFKKNRL
KQIDFIQNTESIQYVYTEKNELVGINKLTCSHIKLRLDENQQIAQVVFITQPIGNLYPEE
KLSKEERLFKEFIWRGKERISHQNEIFSEEAQKIAPKPIEAFKTPEENDVEEIKKTKERN
ESNPID
>OBAHECAF_00003 hypothetical protein
MNRFFLILLFLGGYVAKAQQTNLSDTLKISTVEDKKEVRQVTWNTDPLSPARAAFYAAIL
PGLGQAYNKSYWKMPIVYVAIGTPIYFYIANTREFNRYQAAYKRRAAGFTDDEFYGNRPD
GQPRLSTDGLRRAQQFYRRNQELSLLITIGLYALNIVDANVDAHLKQFNVDEKLSFEPFI
EINEFTAQPQFGLSVQVRF
>OBAHECAF_00004 putative chromosome-partitioning protein ParB
MAKAFKKQALGRGVSAIFGNSPENDINSIADKNAEKVVGNIIELELDSIEVNPFQPRTSF
NEEELQGLASSIEELGVIQPITVRKIGVNKFQLVSGERRFRASKLAGLQTIPAYVRIADD
NESLTMALVENIQRQDLDPIEIALSYQRLIEEINLTQDQMSKRVGKKRSTITNYLRLLKL
APIIQTGIRDGFISMGHGRAIITIENPEVQAEIYQRIISDNLSVRETEDLVRKLQNPEIN
TTENNIVGIEIPKPQIENNKGTTPSYVLESMDTFDRFFGTKVSVKVAKNGKGTLIIPFSS
EEDFRRIQRLLNRE
>OBAHECAF_00005 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSVNLAASLGVLEKKVLLIDADPQANATSGLGVDVESVEHGT
YELLEHTIPAKDMIIKTESPNLDLIAAHIDLVAIEIELVDKEQREYMLKKALEPIRDQYD
YILIDCAPSLGLITLNALTAANSVIVPIQCEYFALEGLGKLLNTIKSVQKVFNPSLDIEG
LLLTMYDARLRLSNQVVEEVQKHFSDMVFKTIIQRNVRLSEAPSFGETIINYDAGSKGAT
NHLNLAQEIIEKNKA
>OBAHECAF_00006 hypothetical protein
MMENNQNNEHTLKESPKSIFVQIKDFLADLMNIHEQTDKEATIESIKADISLKGHTSWIL
ICAIIIASLGLNANSTAVIIGAMLISPLMGPILGMALALAMNDVDLLKRALKNFGVMVVL
SVVSAFTFFYIFPLSNTSSELLARTAPDIRDVLIAFFGGLALVIARAKKGTMASVIFGVA
IATALMPPLCTVGYFLSIGDFKLASGALYLFLINTFFIALATFLILRIIKIPMVVYANSS
KRKRISQMAYFVSTLMMIPAGYTFYGVWKESKFEIDANRFIKNSIEVYDFGEKGYFLKDF
SKANYNDGNPYIELVFFGDVSISPEVRVLWENQKNGYSYLQNTQLRILSDNENKDQSGYI
AELYNTNKEQLASSQGEIKLLQSKLESLNKYMREASKFDQISKEIAAKSDLIASVSFANE
LRSNFKKTDTIPVFRFEWEKDVDESTKKKELEALEKWLKVRLNTQKIEIK
>OBAHECAF_00007 Nucleoid-associated protein
MFGDLMGMMGKLKETQQKIEETKQRLNHVLIDETSSDGSIKVTITANREIKSLEISDSLL
EDREQLEDYLVLTLNKAIEKATQINETELAAVAKQGLPNIPGLF
>OBAHECAF_00008 Tetraacyldisaccharide 4'-kinase
MIQLLRYMLFPFAVLYGIVVRVRHLAYDKRVLKSVQFEIPTICVGNVSVGGTGKTPMVEY
LIRNLQENYKIGVVSRGYKRKTKGLVMADTTSTVYDLGDEPFQFWKKYPKISLVVNADRA
SGISHLLDLPQPPEVILLDDAFQHRKVEAKINVVLTAYGNLFTDDWLLPTGNLRDVVSRV
QQADVIVVTKCSPHISQQERKKIATQIRQKEHQSVVFATIAYGEKVISANQSVYLEEFIK
LPFLLVTGIANPIPLLNFLNKCGATFEHLNFADHHHFSETEIEKLKQYPRVLTTEKDYVR
LESRLSDIFYLPIETVFIDKTEEATFWKILDLQRKS
>OBAHECAF_00009 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MSRKNKNIIFENVEVIDAGAKGKSVAKAPDGRVIFLSDAIPGDVVDVQTTKKRTAYFEGF
VIKFHKKSDKRTEPVCSHFGYCGGCKWQNMSYQHQLFYKQKEVENNLKRLGRIEIPEMQP
ILGVENPYFYRNKMEFSFSDTRWLTPEEIKKMETIDNRNGLGFHISGAWDKILDIDTCYL
QEDPSNDIRLKIKQFAIENEMPFYSPRQQTGFLRSMMIRITSIGEIMLVIQFFEENRKMR
EQLLDFIIESFPQITSLQYIINGKQNDSIYDQEVICYKGRDCIYEEMEGLRFKINAKSFY
QTNSKQAYNLYKVARDFAELKGNELVYDLYTGTGTIALFVAQKAKKVIGVEAVPEAIADA
KDNAKNNNISNVSFFVGDMKNVFNEAFIEENGTPDVIITDPPRDGMHKDVVTQILSIAPP
KVVYVSCNSATQARDLALMDAMYKVTKVQAVDMFPQTHHVENVVLLEKRI
>OBAHECAF_00010 Peptidoglycan glycosyltransferase MrdB
MKQSLIKNLDWLSVFCYILLVSIGWIAIFSTTYNEAEVTSIFDLDQFYGKQTLFIGLGLL
LIVFILAIDSKFYENFSFVFYLISLALLAGLFVLGKKTNGALSWYAIGSITVQPSEFAKV
ATALFFSKFLSDIHTNIQNFKDLFKAILILALPAILILLQPDVGSLLVFFSLTFVLFREG
MHVALLFYMVLVAIVFIITLKFGVLFAVIICLLMIGFYGFWYKRRTNRIPFQNIFILLLV
CLLTSFSTSIVFDSVLKQHHRNRLSLWLRMEQDPQKISEMRRDFGYNTYMSESAITSGGI
FGKGFLEGTRTKGSFVPEQHTDYIFTTLGEEWGLVGTLTVIVIFTFLLLRLIILAERQRS
KFSRIYGYCVASILFMHYCINIGMVIGLIPTIGIPLPFFSYGGSGLWAFTILLFIFLRLD
ANRVNDWIK
>OBAHECAF_00011 hypothetical protein
MRRNRIYQSFEEIESDLKILRLKKEIDWLQLKNSTSNFTDSLAPKNLMASAFSNVGGSFF
KPKSRWFGLILNYALYYFFKKK
>OBAHECAF_00012 hypothetical protein
MNNIKEAFKELPDRGNEALETNVSYYKLFVFRFIAKTSYGLLSILVLGMISLLVLFSLSF
AFAYAIGIWIGNIALGFVVMALFYCLVMCIAYLFRKKMIERPLLKTLSEVYFKAGEEDEE
K
>OBAHECAF_00013 hypothetical protein
MAKTGNVLLALVTGVAIGAGVGILFAPDKGKNTRKKIKDSVDDTTHMLKEKIDNLTREVK
SKTTEIKGSLEENMDRVLSKSSYKAEDVITFLEKKLAALKEANAKLQK
>OBAHECAF_00014 hypothetical protein
MSVIIQGDKDIAIEDVPSTLAKALRINLNENIYGTFAEIGAGQETVRHFFRAGAASGTIA
KAMSAYDKEVSDAVYGVEEDGRYVTESRLKKMLDYEIKLIETRLTRNNHPNKVFFSYANT
VATIDFSKRYKGHGWVGLRFQTKPHGAYNEIILHVRFHQTEARAQQETLGILGVNLIYGA
FYKTSKPKKILKYLYDHIDKDLIEIDMINFSGPDFEDVDNRLMSLQLIRNGMTEAVMFGP
DGNNILPAEHLYKKNVLTLRGSFRPVTKVNMDMYQKSLEMFLAENKVNPSRTEVIFEITL
SNLIAEGEIDEQDFMDRAKLLCSLGQKVLISNFKEYYRVVEYFSNYTRMRMGLAMGVNNL
IAIFDEKYYRHLSGGILEAFGKLFYRDIKIYLFPMKDPETGQIITSENLRVHPRMKELYK
FFKFNGKVVDIEGYDEAHLNIFSREILSMIERGETNWEELLPGGVSEIIKEKQLFGYKPQ
KTEC
>OBAHECAF_00015 Ribonuclease BN
MKIPIFVVNFFTLRVIFLGTGTSQGIPVIGSNHPVGLSKNHKDSRLRTSALISWDNINLL
IDCGPDFRQQMLTHKINHLEAILFTHEHADHTAGLDDIRPFVYQQGDMPIYALPRVISEL
RQRFNYIFSTENRYAGAPSVAVNEVNNESFEFYGKTIQPIHVMHGDLPILGYRIENIAYI
TDAKKIINNELDKLHGLDLLVLNCLREEIHPTHLNLDEALEIIRIVQPKKTYFTHISQTF
GFHDEVSKKLPENVFLAYDNLILNNI
>OBAHECAF_00016 5-formyltetrahydrofolate cyclo-ligase
MDKKELRNYYKQLRAGFSEEEREQKSLQIANQLLRMPIWDRENYHIFLPITRLFEINTEY
ILHILHGKDKNIILPKMDGDVGLLKHILLTEQTILKQNHLGITEPCNGIEVQPAQIDVVF
VPLLAYDQKGNRVGYGGGFYDRFLSNCPVTTLKVGLSFFLPELKIEGVFSTDIPLDYCAT
PDGFFRF
>OBAHECAF_00017 Serine/threonine-protein phosphatase 1
MRILVIGDIHGAYKALIQVLERVNIQDQDKFIFLGDYADGWSQTPQVIDFLIDFGKKYDC
TFLRGNHDDLCLDFLSGKSMEKMWYFHGGDATEKAYESIPEETKQKHIDFLKKLSNYQLD
SQNRLFVHAGFTNLRGVEYEYFPKAFYWDRTLWELAISVEMSPEQIRYPNRLKLYSEIFI
GHTPTVRFETDKPMSANNVWNIDTGAAFKGRITVMDINTKEFWQSNPVFELYPEEMGRNK
>OBAHECAF_00018 hypothetical protein
MINKRLLIKNLLAHSDENSFYDRKRFINLSDREGKAKFLKIVCALANSNPYNNAFIIVGV
EDESRLIFGVDFFDDSHIQNLVNSYLENPPSVMYENIIFPDIAENKVVGLVTVRSSQKIC
SLSKGVWKYPKGTIFKREGSNSKIVDKTFKISDVNLKTVRQIEKLSSNNIQHTLDATIHF
LNHRHKDLQAFYHVFREQFVLCYAGKPERVDGKLFYSRVDIELINEQVQLFFSALDLVEI
HIQANSFQITEYIELATDFSQKYHPLETLTIEFFNNGTYKIHQKLVFIPPAYNLEKSALL
WDEYMPIVKNIIEGNDLNNSSLNKLKLLPSTFLTCYLSGYIQAKELLEEARFKYREIDRE
SYPALKRTLRIMRKLKYNTHR
>OBAHECAF_00019 Glutamate racemase
MKKQAPIGLFDSGVGGTTIWKEVVALMPNENTLFLADNKNAPYGGKTKDEIISLCEINTE
CLLNNNVKIIVLACNTGTTNAISYLREKYRHIPFIGIEPAIKPAALGSVTKKIGVLATQG
TLTSELFQKNSNSLAQNNGIEFIERVGEGLVKLIESGKINSPEMTILLKKYLYPMVEEGI
DYLVLGCTHYPYLLPQIKQLIPENIQVIDSGYAVARQTKNILSQNQLLNGATEKPKHRWL
ANGNIEILKEFAPDRNDLEISML
>OBAHECAF_00020 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHGANLMKALIAKDSSADIRFWGGDKMKSVAGTLVKHYRDLAFMGFW
EVITNLKTILKNIAFCKKDIQDFQPDVLIFIDYPGFNMRIATWAKKQGFQTHYYISPQIW
AWKENRIKAIKRDIDFMYVILPFEKDFYEKKHAYPVHFVGHPLLDAIANREPIDPHAFKV
ANNLDQRPIIALLPGSRKQEIAKMLSVMLSVVDYYPDYQFVIAGAPSQDYGFYQQFIKNN
NVYFVSGKTYDLLSVATCALVTSGTATLETALFNVPEVVCYRGNWLSYQIAKRVINLKYI
SLVNLIMDKPVVTELIQEELNTKNLRFEIDKLLTPTHRDKLLQDYMDLRNQLGGSGASQK
TAELILSNRIKER
>OBAHECAF_00021 hypothetical protein
MKILDRYILTQFLKNFLGTLFVLILIFMFHTLWTYIDDLAGRGLEMWIIAKFLIFFIPQL
IPIILPLAVVVSSIMTFGAFAENYEFAAMKASGISVQRAMRPLLVFMGFLSLFTFFLVNV
VIPVSYTELFDLRRNIAKVKPAMAIAEGIFSDIGDDISIKVDKKSGKNDEFLEKVVIHKK
SPDRVNRTVIIAERGELKNVKNSDFLQLILEDGNYYEDIKTQTYAQQQRFPFAKVHFDKY
VINIDLSHLNNVDFNEKTNITTYRMMNVGQLNYAIDSLRNDFKQHIADHGGSMMRRTGIF
LPEKNIKTSENNNVEDISELLNLFEAHKKRQIWDMAVSNAQSQYDNLDFRQRDIEYRYKT
LNLHILNLSDKFALTFSCFVLFFVAAPLGAFIRKGGLGLPFVVAMVLFLSYYFISLFVKN
IAENNTVSPVIAPWFSTLILLPLGIYLTIRVTTDKGLFQFEKLHKLFDFLKRKQQSNKR
>OBAHECAF_00022 Outer-membrane lipoprotein carrier protein
MKKIIISIITLCSFVAQAQNANKAKTLLDEVYNKMISYDNIYIEFRYNLDNISENINQEI
KGNVTLAKDKYVLNYMGATKIYDGNKSYTIIPENEEVVIESTSEEETSITPSKMLTFYRK
GYTYKWDIEQNVRGRKIQYVELKPQKASDVKQILLGIDVQTKHIYNLIEIGKNNTKTTIT
VNTFKTNQPIPANLFKFDKEKYKKEGYYISEL
>OBAHECAF_00023 DNA translocase SpoIIIE
MSQKKQKDSDKKTKTKTDKGKQRKLIFGVVLTFVSLMLIVAFVSYLFTWQTDQSVWLALG
DRQQEAQNLVSKIGAFLGHFFIYKGFGIAMFIPAVLAFLTGLKLSFGLRMPLFNRWFWGI
LWMIFIATFFGFFSGKASILGGISGYEINHFVQDYIGVFGTALLLILFLLLYAILKAELT
PEKVSKMFQTVFTKINQVKISDTLSPSKLVKKVAVPANPEENNDDFLKSTDVNNEKIFID
NNKPDEKLDVFTHKKEIPFLTNEENEENFFITNTPSEELDLQVEKPKQSEEVDPELLAKK
LVENYGEYDPRLDLSDYRFPTIELLNEPKESGIIINQEELEENKNTIVQTLRDYKIEISQ
IKATIGPTVTLYEIVPAAGIRISKIKNLEDDIALSLAALGIRIIAPIPGKGTIGIEVPNK
KPTTVFMRSMITSPKFQHSEMELPVAFGKTISNETFVADLTKMPHLLMAGATGQGKSVGL
NVVLTSLLYKKHPAEVKFVLVDPKKVELTLFNTIERHFLAKLPDSEEAIITDNKKVVNTL
NSLCIEMDNRYELLKNAMVRNIKEYNAKFKARQLNPNEGHRFLPYIVLVVDEFADLIMTA
GKEVELPIARLAQLARAIGIHLIIATQRPSVNVITGIIKANFPARIAFRVTSKIDSKTIL
DGSGAEQLIGRGDMLYTQGNEPIRIQCAFVDTPEINHITEYIGAQKAYPDAYLLPEYVGS
ESEATELDFDPADRDKLFREAAEIIVNAQQGSASLLQRKLSLGYNRAGRIIDQLEHAGIV
GPFDGSKARKVLVSDIVSLENLLNGR
>OBAHECAF_00024 Thiol peroxidase
MATITFKGGAVHTQGELPQVGAVAPDFKAVKTDLSEVSLQDFKGKKLVLNIFPSIDTGVC
AASARRFHQEVAALDDVVIACISKDLPFAFSRFCAAEGIDDLVMLSDFRGEFSQNYHVTF
TDGPLKGLLSRCIVVIDEKGHVIHNEQVAETANEPNYAAALAKL
>OBAHECAF_00025 hypothetical protein
MQLIMKTQILIFFSLISSHIVVAQKYISLEELNSKYDVKEYNFSLSSFGIERAFEVYNIE
RGEDLLLITILPDLKDGYDWIEVQKSELQEENFVSYRYLIDKLEVNNNLSNKYFLVKKIG
DQIFRARLTNLQLFKIVNLSDEDIQISGKNVLNLGGKQITKEQVYIKYKKQFPDKVFLFE
NGFGIPSYLESVYLYDVQLINNEQVYFFWVFNTYGGIGNLAYVKGKGIVAGRYPYYFSLK
TGGKIAVSNEPSYLLRKVWDKNDAENKMMWAKELFPERQ
>OBAHECAF_00026 hypothetical protein
MKKQLKLLGIAGLLLSVTSACQREEGLITETTLHGEDYETVNLSEAKELFNQVEKGKLEK
RKVNKNGYFLALTPNWGSFEQNKDLTDKNYSKVETTLFESNVKGEILFVKENDSIKQFLF
MTRIDSVSAKGEIYNARLYFFETTGELVDAYKMENQIITKRWGVTQQKGLTARGVSECGR
IHKKIVSEIDDWEIGCNRGGGGNNPWGPNPFTFDGVNELYEVTVTAERWNPFGDKDLLFI
NQIYTRATQNHHQADAFENNRNLSGVGGTIIRGYIAKRKLDSKDHIIDELKNPCAKDLLK
QLPNLKNDIAKLLKETFGGDSKYDITFTEDEKLRGTNIDGQADAPNATKISEDEIIFRGN
IYLNPDILENATQEYILVTMYHEVVHAFLNYEQTRLRGELLPNEKYDNSEFERKYPGVKE
IEVEYGNKNKVKKYQLLQEQGHNRFAPFIEKLAQSIISFNPKIPLKTARAMAKMGIVDEK
SMSNEEKQLSGYQRKGTDPKGTKCN
>OBAHECAF_00027 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MLEMKVPSPGESITEVEIARWLVKTGDYVTKDQAIAEVDSDKATLELPAEASGIITLQAE
EGDAVKVGQVVCLIDTSATKPTEGVAKAETKKEGPKKEEIKPVAASVAEKTTYATNAPSP
AARKILQEREIPASSVKGTGKDGRITKEDALKASKPSMGTPTGGLRTETRAKMSMLRRKV
AERLVSAKNETAMLTTFNEVDMTTIYELRSQYKDAFKDKHNVNLGFMSFFTLAVVRALKM
FPDVNSMIDGQEKVTYDFCDISIAVSGPKGLMVPVIRNAENLSFRGVEAEVKRLALRARD
GQITVDEMTGGTFTITNGGVFGSMLSTPIINPPQSGILGMHNVVDRAVVKNGQIVVAPVM
YVALSYDHRIIDGRESVGFLVAVKEALENPVEILMNGNIKAALEL
>OBAHECAF_00028 hypothetical protein
MSRSFYIKNTEAPRVMSPNEILSLQPPTFIQYDVHDEEEHFLDVMNSPIDHYGSMLMGEE
FVSGRGFEVCYQAELDSYQVRVFTPSTKADWQGAFEFMVNLARYLGVQVVDEEDTTYQAD
SITYDYLRDIEFGIQCYEGREGQYIFGVNYPMCLNEEMIDRLLSADDKATYFSEMVEAHQ
YVDAYFAKQRFYESSLDKNEGIIGVYALTEDLPTILPYEYPPFIDITKISLNQEDISRWR
ISLVTIEGDEDDPNSYKVMGDMDFKTFLERLPEEKIEKLDGHYMIVELSKSDMQDIIYQK
SETSSLFGKIKNLFNNN
>OBAHECAF_00029 hypothetical protein
MSDLDKIVAIFPVVFMLHDFEEIIGFESWLKNNREELARRFPRIEKRFDKGGMFLLSTST
FAFAVCVVFVLVSLMSFISLYLGIYQWWFVVFSAFFVHLFIHIGQWIVYGKYIPAIITSF
LSLPYCFYAFYVLFEYSDFSVAEMLFWMFLGTILMLIIVPCVLNLAGRLQKTLS
>OBAHECAF_00030 hypothetical protein
MKEIKFFNFGNVRSFRFWLFVFSGIAMVMLLLERFFLEDSILRPYIRVSAYLGFALYYLT
PFLYRNSVEWNKRGITLKLNTLVFSRTFSFEDIKSVEFLEKELRVTRHDDVVRRLDLTGI
TPESIERLKAVFQQHYVKFRVEQDFQEPIIC
>OBAHECAF_00031 2-oxoglutarate dehydrogenase E1 component
MDKYSFLNAASTAYFGELYEKYLENPDAVEPSWRAFFQGFDFAQENYGGSYDQTVQVMAQ
SVDTGNSVASEKLQKEFKVLNLINAYRTYGHLFTKINPIREREAYVPNLNIENYGLSNAD
LDTTFDSAKEIGLQPTSLRNIISALNDIYCRSIGVEYTYIREPEIRKWIETRLFSNNNKT
QFSKEEKIQILKKLNEATSFENFLHTKYVGQKRFSLEGNDALISGLDFLIQSAAEQGVEH
LVLGMAHRGRLNVLANIFNKNPQDIFSEFDGKDYEMEDNFDGDVKYHLGISSELVTKSGK
KINVNLAHNPSHLETVGAVIQGIARSKQDRLTAGDRSKVLPIAIHGDAAISGQGIVYEIM
QMCQLDGFKTGGTVHIVVNNQVGFTTNYTDSRSTTYCTDIAKVSSSPVLHVNSDDAEAVV
HAFLFALDFRMQFGSDVYIDLLGYRKYGHNEGDEPRFTQPKLYKIIGKHDNPRNIYAKQL
IEEGVITNDFVAQIEMDYKSVLDMHLENSRKENLTVIKPFMQDEWKGFEIASRQKMLEKF
DTSFDRKDLDELAKIITELPADKKFINKITKIISDRKEAYTNDNIDWGTAEHLAFATLLS
EGFDVRLTGQDVERGTFSHRHAVVKTEDTEEEITLLNELKKHDKFNKGSLHIYNSLLSEY
GVLGFEYGYALASPNTLTIWEAQFGDFSNGAQIMLDQYISCTEDKWKNQDGVVMLLPHGY
EGQGSEHSSARIERYLQLCSDKNMYVANCTTPANFYHLLRRQMKTNFRKPLVVFTPKSLL
RHPQVVSKAEDLANGHFQEVIDDPIADVNNVKSVVFCSGRFYYDLYAEREKLGRNDVALI
RIEQLFPLPVEQIKAILSKYKNADDYVWAQEEPKNMGAYGYMLMFFDFIQWRLASNTVYS
APASGSHTRDRKRHAEAIAMVFDRKADAKKNF
>OBAHECAF_00032 Cell division protein FtsX
MARSIDIFNRRRLITSYFSVTISITLVLFLLGLLGFLLLSTQRLANYFREQVSVTIFLSD
DAKMADIEQLQRTLSVAEYVKSLQFISKEEAAESFSEEIGEDFVTFIGDNPLHNSIDLSL
KAAFAEPEKMKELEKELSQHSFVSEVVYDKSLITLIHENVNRIGLILLIFSGLFTFVAVL
LINSSIRLSIYSKRFIIKTMQLVGATRGFIRRPFIWTNVRLGILSALFAMGLLYGCLRYI
YIKFPEFHILANTNDMVIVFTSIFAIGVLISWISTYFAAQRFLNLNTNDLYY
>OBAHECAF_00033 hypothetical protein
MEEERKHHSELIFGRKNYIVMAIGLAIIALGFILMSGGGSSDPNVFDASIFDSQRIHVAP
TLVLIGFAVEIYAILLNPNKKKN
>OBAHECAF_00034 Undecaprenyl-diphosphatase
MSVIEAIIIAIIEGLTEYLPISSTAHMGFTASLLGMNSDDEFLKMFQVSIQFGAILSIVV
LYWKKFFDFSNLNFYIKLGSAVVPALVLGYLFDEKIESVLGNQQVISAVLILGGIVLIFV
DQWFKNPVIFDEKDISFKKAITIGFWQCLAMMPGTSRSAASIIGGMTQRLSRKAAAEFSF
FLAVPTMLAVTVYSVFLKTWGKNTATPQKGYEMILATAENTQVFLLGNLIAFVVALIAVK
TFISVLTKYGFKFWGYYRIIIGIVLFIYFTYYGK
>OBAHECAF_00035 hypothetical protein
MTLLKYIYFLAKSTNQHGVHSPFVYDFITKCLYSRKKIDEKESYSATIEGINPKQYNLLL
KSMRYFGVKTVFVDSENLKNAILGAGIDVSVDVKLKDNQKYDIIFLQNISQPSNITSLLT
YMHNNSVLIINNLYKNTPTLAWQEFTSHPQVTACINIFTQGYIFIRNEQGKEFFYIRV
>OBAHECAF_00036 hypothetical protein
MARDEQLKSRWEHICRELSKTFGNGEILDVDDIIYLVGLQEFGKFHRKFKKDDKINLMHI
AICKLLEPYGYYRFDFVDPDGWPHYTLVEELPPLKAGEQSILMKEAIVHYFEKNGFFD
>OBAHECAF_00037 hypothetical protein
MYPYHNKIKQRINNGELIKYEFVEKYKNISPCLLLYFRTEPFVRPVREHRFEEYKQILDG
FEKNKTVENHID
>OBAHECAF_00038 hypothetical protein
MKIVISPAKSLNFERNIPTKEHTQPVFPEKIATVNATLKELSPKRLADLMHISDKLANLN
WERNQAFSLPFSLENARQAVYVFDGDVYDGLDVYSLDSKEVERLQFSLRILSGQYGILKP
LDLIQPYRLEMGTKISIGRAKNLYDYWKESVTVFLKEELDSNELFVNLASNEYFKVIDYK
QIKNQLITPIFKDWKNDELKMISFFAKKARGLMVRYLIKNNIQTLDELKGFDYEGYRFSQ
QHTTNINEPVFIR
>OBAHECAF_00039 Phosphoribosylformylglycinamidine cyclo-ligase
MEVSKRYAQRGVSASKGDVHNAIKNIDKGLFPKAFCKIVPDFLTHDPDYCLVMHADGAGT
KSSLAYLYWKETGDLSVWKGIAQDALIMNIDDLLCVGAVNDIMLSSTIGRNKNLISGEVI
SAIINGTEELIEELKAHGVTIHSTGGETADVGDLVRTVIVDSTVVARMKRSQVIDNANIK
EGDVIVGLASFGQASYEKEYNGGMGSNGLTSARHDVFAKYLAINYPESFDASVPADLVYS
GSKKLTDTVDDAPINAGKLVLSPTRTYAPIIKKILEKYDVSQIHGMVHCSGGAQTKILHF
VDNLHIIKDNLFEIPPLFKLIQQESKTDWKEMYQVFNCGHRMELYVPKEIANDLIAISES
FGVPAKIVGRVEKSESKKLTIHSEYGVFKY
>OBAHECAF_00040 hypothetical protein
MRTNFVIAFNKMTAKSKTIKYLKSFYVKDYLIIVLGLTIFTLGITGFILPNKIVTGGLSG
VSAMIKYATGIEMWITNLVINTVLLAIAFKAVSKQYVLRTLIAVGILSLMLSFGETYLQP
YFTAHPPVGEPFLSAIVGGLFCGTGLGLCFSVNGSTGGTDIIGALVTKYFNIRLARILLI
VDISIVISSYFILGGDGKALERTIYGLILLPLMWQMVEMVINGARQSVQLFIFSKHYEEI
ANHINSEIKRGCTIVDGIGWYSKTPMKVIIVIARRTESTSIFRLVGSIDPEAFITKSNVM
GVYGKGFDKLK
>OBAHECAF_00041 Riboflavin synthase
MFTGIIEDLGTITHIEQEQSNLHLYVKSRFTSELKIDQSVSHNGVCLTVVDIQGDTYKVT
AIQETLNKTNIGQLRVGDMVNLERGMLLNARLDGHIVQGHVDQTGKCIGIKDENGSTRFT
FSYSSENGNVTIEKGSITVNGVSLTVVNSIENQFSVSIIPFTLQHTTFKELQIGSIVNLE
FDVIGKYVAKLMNRA
>OBAHECAF_00042 hypothetical protein
MPRVYYRDRKINGKPFKNEKITLPLFDYILSKTTFIPDDGMHIFELPQKTSILPWKRNEK
GFKYAVVWNNDRIHQTHEYGDFYLPKSIVFFDVKDAYFPSEYFFIVEINRQLEISHCRAG
IDTTWFQQPELRRDITDSKIVKRIEKSVIELQMILNNM
>OBAHECAF_00043 Phosphoribosylglycinamide formyltransferase
MRKIVIFASGSGSNAEQIVAYFNKENTAKVSLILSNNLNAGVLNRAKRLKIPSLVFDRQA
FYHTNVVLDILKNEAPDLIVLAGFLWKFPEHIISEFPNRIVNIHPSLLPKYGGKGMYGNF
VHQAVIDHKEAESGITIHYVNENYDEGAIIFQAKTEVSTNDTAETLAQKVHLLEYEYFPK
IVEQLLEQN
>OBAHECAF_00044 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MSNTIPWQERPAGSTDVMWRYSENPIINRYDIPTSNSIFNSAVVPFKDGFAGVFRCDNKA
VQMNIFAGFSKDGIHWKINHEPIEMKAGNTDFLHSEYKYDPRVTFIEDRYWVTWCNGHHG
PTIGIAYTFDFQEFFMCENAFLPFNRNGVLFPEKINGKYAMLSRPSDNGHTPFGDIYISY
SPDMKYWGEHRCVMKVSPFVDSAWQCTKIGAGAVPIKTSEGWLMFYHGVINTCNGFRYSM
GAALLDLENPSVVKYRTKPYLLAPATLYETTGDVPNVVFPCAALHSLEEDKVAVYYGAAD
TVVGVAFGRISEIIKFTKENSL
>OBAHECAF_00045 hypothetical protein
MKHLFYSLFLILTVSCSKSDTSDYATESSEKGIIGKWRLVEVHSSDGTPQVNKVDVSSEN
YVVVFDANGNVESVDFPCVGKYNFDSNASGNLGNNLVVTFDKCKSNKSFSYSINGLANAR
ISDYNYLILNVANCDEPCTRVYRRLK
>OBAHECAF_00046 putative peptidyl-prolyl cis-trans isomerase
MQTMKLITLFFTSLAFFSCKSQKNSKLGDGLFANIQTSKGDIVIKLHYDQTPVTVANFVS
LAEGTNSFVKAEYKNKPYYNGTIFHRVIKNFMLQGGDPTGTGMGDPGYRFEDEFVEHLKH
DKKGILSMANAGPATNGSQFFITEVPTPHLDGRHTVFGETVQGFEVIDTIASVPTHQADR
PKEDVKINKITFIRNGKDAKKFDAKATIEEYFSSLEKRAKEKEAALQALKTQFLTEIAQQ
KSEAKKYPSGIQVFSLKKGEGVKPKNTEQVLVSYAGYLTDGTLFDSNIKSVEEAYQKYDP
ARERGKGYEPFPVPYNTSAGLIPGFREAMLTMNVGDKVRVFIPSALAYGEAGAPGVIPPN
SDLIFDIEISGIVK
>OBAHECAF_00047 hypothetical protein
MRNIYVFLICVVFLVSCGEKQARRPISVKTTNTFLKESAKKNKLLLQAEEAIIDSIIKKD
TLNTYVDSQHGFKFYYTNQNPESDYTASFGDVVTYDYSISDLEGNEIYQEKQDGEYTYHV
EKEELFFGLRSALKILKEGESGVFFFPSETAYGYRGDKNKIESNQPVIAKIQVFKIEKAK
EKMEQNQTIAPKNTEH
>OBAHECAF_00048 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MNIHDIESTKLLLKKQSKISIIPHKNPDGDAIGSCLALYHYLKLKNCDVTVVSPNDFPSN
LKWLPDAETILIYDNQPEKAREQIKKSQLIFTLDFNSLKRADTLTPLLETSKATFVMIDH
HEEPDGYAQIAFSNPKASSTCSMVCSFIDAMGDQNLINKTIATCLYTGMMTDTGNFKYAS
TTSSTFKKASFLIEKGADNSQINNNVFDTNSYNKLQLLSIALKNMVYLKDYDTAYITLSA
EELAQNDAQKGDTEGFVNYGLTIKDTKLAVIFIQEKDYVKMSFRSKNQYDVNAFARKYFK
GGGHVNAAGGKYNGSIEEAVAFFKEVLPEIIKKRY
>OBAHECAF_00049 Glycosyl hydrolase family 109 protein 1
MTKSVFNLAVAPIENLSIGFIGVGIRGVEALKRYMCLDVHISTICDIYPEYIEKAKKITE
KQSVAPVFLSGKEDWKKLCQLPNLDLVYISTPWEMHTEMAVYAMQQGKHVAIEVPLAMTV
DDCWKIVKTAEATQRHCMMLENTCYDNFELMTLQMIQKGLLGEIVHGEGAYIHDLRRLNF
QQNDRDTLRGEWRMKYSQTHNGNPYPTHGIAPICQAMNILRGDNLTRLVSMSSLAIGMQR
YAENTFGKDSPQAQVQYTGDMNLTLIKTALGKTILLQHDATSPRPYSRIFLLSGTDGFVQ
KYPTPQIYFDKRATPQLSTHEMELYMQENEHPFVKQTAYLRELLPDQKPMDIIMDYRLVY
CLKNGLPLDQNVYDGALWSCITELSELSVQNGNIPVEIPDFTKSISH
>OBAHECAF_00050 DNA topoisomerase 4 subunit B
MENIQYTEDNIKSLDWREHIRMRPGMYIGKLGDGSSSDDGIYILLKEVLDNCIDEFVMGA
GKTIEVKISDNRVDVRDYGRGIPLGKVVDVVSKMNTGGKYDSRAFKKSVGLNGVGTKAVN
ALSTYFKVESVRDNQSKSAIFEKGILLEESPVEESNKRRGTNVIFIPDESIFKNYKFRNE
YITRMLKNYVYLNPGLTIHFNGEKFYSENGLKDLLNDNNNEEDFLYPIIHLKGDDIEVAI
THSRTQYSEEYYSFVNGQNTTQGGTHLTAFREAFVKTLRDYYNKSYEAADIRKSVIAAIS
IKVMEPVFESQTKTKLGSTEMGEGMPSVRAYINDFIGKHLDDFLHKNLEVAEEIKKKIEQ
AERERKELAGIRKTAREYAKKASLHNKKLRDCRVHLTDSKNSRNLETTLFITEGDSASGS
ITKSRDVETQAVFSLKGKPLNTYGMTKRIVYENEEFNLLQAALNIEDSIDDLRYNNIVIA
TDADVDGMHIRLLLITFFLQFFPELIKEGHVYILQTPLFRVRDKQQKIYCYSEEEKQNAI
KKLKGKPEITRFKGLGEISPDEFKHFIGEDIRLDPVMMDKTIHTDQLLDFYMGKNTPDRQ
EFIINNLRVEVDMADER
>OBAHECAF_00051 DNA polymerase III subunit alpha
MYLIFDTETTGLPKRWDAPFTDTDNWPRAVQIAWQLHDRMGNLVEHQDFLIAPDDFNIPY
DAEIVHGISTELAQSKGVPIQVVFEKFNDALKKSQYVVGQNIGFDINIMGAEFLRYGVES
PLTTTPILDTCTEITAELCKIPGGRGGRFKLPTLTELHEFLFGIPFAEAHNATADVEATT
RCFFELIRIEQGFSKEFITPEYVSDFQKHNPTEIHPIGLKHINLKEASDKIRQSQKTEGG
LTEQQIEANIALLEDAPFAHLHNHTQFSVLQSTTSISDLVKKTAQEKMPAVALTDSGNMM
AAFHFVKEVAGYNKSAEAKNKQAIENGEQPTEITIKPIVGCEFNVCEDHLDKSHQDNGYQ
IVILAKNKKGYHNLAKMASIAYTQGYYYVPRIDKKIVEQYKSDLMVLSGGMNGEISSKVL
NIGQKQAEDALLWWKEQFGEDFYIEIMRHGQEDENRVNITLIELAKKHHVKLIATNNTFY
INQKDANAHDILLCVKDNEKQATPIGRGRGYRFGMPNEEYYYKSTEEMKALFKDLPEAIL
NISEVIHKVEPYGLGRDVLLPKFDIPAEFTVEDDPDGKKGENNYLRHLTYVGAEKKYKQG
ITDEIRERLDFELSIIEKTGYPGYFLIVQDFIAAARNMGVSVGPGRGSAAGSAVAYCLGI
TNMDPIEYDLLFERFLNPDRVSMPDIDIDFEDSGRQLVIDYVINKYGANQVARIITYGTM
AAKSSIKDTARVLAVPIEESNRLAGLVPDKMPSLKKIFNADDKTLKEKIRSEDFPKVNEL
KQLLEGDDLSSQTIQQARVLEGSVRNTGVHACGVIITPDDITNFVPISLAKDSDLFVTQF
DNSVVESAGLLKMDFLGLSTLTLIKDTVEIIKLRQGIDLDPEEFPLDDKKTYELFQRGET
VGIFQYESLGMQKYMKELKPTVFADLIAMNALYRPGPLEYIPSFIRRKHGTEPIVYDLEA
MEEYLKETYGITVYQEQVMLLSQKLAGFTKGDADTLRKAMGKKQKDVLDKMKPKFISQAA
ERGHDPEKLEKIWRDWEAFASYAFNKSHSTCYAWIGYQTAFLKANYPAEFMAAVLSNNMN
DIKQVTFFLEECKRMGIKVLSPDVNESFYKFTVNKNGDIRFGLGAIKGVGRNAVDTIVEH
RKEGMYTSIFDVAKRVDYKNINKKAFENIALAGGFDSFTKVHRAQYFHAEADGIPFLEKA
IRFGSKYQESKNSAQMSLFGGSSEVDVPEPIVPNCETWGNLEQLRREKEVIGIYISGHPL
DEFKHVIRQYCNLSLNQLSDLKPFVNREVNVAGMITDVKHNTAKNGKGWASFIMEDYDGA
YEFRLFNEDYLKFRNYLIPSTFLFCKFKVEEGWVKKDTNERGEPRIKFMEMIMMQDVLQK
MTKKVAFEFGVNDISEHTVHFFKENIAKFSGNCPVIYRIKSAEEKISISMDNPNQGVHIS
NEFLDALDKEKIRYLLNEREPKKLIDTKEDSKTVETEEEEEIHESLVDDND
>OBAHECAF_00052 hypothetical protein
MQIQTSKKLTWAPKADERERIDLIYYKGKGIKVLEAKLFGTDSSVCRSKPIKDDFQDTII
KPLGIYPSDHKGVWMKFKITPSKRSKK
>OBAHECAF_00053 Serine--tRNA ligase
MLQLTFVRENKDVVLNGLKKRNFKDLHLVDDIINLDEKRRATQAELDKVLAESNNISKEI
GILFKSGDTQKANELKAKTGELKDKSKTLSDALNEISENLNVLLYRIPNIPNELVPFGVS
DTDNEVVFQAGEVPNLGDKALPHWELAKKYDIIDFELGVKITGAGFPVYKGKGAKLQRAL
ITYFLDKNTEAGYQEFQVPHVVNEASGYGTGQLPDKEGQMYHVGLDDLYLIPTAEVPVTN
FFRDVLVSENELPICCTAYTPCFRREAGSYGAHVRGLNRLHQFDKVEIVRVEHPDNSYKA
LDMMVEHVKSILNELKLPYRILRLCGGDLGFTSALTYDFEVYSTAQQKWLEISSVSNFET
FQSNRLKLRYKDTDGKNKLAHTLNGSSLALPRVLAGILENYQTEDGIVIPEVLRKYTGFD
KI
>OBAHECAF_00054 hypothetical protein
MENKELQFKTNLNCGGCVSKVQNELDNALGKDQWSVDTDNPDKILRVNSDVSTEKIIEIV
KSKGFNIEFLES
>OBAHECAF_00055 hypothetical protein
MKERWMFSETGNINALKKSVSEKTMFFWIMTPKIQC
>OBAHECAF_00056 hypothetical protein
MTEKQILAKIEKWDKDNKVSAIIEFIENLPVQQKTSQVLSELGRAYNNFYWLMPSEENRA
YLQKAVSVFNYVKDDIPSQIWHYRIGYAYFFLDNIEKAKEHLSHASEGNGKDLLEFLKIA
EQKGLKPTEVAPQGALKFEFLFEKFIALIQEKAPALVSVLGKGASDTTLDAFEQRMGINL
PEDVRYFYKTFDGQTDNNVFFLNNAQRFISIQEVEELQKRWLSFVVNNYGKNWQDLTFSS
DDFFDDDIIKNQLFSQRWIPFLMQHNEQGNEEYLCFDFDSINEEDFGQLISVSLSDKLQS
YYVDYVSPNIWSWLYTTTKNIEEGFVVYDEKLNSLMFTTTDDFSAVYYTEDELDTLKNYI
SENIGQIDDVLPGLISSDIRCDIYIIKPTPERNYYTLITGGMGAFDMLVPQDHEGSTNAE
LMINLPPDWNVYGNDEKDFWPIRWLKTLAQLPIEQQTFLDWGHTIPTGEPLPDTPFTCLM
LIGSETKDRSNALVTLSTGRQVQFFTLVPLYEEEMLYKLQNMAEALIERFEAKAIPYPPV
VDVNRLNVCENFVPSENHAALDGVAWAFNKINYVGLMQFWDDVRAYNEYIEQDLDYFNPF
TTLFKTSKVKVIYEAWVRSEKDLLPFEEFVEPIDNIFNEYNEQNGFYQAEIIAELQSGDN
NSFGALELLWNIHNCLQNKELGDNIFFEGFEIEGYEDDITPVIYLCLGD
>OBAHECAF_00057 Cystathionine beta-lyase PatB
MEYNFDEINDRSKSDALKLEALQPRWGRTDLLAMWIADMDFKTPPFIVNALKKRMECEIF
GYTAKPQQWYDAIINWQQKRFGWNISQEMISFTPGVVPALAMVVQAFTEKGDKVLIQQPV
YYPFSLVVENNSRVLVNSPLELIDGQYQINFDRLEKDIKGCKVFLFCHPHNPGGRVWRRD
ELERVADICHRNNVVLVSDEIHADLTLPPHKHIPLGSVSDQARQMSITFASPSKAFNMAG
FTTSYAVIQNPELREKFQSYVEGNMLGDGNVFAYQTVIAAYTEGEEWLNKLLKYIQKNID
FVVDYVEKNIPKVKCIVPEASYLVFLDFRGLEICQESLVHLCVDGAKLALNDGAMYGKEG
EGFMRINLACPQSIIAQALHQLKDAIEKQEECV
>OBAHECAF_00058 hypothetical protein
MINVYRMIKSKIYTFVLFCLLPLCSYAQEDEDDGMIQSPSKVDKKNRDYGVKYLEDQFYL
GLTYNILSSKASRVVQHGLSHGIHTGIMRDIPLNERRNVGIAVGMGYAYDLLYSNIVVFS
ENGVRTYQIPDGIKSLNLNKNNFSLHTLEIPLEFRWRTSTAEDHKFWRIYTGMKFGYVLK
SKSFYEHNELSTSFSNLELKGKFHTKLYAALGYNAVNFYVQYSLTPLFKNVNTIEGTSLK
ANILQLGVMFYIL
>OBAHECAF_00059 3-deoxy-manno-octulosonate cytidylyltransferase
MIPARYGATRFPGKLMKDLGGKPVIVQTFEAVRATQLFEDVYVVTDDDRIEQAIIEVGGK
VIRSKREYQSGSDRLAEACESMNVDVVVNIQGDEPFTAKKNLEMLIEIFEKDTDNQVDVA
TLMEELYDFEDIKNPNNVKVVTNNSGDALYFSRACIPFPRDEKSLGNYFKHIGIYAYRKP
ALIQFSQLEESMLETTEKLEQLRYLENGFKIRVAKTDIPTIGIDTESDLEKARKIWNSL
>OBAHECAF_00060 hypothetical protein
MKIKQLIGILALVLVTFSFTKQQPSSKYKCMIQLTNYDGEGAYIVVSLLNPEGKYEKTLQ
VLGDDPEWYSDLPEWWKFYGKRETIDAITGETISGGQRAVKVIEIEDDKIDKGYKIRFET
AVEDQKYYATDVEFELTSQSLKSKVEGKGYIRYVRMMPN
>OBAHECAF_00061 hypothetical protein
MKKKLVSLFVFITTCISAQNNVFFSADFWKSKPSVEQVKQKIAEGNDPVALNERAYDATS
LAINNGASFETIVYLLSLKGNEVDKLTHDKRTYIFWAAFQNRLDVAKYLLDKGAKTDVRD
SHLYSPLLFSAVRGNKSIEFYEMLIKYGANVKDRNENGATALLLLIPHLKDLKEVDYFIK
KGLSLKDVDNKGDNSIFYAARYGNQDIINQLIKKKIDVKAVNKKGQNIAFAAAEGGRGKS
NDISFFKYVESLGINPNQKDKEGLTPLFILSFRHRDVGVLSYFIEKGNDVNQTNASGQSP
LMNAASSNILPIVTLLADKTQNINAVNNHKQSALTLAVHRNSAEVVDFLIGKGADVNVKD
DKGNSLVYYLVDGYSPLKQEDFKKKWDILLEKGLDMAQLQANGNTIYHLAVQKGNLDLLQ
KASSASVSVDTKNEEGLTPLHQAIMTAKNLDIINFLLEKGADKTVTTDFGESAYDLAQEN
EALNGLNINFLK
>OBAHECAF_00062 hypothetical protein
MIAEASLMGFLRTLLIVLLVILGLRILIRILMPFVLRYFFKKVEKKIYNQFQQTQNQYQR
QTDSRQTIMNDDARSKESTSRKKKVGEYIDFEEIK
>OBAHECAF_00063 hypothetical protein
MVTGQLHTMQKLQENNILEPYFKELSIQINLDGLSFCVFNPVLNYVESIYNFSVNFNKSN
QEIEKQVYTILQSEEDLRQDFNNIKVLHNTPAYTLVPQALFSDEKEAVNYLKYSIDTSGL
KEKFIEVDKIIPIDIVNVYVPDVLINNILIEHYGMVDYNHFSSSLLRMLLKHYASHSYQI
MYAYTEQSSFYFVVFKDKKLYHFNRFYYETTEDFLFYTLYCIEQLGIDSERIPLYVIGDF
NHKSLVYRQLSRYIKYIYLMDFNRKEYYKGMDEELIRKNFVLTQCF
>OBAHECAF_00064 hypothetical protein
MKKVLQIALWAVGLFFCFMIYKSVTGPIQFKKIKTERYTEVIRKLKDIRDAQEAHRVVKG
KYAANFDELTSFIETAKFTITSQRDTSWVEYDKVYKIDMLKQGVVVDTLGYVAVKDSLFK
NSDRYKNLRYVPHAKSKEEQFVMNTAMLDRNGVQASVFEAYVPKKVVLWDQDENDVQVEI
ARNSVEEVKGDLIKVGSLDDITINGNWPTSYDAKTARK
>OBAHECAF_00065 ATP-dependent RecD-like DNA helicase
MDKTTFYNALLEAFNHSPTPLQNIALQQLSIFLLDTKTNNKLFLLKGFAGTGKTSITNSL
IQNLPKIKHRAVLLAPTGRAAKVMSHFAKQQAYTIHKHIYYPKNQNGSFSYNLKPNKFKN
TLFIVDEASMIADNDGQFFERNSLLDDLMLYVYSGEGCRLLLMGDTAQLPPVNSLYSPAL
DIRNLESRYQKDVSHIELTEVVRQEKKSGILYNATKLRESLNQTFYSNFEFQTKGFKDII
RLRESSEIQEAIEDAYNDYGTEHTSIIVRSNKRAVLYNKQIRKVILDNEDELTAGDLLMV
VKNNYFWLKDSSEVSFIANGDTLEILRIYAFREYYGFRFAEVSVQLIDYPNQPPFDTVLL
LNTLESEQASLSHQDSQRLYEEVLLDYEEETSSYKKYQKVKENPYFNALQVKFSYAITCH
KSQGGQWDIIFIEKPYLPNGADEEYYRWLYTALTRSTKKVYLLNFKDEDFKS
>OBAHECAF_00066 hypothetical protein
MKKITSIIKFLVVPMIMFIGCDKPETPQQAEEIDENGIVLSNDFYIKAKVDGEWVVVKGD
RCTYTINKDGSIQIESYRSGNDATDKTFSFSISSTTLGNHKFGDEKNGGTGLYIVNKQQY
LTIDDGNVEITKLDSSKNIIEGRFQMNVKKNGIGDMKKITEGVFRCKQK
>OBAHECAF_00067 hypothetical protein
MVKKIFLTLCLLATINIQAQINKQKDNRLEWFEKAKLGIFIHWGYYGVNGITESWSMYHK
RISHADYLAQGKEFTASNYNPDAWLDLFEKVGAKYVVLTTKHHDGVALWDTKYSTLSTVK
HAAAKKDLLTPFVKAVRKKNMKLGLYYSLCDWSHPDYKPVTFERIKTTNNFYPQKGQQKL
SPWERFVKFNFDQLEELNAYKPDLYWFDGDWEHKAEEWKSAEIKQSLLKSNPQVIVNSRL
NEYGDYKTPEQGVPIVRPEGAWEFCMTMNDNWGYFPSDTNYKPISQIVRTFVEVISTGGN
LLLNIGPKPDGSIAPEQVERLEALGKWIQKHKTAVYDSEAGLPYGHFFGPTMLSHDHKKI
YLCLFDAPKNYIQLKGIQTKIKSIKVLGSGENLSFERNGGAAWNNIPGILRISVPSENSL
DPYVTVLEVELEDKLVLYRGHGNAVELNM
>OBAHECAF_00068 Elongation factor 4
MKNIRNFCIIAHIDHGKSTLADRLLDFTKTVTEREKQDQLLDNMDLERERGITIKSHAIQ
MEYEYKGETYILNLIDTPGHVDFSYEVSRSIAACEGALLIVDAAQSIQAQTISNLYLALE
NDLEIIPILNKIDLPSANPEEVKDDIVDLLGCDPDDIIPASGKTGLGVEQILEAIIERIP
APKGDPDAPLQALIFDSVYNPFRGVETYFRVMNGEIRKGQKIKFMSTGKTYDADEVGTLK
LNQVAKQSVKTGDVGYLITGIKDAREVKVGDTITSAVNGCSEIIDGFEDVKPMVFAGIYP
VDTEDYEELRASMEKLQLNDASLVFTPESSAALGFGFRCGFLGMLHLEIIQERLEREFDM
TVITTVPNVSYLAYTKKDPETPIVVNNPSDLPDPSKLDRVEEPYIKASVITKADFVGQVM
SLCIEKRGQITNQTYLTPERVELNFDMPLAEIVFDFYDRLKTVSKGYASFDYSPIGMRAS
NLVKVDVLINANSVDALSALIHADNAYNIGKKMCEKLRELIPRQQFDIPIQAAIGAKIIA
RETIKALRKDVTAKCYGGDISRKRKLLEKQKKGKKRMRQIGNVEVPQSAFMAVLKLND
>OBAHECAF_00069 hypothetical protein
MAWIKKYINVILLGISIIIYLVFLVVSPIIFTRSNWFGFDFSKTGQIGDTIGGITSPFIG
VIAVFITGLAFYAQYRANQIQINALEQQKKQFEEEQKEYRKETELQKFETQFYEMLRLHK
ENVNEIEIETIDGKTIKGRNAFFEMKKDLENLLILSDEDNNSFKMNYNIFFWGFKEDRKP
IRYTNVTDEESEAFLVEFIKSMEKKEEPTNLAKYMHDGEIELSDGSGKVSKLRISKLEGH
HSYLGHYYRHLFLIVKFVVNQKEDLISEEEKLNYLRILRAQLSNYEQIMLFYNWLSSYGG
DWESSENQFFTKYKMIHNLWHREMYKDDFIKEKLEELIVKYKKNGGSGDFFEMGDDIEDT
ENK
>OBAHECAF_00070 hypothetical protein
MPVKYNVVGRKNPQKPNEAPKFYASAKADGEITLKAIAKEIATGSTTVSDTDVLATLNEL
TKVLIKHLSNGEIVKFGDFGSFQITITSEGVDDEKKFTAANIKGNKIQFRPGTDLKEMLA
TVKYEKYKK
>OBAHECAF_00071 hypothetical protein
MKSKLKAVTEFHTAFGLGVKQQPTTELTPETINLRFKLMAEENQEYLEAARNNDMVEVAD
ALGDMLYILCGTIIEHGMQYKIDEIFSEIHRSNMSKLDADGKPIYREDGKVMKSSRYFPP
NIAEVLKSTD
>OBAHECAF_00072 Regulatory protein PchR
MTAKLVCIFACQFNLTDIFFNLTEEITMRKMDFNKIVEEDVVLSRRDEGNFNLSLKNEVG
NIQLHVKNMKEISIYKWHSHFSESTQIYGNASVPSVRFYALNQSKSGVQMKMKKIDLTMK
QGMFNVLFINMEEEGHDLFRENDHTVFSGFFVSSDRFLHLANTYPEVFESIVNQYQQNKN
FILSDRNGLPLTSQMNTILQQLEQSHLMGNVCETYAEIKILELFILQQQLLGQHIKTKKH
CKTQSDIDKIHEVRHLLMHNFHAPLSLSELSRRVGLNENKLKYGFKEIFGTTVFGYLFDH
KMQLAKQLLLETNKSISEIAEACGYDYVSHFSTAFKRKYHVSPLKFRE
>OBAHECAF_00073 Vitamin B12 transporter BtuB
MSKQFLSVFIFFISIFITYSQTQFGNLSGFVFDESTKKPLPATEVYFREFQKGVISDSKG
FFRIEKIPHGTHTLIVSYLGYETQTVKISIEGDKTINVSLKPEVESLSEVVVKAQKNEER
ILRNSAMTVSVINSKQFEGTTSSLNDVLNKTVGVTIRNTGGVGSASRISVRGLEGKRIGV
FLDDSPIGLFSDYVSLYDVPIDLIERVEIYKGIVPARLGGSAMGGAVNMITKEYPPLYYD
VSYEIASFNTHKIQMMGKSNLKEAGIEFGASANYTYSDNDYEMDLPHHRGLRVKRDHDRH
RKMLIGGGFKATKWWFDEISIEAVTIQTDQQIQGIETNIKHAFSKTNMFAFINGFEKDNF
LIAGLDFDMDTAISSAEFNLNDTSMMRYNWDGMSYPSSGEIGLYASDSYRKNFALNNRLN
LNYIISENQNINFNSQLNHIKNSPFDPVKEQIIGYRTDFDNKMISWVAGISYDLSSRNKK
WLNSLTGKYYHYKSDAKQAGLLGLGGVKDINISEGNWGINNAIRYNFTDNLMIKSSVAYD
VRLPSDNELLGDGFLTAPASNLLPERGTNANIGLLFHKNTLTDKRLEIELTGFYSYLTNM
IRYTGGLLQSFYENFGEMRSFGVEFDAKADIFPSLYGYVNLTYQDLRDMRDYEPNSSIPN
VTKGKRMPNIPYFLNNMGLEYHKENLFGGQNQNTRLMLDSSFIEGYWYDFEVSKHQERRV
PRSLTFNFGIEHGFRNGKILLSFRMNNLTNEKVISEFNRPLPGRNFGLKLRYRM
>OBAHECAF_00074 hypothetical protein
MKKNAMLVACLATFFAVSCDKENETPDIISGKGEILIEATVVNTDQSGSGYIQLLDDISP
KTVNNKNAFPVGPSIPPFVHKNWIFTFPNFFGSDVSELTKFVREDGVLKKSATMPLPGNS
QATHLTVVNDTKAYLGLTGLGKIFIFNPTTMVKTGEIDLNTYGDPNPEPSGMIVRDNLLF
VTLGQWTAGTWFPQEKAVEVLIINTQTDAIEKHIKETASGLSFPTNPGDRILMDEHKNIY
LVCIGAFGQVDGFGGGFLRIKAGETDIDPTFSMKFDDITVADAPGKISYFLPARYIKNNI
TYGYVAIKEYTPDQQMSPLAVMYAPVKVDLSSKQVTLIKGIPVANGYSTGMGIYKNNTFL
FGSINQTSKGFYTYDLSTGKVSTEPIIKVEGFPKFFYWFGE
>OBAHECAF_00075 hypothetical protein
MKFIVNRLLVPKGYSGITLFPFVFVSKKECLNDPQFLNHEKIHLQQQKELLVVFFYLWYV
LDFLFKYIKYRNWQKAYHNIIFEREAYHNQDNLNYLNSRKRFAFLKKDI
>OBAHECAF_00076 Ferredoxin
MAIKITEDCINCGACEPECPNNAIYEGADDWRYSDGTALSGGVVLPNGKQVDADEVQQPV
SDDFYFIVVDKCTECIGFHEEPQCAAVCPVDCCVPDEDNKETQEELTAKKKFLHNE
>OBAHECAF_00077 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAKYELKLPQMGESVAEAIVTNWLKKVGDTVEVDEGIVEVATDKVDSEVPSEVSGVVVEL
RFEVDQVVKIGEVMAIIETEASAEAVATPTVETTAKVIEKEIEQLQQNVTKTDVVVSGLK
SDRFYSPLVKSIAQKEGISLQELDQIKGTGADNRVTKNDMLSYLENREKQTVNRSAELPQ
NKVAEVKATSFQKGDERIEMSRMGKLIAEHMVHSKQTSPHVQSFTEVDVTRIWNWRNKVK
KAFEAQEGEKFTFTPIFMEAVAKALKDYPMMNISLEGTTIIKKKNINIGMATALPDGNLI
VPVIKNADQLNLRGMTKVVNDLAKRARANQLKPDEIKDGTYTVTNIGSFGNVFGTPIINQ
PQVGILAIGAIRKTPAVIETPEGDVIGIRYKMMLSHSYDHRVVNGALGGMFVQRVGEYLE
NWDMNRDI
>OBAHECAF_00078 Recombination protein RecR
MEFSSKILENAVYEISQLPTIGKRTALRLALHLLKQPEEQSARLASALINLRTQIQYCKK
CHNISDVEICDICNNSSRENGIVCVVEDFRDVIAIENTGQFFGQYHVLGGKISPIDGVAP
SSLHIQSLVEKVASGKIKELIFALSNTMEGDTTNFYIYKQIEQYDVVISTIARGISVGGE
LEYADEVTLGRSITQRIPFELALKG
>OBAHECAF_00079 Ribosomal large subunit pseudouridine synthase B
MEKKYSSNNTNSQRSNNSYKKREYSNNSFQKKEYGNSERSSDKPYYTKKEYGSSERTYNK
KEYNSDRTKTNSGFKKSYNPNFKDTSNEGGYRKPYNPNFKDASNEGGYKKSYNPNFKRNN
SYKKPFIKKNYNTEIEQQDNTPETGEIRLNKYIANAGICSRRNADIYIAAGNVEVNGQVM
TTLGYRVQPTDVVKFDGKVISSEKKEYILLNKPKGFITTTSDEKGRKTVMDLVANATTAR
ILPVGRLDRPTTGLLLLTNDGDLAKKLTHPTHGVRKIYHVVLDRKLDYKDFIKIEEGIEL
EDGFIQVDEISYVNDKPKNEIGVKIHSGRNRIVRRIFEHLGYEIEKLDRVVFAGLTKKDL
PRGHWRKLTQQEIINLRNIK
>OBAHECAF_00080 hypothetical protein
MITYLEGNILESDAQALINTVNTVGVMGKGIALQFKNAFPNNFKQYQKACKEKSVVVGKM
FVTEDENLTSGKKVIINFPTKTTWKKPSEYEYIEWGLDDLVKIIKERNIKSIAIPPLGAG
NGGLDWDKVKQIIERKLSHLDTEIYIYEPSVQIKEQLKNERVKLTQGRALLLYVLHDLVR
EGEFVSEFSSEKVCYFLQKFGAEKYLKLKFTPYFYGPYSGKVRFVLNALNGSYIMGYSDM
NKKPFEPLNLLGDGFQEVEKFIEGNEELKQIANDTTHFLEGFYSDYALELLSSVDYIMRE
EKTKEKEIIIEKLKSWNSRKSEMTSNERYLDIVLKHLIQN
>OBAHECAF_00081 hypothetical protein
MNLSEIKVFRMTHIDNIPHILQNGITHKNSPNANVNYVSIGDNSLIDTRASKTIQVTNGT
LDYGDAKRICLGDFIPFYFWLRMPMLYIIQRGFHNVVKRNPEEIVYLVCIPSKLADQYSE
VYFSDGHAADKFSVLYDKTALNKIGTILDWKAIKARDWGGDQNLDIKRKKEAEFLVKADI
ASDFIIGFGCYNEVAKQKLISFGIEEVKIKVIHQYYY
>OBAHECAF_00082 1,4-dihydroxy-2-naphthoyl-CoA synthase
MNWQTVKEYEDITYKKCNGVARIAFNRPEVRNAFRPKTTSELYDAFYHVYEDASVGVVIL
TGEGPSPKDGGHAFCSGGDQKARGHQGYVGEDGRHRLNILEVQRLIRFMPKVVIAVVNGW
AVGGGHSLHVVCDLTLASKEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFFLGR
NYSAQEAFEMGMVNKVVPHARLEQEAYEWAQEILAKSPTSIRMLKFAMNLTDDGMVGQQV
FAGEATRLAYMTDEAKEGRNAFLEKRKPDFGENQWIS
>OBAHECAF_00083 Transaldolase
MKFFIDTANLDQIREAQDLGVLDGVTTNPSLMAKEGITGTNNILKHYVNICDIVDGDVSA
EVIATDYEGIVKEGTALAELHPQIVVKIPMIKDGIKAIKYFSDRGVKTNCTLVFSAGQAL
LAAKAGATYVSPFIGRLDDISSDGLTLIEDIRLIYDNYGFETEILAASVRHTMHIMQCAK
IGADVITAPLSAIVGLLKHPLTDSGLAQFLADYKKGN
>OBAHECAF_00084 putative oxidoreductase
MKNEKIVLITGATSGIGKETALLLKEKGFTVYGTARNVEGKSLPFRLLPMDVRCKESVDK
AIQSILSEVGKVDILINNAGVGISGAVEELPSEELENVFATNFFGAIYLIQKVLPTMRNR
KSGLIINVTSIAGYMGLPFRGAYSASKGALMLMSESLRMELKNFGIQVTTIAPGDYATDI
ASRRYHAPVKEGSAYREKYQKSLDLMNKHVDSGGNPIEMAEKIYKIIKTKHPNVHYKQGN
FLQKFSIVLKRVLPSKTYERMLMKHYEL
>OBAHECAF_00085 hypothetical protein
MNRQWLIFVMCLFSLPVFSQQKHVYLNDDLEYISAKKFNDYRKSNNHYILTYELDSVVMH
VQVQRVKRGKITLEQLAVIRTELSGFSGQSVPEKNIIVVNYHHGKDPCNDSPEDSSYYAL
IKDYLKKIQKKKDVSQFFVYNERDGIKDYGKKISWLEDKNKTLRDLFFPLQYPCGSFVLI
DAEGNYYVQKGEYSNHYILDILRDKSNIINESSHIKNGETNRTPRRVEVRAIRQ
>OBAHECAF_00086 DNA polymerase IV
MESLTDIPLRKIIHVDMDAFYASVEQLDFPQLRGKPIAVGGEKERGVVAAASYEARRYGV
RSAISGVQAKKLCPQLIFVPPRFERYREISMQIRSIFYEYTDLVEPLSLDEAYLDVTHNK
KNNPSATFLAQEIRQRIFETTGLTASAGVSVNKFVAKIASDFNKPNGQKTVPLEEVQGFL
DVLDIKKFHGIGKVTAEKMYLNGIFTGKDLREKSLEFLELHFGNRGTYFYELARGIHLSE
VKSYRLPKSLGVEHTFEKNITSEVFMEEKLTVIAKELSQRLQRKKIAGKTVTLKIKYGNF
SINTRSKTLLHYVDKEEDISYHAKELLYKQPLEDSVRLLGISLANLNNIPEKKEKNMPRY
VQLKLIFPQ
>OBAHECAF_00087 Hydroxypyruvate reductase
MRILHIDTNHPLIIEQLTAHGFENHEDYKSSKSQIESKIDQYDGVILRSRFAIDKLFLDK
ATRLKFIARVGAGLENIDCEYAEQKGVMIISSPEGNRNAVGEHTLGMLLALLNKFKKSNR
EIERGVWLREENRGSELDYKTVGIIGYGNMGKSFARKLKGFDCQVICYDIKPNVGDENAR
QVFLDEFFEQSDVVSLHTPQTPLTTKMMNTDFIHRFKKPFWLLNTARGKSVVTDDLVEAL
KSGKIKGAGLDVLEYEKTSFENFFTDELPASFRYLLEADNVILTPHIAGWTAESKTKLAQ
VIVDKIIENFSEK
>OBAHECAF_00088 Endoribonuclease YbeY
MISFFSETKFKLPYKKNDLKSWVKMICNTENHKIGDVNYIFCNDEQLHKINVEYLNHDTL
TDIITFDYTEDFQIAGDIYISVERVCDNANDFEVSFKEELLRVMAHGILHLCGYKDKSES
ESQQMRQKEEEKIRLFTEKE
>OBAHECAF_00089 Cysteine desulfurase SufS
MKSIEQIRSDFPILNRLVNNKPLIYFDNGATSQTPNQVINTIVNYYTQLNANIHRGVHTL
SQESTDAYEQAREKLRKHFNAKKSCEIIFTSGTTESINLVANGYTSLLKSGDEIIVSASE
HHSNIVPWQFVCERTGATLKVIPMNEQGIWNMESFDNLLTSSTKLVCVQHVSNALGNIHP
IAEIIEKAHQRGAKVLVDGAQSAPHIQPDVQSLDVDFYAVSAHKMYGATGVGILYGKEEL
LNAIPPYQGGGEMIKEVRFEGSTYADLPYKFEAGTPNICGGIAFGAAIDYIHELGIENIA
KHEQALLRYAVEKLKELEDIQLYGNPDLSKRTAVISFNFKGIHPYDVGSILDKLGIAVRT
GHHCTQPIMDFFCIPGTIRASFAVYNTFEEIDTFVEALKKAHMMLS
>OBAHECAF_00090 Spermidine N(1)-acetyltransferase
MNCISDELCLLRALEPEDIDFLYELENQESLWEVSQTQLPFSRYLLKEYIQNATQDIYEA
KQFRYVISSSDREPFGCVDLYDFDPKNKRACVGIAILEKYQRQGKGEYALAKLLNYSKVN
LHLHQLIAYIPVDNIPSIHLFEKLGFVSHGIKKDWIFSNGTFKDVLIFQRIL
>OBAHECAF_00091 Diaminopimelate epimerase
MIIHFYKFQGTGNDFVMIDNRNSDFPKENTSLVASLCHRHFGIGADGLILLENDEKYDFR
MIYYNSDGKESTMCGNGGRCIVAFAKLLKIIDNKTIFIAIDGEHYAEINNENQVKLQMKD
VDVIRKEDSYTFLDTGSPHHVQLAENVNNMDVKSEGASIRYGQLYKNKGGANVNFVTPLG
NEKFAVRTYERGVEDETYSCGTGATAVAIAMYHQEKTKERDVHLQTLGGDLRVSFDVENG
VYTNVFLIGQATFVFEGKVEM
>OBAHECAF_00092 Phosphatidate cytidylyltransferase
MNELFKRTATGIIYILFLLSAIMLDEGAFDFLFLSFGLVCMYEFKKLIRLQGLHVYLIFL
FFWWLFIHLQVSVFSIYILLLFTIIANVYLTIMLFYGKTPLRYAPYSHKLIISMLYIGAG
CVFIPLIYKHECIKSYSVGEAQLTMIGILCIIWASDSFAYLTGKNFGKHKLFEKISPKKT
VEGFVGGLIGAILTAYVISIYSNKEIWSWIVLAIVLVTTGTVGDLVESSFKRVAKVKDSG
RILPGHGGLLDRLDSLIFASPFAFFVLQILYYFS
>OBAHECAF_00093 hypothetical protein
MNFLKKIFGKRSSEPNLGEEKIVATNVLSGDNLPADEQFAINFTQNGGKFIYCTSELEIQ
HFFRNILMEIGVYVKISTPNESLVDFFEEHQSLFTDDVETANVYLTTCEYLITSMGGIML
SSNQLRQRRTSELPEIFIVLAKTSQMVKSIDEGMRGINLKYPKQKPTGLVTLRSFDENRT
ANDVMNYGGSYKKTYLILLEDLPI
>OBAHECAF_00094 ATP-dependent zinc metalloprotease FtsH
MAENKTNKPKFSAYWVYALLIVILLGFNFYSGGSFWMQPKEIPQAKFEDFLRNGDVLKIT
IVNRKEANVYLTDEALKKEEHKDVRPSGNMLSQTTSAKNESPQYRFELGDLSNFENRFDQ
IVQENNLTTTRENKTQQNVFSDFLVTLLPFILIVGLWIFFMRRMAGGGGGGQLFSIGKSK
ARLFDEKREVRVTFQDVAGLEGAKEEVQEIVDFLKNPDKYTSLGGKIPKGALLVGPPGTG
KTLLAKAVAGEAQVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKEKSPAIIFIDEIDAIG
RARGKNNFTGANDERENTLNQLLTEMDGFGTHTNVIVLAATNRADILDKALMRAGRFDRQ
IYVDLPNLNERKQIFEVHLRPIKKAETLEIDFLAKQTPGFSGADIANVCNEAALIAARKG
KTAVGKQDFLDAVDRIVGGLEKKSKMITDEERRTIAFHEAGHATVSWLLKYAAPLVKVTI
VPRGQSLGAAWYLPEERQIIRTEQILDEMCAALGGRAAEKIIFDKISTGALSDLEKVTKQ
ARAMVTIYGLNDKVGNLTYYDSSGQSEYGFTKPYSEKTAHVIDEEISKIIENQYERAIQI
LSENKDKLTSLANLLLEREVIFKEDLEDIFGKRAYEKEEELTEKTETKVDDSNLLTT
>OBAHECAF_00095 Ribosomal silencing factor RsfS
MTQNKEITSNQLISNIIEGIEKVKGTDITIMDLREIENSVCDYFVLCNGSSNTQVSAISG
AVQRVVSQAEGHVKPWHVEGGMNAEWILIDYVDVVVHIFQKRIREHYDIEGLWGDAKFLN
IETNY
>OBAHECAF_00096 Glucose-1-phosphate cytidylyltransferase
MEVHQKRAEPWKVTLIDTGDNSMTGGRLKRVAPYLKNEDCFCFTYGDGVADINIADLINF
HKSHGKQATLSATYPPGRFGALDIVDNQIRQFQEKPKGDGALINGGFFVLSPKVIGRITD
DNTIWEQEPLKGLANDGELMAFKHEGFWQPMDTLRDKKLLEELWDSGKAPWKVW
>OBAHECAF_00097 CDP-glucose 4,6-dehydratase
MGLWKSSLESMVKMQHEGQVNPAFWKGKKVFLTGHTGFKGSWLSLWLQSMGAEVKGYSLE
APTTPSLFAEAGVHKNMISEIGDIRNLEQLSRSMQTFNPDILIHMAAQPLVRLSYKEPVE
TYSTNVMGTVNVLESSRYCNNLKAIVSVTTDKCYENKEWEWGYRENEPMGGHDPYSNSKG
CAELVTSAYRNSFFNTENTVAVASARAGNVIGGGDWAEDRLIPDILRAFEKKEAVIIRNP
LSTRPWQHVLEPLSGYLVLAQHLYENGKTFAEGWNFGPKDEDCRPVSWILDKMVTFWGEG
ASWQLDKKENPHEANFLKLDCSKAAIRLKWKPSWRLERTLEKIIYWHRAWLQKEDMQMHC
LNEIKEYLNY
>OBAHECAF_00098 GDP-4-keto-6-deoxy-D-mannose-3-dehydratase / pyridoxamine-phosphate transaminase
MSLDTIRTEIAQLVAKYAEEAYKEKPFVGGTTVIPPSGKVIGKQELQNMVEASLDGWLTT
GRFNQLFEQKLADFIGIKYCLSVNSGSSANLVAFSALTSPKLGDRAIKKGDEVIGVAAGF
PTTVNPIVQFGAVPVFVDVDLRTHNIDVDLIEKAISPKTKAIMIAHTLGNPFNLRKVKEI
CEKYKLWLVEDCCDALGATFEGQKVGTFGDIGTLSFYPAHHITMGEGGAVFTNNPELKAI
AESFRDWGRDCYCAPGKDNTCACRFTQQHGDLPFGYDHKYVYSHIGYNLKITDMQAACGL
AQLDRVEEFIEKRRQNFNYLHQRLSSLTDFLLLPEATEGSNPSWFGFPITLKSDCGVARV
DLLRFLDDNKIGSRLLFAGNLTKQPYFKNVEHRVVGELTNTDITMNQTFWVGIYPALNEQ
HLDFIAEKLEEFFGLNF
>OBAHECAF_00099 CDP-abequose synthase
MKTILLTGATGFLGSHLLKALVKRNYKVIALKRSTSNMWRLAGYESMFISYDVDKQPLRQ
VFEENKIDVIIHTACVYGRKGESLTEILQTNMMLGIELLELGSFFNTGSFFNTGSLSYKY
LNAYSLSKKQFEEWLSIQSKKIQVVNLVLEHMFGELDGNEKFTTWIFSQIKNNVSEVNLT
TGEQKRDFIYIDDVVSAYLVCLDNLEKLERFTTTDVGTGVLTPVRSFVKSVKEIYENLTG
KEVSTKLNFGAIPYREGEIMEPKVDNRKLLALGWKPEVDLRKNITEFIKKEIK
>OBAHECAF_00100 CDP-paratose 2-epimerase
MKYLITGGCGFIGSNLASEVLKRGEELVVFDNLFRYGSGQNLEWLKKQGKFTYYPYDIRN
TNDVETVIKKEEPDVVFHLAGQVAMTTSIQNPRLDFEINALGTFNLLDAIRKYCPEAMVM
YSSTNKVYGDFANLTFQERDKRYVCKEYPNGFPEDFPLDFQSPYGCSKGAADQYLLDFYR
IYGIKTVVFRHSSMYGGNQHATEDQGWIGWFVKKAVEIKQGLLKEPFTISGNGKQVRDVL
YSSDVVNLYFKAVENIEKAKGQVFNIGGGIQNSLSLLELFDLLEDILGIKMKYKELPFRQ
SDQLVFVADNTKAERLLGWKPFIIAKKGMEKIISK
>OBAHECAF_00101 hypothetical protein
MNFFKKIQDYEVSKNERSVRARINMLKLLVLKGYSIFLNILLVSITLDILGDYKYGIWIT
VFNVLTWISFFDIGIGTGLRNKLAESLSKNDTNEAREYVSTAYIIVILITICLLILFIVP
WFFVNWSSVFNVPAILEGDIRTLIAVTYVFTCIQFVLNLINMLLLAMHKPAVSALISAIS
NTLILIVFIVSKQWLEGNLIAVGSVYVISGVFVFSIASAIMFFGKIRDIKPSISFFRKEK
IPPLYNLSIKFFIIQIAVLVIYQTDSMIIAHKISIEDVTPYNILLRYFGIVNIIAVTLMT
PLWSAYTDAAVKNDYAWIKKTIKEQLKLLVFLFFCVVLLCLSSSFLLEIWLQKEVRIPRG
LLIAVAIYTVLLVWNNIFSSVLGGLSLVRLGTIVTTVTAILNIPLSLYFLDAFAGDSRGV
IYATIACIGVTAIISPIQVYYFVYYEKKNKFLSKILR
>OBAHECAF_00102 Abequosyltransferase RfbV
MKPKLSVCIPTYNRCEILKDTLEGVITFFVERNVEVCISNNASTDGTDEYIKELVRLYPS
IKYNKQVKNVSIDENMVDVILMATGDYIFPLGDDDKIDVRHIENEIFDSICDGVDLKIFN
GRLGENYLLETDLLGSSFDNLECAFESLWSKMPFGSFMFHRDLLVFMQKDNRFMNTSHAY
TGIIWDGLYAKKVQGKQMIRIVCGQEPLIEFKQEKKTWEKDRFKILYYEIPLWFYLLLDK
YPVISNKRILKKYLIQMSSFKTLLRFKCKNPDFSNHIREYMSFFSYIQRKKALLINSIPS
NILNNLYNFVKRWKKKKLVF
>OBAHECAF_00103 Putative glycosyltransferase EpsH
MEEEKVSILIPVYNRENLIEETIKCALNQTYENIEIIVVDNKSTDGTWELLQQLAQGDKR
LKIFHNEKNIGPVRNWKRCIDEATGEYVKILWSDDLISSDFIEKTLPFLENKEVGFVYTK
TVLFQDLNDLSNKVYSLGKTGLYKTEKYIQGVLFDINYPVSPGCAIFRMTDLRNNLLVDV
PNSIGSDFSMHAIGNDMLIFLLTAQKYNQFAYVDEELSFFRVHNGSITIASDKGKIPLHY
VLAASYFIENYRPELVEKHNVNIQNLLRQYKEEAIKYKMLGLSDFYIQNKNLKLDYLFIL
QKVIRRIKANCIFKKYK
>OBAHECAF_00104 putative glycosyltransferase
MECSPLISIVTVSFNALKTIEQTILSVVNQTYPNIEYIIIDGGSTDGTVDIIKKYEDKIA
YWVSEPDKGIYDAMNKGIEKASGEWINFMNSGDEFYNENVLRDVFLKENLKEVDVLYGDV
VVKLPKKEVLKKATPLQNIEKWMVFCHQSTFVRTKLHRENFFNITYKICADYDFFLKLYR
KRKKFRYLSKVISKFLHGGVSDSLMKVSVESWHISGMKNSKRFLFVIAKEFFLGRFIRFY
SKWI
>OBAHECAF_00105 putative glycosyltransferase EpsJ
MKLSIIIPVFNTAQYIDQCIYSIYDSNMINLDEFEVIVVNDGSTDDSRKKVEKLQKEFQN
LILINKENEGVSRARNVGLDNAKGDFIFFVDSDDFLLKNALIFLLDRIKQVTKNLYKFKT
CRCSKGIISEKSTRRELFSPELWNFIFNKKLINKLKLRFIDVKYGEDFNFVAKFIALCDS
YEFIDENIYVYREDNVNSAMNVVSYDLLLYDNFKFADNLIDFYMENRTIINYSIVKDIFF
RIFRSFISYKVRSSINDSVFFQDYKRIYFKSANISILYRCHPFTIKFYEIYYRLRFFRN
>OBAHECAF_00106 UDP-N-acetylglucosamine 2-epimerase
MKKHLFIFGTRPEAIKMAPLVKAFQKEKSFKTKVCVTAQHREMLDQVLNFFNIRPDYDLN
LMKPNQNLYSLTADIIIQLKDILEDFCPDFVHVHGDTTTTMAASVAGFYSGAKICHIEAG
LRTHDKHAPFPEEINRQVTGRIADFHFAPTQTSKENLLNENIKEENILVTGNTVIDALIQ
SVEIVEHFEDDEIVRLKSLVITSKKLILVTGHRRENHGEGFMNICMALKQIAENNSDVQI
IYPVHLNPNVQKPVREILSDVGNIHLINPLSYPAFIWLMKYSYLIITDSGGVQEEAPSLG
KPVLVMRDTTERPEAVEAGTVILVGTNTEKIVSESQFLLDNQDLYNKMSALHNPYGDGRA
CERIIEFLKQYNETK
>OBAHECAF_00107 hypothetical protein
MLADSSKISIGLLTYKRTDLLISTIKDIVASEYKIDLIVVNNNEDIDIVNELYFIKDYPH
INLIYIWDRRNYGVSIGRNRIIEEVKTQYVIILDDDVDIPSIDTIIDDCVYNFEKDSTIG
GIAFHIKDIKTRKPNRFEIPHKNKKIDLEQDFDTYIFIGAGHALNMNVIHQISAYPDDFG
MYGMEEIDLSFRIINSGAKIRFLSKCVIFHKRSPNGRHANNIVYYLSYINRVKIALRYFK
LKYIISVIIVRGIYMLYRTRNFGFIVKAMKDIKREIDITDKKNKFKRDFYLYIKRVKGFI
WW
>OBAHECAF_00108 hypothetical protein
MTKYIVLSFAFLLNVVLSLVYASFVQEVVFQDFIDVIRPITIVISLLLGVALFQKDFKKE
NLIDFFISLGLISSAVVFLEKLGMSFFYELYSDFNHKSMNRATGIYYDFAELGAMQSIAI
IAATIKFIEEKKHIYIYYLLIFSISIILSTSKASILLLGILFSLLVIKIFTSSKFYRPKY
ILSFFLIMGVAFYLTYIYVENDPLLLDGLKAVFSVSRENHSVNNRLDNIDYVVGLVEKFD
LRSFIGYSASRNVEGSYIEVAFFSVLFRYGIVGTVLYYLIFIGVLFEKIPKPYNYFKYVV
FATIVLDTVAAMTNRFSFPIALFILVGILISEKNKLHTK
>OBAHECAF_00109 hypothetical protein
MKIAFISSEIWSDYNPEGIVARKILNGFLQEGHEVDVFTVKPFEYDRIIVFSNKIPEIFD
KVIKNIIGLEKLPFVYKVYNYIKRNHAEYDLIITRSEPISLHLINIYLKTSAKKVAMFSD
VGYLNPYYGKIHFVKKTISYLLEKKLSYRCDLITHTNQYVIEEYIKRGFSSKVFYDFPNP
LEKSVLELKNRGGREKINLAYTGSLYGNRNPNKLFEYLQSQKKDNFTLYLIGAVRNMYYE
NGRLGKIGEQLKNKELASLERTIGDFGLSEKVRVLPFMKKRELNDFITKNIDILINIDAC
AETNLFLSSKVVDYLQYNLPILNVSTKGASVSFLKKVGIYDYLDYNNTFSFSIEDIAFSE
RFRPNKTLIDQFLVINIVKRLLNRINLLHSNKT
>OBAHECAF_00110 GDP-mannose 4,6-dehydratase
MKKALITGITGQDGAYLAEYLLKKGYEVHGMKRRSSLFNTDRIDHIYQDPHVENRNLILH
YGDLTDSMNITKIIQEVQPDEIYNLAAMSHVHVSFQTPEYVGNADGLGTLRILEAVRLLG
LTGKTRIYQASTSELYGLVQEVPQSEKTPFYPRSPYAVAKMYAYWITVNYREAYNMHASN
GILFNHESPIRGETFVTRKITRALSRIALGMQDKVYMGNLSSQRDWGHAKDYIRAMHLIL
QQEKPSDYVIATGITTSIRDFIILSAKEIGLTIEYQGEGVDEVGYFTAIDKTVFSEKVGE
KYISNIENKIKSKAEIVLVDPKYFRPTEVDLLIGDPTKSKTILGWEPKYDLKGLVADMMQ
SDIKLFKRDAYLKEGGFTIMNYFE
>OBAHECAF_00111 Bifunctional protein HldE
MLHSGHVAFFEEASQLGDLYVGIGSDRTIQELKARKTINPEQERLYMVKSLRFVKDAWIN
SGSGILDFKEDMLRLKPDVLFVNEDGHSPAKEALCKELGVEYHVSKRIPHGNLPARSTTA
LRKECLIPYRIDLAGGWLDQPSVSKFCPGPVITICIEPDYEFNDRSGMSTSTRKKAIELW
HTDIPEGDKEHLAKILFSYENFPGEDYISGSQDALGIVLPGLNYYWYDGGFWPEKIEKNL
SEDLLVWIENHLYLLPLQPRHSELHVTEGADISPEKVKKLSDAAQQFWDALLAKDINATG
EAMIASFEAQTSLYPNMLNEEIKQEIATLPKSAVGYKLSGAGGGGYLVVLSEIPIEKALK
VRIRR
>OBAHECAF_00112 GDP-L-fucose synthase
MKKDAKIYVAGHQGLVGSAIWKNLENKGFVNLIGRTSSQLDLTNSQDVANFFHEEKPEYV
FLAAAKVGGILANNTYRADFIYQNLMIQNNVIHHAYKNGVKKLLFLGSTCIYPKEAPQPM
PEDCLLTSPLEYTNEPYAIAKIAGIKMCESYNLQYGTNFISVMPTNLYGPNDNFHLEKSH
VLPAMIRKIHLAKALLKNDWEALAMDLNKRPVEGISGKNSQQEIKAILEKHGIFGDRVIL
WGTGMPMREFLWSEDMADACVFVMQHINFNDTCDKNTTEIRNTHINIGTGKDITINELAQ
LIKKTIGFSGEIHFDTSKPDGTMKKLTNPSKLHQLGWKHSIELEQGIEQMYAYYLR
>OBAHECAF_00113 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MDRELRISVIGSGSWGTALTKILTYNVSKVCWYVHNEVAIEHIKDTSRNLNYLSDVEFDT
DRLILTNDINEAVAYGNCLVLVTPSAFLSSELSKLTVSLEDKTIFSAIKGIEPNSGLIVG
EYLHKFYNVPYSNIGVIAGPCHAEEVALERLSYLTIACIDKQKAKIFAEAMTTYFVKTKV
SDDVIGIEYAAVLKNIYAIAAGIAHGLGYGDNFQSVLMSNSIREMRRYIKRIHKIKRNIN
NSAYLGDLLVTGYSLFSRNRTFGSMIGKGYTVKSTMMEMNMVAEGYYAVKSAYKINNSHK
KKSHTPILDAVYQILYENRRAKKVFAELVNHLD
>OBAHECAF_00114 hypothetical protein
MKKYFYTLPLALALLFGCNQSHEPKSTSTEETSVSKNKEFTFSTWITYKPERTDESYHEE
FKKYKTHGISEVLVNTEADVEGLKRLVPIAKEEGIKLHAWIMTVNRPGDKEALQHPEWYM
VSREGKSCFDHRPYVDYYQWLCPTRKESREHILKLVSNLADVEDIASVHLDYIRFPDIYL
PIGLLPNYNLVQEEELPQFDFCYCDVCVAEFEKTHHKDPRKLKNPALDLEWRQFRLNKIR
NLVNDAAEIVHNKGKKITAAVFPYPEMAGQMVRQRWDKWNVDRVYPMIYHNFYNEEVDWV
GFATQQGVEDMKGKETELHTGIYVPPISAQELKQAIEHAKASGATGVSFYDGPDISEDQL
KVIQELSR
>OBAHECAF_00115 Quaternary ammonium compound-resistance protein SugE
MNWIILVIAGLFEVAFTFCLGKAKMTVGNVSYAWYAGFATCTFVSMYLLTKATQTLPLGT
AYAVWTGIGAVGTALLGILIFKEPASFWRLFFITTLIGSIVGLKFVSNY
>OBAHECAF_00116 Fosmidomycin resistance protein
MEQTRPKTVYSILFAIAIAHMLNDLLQAVITASYPQLKQEFGLTMTQIGIITFCYQISAS
IFQPLVGNYIDKRPMPYAQVFGMFITALGIITLAYSSSYAWVLVAVLLVGTGSSIFHPES
SRVAFLASGGKRSLAQSIFQLGGNSGTAIAPLLIALIIIPNGRIYSLWFLVFAFIAIIIL
AFVGKWRSNVLKIHRKTKKKEVVLPNLTPFQINMSVIILMVLIFSKYFYTAGITNYFQFY
VIQKFGVSEVQAQMYLFYFLGAAALGTLLGGIFGDKVGRKFVIWFSILGAAPFAILLPYA
NETWTAILIVLIGIIISSAFPAILVYVQELLPKKIGMISGFFYGFAFGMGGLASAVLGKV
IDLTDIYFVYGLCSFLPLIGLIAYFLPNLKR
>OBAHECAF_00118 Sulfate permease CysP
MAPIYNQLLIPYIIAMALAITMGGSGTAPAFSASYGADVIRKSLIPGIFGIAVFLGAFIA
GKNTASIMGGGILDANYMTFVVVSIALFSVAITLLVSNILGIPQSTSQAAVLSIAAPAFY
FGKLDTVKLFAEIIPSWFVLPIIAYFLSYLAGKYIYKPMRRRGLTMLRAQNENLRPVWST
ILILMSVYVSFAIGSNNVANAAGPISTMTINELGLKTESDFTVILMLSALIIAPCFGIGS
SLFGHKIVKNTGKEIILFGKFEAVIIAFISGSLLLLASLVKGIPTSLVQMNVAAILGIGV
AKMGAKNIFRKSQVKRFFTMWMIAPTICFFLSLLLIYLADIYGFILLH
>OBAHECAF_00119 hypothetical protein
MKYRLIYTVFFISILLIINACTTKANTYYNRQMQPIVTKYNVLFNGEEAFESGLKQLHEQ
YQDDFSQLLPVEPIRMTGKVQLEGVENPNFERAEEKAIKTIQLHSMVFKGEQRNYKIDDA
YILLGKARYHNERFLPALEAFNHLLTNYGKSERINESAIWAQKTNMRLGKDKIAIEKLNE
LLSKEKLRKRDRAEAYATLGQAYINQKMYPEAAESLYLAGKYTSSKTLRGRYYFIAAQLY
EHQKQRDSATIAFEKVVKLNWKIPRKLWVEAQAGKARNRDFTPEEKTEFLTYLTKLENRY
EHKDYLDVLYFTHAFLIEENSRRMAIEYYRRSLKNNKENNPLKAKTHERLADIFFEQKDY
TGAYHHLDSTLAYIPEHTFEHLYVERKKENLAKITELEYTVKQNDSILKIIKMSDSDRVA
FFQKHIDSLKKKTEQKMKSSSTVNQGMGFSLQNATETKGGKFYFYNPMAVAYGKQQFQQY
WGNRKLEDNWRWSAKQQTEIETNPATTGREENVPKKDITPDFYLSQLPKNEKEIKRLERD
RNQALLQLGILYKAKFNDSELAIDRLERVLGFNPEPIVESAVLYELYKNYRYLNSPKAET
VKNHLLGRYPQSDYAQLLQGNDTSRKQRDLEAQQFLQELTVEFNNGKIVEVLQRLNEEGT
TFKETAMASKLDMLRANVVARLEGILPYREELLKIQMNYPETDESNQAKELLENLIDVEK
ESFVDDAKASSWKVVLMDIPQGRREVIKTQLVEKLKVISDKISISQDVYNVKETWFVIHG
LQNRDSADSVIIELQKIISENQLATFPISTENYRLVQIKKAKESYLNR
>OBAHECAF_00120 50S ribosomal protein L32
MAHPKRRQSRTRRDKRRTHDKAVVPQIAKDPITGENHLYHRAHWHEGKLYYRGQVLVDST
EESK
>OBAHECAF_00121 hypothetical protein
MNKLKKYNISFAGLKLGKHQFVYELDKSFLDLFAYDDVNDVHQKVTVDLDKKSNLLELHF
RNEGTVNVNCDLSNEPFDLEVASELFLVVKFGEEFNDEDDELLILPHGEHQVNVAQYIYE
LVVLSIPAKRVHPDVQNGTLHLDILDKLEKLSPKGDVDEREIVDPRWEGLKIIIITDKEK
>OBAHECAF_00122 dTDP-glucose 4,6-dehydratase
MKKNILITGGAGFIGSHVVRLFVNKYPDYRIINLDLLTYAGNLENLKDIEKSPNYEFVKA
DICDFQAMKQLIESKNISGIIHLAAESHVDRSIKDPFTFAKTNVMGTLSLLQAAREVWNG
NWDGKLFYHVSTDEVYGALQMDNTLFTENTKYDPHSPYSASKASSDHFVRAYQDTYGLPT
VISNCSNNYGSYQFPEKLIPLFINNIRNNKPLPVYGRGENVRDWLYVEDHARAIDVIFHK
GKIGDTYNIGGFNEWKNIDLIRVIIKEVDKQLGRPEGSSEKLITFVTDRAGHDLRYAIDA
TKIKEELGWEPSLQFEEGIQRTVAWYLQNQEWLDTITSGDYQKYYDQMYKGR
>OBAHECAF_00123 hypothetical protein
MKSINLQNRLFEFSISAINEVRKLPIGIEYKLIAHQLIRSATSVGANYEESQGAVSQADF
TNKIGICLKEIRETNYWIRILIRIYDDNRNWKDLEQESKELMSIIGAIHSKMRKKST
>OBAHECAF_00124 dTDP-4-dehydrorhamnose reductase
MRFETMKNILVTGANGQLGSEIQNIQGKTKNYFFTDASDLDITDRQAISDFVKKNNIQIV
VNCAAYTNVDKAEDDIQTANLINNIAVGYLAEVCKENNASLIHISTDYVFGGTKNTPYSE
TDPTEPLGIYGRTKLEGEKAIQNADIDYLIIRTSWLYSLSFGHNFVKTIQRLSSERNELK
VVFDQVGTPTNARDLAAFIVHIIEKDLYKRREVYHFSNEGVCSWFDFATEIVRMSGNECL
VKPCLSSEFPSKVKRPSYSVLDKSKLKNDFNYTISHWKDALEGK
>OBAHECAF_00125 dTDP-4-dehydrorhamnose 3,5-epimerase
MNIIQTEIKDVIIIEPKIFGDERGYFFESFSQEKFVEQVCKTTFVQDNESKSRYGVVRGL
HFQKPPFSQSKLVRVVVGKVLDVAVDIRKGSPTFGKHVAVELSAENKRQLFVPRGFAHGF
AVLSEEVIFQYKCDNYYNPKEEGSVLWNDPALQIDWKIPHQNIILSQKDKESPLLKDAFH
FDFDVNLYE
>OBAHECAF_00126 hypothetical protein
MHEEFTNVPFTFGTIILKTDFVNRQKEIKLLRQCFLSGTNVILISPRRWGKSSLVEKVAE
SFENNKTLKICKLDLFNVRTEEEFYISFTNAVLKATSSRWDDFVTNAKQFLSQLLPQVSL
ASNDETTLQFGISWKELQKNPDDILNLAENIAQNKGIKIVVCFDEFQNIASFSDSLSFQK
KLRAHFQRHQNVSYCFYGSKRHMLIEVFTDTSMPFYKFGDIIFLEKINTKEWVNFIKQRF
EETNKQITDSQAKKIVELVDNHSYYVQQLAQQVWLRTTQKSNKKLIENTHQSLIQQLSLL
FITLTETLTNTQLGFLKALLNGEQNLSSKEVMDTYKLGSSANVVKLKRALVDKDILDDMA
GILTFQDPLYREWLKKYYFKLNY
>OBAHECAF_00127 Glucose-1-phosphate thymidylyltransferase 1
MKGIILAGGSGTRLYPITKGISKQLLPIYNKPMIYYPLSVLMLAGIRDVLVISTPQDLPG
FQRLLGDGSDYGISISYAEQPSPDGLAQAFIIGEQFIGNDDVCLVLGDNIFYGQSFTKML
LQSVETAEKERKATVFGYYVKDPERYGVAEFDAEGNVLSIEEKPEKPKSHYAVVGLYFYP
NKVVNVAKNIKPSARGELEITTVNQQFLKDNELKVQLLGRGFAWLDTGTHDSLSEASNFV
ETIEKRQGLKISCLEEIAYRRGWISAEKIRELAQPMLKNQYGQYLINLLK
>OBAHECAF_00128 L-rhamnose mutarotase
MKRFGQVIKVKPEKLAYYRELHANPWQSVLDKIHECNIRNYSIFLLNDELLFAYFEYIGD
NFQEDMQKMAADPETQRWWAETDPCQQPLELKEGEWWHTMEQVFHTE
>OBAHECAF_00129 Biotin synthase
MGETRHNWTKEEIIAIYNKPLMDLLYEAATVHRKYHDPNTVQVSTLLSIKTGGCSEDCGY
CPQAARYHTHVETEEQLMSVSHVKAQALRAKSSGASRVCMGAAWRNVKDGPEFDQVLEMV
RTINKMNMEVCCTLGMITENQAKRLAEAGLYAYNHNLDTSKEYYEEIISTRSYDDRLQTI
ENVRKTNITVCSGGIIGMGESLEDRAGMLVALSTLNPQPESVPINALVPVEGTPLEDQEL
VEIWDMVRMIATTRIVMPTTQVRLSAGRTQMSREGQAMCFFAGANSIFAGDKLLTTPNPN
INEDMQMFEILGIRPQEPFEKHKQPVTVEAKDSQYVDLGENPKWTRPTHKIERNEQKRKT
RMTE
>OBAHECAF_00130 hypothetical protein
MKILLLSDTHSYMDDKILSHASQVDEVWHCGDFGSMEVAKALAQQKPLRGVYGNIDGADI
RSQFPEVNRFFCEGIEVLMIHIGGYPDKYTSLARKEIMKNPPKIFISGHSHILKVMYDKK
FQLLHLNPGAVGKHGWQTVRTMIRFEIEKEEIKNVQVIEFPR
>OBAHECAF_00131 Sodium-dependent dicarboxylate transporter SdcS
MQKTLRKAFIIGLSILIALLLNYLLPYEDKVNKGLALLVFIAILWLTEIVHITVTALLIP
ILAILLGLEQTKPALQAFANPTIFLFFGGFVIATALSVQKLDRYIANRVISLARGNFVVA
ILLLFSVTSLLSMGISNTATAAMIIPLAIGMLKNVDYQTNRNTYVFVILGVAYSASVGGM
GSLVGSPPNAIVASQLHLTFSDWLKYGIPVMMGLMPLMLLAMYIVLKPNFKIKVTTENLV
DKLTRKQYITIIIFIVTALSWIFGDFLNSTISSILGIAKIAEFDAIVAMIAAVLVCFSGV
ASWKEVQDNTDWGVLLLFGGGLTLSAVLTSSGASKALVDGVVFLVEGKHFYLIGLLVAVF
IIFLTEFTSNTASAALLVPIFISIAQELEMNLLGLSLIIGLGASCAFMLPVATPPNAIAY
GTGMVNQNDMIKIGFVLNILSVIFISTMAYWFWF
>OBAHECAF_00132 50S ribosomal protein L27
MAHKKGVGSSKNGRESHSKRLGVKIYGGQVAIAGNIIVRQRGTQHNPGQNVYIGKDHTLH
AQVDGIVKFEKKRDNKSYVSIVPFEA
>OBAHECAF_00133 50S ribosomal protein L21
MYAIVEIAGQQFKVSKDQKVFVHRLQNEEGQKVTFNNVLLLDNAGAITVGAPAISGASVE
AKVLKHLKGDKVVVFKKKRRKGFKVKNGHRQYLTEIVIENIVASGTVKAEKTEKKEAKSA
KADDLKKIEGIGPKASEALVAAGVDTFAKLAKKSVDEIKAILTDASSTLSHLDPQTWAAQ
AQLAADGKWDELKKWQDELNGGVQK
>OBAHECAF_00134 L-methionine gamma-lyase
MSNLKQATKALHAGHNVKEHNGTRAIPIYQTTSYVFENSDNAAGRFNLTQPGYIYTRLNN
PTNDILEQRLAALEGGIGAVVTSSGTAAISTTFLTLLRAGEHIVASNSLYGGTYNMLNVT
LPRLGITTTFVDPKDPKNFDVAVKENTRAIFVESLGNPKLDVLDIEAIAKIAHAHNLPLI
VDNTVASPALLRPIEYGADIVIHSLTKYIGGNGTSLGGAIIDAGNFDWSSGKFPEFTQPS
AGYHGLVLHEVLGNAAFIAKIRIEGLRDLGAALSPFNAFQILQSLETLEVRIKKHSENAL
ELAKWLQTQPEVAWVNYPGLEGSPYKELSNKYLPKGQSGVVTFGLKGGYDAAKKTVDNVK
IFSLLANIGDTKSLLIHPASTTHQQLTETQQKTTGVTTDLIRLSIGLEDIEDLKNDLKQA
FSSAQ
>OBAHECAF_00135 Homoserine O-acetyltransferase
MDTNFEKACSGYRYIDILDFSTLSGEHYKEIRLQYQVFGQELGTAPLVVVNHALTGNSQV
MGENGWWNEAIGYGKPIDAQRYSILCFDVPGNGYGASMLIQNPYKWVARDVARIFLQGLE
ILNISKAFALVGNSVGGGIAWEMIALAPKLFSHFVAVATDWKSSDWIIANSLIQERILET
SSQPMHDARLHAMLCYRSPQSFKIKFNRTLHHENQSLHNVETWLLHHGEKLEKRFSLAAY
KLMNQLVKTIDITKDRGNFEQVMQSVETQIHIIGTNSDLYFVPEENIETHQLLQKMGKQS
TYQEIKSIHGHDAFLIEYQQLDVFLKKIF
>OBAHECAF_00136 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKILKFGGKSLANGNGLDTVLNIIRQKVQNKEQVAVVVSARGNATDELITLLEKARNGVD
YQSELKSFKSYQLYNFNDNYQQEIAESFELLEKLLEGVSLLGDYSLKIKDLVIAQGELIA
AKLIAELLREQGVKSSFVDSRDIFVTDSEFGNAHIISDVSKKKTQDLFLRFSKDEVPVVT
GFIASTQKGETTTLGRNGSNYSAALLANFLNATEMQNYTHVDGIFTANPELVPEAKIIRH
LSYEEANELANFGASILHAKTIIPLIERNIPLRIKNTFKNEDSGTLIHNESSEDGIKSIS
VIENNALIVLEGRGLLGKVGVDARIFRALANKNISVSIISQGSSERGIGFVVHSNDANAA
KLALEEEFSQDFYTNDVSSVSVIDNVAVISIVGQNLATFHYPYNALIRNQIVPLLINNAI
TGKNVSLVLKTDKLHKALNVIHGEIFGVSRRINLVVFGKGTVGATLIDQVIDAHDNILKR
KNISLRIVAIANSSRILTDASGISTNWKEQFEQEAVNYDFSILQQFIEKNHLENLIAVDV
TASKAFVENYIQLIKSGFDLVSANKIANTISFDFYQELRENLAKYQKSYLYETNVGAGLP
LIDTIRLLHHSGENITRIKGIFSGTLSYLFNTFSEENKPFNEVLQFAINSGYTEPDPRED
LCGNDVGRKLLILARELDLGNEFTDVKIQNLIPEHLREGSVSDFLERLEEFNAHYQDIKD
GQADDHVLRYVGDLHGDLSDTATAKLEVSLVSVPKNSALGQVKGADSIFEIYTESYGNNP
IVIQGAGAGAAVTARGVFGDILRLAERNNF
>OBAHECAF_00137 Alanine--tRNA ligase
MTSQEIRQKFLDFFQSKGHTIVPSAPMVIKNDPTLLFTNAGMNQFKEYFLGNGKPNSKRI
ADTQKCLRVSGKHNDLEEVGKDTYHHTMFEMLGNWSFGDYFKKEAIEWAWELLTQVYKIP
KDRLYVTVFEGSQQDNVPFDQEAYDIWKNLIETDRILLGNKKDNFWEMGDQGPCGPCTEI
HVDIRSDDERQKIDGKELVNKDHPQVIEIWNNVFMEFNRKADGSLEKLPAQHVDTGMGFE
RLCMVLQGVQSNYDTDVFTPLINRIEEITQSKYVIGNNVSHEQEQINIAIRVIADHIRAV
AFAIADGQLPSNNGAGYVIRRILRRAIRYGFTFLNQKEPFIHQLVTTLSQQMGKTFPEIE
KNAILAENVIREEEASFLRTLEQGLLMLDAMMNNSMDKELSGAKAFELYDTYGFPIDLTA
LILSEKGFTLNEKDFEENLRKQKERSRAAAQVKAGDWVVLRDDDEEEFIGYDTLEAFVRL
VKYRKVESSKEGTYYQLVFNTTPFYPEGGGQIGDKGTLQSANGEVTYITDTKKENNLIIH
ISETLPENVTDPFKAEVHPLGRSLTAANHSATHLLHQALREVLGTHTEQKGSRVDMHSLR
FDFSHFQKVTDEELERIELRVNELIGQKINLQEYRNLPIQQAMDMGAMALFGEKYGDNVR
VIQFGDSKELCGGTHSKNTADIWYFKIVSEGAVASGIRRIEAITKHGALQYFKDQEKLVK
EIRHGLKNAQDPLKAISHLQNENLRLTKEIEELKRQQAKNLKSELKSEFKPVNGINSLIK
RLDLDLASLKDLAFQLGNEVEKVFILFGATQEESKALLLCYISKDLVADKGLDAGKIVRE
LGKHIQGGGGGQPFFATAGGKNPAGLDQALEKAIEFVK
>OBAHECAF_00138 Malate-2H(+)/Na(+)-lactate antiporter
MERKPIFKISLFEAFLPIIILIVMLGYNVFYVYGDNALGGSNQFILLLGAAIAVFIGFIN
GVPIRTMTHEIYNNIKSTSGAILILLLVGALSGTWLLSGIIPTMIYYGLQILTPSIFLPA
SVIICSAVSVAIGSSWTTSATIGIALVGIGTSLGIPLGLIGGAIISGSYFGDKMSPMSDT
TNLAPALAGTDIFTHIKYMTYTTVPSIIIALIIFTVIGFTIDTHGISDTQAIQNAILERF
NVTPWVFVVPAIILVMIYKKAEPLVALFCGVILGALFALVFQHDLLLELTQTMSMEFAST
YRLMMETITTSTQIPTDNEILNELFSSSGMSGMLHTIWLIICAMAFGGVMEAIGALERIT
DFLLNLFSSVFGLFASTVMSCMALNITTSDQYLSLVVPGKMFSKAYAKKGLAPENLSRTL
EDSGTVTSVLIPWNTCAAYNSGVLGIPTLTYLPYAFFNIISPFMTLIFVAFRIKIRRITE
KNI
>OBAHECAF_00139 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MKTLKVIIAHHLKKLGHTPRWLVLVIDLLINTISLWITVFLFEKIGIKAQSSGYERMVLI
LAISFLFLWLFKSQRGLVRHSTFRDIWKIFFITISILFASKAVSWLWQRVYGYPIFLDIH
LVVNFVLSFFLLSFFRITVKEFFRKINEWNNGKKQHWKIIALGTDTEMVSVAKVIRDNPY
TPYDLVGFLVDGNIGKATLLGKKIIKKQSFLAKSKAQLQIDGVLINQNALSRSEIAEWTN
IFLDKGLKVLKTPRLQKVRSNQDVKLKSLQIEDLLHRKPIVIENEEVIQKHFQKNILVTG
GAGSIGSELIRQIATFKSAQIVVLDQAETPLHDIELELREKFPTVSFKFVLADISNRERL
ERIFQKYHFSIVYHAAAYKHVPLIEENPYEAILVNIQGTRNVALLSSKYKVERFVMISTD
KAVNPTNVMGASKRTAELFVQALQKETTNTTKFITTRFGNVLGSNGSVIPHFKRQIEKGG
PITITHPDIVRYFMTIPEACELVLQAGTMGMGGEIFVFDMGEPIKILNLAIRMIKLSGYE
PETDIKIVYTGLRPGEKLYEELLSDNTKTLPTHHEKIMISKDPSVPFDQINQLSEKIVAV
AQTGDKLQMVRVLKEIVKEFKSNNSIYEELDK
>OBAHECAF_00140 Cell division protein FtsQ
MGIATKMKLKLSKINKLLIIILLPLFLQIFASMRHANRSVKEVNVNHLSDEQFVTDESIR
RILLKDPQALTPLQLVDLKDLEETLNNHQMIEKAEVFYTIDGVLEATVKQRQPIARIYEN
GAFSYMDSQGKLMPLSNIYSARVPLVYGNAQKFWETTYQLVQFIKKDDFLTKNITEIKVT
NKGDYHFRLRIPNFVVIFGKYENIEQKKANLKAFYRQMEKDDRLNDYKIVNLKYANQVVC
TK
>OBAHECAF_00141 Cell division protein FtsA
MKNALNDKKYYVGLDIGTTKIVAMVGTRNEYGKIQILGYGQSKSDGITKGVVQNIIKTTQ
SILEAIADAKTKTGLEDIQDVMVGIAGQHILSRSHSDYIIRPDADKLIDIDDLEQLKQQV
YRIGLTPGQRIIHVLPQEYRVDDQEPTSDPIGMIGSRLDASFHLVIGQVSSSTNIERCVT
SSGLNVVDLTLEPLASAEAVLTEEEKDVGVALVDIGGGTTDVAIFKDGIIRHTAVIPLGG
NIITEDIKEGCAILSRQAEKLKVEFGSAWPGENRDNEIVAISGIIGREPKEISLKNLSKI
IHARVSEIIGMVYNVIKNYGHEENKKKLIAGIVLTGGGSQLKHIVQLTEYITGMDVRIGY
PNQHLTSKPDAKISSPVYATSIGLVMSAIAHESEKLIMQQLEEKKKQEAEEKEREQEALK
EQVKQAQLRVALDSEEVRKEEEAPKEKSGGFWGRVRNLKDKMDSFFSEDYDDDKDYK
>OBAHECAF_00142 Cell division protein FtsZ
MNTNDTDKDLGLFDLPKGKSNVIKVIGVGGGGCNAVNHMFLEGIKGVDYVVCNTDAQALE
NSPVTNKIQLGVTLTEGLGAGADPTIGEKAAEESLEEISKVLENNTKMVFITAGMGGGTG
TGAAPIIARKSKELGILTVGIVTSPFIYEGLKRSRQAKAGIEKLRENVDSLIVINNNKLT
EIYGDMGITEGLAKADEVLMKGAKGMAEVISKHYTLNIDLRDANTVLKNGGTAIMGSAIG
EGENRAFQAIEGALNSPLLNDNKITGAKNALVLIVSGSKEATTREVEEINYYIQDQAGDD
MADIIMGVGKDDSLGEALSVTVIATGFDADQQREIVSSETKKVIHVLDETKPVVHDLTER
KTVPVVDTTWAKPATPEAPKAPQNQSAITSMVDLFNIWVSQELVLPEEKFTIIEKPQVAN
RSQQHMQSGQSSRAVESTKKQDSSERIVHQLGDTEENQPRNFTTKAHITTSGEIRHSLND
YMELEETLTQAHPSEVSDNEVILYKRVEPLSEAGQQMDMFTESESNDPFNNPIPANIMKT
RSNRLQDYNYKFNTSNYTDSNSHSRTSISRDSSGEIQFRKNNSFLHDNVD
>OBAHECAF_00143 GTP cyclohydrolase 1
MIDKHNSEEDILGDNHVCTSAKTPLRNDAFDKSDSEKIDAIEKNVREIMHTLGLDLDDDS
LRGTPKRVAKMFVKEIFGGLHPDRKPSASTFDNSYKYGEMLVEKNIVVYSTCEHHLLPII
GRAHVGYISNGRVIGLSKMNRIVEYYAKRPQVQERLTMQIVQEMQQALGTEDVACVIDAK
HLCVNSRGIKDIESSTVTAEFGGKFKDPQIRKEFLEYIKLETRF
>OBAHECAF_00144 3-oxoacyl-[acyl-carrier-protein] synthase 3
MATKIIGVGNYIPTQTITNVFFDSYLFLDERGNILKQDNSTIANKLKEITGIEERRYAEK
EQNTSDLGFLAAKEAIENAKIDPNTLDYIIFAHNFGDVAFGTIQSDMLPSLAARVKHKLG
IENSSCVAYDLIFGCPGWVEGMIHANAFIKAGIAKRCLVIGAETLSRVVDIHDRDTMIYA
DGAGAAVIEFSDDNAGLKSHLSASFTAKEKDYLFFGKSYNTDSCPSVRYIKMNGRKIYEF
ALSNVPQAMKECFDKSGFSIEQLKKIIIHQANEKMDEAIVNRFYQLYNLHAPENVMPMVI
HKLGNNSVATIPSLLAMIMKGELDEHRINKGDVVLFASVGAGMNINAFVYQF
>OBAHECAF_00145 putative zinc protease
MKIIRGLAVALLLPALLQTTMATTKLEEQHISVKDSVSFKKPLPFDNEVKVGKLPNGFQY
FIRKNVEPKNRVTMYLAVKVGSILETESQLGLAHFLEHMNFNGLKHFPKNELVNYLQKVG
VRFGSDLNAYTGFDQTVYQLPIPSDDPEILKNGLQVMRDWAQDALLTAEEIDKERGVVLE
EMRGGRGAMQRMRDKFFPLMFNNSRYANRLPIGTEPIITNFPYEELRKFHRDWYRPDLQS
IIIVGDIDVNQIENEVKRLFSDMKVHPNAPKREEYQVPFLNKNQFLTVTDPEMTAIVTQM
FIKHPKTNIKTEGDYRKSLLKAVYSRMINNRLSELRQSANPPFLSGTISISDFLANMQTF
GASMVSKPNEYEVGFKAILRELERVQRFGFTQTELDRAIASISKGNETAYIERDKKKSDE
YVNRYLNYFLEDAPALSNEDSYNITKRLLPTLTLKEVVALTKEYYTDVNRDIIILAPDSQ
KNSLPTEAQINQWIAEVEAEKVTAYEDKVSDLPLLAKQPVKGSIVAEKNLTKVAAKELTL
SNGVKVVLKPTTFKNDQILINAFSPGGTNMYADKDYHSSSYASSLVGQSGVGQMNAIELK
KYLTGKNVHVGTYIGEREEGVSAFSDKEGLKTTFELIYGYFTEPRIDEDIFQGTLANVIS
GMSNRENDPNFVFRRDITNKLYKGNVRRVPNTEEDIKSISKDRALNIYKDRFADASDFVF
VIVGSFDEKDIRPLLEEYIASLPSLKRNEKTPDLGIYEPKKGFNLVTNKGKEEKALANLR
YYGDFKYDVQEVLNMQALQSVLTIKLIERLREDEGGVYGTGARINTSKYPKGRYNVSITI
GTGTEKYRHLINLALEEVEKIKKNGPSQADLDKFKIEVQRQNELMVKENGFWQGLLSGAY
RNQQPIETPEEILKRLDKVNIKSVQKVAQKYLKKDQLFEFILLPDAK
>OBAHECAF_00146 hypothetical protein
MFKKHHLKIRLAFVIFLILLLNKFLKEGLDVINFEKAEIHYLLKIGAKMILCLLTLWLIK
KNNFQTSNKNNIIITVVGIVIFCFSLFTIQKKIPSVISFDTNLLFLLSCLAVALFEELFF
RVFIFNALKRMRYKSFKLILITSIVFGLAHLVNFFNTDYEKLSVFNQVVFAFSIGLLLQS
IYVKFKSITICIVIHTIINYFGTYKARLIHYNPLIENTHLESSYTFTDFIGTFLALIIIT
GIFILPISYLLQKHVN
>OBAHECAF_00147 hypothetical protein
MKHLSKITFILSLLIIFSSCSKDNLTSNGSEPTFETSVIIIQNNDFFNTHNSKSLESFAL
KVTLKSFDSDFKLSPVYKFDGIEYCDNGLFNDEVAGDGVYTSVQKFNSLPERNLDSDITI
NKSDKFQHSEKLNSFLQANYTNNDNNIYAKLKPKLSIKFGCKVRLVDCPNTHWYNTSFFG
EPCVEFYDCEASVEIGIE
>OBAHECAF_00148 hypothetical protein
MKFLINIRKKRIEKGFSQEMMALELGISQSAYAKIENGKQKLPTRTLVRIAAILDTSIAS
LFDENVKDES
>OBAHECAF_00149 hypothetical protein
MKPKIPVLGIVITVLIFISVMMFGLPVYNVWQQEMAGKAEMAKAEQNRKILIEEAKARLE
AEKLNAQAEIERARGMAEAMKIENGTLNSVYNQYLFIRTLEKLADKGNLPQIIYMPSEGL
VPVMDVTKHEIK
>OBAHECAF_00150 Asp/Glu-specific dipeptidyl-peptidase
MKYVKLLLLFCSVSLYAQQGGMWIPSLLEGMNEKEMKSLGMRMSVSDIYSVNKSSLKDAV
PHFNNGCTSEMISAQGLLLTNHHCGYGQIQSHSTLKNDYLADGFWAMSKSEELPNPGTVA
TFIIRIEDVTEKILKGTENVSSESEKSNVIEKNIAELVKTSPKEAWQENRVRAFYNGNQY
LLFVVEVFKDVRLVGAPPSSIGKFGSDTDNWLYPRHTGDFALFRIYADKNNRPAEYSKDN
VPYRPKHFFPISLDGISEDDFTMVFGYPGRTQEYLPSVAVEQIINVVNPARIGIRDVVLK
VQDGYMRKDQAIKIKYASKYARVANYWKKWIGESQGLKKSNAVAIKQQQEAIFVKNIEKD
KKTEEYGAILPEFSKKYKAFEPYSLSNELFNELMLRNIDFLTNGYRMYQLQLILEKRGQQ
SFNDRKKNLLETFKNVFKDYEKVVDRDVFEKAIVFYAENMPKQFLVENLRSFDSKKLADE
LYGNSFLASYEEIEKVLSLSPEDFAQKLKDDKGMQIVTLMAENYVNNVLPTYQKLDAEIQ
ALQRTYMKAILEFSKPEDRIFPDANSTLRVTYGKVKGYAPADAVYYSPVTYLEGVMEKYV
PNDYEFDVPQKLRDLYEKKDFGAYADKNGKIPVCFIATNHTTGGNSGSPAIDAYGNLIGL
NFDRVWEGTMSDIHYDPEICRNIMVDIRYVLFIIDKYAGAKHLIDEMRLVHPKKSTSSKK
SKKKRK
>OBAHECAF_00151 hypothetical protein
MKSDSLYFEKQRFTPIWVSILLLILWFYFAIRAYQQIFLHKPFGDSPMSNMGLILFNLIL
LVIISVLLVLKLKLTITPEAIQVQFHPIYTRKVPLKNIRKIEIIDYKMISSGIRISLKYG
TVYRVRGNKGLFITLKNGETLLIGIQNEETLSQNEILNTYLVAN
>OBAHECAF_00152 Deoxyribose-phosphate aldolase
MKLNKFIDHTLLKANATISEIETLCKEAVTYDFFSVCVNSAFVPYAKDFLKGTDINVCSV
VGFPLGAMSLKSKVFETEQALADGANEIDMVINVGLLKSGEVDKVREEIAQIKKACGNNV
LKVILETCYLTDEEKKLACKLSVEAGADFVKTSTGFGTGGATLSDVQLMKEAVNGKAKIK
ASGGVRDFQTAKQYIDLGVERIGTSNGIAIVTGGKGEGY
>OBAHECAF_00153 hypothetical protein
MNTIDIILLVVLGFGLVRGLWRGLIIELASLLAIILGIYGAIHFSFYIADILSQYVSFEK
STMEVISFIFTLILIMLGVMLLAKLLTKVVKFASLGLLNRLGGGVFGLLKTAIIAGSLFI
VLEKTWQTDKWLPQETLKNSVLYEPIKTIGGVVYGNVF
>OBAHECAF_00154 Ferredoxin--NADP reductase 2
MKETDIIIIGAGPTGLFAVFEAGLLKMKCHLIDTLPQPGGQLAELYPKKPIFDIPGYPSV
GAGELVDNLMEQIKQFQPEFTLSETAETIDKNEDGTFVVTTNKGTKIKGKAVAIAGGLGT
FEPRKPELANLVDYEEKGVEYFVRNPESFAGKRVVIAGGGDSALDWSIYLANIAKSVTLV
HRRNEFRGALDSVEKVKALKDAGKINLITPCEVVEIKGKGKVESLVLDVEGNRQEVETDY
FIPLFGLTPKLGPIANWGLEIEKNAIKVNNALDYQTNVEGIYAIGDINIYPGKLKLILCG
FHEATLMCQSVYNRLNPGKKYVLKYTTVSGVDGFDGSRKEAEKAVVKSIE
>OBAHECAF_00155 hypothetical protein
MKRLRNLIMFVIFMTNTVSLWGQIDTISTKTLQLKGNIKQVQDYSYSLEPDKEGKKTVDS
KKYELIPLTEDWNIERDKTKYSKTNIAYTFDRTGKNMSVTTYFTDRVPFGGMTFKYDKKG
KVIGSKTIFTADDGDLVVDKGYFYNEKGQLVKIDENEGGEWLLTTTFKYDDLGNCIEKNK
VASLSVLEKDIQEYEEKNLILEKKIRPEYVKEKHYRYNKANKVTHSEELYPDIGVFLRVE
NEYDKEGYLVKSKFTNEDDQVTICVYKYKKGKLVQSVCTAIDDPDFYMETNLAYASSGGE
TEVIKTKTETVSKKVFDKNGLLILHRTPDFDHQYKYSFDKFGNWKEVVLYENKVPSKIRT
RKIEYY
>OBAHECAF_00156 Rhodocoxin
MSDITLKITDREGVLFELQAPTDMNMNLMEVMRAYEIAQDGEIGVCGGMAMCASCQCYVQ
NDVTLPEMSADEEAMLFEAYHVKENSRLGCQIPITEQLDGLEVILAPYP
>OBAHECAF_00157 Dihydrolipoyl dehydrogenase
MYDRVFCFISRNDRKFIVNNKRFKKNTSDILKNVQKFDIVIIGGGAAGFFTAINCAERNP
NYRIAILEKGKEVLSKVRISGGGRCNVTHAEFIPQNLVKNYPRGERELLSPFSRFMCGDV
IEWFESRGVALKTEADGRVFPKSNTSQSIIDCFLEQVKCLGIELFNSHNVIDFYREDAYW
EVKTSDSIFRAEKLIITTGSNPKIWNLLAKLGHTIVPPVPSLFTFNTSDDFIKDMAGIST
TAEVSLYDIHDKSLKIKNIAPLLITHWGFSGPAILKLSAWGARVLAERDYRCVLKVNWLC
NDLQQPSKEEVLQYLQEIKQTQPKKMLQNTSFPNLPKRLWLRLLDRVGVSHSILWANLNK
TSLHSLSEVLTSSRFVINGKSVFKEEFVTAGGVALSEINFKTFESKMLKKLYLAGEVIDV
DAITGGFNFQNAWTGGYLIAEALQG
>OBAHECAF_00158 Trigger factor
MNITKEQIDALNAVITVAIEKDDYADKVEKVLTNYRKTANVPGFRKGHVPMGMIRKQYGK
AILFDEVNKLLQDSLNKYIVDEKLDILGNPLPKEQQDFNWDAESFTFEFEVGLAPKFELD
LQPQNGITRYEISIEDELIDRQVERIRKQFGKLISKGEVLDQNDIEITGSFFNEEKNIDN
QATFKLEALSADNRKVFVGKKIGDQLQLQTKGLFNDEHDLMHFLKVSHDDVHHLDVTVTF
TIEEVNVREEADLNQELFDKLFPAGTVTSETELREEIKKNSQFQYTEQADQHFLNQVTDH
LVNTTQFDLPAEFLKKWLRTAGEKELTKEEADAEYEKSEKGLRYQLIEGKILGDNNLHPT
FDELKDYANSYVKNQLVQYGMPVDDDSYIDGIVSKILQNKEEIQRINQQLVLNKLLEFYK
ANVKTNTKKATFDEFIKEVYKTDEA
>OBAHECAF_00159 ATP-dependent Clp protease proteolytic subunit
MNFNKEFKKYATKKHGINSLYYDKIISSMTPYIMEERQLNVAQMDVFSRLMMDRIIFLGT
GIDDHIANIVTAQLLFLESVDSSKDIQIYINSPGGSVYAGLGIYDTMQFIKPDVATICTG
MAASMGAVLLCAGADGKRSALPHSRVMIHQPSGGAQGVATDMEINLKEMLKLKNELYEII
ATHSKQPFERVYKDSERDYWMKAEEAKEYGMIDEVLVRK
>OBAHECAF_00160 ATP-dependent Clp protease ATP-binding subunit ClpX
MAKKQSDNFCSFCGRPESETELLVNGLDARICNHCIEQAHGIFLEEMNFQNVKTADQNEL
ITLKKPKEIKEFLDQYVIGQDATKKILSVAVYNHYKRLQQPDTDDNVEIQKSNVIIVGQT
GTGKTLVAKTIAKLLNVPLAIVDATVLTEAGYVGEDVESLLVRLLQAADYDVAKAERGIV
FIDEIDKIARKGDNPSITRDVSGEGVQQGLLKLLEGSVVNVPPKGGRKHPDQKYIEVNTE
NILFIAGGAFDGIERIISKRMNMQAVGYNTSKNTQIDKKNLMQYIIPKDLKDFGLIPEII
GRLPVLTYMNPLDKETLRMILTEPKNAIIKQYQKLFEMDGIKFSIDPEALDFIVEKAIEY
KLGARGLRSLCESILTDAMFELPSSNKKKLVVTKDYAKEKLDKSGLQVTS
>OBAHECAF_00161 hypothetical protein
MFLLNANILIRNIPTKVMKNVIDNKKTQHIFLR
>OBAHECAF_00162 hypothetical protein
MIVAFVYFFWLMLKITWLYIPIRSDVAFLMIKQTEVNADSMYLPIFYVHVYTSIFILLFG
FLAILRKNFGIAKLHRWTGSAYVVLILLFAAPSGIYMGIYANGNVYSVISFLILGILWWW
TTFMAYRTAREGNFIKHKHWMWRSFALTLSAITLRMWKVVIVYLFHPPPMDTYQIIAWLG
WLPNIILVEYLIWKKII
>OBAHECAF_00163 hypothetical protein
MKKSYLILFMAFFVLIGCNESPKNKKQENPEENPGVQIERLLPEVTEREALAKEDYPELY
GIYSGDFMIPENDEEINYSRVEYGDYNKKISLKFNRIINDTVYGHSITGGNQRPFVGTYD
KTSNVFILNEPGDDKTDGKFELQLKNDSIVGVWRVYQKKNVRIPKKELRLQRKVFAYDPN
LMLDRDTDLIDWSSPKEFIDSFVDSDTEEGEEENYSDVGYRVASELIFEINASTQKLTEK
DLKNLKKLDLEIIRNSVYARHGYSFKKATYRYFFEMTDWYIPVSDNVDDQLSVLEKENIV
LLNRMIKYAEDHYDTFGR
>OBAHECAF_00164 Mannose-6-phosphate isomerase ManA
MYPIKFKPILKERLWGGTKLKTLFNKPIETDITGESWEVSAVKGDISVVANGEFKDKSLQ
ELIDLYPNELLGKHVYERFGTDFPILIKFIDAREDLSIQVHPNDDLAKKRHNSFGKTEMW
YVMQADPGAKLIVGFNKDVTKEEYQKHLTEGTLTDIMNYEEVSEGDTFFINTGKVHAIGG
GIIIAEIQQTSDITYRVYDFNRKDKNGNLRELHTELALEAIDYQKKDDFKVSYSKSENTT
NKMVDCPYFITHYLSLSEDFEKKIGAEDSFHIYMCVKGSGIVSDGKTELSINQGETVLFP
AVCDTLQVKTSGIELLEVSL
>OBAHECAF_00165 Alpha-xylosidase
MIKKISSLISLFCLTLVVSAQEQKEINLLTGEKWWGGATSFGNSMPFSQTKVIDLRTHNF
NNQTVSLFVSNKGRYLWSEAPIEFQFTENQIKVKTTRGKIELGTDGNTLREAYLAACNKY
FPSSGKIPPELFFSKPQYNTWIELVYNQNQEDILNYARNIVKNGFPAGILMIDDNWQKYY
GNFEFRPDKFPNPKALINELHKMGFKVLLWVSPFVSPDSQEFRDLQRKGFLVKKKNSKYA
ALLRWWNGFSACYDFSNPNAFDHFTQILKKMQEDYGIDGFKFDAGDPERYLEEEIDVFDK
QSFDVEQTFLWAKLGLEFPYNEYRACWQMGGQPLVQRLGDKTYSWDGVSRLVPDIIACGL
LGYAYTCPDMIGGGEFSSFQGIDPTKFDQSLIVRSCQIHSMMPMMQFSVAPWRILSKENL
EICLKYAKWHEQLGDYILQQAKKSAKTGEPIVQHMEYAFPNQGFEDCKDQYMLGDTYLVA
PIMEKSNVRSVKLPKGKWKDDKGKVYKGGKSYKFTVPLDRLLWFTPVK
>OBAHECAF_00166 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLKRFKENETFSNVLQPKRDELLAESFAFKGKWHQEYFKNNLPIVLELGCGKGEY
SIGLAKKNRNKNFIGIDIKGARFWRGAKTAIEENIPNVAFLRTQIELIEHCFAPGEVSEI
WITFPDPQIKYKRTKHRLTNMDFLNRYKNILSSEGYIHLKTDSEFMHGYTLGLLHGLGHE
VVYANHNIYNSDGVPADVTEIQTFYEQFYLSQNKPITYIRFRIKDNV
>OBAHECAF_00167 Vitamin B12 transporter BtuB
MNNIYIRFLFFLLTYASIGVFPIIHAQQPPKNRGMLMGRVVYANGAPVDMATVVIRSLNR
HTSTDEKGMFRLENLALGKEYIVEVIPFGGQSVQLKADLRRKSTELFVRLKYDEAITLSQ
VEVSGKSKGRQSKDQGYAMNVISTKDVLMQNIQTTELLGRSAGIKIRQSAGMGSDISFNL
NGLSGNSVRIFIDGIPIRNYGRSFSLSSIPPSMIERIEVYKGVLPAELSEDALGGGINVV
LKKDMRSNIMTSYSYGSFNTHQWDLNASHRDKETGFLATLSSFYNVTDNNYKVWGENVYV
TNPITGEYTHVKAERFHDKYYSSGIKSNFGFTRKKWADEFLLGFMFSEMERDIQTGATME
VVYGNRRTEYKTAMGNFQYKKNDLFVNGLDVSAFVTYSKTYRQLIDTVPYVYNWKGEIAR
GYNNQLLKWQSGAEGDSPTLATNDERNLANRLNAHYHIHKNHLIGVSYFLGTFIRQIDDP
LLPEDIRNLLDERKYHKKITSFNYDVNLFDDKLKSSLFYKIYSQQVSLTEFIRTRNPNGT
IVVNNVKHNNKVNDQGYGFTLSYALTPKIIVSLSGEKSIRLPESTELLGNTSQGVSPSLG
LKPEYSNNLNAGINFRDFSFGKHQLGAEMNFFVRDINDMIVRGVPRPSDDFFRFENLGKI
ISKGIDVELRYIWDKHLIFNGNVSYFNALFNLEFSPDTGLRYAHYRNRLRNAPYFTANAN
VEYIFKGIIQEKSQVSFNYNFSYTHEFFKEWEAYGAVGKIIIPSQPLHDLGITYSFPNRK
WILAFNAKNIFDTQVFDNFALQKPGRSIFGKITYTIF
>OBAHECAF_00168 hypothetical protein
MKQKKITSKTLFLAIIATGLTVVGCNKEGSSTPEVDPNAGVIFHLGYGSGYKGTASANVA
PITNLKTGSITFEGEGKIGKAFESARTHRFYASADGKFLYDLEYGNGKIVKYSVSGNDQL
YSKVKDLSVKEIMGTSNPRWKMIDDKTALLFNITPKYKVDSNTGAVTAKEKSKLRILSVN
LADFTLGKPVDIEIPDAKSSDVLPNAHIWRVDNAIVHNGKAYIGTAVQGFNETTQKIVAT
RQYGSGNSLIAHDATTLVLDYPSFQNPKLTYSTQGYGETYGYRAPSYLIDGNDVYNISME
QTHIFKINSVTGEYDNSYDFDLKEKLGLSHDVAGTGFFYAGNGIAYVPFAEASKLEATDA
TWGLARVDLRAKTAKKMNMPSKLWMRYYQAAKLGKDGKLYMAICPTSGSGNIYIFDPTKD
DPNGFEKGATLQVSGEGFYMGVY
>OBAHECAF_00169 Beta-monoglucosyldiacylglycerol synthase
MELIINYTLVAIYAVALILIFLYSLSMLNLLFNYLKHRKQNDESPKFNLLDPKEIPYVTI
QLPLYNEKYVVKRLLENIAQLEYPKNKLEIQVLDDSTDESVIETAAIVEDLQKTGLDIQH
IRRANRQGFKAGALKEGTAIAKGDFIAIFDADFMPQPDWLKKTVIYFKDPEIGVVQTRWG
HLNRNYSILTRIQALALDVHFTLEQVGRSSKGHFINFNGTAGIWRKECIYDAGNWEGDTL
TEDLDLSYRAQLKNWKFKYLEDVETPAELPVVISAARSQQFRWNKGGAENFRKSMMRVLS
SKNIGWKTKFHGVMHLLNSSMFLWVFIVSILSIPVLYIKNTYGHLDWLFQITSFFILSTI
ILFICYWVTYKNLQGKTFDDFLSYVTLFFTFFSVALGFSFHNTIAVLEGHTGKKSEFVRT
PKFNISSLSDSWKNNKYINTKLSPNMIFEFMLMIYFIFGLYSAVRLNDFGMFPFHCMLTL
GFGFVFFKSLTSKA
>OBAHECAF_00170 hypothetical protein
MKKFTFLLFAMLLVACGGNKPKESRVANKTIKGEWILESVTYNQTGKYDITLLNDTSKEC
FEGSKWKFVPNNNRGTYSIENGDCSTGQRNFVFTVQEIDKSSGYYDFLLKPTNEKYQSET
NQGIRMHLAYLSDDKMTWEQTLRVDGKPFVISMNFVK
>OBAHECAF_00171 putative lipoprotein YiaD
MKKIGIVLLSATMLMGCDAYNNSNKTQRAAVVGAAGGALLGAILGNNVKGGSSEIGAVIG
TVVGGAAGAVIGNQMDKQAKKIEEEIPGAEVKRVDDGIIVTFDENSGVYFDTNKSDVNVA
SQETLNKLVDVLKEYVETNVIIIGHTDSSGSDTYNMKLSERRAKSVTDYFIKQGLKSDRF
TTKWFGEEQPTHDNSTAEGRAKNRRVNVVIVPNEKMKEQAQKEAGQ
>OBAHECAF_00172 Deoxyguanosine kinase
MMHEVYISLGSNIGDRKRFLQDAVNAINEKIGSVRNISSIYETPSWGFEGEAFFNVCLLL
KTWLTPTEVLTELLNIERQLGRVRSSLKKGYQSRCIDLDILLFDDITLNTNELTIPHPQL
PNRKFVLFPLAEIASEKKHPVIQKSIATLKDETSDTSDIQKITEKLIPPRFNSPFANYNY
IAIEGNIGAGKTTLATKIAEDFNAKLILERFSDNPFLPKFYENPKRYGFTLEMSFLTERY
QAVSEQLMQLDLFKQFVVSDYDIFKSLIFSKVTLTKDEFILYRKLFYILHNQIIKPDLYV
YLYQNTDRLIENIAKRGRSYEKNISADYLKRIQEEYLSFIQQSNMENTLIIDITCLDFVK
NKEDYDYIIQKISNFSK
>OBAHECAF_00173 hypothetical protein
MLTPVLSTKKLNLDQQNRLLNKGYQLVEWDFITTEYIDIQLDRIGNLLLFTSQNAVKSIL
RNRNIDSLKQITTICVGEKTADLLTRNGWKVLCYREYATELGDYILQNHTEDNITFFCGN
LRRDVLPNILKNNNITHKEYEVYRTNFCSREIEIPIKAILFFSPSGVISYMQKNLISDQI
CFCIGTTTANEALKYTKNVVVAKKPTIDCVIDACTVYFEKDYREVNDGKAI
>OBAHECAF_00174 Bifunctional polymyxin resistance protein ArnA
MKKVLITGGAGFLGSHLCERFLTEGFYVIAMDNLITGDIKNIEHLLPDPNFEFQHYDVTK
FVHVPGNLDYILHFASPASPIDYLKIPIHTLKVGSIGTYNLLELAKNKKARILIASTSEV
YGDPLVHPQSEEYYGNVSTIGPRGVYDEAKRFMESITMAYHRSYGLETRIARIFNTYGER
MRLNDGRVIPAFIGQVLRGEDLTIFGNGEQTRSFCYVSDQIEGIFRLLMSDYIYPINIGN
PEEISINQFAQEILEITQTQQKITYLPLPENDPLQRQPDISKAREILGWEPRISRKEGML
RTYNYFKSLPKEELLKKEHRNFEDYL
>OBAHECAF_00175 hypothetical protein
MNDKQTFIQQGFSVLDTENKENKLIHFLKEHYPQVLKDGELNLTELKAVLGLPIDEKVNG
YGLNFVGRGVARAKYAQETQKELLLNRTLSKNTDTTQNMVLKGDNLDSLKLLKPHYSGKI
KCIYIDPPYNTSSDEFVYPDKFDRHEAEVLGIADSLSEEDFARMEFSFKTKKSHNGWLAF
MYPRLLLARDLLAKDGVIFISIDDNEQANLKLLCDEIFGEENFVADFIRKTKSTTNDAKT
GVNYQHEFLLCYAKNIEKIDRLRGGLKDTTKYTNPDNDPNGRWAVTDPSAKSGNFQNGYF
PVINPYTGKEDYPPKGMFWRFSKNTIQKHINEGRICFKKEHKPDERGFIYKRYLKDLKTL
DSTLDSLNFTDNKYMNQVATKELKEMELVEYFSYPKGVKFVYDIISSCTQDNDIILDFFA
GSGTTGHAVIALNAEDGGNRKFILCQIDEPIAEGKPAYQFCIDNDLPPVISSITIERLKR
VSSPPSLSEGEGAKKHPKTDLFSSEKLENASQSPLLRRGLGEDTDYGFKVFDHTNAPKLT
TDENGQILFPTLHTDALSRIYTMIFKVGLDEPSHTPQEVLENCIYKIDNNYYITNSQRIS
EDYFANVIKDISKNNGKIFVDGWTTSLNATLQYYKEEIQIVF
>OBAHECAF_00176 hypothetical protein
MEKNKIIQYKSLFDEVVHSIEDERNDKIEVWYARELQSVLGYARWENFLVAIHRAIDSCK
TQNINVDDHFREVTKKVSLGSGSQRSIQDFMLTRYACYLIAQNGDPKKEEIAFAQSYFAL
QTRKIELIEERLQHLSRLETRDKLKSAEKQLSQNIYQRGVDERGFGRIRSKGDTALFGGK
STEEMKKRLGVKSNRPLADFLPTLTIAAKNLATEMTNYNVENKDLYGESSITNEHVQNNK
SVRTMLGDRGIKPEELPPAEDIKKIERKVAKEQKNIQQNSKKLPKSKE
>OBAHECAF_00177 hypothetical protein
MQEIKLFETKKVRSHYNEQEEVWYFSIIDIVGILTDQPHYQGARNYWKVLKNRLIKEGNE
TVTNCNQLKLEAEDGKMRKTDVGNVEQIFRLIQSIPSPKAEPFKQWLAKVGYERLQEIQD
PSQSIDRARENWQKMGRSEKWIQQRMTGQETRNKLTDYWKESGIEEKKDFAYLTNIIHQE
WTGLSVKKHKELKGLKSQNLRDHMSEAELLFTALAELSTRQIAESENAKGVNQNAQASKK
GGAIAKNARKELEQKTGKSVITGENFLPPKKEKK
>OBAHECAF_00178 hypothetical protein
MENPNKQIIIYQTTEDNQLKVRLEDENIWLTQQQLVELYQTSKSNVSEHISHIFEEGELQ
ENSVVRKFRTTATDGKTYNVTHYNLDMIISLGYRIKSHIATKFRIWATERLKEYIVKGFT
LNDERLKNLGGGNHWKELLDRIRDIRSSEKVMYRQVLDLYATATDYDPKSKVSQDFFKIV
QNKLHYAAHGNTASEVIYYRVDSDKPFAGLTNFKGSQPTQAEAMIAKNYLKEQELKVLNN
LVAAYFDLAELNAIEEREMKMADYVRELDNILSSTGRKVLTDAGKISTEKAKEKALTEYR
KYNAKTLSSVEESYLETLHQLEKQAKKESRKK
>OBAHECAF_00179 hypothetical protein
MKLKQFQYETQSYQEDCIHNIVQIFENLHEQDSFEKTLTEHKNKNQYPFPVQDAKNIDIM
METGTGKTFTFIKTIFELNRNFGYQKFIILIPTVPIREGTKTNLEDTKAYFKGLYANEKE
KEIEVFTYEGGNISAVNNFIHSQHLSVLIMTPSSFSSKDNILNRPLEREINNLFTYQNPI
QTPKTYLECLKQLNPIVIMDEPHRFDGDAFKKYFEGFNNYYLRFGATFPRKKDSVQLSNV
AYVLDSISSFRQNLVKKIVVYTQDIVESIDTLVGIEKKGSKNIALIDTLSNGTIVRREVS
VGGIFNGTSVRKINKDNIILENSTIEKVDYSLTDESLRAMISKTIEIHFQKEQMLFEQGI
KALSLFFIESDTSLFRGDNPKIKTLFEEEFKKKYDEVIAALDVNSDYYHYLKNSFDADGN
LQVHKGYFSGDKGNADQKVKDGVDEILKDKKKLLSFESPTRFIFSIWALQEGWDNPNVFT
ICKLSNQGSEISKLQQIGRGLRICVDQNLQRKTFKNLGNNQEEFWKINNLDVVVSSKEQG
FVESIQNEILSNSFLISKSFTEKEIIHILKEKTTFDDDTIDFLISDILRGEKLIVRKAII
DGERIFEKADNFASLLKEQNLPAEQEKALLDVFVSPAEINTFIQKANKVKEKKKIFIKQS
HLQEFKDLWNTINQNAFYVLDTLSEEKQQQLIENIKTDIENLQIDEVLLQTKRSDLNVNK
IDRQDAITTEIVSTQHRKQEVNLLAMVQWIATKTKTPLAFVVQIFNVLSEGFKAENLANN
PAQAQKEIVKIINKNLINTLKAHIRYDGISGKVLANVFQTENDKTYIEKGSVGKFQKDID
TDFALKEKWIFEEVIEYDSDFELQIIEKDPNISEIAIFGKLPKLKIKTPMGEYNPDFCYA
IKGEQGNKVFLVVEAKGYDTLGDVSDSERAKIDFAKKYFQTLNEHYKDQNIKISFKERIN
RTQLSALVKG
>OBAHECAF_00180 hypothetical protein
MKPLNYQSRITEVGDVANRLAVLYKGTATLQDDAFLKNLLSEIQTQGDAITEAIKKDKAV
SNLEDADAERDEAIRVLDKMLKAYEVFPVESTKAHGQKIAAIFKKYGVKITEENYSSQSN
LIDSLLKDLSANEVQASVTALSGVSEAIATIRTTQEEFSKVRLQYEEAFTENHSKVSASS
LRKPLLGLINKKLIPYLVAMTLVDGAKYTAFADKVAKIIDDMNEVVKTRGKKK
>OBAHECAF_00181 hypothetical protein
MIKTKINTEFPHHTITQHSGDVYVADYTEQTKSNATKRGTEIFDNPPTDIEYFSVYNPNG
VKMGNVVFDNQSFRYPNGNSKSQCESCLFPFNSNQDSWVLFAELKYANTPKRNKKHFEKA
IKQLYKTRYHYLERGIFDKKNNCYLLISMPRQQEPFPNFNNLTPARIADLKKKHKITLRA
TNSVKVKDDKYLEV
>OBAHECAF_00182 hypothetical protein
MKKLTIKNIGPIKEVTFDIKKVNVFMGRQSSGKSTIAKILSFCSWVEKDISFHQSFQKYE
NKPSEFIKNIEIFHKMKGYFNEKSEICYVGDAVKISYINSTIEFEWLNTRYEYKRPKISY
IPSERSVIILPEMEKVELPNNYLKSFLYDWLNSRRNYTPEKKFHILDTNVEYYYSEEDRN
NHIVNNEYDIMLSQSSSGLQSVVSLLTMVDDLIVNLYNTDRETSSYELDSIKIEVTQSLI
KKYIVEPFISKYVENNDNYEQATMIKTLNDSINNQSEDVIPLLEEYHKVRENLFKYHRTN
LIIEEPEQNLFPATQKELTYQLLEYLNKSEYDHTMAITTHSPYILYAINNCMLTYLVKDK
NEDSKLKNSMISPEDINIFEIEDGKNRSIQQENGLIGDNYFDQQMKEVMDDFYQSLNYL
>OBAHECAF_00183 Leucine--tRNA ligase
MNYNHKDIEAKWQKYWSENQTFKTENYSEKPKFYVLDMFPYPSGAGLHVGHPLGYIASDI
FARYKRHKGFNVLHPQGYDSFGLPAEQYAIQTGQHPEKTTRENIARYREQLDKIGFSFDW
SREVRTSNADYYKWTQWIFIQLFHSWYNNTTNKAEDIQTLVQHFEKFGTENLNAAQTEEL
HFTAEQWKNYSEEEKQNILLNYRLAFRAETTVNWCPALGTVLANDEVVNGVSERGGYPVF
QKKMTQWSMRITAYSERLLQGLETVDWSESVKESQRNWIGKSKGAKIIFPLAPEGGTNAQ
TDKSSKQGYMTGGNNAHLLAEKAKGLRNNMTQAETILWEQLNAKKLDAKFRRQHVIGDYI
VDFVCLAKRLIIEIDGGYHNAENQQVLDKERTEILNELGFEVIRFTNEEVISDIDNILQK
IQEKLALKVDVREEISVSASVCPPSGERGIEVFTTRPDTIFGVTYLTLAPEHELVLQITT
EAQKQAVLDYIEATSKRSERDRMADTKTISGVFTGAYAEHPVTKRPVPIWIGDYVLAGYG
TGAVMAVPAGDERDYAFAKHFAGAEGMSEIINIFDKDISENAFTEKGGFKLQNSDFLNGM
DYEEATEKILEELEKTGVGKAKINYRQRDAIFSRQRYWGEPVPVYYKNGMPYTLPLSALP
LELPEVEKYLPTEDGDPPLGNAKEYAWNEAEEKIVSTDLIDNQTVFPLELSTMPGWAGSS
WYWLRYMDAHNEKEFASQESLNYWQNVDLYIGGSEHATGHLLYSRFWNKFLKDRGFIQAE
EPFQKMINQGMILGTSAFVYRLEGTNTFISKGQIGDKKVQAIHADVSLVNTSSELDIEGF
KQWRPDFADAEFILDENGKYIVGHEVEKMSKSKYNVVNPDDICEQYGADTLRLYEMFLGP
LEQAKPWNTAGITGVSGFLKKFYNLYFDGDAVSISDEEPTKEEYKILHTLIKKVEYDIEN
FSFNTSVSAFMIAVNELQKIRCNKRAILEPMAVLISPYAPHIAEELWEVLGHNESISRVP
FPTFEEKYLVESTKEYPVSFNGKVRFKIELPLDLPNEEVEKIILADERTQAQLGGNPPKK
IIVVKGKIVNVVV
>OBAHECAF_00184 hypothetical protein
MKAIKSLTLFFIFILMLHSCSSPKLGKNRLDLEKFDLNFDVAAFYTDEIEKAEKNMKESD
NLLEKRNKGNLSEKEKKALTEKIFELLRFHVIQIDTVFKGEFTKEKTPMAYRYDMRSWST
RDSLAYFQKMHFCKINMATSLKGDFMALVAESESKGTDDFKALLDYLEQKHGKPTVKENS
FYNDSFTYHWELDDRLLAIFSRYDNKESSLKLGIEVTENDVKVDTTKHPTHVTRLFILKN
QYKQDSILRRFTRGDWISFNDILSDDR
>OBAHECAF_00185 hypothetical protein
MKTIKNVILFFIVTLTMYSCSSPKLGKDRLDLEKFDLNFDVDAFYADEIKKGKENMKELE
KLEEKREKEGFSEKARKELVKKAWKLLKFKSIEKDTIFNAQFYEDERSPIGYQYDMWGWN
SADSLANYHKMHFHKINMATSLEGDFMALVAQSQGEGTEDFEALLRYLEQKHGKVTVKEK
NFFRNFPIYYWELDDRLLAMISKQQKQANLILKLSKEATENNPTTDTIRFNTTHLFILNN
QYKHDSIISNFRSGDWIDFNAVLKK
>OBAHECAF_00186 hypothetical protein
MKLLISPQKKENWKINKEKFISQLKDIFEDIEITEIKDEKRNFCYEWKIESSNSFFYGLL
DKQLNEVYFESNSISIIHKFSNFVRKFMPAESEILMYDEDFTTYTVFPYTGIEISEIMIF
KK
>OBAHECAF_00187 hypothetical protein
MVGFFLGVIFYLFEVMVSNSEVSSVAPTLRELLRNINYFALFIYGIIGFIMMYILITTLN
KLTK
>OBAHECAF_00188 hypothetical protein
MFVFPLLVTIFFVSVIKKTDSNLEPIREVVVTEKLQTNKITIDKHASKRRVYFFVEKQNQ
KIKFERKYNGLVTNWAKAAEYKKYENNETQYFYIEKNTQFNPKENIPFFGLNQSEKNLAY
YFDIFLFFREKYFFALLSLFIGFIFGGGYLVDNSGGISANKSLSIMFFLNIVYLLFLMIG
>OBAHECAF_00189 Antitoxin YqcF
MKPSQYQINLFKKLSPILGTQPKVELYGDETGNFSIRILSCPDPVDEKVLFYSTLGLSEL
ASENNHTEILAASYVQFKDFSNVLSSIAFFILKDKWKSVEGAVFQTLIEMYYPNIEMKHI
YFTSPFLWEDKLEEFSINEVNINFLLAIPISNNELEYLTQYGKDALEDLFEQKNIDIFDI
ERESVL
>OBAHECAF_00190 hypothetical protein
MSYTQDNFQDWIFYIDDKMDDFTQNFAQQHHLTLDYSIQSLDDLEQWIFTNFENNTLLIE
NAKLLDLLTIYIGETFRKHIGGKWVMDTENKKNAYYMLPVLWSENFKGVIYKSPRTYATA
CISRKKGNYISTILKNNMADMGIAIGE
>OBAHECAF_00191 hypothetical protein
MEKFKVKELENKFENFIFNIDDYLESIQNKAKSQGLDFDLSIKSIDLIEKYIVNNDITIE
NDDYNDLSAYLGEVVRRNFQNAQWKCNLDKVNNSLYYGFPVIEGHSTEGILLSPFHLIKA
FILRKKERLLLGAIENQINPELIDWSDFPTEK
>OBAHECAF_00192 hypothetical protein
MMNIIKEIEINHYPEDNTPVINVFDNGTSFLLFEEFPMDEEENYFSEEESDNFEQILSEL
IGVKVAQEDRGCFVLMTNDLQKIQQVKDYLEGKKVVKNKVRKNLRAKEIDAIIKEQTEAF
FKQEGFKYIKKSIGYVKKTKDHHISYGFVHCEYHPEYHYEIVLFVQLREVEEIFGKIDGF
GVLGHTFVFPLSYFLNIEYWINNNPIWSIRAEEDIPAFSQALIDAYKQYVKDFIPFITQP
QNMLNFLLEQIATGARYANTENVFIRALILMKFLNYPIEEIQKRLAEFKSKLIKYDEDLK
KIYYKQMDNVVAGNW
>OBAHECAF_00193 hypothetical protein
MNKKLKIQHLLKLFVALAMYSCSNGQTPTAYHIGKIPQLERFETLTKNEIRLDSLKDKHQ
KEELQMMLDGKAFIAGTPQEFVQQMIEKHKITALRYKDNRSRYFVKTLAKGKEYPFLSTE
EEPFTTDCTCVLDNDTIKIRMGIWVFGGFKFNINLSKNDFQTLYWEDTHERNTYKQTLSD
TLTDNITLEMQQQKLILAKKPTFTLGEELLGHLTFKTNEFYQQTEEIDAENSQDMLKVAK
AGELYFRCQVRQKTEDDK
>OBAHECAF_00194 hypothetical protein
MKKIITLALIFLNGMLLAQQYRPLSEQKNGLILSKLDWQNDLQSENLKGKIKSIETYFYN
EGSLSPQGKEFMKQEKRFFELFHYNPHGNLTEHHPPHDSIPVVWKYNPNHQPIAVSSRWA
NIQYFYENGLLVGAVLKTENTVTESKITLNEKGNVIKQTLSRKKISVGEHNLEYDENGYL
SKFQEVSPLGILDILYTNDSLGRVLKETILENDAVVKTKTMQYNPNGDLIQEIDGAYTKT
FSYEYDNQGNWMLRYEYINNKRTGITERVITYYE
>OBAHECAF_00195 hypothetical protein
MKNILFLLLLLLCSCDFSSNKKQKSKESVSNNEIYENESSKNDSITEAAKHIQSFSNEDL
PLEIHQISEKEFHTAQSKAPKSDSIPKITNFAEAEKLLKDIITFRKDRDWTHFPQEIRFR
NGTKLDTIYDLLNEIGFAAYFPTEDIVLFEGGHSSDVSFNLSNGKQTEEVGNPDYVIASP
NNKVRLNGFYGGQECVFYFIQQYKDGQWQKTINLDHIFEKITTKMLCNLSAFWADDTTLY
LAHPNYDEQGTLGFIHYKIILKPIVSDVTWSDFPTVSFPKKEQTNADNYDLLPALSSRQA
QLLLSGLFPDAENFKRVYSVPFSDDFTSVVVAFQQGEHQFSTILFNLDKNNQIIDYLLIA
YDEIAESAVFTESVLNKDSIVVRKEFYENVITFTYEISPKGEFVLKKIE
>OBAHECAF_00196 hypothetical protein
MKKIATIVTFLLSLQGFSQTIISQTYYEGIIGTDLKVGLYLAIKETGCPNTYAEAYYKYE
KSNERILLESFMDHKEERFTFVEFGNTGILLLHRKGETLEGLWIAPDGKKQLQVTLKALP
QSQKSYERMEEHLEQLNYEAHDC
>OBAHECAF_00197 putative peptidoglycan glycosyltransferase FtsW
MQKWIAQNIKGDKVVWAIILVFTLLSFLAVYSASTNLVYVVGKGTTFGHFIKHGFLMGVG
FVIIYLVHKVPYRFSRPISKIGIVLAAIFLVFAAVKGTVIAGANASRWIEVPFVGVSFQP
STFAFVMIMIYVASYLAENFEKKPTFSDSFWPLWMPVGVTIILIVPSNLSTSLLVAFSVI
ILTFIGKLPMRNILNFLSICAVGVVMFYITAKAFPELLPSRASTWVSRIDSFTDSNENSS
GRFQIERAKMAIAKGGFLGEGAGKSTMKNFLPQSSSDFIYAIITEEYGSFGALIVLLLYM
LLLFRIMVISMNARTVFGQLLVLGMGLPIIFQAFINMGVAVEIFPVTGQNLPLISSGGTS
IWMTCLALGLILSVSTSKRNKEDNLEKDKNIEDVEEELAEGIIKGIHKGNAEK
>OBAHECAF_00198 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKKLVILGGGESGVGAAILGKKKHWDVFLSDKGKVATKYAEVLNQHTIRWEENKHTESKI
LSADCIIKSPGIPDTVEIIKKAKEKHIEIISEIEFAYRYTKGKIIAITGSNGKTTTTSLT
YHILKESGLNVGVAGNIGKSFAQMVAEDDKEYYVLEISSFQLDGITSFKPHIAILLNITP
DHLDRYDYKMENYIASKFRITENQTEDDYFIYDADDPVIEQWLEKNPIKAKKLPFSLEKE
IKQGSYNHKNTIIITINNHIVEMNTEEIAIKGKHNVKNSMASSVASHLLKVRKEKIRESL
KGFIGEPHRLEFVKTVEGITYINDSKATNVNSVFFALDTMKTPVVWIVGGVDKGNDYSPL
LPYVHEKVKAIVCLGIDNNAILQSFGNIIPNIVETKSMEEAVKYARRFATVGDTVLLAPA
CASFDLFENYQDRGNTFRKEVEKL
>OBAHECAF_00199 hypothetical protein
MKQKILFIILCANIFASCENVNQLVNNISNEISESSERIETEISKSTNQIKDEVLKNVNL
EAITNELLNVKHLESIENVALKVVEYQNIAERISLLQENITTGELGALEILAITQFTKNA
QQELMKLKEGNTSIETKKKIDSLLINYENVLNNYSQQNIRGNSEFNNRFQEDMEEDEDFD
N
>OBAHECAF_00200 hypothetical protein
MDIFEEYLQQGEPNKREKANAWNTAIGLQEVDGIKPSEYLIQTAKQNIEGNISIEEAKQQ
INNYYQQQNSKNEENRTEEADKVSVRIAEILGENTFSFSPIEYISIHRRLFEGIYPHAGK
IRTYNITKAEWVLNGETVIYASAENLKQTLDYDFAQEKIFSYKGLNKQQIVEHIAHFISY
LWQIHIFGEGNTRTTAVFLIKYLRKLGFKQINNDMFARHSWFFRNALVRANYEDLSQGIH
KTDVFLIRFLSNLLLGENHMLRNREMHVHFEPVNTQNEPVNDPLLLLIQKQPNITIKQIS
EILKISISTAKRRIQAFKEKGVIYRVGSDKTGIWKLK
>OBAHECAF_00201 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFDYLEKEYNLAGAGLFQYLSFRAGIAAILSLLIATIFGKKIIRRLYALQVGETIR
DLGLQGQNEKAGTPTMGGVIIILATLVPVLLFAELANVYIILLVVSMIWMGIIGFADDYI
KVFRKNKDGLKGKFKVLGQIGLGLFVGAMLYFNPNVTVKNESTKASTVTEVQIQQEEIKS
TKTTIPFMKNNEFDYADLISWAGEGSKDWVWVVFIPIVILIVTAVSNGANLTDGIDGLAA
GSSAIIVLTLGIFAWVSGNIIFSQYLNIMYIPNVGEMTIFIAAFAGALIGFLWYNTYPAQ
VFMGDTGSLTIGGVIAVIAISVRKELLIPLLCGIFLIENLSVMMQVSYFKYTKKKYGEGK
RIFLMSPLHHHYQKKGYHESKIVMRFLIVGIILAIMSFVTLKIR
>OBAHECAF_00202 hypothetical protein
MKKYNSDIHKRRSIRLKGYDYSREGLYFITICCQNREHYFGEIVDGKMQLNEIGKIAYNE
>OBAHECAF_00203 Putative ribosomal N-acetyltransferase YdaF
MKLIINEKLYLELVQLSDAETIFSTIDTQRKYLGEWLPFVSFIKNLADEENFIKSALETM
EQTKEYIFCIRKEGEFVGLISFIKTDKLNQKTEIGYWISETYQKQGIATQATKRMYEFAF
TEMGMNRVQIRCAVGNLPSKNIPKRLGFTFEGVERHGERVSENVFRDLEIYSKLKEEFLI
P
>OBAHECAF_00204 hypothetical protein
MIKILTESFLQVALLLPFAILFLKERSKINFLRLLIFVGCYVAYQLFLVLPSINAVFDVI
ESRWNWEGKALGIICGISCYFIFRRYFHENDFFTLKQNRENLKPTLIVAVGLVLLSTVVW
FLLGKSQFNMETLAFQMSLPGVDEEIMFRGILLGLLTSSLKEKITFVGNPSVLLTAILFG
FMHSLTLDKNYAIDFESIYFIQTTFAGYLWGWITLKSRSILLAILSHNFSNFFGTLATMI
K
>OBAHECAF_00205 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MNLKDILQNIEIISLSGEINTEIGDLVQDSRLVKQGDVFVAIKGTASDGHQFISKAIEKG
AKVIVCEEIPQETISEIVYIKVKDTTSALATMASNFYGNPSEKLKLVGITGTNGKTTTTS
LLYQLFRKVGYKVGLISTIAIYVDEQKYDTKNTTPDILTLNKYLKMMVDAGCEYCFMEVS
SHGVEQRRIEGLQFAGGVFTNLTHDHLDYHQTFANYRDAKKKFFDQLPKTAFALTNIDDK
NGSVMLQNTKAQKKSYALKTMADYRLQILENQFSGLVLKIDGQEVWTNLIGQFNAYNLLA
VYAVADLLGIEKIQNLTALSTLQSVGGRFQYFVSKDKITAIVDYAHTPDALQNVLDTINN
IRTKNEQLITVVGCGGNRDKSKRSVMADISTKESTRVIFTSDNPRDEDPQTILEEMESGV
SAEHYKKFVTITDRRQAIKTACQFAQSGDIILIAGKGHETYQEIKGERTHFDDMEEVKKI
LNV
>OBAHECAF_00206 hypothetical protein
MKNNNQNWIDKWNNNFQNKEYVYGKLPNVFLKEQLDQLPAQNILFAAEGEGRNAVYAAQK
GWKVTAFDISEEGRKKALQLADEVGVNIDYRVGELPNLDFSNQNFDVVALIYAHFPAKIK
SDYHKQLAKLLPANGLVIFEAFSKKHLAYREQNPKVGGPADEALLFSIEEIKADFSDFEF
LYLEELEIELNEGLLHNGKGALIRFVGRKK
>OBAHECAF_00207 hypothetical protein
MNTYIVLLRGVMPTGKNKIPSMAFLKEILGKGGFVNVKTYIQSGNVVLQTELSPAEVSRK
VHEVIKENIGAELPVIVKTADEMRQVLNENPFTENHDIKRVFFTLFNDELPQPLANELKK
QDFGEEKFDFTEKAMYMYIPTNASRSKLSNNFLEKKLKITATTRNLNTLTKLIALAEEME
N
>OBAHECAF_00208 hypothetical protein
MTPEIQNRKGATKLENIPQEVLELLNEGSIESVNLTEWLAVNHTALVATVFPKIGISNAY
ISEIQELIENQKKPSTMNTIKLIGAFLYEKYAKSTDYLAVFEKLATHLSDSVRCYATYFM
ALNSDFSLEKKLGLLQPLVADKHFGVREVVWMALRPELSENLAFSIDFLSVWAENKDENI
RRFSSEALRPRGVWCSHIETLKNSPELALPILEKLKSDSAKYVQDSVGNWLNDASKSRPD
FVQELCKRWEKESPTKSTEYIIKKALRTILK
>OBAHECAF_00209 hypothetical protein
MKKHQYQSTILWTGNKGQGTKTYTTYERSYLIEAEGKSAIQGSSDPAFRGDKTKHNPEDL
LISAVASCHMLWYLHLCSENNVIVEEYSDTPQGIMIEEKSGKGYFEEITLNPIVVVSDKE
MVEKAIDLHEKAHEFCFIANSVNFPIGLNPIIKTKK
>OBAHECAF_00210 hypothetical protein
MSKLILKAFEKIEYLFYIPLVFITMLLVLNIMCLEMKSTPIWEVKNDLFSLFNIVFFVIV
YGISFFFTILIIGLFKFIFTILNIHLGSTSTNKEINEGCYQLDELRQESICNNNSIMYQE
YKELKGNKNLKEYMSYFYFFGNFLLFYEAQLFENGVWHKLKNLNDHFAGILSIINMILFF
YFTWVINYNPDYTGVQKVANKSLES
>OBAHECAF_00211 hypothetical protein
MINREFTHILQQKLRKGKVILLVGPRQVGKTTLINELLKGKDYLFLNGDDTSVVELISGA
NTEVLRNIIGNYKYVFIDEAQRIPNIGLKLKIIADQMKEVQVLVSGSSALDINNMTQEPL
TGRKLEYHLFPISWKEFQDDVGYLKAEQQLEIRLLYGMYPDVINHFGEEKEILENLVSSY
LYKDILSLANIRKPEVLEKILRALAFQVGSEVSYNEIAQLVSVDKNTVSHYIDLLEKCFV
IFSLHSFSTNLRNEIKTNRKIYFYDNGVRNMILGDFTSFALRQDKGALWENFMISERKKR
LNFHRSLARPYFWRTTAQQEVDYLEVTANEIRAFEFKWSDTKKAKLPKPFLDNYSSDFMV
VNKKNFRDFVSEEVKD
>OBAHECAF_00212 hypothetical protein
MTHEFKIIGISVRTTNANGQSATDLGKLWGQFMSDTISKIPNTISEEIIAIYTDYESDYQ
GAYTAIIGKKVSSLDEIPNGMIGREFPATKFQKFIAKGAMPNAVMQTWKTIWEQDEVLNR
AYQYDFEVYGEKSQNGSESEVEVFVSVK
>OBAHECAF_00213 hypothetical protein
MQTLLKLEYIALFVLGVVMFGQSEYEWWWFLVLFFVPDVSMVGYLANPKIGAMFYNFAHH
FGTAVIVFILGKYLSINELTLAGGILLAHSAFDRILGFGLKYSDDFKNTHLGKIGKK
>OBAHECAF_00214 hypothetical protein
MINKDKKYFTSQCKGKTFFTPQCKGKKYFAPTKLWLYFIITMSVYLLMVFITIPTLNRLA
NGLEIIDVLPFYDSEYVVRLLEYLESEGRHYYLYRQLPIDMIYPLLYAFTYRQILKHFID
KLDFKRVRWVVFLPILAAVFDYLENISIGISLYRFPSLSDAVLSVLPFFSLLKNLFVVLY
LLAFFGLGIMVLVRRRKKI
>OBAHECAF_00215 hypothetical protein
MNYDNFFLPAEDFEKSKHFFADVLGLEIKFDFSQMGMIAFKVGNEEAAIILKDKKKFPNV
KPTIWVEVDNVTEVYEDLKTKGVEFLTPPFPIKTGWAVEFLDPSGNVMGFTDYRSNN
>OBAHECAF_00216 hypothetical protein
MSIKYKVIEKGQPGVAGGGTKKFYANVVTEGELSVDDLVKQIEKFSALSEADIRGVIIAL
ENVIQQGLADSKIIRLEKLGSLYPTLSSNGVATEKEFTANQIKSVSVNYRPGTRIVEAMK
AAGFEKKK
>OBAHECAF_00217 hypothetical protein
MKKLIVISDLWGVKQSQWWQYYTETLSKHFEVIFYDACQLGQIDVSQYTEAVLHQQFMDG
GVLQSVQNLTHKEKETFAILGFSIGGYIAWRALHSGLKAQHLVAVSSTRLRYETIPPKAQ
LHLFYGKKDHHLPSTAWYDTMKTSPYLFDEAYHNFYQKEHIAQQICEYIQNKML
>OBAHECAF_00218 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MYKIVLLRHGLSEWNKLNLFTGWQDVDLTEQGIEEAREAGRILKKEGFKFDIAFTSVLKR
AIKTLNYALEEMGDLWVPTHKHWRLNEKSYGALQGLNKAETAEKYGEDQVLLWRRSYDVK
PPLIEETDERHPSHDRRYADLQPEEKTGGESLKDTYDRMLPFWFSEIAPAIKLGKSVIIA
AHGNSLRSLVQYLDGLSEEAILKLNIPTGVPLVYELDADLKPIKSYYLGDQEAIAAAINS
VANQGKSK
>OBAHECAF_00219 Membrane protein insertase YidC
MEEKKIDFKTILGFGIIFLLLLWMSYNNQPTAEELAKREAEKERLEAELNSQNQLTSTQT
KPATIPTDSVALAQYKSTLGAFAYSASLPSASEGVTVLENKDIKLVISNKGGQVKQLFLK
EFTTYDAQPLYLIQDDNASFSLNFTTTQNQNLDTKDLYFEPTTTEKDGKKVVSMKLKVSE
NQFLEYVYELKSEGYMVDFSVRSQGLSEVLNGAKPVALQWAMKSRRMEKSVTYENRYTQM
TVQHEGDKIDRMSESGDDDEQLKNVNWVAFKQHLFSSILISDTPLAEGKFVSKNLVKDEG
VDVQFTKDYVASLPLTLKGGELGESLHFYFGPSDYNVLKQYENHDLTDLIPLGWGIFGWL
NKFLFIPLFNLLTNYFSVGIAIILMTIIVRVLLSPMVYKSYISQAKMKVLRPEINEINEK
FKEPMKRQQETMDLYRKAGVNPLSGCIPALLQLPVFLALFNFFPTAFGLRQHSFLWADDL
SSYDAVMELPFSIPFYGSHISLFPILASVAILIYSLMTMSQSMQQQQPGMPNMKFLIYLS
PIMMLFFFNNYASGLSLYYFVSNLLTILIMLAIKYWIIDEKKIHARIEENKKQPKKESNF
QRKMREMMEQAEAQRKAQQKK
>OBAHECAF_00220 CTP synthase
MAKTKYIFVTGGVTSSLGKGIIAASLAKLLQARGYRVTIQKFDPYINVDPGTLNPYEHGE
CFVTEDGAETDLDLGHYERFLNVPTSQANNVTTGRVYQSVIEKERRGEFLGKTVQVIPHI
TNEIKERMQLLGKTGDFDIVITEIGGTVGDIESLPYIESVRQLLWDLGENNGIVVHLTLV
PFLAAAGELKTKPTQHSVKTLMESGIKADILVCRTEHELSDDLRYKLALFCNVKREAVIQ
SIDASTIYDVPNMMLLEGLDKVALKKLDLPARNEPNLVQWNAFLQRHKNPKHRIKIGLVG
KYVELQDSYKSILESFIHAGAENEVRVDVESIHSEYIDQDNVHEKIGHLDGVLVAPGFGG
RGIEGKIIAIKYVRENKIPFLGICLGMQMAVIEYARHKANLINANSTEMNPEADYPVINL
MESQKEITQKGGTMRLGAWDCKLKKGTLIYEAYKKEAISERHRHRYEFNNDYKEQLENAG
LQCSGVNPETNLVEVIELKKEEHPWFVGVQYHPEYKSTVANPHPLFIAFVKASLENKISR
EPRHSF
>OBAHECAF_00221 Ferrochelatase
MGISFFCTEKIYLCKLTIQIQYTIHKMKGVLLVNLGSPDSTEVGDVKRYLDEFLMDERVI
DFPYLLRSLIVRGIILRIRPKKTAAAYKKIWWEEGSPLIVITKRLLEKVQTQTSIPVEMA
MRYGNPSIEYGLNQLKNKGVTDVLLLPLYPQYAMATTQTIEVLTEKLVQTKFKGMKITKF
PAFYNRTEYIDALAKVTKTYLDANEFDHLLFSYHGVPERHLYKTVRTKNHKKIVDHEYCC
APESEESKYCYRTHCFETTRLLVEKLGLQEGTYSQAFQSRLGIDKWLEPFTSDRVEELAK
SGTKKLAVITPAFVADCIETLEEIEMEAGEDFLHNGGEEFKMIPCLNDDDSWVSALVTWI
QEWQNK
>OBAHECAF_00222 Protoporphyrinogen IX dehydrogenase [menaquinone]
MEKIGIIYATVDGHTKKICDSIHEVLSSKQKEVQLIPVQTFDGNLHFFDKILIASSIRYG
KHHTDILKLINENYAVLNIKKAAFISVNLVARKPEKSTETTNPYVVKFLKNIEWKPSVVK
VFAGKLNYKIYGFFDRIIIKLIMFITKGPTSSPTEIDYTNWDEVKRFANDFAEL
>OBAHECAF_00223 Putative peroxiredoxin bcp
MNTVKKGDQIQDFQGTDQHGNVVKLSDFQGKKVIVFFYPKASTPGCTAEACSLESGYEIL
KQKGYALLGVSADSVKRQANFATKNKLSYPLIADEEKKIIQQFGVWGPKKFMGMEFDGIH
RKTFVLNENHVVTHVIDKVKTKNHTEQLLEFLE
>OBAHECAF_00224 Sodium-dependent dicarboxylate transporter SdcS
MISLSSTILGFDAYATLAILLVAAVFFVSGKVRADLVAVCSLVLLITFGILSPKDALSGF
SNPVVIMMLGLFIVGGAIFQTGLAKMISSYFLKLAGDSEIKLLIIIMLVTASIGAFVSNT
GTVALMLPIVISLAMASNKINISRLLMPMAFASSLGGVMTLIGTPPNLVIDEVLIEKGYP
QLTFFSFTSVGVIGLVVGMLVIIPLSKILIKKKEKVGEGSEKNDKTPYDLVREYKLSKNL
YKVQVQKDSPFVDKSLKELHTTEKYHINILEIRHKSPLGAPFFESNHQEVVNANSVIYEG
DILYTQGKKDDVQQLIDDNKLQLLELKGNKDETEVLKFSDIGIAEVLVMPASKLVNVPVK
KSRLREHFGLNILGIQRQDTYLLQDIKDEKIHTGDILLVQGTWDNIVKLGAERSQLVVLG
HPLEEASKVTLTHKAPIAAVIMIAMVVAMMFDFIPIAPVTAVIIASILMVVSGALRNVEA
AYQTINWESLVLIAGMLPMAMALEKTGVSHYVSEMLAQNLGNNSYILLAGIYFTTSVLTL
FISNTATAVLLAPIAFESAVSLNFSPYPFLFAVAVAASLAFASPFATPPNALVMSAGRYK
FMDYVKLGLPLQIIVGIIMIFVLPLIFPLNP
>OBAHECAF_00225 FeS cluster assembly protein SufD
MSLQKKWVDSFQLFENKEDILKNKRQEAIIFFEQKGFPSKKDEAWKYTSLSTLLKNDFEI
LVSKQTSLTSEDVRPFWIQEDSHKVVFIDGVYSSELSQVQADSFMVSSFREILKSEDAAD
FTSKYFDRETRKDDVFTALNTAFSKDGICIYIPKNKVVEKPIELLFIATDLGKAMCYQPR
NIIEVGENAQVKIIEMHHNLSTQKVLTNVVTEIFVDKNAILDYYKIQNDSLTSSMIDNTY
ISQEGNSNASVHTFSFGGELTRNNLNFYHHGERLESTLKGVTILSGTQHVDNYTLVNHAE
PNCESHQDYKAILSDNSAGVFNGKIMVEKIAQKTNAYQQNDTILLSEKATINTKPQLEIF
ADDVKCSHGCTVGELDKDALFYLQTRGIPKKEGEALLTYAFANTVLESVRIPALEDRVSE
MISVKLGTGVLI
>OBAHECAF_00226 hypothetical protein
MKKLYFILIALLLVSCVNAPKPLTEAQRTEYIALADSVTTETQKLLLMNVSKKIGEVGFV
GAVDFCNENAVPLTNSFADNRFEIKRLSNKNRNSDNAIATDIDLQAWNEITALMGDKNQP
KHILLEEENKIYFYKAIPLGMPTCLACHGNTQGDITDEVQKVIVDKYPNDKAVNYTMGEL
RGLWKMTFERQ
>OBAHECAF_00227 1,2-phenylacetyl-CoA epoxidase, subunit E
MNKFYQLTVTKIEKLTASSVKITFQVPDLLRKVFSYEAGEYLTLQQTIDNQKIRRAYSIC
SGVNENELSVAVKRVPNGIFSTYATTQLKEGDTLEVMPSKGAFVFFYDIFGNKDIMLFSA
GSGVTPMMSIAKTALAKTNIKVVFVYGNKSKEETLFFDEIESLRATYPDRFLVHYVFSQE
MWGDNLSGRINDQVVSYIFEKYKDLNWGRYYVCGPNQMVVNVKENILNRGITKDRIFTEL
FEAEPASNDFTQLKGNVTVFSTLSGKEIVFESPKNQTLLNSILSQGVDAPYSCLNGVCSS
CIGKVTEGEVKMAKNETLVEKEISDGLVLTCQAYAMSDVVRVTFDY
>OBAHECAF_00228 putative CtpA-like serine protease
MRKILSITLLIFSVFSCKKDIDDTPNGGLISQLTPEQQVDLQIKNFIWKGLNLYYLWQAD
VPNLADNRFAPSLMKTDFNNKEYVDFLKKGQAPDEFFYSLLNNYPKIDRFSFITDDYEEL
ERTFAGQVYSSGMDFALSRYGTQGGVLGIVRYVLPDTDAAQKGIKRGDVFTQVDGQALTI
NNYQQLLFNDKTSMVIDINRIKIVNDKPTIVSENRTVTMAKKSIKENPVHISKVIEKGSH
KVGYLIYNSFVADFDLQLNEAFGMFKSQGINDLVLDLRYNGGGRISSAVYLASMITGLSK
QNVFAKERWNDKLQPAFKDSDITNYFADKIIKEGVSYPINSLSGLKRIYILTTERTASAS
ELVINGLKPYIEVIQIGGTTTGKNQGSITLYDSPAGYNKKGVNPKHKWAMQPLVLKIVNK
DGEGDYTSGITPNHAIEEDWANFGELGQETEPFLAKALELITGINTSGKSIPAQPLMPVK
PLADSKTYNFGANEMYK
>OBAHECAF_00229 ECF RNA polymerase sigma factor SigW
MTHQTFLDGIRPFQDKIFRFAKRLLLSSDEAEDVSQDILMKLWQQRNTMETIKNWEAYAM
TLTKNLCYDRLKAKSSDNISLSHITYQAENEISLQKQVEARDLLEQVKNIINGLSEQQRM
IMQLRDIEQYEFEEIEKITGIKEATIRVILSRARKTIRESLRGELTTKIEQTRVY
>OBAHECAF_00230 hypothetical protein
MSEKIHELIEKYFEGTTSIEEERTLQTYFNSENVASDLKHYQPMFAYFKTNREERLVKEF
SVKTPKNRSLFWKIGIAATIFPAVFGWFYVKEQREQQEAELIYQQVKYALELVSVNYNKG
TEKMVYLGEFDKNTKKIFKNLE
>OBAHECAF_00231 hypothetical protein
MKTRFLFLVSFLFCNVALFGQSIFDKYEDNENITTVVISQKMFQMLSKIDSNDPDTKEFM
EIANKLKALKIFSTETASVSQQMKKEVESYVKGGSLSEFMRVKEKNTNVKFYVKEGKTKD
IVSELVMFVQEDKETVLMILTGEVDLNKIGVLSKNINILPKEMNQI
>OBAHECAF_00232 hypothetical protein
MKKIVYLLLFFLISISIISCNSNSLQSYIVKNSENKDFKSITFSPKDFLKLGGSSVDEKN
ILNVIENVHILMYEKKNNGDFQKEYQEVKQLLKTDKYEELIQISNKEYKINVNYVGSDDN
IKEVILLVSQNKEKFALMRMITQNLNIDELSKLSSDLTDIENSVDHDKAHNVISEIRHLL
Y
>OBAHECAF_00233 hypothetical protein
MEIKKSINTKDIMLKYGAYFGVGVVAINVIMYATGMVYSGNMMVGLVSSALTLLVSILAI
VYGIKAFKGANGGFLAMGEALKIGVGIALIGGIIVTLYTYIFMNYIEPDFTKKIMELQFE
KMGEMGMSMSETEMDAAIAMSDKMGAFTYVSSLVGYLLLGLIVSAIAGAVMKKQEQVY
>OBAHECAF_00234 hypothetical protein
MKTFIDKIGSKIGIAFIMLLVFNWIISQWYIRWDLTHDKRYTLSETTRKTLLKINQPVVI
DVLLKGNIPIEFKKLQTETLQLLEEYVAQNKNIHLNFVNPLEEGNDPQQTINELIQFGLN
PLQISQTEAGMSSIEYIFPWAVISDSIQSQKVSLFVNKIGTTDQERVQNSVQLLEYNITD
ALHKLTLKKHKKIAILKSNGTLNDTYIADFLKTMKDYYLIAPFTLDSVPTQPEKTLAHLQ
SYDLLIVPKPTTPFTDPQKQVLDQFVMNGGRALWLIDHVGIDIQDFYTQNGTAVAMPMNL
NLGDMFFQYGFRVNYTLINDLYFSDLMIATGEGSQTRYIPIPWVYNPMILSQNNHLINNN
LDAIRLQFSNSIDTLKNGIRKRVLLTSSPISKADGTPREVTLNVDTKKMDKNAYKSGNIP
VAVLLEGEFSSVYKDRITPIELKNNLQTSKPTKMIVIADGDIIKNDLSNNTPLELGLDKW
TNRFYDNKAFLQNSVNYLLDDTDFLSLRNKKVQLAFLNKEKVADYQSSWKIKSILYPLLF
LIFTILGIRIIYQRKYKI
>OBAHECAF_00235 hypothetical protein
MILYFEFMFALFNKEIRYFFTSAIGFTVIGLFIVLNGIFLWILKTDYNIFNGNSADLLPF
FRLSSWIFVFLVPALTMRSISEEKRSGMLQLLFTKPISVFQIVLGKYLGILFLLFVTLLP
SLLYVYIIWILGNPVGNLDIASTVGSYIALFLLSATFGAVGLWSSSVSNNQVISFMLAAF
LCFFFFFGLDQTAMLLFPDSVTAFGFQSHFDAISRGVIDTRNVFYFLSFIAFFLYTTTLS
LKYYKL
>OBAHECAF_00236 hypothetical protein
MNKSKYAGIFSFLGLTILLSSCTDDSFKEIKSDLLKGPNFETAVFDASVSVENIAKNRVQ
TNGLGGYLLGEYTQKPFGKKKASIIAQVQLPSVSPIFGDKAQSSENTDNKPEKETVTEAY
LYLPYFNPYSTRSNTAYVTETEYALDSIYGNTKASFKVNVQELTYFLRDIDPAQNLAPQR
YYSDFEVSNHLGTTLTNVNNAETVTISKKSITRNQFDNPTTPDDESKGVADVLAPGIRIA
LDPEFFQTKIISKEGTTELENQNNFKNHFRGIVIDADGFSDNLMMLLDMSKAKIELVYTY
ETESNNQKATLKKRYDMNVNGITFNTYTTEDESISLETDSNNISRIYLSGGIGQIANLKL
FTDAELAEIRQRDVLITDASLYLYVDQSVTYGKEPERIFIYNAKTGAVIADYVNDPTSTL
QSAEGSHLIHLGKLQKQNNKGNYYQIRLTTHVINIIKNKVENVPLAIAVASTVKNPYVVN
YFDSANKKRVIPTTSVVTPLSTVIYGNDASIDDSKRLKLRINYSKLR
>OBAHECAF_00237 Glycogen synthase
MTDKKVLFVSSEVLPYSPENEISKMSFETPRMVNSYGGQIRIFMPRFGSINERRHQLHEV
IRLSGMNIVINDIDVPLIIKVASIPKERIQVYFIDNDEYFKRKATFVDEDGVLFADNDER
CIFFAKGVVETVKKLNWLPDIIHVHGWLASLLPLYLRTYYKDEPIFSESKIITSVFNQDF
EGSLRSDITSKVAFDGINKKMAEHLAEPNYFNMMRVASKYSDGVIVVGDNVPEDFSSYIN
GLKKPVLFNSDMETFQASYREFYQQFLK
>OBAHECAF_00238 Pantothenate synthetase
MIYTQQKKLNTVISDFKKAGKSIGFVPTMGALHNGHLSLMKKALEENDVVVVSIFVNPTQ
FNNPKDLEKYPRTLEADVEKIATISKDILVYSPEISDIYGTNVSSDFFDFHGLDRVMEGA
FRPGHFDGVGTVVKKLFEIVTPTKAYFGQKDYQQLLIVKKMVEITELPVEIIGCPIVRNA
DGLALSSRNQLLSEYMQRKATFIYKILQEVKELFITKNIIEINEYVTKAFTDDKDFELEY
FTIAEADTLQTATAKEIGKRYRAFIAVYAEGVRLIDNMEL
>OBAHECAF_00239 Proline--tRNA ligase
MSKDLTRRSEDYSKWYNELVVKAELAENSGVRGCMVIKPYGYAIWEKMQAELDRMFKETG
HVNAYFPLFVPRSFFEAEEKNAEGFAKECAVVTHYRLKTDPNAKGKLMVDPEAKLEEELV
VRPTSEAIIWNTYKNWIQSYRDLPILINQWANVVRWEMRTRLFLRTAEFLWQEGHTAHAT
KAEALEEAEKMLEVYAEFVENFMCVPVIKGFKTESERFAGADETYCIEALMQDGKALQAG
TSHFLGQNFAKAFDVKFASKEGTLDYVWATSWGVSTRLMGALIMTHSDDNGLVLPPKLAP
IQVVIIPIYKGEEQLEAVRERVLPLMATLKKQGISVKFDDRDTHKPGFKFNEYELKGVPV
RLAVGQRDLENNTFEVARRDTLTKETVSGDSIVEYIEKLLQEIQENIYKKALDYRNAHIT
EVNSYQEFKEVLESKGGFIAAHWDGTTETEQRIQEETKATIRCIPLEAKEEAGVCMVTGK
PSAKRVLFAKAY
>OBAHECAF_00240 Ribonucleoside-diphosphate reductase subunit beta
MGIFDKRESYKPFEYPEVMEFVNAMHKSFWVHSEVEFTADIQDFKANLSIVEKEAVKRAL
LGIAQVEVSVKTFWGDLYDLFPKPEFNGLGATFAECEFRHSEAYSRLLEVLGYNNEFENL
LEVPIFKERNLVLKEYLAKNKENAMQRILFFTLIIENASLFSQFATILSFTRFKGYMKNV
ANIIAWTSVDEQLHANAGIYILKKIFEENPAMKEHAQTEATEFIRNYIQLEDKMLDWIFE
EGEIEFFSKEDLANYMRYRLDDSLTQLGFGKPFGITTDQAKPMLWFEEEVFSNSLDDFFA
KRPVDYTKHDKSISANDLF
>OBAHECAF_00241 hypothetical protein
MKKHQKDIIIGLFVGLIANALGILLYILIFSRHSIELTIRDAYVKGYLGALIALGGLLDL
ASFFVLLRLGQDNRAKGVIMASMILALVILMLEFN
>OBAHECAF_00242 hypothetical protein
MLRDQLKNLFPNHVEEEIPEKEASNVWLQDDPLICKYEKRNGKPVTIIEEYNGADSDFKI
LSKELKTFLGVGGSVKNEKIIIQGDYRDKIMQFLRNKGFKVKRVGG
>OBAHECAF_00243 Replication-associated recombination protein A
MNVPLAERMRPNSLSSYVGQTHLVGENGSLRKQIESGWLPSLIFWGPPGTGKTTLANIIA
LESKRAFFTLSAISSGIKEVREVIEQSKNSSGLFTAKNPIVFIDEIHRFNKTQQDSLLQA
VEKGWITLVGATTENPSFEVIPALLSRCQVYVLNAFDRADLEKLLKNAIEKDSILRTKKI
QVTEKEALFRLSGGDGRKLLNTFELIVNAFSEGETIEITNEKVMQIVQKNTVLYDKTGEQ
HYDLTSAFIKSIRGSDPNGAVYWLARMIEGGEDVKFIARRMLILASEDIGNANPTALILA
NNTFQAVTTIGYPEARIILSQCAIYLASSPKSNASYKAINTAQQVVKQTGDLSVPIHLRN
APTKLMKELNYGKDYKYSHDYAQSFVFQDFLPEELQGYRFYEPADNVRENGLREYLRNLW
GKRYGY
>OBAHECAF_00244 Arylsulfatase
MKKVFFLCSFFFSCVVLAQQRPNIVIIISDDHSFQSIGAYNEGKTSYTPHIDKLSEQGMT
FNKAYVANSICGPSRACILTGKFSHKNGYTDNETSRYNSNQQQFVNILQENGYQTAWIGK
YHLGKDPKGFDFFKILIGQGHYFNPDFYVPGGKVVREEGYVTDIVENEAEQWLDNRDKSK
PFCLIVGHKATHRTWMPDIQDLGSFEKVNFPLPDNFYDDYKGRIPATMQEMTIAKDLQMG
YDLKMFPPNQEEKDGNFNRMTPSQRKAYNDFYHQIQKEFESQKLTGKALTEWKFQRYMRD
YYATAVSLDRNIGRMNDYLHKNNLADNTIFIYLSDQGFYMGEHGWYDKRWMYEESFRTPM
VIKYPTYIKRNKSTDSFVMNVDIAPTLLEAAGIPIPADIQGKSFLNVLKGSKRPSRETVY
YHYYENGEHAVSPHFGIKNKRYKLIRFYKRHNGWELYDLKKDPKEMNNIYEKRSTEKLTK
RMKSILLKEIKALDDTTALEVFHSSN
>OBAHECAF_00245 ABC transporter ATP-binding protein NatA
MSIEVKQLTKTYGKQVAVNQINFSLNKGEITGFLGPNGAGKSTTMKMITGSLIPTNGEIF
VNGIDMIKNPIEAQRNLGYLPEHNPLYLEMYVREYLWFMGKLYKNISKKRIEEIIEITGL
TPESNKKNEQLSKGYRQRVGLASALIHDPEILILDEPTTGLDPNQLVEIRGIIKEFGKNK
TILLSSHIMQEIQAVCDRVIVINKGNIVLDQSMKNLQNKEQTIEVAFDLRVEERFLRQIP
MLKSVVNIHEFLYHMVFDTQEDMRPKLFDFANENGLKILQINHRHKDLEQLFSELTRDQT
KTAPKSI
>OBAHECAF_00246 hypothetical protein
MKTEQEQKEFYERLKKELEETSQWPSTYLYKFIIPNDTEKKHTLEAIFEGKKADIKTRTS
SNGKYTSVSISILLQNPDEVIAYYREAGKIEGILSL
>OBAHECAF_00247 hypothetical protein
MFKKIFFLLFIFNLSFIRQIAPLDGNESVIGCVEKIQQSYVGNRNTKKFHRTDCNSVYKI
KDKNKTKLKNRKTAIEQGYVPCKICKP
>OBAHECAF_00248 Nucleoside triphosphate pyrophosphohydrolase
MKKNRLQQLQAFERLLDIMDDLREKCPWDKKQTLQSLRHLTIEETYELGDAILDNDLNEI
KKELGDLLLHIVFYAKMGSETNDFDIADVANTVCDKLIERHPHIYGNVKIENEDDVKRNW
EKIKLKEGKKSVLEGVPKSLPALVKATRIQDKVAGVGFDWDSIDGVFDKIKEEINELHHE
VTHKNKENIEKELGDVFFSLINYSRFLKVNPEDALEKTNKKFIKRFQYLENKAQEQHKSL
KNMTLAEMEAFWQEAKKFDL
>OBAHECAF_00249 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MITLENKKKVAFYTLGCKLNFSETSTIARSFENEGYQRVDFEDFADIYIINTCSVTENAD
KQFKQIVRKALKINDKAFVAAVGCYAQLKPAELAAVHGVDLVLGAKEKFDITQYIDDLTK
NNEGQVHSCEISETDFYVGSYSIGDRTRAFLKVQDGCDYKCTYCTIPMARGISRSDTIEN
ILKNAQKISEQGIKEIVLTGVNIGDYGKGEFGNKKHEHTFLDLVQALDKVKGIERLRISS
IEPNLLKDETIEFVARSKAFVPHFHVPLQSGSNHILKKMKRRYLRELYVSRVAKIKEVMP
HACIGVDVIVGFPGETDELFLETYHFLSELDISYLHVFTYSERDNTEAVLMDGVVPDEVR
AKRSKMLRGLSAKKRNNFYVNQLGTERTVLFEGENKQGYIHGFTENYVKVKTPWNPELVN
TLRRVKLTKIDSDGMVRFDFVDNP
>OBAHECAF_00250 hypothetical protein
MHIHFTSYKDFQADLVSELLAANHTISEGELINKNADFVVINRSSKANSDLEKEAQLLGL
ATGTENDFLYTFFKDKTRVVIAGKGKENVLKTVVHTFDFHNIPLSFFTENPIKGKSFRLS
THAEFVLFDGSEEINSIVDKHPKYLTYQPTLALLESISVDTENYATFVDSITKGGILVYN
EECENVMKIVQNTENPIRKIAYKTPDYEENNESFFLITDEGELPLNITQKEEVRYVEAAK
WICQNMGIDAADFYEAIASM
>OBAHECAF_00251 5,10-methylenetetrahydrofolate reductase
MFVVLPREYNFLLKTKMKVTEHIARSKGKTLFSFEIVPPKKGNSIEELYRNIEPLIEFKP
PFIDVTTSREEFFYKQHPNGLLEKKITRMRPGTVGICSAIQYKYGVDTVPHVLCGGFTKE
ETEYLLVDCFYLGIDNVMALRGDARKEERYFEPTKDGHTYAVDLVRQIKDLGRGKFLHDV
IETDYGTDFCVGVAGYPEKHIESPSMTFDLARLKEKVDAGADYIVTQMFFDNQKYFEFVE
KVRLMGIDIPIIPGIKPITTKKHLNLLPQVFKLDLPEILVSELEKCKTNEDVKQVGIEWA
IEQSKELKLWGVPTLHYYSMGKSDNIVDIVSKVF
>OBAHECAF_00252 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MKTNLLGYPRIGEKRELKKANEAFWAGKISEDELFDVANTIRIHNWKLQKEANIDLLPSN
DFSFYDQVLDFSFSVNAIPSRFAPIDNLSDMELYFALARGYQKNGIDITAVEMTKWFDTN
YHYLVPEFTKNQSFKLRYNKALAEYQFAKNNGFETKPVLLGLITYLLLGKEKEDGFHRIE
LVENLLPVYKQIVQSLVDAGAKTIQIDEPCLVLDLTKTEKEAYKQVYTILKETFPTTEFI
LTTYFGALEDNTDLALSLPLDVLHIDLVRAENQLDEILSKLPKDKKLSLGVVDGRNVWIN
DFQKSVTLIEKAQKALGTDRVLVASSCSLLHSPCNLEHENNEKILTPEIKQWLAFAKQKL
VEISTIKSLVTNDLTEVQRETVTQNKKANDNRKTSKLIHDEDVKSRVGAITEKDAHRKSG
FAQRQVIQEGALKLPLFPTTTIGSFPQTQEVRSWRANFNKGVLPLEEYETLLKKEIEESI
RFQEDAGIDVLVHGEFERNDMVEYFGEQLKGYTFTKFGWVQSYGSRCVKPPIIYGDVSRP
TPMTVRWSQFAQSLTSLPVKGMLTGPVTILQWSFVRDDQPRSVTCTQIALAIRDEVVDLE
KAGIKVIQIDEPAVREGLPLRRKDWEAYYNWAIRAFRISASGVEDSTQIHTHMCYSEFND
MIEAIADMDADVITIECSRSQMDLLDVFAEFKYPNEIGPGVYDIHSPRVPSVEEMTFLME
KAIGVIPKRNLWINPDCGLKTRHWEETKKALVAMVDTAKELRAKYNA
>OBAHECAF_00253 Putative electron transport protein YccM
MEEQDKEIFRDSIGTIDKEGKRAWVFPKKPSGRFYRYRKYVSYVLLIFLLVSPWVKINGN
QFLLFNILDRKFNIFGLPFWPQDFYLFVISMIIGVVFLALFTVVFGRIFCGWICPQTIFM
EMVFRRIEYWIEGDRGSQMRLDKQAWDKEKIRKKTLKWSLFFLISFSVANTFLAYLIGSD
VLLTYIKEGPINHWGTFIALFIFTCIFYFIFTWFREQVCIIACPYGRLQGVLLDNRSIIV
AYDYVRGESDNGRKKFRKNEDRQALGHGDCIDCMQCVHVCPTGIDIRNGTQLECVNCTAC
IDACDEVMDKVGFKRGLIRFASEENIAKKAPFKFDLRMKGYTAVLTILIGILIGMLFIRT
DVQADILRLPGQLYQHEENGVISNVYTYKIINKTTRDFENVTVKVVGSLDAEVVIVGKNS
IFVPKQGLAEGTLFLKIKESSLEEEKSKILLDVYSNGNKIGSTKTIFLGPRTFR
>OBAHECAF_00254 Cbb3-type cytochrome c oxidase subunit CcoP2
MKKNLIPFLRVVTIVGVVALFIELLYGTKESTAFAKYYQVPLFLTFLFFLLVFTEVVLKA
VQNLISGIKSRSGAEEGTLWQRFYAGMVEQVPLEKEGDILLEHEHDGIRELDNTLPPWWV
YLFYATIVFMVIYLVRFEVLKDDNQIDEYNKDVARSKIEVAEYKKNNPFEVRLLVDDASV
VEAGKKVFQTNCVACHAMDGGGGIGPNLTDDHWILGGNIKDIYNTISEGGRDGKGMVAWK
SLLKPTEIEQVANYIKTLKGTKPANPKGPEGDLYTE
>OBAHECAF_00255 hypothetical protein
MLKFIKEHMATIDGIEIFPIISFLIFFIFFLALFWWVFGYKKETIDTMNNIPFDNDEDEN
NNTLQ
>OBAHECAF_00256 Cbb3-type cytochrome c oxidase subunit CcoN1
MEKQQFYYDNKIVRKFLFATLAWGVVGTLVGLWLAYLFLFPNMSNEIPWLSFGRLRPLHT
NAVIFAFVGNAIFAGVYYSMQRLLKARMYSDFLSNLNFWGWQLIIVAAAITLPLGYTSSK
EYAELEWPIDIAIAVVWVAFGVNMIGTLLKRRQRHIYVAIWFYLATFVTVAVLHIFNNLE
LPVTMWKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFVPKAANRPVYSYRLSI
IHFWSLIFIYIWAGPHHLLYTALPEWAQNLGVVFSVMLIAPSWGGMINGLLTLRGAWDRV
RENPTLKFMVVAITGYGMATFEGPMLSLKNVNAIAHFTDWIIAHVHIGALAWNGFLAFGM
IYYIVPKMWKTNLYSMKLANFHFWIGTLGIVFYCLPLYVAGFVQASMWKEFNPDGTLVYG
NFLETVTQIIPMYWMRAIGGTFYVTGVIVGAYNVIKTLQTAPKLQDELAEAPALTKISNG
RLQGETFHTWLERKPIQMTIWATVAILIGGVVQIVPTIFVKSNIPTISSVKPYTPLELEG
RDLYIREGCVSCHSQMVRPFRSEVERYGEYAKAGEFIYDRPFLWGSKRTGPDLLRLGGKY
SDNWHFNHMYDPTSTSPNSIMPAYPWLTRNKHDRSDIEAKMRALVKLGVPYTEEDIANAH
ASMEAQAAKIEQNLHNDPDFVKQYEGAKASAQQAGKEFVPMKDREIVALIAYLQRLGTDI
KLEKK
>OBAHECAF_00257 hypothetical protein
MYFCHIYYSEFDLTMSVIYMLITISIAVALLFFFLFITAVRRGQFDDSHTPAVRMLFEDE
LVGSEDTESKQSKTEKLTDN
>OBAHECAF_00258 hypothetical protein
MKTIVTLIFCVCANFVTAQINPSSLFLVIDDKDGIQKTETRNIKGEENYTLKTSYYKEHQ
NVELLFDNGKNANYYIAYYINQSENWQVSFRFDYYKGEENETYGGYILLLSNPMFESFKR
KGNVAIFQDAQKQWKIYNRKEFINKIRTNHSQYIYRHLSGGKYRDTTRNNIFIVFSSDLE
RDYIPCYEVDVLISTIEEE
>OBAHECAF_00259 Long-chain-fatty-acid--CoA ligase FadD15
MNLLPYHYVSVFQENVKKYGSKKALGSKPDQNWTTISWQNFGELTEKVANALLSFQIKPQ
ETIGIFAQNMPQWTITDIGALFVRAVPVPIYATNTSEQALYVINHAEIKILFVGDQEQYD
KVLQVADKCPSLQKIVVFKENVALKESKFSMSWQDFLALGAEKKYREELQKRIDDKKLSD
LFTIIYTSGTTGEPKGVMLDYENLAYQLIGHDNKLKLSNNDESLAFLPLSHVFERAWTYY
CLYKGATVYYLENTNNIKTALIEVKPTVMCAVPRFYEKIFATVHDMVAKSSFIKRGIFAF
AVKSGRKMFETKQRNQKPSWILQKSVQLSEKLVFAKFKKSLGGRIRFMPCGGANLEPSIG
RFFHSIGINVKLGYGMTETLATVSCWDDSSFNFKSVGSLMPNTELKIGENNEILVKGGMV
MRGYYKNPEETEKAFTSDGFLKTGDAGNLDAENNVFITDRIKELMKTSNGKYIAPQHIEG
KIGKYNLIDQIAIIADGKKFVSALIVPNFEILTQMIEDLNVKYKNTSELIKNVQVLDFIN
RQIQRFQKDLPDYEQIKKFTLLPNSFSIEKNEITPTLKLKRKVIYVNYQREIEAMYK
>OBAHECAF_00260 ECF RNA polymerase sigma factor SigW
MALLEQKIKEAKTGNQKAFSYLLDVFWSEVYAFQLKRTDNENDAEDITIQAFSKAFDRIE
TYDENLSFKTWLIAISKNIHVDMIRSRQNSTRNTTSSEDNEVKTIADESPTIEDQLITEQ
SLNHLLTTIKQLKEPYRTVIQLRYLNEKSYKEIAKIMNISLSNVKVTLLRAKKILAELLK
NNFS
>OBAHECAF_00261 putative ABC transporter ATP-binding protein YheS
MLNVHDLSVSFQGEYLFEEVAFMLNAGDRVGLIGKNGAGKSTLLKLLAKEMKPDSGIIAT
DRDVNIGFLKQDIDFEEGRTILEEAYQAFDEIKELELRMDEIHREMGSRTDYESQSYHDL
VDTLSEITHRYDIIGGYNYQGETEKVLIGLGFQRADFQKKTDTFSGGWRMRIELAKLLLQ
NNDILLLDEPTNHLDIESIIWLEQFLTSYTGAVVIVSHDKMFLDNVTNRTIEISVGKIYD
YPKPYSQFLELRQEIREQQLASQKNQEKKIQQTEKLIEKFRAKATKASMAQSLIKKLDKI
ERIEVDQEDNSVMNIRFPMSVTPGKVVLEVQDVSKSYGDKQVLQHIDLLIERGSKIAFVG
QNGQGKTTLAKMIVSEIPFEGNIKLGHNVQLGYFAQNQSSYLDGEMTILDTMFHAANDSN
RMKIRDILGSFLFRGDDVEKKVKVLSGGERNRLALAKMLLSDFNVLVMDEPTNHLDIKSK
NVLKQALQNFEGTLIIVSHDRDFLQGLTDKVYEFKNKKIKEYLGDIDFYLEQRAVSNFRE
IEQSKENTPIEKPNAQVKISFEQQKQQKTLQNKLNKIENAITELENELKAMTNQMGESLQ
SQEFYALYESKKADLDQLMFDWEVLQEQLG
>OBAHECAF_00262 General stress protein 13
MTNIQYIQNQNATLQANQIQNTLQLLAEGCTIPFIARYRKDKTQNLDELSIEQIAKSQTD
YENIIKRKETILSAIEQQGKLTDELKNKIASCFVITELEDLYLPYKKRKKTRADLAKEKG
LEPLAKIIMSQRVSDLQHAASKYITKDVSDEKEALQGASDIIAEWISEHIFIRKTLRRMF
QRKSTIVSQVIKTKEDEQEAQKFNMYFDWQENLMKAPSHRLLAILRAENEGFIRLKVEID
TEEALEFIEKTIINSKGEVADFLKDTITDSYKRLLAPSIANETLQEAKEQADAKAISIFA
ENLKQLLLASPLGEKRILAIDPGFRTGCKVVCLDEKGDLLYNETIFPHPPQKELHIASKK
IKSLVNSYKIEAIAIGNGTASRETELFIKQIGFDRPVQVFVVNEAGASVYSASKIAREEF
PNYDVTVRGAVSIGRRLADPLAELVKIEPKAIGVGQYQHDVNQSKLKEELDNVVVRCVNS
VGVNLNTAGKALLSYISGVGEKMAENIVTYRSENGTFTQRKDLLKVPRLGEKVYQQAVAF
LRIHEGKNPLDNSAVHPEAYPIVEKMATDLGLSSQKLIGNKEAIAKIDIQKYITEEIGVI
YLKDILKELEKPGIDPRKSAKIFEFDPNVKSFNDVKVGMILPGIVNNITAFGCFVDIGIK
ESGLIHISQLKDGYVSDVNEVVKMHQHLSVKVVEVDEQRKRIGLSLIF
>OBAHECAF_00264 hypothetical protein
MASIRNLKKDVNYVFGDIIDAVLHWEYATDNTESQKGSELIKEIISTYDGVMDKISDKKV
ENRAVHLKQVRKEFEQKAGEFIVKLNQL
>OBAHECAF_00265 hypothetical protein
MKESIITFILFFVVFQFYAQYKDSIYHRDAIWRETIRSFEKEDQRKPPRSNPILFIGSSS
ITNWKNLHIYFPDKNVLNRGFGGSELRDVIFYFNRIVTPYRPSQIVLYEGDNDITFGQTA
EQFLDDIKTFVRLVEIHLPGTPIIILSIKKSKARSHFSIEFDKANALLYQFAQTKRIVQF
VDVAQILFDENGNIKDDCFESDNLHINTRGYWLWTDILKNYLK
>OBAHECAF_00266 hypothetical protein
MSLQTKVMEALKDAMKSKDSVALESLRAIKSAILLAKTESGASEELSESQELVLLQKLIK
QRRDSATLYASQGRNDLAEPELAQIKVIERFLPELPSEEEIEAIIKKIISETGASGMKDM
GKVMGVASTELAGKADNRVVSTIVKKLLS
>OBAHECAF_00268 hypothetical protein
MIIISMYCVSNKYDINDKKLILYVFQEKNPTYSLQKNSIN
>OBAHECAF_00269 ATP-dependent DNA helicase RecQ
MDASVFHILKKHWGYDSFRHPQDAIIESVLQGNDVLALMPTGGGKSITFQVPALVNEGIC
LVVSPLIALISDQVENLKNRGIRAISLAGSMLQDDLERLLNNAVLGDYKFLYLSPERLQQ
ETVRYFIKLMKINLIAIDEAHCVSHWGKDFRPAYLECKWLKENFSQVPILALTASATPNV
QQDILQQLGIPKAEIIATSLKRPNIAYITHKTDNKWLQLERVLKKNTGTSIVYIRSRNGT
VRMAEYLQDIGISATFFHGGLSSEEKNKKLSMWLMDDVQVMVATNAFGMGIDKPDVRTVI
HWEIPPTLEDYFQEAGRAGRDGQKSLALLLFNDLDIETTKKQFISNLVTSEDLKLLYAKL
NSYFLIAYGEGVGITRSFQLADFCKKYNLQIQKTYNGLQLLDRLSVISFSQNFQKKATIF
FVASNYEIIQYLQHKQMFKDIVFYLLRNYPGIHTQAISVRIEKIANKIHKDTEDIRQQLS
VLQEDGIITYQDDTSDIEITFNMPREDNRTIAFVAKNIKEYNQTKINLQKSVFEYIINNG
ECKSVQLLRYFGEKDTATCGICSVCKTQNNQKSIDYKQVEEQIIKVLHQGSRNLNDLLLL
LPFEEKEIQKVLFSMLDMNKIRFNDYNQYVLRQ
>OBAHECAF_00270 Hydroxypyruvate reductase
MKILANDGISELGKRQLEAHGFEVLTIKVAQNQLVNYINEHQIPILLVRSSTEVRKELIE
ACPSLKLIGRGGVGMDNIDVEEAEKRNIHVINTPEASSNAVAELVFAHLLSGIRFLHDAN
RNMPLDGDTQFNQLKKNYAKGSELRGKTLGIIGFGRIGKAVAKMGIALGMRVLACDLFVK
NTNIELSFFDGTSVSFQIDMVSKEEVLKNSDFITVHTPAQKEYIIDEKEIEMMKEGVAIL
NLARGGVISEVALFNALESGKVSFAGLDVFENEPTPSIQILMHPDISLTPHIGAATQEAQ
DRISLELASLIIEKMK
>OBAHECAF_00271 Sodium/glucose cotransporter
MNSFTTLDIVVFVIYAVVILSVGLFVSRGKKDTQKTAEDYFLAGKTLPWWAIGSSLIAAN
ISAEQFIGMSGSGFAIGLAIASYEWMAAITLIIVGKFFLPVFIKQGLYTIPQFIEKRFNT
SLKTILAVFWIALFVFVNLTSVLFLGAKALDTVLGGATGENLMLFMIGLALFSAAYSVWG
GLSAVAWTDVIQVVLLVVGGLITTYIALDNVTPQGGALHGLQHIYDVAGDKFKMILDKDN
PQFNNLPGIAVLIGGLWVANLYYWGFNQYIIQRALAAKSLAEAQKGIAFAGFLKLIVPLI
VVIPGIIAYVMYYEPAGTVAIEGVKEAFTKADGSIDFDRSYPWLINQFVPAGLKGLVIAA
LSAAIVSSLASMLNSTSTIFTMDIYKPFINPKASDSKLVTVGRITVLVALAVATYFAQFL
GALPQMFQYIQEWTGLVSPGILAVFLMGLFWKKTNPTGAVVGVLLSIPVALGLKFLPGVE
LPFMDQMLYTLLVTIVVIMGVSLVTGKGDDDEKGIPLTQETFATNATFNTAAYAILLITA
TLYVVFW
>OBAHECAF_00272 hypothetical protein
MKPIGKFLWKKVGIIAFCNQKNILKKRIRNVLFRILAPQKS
>OBAHECAF_00273 hypothetical protein
MYIPFKELPETSRIWIYQSNRSFTPEELVDLEQKIKVYLDQWSAHGIGLTTSFEIRYNRF
IVIGVNQEIHPVSGCSLDDLARFIQELERNYQVDLFDRMNVSYRQGEHIAYKKLADFKKM
VKEKAVSAKTIVFNNLVNTKSEYETDWEIPMEESWHNRFL
>OBAHECAF_00274 Acetate kinase
MEILIINSGSSSLKYQLINSETGDSIAKGLVDRIGIEGSLIKYVAFKDGKEYETKKQVPI
RNHEEAMKQVTDVLSDAEIGVISDADAIQVIGHRVVHGGEKFVQPTIVTEEVKQQIEKLI
PLSPLHNPACLEGIRSAEKMFKKAQHVAIFDTAFHQTLPAKAFRYAIPNEYYEKHGVRVY
GFHGTSHKYVDSQARNYLKNNNIKNITIHLGNGSSMAAVNEEGRCMDTTMGLTPLDGLVM
GTRCGTIDAGVIFYLANQLQMTTDEINTVLNKKSGMLGLTGSSDARDVSDKYFANDPNAV
LCYELYAYRIKKFIGAYAAVLNGLDSITFTAGLGENDDLIRLLVCQNLEFLGIEIDEEKN
KTRNRPKQTVEIQKDSSKVKILVIPTNEELQIVNEIKSLL
>OBAHECAF_00275 Phosphate acetyltransferase
MNKSVYIITSDAYSGKSLVTLGVMQMIMRNTAKVGYFKPILESKTQKDNHITTVLSHFQL
DMDYEDAYVYTRSEVTNLQNKGKIGEVYDTIIKRYKALENKFDFVLVEGTDLLEDSNVFD
IKFNASLAQNLNIPALVVLKDSFLSEDELVNQIQIEVNTLLEQEVQILGVFVNKVKNYND
SVKQRLEKEFKDIHFTFIPREEDLSRPTLKEIADELGAKFLYKGDDVNMITKKTIIGAMQ
LHNFLNHVSESCLAVIPADRSDLIVGSLTAHISSNYPRIAGLVLSGGIVPERSIIKILDG
TQKIIPIMLSKSGTFETATRIGNIKSKIYPESAEKIKLSIQLFEKYADVSSLNARISSFK
SDAITPRMFQYNMVQKARKAQRHIVLPEGTDDRILTAASQLAVDELVYLTVLGDAEKIMS
RVNELGLKWDERRIFIVNPVESPKYEEYVQKLYDIRKSKGLELSQARDLMLDVSYFGTMM
VFVGDADGMVSGAVNTTAHTIRPSLQFVKTKPNVNTVSSVFFMLLNDRVLVYGDCAIVPN
PTAEQLAEIAISSAESAKAFGIEPRVALLSYSSGSSGTGADVDKVRTATEIVKSLCPDLL
VEGPIQYDAAVDPKVGKSKMPNSKVAGQANVLIFPDLNTGNNTYKAVQRETGALAIGPML
QGLKKPVNDLSRGATIPDIYNTVLITAIQSVMEE
>OBAHECAF_00276 SsrA-binding protein
MQKVINILNKRAKFEYEILDKYLAGIVLVGTEIKSIRLGKASIAESFCEFNDKNELFVIN
MNIEEYAYGTHYNHKPKSERKLLLQKRELKKLNKEVRNTGLTIVPLRMFINDKGLAKVEI
ALVRGKKLYDKRETIKERDNKRNLDRIKKIR
>OBAHECAF_00277 hypothetical protein
MATRFSDTQTAFALKDNFELGRAYWLFRFIGNNSLIGIGTTMTNLSLKLRLPVEWLIRKT
VFNQFCGGVSEENCKPVIQKMYEKGVSSILDYSVEGKEDEASFEATFKKTMEIIDFVHEN
RKQGTPFAVFKPTGFGKIDIYQKISEKQQLTDEEQQAWERIVERFDQACGKAASYKLPIM
IDAEESWMQDAADQLIEQMMQKYNKEEAIVYNTLQMYRHDRLDYLKGLHQRAIENGFYIG
VKVVRGAYMEKENARAQEKGYISPICISKQATDDNYNSAIVYILEHIDRISLFAGTHNEK
STGLVMDLVEEKGLKHNDKRIWLAQLYGMSDHISFNAAKMGYNVAKYLPFGPVREVMPYL
IRRAQENTSVAGQTGRELTLLKREYDRRKKQKK
>OBAHECAF_00278 3-dehydroquinate synthase
MNIQSQGYSVYFSESSFYFLNKLLQEKKYSKIFILVDSNTNTYCLPLFLADMATETPIEI
IEIEAGEEFKNIDTCSQVWFALSELEADRKSLLINLGGGVVTDLGGFVASTYMRGIDFVN
VPTSLLAMVDASVGGKTGVDLGALKNQIGVINNPKGVMIDTRFLGTLPADQLRSGMAEMF
KHGLIQSETYWKKMLKLDELTIEDLEQLIYESVEIKNNIVKQDPTEKGLRKTLNFGHTLG
HAIESYCLQNSSRQALLHGEAIAIGMILATYLSSELLYFPKEKALEIKNVFNQYFEKHTF
KKEEIDQIIDLLKFDKKNSYGNINFVLLEQISQPKLDCKVSNELIYKAFEYYRS
>OBAHECAF_00279 Alpha-agarase
MKIVVRNIIYMFFILFFGSLNAQSYWQPNNTTGKQGQKEGKFYYRLDKEAFAKALLKNVR
QTSKSIAEVYIPNGEGDIESFRLQETQVLSSVLQEKYPHIKTFAGVSVTNPLRSIRITWS
PRGLNAIMEENFHYSFIESTDDEGFLYEVYHRDMTEKNPIKCTTQAFASEKKLTKRATYS
TENKVRTFRIAIAATHEYTQYFGGKSNALIQVVNTINRVNQVYGSQMSIQFQLVSDQNIL
FDTEAADPLKNINYDQWLNEQGNLKEAKILQELFDNQVGSVNYDVGHLFHHEDVGGNAGC
IGCVCESGKKGAGFSAINFSKVSPDYFEIDLFCHELGHQMGAYHTFSYDNEGTDSQVEPG
SGSTIMGYAGVLMSQNLQQRSDAYFHHRSIYDIMQNVKEKRCAIITDSGNTVPEIHDILS
YTIPKGTAYLLEGTASDADEDTLLYRWEQADSRTNSYSFSPNAKTGAIARSLPPSINSKR
YIPRLSRIVSGELTQTHPAQNSAWETVTNVGRTLNWSFVVSDRNTSATTVGNTTYKTIQV
VVNDKAGPFSVLSHTTPSNWYVGQTETIRWDVANTNSDNINVKTISVLFSEDGGATFSHT
LATGIPNNGTAKITIPSIPITNQGKFMIKAEGNIFLAVNKSTITIKENDDVDGDGIMSNA
DNCPELANPNQEDLDRDGIGDACDDDWDGDGVHNDNDNCPRQSNSNQLDLDRDGIGDVCD
DDLDGDGVPNDSDNCPEIYNPNQADLDNDGIGDLCDNDIDGDGIANDIDTSLDYVLISNA
FSPNNDGIHDYFSILRAEEYPNSTLRIYNQLGQLVYETKGYKNQWSGMGSNGKKVPQGSY
FYIFTLDNTEMYTRKGWIFINY
>OBAHECAF_00280 hypothetical protein
MKKQIYYIILIGFISVINIYAQNPTHIFYNQHKNLVNPAATGQEKGHTISVDIRNQWQGD
TEAPQSQTLLTTHRINERVSVGFSIQNNKVFIQKQAGLYADFAYAIPINEYSKLYGGLKF
GGDFFNIDGNRIRTYTSPHNTYYDPYLQTISGKFQINIGTGAYYEHRDFYVGLSVPNLLA
SEEVKVKEDVMTSVAQRFHIYGLAGYFWKLSPEFTLKPMLQTRFVKDVSPSFDLTLAGVY
LKNSELGLTYRTDKAFNAYIMFHIPKYYVVVGYGYENNSQPQLNIYARSSHEFLVQFKW
>OBAHECAF_00281 hypothetical protein
MHVQIFEMIQRVQTIYMLFVFIIGGILPFIFSLYVQNQQSVYAYLDDVLSGIFFGISAVL
AVYAIFKYKTRQLQFVLNRLNILISLTLLGIFVYRVLSSSGESGISEKGVGIFLPVLSIV
FLFLANKAIRRDEDLVKSADRLR
>OBAHECAF_00282 hypothetical protein
MIGLKLTTDNKTFFASLKEGSIGLIISRMIRDTRNCVSVNFGGYDMQTETYPLWLLQKLF
LGAKFTVKVEEITVNSPIIQRVPEIESHFFEHPKNIGVELTLKEEKLSAVVEKGSIHLIV
TVLNKEDKTEIDLDFLATNHSNNGDITKYWCKKTYN
>OBAHECAF_00283 putative CtpA-like serine protease
MRIKTYILPIIISVILGIGIFLGRVLSDFYIQEPLPTPTPVVDIDSIVESPSKKKLGTLI
DYIENDYVDKINPDSIVELTVNGILSKLDPHSSYISKRNIQEISENISGKFVGVGISFYM
YKDTIAVMKPIEESDAFSKNIQLGDRILKADNDTLFGKKLTSEMVRNTFKGEKDSEVLLT
IYRKSNDSIFTLPIVRKHIPIKSVDCFYKVNDTLGYIRMNRFAETTHQEFRSALQTLIDK
GINSLILDLRNNTGGLLNVGIDISDEFLKEDKMIVFTKNNRQEIDETYATGGGMFEEQPV
FVLVNEQTASASEIVSGALQDNDRGVIIGRRTFGKGLVQSEMPLPDGSAIRLTTARYYTP
TGRSIQKPYSRKQIRNFQLNSSKMPDSLKFTTPKGKVVYGGGGIYPDVYLHSDIKPETYL
VNELLNSGLTNFFLFEYLDTYPKVNVKPEKSSFIKDYKISKEMLNAFSKFLSKRKIFIDF
KKNRDDISKYLKASLAEIWYDDNTAGMLRNQGDLYIEKSMYYYKGEPAKRKKITKKKVVK
KTTSKEYSKKKN
>OBAHECAF_00284 Thiol:disulfide interchange protein DsbD
MKKILTFLLSVSFILVNAQIFDPVKWDTKVEKINDQEYDLVTTATIDQGWKLYSQTIPPN
GPVPTTFEYINDGTFELVGKTVETGSVVKHDAVFDMEIGFFYKNATFKQRIKILKPLSSI
KAGVEFMVCDDANCLPPDTVDLMFIFSENTGSTEANQTQSVDNSNAAIFSLEGDDKTPSD
KTVKQETQKVEENDNKNVANKGLWSIFFISFLSGFAALLTPCVFPMIPMTVSYFTKQSKS
KIKGIRNAIFYGLSIIVIYVVLGSVVTAIFGADALNALASNFWFNIIFFLILIFFAASFL
GAFELTLPSSWSTKVDAQADRSGLVGIFFMALALAIVSFSCTGPIVGTLLVEAASKGGIA
PIIGMLGFSLAIALPFAIFAAFPGWLNSLPKSGGWLNTVKVVLGFLELALAFKFLSNADL
AYQYHWLEREVFIAIWIAVFGTLALYLFGKIRLPHDSPVDKISVGRLSLGLLSLTFTIYM
IPGLWGAPLNLISAFPPPQHYSESPYGVGYTKTGGIVSSQEDRLPEGAHLLEPHNILAFD
DYETGIAYAKKVNKPILLDFTGWTCVNCRKMEQNVWAKPHILDILKNDVVLISLYVDDKR
PLPENQIVESKLKPGKQIKYIGQKWSEFQTVRYKANSQPFYVLMNHDESNLIDPIGYTPD
VDEFHQWLTKGVGAFK
>OBAHECAF_00285 hypothetical protein
MKKNIFILFCLVFFSCQQSKKGTVVIWNNEGAETFVIDAVNKKSNQTTDLNDYIESCRVV
PLETRRDALVNKIEKVIVANNKVYLHCDRDKILIFEADTGKFINKIHAVGQGPEEYTEIT
DFAIEKRTNNICTYDERKHKVIKYTADGRFINAVRTKFHGLNIYSVNDSIYAVYDDINIL
TSEKSDLLLVNNDFSKLEELYFPHQEKFYDRPPEKSYYSKLHYFNTYDDKTYITPSIYHY
TYEIIGTKLKPKYNFDFGDKNIEPTDDIFFTEDLVDSEKVFGVNYYENSRTLFVEYGLNM
TRSILYIDKETKNQVFMLGKDWKNMPLLYFLFTDKVVRAVNEDEDTFMAIVSFAEDDFIK
NNEHFLNATDSLHLPEIDKLRKVKSDDNPVLIFFRMKKF
>OBAHECAF_00286 p-hydroxybenzoic acid efflux pump subunit AaeA
MKKIILSTIGLIFLLSCKTDTTNAKEENVQQLLPESPTEVTIMPLQSKPFTHELVSNGKI
HASQMVGLKFKANEKIARILVKNGDNVTQGQIIAALDGFSFENKLQQAQDDVSRARLELQ
DMLIGQGFKLKDSTNVPPQTMELLKVKSGYNKALSHYKMAKNELQGVTLYAPISGTIANL
NSKPNTYPDMSKDFCNIVNLHSMEVSFPIMESELGFVQKGGEVEVIPFSIPDVKIKGKIT
EINPWIDQNGMVQLKASVAYHPKMVEGMSVRVSIFRALEKQWVVPKSAVVLRTNRKVLFT
LKDGKAFWNYVQTGLENATEYTITGETLKEGDPIIVSGNINLAHESPVVVKK
>OBAHECAF_00287 hypothetical protein
MSNINIHIRRELSSELIRLSDFYSVLVVTGPRQSGKTTLCKVNFPSYHYVNMEDIALREQ
IMLNPKAFLKQFPKGLIIDEVQNVPELLSYIQVVVDEDNSRKFVLTGSNNFSLMQGITQS
LAGRVSVFTLLPLSLQELGDIPYRTDTNTLIINGGYPAVWAKKIPIQDVSRNYYNTYIER
DVRQLMKVKNLSNFQTFMKLCAGRVGTELNINALSNEIGISSPTLKEWFSILEASYIVFR
LPPFFKNIGKRLVKSPKIYFYDTGLACFLLGIETPQQLAVHPLRGVLFENMVVLEFFKNK
FNKGVLPNYYFYRDKNQKEVDLIEEKANEIKAYEIKSAQLFNKNFIKNLDYIKNLLGEEV
ISTQVIYDGELTVHSSENGMVNFRNIHF
>OBAHECAF_00288 hypothetical protein
MTKRILSAFLLMLGLFSCQDVDNQRKQIKTEKLTGTKIKADDFVGKWILGVVQDSIALVT
SPSGESLVEMYILKNEEIIFSQKILNRGGGPKELLAPFYATSLTFLSFCDFTQNGKMLHI
RKDAINDFNIDKLENSKLPIIGMYPTKYLNGYLWLDDERVMYIGGETGEANILTVVDVAK
QQSIPTGMWFEDDYKGDNIIKQGAYGINASIYQHPSKSIYVYACGFGQYVETFTLNSEYQ
VENRKIILDKKPIYEAYPDGLNSKIKDSDRHNPQGVKNVFPTEKYLYVMLENPFYNENGN
LTSYKGYSSFHNDMIQVFDWEGNHIKNIELELPSQLLAWDAKNKKLYAVTEGEELDTLMR
YELE
>OBAHECAF_00289 hypothetical protein
MTKTILPMLLFAIGLFSCEDKKQDQTNGIRILKIQDSEKQEVIEKITYLPIQEDEQFLFS
ELSKVIIKNDCIYILDLHQSNSLLCFSKSGNFMRKIGNQGQASDEYIRLQDFDVDDSYIY
LYDRRQKKMLTYDLEGNFIESKKTPFVGKNFKVLPNQQFLFALAKGDGKEPLLVQTSADF
ADQKNILNFQKEYVDDNGTPTVFQPSQEHILFNRAVNDSVFVLNKTGAIASTYVFDFGTK
KVPNDLKNSYETLVEVRKENDFAYLIGAPLLIHNRYLVSEIFYEGSKATLLYDLSEDKCE
ITQWLPEKMYSTDIILPTAAFDNGVVGWMDIDVYDVLKEKPTLSGDLMRHLEEGGKILTF
YHFKK
>OBAHECAF_00290 Multidrug resistance protein MdtC
MIKFLLTRPIAVLMSFLGLIIVGAITFGSLPVSLLPDIPIPEITVQVTGENVSARELENT
VVTPIRQQLLQVGKLRDITSETRDGNAIIRLKFDYGTNTDLAFIEVNEKIDGSMSRLPRD
TKRPQVVKASATDIPVFYLNLSLNDDKSYSEPDEQRFLELSEFAQNIVKRRIEQLPEVAM
ADITGYMQQHIRIIPNMDFLETVGLQLSDIENTLQANNVEPGSMVVRDGYYEYNIKFSSV
LRTIEDVKNIYFRKGDRLLQLKDFAQVELSKKGETGLSVTDGKRSVTLAIIKQSDETMQN
LKESLYQTLDNLEKSYPDIQFSINRNQTELLDYTISNLNQNLFLGFVLVFLVAIFFLGDA
KSPMIIGLSMFSALIISFVFFYLFDKSLNIISLSGMILALGMMIDSAIIVTDIITQHREK
GETLFDACVKGTNEVITPILSSTFTTIAVFLPLIFLSGISGAIFLDQAFAVSVGLLVSYF
TGIILLPILYHTFYHKKWLSKTTIFQKTQQKIDKILFLSYDKGFNFTFSHKKPLFLAIIL
MIPLCFLLFREVPKSNMPHLDHIELIAKVEWNENIHIDENKKRTYELFQSVDEWTVESAG
YIGNKQYLLEKENNLSITESEVYFKANSPKEIEKIKENLSQWMHKNYPQSVLTFAPPKNI
FEKIFDTNEADIIAQLYSKNRQKTPSIADIKQVQTRIEQSSGVSSVDIAFEEQFVITVDK
EKLLRYKVDYSEVHRELKTAFKNNEIATLRSYQQYLPITLSGNLQTINQVLQNTMVRTNL
RDENEQFIKIPLQSLLSISKGQDLKTIVSGKNGEYIPLVYPSLENAKNFIQATENELKND
SQWEVQFTGGFFSSQKMLSELVVVLIISILLMYFILAAQFESFTQPLIVLIELPIDIAFA
LLLLWGTGHTLNLMSAIGIVVSCGIIINDSILKLDMINELRKVNMPLMEAIHTAGQRRLR
SIMMTSLTTILAMTPLLFSFDMGSELQKPLAVAMIGTMMMGTLVSLFIIPLIYWLIYRDK
NK
>OBAHECAF_00291 Elongation factor Ts
MANITAADVNKLRQATGAGMMDCKGALIEAEGDFDKAIEILRKKGQKVAAKRADRDSSEG
AVIAKVNGDNTKGAIVSLNCETDFVAKNESFVALAKDLAEMALSVNSKEELLAADYKGIT
VAEKLTEQTGVIGEKIEVGAFEKIEAPFVGAYIHHGNKIAALVGLSANVADANDVSKNLA
MQIAAMGAETLSYKDFSADYIAKETEARIAVIEKENEELVRLGKPLKNVPKYVSYAQLTD
EVLKQAEEDAKAELKAEGKPEQIWDKILPGKLQRFISDNTSLDQEKALLDQVYISDETKK
VSQYVASKGVEITTFKRVSL
>OBAHECAF_00292 30S ribosomal protein S2
MANNIEIKDLLDAGVHFGHLTRKWNPNMAPYIYMERNGIHVINLYKTAAKIEEANEALKK
IAASGKKILFVATKKQAKDVVAEKAASVKMPYITERWPGGMLTNFVTIRKAVKKMSSIDK
MKKDGTFETLSKREKLQIERLREKLEKNLGSIADMSRLPGALFVVDTMREHIAVKEAQKL
NIPIFAMVDTNSDPREVDYVIPANDDASKSIEKILSYVTEAINEGLAGKTSDNKEAETAE
>OBAHECAF_00293 30S ribosomal protein S9
MEVIHKIGRRKTAVARVYLKPGNGAISVNKRELNDYFTTSTLQYKVRQPFALTGTEDTYD
VKVNVYGGGVTGQAEAIRLAISRALCEVDVENRATLKPEGLLTRDPRMVERKKFGQKKAR
KRFQFSKR
>OBAHECAF_00294 50S ribosomal protein L13
MDTLSYKTISVNKNTANKKWVLVDAEGQTLGRLASKVAKLLRGKYKPEFTPHVDCGDNVI
VINAEKINLTGNKWNDKEYLRYTGYPGGQRVQTAKDVLAKHPERLIEKAVKGMLPKNKLG
VAILRNLKVYVGTEHKHEAQQPTAVNLNDLK
>OBAHECAF_00296 NAD-dependent protein deacylase
MKKVVFSLGGEGFGIDIVRVTDGKRSSYGVESSSCFGEFTGDMNDSGTLSHLDNDTIEEA
FKKLDKICPEWYIFSPLTVSFEYREYVAKQYVEGLNTSRKDLKDWITNSEWEKILGIELT
YHDNPITPKAQKSAYPQHWSYKLKKLKIVAITGAGISAESGVKTFRDADGLWEGHNIMEV
ASPEGFAKNPALVLEFYNQRRRQLKEVVPNPAHLLLAQLGKYHQVVVVTQNVDDLHERAG
STDIIHLHGELLKMRGVDNSEVVYPCEGDILVGDLSPSKAQLRPHIVWFGESVPMIEKAI
EEVKTADVLLVIGTSLQVYPAAGLIDYAPNTAQIYYIDPNPAPVGNTKIKVVKDKASTGL
EKILEYLHSHFDYYPIPQRPR
>OBAHECAF_00297 hypothetical protein
MNEIKLNDILQIPIEDLKRTKIRLIIMVDKNWNPIEMFQDKKTESLLEGQYWNYSKNVYQ
EGEITIGLVRIKDDKWLLFHIGKVTKKLDIYDGVGYEYEDLKEYQKYVGRLIVEYKNTSQ
TLVRWAESIINDCKVSQILPDVFNEEIFPGYDKVNLSWKELSKVVEKEVWKTALENQKGV
YLITDVSNNKRYVGSAYGSQMLLGRWKNYVENGHGGNKGLLNLDFDHIKENFRYSILDIF
KSTIDDEIIIQREQWWKRVLLSQQEEFGYNKN
>OBAHECAF_00298 hypothetical protein
MESEKYFKNLSNKELDSLYAVLVRHPESTENMRQAKEIEKIMLDRYETCHNIKIGFKNNN
KLKPTELNPKNT
>OBAHECAF_00299 hypothetical protein
MKKFFMLALVAVASLVASCEKNSDDTQTENVRLVGTWKCVKKENVKDGIRINPQNVIDDG
CTKYVFTDKVLTYFFVNPEPEVNGEGECINQELLYRIENGRIYNGYYEEGEYIENDFGFK
FIDDDTFEEFEDTTDGKNGVISTYKRVK
>OBAHECAF_00300 hypothetical protein
MPNADLDLILRKEVEKIFGKSIKDKPDSELLSDRISEEIREQISSQTIRRFWKLIQNGSN
ISPQTKDIFCRYIGFNDFKAFAENVQNNRVNTYDFSFLGNWQTISKYDKPL
>OBAHECAF_00301 hypothetical protein
MKQEYYQKSITNEIDEMQQHQSNLFYLLESPPHELTEEQKNELFKKIDFETQMLKSKADG
VLINSKLMQSELDLQQSTQEAQAQESKLQALQEAKKTAFDIPDFPNFEVTKYSNTNVSKY
AKLEFQSYTDLISKITNIIEVCRTC
>OBAHECAF_00302 hypothetical protein
MKVIQTKKVYYLDHEGNTTHTAKEFYVLNYRILTLKSKAK
>OBAHECAF_00303 hypothetical protein
MTAQALQDIKGIATKRTHAHKGDRLKVIATHGEVYILEHPNGERFPVHKTQVQILEN
>OBAHECAF_00304 hypothetical protein
MTRRKYPKGLLKAVANEINLSYSTILLYTTGKGKNEAVKTQILEAIENHLATHRQRQTEA
KERIQALLQ
>OBAHECAF_00305 hypothetical protein
MGKITAKHFLNVRAVPRIEKNQNKFPLFFMVVFNRMTIRRMSIFLENQYFSEKDFETQKI
DKTQKKAIEHEQNILYKIVEKFKHDKESNTLTNNFLYFNKSYAYTSKNEDLNILNSYINY
YTTYTHEAIINEIYKNIKTELTEKLKNTFDFSDNENLIDEILDLFHNNDVFAGIPYDDFL
QKNISEHAKKLLFLQFCLSEFQSNRELKTGVGFISLFEWLFEFDKMAREYKKFVSKDTET
INTAQKIGIDIDETMINLHLNEIKKVIFDPLFYEKNRI
>OBAHECAF_00306 Tyrosine recombinase XerD
MDKVKFSVVFNRKKQLNAHGKALVQIECYLNGKRKYFSTGIYIKPTEWNEKTRSIRNNAP
NYIGLNKQIKDKITAFESYELQKINAGKPFALDMLQEVERPQIKSFYEFMRLEIDTNPRT
TKGTKADQRQTLNLLQKFRTALNFDEITFEFLHDFEKWIRTQTFSNGKKYSQNSIFKHFK
NLRTFVNLAINKEHIPLEKYPFRKFKVQQENKERTFLTPSEIDLFASVEVKSKAQEVAKD
LYLFAVYTGLRYSDIINLQTSEIVKEKGVIWIVKRTQKTNEPIKISLSELFNGKAFEIVK
KYRKLGNLCVFPKVANAELNAQIKTLCEVAGIQKNITFHTARHTNATFLLSKGMSIFAVQ
KMLGHRKISTTQIYTHLIEETLLNEIKAINF
>OBAHECAF_00307 hypothetical protein
MLITITLHCPNCQCAKIVKNGNKKNKKQNYLCKTCKRQFIGDHNLTYKGWASHIAAKILL
LLARNVGIRDIAEIKKVSIKKVLSVLVNFNREIKPKQNKYKSLQVDELWTFVGKKKNKKW
LIYAYSAETKEIVAWVWANET
>OBAHECAF_00308 hypothetical protein
MGQNTNPLLCDPKTGVCETSQSNQKSERNLQNHSKKIEIIYYTDPICSSCWGIEPQLRKL
KLEYGNEIVINYHMGGLLPDWSYNSGGISKPSDVAHHWDEVSPYYDMPIDGDIWLENPLD
SSYPPSIAFKAAQLQDNDKAVIFLRELREMVFLEKKNITQWEHIATAAQQAGLDISKLKS
DYEYQGRKEFQKDLELARKIGIRGFPTAIFISGNKQEIVYGARPYALFEMAVLKLLPDAT
KQEYHKDWKSLFNYYPSLTAREFTELSGMPRKDSEQLLNDLTQQGILSKLETKNGAIWKI
K
>OBAHECAF_00309 hypothetical protein
MKITLILIIICSWTKVQAQFLDKLAVSAEYRYLGRNIAGLGIEYRASNKDEAVLNIGAKA
FYTTVKRKAKILPQINIECGNFLNGGVSITPYAIEPQFIINVLNLIKLNTGYAIPIHQEK
YFKGITFGLQINIAVGKYSRFYDDLKVGF
>OBAHECAF_00310 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MEHSHEGHSHSVASLESINRAFYIGIGLNLVYTIIEFVVGFRINSLALISDASHNLSDVA
SLVISLLGLKLTQKAATYSFTYGYKKASILASFINAVLLVYIAVKIILEAIERFDAPPEM
AGSMIIITATIGVIINALSAFLFYKGQKQDINVKGAFLHLLVDALVSVGVIVSGVIIHFT
GWYTADVLTSLVVAVVILVSTWNLLTESVKLILDGVPQSIKVDKIRQIMESHPKVCSVHH
IHIWALSSQENALTAHLVIEDSSTFEEIDQLKKEIRHTLQHEHIQHTTFEVELSKMKCKC
DDCH
>OBAHECAF_00311 hypothetical protein
MIVIDRVNIKFEVLKGKAKKFLIEPNHLFLPIFLIIYLIKFYFFHL
>OBAHECAF_00312 hypothetical protein
MWFVNQIPQMAKRIKPIKCPQCGSTQATETKTDYYRCNSCQSEFFIDSDDININHRHIYN
TAELPPVNKKYLVMSTIISFAFLIGVIVFYTFIQKNSYPLSSTLQKNTEYWDIEQIIPTS
NKDGEPIAIVVGDIVSGNYPNEVYKPTFGFFHAQTFKEIAAVPIDIEKVDDVSYKKMDEG
KTYIIINKNRLFLLDEKTLSINEVTPQSIGLAEFEKGFAGVELAVAYENTLKITNNLGQG
YYYYPKLNKAVVYGNYKEIDQLIAQNPIAPQGVTKFVFTKKGVGFSEKMTDKFPELFKVK
TQSQIGYPYRELMMRWNYNLSEQRVELETFQKESRIVEYKNFTPNRIYFVPEVFHYDDNE
VLIHFKHELAESSPYFFQVLDAQTGEVKLSLQSHKNMHYVRDDFVAKTKDGYLITLRDIF
LLNTKNGKLEKLELREKLTQR
>OBAHECAF_00313 hypothetical protein
MSILNIFSNQLSAVIEWKNPKANVIWWKYPSKRDEIINASKLIVAPSQGCALVYEGKLVE
IIEEEGIYNLKTDNHPFITTLVNLRQNFDSEHKLKIYFFRKAQILNQRWGTPSPIKFIDS
TYKIPVELGVNGNFSYRIANPKYFYTEIIGETDEFDAEAMSKTVVERIPQLIAQNIHEKK
YSYIEIDGKIHDIAQEIKGEINSEYGNLGLELTDFRIVGTQFDEATQERIGRVADISADV
QAAKEAGLDYVELEKLRALRDAARNEGGLAGAGLQFGVGMEIGKKFNEQSDTILAKGSAD
AAEQLRKLKILLDENIITAEDFELKKQEILRKM
>OBAHECAF_00314 hypothetical protein
MKYIIGIIVVLIVLSVGAYFLADLWEYDTLITPEELKKGAITVMIVGGVSVLLLILVPFF
FKDHAKGYDKNHNGIAQPKKKHIKKERNSEK
>OBAHECAF_00315 hypothetical protein
MNLHTIFTENFSLEKEIVIPRGAFLKTPDTKDTQIYLVKEGSLKIGFFTENEDKILRFGY
ENDAITALDSFITEQKSKLYIQAIKKCRLAVVSKSDFMAFAQKSSENLWIYTKILEKLLV
DQLEREQDLLLSSPRERYQRILKRNPKLFQQIPHRHIAVYLGMTEETLSRLKKTLTPIKI
>OBAHECAF_00316 hypothetical protein
MDRKQLLDTLTQITLENKTFAEALLLKSETELNHSPSDDSWSILECIEHLNLYGNFYLPE
IASCIAKADESNRNLFKSGFLGNYFVKLIQPKPRLNKMKTATKMNPKGRRLTKNCLEVFI
RQQNQLLDLLQKAHTTDLTQLKTKISISRFLRLRLGDTLQFVVYHNQRHMEQVRRILQEK
KRDCL
>OBAHECAF_00317 hypothetical protein
MIMRLFFQFLSTVFVFSMTTLLAQSKPDPKTYIAYRVTEKIEIDGKDSELSWQKSEYTDD
FIDIEGVKIPHFKTNVKMLYDDDYFYFFAKMEEPHIWATLKERDTVIFHNNDFEIFLDPD
NDSHNYYEFEVNALNTVWDLFLTKPYRETNKVLDGWDINGLKSAVYVNGTLNNPSDIDTF
WSVEIAIPWAAMREAHKQNNIPTNKFWRVNFSRVQWDFDLTNGRYDKKKDAYGKYLPEYN
WVWSPQWKISMHEPELWGYVYFSDKIIGQKDSFELPKDESIKRYLYDLYHFSKKNSSQKL
ITETKKGTTIANKKIIPKFNTNPHFWNISVVSPFSGETIVIFQDGKVEVFKK
>OBAHECAF_00318 hypothetical protein
MKLNAGIITEKLAETKAFYTEILNFGVSFENEFYLLLHTPNQEAEISFLFPNHPSQQPIF
QKPFQNQGVYLTIEVENVDEVYKELKNKNIRIEIELRNEPWGDRHFAIKDPNGIGIDIVT
YTEPE
>OBAHECAF_00319 hypothetical protein
MGTNYSITEKFGANLAELLAEKINRVYPDFNSKNFIKDTENKVIGQTYAQRIITIADLLK
NYLSADYKEALRVLFSILGEENPNQTGMFTHYYWILPIGKFVERYGINHFTLSMNAIEEI
TKRNTGEYAVRPFIRKYPEKSLEIIEKWAKSPNFHLRRLASEGLRPKLPWASKLDTFVEN
PAPVFQILELLKEDEIMFVKKSVANHLTDWIKVNKEAVLPLIHCWKTFENPHTQWIIKRA
TRKFDV
>OBAHECAF_00320 hypothetical protein
MQSSLNIRNYYKPIQPTIIQSTKNVFYTEIFPDKKLLPFIYCYWQLKTKTQLTENYTYRV
ISDGCIDVFFELDNPDESYLMGFCRSYTEFPLGKEFNYVGIRFLPSAFPLIFKQDAKELS
NNDILLNLVSSDLATFIAHKFSSLQGLQQIKNELDTFFSKHLKKIDFSIDNRFYKALEII
LKSKGNARIVSDLDTGISPRHLRRLFEFYIGDTAKTFSQVVRFQSFLNAKISNQNTDKPS
FYDMGYYDQSHFIKEFKTFCGVTPREVYYK
>OBAHECAF_00321 Aconitate hydratase A
MAFDIEMIKAVYENIPSRVDKARELVGRPLTLSEKILYAHLWDGQPSQAYTRGKDYVDFA
PDRVACQDATAQMALLQFMHAGKSKVAVPTTVHCDHLIQAKVGAEKDLSVANEQSKEVFD
FLSSVSNKYGIGFWKPGAGIIHQTVLENYAFPGGMMIGTDSHTVNAGGLGMLAIGVGGAD
AVDVMAGMAWELKFPKLIGVKLTGKLNGWTAPKDIILRVADILTVKGGTGAIVEYFGEGA
ESISCTGKGTICNMGAEIGATTSTFGYDDSMRRYLKATGRQDVVEAADKVAKYLTADPEV
YANPEKYFDQLIEINLSELEPYINGPFTPDRGTPVSKMKEVARENGWPLKVEWGLIGSCT
NSSYEDMSRAVSIVKQALDLGITPKAEFGINPGSQQIKYTIERDGMIEVFEKLGTKVFTN
ACGPCIGQWDREGADKQEKNTIIHSFNRNFSKRADGNPNTHAFVTSPEMVAALAISGRLD
FNPITDKLLNDKGEEVMFKPPYGDELPVKGFDVDDPGYQAPAADGSGVEVVVRPDSQRLQ
LLAPFEPWDGKNITGAKLLIKAEGKCTTDHISMAGPWLRYRGHLDNISNNMLIGAVNAFN
GKTNAVKNQFTGAYEEVPAVQRQYKAEGVPSIVVGDQNYGEGSSREHAAMEPRHLGVKAV
LVKSFARIHETNLKKQGMLALTFANEADYDKIKEDDTVNFLDLVDFAPNKPLQLEFVHAD
GSKDIIVANHTYNESQIEWFKAGSALNLIASNAKK
>OBAHECAF_00322 hypothetical protein
MKLHKIVLSAFCLSATVLTAQTPADYVNPFIGTSNYGATHPGAIAPRGMLSISPFNVAFD
TKGIKDPLEKDSRWLSNPYVNENRFLTGFTHVNLSGVGCPELGVIITMPTTGELKTNHLD
YGTTYSNEKASAGYYSTHLTKYNVKAEMTASTRAGVSRYHFPKGEANILLNLGLGLTNEQ
GAMVKIVSPTEVEGMRMVGSFCYNSPELAYPVYFVAKLSKPAMNYGVWHKPETYKGVEAE
WMWYNGDVRLKEGFSREVVGDSIGAYFRYKFDKEEIVEVKVGISYVSIANARENLEKEIG
VKTFADVYQQTKNEWNKQLHARVEGGTDDQKTIFYTGLYHASIHPNVLNDVNGDYPQSKT
NKIGKSNNRYTVFSLWDTYRNYHQLMTLLYPEQQLGMIKSMLDIYDESGWLPKWELNSTE
TFTMVGDPASIVLADTYLRGLTNFDVEKAFQAMLKGANTLEKNPIRPGVAEYWKLGYLSV
DGGVAGPVSTTQEYNIADFAIAQLAKKLGKKSDYERFNKQAYSYRKLFDSQTKLLRPKYS
NGKWYEPFNPASGANFEKNVGYIEGNAWQYVYMVTHDVKGMIKMMGGERAFEKQLDHIFD
SKQYDMANEPDIAYPYLYNYVRGSEWKTQKRVHDLIEEYFQNKPAGLPGNEDTGVMSAWL
IYGMMGFYPVSPAEPIYTFTAPKFNKIILSLDKKYYPNGELIIESNASPENVYIKRILID
GKPYKSYFITHEELKKAKNIRFELDRKPLNTKK
>OBAHECAF_00323 Protease 4
MTFLKNVLATILGFFISLGIFFIIFLIFMSVMMSSIGSTDSAAVIVKDNSVLELEFKMPL
RDYGEKVYLEDFDYTIEEYNGLNSILKAIKHASTDSRIKGILLKSSGNLSGLALVRELRV
ALEDFKTSGKFIYAYNDVIPQSDYYLQTVADKIYVSPLGKLNFRGLSSEVLFFKDLQDNT
GVSMEVIRHGKYKSAVEPFLDNKMSDENRLQIKELLSSVWDIIVQDIAESRAITVEDLNA
IATNLEARTPQLALKNKMVDGVLFQDEFENILCEAMNVSKIEDVNYINIEEYTESVSKKY
SKKAKDKIAVIYAEGEIMYGSGNSRIVGDKTIVESLRKAVKNDDVKAIVLRINSPGGSVL
ASELIHREIAVTKQHKNVYVSMGNYAASGGYYIACHADKIFAEAGTITGSIGVFGAVPNV
SKLAEKWGVNAEQVTTHSNALEYSLFEKPSKSFIDENTESVEQIYELFLERVAEGRGMTT
EQVNEIAQGRVWSGKDALRLGLVDQIGTLDNVLEFVANEKGLESYSVVSYPLFKTSLKEM
FGTYAMSLKSHSLQEELGKEAYQMYEKIKLLSQQEGIQARMLFDVSLD
>OBAHECAF_00324 hypothetical protein
MKRPMVEYAKLILSKVSFNSELFCKELNKALDKLLPYEQEELKVWLDNYTKDKPELIDCV
VSINKK
>OBAHECAF_00325 Adenylate kinase
MRKIRTFVFYLFSMEIIKIHDKSFEPYIDAAQIQQIIQRMTSEVARDMEDTTPVFVSVLN
GAFMFASDFVRNYKADCEITFVKLSSYEGMHSTEKVRELIGLDISVEGRDVVVLEDIIDT
GNTLEEIYRIFHNKGVKSLRIATLFFKPDAYKKNLKIDYVGMPIPNRFIVGYGLDYDELG
RNLPHVYQLNTSLTMTNLVLFGKPGAGKGTQATFLKEKYNLVHISTGDLFRYNIKNETPL
GKLAQSYMDKGDLVPDEVTIQMLQQEIDSNPDAKGFIFDGFPRTIAQAEALDAFLTSKGI
KIHGTLALEADDEILIQRLVERGKVSGRTDDQDESKIRNRFVEYNQKTAPLIEFYKKQGK
YHAINGIGSIEEITNRLSEAIENLEK
>OBAHECAF_00326 Beta-hexosaminidase
MKFMFTSLICLLTFYSYAISGVNHLLPKPQLIEINNSSFSLHKVRLSTPVLQTQWQNFIK
QMRGTISDKANKLIEVKLVNDIPQARVNKEEAYTLSISKDKILIESTTEKGVYWAMQTLR
QLATNKGDITEFQGCYILDFPAFRFRGFMQDVGRTFISLEELKKEISILSQYKINVFHWH
LTENQGWRLESKKHPILNHLSSYERSHGQFYTLDEAKELVEFCKQHNMILIPEIDMPGHS
LAFRKAFNHDMQSEEGMKILKELLDEILPYFDVPYFHIGTDEVEFTNPNFVPNMVQFIRE
RGKKVISWNPGWNYKVGNIDMTQLWSYRGKVQKDIPAIDSRFHYLNHFDAFGDIIALYNS
RILNVTQGSDNYAGCILAVWNDRFIPNEQEILIQNNFYPSMLALAERSWLGGGTEYFDNK
GTILSSKNDLNFIAFADFERRMLWHKNNYFNKLPFAYVKQTHMEWTITDPFPNEGDLTRS
FPPEKELSNSYTHQGKTYYTQKTIGGGIYLRHVWGKIVKSLYENPLPNHTAYAYTHVYSP
KRQKVGLWISTQNYSRSEKDLPPPQGKWDYKESRVWINNSEIHPPNWQSSHTQKSNETPL
TNENFEVRPPIPVILKKGWNKILLKLPIGHFSTPEVRLVKWHFNFAFVSLDGKNEIQQLR
FDADRKTQ
>OBAHECAF_00327 NADP-dependent malic enzyme
MRIVLLIYYYNINMKDNRKKQEALDYHQFPKPGKIAIVPTKKYASQHDLSLAYSPGVAEP
CLEIAKDKQNVYKYTSKSNLVAVISNGTAVLGLGDIGPEASKPVMEGKGLLFKIFADIDV
FDIEVDATDIDKFVETVKAIAPTFGGINLEDIKAPEAFEIERRLKEELDIPVMHDDQHGT
AIISAAALKNALEIVKKDIHQVKIVVNGAGAAAISCTRLYIALGANPKNIVMCDSKGVIR
KDSPNLTEQKAEFATDKNIHTLEEAMKDSDVFIGLSKGNVVSPEMLLSMAKDPIVFAMAN
PVPEIDYQLAVNTRQDILMATGRSDFPNQVNNVLGFPFIFRGALDVRATKINEEMKLAAV
HALADMAKKTVPDQVSLVYGNENLSFGRNYIIPKPFDYRLIYEIPPAVAKAAIESGVALK
PITDWDAYREELIERSGKGSKEIRLLQDRAKRNPKRVVFPEADHIEVLKTAQRLYEDGIG
IPILLGRKEIITELKEEVGFTADVMIIDPKTDTEKSRREAFSEVYWQKHQRRGVTLVSAE
RLMRERNYFGAMMVNTGEADAMITGYSRSYPSAIRPILELVEKEEGVKRIAATSIMMTQQ
GPLFISDATINVDPSAEDLANITLMTAKAVKMFGIEPSIAMLSYSNFGSASSKSTQKVRE
AVAYLHKNHPDLVVDGEIQADFAINPEKLAKSFPFSKLNNGKGANVLIFPNLESANIVYK
MLKEIQRLDTVGPIVLGLSKPIHVTTLGSSVDEMVNLATLAVVDAQERELRKK
>OBAHECAF_00328 UDP-2,3-diacylglucosamine hydrolase
MEISLAGDKKIYFASDNHLGAPNFVASRPREKRFVQWLDRIKTDAGAIFLLGDLFDFWFE
YETVVPKGFVRTLGKLAELSDSGIPIYFFVGNHDLWMEDYFQNELGIPVFHKPLSFTANG
KRFFVGHGDGLGPGDKGFKRMKKVFTNPVAKWFFRWLHPDFGVRLAQHMSVKNKLISGSE
DVKFLGEDREWLVLYCKRKLETQHYDYFLFGHRHLPMQIHLNDKATYVNTGDWIHHFTYA
VFDGNSLRLEKWDE
>OBAHECAF_00329 hypothetical protein
MAKIRITKKFDFEAGHALYGYDGKCKNLHGHSYKLHVTVIGEPITNPSDVKFGMVIDFGD
LKKIVKREIIDVFDHAMVFNGNSPHLTLAQELIDKEHHIITVDYQPTSENLVVDFAERIK
KHLPSNVTLFSLRLQETESSYAEWFANDNL
>OBAHECAF_00330 Protease HtpX
MDATTLFYLILAIFIAEHLLDEWISTLNARKFRDPIPEVLADVYDTKSYEKSQNYKFEGH
RFSTLSSWLSFALTLVVLSLDGFAFLDGFIRQYFENEIVISLLFFGILMLISNLIALPFE
YYATFVIEEKYGFNKSTRTLFFTDFLKGQALTLFIGGGILALVVWFYLWVGTYFWIYTWL
LVSGFSVAMAFLYTRLIVPLFNKQTPLEAGELRDAIEEYAKKVGFQLKNIYVIDGSKRST
KANAYFSGFGKTKQITLYDTLIKDLTTDEIVAVLAHEVGHYKHKHILFNILESTILTGIT
LYVLSLAIENSIFSEALGVQTHSFHIGLLAFGLLYSPISTVTGLISNYISRKFEYQADEY
AKTTMGTAEHLVTALKKLSRNSLSNLTPHSWNVFLNYSHPTLYQRVIHLQKEM
>OBAHECAF_00331 Fructose-1,6-bisphosphatase class 1
MGEFIIQNQKDFQYSTGELTRLLSSIRLASKVVNREVNKAGLVEDILGDMGEENIQGEVQ
KKLDVFANEIFIKALTQREVVCGIASEENEFFISVEPSQNSHLSKYVVLIDPLDGSSNSD
VNVTVGTIFSIYRRVTPEGTPVQLEDFLQPGNRQVAAGYIIYGLSTMMVYTTGRGVNGFT
LDPSIGTYYLSHPNMQFPKDGSIYSINEGNYVHFPQGVKDYIKYCQELEGDRPYTSRYIG
SLVSDFHRNMLKGGIYIYPSGTRTPHGKLRLLYECNPIAFLTEQAGGKASDGYRRIMDIQ
ADHLHQRVPFFCGSVNMVEKAEEFMAKYPRE
>OBAHECAF_00332 hypothetical protein
MVSKLAKKHKEYKNVYSLFSTFFFRNFAFCKTIVHHKMSLEDRIFSINNEIDFENISLEV
FEYQFNHNLVYQDFCTYLKKTPKNVRSLFEIPFLPIEFFKSHRVFCGQDSEQQIFTSSGT
TGMLTSKHYVKKLSVYEKSFRKGFELFYGNPSEYVILALLPSYLERTGSSLIYMVEDLIQ
QSNNPNSGFYLNELQSLANLLKALDEAGKKILLIGVSFALLDMVEKHSFSLKNTIIMETG
GMKGRRKELIREELHQILCNGFGVQAIHSEYGMTELLSQGYSCGNGIFKTVPWMKILIRD
TNDALSFQPNKKTGGINVIDLANLQSCSFIATQDLGRRLSDTDFEVLGRFDNSDIRGCNL
LVL
>OBAHECAF_00333 Na(+)/H(+) antiporter NhaD
MEILLIAVFFIGYFFITIEHQVKIDKTISALGMASVCWAILKMGGLTVYEIEDQALHAIN
PTNNDLAIDNILLHHLGKIAEILFFLIGAMTIVEVIDMHRGFEIIKKIIKTRRKKRLLWI
VGIIAFFLSALIDNLTTVIVLVTIMRKLVPFKTERIWYISLIVIAANAGGAWSPIGDVTT
TMLWMANKVTAAKLTEYVLLPSIICFVVPFAIASFLPVFQGRLDIPRSDKTQAFKSSTPV
LIIGFASIIFVPVFKSVTGLPPYIGMLFALATMWFFSELLKPIKELNEDAAVSFSTHRAL
SRIEISSILFFLGILLGVAALESVGILFNFANVLNEAVPNQNIVVALLGMGSSVIDNVPL
VAASIGMFQEPVDSALWHFIAFAAGTGGSLLIIGSAAGVAAMGMEKIDFFWYLKNILWLA
FLGFIAGFLSLIVLESFHVFE
>OBAHECAF_00334 Formate--tetrahydrofolate ligase
MSFPTDLEIAQNAKMLPIKEVAKKLNVSEDDLELYGKYKAKLPLHLIDNEKLKKNKLVLV
TAITPTPAGEGKTTTSIGLTEGLNKIGKKAIAVLREPSLGPVFGIKGGAAGGGYSQVVPM
EDINLHFTGDFSAIEKANNLLSAVIDNNIQSKTHSIGIDPRTVVWKRVMDMNDRALRQVV
IGLGGSANGVPREDGFNITPASEIMAILCLSESFSDLKKRIGNIYIGKKFDGTPVFARDL
KVVGAMALLLKDAIKPNLVQTLENNPAILHGGPFASIAQGTNTVLATKMGMSLAEYTITE
AGFGADLGAEKFMNIKCVSAGLAPDAAVIVATVRALRHHGGAMKEEYTTASLEKVKKGIG
NLEKHIENVQKFGLKAVVAINFFPNDSDEEIQFIRQVCEQKGVKAIVCKGFAEGGNGAKE
LAQTVVEIVESGESKFKPLYDHAISIEDKIVKIATEIYGAKSVNFTSKARTQLNNINKLG
FDKMPVCMVKTPKSLSDNDKKLARPTDFEVTVREFEFASGAGFVIPILGDTMRMPGLPSV
PAAEGMDIDDNGIITGLS
>OBAHECAF_00335 hypothetical protein
MNNKKIAEILASQYKASLGMLRKTLEKVPEDQSNTDEYNNPN
>OBAHECAF_00336 hypothetical protein
MVVEGFHTKEELFSFIDELNENLLQRIEALPFEADSGYEWYPVSRFELHLNCIRHTQHHT
AEIIERLKIKGISGFRWWVNEHEPEEWEG
>OBAHECAF_00337 Dihydrofolate reductase
MVTDRKVILYIASSLDGYIAKPNDDLSFLSIVQQDGEDYGYADFVKSVDTVILGRKTYDW
VMTQVPEFPHADKNSFIITRTSRPSVGKTSFYTDNLKDLILRLKSEQGKNIFIDGGAEIV
NELLKENLIDEFIISIIPILVGSGTKLFKDGRPEQKLELISTKQFDKGLTQLHYKRADN
>OBAHECAF_00338 hypothetical protein
MYFISLIYNGLKIMGKKSSKKVCKSFGSLEKSITFAPALEGS
>OBAHECAF_00339 hypothetical protein
MKNKLSVVFFLFSMGLFAQVRKEVENGIFVTFPNRPEYTTVEGYRSYISKTENVIFMVQI
VDLPQRAEYMIAERKFSEADKKTIADSFLNNFVKGAMASIGNKVQVQEIKKGKFYGRKME
YRAVNPATGDVSGRAKLALFIRGRVITFECILMNDSPQAVNEKDNFINSVIVK
>OBAHECAF_00340 hypothetical protein
MKKIILFITLAIFTGYVNGQNKKTSATKSEIDKLYEKYKDSDNITLFTPQGDLQGIVTIK
MNDNYKPVSITIKGSSEHKASIAEFISNTIKMKLKQGYKVTKAPFGWNTWSYAELVEQGL
GWGFKKDRQSFQLLMKKGNMYFRADAGCCVGYDTSYTWEIETGDSKRQGGSSATNFEF
>OBAHECAF_00341 hypothetical protein
MKKIVLIMSLVVSLGATAYMGVRETVKDECCAKCVGAKNCKACKNCKYCKHCNSGGSCGV
CR
>OBAHECAF_00342 hypothetical protein
MDTYNLGYVIGYFLGKLLMLSLIVGVIYLIIKAFRKRNRGEK
>OBAHECAF_00343 hypothetical protein
MKYKILFITLIWFSICVNAQKKIQAKHFDFSCDCTEVENYYEPKNSSNNYSYVNEKQRFG
YTFATREISFRNKSEQKDFLKAIKNSGTLNYQWQNFLGQEAIIADLNSQEDQIYAKHIAF
FYNNVAYTIMVFAKSPTQLKQHFNHLKNTLKLK
>OBAHECAF_00344 Secretory immunoglobulin A-binding protein EsiB
MLLTISALITVLSYGQDISTLIEKAEKGNAEAQFDLAFAYFEGTGVAQSYEKAVYWWEKS
AELGNAHAQLNLGSAYYQGVGVAQSYQQGIYWWKKSAEQDNTYAQLNLGDAYKKGKGVEQ
SNTEALFWYQKSAELGNAHAQLNLGNACYQGVGVAQSYQQAVYWYQKSAEQGNAEAQFYL
ALAYRDGKGVKQSAEKAIEWLIEACEEGQLEQACEFLNKMK
>OBAHECAF_00345 Secretory immunoglobulin A-binding protein EsiB
MKKIVLSLMMAITSLSYGQNDIEEIEKKAQKGDAIAQYNLGSAYFEGKGVAKSYEQAVYW
LIKSAEQGNADAQDILGIAYRFGLGVTQSHEKAVYWWTKSAEQGNNHSTQYILGRAYYLG
EGIEQSYKRAVYWIRKSAEQGDAVAQEHLGRIYHKGEGVSQSYEQAVYWFRKSAEQGDAD
AQYNLGNAYYNGKGVSQSYEQAVYWYRKSAEQGDADAQFNLGRAYDKGKGVSQSYEQAVY
WFRKSAEQGNADAQLVLGRAYDKGEGVAQSSEKAVYWWRKSAEQGNALAQYILGNVYYMG
KGIAKSYEEAVYWWTKSAEQGNTDAQFNLGRAYYYGEGIAQSYEQAVYWWRKSAEQGNAF
AQYNLGNAYYIGEGVSQSYEKAVYWWRKSAEQGNADAQYELGIAYYKGAVVAQSYEQAVY
WLRKSVEQGNARAQAALGAAYYYGQGVPQSYEQAVYWVRKSAEQGNADAQYLLALAYYKG
EGVTQSYEQAVYWFGKACEKGNEKACLMFNKIKSK
>OBAHECAF_00346 hypothetical protein
MKSISFKDAIDQTFQQQNWNYYKGKEEFTENPMLSIEESKEFIKNFIKLSGKAENALNEE
IDKIEDRATHIVSTFFIGHYIYQNNEKIKDLIDKQLGELIKKMKISSDNRLFTFVWFLTC
LFHDLGYAIEKSTGIKYISLEELKNKTSDLKEVEGIPPFYKEIHPKYYDYRIREGGKNDH
GITAAYLMFHSLCKIRYWTELSGDATFNWEQGLEDIYNFCAWNVLAHNIWFSEKNDEDKY
RKYGMHELIFDHSLGDNYKITLEEYPFFFFLCLIDTIEPYKRIKDYEKLSKIKLKMSDEK
IEIISELENNEEKKVLDQVESLKKWLIPTERTNKVTIYLTPKKGN
>OBAHECAF_00347 Secretory immunoglobulin A-binding protein EsiB
MTVLFYGQDINLTIKGAELGYPKAQFNMGVAYERGEGVEQSYEQAAYWYKKAAEQDYVSA
QYNLGILYYYGNGVKKSYTQAVYWWKKAAQQNDASAQSVLGLAYYEGEGVEQSYKQAVYW
WEKAAEQGIVEAQTNLGIAYINGDGVRRSVKKSIELLRKACEEGSDRACEVLNEIKKRY
>OBAHECAF_00348 hypothetical protein
MKKIIYLLLLVTGSISAQTLHIYGGKNHDVYLGCLNCDHYDSDSIWNKYGEYGNSYNSNS
IWNQYGNYGSQYSDTSPWNKYASNPPVIVDKQGNFYGYFTINEYKDKRANFDLALYLYKY
YDMIRKDVGEWYKKIFE
>OBAHECAF_00349 hypothetical protein
MKKIILTLFLFIAVTMMVSAQSVRYQRGYQKSNGTYVVPHYKTDINKTNHDNFSTKGNTN
YYTGSSGYRAKDYSSGAYNYGSGQTIRTGSRGGQYYINSNGNKTYVPKRK
>OBAHECAF_00350 hypothetical protein
MKYNNTFSIGILVIAVVFCLLSYRSCSQYKEKYETNSVQIKTLQDLLKAKKESLSENQTT
ILVEKDTFEIQSLNKEIEHLQALVKKLQSIQKPKIITKVDTIIKEVIVKDDNAIRKVNYD
FNGWVYGSIISYRDSTGVNVNIKNDLSIVHKKDKKGRYVEVFDKNPYTTTEAIRSYYKLN
NKKPIIKRWGVGPNLSYGINYKGDFLPYVGIGIQYNLIHF
>OBAHECAF_00351 hypothetical protein
MAESKNNIITHGLSGKVGNMLVFSQRNGKTIVSQKPTKKAITSEKVKEQMAKFQQATIYA
KTALKNPTVKEEYQSVADKKQGVTAYNVAVADMLQAPKIEQIDLSDYAGQVGDTIKVRAY
DDFKVASVTVHIYNSDGSLVEEGNAVDNGLDWVYTATQTNADLSGDKIVVRATDIPANTT
ETTKNL
>OBAHECAF_00352 hypothetical protein
MKNLCNSHKISIFVRALAQHSTAQHLNSQNSVVTTLCNINPLDGDCSPSSGFFIFLKGTF
SINS
>OBAHECAF_00353 hypothetical protein
MHYLTLNYVCNELKPIVKKVKKPPENTLFDRDNSAQQTSLPL
>OBAHECAF_00354 putative peroxiredoxin
MSFVGKKFPNFAVNAMSDLGDTFKINVYEEAVNDKKKVLLFWYPKDFTFVCPTELHAFQE
ALAEFEKRNVKVIGASCDTAEVHFAWLNTPKDNGGIEGVTYPILADSNRNLARALDILDS
REVYDEVADTYLQEGDDVPYRATYLIDEDGKVFHESINDMPLGRNVKEYIRLVDAYTHVQ
KHGEVCPANWEEGKEAMNANRDGVAEYLKSH
>OBAHECAF_00355 Putative thioredoxin 2
MQELAQDNLQEVVASNDVVFVQYGAGWCGNCKIMKPKFKKYASETADAVFVYVDAEKFPN
SRQLAKVDNLPTFAAFKKGALVNQIQTNKAESLKQFIDEITAN
>OBAHECAF_00356 hypothetical protein
MRLPLIKHMVQFISENDQDYVHETIETLENLIECDHLKDEELDVIGELLSNFYGAIEVDT
MIKEGMPQKEALNSFMKRVVGAIDK
>OBAHECAF_00357 Peptidoglycan-N-acetylmuramic acid deacetylase PdaC
MKKKLLSLSLLVALVFGSCTGNKSQTGSTSVESSTESIVEVVELPEEISITQSEDDIQVY
TVKIGNDPDKSHLTASFPITAYDFVNKNEKSFTEKLITEFKTAAKDYQDSETSALDFNQH
FEVKYHSEDFLIFLYERNVSYGNNYDNSHFVSVFNLKDKKKMEPVDFFKNQESFEKFASE
VNLIATDLVKKRIYEDTNYANDGEREQVLESSKDMIQEGTAPTSANYDALFFDQKGEWYL
LFDKYQIASGAMGDFSVKIPQDLVNKYMNETFLKIFKKEDIAEQSAGIEVSEPKYSEVDC
SKVPCVALTFDDGPSVYTAQLLDALKEENVKATFFVLGKSSSVQKQTIKRMAEEGHNIGN
HSYDHKDFRKISREEAERQIQLTDEVIAGITGQKPRYFRFPYGAHTKENLEMVGRPVIMW
NVDPLDWKHREVNRVAEAMSKASPMGIILAHDIHKTTVQSIPQVIKNLKSQGYHIVSLDD
LFRHKELQNGHTYSSGK
>OBAHECAF_00358 hypothetical protein
MRYKIITTLFFACFQLLFSQENFKTHLKTNDLTSVFSASSLQWAIPVSPSEKVNLQWHER
KNSFTDKEGIRTFVGYEGDLFVATLSISKGGDDISGDFTWKEHQWKIATTNDGYLFISKE
HSEGECGGCHNGHCGTHSDKKSLRGRLTARPEKIVRKIHTDNALRVFRLAVLVDKYYYDR
YYGSKDAVKSFWSRLEIALNEYYIREIGIKLQIVNDDRLIIDSSKEKVFDGELSNKILNK
STAKINELIGKDSYDAGIIISRNSDTNIAGLASVGAIRLDRIKARAMANNSSHIIAHELG
HLFGSSHTFTVGGTGTYQTEPGKGQSIMSYGHPVNFFSLPSIYYIRRKISEIEHKITEIQ
TSNKAPIINKSKLKEEYTLPKETFFQFTVDATDPDNDPLLYAFHQADMNISNAEFESEKS
TDKNTKAFYNHREMGTFAKKEYNFSSGKVYTFWLGVNDTKNTFDERLNHPTRYDMYETKV
KFVEGNPFKITNFQRKYKTGEKVTLTWDVDPTLFQNTKVRILLSDDFGQTFNHILVPETE
NDGSCEIVMPNTPIGRKVHYQVNGNPIFHSGLGLIKIEVLDHVAFALTDNDIATGKGGFE
VEASAITFTKTPTKYLKVSNEKDIPNEPIEAVSNCTADGKTQITLNEVKNQNFITRTWIA
RDNCHNTSSFVQHIEIQATTPKDLVFTKTPEVFLSATCNAVPSADYSQFATDGCDLVNIT
HQDTRKGNNCNYTIERVYTATGCKQNLIFTQTISVSDDKAPTFNESLPTDISVEENKVPT
QVDLTATDNCSENIQVTKSQENKEENGNKVIIYKWEAYDDCGNKATHEQKVTVISSKIEF
TGDLPKDMTISCEKEIPSVPTLQVSGNCNPKVVYNGETKSNEKCKNDYVLTRSWTAINDC
GKSITHTQTITIKDDVKPVFSGTLPADISVEENKIPEQMNLTATDNCSEKVQVIKSKEEK
QERENKVITYKWEASDDCGNKVTHEQKVTVISSKMEFTGDLPKDMTISCEKEIPSVPTLQ
VSGNCNPKVVYNGQTKSNEKCKNDYVLTRSWTATNDCGKSITHTQTITIKDDVKPVFSGT
LPADISVEENKIPEQMDLTATDNCSEKVQVIKSKEEKQEGENKVITYKWEASDDCGNKVT
HEQKVTVISSKIEFTGDLPKDMTISCGKEIPSVPTLQVSGNCNPKVTYNGETKSNEKCKN
DYVLTRSWTATNDCGKSITHTQIITIKDDKAPTFNESLPADVSVEESEVPIQVDLTATDN
CSENIQVTKTQENKEENGNKVIIYKWEASDDCGNKTTHEQKITIQKSSEKITVYNGVSTE
SGSENYLKIEPIENYKNLQIEIFNELGQKVYESKNYQKNGEVFRGYANVKGVFRKGKRLP
TGTYFYVLKYQDITGKSNTKQGYLFVR
>OBAHECAF_00359 50S ribosomal protein L21
MKYYIYLIFSFISFGQVVFAQETIKTSTKAIDVIRLFSAENKAKWAVPISKNEKNLLQWE
ERHTSFTQSEGIRSFVGYHDKNLVAVISILNGTISGNIRWKEKEIVLKTSEDGFLILYTE
SSNHKCGTCANGHCHSEKPSTKRPVLPSGSNTSTPSIPNTNVLRVYRLAMAISYEYFSDT
YVGFSSKVEEVKTFWATKEMELNEAYTRDLGIRFEIVKDENLISKQKDEVSDQRADYIIN
NATRIINSKIGNHNYDLGIYIAKVTEVAGLAYLENAYKTEKAAAVALVSRSVIMHEIGHL
FGARHTFAMTRNRLIDPASDKTEMLTGQSIMSYGNPRDFFSLRSIQMIREKLVNVPYFSD
ANRTQKVGNNSLVTNFPYGIAIQNQPPTIDKTKIKASYKIPKETFFQFYIPAQDPENKPL
LYAAHQTDIRRGAERSIASFLTRKATTNNPVVFQTEYSEKSRNLVHNTTPNAVGKFTFWL
GVSDAQPQQTSDYISQYDMAQTQVIIEDGTPFKITSLMGKNYKGGDNVQLTWNVDEQIFN
KNTSRVRILLSDDFGKTFKYTLAASTENDGNHTVKLPNISVNTIAFGGQKPDVSAGVIKI
EEIDGIAYALTTFDPKKGGFTITRDLSLPETLVFTKTPKTSLSATCDDIPNADDSQFKTS
GCDLVNITHIDTKINGSCANTYTIKRVYTATGCGQSVDFEQTIFVRDDKSPVFKEPLPTN
VSVEEGKIPEQIHLIATDNCSENIQVTKSQEERQENGNRIIIYKWEASDECGNKATHTQK
ITVIPSEINFVGELPKNMTVTCEKEIPSVPTLSASGNCNPKVVYNGETKSNEKCKNDYVL
TRSWTATNDCGKSIIHTQTITIKDDVKPVFSGNLPTDISVEENNIPTQIDLTATDNCSEN
IQVTKNQEEKQENGNKVIIYKWEASDDCENKATYTQKVTIIPLEIQFIGELPKNLTISCE
KEIPSVPTLKVSGNCNPKVVYKGETKSNEKCKNDYVLTRSWTATNDCGKTITHTQIITIK
DDVKPVFSGTLPADISVEENNIPTQIDLTATDNCSENIQVTKNQEEKEENGNKVIIYKWE
ASDDCGNKATHTQKVTVVPSEINFVGELPKNMTVTCEKEIPSVPTLQVSGNCNPKVIYNG
ETKSNEKCKNDYVLTRSWTATNDCGKSITHTQVITIKDDVKPVFSGTLPADISVEENNIP
TQIDLIATDNCSENIQVTKSQEEKEENGNRVIIYKWEASDECGNKATHTQKITVIPSEIN
FVGELPKNMTVTCEKEIPSVPTLKVSGSCNPKVVYNGQTKSNAKCKNDYVLTRSWTATND
CGKSITHTQIITIKDDVKPTFSGTLPTDISVEESKVPTQIELTATDNCSEKAQVTNSQEE
REENGNKVIIYKWEASDECGNKTIHTQKVTVKKSSQPIPPNGGSEVEKEMIVYNGVSTES
GSENYLKFEPIENYKNLQIEIFNELGQKVYESKNYQKNGEVFRGYANVKGVFRKGKRLPT
GTYFYVLKYQDITGKSNTKQGYVFVR
>OBAHECAF_00360 hypothetical protein
MKYYIYLIFSFISFGQLAFAQEMIKTSTKAIDVIRLFSAGNKIEWAVPISKKEKILLQWE
ERNTSFTEKEGIRTFVGYNNDEFVATLSISKDQKISGNFEWEQTQWDIKTSDDGYIILFS
EEKGEKCGLCSDGNCHVHHPKTPQQTPFSRPATEKNTYHIHSDEILRVYRLAVLVDWYYY
SSEGSIEAVKKYWSSLEATLNEIYMRDIGIKFEIVNDEKLIFNTSDKQTFDYKTSRYIID
NSTLKINQLIGADNYDVGIVIAKSRSRNNGLAVLGGAFDASKKAAAVAIKSYATIGHELG
HMFGSLHTFTTGGDSTIKTEPENGTSIMSYGSPRDFFSLPSIYFIRRRILGDGAYYQDRA
RTILKKEWLKGENPVFGIDTKNQAPIIDVSKLESEYRLPKETFFQFTINATDPDNDPLLY
AIHQADIKNDETSSVAEFVTEKSSSVNTKAYYTHWVTENSFLRKQYDLKVGKEYTFWLGV
NDTKNTLNERSNHATRYDMHEAKVKFVEGKPFKITKFERKEYKMGEKVTLTWDVDQTLFQ
NTKVRILLSDDFGKTFKHILVPETENDGSCEIVMPNVAIGRKVYYTDQNGRPIFHSGLGL
IKVEVLDHIAFALTDNDITTGEGGFEIEKSVITLNNLPEKYVVVNQESEIPLKANVTATS
TCGSNPVTIVNKEEKNGNITTRTWTATDDCNNQTSFVQYIEVKLLPESVEPLQFVGTLPK
DFVTYCHNAYTENEAPQLQVIGGKSPKVYLTENKQLFGDQKGFQIKRVWVAVDEVAKTIS
HTQYIVVRDIENPKLSAYPQDMVVKSRSEVPQRAELTATDCGNKIEVKSSTDNRTNGQGK
EVVIYSWLATDSYGNEEYHEQTITIDPDATPPPPIDLKFITTPPASISATCNAVLSADYS
QFATDGCPFVNITHTDTKINGSCANTYTIKRFYTATGCDQSVSFEQIISVTDDKAPTFNE
SLPIDISVEENNIPTQIDLTATDNCSENIQVTKNQEEKQENGNKVIIYKWEASDDCGNKA
TYTQKVTIIPLEIQFIGELPKNMTVTCEKEIPSVPTLEVSGNCSPKVVYKGETKSNEKCK
NDYVLTRSWTATNDCGKSITHTQVITIKDDVKPVFSGNLPTDISVEEKKVPTQVDLTATD
NCSENIQVVKIQEERQENGNKVIIYKWEASDDCGNKVTYAQKVTVVPSEINFVGELPKNL
TISCEKEIPSVPTLQVSGNCNTKVVYNGETKSNEKCKNNYVLTRSWTATNDCRKSITHTQ
VITIKDDVKPVFSGTLPADISVEENKIPEQMDLTATDNCSEKVQVIKSKEEKQEGENKVI
TYKWEASDECGNKVTHEQKVTVKKSLQPTPPNRGSEVEKEMIVYNGVSTESGSENYLKFE
PIEDYKNLQIEIFNELGQKVYESKNYQKNGEVFRGYANVKGVFKKSKRLPTGTYFYVLKY
QDITGKSNTKQGYLFVR
>OBAHECAF_00361 hypothetical protein
MKYIGRLLIFMIVFGQSVFSQEQFKTSLKVEQVRQEFSKGGKISWAVPISQGKTLSVVWQ
ERPNSLAGIQTFVGYKEDELIGVLSIDATSVSGNFNYDGNTYKITSEKRKVVVTKEDENQ
TECGVCCGENHNHTTQRPSSPDTENNKCAPDANGFLDNHCLDNIQIYTDGVLRIYRLALL
INYSQFQNHFKKDKQEVRRFWAATEAFANELYVRAVAVKFTIVDDEALIRDTPEKEILKN
YRYGYQMLQNQRSTQAMNEVIASDKYDVGLIVTFLPRVNGQAAMEAAHSAHTKADGVIGR
PAPSTVAHELGHMFGADHTFATGQDSGKVEPERGRSIMGYGHSFPRDFFTLYSVHSIRRG
LTHSSVYFSDKERTQKVMLARGENPIYGIKTSNRRPVIDASKLKKKYVIPQNTYFQFRIN
ASDPDNDKLIYAAHQTDIRLRTNPSNALYYSAKPSYNNVIRFQQEYKKDGTVDHFFSTQG
VYRFWLAASDGILGQEALTNETHATHYDMVKTDVEVKNGTPFIISSDLKKTYSAGEQVEL
RWNVDKSIFGANSKVRILLSDDFGQMFKHIIVSETDNNGTFTFTMPHIKVTKNGNRGNGL
IKIEVLDHIAYAVSDYNPSNGGFEITPSAITFENLPEPTIYVKEKDIPENYSITAVTTCS
DKAVNLKYTDERKENFIKRTFSATDNCQNQASFVQHIFIEEDVLPLQFVGVLPQDKVYHC
EATFDKTLPNVQVVGGKSPTIELTQTRMESDYHINYILKRTWRVTDPVAKPIEHTQLVFV
YDNTSPILVTNPQDIIVNNDTEAYNYVETPPVAFDNCGNKLQWRRPISPDYKFGSNGLES
VSVIWEARDGTFNPVRVTQKIIVDKNATDIYFQNLPADMQLSCKDGIPQVVDLKVVNCSS
AQVSHTQTEKIEGGKKIITRIYKAEGCGKTISATQRITITDDEAPTFIGKLPENISVANS
ADVPPLVDLGATDNCFQSCSQRKIVITTESDPRNQEYYNSWKVVGDENCIKTVQVTKNRT
QSTDGKIITDTWIAIDEFGNTQTYSRTIKVASPDVPKAITFDNFPADMNLSCGKDKPQAE
SKLQVSNCDGTTEISVTHTDTETGDCKTGKTIVRAYTATVCGQTISQKQTITIAGDNEAP
VFSGELPKDISITEYQEVPTQKTLIATDNCSAVQVTKSQENKVENGNKVIIYRWTATDTC
GNETKHSQTITITPAPEITFINFPADVNLSCGKYKPQVESKLQISNCYGTTEISVTHTDT
ETGDCKTGKTIVRTYTATVCGQTISQKQTITIAGDNEAPVFSEELPKDISITENQAVPTQ
INLTATDNCSAVQVTKSQENKVENGNKIIIYRWTATDTCGNETKHSQTITITPAPKVTFI
NFPADVNLSCGKDKPQVESKLQISNCDGTTEISVTHTDTETGDCKTGKTIVRTYTATVCG
QTISQKQTITIAEDNEVPVFSGELPKDISINENQEVPTQKTLTATDNCSAVQVTKSQENK
VENGNKIIIYKWEASDECGNKVLHEQKVTIRKTSQPTPPTGGVQPPTGTEPTQEIIVYNG
VSTESGSENYLKFEPIENYKNLQIEIFNELGQKVYESKNYQKNGEVFRGYANVKGVFRKG
KRLPTGTYFYVFKYQTITGESNTKQGYLYVR
>OBAHECAF_00362 Aminopeptidase N
MKHLAFVLLLVGLSQTFAQTDTSGRILHRATPEMKTKLQHTKLKVGFNFENQTLNGEEWL
TASPYFYATDSLILDAKSMLIHEVKLNDQPLKYVYENDSLKIKLDKIYQKNENYTVYIRY
TAQPEKVIEKEGARSDAKGLYFINPKGEIPDVPTQIWTQGETESSSCWFPTIDKPNQKTT
QEIYMTVPDKFVTLSNGILKSSVKEANDLRTDHWVMDKPHAPYLFFMGVGDFAVVKDTPW
RGTIPVDYYVEKEYESVAKKIFGHTAEMMEFYSKKFGYDFPWQKYAQMVVRDFVAGAMEN
TTAVSHAESAHQPSEVLADENYWEAVIAHEMGHHWFGDLVTTESWANLTINESFANYSEY
LWYEYKYGKDAADYHLNNKVGQYRHRSTDFLKNLVRFGYNDKDDMFDLVSYNKGGAILHM
LRDYLGDEAFFQGITDFLKTYEFGTGEAHQLRLSFEKVSGKDLNWFFNQWFFSHGHPFVA
VEKNYDAKTQKVHLKIIQNQEEDVLFEFPLEVDIYENGTYHRHQVWVKAQKENEFYFSAK
NNPNLVNINPRGVLILVEESYKTPAEYTFQYQHAKDFKSRWQAVEFAEENQDNPLLMKAI
KDPFYQVRIKALNALAGQKLSKKEFAEIEKIAKTDPKNLVKSAAMWTLAATQNRKYLPVF
ENALGVHSAAIQNAALNGIGKIDPTRAKNFLLKSAPENFTSDQLVWVFSVIVDNKMEKYL
PKVLPYIIYYPFIEKDNPKQAEIFRKGYLWAMSLDDKALVEIIAKSFRAAAPYSDKGSEA
NKATIRVLDEGIATKRKLPPTASVQQQIQLLEEVKALF
>OBAHECAF_00363 hypothetical protein
MRKFFMLTLIVVSMLTISCGKNSDDSQTENVRLVGTWKCVKIERVKDGKRIDPRDVKDDG
CTKYVFTDKVCTYFFINDEEGGKCMSIEILYRIENGRIYNRHYFEGEYQGENDFGFKFID
NDTFEFFEDTSDGKNGSISTYKRVK
>OBAHECAF_00364 hypothetical protein
MEETRELQKLYTFMQSLIYISIVVEIIMFVHFSFMDGLAPILVRLGKVPIYSNIFYSKIF
TFILIAVTCIGSKSKKDLELQPGKQIYTPLIIGVFIFLGSVLFLTFQSKTDKGLEWYNIL
YIIFSFLGAILINVAFDNISKIIKSNFMKDRFNKENESFEQTTKLVNTPYSVNIPMKFYW
KGKMRNGYINIVNPFRGTFIIGTPGSGKSFIVINSFIRQHSAKGFAMVVYDYKFPDLGKI
AYYHFLKNKQEGKINKDFKFNVINFSEVEFSKRVNPLKREYIETLADATETAEALYESLE
KSGNEGGGNAKFFKVSAVNFLASCIFFWSRYEGGKYSDLPHVLSFINKSYKEIFDVLFSE
PELQSLLSPFKSAYDAGAVDQLEGQIGSLKVQISRLATKESFWIFSGDDFNLKVSDPKDP
SYLVIANNPKTQSMNSALNALIINRITRLINSDGNLPSSIIVDEAPTLYFYQLANLLSTA
RSKKVSVCLGLQELPQFEGQYGKTEAKTIMSVIGNTLSGSARSKETLDWLQTLFGKVKQV
KEGISIQRNTTSINLNEQMDYLIPASKIASLNAGSLVGQIALDFGQENDFPSTYYNCKGN
LNMEEIKKEEQNYVDLPKFYNFGTLEERERKLQQNFKKVYDEVEQVVAKYV
>OBAHECAF_00365 hypothetical protein
MKSNFFLFLMSLLALVSCSKDNTSKEENKPKKVKYEVFMTDYSKGSIFISYLDKDSKSVF
DFQLKNGSFIYEFETFGNFSASMQTHVKDLENNVVFEPEIPRTMRIYVDDKVVAEKITKE
TFEELQYFIPVKL
>OBAHECAF_00366 DNA-binding protein HU 1
MNKSELIRKVAERSEVSIKETSKIVEFLFQEISEGLKNEDVIIKDFGTFKKSIRKARKGR
NPNTGEILNIPEKEVVSFKPSKNILRYKWL
>OBAHECAF_00367 hypothetical protein
MANFELEKLGVCPVCKKGHIVRGSIGYSCNYFKSFEDKCTFTIYSSYFGKEITSDIAKEL
IENGETRVFNDFKTQEEKPFSASLIIEDNIVKPNFKKETLETPCPICDGKIEIGQKSYMC
ENYHPQEEDACKLYIPRVICEKEITKNIAELLVKGEKTPFISGFKNKLGEEFTTRLYLND
DLRIEFKNDLCECPKCGGDVLVNQKAYSCSNYKNEDIKCDFVIWREMSGRKITQSEAIQL
CEKGETNILNFKSKDGNTYERKLILTDDFKVKMI
>OBAHECAF_00368 hypothetical protein
MKNLFILFALIYSGNIIAQTDRIVIDPALNGALWTTHSIQSSNLKEIKSNEDKIRNFQAI
ITKKMDDLKKLEEKYQKYLSTVNSVVKNSKDIKYCLELVKDIKKYQGQMFDMAVSDPKLL
AIAYKTEVELVTRSVDLSMYIYQMALKGGDVMLDNKQRTDIILYVVDELRTMRGLAYSVA
RQMRYAKRGDFLQHLAPREFRYVRNTKKSIENILNTKF
>OBAHECAF_00369 hypothetical protein
MNNVILKPDVVYWAIKNCLAFFILIISAFIFQFENLLLRYVQVFVSFSLLCYIGFSYLTI
MCTKWIITEEQIKIYTGVFFKEINYIELYRVYDYEERKNIIQVLIKNVNYLIYSKDKSTP
ILIMGGVRDKGNIIELIRERVEIQRQNKSIYELINQ
>OBAHECAF_00370 hypothetical protein
MMTFDDYKDKVSIIQVLEDLGYQQDISKGRVSPVFVKTQQGKKVDEVIIKNPNSSLNQHY
FDRNYKGGDLIAFIKNHISEFPQFYHENQFVHINKILGHYANIPYVPKYQNYKASSQEIH
FEANRYKQVPTKVDDLKYLTIERKISPNTVETFLPFIHRIQDTKANNNFINIGFPYTIPG
QPNITNYEVRNFGFKGMTEGGDKSNSVWLANFAGDNNLVKSVFIAESALDAMSFYELNKS
KVILGHSCFCSVGGYITNNQINNILKAFPNANIHTCFDNDLAGTLYNIRVNSAIQNTNIK
IIDKRAEDKILFEPEGKKSFTIPKSEVSIERYKKESGDEFKCRIHKPVGNHKDFNEVLQQ
NKKISIKR
>OBAHECAF_00371 hypothetical protein
MKTSIDNYYYQNAGQARAIANVLGYQESFNPETKSLTFSKGDISKTYSLQELKQGSQLPD
RENILEKSRENLVSFFDKERATNNFDEYKAELLRDNNIAIVKWDNIKGNQKDQNSDGFTI
IDLNNKISFTGADFYKYAFENNHLLNGQGEKLDVNWEALNAVGIDHNKLTEQEKESIARG
EKSELKGLIIDDNEQNRKYLESEKIDYEAKDGKLHFQAKISTAKEIEVENTPQNKKKLKD
ENIDFRETPDNKLKIQDKVSLRKLVIGAVLIISPIAGIALMMTPKRNEIKQSNDNSLKLN
KKDIESLKQGNIITKNNSKNERVVMQIDKDTNELVTVKAKDITIPNKIGGVVLTPAQKES
LSKGYEINLQNESLNKTYSVKLDLNSKNGIDIKDNTKIKEEVNINRTQGKENTTPEQKVE
KAEQSIKSDKVQEETVKEQKKENTTTEKQELSKDNNKSISNEEDKKEKTDISKEYKKEVE
NYYNKSEKSNKGLKL
>OBAHECAF_00372 hypothetical protein
MEFGKLGKGRNIYDIERRIKLKEAKLQFLFWGGIFFVVIVVFLLMKYILDVELIYVLLTG
FILVFTLTQFFFRSKTMDKIFEQIQMLKKERDLLKRLIDEERMAFSGEITLITNEVVKSD
FFIEYEKEVFDKNTNIGYLKDKIVSLKRYKYNGRNR
>OBAHECAF_00373 hypothetical protein
METRDIFWMIVIAIFGVGLLFLFEKLESDRENEKQKVISYMEKSGTGVVLGKRLVGRDNA
TEVAIQFKDTILYSNDREWYYLLKEGDSIKVEGKRIFKVAN
>OBAHECAF_00374 hypothetical protein
MNTKQVFFEKDIPYSSLEKLGISKMDILSLDKKNIEALLSGKRTNVFDMKGVDDKGRPFE
LKGKISLYRNSDNRVSINIHPVRKEIKNDIGLKDDEIDKLKKGVLMPKNINGEKYLVQLD
KDTNEILKVKLKNIIVPSHIKDVELNSEQKNRLKLGQPITIESGKEKLQVGIDLNNPKGL
TITNEAFEMKKKIDFDYHNPHIIGTIQTDKNRQEFTEYHKKQGNKLKNN
>OBAHECAF_00375 Murein DD-endopeptidase MepM
MKNKINLIFYLFFFIISAKAQFNTVVNKNIKSIKVEKEEFIQAKEDTILVRTKDSISNEI
YFSLPLDTIIITSRYGKRIHPTTGKKDFHKGIDMRAKSNYIYSVMPGKITKTGKNRLLGN
YVEIEHGKFKSLYAHLSQILVNKKDVVTAGQKIGITGNTGRTTGEHLHFAVTFNGKYTDP
KIILDYIARVKNVKL
>OBAHECAF_00376 hypothetical protein
MKLIQQTIIDSVKLFLKKQNDKDSRLTFLLDKIFCEFYKTQNSIRREDFTNSKLVFSIHS
KKDLDTLFTLCKFFTYKINEFENVQTIYVESLIEELRYLKDKEGHSYVVMLRLSASGKVF
FTSLLNEIVNREISYNYGERLDSSYYF
>OBAHECAF_00377 hypothetical protein
MNTLTTNEFYITENVKERVEKDRGNYNEILNNFFPNDMETIPLLAFAYHSIEEYPNLLDK
LNYAESRDEFSINAYYYLLEQQDEYWSAGTDPVISSELARRDLLEIYKSYDEQPLIP
>OBAHECAF_00378 hypothetical protein
MSKKISMLEMVSTIVDVIKNGNPQKYYINNKGLSELGAILFYPKENQIDESKELHKLLKE
TFPNEIEAVLDSLKKYHFTSYYTPKEVIDFQIDILKENNIEPKTILEPSAGNGAYVEQLK
KIFPYAQIVALEPDMFSYQVLKANNLHSPNVETINTTFEDYFLENKDKKFDLVISNIPFG
DFSIKTPYKHDYITNVEKNVNIFFNRYMPEMVNENGHCFILTSKNFLDRGKYTEVRQDIL
KQNEFVENYRFNNKLFEKENTKVVTDLTIYRKNSNRPQELSTKEKSFLATTNIELDGKEF
PINQYVNEQVSKTNGDYKIGFFHNKEDITIIPNEKENLHQFLDRQLNESRNLFLSIGQVQ
QEPNKSVSKDVKVEVTNNKEQQKQQSSSSTETLFSLNLTKDYLINNTNLYKGTYNVDPDT
GKIKYYKSFKETFDVKDKKKALLLNTYIPLRNEIVLLELNSIYNKVDSSYINQKYNDIQY
MIDMFRFQYGSLGDYKDFLSKDHYFDKLYKLLEYKSGQTIQANPNFKVDYFLNLLPKGKI
EIKKEPVQEQLPVDNSKEQSTITDTGAKIEPVNYNQVTDLKELCYNFYDEKGYIDIHFFA
EKLGKTSEEILEQGFKEKLFFLNPIRNENNQFVGFVPELFFRVESGNIDEKIYDFQNFKS
QYEIDTSPMIKYLESIKNERLDIEHISFNFESFFVPIQAKNEFLREATGERVTVVEEQFS
SSLNLHFERQFNSTANEKYSVKDKDGIEIYSYKKLLQDFADNKYPIITKSHKDNDGKTIS
VLDKEGTLLAQNLYEQVHLEFKSFITENAKYKDAVERAYYHYFLAEKNIKTTDQVLKFPD
TIPFEPYKHQKEAVMFSLLNKTALLDHEVGHGKTLTMGMLGYKLIQQNKAQKVLISTMKA
IAPQFEKETKDNFPMLKIFRLDDKNFSKKNREKTLEHIRKSDYDIVICEHTHLARIPKDE
KYVQQIYQEKINMIDKDLEVAEKYGTDISKKIIKGLVKRKDTLQGKLDALLQENIAKNGD
VSKENTFSKLGFDALMVDECHEFKNIGYTTRHERVSGLNAREDKGKNLDLEITIASIHDK
KGRDSNVFFFSGTPIKNSVTELYAYQRYLQPAMLKNKNIHNFDAWASVFLKQSVKLESDI
LGNPKINSRFRYFTNMPELSKMYHSMSHISNSNTFKTHKLSVNKEFITLDITPKLEELKV
ASSKFANSGDQEVLLKVAKYEEHQMKGAHVLALGINRRILVDPLIEKDNVRIHFDENDQI
KINKLCEDVKDLYNQTTPHKGVCLVFSDVGVWSKQKDYNTYDTIKNILSEEYNIPKEQIG
IAQEYKEKNKTQEFQEKIRNGEIRIAIGSTSSLGTGLNIQKRAVGVFHLDIPFSPDAYIQ
RLGRALRAGNEIAQHYGSKIVEKSYGIKDTTDIFSYSLNGHKEKFLSQLRDFNTTTRIYD
DVLTEEKDLSHSQREAALIGDMKAFKLSSLEDDLKALEAQKQLFDITKNNAEKKIGKYEL
ENKQILKEIIKYEKLQEKLLPLVPDISKVERNENYDKKVEAITYEAYKNILSKEDLAKYG
SHTNFKEFSKGIHNHISHFGINDTEKRIFSIYKNDFAVKFNIIKGQNNSGNTCYRYEANV
EIADNGQLSKFRLYSKNLMGISDKNIPFQLFKIINEIPKYTKELKSTFDYNLKTIENNKE
NLKRAFPIEKEKRMEQIKSEIKEIKKSRIKI
>OBAHECAF_00379 Toxin zeta
MKVEDVLKIFEKNKDFLLGEVYSKSNPVACILGGQPASGKGNLASIITKNIYTGEQFLIV
NGDTYRNFHPDYQNLVKNPHIYSRETQIFSNVFTEELIKEAIRNKFNIIIEGTMRNPQIP
LNTSNLFKQNGFKVEALAISAPAIFTEIGIYIRYQEEVNKQKMGRLAEISSHNSAVEGVP
KSLDLLYSKNAVDRIHIYSMYANEKVKSLSFDGKKWNCSLPPSNFIKTSREKQLLDKDLL
QNLITKGKETFNSIRTDLKPNVAELLDKLSSISQKIDNSLKW
>OBAHECAF_00380 hypothetical protein
MVYPLSLDTAITLVSSVKVIKMNEFNKATTQEEKNSLKQEIQMLSKEEYLLYSGEELVRL
SIMDKADKVYSPFLKKHYES
>OBAHECAF_00381 putative lipoprotein YiaD
MKKYILIVSSIYFIASCSSSQKAHSGINQSIEEKTKLIENANTEFSTATIVGLTAEILLA
KEQEKIREKKIKDLVNSLKDIEGVNIITHKDDNSFEMSVENDIFFEFDKVDLTPQALNIL
DKIYTNLADLLDSTKFKIVGHTDNVGSVIYNLELSKLRAKAVGNYFKERGANENKIKEFG
KGLSSPIADNKTEEGRAKNRRVEITIIPEI
>OBAHECAF_00382 hypothetical protein
MSKLLYFSLFSLTFISCSFPDEEDIYDHKIKVGYVYCSDGSTLHPDFFKDSNKKAIGVVF
WINSNFKANDDLAYAVSLEDLENDFLINSDENIDNVTEDENDFNGASNTAGYLAIGIKDS
LKKIPAIEKVVKYAPENVTGWFVPSAGQAKTISNNIEAVYETFTKLNAQKFNDWYWTSTE
DGNGEKSPDYFSLIISLNKGRVTNSRKSNIYKIRPIIAIR
>OBAHECAF_00383 hypothetical protein
MKRLFLIMMILFSIPTFAGDGGRYIFFGTGYQWSMIDWERRFLNFNIGFEFEKKHHNAWE
IYVDVTSKYKNCKSCNPTNYRTYDYNSFGVGVAYKSVILRGKNTNLRWKAGADIGSNVDK
RFQASIDLGLEFSYTFKNNMQVYVLQKNDIVFWNNNLFQNGLLFGLKIPLN
>OBAHECAF_00384 hypothetical protein
MKKHYLYLLLTIFGSYFSANAQNREGLAGSNIDSLNIIYINKDISTHFVSTEDIKYVDIS
TADVVGDLPLNNTLRIKPLKEGTNAVITITTERYFVQYMLVYTPNISKAYTRYTIPYEDV
KSYMNPEVNLTKSEMYDYAHRMYISTNKYYDVSTTENLMKLILNNIYTLDKYFFIDVSMI
NKSNIRYDIDEIRFKIEDKRQTKATNFQSVEIFPIIKVNEDMIFKKKYRNIFVFEKFTFP
GEKVFTIEISEKQISGRKIILRIDYSDILHADTFIN
>OBAHECAF_00385 hypothetical protein
MKKKIDFKKPKYIIPLLILPFIIGIGYVVKDMFKEKVDTLESTEEINMNIPEANLEKRDI
KSKLDALENAYKKSSDYSSIQEITPDEKVNEAEDLGSLYTTEEMLTIDSLNNASRIAQEQ
LQKQYDEHIKDQEEPKGKEEAPKNRIDEEMELFRRQMAYIDSLQNPKPKQTPKIVQNQKN
DDVLEVKRATNPQVNHFNTIRKNTNNSTSISVILDENIKAVQGSRLRFRLMDDIVIGENV
ISKGSYIYGEVSGFKDQRVLVKISSVAVNNRPLKVDLSIYDNDGQEGFFVPASAFRDFTK
DVGGQTSNQSIQIDQQGGGVEQFAYGALQDAYKSAQQAIGKRIKQNKALLKYNTQVFLVN
NKEKNK
>OBAHECAF_00386 hypothetical protein
MGIFKPDKKRLEQIDKGMEESTRNFLTPLLEKSLGKHLKKFVMWANNNRKKMFIINISFL
SLLVCYSIFRAFTAKTDFESVSNVSNRANSIYTEKNNRLEKQFDNLFKMYDLKYELEELT
SKDSLTKKDSIRIEELYNQIFKNEEEN
>OBAHECAF_00387 hypothetical protein
MIIKNIETKIKLAFGISILSFISAVIIVIVGLFFAFQMIRDERKQIYVLDGSVPILVQQT
GVEVNQEVEAKSHVNLFHSLFFNLPPDDDFIKYNMEKAMYLIDESGLKQYNNLKERGYFN
TILASSATVSIKADSILFDSQKMRFEYYGTQRIERETSILKRQLITQGNLRNVPRTENNP
HGLIITEWKTILNKDLEYKTKRNF
>OBAHECAF_00388 hypothetical protein
MNELIDKGLLTLIEGLRGKISELFGMFIYDAQALAAVFMLLYFGIESYKMMSGDKKLEIM
ALLRPFALGFVLIFWIEFVAVISYPPNYLTAKSKNMFEKQLDIVENLSRERYAKIDSVAK
KLNDRAMEVWRAEKETEKSFWDKFKIDLEAIKDKIASLFLYVVAWIKQIFFSIIEFIVVT
IWQVCVYIVLFLQLIFSAILIIFGPISFALSIIPAFKDAYIQWLSRYISVSLYGCIAYIC
LSVILKIMIYGQEQELQVLTKAMTDEEIFIGYTALSSGGINLFIITCLLGAITMLTIPTI
STWIIATSGVGQAISGMTRGVTGSVSSVARVI
>OBAHECAF_00389 hypothetical protein
MKSILLLLFPLSLFSQVSVKDESKINQLKSMEYAQWEFSPDWYYYSWVRRSRSVFGISWS
WTEPGLGVHDNGPAGVGGGDGYVNKDKRNIFQYAPMLVFVRDKKDKTEKQGEKTDVVYKQ
ERAKFADKSIDYQYHFYSSSFKNLQNEIIEGTFKYLKNKGNIENVNIIKTELQRINANIS
IIHKSHLSNSKKRDAYIEYEDELKELKGYVKSLNRINNINKF
>OBAHECAF_00390 hypothetical protein
MKKLLALIILLFTSNHIFSQMMVWDMTSVETLIANHKVQHAHFKEMKEKEGQIATIQRKI
SEQMVQIEFFKTKLYNSLKDVSLIVKTGKDVIYAKDIAKDIAKYQTEVAKLAVGDPKLVL
IAAQTQMALVNKTTDLMKYIYETAIIGTDFNLMDNKQRLDLVQYVIRELRTMRGIAYSIA
RQMKTAKRVGILHAISPSIFKKDKDATKKLIDDIINDRY
>OBAHECAF_00391 Type IV secretion system protein virB4
MLKKNQFVSPYIGIEVKNNIPILYTQKGDYSVIIKCENPVLQYSANIDNYYDFHNLFSNI
LKILGAGYNIQKQDIFSRKSFDKSSKDDDFLSKKYFELFKGRSYTDIETYLVITGEIVRS
SFFSFDVKLFNAFLVNIDKIIDLLKNKGIKASVLSKKEINIYLKRFLSLNFSSNTINLSN
IKANDTHLKFGERTVQNISLVDIDEVNFPTTIKPYKDVKIGLTFPIDLFSFLHETPNIET
LIYNQVISIPDQRIESVKLEGKKKKHSGVPDPANDLCVQDITAVQEDIAKEGQLLVYAHY
NIIVCGKEITKAVNYIESSLFDSGIIVSKQSFNQLELFECALPGNTGKLKKYDKFLTTSD
SAICLLFKERLHVTEPSNFLTYLTDRRGLPIGIDMSGKEGDIKLTSNANKFILGPSGSGK
SFFMNAVIRQYTLYNTDIVLVDTGHSYSGLCEYYNGKYITYSEEKPITMNPFKITEKEYN
EEKREFLKSLIATLWKGTEGSINQVEDTLLTNLISAYYDNYFVSGTIETLSFNSFYEFAI
QEIQTIVKREGIVFDLTSFQYILKRFYRGGEYDKILNDDFDSSLFDEKFIVFEIDAIKEH
KTLFPIVTLIIIDIFIQKMRLKKNRKALIIEEAWKAIASPMMAGFILYLYKTVRKFWGEA
MVVTQELDDIIGNPLVKSSIINNSDIICLLDQTKFKDNYDEIASLLSLGEVERKKIFTIN
KLNNKDNRNRFNEVYIKRGDFGSVFGVEVSFHEYFTFTTERIEKDTLGLYREIYNKENSL
FALDQFVSDMKKSGLGMREWVRKSNTVLNKIKEKQSLNSLSPSNNLCNYILEESKKLNL
>OBAHECAF_00392 hypothetical protein
MEYPVYNVYKGLQKPLIFKGLKGRFIYIGAGCVISSLILCAILSTIFSFLYGGIALTIVL
FGGLYLTSISQKKGLHRKDKRAGVFIVNKVFNR
>OBAHECAF_00393 hypothetical protein
MYKFSKKLIYFVGATLFINSTYGQGKAGIDAASSELTTYIDPVANLIMIIGAIVGLVGAV
RVYLKWNSGDQDVQKAVMGWVGACIFLVVSGILVKAFFGV
>OBAHECAF_00394 hypothetical protein
MELIFFECMNFSSFVLKIIVAYLIYYGINILYDVFIKKDKSSRDNDSERVVDFGDVIQEE
TIDVTDHIEPISIEEKYNHTITSNIKNSVFSESTENEKNTDNIIPDTMILVDEEDDSDEI
DLPIEGQAIPFEALLKEGKELFSNVNF
>OBAHECAF_00395 DNA-invertase hin
MEVIGYARVSTKEQNLDLQIDALKEAKCTKIFTEKISATKERPELDNALKYLRKGDVLVI
WKLDRLGRSLKQLINILENLKDKGVEFRSIKDGIDTRTPMGRLQFGIFASLAEYEREIIV
ERTLAGLQSAKERGKVGGRPKGLNAEAKKKAKIAKNLYADKDIKVEDICKTLNINSKATL
YRYLEYENVKIDRKNV
>OBAHECAF_00396 hypothetical protein
MEGITIEECFSQLLEKRAWYKNSPYDRKSAFVHKKKFLEGTLSIDIMKIYLQSSGYVVVQ
QELWNKKEVYEKRNKGGNNIITE
>OBAHECAF_00397 hypothetical protein
MKKGIKEEITLLPNENLTDKGMLSPDVRKYILDSNKDVIIVNGEEKSFSINALRIVLTLC
LNLKERQLKFRSKDKDYQLSLFDNEWFSIDNNESMSVQINFKFSDFLPKGSKNYDLVRKG
INELQERIYTIEFERENSKGEKTKYRLRSALISQYVEEEKKGFKFVINNFWYRALLNVSQ
YYTPMIKKTIFSLSHNAMIFYIYLNGLPKIKDQKDSAKYDLDKVFNVDNLPLLRGTIINK
YKFQEMFKTTYKYDSKIKEKLLDPFRKELNKVDISFNYKFEGDNIVLVAYEMLSNQVKLE
ITSKEEVDIEKAVAYRFVKKELSPTQAMLLCEIYLKYTYDIVTKATSRSSKIRNLKGEEF
INTFVKIVEDYVTRNKINLNDIEYSNKQELRKKITKKYYNRMNEITPTK
>OBAHECAF_00398 hypothetical protein
MSLIIQNNGLNNRKSLIFNRIIGYKKYCVGENRVLCRGKQKALNN
>OBAHECAF_00399 hypothetical protein
MSEKVNKTVTLRFRCSPNEKELFFKKSEMYKSFSHYVRKNLLEKERGEVVPPVEMIRMID
NLVFELNRVGNNINQIAKYINQRKEINDAIMQEYRSLLNNLVEIEKEISLSIKSIINKK
>OBAHECAF_00400 hypothetical protein
MIVKILKSATTFAGVNYNEKKNEQGKSELLVAKNFPLYGEISKSDYISYMEAVSNTNPNV
KKKQFHAVVSCKGREYTPEQLADIAEKYVQKMGYGDNPYLIYSHSDTDNNHVHIVSTRVD
KKGNKINDSMERVRSQQIMNEILSINPKEQVKIDISEALKYQFSTIAQFKMLLEMRGWKL
SEKGEELHLWKGGDKFLIPIEKIKDRLENYEPNLDRRKQLTALFHKYKEGLNHLELQALM
RNKFGVELVFHTGKGHSKPYGYTIIDYPNKLVMKGNEVMNISELLISPEKQAKIDSCNKI
IEAILKDNKPTFKEFKDSMFSYGYEVSDKKLIKLKGEKEYLFKLNDKTLKELKYNGRLEQ
ANRFNPVSKEEQNVLSRLFFVRSSDIQMRAEKDFDKLVYSEMMKSYFYNNVGDVEKLKEK
EISFVRDKGEVYLIDNINETILNSRELDIHFDRSVYLSSDNVYDLERLKDIENIEPNNYE
RGILDVIESALTVQTFEMTVEEQGINKKKKKKKQQNQ
>OBAHECAF_00401 hypothetical protein
MIIVFGNQKGGCGKTTNCIQFANYIADKGMETLVLDLDFQRSITDRRQEDINTYDNEPKY
EVIQANMEDLGKLIEDFTKIEKGNLLIDLPGRIDDDALIPILKNADVIICPFKYDKLTMD
STGFFIRILEHLEAKAQIFFLPNNIKKSIRYDTKEQIYNVLSQYGKITPEIPDRVAMERV
NTLVITSEAINVVEETYNYIIKEAKIK
>OBAHECAF_00402 hypothetical protein
MAKLKPKEVSNAGSSKSISSIASLLRGGERTLQPKKETEEIAVPQQEEREQVVEPVKETQ
NIREKKVQEFPLSYWIEKVGDKQYNCKEILYVDEEIKEVFGLLKSKGKIQISSLVSLILE
EWLEENKDDVLKIINSSKNRFL
>OBAHECAF_00403 hypothetical protein
MDFIYSIGNSLLIAILSSVISSIFVILILQAFLKPKIKISPVICKKTKEDGRIVYVIKVI
NVTGVDIFDIQARLHLVSREQTFTGEFTKTSEIKLKRSNPFVISAYGSNRKNYGVFRFLT
EEDIEKKWEKDDIQYLRFTILGKHRRSNTLGYFEQEYRTKRSSIKEGVFLVGNTFDIK
>OBAHECAF_00404 Putative zinc metalloprotease
MEIFMIRAAQLILSLSILVVLHELGHFIPAKAFKMRVEKFYLFFDVKFSLFKKKIGETIY
GVGWLPLGGYVKIAGMIDESMDKEQMAQPPQPWEFRSKPAWQRLIVMVGGVTMNLLLAFF
IYAAILFTWGEKQVKEDGLTGGFAVSEVMKTYGFQNGDIVTEVNGNPLGNLLDINRYVLL
RDVSNLKVKGLNGDERMVHLPDSIGKQLFHAGEMMAFRPRLKPIVDSVLVGFPAEKAGLQ
AGDKIISINDISVTYYSDVQDIIKVFPKKSTIIVGVERSGRKEFVEVTPNDEGKLGFFAT
QLANVEYTHKTYTVASALSEGISYGYWTLRDYISQFKFIFTKKGATEVGGFAAIGKMFPE
KWNWHAFWHTTALLSIMLAFMNILPIPALDGGHVMFLLYEMVTGRKPSDKFLEYAQMVGF
FILIGLLLFANGNDIYKAIFK
>OBAHECAF_00405 hypothetical protein
MKKILVSLSVIALSGIVSCENVKQIKKETQNSVENVVETLQTETEKAVDQVKKSISEFEV
PSFQDSDLQKMAADYKAYLLELEEATKAGSQEKIDQLKAKSEEWAKKIEEQGKKVSSEDL
KKWSEWAEQFVQ
>OBAHECAF_00406 Chaperone protein DnaK
MSKIIGIDLGTTNSCVSVMEGNDPVVITNAEGKRTTPSVVAFVDGGEIKVGDAAKRQAVT
NPKKTVYSIKRFMGNKFSESEKEVARVPYKVVKGDNDTPRVDIDGRLYTPQEISAMILQK
MKKTAEDFLGQTVTEAVITVPAYFNDAQRQATKEAGEIAGLKVRRIINEPTAAALAYGLD
KKHNDQKIVVFDFGGGTHDVSILELGDGVFEVLATDGDTHLGGDDVDEKIINWLAEEFQA
EEQMDLRKDPMALQRLKEAAEKAKIELSSSTQTEINLPYITATATGPKHLVRTLTRAKFE
QLIDDLVKRTIEPCRTALKNAGLSTSDIDEVILVGGSTRIPAVQEAVEKFFGKKPNKSVN
PDEVVAVGAAIQGGVLTGDVKDVLLLDVTPLSLGIETMGGVMTKLIEANTTIPTKKSQVF
STAADNQPSVEIHVLQGERPMANDNKTIGRFHLDGIPPAPRGVPQIEVTFDIDANGIIKV
SATDKGTGKSHDIRIEASSGLSQEEIEKMKREAEANAEADKKAKEKADKINEADSMIFQT
EKQLKEFGDKLPADKKSGIELALEELKKAHQSQDLGQIQPALDKINEAWKQASEDLYKAQ
QAQSEPQPNTGGQQQQNGDNVQDVDFEEVK
>OBAHECAF_00407 NAD-dependent protein deacetylase
MKNNNTEKEVEKSKKKYILLQNNYTISYDDNECFVNGEKYKQNDEDTPAEKIAEDLKKKK
FYDTFLKKHFKNIVVLTGAGSSMDNGSSSGKSMEGLWKECQEEIDDLETEISDLKSKPFY
INSDIEALISYNTLLEKISDNDKAESLKGKRQTIEQKIKKECTLTLEKEAPHIDFLNKIT
SRKNNDTRVQIFTTNYDTLFEQAGNQAGFVIIDGFSFTQPREFSGSWFDLDIVNREKTRL
KQEESFIQKVFHLYKLHGSLTWERDEKTKKVIQKNNPENPLMIYPSSEKYESSYEQPYFE
MMSRFQQALRKEETLLIIIGLSLADKHIKNVILEAVDQNPSFQLVFVKYGGIKVEDFDKD
IKDIEDLFISRDKDNLKVKRNVNIVSDSFKKFTDNFPENKTYSNKNHSNESFQ
>OBAHECAF_00408 hypothetical protein
MNPFNDNYFLGYVNEVTPQYIKIHFPSSTLLNRFHHEGTNYAGGGVGNFIVIEGEEYGFL
AQMTEIKLSDSEKKELTAKAIEHKDSDFRPIGKAELLLSFNVFSPEKVQKTASKYPLIGA
KVYSCSDDQIRKYVAEFGKKKDENENVYATLGKLVTNDAECNVSLNSLFGRHCAVVGTTG
GGKSWTVSKLIEEVTTQTNNKIILIDATGEYNSLNAESFILGLNSYFPYQKLSIPDLFYL
LRPTGQSQRPILLEAIRSLKIQKILGKTSVYVKTNTLKSDYRNYYNTYIKQIENNLCDFD
IKLLSNQIKEECIYPDADFGKAPEKFGSEDKKTYDYQTSLISRITDLLNTDVFEKLFGFN
ITQNTDCTSIIEKIDGFLKAETTDTILRISFENIPSSFSAKEIVSNALASYLLQKARKGE
FKAVPIVLIMDEAHQFLNKAIKDEFFEMHSLDAFDLIAKECRKYGLFLCLATQMPRDIPI
GTLSQMGTFIVHRLINEKDKQAIENAASSANRNALSFLPILGEGEALLVGVDFPMPLFIK
IDEPKTPPNSNTPRLSKK
>OBAHECAF_00409 hypothetical protein
MLKAFYIKYFFILLIAEIRRVQLYFWQITNEMGCVQLYF
>OBAHECAF_00410 hypothetical protein
MLKILKPSVRITEMADTAKQLVMLYKSETALANDPILKPVFAQIEPLAEALSQAIKSDKI
LSEVDKADDVRDELVRQLEKYLKSYANIPVENLRKSGERLYAVFSKYGVRITRESYAVES
AHIESLLKDLAEPTLQTDISALEGIASTIEALKTAQADFDQKRLVHDKNLATQSKRPKSA
DLKKQLLKQINIGLIPYLTSASFVNPQAFTHFADTVAQIINTINAAISGRSKKA
>OBAHECAF_00411 hypothetical protein
MNIKNAQLEVDNWIKEHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKQKDL
GEELADVVFVVLCLANQTGIDLQEAFDRKMDKKTKRDHDRHHSNEKLK
>OBAHECAF_00412 tRNA threonylcarbamoyladenosine dehydratase
MKNWLERTELLVKSEGIERLKKANILVVGLGGVGSFAAEFIARSGVGKMTIIDGDVFDVT
NINRQLPALQSTVGKSKAEVLASRLKDINPELELTVLTEFLSPERAFEVVTPDFDYVVDC
IDSITPKLNLILSARAKRIKLISSMGAGGALDPSQVKVADIRKTRDCPLARNIRKRLKKE
GIHSGFKAVYSSEVASKDTMQQTDGTNFKKSFYGTISYMPAAFGLHAAATVINYLLEVKN
EQEEVL
>OBAHECAF_00413 Ribose-5-phosphate isomerase B
MKIAIGNDHAGPAYKKAIVDYLESRSIEVINFGTDTFDSVDYPDFGHKVAEAVTSKQVDL
GIVICGSGNGIAITANKHQGIRCALCWTKEIAALARQHNDANVVSIPARFTAIEQAVEIV
KTFIETQFEGGRHTNRVNKISCA
>OBAHECAF_00414 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MKEITSTQNSLIKQLLLLQEKSRNRKKEGIFVIEGTREITLAIKGGYTLQTILFQQDIFS
EAQLKSLLLETKSSPECICISKEVYEKLTYRSSTEGVIAVAVAKSHSLSDLHLKKTKPLI
LVAEAPEKPGNIGALLRTADAAGVDAVLIANPKTDLYNPNIIRSSVGCVFTTTIAMGTTT
EIIDFLRGQGINIFCAALSASKPYTEVSFNQGVAIVVGTEDEGLTEEWLSNSNQNIIIPM
QGVIDSMNVSVAAAILVFEAKRQRSV
>OBAHECAF_00415 HTH-type transcriptional repressor BluR
MEINLPEKLYYTIGEVAKAFNVNTSLLRFWEKEFGIISPKKNLKGSRKFSADDVKKLQLI
YHLVKEKGFTLEGARQKLKEGHEQVLSNYEIIEKLEHIKRSLIRIKEEL
>OBAHECAF_00416 Murein DD-endopeptidase MepM
MKKVKYYYDPETLSYKRIASKKRTKIRNIILFLVASALFGGITMFLMINMRFFYTPRELS
LQREVKQYETQYQILNKKMEQMEEVLANIQERDNNMYRLYFDVAPIPEEQRKSGFGGINR
YEHLENFDNSKLLIATTKRLEILQKQLVVQSKSLDEIAGLSKEKEKFLASIPAIQPVDNK
DLTRIASGFGWRNDPFTKAKKFHNGIDFTAPTGTPIYASGDGVITRADDASSGYGKHIRI
DHGYGYISLYAHLNDYKVKAGQRVKRGELIGTVGNTGRSQAPHLHYEIIKDGEHINPIHF
YYGNLSPDEYAEMLRVSTHENQSMD
>OBAHECAF_00417 Aromatic amino acid transport protein AroP
MEDTNKNQELRRGLSNRHIQLIALGGAIGTGLFLGIGSAAVLAGPSVILGYALAGIIAFF
IMRQLGEMVVEEPVSGSFSYFAYKYWGNFAGYISGWNYWVLYILVSMAELTAIGVYVRYW
WPEIPLWASSGFFFLAITALNLGSVKLFGEAEFWFAIVKVIAIIAMILFGTYLLLSGTGG
AEATVENLVNNGVFFPKGWFEKTDSGYQGLLAVMAIIMFSFGGLELIGITAAEAENPEKN
IPKATNQVIYRILVFYIGSLIILFSLAPWETITTNTSPFVTVFDNLKGLNFSLFGKEHSV
THLIANALNIIVLTAALSVYNSSVYSNSRMLYGLSEQGNAPKFLKHLSKNAVPIRAIIVS
SCFVALCVIINKFVPEQAFNILMSLVVSCLIINWVMISFTHIKFRKVKNQEQVKVKFPSI
LYPFSNYVSIAFLIAILGVMTLTGMLLSVLLIPVWIGVLGLSYFVIKRSSDRKKTRNKST
NFN
>OBAHECAF_00418 Cyclic-di-AMP phosphodiesterase PgpH
MKQFRFALSLRKSTIFKTFLFLAALILIVQVFPKKAKFKYEFQKGKPWQHETLYAPFDFS
LKKSDEQITAEKRAIEEKSVVYYKKDTTVFQISQVKFDDRKNQYFRNISQEKKEKLFSKG
ADFLKFAYQNGVMISSEYVKGSNLTMIQHNNEVCELPIEQVFFLDELNAKIHDFFEENEY
ANFTDAYYDLFFEVLQPDIKIDQNFTQKALEENLKEIVYTRGWIKQGQLIIAKGEMIEGE
KLNALNSLQAEYQSENWNQSNYYWSLLGYYVLVGMVLFLMGLYLRIYERKIFKNNTKISV
ILFSVLSIILLVSFIAHRFPDYIYLVPVGIIVLILKSFFDLRTVIFVFIVTVLLLGFVAP
NSFQFIVIQIIAALTIIITPKGLHYRLNSFVSAALITGTYLITYIAFHFITEGSYQNIDI
SLLTLFILNGIGILFSQPLTYIYEKVFGLVSDVSLLELSDTNSKLLRELSDKAPGTFQHS
MQVANLAEAAAAKIGGNTLLVRVGALYHDIGKMLNPIYFIENQKTSINPHDKLSPLQSAK
IIINHVTDGVELARKNKLPKRVIDFIRSHHGTTLTYYFYKKEQELNPDCQEADFRYPGPA
PFSKETAILMMADSVEAATKSLKNPTYQMIDEFVDKIIKKQLDENQFANADITLREIEKV
KQVFKNKLTNIYHVRIAYPE
>OBAHECAF_00419 hypothetical protein
MKKIFIIPILMLLTLSSCSVDDKYDNRLHLHEFLHSFDLWHIDINQTMGNARIPMLSRAF
TMTFHYNTEVTANNNLVGLGTIGNGYGLRIGRYNTSGDHLTISHDRDGVFHFKVVQISSN
EIDLIDLDSDAVYRLIGYRKAKFDYNQLFFDNIAYFLQEYEFWQKSHTSVQGLENPFDQE
NFLFFFNNKGAYAFETKHSLYNSNLIGFGTYRIESTNFKDVKRLILLYGRDTEVFELRVI
NDQTIELYHLKSRTTYEFVGMRNIVFLKDKDSPQREKVQ
>OBAHECAF_00421 3-deoxy-D-manno-octulosonic acid transferase
MVILYTISIYFLGFILHIVALFNPKIRLFISGRKDVFDILQSKIAKNQDYVWVHVASLGE
FEQGLPVIKELRKHYKVVVTFFSPSGYEVRKNSPEADVIVYLPLDTPRNTRKFIDIIQPK
MAVFVKYEFWYHYLITLKKRNVPTFLLSGIFREKQIFFKPYGGMMRNALHCFSHFFVQNQ
KSKQLLQSIGFENITVSGDTRFDRVTEILHRDNHLDFIEKFVSNSLCVVFGSSWEEDESI
YVDIINSGKENVKYIIAPHDIHTEKINALREKIHLKSVLFSEKKDFNTSDFQVYILDTVG
ILTKVYSYADIAYVGGGMGNSGLHNVLEPAVFGIPVIIGKNYEKFNEAKELVEKGGVISV
DSSEKLEKILFSLIDSPIRRAEIGNINRTYIQNQSGATQKFMNFVKKNICKSDSYKN
>OBAHECAF_00422 hypothetical protein
MQKRKINQPKENDFKIILPSAIDLCIYFFYNRMLLGEMSLSKSEK
>OBAHECAF_00423 hypothetical protein
MIKRIVNRITNNPFIKLLKTSGMEFMDDNCLKLSASLSYSTIFALPSLAILLISSVGLFH
DSREVSDEFFLQIANLVGEKSAEQIQEVILNMNFDGSNQIAYWVSIGTLLFTASAVFAEI
QSSINYIWELKAKPKKGIIRFIINRLLSFAMIGALGFVLLVSLIINTVIDLLSRQLVRLF
SENTVYIAQLINVGIVFLIVTIIFSFIFKTLPDGKLKWKDTFIGAAFTSVLFMLGKFIIG
NYLVNTAKLDVYGAAGSILVLLLWVYYSAMILYFGAVFTKNYSEQYGTPIEPSNYSVRVI
IKTEEVTYAKKKNKSA
>OBAHECAF_00424 Murein hydrolase activator EnvC
MFVLLFVVFLQLTIIPEYKSMSLQKHTTLFVRLLQKVFFLLFFVLFSLGGTAQNKQKELE
ERKKALIEQIKQMSVLRSQQAKQHKSTVLQIEETNEKIQMRSRLIQITQQQANLLSKEID
ENEKQLGSLKKDLDFHKSEYAKLIEQSYKSKSSQNRLMFLLSSESFWQGYKRLSYMKQYV
DYRKKQVFLIQDKSKRIKEVNQKLVSQHQEKKVVLEENRQEQQTLKGEKKQLEELATTIR
KKERDYEKQIREKQKQADAIDREIQRLIRLAIIEANRKERERLAKNNKNAKSSSENAVFM
LTPESKKVADSFEANKGNLIWPVVKGYKSQGFGEYSDPVYPSLKHYNNGVTIATEPGAEA
RVVFEGEVSAIQSIPGSNKVVQVRHGNYITIYYNLTDVYVKKGDKVKARDFLGKIFTDKN
GKTEMKFFLYKNTTRLNPEFWIHKM
>OBAHECAF_00425 hypothetical protein
MVSCGIYNFTGGSTGNAKTFQVNFFRNDAPIVEPGLDRDFTIALQDLINNQTNLSLTDRN
ADLVYEGEIIDFSIAPMTATAQQTAAQNRLTISVNVRFTNNTEENKDFEKRFSHYYDYPG
NSQLSAVKGTAIPEIFERITQDIFNASLADW
>OBAHECAF_00426 hypothetical protein
MTVKEFVEILKNPHTINERQAHELDNIVQEYPFFQAARMLQLKLLHTQGDYRYSKALKLA
SVHVLDRSILYHFIHSTDKNTQIQEFTRQLFERRIEQPQSIVKPSQQEIPLSQPVILPQQ
PQSMNPPQRQEGFSHVPNFMPQIPKNEKQDENFANPFGKMEDFNPTFVPKQEAKTTSSQE
EQNKQTGKPFESIPKWIEQISEENEVLQRDHDKQIENKEDKIAEKFRLIDKFLENNPKIE
PSKDYVSNVNLADEVKSDPQQLMTETLAQVYVNQRKFKLAIQAYEILILKNPEKSAYFAT
QIQKIKNLQQNNL
>OBAHECAF_00427 hypothetical protein
MTAFNIFLVLIVVVCLLLGLVIMVQNPKGGGLSSTFGGNTQVVGGVKKTGDFLERSTWTF
ATLLAALILIANTLLQSKTETDSDSRLLDGAPIENNILNAPANSSEQPGTTSETAN
>OBAHECAF_00428 10 kDa chaperonin
MAKVNIRPLADRVVIEPAVAETTTASGIIIPDTAKEKPQKGTVVAVGAGTKDNPVTLKVG
DVVLYGKYAGTELKLEGKDYLIMRENDVLAVI
>OBAHECAF_00429 hypothetical protein
MRDFKKFVVWQLSHNLVLNIYQVTKNFPKEEIFGLTSQIRRSFASISYNISEGAGRVSEK
EFANFINIALGSSNEAENQLLLAKDLGYISQDDFEILNNDLILIKKQLVSLRNKLIK
>OBAHECAF_00430 60 kDa chaperonin
MAKEIKFDIEAREGLKRGVDALANAVKVTLGPKGRNVIISKSFGSPHITKDGVTVAKEVE
LEDALENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVKEGLKNVAAGANPMDLKRGID
KAVTKIVENLAKQAKEVGSSSEKIRQVASISANNDDTIGELIAAAFEKVGKEGVITVEEA
KGTDTYVDVVEGMQFDRGYLSPYFVTDSEKMVAELDRPYILLYDKKISTMKDLLPVLEPV
AQSGKPLLIIAEDIDGEALATLVVNKLRGTLRIAAVKAPGFGDRRKAMLEDIAILTGGTV
IAEERGFTLENATIDMLGTAEKVSIDKDNTTVVNGAGDAEQIKARVNQIKAQIEVTTSDY
DREKLQERLAKLSGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGIALL
RAKSVLAKLKPVNADETTGIQIVAKSLEAPLRTIVENAGVEGSVVVAKVTESSRDTFGYN
AKTDQYADMFKAGIIDPKKVTRVALENAASVAGMILTTECALVDIKDEKAGAGMPPMGGG
MPGMM
>OBAHECAF_00431 hypothetical protein
MKESKSIIANIKKGQIAPIYFLMGDEPYFIDEIANYIENNVLSEDEKGFNQMILYGQDVS
VSDIVNNAKRFPMMASHQVIIVKEAQNLGNSIEDLVPYVENCTPTTVLVMCYKYKTLDKR
KKLVKSLAKNGVLLESKKLYEKDVIPWISEVLKEKKYTIQPKATQMLVEFLGTDLSRIAN
ELDKLAIIVPQNSEITPEIIEKNIGISKDFNNFELRRALGERDELKTMRIINYFADNPKD
NPIVVTLGTLYTFFQELLAYHGLTDQSDQNVAKVLGKNPYFVKEYHIAARNYPMKTVSGI
IEKLREIDMKSKGVGSVNMSQSDLLKELVIKILR
>OBAHECAF_00432 putative ABC transporter ATP-binding protein
MSKIHQNNKQTLIQLYQFVKPYRLTFFLVALFAIMASILSAAQPYMIKIAIDDYITAKNY
EGLLVVTYILLGLLLLEVFIQFLFSYFANWTGQSVIRDIRKKLFAHLLGFKMKYYDKSSV
GVLVTRTVNDTERIGEVFSSGLFEIVSDLLKMVVISVVMFVIDWRLALISFVTMPFILYI
TRWFQKSMKSAFVEVRKEVANLNSFVQERISGIKILQLFSQEGVELDKFKAINEKHKKAW
LRTIWYNSIFFPVGDLAVSVTIALIVWYGGYNAVTERTFDLGTIFLFIQLTQMLFRPLRH
IADKFNTLQMGIIASQRVFAILESTQDSEVNGTTILTEVKGQIRFEDVYFEYVEGEEILH
GISFEVQQGETIAIVGATGAGKSTIINLLNRFYDIKAGAIYIDNTNIKDVQLTSLRSHIA
VVLQDVLLFADSILNNITLGNTNITEAEVIEAAKSIGVHDFFMQLPNGYHYNVKERGTML
SAGQRQLIAFLRAYVNKPQILILDEATSSVDSHSEKMIQEATEKITQGRTSIIIAHRLTT
VKKADKIIVLDKGKIVEMGKHDELLKLENGYYRNLYEVQFRDAPIESQKRNFLH
>OBAHECAF_00433 hypothetical protein
MQDLELDLILQKEVEKIFGKTMGDKFDCEQLSAQISTEINEYISYQTIRRFWRLIESKNK
VSLQSKNILCRYIGFNDFSTFSENIRNKHTDTYNFSFLANWQNISKYDNPLDDSVYWHNK
LSQSFASFVLTNPPIFEEFSKVMNKNEVILKYIISYHPMYDNLAKEWYFRGLKLFIRNAK
ELHYHLFYANIQFMRCVLTMQNNDYEYFANQIETLLPKIRHKYGVIWSLEARSLSALLHY
YDTLGNDEKVSQLERETLNFVQIHRNLKFEIDDYKIFVFFISDMLNIYGFHHLSHRIQEK
YVFKESPSILWENGYEEAGKIVKSLTLFYQEDYTESKKIFQTIDVNKLNFDFKKYFTIQY
LLLALGFCPQNNNTKRHKIRKQLTQIIDETGLIYFENFLKGTFEKHSFSTKT
>OBAHECAF_00434 hypothetical protein
MKKFFMLALIAVSMLTISCGKNSDDTQPENVRLIGTWKCVKIERVEDGKRIDPREVKDDG
CTKYVFTDKVSTYFFINDEEGGRCMSEEGSYRIENGRIYNRWYEEGEYGENDFGFKFIDN
DTFEFFEDTSDGKNGLISTYKRVK
>OBAHECAF_00435 hypothetical protein
MKKLQYLVLMTLLVIGCGKDNPTGEIPNEPEQKLSSQKILGDFTLFDEATGKWRNTEIKD
NVVTAVIETPFDIKALVATVRIPDKATISPDPTQKRDYTNPVIYTITAEDGTKAEYKVIV
TKRLLSESNIYRLHFKEVGKSRDHYNPHPSLNQHDKNADIRIVVPLTTDVTKLTSVFEIS
EGATIHPKAGQTLDYTKPVEYTVTSEDGKTVLKYTVTVIFDDLPKLSLSINGEEFRNVPP
GGTIVFGVNVLPKHEDIRVSLVTENGKSSVPLTIQKVDDTNKKIHVKLPDTYLNGIYKLD
VRIAENNSAMSYTFVLHGGDPVFHYITSNGGGPKTPNSLLYLAEQFGIFASINRKDFAKH
SFFIKKNGEYLPLENARFHTNSTTIILEAPLELPNTSLETGTDFEFVIRYEGKEYTYPLV
NNKNEPVKVYIPKPPVVTGVSKTSVTQGETLVIKGSNLFYPHGDLRDGGRDKINHYTAIR
SRTPSKELISMIGKEIDAQGNLVLTVPFNFLAETEYKLFIDSNVDSFGEVETPITIKVEL
PKPTHPTMRIQEAEVYHENSKYFKKQLRVKFNGDISKINIKAIVFPEYQNAKITNFIVYE
GSNSIMTGELNFWDYRDVYTRRHTLYVLFEEGGKEYKLYFNAKRGEQND
>OBAHECAF_00436 Histidine--tRNA ligase
MAAQKPSIPKGTRDFSPTELAKRYFIINKIRNEFTKFGFQPIETPSFENYDTLMGKYGEE
GDRLIFKILNSGNFAEKVDPSDWETKNVTKLTPQISEKALRYDLTVPFARYVVQHQNYIT
FPFKRYQIQPVWRADRPQKGRFREFYQCDADVVGSNSLWQEIEFVQLYDGVFTQLNLKGV
TIKMNNRKILSGFAEVIGESEKLIDFTVALDKLDKIGQEGVINEMLSKGISAQAIEKIKP
IFHLKGDFSQKITTLKTILQTSEIGKKGIEELEFIEKSISVLPLQTAFLDLDVTLARGLN
YYTGAIFEVAAPKNVNIGSIGGGGRYDDLTNIFGLKGISGVGISFGLDRICLVMEELNLF
PSEISETVDVLCVNFGEQEALQSLKLIQQLRTLGLKAELYPDSAKMKKQMDYANKRNIPY
VVIIGESELEKKSFVVKNMQTGEQFEHGFNQVSISTFK
>OBAHECAF_00437 Pyruvate kinase
MLNIKKTKIVATLGPATDSLETIKAMVEAGVNVFRINFSHADYEEVKKRIGLIRTVNEEY
GYNTAILADLQGPKLRVGVMEEGVFVAPDDRITFVTGEPFVGTKERVYMNYKEFPNDVNP
GERILLDDGKLIFEVVSTNNVNEVEAKVIQGGILKSKKGVNLPNTNVSLPALTEKDVKDA
LFAITQDVDWFALSFVRHSRDIQDLKDLIAENAGYKIPIIAKIEKPEALVNIDKIMANCD
GIMVARGDLGVEIPAEEVPLIQKELVRKAKINHIPVIIATQMMESMISSLTPTRAEVNDV
GNSVMDGADAVMLSGETSVGAYPVQVIEQMSRIIHSVEHSDLIKVPMITPFVRSNRYVTN
SICFHAATMANEMNAKVISTLTNSGYTAGLISSYRPKSHILVFTSNRRILTRLSLYWGVT
TFYYDRFVSTDETIEDVNHIANEKGYVNMGDIMISLAAMPIQGKGMVNTLRVSEIDSCAI
RTK
>OBAHECAF_00438 hypothetical protein
MATYKLSNDWFDDTFKLIAIHTTLEDFRLVYFLNNHLKINLSRNKKKKIVNEQNSVPFPY
FEWYDELSDVNWHCISNKVNVENNIKDSGLLFDSLYTASYLLKDKKKVDFFLKIDCDNRF
KTQNVLDKVNEITQVTAYEIDTYTLNTKNKLILQGC
>OBAHECAF_00439 hypothetical protein
MNTRIFFEYAYLIISIYAAFQAYRLWDSTDRKDFYMYLIFGVVAFGMFLLRRFTRKKGNK
>OBAHECAF_00440 Lipopolysaccharide export system protein LptC
MINKRLHKIKSIAVLGCMAILFSCTTDLRTLQELNITHKFPQGEIYDFKLIYTDSTKVIA
VLSSPLSNDFSNQQFPFTDFPSGLQVDFFDKDNNKNTVEAKYGIIYMNSQMVELRDSVVL
TTYDGKKLTTEQLFWDQKTDWIFTDQEFSFTDHKKGTVTKGVGMDFDKAFSTVKAHKTTG
VLAVEEKE
>OBAHECAF_00441 Photosystem I assembly protein Ycf3
MTSGSKKRNINNKIKTDEKMKKRVLLATAFVVSAFYVADVQAQDCKQDREILQNLSIFNE
DVKAKRYDDAYPVWKSVYEACPNINAAVYVRGEAILKHKIQKSTGAEKDGFVKQLVKLYN
DYLTHFPNRITKADVLTREALLLFDEKIGSNQQIYELLHKAFTEDKANFKNEKALYLYFS
SLVTMYESNEKSLQDVFNTYDDVSEKIQDEKNILSETINKFIAQEEAGTIDGKDKKVLET
SRQRMDNYETIGESVDAKLGKLADCDNLIPLYNKNFEANKENEEWLRRAAGKMSDKDCTS
DPLFVKIVSSLHTLSPSAASAYYLGVLNDKNKNSAKAIEYYNESVRLESDNLKKARILTK
IAFKYSKANAVRYAQEALKYNPSNADAYRIIANAYAESANECGNSSFEKRAIYWLAANTA
RKGGLESLATRYEALAPSKVDIFESGMAGKTITFKCWVGQSVKVPSL
>OBAHECAF_00442 hypothetical protein
MNNKTIAFIFALVTTISGVYAQQTIESPYSYYGIGTLNTDGSIEESLMGGIGVYADSTRV
NMQNPATLAKLKFTAFSAGLSFDTKKIASNQTSVKSKETYANYVSLGFPIAEKLGFSIGL
RPYSSVGYRLLSTQTTNGVIRKNEFEGIGNVNQMFASVGYTVYKGLRVGASFKFNFGRTE
MTDNLAISDVQYVTREYSQSVLRGFSTNLGLFYDGKFDNKLGYSLSLAYTPESKLTSKNE
RTISTMGYMGGSQNNSLNVIDSQSIDLLNLGLKETKLTLPTQIDFGVGVGEFRRWFVGID
YSYSNMKRFSNPFLTTTQVGYEDAYKLSIGGFYLPQFNSISSYWKRVTYRAGLRFENTGI
VLKNESINDFGISFGVSLPVRGFSNITTGFEYGRKGTLNQNLIKENYFNLKIGFTLNDKW
FQKTKYQ
>OBAHECAF_00443 Type III pantothenate kinase
MNLIIDQGNTKIKVALFEKQTLIVNEVFSDVDYAEKISNIIDNHPIKKGIVASVVKDAES
RYSFLNAKIQQLVFVNSETPMPFLNEYATPKTLGVDRLALMAAAVNQFPNQNVLVIDAGS
CITFDMMTSDGVYVGGAIAPGIQMRLRAMHEFTSKLPLIEQQNFDISHFIGKSTRDCMLS
GVYHNVVCEIEGVIARYEQQFKNLTIILTGGDHLYLVENIKNRIFAKSFFLLEGLNAILE
QTKER
>OBAHECAF_00444 Membrane-bound lytic murein transglycosylase D
MAIIRTSFYCLAIVVMSGFLINAVAVKQDKNNIFQQEDYSQYDISKGYDAQNVEKRYNVY
AIDLPTSLDFAGERVPIEIPDVYERLDREFLVNTYWQSNGLLFLKRSNKYFPIIEPILKR
NNVPDDFKYLALIESGLMDVVSPSGASGFWQFMKPAAIEHGLEVNNNVDERYHVEKATQA
ACDYLKKAKESTGSWTMAAAAYNAGISGMKNQMNAQQTTDYYDLWLNSETSRYVFRILAV
KEIMKNPAKYGFNFEARHLYNEVPTYSVKIDTSITDLTDFAKKHNITYKELKLHNSWLRS
RKLENKSGKVYYIKIPKR
>OBAHECAF_00445 Prephenate dehydrogenase
MNKAVIIGLGLIGGSIALELRKRCGYTLWGIDANPAHINKAMALGIIDNEVDYEAIKEAD
VVIISVPVHITPQVVAKALDYVGEQTLVFDVGSVKERICKYVENHPNRSHFVAGHPLAGT
EFSGPESAVYDLFDGKVMVLCDTEKSHWKHLDKAIEISKKLNMRVKMMPAHDHDLHAAYV
SHLSHVISFVLGQTVLDIERNEQQIFDMASTGFASTARLAKSSPSTWSPIFLENKKHVLR
SLEEYIKNLQTFKQLIENEDDENIRKTIKEINYIKKVLQK
>OBAHECAF_00446 P-protein
MTPKVAIQGIKGSFHYQAATECLGQNIEIVECDSFDKTVKSLLNNSSDLIVMALENSIAG
SILPNYALIDRFQLHIIKEHYIDIQQNLMMFPNQKWEDLQEVHSHPMALLQCKQFFEDFP
NIKLVEDTDTASTARRIREQKLKNIGAIGSKSAAELYGLEIIQHSIQTMKVNSTRFVVLS
LSENKTEKSKLTKASLKFQVDHKRGSLATVLNVISDCNINMTKIQSLPIIETPWKYAFFV
DIIFEKYEDFEKAYKLLSIMAENFRVLGIYESKNTNISKIGN
>OBAHECAF_00447 Dihydrofolate reductase
MITLIAAASENDALGKKGDLPWHLPKDFKRFKELTTGHCIIMGRKTFETFPKLLPNRTHI
VITRQKDYVAKGCMVVSTLEKAIEEAYQLDTSPFVIGGGEIYNLALPLADRIELTRVHAS
FEDADTFFPKIDINEWEIVHSQHVEKDQQHQYNFTYETYERKKKNAK
>OBAHECAF_00448 hypothetical protein
MAENIKIDTNQHILFEEAQKRIKQKKMLTFHFFVFILGCIFMYVINRILDYGIAYNWYIW
GIMIWTFLFLLHVINVFLINRFMGKEWERKQRERLVELQQKKILKMEVAIEKEFEKQKEQ
VAKELLKEQNTNLEQNISSEQNTQRI
>OBAHECAF_00449 Septum formation protein Maf
MKKIILASASPRRQQFFNELHLNYEIVINPVDEIYPQNLVQEQITNFLAELKATPFKDTL
NDDEIVITSDTIVCIENQVLGKPKNYEEGFAMLQSLSGRQHEVITSVCFTTTKTQKTVHC
ITKVTFKTLSKEEIDFYLTNYKPYDKAGAYGIQEWIGYIGVENIEGSYNNVIGLPTHLVY
KTLQELL
>OBAHECAF_00451 hypothetical protein
MIGNISPCSPMTQDFVSFLKDHETIPLELLFLYTVLIAKKNKQQYKNN
>OBAHECAF_00452 Multidrug/solvent efflux pump membrane transporter MepB
MSNIKDKEFKMSSWAIDNKFTIYVMIFIFFLAGMLAYMNMPRESFPEIKDTKIYVSVVYP
GNTAEDIERLIIDPLEEKLKGVSNLKKIQSSSQEDYGMITLEFTEKITIESALQKVKDEV
DKEVSNEDWPTFNGAKVEPNVFDITISEFIPILNVNISGNYPTAKLKEFAEQMQKKIENL
PEIKEATIRGVQDKEVEVAIDMYKMMASRVSIDDVINAIGRGNVTMSAGNLIASGQRRTI
RMVGEIEQPSDLKNFIVKSEKGIVFLGDIAEVSFRDKDKTTYAREFGQGVVMLDVKKRSG
ENMIQASEKIKELVAEMRSDFPKDLSITIANDQSQQTENMVSDLSNNVIFGVFLVVGVLM
FFLGFRNALFVGFAIPMSMFMSFMIINALGYTLNTMILFGLIMGLGMLVDNGIVVVENVY
RLMEKEGMSRYEAAKAGIGEVAVPIIISTLTTVGAFLPLAMWPGIMGDFMMYFPLTLSIV
LGSSLFVAIFFNSMLVSEFMDINEKVLSVKQLVKISILLFVIGTFILLVGGAVRGLGTVL
YFTIFLLWSYKYFIKKLADNFQRKILTWMEDTYERTLRFTLRGKNPYIMVVSTVALLIVS
FVLFGWSVGTGRTSINFFPDNKPNQIIVYIEYPEGTDIEKTNAVTQDIEKRIYTLLNSDQ
YRDGDYNFMVESAVAQVGEGAGNPYTDGASSAEMPNRGKVTVTLREFKYRRGQDSEELRA
KIQSDLRGVYPGVSISVEKDQNGPPAGHPINIELRGEDYNELIVTAERMRDFIKQKNIAG
IDELKIDVNKNKPAIEVEIDRVKAGELGVSVGQISNQLRRSVFGEKAGVYKEKGDDYDIY
VRFNKADRYNTNVLFNQHIIFRDANTGEWRHVPISSVTKYKNTSSFSTIKHNKTDRVVTL
YSALSPGFSDASAIVRQIQQEMKNFDLPQEIKIDFTGQIEEQNKEMAFLSTALLIAVGLI
VFLLVYQFNSIVKPTLIFITILLSFTGVFLGLIITGQPFVILMTMMGIISLAGIVVNNGV
VLLDYTQLLIDRKKATMGLNVYDKIDNQSVYDAIVSGGKARLRPVLLTAITTVLGLIPLA
IGFNINFFTLFDSLNPNIYFGGDNVIFWGPLAWTVIYGLVFSTFLTLIVVPVMFFLTSKF
SNRFGKVYKQDNEGNTILVER
>OBAHECAF_00453 hypothetical protein
MNSNIHQIEVNTREDFAKFLEFIKNGYIFKSKFATLETKR
>OBAHECAF_00454 Cobalt-zinc-cadmium resistance protein CzcB
MKYINIQLIVSALVLLASCGETKNPSVEEVIAKGSKTEIRQKRDEISAKIKELETQIASL
DASLSKFPEEGSAQVLVSLLEVKDTLFNHFLELQGTIKTTQNITLNAEFGGVLERIHVQK
GQNVQKGQLLASIQDGGISQQLAQLKIQAELAKTTFERQSRLWENKIGSEIQYLQAKSAY
ETQQSAVEQMQKQVAKANIYAPFSGVIDDVITDVGTVVAPGMPVLRLVNLSDMYLESEVP
EQYVANVKKGSQAKVEISVLGEQLDTKISQVSNFINPANRSFKVEIRLPNKNNAIKPNMT
ARLQVNDYQNKEAILLPTDIISENAQGEQYVFLAKKGDNENQYVAERVVISTGKTQNGFT
EILSGIQKGDKVIREGARSVQEGQRVSTL
>OBAHECAF_00455 hypothetical protein
MENNIKIFEQKKVRSQWDEQQEKWWFSIVDVIEVLTESIDASAYWRKLKQRLKEEGNETV
TNCHTLKMEARDGKMRVTDVADTEQLLRLIQSVPSPKAEPFKLWLAQVGSERLDEMQDPE
ISIDRALQQYLQLGYSENWINQRLKSIEIRKELTDEWKKRGVKEGQQFATLTDIITKTWS
GKTTKEYKVLKGLKKENLRDNMTNTELILNMLAEASTKDISQVTQPETFEQNIAVAQQGG
NVAKVAREELEARTGKKVVSSASAKKMLQNKNNSNNK
>OBAHECAF_00456 Putative NAD(P)H nitroreductase MhqN
MNLKDILNYRRAVRLYDETQPIETEKVRECLELAQLAPTSSNMQLWEAYHVTDKSVLAKL
TEACLSQSAAKTAQQMMVFVTRQDLYKERAKAILEFEKGNVQRNSPSERQAKRIKDRETY
YGKLMPFLYRRCFGLLGWVRKIMVLSIGLFRPIVRQVSEAEVRTVVHKSCALAVQTFMIA
MAEKQYDTCPLEGFDSKLVKKALKLPSGVEINMIITCGIRKEGGIWGERFRVPFEEIYHQ
V
>OBAHECAF_00457 hypothetical protein
MNFILSKFEDTDFECYFQLVSDIRVMEMITERAIPLEEAKSDFDKELTKNQIHPDFGIFK
IINSENQSFVGLAKLEIEVSNSKEAELGYMILPEFWGKGVAGEVAKYLVDFAQNHPQIEE
LFAIIDPKNIPSRKILINNHFEHQEYKDFDGLPGEILRLKFKNKT
>OBAHECAF_00458 hypothetical protein
MNIEPTNYTNLVSEIGNLLKKGREQAATSVNTILVQTYWLIGRYIVEFEQKGKEKATYGS
ELLERLSKDLTAVYGKGFSRSNLFYMRKLYISFPNSETLSHKLSWSHYFEILKAEQPLAI
KFYTIQAEKDNWSVRELKRQMKSMLFHRLALSKDKKGILELAEKGQEIHKPQDILKDPYV
LEFLNLPMQHQYLESELESKLISNLQDFLMELGKGFTFVKRQYRISLSGNHFYVDLVFYH
RILKCFVLIDLKRGEVNHQDIGQMNLYLNYFQKEENVEGDNQPIGIVLGAYKDHILVEYA
TENISNQLFVSKYQLYLPEKKELERELEKLL
>OBAHECAF_00459 hypothetical protein
MNHKFIFILLVFCGLSGFSQETQIYRFSLEEAVAFAIENNLKSKNAAADIEAARKKKWEA
TATGLPQINAKVDYQHFLKQQVTLIPAEFFGGQKGEFAEATFGTKQNVNASATLSQLIFD
GSYLVGLQSAKVYLQISELSKQKSDIELRKTVVDAYANVLLSEESIRILEENKRVLEKNL
NETKAIFENGLGEEENVEQLQITLANINNNLNNTKRLYELSKKMLNITLGLNLDDQVQLK
DNLEQLTTQTITESIENETNFNLESNIDFKIASNSVRSQELLVKFEKSQSLPRLSAFLNG
AYNAFDNKFSFFDTNKRWFGSALFGVSLEIPIFSSFMRSSKVQRSQIELEKSKNDLNLTK
QQLQMQHDKALSDLQFAIEEHQTLRENLDLAKRIENKNQIKYTEGLATSFDLRQAQLQLY
AAQQEFLQSMVNLLNKKEVLKSLQVN
>OBAHECAF_00460 HTH-type transcriptional repressor KstR2
MAKEQLITIARDLLIDLGIKSVTMDDIARKAGVSKKTLYNHFKDKTDLVRTVVMSVSKEL
NEQIKVIIINEQNPIKQLYEVEHFFSCQPVITNNSPQKQLQKYYLKIYKEMKNKQLEEVG
GLILENLKRGIELGIYRKDINLDFTMRLYLHIMIESGNDLLFFKDYDKNIISTSYLEYHI
RAIATPKGVTTLEEILRKNKKN
>OBAHECAF_00461 hypothetical protein
MKTVSSAVENYIKSKPFLQTALSQGIINLTSLARIIRKEIQTDTTSREVRNGAIVMALKR
LSTDMEFRSTHRIVKVLKNIGEIIVRSNLTDYTFLVSETLLNNQSELLRQIQNTKDVFYA
SSRGVNEISLIVSNSVEPIVETVFSTERCTHKYSNLGSISVKLPEENVSIPGIYYFIFQR
LAWEGVTMNEVISTSNEFTIVVPESQIDIAFKVIKDLKML
>OBAHECAF_00462 DNA ligase
MDVKNQIEQLRNELNQHNYNYYVLDNPIISDYEFDQKLMELQLLENQHPEFFDSNSPTVR
VGGTITKNFNTITHEFRMYSLDNSYSKEDLEEWEKRIIKLSGSQNLSFTCELKYDGASVD
LLYEKGKLTQATTRGDGFQGDEITANVRTIKSVPLVLQNDFPERFHIRGEIILPKKGFEE
MNKERIEAGEDPYMNPRNTASGSLKLQDTSEVAKRPLDCLLYALVGSVNIKTQYEGLEKA
RSWGFKVPKESKLCHSTDEVMDFINYWDVHRHDLPYEIDGVVVKVNDIALQEELGYTSKS
PRWAMAYKFKAEQATTILESISYQVGRTGAITPVANLTPVLLAGTIVKRASLHNADQIEK
LDIRVGDTVFVEKGGEIIPKIVGVALDKRPSGSMITTYISHCPECQSELIRNEGEAQHYC
PNVEGCPPQITGRIQHYISRKAMDIEGLGGETIELLFRSKLIENYADLYELTVSKLLPLE
RMASKSAENIIKGIEKSKEVPFERVLFALGIRYVGETVAKKLARHYKTIDNLEKTTLEEL
MQVDEIGVRIAESVVQFFDNEQNKNIVKRLKSYNLQFSLSEESLANQTEKLKGFTFVVSG
VFHLHSRDELKNIIEQNGGKVGSSISSKTSYVIVGDNMGPSKKQKAESLGIPMISEEDFI
KMV
>OBAHECAF_00463 Photosystem I P700 chlorophyll a apoprotein A2
MKIYHKLLFFLLLGITANIFAQEKELQKANDLYQNYAYVDAIKIYESIAKKGFVNQELLE
RLGNSYYFNADYTAALVWYEQLFANPEYKLKPEYYYRYSLSLKSADRYDEADRMMVKFVE
LTDANDTRAVLFQENRNYQEIIKDNSNRMELYHTDINTEHSEYGAAFYGGDKVIFAASNS
SMFKQTSQWTGESFYDLYEASRDSISLAKKSLFSSDINTKFNESTAVFTKDGNTVYFTRN
NYVNKKVGMNSENTILLKILRATKDANGKWGNVIEMPFNSNVHSVAHPALSPDEQYLYFA
SDMKGTLGNSDIFRVQILKDGYGKPENLGNVINTTGRESFPFVSDDNVLYYSSNGFPGLG
GLDIFAVKLYDNGTTSKPINIGRPGNSADDDFCFVIDSDKKIGFLTSNRPGGKGKDDIYS
FYEHTPLRFVCTRTMRGIVKNQETNEIIPDAKVTLSNKDMALLGSKQADSKGAFLFDDES
INCTDAHFYLKGEKEGFETAEVNVVAGKDKEIYYEILLKPRVVKVGEGTDLAKVLHIDNI
YFDLDKSNIRPDAAVQLAKVLEVMKEYPNMKIDVRSHTDSRASHAYNLSLSDRRAKSTVK
WIIDNGIDKSRITGKGYGETQLVNGCSDGVSCSEEEHQANRRSEFIIVELK
>OBAHECAF_00464 putative type I restriction enzymeP M protein
MDKCNLHTILRLPTGIFYAQGVKTNVLFFTKGKTEKNNTKEVWIYDLRSNMPNFGKTNPL
KYEHFQEFIECYCEDDFSKRKETYSAENPQGRWRKYTIEEIMARDKTSLDVSWLKQGEET
EDIPLDELLENIEEKATNIMSAVEKLKLMIKD
>OBAHECAF_00465 hypothetical protein
MITTNVMSKELTNTTEYREILSQAISQIHITRTIIAQQVNSAANSVYWNLGKILSERQLA
EGYGSAVVKQLSVDLKNEFPDMGFLPRNLWNMKRFYERYYQADEKLQRSIAVLPWRHNLL
LLSKVESLEAVAFYANEVIAKGWSRDLLLNAIKMDTYTHTTKQLPTNNFA
>OBAHECAF_00466 hypothetical protein
MEQQNIIIYKTQDGKAKLALYARDGSVWMNQSQIAELFDTSKQTISYHILNILEENELNE
NSVVKNYLTTASDGKNYEVTFYSLDMILAIGFRVRSKRGTQFRQWANRNLKEYLIKGFVM
DDDRLKNPDGRPDYFDELLARIRDIRASEKRFYQKVRDLFKLSNDYDKTDKSTQMFFAET
QNKLLYAVTHQTAAEIVVSRANAEKPNMGLTSWKGSIVRKGDIFTAKNSRC
>OBAHECAF_00467 hypothetical protein
MYSTFLQVHSLFAYVVLATVLIATINAAIGFFVKREYGSKDLRIGLFALIFSHLQLLLGL
ILYVVTPLIENWKAGGVMKNSYIRQLLLEHPMMVIIGVVFITIGWSLHKKQKTSNRAFGK
IALFYALGLVCFLSRIPWSKWLA
>OBAHECAF_00468 D-alanyl-D-alanine carboxypeptidase
MKTPLKIFLLFVCQITVAQQFNKQKLDAYLTTLEQHNKAMGSFAISKNSKIIYERSIGLA
NVNTQQKATNDTRYRVGSITKTFTSVLVLKAIENKKLAIEQRLSDFFPNIPNANIITIRQ
LLSHQSGIFNFTSAKDYFNWHTTQQTKEHMLERIALFEPAFTPGSRTEYSNSNYVLLSYI
LEEIYKKPLALIIESQIVKPLKLKNTYLGGEAKTNDGEATSYQFVKEWVKEPETHLSFVS
GAGALISTPTDLITFAESLFDGKLLSKESLKQMQTIERGFGLGLFTYPFYEHTGYGHSGG
IDKFVSVMIYFPETKIAYARVLNGITMTANDIDIAALSAVFGKDFKIPDFTKKISDKNIE
VGYEGVYTSAETPLKITIFKKDGQLMAQATGQLAFPLTEKTKDIFTFQPANIEIEFVPNE
YQFIIKQRGTTTVFHKE
>OBAHECAF_00469 Vitamin B12 transporter BtuB
MKKLFFMGAMSLITSAYAQTIESEKDSINQDVIQLDEVLVSAVRADRKTPIAFSSINKKE
LAKRNLGQDIPILLNFMPSVVTTSDAGNGVGYTGIRVRGSDATRVNVTINGIPYNDSESH
GTFWVNMPDFASSVENIQLQRGVGTSTNGSGAFGASLNMLTDASSYESNALLSTSYGSYN
TQKHTAKFSTGLMNNSFELSGRLSKLYSDGYIDRASSKLNSYFLQGAFVDQGTLIKGLVF
GGNEKTYQAWNGVNEEEMKKYGRRYNPSGKHKDNNGNTVFYDNETDNYKQDHAQLHWNQR
WSNMWNTNFALHYTKGFGYYENYKKDQKLSKHGIKPIESGGVTSSKSDLIRRKYLDNDFY
GAVFSLNYKNKNLDFTFGSSANRYVGDHFGEILWVRKPAKYNFKQEYYRDDAIKTEANNF
LKATYSIGKWIFFGDLQLRNVNYKANSEDTGLVNDSFDFFNPKAGVTYSLNTQNQLYISY
AKAQREPNRDDYENGNPRPEKLNDFEGGWRFKSENIALNINGYYMQYQDQLVLTGALNDV
GAPVRENSGKSYRLGVEIDAVVKLGKWQIQPSVTLSQNKNIDFYTNFDGKLVNLGNTNIS
YSPNIVAGNGLTFNPLEGLQLSLFSKYVGEQFMSNTDADKSKLNSYLINDLSINYQIPMK
KWAKSVTFSLLVNNILNEEYISNGYYYTYDDDWTTVGVIKTIEATGFYPQAERNFLAGVT
VSF
>OBAHECAF_00470 RNA polymerase sigma factor CnrH
MKALEKEFLERVQKHKSVLFKIAKMYMNDPDDQKDLFQEITYQLWKSYPTFQEKSSFSTW
MYRVALNTAIVFLKSEKKRGFISNHENWEQIKIVEEDSSEKEQQIKQLYEAIQKLNPIDK
ALIFYYLEDYSGREIAMQLGISEGNVRVKLNRAKAKLTELVNKS
>OBAHECAF_00471 hypothetical protein
MNIENIKNLWSEEKVSQTPEISIEKQQQLRTPLEKIRANMEKEFWFSVFTLVVVAGLLFL
CETSEQLFVFGGLYLILILITAYYFRKFYSLYKRINTQSFSTYHNLLNLRYELVLNTELY
KSYYISSIPIAFCFYWAMSPTFLNGNIPHLMLVACCMVVFVIALYIIGKMWLKEMYGKYI
VEISDLVTSMSDENDEFQFGRDSLNSEISYVWYTLSRGYFEKKFGKAGKIINGILWVSLI
LLALFIASFCVGFIIGFAVAWWEG
>OBAHECAF_00472 Arylsulfatase
MNEILIINFMKQIFSFLLLLCAIPAVAQMEKKPNIIFILADDLGYGDTEPYGQQIIKTPH
LNKLAEEGMKFTQFYAGASVCAPSRASIITGETTGVTHIRGNKEVSEPIDGQAPIPENSR
SIGKILKSAGYNTAIFGKWGLGTVASTGNPLLHGFDTFFGYNSQLRAHRRFPPFLWQDNE
RYYLTENENYEHQIVYSEDVIHEKALDYLEKQSSEKPFFAMLAYTLPHAELVVPQDSILE
SYSHLPEKPYKGIDYNGEKTIIGGYMSQPKAHATHAAMVSRLDKYLGDVRKLLKRKNLDD
NTIIIFASDNGAHFEGGADPDFFKSSGILRGLKRDLYEGGIRTPFIVYWKGKVKQQTTSN
FVGAFWDLMPTFADIAGVPYTKTGSEVSILPTLLGKDKKQKQHKYLYWEFHELGGRQAVR
YGKWKGVRLNVNKDKNGSIELYDLEKDPSEKNNIAKNHPRIVKKIAKMMEQAHQRSALFP
FAWEK
>OBAHECAF_00473 DNA gyrase subunit A
MEENTPQEQPSGESIIKVTGMYQNWFLDYASYVILERAVPVIEDGFKPVQRRIMHSLKEL
EDGRYNKVANVVGHTMQYHPHGDASISDAIVQIGQKDLLIDMQGNWGNILTGDRAAASRY
IEARLSKFALDVVFSPKVTQWQMSYDGRKKEPVHLPVKFPLLLAQGTEGIAVGLSTKILP
HNFVELLDASIAHLKGKPFELYPDFPTAGVMDASNYNDGQRGGRIRVRAKISQVDKSTLR
ITEIPFSTTTDSLIESILKANEKGKIKIKKVEDNTAENVDIIIHLPSGISPDKTIDALYA
FTACETSIAPLACIIENNTPLFLTVSEILRRSTDNTVQLLKSELEYDLAELEEKQHFSTL
EKIFIREEMYIDFKLYSERETLYQYLRDRFEPFKEQLIKEITDEHLQRLTQIPMIRITKF
DTFKADENLLKIEADIEEIKNHLANLIDYAINHFKRLKETYGKGKERKTEIRPFDNIEAT
KVVVRNIKLYVNKGEGFVGTSLKKDEYIGDCSDIDDVIVFTESGMMKVVKVSEKTYIEKN
IIHAAVFKKDDKRTIYNVIYKDGHTGFSYIKRFNVTGIIRDKEYELIPKHKDSKILYFTP
NPNGEAEVVTINLRQVGSIRKLKWDVDFADTIIKGRGVKGNLVSKFAIKRIELKEKGVST
LKPRKIWFDDIVKRLNTDERGNLLGAFKGDDRLLLITKDGSVKTVIPDLNLHFENNILIM
EKWIPQKPISVIYYDGEKERYYVKRFVIENENKEELVITEHPKSQLLFVSSDWRPMAEVV
FAKEKGKSEKENLIVNLEEFISIKGIKALGNQLSTEKVKEIITIESLPPHQENEMEENLE
EELGDDEITDSSDESDGLQTELEF
>OBAHECAF_00474 hypothetical protein
MKKFFILLLKTIGTIIGFIVLYILLGVLLPFVQIAEKEVSEPKNMPIYIYTNGMHTDLVV
PIKTEIIDWSQKILFENTLSKRTDYQYVGIGWGDKGFYLETPTWADLKISTALKAAFWLS
ESAMHCTFYDKIIENEDCKKIMLTEQQYQDLVNFIQNQFDQDEKGNFIFIKTDAVYGEND
AFYDAKGKYNLTRTCNTWVNDGLKVAGQKAALWTPTDTGIFRHYKE
>OBAHECAF_00475 Free methionine-R-sulfoxide reductase
MFEELSLSITAICNQEDASRDEKMQTICDLLQSRVEHYDWVGFYFANHQTRTLHLGAFAG
EPTDHTEIPFGKGICGQVAVSNQNFVVPDVKAQDNYIACSLTVKSEIVIPLFVNGVNIGQ
IDIDSHQLNPFSQEDVRFLEFVNTQVAKLFD
>OBAHECAF_00476 hypothetical protein
MKKIGIYVVTLLFVMATACTPEEKIEKLTLNKQELVATFTGDASKDFNETIEIATGNGQY
EITSENEKIATARVVKNVISIRFNSSGETRISIKDKVSGEELKIKVVVNLPFSVATTETT
LHVGASKSIAITSGNGSYEVVGGDEKIVATTFSSTTSTTTAIVFKGKEEGSTTVKIKDKT
SQEVVEVKVVVQLLKLEFSIKEEVFEFAPNCSESSFQIFGSGEYELMMDNPNIDASLAVD
EIGTKIIFNAKGKTEGKLTVRDLETNFEKSIKIKSLEDFVVNIGTDKTEIKTWSKVTYKV
AKGYDYPIKVLKGSGNYEISTSNSTVAEVSNDNNGMKFTTKDLGQVNIVMIDKANPCLKI
EIGIEVVNMDKKLQLETDKIQIQEGYLSFIRIISGNGNYAVESTNPSIVSASVEEDFIQI
ETNAVGKATLTVTDLKTNEKKSLEIDVIKALKPLILEPSSISVHKGKTEEAIILSGNDSY
SVSSVNPSVATANISGQKVVVTGNAKGNTTIKVVDNETKHEFAIAVSVIEVIPDVKFSVR
EFNIKKGKTESTVQIVSGSGFYSIASSNPDIARASQSRGVLYIHSSYREGEAVLTVTDTR
TGKTDTLRVIVSDGERLALDKTEVTVLKGQEVAVVITSGSGDYSFSIQHAYASAEINGNL
LTIKGSQRGNTTITVTDRRTHIKAEIKVTVLNQIGDVKFSARELRLKKGETNSSVSVHSG
SGAYSFGTSDSKVAYSFRSRGVLYIYAANSGRATITVTDAQTGKTDVLNVIVDGAPDLVL
STGIISIEYPKSANVLIISGSGSYRVTESNGRIVSAALIGSTLNLKTYAAGESFVTVEDT
VTKQTKVVRVNVTEPVVDVPFELSHNQLFIWGTVGSNYVNEDTVAWISITSGSGDYEIIK
NELGDLITVKIVQNSIRIESTRNETKEGVITIRDKKTKKTASIDVRVGMVVN
>OBAHECAF_00477 Thiol:disulfide interchange protein TlpA
MKRFIIPVLGCAVLASCTDKAPEYTVLSGKVSNYDFEKIILVGDGFEKEIMLNADKSFID
TLMLAHDGGYTLARTDIYLQKGKDLNVDMDFKNPQENKFSGSLAPENNYLLSKVKLSQEV
LGKDKTDFYKLEEADFIAKVNEYSTKQKELLNKTNFNVKGFKALEEKTIAYEADFLLNRY
ENYHSYFAQKEGFKVSENFPKLNTTDLDNAEDFRFSRTYRSLVNELFQKNNDNAYNEQFG
QEYDEEKYLGVILTNFKKIKSDNVRNAIAKRFLEHYISPESPLTEKVYQELMANVTDETL
KGKFTESYNKVKALAKGNPSPTFNFENHKGGKTALADLKGKLVYIDVWATWCGPCLQEIP
HLKEVEKKYHGKNIEFVSISVDDKRDYDKWKNFVTERELVGTQLFADNAWETPFVKDYVI
TGIPHFILLDTQGNIISADAPRPSDPKLIELLTENGI
>OBAHECAF_00478 Solvent efflux pump outer membrane protein SrpC
MKQQIKKGIIALGGLLILASCAGRKPYIRTELPTENLYRTDQLPTDSISTGSVSWRTIFT
DDKLQGYIKQALENNLDIRIAWQNMEKSKAQLLQSKYAFLPTLSLNPSYTYTSPSLNAPS
GNFSGERTHLRQWDLTATTAWEADVWGKINAQKKANYAGALSSIASHQAIQSEVVATLAT
AYYQLLMLDKQQQILEATISLRLKSLETTQALKQAGSTTEVAVQQTQALYYNAQAQLIGI
KNNIHALENSICILLGIPSQPIARNSLEGQSFPTDFNQGYAVSLLENRPDVRKAELDLIQ
AFELTNVARAAFYPTFTITARGGFSSQTFENWLDTKSIFANFIGGLVQPLLNKRQIRSQY
EISQANRETALLKFKKTMLTAGKEVSDALQNYHSQHEYILLKTKEMEAYQKATEYSQELF
NSGMASYLEVISAEVNRLNAELSVANAEFNKMQYGIMLYKALGGGWK
>OBAHECAF_00479 hypothetical protein
MEMILKIKEVNLGKFNNAEYTQFLSFTKELIEKAGLEQLGIADTAFEQFKSNIELLTDAA
HQSRISSETKELSEIDKQRNEILAFLLMNFRSELKNPIEKRRKAGTELYNATKPYSKIKS
LPIRQKTQNIEGLITDLTKEANLPHLNTLGIKEAVEKLNALNVKYKKLLANRADSQISVP
QIRIGQLRKETNQIYDYLITKAFVSSVASPSEENKTFVHSINKLITDTTIAYKLRQGQKV
RKDGMNTN
>OBAHECAF_00480 Efflux pump membrane transporter BepE
MVKLFIDRPVMSTVISILIVILGILGIVGLPISQYPDIAPVTVQVSANYTGANAETVLKS
VVIPLEEQINGVENMDYITSTATNNGSASINVYFKQGTNPDIAVVNVQNRVARANSILPA
EVTRAGVVTQKQNTGALMFMTFYSTNDKINDIFIQNYLNINIIPAIKRINGVGDANVFGG
KDYAMRIWLHPEKLAAYGLNPAEVTAAITDQSREAAAGTLGQNSGSSYEYVIKYKGKYNE
VQEYENIVIKAMNNGQILRLKDVADIELGALSYTGFARNNGNPAVSMGVYQTPGSNARDI
INDVKKYLKEAELALPEGIGYTINMDSNEFLDASISKVLTTLLEAFLLVFLVVYLFLQDF
RSTLIPAIAVPVSIVGTFFFLNLFGYSINMLTLFALVLAIGIVVDDAIIVVEAVHAKMEQ
TRNKAKASTLSAMHEITGAIISVTLVMAAVFIPVTFIGGTTGVFYKQFGITLIIAIAISA
VNALTLSPVLCALLLKPHPDKAYQDKSFMGKFFHKFNLAFEAATKRYGKTFTFFLRHKWV
TLILFVVAGGVLYYSNEKMKTGFVPTEDNGMLMMNVELIPGASMERTANVLQEVQERVRK
IPGVHSVTGISGRSFISGAGSNYGMGFLRLKPFAERQADPRQSIQAILGQAFGAVSGIAD
AKVIFFQPPAIPGFGMSSGFSMVLLDKTGGEISELNSTTQQFLQALNQRPEIQYVQTSFN
VNYPQYQLEINVERAAQSGISVTHILSVLQNYIGGLYATDFTKYGKQFRVMVQALPDDRK
SIQSLDGLTVRTSNGQMAPISQFVTLKRTFGPQSVNRYNLFTSVALTGANAEGYSTGDAL
NAVKEVASETLNSNYGIDYTGLTREEQRAGTQTLVIFALSLIFTYFILSAQYESYLLPLA
VICSLPFGIMGAYLGQWAMGLENNIYFQISLIMLVGLLAKNAILIVEFAVQRRHHGESLS
KSAINAAMARLRPILMTSFAFIVGLLPLVFAGGVGAAGNRSVATGAVTGLLLGTFIGLIV
IPVLFVVFQHLQEKIVGIKSVEKQHESQA
>OBAHECAF_00481 Multidrug resistance protein MdtE
MRIFFILAGLSLMTACNNTPKQVQQGVKTLPVITVGEQSSTYHLSYPVNIEGKVNSPVQA
RISGYITQVLVDEGQQVTKGQPLFRLETQALNQSSQAAKSAVDAAQVEVNRLEPLVAKNI
ISSVQLETAKANLARIKASYAEVNANIDYAIVRAPVTGVVGSIPLREGALVSANNTVLTT
VSDVKEVYAYFSMNEKDYITFLEVAKGKSLNEKISNLPKITLVLANGERYPHQGTISTVT
GQVDKNTGSIRFRATFPNAEGLLTNGNSGTILIPEVHANSLVIPEVATFEQQGLVFAYKV
EQDTVKQVIITLKNRNNNLAVVSDGLQKGDILVVQGLNGIRTGMKIQTKPVSMDSLVQAI
KPAFR
>OBAHECAF_00482 hypothetical protein
MDFFTEMIKNTDHTLLQDLITLYTNHFGLSPIMAKICAYLKLDFEGNGATFDQLQQALGV
SKGSISMNLRKLIDKGIILEINKFNERKTYFVYNQDYIILWLKQSIERMEYTLSVVQRVN
NLSKKHPNTPKTLLKRKQIHQEFLQQGIEAFKETLFKIENV
>OBAHECAF_00483 hypothetical protein
MKKIIATMFMVLGLNAVYAQHVSVEKDLVGIQAGLLGVNIYNEHRLSDAITLRSDASLHG
GFWTGDIYDKTGFLLAPAISIEPKWYYGLNRRVKKGKNISNNSGNYFSLRTEFSPNWFVI
SNDSNVSNDYNAISVIPVFGIRRSFSRNFNYEFNVGYGYSTTLGRTPNSKGGTFWISFKI
GYDFFKR
>OBAHECAF_00484 Sodium/proton-dependent alanine carrier protein
MEKYFEIISGYVWSYALIGLCIFSGVYFTIRTGFLQFRYLKSMVRLLFSGGNSAQGISPF
QAFSLAISGRVGTGNIIGVASAISFGGPGAVFWMWVIALLGATSAFAEATLGQVYKQEIK
GQYRGGPAYYIEKGLGIKWYAVFFALVAILSCGFLLPGIQSNSIVTSLNQSVQIPNVNIA
GYEVHTVGVAIIILVSIIIFGGVKRLGKVTQIIVPFMAVSYIVMVLIIIGMHFSQIPDVF
MLIIDAAFSSESIYAGITGSAIAWGVKRGIYSNEAGQGTAPHAAAASEVKHPVEQGLVQA
FSVYVDTLFICTATAFMILFTGKYNVIDEKTEIAIVEKIPSVEYSFFTQEALNIHFPVIG
SHFVALALFFFAFTTILAYYYYAETNIAYIFKGKRNAQLYIWILRIGFLYGVYMGAIKEA
KLAWTVGDIGVGLMAWVNVVAILLLSGVVIRVWKDYVSQRKKDIKNPIFDPKKSNIKNSD
FWNP
>OBAHECAF_00485 Serine/threonine transporter SstT
MKLFNNLLFRVFIAIIIGILVGSYAPEWYNRLFVTFNKLFGSFLGFSIPLIIMGLVMPAI
AELGKNAGRLLFMTVIIAYSFTLFSGFSTFFVGKIVFPKLLGQSPTVNTEVVERTLTPFF
TLDIPPILDVMSALVLAFMIGIGLSLKSNSTLGGILKDFKDIIVLVIEKVIIPLLPIYIM
SIFSEIAYSEKVASVMGLFFKIIGIIFVMHIALLLLQFLLAGIISKKNPLKALLTMMPAY
ATALGTQSSAATIPVTLQQVIKLGVSERIAGFVVPLCAAIHLSGSTMKITACAMALMLMN
GQTVSIDLFAGFIMMLGVIMVAAPGVPGGAIMAALAILQSILGFDAQQQALMIALYIAMD
SFGTACNVTGDGAVSLIVNKLSSRQVGE
>OBAHECAF_00486 Aspartate ammonia-lyase
MSKFRTESDLLGDLQVPFDAYYGVQTQRAIDNFHISGSKMSDFPEFVRAIAYVKLAAAQT
NHELGLLSDSLLNVISQACNELIEGKMHDQFPVDMIQGGAGTSVNMNANEVIANRALQIM
GHGLGDYQHCSPNDHINLSQSTNDAYPTTIKLAIIRMNQTLIEHLRLLIASFRKKGVEFA
DVIKMGRTQLQDAVPMTLGQEFEAFAATLEEEITRLQYNANLFLEINMGGTAIGTGINAP
KEFPAVCAKKLADLTGEAFVAASNLVEATPDTGSYVIYSSALKRMAVKLSKICNDLRLLS
SGPRAGLNEINLPPMQPGSSIMPGKVNPVIPEVVNQVCYKIIGNDLTVTFAAEAGQLQLN
VMEPVICQSIIESIVFVQRAIETLRTKCIDGITANREVCLNMVKNSIGIVTALNPHIGYK
NSTKIAKEALETGKSVYDLVLEKGLLSQEQLDTILDPKNMLGI
>OBAHECAF_00487 hypothetical protein
MSLKSFGAKLFASIVKRKIDKWAKRPIETQQNVFEELIRRAKHTAFGKDHDFENIKDHAD
FVKKVPVRDYEDLKPYIQRLISGERDVLWRGKPLYFAKTSGTTSGTKYIPITKESMPYQV
QAARDAFLCYIHETKKANFVNGKMIFLQGSPVLEEKNGVKIGRLSGISAHYVPQYLQKNR
VPSWETNCIEDWETKVDAIVEETISENMTLISGIPPWVQMYFERLKAKSGKNIGDLFKNF
SLFVYGGVNYEPYRQKFEHLIGRKVDSIELFPASEGFFAFQDTQTERGMLLLLNSGIFYE
FIKSDDFFSENPKRLTLAEVELNVNYVMIISTNAGLWAYNIGDTVQFISLNPYRVIVSGR
IKHFISAFGEHVIASEIEEAMIQSIQGTEVRVSEFTVAPQVNPSENQLPYHEWFVEFEKE
PDNMADFASKLDNFLQQKNSYYFDLIQGKVLQPLKITKVAKDGFVRYMKQSGKFGGQNKV
QRLANDRKIVEQLELENLK
>OBAHECAF_00488 Branched-chain amino acid transport system 2 carrier protein
MKTHKNKTLTITTVGFALFAMFFGAGNLILPPFIGLQSGDEWLMALVGFFLTAILAPFLG
VLVISKSGLSFTDLGYRTHPKLINVLAILIILCIGPLVAIPRTGATVFEIGVQPSFPSFS
NVVFAILFFGTVFLLSISKTKTVDIIGKFLTPFLLLSLVLLVVLGVINPPDVITESTMTA
TEVFSFGFVEGYQTLDVLASVIFAGVIIEAVIDKGFSSENERSRITLTAGLVSTISLLLI
YGGLIYLGATTDFPMQDNSTRTQLLLHISSSILGEKGTFVVAIAIAFACLTTAIALTTAT
GSIFEKISHGKIPYRLSVILCTLISVVLSINGVDAIIKYAVNILLFIYPIVFALILYLLL
FGRYIKIRQPYVASIITTAIVSLISVGINLDMQKELLSTLKSYLPLQEYSLEWLLPSLIA
FVFGTALDRNQN
>OBAHECAF_00489 hypothetical protein
MKTNSQRWFLAGSIFSFCYFVFLLLINYHSLNNEIMVGSVSFFGELLTIPLILFLLFMFT
FSLIKVIKKDNSFRLIFIINLITIVLLISSTFYN
>OBAHECAF_00490 hypothetical protein
MLYRNALQKMEYSLSVLKIYLYSQRVLKLLFISIVTFTLFKTRSKDFGFIKKLLKNHVDI
GQRILRTTPKIFFLFTVYKHTEMDIYLSSGKDIVSQFKFIIGII
>OBAHECAF_00491 hypothetical protein
MYYMKKSITYLLIICGFCLSTAQNTVENDTIFLSEVVVTQFQKEKLNKIATKGRKNYSIG
SYYNTFFANEIKVDKCFIIKKIVFFIEKIEKNYDTKATFELVFFSVGENGFPDKKLHSQT
LLFESVRKNKLEINIEDLSPKFCENFFVALKKTEDTNKKSTNYRILGHMNKRKEIYLNLE
NKGWHKLEGGNLAIEIYYIEEK
>OBAHECAF_00492 hypothetical protein
METLPILFGISILLLLGFIVFVKYKVRVHLVYNKNITNKSFYIWVPFADVYYYFRYIFGK
KTFF
>OBAHECAF_00493 hypothetical protein
MFFQNKERLLQLQSINFAVMTMNKNTILGYATLIMVVMGLILIGLGIFKYNEVAGIGFAT
VGIGFLAIAWVFNSLKGRV
>OBAHECAF_00494 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MKKFREIPEEFRVEPLHQDIYLANGELRKWEGAMTDVYSTISSTENYEPTFLGSVPNMGE
EEALELLYSSCEAYNKGKGLWPTMKVKDRIQFMEKFVKQMATKRDEVVKLMMWEIGKSLE
DSRKEFDRTIQYIYDTIEEYKNLDRDSSRFEKRDGIYAHIRRGPLGVVFCLGPYNYPLNE
TFALLIPAVIMGNTVIFKPAKHGVLLFAPLLEAFKNSFPRGVINILYGRGRTVAPPIMRS
GRVDVLALIGNSKTAIALQDLHPNKNRLRLVFGLEAKNPGVVLPDANLELAVEECVKGAL
SFNGQRCTALKIIYVHKKIKDKFIKEFSKKVDELVYGNPWDKDVTLTPLPEKEKPAYIQE
LIDDAISKGAKIVNQRGGERSENYIFPAVLYPVSTDMRVFSEEQFGPLVPIKSFSHINEI
LDEIANSKYGQQISLFGEDAYELSPLIDNLVNLVCRVNINSLCQRGPDVFPFTGRKDSAV
GTLSVHDALRSFSIRTFVASRDDDYNNKIVENLLRTGVSNFMNTDYIL
>OBAHECAF_00495 Beta-galactosidase
MTTVVKFFASTLLLSCFSANLHAQDQPFLDPIFENPAVQEINRMPMRSHYLPFESSEKAE
KKNYKASNRYIDLNGKWNFLWKEDYKQLPTDFFKTDYNDSSWDKIQVPSVWELNGYGTAI
YVNEKFEFATKNPNPPDVPDGINQPAGLYRKEFSIPSDWKNEKVYLHLGAVKSAFKLYVN
GKFVGVGKDSKLASEFDITDYVSAGKNQISMEVRRWTDGSFLEAQDMWRLSGITRDCYVY
ARPKVHLYDIDAKTGLSNGYTDGKLDLLVQIWNETDENKGNYQLETAIFNDKNQKIWQET
KSITQIQRKNSKTELYFSANLPLVKQWSAEIPNLYRLEVLLRDDKNQISEAVSMHIGFRS
IEIKGSDLLVNGKRIFIKGVNRHDTDPVTGQVISRESMEKDILLMKQLNVNSVRTSHYPN
DPYFYELCDKYGLYVMDEANVESHGMGYKPERTLATNTAWEEAHKQRIMRMYQRDKNHPS
IIIWSLGNEAGNGWNFYQAYKMLKALDPQRPIHHELAHYDWNTDIESRMYRRIPFLIDYG
LSHPKKPFLLCEYAHAMGNSIGNFKEYWDVFESYPGLQGGYIWDWMDQGIYKKNASGKTI
LAYGGDFGDKNTPSDNNFLINGVIASDRTFHPHSYEVRKVYQEIGIFFEKDKLMVQNKYF
FRDLSNFEFSWTLLRNGTPINQGKLDNINVLPRQKGVFPLVIREKLTKKGKNTQEINRLA
SEIVKNDPENEYYLQIEAKLKSDEGILTANTSLAFAEFPLNTYKKPVYQVDNNIITTEQT
DKEITLSNRNFKATISKEKGRLVYHQTNGKENISGEGLYLNLWRPATDNDFGAGLQKKLK
DLRYADKDAKIEKITLSDAENGQKQVKIYKFLIENSIKFTQTLTFDGKGSVLVENTFVPL
KESDRLTFKIGNHVTLSKDFTNLEWYGRGPWESYEDRQTSAFVGLYKGSIDEQYHPYVRP
QESGNKTQVRYAKLLRKDGSGILVQSEEKFMNINALPYSPASLYPGEEKQQTHSEELEKD
QHIHLDVDYQQLGVGGDNSWGNLPMAQYLLYLHRPYSYSYRIIPVK
>OBAHECAF_00496 hypothetical protein
MYEKNIQRQDMTKFFHSRGKLLLTGEYAVLDGALSLAFPTRLGQSLCISETNQGFSWRSF
DFHKKVWFEHHELTFDDFKQNTTLSTTAKTLLNILNTAVELNPIFATQLTHCQIETHLEF
EREWGLGTSSTLINNIAQWAGVNSFELLFKSFGGSGYDIACAMHKTPILYKLTENRPSAY
PLQFLLPQTNQLFFVYLNKKQNSKEGIALYKSIKRSKKNLVSRITEITENIIRTTSLPDF
CQLIDNHEQIIADFLKIPTVKETLFRDFSGSIKSLGAWGGDFVLAVGERNYVFDYFHKKG
FSTVVPFQEMVYIEP
>OBAHECAF_00497 hypothetical protein
MFTNSNTYLSAYPKKIGHLSVIFFTFATQETNVRKKYSATRYDKIFSQ
>OBAHECAF_00498 NH(3)-dependent NAD(+) synthetase
MNAEKVTNHIVHWLKTYAENAKVKGFVIGISGGIDSAVVSTLCAETGVPTLCLELPIHQA
ESHVSRAKEHIAFLKEKYSNITDLQVDLTPVFDQFVKQIPTTDQHSYEMALANTRSRLRM
TTLYYFAGLDGRLVVGTGNKIEDFGVGFFTKYGDGGVDISPIADLMKSEVYQLARYLGVP
ESIVMAKPSDGLFGDDRSDEDQLKANYDELEWAMLQHENGKTTEDFSGRQKEVFEIYQRL
NRANQHKMNPIPICKVENSVKKG
>OBAHECAF_00499 hypothetical protein
MYSQTLEGFVIDSLTQEPLPYANISFLDRNIGVSADENGFFENDTNLCVKQK
>OBAHECAF_00500 Phosphoribosylamine--glycine ligase
MNILILGSGGREHAFALKISQSKLCENLYVAPGNGGTHQVATNVSISPTDFQSVKKFVLD
NQITMLVVGPEDPLVHGVYDFFKNDSDLQHVQVVGPSKEGAKLEGSKEFAKQFMQRHGIP
TAKYESFTKETVERGCQFLSTMQPPYVLKADGLAAGKGVLIINDLSQAQSELRNMLLNEK
FGSASQKVVVEEFLDGIELSCFVLTDGKNYKILPTAKDYKRIGENDQGLNTGGMGAVSPV
PFADADFMQKIEERIVQPTIAGLKKDSIEYQGFVFIGLIKVKGEPYVIEYNVRMGDPETE
VVLPRIESDLVAVFQSLRSQTLDELTLQINPESATTVMMVSGGYPEDYEKGKIITGVENV
SGSIVFHAGTARKGDDLVTSGGRVLAVTSFGKDFKEALKKSYENIEKIHFDKMYFRKDIG
FDL
>OBAHECAF_00501 Serine/threonine-protein kinase pkn1
MYHKAFFIFLVSFATMTKAQIKGTYPEKDKVLVEGGFFLMGSPKSEGETIEHPQHKVFLQ
TFKISKYEITNAQYAEFLNAKGNQMNGDIPYIELKEGWSQIEKVNGKYIAKKGYEQHPVV
LVSWYGANAYAQWVGGKLPTEEQWEYAARGGNKTQKYTYAGSNTLDEVAWHRQNTDYLQP
VGKKKPNELGIYDMNGNVSEWCEDDFTSYDYKLRNTEEKKEKPSVFSAFFMAIMSKTPSN
HSYPEDKVTRGGHYNQQKMNIRIARRDNRNALGQIFVGFRVVFM
>OBAHECAF_00502 Adenylyl-sulfate kinase
MRPILFVFSGLPASGKSTLSKWIVSKFIAVYLRIDTIEQGLRDLCNVNVEGEGYRMAYRI
AKDNLLLGMNVVADCCNPIALTRDEWRNIAHNTNSFLINIEIVCSDKEEHHRRVFNRISE
IENLKLPNWEAISEYHYENWTENRIQIDTSHKTIEECVRELFSKIELILEK
>OBAHECAF_00503 Amidophosphoribosyltransferase
MSDNLKHECGIAMVRLLKPLEYYKEKYGTLFYAINKMYLLMEKQHNRGQDGAGLASVKFD
MQAGERYISRVRSNESQPIQDIFKQINTRISNLLKEYPELKSDVQEQRRMLPYLGEIYLG
HVRYGTFGKNSIESVHPFLRQNNWQSRNLIVAGNFNMTNAKELFQRLVELGQHPKENTDT
VTVMERIGHFLDTEVENLYRKFKDEGLSKIEASKRIAEELDVAKILRKSARRWDGGYAMA
GILGHGDAFVVRDPAGIRPAYYYKDEEVVVIASERPVIQTAFNLEFEQIHELEPGSGIII
KKNGDLSIEQIVEPLERKACSFERIYFSRGSDKEIYRERKKLGALLLPDVLKSIDNDLKN
TVFAYIPNTAETSYLGLVEEANTYLNQLKQQLILAEKNITPERLNEILSEKIRKEKVAIK
DAKLRTFITEDSSRDDLVAHVYDITYGSVEKGDNLVIVDDSIVRGTTLKKSILSILGRLH
PKKIVVVSSAPQIRYPDCYGIDMARMEELIAFEAALALHRERGTYNIVDETYKKCISQVN
LSDDKVINHVKEIYAPFTDEEITRKITQMLLPDNFMPEVEILFQSVENLHQACPQNLGDW
YFTGDYPTNGGNRVVNRAFINYYEGKKDRAY
>OBAHECAF_00504 putative sugar kinase YdjH
MGKLLIVGTVAFDAIEMPFGKTDCIMGGAANYIALAASHCCGESAVVSIVGEDYPSEYLQ
LLSDRNIKTSGIEIVKGGKSFFWRGKYHHDMNKRDTLETQLNVLADFKPVVPEEYKKADV
LMLGNLHPRIQLDVLEQMQQKPSLVVLDTMDYWMIHTWDLLMEVIQKVDLITINDQEARQ
LTGEYSLVKAAQRIMKMGVKYVVIKKGEHGALLFHQDKVFFAPALPLEEVFDPTGAGDTF
AGGMVGFLTNAEDYSFESIKNAIVYGAVLASFCVEKFGTERVLNLSKNEFSQRLLQFKEL
TKFEIDTP
>OBAHECAF_00505 Vitamin B12 transporter BtuB
MNKHISYRKSLLIIALSTFGIVTGQTKRDSLSTKVVDVVRSYTASIADAYKKREDANLKA
DSLSIAKRQINYSIYSVPVASTFVPEKGKASAMRTNIKRERYLDSYIGGAFGNANTLYGD
ASITLPVNNESNLAFIAEHLSSNGDIKGVIPDNNYAKTTAQLRYDFLNSDYNFGIAADFG
RRSNNWYGIQKGFYASEEQLKALTGLKQTYIDYGVNAYIKLANPYFKGLDFEFSGLSDAF
DTSEINVKTSPSFELPISSEEQKIHFGVLLDYYNSKFNRATALTPSAIENKWLIFGANPS
YNLTMDNLDLKVGLAIAYLGGNQTNESRFKAYPDVEISYKLLEGNTIFHGGVRGMMQQNT
FEKLSKNNPFLAPIQHITPTNIGIDAFGGVKGEVGTGLYYKIKAGYKQCENLPMFITHTE
TGNLGYQHNNAFSLVYDKVNMFNLTAGMEGSIAERFFFDFEAQYNRFTPDIQTQVWNLPE
TKASLFTDVKIIENLFAGVDAFYVGNRYDLNYSTQTLTVDGYFDLNFHVDYTINKQFMLF
AKVNNLLSNNYNQWAYYPVQGIQAYAGLRYLFSLKKK
>OBAHECAF_00506 Lipopolysaccharide assembly protein B
MIRAFFVTILLSVFCPFLMAQSTETHTNSLVNFEKAMFLYNRNLYKPAQHLFLKEIAETT
DSDLRTKSKFYVASIAVILGEPGAESLMRNFIEEHPESPLASGAFLRMADLYFQQGNYKE
ALKWYDQVKESGISKSERSKYYFQKGYALFATNKKAESEKYFNFVKNHPDYSTDANYYLG
YIAYDSDDYEKASTYFSQVQDDPSVSYFQANMNFKQGLFQEAIDEGLKQKSKTKNAQDLS
EINKIIGESYFNLGKYDEAIPYLKEYKGKREKFSNTDYYYLGYAYYKNKDYANAIDQFNK
IIDGRDAVAQNAYYHLAECYLKTGQKPQALNAFRNAYQMNYEPQIQKDAHLNYARLSYDI
GNPYESVPGVLLDYSKNYPNDNQQEIQALLVDSYISSRSYQAAINLLEKSNDPKDQQIYK
KVAFYRGLELFNELQYAEALVFLQKAVGGDPKLSARALFWSGESAYQLHDFESSKKYYTE
FINHPNAKSTYEYKNIHYSLAYSDFNLKNYGGAVDNFEAYLKQNPKANSWTNDALLRLAD
SYFVQGKYWPAMERYNKLIDLKSADEDYAAYQKAMSYGFVDRPQRKIEDLEKFVKTYRNS
NLRPNALFELGNGYVSAGNSEKGTKLYKQVQTEYKNSNLVPRAMLREGLVYYNKNENQKA
LQLFKDIAKQYPNSNEAIQSIASAKQIYMDMGQVNEYASWAKSLGYVEVSDLELENATYE
AAERQHIQQNEKEAIAGFEKYIKEFPNGMRITNAQFHLAQLYNASNQKSKAVTLYENVIN
SGSEEYSEQSLVRLTQILLDAGSYLKAKPHLEQLEKTATIAQNKVYAQSNLMRVCYTEKL
YSNAIQYAQKVLAEKSVDTRIKNDAYSVLARSYIKTENEAEARKAYQEVAKTATGSLAAE
AMYYDAYFKHKDGKFKESNDVVQQLAKEYGGHKEFASKGLVVMAKNYYGLKDSYQATYIL
ENVINNFKDYPEVVAEAKKELAVVKAEAAKSNSSVKM
>OBAHECAF_00507 hypothetical protein
MDKLTYFYRTKKEKCFLVESLDSISSIIIRLNLFNAK
>OBAHECAF_00508 hypothetical protein
MKRFLKFPTPYTVLMIVIMFAALLTYLLPSGSYDTLTYDATQDVFVLKSKEITQTLPATQ
QTLDEKSIAINIAKFKEGKIKKPVSIPNTYTETSPHPQGVKEVLFAPIRGIYETIDIILF
VLILGGFIGVFNNSGTLNEGVGYLSHKLKGREGILIIIVCTLIALGGTSFGLAEETLAFY
PILIPVFLAAGYDLMVPLAVIYLGSSIGTMAATINPFSVIIASDAAGVDWTTGTTIRVIM
LIASLTITIAYVIRYAERVKRNPQLSIAYQTPLPDSLTSQKVAPVERLKLSSKWLLLVFA
LSFLIMIIGVARWGWWFEEMTALFLVASVCIALFLRMSEEQFITDFIAGAKDLLGVAFII
GIARGVTFILNDGQISDTILHYSTNLVGGMSPILFLPVLMCVFGLLTLFISSSSGMAVVT
MPIMGSLATVVGIEGQHVVNAYLFGMGLMSFITPTGLILPSLAMVNLNYKQWLKFVSPLL
LMLLLLSVGMLLLGYYL
>OBAHECAF_00509 Peptidyl-tRNA hydrolase
MKKYLIVGLGNIGEEYKNTRHNIGFKVVDFLASQHTTTFSTQRLGDLAEVKHKGRTFILL
KPSTYMNLSGKAIRYWLEKENIPIENLLVITDDLNLPFGTIRIKSKGSDGGHNGLKDTQA
QLNSTNYARLRFGISNDFAKGKQVDYVLGEWSDEENTALPERLEKCVQAVLSFGLSGINI
TMNTFNNK
>OBAHECAF_00510 hypothetical protein
MENQYLSADKLEFTQSIQENLKEIAKWAKFLAILGFVGIAILVLVSIFTIIFGVIASSME
DTPFPLAFVGVLYLGMAAVYYFPIKYLYDFATNMKDSLKTSNRIVFSRAFENLKSHYKFM
GIFTIVMLSLYILILIGVLLIVGFLGAIGGY
>OBAHECAF_00511 Ornithine aminotransferase
MKTEKLSSQQAMELEDKYGAHNYHPLPVVLSKGEGVYVWDLEGKKYFDFLSAYSAVNQGH
CHPRIIEAMTKQAQTLTLTSRAFYNDKLGVYEKYITEYFGFEKMLPMNTGAEAVETAIKI
CRKWAYERKNLPESQAIIVVCEQNFHGRTTTVISFSSDKNARKNFGPYTPGFVSIPYNDL
RALESFLAENPNVAGFLVEPIQGEAGVYVPSDGFLSGAKAICEKYNVLFIADEVQTGVAR
TGKRLAVDHENVKPNILVLGKALSGGTYPVSAVLADDEVMHVIKPGQHGSTFGGNPIAAA
VAIEALQVVKDEKLAENAQKMGEIFRKEIGAYIENSNIATAVRGKGLLNAVVINDTEESD
TAWNICLRMRDKGLLAKPTHGNIIRFAPPLVINQEQLKECIDIIISTLKEFER
>OBAHECAF_00512 hypothetical protein
MATINIKKLVPKQATYPGEHLLDEIQAREMSQKDLAMEMDLPKSVVNEIIKGKKNINTDI
ALRLEKVLGIPAKFWLNAQADYEIDKRRVEEKHQEFVKNNEIWSVIKSYIRMPFFKREGV
ITDDLKQNINIIFKVFAVSDLDGFVGRFAELEYQRFRKSEKSNIERNSLVCWVNYVKYKA
SQLYVSDFNQSEKEQVFKAISEVLYKNKENILDEVKEVLSSYGIKFLIVPKPKDCAVDGV
SFWSENPTICLSLRNKSIDSFAFTLFHELSHIYLHLVNNNRKEYINLEEKHQKEEQEADE
LASKLLIPDDVWKKIKSINFHNESSVMSVSKHYGIHPAILQGRYSKENNNYKIKKIDKDI
RQVSFTEKNQ
>OBAHECAF_00513 Toxin HigB-1
MQIEFIDEELARFYEGGKVKNKELKSNGNLQKLFIKTVDRLKSLEKIEDAFLFKSLNYEK
LQGNLSGKSSVRVDIKYRIIFEEIEDEEGKVIILSIEELSNHYQ
>OBAHECAF_00514 hypothetical protein
MYAEAGNHNIRQVFEYDSENAFLQRSVPILFYVPEDYKPLFFDANVMASHKDIFPTLFHL
SLSNQKYMYSGDDLFSKSLNYRFGINDYNFIADSLGVLFKGNQKPLYFTWKDSTKRKLAP
NNFDSPHAEFLSNKLKSFETLQTIQIYSDIKNQKKN
>OBAHECAF_00515 hypothetical protein
MNYDRINEKLTILADAAKYDVSCSSSGGNRKNTHKGLGNSDPWAYATPTPKTDAVCLCSK
YYSPTTVFTIVSTAYPEKATTLNELLLL
>OBAHECAF_00516 hypothetical protein
MERLILIAKKLRTEHRFNGYIHLKTIPNASPELLQEAGLWADRLSINMEIPTVSGLKLLA
PDKSHEQMIQPMNHIKNSIVQAQSERKIIKSTPKYAPAGQSTQFIIGAAGENDVQIILSA
DHFYKQFQLKRVYYSGYVPVTADSRLPALTTPVPTIRENRLYQADWLMRFYGFEAREILT
LQNPFLDLEIDPKLAWALRNPQLFPVNLQTAAYEMILRVPGIGRTSAYKIVNSRRFQTIT
MEHLKKMGVAVNRAKFFIDLAEKNPFLKYLDQLELRQLVISSMKSKYKNHFSQQLSLF
>OBAHECAF_00517 hypothetical protein
MIRLVYDGSFEGLLTAVFEVFEYHYADVEIVCSTHTLGALFSEEQEVVTHFEKAERVVKG
IEKYADKSAVNQLLKVFLSEDPQRESLILYAVRYLVNTKENIFENYADAQMMRIARLVKS
VQRESHRMKAFVRFQKLQDESFFAQIAPDFDVLPLIIKHFKDRYADQKWMIYDLKRGYGI
YYDLEEVLPVVPDAATKQKLRNPEALFHEEERPYETLWKNYFQSVNIKERYNPKLHRQYV
PKRYWKYLVEK
>OBAHECAF_00518 Malate-2H(+)/Na(+)-lactate antiporter
MSTDKQASIISILPLLIFVGIFLWSGIYFNNFYSIPSPLIALAGVVVALLIYKSTLKEKI
QIFFTGAGNSNVLAMCVISLLAGGFSFVTKASGSVDSIVNLGTYYISPAYLPLGVFLVSS
FLSFATGTSVGTIMTLGTIVIDLATQSQSNISLVGACLLSGAMFGDNLSLISDTTITSTQ
TMGAEMSDKMKANSKIAIPAAILTMIILIFIGNSDVQPAVSKATADFDVVLILPYIAVVV
LSLLGVNVFASLFTGIIFAGTLGIIYGKFDFLGFTTNVYEGFMSMSEVFLLFFFTGGLAT
LVEYFGGIRFLMNGIQKYIKSYKTALLGIGALVSSANLCVANNTVSILIVSKISRKISTK
FNIAPRNGASVLDIFSCYVQGIIPYGAQVLGLIYLSKNTINYPELVLYAVYLHLLLLLTL
GYIIFRSKKTLLEK
>OBAHECAF_00519 Major NAD(P)H-flavin oxidoreductase
MRFIELAQNRYTTKAYNNKKIDQNLICELKEILRLSPSSINSQPWRFIIVSDEKTKRALA
DVSHFNKSKINEASHLVVFLGFKDLRKFEKQITDFLPEGAVNYYHQVLKPKGDEQVHIWL
NKQVYISLGFFLSACASMNIDSTAMEGIQNEKYDEILQEEGYQTLFAVAIGYRHEDDANQ
PDRNPKLRLPLEQVVKER
>OBAHECAF_00520 Tyrosine-protein kinase ptk
MENQLSFNEKDEKIDFSKIIQPYLSRWLWFAISVVVAFIFAYAYLRYAPSIYRATTTVML
KDDKKGGVVNELSALSDLDILKDIKDNIENQIEVLKSRTLSEKVVQKLNLHISYISEGKV
KTFDVYNNTPAFISIETLARSSVKLKVVGEENEFTLFEDEQPLGTFRYGEIIQNHIGQFS
IHKSAENTKFPYSIGIDIEDHIRVASGYRSSLNIKLVGKNTSVLELSVSHQNKKKAEDYL
NTLVEIYNTETITDQRFISQNTSDFLTKRLEVLTKELHEVEKHAEIFKKENRVTNIQTDA
QFNLENANLFDRKYVEATTQIELIENTIKGFIDVKSTGKTFPLLDVFTSNQVLSAAIEEH
NKKTIHRNQIALNAGEGNIMLKQIEEEIEALKITIKENLLLMKSNLLIQKNEISKKQASL
SGRVRTIPTLEKELREITRQQSVKESLFLYLLEKREEAEISMAALAPKAKVIDRALGGAT
PISPRPMIILLGAIVLGCIIPFLVIYIMELFNIKVRSKSDVEERLSLPFVGQIPHTDDTQ
QIVTLDTLSPLAEGFQMVCTNMDFVLNDTPQGQSKTILVTSSFPEEGKTFVSVNLAATFA
VSGKKTLLIGMDIRNPKIGEQLNLRSVGLTNYLASDIDLSSVIVKIPNFREFYVLPTKVV
PPNPAELLTSSKITKMFEQLKQEFDYIIVDTAPVNVVADTLLIAKHADACVYVIRENFSD
KRMLESVQRLYDDKRLPNMAVVLNDVSLGNMTPYYGYNYGYGYGAKNQKNKSPFKKILHK
FRW
>OBAHECAF_00521 hypothetical protein
MKKISVIICLVSILFSCTSRKNVAYFSDIENNKTEILKSYEIRLQPDDLLKIIINSQTEE
LLSDFNKTQNTGVAAEGSSPLQTYLIDKDGYITYPVIGNIKLGGLTRNEAIDVLTKAVRT
FIKDATVNLRIANFKVTVQGEVRKPGTFTIESERITLLQALSMAEDMTIYGKRSHVIIIR
EQDGQRTFNVVDMSSSEFMNSDFYYLAQNDVVYVEPNKTRINSSVLGLDTSTILSAISVT
ITVIALLLKF
>OBAHECAF_00522 putative HIT-like protein
MASIFTKIIQGEIPAYKIAENEGFIAFLDINPNAIGHTLCVPKKEVDKLFDLDETTYNEL
MAFSRKVAQALERAIPCNRVGVAVIGLEVPHVHVHLIPINEMKEMTFGHKVSLTDAQFKE
VVEKVQRELK
>OBAHECAF_00523 Transcription elongation factor GreA
MNNISYYTAEGLKKLRDELNQLKDVERPKASQAIAEARDKGDLSENAEYDAAKEAQGLLE
MKIAKLEQLLANARLIDESQLDTSKVLVLSTVKIKNLSNNMQMTYTLVAESEADLKTGKI
SVSSPIGKGLLGKAVGEIAEIQVPNGILKMEILEISR
>OBAHECAF_00524 S-ribosylhomocysteine lyase
MERIASFCIDHLKLQRGIFVSRKDFVGNEVITSFDIRMKLPYREPVLGGAEIHTIEHLAA
TWLRNSDWKDKIIYWGPMGCMTGNYLILAGDYTSEDILPLITRLFEYMTHFEGEIPGASA
LECGNFYNNNLPMAKFEAKKYLEEVLYNMKEENLNYPL
>OBAHECAF_00525 Thioredoxin 1
MALEITDATFEEVVLKSDKPVLVDFWAVWCGPCRMLAPVVEEISKEYEGRVVVGKVDVDN
NQEFASKYGVRNIPTVLVFQNGEVVGRQVGVAPKKTYTEALDGILG
>OBAHECAF_00527 hypothetical protein
MENLVLYLLKHFVFMGILWGGYRLFVSGNTFHRTNRITLLLIFAIGMMCPLVNIPLPYDS
IFTEKQIVAFELSSSETQTESIVATESDNSYSLTTLLWIVYVVGILLFLLRYLIGIIFIG
RIVSRATLEKTTNNKNIYVTKKKVSPFSWFGYVVISEEDMTKGADNIIKHELAHVEFGHS
WDLLFAQLYCLAFWWNPFVWLLKNQLITVHEFQADQRVIEQTTHPNEYRKQLIHLCVGAE
RIAMAHNFETSNLKKRIYMTMKNKSTAKAKWGYAALALAATLTMSLTSTETIQAQEKEPQ
IVVLGYVTDDKNPQPLFFIDGKEATKEAISGIPADNIGWINVLKDEKATKMYGEKGKNGV
VEIYTQGNVPEEFAKKAKDKKTFKLSKSSEKAPVTSGNMTVLKLKQESDTLMSDSKVVDI
KEVQVTQKVTAFKMNGKKANDPLLLVDGKEMEYTKLADLGAENIQSIVVLKDKKALEAYG
EKGKNGVILITLIK
>OBAHECAF_00528 Methicillin resistance regulatory protein MecI
MKELTAKEEEIMTFFWKHNKLFVKQIVEQYPDPKPHFNTISTYVRMLEEKGFLAHEPFGT
SYQYYPLISKEEYNNRTLKNIVAKYFQNSYLNVVNTFIKSEKLSIEEIRQLLDDIEKKQ
>OBAHECAF_00529 Transcription-repair-coupling factor
MKLNDILLKISENPIFIELNSKIKAGISSLQINHLSGASLSFVIANLFRNTKRNLFVMLS
DKEEAAYFLNDLESLLGDEHVIFFPDSYRRPYQIEDTDNANVLLRAEVLNRLGSHQTPLI
VVSYPEALFEKVITRKQLEKNTLKIKKGDSLSLDFLNEMLFTYNFNRTDFVTEPGEFSVR
GGIVDVFSFSNNEPYRIEFFGNEIESIRTFDVETQLSTQQLSKITIIPNIENKENEEVRQ
SILEYISEETIFIAKDIDSFPQKIDKLFNKSVEIYEKLSNEVKHIAPEVLFCQSNELLER
IGSFQSIFTGANSLFSSEKIVFRTNPQPAFNKQFELLISYLNEKHEEGFTNYIICSTEQQ
AKRFDDIFKEMEQKVHYQTAILSLHSGFVDSDNKINVFTDHQIFERYHKFHLKNGYAKKQ
AITLKELTQLTVGDYVTHIDHGIGKFAGLQKIEVEGKMQEAIKLIYGDRDVLFVSIHSLH
KITKYNGKDGKPPKIYKLGSGAWKALKQKTKARVKEIAFNLIQLYAKRKESSGFAFAHDS
YLQNELEASFLYEDTPDQSKATAEVKADMESPKPMDRLVCGDVGFGKTEVAIRAAFKAVD
NGKQVAVLVPTTILAFQHYQTFSSRMKDFPVRIDYLNRFRTAKEKKNILEELAKGSLDII
IGTHQIVNESVKYKDLGLLIVDEEQKFGVGVKDKLKTLKENLDVLTLTATPIPRTLQFSL
MAARDLSVINTPPPNRYPIDSQVIHFNEEIIRDAVAYEIQRGGQVFFINNRVENIREVAG
MLQRLVPDAKIAVGHGQMDGKKLEETMLAFMDGAYDVLVATTIIESGLDVPNANTIFINN
AHNFGLSDLHQMRGRVGRSNKKAFCYFITPPFVAMSDDARKRIQAIAQFSDLGSGFNIAM
KDLEIRGAGDLLGGEQSGFINEIGFETYQKILQEAIVELKENEFSELYQTKEEDKSYLND
TQIDSDFELLFPDTYVNRVAERLNLYNELSNISSEADLLTYEKNLIDRFGQLPPQAVDLL
NSVRLKWFATKMGIEKLVMKNGKMTGYFISDQESPFYQSSRFQKVLQFVQRHPDRCRMQE
KETRNGLRLLLHFNSINTIHQALKVMQLVFNEQHSF
>OBAHECAF_00530 hypothetical protein
MLCFYMVFIYRNYPYKVKNQDEFGNSHTCIHDFLKTI
>OBAHECAF_00531 hypothetical protein
MKQTIFTETYKVRSTQLNVNNQLGLYGVLGILQDIATEHAENLGFGYEQLVKEGFFWVLT
QQKLKMKRWPKWNERITVKTWSLPVMGVYAFREFEILSEKGEVIGSCSSTWITLDIASRK
PIDLSDRQELFYARTDGALDFKTERIDLPSDLELIKKFNVRISDLDVNLHVNNIKYSQWV
LDMLSLKNHKNYVIKEYDINFLSETFYNDEIQGYSSTPILESDEKITVFFCGKKSEQTKP
AFIAKLVAEPIKKNL
>OBAHECAF_00532 hypothetical protein
MKLFTKKSKTFLFLCFLIGASGYAQQKKVHNTIKIEENDSKEVIIEKASRVVPNQNQWEA
LSNEYIAFVHFGPNTFTRMEWGSGKEDPKIFDLKTLDTDQWCKAMHDSGMKMVILTVKHH
DGFVLWQSRYTNHGVMSTDFRGGKGDILKDLSESCQKYGLKLGVYLSPADLYQIEHPEGL
YGNLSKYTKRTIPREVPGRPFANKTTFEFEVDDYNEYFLNQLFEILTEYGPVHEVWFDGA
HPKTKGGQQYNYTAWKQLIRTLAPKAVIFGREDIRWGGNESGATRETEWNVIPMPMNPAT
AQRFPDMTGKDLGSREKLYNAKYLHYQQAEINTSIREGWFYRDDTFQKVRSADDVFDIYE
RTVGGNTTFLLNIPPNREGKFPQTDVDVLKEVGQRIRETYDNNLLYRAKGCKKVLDNNPD
TYLTLNKKNQEIIISSKKPITFNRIVLQEAIRTHGERVEKHSVEAWINNQWQEIASATNI
GYKRILRFPEVTTSKIRFRVLESRNTPAISHISAHYYKTRPPQLSFFRNLDGMVTIAPMQ
TQFNWKPHGQNASENLNTGYEIFYTLDGSEPNENSAKYTEPFFVENKQLKAVSFNKGMKG
AVRSEDLGILKKQWKVLNFSSEQNDRKTTMAFDAQPNTYWQSQKSSEKPFIAIDLGKIQT
LKALVYTPQTFHSKGMLAKGLIQVSNDGKTWQTVANFEFGNLINDPTPRTFYFPESVTSR
YVRIEASEIAENGDILTIAELDFL
>OBAHECAF_00533 hypothetical protein
MVYLSYISCVMYRKRFYIKRCTPLKINNKTKLISFFLRLQLPEDYLNLNNLKKTKNITVH
LWYIVMFLIDKGSIYL
>OBAHECAF_00534 hypothetical protein
MKKTIFTLVTLLLGSVLCAQNQEDIVGVWLSETKDGKFQIYEEGGLFFGKLIWMKEEFEK
DGKTPKKDVNNPNKSLRNEPLKGSVILKKLKYHKGEWKNGEIYDPQSGKTYHCKAKIKNN
QLILRGFVGVSLLGKNTTWTRVES
>OBAHECAF_00535 3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase
MQKKTILLTGAGGSVGKEALQLLVNKHNLYNIRIFDLDTPKNRKYFETFSDKIEIFYGDI
TRKEDTVAPVTGVDVIIHLASVIPPLANEKTHLVDSVNVGGTRHLVENTEKYAPDAFMLF
ASSVATYGDRLQDPYIRVTDPLVPSEGDYYAQGKIIMEKIVRESRLQWSIFRLGAIMGPK
NHKISGIMFLMSLDQLMEIATPRDTARAFVNGIDHLQSLNQKIFNLGGGADCVTTYREFL
GKNFEIYGLGKLNFPERAFATKNFHCGVYVDGDELEKIVCFRKDTLEDYYQMVREATPIL
QRWATRLFAPIIKKYLLSKSEPYKAWKQNDTEKIKRYFQ
>OBAHECAF_00536 hypothetical protein
MKRKILNGYPVLYDALFCLDNQTKRLVIVEEIKKIEFEVGYNYILKVNKVIKASPYSVSY
ELIEMKSKKLP
>OBAHECAF_00537 Beta-galactosidase BoGH2A
MKNIFLSTILVGMSSLSIAQTSKTLEKNWKFTREDNKNFSQISVNDKKWQNVVVPHDWAI
YGPFDIENDVQRTAIKQDGQVAPIEHSGRTGGLPFVGVGWYRTSFDVADFNADKKVFIKF
DGAMSNAEVFVNGQKAGQWHHGYNTFFLDVTPFVKAKNNTLAVRLENLTQQSRWYPGAGL
YRNVHVITKNKTHIPIWGIQLTTPEIEKNFAKIQLKTEIESQNLSNIEVETEIFNPKGEK
IVSDRKKYDEFVINNKIQQDIYVKNPVLWDIQQPNLYKAVTKIYENGTLKDTETTTFGIR
KIEIKPNDGLYLNGRKIKFQGVCMHHDLGAIGAAVNEAAIRRQIRIMQDMGVNAIRTAHN
MPAPEYVRIADEMGMMLALESFDEWAIPKVENGYNRYFKDWAEKDLTNLVRHFRNNPSVV
MWFIGNEVEEQSVQEGAKVARWLQDIIHKHDGTRPVSNGMDRPDHVFKNNMAATMQVAGF
NYRPFRYQEAYKLLPQQIILGSETASTISSRGVYKFPVERKSMPKYEDQQTSSYDVEHCG
WSNLPEDDWIQHEDLPYTIGEFIWTGFDYLGEPTPYYVEWPAHSSYFGAVDLAGLPKDRF
YLYRSHWNKEAETLHVLPHWNWEGREGQVTPIFVYTNYPSAEVFINGKSQGKRSKDLNIP
LDGSYTKEAQQSFERQKRYRLMWLDTKYEAGEVKVVAYDKNGKAVAEKIVKTAGKPHSLR
LTADRNVITADGKDLSFITIEAVDKDGNLCPNVNDLVTFKVSGAGTYRAAANGDATSTDQ
FHLPKMHLFNGKLVAIVQSSEKAGEITFEAKSKGLKTAVIKVKTK
>OBAHECAF_00538 Cytidine deaminase
MEKQQLTIRYTTYEHISELPEEVQTLMAEAVKAREKAYAVYSNFKVGAAVRLENGAICIG
SNQENAAYPSGLCAERVAIYQASTQFPNETIQAIAISGTAKAPTDQPVSPCGACRQSLSE
YEIRQKKAIPVYFMGACGKIIQTDSIKDLLPFLFDGSLL
>OBAHECAF_00539 hypothetical protein
MKKHIFLLVLTLVVAFSAGQLGYAQTSYATTITLDGQSIIKEKNGTTSTIGAGTVVQVTD
LQEHIFSGSSQNGNGINYNRILVKNGIEFEVEFPTHYTKIEKVYGPFTIITTNGKTRLKF
TKAGGFSCSYETVVGGVTEDRRIAGDVNYYGVLQLGASATSATQDAPTKIAVVSPDDARI
GQVIGGFHYVSENYVLSVPNGRFDGIFWASSLPNQNNFINLHDNFKLSSMQIKDIILKSK
EQHGNTASEFSFRIAFYDGTSNLLADGSDPGTNQKIFSLKDERTVQYTLTTESHHPTWGT
AQPATQTVNAGTEVTLQATPKTGYRFVGWAVGTPSFIVANDNPYQPAINENVRFIAVFEP
LPLQITANSNNTALGSVSPESQTLNAGQTAKVTATPVAPHKFKHWINTATQAVVSTQAEY
SFTVNENSSLTAVFEQGVFTYNVTAKSNNTAWGSVSPENQTLNAGQTAKVTATPVAPHKF
KHWVNTATQAVVSTQAEYSFTVNENSSLTAVFEQGVSTYKVTAKSDNTAWGSVSPENQTL
NAGQTAKVTATPVAPHKFKHWINTATQAVVSTQAEYSFTVNENSSLTAVFEEGVSTYKVT
AKSDNTAWGSVSPENQTLNAGQTAKVTATPVAPHKFKHWINTATQAVVSTQAEYSFTVNE
EISLTAVFEEVILLDPNAVLPHLTGLDTAVLKTGTPQTFVWEDMPQNATNFKATLIDMSN
ASAVTALVSTIDATQAQLEFAKAGTFTLMIHFEVLGVSYTVSYDGIVVK
>OBAHECAF_00540 hypothetical protein
MRHQHIIKSLLLLFVVALTACSKEEDTPTPAPTPPDMQLTLTEVSLMQGLYTQVGLSNAS
QVSITPNTSDVATLTHEKGQLNIRATKAGSVTFKITDATNSKRSVSLKVNVVPVKFGIME
NIGGAMKVETKYRYQTPKTLHTAVSATDRKTHFLKLELPTAWKEGEATTVLYKDVSATQP
HPIKASVLQLYRQQGLPLVVYLVSEDKKQYFVFPILEK
>OBAHECAF_00541 hypothetical protein
MNIEKLSQKIKELRKMKCLSQEELATQAGVSLRTIQRVERAENTPSGETLKRILTTLGTS
YETLIAETINEKPLRTLQGVKEYLHIFSDKLIINRSVTPENITKTYEKSISFLFKTLGIV
FIGTLLFSVIAVVLFFLDNTDLAIFATGFAAIFLIVTFLIMWFSSGTVPYIERKHIVATK
IENTKLGNIHFIITYRDGKRIKERVIAFETRDLMYIQEGLISENLLENDKVGRNYDTLII
IFSIPILSSLARFSDKFDFPVIITLWSLTGIVCIAMKVIIKSIRNNKKYAQSL
>OBAHECAF_00542 hypothetical protein
MKAPTVFIIFFLFNQFIFGQIELDYKNSDFYSGVSIVGLSEKGNLYVHKGSTLWKIDLNV
GEVEQQTSETRFLNKNIDFSKDEKYLIVQDLSGITVWDKCKIHKKWENRLDFGVTRLKSN
KANHNFALSNNKKIQIWNAEIGQLVDEFHTEKVIQTLYYTPDGNYLLIGTENCDLILWDT
KQKKIRYKTTLNNCEDARGILDLSSFEDKYILSGIRHADTRLIDFQTGTEIKRFKSFGAS
TLAFGLEGKNFYEGSGQGAVTVNELKFVDIDKGTAFEIDDESPIWGYSDFVYPSNFHFWI
VKGDGIEFWSKKDNIKLLDLFFHQDKNDSSLFFWNAIDYRRQRVGGQSSRFLLQRGEPIS
EKDNIFDKNILQNALKTNDKY
>OBAHECAF_00543 N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase
MKKAYFVSLCVLLSACNQTVTKNTEEKTIVKPVVISTWNHGLPANDAAWKILASGGSALD
AVEKGVMTAEADPEETSVGYGGYPDREGNVTLDACIMDSQNNAGSVACLKNIKHPISVAR
LVMEKTPHVMLVGDGAKQFALSQGFKEEDLLTEKSKKAYEEWLKTSQYKPIINIENHDTI
SMLALDENGNLSGACTTSGMAWKMAGRVGDSPIIGGGLFLDNEVGAAAATGLGEAVIRTA
GSAMVVELMRNGKSPQEACEIVTKRIYDLYKNTPELEHLQVGFIALSKSGEIGAFCVRKG
FNYALQSKNQQNTLIDATYMME
>OBAHECAF_00544 hypothetical protein
MTNRLLYLHGLDSLLQDDRRAVLQTYGMVEGPTIDYKNTPNLFQKLQQNYADIEAIIGSS
AGGLVAYYLAQYLQKPCLLFNPALTFRAEMPIPTAFNKNYKEYMQIVVGGQDKIISAWES
IEIIKEDISENQNINIHFTNTMQHSYDIDIFRKEVEFFFTQIR
>OBAHECAF_00545 CRP-like cAMP-activated global transcriptional regulator
MPTRCEKCSVRNQNALKTLNEGQLCCISEHKTSIVIKKGEVIFEEGDMLPGVYCISEGFC
KLTKLSFGGKNQIVRFVTKGDILGQKSIITKRPVSLTATALTDVQACLIPKEDFQNSFAE
NHFFSSELFKNICDELKQADDAILDLAQKTVKQRLAHTLMFLEEIFGKDHDGYINMQLSR
EEIGTMIGSATESLIRMLSEFTKNGWIETKAKRIKVLNRKQLDKTSQGM
>OBAHECAF_00546 Copper-exporting P-type ATPase A
MSNTCYHCGNECDSRPLELDDKIFCCLGCKTVYELLSENNLTSYYDLEKTPGARPEASSE
KYAFLDNEKIVDKLLEFNDGNVQVVSLYIPHIHCSSCIWVLENLDRLHKGVTTALVNFPK
KTVRITYNADMLTLKELVLLLAHIGYSPYISLDDYQSKKNNPNRDIYYKLGVAAFAFGNV
MLLSFPEYFEADEFWIEQYKPFFRWLMFFLSLPVMFYSASDYFISAYKGIRSGFLNIDIP
LALGILAMFVRSCYDILTDSGQGFFDSLNSLVFLLLIGKFFQQRTYDFLSFERDYKSYFP
IGITKIHPDGKEESVQVYDIQQGDRLLIRNQELIPVDAILIRGEGHIDYSFVTGEADPMQ
KLSGDKLFAGGKQTQGAIEIEALKGISQSYLTQLWSNDVFNKDKDDDFKSLTDKVSKYFT
IIILSISLISLLVWILRAYWGISAPVMALNVFTAVLIIACPCALAISAPFTLGNMLRIFG
QRKLYLKNSKVIEKMAKIDTIIFDKTGTITTANKSDLTYEGISLTPNEQRVVKNTLRNSN
HPLSRQVYDFLEVSDNSKLIDNFEEITGKGIQATVEGIAVKIGSASFVGKHVEHNNLKTS
VHLSLDNVYKGCFVFHNSYRDGISELFTSLSSDYEIVILSGDNESEQMNLEKILPKGSIL
LFNQKPEDKLLYIKHLQEKGKKVMMVGDGLNDAGALKQSDVGIALSENVNVFSPACDGIM
DASKIKQLNVFMALTKKSMQIIKGSFVLSFLYNMVGITFAVLGLLSPLVAAILMPLSSIT
IVLFTTISANVASVKRLGK
>OBAHECAF_00547 Tryptophan synthase beta chain
MENQFKKQPQTEVSPVAKMLENNGTYGVYGGAFVPPVLETQLKKLSDFFDQITQTDEFRT
EFIDVLKDFVGRPSSLYYAKNLSEYVGSKIYLKREDLNHTGSHKINNAVGQILLAKKMGA
KEIIAETGAGQHGVATATACAFLGLPCKIFMGAVDMERQALNVRRMRLLGAEIVAATTGN
QTLKDAVDSALDYYINHPDSFYLLGSQVGPHPYPKMVGYFQSVIGNEARQQILNKEGRLP
DSVIACLGGGSNAIGLFSAFIDDPQVKMYGAEGGGKNIANNTAATLNYGTPIVFQGTYSY
CLTDTDKNPIASKSIAAGLDYPGISPQHAYLKDSQRASYFSVTDEEAIESFKLLARLEGI
IPAIESSHAVALAVKLLKNKNSLSIVNLSGRGDKDVEREM
>OBAHECAF_00548 tRNA(Ile)-lysidine synthase
MLDLENHITRYSLLSKRVLVAISGGLDSVVLTHCLYRLGVDIILAHCNFQLRGTESDADQ
QFVVDFGDKLNIETLVKRFDTKKYISENQTNTQLAARKLRYEWFETVATEKQCDYIAVAH
HADDNLETFIIHLSRGTGLDGLLGIPPKNGKIIRPLLAFSRDELYRYAIENQLSWREDSS
NASDVYLRNNIRHHISPKLKELHPTFIQNFQQTLFHLEQTADFVDFHISELKKNIFTEEN
NRIFVDSEALKQLQNIDFVLHKLFYPYGFSNLQDLKQLLESESGKQLFSSSHRLLKNRNQ
WILEPKTKISEEIYQIKEFSESIDLPIRLHFDFVEEVGEFSDNQIFVDADLINYPLVIRH
KKDGDYFYPFGMVGKKKLSKFFKDEKYSLIEKEQQWLLCSEADIVWVVGRRLDNRFKVTK
NTRKILKIQFFEKKIQFYLEE
>OBAHECAF_00549 Lysine-sensitive aspartokinase 3
MQIFKFGGASVKDAAGVRNVASILEQVGYSDTLIVISAMGKTTNALEDVIYAYFKDKYIL
NDSIKVIKDFHYNIIKELFSNENHPVYWKVDGLFAELESFLERNKSPKHSFVYDQVVSFG
ELLSTTIISQYLNDTGIKNTWIDVRNLIKTDSNYRDGSVNWEETQENITNSVNKSLLNIT
QGFLGSDANFFTTTLGREGSDYTAAIFAYCLNASSVTIWKDVPGVLNADPRYFEKTQLLH
KIPYKEAIELAFYGASVIHPKTLQPLQQKEIPLYVKSFINPTATGSAVCNVAELEPKVPC
FILKKGQVMISLSSLDFSFIMEDHISYIFKQLHDAKMKVSVIQNSAISFSVCVDNKFDTL
THLLEKLEAKFRVSVAENVDLYTIRHATEEVIGEVENNKNVLLKQVLKNTVQIIVSNNSE
K
>OBAHECAF_00550 Glutamine synthetase
MPNLRFHALKEVGKRKPVVITEKGKRSELFGENVFNEETMRQYMTKEAFESVMNAIQYGA
KIDRKIADQVATAMRDWAISKGATHYSHWFQPLTGSTAEKHDAFFEPIGRGRAIEKFGGG
QLVQQESDASSFPNGGIRDTFEARGYTAWDPTSPVFIYGTALCIPTIFISYTGEALDNKT
PLLKALTAIDQAATEVAKYFDKNVTKVISTLGWEQEYFLIDKDLASTRPDLMIAGRTLLG
HTPAKGQQLDDHYFGSIPGRVLSYMRDLEQECLLLGIPVKTRHNEVAPNQFELAPIFEEA
NLAVDQNSLLMDVMNKVAERHDFIVLFHEKPFAGINGSGKHNNWSLATDTGVNLLAPGKT
PMKNLQFLTFFICTIKAVCEYEELLRASVASASNDHRLGANEAPPAIVSVFIGQQLTKVL
DELEDVSTGKLSPEEKTDLKLNVVGKIPDLFLDNTDRNRTSSFAFTGNKFEFRAVGSKAN
CGKPVTIINTIVAKQLIDFKKEVDVLIEEKGLKKDDAIFNVLREYIKQSKKIRFEGDGYS
QEWEEEAMRRGLSNNKTTPEALKANISEKTIQLFESMNVMTRVELEARYEIELEEYAKNI
QIEGRLIGDIARNHVVPTAVKYQNTLIENVRGLKEIFGDGYMDVASEQVELIKRISEHIK
VIHSKVDDMIEARKKANKAKNAEETAKIYCNEVKPFFDQIRYHCDKLEIMVDDELWTLTK
YRELLFTN
>OBAHECAF_00551 ECF RNA polymerase sigma-E factor
MFFFSKTCNILFFLASLYQKRDLTTEFSDILKGCKRGDPKAQTALYRQYVKAMYNTAFRI
LQQSDKAEDVVQESFIKAFEMLDSYRAESTFGSWLKRIVVNESLMLLRKEKVSISLDTIP
YEAIDDNPQEIWDFQQEEVQILLKCLGNLPEKQRVILNLSLIEGYDNEEICEILNVTDQN
CRTMLSRAKKLLRETIIQMKHDRK
>OBAHECAF_00552 hypothetical protein
MIENKFDIYEPLDGHEERFLQKLSERNITKKTKRRSLIRKIVYTNIAAAVLIFVAFTWNY
NAGDRLEIVSQVVYESEQYYLPMIEENIEIIKNSNNELLAKDALNQLNKMKTDYERLRNE
IIAQGENEFLITAIHTNFDTQLQFSNRVITIINPLQGAENET
>OBAHECAF_00553 hypothetical protein
MKDIMVKIKNNMFLNLLENRNWGVAILLLFSLSIWANEPYFKEQKHTEIQKISKEFQVSS
SPSLYVSNRYGDITLLTDKNLKDKIKIEVEIKVSANDPSVAQSRIKEISVNFSQNASDVW
AKTQIAESNSFFGLRGRKSSVQMKINYKVSLPVKTHLTLENKYGNIFLNRIEHDVKIDAQ
YGNLQLGEVLANAKLDLEYISKANMESIKYIDMDASYSNIFVEKADKVDLEASYTNLKLG
SIKQLQADVSYGNFDINEADFLSLESDYTNVSIGKISNQLSVDSDYGRVIVKEVLPTTKS
VSMKSSYASISVNYHRNWLFNYYFSTSYASLRTPDNLPFTERDHRQTSKYVKGSKGKANN
LFRIESDYGGVSITEE
>OBAHECAF_00554 hypothetical protein
MKNIFTFLFIAFSATSYGQFFLKETIKDNGNVKVENRTTEAYTKVSNIGNLYVVLTEGKV
GSIRVEASDNILQYILTKVENGELSIRLDPKNNYTLKHKVVVYVPVDQSLQKILQKGSGD
VELKDLLKVEQLSCELAGSGDLKINVKAKQLSLSVVGSGDLEAKGSVTELQAELTGSGDL
DAEKLTAMNAKVTVNGSGDITTFVTENVEARVSGSGDIAIKGNPKKRDSKVMGSGDIRFM
P
>OBAHECAF_00555 Small-conductance mechanosensitive channel
MFVLNFLEAYTNQIIASVVSIVILVIVRSISFSIVERVARKASFLENRTNLVKRYISYLI
FTFIVILLISVWGIERDKLFLFLSSVLTVIGVAFFAQWSILSNITAGVIIFFSFPFKIGD
KIKFIDKEFPIEGEILDIKSFYTLLRTSEDEEICLPNNLLLQKGISIVSNVKR
>OBAHECAF_00556 D-inositol 3-phosphate glycosyltransferase
MRGLGNYSRDLIRILQEQQMFELVLFNPKPKVHSGVRIDGHTKVITPKSFFWKKMKSLWR
MLKISRLAQTESLDLYHGLSGEIPFGIQKHTRTIVTIHDLIFVRYPQWYSFFDRKMYFWK
FRQAAQKSHHIIAISEQTKRDIVEFLGVPSEKISVVYQGCHEAFKKKYSPEIKKHTRKKF
ALPERFVLYVGAIEPRKNALEIVKAIKDLDIALVLVGKKTKYYDQIEAYCRKHQMKNRVI
ALKNVSMEELAVIYQLSTIFCYPSIFEGFGIPIVEALFSKVPVITSQGSCFSEAGGEDSI
YINLNNATEEIKRAIIAITSDDEKRLQMIEKGFKHAQKFTDSSVYQELISVYNRVRTID
>OBAHECAF_00557 hypothetical protein
MKTLKKLGTLMVVLFATSVATAQHKILTLEQLPAKAQTLLKENFGGLDIAAIWEETEYFS
QKEYNVTFNDGSEIEFRSNGDWKEVKSRTGNVPANIIPVAISQHITKYFQNTTVREIKRR
KSGGYEVELSNGLDLEFNSKGRFVRIDD
>OBAHECAF_00558 Inner membrane transport permease YbhS
MRRISRVTYAYMQEMKRIISDSAVWASFFIISIIVAWAYTYVYSYEVTNDVHIAVVDECR
TSESRQLIRMINATEQVSVSESPSDFDAARELFYQGKVHGIVVIPRDFSEKIYKKMRPSV
SGYYDVAYFIYYKQVYKAVATSIAYMNAGIELKGLTAQGVSNHQAMNTIKAINAQTVTLF
NPNGGYATFAMPMVYLLIIQTLLLTGIGLLGGTQREKKEFLQNHYTVRTIRGVIATLLGK
AGSYLTIALLYITIVLGIIMPFFDIPQRAKLIDVYLFMLPFFLSVAFMGLFLIRFFKHRE
DAVMTISFTSIPFLILSGISWPVESLPKLLQFLSQFIPSTTAIKGFVSLTQGGVALTDIH
DMYLKMWLICLFYFVLCVFFFNSYRKKNENELV
>OBAHECAF_00559 Ribosome-associated ATPase
MGLRTIFIKEAKQLLTSPKRLMMALGLPVLIFGFFGYAFQEDTPKDLPVLVTDYDQSVMS
RQLIRWLDATSIMQISEQVESPKNAENQLRKGEVYAYIIIPSGFEKDILQNKTTQAICYT
NGAYLLPSGFIQSAFINTVSTLSAGINLNKRTKKGASYQQAFAEVQSIKNDAHSLYNPYK
NYNYFLSLGFIPMMFQMVVMIVSIFALGQMFKYRTAEIHFEEAGQNAWILLIGKLLPYTI
VFMVLALCMDIYLFKVIGIPAKANYAGATILLSLLLVIVNQVLAVFFVSFFKDLRMALTF
GGGFTAIAFSFSGYTFPLEAMPVFIQYVAKIFPFTHFLQSYINTAIRGLSFYYSWENILA
FCLFISTITISFPKFVKLIKQNGYEKN
>OBAHECAF_00560 hypothetical protein
MNQEEKFEELAKQLKNPFGEKGLQVAQMMSDTNTAMTLNTVDLLNLRPDDLLLELGHGNC
QHLKNIFERETDIKYHGLEVSDLMHIEAKRINQEYIKLGKAFFHKYEGGVLPFAKESFEK
IFSVNTIYFWNDTPRMFDELFRVLRRFGILNVTFAEKIFMTTLPFSRFGFTLYDQEEVIE
FALKSGFKHLKTQIHTESIQSKSGDIVNRKYLITSFLKPE
>OBAHECAF_00561 Multidrug resistance protein MdtN
MKGKRIFKLIPIIIIIVIAIIAISSLFRAEEHYWQGQAEAKQINVAPKIPGRVDKIVVQE
GQSVKKGDLLLSIETPEINAKLEQANAAHNAAQAQLNKANAGARSQQIQGAYSLWQQAKV
AADFAETSYKRVENMFKEQLVSAQKRDEVYTKYQAAIQQANAAKSQYDLALAGAQQEDKQ
AAKALVDKAQGAINEVTSYKNESNLYAPLSAEIQKIIPNEGELVNTGYPIITLVDLSDIW
VVLNIREDFMGRFQKGTKFNAFVPALDNREITLEVKHIAVMADFATWTATKSQGDFDRKT
FEIKAYPVEKVEGLLPGMSVLVKQ
>OBAHECAF_00562 hypothetical protein
MHRILLAIKSYLIMNAKKSFLIIGATLLSICSKAQVIVSQSLDQAIRSGLKKNETLKQKE
IEQEKLALERKDVLQKYIPRVEASGAYLYADSNTKMELETQHLPLLKLPLFNTIFNTTKH
SESYGNVMMGGVTAKMVLFSGLQIPYGAKALESKRIGTEYLGKIVADELIQEIVTSFDQI
KVLEAIQKLIDDSTKRLENEAKRVEKGIEQGLAIPFDRDKIKLAQLELASKQAELDGNKS
LIYKKINYLTGLDSAQIESVVNDFEPFIMIDNTNLSIENKHEIKALQSFIEAQEWLLKKE
KGSFLPQMMAMGGVRYTSLFDANLDLGMSPLTKKHIHIGVNEITFSPTWFVGVGVKWELF
GGMSRINKIKQTKLDIATTKSKLTDAHDKLSLLLDKNKVNYRIANEKMHINQQKVVVAKN
SLDTAIRQYTEGLIDISDRLEVENEYYKVVIEQIQGIQQQRQAAMEMLKTTGTLSNYSVQ
>OBAHECAF_00563 hypothetical protein
MQDVMIKYLSFVKTLCPKLTEEDLCYFAKGLSIETLPLKDFYIKADEEQTQIGFVAEGLL
RGFYIDEQGNDITVSFHQEEIFVADYTTLDSPRRSRFYFQCLEKTTIINHSYEHLRKCSD
KIPFFERYMRLVAENAFKRVYRRVESFLFNDAETRYLDLMKENPELVNRVSVSHLCSYLG
ISRQALTRIRKNILNKE
>OBAHECAF_00564 hypothetical protein
MKNYGVVVRHRVRIFMAVVMFFTTMLGFSQHGGGGVGPGPSPYPVLVGETDPPQPSACGD
ASRYTVDIYLGTTAYNNGILEITFPDDFEYKNGTVSANIGTVTLQSQAGNQVILNVSIPA
KTVSASKMTVTFEAKTLCGAIATAVVGVAKPKMIYKLKGAGAEQIKTSKDINVLYAALKT
SVTPPTSTMASGEQVVRNITITNGGNGAIKSFKLTTTMGAGLQIVNSDTSLATGWTVNHN
GAGEYEFSGSTLDPGQSVTIKQTVSLQGCSDFTSSYTASYGCGGTLSCDYPKKEEATANP
TANFDPTKKPNLEVTNVKADGTFDAIVTPGELCLNTDITHHIRIHNKGGALAKNPIITLE
TSRGERFGSTHLLDGQYEMSFDPNFTTVQIPTVKHSTPINSTYGGRFGTAGKTELVELNL
SDIPAGQSLYLRFKSRNNAPVGDCTNRPDTEIAFGYIVDKVKYSDSGVCNPDPDRYTSNH
VISEGMQIEASGSNVMGAPTVSNGQIYDGKFTLHRLLASSKGLKAGDYFDVVLELSPSLT
VEDVNTLKIKNSEGNPYTVTPIQDGNKWRFRFKFDEIFIGTAKWTSTFQAFSALLEFKAR
YQCGSGTSGAPAWYKVNMELKRETSCSTSDIMSTRCTQVDLQPLGCTSGCTDGLVRQTPK
IQRLTYGNKPTNPDNAGKPLYPLTPIDDFSNIATSSYHAGDRIRFEQSGVVQKTIATEVW
TEGQFSVEIPDIYALGTAPKSIIHNETLKLVLERGGNTYTATGLSYTGGDNAATATITVH
FDMNTLRTKGFPNTITDFQNSDKLTISFEMTPNNYGVTNSGGKVIVKGQKIFRPNFKLTY
GGNDRVCGPSGLANSYYALTRFAIYIGGNSVESHRRITECQTTGNVYFYYDTFVNEQRIS
NTLFPNEHRTFLTPKKAVFNVPKGLLLTEIYFTLEGQGTSSFWGANGRYVLPTPITDNPN
FEFDLKEYLSNKLGTPTLNLDEGYRFFINPVLKPTCHAGDSEELKMSLFLEGTGQSVHSP
RLVYNNNDNIPVPTQTITYLIDNNKITSFVAQPIHTGNTDEVSWVVQVANSSIFHKFTNL
WIGATDMNITSVQEVTNATGNIPMGTPFTKETSGIFKLDKLDPTKTRYFLVKSNISDCGQ
GDRTILFGQGCEGYPNAIDAASPCVKKLPVKYAKTEAAFQVKIISQPPADYRPNLCDQIE
YDIEINNSGAGLAKDIHLDIPLGTDQGLFFVSGSAYISQKYTTGTQSTTGSWANANVTSA
NDIISIGLATNTLSIGEKIRVRFKVQTTSDCRFTSHQKLQFIPKGRNFCGSDIIDINSAT
SDNIIIQGDNSNRPIVVIEKGTATVTFAEIGATGSPMAKYEVKFVNKGSDINSDAINANA
KFAVKLPTGWTFIDQQEIATKSGGKLQYESLEDGFYVYKLLTSMPKGEALEINDISMKFT
GAMNCNNAGEVQTQLYYVVDVGTFGSNCSVAPTCNLKTVIVDRKQLLVNKVPKAKLKTDA
NTDLCGTKTIADLNTLVTGNANLVWYDTQTGGVPLATNVQIPIGTTSYYLALKDALTDCE
SAERLVVTVTVKEISERGHISRRQFCDISSLTVQKLKETINLDEEGLIKVYDNGGGTAKL
DTDILTPGVLYQYTRTQAGKCESDRRDITLIIGKTLTPVLSEVLCGQMTVDQLKAKFPTP
STIKVYNGTSEVTSGNLGVGNYQITNTENGKCESDKLNKTIYESPVLNITKTDASCGVAP
SVKINGYNTAFTYTITPNLTIATDGTITGYTYGTSYEVKVTNGGCSAIQNFVVSNTCTID
AVDDPVTVTSTTTPVVAGNVLGNDTMTSGTVSTSNVDIFIVTPATGAVVPSVQTGTGDII
VPPSTPAGTYTIVYKICSKVVADTCDTATVIVVVPPFIEANDDVYTVTSTTGGLVSNVLS
NDTANGSPATVGTVSITSVTPSPLPNAPILDAATGNVTVSSTTPSGTYTITYEICPLGVA
SADVSCDTATVTVVVLPFIEANDDVYTVTSTTGGLVSNVLSNDTANGSPATVGTVSITSI
TPSPLPNAPILDAATGNVTVSSTTPSGTYTITYEICPLGVASADASCDTATVTIVVTAVT
TPTVITATDDPVTVTTTQSGTVVNVLDNDRLGTNTPTTSDVTITVTSTPTGTIVPNLDPS
TGNVTVPSGTPTGTYVIGYEICTKSGTITCDTATVTIVVTAVTTPTVITATDDVVTVTTT
ESGTVVNVLDNDKIGTNTPTTSDVTITVTSTPTGTIVPNLDPSTGNVTVPSGTPTGTYVI
GYRICTKSGTITCDTATVTIVVTAVTTPTVITATDDPVTVTTTQSGTVVNVLDNDRLGTK
TPTTSDVTITVTSTPTGTIVPNLDPSTGNVTVPSGTPTGTYVIGYRICTKSGTITCATAT
VVITVTEVVTPTVLIATDDPVTVTTTQSGTVVNVLDNDRLGTNTPTTSDVTITVTSTPTG
AIVPNLDPVTGNVMVPSGTPTGTYTIGYNICTKSGTIMCDTATVTVIVTAVTTPTVITAT
DDPVTVTTTQSGTVVNVLDNDKIGTNTPTTSEVTITVTSTPTGAIVPNLDPVTGNVMVPS
GTPTGTYTIGYSICTKSGTITCDTATVTVIVTAVTTPTVITATDDPVTVTTTQSGTVVNV
LDNDRLGTKTPTTSDVTITVTSTPTGTIVPNLDPSTGNVTVPSGTPTGTYVIGYEICTKS
GTITCDTATVTIVVTEVTTPTTPVVAKDDVEQTVVDTPVTVKVVSNDEHVPTQGTLTIVT
QPKNGTVVINDNGTTNAPSDDEVVYTPNRGYAGVDSFEYELCDTMGNCSIAKVTITVLDE
VIPYNAISVNGDGLNDYFHIQGIERYPNNTVRIYNRWGVKVFETKGYDNVNRVFRAISNG
RVTIEAPEKLPQGTYYYIIEYTDNNNKKHTKGSWLYIKK
>OBAHECAF_00565 hypothetical protein
MKRLIGICFFFLSIGMSAQQFTIVGEIYDKETQKPVEAATVFVRTVKDSILVNYTISDAK
GKFTLKGKSSDDFLNLIISHVGNATFKKRIETPKPRLDLGKIELEAKAFELESVTVTSEA
IPITVKKDTLEFNADAFKLRPDATVEELLKNLPGVEVDASGNITVNGVAVNELLVNGKPF
FNDVKTATRNLTKDIVKKIQVSDTKTKEQKFTRQESTSDNKSINIVLKEDKNKGVFGRVT
AGYGTKDRYEFSGIGNYFKDKTRVSVLASSNNINSAGFEFDEIYGMMSRGFRGTRTISMS
GSSFSINGVSFGGSSEGLNVSHSAGMNYADTYAKNMEVDANYLFTHSDNENHTKSLRETT
LPNRHYFSDREHWGNSWNDNHSVRASLEYKLDSLTQIEVSPNLGINNAHSGSRSVEQSLN
SNRTLVNSSESTNQAQTNNVNFNNYVSLRRRFKGRGFWGIGFENSNSRSERFQQIDNRTE
VFGANPSVQVRDQQQEANNTSDQYRLRTSFRYPIAKTFFVRGEYVFSKTNIKNDVDTYDA
NQSGNYVNFNTALSSDFITQNTQQRPSVGLEWNNDKFWWNGEIKLVSNRIENQDFLRDLD
LDRTFTNLSAETSFRYKFEQGKNMSIRYDSNIHVPSVSQLQPIDNVNDPLHTFTGNPDLR
PTFEHSIRADFSNYNWETRTGYFLWLNAHLSEDKITSITLTNDDLTRRTTYTNIDGDYSL
MFGIDYNKSNKWDKNKLKYGFGTFSSVRKNNQFSNGTRYALTNYSISLRTSLGYDYDEKI
NMELTYNPVFNMARYNSDIFENQNYTQHRTGLRITSYVPKNMVIGSDFSYSYLPYMGEGF
RKGYLYWNASVGYKFLEDKATIQLKAFDILNQTVDSSRIITEDYVQDSQRLMLKQYFMLT
FTYKLNKVGGNKGKGSRVILF
>OBAHECAF_00566 3-phosphoshikimate 1-carboxyvinyltransferase
MIKKLNKTHLKSGKTIFISGSKSETNRLLLLQALFPQLEIVNMSNSDDSQVMIAALEKGN
GTIDIHHAGTAMRFLTAFFASQEGKEVVLTGSSRMKERPIHILVEALQSLGAEITYLESE
GFPPLKIVGRKLCNNEVSIPSEVSSQYISALMLIAPSLDKGLIIRLLGKSTSLPYIKMTL
QLLDEIGVTTSFDGTTIVIHPLQLTVNKTLVVESDWSSASYWYSFIALSDIETSIHLRSY
KQSSLQGDSILSEIYSFFGVETIFLGNEICLQKKHTPKQSHFSCDLRNTPDIAQTIAITC
FGLGLSCDLTGLHTLKIKETDRLQALKTELTKLGGVVKVTAESLHLNRCKEIRSNIAIDT
YDDHRMAMAFAPLCLKSNITINNSEVVSKSYPDFWSDVESIMGH
>OBAHECAF_00567 General stress protein CTC
MKSITIKGSQRESVGKAATKALRNAGQVPCVLYGGDNVLHFAAPDLAFKSIVYTPNVYTA
TIELEGKTYSAILQDIQFDPVTDKILHIDFYQLHENKEITIEVPIQITGTSPGVMAGGVL
RVVNRKLKVKALPSKLPDFVNVDISGMEMGQKFYVTKLQQDDYKVMHPDNTVVCQVRISR
AAMKAAQEAAKAEKGGKKK
>OBAHECAF_00568 Ribose-phosphate pyrophosphokinase
MAYIVPESKIFACTQSVELAKKIAEKYGTHLGEVNISRFSDGEFQPSFEESVRGTRVFII
GSTNPSSENLMEMLLMLDAAKRASARHITAVMPYFGWARQDRKDKPRVPIAAKLVANLLE
SAGATRIITMDLHADQIQGFFERPVDHLYASTIFLPHLQSLGLENLCMASPDMGGSKRAY
AYSKYLNSDVVICYKQRKKANVIETMELIGEVKGKNVILVDDMVDTAGTLVKAAEIMKER
GAISVRAVATHGLLSGGAYERIEKSELEELIITDSIPLKQESPKIKVLSCADLFAEVMHR
VHENNSISSKFIM
>OBAHECAF_00570 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MILKEIKGVAPVLGLNCFVAENATITGDVVLGNQCTVWYNAVIRGDVNTIRFGDKVNVQD
GAVIHATYQKYATTIGNNVSIGHNAIVHGCTIHDNVLIGMGSVVMDGCVIESNSIIAAGA
VVTEHTHVESGSIYAGVPARKIKTLSNEQKEGIQRTADNYVKYASWIEDV
>OBAHECAF_00571 L-fucose-proton symporter
MSTKQNYKKAFIFVTALFFLWGFLTVLIDSLIPRLRDVFTLNYFQAGLVQFAFFTAYLLL
SIPAGIILSKIGYKRGIILGLLTMATGCFLFYPAASERILGVFLLAVFILASGITFLQVA
ANPYVSILGDESGASSRLNLSQAFNSLGTTIAPIIGAVFILSDRVKTEEEIAVLSSVEKE
AYYLTEAASVQTPFIWIASCIIILATVFAFVKLPEVISLDAKRHSYGELFKKRGLMLGAI
GIFLYVGAEVAIGSYLVNYFIDINIVRDILENSTMRSLVSGMGGLLGKADLIHGDPKSIV
GIFVMFYWGGAMIGRFIGAYLTQKIAPSKVLIAFSLIAILLILVSINTDGLLSMWSILAV
GLFNSIMFPTIFTLASEGLSDLRPQASGILCTMIFGGAIIPPVIGFFTDNIGFRMAFLTL
VVCYGYILFFGYYKRYHVE
>OBAHECAF_00572 Deoxyhypusine synthase-like protein
MNKGPISQFIEKNFLHFNAAALVDAAKGYETHLLEGGKMLVSLAGAMSTAELGISLAEMI
RQGKVDIISCTGANLEEDVMNLVAHSHYKRVPNYRDLTPQDEWDLLENHYNRVTDTCIPE
EEAFRRLQKHLEEVWHKAEKNGERYFPHEFLYQVVNSGVLEQYYEIDPKNSWIIAAAERN
LPIVCPGWEDSTTGNIFASNVIKGNLKASTVKSGIEYMVYLTEWYRANSGGKGVGFFQIG
GGIAGDFPICVVPMMYQDLEWTDVPFWAYFCQISDSTTSYGSYSGAVPNEKITWGKLDIN
TPKFIVESDATIVAPLIFAYILGQ
>OBAHECAF_00573 hypothetical protein
MKYKHLTLEQRYEIKAYLKCNKSQKFIAQQMGVSESTISRELKRNKLKRGGYNPQNAQEQ
ANIRKERFAVNRKFTPKVAAFVEEKIRREQWSPQQIVGYCKKHEISMVSTEKIYQYIRED
KEKGGDLYQYLRHQLKHRKRPVSGKKEVIKNRKPIRLRPEIVLTNEEFGHFEVDLIVGAE
HKGAILTIVERKTKFLIMRKLSGKNAKSLAKAMIYALLPYKDYVKTITSDNGLEFSEHEY
ISKKLSCDFYFANPYCSWERGLSENTNKLVRQYIPKGTYFEKISKEKIKEIQHKINRRPR
LTLDFEEPKNLFYKFVA
>OBAHECAF_00574 CRISPR-associated endoribonuclease Cas2
MNSERFNAYRIMWVMVLYDLPTETKAMQKAANLFRKRLEDDGFSLFQFSIYLRHCPSREN
AEVHKKRVKMMLPKYGKVAVMTITDKQFGDMEIFHSKVREDPPPTYQQLELF
>OBAHECAF_00575 Putative defective protein IntQ
MSNFKYQNSRSHIVGFKPAELRIGTDWLIVFYAQNPHTGKLQRFRNRVPKHSNKKERQKF
AQKMVETINEKLYSGWSPFLEISDKNELKTIVYCLDFFLKNLEKEEKDGAKRPATVSNWK
VFIILFKKYLSENQKNITFISQIDIRICSHFLDCIYLQKNNSSRTHNTRLKQLKALFNFF
ISKGFLSDNPVKNIKLKTTTEKKRVVLNEKEKQRLQQLKTDDFHFFVFCMTTYYCFIRPA
ELQQLKVSDVDLQNGFIAVSAEISKNRKTENVTIPNVFLEDLKKHIGIAKKDYFLFGDKF
APNKKKHKQINYHWNKVKQKYNFRKEVQFYSLKDTGITDLLNSGIPAVKVQTQARHSDLK
ITENYISRNKFADEMIKNADFRTSNL
>OBAHECAF_00576 hypothetical protein
MATKKEGLKANGKLKKGYKFKKGGTIVKAKSATKKKGSVKAGKR
>OBAHECAF_00577 hypothetical protein
MNREQLEQRKQAIQQRIREIQTELQPTIYRQSVFGILGAVAVGVWAWKTKQKWYIKGAAI
LGGNMCANVISNLFISSKKYNVSAEIRQLQTELNDIERKLMSVNLREAIANDYKLSGK
>OBAHECAF_00578 hypothetical protein
MTSIELFNGLNGKEVSRNYLEEILQQAKAENQTAIVYRLSKVLNDNPKYKRFEMTIQSYP
HAKGLAGIQHTGDYREALDDCGRLRKGWKFVKGNVVKVEKKEKKEVSKPKKQEAKTEKNE
CKTCDKKYKFLIYKTQTSNKYTLAFSYADLADKNKSVFDFRKTHKGQGYNEFFVINNAIL
LEKYKKGTDYLILSKSDFDKKEFYKHLEKQEIKNTENQEETFIKYVLPLYEERKANPDKK
LSVKESKDSFFVESKEFWKVFKNIQTDYVKTQHLRGIIKILPKGFEMLKKNCKTCEIVDK
LQTKLIFSKMNGRGKESSLKNRLNDLFGKEITLEALFLEFENYSATKYELGDVGKERKVF
YNGLEFSFWWQNESLDIQISQSFADYIFTHIEDKDKALFETIKKIIDKERKKKTAKPVKK
SQDKKQNSVEKSSNDLILADNQPTKLNILLSSTEKENQSAKDIQNIFDKKLSKMLRLRSG
FINTNEFDFKAPKTSKKGIESFEKIVIKDELRPALTGVLIEKEVYVGTDTHKLLVIERTK
NDGLKTGKIYDVNARYINYLNVFKNIDDALSEKEWNDERYIDAVFPNYETVFPKQYRWKT
PFVDIEPILNHAYKAYYLLKFDVQKEDSYTIPFRIGKLDIYISALKLFESLQCLYVNGTK
QVSFECVAYNKPITIKSKENKNVALLMPVIVEKKSDLNVNQVQISATENKDFKESQGLAA
PCLSGLAAPTAQNSETIAFNKEILKAKREGFNTDKVLKLGKAKGELKKIVGDKEMRISQA
TIKKAMTKDDSHIITWENLINLPDYLNNPLAIFKSKTAGFVVLTEIINAKNKPVIAPLHI
VKKGNYIEVKSLYSRKNDSTYQNWVKEDLLLYINKKSDLAFKTMGTIPNLDSKSQDKNTK
KSVSNKKTAENFGLGLPQEPMSSESVGPQVFVEESPLTPEGETYQPEPVNPLPAVAHHRK
GSLAEQLANASTQTESYQIDRVDMAQFLGDMEIKNTDSLVITLTGGQGSGKTRFAFQFMN
DLAQRYKVGHISIEEHPKSRLYIEKVHQYLNPTALNNIEAHDVRSLSEIDKVIRENEVIV
IDSFQKIKEIDSKFEVDKDLRKKYNGKLFLVIFQQTTDGKMRGGSKSQFDGDIILFTEKF
ANYQENYVYPDKNRYNPIPADHLRYNIFQQRLLPIETEEQTTENIVYDVIY
>OBAHECAF_00579 Lysozyme RrrD
MKTSQQGIDLIKKWEGFRSAPYLDAAKVPTIGYGTTFYPNGKKVSMSDKPITEQEAEAYL
RAVIAQFEQVVNRLVSSKINQNQFDALVSFVYNVGSGNFQKSTLLKLINENPNHPDIGNW
FLKYNKASGRELKGLTNRRNDEASLYGVKKKPLP
>OBAHECAF_00580 hypothetical protein
MKNNYIKAILSQTLRLGLTYSSEELEDRFRDIDLPVMNPQHPSLESEVQPIRQSGSGSPR
GERYRDSDSSSVRFYGEGSGREGTRGRYYKDENSTSTNNTRSSGTSTRSYGVVENKNPTD
NQSRTPDASVYVNPNPAPREVPTRSENIRRDIERDVFVYREDLKDADIQKGEIPKDVPIY
KRTPTERREEKPKRNFTSLYLNSRAGNKPAKNEWLTPTNMMIGGMLLLLGVYWIKK
>OBAHECAF_00581 hypothetical protein
MNSLIKNSTKNLIRDANGNIVEKKGRAFEPIPFDGRGGPLAEEMRKKAKEKGPYVLDVNR
MNQMINETGNLKTTTSTPSVVAPPPGVVAPPPSVVAPPPGVNTPSHTKKEFFTTENILIG
VGILFVIFLMKK
>OBAHECAF_00582 Zinc D-Ala-D-Ala carboxypeptidase
MQLTQNFTKSEFDSKDGAVMPQEVLKNIKELARNLQVLRDVLGKRITINSGYRSPAYNAQ
IRGAASNSQHMYGRAADIVVQGIAPEKVAQTIETLIAQGKMKQGGLAVYDSFVHYDIRGQ
KARWDYRVKKK
>OBAHECAF_00583 hypothetical protein
MKIKRKHIVIGGLTVLAISLMSFAGAKKAQASQVFEKIVFKIVGIRNVDLNWSRLKFHFD
LMLMNPTANDFSLSSAGAIRGKAYRVYRGNQLLVSGTLNNISNVNLPAGGSQVFKDILVE
IPIATVGQELLNMVGGFQGLTNLDNIKNINYMQFFQSLRYEVDIEGFGSIFTFKDNVKV
>OBAHECAF_00584 hypothetical protein
MKKFLFENRFLLFLLLAVWIIGLSSCKSTKQTLQKTEKQIVTTNDTIYIVKNQRVTDTIF
MSVPEPKTNDKKCDSLCQNEVQRLLKQLNTKKKSGNNEYGFYYDAYKNALVAYALLDSTF
TQYKSKHTDNQITKSETKTIFKTEKYVPFWVEILAWIGAISLIYIGFKIKKWTINN
>OBAHECAF_00585 hypothetical protein
MYQIIIDHILPFLFGAGGSGLVYYFLDKNKRKTEAVEKLQVIYDEFITDVKKQFDELKTE
KDLLKEQNKILKQQNLELKKQNQELKELVDILKKNNKNSHL
>OBAHECAF_00586 hypothetical protein
MVLWLIAFVLIFPLTVVNFCFVWKQKGTPKGYFLSTAVSIDRWANSEFRTLWNSTLIKPQ
AVYRFGDVRETISSVLGKNQERQTLTRTGRILASVLDFLDKNHCEKSIVYYK
>OBAHECAF_00587 hypothetical protein
MITFKTKSTHNVPFGRGVIQTEVYLKISDFRIDENGVVPHGYYYIIQNEQPHQLDKIVPS
ILLWERVEQAETQLSAFTSNSLKNAIYQRATEFAIAKLQQEGTQNYGIDPSDWEIFLSPP
LPRFRSQLSEGEGITEPTILPPAPSEGGDDSQNNGDEPINNEPENEVGDEENV
>OBAHECAF_00588 hypothetical protein
MNAMQFWQWGANGRPTFNFDESEVNQGNIEDYMTIGCYRQLYTFDKIILVNASPSRAYIA
GESIFLTQFTEADFDTINKYAHFYINPYHWGYNKEFLMILSDSYDNDKILYEGPIGGKNL
IVGCVSKNIPINDMYEDVYDSYVDATTFYKATFLHNSFRMRIRIVDLPTNKLLFNYDINV
EFHRN
>OBAHECAF_00589 hypothetical protein
MAILLNDSIKVQGGKPVEDKRLNNGTPWESVEQVNQNILPTDRYISLEVLIGDRIYWYKG
GVADYDLVEKEMPPMMPPINAVIKVTVDTPSSTKDKIGITTAGNYVPQEGDVLSVEFKKG
QTANNVTLNIDNSGEKKIVIGGAIANARTMLVTDHKLGYKKIVRLWYDGENYQLTGSTYN
SAYEVIHTARLEDVQNQQPHLVSGKILAWVRNWANIIGKPDIETVLLKITNNTNTEDLIS
NVPQKGKTIISQGTANIVVTVNSADGFVASYQKAGTGNITFQAGIGKTLVQVDGTNEING
AKGSTATVTVVGNEVLLRVSNV
>OBAHECAF_00590 hypothetical protein
MVGKKVKRNVEASEETVSLVQEYPLFSLTQTDNQKAFNEKVANAIEQMMPLPSYVVPTIV
LANIPTLAEVGASMQLILKATFTQNDAGAIRQQAILKGDTVLAHALTHTDSFTMPNATLS
YTARTSYEQGAVKQNSLGVEVEKGRIPAGSITSTAKHIKGVYPVFFGVIEPTQSIDNVNV
SNLTKSVVDSVGNVSCSFNFVGKRMVIAIPKVATQKTAWFVTELNKGTIGNAGDLFAAPV
EKIISSPELHWNNIAYNIYVSSPTTLKGAMQLRNS
>OBAHECAF_00591 hypothetical protein
MCDRKFKVGVIDEFAPCNCNKKKMSSNSKRVVERSGNIANPMPYVHVFNITQNKGTTTRN
DGTYDLTANPADEIQFSHIGFKTVKMLFRDIPQVLEMTEQIETLSEVTVVAPSTNTGSTT
NVEIKPSNNAKLKRAGGWALGTVLFLGVLLLVTKDNKKKK
>OBAHECAF_00592 hypothetical protein
MKLNWKHILWSAVGIAIVGGAAYFIFRSKDEQPPTTLPTVDPNSEYGKRLEAFRKDTPRK
QRMVDELLVAMKGLGTKFSKIKEILQEIEDENFMRSLIGYFHKKTYRKVVVKPPFYEEVE
LDLIGWFKEELSESEYKELKDMYPNSL
>OBAHECAF_00593 hypothetical protein
MKKQRKKNQLSNPAVATAAASYVAQNPKVVGKAVNIGMIIVGITVVAIGGGAYYYLYWKH
RFRKMKKNSAYAPSSVTPSEAKVKADIIYKALYGKDDFDAVYEAMKGVNHNGYIEIYNAF
GKRTPADSLFSIGNKNDLTLTQYFQTLWDSEKEKLRNLTKIKGLF
>OBAHECAF_00594 hypothetical protein
MKDKYLAELAKLDEKVLEKLASLSKSEKALSYFKNPALYAILKSFLKIK
>OBAHECAF_00595 hypothetical protein
MKTVTDKITAFLSERDIHCVSVSQGDRRLAKTTVPKYSFSLTDIQTLYGSVADFIKAIPE
KGFTENVKISLRSIYGSGAKASSIIHETLTLNFTKKTETATPMPTTEPQNNMLPMTPQQP
TYQPNVPAVPALAAPALGYAHIPQTDWISYEVSKQRLEDLKKDHSRLENELQDAKSEIRQ
LKEENFSLRLKIDTADEKHAVKLERELLNKKGFWESETGGNIVNALGSVLPMVAEKMIGS
GSSTPPALGMPNLSPNKQAFMDVLMNPQITDEQVGIWYQQIFEEN
>OBAHECAF_00596 hypothetical protein
MKGKIFAVRLTSDRTFNFHDETMGRGAMGLSIRNVGETNLIIDDAAQEEIAPGEYFLVEN
NIAIVNTDFRVKFKKDMNKRNDAVMRYIVPMD
>OBAHECAF_00597 hypothetical protein
MTSSIITNKINVAIASGNNVFSEYISLDKGTCVGVYFVPLKANEPEHLVEISVRDPQSNS
LIEPVDFRDFKHKGGGYLDGMKQVGFPTNNNKFLVSINASENLADDFKGQLIFVIQRDCG
CNME
>OBAHECAF_00598 hypothetical protein
MNQYFNNEEQYTRVATFLANQGGRFGLTTEQAMRMKPTPSELYVHSKFSAGGSVPLLNGN
STQEIGVTNFDGNRLDAGRFFIIEAVTVQYGEAADTKKVWEVKYDDKMPEVLEASHLVLR
QNGEVLIKLPISAIQNAKKMETFYRKLGALALIEPTQTVELTIDTPSGSSITTSNGSDKS
FVRVLFKGFETYLKR
>OBAHECAF_00599 hypothetical protein
MKTNKLNSKTIVESVAFSVAAFGGGAVSRVLHDKIPLKDEDGKNTKSMIKRGGIALAGLA
LAALIKGDSTTGKALQGVGAGMAATQINDLVKDLMKPKEGVIKTALGSADTVYIAPSYDY
YPYEDVNPYGAEEKPLFLSGATADLFAAS
>OBAHECAF_00600 hypothetical protein
MESKLAMYQLAAVQPIPTITAGIQPPANPITGVRPPITTTVNNPVTSVGGGKQNWFKRNN
INFNTVAGGLESLLNLAGGTANIINAFKSGQQIDLNGHAASEQEKQMLYQLAMAKQQGGS
NDAMMQMFMQNQQMMMQMFANAGMRGGDVDNNNSNNNSHGGGSKMPLYIGLGVGGLLLVG
VIVAVAMKK
>OBAHECAF_00601 hypothetical protein
MNYVKSSLGSAVNWINTGANVANAGASIIGAIRGGGGSSVNMNENHHHYHERQLTPEEIK
ILQDRYALEEESIRMMMAMQMNQNATSQRLLLKKNSPVPESNDKILYIVGGLLFLGFLFV
GLKKIKN
>OBAHECAF_00602 hypothetical protein
MFDSLHTIRGLGAWDGCDNHRARAEQAEQQYHTLELQIRNYEHTLRLLKNGESQKRYEQL
REQQDALLIEKGQLEVKLKQAKLVLEAWRTSPDVQFNAEGLGGLGNWFKKQWNSLKRDVN
NAITCDRYTERQVEWERKSTPLSNRVAELMTDIKNERAKLSPENMRLQTEAVQKLNEAIS
SLKIELQNVEKQIAEHRQSYIVRKDAEKLALQQEAEEERKKLANKQEENSMDNFATRTTQ
PSGNWQPSGNTRPINNWSQNRGFSLFNRPPAAPQEDNNNTLLFGGLIFVLAGAYIMFGKG
EKVKKTTA
>OBAHECAF_00603 hypothetical protein
MFDTLYTTRGLGSVPCRAEIEESDRMQEAFLEKNNQLKELEKKINNASRGSHLQISKGQY
QSLQENTEYAERKLSRIKQSIEVYKEGAKKYREYILKLENALNISSLGFFEGKNCDRYTK
DIERYKKEIQRIEEEIFHRERDFKRFAGNFVPKEQHDALLEKKNQMEVEHRELEEQVFKP
LVEENRVLSEQYKALKDKLIASGATGSDIDYILKKPLPPEAKQILKEDVANLEYSINQVT
GEAPSGSGGSAKKGGNSTLLIGIGAVLFLGFLIKKRKKK
>OBAHECAF_00604 hypothetical protein
MTRAEINKTLYRPIRAGKQYESVMPFSDCSSTKLGYGDTQFAINNMAKTAKKYKHHTTEL
SKKFFANQPLQRLCNNIHNFLFWHFQYAIDGDDQLLRSPACSWVSRKQGIDCKSYSIFAS
TILLNLGVSHYMRRIKQHSNPHGFTHVYVIVPKDQKNHNLSQGYYFIDGTINSSVEPHFL
EKDDVFVKADSKDGLGVPAVFVQTAKTTAETTIPQKRKAWETFVQSLETMERMNPENADL
KRLKIRVHQLAMQGRTDVRFSMNGFSVVLENERFDLWKKPVAKLGNAERNQVIDNIINDA
YQQSSAYLEQVNASKKAQTVAVVNAVGNASAALVNVIPGIGQIISVALVAVTALVSMAVM
FGYDPCSSRFYRTDYINENLEKKFLPQFKETLNSIEAHFKNGTSVLAADQLNKLLQEVDL
GYAHFMNETKIVTDQCNQAVLLGYTDFVKSIHQVVTTTLNGIKANLDPYFNVAVVEKEAS
VNARSWFFIVPISRNAVRKKFRFLEVESRDKKKGIYPYASEENFDNWLNTNVSEIKFNYG
QAAADNYKREMLPFKEKIKKIRENLNIPVVTRVVLEDKLRKQQYDIYLKYDRKYMEGLVK
KAKDEAVAYALANKSFWEELKKLRQMRFKDETNRVENIRRIAFTDARRDFKTEKKKQENV
LLLGMIGIGTLVLMNEL
>OBAHECAF_00605 hypothetical protein
MEQIAIILFLVGTVLFIGFGVAVGNYHQEDEDFGDLNRLNKVKVSIFTALSLLGLTFILT
SCILGIIDSI
>OBAHECAF_00606 hypothetical protein
MKKCIEYTIVVIIPCLFLFLLGAFANATFDITLWSNEARSIIAIFMFFAVICMIMVYSLI
KKNL
>OBAHECAF_00607 hypothetical protein
MNLKMNTLGFKHKVEIIKKHFKNNSVRYILDKLEYEGYFLCPATNILSYNDIVPFRDDIM
LHETDICEVNRMSDKIEEQPIEFIDFLYNLIKE
>OBAHECAF_00608 hypothetical protein
MLGIMDLSKPLLKDQSEYFIKFLYEFKNEHFRI
>OBAHECAF_00609 Modification methylase HpaII
MKHFDAFAGMGGFTLALKNVFGERYENVGFAEIDKHATACYQHHFKEHKNYGDITTIRPR
DIGQIDIITGGFPCQAFSIAGKRRGFKDIRGTLYFEIVRLCKELQPKYVLLENVKGLLNH
EGGRTFSIIYRILANIGYTVEFQVVNTKWFLPQNRERVYIIGHLATNGGGFRGVFPIGEN
LEKRNANNTEATIKVGTLRTHNDGKGFRQVKSEVCPTIPARARQDGSGQPVILSYTRDSK
GKVIKRNERQICNTLTQATGGGGNTDVFVKQLPRGKNKGNDFEICPTISSNAFQENNFVS
GIRRLTEIECERLQGFPDDWTKYGNYDGVVKEIAKTQRYKMLGNAVSVPVVEEIARRLKN
NFKG
>OBAHECAF_00610 hypothetical protein
MNKLTIISIKDIMRILKCGKHTALKIRKDICEEYAIDFKRITYGHLKRYLKLEE
>OBAHECAF_00611 hypothetical protein
MPTAYCLKPNAKKNMKNEIPLHKMITWCWENGITIYPIPLVPNGSSMKICVNNNGEETIG
KDIYYNKTHKIYDKIKELYVTIYNKNNKI
>OBAHECAF_00612 hypothetical protein
MNDYKYTPEKLYEATDNGLAILHRYLPDSVGCERTKKHFKLRNERTPSATIFKGQECWMV
KDFGSGEAFSPIKIFQRETGISDFHEALKTLYSEFNVSENNTFFQPNKEFTDKGDKPDDY
FFIKVKKKVERPQCFSEFVTAEICERYNVYEVEYYEKVTSEKKVLMRVNATENYPIFCYS
DNLEKWAKTYCPAEKKRTLTKEDGTRETYNFKHGYLGKKPEKYYHGLTAIKQKIKELAQK
QEDVMWSIEDETQGIKETPEDATLIPYIVICSGGSDGLTVASLSDDFMPIWGNSENDIID
YETYEFLKKSCKNLVYLPDVDSSGINFAYDYSKVFWKLPIVFLPKYYLSEKGKDFRDFVS
YFTKKEVDKSVIASEFKKLLSVPVSFEFVMVEDKRYSINHRSLYYFLNAHNYFVHNDSLF
SHLDNEDKGKLVHFEGFKVTVPASKEIRDFCIDYYIRKGTNSKVLRLLETCNALRGADLK
KLPSKEFNFTRHGKDFQLFFFQNMCVKVTADNVLNIKNKDVENFVFEGNIKEHDIRILQE
PFFEHYQDEQGRNRVKILKDDFSFMNFLINGSRVFWKKEADSNKDFRKITLNSSFLSEDD
QIVQEQHFLGKCFAIGYLLHKYNVSDFAKFVYVVDDEEKEGFFEANGGSGKSLMMKGIEY
MVKFFDMESKKDDLLKGNHTFAGLTEEHDLVYFDDMTSQNDFTKLYPLITRGFFINPKGR
DGYFLPFEKSPKLAGTFNYALKNTDQSTLRRILFVSFSSYYHAESQDYKEWQPSDDFHDR
FFEEWNIATWNLFYNFMFRCLQLYLNNRKNPLLSPTGNVTKNNLKAVIGDSFLEWIQDYL
QDEKFNIYITKDEMFDAFKSDMPRSTLTKPSFKKKIVNYCKLKGYEFNPEYVEGFQANGK
RIVRFIYGKTQECFYFTKKQESNQVSSNQNPSVKKEIDTDGIEF
>OBAHECAF_00613 hypothetical protein
MKHLEFYAQKLQKSLEEIKGVSNVLNYNTSTTINFSFWFENYEVFNEIDKQLPKDWYVSF
LQRDKIAVLKYHISEKQHQFLTDEYLMSLNAK
>OBAHECAF_00614 hypothetical protein
MRKVFLFATLVALGSCTTVDTGKEGVLVSWGGETNMNYTLKEGVDWGFHYLYDDVVEYDV
REQTVNYGVSLNDKNDMVTPVELTIYYQPIKGSVNKLHSLVGEDYVDNKLLPFVKSAVGK
IIPQYSAQEINKFKRAEVENKISELLQQEASSIYVNIPRVQFTRVGIPNEVARLAEQTAV
QLGKNELAEKKEAEQVALAKAKVAEAEGEYQAGILKAKTRDLLSQPKMIELQRIENERLM
WEGFKQHGKSPFGENNIFGNSNPTLLLNRK
>OBAHECAF_00615 hypothetical protein
MVYTLIFIVIISIIYIGIARALYIRDMENYISKNRYSREYGKRNFDDECCCLTYVFWIFW
FPIKWISELIIKFLKK
>OBAHECAF_00616 hypothetical protein
METKIKHQGSCYFNKVTKCKILYQVNEDGYEIIQKIYPEIEIGDYITKYRVFDKNLKPKD
NKLSENYSFTFDKKKKNIIGIEKEKCSFYFIQTNETLNLLKVTGYNIFESETIFIIDSRK
RNYTISMKEFKKEYTIIEE
>OBAHECAF_00617 hypothetical protein
MNKTKVTLKEETRQELLNNGVALTQVAALIGKSSETVRNWLKKNTENQIRYDFLLAVCQV
LDMEMSQILEIEEN
>OBAHECAF_00618 hypothetical protein
MNVVENIKRIRLEKSINQELIAEALGVDVSVISNIEKGKRELKVSELDKIANVLREDVLY
LFTYPKRFVDKTSIEDNHDRISITFEVSADKREHLLKLVTGEKRVE
>OBAHECAF_00619 hypothetical protein
MENEFWKSFFSIIVSLKNISIKFTDKEIEIFKTMLYKTKLPLEINLKNDAFPSIIFSFKG
NSFEVKRGANKDTFSITYNNSNTSTTVNNISLELLKMKFVNWTNGIKNCYNIMRDKYVIM
VSDQFYNIYEDAFFLEKMGSVNSGMLYRKSLEFILLDYLKYLNPDINITRKFRTKDIKDE
LCNLDGLSQEKDKVLLDFIDKNFKIGHEFTHYRQQIDADVSELRTNIDILIELISEKVKF
KEKQKQIYNKIGTKK
>OBAHECAF_00620 hypothetical protein
MRKLLLTLLIAGGTLASCTKEIIREVEKPEKPENQLNNGGLNNSGSSGSGNTSGSTSGSS
VNNEPVKQAKIKTYYEAVQIHVEKNFWLYSKWGEGSQSGAISFVLPKNSVALYYAFSTSK
KKQDQVKNLNLLKQIKDFIAKDIYALPIGKMDSFLTVPDTGYLEGIDVYFIDSNQKEDFL
KGNGFMTYTDFNYTNRKKSYREVTGLKAMFFNDPQYNRNFSLGFFNDNQVQGVGVTVEVV
AVVKKEKTVYE
>OBAHECAF_00621 CRISPR-associated endonuclease Cas1
MLYRSIYIGNPAYLKLKDQQMKIVCPETKAEKGSVPVEDLGLLMLDHFQITISHQLIQWL
MGNNVVIISCDAHHLPHGQMLPLHGNAIHSQRIKDQIEASEPLKKQLWKQTIECKIANQA
AVLERLGTYASPMYEYLSQVKSGDISNMEGIAAQHYWKYLIHPDFLRERYGDSPNQFFNF
GYSVLRSIVARAIVETGLLPVLGIFHKNKYNAYCLADDLMEPYRPFVDLLVIRWLEKNPE
AEELTKEAKAYFLQIATKNKKTKYSNILLLIISKL
>OBAHECAF_00622 CRISPR-associated endonuclease Cas9
MKHILGLDLGTNSIGWAYVKEAENDTETSEIVDLGVRVNPLTTDEKTNFEKGKPISTNAD
RTLKRSARRNLQRYKLRRKELIELLKEHQLISENTILTENGKGTTFQTLELRAKSAKEKI
SLEELARVFLTINKKRGYKSSRKAKNEDEGQLIDGMEIAKRLYEENLTTGQLSLQLLKEG
KKSLPDYYRSDLQFELDKVWNFQKQFHSHILTDEFYAQLKGKGQRATSALFLAKYQIYTA
ENKGSREDKKLQAYQWRVDALSKELTREQLAFVITEINNNLNNSSGYLGAISDRSKELYF
NNETVGEYLWKQIAANPHTSLKNQVFYRQDYLDEFEQIWNTQAQFYPQILTDELKKELRD
VVIFYQRKLKSQKSLVSFCEFENKEIEIKKEDGTSTKKVIGLKVAPKSSPLFQEFKIWQN
LNNVLIRKKGSKTKKVAKNQQAVLFEEEKTISELDLEAKQALFNELNLKGNLKADYCLEI
LGYSPKEWEMNYSVLEGNRTNKALYEAYLKINDLEGYDAKNHLKVKLNKDEVELDDLKVP
ASEIKDMVQAIFKEAGINRDILHFNAELDGKDFENQASYQLWHLLYSYEGDDSKSGNELL
YKLLETKFGFKKEYAQILANVSLSDDYGSLSTKAMRKIHPYIKENKFSTACELAGYRHSK
HSLTKEENDNRVLKDSLEVLKKNSLRQPVVEKILNQMINLVNALLKKYRTENPNFKFDEI
RIELARELKKNAEERANMTANINKAKTEHEKIIKILKNEFGLPNPTRNDIIRYRLYEELK
ANGYKDLYTNIKIPQEKLFTKEIDIEHIMPKSRIFDDSFSNKTLSFRKTNLDKGERTAFD
YMESKFGADKLEEYVARVEDLYKNNIISKAKYQKLLKKESEIGDGFVERDLRETQYIAKK
AKEILLQITPNVLSTSGGITDRLREDWDLINVMKELNLPKYRALGLTEMEDRKYGQQVEV
IIDWTKRNDHRHHAMDALTVAFTKHNHIQYLNYLNARKNEKHKEHSNIMGIQQLETIKVT
DKNGNEKRVFKAPMPNFRQVTKAFLENILISHKAKNKVVTKNKNKVAGSNKVQEVLTPRG
QLHKETVYGKYQYYVQKEEKIGGKFDLETIKKVANPLYQSLLKKRLEENGGDPKKAFTGK
YSLAKNPIYLDDAQTEQLPEKVKLVWLENSFSIRKDITPENFKDEKLIDKILDEGVKRIL
KERLQSFGNDAKKAFSDLDKNPIWLNKEKGITIKRVTISGVANAEPLHTKKDHLGKEILD
KEGKPIPVDFISTGSNHHVAVYRDEKGNLQEKVVSVFEAVVRANQGLPIIDKTYNQHLGW
EFLFTMKQNEMFVFPNESTGFNPNDIDLLDPKNKRIISPNLFRVQTISVVKYGNAIVRDF
KFRHHLETTVEDKKELQGKTYQQIKSLSPLNDIIKVRINHLGDIVSVGEY
>OBAHECAF_00623 3-oxoacyl-[acyl-carrier-protein] synthase 2
MNISIVGMGSISALGNSFTEVCLSYQNPTSLLKPYGEVTMGKLSESSLTAVNNLQLSSPA
YTNLDDTVLFAIISARQAVKQSDWRDGNFGVNIGSSRGATTLFEKHHSYFIENKACETLA
SPTTTLGNIASWVGQDLGSIGFEMSHSITCSTSLHAVVNGIAWLQSGMEQRFLVGGSEAP
LTPFTIAQAKALKIYSSLTDDFPCRAMDVHKKLNTMVLGEGASVFCLENGLKDNRLAGIT
GFGFASEKLTHNVSLSANGECLQKSMLMALRNTDVCDIDVIITHTPGTIKGDLAEITAIR
EVFKESVPFMTNNKWKIGHTFGASGALSLEMAICMLQKQEVYSVPYVEKQKKPEKIEKIL
INAVGFGGNAVSILVEK
>OBAHECAF_00624 hypothetical protein
MYICNLVQTVFFMIRNIFVLLLTILPIYIYSQTQVSGKVIDDQGKPLPFANIIFVNSTKG
VVSDASGKFSLYSEKNHNYIEVSSLGFTSKKIRLQHKITKNLIVELTEGEELEEVVVVGK
PTKSLSKKENPAYTVLQGIWKNKSKKGLKNSQAYEYKKHSVSELGINQLDTIFLKKVLGN
DYAEFEQTLMERKNRGFFSMPIYIKENVQKVYGNNQINKQRVDTEAERSQGVAQNGYGLE
RITKAFDEFDIYENSYLILNRPFVSPLSEYGYGTYHYVLKDTLVEENRNFYRIYFFPKID
ADLALEGNFIVDTKTFIIKSIEMKTTPKTNLNMVRGLFFEKHFTIENDSIYYLEKEIQEA
DFTILSKDIEEKGLYIRNTIGYSDVVLNQPKATLFYEQKIVQKYRDQFVKGDTYWQQATV
KSANISKTTRLIKEVADNPKVKLITTLADIIGTGYVSLNSIPLGKGLQFGTYWQVYESND
VEKHRFRLGFRTFNSIEDRFRSYFYGAYGIGDKRFKYGLSAKYLLSEEPRVTFGGAYQDD
YLQLGNYLIHDDGNFTFRRGSNAIINRGENYFLTRNQKTSAAITYVPLKNIEVSVFGVYQ
HSQSADPEHFFIAFRDLKNNQTYTNYTDFNTGLNIKFTPGRNVFGYGVEQRYGEKIHDTY
VLKYTKGASGALGSQFDYDKVQVLIKKPITVWNLGMLNTTFEAGKIFGTVPLTILTPTPA
NQAYSIIPQSFALLDYYDFINDTYLNGYFEHHFNGFILNKIPLVDKTKLRSLLFARFAYG
TISQQNRDAHQTNLIYNTPEKLYWEYGFGIENIGFGNIRPFRLDFIWRGDFNDVNGTRNP
KFGIRFSVMPNF
>OBAHECAF_00625 N-acetylhexosamine 1-kinase
MKNTAERIAPLFDFKGDIISVEPFGNGHINYTFLVKTTEQEYVLQGINTNVFKKPHAIIK
NIELLWETVADNTIILNMLPVKTGGFSVEADNALWRAVPFAKNYVAYEFVKEAWQAEKAA
SAYATFIKTFEKIDTSRLEDTIPDFHNGMKRFQQLEDAFAQAKSERIEKAQHLYDFAKSH
KVIFDEVQKAVDEKRIPIRVTHNDTKINNVLIHKDNPNDFKVIDLDTVMQGILLYDFGDM
VRTSVSPTNENEPDDSKIVFNETFFEAICKGFSVMKDVMTETEKRMVLDGAKYMIFIIGV
RFLTDYFNNDIYFKTSFPEENFVRARNQFVLLQRLEDKEPALRAVVDKWFK
>OBAHECAF_00626 Bifunctional protein GlmU
MNTTLVILAAGLGSRFGSDKQLEEIHNGNALFDYGIYDAIEAGFSDVVLIIRTQIEELTK
KHLENRFKGLPVSFVYQDLQNPEGIVRQKPWGTGHAMLCVKDVVKNPFLIMNADDYYGKD
AFSYMVKALKSGKEKTFYSAGYLLKNTLSENGTVSRGVCNVNENNHLQSIVEATKLRKID
ENMAIDEETGEKYPLGTFVSMNFWGFTPEIFPMAQKLFAEFVEANKENPKAEFFIPLVVQ
HAIEKEGYTLEVLPNNDAWFGMTYREDLLKVREEIKNLTVAGGYPENF
>OBAHECAF_00627 PhoH-like protein
MHNVSRLEKFEFNSLIKKTSYILNELVLELTDIHPQQFFGEDEVNIKKIKSCFPKLKIVA
RGNKILAFGEENLLKDFAKKIELLQAYFSKYNRLDERSIDSICNADDTEPIETINQKETD
VIVHGVGGKVIRPQTKNQFKLVELMKKNDMVFAVGPAGTGKTYVGVALAVKALKEKQVKR
IILTRPAVEAGENLGFLPGDLKEKLDPYMQPLYDALRDMIPYEKLSGFIESGVIEIAPLA
FMRGRTLDNAFVILDEAQNTTHAQMKMFLTRMGRNAKFMITGDPGQIDLPRKVSSGLKEA
LLILKNVKGIGMLHLDDKDVVRHPLVRNIIEAYKSIENIE
>OBAHECAF_00628 hypothetical protein
MEKNKKHIYLMPGMAASPKIFEFLEFPSNYETHLLDWILPIEEESLSEYAFRLAQQITHP
KPTLLGVSFGGIIVQEIAKIIDYEKIIVVSSVKTKYELPKKMLLARYTNLHKLLPVGLVN
SLEYWKQFSFIDSITKRIELYEKYIGMRSISYLDWSIDKIVNWEQTEPLPNTIHIHGDKD
AVFPMKYISDAIVVKNGTHIMVINRYKWFNENFSNLL
>OBAHECAF_00629 hypothetical protein
MIEIIDSEFSRQFQTKVNNETAFIEYSVQDIKIFLTRIYIPENAEATFFDDFMKKVLENI
AERRLKVVPTCSKAVSFFRKNKEYQGMLSVGIRV
>OBAHECAF_00630 Dodecaprenyl-phosphate galacturonate synthase
MNQTPNISIVIPLLNEQESLPELHQWIRRTMISYEFSYEILFIDDGSTDHSWQIIKDIKS
QDSCVVGIRFLKNYGKSQALNIGFKKAKGDVVITMDADLQDSPDEIPELYQMIKVDGFDL
VSGWKKKRYDSKLTKNLPSKLFNWAARKTSGLKLHDFNCGLKAYRNEVVKNIDVNGEMHR
YIPVLAKNAGFKKITEKVVIHQARKYGQTKFGMNRFINGFLDLITISFISHFGKRPMHFF
GALGVLMFFIGFLFAFYLGVDKLFINPSNRLIANRPEFYMALTTMIIGTQFFVAGFLGEI
ILRNKRKEKRYKVKERI
>OBAHECAF_00631 50S ribosomal protein L17
MRHGNKINHLGRKTAHREAMLANMACSLIEHKRINTTLAKAKALKLFVEPLVTKSKEDTT
HNRRIAFSRLRNKYAVTELFKEVSVKVGDRPGGYTRIIKLGNRLGDNAEMALIEFVDYNT
TYNVEKSAAKKKSTRRSRKKAETTSASETETTATEE
>OBAHECAF_00632 DNA-directed RNA polymerase subunit alpha
MALFNFQKPDKVIMIESSDFEGRFEFRPLEPGYGLTIGNALRRVMYSSLEGFAITSVKFD
KVGHEFSTISGVVEDVTEIILNLKQVRFKRQIEDIENETVTIAVSGKKQLTAGDFQKYLS
GFQVLNTDLVICNMESSVTFNMEITIEKGRGYVPAEEHLNQNTAVGVIMTDAIFTPIKNV
KYSVENYRVEQKTDYEKLVFEIKTDGSIHPKQALTEAAKTLIHHFMLFSDERITLESDEI
AQTESYDEESLHMRQLLKTKLVDMDLSVRALNCLKAAEVETLGDLVSFNKVDLMKFRNFG
KKSLTELDELVANKNLTFGMDLSKYKLDKD
>OBAHECAF_00633 30S ribosomal protein S4
MARYTGPKTKIARKFGEAIFGDDKSFEKKNYPPGQHGIARRRAKRSEYAIQLQEKQKAKY
TYGILEKQFRNLYEKAKRSKHVTGEVLLQLCESRLDNVVYRMGIAPTRSAARQLVSHRHI
TVNGDIVNIPSYSLRPGDVVGVREKSKSLSVIENSLSASSAVYEWITWNTEKLEGTFVAV
PQRIQIPENIKEQLIVELYSK
>OBAHECAF_00634 30S ribosomal protein S11
MAKSNAKNAKVSKKRKVVVESVGEAHVSATFNNVIISLTNKKGDVIAWSSAGKMGFRGSK
KNTPYAAQVAAEDASKVAFDAGLKKVKVYVKGPGNGRESAIRTIHNAGIEVTEIIDVTPL
PHNGCRPPKRRRV
>OBAHECAF_00635 30S ribosomal protein S13
MARIAGIDLPKNKRGVIGLTYIFGIGKSRAKEILEKAQVNEDKKVNEWNDDEISNIREVV
ASYKIEGELRSEIQLNIKRLMDIGCYRGIRHRIGLPLRGQKTKNNSRTRKGKRKTVANKK
KATK
>OBAHECAF_00636 Translation initiation factor IF-1
MAKQAAIEQDGTIVEALSNAMFRVELDNGHVVIAHISGKMRMHYIKLLPGDKVKLEMSPY
DLTKARITYRY
>OBAHECAF_00637 Protein translocase subunit SecY
MYRIIMKFIENLTNIWKIEELKNRIILTLGILLVYRFGAHIVLPGVDSAQLHELATRTSG
GGLLDILNAFTGGAFANASVFALGIMPYISASIVVQLMGIAIPYLQKLQKEGESGRRKIN
QITRWLTIAICVVQAPVYLYGIGQLGVPDSAFILGKGLDFMIPAVLILVTGTVFAMWLGE
KITDKGIGNGISLLIMVGIIARLPQAFAAEFDARVAQSNGGLMMILIEIIIWFVIILLCI
YLIKATRQIPVQYARRTADGGTVAEKNIFGARQYIPLKLNASGVMPIIFAQALMFIPAAV
AGLSKSETALSVQQAFSNMFGFWYNLLFATMIILFTYFYTAITVPTNKMADDLKRSGGFI
PGIRPGKETGDYLDKIMSLITLPGSIFLALIAIFPALLKVIGMQDSWALFYGGTSLLILV
GVAIDTVQQVNSYLLNRHYDGLMKTGKNRKA
>OBAHECAF_00638 50S ribosomal protein L15
MNLSNLQPAEGSIHREGKRVGRGQGSGKGGTATRGHKGAKSRSGYSKKIGFEGGQMPLQR
RVPKFGFKNINRKEYVGINLGQLQDLVDSGKITDTVNMETLVQLHIVKKSDLVKILGGGE
LKAKLKISVHKFTASAKSAVEAVGGEAVTL
>OBAHECAF_00639 50S ribosomal protein L30
MAKVIVTQVKSSIKRPKDQKLTLEALGLGKIGKAVEHEATPSILGMINKVKHLISVEEVK
>OBAHECAF_00640 30S ribosomal protein S5
MYQKYKNVEYVKPSGLELKDHLVGVQRVTKVTKGGRAFGFSAIVVVGDENGVVGHGLGKS
KEVAEAIAKAVEDAKKNLVRIPLNGTTLPHEQKGKYGGARVYLQPATEGTGVIAGGAVRA
VLEAVGVHNVLSKSQGSSNPHNVVKATFDALLQLRSAKTIAAQRGISLEKLFKG
>OBAHECAF_00641 50S ribosomal protein L18
MALSKLERRQRIKSRIRKVVSGTAEQPRLAVFRSNNEIYAQIVDDTKGTTLVAASSRDKE
ISAAKATKTEKAALVGKAIAEKALKQGIEKIAFDRGGYLYHGRVKSLAEGAREGGLKF
>OBAHECAF_00642 50S ribosomal protein L6
MSRIGKAPIKIPAGVTVTINGAVVTVKGKLGELTQEVKDIAVKQEDGQLVLEKTAETKDQ
NAKHGLYRALLNNMVVGVSEGFTKELELVGVGYRASNQGQKLDLALGFSHNIILELPQEV
KLETVNEKGKNPIIKLTSHDKQLVGQVAAKIRSFRKPEPYKGKGVKFVGEVLRRKAGKSA
>OBAHECAF_00643 30S ribosomal protein S8
MYTDPIADYLTRIRNANNARHRVVEIPASNLKKEITKILFDQGYILSYKFEDDTVQGTIK
IALKYDKVTKEPVIKHIERASRPGLRKYAGADNLPRVLNGLGIAVISTSQGVMTGKKAKE
LNIGGEVICYVY
>OBAHECAF_00644 Alternate 30S ribosomal protein S14
MAKESMKAREVKRQKLVAKYAAKRQALKEAGDYDALQKLPKNASPVRLHNRCKLTGRPKG
YMRTFGISRVLFREMANKGLIPGVKKASW
>OBAHECAF_00645 50S ribosomal protein L5
MAYVPRLKQEYKERIIAALKEEFGYKNVMQVPKLEKIVVSRGVGSAVADKKQIDYAVDEL
TKITGQKAVATYSKKDVASFKLRKGMAIGARVTLRGERMYEFLDRLITAALPRVRDFQGI
SATGFDGRGNYNLGVTEQIIFPEIDIDKINKIAGMDITFVTSANTDKEAKSLLSELGLPF
KKN
>OBAHECAF_00646 50S ribosomal protein L24
MKLKIKTGDTVRVMAGDHKGSEGKVLRVDREKNKAIVEGVNLVSKHTKPNAQNPQGGIVK
KEAFIHISNLALIDAKTKQPTRVGFEVRDGKKVRISKKSNEVI
>OBAHECAF_00647 50S ribosomal protein L14
MVQQESRLKVADNTGAKEVLTIRVLGGTKRRYASVGDKIVVTVKEATPNGNVKKGQVSTA
VVVRTKKEVRRADGSYIRFDENACVLLNAAGEMRGTRVFGPVARELRDKQFMKIVSLAPE
VL
>OBAHECAF_00648 30S ribosomal protein S17
MEKRNLRKERIGVVSSNKMEKTIVVSEVKRVKHPMYGKFVLRTKKYVAHDEKNECNIGDT
VKIMETRPLSKTKCWRLVEIIERAK
>OBAHECAF_00649 50S ribosomal protein L29
MKQSEIKKLTIAELQEKLGEYKKSYADLKMAHAIQPIEKPIQLRQVRRTVARLACELTKR
ELQ
>OBAHECAF_00650 50S ribosomal protein L16
MLQPKRTKYRRVQKGRMKGVSHRGTLLSNGTFGIKSLDSAFITSRQIESARIAATRFMKR
EGQLWIKIFPDKPITKKPLEVRMGKGKGAVEYWAAVVKPGRIMFEVGGVPLSVAKEALRL
AAQKLPVRTKFVVARDYQD
>OBAHECAF_00651 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWESNWYGGNDYGDKLAEDDKIRKYVQTRLSKASVSRVIIERTL
KLVTVTITTARPGIIIGKGGQEVDKLKEELKKITGGKDIQINIFEIKRPELDANLVAAGI
ARQIEGRVSYRRAIKMAIAAAMRMNAEGIKVMISGRLNGAEMARSESYKEGRIPLSTFRA
DIDYALDEAHTTYGRMGIKVWIMKGEVYGKRELSPLVGMTKKTTGGTGKSTTEKPSGAPK
KARRKK
>OBAHECAF_00652 50S ribosomal protein L22
MGVRKREKAIQIKEAKKSLAFAKLNNCPTSPRKMRLVADIIRGQQVDKALAILKFNQKEA
ASRLEKLLLSAIANWQAKNEDADLEDAGLFVQEVRVDGGTMLKRLRTAPQGRANRIRKRS
NHVTIVLGAKNYNTES
>OBAHECAF_00653 30S ribosomal protein S19
MARSLKKGPYVHYSLEKKIQQNIESGKKTVIKTWSRASMITPDFVGQTIAVHNGRQFVPV
YVTENMVGHKLGEFSPTRSFRGHAGAKNKGKK
>OBAHECAF_00654 50S ribosomal protein L2
MSVRKLKPITPGQRFRVVNEFDTITTDKPEKSLLVPLKKSGGRNNQGKMTMRYIGGGHKK
KYRLVDFKRNKFDVEAKVVSIEYDPNRTAFIALVQYTDGEKRYIIAPAGLKVDQTIVAGM
SNVAPEIGNAMPLSQIPLGTVISCIELRPGQGANIARSAGTFAQLMAKDGRYATVKLPSG
ETRMILLTCLATIGAVSNSDHQLIVSGKAGRSRWLGRRPRTRPVVMNPVDHPMGGGEGRA
TGGHPRSRKGIPAKGYRTRSKTKASNKYIVERRKK
>OBAHECAF_00655 50S ribosomal protein L23
MSVLIKPVISEKATANSELKNCYTFEVSKDANKIQIKEAIESAYGVEVASVRTLNYGPKR
KVRYTKTGLQVGKTNTVKKAVVQVAEGGTIDFYSNI
>OBAHECAF_00656 50S ribosomal protein L4
MEVAVLNSQGKETGRKAVLSDSVFGIEPNNHVIYLDVKRYLANQRQGTHKAKERNEVAGS
TRKIKKQKGTGTARAGSVKSPVFVGGGRIFGPRPKDYTQKLTKNVKRLARRSALSAKAQS
QAVLVLEDLNFDTPKTKEFTNILKSLGLENKKSLFVLPDTNNNVYLSSRNLKTSSVVTAS
ELNTYDVVNATNVVLLESSVEVLESILTK
>OBAHECAF_00657 50S ribosomal protein L3
MSGLIGKKVGMTSLFDENGKNVPCTIIEAGPCVVTQVRTVEVDGYEALQLGFDDKAEHRA
NKAELGHFKKAGASVKKKVIEFQGFEGVYKLGDTITVDLFEEGEFVDVTGISKGKGFQGV
VRRHGFGGVGQSTHGQHNRLRAPGSIGASSYPSRVFKGMRMAGRMGAEKVTVQNLKVLKV
VAEKNLLVVKGCIPGHKNAYVTIHK
>OBAHECAF_00658 30S ribosomal protein S10
MSSQKIRIKLKSYDHSLVDKSAEKIVKTVKATGAVVTGPIPLPTHKKIFTVLRSPHVNKK
SREQFQLSSHKRLLDIYSSSSKTIDALMKLELPSGVEVEIKV
>OBAHECAF_00659 Elongation factor G
MARDLQYTRNIGIAAHIDAGKTTTTERILFYTGKTHKLGEVHDGASTMDWMEQEAERGIT
IQSAATTCTWNFPTENGKPTADAKEYHFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSAV
DGVEPQSETNWRLADNYKVPRIGFVNKMDRQGANFLNVCNQVKEMLKSNAVPIVLPIGDE
VDFKGVVDLVKNRAIVWHEDTQGATFDVVEIPEEMKDEVHQYRSQLIEEVAAYDEGLLEK
YMEDENSITEEEVHKALRAAVMDMAIIPMVCGSSFKNKGVQFMLDTVCRYLPSPLDKEAI
EGTHPDTGVVALRKPSVEAPFAALAFKIATDPYVGRLAFFRAYSGHLDAGTYVLNARSGN
KERISRIYQMHANKQNPIEFIEAGDIGAAVGFKDIKTGDTLCDEKHPIVLESMVFPDPVI
GIAIEPKTKADVDKMGMALAKLAEEDPTFQVKTDQASGQTIISGMGELHLDIIVDRLKRE
FKVEVNQGQPQVEYKEALTAVANHREVYKKQSGGRGKFADIVFRMEPADEGKVGLEFINE
IKGGNIPKEYIPSVEKGFKEAMKNGPLAGFEMDAMKITLVDGSFHAVDSDSLSFELAAKL
GYKEAARAAKAVLMEPIMKLEVITPEENMGDIVGDLNRRRGQVNNMDDRNGAKVIKASVP
LSEMFGYVTSLRTLSSGRATSTMEFSHYAETPSNIAEEVIKKAKGN
>OBAHECAF_00660 30S ribosomal protein S7
MRKRQAKKRPLLPDPKFNDQLVTRFVNNLMWDGKKSVAFKVFYDALDIVDQKKNNEEKTA
LEVWKDALTNVMPHVEVRSRRVGGATFQIPMQIRPDRKVSMAMKWLIGYARKRNEKSMAQ
KLAGEILSAAKEEGAAVKKRMDTHKMAEANKAFSHFRF
>OBAHECAF_00661 30S ribosomal protein S12
MPTISQLVRKGRTRITKKSKSVALDSCPQRRGVCTRVYTTTPKKPNSAMRKVARVRLTNG
NEVNAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTAGVAGRTQRRSKYGAK
RPKPGQAAAAPAKGKKK
>OBAHECAF_00662 Pantothenate precursors transporter PanS
MDLIDQLMSAVLMLVTFAIGSSLKFKDFENIFTHAKAFTVGLTAQMVFLPLLAFAIAYFS
DLPPALKVGLIIVAICPGGTTSNFVSYLVNADTALAVALTSINSLLMFFTIPTLTNLGIS
IFMHSSSEFSLSMTETFWEVSKIIIIPAFLGLLFNRYYPNLALKIKIPLKIINTILLGLV
FIIKFFADQESGGTGILFEEILSILPYALAIHLLSMVLSYIISKKTFGISNVQATTIGIE
VGLQNTVLAIYIAGLVQSVEMAKPALVYAMFSFFTTLAFAFIVMGRRYNQ
>OBAHECAF_00663 hypothetical protein
MFRTIVPIHPNKAQIQFESKIVSFGSCFSLNMAKKLSYHKMRTVSNPFGILFHPLAIEKV
IRKSVKNELFTEKDFFFHDDKWLCFDLHSELSQPTLDSAVERANQQLIISQKALQSSDFI
FITLGTAWVYTHETGKVVANCHKVPQQHFSKRLLSFSEIENSLQSIFQLVNIINPKIHCI
CTISPVRHLKDGFTENNISKSLLISSLHSVIKKSSHTSYFPAYEIMMDELRDYRFYADDM
LHPSDVAIDYIWKRFTESYFCPDCLSILKEVDAIQKGLQHRPFNTNSKSFISFQEQLHKK
ITLLKKRFPFVEF
>OBAHECAF_00664 Na(+)/H(+) antiporter NhaA
MEKYLFDRLTSPIYKFTKQAKSGGIVLGINVILALFLANSPWSDSYFHFFEHHFGFVFDG
EPYLNFTVHHWINDGLMSLFFFVVGLELKREIVAGELSNPREAMLPIAAALGGMIVPAII
YLALNPSGEAHSGWGIPMATDIAFSLAVLYLLGDKIPLSLKVFLTALAIVDDLGAVLVIA
FFYTSEISFANLGLGFALLFLLYLGKRIGIRHVLFYALIGIVVWIAFLLSGVHATISAVL
VAFMIPTDVQMKESEFVHNIQSYLKRFKRLDPNNTRPTLTEKQLHLLEKVSIDTRRSIPP
LQRLEHAMHPFVTFVVIPIFALANAGVSLDIELSTLFETNVALGVALGLFFGKVIGVVSF
TLLMVKLGLGTFPRGMNLRNLFGLGLLAAIGFTMSLFVTTLAFKNPMLIDQAKIGIFAAS
LFGGICGYLVLNKKEKDKIEVEEV
>OBAHECAF_00665 Superoxide dismutase [Fe]
MKINHTLPELPYDKNALNPIITEETFDYHYGKHHAAYVNNLAGLVKDTEWEEKDIVDIIR
KSHAENNVAIFNNAAQHWNHSFFWNCLSPDGGKNPTGKIAELIHRDFGSFENFKEQFSTI
AVKLFGAGWAWLAQNQEGKLEILPMKDAYTPLTENKTPILTIDVWEHAYYIDYRNARPKF
VEGFWELVNWNFANQNLK
>OBAHECAF_00666 hypothetical protein
MSDICINHIENYWKLLTEEANNFFNQEKYELALDSYLNALYRAEVLSNNLQDCIRMKVPF
VQVYTISCYNLANCYQEVKDLNRAEEILQKAIYFLLHLYEKNYEKESIQKELRKSVLNYL
SFTQKSNVKTSRTDAFLTYLKNQTTKYNLQNIKTFDYVQFN
>OBAHECAF_00667 hypothetical protein
MCNSIKLVQKEQLQLIQKGILSIGDKLPK
>OBAHECAF_00668 hypothetical protein
MWLQGSSPIKALANQTFYPYTDMLLHDMGEDLADGRPDFLANGNKWKTRPLWGIGLQFLV
NGHTEFLHDGRAKNVTEAILWHGGEAKDTKEKFKQLSKKDREDLLEFINSI
>OBAHECAF_00669 Rhamnulose-1-phosphate aldolase
MKTKELPKSVRKEIKKVSEVASYLWQREWAERNAGNISIDLTDHFTKELINSTPKKYVPC
VQLPKESAGKVIFVTGTGRYLRSLIHDINKTACILHINETADSYAIIWGGKGEAFAPTSE
LISHVKIHCFNQKYKPTHKTVLHTHAIELIVLSHHDLFYNEAKLNHSLWKLCPEIRVFVP
NGVHCCPYALSGTESLADITIEGLKTHDVILWEKHGVLATGEDVVRAFDYLDVANKGAKM
LLMAWAAGFEPQGMNDQQLDELERLFLGKK
>OBAHECAF_00670 hypothetical protein
MGFAIDWARTVGDKNFENQLIEKSKAFYLKDKNIPAYLEPNGSDFFSPSLETANLMRRIL
PKKEFTKWLNQFYDKRSLNNIKELPIISDLNDYQIVHLVGLSFSRAWCMKAIAKELPRNH
RLKKEFDLSSKKLLNNALPLVFQGNYGGSHWLASFAVYALSEF
>OBAHECAF_00671 Elongation factor G
MSYNTNNIRNAVLLGHAGSGKTSLVETMLFESGATTRIGNVEEGNTVSDFHDMEKDKKHS
IFSSLMHVQWGDVKINLIDTPGFDDFIGEAISGLKVADTAVVVINAKEGIEVQNELHKDY
IDEFGTPTLFVINQLDHEKANFDKSLQDIKTTFGDKVIEIQFPYNIDKGFHKIVDALRMV
MYTFDANGGKPKKESIPADVLDRAKELHNKLVEVAAEEEEGLMEKYFDQGTLSEEDLTKG
LQLAMGKQNFFPVFCVSSKENKGTGRVMGFIRDICPSPLQRPARILQNGDTLAPKADLPT
SIFIYKTLNEAQIGELSYFKVYSGTLKTGDTLTNQMNGEDERINKIFVVNGKNREAVEEL
VAGDLGVTIKLKNSHTNNTLNSQGHEGVQIRKIKFPQMKIRMAVVPPSKSDFEKLTNALH
VIQEEDPTFTLQYSPELKQTIIHGQGQMHFDVVKQRIKSLYNIDMELIRPKIPYRETISK
TAEAQYRHKKQSGGAGQFAEVHLRIEPYETDRPLPTDLNIRKEELIELPWGGHLHFLWCI
VGGSIDTRFIGAIKKGIMAKMEEGPLTGSYCQNIRVSIFDGKMHPVDSNDIAFQLAASAG
FAEAFKNASPKIMEPIYELEVLCDTVAMGDVMTDLQSRRAVITGIDSVRQYQQIKALVPI
AEMYGYSTSLRSITQGKSKFNRHLWGYQVMSHEVQEKLLLSGITELKN
>OBAHECAF_00672 Miniconductance mechanosensitive channel YbdG
MERLVFYRKESVAFFESYGLENHWAVFVQSIAILVLIFTLAYLVDRVLTFVMRRVIPKIV
GYTANQWDDIFMENRVFSNFAHFFPGILMQNLQDLISSSSVRWFVSTFIGVYFIVVTVLF
LNALLNAIQQLFIHLKGVSAIVKIYIQLGKVVLYSLAGVAIISIFANKNFMDILAGLGAM
ITILLIVYKDMIMGFVAGIQLSANKMVYVGDWVELPKDGADGIVIDIGLTTVKVQNWDRT
ITTIPTYKLTSESFTNWRGMQESDGRRIKRHVNIDMESIHFLSEEEINTFRKIRLISEYI
EDKIKIINQVNANEPEQFNQRRLTNIGTFRKYVENYLRESGYVNLDMMFLVRQLQATEKG
VPIEIYMFSKIKEFIIYEGIQSDIFDHIIAIVPTFNLRLFQEPTGHNFSAIREIKNQTAE
>OBAHECAF_00673 Regulatory protein RecX
METVKTYTVEEAKRRMEVFCAYQERYQAEVVEKLRQMRMIPLAIDEIMVYLIQNNFLNEE
RFAKSFVRGKLRYKKWGKIRIKRELKFRGLSTYIINSAMEEIDDEEYEEIFDSLAEKKQA
EIKEKSVYKAKRKLADYLLYRGWESELVYNKVHELYED
>OBAHECAF_00674 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MKIGIIGAMELEVSTLRAKLNNVKTTKIGRFEFYEGELYGLSVVVLLSGIGKVSAAVGTT
LLIEHFEPQLIINTGTAGGLGDTVVYDIILAAEVRHHDVDVTAFGYEIGQQAQMPPAFLP
DKKWFDLAKKVAEKHSNQLHVGMVVSGDSFISEPQRLKIIETNFPKAKAVEMEAAAIAQT
CYMMNIPFIMLRAISDKAGEGNAVSYETFVHEAGKLSAEINIDLLKYFSELQN
>OBAHECAF_00675 Ribosomal protein S12 methylthiotransferase RimO
MRTKSIKKNVINVVTLGCSKNVYDSEVLMGQLKAGGKEVVHEKEGNIVVINTCGFINNAK
EESVNTILDYVQRKEEGLVDKVYVMGCLSERYKPDLEKEIPDVDQYFGTSDLPALLKVLG
ADYKHELIGERLTTTPKNYAYLKIAEGCDRPCSFCAIPLMRGSHRSTPIEDLVQEAEKLA
TKGVKELILIAQDLTYYGLDLYKKRKLADLLRALVKVEGIEWIRLHYAFPTGFPMDVIDV
MKEEPKICNYLDIPLQHISDSILKSMRRGTTKEKTTKLLKEFKQKLPEMAIRTTLIVGYP
GETQEDFETLKEFVKEMRFDRLGCFTYSHEESTHAYSLEDDVPEEVKLQRANDIMELQSQ
ISWELNQEKIGKTFRCLIDRKEGNYFVGRTEHDSPDVDNEVLIDAKKFYVKLGEFIDVKI
IDSADYDLYAEPLNL
>OBAHECAF_00676 hypothetical protein
MDLQGRIKLISPIQQFGTNGFQKREIVITTEEQYPQHVVFEFTQDKCSLLDAFQPGQLVR
ISFNVRGREWINPQGEAKYFNSLQGWRIENMEMAQQYPPQGQPYQQEPYQQPYGGQPYAQ
APQQVPPAQTNVNQQEAIDDDLPF
>OBAHECAF_00677 Purine nucleoside phosphorylase DeoD-type
MIKESELILTPKGSIYHIDLTPEQVATTIILVGDQNRVARISAHFDTIEHKVQKREFCTH
TGTYKGKRLSVISTGIGPDNIDIVINELDALFNIDLQTRQIKEKHTQLNFIRFGTSGSLQ
ADIPVESIVLSSYGLGMDNMMHSYRDLDKVAESEMENAFIKHTQWSENKGRPYIVGCGQE
LKNKLLTSEIFEGITGTAPGFYGPQGRVLRLQVQDAQLNDKLHSFNHNGHRMTNLEMETS
AIYGLSKLLGHQAVSLNVIIANRATQTFVEDTQKAVEKLIHFGLNQIAKNV
>OBAHECAF_00678 hypothetical protein
MQFTPLTEQELHNLAMNIVGATLRDELKWEFLLVNSKLKKDPQFVCIDKNKQRYFIIVRA
VLYGENPDAYDAVFMEIVRQHAEKHNAKTYFAGVGLINVENTTLPIYKNQPYQVNFKGLL
EIV
>OBAHECAF_00679 FAD:protein FMN transferase
MKPFISIISICVFLLFSCTPKDKIHLMRGEAQGSTYAIKYVSHSDEALKPAIDSILEVID
LSMSTYRPESLISKINRGERITIDPHFEKVFLASQIIWQQSEGAFDPTVGVLVNAWGFGK
EKHSRNLTENQIDSLKQFVGFEKIRLTDGKYIEKQHSAIFFDFNAIAQGYTVDIIADFLK
SKGIENFIVEVGGELFLSGQNTVENKKWTIGIENPTLADENQLIATVQFSNQGLATSGNY
RKIRTDALTGEKFVHSINPKTGLAKQSNLLSATVITDSSMYADGYATMLMVLGLEESKKF
LEKHTNLHVLLVYNNENNEIKTFETEGFKKLSMN
>OBAHECAF_00680 GDP-L-fucose synthase
MILVTGGTGLIGSRLLFHLTKNEKYKVRSIYRSDDSLKKIKAIFKNLSDEGEKQFSRIEW
VKADINNIPELEKAFRGVVFVFHVAGFISFKPTDFDKLIKINVEGTANIVNLCIDFKIKK
LCHVSSIATITSVDGKILDENSEWNPEASNNDYAISKHGGEMEVWRGSQEGLKVLVVNPS
VVLGAYFWDSGSGTLFKRVANRFPFFPTGGTGFVDVDDVVRAMIALQFSEVENQRFILNG
SNQTYQHVMKTIATHLGVLPPHKKVSHNVLRLLARIDGLLSFLQLKKRTLTLRNADSVSL
VSSYDGSKVPQFIDFHYTDFEESIKNICKQYPLIHR
>OBAHECAF_00681 Bacterial non-heme ferritin
MAKVKYTRLQTSLHPEVIEMLNKQVSMEAEASSIYLAMASWCEVNGFPRSAEFFYGHAVE
ERDHMMKIFRFLNENGARAYAPEVGKVKQDFASLQEVYEKTLEHEIEVTKAIFAIFKKAR
QESDYASENFLQWFVEEQLEEERLVHSILDLFEFTNEKDSPLALKLIDERIPLGE
>OBAHECAF_00682 hypothetical protein
MKTLSTKNTKSLAKVMIGILLSYKDFVKPITSDNEFEIRSIREHFKKTADNFLKISILVR
S
>OBAHECAF_00683 hypothetical protein
MKKIFLVLLYGFTLLASAQEIKVMTYNIRYDNSHDGINSWTDGNRKEKVLKMIQEQQPDV
FGLQEVLHHQLEFIESHFTDYHRVGVGRDDGDRAGEYAAIFFRKDLYKLLDTGHFWLSQT
PMIPSKGWDATCCNRICTWVKLQYKNKIFFVFNTHFDHEGKVAQQESAKLILHKISEIAG
KNKVILMGDFNMTPNNPAIAKISQKLYNTQTSEKNMTPMLGTYNDFNLSTPVVQNIDYVF
LQKVKLIDFKILETRLEGLYPSDHFPVVVKVRL
>OBAHECAF_00684 Prolyl tripeptidyl peptidase
MKLKTLLTSFILGISFAGLFAQTSITLEDIWAKGVLYPQRMAHLSAMKNTNQYTVLNYDR
QSNSQQIDLYDFATLKKVKTIFDTKNFQLEIKSISDYSFDKSESKILIATNTQSIYRHSF
IADFYVYDIKNQILQRVSDKKIQEPVFSPDGKSVFFVAENNIYHFDLQSKSETAITLDGA
KNKIINGITDWVYEEEFSFVRAFDVSKNGDYLAYIRFDEREVPEFSMDVYGNELYPQQQV
FKYPKAGENNSKVSLHIYHLKTKNTVEIPLDAYYIPRIQWTQENDILSVQTMNRHQNHLK
LQFINASNQLIKTILEEKDKAYIDITDNLTFLYDNSFVWTSEKDGFNHIYHYDKNGNLKK
QITKGNWEVTEYYGYDPRSRRIFYQSTENGSINRGVYSIDLGGKNKKALSAQRGMNKATF
SPDFSLYINQFSSATEPPIYTLNDSQKGKQVKEILNNKSLKNNIKQFGFSDKEFTEITNE
KGDKLNAWIIKPADFDPNKKYPLLMYQYSGPGSQQVNNVWHSSNDYWHYLLAQKGYIIVC
VDGRGTGYKGADFKKCTYKELGKHEVEDQIFVARFFAEQPYIDKTRIGIWGWSFGGFMSS
NCLFQGADVFKTAIAVAPVTSWRFYDTIYTERFMQTPQENPSGYDQNSPITHAQKLKGNY
LLIHGTADDNVHVQNAMVLINQLVHLNKDFDWLIYPDKDHGIYGGYTRLQLYKKMTDYIL
EKL
>OBAHECAF_00685 Dipeptide permease D
MTNNRKHPKGLFYLFFTEMWERFGYYLMLGIFVLYMIDPKNTGGLAIDDKNAYDIFGTFI
ALTYLTPFLGGFLADRILGYVKAIYIGGSLMGLGYIGLGLFQDLAMFYTSMGLIIVGNGF
FKPSISTLLGNLYSEEPYRENKDAGYNIFYMGINIGAFICNIIAAFMRNKFGWSEAFITA
GVGMFLGLIIFTLGRKHIIHANVLKPVQEGDTTITSVLVKVFLPAIITGVIGWVIPGNIL
GSDSTDAFIFACIPVIFFYFSLYARASQSDKKPIGALLAIFAVSLMFWAVFKQNGTVLTT
WAKYYTDRSVPTSIEKPMESIYLVEVKDFQDKEVTMYDSEYRIVKDENDKPKKEIGKDIY
FRNIPEEQKAKLTENPNQKVFLYNPELFQSINPFWVIVFTPLVVGLFMFLRKRGSEPTTP
AKIVLGMFISALSCLVMVAAVYASDNGMVKASALWLVVAYGVITLGELCLSPMGLSLVSK
LSPPRITALMMGGFFLSTAIGNKLSGVLAGMWYGYEHKSTFFWVNFGLLLIATLIGLSIL
KSLNRVLKEKGVN
>OBAHECAF_00686 hypothetical protein
MLKQIYIIAGCNGAGKTTASFTILPEILNCKEFVNADEIAKGLSPFQPEKVAVQAGRLML
NRIKELLNEGINFAFETTLATRSYRNTVLSAQKKNYHVTLLFFWLKDVTMAKKRVLSRVK
EGGHYIDSHVIERRYTKGIQNLFKIYLPIVNSALIFDNSDDEPHLIAESNEKQLKIIDYP
KFNNLKLYSDE
>OBAHECAF_00687 hypothetical protein
MNKQETYFQDMKIKIQEGLKRSYVRLLKEKIKNKGELVVMRDDKIVVLKTSEIKKILQQK
KNLMVE
>OBAHECAF_00688 Dipeptide and tripeptide permease B
MLNPDYQLMLIAWLGVALWVGFVIFSNRKIHPKALFTLFMVELWERFSYYGMRALLILYM
TANLIDGGFQFDDAKAFGIYGAYGALVYLTPILGGYFADKLIGFRKAIVIGALLMAAGQF
TLFMNNQTTFFIGLALLVVGNGFFKPNISSMIGRFYADGDKRRDGAFTLFYMGINMGAFL
APLTCGAIGENEGWQYGFLTAGIGMLLGYIIFFFASRTSIFENVGLAPDEKPTKNVVSFV
PNSVLPYATIVVLIIISWILIQYNDVVDVLLASLAAIIIGYLLYQASKMEVVAKQRIWVV
VLLLLFTTIFWTFFELAGSALNLFTARNVHKEIFGTEIKTTFFQSFNPLFIMLFAPVFSW
IWIKLSNLNKEPAAPYKFGTGLLLLGLGFLVLKFGGSYAKLGMVPAIFMVFLYLLHTLGE
LTLSPVGLSLVTKLSPKHMVAFMMGIWFLSSSIAHQGGKHISKLTTVNEKTIVESSAFQN
SDIDKDIKAVLSENEFKDRLADNEEKKTHAIPIEKLLVSNDFIARMNEVNPQKQYAKSIV
VVKEVLQDAENYSGMKRQKMIKSASQEFLSFKGSEVNTEVATLADYEKLFEKSASISVTN
VIKSESLNKGLSVFTMLGFIAIGCGIVLFLMGPFITRWMHGVK
>OBAHECAF_00689 Beta-hexosaminidase
MKLKSILASLAFTVTFASCDTGKESSVSADYHVVPLPNSIQKTTNEQPFLLNSSTKITYP
KGDEALKRNADFLAEYVKEQTGMSLSVVEETAEIDNVIKLSKGLASDNKEAYQLTVNQKS
ITIQGASSAGIFYGMQTLRKSIPVEKTQKVVFDAVVINDAPRFAYRGAHLDSARHFFTTD
SIRIFIDMLALHNINTFHWHLTDDQGWRVESKKYPNLTVVGSTRSQTVIGRNSGKYDGIQ
HGGFYTQDELKELVAYAQDRHITIIPEIDLPGHMLAAIASYPELGCHEGPYSVWGQWGVS
DDVLNVGKPETYEFIQTILEEVTEIFPSEYIHIGGDECPKVQWKTNKDCQLKIKELGIKG
DDKHTAEEYLQSHVISFAERVLASKGRKIIGWDEILEGGIAPNATVMSWRGIEGGTFAAK
TGHDAIMSPMSFMYFDYYQSQDIDQEPLAIGGYVPVERVYSFEPIPEGLTPEQQKRILGV
QANTWTEYIKTFKHVQYMTLPRFAALAEVQWTQPENKNYDDFLQRIPSIIKIYDAQGYNY
ATHIFDLKVDITTLESEGAIQVAFTTLDNATVYYTLDGSEPSEKSTKYTEPIKINQDAKV
RAVGIRKNGKTRVFSEDFKFNKATARPIKMLTNIYPSYKYKGASVLVDGNVGTNNFRTGR
WIGFSGDDLEAVIDLGEAKEISKVSFNTNVITGDWIYDARSCSVAVSDDGVNFKEIASEQ
YSQESKHIQEIRTHSLGFEPLKTRYVKVKITSERSIPEWHQQAKGKLAFLFVDEINID
>OBAHECAF_00690 Nicotinamidase
MKALIIIDVQNDFMPSGTLPVAEGDQIVPFINQEMYKGYDLVVATQDWHPQNHQSFASNH
EGRKPFEVINLHGIDQVLWTDHCVQDTFGASLHQDLDTHRIAAIFRKGMNPEVDSYSAFF
DNNKRNNTGLHGFLKDKNITELTFCGLAGDFCVAYSVNDALSLGYKVRLLDNGIRSINPE
NYQKYKADWGI
>OBAHECAF_00691 hypothetical protein
MPLFETINVNEKTQLYIWKVSETLEDLTQGVVLSGEHQSKFDSLKVESAKKNFIAVRRIL
KDLGYSSDDLFYNHEGKPYLRDGKTISISHSFDMVCLIVGEKPVGVDIEKKRRKIIDISE
KFTQWDYRSTSFSQKNVLQKLTMIWSAKEAGYKAHGKSGITAEHILVKDFFPNDSETKIK
IEKTFYDVSFINVEDYVLAYCL
>OBAHECAF_00692 Hydrogen peroxide-inducible genes activator
MTITQFQYVLAVAKHQNFSTAAENSFVTQPTLSMQIQKLEEELGVIIFDRTKKPLQPTDI
GKQIIKQAQIIVNESERMSDIVAQQKGVIGGEFNVGIIPTVSPTLLPMFLTNFINKYPKV
SLKIEEHSTKTLINYVEDGTLDAAILATPLHRPNIVEKPLFYEPFMAYIPNNHKLQNTKT
ITSDDLDINDILMLEDGHCFKDTVLNICNQDIVDSKKRFELKSGSFETLIRLANEGLGMT
LLPYLHTLELKEEEKKNIHHFATPYPAREISLVHHKNELKAQNIKALHEVISGVVRGAIA
FHDVKIISPTRKSLA
>OBAHECAF_00693 F420-dependent hydroxymycolic acid dehydrogenase
MLDTNKLSIGILLPIESYEGAIPKMENQIRLIQQAEAYGFESIWVRDIPLNNPEFKEVGQ
IYDPWIYLSHVATLTRSIKFGIASVILPLRHPLHVAKASASLDVLFPNRFHMGVASGDRP
VEYPAFNKPFELRSAQVSEHMRLLKELWSKDFPVYNNDYGTLMENVGDVVPKPIKKSIPM
YVTGHVGGVNLEWIAKNSDGWIYYPREFTFTGKIVKDWQDTLDKEGQPRKPYIQPVYIDL
MEDPDFEPQKMDLGFRLGRNYLVDMFLTLQKIGVNHAMLVLKYSSRPVDVILDEIGREIL
TQLR
>OBAHECAF_00694 Glycosyl hydrolase family 109 protein 1
MFKKINRMLLGGMLCLSLVACKTKQVGATSMDKIVYQPIKVETPKRPAGQTDVVNLVTPK
LETVRVGFIGLGMRGPSAVQRFTHIPGAKIAALADIRPERVEKSQQILEKAGLAKVPGYS
GSQDAWKALCEREDVDLVYIVTDWETHVPMALYAMEQGKHVAIEVPGAMTMEDIWALINM
AEKKRLHCMMLENCVYDYFELTSLNMAQQGLFGEVIHAEGSYIHSLDDFWKAYWNNWRLD
YNAKHRGDVYPTHGMGPACQALDIHRGDKMNYLVSFDTKPFKGKKLYEQLTGKNGDNFQN
GDHTMTMIKTEKGKTMQIQHNVMTPRPYSRMYQLTGTQGFANKYPTQGYTIEPENISKDD
VPNHENLNSHGFVPEDVKKALMQKYKHRIHIELEEQAKKVGGHGGMDFIMDYRLVYCLRN
GLPLDMDVYDLAEWSCLVPLSKLSLENGSAPVEIPDFTRGAWNKVKKYRHAFVD
>OBAHECAF_00695 hypothetical protein
MNKFLFGIGVILTSIISYFAFLWFHIFNHSNSREKAIESFDKNIPDLINNTIGITAFCIL
LGFISIFCFYLSATKSNGIFKKINFLFLSLSLFISLWYIWTLL
>OBAHECAF_00696 hypothetical protein
MKQILSLIICFCISIVCGQNKILKGQIVGEKGESVEYANIGVVGTYKGVISDEKGYFSID
ISTQKPIDSIYFSHLSYHRKAIAIKDIPSDSKIILKENHIELTPVVVFDKEPKLRTIKGR
GTRFPGATISFGKYSENDKENSSSHEKSNTTYKATQISVGDFVTLSQEYVAREFHITCLK
NISGKTLFRLNFYKVEADESLVPLTEKPIYIDFPQITEKTDFSEKIYVNLPKGKIWIELS
LVDIQGDNYNILFPIAFSGGWVRYDGKFQKIPLGLGVSFAIKGHKTKI
>OBAHECAF_00697 Oligopeptidase A
MFMKKKIITLCTIASFGSLQAQQSMREPIFTTSYESAPFNAFKAEDFKPAIEKAIAESLK
QIDAIANSKEKPTFQNTIEALAYNGEKLDRITAIFFNLNSAETNKDLQKVAQNISPLLSD
FSNDIRLNTSLFQRVKKVYDGRKKLKLSPEETTLLEETYKGFTRNGANLSEKDKERLREL
DKEMSRLRLLFGENVLAETQAFELHITDKNDLKGLPNFAVEAAAQIATDRKKQGWVFTLD
FPSYSAFIKYAENRELRKKMFIAFGSRGFQNNNNDNQKIALEIAKLRHERANLLGYKTHA
DFVLEETMAENPTTVNNFLNNLLEKAKPAAQRELEELKTFALERDGIRDFQKWDFTFYSE
KLKQKRFNVDDEKLKPYLSLNNAVNGMFQVANRLYGLNFEKINNIEKYHEEVETYKVTDE
KGNYVALFYTDFFPRPGKRAGAWMSSFKNQYIKDGVNSRPHVIIVCNFTRPTQTQPSLLS
FYELRTLFHEFGHALHGILANTKYPNLSGTSVSRDFVELPSQVLENWCSEEETLALFARH
YETNELISMELVHKIKESSAFMEGLQTMRQLGFGVLDMAWHNSNPNTIKNIKSFEDKAVA
PTELYPKIDDTCISTAFSHIFQGGYAAGYYSYKWSEVLDADAFQVFKEKGIFNREVGNSF
KEHILSKGGSEKSMELYKRFRGKEPSPDALMKRAGLVK
>OBAHECAF_00698 hypothetical protein
MKKIALPLLFVASFTLNSCAELQQVINSTSSTTGFNITDGLKQALEIGVSNGVDLLSKDG
GYFQDQAVKILLPAELQKVDATLRKIGLGALADEGLKVLNKAAENAVTEAKPIFVSAIKN
MTINDAMGILKGDNNAATTYLKNNTFSSLEAAFAPKIQNSLSQVGADKIWSNLINRYNQL
PLTTPVEADLTTYVTKQAINGLFTKVADKEKEIRTNVAARTTPLLKSVFALQD
>OBAHECAF_00699 hypothetical protein
MSIAYIFKTAWEVFRTSILVNALGMLVLFLVITGLYIVIFPMLLGIPLEEISRFTIQTPE
QLQSILISPDFQIKFTVFMLLINCIIAPMTAGFYSIFGSVQKNELPTMKQLFSFYNSPYT
ARILGSVLIITAIKTIISILLNFLGLEVANVSISILISLLVTLTIPIIIFENLSLVDAMR
QSSARIAPFMFTVLLVLAFGIIMGFSGILVFVVGICFTLPFFYAINYALYAVTKR
>OBAHECAF_00700 Malonyl CoA-acyl carrier protein transacylase
MKAYIFPGQGAQFVGMGLDLYEKSTVAKELFKQADDILGFSITEVMFNGTEEDLKQTKVT
QPAIFLHSVVLSKVLGESFRPQMVAGHSLGEFSALVANKTLSFEDGLQLVSKRALAMQKA
CELQPGTMAAVLGLDDAVVEKVCESIEGIVTPANYNCPGQLVISGELSAIEKACEAMKIA
GAKRALVLPVGGAFHSVLMKPAEEELAKAIENTHFSKPICPVYQNVTTTAVSDENQIKKN
LIQQLTAPVKWTQSVQQMIQDGASEFIEVGPGKVLQGLVKKINKDAVVSSAE
>OBAHECAF_00701 Isopentenyl-diphosphate Delta-isomerase
MKTMEERVILVDENDNPIGLMEKIEAHQKALLHRAFSVFVMNAKGEMMLQQRALNKYHSP
GLWTNTCCSHQRENESNIEAGKRRLQEEMGFTTELEDVISFIYKAPFDNGLTEHEFDHVL
LGFYDHAPQINSQEVADWKWETPEKVKIDIDANPQKYTEWFKIIFDRFYDYLIVNK
>OBAHECAF_00702 hypothetical protein
MEFFRKYFVPLALGILVIAALAYVLPAFFSGKEQETMTFSEIKEVEIEFTKEAEVSIFKQ
GELVRKIDIELADTPNERALGLMYRKGMDENQGMFFIFKEEEPRSFYMKNTEFSLDIIYL
NKDLQIVSIVKRAKPYDESSMPSEAPAMYVLEINGGLSDKWGIDVGDNITYQLIK
>OBAHECAF_00703 Prolipoprotein diacylglyceryl transferase
MTALNFIWNSDEIFFSIGVIAIRYYSLMFLVAFSLGWYVMKKIYLNEGKTLQQLDTLLIY
TAVATLVGARLGDCFFYNWDYFQHNILEIFLPIRKNPNESLFGIIKGWEFTGFAGLASHG
AAIGIIVAMVFYIRKYKDITLSWVLDRIVIPITIGGMFVRLGNFFNSEINGKVVDSSYPL
GVKFVQGGEISSRQAMELTGQSSPKEAFHLIANDPRFSEVLAAIPYQHPAQLYEAVGYFL
LFWVLWFTYWKTDKRKQPFFIFGLFLVLLWGIRFAVEFVKESQGGFESTLGLLSTGQWLS
LPFIVVGFYLLFRKKV
>OBAHECAF_00704 Glutamate--tRNA ligase
MVRVRFAPSPTGALHIGGVRTALFNYLFAKKHGGDFLLRIEDTDQTRYVEGAEQYIIEAL
NWCGIPFDEGVGKEGKHAPYRQSERKEIYKKYADELIQKGKAYYAFDSAEDLDNQRKEYE
SAGKTFIYNWQTRLQLKNSLSLTEEEVKQRLDRGDEFVIRFKMPEEVLKMNDLIRGEVII
DTKTLDDKVLFKSDGMPTYHLANIVDDHLMEISHVIRGEEWLPSLPLHMLLYRAFGWEAP
QFAHLPLILKPVGNGKLSKRDGIKLGFPVFPLDWTEGDAPLKGFKGEGYFPEALVNFLAL
LGWNPGTDQEIFSLNELIELFDLERVHKAGARFDPEKIKWFNHQYLQKKSDRELAQDFGK
TLTEKGISIATDKVEKIVHLIKERATFVSDFWELGSYFFQKPSVYEDKAMKKQWKENTAQ
ILTEVAQIIKETSNFSSVPLEEAVKNHITEKGYSFGQVMPPLRLALVGEMKGVHIFDIME
VIGKEETLQRIEAIKSING
>OBAHECAF_00705 hypothetical protein
MLRLLQIELIKIWNSKSSRILIIAYFGSLAFLALFATVKIDFGAFVFHLAKQGIFDFPFV
WHFNTYMAAFFKLFFAIVVVSMVANEYSNKTLKQNLIDGLSKKEFVYSKFLTIVLFSAIS
TLVVFLVSLVLGLIYSKYDEILIIFSQLEYLLAYFVKLVGFFTMCLFFSVLTRKSAFSLG
FLALWYVIEQFLAIFSQRHESLGIIKRILPLEAMSNLIKQPFTRMNGIKEFANETGINIP
YDFSVQISDILIVCCWTIFFVLMSYKIIKNRDL
>OBAHECAF_00706 putative ABC transporter ATP-binding protein YxlF
MKTILEIRQLTKKFGSFVAVDNVSFQIEKGSIYGLLGPNGSGKSTTLGMILNVVNKTSGE
YQWFNGNISNQQALKRIGAIIERPNFYPYMSAYENLRLVCKIKGATTDKIQEKLQLVGLW
EVKDRKFSAFSLGMKQRLAIASALLNDPEILILDEPTNGLDPQGIHQIRELIRYIASQGV
TVLLASHLLDEVEKVCTHVVVLQQGKMRYNGRVDAMFNDYGFFELATQHNEKLQEALRDF
AEFDKIIIEGNLIRAYLKTDIPSEELNKRLFEKGYVLSHLVKRKESLENQFLKLTNHTN
>OBAHECAF_00707 L-fuculokinase
MKNPLALLFDCGATNVRVIAMDIHGNIEASQSYPNQTETDPHYEGGRIWNVDAIWEKLCK
AAKIVTSQIDTSRIVGVATTTFGVDGTLVAESGELLYPVISWQCKRTDSIMENIGNYIPV
KELYTTSGILPYSFNTINKLIWFKENHPELLQHPKVQFLYMPSLLNFRLTGNKLNDSTML
GTSMLTDLSQRNYSQKIFNALELQISLMGDTASAGTKVGSITSRASIETGIPENTPVFLA
GHDTQFAIIGSGVGMNQPVLSSGTWEILMSRTQHYTVSEAEFGLGLTTELDAEEHTYNIG
VNYLGSGVLEWIRRMFYMDIPQEDVYSVMISEAEKIPMGCEGVRVNPDFLDKENGSEGAI
IGITLQTTRAHIYRATLEALAHKLKKALQAVEKAGNFKAEYITCVGGGTKNKLWNQLRAD
ICDLPIRLIKQKETTVLGSSMYVFKATGFFNSIEEAQSHLDYQPEIIYPSSRNV
>OBAHECAF_00708 Outer membrane lipoprotein Omp16
MKIYHKLLFFLLLGITANIFAQEKELQKANDLYQNYAYVDAIKIYESIAKKGFVNQELLE
RLGNSYYFNADYTAALVWYEQLFANSEYKIEPEYYYRYSLSLKSAERYDEADRMMVKFVE
LTDASDTRAILFQENRNYQEIIKDNSNRMELYHTDINTEHSEYGAAFYGGDKVIFAASNS
SMFKQTSQWTGESFYDLYIAQQDSITLSNKHLFPSDINTKFNESTAVFTKDGNTVYFTRN
NYVNKKVRMNSENTILLKILRATKDANGKWGNVIEMPFNSNAYNVAHPALSSDEQYLYFA
SDMEGTLGTSDIFRVKILENGYGKPENLGNVINTTGRESFPFISKDNILYYSSDGFPGLG
GLDIFAVKLYDNGTTSKPINIGMPANSADDDFCFVIDSDKKIGFLTSNRPGGKGKDDIYS
FYERSPLQFYCSKIMRGVVKNSETNEIIPNAKVLLSSKNMTLLKSETATEQGTFSFGGDL
IRCEEPHFYLKGEKEGFETAEVKVTTTGNDREVYYEIMLKPRVVKIEKDVDLAKVLNIKE
IYFDLDKSNIRPDAEVQLAKVLQVMKEHPNIKIDVRSHTDSRASHAYNLSLSDRRAKSTV
KWIIDNGIHKSRITGKGYGETQLVNGCSDGVSCSEEEHQANRRSEFIIIEMK
>OBAHECAF_00709 hypothetical protein
MKKNKLVALCMFFLCALGFAQQESQYTQYMYNTMMFNPGYTGSRGVDSFFGIFRAQWIGL
DGAPRSGGISYHAPQERLRNVGLGYSLFYDAIGPQTNTSFMLDFSYTLNFDNSKLAFGLK
GTAEIFSLDYNKLRLYDPSDTHFSENSTIFSPNVGAGVFWYSDKYYIGFSVPNLLETEIY
ESKDRRVSVLKNTQHFYLIGGYVFDLSDNIKFKPAVLSKMSYGAPLQLDVSANFMFNERF
VFGAAWRWSAAVSLMAGFQVNDRWFIGYGYDFETTELSRYNSGSHEIFLRYELVKMYKKV
VSPRFF
>OBAHECAF_00710 Uracil phosphoribosyltransferase
MIIHHLGEKPSILNRFVAELRDVNVQKDRMRFRTNLERIGETLCYEMSKFLQYKSEIVTT
PLGEKKVEIPKDEVVICSILRAGLALHQGLMNYFDNADNAFISAYRKHTSETDFDILVEY
LASPSLENKILFLADPMLATGRSFVNVYNALNSLGKPKEIHLFAVIGAQEGIDYLEKNFP
EDTHLWIATTDPKLNEKGYIIPGLGDAGDLAFGCKMQQ
>OBAHECAF_00711 hypothetical protein
MISNRFEDRKPANLLAVILAIIFGQLLYEFFIFDTIWNVWHVFRIIGVASLLYVTLYFLN
KIDRWNELTQGNSYSLLFFGVFVILFPTAYTNLLILASNLLITIAIWRMLSLKNERNIPQ
KIFDVSFLILCAGLFNVYALFFLLNVWISLLLYRSKKKKYWLIPFFAIFCVGILSSAMFL
VLDLTFTVPSTGDLWDFSYQKVLHPPMLFSLILMGFILITSLLVYFFKNKYHSGSSQLIV
QILSVGLIVTFFSKEPVFIFTPLSILFALYVEKITKKWLKETVLWSLLTIPLVVLLLHFT
SES
>OBAHECAF_00712 hypothetical protein
MRMRKIRKVTFILMSVWFVFVVLFACTKSKIERNPYLPESRFSYTINLNLPVYNSLKYPQ
NTIYISEIGLKGVFVTHVSNNRYVAWEAACPNQYPSACDRLYCASKEGERFQICTNNSNA
YIFVICPCDGSVYNLVNGSVMVASSERSYPLLNYNVSVSGNQITVSN
>OBAHECAF_00713 hypothetical protein
MKKILFLLFIGLFFQQAKAQYVGIKGGYNYASLSGDVNPGVELSRYHGFYGGVTMDFPLS
NLFFVQTEGLYTRIGGTVNVAGSGVKVALDYISVPVLLGMKVYERLSAQVGPQFNFLAKK
SKFSYKKNEEEVIVEKAFDNFDLSLGIGLKYTTSSGYFVEARFNQGLTNIADSSNESLKK
MNISSTNNFKNSYISIGMGYRF
>OBAHECAF_00714 hypothetical protein
MVVVTLQRDKCIGCNYCVEVAPEQFQMSKKDGKSVLLRSTEKKGFFTLKSHDDGIYENCA
EAQKVCPVKIISTKKI
>OBAHECAF_00715 hypothetical protein
MKTYYLSNEQMLQNFGAMFENLSKEGDLKTELAEYGYDDAKIAEGKALYDEARKTFDANI
KETREETSASLAFQEKYQNVQKKYSTHRKKARIVFEDNEEALRQLKLKGSAARAIAAAME
EMRAFYQLLDTTPNLLTPLKQLKINEEDVKNQLQELPEVEKAYATYLQEKGESQQATRDK
NKAFETLDKWVSKFHKVAKIALEDRPQLLEALGKFVRS
>OBAHECAF_00716 hypothetical protein
MIHLERLTKPDVLAKNEAKWTENFIQSGKNRPSSSKYGHPEIKEALASISANKCFYSEIL
LSPISDAQIDHYVEVSEDKTKAFDWNNLYFTHKNCNIGKSPNKCIPVSECLDPFTDSNEE
IEKHLYFEDEMILSDTEKGKRTIQKYNLNSDYFNLQRSRTLNKFQQAIVLCLQDKLSKEE
VIRFANSDRPFSLMIRLYLKKHNIL
>OBAHECAF_00717 DNA replication and repair protein RecF
MKLHKLYLKNIGPFLEGEIEFDQVTILTGENGTGKTVVLDAIRKMLLGNDYYRILPKMRN
IRRENSFKIDLSLSFNKKKIEIESDRINNNYLFESFEIKKSGSQYYDLGSVFSNSTKAKG
NLWIANYWTSQNDHSDFHIPSLDFIKPENYLIDALDGIQKNAETTKIVTFLDYYKSSDKP
EEKKEGEFIFEILKKIFKISLYEGEFVYVDRSRLMPIIIQNGVEVSLDKLSSGNLYLVQR
LIGLLGQMYSVYKLNNLPLEEMCNTPGLLLIDEAENHLHPKWQKTFIKSILELFPNLQIV
AATHSPFIVGSVENAKIYVCKPETDHSIIVDETANYSNKPIEEILISEVFGGTTPFANEE
INKLLKERKEAIEKGDKQEEERTEKRLLELNPQYFSYLEMDKLLDELKNK
>OBAHECAF_00718 putative protease YhbU
MTNSGKIELMAPAGNFESLQAAIDNGADSVYFGVDQLNMRARASINFTIDDLGEIAKRCH
PKGIRTYLTLNTIIYDHDLSIIKTLLDAAKKANLTAVIAMDQAVIAYARQIGMEVHISTQ
INITNIETVRFYAMFADTMVMSRELSLRQVKKIAEQIQREQIKGPSGNLVEIEIFGHGAL
CMAVSGKCYLSLHSHNSSANRGACKQNCRKKYTVIDQESGFEIEIDNEYMMSPKDLCTID
FLDQVIDAGAKVLKIEGRGRAPEYVATVIKTYREAIDAYYEGTYSKEKVEKWMEALSTVY
NRGFWSGYYLGQKLGEWSENPGSNATQKKVYVGQGKHYFPKSGIAEFLIEAYDIKVGDKL
LITGPTTGVQEFVLENMMVNDAPAQTATKGDSCTIKTDFRIRLSDKLYKIVATEFAK
>OBAHECAF_00719 hypothetical protein
MKQLIIYFLFGYSLGVNAQILTEKTPLEFIKTIIFKASENDKSQFPIVRLNEMFTLQFDD
LSGDEETYYYKITHCNADWTASNLLKSEYIKGMDEQPLRTESNSYATLQSYSHYRLNLPN
DLTKITLTGNYLLSIIDRFGMELFSRRFVVYNPLVSIQSEIKRTRDLQHFDTKQVVQFSI
KELGLHLQDPTSNVKVAVLQNYCWNNAITNLKPQFTIGRELIYKHDLESAFDGGNEYFYF
DSKELRVTSGATYQIFQNKLFEHVLFGNISRANRVYTYNPDINGDFLINTLDGRNPDNEA
DYVWIHFSLELPASFGKKEVYVYGKFSNYELLDIYKLTYHEEKRIHQGKILLKQGFYNYK
FATKEQNEENFNEIGGNFQQTENNYTILVYYRAPNALYDQVIGLGGANSSNISR
>OBAHECAF_00720 Ribonuclease G
MNKELIIRSGSSYVDFALLKEGRLIELHKEEDANGVGVGDIMLAKIRKPIPGLNAAFVDV
GHEKDAFLHYLDLGPQVSSLQKFVKMIISGKLKDYSLKDFPLEPDINKDGAVVDVLKAGQ
PILVQIVKEPISTKGPRISSELSIAGRYLVLVPFSDRISISQKIESKTEKERLRRLLQSI
KPKGFGVIVRTVAEGKKVAELDKDLQGLFNRWVLMCKKINKAVFPSKVMSEISRTGAILR
DMFNDSFTGIQVDNETLYEQVIKYVQEIAPEKESIVKLYRSSVPIFEKFHIERQIKTAFG
RTVSMSKGAYLVIEHTEALHVIDVNSGNHSNKADNQESTALAVNLIAATEIARQLRLRDM
GGIIVVDFIDMSNTDNRKILFDHLRQEMSEDRAKHKILPPSKFGLIQITRQRVRQELNIK
TKEENPSKEGEIEAPIVLVDKINIELERIIKESTYKGSIVLNAHPFIAAYITHGLMSIRF
KWFLKYKRWVRVMHRDAYSYLEYRFKTKEGTPL
>OBAHECAF_00721 hypothetical protein
MPSGKKRKRHKVANHKRKKRARANRHKKKK
>OBAHECAF_00722 DNA-binding protein HRL53
MTKAEIVSKIADKLGLDKNDVQSTVENFMDEVKASLESGNNVYLRGFGSFVIKTRAEKTG
RNISKNTTIKIPAHNIPSFKPAKVFVDGVKTKVKVKSGKKK
>OBAHECAF_00723 DNA primase
MISKATIDKVYDQMRVEEVVGDFVQLKRSGSNYKGLSPFSNERTPSFMVSPVKQIWKDFS
SGKGGNAIAFLMEHEHFTYPEAIRYLAKKYHIEIEETQQTDEEKDKADERESLYIVSEFA
QTYFEKILTESEVGKAIGMSYFKERGFTLDTIKKFRLGYSPDQWSAFTDEALSKGYQLEF
LEKSGLTIVKEDKKFDRFKGRVMFPIHSMSGRVLGFGGRILTQDKKAAKYLNSPESEIYQ
KSKVLYGIYHAKQAIAKVDNCYLVEGYTDVIQLHQRGIENVVASSGTALTPEQIRLIHRL
TNNITLLYDGDPAGLRASLRGVNLILEQGMNVKICTFPDGEDPDSFARNNALEDITLYLE
ENTTDFIRFKASLLMQEAQNDPIKKSETIRDIIESISKIPDSIKQEVYIRECAALMEISE
DVLFATLSQILKKDIYEGQKVERKKTQKLEVTRTKEEQIKLSIDRLQVLEHDLIKCLLLY
GDRKYTFVDVILKPDEKGGVQEYKVQQELKIYEKIYLELQEDEIHFANPEFRHIYELVMS
KYEDSTYQLSTFVNQLPIELSGRVTQIIMEDENLTLHDWLRKDIVVKNKDENIDIAVIDI
LLNIRKQLVSNLIADIMQRVQTSVEVAEKNEAMAEIMDYIQLQKTLAKRLNRVVN
>OBAHECAF_00724 Electron transfer flavoprotein subunit beta
MKILVCISSVPDTTSKINFTNDNQKFDTSGVQFIINPSDEYGLTRAIQLKEKLGASITLV
NVGTPETEPILRKAFALGADEIIRVDATATDGFFVASQLEKIVKNGGFDLIITGKESIDY
NGGMVGGMLATLLDYPFINKCIGLEINGIDIEASREIDGGKEVIKTQLPAVIAAQKGLVH
DKDLRIPNMRNLMAARTKQITVIQPESVSAPTSVVGFEKTPAKNPVKMIASDNLDELIHL
LHNEAKVI
>OBAHECAF_00725 Caffeyl-CoA reductase-Etf complex subunit CarE
MSILIYVDSEKGTLKKTAYEVASYGRALADMHNTDLVAVAINVEDITPLQTYGVNKAIVV
NNDQLNQFSAKVYTEIIRKTAEKESSSIVVFSSSSYAKNIAPSLAVVMKAGYVANVISLP
ASVDNFEVKSNVFSNKAVGLIKIDSVNKVVSLAGNAYGVKETPVSMTVEEIPTEVPEPPI
KVVRSEKNTGKVSLDDAAIVVSAGRGLKAPENWAMIEELADVLGAATACSKPVSDMDWRP
HSEHVGQTGKPVAPNLYIAIGISGAIQHLAGVNASKIKVVINSDENAPFFKVADYGVVGD
AFKVVPELISKLKAFKE
>OBAHECAF_00726 Hercynine oxygenase
MKNNLLRFFAVIAIFSGFALTGCKKGTNKNISSATGWSINSKEGGFQYNTDFKEQETGPG
LILVEGGTFTMGQVQDNVMHDWNNLPTQQHVQSFYMDETEVTNKMYMEYLDWLKHVFPPT
EEQYKNIYVGALPDTLVWRSPLGFNESMVTNYLRHPAYAEYPVVGVNWVQAVQFSAWRTD
RVNEAILERTGYIEKNTRYQVEAGSTFSTETYLYTPSDSYGGQATDFAGKKAVTKEGEPT
FAKQTSGVLLPEYRLPTEAEWEYAAKSLNGVREYNSLQGRKKYPWDGAYTRSTKRSSRGD
QLANFKQGKGDYGGLAGWSDDKGDITVPVKTYPPNDFGLYDMAGNVAEWVADVYRPIVDD
EVTDFNYYRGNVYMKHSIGKDGKHVIVAPENVKYDTLSNGKIVARNLPGNIATVPVDENE
TYLRYNFTRSENRSYNDGDKSSTRNYRSGGSELSGGDLDYKNSMYNSPKHQISRDSLENR
IARSYDKSNERTTLINDEVRIYKGGSWRDRAYWIDPAQRRYLPQYIATDYIGFRNAMSRV
GSKSSKANKRPKG
>OBAHECAF_00727 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MKELYELFVQSTGVCTDSRAVFANCIYFALKGDSFDGNKFANEALEKGANYAVIDDSSMK
VSDKMILVDDVLKTLQQLANYHRRKLGTLIFGITGSNGKTTTKELLKSVLSEKFQVIATQ
GNLNNHIGVPLTLLSIQAETDIAIVEMGANHPKEIAFLCSIVEPDYGYITSIGKAHLEGF
GSFEGVIKTKGELYDYLKKYNKTIFLNNDDALQKDLLKNYENVYSFGNQGNTKVKLKNTH
PVEVIFENSALRKMTDGIEKPSLLGIGVLDEFTDSTTVVRSNLTGSYNFSNIGVAIAVGK
YFKLPPEAIKRGIEKYIPTNNRSQIINLEGNTIFLDAYNANPSSMSAAIHNMLTIESFDK
KVLILGDMFELGKFALTEHQNIVDLVESHPWKAVFFIGENFAKTSTKHPQFKTFDEFKQA
FSFSQFSDCLILIKGSRGMALERVIL
>OBAHECAF_00728 hypothetical protein
MERIYKSCKYYKKEKQNPFIDSDKLKARFWEGEKIFCEECEVNEKYYNIMLKELNLSIRK
GNVTGKLLSPSMPIEEKVILFFIDLWNGKWFPYEIDVILKY
>OBAHECAF_00729 Beta-hexosaminidase
MKPYFLLFAILLMGCHEKKNFHFNEDDLLLIPKPEQVVLNNGFFEFTAETKFIANDSLHP
AIKLITDKFHRASEWDFSKNTVTDSDVKSNFVQLIVDENLPKEGYSFSSDSDKILISASD
YRGFVYGLQTLRQLLPKEIEGQKITTIDWVIPSVKINDTPQYEWRGLMLDVARHFFPKEY
ILKTIDRMAMLKINTFHFHLLDNEGWRIEIKKYPKLTEVGAWRVGQFDQHWNVRVTNDPN
EKGTYGGFFTQEDIKEIVAYAAKYGITVVPEIEMPAHVMSAIAAYPELSCHKRPIAVPSG
GVWPITDIYCAGQEETFSFLEDVLTEVIDLFPSKYVHIGGDEATHTEWKKCPKCKARMKT
ENLKNEHELQSYFIKRINTFLKSKNKQLIGWDEIIDGGLADDAVVMVWRGNNIVKKATEK
GNRVILTSQGYIDQYQGLPDNEPLAIGGYLPVSRIYNEAFSEKELSIEERSRILGVQANL
WAEYVPNEKHSEYMLFPRLLAMSEVFWKSEKERNWTDFAQRLQKSLARLEIMDINYAKSI
YQTTGKVFDNGNNSVKISLQSETPNADIRYVLNQSDFSNAIPYTDTLRINETTQIQAAVF
FDNKPHTAVYSNTITFHKAMGKPTSYNPTYHKSYSGQGNKTLTNIVRGTKDFHDKQWLAW
LVDNATINIDLETPQDISKVVVGAMENQGSGIYFPTEIRLFTSEDGKKYTPKGKIERPYS
VNGFAILHDFALEFPTEKTRFIKIEIKNLGSPPKGGDAWLFIDEILVF
>OBAHECAF_00730 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MNKIKHSKVWNEIKTNDSWSIFKTMGEFVNGYEKLSLIGPCISIFGSARIKPGTKYYELT
VRIAEKIVNEGYGVITGGGPGIMEAGNKGAHIGKGASVGLNIDLPFEQHDNPYIDSDKNL
NFDYFFARKVMFVKYSQAFVVMPGGFGTLDELFEAITLVQTHKIDRIPIILVGTEFWQGL
VDWIKVTLLEHFGNISPEDINLFHLVDSEDDVIDVIEKFYSNSNQLRPNF
>OBAHECAF_00731 hypothetical protein
MIQTNATSTSIFQFFGFQENILNIKVIAEPKYKIALCFLIKKSTIKKLTNMSSNKTIEFS
T
>OBAHECAF_00732 hypothetical protein
MKKLELKQMENVQGGEISQRNCGILGVGIVVGSVIGVFNPIGWGLAITSFGAAAASDCF
>OBAHECAF_00733 hypothetical protein
MENLQGGKASERACLIGGGLAAVAFVSGFLVPAFFFTAMAITAGAAYSGCFD
>OBAHECAF_00734 hypothetical protein
MKYMKLGLILVGLLIIISLIVLTNGILETTTVRDVFLVPALVIIFALIFKIIKEEKNK
>OBAHECAF_00735 hypothetical protein
MKSLLNYLLLCIGLISVVFILSEYEFITKIAFALASMGCLSLFAISFEKQNAQKISFGVF
GFVSLLAAAYFISYDEVEKFFIFVIMGSYFCLMSQKRKIYKKKSK
>OBAHECAF_00736 Lipid A export ATP-binding/permease protein MsbA
MIIFISHRLHSLQKVADEICILDGGKIILSGNHENLMQTRNFYSDFFS
>OBAHECAF_00737 Lipoteichoic acid synthase 1
MNKFIRITEYLVFLYRLSLVFLFYFVARLLFIAFNIDVIDGCNFLTVSKLFAYGIQFDTT
AILYVNLLFILLSIFPLWVNTRKGYQKMVFWVYFIPNTIAYATNFVDMIYYPFSKSRLTT
ASFAVIENEQNKTALFFTFVGMYWYVFLIFIALIFCWMYFYKRIKVRESTIHPLPYVFGS
LVGLAGIGTLVLAGIRGGTLSHSSRPINIVDASRYVSVSAHADVILNTPFTLIRTIGKNK
GFRTYDFVSEDYIAEHIKPVKLYYREVKNKPNVVLFILESFGREYWGCMNKDRNIPDYKS
YTPFLDSLAQHSMVFDNAYANGRQSIHGMSSIYGGIPTLQVAYTSSPYAQQPTQSLVSIA
NELGYDTSFFHSAPNGSMGFLGFSNILGFQHYYGKTEYGNDVDFDGVWGIWDEPFFQFMN
TVLSQKQQPFFGSIFTVSSHHPFKVPQQYEGKFDKGNLEIHQCVQYTDHALKKFFENAKK
QSWFQNTIFVFTNDHGNQTYYDLYKQPITKMGSPIMFYSPNEEFVTIGKSSEIAQQIDIY
PSLVDLMGYNKPFRSWGRSLFAEANETPRAYISDTHVYSLMQGSYIYVMNQDGTMNGIYE
REDEGLKNNLLGKENNPETEKGILDLQAFIQDYMDRVIHKKLEN
>OBAHECAF_00738 hypothetical protein
MAVYKKRNNRPNRKKKIDELDELEEEQLHQESTTAEVFDSLDAGASKTEAWVQKNQKTIL
GVLVAVAVVGLGVLLYQQFVSAPKEKEGANEFFFANEFFNEALNATDDRAKDSLFTLSLE
GGKGKYGFLEIIQEYSGTKAANLSQYGAGMAYMHKGEYQKAIDHLKKFDSPDDVMGVLAL
GNIGDAYSQLKNNQEALNFYKKAYTHSDNEFTKPMYLKKAGITAMLLNDNKEAGKLFEQI
KDEYPTSEEARTIDILIGKISN
>OBAHECAF_00739 6,7-dimethyl-8-ribityllumazine synthase
MATENKNLSQYDKTKIPNVANYRFGIVTSEWNEQVTFGLKKGAIDTLKDCGALEESILCW
EVPGSFELIYGSKKMIKTQRVDAIIAIGCVIQGETKHFDFVCQGVTQGIAQLNVSENIPV
IFCVLTDNNMQQSLDRSGGKHGNKGVEAAIAAIKMVTLG
>OBAHECAF_00740 UvrABC system protein C
MSIELTLQTLPSKPGVYQFYDKSDSLIYVGKAINLKKRVSSYFQKKHESGKTRVLVKKIV
RIEHIVVATESDALLLENNLIKKYQPRYNILLKDDKSYPWICVKKERFPRVFQTRKMIKD
GSLYFGPYTSIKTVRTLLELIKELYPLRNCPYDLSEQNIQNQKFKVCLEYHIKNCKGACE
GLQSEENYLQNISEIIEILKGNFKDALARFKKEMVSLATDLRFEEAQQIKEKIDILTNYQ
AKSTIVSSKINNIDVFSIVSDEEYGYVNFLQVAYGAIVRAHTIEIKKKLEETDRELLEFA
IVDIRERFFSNSKEIITPFEVTLPNNLQLTIPKLGEKHQLLELSLRNAKHFRQERFKQVK
IADPERHTNRILSQLQRDLHLSEPPIHIECFDNSNIQGTNPVAACVVFRNGKPSKKDYRH
FNIKTVEGPNDFASMEEVVYRRYKRLLEENEPLPQLIIIDGGKGQLSSALKSLESLDLRG
KIAIIGIAKRLEEIYFPEDSIPLYLDKKSESLKLIQQLRNEAHRFGITFHRQKRSKVAIV
SELDNIEGIGDKTKESLLKHFKSVKRIKEASLEDLQAVIGYRAKKVWEYFR
>OBAHECAF_00741 6-aminohexanoate-dimer hydrolase
MQNALRTYFFLYLCEASTIEIMKKFLIALLLLIAITITVFYAMGYGYVFTAVRVVYGSGH
RTAFLSDFSYFDNRTIQRGKPQAWNIHKNYNEVASTEELDALHDKYHTTAFMIIKNDSVW
HEQYFDDNSHKTLSNSFSMAKTYVSAMLGKAIMQGYIKSLNQRVGDFFPEFSTGLAADLT
VGDLSSMASGSNWDESYYNAFSVTTQAYYDKDLRKIILEKVKIVEEPGQKYVYQSGNTQL
LAMVLEKATGKKLTDYLSETFWQPLGCEYDAFWQIDSEEKGLEKAYCCIASNARDFARMG
KLYLNYGKWNGNQLLDSSFVAKSIQPRFTESPEYGYGMWLLSRNGKNFFMMRGHLGQYVI
MQPEDKIIIVRLGHLKGEDKLGDPFTDDIYGYIDQAYKMLQNAQ
>OBAHECAF_00742 hypothetical protein
MLNKIPLEDILFLDIETVPLFESYQELSEETQQLWEEKTKYSRKEEFSAEEFYDRAGIWA
EFGRIVCISVGFFSFRNQQRTFRVTSFIGDEICILKDFAQLIESHFSRPNHVLCAHNGKE
FDFPYILRRMIINRLPIPAKLQLFGKKPWEVPHLDTLELWKFGDYKHFTSLKLLTHILGI
PSPKDDIDGSQVREVFYKEKDIDRIAIYCQKDTVTVAQILLRFRNEELLDEDEILFV
>OBAHECAF_00743 Transcriptional regulatory protein ZraR
MNKILLVEDDITFSKMLSRFLERNGYDIVESTTLEEALTMLDSSLSMIFTDLRLPDGDGI
LLLKEVKEKYPQIPVVVMTSYAEVSTAVEAMKLGAFDYISKPFQREDVLNVITNAKKSAS
FQIKNTSKPENKDVLPSEKIKQKLFVEGISVASKKLNDFIRLVAPTDMSVLITGESGTGK
EVVAKSIHMKSERASKPFIAVDCGAIPKEIASSEFFGHVKGSFTGAISDKKGHFEEANGG
TIFLDEVGNLSYENQIQLLRALQERKIKPIGSSKEIDVNIRVLAATNEDLLIAVEKGQFR
EDLYHRLNEFSIKVPSLQERKDDLMIFASYFLDLANQKLHKNILGFTKMAVQHMFSYSWH
GNLRELSNAIKRATLLAQGSYITENDLPESIINSSRVPSIQKISFSTKDNEKDLIINALK
EVDYNKTEAAKLLNITRKTLYNKLKAYGINL
>OBAHECAF_00744 Thiol:disulfide interchange protein DsbD
MTKRIFAIVALMVGTLATISAQEINWMSFDEALAAQKKNPKKIFVDVYTNWCGPCKYLDK
TTFKNKDLVEYMNKNFYAVKFNAEGNDVVNYKGQKFENQGYDASKAQTRNSQHSFAGYLQ
VNAYPTMIFFDDNGEYILPVQGGMPATQLEIFLKLVANNDYKNIKTRADFQEYQSNFKGT
FKE
>OBAHECAF_00745 hypothetical protein
MSWYDFIGYAASLFVVGSFLIKDNIIYIRLTNLIGCVLFVIYGVLINNIPIILPNAFLML
VQIYFIFLKRKDKKKQSCDK
>OBAHECAF_00746 Lipoprotein-releasing system transmembrane protein LolE
MKAVFYIAKRYMVAKSSQNVINIINRITALVVVLGAVSLFVVLAGFAGLKNFTLSFSSIF
DPDLKIFPKTGKYITFSDEVANKLSDTDEVAFFSSILEEQVFLNHKQKNHIAYIKGVDEH
YPLVCDVDSILVLGNWEIQAPNVVVGATIFNTLGLGFVDTSSPLQIVVPKSGRGSITQEV
KPYRESFVVVAGVYQLTEELDKKYVFSSLTEAQQILGLSSDQVSAIEIRLASHVSEKEVI
EKIYQIFGDTVIVKNRMQLNDALYRMLNTENIAIYLIFILVLIIALFNLAGAIIMMILDK
RKDLHTLYALGMNVSQMRQLFFLQGTMTSVIGSFLGIIIGMLIVFLQQQFQFVTIGVGLP
YPVEIEWINVFLVFFTIVILGVLASWIASSRVRLQP
>OBAHECAF_00747 Ribosome-binding factor A
MENNRQKKIAGIIQEELAKVLQQSIRDAGQHNLIISVTKVSVTVDLSVAKVYLSVFPESK
AEDILKGTISNTSLIKHELSQITKNQFRRMPDLLFYIDDSLQYIEGIEKSLKGEENPIEN
RELLYKRKKS
>OBAHECAF_00748 Lysozyme M1
MRKRKRQHTAKKRKEFSWNKFLVVFILFFSLLIGGFLYVRKYYPAHYQRILNKVFLSKTN
IDYENKRIERISYNYRTKTFGIDLSHYQERNDIVWDSLYLERGNIPLKFAIFRATMGNNT
RDKNFHYFWEQAKKQKLVRGAYHFYRPDEDPVQQATSYLQTITLEKGDFLPILDIEKLPK
KKKVKQYLQDIQVWLDIVEKKYGRKPIIYTYISFYNDYLHDKFKNYPLWIANYNNVLTPT
HVHNWKMWQFTENGITPGSKVKIDLNIYNGSEEQMQELLIQK
>OBAHECAF_00749 Acyl carrier protein phosphodiesterase
MNFLAHIYLSGEEDNLVKIGNFMADTVRGKQYLSFPEPIQKGILLHRQIDTFTDTNPTFR
SSRKRLVPKFGHYSGVITDVFYDYFLAKNWNLYSDIRLEDYVQQFYELLECEKSKLNEHT
IFIMQHMIKDNWLLAYASLEGMEKILYQMDRRTGFKSNMQYAIKPLIEHESVFENEFFSF
FEDIRKFIVHQL
>OBAHECAF_00750 hypothetical protein
MYTFSNKLRLTAIVLIIIGIIGIGVGFFTAPKTVEDVKTMEQAHHSDAHADAHHDDAHYE
HVLHQLQNKPWAAVYVAALFFMLISLGVLAFYAINRVAQAGWSPVLFRVMEGITAYLFPG
VVIVFTLLVLSGMHFNHLFMWMDETVVAHDALLQGKQGYLNVPFFLGRAAFYMLGWVGYR
YISRRLSIAEDTATTNRPFVRNFKWAAGFLVFFLVTESMMSWDWIMSVDPHWFSTLFGWY
VFASFFVSGITVIAMITIYLKSRGFLPHVNSSHLHDLTKFMFGLSIFWTYLWFSQFLLLW
YSNIPEEVTYYVSRIRDYKVLFFGMLLLNFILPLLVLVNTDYKRISKLVFAMGIVILVGH
YVDFYVMIMPATVGDQWSIGITEISAVLFFLGLFIFVVFTALSKYPLLPKGNPFIEESKH
YHY
>OBAHECAF_00751 hypothetical protein
MKNIVKIALFSSVSLLLVSCFNKREPNYQFMPNMYESVGYETYQQSPAFKDSMQAQLPVA
GTIKRGWQPYEYADTPADLLLAKEELKSPLVADTENLEQGKFLYDIYCAVCHGEKGDGKG
ILVERGKFGGVPSYADKNRVITPGGTYHVIYYGLNAMGSYASQINEKERWQVALYVEKLR
DELVK
>OBAHECAF_00752 hypothetical protein
MSKKVVQALYNDDDILMAAVKTVRSKNHQISEIYTPFPVHGLDKAMGLAPTRLAIASFIY
GCIGLTVATLMVNYIMIEDWPQDIGGKPSMTFLQNMPSFVPVMFEMTVFFAAHLMVITFF
LRSKLWPFKEAENPDVRTTDDHFLMEIAVTENNVSEVTTLLKETGAVEIKIAEK
>OBAHECAF_00753 hypothetical protein
MASHYEAPIRKPLVTGDKSYHDVTVDIARPVEGKANRLWWIVFSISLVAFLWGLGSMIYT
VSVGIGTWGLNKTIGWAWDITNFVWWVGIGHAGTLISAVLLLFRQKWRMAVNRSAEAMTI
FSVVQAGLFPIIHMGRPWLAYWVMPIPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWW
TGLLPDFAMLRDRAVKPFQKKIYSLVSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHT
IVSFDFATSVIPGWHTTIFPPYFVAGAIFSGFAMVNTLLIIMRKVCNFEDYITIQHIELM
NIVIMITGSIVGCAYITELFVAWYSGVEYEQYAFLNRATGPYAWAYWLMMGCNVFSPQFM
WFKKLRRSIMFSFIISLVVNVGMWFERFVIIVTSLHRDYLPSSWTMFSPTFVDIGIYIGT
IGFFFVLFLLYARTFPVIAQAEVKSILKSSGEKYKKLRDNDPNH
>OBAHECAF_00754 Menaquinone reductase, iron-sulfur cluster-binding subunit
MASNKKYWKSVEELNENSVIDTLKQNEFVEEIPVDEFLGDKATLESSSTTRRDFLKYVGF
TTAAATLAACEGPVHKAVPYVVLPEQIRPGVADYYATAIADGYDFASVLVKTREGRPILI
EHNKEANSHCEANARVIASVLSLYDNLRVKNPIAKGGSAISWNDLDAEAMKALEKAAQEE
KQIVVFSHTLASPSTYKLIENLKEKYPTVKLVEYDAISEEATLNAFQKKYGVRAMADYDF
TKADVIVSFGADFIADWQGGGFEGAYAQKRIPKNGKMSRHIQFESNMTLTGANADKRVPL
TPSQQKVALAKFYGYLTGISVSGNLDAKVEEQVKKAAEQVKRAGTRAVVVSGIQDENAQL
LVLDINERLQSVAFNTKNPINVRKGSLVALKELIADMNSGKVGVLIINNLNPLYTLPNAA
EFETALQKVAFSVSFSMKADETAIKTNYIAAAPHYLESWGDVEFKKGYYGLTQPTIRPLF
DTRQLQDALLKWSGSDKTYYDFIKENWTASILGEAKWNKALHNGVFVSAKEELAVSNEVS
VNEALNSLAKTSTNGFELTLYSKIGIGDGQQANNPWLQELPDPITRTTWDNYLTMSSYDA
KELGIKNWHVATGALDGNYAEITVNGITLKVPVLIQPGQARGSVGLAFGYGKKEAMKKEM
QVGVNAYPLYQNFDNVQSVTIKNIGGTHEFACVQLHNTLMGRGDVLKETTLEEFNTKDAK
EWNVKPVVSLDHKEVLASSVSLWETFDRSSGHHFNLSIDLNACTGCGACVIACHAENNVP
VVGKEEMRRSRDMHWLRIDRYYSSADTFKGDLETKAGIEGLNAALSTYGEMEDPAENPQV
AFQPVMCQHCNNAPCETVCPVAATSHGRQGQNHMAYNRCVGTRYCANNCPYKVRRFNWFL
YNNNDEFDFNMNNDLGKMVLNPDVTVRSRGVMEKCSFCIQQTQAVILKAKNEGRAVREGE
FNNACACSAACGTGAMVFGDINEKNSEIAKLITDDRAYHLLEHIGTRPNVVYQVKVRNTN
EA
>OBAHECAF_00755 Menaquinone reductase, multiheme cytochrome c subunit
MKKVKNHNLFGVSVFSILLTFMFSTSAFAQGDPAKGETLFKANCMACHQLDKRTIGPALG
GVTERRTTEWLHAWIKNSEKLIASGDADAKAIFEEFNQVPMAPYEDILSEQDINDILAYT
ANPPVVEEVEEEVFVPVERPEVVAERSLIYFITIVGILAIIVALIVILSVLNMASKVIAE
GNITTEEFSKRKEGFLVRAFAENPFFVLTTVTILLFGSTYAMYGYFMQVDVNQGYEPIQP
IHFSHKIHAGDNQIDCKLCHSAARVSKTAGIPSLNVCMNCHETISEYKGEPDMVNGYTRE
FYSNEIKKLYDAVGWDAQNFKYTGETKPVRWVRVHNLPDFAYFNHSQHVTVAGLDCQQCH
GKVEEMEILHQHAPLTMGWCVDCHRKTEVNTDNGYYENYKEVHAELAKKLNVEKLTIAQL
GGLECGKCHY
>OBAHECAF_00756 TonB-dependent receptor SusC
MYKHVLMLFVLAFLTSPLLAQVKVTGKITDQNNAPLPGANVLVKGTTRGVSSDFDGNYEI
QAQEGDVLEFSFMGFHTQSKKVTGGGKSLIINVLLEEEAEQLDDVVVVGYGTQKKVNLTG
AVASVDVKKMTTRPSSNIAKTLQGTVPGVTIISRPGGTSLNIRGRGNIGNSDPLYIVDGI
EVSASFFNTLDPNSIENVSFLKDASSAAIYGAKAAFGVVLVTTKSAKSGVLQISYDGSSG
IQMPTYLPNMVNSAQYAEMYRTAERNTGVAENNLTFTDEMIQKYRDGSDPDRYPNTNWFD
LILRKQTFLTKHNLQFSGGSDKFKYVFGTGFLRDEDMSPGTATNRYNINSKTSAELKPWL
TLTSNVNLIYSKYNREGGGSNLLESLRVPPTQVAKHSNGEWGSVRNGRQATGEEINANPL
RSWAENGRGNSTTKRFLGSVGIELRPFKNLKITNQFGYNYDDYRGFSFSNRRKGVPSFLN
PSSGIIPATPRAENQMDLNWNYSEKFNYDAWLNYDQTFNDVHSITLIAGTHADMYQYKKL
YVRRKNFASDDMNDFSGGSIKESDQLPTNGDDDGPFYLEENINSYFGRFGYTYNQKYLFE
ANFRADASSRFAKEGRWGYFPSFSAGWRMEQEDFMKDLTWIDGLKWRASWGKNGNIKNIG
LYDTYSTYNSNNTIVIGGVSSTILTEGRIGNKNLTWETTTTTNLGLDLSIAKGLLGINVD
YYDRLTDGILVRANDIATETGLSSSQIPARNVGKVRNKGIELLVSHANQIGDFSYNLAFN
ATHNKNTIEDLGDKVTQLPPDGRWIFRKGGSVGDFYMLQADGLYSTQDIADGKVVPFGEQ
VPEAGMIKFIDVDGNKVINDDDRTIVANDVPKFTYGFNLDLNYKNFGLSVLGQGVTDVMV
YLSEEASQAFFDNSVPRQWQLDNWTTDNQGAIYPKLFTPADQRYKYNNHRSSFWLFDASY
FRIKNITLSYSMPDEWVKQIGFTSLRIFFSTDNPFTIRGDKRMKDFDPEVASGRGYSVAL
KSYTAGLSLSF
>OBAHECAF_00757 Starch-binding protein SusD
MKNILKIILLTTTFIAVGCSDEFFEKTPQGSLDPSKIDETLLVGFRNSIYGYKGGMSLNG
YSAIFLDGYADNGYSRNSWDSNGASVQANTLTTAQNYGYGWFYNGIRACNQVIEKIDDFQ
KVSESIRSKYKNEARVMRAWLYGGLTLYFGDVPFVPNLTNDFPEGIARTSSTQIREWVLK
ELDEAIEVLPVSNDKGTFNKAVAYAIKARMAYYFGKYDQAEVAARYVIDNGGYRLHEVAS
LSEDMKKDGEYFKKFIDFSAYGVSEETFIKGIFNYQNIWKADNSPETIIAQELIANEQEG
TWLRVTALLTPNLVNKQAWATIVPIQELVDAYWTTDGKTQPTLPTMDERITKYNELKAEI
NSIKPNMPKKTYSEAVHSIVNDLPSRDYMLQYKNRDSRLYASIIFPFSAVNRFLPDQYQE
YIPDIVNYGRSGFAFRKMTGADDVISAYGGGYFVTGVDFPMMRLAEMLLIYAESRTQNAG
YDATVTTELNKLRKRAGMPNVPETLSKTEALDFIRSERRIELAGEGFRFFDIRLYEDDKR
NGGYKGSQAASVVMKGQIRDVVGNPGAKKTWTPRLMYMPIPATVIDKNPLMKQNEGY
>OBAHECAF_00758 Holliday junction ATP-dependent DNA helicase RuvA
MITQLQGKLIEKNPTHVVVDCNGVGYFVNITLNTFAALPEADSIKIYTHLQIKEDSHTLY
GFLTRAEREIFVLLLSVSGVGASTARMMLSSLTAAQVRGAIVNGDVASIQSVKGIGAKTA
QRIILDLREKMMKVQNIEEVALTQSNTNKEEALAALEVLGFVRKQAEKVVDKIIKSDSEE
LSVEQIIKIALKSL
>OBAHECAF_00759 hypothetical protein
MNRYLKYIFLIAFLTNLSVWGQEITKDTTQTKNNIPKIGLRTPSSIANRYTYNPQLNRYV
YRQTLGETDLTVPQILTIEEYEALITREQRSAYFREKSSALSGNKGEEQKNKAQRDLLPD
LYVKSELFESIFGGRNIDLIPKGNVGIDLGLYVNKNDNPAITPRNRITYGLDFDQRISLG
LTGQVGTRLKLNAQYDTQASFDFQNVFKLEYEPNEDDIIQKVELGNISMPMSNSLITGSQ
SLFGVKTELKFGRTTITGVFSEQKSERKTVTAQGGGILTEFEFTALDYDENRNFFLAQFF
RDNYDKALENYPFINSKVQITRLEVWVTNRNNRTGNIRNILALQDLGEANPLNTRINQNA
PIGFFSSTTNNMPTNAANRFDPAEIGGSSVLTDAIRDVATLQQGFGAISNLVNQGYDYAV
IENARKLEEGVDYKVDTKLGYISLNVALSSNEVLAVAYQYTYGSEVFQVGEFANDGISAT
TYNTSASQNAITNNLLVLKMLKSNRLNVKDPIWDLMMKNVYSIGSGQLDPEDFRINIYYS
DPSPLNYISKVSDAGWDNGLEDKILLNLFNFDRLNKYQDPQPGGDGFFDFIPGITVDQQY
GKIFFTKVEPFGKFLHQTLGGGNYDDPATYNENQRKYVYPSLYANTKTQAQMDGSKNKFQ
MKGRYKSSGRRGISLGAFNVPRGSVTVTAGGRILEEGIDYLVDYMSGTVEITNPSLEASN
IPIQVSMENNLIFGGQTTRFMGVNIEHKFSDKFIMGASVVNLRERPFTQKTSYGQESVNN
TIFGFGGTYSTELPFLTRWVNRIPTIKSDVASNLSVRGEFAYLVPGTPKGDDFDGETTVY
LDDFESAQATIDIRSPLAWKLASTPLEFGSGSGNSPRRLYGTSPEDPENMRNGYGRAKLA
WYTIDPIFYSSQKPSDVSGDEISKNSTRRIYLEEIFPEQQVAQGESLVQTTLDLAYYPNN
KGSYNNNPAFQSANADEKWGGIMRGLTYSDFQESNIEYIQFWMLDPYHSGEYSGTGELVF
NLGNISEDVLKDGRKQYENGLPGLSSSAAVNSSSWGKVPGAQSLLYAFDTNSSNRALQDI
GLDGLSDGDEASIYNNNLSESPNDPALDNYEYFMSRGGGILNRYFNYNGTQGNSPVSVTE
SNRGATTNPDIEDVNGDFAMNTENNYYEYRVKIRPNITRSDRFVNDIRTVAVEAPNGRTV
SARWIQFKIPIAQGQMVREGYKFPLAPNEEIDIMNSITHMRMYMTGFSQEMLLRFGTLDL
VRGDWRYYSETLETNLDDPSDDNTQVEIGSVNLIENETRTPIPYRMPPGVYRERINANNT
LVEQNEQSLSYSVNNLEPLDSRAVYKVMNLDLRQYKYIKMFVHAEAYQNKSLSDNQMVAF
MRIGTDFNENYYQVEIPLKITPSGANTDMAIWPTENQLIVSMDVLTKMKAIGLRNQTLNN
ATYYDTNLNVVNENTPYTIGENRYVIKGNPSLGSVRSVMIGVKNITGNTQSGEFWFNELR
VAELSNKGGWAMVGALDANAADLLNISATGRMHTVGFGAVDQTPNQRSIDNTQEYDVVMN
INAGKLLPEKWQIQVPVSLNHAQKRSTPFYDPSYQDVKLDDRLNIAQTPEERKAIREQAE
NLTVRKGINLIGVKKNFSEGQKKRMYNIENFTFNYAYNEMHHHDYELRYEDEQNVRAGFL
YNYGFENKTIEPFKKSERFTGKKYWQWLADVNLNLLPTSIMFSSDVNRSLSKQLFRDVYF
EGVDASLQKTLPELQQRNYLHNYQFGVNYNLTRSLKASFNATNNSIIRNYYIYDSNGDVT
SYDRNVTLWSDFWDLGNPNHFLSKLQISYELPLSKFPFLDFMKANYTYSGDFDWQRGSQT
LLQLAKHDINTLQNANTHNLMVNASFEQFYRYLGVKPTPRGEKPSVGKSLATMLKTISVN
YAETNGKTLPGYTQNVGFLGTTKPSFGFMFGSQADVRYEMAKKGYLTDFVDFNDQFLQSK
ERDLTFTANLLPIPDLQIDLKAKRQYTDNYTETFEVNNLTYNKLIGNQVGNFNITTNLIA
TTFNKIDEYNSVPFERFKENRITIARRLASERGVDLNDPNNLDQEGFPKGYSKTSQSVMI
PAFFAAYSGGNANSTSLSAFKNIPIPEWKITYTGLGRLESMKRYFNRFSLAHGYNASYVL
SEFRTNLEFDPNNLFKVNAKGDYLSQQLFTNVTLVEQFNPLIRADMEMKNSISALFEINR
DRTISISLDNDYLTEIIRKEFRMGLGYRIKDLRFVTKVNGVRTTLKSDLILKGTLSHLNE
FTVIRNMEITNNQVTAGQSNWIGDFTAEYALSRNLLASYYFRYNFSKSAISTAFPMTTIR
TGLSVKYTFN
>OBAHECAF_00760 hypothetical protein
MKQIIKNSLIGIGLYLLAGILFSGYHHYMFITFLLLNIFVSYFVVRNKEKKEVRHNLIWI
NAPILSLLLITSFLRMVLGL
>OBAHECAF_00761 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLNGQYQQIKDEVLSSFNEILDSTAFINGPQVSAFQKDLETYLGVKHVIPCANGTDAL
QIAMMGLGLKPGDEVITADFTFAATVEVIALLNLTPVLVDVYDDTFNINIDAIKKAITPK
TKAIVPVHLFGQPADMEAIMKIAKEHNLYVIEDNAQAIGADFTWSDGRKQKVGTIGHVGA
TSFFPSKNLGCYGDGGAIFTNDDDLAYTLRGIVNHGMYVRYHHDVVGVNSRLDSLQAAVL
RAKLPHLDTYNQKRRIAAEKYTKALMENPNIVTPFVKTSYDHVYHQYTLRITNGKRDALA
KALTEKGVPYGIYYPIPLHAQKAYTNDSYDETDFVATNQLVKEVISLPMHTELDNEQIEY
ITSIINEVV
>OBAHECAF_00763 hypothetical protein
MNTEKKRIEEKDKKIKNWLLWGPYLSERQWGTVREDYSANGDAWNYFPHEHARSRTYRWG
EDGLAGFSDNHSKICLSVALWNGKDPFLKERLYGLSNNQGNHGEDVKELYYYLDNTPTHS
YMKYLYKYPQSEFPYKLLEETNRKKGLRDLEFELIDTEIFKNNAYFDVLVEYTKADEKDI
FMKITIINQGEEKAPIFVLPTLLLRNHWSFFDVNPLPSISRKGNENSVKISNALEEDYYL
YFEQADRCLFTENESNNEKLHKHPNEHPYKKDLFHDAVISGDFELATQRNHGTKFSPMYF
FELETKEQRIIYLRLTNEEKENPFSGVNELFASREQECDTFYRNRLKTKNEELYLIQKQA
LSGMLWSKQYYYYNIERWLKGDSKHPAPPKERWKGRNSDWTTLRNSDVLLMPDKWEYPWY
AAWDSAFHCVSMAMIDIQFAKEQLLLFTKEWYMRPNGQIPAYEWNFSDVNPPVQPWATLM
IYNIDQKQNGTSDISFLKRMFNKLSLNFTWWINQVDSSQNNIFEGGFLGLDNIGVFDRTQ
GIEGVETLEQVDGTAWMALYSLCMLKISLEISKHDESFEEMATKYFAHFIHIAKALNHIS
EEHKGIWDEKEGFFYDRIIFKDGNSKLVKVRSVAGMLSLIAVLHIDQETLDRLPRFKNSF
SWFQKHLMNELKYPIIQTSDNNKGMLLSLVPKNRLDKMVRALVDEKEFLSDYGIRSLSKI
YTHPFRVPLEGKMYEIAYDPAESTSNMFGGNSNWRGPIWFPINYILIDTLRELYRFFDDT
TYQFPTGNEQNTLNFNQIADEISKRLIRIFQKDAQENRPVNRLHSDVYRQENFQDLILFY
EYFHGDNGRGIGASHQTGWTSLVANLIDEVGDW
>OBAHECAF_00764 hypothetical protein
MIEKDYLKKQIDLFFQELVAVLTKKTVKETRFKEISNLSEKYTQHGIDFFITSSFEEITA
SYGKDIETLDIIIELLFQMKDESIEIVDKLEKIINYTNQNSLNYSFRRNEILTQILVIKT
>OBAHECAF_00765 hypothetical protein
MRQLLTSILLGIFAYSFGQIQGTVTDQNQQPIPFVSVYIENGTKGTTSNEKGMYLLNTTD
KNPTVVFQSLGYKTERRTIQIDKTPYILNISLSEESYLLSEVTVSSKENPANGIIRNAIK
HKTRNSEKTDRFEADFYSKGFLKLMNVPKKILGQEVGDMGGNIDTITRSGIVYQSETISK
IKFEKPRQIKEHIIASKVAGNSNGFSFNTAASANFDFYDNYMNFDAKMISPIADNAFSYY
RYQLESTFYDDQKRLVNKIKLIPRRDKEPVFEGYIYILEDSWAIYAVEVTAKGYRMNNPA
ISELHIVQNFGFNETYGLWTKNLQRFDLKAKIFMISLEGTFSYVYNNYQFKDSFSKNEFK
GEVRRFEQNSNKKDSIFWQKNRQIPLTEAEIVNYRKKDSVETVRTSDKYIDSVETKNNKF
GFFDIFTGYSYRKTSKRYRFGYDGFIDPGSMGFNTVQGYFLGTGFYFSRWNKEKTNSTNI
GVDFQYSFAEKRLRTAGYFTHLFNRINYPRLSVRGGSEIHQFNRSQPISGFVNEVMTLFF
RDNYMKLYHEEFLYLGYGQNLTPETYIDGSLRFSNRSPLKNNTNYSFSKKNKPYLSNNPL
LPLSDEPSFEPHYTLSASIYARFRFNRTYTSFPDRRIYNENDRYPEIVLGMKNVLSASKK
SYQYQQLHARVDYEPSFDNKGDMFLCLNGGLFFNAKHISFVDYKHFNGNLTHLQVEEDPN
ASFYLLPYYSHSTNEAYAEFHARHRFRGYISNKLPLFNKLQWHFVTGFHQLHREGKRPYT
EFTIGLENVGWGKIRPLRVDYVRSFDGNKAVNGVMFGIKLFD
>OBAHECAF_00766 SCO1 protein 
MKKNLLFLLFIVVFGCTSHDSKLVIIGKAPKFSLTNQHNQTITNDTYKGKVYVAEFFFTS
CPSICPIMTKNTVKIQNTFPNEDRLGFASFSINPDFDTPEILKSYADVQGIKSPNWHLLT
GEEDTIYDLANEGFNLHAKVDDSAEGGFEHSGLFALIDTNGNIVSRKDANGNPIIYYNGL
DEEHIKMLIEDIQFLLQ
>OBAHECAF_00767 hypothetical protein
MKRILNILLIIAVLGCSKEELELHQTVLTQAGAFHFGVELPANELGSVGDVYINTNAMSY
QVKTSTGWGDAHELNKSERSRFHIGEGFPAESLGYKGDFFLNTQTGFLHGPKPYQSSWRN
VHNQYKGVWLLPMTNNEK
>OBAHECAF_00768 hypothetical protein
MIEFFRYISNPVYYGEKKNWGIIKNISYCIGLLLFFIAMTVVLNLGVRIFVYLPKNGAAH
SFFENHSFLYILLIGAFLGPILEEIAFRGILIFNRWIFIPIIVLSFFILNIILGIRNMNF
NDMLFIRITIPVGVGLVSILVIQKYYKNILNFYEKNFKYIFYLSAFSFGLLHFQNYSLEG
KDLLFIPLITLPQMISGFFFGYIRMNFGIIYSILTHSINNAIALILSLKLIT
>OBAHECAF_00769 hypothetical protein
MITIATKEFGIIEGKVEYISLTPSKEGNYYVYITLPKGLKTSYGKDIIFNKEMTGRADII
TEDMRLIERFFYQIRKLLGYQL
>OBAHECAF_00770 hypothetical protein
METNQYIASGDVVLSIIPNEKKGLVGIMNIPSANSGKIQKIVKF
>OBAHECAF_00771 hypothetical protein
MKENNSELKIFIPLQRNLLKIILNKNKMKKILLSLTFVVSSFVVLAQETPIKEASVGVEY
GAGVVDENSVERVYDAEMLASQLNESNREMNDLIIKAKVTNVCPKRGCWVTLENDANMLM
FVKMKDYAFFLPNSIVGKTILLDAKATYKTTSVEKLKANAKKAKKSRKEIRAITEPRKEI
HLLATGIRVVE
>OBAHECAF_00772 Thiamine-monophosphate kinase
MIEDKTPQRTTLSDLGEFGLISHLTKNFELKQPSTLKGIGDDAAVIDFKQKKAVISTDLL
IEGVHFDLSYVPLKHLGYKSVMVNLSDIYAMNARATQITVSIAVSNRFPLEALEELYEGI
RLACKLYDVDLIGGDTTSSTRGLIISITAIGEADEGDIVYRNGAKENDLMVVTGDLGGAY
LGLQVLEREKAVFQVNPNSQPDLDMYSYIIERQLKPEARKDIPLLLKELDVKPTAMMDIS
DGLSSEILHICKQSNVGCRLYEDKIPLDPQVISTCEEFNLDSTTIALSGGEDYELLFTIS
QKDYDKIKGNPNLSVIGYITHKDTGKNLITRMGEPIEIIAKGWNALR
>OBAHECAF_00773 Malate dehydrogenase
MKVTVVGAGAVGASCAEYIAIKNFASEVVLVDIKEGFAEGKAMDLMQTAPLNGFDTRIVG
ATNDYSKTAGSDVAVITSGIPRKPGMTREELIGTNANIVKSVVEQLVKHSPNVIVIVVSN
PMDTMTYLVHKATNLPKNRIIGMGGALDSARFKYRLAEALECPLSDVDGMVIAAHSDTGM
LPLTRLATRNGVPVSEFLTENQLESVAQETKVGGATLTKLLGTSAWYAPGAAVSALVQAI
ACDQKKMFPCSVMLNGEYGQSDICLGVPVIIGKDGVEKIVEVKLNDAEKAKFNESAAAVK
EVNKDLQNIL
>OBAHECAF_00774 Alkaline phosphatase synthesis sensor protein PhoR
MITTLSSVLLGIVIFFFDNIPFLGLIPFATLLFAICFFTLQYRVEKFIYKRIKKIYQDVS
LLESTSFKDQVITTDITTLSQEINRFAHTKKMEIEDLKDRENYRKEYIGNISHELNTPLF
TVQSYILTLLDGAAENKNIRKKYLSQAAKGVERLIYIVKDLEMISKLETGELNLHYEKIN
IVELIQNVFDMFEMQAAERDISLIFDQKYEKPLYVYADKERIQQVLTNLVVNSIKYGRHN
GTTEVSIEDISKKKIIIRVTDNGEGVIKENIPRLFERFYRVKKSGNRRESGSGLGLSIVK
HIIEAHKQKIYVDSVFGVGSEFSFTLDKVIFQSAEKDT
>OBAHECAF_00775 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKNMKILLVDDEPDILEIVGYNLEKEGFQLFSAKNGIEAIKIAEREQPHLILMDVMMPDM
DGIEACERIRRNTNLSRTVIAFLTARGEDYSQLAGFEAGADDYITKPIKPKVLVSKVKAL
LRRFSVEEEKVTSLTIDNLVIDRDEYKVIRNNEEIILPRKEFELLWLLASQANKVFKRDD
ILDKVWGSEVVVGDRTIDVHIRKLREKIGENYFKTIKGVGYKLVVKE
>OBAHECAF_00776 Thiol-disulfide oxidoreductase ResA
MGITNNLQFIENSKLRETKSFVGTFKIYTFLICSLLATIGTVHSQTKVATISGKIAGKNN
SLILVEDGSKVRKIIKPNENAEFRDTLHIKSETYEMYEVKFSKGFNVALRENSDIVLDLT
EPTENVKEIISGNDAFISHFYIDKENFFNTHYDGNIYKEKPDVFKNKLKELFANWEKQWK
SHSFEPIRKNEEKWSKYAFVQMLVHYPRANQMHRKSFKETKVPADFFEEEKSIDYDNADE
FEKVNTYRKLVMSKLLSLLTNPNDTKQVQQLIDKTEKVRSQNIKAAYQEAISDLIDHGNP
NNELIYNYIMKNSASEKLRKECEYIFLNTEKSVKKGSKSPSFSFENEKGEKVSLEDFRGK
LVYIDVWASWCGPCISEIPYLKKLEADFKGKEVVFVSISKDIKKEHWQQALEKHQLKGIQ
LWGGSKSDFYDVYFINSIPRFILIDKKGKVISPSAPEPSAPKIKELIEELL
>OBAHECAF_00777 Phosphoenolpyruvate carboxylase
MRNEQLTEKFRQLVENKYQIYNSLFMSLPYDKMTNIGMLLPFLYEESKIGYEQGKTPEEI
IETFFRNHTNLQTEKQKADLLFTIIQYIERQVVLFDSVEDAAFTQLHSDKDLGTILHLYE
KSVQSQKLEEVRKKMENFAVRVVFTAHPTQFYPSSVQRILHDLRSAILQDSTNEIDMLLQ
QLGKTPFVNKDRPTPLDEATSIIYYLRYVYYDAIGELYSNLKTYFGTINPNIVQLGFWPG
GDRDGNPFVTAEITLQVAEELRINILKCYYEHLKKLRRRLSFRGIAEILTELSLSIYTAI
HEKKIISVEHILERLSKAETILKEEHNSVFLNQLLEFSDRVKIFGTHFASLDIRQDSRIH
QQVIDEITEKYAGEKAQKMTFEEKFNWLLSNNIKLSIHDFEGITKETLLSIIGIKEIQQR
NGEKGLHRYIISNSEHIKDVLNVYALFKICGYQPDEINVDIIPLFETIDGLDLSEKVMEK
LYQHPVYQEHLVHRSKSQTIMLGFSDGTKDGGYLKANWEIYETKERLTAISKNFDIKPIF
FDGRGGPPARGGGKTHDFYASQGSSIANHKIEITIQGQTITSVFGNKDQARYNFEQLLTA
GIDNEVFKNDKKDINQQERLYMKALADLSFKRYSQLKSDSMFVPYLQKMSTLQYYGRTNI
GSRPSKRGSDGEMKFEDLRAIPFVGSWAQLKQNIPGFFGLGYALSELKKQGKFESIKKLY
KNSDFFKTLILNSMMSMNKSYFPLTYYMKNHPKFGDFWNQLHEEFLLSKQLTLELTEQKI
LQEQEPLSRRSVEIREKIVLPLLSIQQYALMKIENGEGSTELYEKMVIRSLFGNINASRN
SA
>OBAHECAF_00778 Dissimilatory sulfite reductase
MNRKHVIYLFISLVVLTLLGYVFLGNDKKEYISVENNITDYKSLYVGSENCRDCHPQAFA
DWKMSDHFKAMQHATDSTVLGNFNDVNYTADGITSRFFKKDGKFYIHTEGKNGIYQDFEI
VFTFGYYPLQQYITKFEGGKMQVFRQSWDSQKNQWFHQYAGQKIPHDDYLHWTNASQNWN
LMCASCHSTNLEKNYDAFSDTYQTSYSELTVGCESCHGAGKQHIDFVKSANYQAEKSKEL
FIRLGKNTDQIAELNSCMPCHSRRGETSQFHSFSTEIMDEYIPEIPTKNIYYADGQAFDE
VYKYGSFLQSKMFHYGIRCSNCHFPHSGKIRAVGNQLCLQCHTTDYGTSKHTFHPTNSEA
SDCRVCHMPTRTYMGNDVRHDHNFSVPRPDLSAKYDVPNACNDCHTDKTAKWAATAVQQW
YGKERKPHFAEDLVRGSDQKTYSLQHLEALLNNSSTPNIIRATAVHYLSGIHTQQSFELI
KKELYSADPQTRYRAVLALGNFPIQSYENELFPLLSDEVKSVRLATAYLVLAQKGGQWAK
MHLPAFEPALQEYETFVLSQADFPLGSATAGDYFTLLGDNAKAILFYERAVSKDKSLNHI
RLNLAMLYNGVGQNDQAARQLNDALTHEPNNPQIYYFLALLRSEQSDYQQAKTLFEKAMQ
LGMDNEAIHRNYEAVKIQLRNGSR
>OBAHECAF_00779 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MNIRKLGAIDIGSNGVRLLIMNVLEAESEQPLFRKNSLVRVPIRLGADVFLDKKISEENI
DRLAESMEAFRLLMKVNKVEKYMACATSAMREAINGAAVSDEVFKRTGVKINIIDGSEEA
KIIASTDIHSLIKDGKSYLYIDVGGGSTEFTVFANGEVQNARSFPIGTVRLLDDMVSSKM
WNEVKGWIQENTKKYDKIEAVGSGGNINKIFKNSGKRERQPLSLKYLKDYAKYVSSFNYE
ERIRVLEFNPDRADVILHAMSIYINTMKWSGAKLIHVPRIGLADGIIKTIYYEQIQTSS
>OBAHECAF_00780 cAMP-activated global transcriptional regulator CRP
MEDLQQITEFRTSPELVEKLYQYSIQKSFEAGRIIVNENAYINSIPIVTKGMIKVIRTED
DGRELLLYYIKAGESCVMSFLGGMHNDTSKVRAEVEEDAEILFLPMDKASLFIKEHPEWL
DYIFRLYHRRFEELLEIINAISFKKMDERLLALLQKKQELTKNSVINITHEQLSNELGTA
RVVVSRLLKQLEDNKVLKLGRNKIILM
>OBAHECAF_00781 hypothetical protein
MEIAGYVASIFIGIALGLIGGGGSILTVPMLVYLFRIDAVLATAYSLFIVGATSVVGSFS
YFIKGLVNVKTAVIFGIPSIVAVYFTRAYIVPAIPHEILAVGEFVITKNILLMLLFAVLM
VVASYSMIKKTKHHQEKVAKKQQFNYPLILIEGIVVGILTGLVGAGGGFLIIPALVILSK
LPMKEAVGTSLVIIAAKSLIGFLGENSETPMDYLFLAKVTAFAIFGIFIGMALSKKIDGA
KLKPIFGWFVLIMGIYIIIKETILQ
>OBAHECAF_00782 Hydroxyacylglutathione hydrolase GloC
MKIEQIYTGCLAQGAYYITSNGEAAIIDPLRETKPYLDRLAQDGVALKYIFETHFHADFV
SGHLDLSKKTGAPIVYGATANPEFEAIVAEDNQIFELGSVKIKVLHTPGHTMESTCFLLL
DENGKETALFSGDTLFLGDVGRPDLAQKAANMTQEELAGLLYESLYNKILPLPDEVTVYP
AHGAGSACGKNMMKETVDSLGNQKKMNYALNQPNKEAFIKAVTEGLLPPPAYFGMNVAMN
KKGYSNFDEVLNQGMNPLTADELETTAENTGALILDTRSNQDFAKGFIPQSINIGLNGDF
APWVGTLIVDVNQPILLVTDRDKEEEAVTRLSRVGFDNVLGYLSGGFETWEKSGKDIDSI
NRISAEEFANEVRIGENQVIDVRKESEYAAEHIEDAFSKPLAYINDWISGIDPKQHFYLH
CAGGYRSMIAASILQARGYRNFTEVAGGFNAIAKTNVPKTDFVCQSKVFN
>OBAHECAF_00783 Thiosulfate sulfurtransferase PspE
MFEFFRNIFGSADNSQLKEAIKEGVFLVDVRTPAEFSAGSVQGAVNIPLDRIASNLSKFK
NKKNIVVFCRSGARSSQAKSILEQNGFQNVINGKTWQNVKEVVSGVTEK
>OBAHECAF_00784 hypothetical protein
MRTNMGTTDRIIRLLIAVAIGILYFTNVVSGTLAIVLGILAGVFVLTSFIGFCPLYLPLG
INTCRNKKK
>OBAHECAF_00785 hypothetical protein
MKHEIVVENIKCGGCINSIKTALLKIEGVQEVHVDKETETVSVEGTVDKTILVKALSKLG
YSEKGNNNFIQKAKSYVSCAMGKISD
>OBAHECAF_00786 hypothetical protein
MKNYLKNWNFMRLFRLVLGVLIIMQGVHTGQWVFIPLGCLFSLMPLLNIGCCTTSGCSTP
TSKTNKKQEQIEYEEVR
>OBAHECAF_00787 hypothetical protein
MKKFVKKHLLTLIGIAVGALAGYFYWQQIGCNSGTCAITSSPVNSTLYGSVMGGLLFSMF
KREKNRTDDISGNN
>OBAHECAF_00788 Thioredoxin
MTFQEIINQDKPVLVDFFAEWCGPCKMMAPILTELKIRVGDRATIIKIDVDKNPQVAATY
QVRSVPTLILFRKGEVLWRQSGVAQANQLEELINQDK
>OBAHECAF_00789 hypothetical protein
MLEFLKQPWPWYVAGPLIGLTVPALLILGNKTFGISSSLRHICASCIPANISFFKYDWKK
EVWNLFFVFGIFLGGVIAINLLSNPEPIEVHPALASELAGYGITNYDNPVPQDLFNWQSL
FSLRGVVTMVVGGFLVGFGTRYAGGCTSGHSIMGLSNLQLPSLIATICFMVGGFIMANLI
LPFILSL
>OBAHECAF_00790 hypothetical protein
MQYQNTDKIDDLQIREKDAMCVNESKLEHKWYHNIKYLIVGILFGILFVKAEVISWFRIQ
EMFRLQSFHMYGIIGSAVTIGVISVFLIKKFNIKTIYGEPIRIAPKQFNKGQIYGGLLFG
FGWAITGACPGPLFAQIGMGATVIIVTLLSAIAGTWVYGFLREKLPH
>OBAHECAF_00791 NAD kinase
MKIAIYAQLYAPEYKAVFSDLLIHFEPTDVVYVEHHLFNSLVCDIPPYEGFRTFSAFSDL
DTSFDMMLTIGGDGTILRAITFIQNWNIPILGINVGRLGFLATAQKDEITEVFTALRNKK
YTTVERTLIEVLNANGDPIHPMNFALNEMTVTRKNTASMITINTELNGEFLTSYWADGLI
ISTPTGSTGYSLSCGGPVIMPTAKSFVITPIAPHNLNARPLVIPDNTEIKLSISGRESEF
LVSLDSRIETLSNEISIHIKKAVFSIKLIRLERESFIKTLRNKLLWGEDSRNKSMW
>OBAHECAF_00792 hypothetical protein
MSIHNSLQTKLPIITPHSTVKEVVAVMDSFQVSHVPILNASHFIGMLPLEAIEIASHDEQ
ISDFLYDLDTFFIKETAKWEEAMELFAKYDTNILPVLDEQNQYIGYYLLQDLMGFFSEMP
FLKEKGSFVVLEKDQERYSFSEIAQIVESHQGRMLGILISNTYSNRVQITLKIISDSISE
ILQTFRRYEYAILLEKEDDLYLQELKGKTDYFEKYLNI
>OBAHECAF_00794 Macrolide export protein MacA
MSKKTIIIGAVVLGIILLIVGKKAGWFGGEPNGKEVEIQKIALATLTQKVAATGKIQPEL
EIKISSEVSGEIIDLPVLEGQSVKKGDLLVRINPDIYQSVVNRSVAGLENVRASLQQAEA
GLRESEESYKRSKTLFDKGVISKSDWDKAVSSYEIAKANRESARFSVQSAMASVSEAQDN
LKRTAIFSPADGTISKLNVELGERVVGTVQMTGTEIMRVANLRSMEVEVDVNENDIIKVN
EKDSVNVEVDAYLKRTFKGVVTNIANSANSVASVDQVTNFKVRIHIEESSYEDLLQGKPS
TYSPFRPGMTATVDIITMKKKDVVAVPISAIVIKKMSEIDPETPEEDADKRQEAVFVMKD
GKAELRAVQTGIQDNTNIEIISGVEKEDEIITGPYTLVSKNLKKGDKVVVKPK
>OBAHECAF_00795 Outer membrane protein TolC
MRRFIYLFLFPALGYAQTLWTLEDCINHALEKNISIKQSEIDLSASDVDKLQARGAFVPS
LNSNMTYSLNEGKNINPVTNQFENTFFQSASGGVSMDMTLFAGLRNWRQLKRAELGRMAA
QYNLEKMKDDIVLMVINAYLDVLSNKEQLKNLKMQSKISKQQLERTKDLIEAGSLPKGDM
YEAESQVFAQEQQIIATENMLFISKMGLAQLLLLKDYQNFEIADTSFDVPITDVLSKNPN
EIFQRAKEVVQDIKIAQANVELAENSLRLAKSAYSPRLAAQWGYNTRWSKSQAQNFLDQL
DANKGMYAGLGLSIPILNGFSTKSNIKRQQLNLLKTEWNKEQAVLNLERTVYQAYTDASN
ARKLFEASEKTMQAKEQSYLYSKERHDVGLMTTFDFNQAKTQYENAENEYIRAKYKYIFK
IKVLQYYFGEK
>OBAHECAF_00796 Murein DD-endopeptidase MepM
MARKKILKRNIFLLLTVVLAWGCDDSSTPAPTPVEEIVEKLPVIEYGFNLDDYTIVKDTL
KSGDTFGKILQSHNIQSVEIHNISNKIKETFDPRTLRVGKMYALLFDKKNPEKLHSFVYE
PSITEYYVIQMADSVSVRNEKRAITLVEKEKAGYIKSSLIESALDVGMTYNVAFNLSQIF
DYTIDFFHLQQGDNFKIIYEERYVEDSIYAGVANIKAAYFEHKGTPYYAFNYVTDSVSGK
RDFYDEKGNTMKRMFLKAPLEIFRITSRFGMRFHPVLHRMKNHFGTDYAAPHGTPIRATA
AGTVIEAGYNGGNGNYVKIKHNNTYTTQYLHMSKILVKKGQHVPQGHVIGNVGSTGLATG
PHVCYRFWKNGKQVDPLKEKMPEAIPMDERLKEKYLQDISTLKQQLDALTATKVEEEKLE
ISLEEQNQVTQL
>OBAHECAF_00797 Glucose-6-phosphate isomerase
MLKNINPTQTKAWKSLQAHFEEVKDIHIKTLFEKDAQRAFKFSINWNDFLVDYSKNRIDE
KTLELLLQLAEECELKDAINKYFEGDLINATEKRAVLHTALRADENSNIQVDGVNVLPEV
ISVKKQMKQFSEDVISGKRKGFTGKAFTDVVNIGIGGSDLGPVMVCEALKYYKNQLNIHF
ISNVDGDHVMEVIKHLNPETTLFVIVSKTFTTQETLSNATTAKAWFLKSAKQEDVAKHFV
AVSTNLPKIAEFGIASENVFPMWDWVGGRFSLWSAVGLTIALSVGYDNFEKLLQGANKMD
KHFRTAEFKNNIPVITALLSVWYNNFYQAESQAIIPYTQYLHRFPAYLQQGIMESNGKYI
GRDGKAVNYQTGTIIWGEPGTNSQHAFFQLIHQGTKLIPTDFIGFKESLYGNTDHHNKLM
ANFFAQTEALLKGKTEAEVRSEMGNNVNESLVPFKVFEGNKPTTTFLIEKLTPESLGALI
AMYEHKIFVEGIIWNIYSYDQWGVELGKQLANTILKDIETVNISQHDSSTEALLQAFKK
>OBAHECAF_00798 hypothetical protein
MKKTLFMLMIASIFVACGKDREKGGDDNTDNSLAIAPPAWIQAEWLPLSGKKGLVFKADD
FCFKETDKADDCHKGKIDSKTIRVTKQTYENKKHYTIKLTDAQGKSQEHLFIWNSETSIV
YNGVTYSKKSNDNNSGNNNSGNNNGGNNNNTGNIIAIAPPAWIQAEWYTLNGKKGLVFKA
NDFCFKENEKADDCYKGKIDSKAIRVTKQTSENKKHYTITLTDAQGKNTEYVFTWESGSR
ISYKGTTYMKG
>OBAHECAF_00799 hypothetical protein
MLFNTIFETLKTYSNEQKAKEMSRYMKNNFLFLGVQSPIRKKITKPFLATLKKDNAIAWE
LIEQCWQNPYRELQYFALDYLGLKKEFLTLADIPKLKDLALRKSWWDSIDQLDRIIGGIA
LRFPELNHTLLVWSVDDNFWLRRIAIDHQLLRKEKTNTDLLEKIIVNNLGQTEFFINKAI
GWSLRDYSKTNPEWVRDFIKRHESKMTKLSVREACKYI
>OBAHECAF_00800 Methionine aminopeptidase 1
MIYIKTLEEIEIMRESAQVVSRTLGVLAKEIKPGITTLQLDKIAEEYIRSQGAVPGFLGL
YGFPNTLCVSPNAQVVHGIPNNIPLQEGDIVSIDCGALKNGFYGDHAYTFAVGEISDEVK
KLLQVTKESLYVGIREFKTGNRVGDVGFAIQNHCERHGYGIVRELVGHGVGKKMHEDPEM
PNYGKRGNGKRFRDGMVVAIEPMVNMGTHKVKQLRDKWTILTVDGQPSAHFEHNVAIVNG
KPKLLSTFKYIYEALGIESDEEKEFEFS
>OBAHECAF_00801 hypothetical protein
MNRFYKTILIFSLILAVGCSKDFLETKPSNRMGQTDAETTVEGLEAIANGIHNMMYMYNH
GGQVGGLGQQGIAAQLDMLGDDMINTKPAYHMPVYRYQDHHKVHADGFINYKTWDYYYTI
IQHANKVFLGVEQVDMLPEQRQFILGQAHALRAFAYHNLVQLFAKRYEAGGTNSQLGVII
RTPDKLEDNLPRSTVAEVYAFIDADMEKALEFLKNAPDKKFKNVIRYSTACGIAARIALT
KSEWAKAEKYAKLAIDKSGATLQVGNALIDGFNNYSATEWMWGYTQNAEQQGYFSHFNSS
YSYNFRGHNKSLRYAVNRDIYDQMGEKDVRRKWWVCLDRGDKIPADADAEYFSGGEKNPK
WEVTGQSIKYKALSNSDSRGDAVLMRLAEMYYILAEAQARQGKDSDAQATLNEIMKTRDV
DYNTVATGDALKEEIMRNKRIDLWMEGQRFFDMKRLGIIPNRLKSKNIQVYLTGPEKQTA
IDRNSGINAVNLPKTMDSKFWQFAIPYGEIIGNPLCKQNEL
>OBAHECAF_00802 TonB-dependent receptor SusC
MRGKLIWTLSLFFFALQFVFAQEKTITGMVKDESGQPLLGVTVTIKGTTRGVATDFDGNY
SIKAKAGEVLHFVALGMKPIDRPVSASTTKIDVIMEEEAHELEEVVIVAYGTAKKQSLVG
SQAMVSAKQLETRPITNLTAALSGVAPGVQSTLSSGQPGSSSSIRIRGFGSINAGSDPIY
VLDGSIYNGRISDIVMQDVESISVLKDAASTSLYGSSAGNGVVLITTKSGSRGKKGKPSF
TYSNNIGFSTRGQEDYEKVGAMDHLPLRFQQWFNHYKYNRKLTDEQAAAWANYDMIQQYT
PEYIPYAGINSYYQFVGGKWNYHETKPSGRFVYPAVMMMDGTLNPSITGLLWAEDLDWEK
ALFRTGVRNEHSINVSHNTENLKSYFSLNYLKEDGYQVASDYERFAGRANLSYDVNKWLT
VGTNIGYSTMVNHSPTLTGNQTANTFRYIRNIAPIYPIHKHNPDGSYVYDDKGNKVYDYS
QSRLFAGNYNPIYLTEVDLLTTDNNSANTRSFAELRFLPELKLKLSYAHDVLRYTTKRRY
NNIFGDQPEGLLRISHYKNATTTFNQVFDYNKTFGKHNINALLGHESYRYQVIESETSKK
GMAFLGIDEMGNFIELSSASSSTDEYTKEGYFGRFNYGFDSKYDFSFSFRRDGSSRFHKN
HRWGNFWSVGAGWHLKKEAFLANVSWIDQLKLRASYGTTGNDATSGFYPYQTAYSFSNNN
TNAGLRIATYGYPNLLWEKQVSTDIALEFDILKRLKGTVELFNKESDDLIFAFPLPTSTG
IGSINKNIGKVQNRGIEIELTVDLVEKPDFKWSFTANGTILKNKVLRLPDHSRKLGQANG
NYRYMEGYSVYDYYLPQWAGVNPDTGHAMYVIDAEQYPNYADVNHTQFKGVDKDKYSAYT
YDYNVAKHDFSGSAIPDLQGGFGTNVNWKGFEFGVQFTYMLGGKAYDAPYQGLMSRDKNS
GTAAHVDLWNAWKKPGDITDVPRLDDSTAGEHASKSSNRFLISRTSLMLRNLSVGYSLPK
EVLTPYGITNLRIGISAENLFLWSKRKGMNPMNSFSGTASNIGYDYAKVVSCGLSVSF
>OBAHECAF_00803 hypothetical protein
MDKTHNISLGGFAFLIEDRAYQQLLKYLNDVRKSLGNTSDTEEIIYDVEQRMAELLKTQM
KGREVIVSQDVVYLIDVLGTPEQYIDEEASHDYSFEEMDRDTKNQYNTSDLKGAMNKIPN
FFRHKKLFRDLENKRLAGVFSGLSHYLDMEAVWLRILFLSVYLLMLVIPKLYYLYPFYAM
IWTSVYLLFASIIPIAKTTADKLAMRGKEVNIDTLSSAKESYDSDKIRMRLNKQKGKFLG
VFAGMSEYYNWDVTWLRIGYALLVLLSLPFEEALFSLFCVVLYIMFWLSMNNPKNNFLKA
DAETSENSERAEFKFVPKSNNFSFWGIVRGFFKGIFYFITAIILSILLVLFVGLSLAFFG
INIFFLGTMGGTMLVYDYLPFLIETKWELALLYVSISMLSFVALFVPIKLLINLFSSKKA
TFPKKWIVTNVILFFVGIIGMSIVAGSTIRSFKAYTFDTQKYSLQNSDNTLVVQNARSQF
MLLDDVFSSNYVDHDGSMFMYHNENIEIYVTDKQPYLEVMRTTRGGNIPKAKLNIDKTLY
PLEIKNDTILLPNHYKIEKGGLFRGQEIRIKLYLPEKKKITFDRYSKTVVWFNKKFTRVM
GNKEYVVTKEGLREEPTLLN
>OBAHECAF_00804 hypothetical protein
MEVNTEKTKTQMRKGILEMCILSIISKQNEAYVSDIIENLKAADMIVVEGTLYPLLTRLK
NEKLLDYNWKESTSGPPRKYYELTDNGKIFLQEIVKTWHELQTMVNKII
>OBAHECAF_00805 Putative cystathionine beta-synthase
MQADKSLRVYDSLLDLIGDTPLVRLHKITKDLKGQFFAKIEAFNAGQSSKDRIAAYIIDQ
AEKNGLLKAGSTIVETSSGNTGFSLSMIGAIKGYRCIIAISDKSSMDKVEMLEALGAEVH
LCPSNVAPDDPRSYYQVAKQIHENTPNSVYINQYFNELNIQAHYHSTGREIWEQTQGRVT
HVVVCSGTGGTISGIGRYLKEQNPNVKILGVDAYGSAIKKYHETREFDPAEIYPYKIEGL
GKNLIPTATDFDVIDEFVKVTDKESALMAREMARSEGLFMGYTCGAAMQAVKQYAEMGKF
DENSVVVVLFPDHGSRYMSKIYNNEWMKQQGFL
>OBAHECAF_00806 hypothetical protein
MPFTAQERKELTAIKGIGDTFVNRLEQMGFDSVDKLAEASVDFILLAGSQITKSSCYKNS
PQARKAAEEAIYWAEEKMKLL
>OBAHECAF_00807 Putative pyridoxal phosphate-dependent acyltransferase
MKDLFERIKDNKGNIGRWASHAEGYYVFPKLEGELGPRMKFQGKEILNWSINDYLGLANH
PEIRKVDAEAAAEYGAAYPMGARMMSGHTSMHEELERQLAEFTQKEAAYLLNFGYQGMVS
IIDALVTKNDVIVYDVDSHGCIIDGVRLHFGKRFTYKHNDEQSFLKNIERAKKIADTTGG
GILVITEGVFGMRGQQGILKEILAHKEKYGFRILVDDAHGFGTLGKTGAGAGEEQGVQDK
IDLYFSTFAKSMAGIGAFVSGDQQIIDYLKYNLRSQMFAKALPMIFVKGSLKRLEMLRTM
PELKQKLWENVNALQNGLKARGFNIGDTNTCVTPVFLEGSIPEAMAMVNDLRENYRIFLS
IVVYPVIPKGMILLRMIPTASHTMKDIEETLEAFSAIREKLQSGQYRKQNAELAEQMGHM
>OBAHECAF_00808 Polyprenol monophosphomannose synthase
MLVIIPTYNEIENIEAIIKAVFDQSGKFHILIVDDNSPDGTSQKVRELQQIFPERLFLEV
RTEKKGLGTAYIHGFKWSLRRNYDYIFEMDADFSHNPADLLRLYTECTQNGSDVAIGSRY
VKGVNVVNWPLSRILLSYGASLYVKIITGMKIDDPTAGFVCYSRKVIESIDLDGIEFVGY
AFQIEMKYKTYIKKFKISEVPIIFTDRVRGKSKMNGNIIKEAIWGVIAMKLRNIF
>OBAHECAF_00809 Undecaprenol kinase
MWRLIRKESPIIVHVTITLFLTFLGFYVGITPSEWIVQIIGCGLVLTVESLNTAIEEICN
FIHPDYHKKIGDIKDIAAGAVGFMVGSVTIVLAIIYFPYFF
>OBAHECAF_00810 TonB-dependent receptor SusC
MKQKLIWTMSLFFFALQLTFAQEKTITGTVKDESGHPLLGVTVTVKGTTKGVATDFDGNY
SIKAKVGDILHFIGLGLRSVDKSVQASTTKIDVVMQEEVEQLEEVVVTAYGTQNKSSIAG
SVQTIKAEQLSKVQSANVMQSLAGKAAGVQIKNTSGQPGAGSEVRFRGIGSISASNSPLY
VVDGIPFHGDIASISAQDIESITFLKDASANALYGSRGANGVIVVTTKKGSGNKVRVTYE
TKVGVNTRAVPDYDVITDPREYYQLEFQRRKLGSWVKNNSLTEVQAAQNAATSLVPSIGY
NIFNVPNNQVIDPATGLVNPNAQILYQDDWYKALFGTGFKTEHFVNLTRGGEKTNTYLSL
GYLNEDGYVLNSGFDRVAVRTNVDYKLTDNIKVGTNLNYAYTFQKSPQEGKNSTTFSNLF
SWTRNAAPIFPIYARDRYGNMRYDAKGNIIYDFGKGQTQNFDGSATKRVYIENMNPYATT
LKNTQTNERHSLGARAFASIDFLKDFNFTYNIAYDLFADNRLRYGWEVGGDSAPYGGSIT
NGVRFQSTLTNQQLLSWKKEFGAHSIDLMVGHESSDFQSKMLAGNKTNVVVSDKVFISNA
TKFGSLNGYNDTYQTEGYLSKLNYGYADKYFVNASYRRDASSVFHPDNRWGDFYGFGVAW
NVTKESFFPHSNTLNNLKLKASYGEQGNDNILYPDYVSFDHRTHFSFRRNYKPYLTQYDI
TPDAEGNASVREAYLGNKDLRWEVSKNFNVGFETKLFNRVNLEAEYFVRKVSDMLYNEPQ
QPSSGNPTISRNIGDMENRGFEVSLDVDVIKTQNSNLNLWANATHYKNKITRLPAPFTDG
YYRYVEGKSAYTYYVREFVGVDEADGTGLWNKGDVDTNGIATGEKTTVKVHSQATQYLSD
KTAHPDLYGGFGLSFSYKNWSFSTGFAYQIGGYIYDSVYNGLFVQNEGFGNSGHNFHKDA
YKTWNFNNRNAQFPRMTTADSQQFGVSDLFLTKADYLSWEDISLSYKLAIKEIQSIGLES
VTLTATGSNLWVWSKRQGLDPRMVSLGTGNTTNIYSLYRTISFGLTAKF
>OBAHECAF_00811 SusD-like protein
MRKIAFTYISVALLALSSCSKDFMDKEPESYISDEQVGSSAVAGAGLLKGVYAGLRSYGI
AGYGGHEDYGHKSMLSISDLLGNDVVMNSLSWNGFYYNYTGRVTTHSRSHLPWFTYYIQI
KNVNSIINSVDVATASTEVKYNRAQALALRGYFHLMLARFYAPTYLGNESVHCIPINTGE
VSKVRNTNQEVYAQIVADLEEAVTELSGFQRTSKELVNQSVAQAFLAETYLEMGRYADAA
DMANKARQGYQLLSEAEWKNGFYDINQKETMWGADLNSELTTFVANFFSHFDNTNSGYSE
GGNIAIDKRLYESIPNTDYRKTVFVSEKGGEFDGVEYPAYTSLKFRDLTPNRTEGDYIYL
RSSLMYYIEAEGLARSGDEEKAKDVLFEITSNRDSGYIRSTKTGVDLIDEIVLQKRIEMW
GEGYAFFDLKRLNKGVERNYTDSNHGSFGKFNIPANDAKLLIQLPQREMESTPTMAPNNP
>OBAHECAF_00812 hypothetical protein
MYLRNLETDNTKNIEINMFTDKVFKKYDLITGWITFSISLIVYGLTVEPTVSFWDCGEYI
STAAKLQVGHPPGAPFFQMMGAFFAFFAPNADSVALFVNYMSVFSSAFTILFLYFIITNL
TRKIVTKNGEAISTAQRIAILGSGFVGALAYTFSDSFWYNAVEAEVYAMAMLFMAAMFWL
GIKWTDNLHSERGDKWLILISFVIGLSFGVHFMALLTIPAIGMLYFFNSNFKKTFKNFVI
ANVVSIAVLLLIFKLILPYTLAYFGYLEVFFVNSFGLPFNSGTIIAGLSIALAFFLVLRY
TYKHKKVYLQTITLCILFVLIGFSSWLMIPIRANADVVINENSPTDARLLLAYYRLEQYP
KTHLFYGPMYSDKYADLDEENPYEDGQPKYERDYVKNEYVIVNDYKNTVQSPNSKHVGLL
PRMWHPSHADNYMQITNYLKFNIKPEYFSHKELYQAVDKFKKDVERGRISTAEYDRFLTR
FREYLDIEKPSFTDNMYYMLSYQMGYMYWRYFMWNFVGRQDDIQGKQDNHGRWLSGIKFI
DEIRLGSQDNLPSDVLNNKARNTYFFLPLILGLVGLWFMYTRSERKTWVIFVLFMFTGLA
LKVYLNEKPFEPRERDYALVGSFFAFAIWIGVGVYALFDMIRRHVNPKLSAPLVIVLTFL
SVPTLMAYQNWDDHDRSGKYSAQAIAHAYLDSIQEDVGAMIFTIGDIDTFLLWYAQEIEG
YRTDVRTINTSLLQTDWYIDQMKRKAYESDAIPSQLVHSQYAHGINEVVHHIPRTENIWN
IKDFMNWITSEDPKTKQELTNGRTIKYYPTNKIRIPVNKENVLKSGLVKPEDADLIVDYI
DLTLPPYLDKARLVKLDILANNDWKRPIYFTGGSSEDQEYIWLKDYLQLDGFVYKLVPIK
TAIDKENPYDIGRIDTELMYDIVMKWKWGNMGSSEIYHDIETRRNSNVFRGHLARLIEKL
IEQDKIEKAKNVLDLVMKNLPMEYYDNYFYLNPYITSYYKVGEAEKGRALAEKVVKKYQE
ELTYYLNLSANELYENYANVDRTIRLYMILLVEMEEVDPTFYKEQQVLLRQLIAPLLSEE
ELEEYDHIQMEIPEEQQVTEQKEIEGER
>OBAHECAF_00813 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MQNSEKQNKMNTKIWLSSPHMGGNELKYIHEAFDENWVAPLGPNVNNFEVDLEKFIGENT
KIAALSAGTAALHLALIILGVKAGDEVICQSMTFSASANPIAYQGATPVFIDSEPETWNM
CPQALEEAIQDRIAKGKKPKAIIVVHLYGMPAKLDEILSIAQKYEIPVVEDAAEALGSIY
KGQKCGSFGEMSILSFNGNKIITTSGGGALVCKTQTQKDQAVFLSTQARDNAPHYQHSHI
GYNYRMSNISAGIGRGQMEVLEERIAQRRANHEFYKQLFKDIEGITLFTEPSSDFYSNHW
LSAIVIDEDKAGFHREDLRLKFLEENIESRPLWKPMHLQPIFADAPYYGGKVSETLFDNG
LCLPSGSNMTDEERERIAKVILKFHW
>OBAHECAF_00814 UDP-N-acetylbacillosamine N-acetyltransferase
MNKCIIVGAGTYGQVYAKYLKSEYEILGFIDDNAQLKGTIISQLPVIGNLQFLLDEMDRK
IKVFVPIGDTSSRERILREVRKNGFSTPNYIHSTVNIGTDVILGDSAIYILQGVVIMPMA
VIDNDVMISSGTIISHHAVIQKNVFISFGVNVGASVLVREKSYVGIGATIMTGVKQTGYD
CLIGAGAVVIRDVPDYATVVGNPAKVIKVKNNAHAL
>OBAHECAF_00815 Undecaprenyl phosphate N,N'-diacetylbacillosamine 1-phosphate transferase
MYKTFIKPFLDFILALIGFLLLSPVFIIVTIGLFFANQGKPFFFQLRPGKDGKIFKIIKF
KTMNDKKDEHGNLLPDADRLTKVGSFVRKTSLDEIPQLLNVIKGDMSLIGPRPLLPQYLE
LYNEFQRRRHEIKPGITGWAQINGRNAISWQKKFEYDVWYVDNVGFGLDLKILFFTILKI
IIREGINQKGKATVERFNRYN
>OBAHECAF_00816 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase
MNRIKLFRITTVPISLKTLLKGQHRFMSDNGFEVVGVSSFGKELGEVSEDEGIRTMAIEM
SRQITPLQDLKSLWKIWNFLRKEKPQIVHSITPKAGLLSMLAAKMAGVPIRIHTFTGLIF
PSKKGMMQKLLIQMDRLLCWAATHVYPEGEGVKKDLIKYRITSKPLKVIANGNVNGINTE
YFSPESISDQEKQELKKTLDIQPDDFVFIFVGRLVRDKGINELIVAFSELNLPNTKLLLV
GREEKDLDPLEINTIKEIQKNENIIAVGFQKDVRLYFAIADCLAFPSYREGFPNVVMQAG
AMGLPSIVSDINGCNEIIAEGENGCIIPSKSVEELKLAMKKMREDKSLYHSLQQNSRRMI
VERYQQEAVWKALLEEYNFLIAGRNV
>OBAHECAF_00817 hypothetical protein
MSGIKGLIYKKADLLSKQHSEEMNLKIIHPKHYGKKINIYYIQ
>OBAHECAF_00818 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MKVLHVINSLGTGGAEKLILDTLPLLSQKKGVEIHLALLDAKAYPFYEQMKKNTNIKIIE
LSKGTPYNPLLIFKMIPLLREYDLVHVHLFPAMYFVAFAKLLSLSKVKLVFSEHSTFNTR
TNNMLLSILDKKVYKLYDHLIAVSHDVKSTFDRYLNKFPITLIDNGVDLSRIFTARGYEK
EKLEIKQIDKNDFLIAQISAFRIGKRQDILVKAMSLLPESAKLLLIGDGPDERKKQIKTL
VKELDLEHRVFFLGLRMDIPELLKTVDVNVLSSDFEGLSLSSIEGMASEKPFVASDVEGL
RDIVNGSGILFENENYKELSSILLKLMTDKQLAIEVGKKCKEKAKQYDIQKTVDQTFQLY
QRLLK
>OBAHECAF_00819 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
MKKITVFTPTYNRAHLLPRLYQSLCEQTSRDFIWLVIDDGSHDNTQELIRQWQKDNIIEI
TYLFKENGGMHTGHNLAYKNISTELNVCIDSDDYMPRDAIQKILITWLQIENKEKIAGII
GLDADNKGKIIGTDIPVELKKGSLWDLYNKYGVKGDKKLVIRTDVIKQYPLYPEYEHERL
VPLDVLYIMIGRDYDFMYQNEVYCIVEYQEEGSSKTIFKQYKQSPRGFAYARNIYKKYEK
SFISNLKSSVHLVSSAIFAKDIKLILKGEKIYQNWIVLPLGFILNMYIRCKIRF
>OBAHECAF_00820 hypothetical protein
MFDWIPLEYYKPLYYYTSLIIVLFIGIHTMSKNLQDRKVVIMSQNIGMLFLIGLVFYVGF
RPVSGQYFGDMSVYANYFNNYQEGNPITIKEDVLFHIFTKICSSFMSVHAYFLTCAAMYI
VPLYFVSKKWFKAYWFYAFLLLSVSFSFWAYGTNGIRNGIATSFFLLAISRTQWLWRGLI
LFIAVSIHNSVALPMLAYLLANFYTQPKYYLYFWIACIPISLVAGMDLQGIFAGFIDSSR
TSYLTDGNVNDDHFSSTGFRWDFLLYSASAIIAGWYYVFKLNYKYKPYLVLYCTYLIANS
FWILVIKANFSNRFAYLSWFMMALVIVFPLIKHKIMSKQTQFLVYVTLAYFGFTFFMFLI
SM
>OBAHECAF_00821 hypothetical protein
MNQLKKGAILSYLNIILTNVVGLVLTPFIIRSLGDSEYGLYTLIGAFVGYLSIMDLGLNN
TIVRYVAKYRAENNKKKEEDFLGTSLMIYGGISLIVMIFGLSLYSNIENIFGETLNPEQI
SKAKLMMLLLVFNLMVSIPGGSFAAICNAYEHFVFPRAMNVIKYVLRSVLVITVLYQGAD
SVGLVLLDTILNVFFILISYFYVKNNLKIIFRFHKMNKRFIFEIFSYSMWIFLFAVTEQI
LWKGGQFIIGTKSDPSQVGIYAIGIVLGSYYAAFSGAISNLFLPKAIQMIVKKTSSIELT
FQMTKIARFSLFSLMLIFIEFLLLGRQFVSLWVGKNYIESYYIAVIVMIGYTTPLIQKFA
NSILEAKNLFKYNALIYLGCIVLGMLSSLFLVEKFGVIGVISGIATGWIIAQIIMNVFFV
KKLGLDIILFFKLTAKGLVFVFVLTLVVSFLITQIVLFKVGWLDFMIKAVLIGIVYICSL
YTIGMNTQEKGMIVSLIKHYLKP
>OBAHECAF_00822 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MNITNTPITNLQSLTTNPKIAVIGLGYVGLPLARLFATKYPVVGFDINKERVEKLNGGHD
DTLEVSDELLQSALVKENPLKTGNNGLLCSADLKDIEDANIYIVTVPTPVDKNNRPVLTP
LIKASETVGKVLTKGDIVVYESTVYPGATEEDCIPVVEKTSGMKYNVDFFAGYSPERINP
GDKEHTVEKILKVTSGSTPEIGKIVDDIYQSVITAGTHLAPTIKVAEAAKVIENSQRDIN
IAFVNELAKIFNLMDIDTHAVLAAAGTKWNFLPFKPGLVGGHCIGVDPFYLAQKAQEYGY
HPEIILAGRRLNDSMGKYVAEQVVKAMIKKNINVNGAEVLMLGITFKENCPDVRNTKIVD
VIAALEDFGVKVTIFDPWANPEEVQHEYGVESTQKLSSTKFDAVVLGVAHKEFKELDIHS
LTKENAVVYDVKGILEAVDGRL
>OBAHECAF_00823 hypothetical protein
MLSYRELDVWKNAMNLVDDVYILTKSFPREELFVLTSQMRRASISIPSNIAEGFDRKNTK
EYLQFCYIALSSLSELDTQIEIAFRQKYTENTEILSEKVLIIKKQLLALIKSLKLKLK
>OBAHECAF_00824 UDP-N-acetylglucosamine 4-epimerase
MMQMEFSELKNKKILVTGGAGFIGSNLSEKLLELGAMVTVLDNFATGHRHNIEAFLSDEN
FILIEGDIRDLETCRKACEGQDFVLHQAALGSVPRSINDPITSNDVNVGGFLNMLVAARD
AGVKRLVYAASSSTYGDSKLLPKVEDVIGKPLSPYAITKYVNELYADVFKRTYDFDTIGL
RYFNVFGRRQDPKGAYAAVIPKFVIQLMNHQSPTINGDGTYSRDFTYIDNVIQMNLLAIT
SENTDAVNQVYNTAVGDRTTIKDMAELLKKYLSEYDPKIAEVEILHGPNRQGDVPHSLAS
IEKAEKNLGYQPTHKFAEGLKEAVDWYWENLK
>OBAHECAF_00825 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKVIDESKQGQSLVLEVNRNNSKKVYIESYGCQMNFSDSEIVASILSQEGYNTTQTLEE
ADLVLLNTCSIREKAEQTIRKRLEQFNSVKRSRPAMKVGVLGCMAERLKHAFLEEEKIVD
MVVGPDAYKDLPNLLQEVDGGREAVNVILSKEETYADVSPIRLNSNGVTAFVSIMRGCDN
MCTFCIVPFTRGRERSRDPFSILEEINSLQVAGFKEVTLLGQNVDSYLWYGGGLKKDFDK
ATEMEKATAVNFAKLLDMVATAHPKMRIRFSTSNPQDMTLDVIDTMAKHHNICKYIHLPV
QSGSDRILQAMNRLHTRAEYFTLIDNIRERMPECAISQDMIAGFPTETEEDHQDTLSLME
YVKYDFGFMFAYSERPGTLAARKIADDVPEETKKRRLAEIIDLQQKHSLYRTQQKIGQIC
EVLIEGNSKKSDAQWMGRNTQNTVVVFPKEHYKVGDFVNVKIESCTSTTLIGKAIGYSEI
MK
>OBAHECAF_00826 HTH-type transcriptional regulator LutR
MIELQKIEPSENVSLVDRIEQQIILYIKENDLRPGDSLPKEMELAEQLGVSRTAVREAML
RLRTLGLIESKRHKGMVLKEPNLIENLEKMLDPHMLDKATLHNLFEFRLMFEIGMTDFVF
ARKTQEQIQTLEQIVNKTRDVQCNSNSFSLEDEVLFHKSLYKIADNEMLLRFQKIILPVF
EYVHHLQREELNGALANGTLQDEISIVTHRDLVEELKNGTPQSFREAMRQHLQPHFSRIL
RSKC
>OBAHECAF_00827 Colicin I receptor
MFRVFFSLIFLMLVANAFGQNDSSKKEEKAIELEEVTVIATRSEKKLKNVPIVVQLLTKE
DIYKSQSTDFQSFLENEFSGINFTYDGGRPNINMMGFSGKYVLFLIDGERVAGETFENID
YERIDLDNIERIEIIKGASSSLYGSNAIGGVINIITKNAQKSFDVSSSYLYDTNIDHRAN
LSIGSKQKWGSLQIGSFYKMREPYLLKDTEQRKIFYTDGRVKELPHDYLHIAGFTNYGIN
PKLNFQISPKWDLELKPAYYFSERNDGTENAKKVLERYYNYALSLKSTYELSQNESIKLT
GSFDRYSKFNYYRLLNEQEKNYENTLKRVSTQYNNLISGKHTLVAGAEVLVDELISLRFN
EKGTEASKDSKNYTLFAQQDWILSDRFTLVAGVRMDYHSLFQEHFTFRLSGMYTIDEFTL
RGGYSSGFRSPTIKELYTNWFHPWGGGFQIKGNETLKPELSDNFNFSVDYSTKKLNITAI
TQYSVVTDKIDFVWSDSHSSIDYTNFKGATRIISSEFSVAYRLNKFFRLKSSYAFYDIEK
RLSDHRPHTFTLKGEYSPSDSLKYIPSLIISGKYVSSTTLFSSEERNTFEEYYSVYEPYW
IWRLQTSMKLPLGFVLNAGVNNLLNYKANTVGFYSSISPGRTFYIGVKYSY
>OBAHECAF_00828 hypothetical protein
MSIGNRNKKTVRKLREKLKRLGISFGQICTDNWEAFISVFEEDNHKIGKITLLILEKITG
I
>OBAHECAF_00829 hypothetical protein
MKTTQILIGMVMLLIACSESKTQSNQGTKSASSLEKIIDLEKAIENPIEPLNLSDFVEDI
EYIRPEYPASLVDIIFDVALNENYLLLQVRERLLCYSRDGKFLREIGRNGQGPKEYLGIR
ASSLHDSLVAIHSNWTRKILWYNTDGEYLKETPVADGILNIDVLNNDRIVIHHFPHTTPI
DDPNLCIVGIIDSKGDTIQLKKSKPYYSKGQTLQQSIWKYNDMVRVLSCINDTVYSVSKD
EILPTYVVNFGKYKVSQDFFSDMHSSPSEKSEKGRKFIRHLSFSEMFDKILITFIYDKKN
WYGVHSKQSGETSVWSVKPDSINKYGFLKGGGWVNDVDGGYSVTYLKSNSDGYFIRIVPP
EELKARFLENKERIEVKYPEKQKKLEQLVNSLDDDENPVIVVYKLKK
>OBAHECAF_00830 hypothetical protein
MKTTQILIGMVMLLIACSDSKTQSNQGTKSTSSLEKIIDLEKAIENPIEPLNLSDFVEDI
EYIRPEYPASLVDIIFDVALDENYLLLQVRERLLCYSRDGKFLREISRKGQGPKEHLGIR
AFSMRDNLIGIHSNFSRKVLWYNPDNEYLGETPIADKVSAINILDRDRIVIHYPPGTTFV
EDPVLYIAGVINSKGDTIQLKKSKPYYSKGRTSRQSIWNYKDVVRVLTCVNDTIYSVSKD
EITPAYVVNFGKYKVSQEHFSDIKLEKSERGQKFIQHLSFSEMPTKMFLRFVYDQKKWYG
VYDKQTGETSVWSVAPDDIDEYGILKGGGWVNDVDGGWSPLHFDSNSDGYFIGIVPPEEL
KARFLEDKERIEVKYPEKQKKLEQFVNSLDDDENPIIIIYKLKK
>OBAHECAF_00831 Shikimate kinase
MKIILLGYMGSGKSTLGKILAERRNLPFIDLDSYIESKENKEIKEIFKEKGEIYFRKLEN
DYLKNLLQSETDFVLALGGGTPCFGNNMNLILEHSPYVFYLRYSPKKLAERLKCEKRNRP
LIADIDDENLEDFIRKHIFERNMFYNQAHFIIASDNFSIDESLAQIEMNIIGKSQ
>OBAHECAF_00835 o-succinylbenzoate synthase
MLKASYKKYTLQFKRPSGTSRGILTQKETYFLFISNGEKKGVGECGLLKGLSVDDRPDYE
QKLQWVCENIHLGKEQLLTQLIEFPSIQFGVEQAFLSVESKNWYQLYPSEFTIGKDLIPI
NGLIWMGTADFMKSQIREKIQQGFRCIKMKIGAIDFEQEYQILKRLRTEFPVEDIEIRVD
ANGAFSPQDALEKLKQLADLELHSIEQPIKAKQSEIMAKLCEQTPLPIALDEELIGVFGY
ESRKQLLEQINPQYIILKPSLVGGYKSSEEWIRLSNECKIGWWITSALESNIGLNAIAQW
TYTLNTEMPQGLGTGALYTNNISSPLFVSSGFLGYDSERSWEVNIL
>OBAHECAF_00836 Glycine cleavage system H protein
MNIPSELKYTKDHEWVRVEGDLAVVGITDFAQKELGDIVYVEVETEGETLDKEEVFGTVE
AVKTVSDLFLPVSGEIVSFNEVLEQSPEKVNTDPYGDGWMIKVKFSDASELDELMSADDY
KELIGA
>OBAHECAF_00837 hypothetical protein
MLNKKTFGILLLIWVIVILVLSLMPPKNVDELPKIPHLDKVAHFVFYFIFTILFFLTFQN
NKENVKKVANIYILSFVVAFSLGICIEWLQNTITQDRSGDLFDVLFNTFGTVVALIGMKY
INKKLLINVK
>OBAHECAF_00838 hypothetical protein
MQPKKNPKADLTKSSGLFFAIGFALISALSYAGFEMKSYDRKEHESRLSDLDNSNLDEDQ
EEFAMEEFTPPPPPPPPPPVVEDVKVVENEEQIEETIISSTETTKEEVVAKVEEIEVVEE
PDEEIDVPFTIIEDKPMFEGCEKLKTKKEQEDCFKSSLDKHVKRNFQYPQSAQEMNIQGK
VTVTFRINKDGTVSVVGTRGPDKSLEAEARRIIEKLPKLIPGKQRGRPAAVVYQYPINFK
LANQ
>OBAHECAF_00839 hypothetical protein
MITEKKKFKIGWGTGIVIAFAFFITFIMYFVLNMSINKKYDHDFVTEDYYKKELAFQNMM
EKAKKTASEQMGVDIQSSEAGVTLTFPQKTTDAIVGTVYFYRPSDQKRDFRIPLQIKDNQ
MLVPMNVLSKGRWVVEVNYQFDSQDYISTEKIDIK
>OBAHECAF_00840 hypothetical protein
MLYTALILGLLGSFHCVGMCGPLTLLLPLRHDNPFKKAFQVATYHIGKTLTYVLLGVLFG
VLGKGLFVREYQQQLSIIIGVLMIVVVVLSLVKIRLNVFTKPIYFLIGFVKRALGQQLRY
KTAFSVFLIGFFNGFLPCGLVYMALFGALAETGITNSAMYMLFFGLGTVPLLTATIYLGN
FLKTKTKIYIQKIIPFFIILIGALFILRGLGLGIPYLSPSNMNLMIKADPDCQVPMYR
>OBAHECAF_00841 S-adenosylmethionine synthase
MGYLFTSESVSEGHPDKVADQISDALIDNFLAFDPSSKVACETLVTTGQVVLAGEVKSDI
YIDVQQITRNVIKKIGYTKSEYMFEANSCGILSAIHEQSPDINQGVERAKPEEQGAGDQG
MMFGYAVNETENYMPLALDLSHTLLRELADLRRENKEITYLRPDAKSQVTLEYSDDNKPV
RINTIVISTQHDDFASEAEMLQKIKHDIITILIPRVIKKYPQYAPFFDDNIIYHINPTGI
FVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYAMRHIAKNMVAAG
IADEILVQVSYAIGVAEPTGVYVNTYGTSKVNLTDGEIAKKIQQIFSLRPYDIEQRLKLR
NPIYSETAAYGHMGRVPQIVTKEFSSPYNATKTVEVELFTWEKLDFVDKIKEAFGV
>OBAHECAF_00842 Aerotaxis receptor
MSDFKRVEPTIQRPTPIDREVVWDKSKVLISETDSFGTITNVNTVFSEVSGYSMAELIGQ
PHNLIRHPDMPKLIFKMLWENLKKGNNFVGVVKNLAKSGEYYWVVTDFEMRRDAMGNITH
YIGRRKAVPQKAIDNYLAPFYETLLKLEKIGGTELSSRYFKNYLAMQGKDYIDFVISVMS
EGENKTFSGQAAGAMDNNTVVSDDIYDVSNAMNEKRRNFFERLFS
>OBAHECAF_00843 Aerotaxis receptor
MIKDYRDIELTVERPTPIDKEVVWDKSKVIISETDVYGRITNVNDIFCTVAGYTPAEMIG
QPHSIIRHPDMPKVTFKMLWDNLKMGNNFAGVVKNLAKSGEYYWVITDFEMRRDALGNIT
HYIARRKSVPKGVIDNYVAPLYETMVKLEKIGGMDLSARFFKNYLDKQGKDYIDFIIDVM
AENRENVAFQDIPVTSIDTNKMVSDDIYTVSDEMNEKRKSFFGRLFS
>OBAHECAF_00844 Protein SprT
MERILAKYIPENAVMPCFELIKRNNVHLKIVNERKTRHGDYRQLLDGQHLITVNAGENKY
RFLITLIHEIAHLVAFEKFGRNIKPHGNEWKYTFQQLMIPFISPSIFPTDLLKVVANHFR
NPKSSSDIDPLLAVTLKKYDENQDICFIFELPLGSIFRIADGRVFQKGRKRVKCFECIEI
NTKKVYVFQPHAEVEPLKM
>OBAHECAF_00845 hypothetical protein
MKKIKVLSLLLVIGITHQLYSQDAESKNFISFKKGVLNTLLLEDGDSSIFDQSKPTSHLF
NETYSDYNISYQRKISSRFLLGVDFYGFNAFNKINPYSLSLQRIGLVRKDFSSHTDVKLF
RGSIFYSLLDSEYFKIRAGMYIPLYEIKNQSITAAYERENKREEVVYIIDNKKTSGIFLG
IVQPEIAVDFLYCFNNIETGIATSWNSNISSNEPIIRFSAVLNVKF
>OBAHECAF_00846 Gamma-D-glutamyl-L-lysine endopeptidase
MPYAICHLSVVPVRLHPCEEAGMVTQLLFGELLQVIDKQEDWYQILVLYDGSEGWILANQ
IQLISDKEYRKCLKKKEKYAHRWITKLRVKNVNNVFLQIPRGATFSHNHLINTSQSTQKP
TEKGIVALALDYLNVPFLAGGRTPFGIDAAGFTQIVYKLNGIKLLRTPEKQASQGILVDF
IEETIPGDLAFFDDEEGNIIHVGILLGDNHIIHSYGKVRIDRLDHIGIFNSELRNYTHKL
RLMKRIVQKTQ
>OBAHECAF_00847 Arsenate reductase
MITIYHNPRCSKSRCGLDILKNSEKQFEVVEYLKNPLTKKEIITLLEKLGIPPMELVRKN
GGIWKENYQNKALTDNEIIDLLVTHPQLIERPIVVQGNKAIIGRPEEKIYEFIR
>OBAHECAF_00848 hypothetical protein
MKVHYLIISLFGFVFFANAQPFENKKRELPVVIPLEKAPTLELPSDTYTLPMGVETKENP
FMKTPEKQIDFTRKSNLVHKKFTENRSYLNNYQQKEEYDAPKGNQFFGDFLSNGGHVNVY
CRDFQAIDGDRVSILVNDKVEIHDILLVGDYKGFQIQLKPGFNKIEFLALNQGESGPNTA
DFKVLDDKGKIIAQNQWNLATGSKAQFVVVKEIEKEE
>OBAHECAF_00849 N-acetylmuramoyl-L-alanine amidase AmiA
MKNILLFLALLVSNLIFSQKTPTFNVVLDAGHGGKDPGKIGKGKIYEKDVALNIVLEVGK
ILEQHSDIQVIYTRKKDVFVDLYERGAIANRAKADLFVSVHCNAHHTQAAGSETFVLGLS
ANDRNMEVAKTENAVIYLEDNYKTKYAAYNINSPESFIGLSIMQEEFLEQSIQLAKYVQD
NFTNVMQRNNRGVKQAPFIVLHQTYMPSILVETGFLSNNDELKFLASKKGQTDFAENIAD
AILSYKTWVQSRSSHIVPENFIEETPAKSSEKKASSPKKTNNIKKTAKTTSKSSNTTKKN
NSTTQKKGNIKKSKVVYKIQLSSSAKKIEAKPYNFKKLSPISSVKCGNLYCYLYGAASKR
SEANVLLANAKKVGYKDAYIIAYLDGKPVQLSVAEKNE
>OBAHECAF_00850 hypothetical protein
MKLSKEFKAAVIVIAGIACFFIGFNFLKSKTMFSRTNTYYAYFDHSNGLKSGTPVTVNGV
KIGNVDAVTLEEKTAKIKVTLSCSKDFLFSKNSKAEIYSSLLGGTSMQIVPVFDDAPLAE
SGEVLTSSIKEDMMTSLSSKIDPTQEKINRLLTDSNATINSINTLLDEKTVADLKKAISD
LSSTMQHLNKSTIMLNKMLATNQEHLNASLQNTNKITADLAKVSNNLANADLDKTIKETQ
SAIANLNAVLANMEKGNGSLGKLMKDEILYNNLSNSSKQLELLLEDLRLNPKRYMHFSVF
GKKQQPYQENKSSEKE
>OBAHECAF_00851 Lactate utilization protein B
MSILPNILFCLLFAIAIVFFVKNVRKLVRNIRLGKDENTTDNKAQRWKNMLWIALGQQKM
TVRPISGILHILVYLGFIIINIEMLEIVIDGIFGTHRVFAFLGSFYDVLIASFEVLALLV
LISVGVFWIRRNLLNISRFKKEELQNWAKKDGNNILYIETILMLLFLTMNAADLRLQDLG
VEGYIQAGSFPISSWISKLFTNFSAVTLIAIERCCWWLHIIGVLFFLNYLYYSKHLHIVL
AFPNTYFASTRPQGALKVNQRVLEEVKLMLDPTADPFAIPVESATPPEKFGASDIFDLTW
VQLMNAYTCTECGRCTDECPANLTGKKLSPRNIMMKTRDRLEEVSKNIDTNKGKFQNDNK
QLLNDYITPEELWACTSCNACVEACPVSINPLSIIMDMRQYLVMEESAAPAELNTMMTNI
ENNGAPWAYSQADRLNWVNES
>OBAHECAF_00852 Lactate utilization protein A
MTRNTLYVPTMAELMAQGKSPEILFWVGSAGSYDDRAKRIVRAFVQLLNQANVDFAVLGA
EESDTGDPAKRAGNEFLFQIQAMSNIQLLEAYNVKKIVTTCPHVFNTLKNEYPALGGVYE
VWHHTEYIEKLIKSNQLHIDKNFFKGKRVTFHDPCYLGRGNNVYDAPRNLLKKLGVELVE
MKKSKSRSMCCGAGGAQMFKESERGDKEIYALRTEQALEVQPEVIATACPFCNTMLTDGI
KSKKKEDVIETLDVVELLCMASPTIQNDEK
>OBAHECAF_00853 30S ribosomal protein S15
MYLTKEIKAEIFKKYAGSETNTGSSEGQIALFTHRINHLTQHLKANRKDYNTERALVKLV
GKRRSLLDYLKNNDIERYRNIIKELGIRK
>OBAHECAF_00854 Polyribonucleotide nucleotidyltransferase
MIPEVKKEIITLEDGREISIETGKLAKQADGSVVVRMGNAMLLATVVSAKEINPDTDFLP
LTVDYREKFAAAGRFPGGFFKREARPSDQEVLTMRLVDRVLRPLFPKDYHAETQVMIQLM
SHDESVMPDALAGLAASACIAVSDIPFDGPISEVRVGRVDGKFIINPNKEQLAQSDIDIM
VGASKDFVAMVEGEMDEVSEKEMTEAIKFAHEAIKVQIDAQIRLAEKVGKTEKRSYEPEA
ENEEIKDKVYNYAYPKCYAIAKEDTGKHERSDKFAAVKEECMALFTEEEQEEYAVLISKY
FGKAHKEAVRNLILDENIRLDGRNTTQIRPIWCEIDYLPSAHGSSIFTRGETQSLTTVTL
GTSREANVIDLPTEQGEERFYLHYNFPPFSTGEARPLRGTSRREIGHGNLAQRALKRMIP
ADCPYTVRVVSEILESNGSSSMATVCAGTLALMDAGVQMIKPVSGIAMGLITEGDKYAVL
SDILGDEDHLGDMDFKVTGTKDGITACQMDIKIKGLTYEILEKALEQAREGRMHILNKIT
DTIAEPKSEVKAHAPKIVKMEMPKEYIGAFIGSGGKNIQDLQSRTNTTIVIEEVGELGIV
EILGTDSEGIEEVINAVHAVSFEPVEGETYKVKVIRLLEIGAIVEFMPGKDSFIHISEIA
WERIEKVSDALKEGDIIEVKYLGVDTKTKKTRVSRKALLPRPPRDNNGKSGTDKKKSHNS
>OBAHECAF_00855 hypothetical protein
MKYKHLTLEQRYEIKAYLKCNKSQKFIAQQMGVSESTISRELKRNKLKRGGYNPQNAQQQ
ANIRKERFAVNRKFTPKVAAFVEEKIRREQWSPQQIVGYCKKHEISMVSTEKIYQYIRED
KEKGGDLYQNLRHKLKHRKRPVSGKKEVIKNRKPIRLRPEIVLTNEEFGHFEVDLIVGAE
HKGAILTIVERKTKFLIMRKLSSKNAKSLAKAMIEALLPYNDYVKTITSDNGLEFSEHEY
ISKKLICDFYFANPYCSWERGLSENTNKLVRQYFPKGTYFEEISKEKIKEIQHKINRRPR
LTLDFEEPKNLFYKFVA
>OBAHECAF_00856 hypothetical protein
MWITLLFFGVLLLLLALPVTQTFIAQEVVNRLNQDFDVDIQIEKIHLKYNGDVAVKGVLI
KDFRADTLIATKQLQTSILNVRQWIKGDLYFGDIEADDLVFHMKTHKGDTLSNLEVFVSK
FDSGEPSSGDFVMKAKTIRLNGSHCYISDENQENPILFQAENLNMKLKDFQLLGANVFFD
MEQGSFIFDKSLKVSDLQTSFFYTDTLVQAKDMILKTEKTTVEGTLKIYPHEGGFGDFAD
KVVLDVELPKATISTRDLNTFYDGFGAGKSLIVNDLHFKGTLNKFVIDQGNITYQNTLIG
GNLSFENLLREDKKIIIQGRGVNFESIYNDLATLMPVELGQNMPVELQNLGMFSLTGDFV
YGTSHLDANLRMTSQRGNATFEGKLSNLEQTENLAYEGRISTQAFNIGALIKQRILGNLS
ADLVVQGKGTDFKTMEMNAYGKINSLRFNGYDYKKINIEGKLTKQLFNGLVVANDPNLNM
KFGGLADFSSIKPTFDFKADIQKADLYQLKVSESDTISKLKGRVHIDIQGIEVDDIVGKV
SFENAVYENSHNIFTFNDFDITSTIYDTGEKEIKINSTDIISGSIRGKYKMAEMKKIIQN
ALGSVYMHYNPYKIDENQYIDFNFSIYNKIVEVFVPELKIGKNTTLKGKIVPDDGSFKMQ
LKSPEINAFDYQVDGLKLTVDNQNTLYNAFFEVGKLDLGIYDIKDFNLISRVVNDTLFFR
SEFNGGESEKDNYQLNFFYTLNEKQESSIEFKKSEINFRGNQWFINRENAEGTNKVTIDR
KADTIKIHNFRIAHRNQHVNLSGVLTDEYKQLHTVANNVSLDKVLPELKGLNLQGTLNGH
LSLVQKGKLYYPSSDVFIRNFRLNGYDYGDLEASIFGNADLSAFKLNAHFVNGKTQGFQM
NGDIKLDSNKGTFVDVDAHFRQFNLAPFNPFLEGIFYDLRGSLVGDIKIEGSIENPTMNG
ELAIEKGGVGITYLNLNADINDKAKIFIRNQTFEIDDWTLTDTAHKTQALLNGSIRHNKL
SDWFFDLNIKTLGDKFLVLNTGYTDDALFYGTGFINGNASIRGALDELVISVKAVTQEGT
QFKIPLSDMESVGDDSFITFIEKENPKVKKERVLESVKGLELRFEMDVLPSTEVEIILDK
KTGSNLVGTGAGTLLIEINTNGKFNMWGDFITYSGYYNFKFENLIDKRFTVLPGGSISWS
GDPLKAVLRNLKAAYTLNANPGVLLESSQYNRKIATQVIISLEGELMQPEPVFDIAFPDS
GQGLVSELNYRLEDKDRKQLQAFSLLAQGSFMSERNTDNRLVAYNLFETAAGLFNQLLSD
EDNKLNLGVSYEAGMVDSSSDITNDDRLGFTISTQITDRVLFNGKVGIPVGGVKRTAVAG
NGEVIFQLNPQGNLTAKVFVRENEWQEYLVDRIGYVYGTGITYNVDFNTFKELINKVLGR
KEEE
>OBAHECAF_00857 Holliday junction ATP-dependent DNA helicase RuvB
MNKNLNPNKENYSAQDLDIERALRPLSFDDFAGQGAILENLTVFVKAANMRGEALDHTLF
HGPPGLGKTTLAHILANELGVGIKITSGPVLDKPGDLAGLLTNLQERDVLFIDEIHRLSP
IVEEYLYSAMEDYKIDIMIESGPNARTVQINLNPFTLVGATTRSGLLTAPMRARFGIQSR
LQYYTTELLADIVQRSASILKVPISTEAAIELASRSRGTPRIANALLRRIRDFAQIKGNG
KIDMEITRFGLKALNVDAHGLDEMDNKILATLIDKFKGGPVGITTLATAVSESPETIEEV
YEPFLIQEGFIVRTPRGREVTDLAYKHLGKVNPNVQGKLF
>OBAHECAF_00858 hypothetical protein
MKLTYVYVFLVFLLSFELMAQEDKTKNEGITFKSMRSTKKKDSITFTANDYKIISYMRDT
IAVDTTLSIKKYYKSNVWQKDIFGKMPFSNMAQPYNTMVYDHIQQDYLASMGAEAKKQLY
LTTEDIKYYLLPTPLTELSYRSGMEQGQMANALFSVNLKPNINVFIGYRGLRSLGKYQQI
LVSNGNLRIGGSYISPNKKYTLFAHYAGHDIESQENGGITSLEQFESADKQFRNRAVMDV
NLSEATNLRESKRYFFQQDYAFLRNRDSLASYKQIRLRHRFLYETEYYKFNQASASEFFG
ESYVSANINDRMQLQKMINTVGAELELPYLGKTFVYGNAYFYNYFFRNAFYKSGVLQRYQ
IKDTDLSLAMQWNKKVAGFVIDAEGEQTFVGKMTGTKLHGKLSYNFDKKNGITAGISLHS
TMPNFNFLLYQSDYKNYNWDNYGSFGKENRQSLYGDLKTQWGNAFVSISNINNYTFFQLQ
PAQRDEREQSVPVQYSGNIQYLKVKLEKEFAFRKFRLDNTVLYQNVVQNDLVLNVPNFVT
RNAFYYASDLFNKAMYLETGLGLNYFTKYYSNRYNPLLAEFEVQTTEKTGGFPMVDFFLN
AKVRTMRIYFMIEHFNPFLMDRVFKNPQYNYYSAPQQPYRDVILRLGISWNLFS
>OBAHECAF_00859 ECF RNA polymerase sigma factor SigM
MAKTINIAFEQRHVIERAKQNDRLAQKQLYDAYAPTLLSICRLYIKDEHFAQDILVKAFF
KILTHLHVYEEKQHFFAWMRKIIVNECIDFQRSKIQKVTYSEWDDSLDSLDELSSNHQFE
EEYIQSFIDELPVGCRLVFNLYVFEDYDHKHISNELGISVGTSKSQLAYAKKLLKEKLNK
KTIHNGKSSEKKYKRNF
>OBAHECAF_00860 hypothetical protein
MENHLKKNIKETFKNRTITPKRDLWSELEQQLDQQQASTMRKTRYYALAGCLTILIAVGL
WFMKPFSENQIIENQIVKLRVKSENEIKNQPENLKETFDVMSQKAIVIQDSNSSKKTNSS
IKNQRDKELDAYIDEVLSDVSADKMIALLNQDVSFESKVDSIYQAMNFQNISAEELLLIA
STEINIDQYVESKINVDTMLQESDKETFKDRIKQFFDKVSTEYDKLKYALSND
>OBAHECAF_00861 hypothetical protein
MKNTILITITLLCLGSLKAQKKENQAIEQAKQAIDSVITAEKKLLKQKLVLIDDMVDKKE
VSKDEGERLRRQIAEESRRNIQTKTALEREKLITILRSKTITTDSIVNSEAYMKALAKLD
SLIEKPVEETPKKDTHEKIVINDEIYYIKATGERVEKSQIAKIYNRYRTSKGGFNFALGF
HTLNGSENFGGDKFRVWGSKSVEIGYSRNVRVFKNSNLLHLNYGVSWVMNKLKMKNNDYF
VANSDGTTTIEPFRTSLNKSKFKNFYLTLPVNLEIDLTPSYEKNGKTYYPYKRNFRAGIG
AYVGVLLNSKQVLCYQENRGVRDVNKGNFHVNDWIYGISAHFGYRSSVFYAKYNLVPLFR
NNPVKEYPLSLGIRFGG
>OBAHECAF_00862 30S ribosomal protein S21
MLIIPIKDGESIDKALKRYKRKFDRTGVVRQLRERQHFTKPSVKRRSQLQRAQYIQHLKD
QEEV
>OBAHECAF_00863 Leucyl/phenylalanyl-tRNA--protein transferase
MELTFLYENTPFPSVEKAVEGIVAFGGNLTCKRLLEAYRKGIFPWYSDEDPILWWSPDPR
FVLFPKELHVSKNMRKLLKKKPYKVTYNQHFKEIITQCASISHKGQDSTWIHPEIIEAYI
ELHHQGFAYSVEVWENEELVGGLYGIKLNGIFCGESMFSKRNNASQYGFIVFLQEHPEIE
LVDCQIHSEYLEKMGAREIPRATFLDILSKLIEQP
>OBAHECAF_00864 Ribosomal RNA large subunit methyltransferase L
MLAKTFFGFEDILADELRNLGATNVEKGVRVVSFEGDKGFMYKANLCLRTALKVLKPITK
FFIRTEKDYYQKLYDFQWERYFSVNQTFAISVTLQTDMFNHSQYVGLRAKDAIVDRFREK
IGKRPNVDTLHPDLQLHIHIQKNEVTVSLDSSGASLHHRGYRSATNIAPINEVLAAGILL
LSGWQGQSDFLDPMCGSGTFLIEAAMIACNIPPNIHRREFAFEKWNDYDADLFEKIFDSS
LKKTREFNYQLVGYDKAPSAVAKAKENLKNANLSDYIEIRQKNFFETEKEDKKRPLFVAF
NPPYNERLHIDVQKFYESIGNTLKNKYPNTDAWFITSNLEALKFVGLRPSRKIKLFNGKL
ESKLLNYKMYEGSKKAKFDL
>OBAHECAF_00865 Phospho-2-dehydro-3-deoxyheptonate aldolase
MNITEENRKWLDDLQLPHPLVIAGPCSAETEEQVLSIAWELKNTKVSFFRAGIWKPRTRP
GMFEGVGALGLKWLQRVKQETGMKVATEVANKDHVKLALEHDIDMLWIGARSTVSPFIIQ
EIADELRNTDKIILVKNPVNPDLPLWIGALERLQRAGVKNLGVIHRGFSTYEKTKYRNIP
EWQIAIELQNKFPDLPLLCDPSHITGNREMIFDVSQTALDLNFDGLMIETHISPDQAWSD
AAQQVTPKKLTEIIKQLQVRKKTTSEEDYQNTLTELRSNIDVIDDQLLDLLKKRMTFSDS
IGKLKREKNVAVLQNSRWYTILGKMIVEGQQRGLSEEFISKIYKAIHQESINRQEKIVNS
>OBAHECAF_00866 Phosphoglycerate kinase
MKTIDNFNFKDKKALIRVDFNVPLDENFKVTDTTRIEAAKPTIEKILKDGGSVVLMSHLG
RPKGERNDKYSLRHIVDEVSKVLGKPVQFVDDCVGEKVEKVVAGLPAGSILLLENLRFYA
EEEKGNEEFSGKLAKLGDIYVNDAFGTAHRAHASTTIVAKFFPNNKCFGYLLAKEIESID
KVMKSGEKPVTAILGGSKVSSKITIIENILDKVNHLIIGGGMAYTFIKAQGGKVGNSICE
DDKLQLALDILAKAKSKGVEVHLPVDVVAADDFSNDAKTQEVDITNIPDGWQGLDAGTKS
LANFKEVILKSKTILWNGPVGVFEMPTFAKGTIEIGNFIDEATKKGAFSLVGGGDSVAAV
KQFGFENKVSYVSTGGGAMLESLEGLVLPGIQAIYE
>OBAHECAF_00867 Thiol-disulfide oxidoreductase ResA
MKLRTVLNLGLILLVLAFFVTPLGYESKIILQRIFSSSVEVLPANEQYKIDFDWKLKDRD
NKEFNFSQSEGKKPSFVYFWSSWRVTSVADLSGIQKLYNDYKEKVDFYIITNELPSPVEE
LMSKRGYNFKVTYLIIGEKMPFDAEKIPSGYIIDKHGVVRAKSERIANWNSDKVRSLLDA
ISK
>OBAHECAF_00868 Iron-sulfur cluster insertion protein ErpA
MIQVSEQAKKKLISLMEDDNFDPTTDFVRVGVKSGGCSGLSYELKFDKITDADDKIFENN
GIRIAVNKKSFLYLVGTILEYSGGLNGKGFVFNNPNANRTCGCGESFSL
>OBAHECAF_00869 hypothetical protein
MAQEFESFRVYKETLALTQKVFELLNHQHLKNEFEFSNQMKRAVLSISNNIAEGSEYNNN
AQFVRFLKYAKGSCAEVRNMLNICNEIYHINTEDLKEHCREISVQLSKFIDYLKNNDNKR
SK
>OBAHECAF_00870 FeS cluster assembly protein SufB
MAKYTEDDLRDELQTKEYAYGFYTDIEAETFPKGLNEEIVIAISKKKNEPEWMTNWRLEA
FRIWKEMEEPEWANVKYEKPDFQDISYYSAPKQKPQYESLDEVDPKLLETFNKLGISIEE
QKRLTGVAPVAMDIVMDSVSVATTFKKTLAEKGIIFCSISEAIQEHPELVKKYIGSVVPK
TDNFYAALNSAVFSDGSFCYVPKGVRCPMELSTYFRINQAGTGQFERTLVIADEGSYVSY
LEGCTAPQRDENQLHAAVVELIALDNAEIKYSTVQNWFPGDKDGKGGVFNFVTKRGLCEK
NAKISWTQVETGSAVTWKYPSCVLKGDNSIGEFYSIAVTNHFQQADTGTKMIHLGKNTRS
TIISKGISAGQSQNSYRGLVKVSPNAENARNFSQCDSLLMGNECGAHTFPYIEAKNKTAQ
IEHEATTSKIGEDQIFYCNQRGIDTEKAIALIVNGFSKEVLNKLPMEFAVEAQKLLEISL
EGSVG
>OBAHECAF_00871 hypothetical protein
MFCPYKEISCIILSCIMYGRIAIRPYGKYLISHHYAQCKGKRCFAPTGKYFISYRPTQCT
CEIFFAPTRKCLIPLGILSIPLGKYVIPLGKCLVLLGILLIPLGKHSISLGKYLVLLGIL
LIPLGICLIPCRKTKYFDEIHFISIGKCFILHYFKRCKGVFNTPLLY
>OBAHECAF_00872 hypothetical protein
MARKSYAENIKSVKLMIDGLRNHKDNLPAGIDEAFINELEALKNKVETLNSEQEKLKADL
KSKTEEFDKQLKLLTDKQSVARKRAKMDYQQSQWREFGIEDKR
>OBAHECAF_00873 Isonitrile hydratase
MTDINLFLFDDFETLDLFGPVEILGKVETFNLKYFSINGGIITSKQGTQIITHKITESNS
TGILLIPGGQGTRRLVDDSIFIDTLSSFAKKAEFCLGICTGSVLLAKTGLLNNREATSNK
KAFDWAVQMAPDVCWKRKARWVVDGKFYTSSGVSAGIDMALAFVADRFGQEKAQQIATHI
EYVWNSNKENDIFS
>OBAHECAF_00874 hypothetical protein
MKQVFLFITLWALASTSCSKAEHTEPPKEQEIPKPEQEAPKENISKEKVKQFFVEHLSGK
TTSFQEGKTLSLTEIAHTQQEIWQSWKEANQSFSEEKLGDLAPLTNATQGNRWQLPANLE
ANAIMPFYWASKGNQPEKGYPLFVYMHGSGNKHQEWANGKILAQRFDDAPSAYFIPQIPN
TGELYRWWQKSKQFAWEKLLRLAFLSGKVDANRVYFFGISEGGYGSQRLASFYADYLAGA
GPMAGGEPLINAPVENCRNIAFSLRTGAKDYMFHRDLFTRYAKEEFEKFKAEDPQGFVHH
IELIPNAEHGIDYRPTTPWLKQYTRNPHPKKVVWEDFPMDGIYRKGFYNIAIKERGAERV
RYTMDIIDNKVSINVDAVSYQIAETSPRWGFATKYNKTHIPLQKGKFVVYLNQNLVDFSK
EVNLIVNGKSIFKGILQPDVQHLVNSCATFFDPERVFPAAVEVHLN
>OBAHECAF_00875 putative ATP-dependent transporter SufC
MLEIKNLHASVEDKEILKGINLNVKAGEVHAIMGPNGAGKSTLSAVISGNENFEVTEGDI
ILEGESILEDAPEERAHKGIFMSFQYPVEIPGISVTNFIKTAVNEARKARGEEEMPAAEL
LKKIREKAELLEINKDFLSRSLNEGFSGGEKKRNEIFQMAMLEPKVAILDETDSGLDIDA
LRIVANGVNKLKSQNNAVIVITHYQRLLEYIVPDYVHVLADGKIVKSGGKELALELEEKG
YDWLK
>OBAHECAF_00876 hypothetical protein
MRKIYLMILFLTSFCGFSQTEEEVRKELEELFTNCKNTNPNDILPFYVDRKLGLMNRKTM
QTLVKPIHTSIYIESFSPIRGKVIYSAFDEHYYTFSIDNNWKISTKEEINYSCVLHSPPY
KKPKYEFVPSDKLSKGFQIKNRTVFFAKEYESCNYFRDNDIFKYKGKYYLIVCKKVEDGY
LYAIIDQQGNISEHFNYKHSWIDVNKYASNENDVWFKVQDSAMSKNKVIGFINMSGEEKL
KNQVPDDISALTVIFGYGIAKNINKENYAVVDLVKMEWVIPPQEKLVFRDLIIDTDKKVN
RHDIKNRAKYRVLISTDSYSKSFYMDFSGKKFLPKEFDNQEENLTPETFAQNKIKDFFKD
YDANTIGNILYFQRGFDTGYIDAETMEEIVPPSGSPILIQGELSTPKIKGNFYSHNGFFE
FEYHPTSGLELKPYKKYASLHPIGDLNIEEVKTEIKTIYVEEKPKKATPNNKNFEYVDII
THNENTYVLARKLSKENPMMGIVNVKDKPLPSFEFEYETIEQNTYAKDNIWFLTKKKGEE
YSHFTSISGDTKTLFIKEIKQKRLGYAIAESINNTMGVIDLTTMQWVIEPQKQLHFLDFR
HTSKEEIDTQNIENRTKARLYILVYQDDYQYFIDLKGKKYIPEKYLKE
>OBAHECAF_00877 putative copper-transporting ATPase PacS
MTIQIPIPNLLADPTSFLEKELLQIEGVVSAKVEINNQRVVLDTKNLESVALAVQKIKKL
GYKVPITQATYPVLGMSCAACASGAENIVKQTQGIVSASVNFATGNLTVEYFPSVTSIAE
IKKAVQKGGYDLLIENEEKQQETLENIHEEKLKKLKFKSFWAIILSLPVVIIGMFFMDMP
YGNEISWLFATPVLFWLGKDFFVNAWKQAQHRTANMDTLVALSTGIAYLFSVVMMIFAEH
LHKIGIHPHVYFEAASVIIAFILLGRYLEEKAKGSTSTAIKKLMGLQPKTVVVLHENTEK
ITPIEAVNTGDIILVKPGEKIAVDGIVTQGNSFVDESMLSGEPVPVQKKEGEKVYAGTIN
QKGSFQFQAVKVGKETLLAHIIKTVQDAQGSKAPVQKLADKIAAVFVPAVLSIAVLTFVL
WVVLGTENQWVQGLISAVTVLIIACPCALGLATPTAIMVGVGKGAENGILIKDAESLELA
KKINAIILDKTGTITQGKPEVTDVLWLNNDNSAESILLSIEKQSEHPLAEAVALKLHSVT
TVEISDFESITGKGAKAIFNDKMYFVGNQKLLLENHINIDAKLLEKANEWTHQAQTVIWF
ADSEKALSVLAISDKIKENSVQAIQELQQMGIELYMLTGDNEATAKAIAQQTGIEHYQAE
VLPQDKADFVKKLQSKGKVVAMVGDGINDSTALATADVSIAMGKGSDIAMDVAKMTLISS
DLTKIPQAIRLSKHTVAAVRQNLFWAFIYNLIGIPIAAGVLYPINGFLLNPMLAGAAMAL
SSVSVVGNSLRLKKSKL
>OBAHECAF_00878 hypothetical protein
MKIVKKLLKITVIFVVLLVLAMVAIPFFFKDKIKEKAISLVNENINATASLEDVSLSLFR
SFPKADVTLTNFSIVNKEPFVGDTLFTAQKIAVKVSVTDLLSGNYNILGFDLKDASVFIH
MNKEGQGNFDIALPSETTQKESQSTPFKLGIQSYNIENMKFTFKNDDGDMHLLLDELNHT
GKGNFENEVLDLNTKTDLKISFSMDKSNFMNRIPVSLDAILGIDLNQQKYTFKENKAIIN
RLELVLDGFVKLLENGQHYDLTFNAPSNSFQSFLALIPEAYSKEIEKVKTTGNFTLKGNV
KGDMVGDKIPTFAMEMTSQKASLKYPDLPKSIQNINIDLKVKNTTGIMNDTQVNLDKFTM
TIDEDHFTAKAHVYNVVDNPKVNAALKGTVNLANLSQAYPISLDKQLKGIFKADITTELD
MNSVEKQKFENVKSQGVASLQQFVYEGEEFVKPFHIDEANLDFSMAHIQLSKFISHVGDS
DLKLNGRLDNLFGFLFKNDVLKGNFALNSNKLVIADFMQPATNPIENPTESQSKEVTTAS
STTTTLKIPSFLDCTFVANVETVIYDNLELKNTSGKLIIKEEKVRLENLRTDILGGNVAI
SGNVSTKDAVPTFTMGLDMSKLNIVEAFTKIEMLSKIAPISKVLQGKINTVINVTGNLKN
DMTPDLSTLSGDISAGLVDSKVKSEESKLLTSLASNFQSLDFSKLNLKDLKVSGKFKDGK
VNINPFKVKYKDVSIDVVGTHGFDQVMDYNVVFNIPPQMLGTEASTTLAKLTGNQTKVDN
IAVTALLAGTFDNPKISTDMKQSVANLASQIAKNQINNLKDKGTDALKGFISSKTDSTTA
GKANQLIEGLTTKKDSTINKVKEEVKEKAKEEVKNQAKGFLKGILGGKKEEK
>OBAHECAF_00879 hypothetical protein
MKKIYFQRFIFLLISLLFIGCNPSKTGVSKVEENYVLFVSFDGFRHDYAEKYNLPNFKKL
AKEGATTPMLLSSFPSKTFPNHYSLITGMYPGNHGIVDNKFYDRGRDAVYAIGDRAKVQD
AHYYQGYPLWQWLQSKGMKTASYFWVGSEAPIRGEYPTYYYDYDGKVSNEARIDEVARWF
QLPKNERPRFVTLYFSLVDTEGHNSGPNSPKMRETVQEADRLLGLIMQKVKNINLPIYTI
VVSDHGMIEMDSSQDIFINLEEVIKATKDKANIISNGMHAQVYVNNPADKTEVYNLLKAE
LPAKVKIYYREETPAHWHYSKSSQIGDIILVVDAPNYMIHRANHPLTRLKNKWGTHGYDP
YVTPDMGGIFYAIGPKIKKGYKVHTFENVNVYPLITRILGVDNPENIDGKPEVLAPILK
>OBAHECAF_00880 TonB-dependent receptor SusC
MKNWFLNLALILCATMTYAQGIVTGKVIDGEFNAPLLGANVLIQGTTKGVFTDADGKFSL
QVDSDSGVLEISYLGFVTRQVPFKLTSGKANINVTLQSDAESLGEVVVTGSVLLDIAKER
QTPVAVSTIRASEIVEKLGNKEFPEILNRTPSVYATKAGGGFGDSKINIRGFGNENIAVM
VNGMPVNDMENSKVYWSNWAGISEVASAMQVQRGLGASKLAIASVGGTINIITRTSDMKE
GGSVFGSYGNNDGNHEMKITAAYNTGKSEKGWSSSILLSRNAGEKYADRTEFEGYNYFFA
LGYTPSDKHNFQFMMTGAPQWHNQRYSSVTISDAIKFGSADKPNRKYNSDWGYLNSEPYA
YSRNAYHKPVMMLNWDWKMNDYSALSTVVYASFGRGFGSGDYGGINRKRLRDFRNASTGL
YDFDKIVEANRTSTAGNLVRTANVNSHDWYGFLTNFNHKIDKNFTFNMGLDGRYYYGYHY
RVITDLWGAPSFKETKNENVVGGYQVSTTYSDKPSFSPFASVHPLENRVDYSNDGEVRWM
GMFAQLEYSDDDFSAFLQGSSSIQGFQRIDEFIKSGKLAVRNNPTTAMDRKTGFKDILGY
NIKGGVNYNINEQHNVFANIGYYSKQPFFNAVYPNYKNFLNPNLTNEKVLGMEAGYGFKS
SFANVNLNAYRTSWKDRFVRKSKVLRNVPDSYANILGITEIHQGIELEADVKVTDYLRFK
GALSLGDWFYEGNAQGSLFNESNELIDKNGNVLSDGSTEYITLFLDKVKVGESAQKTASL
GATVIPFDGLKFNADWRYVSNLYGTLNVTSFDSQTQADKGALLLPSYNLFDLSMSYKLKI
TDSQSITITAHIDNLFDTYYIAESYDNIHANDVPKTYNNAPNSKTYDELGETYKGISTVN
RVYFGFGRTWSFGLRYTF
>OBAHECAF_00881 Fumarate reductase iron-sulfur subunit
MNLTLKIWRQKNANEKGRMVEYKVTDISEHMSFLEMMDILNESLVAKGEEPVAFDHDCRE
GICGMCSLFINGEAHGPDRGITTCQLHMRMFNDGDTITIEPWRATAFPVIKDLIVDRTAF
ERIQQAGGYISVNTSGNTQDANAIPIPKFDADRSMDAASCIGCGACVATCKNSSAMLFVA
AKVSQFALLPQGRVEAADRVMNMVHQMDLEGFGNCTNTGACEVECPKGISLENIARMNRE
YLKASCR
>OBAHECAF_00882 hypothetical protein
MLNKVTSYKELVVWQKSMDLVKRVYEVTRLFPEEEKFGLTSQIRRSAVSIPSNIAEGWGR
ASLRSCLNFLRIAQGSLFELETQIYIAKGLGFSSDSHIEELISEIGKMIGSMIFKMKSRD
NIQSDPKN
>OBAHECAF_00883 Fumarate reductase flavoprotein subunit
MKKLDSKIPEGPIAEKWTKHKNKINLVNPANKRNIDIIVVGTGLAGGSAAATLAELGYNV
KAFAYQDSPRRAHSIAAQGGINAAKNYMGDGDSNYRLFYDTVKGGDFRAREANVYRLAEV
SGNIIDQCVAQGVPLARDYGGLLDNRSFGGTQVSRTFYAKGQTGQQLLLGAYSAMNRQIA
RGKIDMYNRHEMLDVVVVDGKARGIIARDLVTGEVERHSAHAVVIATGGYGNVYFLSTNA
MGCNGTAAWKTHKRGAFFANPCFTQIHPTCIPRSGDYQSKLTLMSESLRNDGRIWVPKNM
DDVYAIREGRKKPTEIAEQDRDYYLERRYPAFGNLAPRDIASRAAKERCDAGYGVNATGE
AVYLDFSSAIERYGKEQCKIHGIENPSKEEIIKRGEKIIEAKYGNLFQMYEKIVDENPYK
TPMMIYPATHYTMGGIWVDYNLMTTIPGCYCIGEANFSDHGANRLGASALMQGLADGYFV
LPYTIGDYLAADIRTGKISTDLPEFIEAERVVKERLAFFINNKGTNSVDYYHKKLGKVMW
DKVGMARNAQGLREAIQEIREIREDFWKNVKVTGELTGMNTELEKAGRVADFLELGELFA
KDALERNESCGGHFREEYQTPDGEALRDDENYAYVAAWEYTGNPNEVKCTYNPSEEIMHK
EELEFKDIKLAQRSYK
>OBAHECAF_00884 hypothetical protein
MAALFKTSIARKVAMALSALFLIVFLVIHLAVNFTSVFSASLFNDLSHFMGTNPLVQGVM
QPILMLGVIFHFVMGFVLEIQNRKARGANAYARYNGAANSTWMSRNMIISGACILLFLLF
HLKDFWVHEMTVKYVNGDMSGLAADGGFRYYTDLIVAMSNPIRVAVYVLSFVFLYLHLIH
GFQSSFQSMGWKDDKRKKFISKLGSIYSLVICGGFVFVALFHYFNHLLGK
>OBAHECAF_00885 Putative phospholipase A1
MNTKISNLALVLSLIISQMAISQEVNHQHRLDTILPIIEKIKYNRYGSALSKMFEIDDKD
QQGIFRPSEYRPIYLIPFRWTDRMNRQPQNTNPLRGNPPYRDFQNVETKFQVSLKTKVWQ
DFLGSKGDIWVAFTQQAYWQVYNGELSRPFRELNYEPEVMYLIPLNLSAGGFKWRLTGLS
LNHQSNGKEHLYSRSWNRIILMNAFEWGDFMFITRFWRRMSEKKNDNDNPDIIDYVGRAE
LNVFYMAKRHQILFLTRNNLNFKNNRGFGELTYVHSVGKGGLRLFAQVSTGYGDSLIEYN
HKQNTIGVGIMLSSF
>OBAHECAF_00886 hypothetical protein
MKVTYLGHACVNIEINGKFFLVDPFISANPLAKHIDISDVKADYILLTHAHQDHILDAEF
IAKRTGAKLITNPEILAHYRSLGLDGHEMNIGGSYRFENGTVKIKMTKAVHSSSFSDGKY
GGNPAGFLINYEGLTVYISGDTALHLDMTIIPSQYKVNLAVLPIGNNYTMGVRDALTAAK
FVDAIHTLGVHYDTFDVIKIDRQASIDKFAAENRNLHLLNIGESFDVKDFR
>OBAHECAF_00887 hypothetical protein
MELAKELEFILTLDKLKNVQRRNYNLDDTRRENSAEHSWQVMVLAQIMYPYAKNKEQIDL
FRVMKMLSIHDIVEIDAGDTFVYDEKAMVGKYERELASAKRIFGILGEPLSAEFLALWEE
FESGESVDAIFASAVDRIIPFILNAHTSGKSWREAKVSAEKVRNIVGAAVEKGSEELTEL
FEILLQRSIDTGKIVHINND
>OBAHECAF_00888 hypothetical protein
MLDLKIPPIVVLSIFSGVIISIPFVFPFYEVKSIWLSTIFIISGIVLALMGVWEFRRLKT
TVNPTTPEKSSRMVSTGIYRFSRNPMYLGMAFGLVGLVFYFGNCLSWFGVAGFVAYITYF
QIIPEEVVLKRIFGKSYEDYCQKTRRWL
>OBAHECAF_00889 hypothetical protein
MVTIEDIIKLEISKEDVILCIEKTKKHEFINNLRYRHKNVQFDCKLRGYIGELAIAKWFA
NNDITLSSTNYLEDGENIDIDFLVKGKNIELKTSLIPDADKNLATTISKRDIKLIKRGND
SIEQLRGDIHMQIYFSHKTKERDNWLKTQDINLHNDSEYLYNKFQADQYLNTTFFVAWID
KPSLITKINSIPISQRYWSFRYSQRFFWNCKLNVSRKPIELISYINNL
>OBAHECAF_00890 hypothetical protein
MIRRITSILLTIFILFSNSGWGFDLHFCQEQLTHISFKYIYATDNEDICSSLSKDCCIIY
DDNLSSSEDLHDECCDGDFFESSDYDNGKITTKSFEWRLYPCVLTQISVAQPPFIITKKT
KKSIPSFYVDSNAPPLYKLYCQLVFYA
>OBAHECAF_00891 TonB-dependent receptor SusC
MKKYIFMLLGILPIGIFSQEYVKGNVFDQEKQPMTGVNVYWEGTSIGVSTNDEGGFTIKR
TEKTNVLIISYIGFETERLTITSSTPLEVILKAENNLDEVVVTHKRATTIRAKYQIANLQ
TMSSGELLKAACCNLSESFSTNPSIDVNFSDAVTGNKQIKMLGLTSPYILMAEENIPTLR
GALQAYGMSFVPGTWIESIQITKGAGSVINGYESISGQINYEFLKPATDIPFFLNLYGSQ
DSRFEINAHLNHKISPKLSTSILTHGNITRQKNDHNHDGFLDMPIGNQINVLNRWQYTDN
ENGWVSFLNLNYMKDERQAGQLNFDPSKEKKSKKNWGSEIDSEKLSVSNKIGYVFPDASY
KSFGFQNAFLSHRQNSYFGMNQYDIHQKSWYSNLLYNSIISNTKNKFATGFNIVYDDFYE
WIDSNFEANYSRIDKSIGVFFEYTYDNLDNLSLVAGVRADSHNHLGNFITPRFHLRYIPW
NESTLRISAGRGKRMANIFAENQHLFISNRDFNIIQKNDKIYGLNPEIAWNYGISFLQSF
HILNRKAELVIDWYGTSFENQVVIDLDNSPQQVWFYDLEGKSFANSFQAEFSLSPIQGLD
VKSAYKYYDVKTQYIKNQMEKPLTPKHRFFVNIGYETEEKHEKNHSKWKFDLTYNWVGKQ
RLPSTKQNPTPYRLEDYAPSFGIFNAQITKVFSHNFEIYLGGENIGNYKQDNGILAANDP
FGSFFDATMLYAPAFGRMIYGGLRLKIRNFKH
>OBAHECAF_00892 hypothetical protein
MRNILFLITSLLCLTLVNAQETKEINKNKKAEFPVGGNCQMCKKRIEKAAYSVKGVKSAD
WNVDSGNMKIVIDERKCSVEDVQKAIAKIGHDAGKIKADEKTYEKLHHCCLYERLPE
>OBAHECAF_00893 tRNA N6-adenosine threonylcarbamoyltransferase
MTNTYILAIESSCDDTSAAVLKNDCVLSNVVANQDVHRKYGGVVPELASRAHLQNIVPVV
DRALKEARISQNELSAIAFTRGPGLMGSLLVGTSFAKSLSMGLNIPLIEVNHMQAHILAH
FIDEGTKKPEFPFLAMTISGGHTQIVRVDSFFSMEVLGETLDDAVGEAFDKTAKILGLPY
PGGPLIDKYAKEGNPKAFSFPKPQTNELNFSFSGLKTAVLYFVQKQTKENPNFIKENMPD
ICASVQHTIIDILMSKLKKAVKQTNIKQIAIGGGVSANSGIRETLQSLGEKYGWETYIPK
FEYCTDNAAMIGIVGYHKYREKLFTNQEVTAKSRWELGNEH
>OBAHECAF_00894 Acetylornithine aminotransferase
MSNLSQKEDFLKYQAPTSPYPMLLEVSHAKGNYIFTTDGKKYLDFVAGVSACTLGHCHPK
VVEAIQKQCETYMHVMVYGEYVQKPAVDFCKLLAEHLPENLNTTYLVNSGTEAIEGSVKL
AKRATGRTQLIAARNAYHGNTQGSMSLMGYEERKQPFRPLLPDVDFIEFNNESDIQKITH
RTAGVVLESIQGGAGFIEPQNDYLVKVKRRCEEVGALLIIDEIQPGFGRTGTLFGFQNYG
FVPDIIAIGKGMASGLPVGAFVASNELMKLLSHSPKLGHITTFGGNPVIAAASLATLKEL
LTTDLMAQTVEKEKLFRKYLQHPLIESVNGRGLMLAIILQSAEMADFVVNYCQDKGLIVY
WLLFERRAVRLSPPLTLTEAEIEIGCEIIIEALNAYRCR
>OBAHECAF_00895 Glycine--tRNA ligase
MANQEELFKQVISHAKEYGYIFQSSEIYDGLSAVYDYAQNGVELKKNIREYWWKAMVQMH
ENIVGIDAAIFMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLVEDYVAKIEDKIEKE
VAKAAKRFGESFDKQQFVTTNARVIEYKEKADSILKRLAKSLENEDLADVKSLIEELEIV
CPISGSKNWTEVKQFNLMFGTKLGATTDTAMDLYLRPETAQGIFVNFSNVQKTGRMKIPF
GIAQTGKAFRNEIVARQFIFRMREFEQMEMQFFIKPGTQQQWYDYWKETRLNWHLSLGLG
EENYRFHDHEKLAHYADAACDIEFKFPFGFKELEGIHSRTDFDLSNHEKYSGKKLQYFDP
EENKSYVPYVLETSVGLDRLFLAVFSNALQEETLEGGETRTVLRLPFVLAPTKVAILPLL
KKDGLPEIAREIFDDLKYDFNVAYDEKDAVGRRYRRQDAAGTPFCVTVDHQTKEDNTVTL
RHRDTMEQTRVDISDLRNIIFKEVDMNQWLRKTQK
>OBAHECAF_00896 hypothetical protein
MSFSGLLSVIFPEYCSGCGQVLGHEETFLCIYCRGKLIETQLHLHKDNRLLERFYGQCEL
FGATSLFYFHKDSVVQHLIHQLKYQKKESIGGWLGGWLGEKIKNVPHFQEIDVVIPVPLH
KKKLKMRGYNQVALFGQKLAQILKANYVDDVLIKVKANTTQTKKDLWSRFKDSENIFSVQ
NTEKIENCKILLVDDLITTGATIESCYTQLVKAKNVNIGIASMAYSLLGH
>OBAHECAF_00897 hypothetical protein
MKKIVRIATATLFMFAITNVQATTLGEEVNVSIEKTTQDQDGVKQDKEKKSCCKSGKSKD
KESCSKEKKSCSSKEKKSCCKSGAAKDKGSCSKEKEVK
>OBAHECAF_00898 Iron-sulfur cluster repair protein YtfE
MELKNKTIGEIVAEDFRTAAIFKKYGIDFCCKGGRTITEACDKKDLNENQLINDINTITK
EKDDSLKVNDWSLDLLTDYIVRKHHNYVREKTPYLLQFLDKLCRVHGGRHPELIEINKLF
TENTYELEKRMEKEEQILFPLIGELTHSQQNNQAFLNLNFEKITNTISIIKEMFTTEAHR
FESISQLTDKYTPPMDACSTYRVAFAMLQEFEENLLQSIHLENNILFPKIVDLKTQLN
>OBAHECAF_00899 Glycine dehydrogenase (decarboxylating)
MPISCKIIFLVVALCLISKDLFIIMNTENFSIRHIGISKEDAAEMLQTIGAASLDQLIDQ
TIPKDIRLKSALNLPKGISEHHFLQHITELAQKNKIFKSYIGLGYHEALTPSVIKRNIFE
NPGWYTAYTPYQAEIAQGRLEALLNYQTVVIELTGMEIANASLLDEGTAAAEAMAMVFDL
RSREQKKNNANKFFVSETVLPQTLSVLQTRANPFGIELVVGNHETITLDDTYFGAIVQYP
ATNNGEVFNYADFVNKAHDLGIKVVVAADLLSLVLLEAPAKFGADVVVGTSQRFGIPLGY
GGPHAGYFATREEYKRSIPGRIIGITIDADGNPALRMALQTREQHIKRDKATSNICTAQV
LLAVMAGMYAVYHGPKGLQFIAERIHQTAVTLKNSLEKLGVTVTTKTFFDTISIKADAQK
VKTIAEKHEINFFYPNQDTVLVSVNEATGVAELNQIITVFAEVVGKSVEEVTTLDTANAI
PSDLVRTSEFLTAPVFNSYHSETDMMRYIKKLERKDLALNHSMISLGSCTMKLNAATEML
PLSMGQWANIHPFVPKNQALGYQEMLTELEKSLSIITGFEATSLQPNSGANGEYAGLMVI
RQYHISNGQGHRNICLIPSSAHGTNPASAVMAGMEVVVTKTDAHGNIDVADLKEKAEKHK
DNLAAVMITYPSTHGVFESSIVEIVNIIHENGGQVYLDGANMNAQVGLTNPGTIGADVCH
LNLHKTFAIPHGGGGPGVGPICVAKHLAPFLPTNPIVSTGGNEAITAVSSAPYGSAYVCL
ISYAYIKMLGAEGLANATRYAILNANYLKENLKNYYEILYTGEQGRAAHEMILDCRPFKQ
NGIEATDIAKRLMDYGFHAPTVSFPVAGTLMVEPTESESKNELDRFISAMISIRREIEEA
TPTDEANVLKNAPHTLSMITADTWNLPYSRQKAAFPLEYIAENKFWPTVRRVNEAHGDRH
LICSCAPIEAYM
>OBAHECAF_00900 hypothetical protein
MRNILFVLTLLPIFGLKAQQKGKITYELVVTKNPDGKKKKNFL
>OBAHECAF_00901 hypothetical protein
MKRNLFLGLALVMLTACGGTKSPELKRLEAKEEILSLNTKLNNLKIELEKERIATAGFRD
EVAKINANADEKTSSFSNSDDASDAAQKARRARTALKKAQKANRNLAKSERKMQKIQRNI
SKVETKLEKLNKSIEFVPNSETNPADQ
>OBAHECAF_00902 TRAP-T-associated universal stress protein TeaD
MKNILVTTDFSEKSIASLKVAIGLAKRQKAQIFLLHALELPFRLVTQSEVSIPEAMYFLN
LSKQRFSDIKKEIGEDVEIKDIIETQPLTDAVQEAIEKYNIDLVFMGSNGASGSKELFIG
SNAEKVIRSASVPVLVIKNPEEKLQIKHVMFACDFSKKFLKPFEKAVKFAKLFNAKVDLV
YVNTPYQFLTTTEINERMKEFLSSTDKVSAKKFETHVYNDIRVETGILNYVAENNVDLVC
MFPSGRRGIAHFFNGSISSDLVNHATKPVLTIKL
>OBAHECAF_00903 Cytosol non-specific dipeptidase
MSTEIRNLDPKALWENFADLNAVPRPSKKEEKVIAFMMDFGKKLNLETLKDEVGNVIIKK
PATKGMENRKTVVLQSHLDMVHQKNNDTIFDFDTEGIKMRIDGDWVKAEGTTLGADNGIG
VAAIMAILQSTDIAHPAIEALFTIDEETGMTGAIGLKGGLLKGDILLNLDTEEDDEIDIG
CAGGVDVTAYREYDEEQTPDNVTSYKITVKGLQGGHSGMDIHKGFGNANKIMNRLLFDGF
ENFGLRIAELNGGGLRNAIPRESVATIVVDKVQNEAFQFEFQQLVKTIQHELAVTEPQLV
ITLENIATPERVMELGVQEGILRSIYTAHNGVYAMSRTIEDLVETSNNIARVIIKDGEIK
VLCLTRSSVESAKFDLANALRSAFELSGCEVTFTGSYPGWEPNVNASILKVLKEQYEILF
GEKPNVVACHAGLECGILGQNYPEMEMISFGPTIRGAHSPDEKVSISSVQKFWKYLLEIL
KNTPQK
>OBAHECAF_00904 Penicillin-binding protein 4*
MIFIPCLLFGQKINISYIDSLFQKEFKNGKFSGHVLVSQNDTIVYDVFFGKADYEKNIPF
TRNTIFQLASVSKQFTAAAVLILEQQGKLKLEDYVKKYLPTYPYKDVKIIHLLNHTSGMP
DFSKTMVPDLNMKKINGNKELMKMLSSRKYPQQLSAGDKWDYCDIAYCTAAVLIEKVSGM
PFKEFMHKYIFKPAQMNDTSAEYYTDKRLVTKKEICQGYELDELTKTRKIAYEQPHNSYV
RGLGGFYGDGSVYSTAYDLLKWDKALHSDVILNQSSKQKLFSPTLLNDGSYAKDLDYNYG
LGWYIGENPQWGTFYFHPGGQAGYCTKFIRFPKQKVAIVILSNLTHIDFYSFTNIYHHIF
GISKIFMQK
>OBAHECAF_00905 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MFQEKYDVIVVGGGHAGAEAAAAAANMGAKTLLITMQLQNIAQMSCNPAVGGIAKGQIVR
EIDALGGYTGIITDKTAIQFKMLNQSKGPAMWSPRAQSDRMRFAEEWRLQLERLPNLDFY
QDMVSDLIIENHQVKGVKTSLGIPIYSKSVILTNGTFLNGVIHIGMKQLGGGRAGEKASK
GITECLVSHGFESGRMKTGTPPRVDSRSLDYSKMIPQPGDENPEKFSFSEETQPLQIQKD
CHMTYTSEEVHDLLRTGFDRSPMFNGAIQGVGPRYCPSIEDKINRFADKDRHQIFVEPEG
WNTVEVYVNGFSTSLPEEVQFEAMRKIEGFENVKFFRPGYAIEYDYFPPTQLKHTLETKL
VENLYFAGQINGTTGYEEAAAQGIMAGINAVQKIREQEPFILKRNEAYIGVLIDDLITKG
TEEPYRMFTSRAEYRTLLRQDNADARLTPLGFSLGLASQKRMDVLERKQAKTNAFVEFFK
ETSIKPEEANPILEKYDSSPMKQGDKMFKVLSRPNITIADLQQLENVKSFVEANEIDKEI
IEQTEIEVKYAGYIEKEKNNADKLNRLEDIRIPENFNYDKLTSISFESREKLKKIRPTTL
SQASRISGVSPADISILLVYMGR
>OBAHECAF_00906 hypothetical protein
MRLIYHKTDSFEEYSIFDVELITLSYQQNLCLISPYIGTKITMSVTKDFRMPISIGQRYV
IWAKSQRNKVGLILPLEFRDLISGYPAAEIDEDYFYDKKKNKEALWVNFGNDVIFYDDHF
LFEQWKKAAKVELDRTNYSGYTRAHNPLYYRLVMDLEYRKKILDLCD
>OBAHECAF_00907 hypothetical protein
MTKKILLLFVGIFFMNISVAQELRLGIKSVVPPLNGSLAKTIEDETGNTTYNGFMSRINM
GVFINNAFSKHWSLQIEMLYRRQGFEYKSSDAIIDIARWNGSYRFDYVEVPMLVRYKNGR
DFEWFVQAGFSSKIILQVYNFGYEWDSEIHRYTEKYVGTYATERVDEHFHPSSITAYGGV
GVIYNFSDSFFAVAETNVSYDLTPLSNRTKILNKKWSFDKAKLFNIAYFSIGFGFKL
>OBAHECAF_00908 Toxin-antitoxin biofilm protein TabA
MIVAHLDHSERYEKLHPAFTKVFAHIKQTNFLNLELGKIEFDGEDVFFINAEPECLSKEN
QVLEYHQKYLDIHVLLTGEETIGWKSLTDCKHEKKAFNTEEDYGLYEDQPTTYVTLQPKH
FAIVYPEDAHAPIIGQGKIRKIVVKIKVL
>OBAHECAF_00909 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MELFEQKFQESMSSKVALLNRITYYIVNRKGKQMRPMFVFLVAKMVSGAVNERTYRGASV
IELIHTATLVHDDVVDDSNKRRGFFSLNALWKNKIAVLVGDYLLSKGLLLSIDNDDFDQL
KIISVAVREMSEGELLQIEKARRLDIVESVYYEIIRQKTATLIAACCAMGACSVKPDDRE
IIEKMRQFGEYIGMAFQIKDDLFDYTDDAIGKPTGIDIKEQKMTLPLIYTLNNCSEKDKK
WIINSVKNHNKDKKRVREIIDFVKNNNGLSYAETKMKEFQQKALQILNDFPDSDYKDALI
MMVNYVIDRKI
>OBAHECAF_00910 UDP-glucose 6-dehydrogenase TuaD
MKIVVIGTGYVGLVSGTCFAEMGNTVTCVDVNAEKIEKLKKGVIPIYEPGLEAMVLGNVA
NKNLNFTTELSEVITDAEIVFIAVGTPMGDDGSADLQYVLSVAKSIGQTMQSRLIVVDKS
TVPVGTADKVKATIQAELDKRGENIEFHVVSNPEFLKEGKAIQDFMKPDRVVVGSDSQYA
MEKMKVLYAPFFMQHDGFIGMDIRSAEMTKYAANAMLATKISFMNEIANICERVGADVNK
VRIGIGSDSRIGYSFIYPGCGYGGSCFPKDVLALKKLAEEVQYDAELIQSVDNVNNRQKF
VIAQKVIKKYGEDLSGKTFAVWGLSFKPETDDMREAPAIYVIKELVKRGAKIRAYDPKAV
HEAKICYLKGVDIEYVDSKYDALKGADAMILLTEWKEFRVPDFDEIAKLLKEKVIFDGRN
QYNSFDLPNRGFEYIQIGVE
>OBAHECAF_00911 dTDP-L-rhamnose 4-epimerase
MKKKILVTGGAGFVGSNLCEALAQNPNNQVYSLDNYFTGSRDNHVEGVTYIEGSTEHIFE
LVDFKPDLIYHLGEYSRVEQSFEDIDKVLLFNRIGTSKVLEFCRKHKSKLVYAGSSTKFG
DGGIGKNQSPYAWSKSANTEMVKNYGEWYGLEYAITYFYNVYGKREIRDGKYATLIALFS
EKIKRGEPLTVVSPGTQQRNFTHIDDIVEGLLLVGEKGQGDEYGIGSPEAYTVLEIAQMF
GGEIQMLPSRKGNRMTAEVVTEKTQALGWKSRKHIKDYIDLFLKENNKK
>OBAHECAF_00912 UDP-galactopyranose mutase
MKQYDYLIVGAGLFGSVFACEATKKGKKCLVIDRREHLGGNVYCENVEGIQVHKYGPHIF
HTNDKKIWDYINQFADFNHFVYSPVANYKGKLYNLPFNMNTFYQLWGVTTPEQAKDIIHK
QIQEEGIQEPKNLEEQALSLVGKDVYQILIKGYTEKQWGRKATELPPFIIKRLPVRYTFD
NNYFNDRYQGIPIGGYNVIIDNMLKGIETRTGIDYLENKVYFDGLAQTIVYTGKIDEYFN
YCFGELEYRSLRFETEILEEENFQGCAGVNYTDVNVPYTRIVEHKHFEFGRQKHTVVTRE
YSQKWDREKEAYYPVNDQVNQKLFSKYKEKAQELKNVIFGGRLAEYRYYDMHQVIASALH
QIKILNL
>OBAHECAF_00913 hypothetical protein
MQINYIILAHQNPQQLERLIDRLNGNDICFYIHLDAKSDMKHFEYLQRQNVIFVEQRIDV
IWGDFSIVRATLNSMIYITDNHKNGEGYTILLSAQDYPIKTNKEIQEYLLENKEYDFIDI
KKIEEVWNNYRERVVARKFNFSSQRGNFVVIFPILKVKNLRELCLSLKNIIKLFIRNPKK
GFCFLVYRRNKVPVKQHYAGSAWWVFRNQTMLKILELIKKDEKRYTNYYKECLLPDEIFF
QTLLMNIPNYNSSNIKDSVTYVNWTRQGCELPVTFDENDIEELIQQPKNKLFARKFNSSK
ILDSIDRRLFRR
>OBAHECAF_00914 UDP-glucose 6-dehydrogenase YwqF
MIEDYLGGKTFAVWGLSFKPETDDMREAPAIYVIKELVKRGAKIQAYDPKAIHEAKVCYL
KDIDIKYVESKYDALKGADAMILLTEWKEFRVPDFEEIAKLLKEKVIFDGRNQYNSFDLP
SKGFEYVQIGK
>OBAHECAF_00915 CDP-6-deoxy-L-threo-D-glycero-4-hexulose-3-dehydrase reductase
MSYKIRLKNNKEFHCETSKTILEAALEQGIGLEYSCLSARCRSCVVRVVEGRYGNIKDDM
VLSEEERKQGFVLSCNAVPCSDLQLDVEDLGMQLFKKQIIPVKINLISVLSSDIIRVELR
LPPTANFRFIPGQYVNIIRGGEKRSYSLANVPNAENHLEFFIRNYHGGLFSKYWFREARQ
NDLLRIEGPLGTFFYRENDSCENVVLLATGTGIAPIRSILQQFAEKPHLIKNKKVWLFWG
GRKQEDLFMDFSFDEFDFTFIPVLSQESNKNTEKGYVQNVALKQEINWLNSQVYACGSPN
MIETSRTILVQNGLPSEMFFADPFVSTN
>OBAHECAF_00916 hypothetical protein
MEKFEGKNLLNFIKELPDDNACRAYLAKYKWSEGFKCAKCGHEKGCLKKNFSYYCYKCSY
VETATANTLFHKVKFGLHKAFCMVFEMVTSSKSLSSVQMGERYGVSQTSTWGFMHKVRTA
MESSRKYPLSDLVHVDEFTIGGMEDDKPGRSYNTKKKKAVIAIELTDKQRVKRVYVKSID
DYSCKSLTPIFEEHISEKAQITTDKWNGYSPLKKKYNITQIESDKGKNFKKLHIVIHQIK
SWLRTIMVHVSKKHIERYFNEFCYRINRSQSKINIFHNTILRMINHKPITIKEIQNVNL
>OBAHECAF_00917 hypothetical protein
MFRPNNRLIMKKYNPDKHKRRSIRLKGYDYSREGLYFITICCQNRAHYFGEIINEEMQLN
EIGEIAQKCWRDIPNHFKNVLLHTFVVMPNHIHGIIEIVTPVGANQHLPHNETANQHLPD
DNRAKDISPLRGTSNTIGSIVRGFKIGVTKWVRSNTNIHQIWQRNYYEHIIRNEASYFRI
HEYIENNPAKWTEDCFHK
>OBAHECAF_00918 hypothetical protein
MKKILLLSENHTDYHLGFEVQSPEPKFFSWDATYEEVIASPLVEWDSPFDLDYEVYEYYY
FKYPVRVGNLLFSKFEFRIHNTQRRDIAVREYYANGDRQVEEFGFWQVHQQLEKHLSLDE
HYKTREDLYSFFQKDGMTFLSVYYGEPQHQYVFFNIINARKYSELITPIENEENIQLTDW
VLFPKEYIGIETDYQENEIVKRRPSLLTERFGDQAVLWRDEVNKQLGVSMGEFCNIFPLS
NIKKVDIDRMLPAKGSGADTLRVYYKKQKYPMLIFGAKEYDLDNYLPQLEKFFGMRIEVT
GFYYNC
>OBAHECAF_00919 hypothetical protein
MTPKQLQNIAEMEEILNKIEDFTPKAEEFLKQWQELLPEVQKLNAYYGSDQWRQDYDDAN
AGKIPEGMPHGVLSEDLAYNALGDQYFLAVDFLKLVTKIISREE
>OBAHECAF_00920 Arylsulfatase
MKKHWLKVSFFCLLTFVLSCKSTEKKGKTVFPNVILIYADDLGYGDLSSYGGKIATPHID
RLADHGILHCNAYAAASTCTPSRYTLLTGEYAWREKGRGVINGNEKALIPRGRQTVASVF
KKAGYTTAVIGKWHLGLGDENGIDWNTQISNIPEDIGFDESFIMPATSDRVPCVYVSNGK
VLNLDPTDTLAVSYQKKIGNLPTGKENPELLKLKYSHGHDMTIVNGISRIGYQSGGMSAV
WKDENIADDFVRESKKFIIKNKQKPFFLYLATNNIHVPRMPHPRFQGKTSQGLRGDAILE
LDDMVGSISKTLDSLQIAENTIIIFSSDNGAVLDDGYADQAIEKSGEHNPFGALRGAKYS
VYEAGTRIPMIVSWKGNIKKQTSQALVSQTDFIASVGAMLNVRIDSNQAFDAKNQWDSWI
GKDKKGRSEIVQEAIQNTLSIVEGDYKYIEPSKSKMKVAWQTGIETGFSDKPQLYNLKQD
PAEKVNLAEQQPQLVIDLAKKLDSIKNQHKGK
>OBAHECAF_00921 Peptidoglycan D,D-transpeptidase FtsI
MKTQKENKIRGRAYMVAFMLLILAVVISVKLINIQINGKDYREDSDKRYLREADIEPNQG
NLYSDDGSLLATSVTRYDIRWDAVASIKNEDFNKHIRALSDSLGKMFKKPSSYYQNLLRK
ERNLKNRYLLIGKNLGYGEYVRIKKFPLFNLGANKGGIIVEPIIKREYPLGGIAHRSIGY
SRVGEDGYVNRIGLEGAYSNYLVGTKGKRMEQKIAKGQWKLASGFNIIEPKDGYDVVSTI
NVNIQDIAHHALLSQLQKYKAHHGCVVVMEVSTGEIKAISNLELNPKNNTYSERYNYAVG
ETHEPGSIFKLMAVVASMEESGIDTTYVVDIKQGKAEYYKETVEDSQRSFRGKINIAKAF
AISSNVGMTEMVHHLFAKNPKDFTDKLSEMNLDKPLGLPILGEGIPYIPKPKDKNWSGIS
LEWMSFGYGLKLTPLQSLTFYNAIANEGVMVRPRLIKEVKEWNKTIEKFNVEIIDRRICS
KETARKTKGLLADVVEKSYGTGHKLYSPNFSMAGKTGTARKDYGSNQKGRGFNYISSFAG
FFPVDKPKYSCIVVIHEPDKSVGYYGADVSGPVFKSIAQKIHTNSLLINTIEDVQNSSLQ
TEKEYDLYYTKAQKYKTVMPNLFGMNAMDAIALLENMGVRVKLVGEGKVRGQSLPSGQKI
RKNENVILTLGT
>OBAHECAF_00922 hypothetical protein
MGKATNEIKNFIRGKFLVEGKNAIKNWTVIAFLFVLSVIMITSAHNADRKVHEIAQLNRE
VNELKSEFVYVRSKLQKVKLESALLDKLRSKGLKQPERPPHKIKVIVSN
>OBAHECAF_00923 Ribosomal RNA small subunit methyltransferase H
MTATNSYHKPVLLTESIDALNIKEEGIYVDVTFGGGGHSREILNRLGKKGRIYAFDQDED
AIKNSIDDERFTLINQNFRYIARFLKFYGVKKVDGILGDFGVSSHQFDVPERGFSTRFDG
VLDMRMNQNGGVSAQNIVNEYDENQLYRLFYNYGELKNAKAIAKAIVAARVNTPIRTGSE
LQEILKPFLQKFKENKTLAQIYQAIRIEVNEEIQVLEDFLLQLPDIVSVGGRISFISYHS
LEDRLVKRFIRDGKFDGAAEKDFYGNTFVPFKKIGGMITPTDEEIKENNRARSAKLRIAE
RI
>OBAHECAF_00924 Transcriptional regulator MraZ
MECGKKFLFLSKNNFKNISLKILIGTYECKIDAKGRVVLPAPLKKQLGDLEVGFVLKRSD
FQRCIDFYTTEEWNNEMLKIRSLNRYVKENDDFIRKFMSGVKLVETDAVGRILIPKDLLD
FAQINKEIVFSALGSRVEIWDKNAYERAIDTTTEDFSQLAEKVMGGLRNDSN
>OBAHECAF_00925 hypothetical protein
MKQLFFIILIISSIPILAQDLDEINTDRPDQSEGVYTLSHKKLQFENGFTFAENSFADNL
MLRYGLWQGTEVRFSTDISKIKSEKWQVDNLFVSVKQHLLSENEWIPSITLVGYGGYDFR
DKTFKPDVCLAFENTLSEQFLLAYNIGTAEKFQNLTTTFQVGYAPLKEVYLFVEYFAVFN
AETLPSHNIDTGVLYMLNPKFQIDVAFGRALFSSSADFFVTTGFSYLF
>OBAHECAF_00926 hypothetical protein
MRFFLLAICCAILGCSSKEQDLRIYVSGKVSNESGEGISNVKIQILRGKIGHYAATRYSN
YETIHTNHKGEFNYTIQNDTYVYKICCELPSGYQSVTPSCKEIDHSIVNGGTIFNVISFK
LVK
>OBAHECAF_00927 TonB-dependent receptor SusC
MNKILCVFSMFLVTMLSAQTKTGVAGVVIDQEMDGEPLSFASVIVKGTSRGTTTDLHGKF
DLNLEAGDYTLLVSFMGYEEKEIPVKVETGKRLQIEVGLNSAGVGLEEVVVQWNVNREAE
SVLLVEQKNAVLMKQAIGAQELSRKGVSDAEGAVTKISGISKQEGVKSVFVRGLGDRYNA
TTLNGFPIPSEDPEYKNIALDFFTTDIIQSIGIDKVFGVGTLSDVGGATINITSKELVND
SELKMDLSLGMNTQVMRSDTFLEQQGINSLGFSNRKKPSTNLNVYEFANSLDPSQSKFLI
NTGVGFSGGKKMMLGHHPLSIYGVFSHSSDYSFTEEIIRNTTTEGTIFLDQKGKKYSKKI
NQLGLLNANYTIDNLQLRYNLMLVHANNQYVGIYEGKNSERYQDAYDDTYLGYLVRQQNN
DNMLITNQLLSDWKLNEKSVINLGIAHNSLKGLEPDRRINNFSKISDSNHYKLTGSTGRQ
QRYFIELKENDLNTKLEYTYRFNSQEKVSNWKIGYNGRFLTTDFEAIEYDLSSQQLLNIN
SYKLDQLYNQANLNAGLFQLDRNFDRYDVSKFIHSFYSEFTYQIDPKFVLNAGLKGENVD
MKVSYNVNRGGTKGDTEITKLYILPALNLKYDIHSKHALRFGVSKTYTMPQSKEISPYVY
IDVSFKSQGNKDLKPSDNYNVDLKWDYYINGNELFSLSGFYKYVVSPIARVEEGGSGGYL
TYRNISDYATFAGIELELRKNLFQTESELSNQKWSFGWNASLIFTELNINVANTQARKTQ
LEGAAPFITNADLTYSLQKNNKNFTASMVFNYFSDRIYTIGTLQYKDIIEKGIPTMDFVA
SLDLTERLSLKLKTKNIFNSKRELSRKATNNDGNIILNTYQRGVDFNLGLSYKF
>OBAHECAF_00928 hypothetical protein
MKTKTFKIGTLIALTGLTLISCNKSDKEEETPLENTYLKGEVTQNRTLDASKTYILDGSL
IVKDGAVLNIPAGTVIKANKGFDKYILVLQGGKLNIQGTAENPVKMTANAPQGTAKAGYW
GGLIINGKARLSGDWTAGVPQGSTEIDSSIPYGGTMDNDNSGTIQYLILEYTGARSNADV
EHNGLTLNGVGSGTTVENVYVYECADDGIEFFGGSVSVKNLLCVNTDDDMFDMTQGWNGT
LENCYGLWQGDFSSSESDPRGVEADGNLDGANPTHTHQSDFTIKNMTIDLKIAKSTDVAK
VMQDVIKVRRGAKATIDNVLVKGTGQVIDLVDLKDGKGGGVATVSFTNSLTTAISGKESN
MDADNINSQITIKDSNKGCSTSIFGWTKYNF
>OBAHECAF_00929 hypothetical protein
MVSNVLSNDTANGSPATVGTVSITSVTPSPLPNAPILDAATGNVTVSSTTPSGTYTITYE
ICPLGVASADASCDTATVTVVVPPFIEANDDVYTVTSTMGGLVSNVLSNDTANGSPATVG
TVSITSVTPSPLPNAPILDAATGNVTVSSTTPSGTYTITYEICPLGVASADVSCDTATVT
IVVTAVTTPTVVTATDDVVTVTTTESGTVGNVLDNDKLGTKTPTTSDVTITVTSTPTGTI
VPNLDPVTGNVMVPSGTPTGTYTIGYSICTKSGTTTCDTATVTIVVTAVTTPTVVTATDD
VVTVTTTESGTVGNVLDNDKLGTKTPTTSDVTITVTSTPTGTIVPNLDPVTGDVTVPSGT
PTGTYTIGYSICTKSGTITCDTATVTIVVTAVTTPTVITATDDPVTVTTPQSGTVVNVLD
NDRLGTNTPTTSDVTITVTKTPTGTIVPNLDPVTGNVTVPSGTPTGTYVIGYEICTKVGT
VTCSTATVTITVTEVVTPTNTTVAKDDINNTYVNTPVSGSVAANDLDPEGDTQVWTTQTN
TTGGHTFVLNADGTYTFTPSTDFVGTVSYTYEVCDNGTPQACATATISIQVLPKGINSLV
ANDDTAVTKVNTGVLISVLSNDFDPEGDTFSVTTHTNPSHGTVALNADGTFTYTPTTDFV
GEDEFTYIICDGNVTSTCATARVHVSVVSTTTNITVANDDAYNTDVNVAVVGNVLNNDTD
PEGDTVTTTVVTTPSNGTLSLSTDGTFTYTPTTNFVGTDSFTYRVCDSGTPQACDEATVY
ITVKGVVATPTANTDTFTATTSTNTQTVGNVLDNDKLGTNTPTTSDVTITVTSTPTGAIV
PNLDPSTGNVTVPSGTPTGTYVIGYEICTKSATITCDTATVTIVVTEVTTPTTPVVAKDD
VEQTVVDTPVTVKVVSNDEHVPTQGTLTIVTQPKNGTVVIKDNGTTNDPSDDEVVYTPNR
GYAGVDSFEYELCDTMGNCSIAKVTITVLNDVIPHNGISVNGDGLNDYFHIQGIERYPNN
TVRIYNRWGVKVFETKGYDNVNRVFRAISNGRVTIEAAEKLPQGTYYYIIEYTDNNNKKH
TKGSWLYIKK
>OBAHECAF_00933 hypothetical protein
MKLILTLILCACVNFAQAQLNSNNLFLVFDNKDGIIKTEREDIKNERSDFQRTTHHYKYH
QEIKEFDRKTKRKSTSFSYQYRNKEIWGVTLSHLNAEESKHNNYILLLPKQMFDLYKETD
RVKNISEMETIWETLTQNSFSMFFRNYQYFFQMPIFDGRSFRSNVFMVFSSDLNKDYIPC
YELNVYTMDIEAHNDVVEDNDNF
>OBAHECAF_00934 hypothetical protein
MRNKLIIALFLFAFKSFAQIATNHLFIIIDNKDGVQKTESRKIRSNDEGTKFHIKKITHY
KEHQEIDLIYENGEVSKIYEYFYVNEPENWQISFRFRNHFNGNIINNFILMLPKERFEEI
ARERYYANYLETLWSKIELNTIGPFYRKYEYYDKRASYAKGVYRSNVFIVFTSDLEKDYI
PCYEVDVLISTIEEYCD
>OBAHECAF_00935 hypothetical protein
MKNTLLITLLLLTFKLYAQISERALFVIFDDTDGVLRTQKEEINSGETYWLDITKHYKHH
KVFERFDKNNKLFYKSIEYDYKNDKEDWLLNISHIIKVQNSDKYSVIKRDHILLIPNEHL
DFLKDMRQVKTIAQLEEIWNTLSQETYDFFFDSYAYIYKIPPFVKYHIFVIFSSDLQKDY
IPCYQVRVHPSNIQYE
>OBAHECAF_00936 hypothetical protein
MKTLIILIFCACVNFAQAQINSNSLFFVINNDNPNFYEKVIGKNITQKTYGINCPNSPFW
SVSFMYFSKDFFDYPARFVLLMPQTMFKEFEKKNSVIYVKQEEEKWIKMQFDEFSSQVLE
RSPHYEDRFYNYYDKEYQTEKRYNIFIIKEENLEKDYIPCYEVQLFIRPTALE
>OBAHECAF_00937 hypothetical protein
MKTKLLIILFLCSFLGFSQSEKSYVLLDSLASKYQVNKYTLNTNKLYGVHTEVEMYNILR
GEIILLISVLPNLYNNQPQWKEIQWQEIENNIISPEKITRRIINIISPYEASDYMLESKE
FNKFSLVKKENEKYYVAKFSLFEWFYVVEFKSYINVSQIKNYILNLGQNPIKRIDFMEGK
DKESFFIPHHLRNIYLSQIENHGNEKIYRFWTFDGWQVSDYYNEHRGIDRFAYIEGKGIV
GGSYDFYFKFVPKYTSKNHIYIKLTPEQWEENRLQEKIMWAKELFPERQ
>OBAHECAF_00938 hypothetical protein
MKIKNGKYTSYSFLTHRENLPKNVVENLVVEQVNDTLRAYLIRYQYSDRYMDNLAKGVKN
QRFDGTIIRTGYHTDLDALLKMEEPSSVHENLTRMTFNRICYDINLIISYSCNSGKHFVG
DDRCALSGSARAHNEYRIVTKCYNEIDYGWTPPMEQIDHIADDYLGGGGGTPSAPAVVVN
IKRERADGGATEIEDEIIDNLTNPCAKDLLKQLPNLKNDIAKLLKETFGGDSKYDITFTE
DENLRKKGIDGQANASNATKISEDEIIFRSNIYLNPDILENATQEYILVTMYHEVIHAFL
NYEETRLRGKILPNGKFDNSEFEHKYPDVKIVELEYGNKNKVKKYQLLQEQGHNRFAPFI
EKLAQSIISFNPKIPLKTARAMAKMGIVDEKSMSNEEKLLNQGQRNGTDTKGTKCN
>OBAHECAF_00939 ATP-dependent RNA helicase DeaD
MNSFKQLGLNESILKAITDMGFEKPSEIQEKAIPTLLSEDVDMVALAQTGTGKTAAFGFP
LLQKIDAETKETQALILSPTRELCLQITSELKLYSKYMSNIHVVAIYGGASIEEQTKSIR
KGAQIIVATPGRMQDMIRRGFVNISNIDICVLDEADEMLNMGFYEDITSILSHTPDTKNT
WLFSATMPNEVAKIARQFMYKPFEVTVGSRNQASNNIRHEYYMVNGRHRYQALKRLADAN
PDIFSVVFCRTKKDTQAVAEKLIEDGYNAAALHGDLSQNQRDLVMKSFRARQIQMLVATD
VAARGIDVDDITHVIHYQLPDETETYTHRSGRTGRAGKSGVSMVIIPKSEVKKIKSIEKI
IQQPFEQKPLPSGIEICEIQLYHLANNIKNSTVETAIEDYLPAIYDVLQGLDREEIIKRM
VAVEFSRFFNYYKNAEDLNASNGKEKGSSDNGEVRYFINIGERDGYDWKTLKDFLKATLN
LDRDDVFKVDVKNSFSFFNTDAELVDLVTSTFNDFQLDGRFVNVEISKKEERGSGRNGRD
SRGKGEFKGRNRGDSKRRDRDSKSEGRSSSRRKDRGRGQKAAQAFDNAFKKKKRK
>OBAHECAF_00940 Bacterial leucyl aminopeptidase
MVLTKWNRKYYEIKETFMKNIITVICCVAFFTSNAQTFEKDSIMLRSIHTETLTKGKAYD
WLHHICYQIGHRLSGSHGEKKMIEFLKTELEELNTDVKLQPVMVPHWVRGLPEYAYIQTA
KNKITPVPILALGGSVATPASGIKGQVIEFKSLEDLEKADINSVIGKIVFLNGALPNEYI
DAFDSYSACGSQRYSGARVAVNKGAIAVIVRSLSHKIDDHPHTGVMSYEDLPKSRHIPAA
AISTKGADLLSTLLVLNPKLEFYFKQNCKTFDDVQSYNVIGEIKGSLYPDEIITFGAHLD
SWDVGHGAHDDGAGVAQSLEVIRIFKSLNYKPKRTIRIVLFANEENGARGGQKYAEESKK
NRENQIFALETDAGGFSPRGFNLRGEAQKIEKIKMWEKLFTPYYIHLFRKGYPGLDISPL
QTENNVLAGLIPDSQRYFDHHHSETDVFDAVNKRELSLGAAAITSLIYLVDMYGL
>OBAHECAF_00941 Formate acetyltransferase
MVATELKKPFVGGKWENQVDLVDFITKNYTEYRGDASFLEGPTADTTELVRKFDELMKQE
RLNGGVVDMDTKIPSTILSHSVGYLDKEREKVVGLQTDKPLKRALMPFGGINMAIHSCEA
YGYKVEDEVVKIFTDYRKTHNQGVFDVYTPEMRAVRKSGVITGLPDAYGRGRIIGDYRRV
ALYGVDQLIQFKVKDFNEIGSDGVMTEHIIRDREEVAEQIRALKELKELGKMYGFDISKP
ATNAREAVQWLYFGYLAAIKQQNGAAMSIGNIATFLDIYIERDLQDGTLTEVEAQELIDN
LVLKLRMVKFARTPDYNQLFSGDPIWATLIVGEMLDNERSLVTKTDFRFIHTLDNMGNSP
EPNLTVLWSSRLPKGFKDFCAESSINHSAIQYESDELLSDFLKTCDKSIACCVSGMTTGK
DMQFFGARANLAKALLYAINGGRDEMTGEQIGPKTEPLRGVLNYDKVIESYDQFMEWLCK
LYINTLNVIHYMHDKYSYESLEMALHDTNVRRFMATGIAGFSVAVDSLSAIKYAKVTPIV
DETGLAIDYKIEGEFPTFGNNDDRADAIAVELLKKFMTMLRKHKVYRADETTTSILTITS
NVVYGKKTGNTPDGRREGEPFSPGANPMNGRDRSGALACLSSVAKIPYEYSRDGISLTAA
FTPSSLGKTKGDQIKNLTSMMDGYFLQGGFHLNTNVFNKEMLEKVIAAPEEYPNFTIRVS
GYAVRLISLTPEQQRDVLSRTMHELM
>OBAHECAF_00942 L-asparaginase 2
MNIPKKIILLLVIFIPMAVFGQKPMIRIIATGGTIAGVSKSTTDSNYKAGELGIYELLQA
VPEVKNVAEVSGEQLVKIGSQDMNDQVWLKLSKRVNELLTKENYDGVVITHGTDTMEETA
YFLNLTVHSNKPVVMVGAMRPATGMSADGPLNLYNAIVVAASSKATNKGVMVVMNDVIHD
AKDVIKSNTLAVETFQSANFGKLGYIHNGKTFFSRIPQNKHTTQSIFDVDNLKFLPKVGI
VYGYSNMSELPMKAFIDAQFDGIVYAGVGNGNFYHTLFDLAVQAQKKGIQIVRSSRVPMG
ATTLDAEVDDTKYNFVAAQTLNPQKARILLMLALTKTKDWKLIQQYFNEY
>OBAHECAF_00943 Anaerobic C4-dicarboxylate transporter DcuA
MDWLIFTELFVVLVAIFVGARVGGIGLGVFGMLGLAVLVFGFGLKPGNAPIDVMLIILSV
ITAAAALQAAGGLDYLVRVAERILRKNPSMITFLAPVVCYIFTFLSGTGHIAYSLLPIIS
EIATESKVRPERPLSISVIASQQAITASPISAATAALLGTTLLGGQGIELSDILMICIPS
TLIGVIVGAFAVRFIGVDLEKDSEYQRRVRDGILKNEKQTTYEISAKENQKALISVIIFL
IGVLLIVIFGSIPSLRPSFVLTDGTSYRLGMTEIIEIVMMSIAGLMLIFTKTNVDKAVKG
SVFIAGMQAVIAIFGIAWMGDTFFNGNIEFFKTHIEHIVTDYPFLFAIALFVMSILLFSQ
AATVRTLYPLGIALGIPPLALVAMFPAVNGYFFIPNYPTVVAAISFDRTGTTRIGKYVLN
HSFQLPGFVATIVSIAVGYFLILFF
>OBAHECAF_00944 Energy-dependent translational throttle protein EttA
MNLLSVENISKSFGERVLFQNISFGINKDQKIAFVAKNGTGKTTLLNILSGKDQPDSGQV
VSRNGIHIAFLSQNPEFNKDFTIEETIFSVDNPILRIIQDYEKALKNPSDEKNYQKAFEK
MELHNAWDFETQYKQILSRLKLDNLQLKVKNLSGGQKKRLALANVLITKPDLLILDEPTN
HLDLEMIEWLEQFFAKENITLFLVTHDRYFLERVCNEIVELDNGELYTYKGNYSYFLEKK
EQRLAQEQASIDKAKNLYVKELDWMRRQPKARTTKSKSRIDDFYIIKEQAHKRRKDHVVQ
LEINMERLGSKIVEFHNVGKQFGERIILNKFNYNFLRGERVGIIGKNGTGKSTFLNLLTQ
KIEPDNGKIVIGDTIKFGYYTQEGIEVKEGQKVIEVIQKYGEYIPLLKGKTLSAAQLLER
FLFDRKKQYDFVEKLSGGELKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLEEFLLDY
PGCLLVVSHDRYFMDKIVDHLFVFRGDGVVEDFPGNYTDFRVYEESTPPVEVSSEKKETT
KNVWRKDGLKGLSFNEQKEFNRLEKEISILEDKKTSIEDLFSKGELNSDEIQQKSMELQQ
IITELEEKTERWFELSMKMEENGN
>OBAHECAF_00945 hypothetical protein
MEINLSELPKLAKQKRDESLQFFAQLKKKPPKKLDYMMQEIHDEVSAEVDCLQCANCCKT
TGPLLTNIDIDRISKHLRVKPSDFITKYLRVDEDKDYVFQSMPCPFLASDNYCLIYEVRP
KACREYPHTDRKKIYQIGNLTVKNTEICPIAFKVVEKMKESIKVR
>OBAHECAF_00946 Tyrosine recombinase XerD
MWHKTKEEYQFYLQLQRGMSKNSITSYGLEIEKLISYLETYHIAETPNTISVDTLRQFVY
ETSKELNSRSQARLISALKSFFKFMMSEKNREDYPMDLIESPKIGLKLPDTLALEEIDKL
LESIDLSIDEGHRNKAIIETLYGCGLRVSELISLRLSDLFFEEDFIRVMGKGSKQRLIPI
GEFTKKQILNYIDNQRKKIKIAKGHEDYVFLNRRGKQLTRAMIFTIVRQTAENIGLQKKI
SPHTFRHSFATHLLENGANLRAIQTMLGHESITTTQIYVHVENSHLREMLVKFHPRRTFE
L
>OBAHECAF_00947 tRNA (guanosine(18)-2'-O)-methyltransferase
MNQNTLLTYLENFITDSRKERFTEILSLRTNHFTVAVEDVFQMHNTSAVIRSCEVFGVQQ
AHLIEQRFGKRLDAKIAMGAQKWVDTFRYESTQECMDTLRAKGYQIVATTPHQDAYLLND
FDITRKSAFFFGTEKSGLSKEVLNQADTYLKIPMVGFTESLNISVCVAIILQQLTEKLRK
SDVSWQLTEEEKTCIRIDWTKKSIRSVEAVLQRFNEKYAE
>OBAHECAF_00948 hypothetical protein
MFEYIIEKDKELFLYLNGLGSEHWDIFWLFISHKFSALPLYVLLLFFCFKYFKWKKTIVI
LVCVALMIVATDQLANVFKYGFERLRPCHDESLISQMRLIICGGKYGYFSAHAASSMAVA
VFFGKLFRKKIKWLFLVLLLWSFLVGYSRIYLGVHFPGDVLTGFIIGGLLGFVFYLIQTG
RYEHKTM
>OBAHECAF_00949 hypothetical protein
MATINNINQLDLVNGVYTYADYVLWKFEERVELLKGKIFKMSPAPSLKHQRISLNITLFL
GNYFKNQKCQLFVAPFDVRLPKKEEKGDNIHTVVQPDLCVICDESKLDERGCIGAPDLII
EILSPGNSKKEMKNKFELYQESGVEEYWIVNPTDENILVNVLEDGKYKILKPVVDEYITS
VKFPELKIHTSDIF
>OBAHECAF_00950 hypothetical protein
MKNVLNINQLDVENGVYTYADYLLWKFEERVELLKGKIFKMSPAPSLKHQKISMNLSGLL
WQFLRGKKCQLFSAPFDVRLPKKEEKGDNIHTVVQPDLCVICDESKLDERGCIGAPDLII
EILSPGNSKKEMKNKFELYQESGVEEYWIVNPTDENILVNVLEDGKYRILKPVVDEYITS
VKFPELKIHTSDIF
>OBAHECAF_00951 hypothetical protein
MSNFPKFLLGDNSDFPDAIFVIHTEYPRFVLNLETDEVEWLEDFDEEDTKELEIEAENLI
QQSYEFYEREIDRYEG
>OBAHECAF_00952 Phosphoethanolamine transferase EptA
MLKKLINNITLYRFVLIISILNFIFFHYGFFSFVFQNIDYHSFNGILLVISLFILMVVAN
FFAFYLILFLLRAIGKFLLAIIFILSAIAVYFINTYSIIVDESMIGNLLNTNYEESSSFF
SVKLILYLLVLGIIPSIYILKARVTYPSVKKFFKNLGAILLVILILVVINAKNILWIDKN
SKYLGGLAMPWSYSVNTILYYVHKAQENRQEILLPDATIKNKEKSVMVLVIGESARSENF
SLYGYKKNTNPLLSKTENVFHFNANSCATYTTAAVKCILEHQYTGNLYEILPNYLNRSGV
EVVWRTTNSGEPPVHVDKYFTGSALRQNCEEKNCDYDEVLLSGLKEQISKSDKDKILIIL
HTSTSHGPTYNKKYPAEFEVFKPVCNSVELGNCSHEELINAYDNTIVYTDYMLHKIIGDL
KELEDYKTAMLYVSDHGESLGEKNLYMHGLPMSIAPKEQYEIPFIVWKSADSKSIKSLKD
VTQHHVFHSVLKFLDVESPIYKEELSIFGD
>OBAHECAF_00953 hypothetical protein
MNQTITANFEKVKPYFLIFPLLVMASVFCFLFVNNALEPEKYVFIQQECFFYLNEKLSQF
PYLQYNLTQFGDAFIVLCMLSVFFFYTPKIWENLLSASLLSLFFSRGLKEFFDVPRPATI
HPIDSFTIVGEKAVGFSSFPSGHSITVFTTLCVLLIAFLPKSLIKKVLYVVILVFLGLIL
AFTRVGVGAHHPLDVISGCAIGSISAFLGILINQKYNAWTWISNKKYLPIFMVLFLGSVI
FLIYRILEENIFVYYLSLSSLIVSLYTIIKAYVKKINK
>OBAHECAF_00954 Alanine dehydrogenase 2
MSSISTFSKFLPQEECLAVSNQQVSLKIGLPKEHTFQERRICLAPDDVAVLVANGHQILI
ETGAGEEANFSDRDYSEAGAQIVYDSEQVLSCPIVLKVEPPTKAEIEHLKPKSVLLSALQ
IKTQDKDYFTSLAKKQITALAFEYIQDDEYNHPVVQSISEIIGVASVLVASELIGNTSYG
GGGILFGNITGVPPIEVVFLGANEVTQAAVKSAIGLGAKVKVFDNSLANLRKLKQAVNEN
VFTSTLQPKVLKKALMRCNVVIGAMRGENRSPVVVNEDMVKTMKRGAVIVDVSIDTGGCV
ETSRITTFAEPTFMEHNVIHYCVPNIASRYARTASFSLSNILTPYLLKIGEEGGIENVLH
IDKGLRNGLYFYHGVLTDNTISQWFGIPYKPINLLFI
>OBAHECAF_00955 hypothetical protein
MSILKRFGYYSIGLGIGIVFVAFFFKKKDTEPFCYFPNCRVLKDIRSKTIEVDIQTSLTK
DDFMELFTHGDVLFSKSDTKATPCKIYVIEGVIAEKEIEVTLENCSDKVVIKKINDK
>OBAHECAF_00956 hypothetical protein
MAGILDFLGENNFQQIVNGVSKETGVSPSKASSVIEMATPLLLGAMQNKSDNEQAATGLL
SALTSDKHNGNLLNNLGSLFENKGDNPLTNEGSGILGHLLGGKESTLSDAISSKTGVSSS
NVLQILKILAPVLMSFIAKKMSENNVSSASGLGGLLSTLTGNSSGGNLLTSLLDANGDGN
ILDDVVGKLGNSSTSSKNGGLGDVLGGFFGGK
>OBAHECAF_00957 tRNA-specific adenosine deaminase
MDDFYFMRRALEQAEKAFDKNEIPVGAIITIQGQIIAQAHNLTELLTDVTAHAEMQAITM
ASNYLGGKYLKDCTLYVTLEPCTMCAGALYWSQISKVVFGASDPKRGFQTTGVKLHPKTQ
IIGGVLADESSKLLVDFFEKRR
>OBAHECAF_00958 hypothetical protein
MKKLCLYLSLLLVGLQNVTSQVIDSLDMVQIDSLKTQRDDKFYKDAGEYLKKRKLTQKIY
DFLFTKPKVTTPQTGKVTDEINFKPHQGKIIRNIEIITLDPFGYSEKDLSKKPGKKLEIY
GNALHNKTKRGTVKKQLLFSKNDRLDSLLVQESERILRDQNYIRRVVIRPIPITPVSDSI
DIQVVALDSWTMFFDSDWTDKRGWIRVSEYNLFGIGHQLSLTYRQYFKKFSENGKGIYYR
ARNIENTHIDGIASYYQDLEEYSGRLVLDRPLFSPYARWTGRIAFYENRQAERMFVNDSL
LYPYIKYRIYDAYGGYAIPLKNSDDKSIHRAIISARYKQTKFLETPVDSLNVGNFYSDEE
LFLSKLSLNSTRFVQDRYIFRHGDIEDVSIGHSFFGTSGVSKKNLNYYPYLGIGASWANY
TDKGYFSIDTEAGGFLSNGRAHRVAIKGELSFFSNLFTLGNWYFREFAKAQFVMGFNRAT
HINDKITINEKEGMKDFDSNIYDGTRKLLLVSQTQLYSPFHWYGFRISPFLNVELGIIGR
EHTSFFNVGMYPKFAIGFYISNDYLLFHNFQFSFCYFPEIPGVGNNIYEITNSRNDDFRL
PSFGHNAPSTILFK
>OBAHECAF_00959 hypothetical protein
MKYTRLTKEQLEALHHDFAVFLATQQITADEWEQLKKEKKHIAEEEIDIFSDLVWEKSLQ
KVSFLERIDKKSIHCFHFQDTNAKMISVQVSDGNIDLTEPEGFLWLKKNMLSDDVQLFTG
EKTYTTERNMEIFNLIQQGMQISDGQLFISLNEMLN
>OBAHECAF_00960 Nicotinate-nucleotide adenylyltransferase
MQKRQIGLFFGSFNPIHIGHIIIANHLVEHSDLSEVWFVVTPQNPFKQKRTLLNNYDRLE
MVHRAVESYEKLQPSDIEFHLPVPNYTTHTLSYLEEKYPTVNFALIMGEDNLKSFHKWKN
YEHILANYPIYVYPRISEGEVPKEIENQGNIIHVDAPIIELSATFIREEIKAQRNVRPLL
DAKVWKYIDEMGFYR
>OBAHECAF_00961 hypothetical protein
MRKYVYLFGIVSSLIFACNDGDLEVETISFENNEVLSCTADTTATFLFKYNGKQAMILEL
PQGVLKNSENNTKGKVASNYKLYYRSFSENVSTNYFCANYPPANPLVQSQFEATGGSITI
DTKPIVNTMTNQVERYDHQITISDLVILNAEGNKVVDSEFIFGVYQTRK
>OBAHECAF_00962 7-carboxy-7-deazaguanine synthase
MLDKETQKAVDKGEMLPLMEAFYTIQGEGFYKGTAAYFIRVGGCDVGCHWCDVKESWDAE
KHPPTHIEDIVNQSLKYSKTIVVTGGEPLMWNMFPLTQKLKEKGMKTHIETSGSHSLTGI
WDWICLSPKKLRLPTSEIYQKANELKIIIYNSHDFIFAEEMASKVSDDCILYLQPEWSRR
DKVIPEIVDFVMKNPKWKVSLQTHKYLNIP
>OBAHECAF_00963 hypothetical protein
MKHITHIICIIFCFLCFSIKAQSIKTEFKIRYEAFVKGDIKIIGNNIVNREDRRNNSNIP
FDDRSRGAKLNDELNMQYIDVDDDPTTFSSSSASFSFEGKQKAKVIYAGLYWTATYPYTS
GTLKGTNYGIKDGTRENSQSVMIKTPSRKDYVHLQGELIYDGSKEHSLKGISPYVYYVNI
SYLLTNTASEGEYTVANIRAATGHIAGGSAAGWALVLVYENEDSNIKKIITYDGFESISN
EPKTFSFSGFTTPAKDAFQTRIMGITLEGDFSMGGDQVTVSVPASGKSLTLESKIRPQRN
FFNSAITWNDEFVRERNPASQNTLGFDIFKMDIPNVNQELIPNDASSLDLTYSKSLDRYY
LFFTALEIENNPDAITRLHSSTRVTKISAEDVNKGYYIVVGVFLNQKNVKKRIQEMQSHG
YKADTFHYKEQVLNYVYLEKYDSYEQALKRVEEIKNEGKIADPWILDVENYL
>OBAHECAF_00964 Phosphoglucomutase
MLEKSIETAKTWLSDAFDAETRKKVQELLDGNLDELKESFYKNLEFGTGGMRGIMGIGTN
RINKYTLGKNTQGLSNYLKKSFPNGEIKVAIAHDCRNNSKNLAKVVADVFTANGIKVFLF
SDLRPTPELSFAVRHLGCQCGIVLTASHNPPEYNGYKVYWQDGGQLVPPQDGEIMKSIDT
IDFKDINFNANENLLQWIDSELDNAFAEASIKNGSFNAPQKENLKVVFTSLHGTSITMVP
EVLKRAGYTNVHIVEEQATPDGNFPTVKSPNPEEPEALTMALKKAEEIGADIVIGTDPDC
DRVGVAVRDLDGKMTLLNGNQTMVMMTLFLLQKHKEKGFKGNEFIGSTIVSTPMMNDIAT
AFGVECKVGLTGFKWIAKMIKDFPEQTFVGGGEESFGYMVGDFVRDKDAVTATLLACEIA
ATAKASGSSFYKELVRAYVDYGFYKEYLISLVKKGISGSEEISQMMKDLRQNPLKEIYNE
KVTMVEDYQTSKAHNLLTGEVEDIDIPKSNVLIYYTEKGTKIAARPSGTEPKIKFYFSVN
TPLDSIENFKKAEKTLDERIKNIVKDMKLEG
>OBAHECAF_00966 Lon protease 2
MTYYIPFMKMKLSNFDSFSSETIDTDAEFIPLLTAEDEEEIQKESLPTVLPILPLRNMVL
FPGVVIPITAGRDASVRLINDANEGSKTIGVVAQIDENVEIPTGKDIYHLGTVARILKVL
KMPDGNITIIIQGKKRFEIDTILEEKPYITATIKEVEETRPPKNDKEFGVVIESIKDLAT
RIIRENPNLPSEATFAIKNIESGAFLVNFVSSNMNALVKEKQEILETNDLKDRALCALKY
LDLELQKLTLRNDIQSRVRFDIDKQQREYFLHQQIKTIQEELGGVSYEEEIEEMKKVAKT
KKWDDKIKEHFEKELGKLQRMNPQVAEYSVQRNYLDTLLELPWNEFSKDNFDLKRAQKVL
DQDHYGLEEVKRRIIEHLAVLKLRNDMKSPILCFYGPPGVGKTSLGKSIAKALNREYVRM
SLGGLRDEAEIRGHRKTYIGAMPGRILQLLKKAKTSNPVFVLDEIDKLSHSHNGDPSSAM
LEVLDPEQNSEFYDNFLEVGYDLSKVMFIATANELSTIQPALRDRMEIINVTGYTIEEKV
EIAKKYLLPKQLEEHGLKSRDLSLGKKEIERVVEGYTRESGVRGLEKQIAKLVRFCAKSV
AMEEPYESKLSLDEITKILGPARMERDRYEDNDIAGVVTGLAWTSVGGDILFIESALSKG
KGTLNITGNLGTVMKESATIALEYIKANAERFGIEPTLFSDNNIHIHVPEGATPKDGPSA
GITMLTSLMSLFTQKRVKKHLAMTGEITLRGKVLPVGGIKEKILAGKRAGIKEIILCKEN
EKDVLEIREDYLKGLTFHYVTEMEEVIKIAITNQDVKNKKQF
>OBAHECAF_00967 tRNA (guanine-N(1)-)-methyltransferase
MRIDIISVIPELIESPFNASIMQRAAKKGLVEVYFHNLRDYSTGSYKQVDDYQFGGGAGM
VLMIEPIDKCISALKAERSYDEIIYMTPDGETLNQKIANRLSLYENIIILCGHYKGVDQR
VRDQFITKEISIGDYVLSGGELGAAVLCDAIIRLIPGVLNDETSALTDSFQDNLLAPPVY
TRPASYKGWDVPEVLMSGNFPEIEQWREKKAYEHTKNRRPDLLNKEY
>OBAHECAF_00968 hypothetical protein
MKKQLLIGAFTILFTCPIVNAQEGTRIQNTKNQKKENTLNSQFENLISQSNSWQNYKVID
KGSLTVYQRNVMDSLESVKSKIKAQQQVVDAHENEIKKLNNNILSLENTLEETRNEKDSV
SLLGILLPKSTYSLIMWSIVLLLIAMLVFYIYRYSNSNVIAKKSMQDLNDLQEEYENYRK
SAIEREQKVRRQLQDEINKHR
>OBAHECAF_00970 ATP-dependent zinc metalloprotease FtsH
MVTSDFIIHDRESIPFEDIFLSDENKTALQQLIKEHEHIAELMKYGLQADNKILFYGASG
CGKTTTAKSIANRLGKSIFILNLSNLVNSRIGETSKNLKAVFDKAQREKAVLFLDEFDQI
GKTRTDDERDVGEMRRLVNTIIQLFDYFPKEGVLICATNHIDFIDFALLRRFQLKLDYEM
PSRERLDAYYDKILADFPEKFTNIDRKYDISYAEVKDYIHTQMKKAIIYSLENSH
>OBAHECAF_00971 Periplasmic serine endoprotease DegP
MKNYASIVSAAFLGGILSLGGYKLFLDKTDSVAQPVLTEKPNFVQTNNHVGGTRFELNEN
SFVEAANKTVNSVVHIKNVATKQGGGNSVFDLFYGGGSQTQVGTGSGVIITPDGYIVTNN
HVIADATTLEVTLNNNKTYTAKLIGTDVSSDIALLKIEAEEQLPFLTFADSDNTQIGEWV
LAVGNPFNLNSTVTAGIISAKARNISERSNDKVESFIQTDAVVNRGNSGGALVNLKGDLI
GINTAITSTTGTYMGYSFAVPSNIAKKVIEDLIEYGNVQRGVLGVRGTELNSINAERLGI
KQTEGFYVDSVDEESGAGAAGIKKGDIIKQIDNVRIHKYSDLSGYIASKRPGDQLKVIYD
REGKERNTTVNLKKNTTYVVNTLGLEVKNLSEVDQKKFKTKTGVKVTGASQFYEYNNVSV
VGKVLVAVNSKPIKDIDELKNIVASLSSRNRNSLELINEKGERERLFF
>OBAHECAF_00972 Ribosomal RNA large subunit methyltransferase H
MNIKLITIGKTDNSNLQQLISDYEKRLLHYINFELVTIPDLKNSKSLSEEQQKTKEGELI
LKQLELSHELILLDERGKEYTSVGFSEYIQKKLNTGIKQLTFVIGGPYGFSQEVYARANG
KLSLSKLTFSHQMIRLFFVEQVYRAFTILKNEPYHHR
>OBAHECAF_00973 hypothetical protein
MPRINLNINKMKKVNILILTLSLFINGYAQNKKDIAAIKNMCGCYEVTFRYAETFRYGAD
STYVPSKPSRSKALEWVEAVEDKKDKIVLQHLLIVGKKGNERIIKHWRQDWEYQNRNFYT
YELGDQWLFSQKPKSDVKGQWTQKVFQVDDSPRYEQTATWVHVDGKSFWESEVVSPLPRR
EEEVRSDYNVMFRRNRHEITNYGWLHEQDNDKILRRDGKDDLVIAQEKGYNTYKKVDDEK
CKAAKDFWQKHHEKWGLVRAKWNEIYAKNATLRFETKVDGKTLFEYLFDEENYKTKEKID
EIIQKFVL
>OBAHECAF_00974 Sodium/glucose cotransporter
MNVQLILFVILLYFGILISISYFTSRKTGDETFFTGDRKSAWFLVAFGMVGSALSGVTFV
SLPGSVANNHLYFSQFVMGNVVGYMFIAFVLTPLYYRLQLVSIYGYLKERFGKVSYKSGS
LIFLVSQSFGAALRLMLATKILQLAFFDRIGIPFYLTVIIIIVFVWLYTFKSGIKTIVWT
DTLQTFFLIISIVAIGIGISDTLDMSFSETAQQIYNHKYFDFFNWDTKSGNNFFKQFIAG
FFVSVAMIGLDQNMMQKTLTCRNIWDAQKNMLTYSLVLAGTQILFLCLGVLLYIYAENMG
IILEIDPKGLVLNTDNLFPDLALNYLGIVAGMCFLLGIIAASFSSIDSALTALTTSFTYD
FLDMSKKTSQQKKRYKNLALFGFSIVIFCIIMIFSQSKGDVISLIFNIAGYTYGPLLGLF
IFGMFTKMKIHDKWVWLVCIASPLLTYTLSIYLKNHFKFDFGFVSIAVNGILTFFGLLLL
HKRN
>OBAHECAF_00975 Ribosomal RNA small subunit methyltransferase A
MNKQQGHWLLAKMGKKVLRPGGKELTLKMIDNLVVNNDDVVVEFAPGLGLTAEITLAKNP
ENYIGIELDEEAAEKLRKKFAKKNVQIINKNAAETELPEQVANKVYGEAMLTMQADHRKR
EIIREAHRILKPGGLYAIHELGLTPNDIAPEAKATIQRELAQVIRVNARPLTVSEWSEII
ESEGFKIIKVETNPMHLLEKKRMIQDEGFFRTLKIGFNILTNPDARKRIRAMRKVFRTYE
NNLNAVAIVAEKK
>OBAHECAF_00976 hypothetical protein
MRKYPLLLVLLPLGLQAQMKQIIEKEENVITDVMTASMLKDVTYKDDKPNVEVILETEFT
KEVRITFKEGQIMKRHKAPRAIVVQVLEGKINFEVGETIYQLNKGDFITLKATIVHELKA
LENSVVRLSLSKYETQEIEKSKK
>OBAHECAF_00977 Fe/S biogenesis protein NfuA
MDSFAKKNRTMSEVTISIQPTSNPEIIKLEASKILVKGSYEFNNIDEAKNSPLAQQLFYL
PFIKTVYISSNFIALKRYPIVEWADVQEELAEQISVYINSGNELITTEQPLKKLPITVYA
ESTPNPTVMKFVVNKQIVPVVLEYKNVTQTQNAPLAKALFDFPFVKEVFFDENYISITKD
ESVKWFEITMELREFIRTYLADGNKVVLDKETKKEQVTNEKQIEKSPLVTDITSQKIVAL
LDEYVKPAVASDGGNIQFVSYNKETHQVEVILQGACSGCPSSTMTLKNGIENLLQDQLQN
SEIRVIAING
>OBAHECAF_00978 hypothetical protein
MNINRKIKSLNTAEQIAIVNILLFIVGYSVVFLGLISQEQLNQWVGMPQKWDVFLTKPWT
IFTYAFFHARWQHLFWNMLFLYLVGQIFFNLFNNKQFLKVYLSGIFFGGICFLSVYFLPS
VFFENSILLGASGAIIAMLFFVCVMAPTYVVNVFFSIRMRLWYVALLLLAFDIIQFASDP
GGKIVHIGGAFIGCFLALLGKYPLQLKRKKYEKLTKKQISSKAIKPSESRSKLSESQKIK
QHKVNVILEKISSSGYTSLTEEEKKFLFEASKEMNL
>OBAHECAF_00979 Putative esterase
MLILVNYILFNSMENLHFDYVLRTRYGETDQMGVIYYGNYPQYLELGRVEWLRSLGISYK
EMEKEGVMLPVVSLHIDYKKPAFYDELITIRTQLKELPSSKITFDYQIINEKGEVISTAN
TTLVFVDVNTWRPVRCPQRILAAIQQKMKS
>OBAHECAF_00980 Chromosomal replication initiator protein DnaA
MKDLAEKAWGRCLDFIRDNIEEQPFNTWFAPIVPISLENNSLKIGVPTKFFYEYLEQNYI
SLLKSAMTFSLGEKARLTYVINSLTREQLPSTNRPELARQSLTLPIQNKDPELRNPFVIP
GIREITIDPQLNLNQNFDNFVEGNSNRLARSAGMAVANKPGGTAFNPLFIFGGVGLGKTH
LAHAIGVDIKEKHPKKKVLYVSAEKFTQQFVNATMSKDKDKTSLNDFIHFYQLIDVLIVD
DVQFLSSKLKTQDAFFHIFNHLQQNNKQIILTSDKAPVDMQDIEQRLLSRFKWGLSAELQ
TPDYETRYKILKNKFYTDGAEVEDEIISYLAENVRTNVRELEGVSNSLIAQAAFNRKEFS
IELAQSIIERSIRNHRKEITIDHIQQIVSDYFNVGLEELQSKTRKRNVVQARQLAMFFAK
KYTKNSLTAIGSQIGQRDHATVLHACKTVENLTETDREFKRYVEELTSKFSN
>OBAHECAF_00981 Low molecular weight protein-tyrosine-phosphatase YfkJ
MVCLGNICRSPLAEGVLRAKLDPAKFEVDSAGTSNYHVGDAPDSRSIEVARKNGIDIANL
KGRQFKKTDFEDFDYIFVMDRSNYINVCNIAENEKHKEKVSFLLDVLDSMKKKEVPDPYY
GDKNGFRTVFTMIDEACEVIAEKLNSTHP
>OBAHECAF_00982 Ribosomal RNA small subunit methyltransferase I
MSNLGNVYLIPNLLGDSLIGNVLPPMITNIIKELTHFIVENEKSARKFIKQIAPEKPQQE
LVLFTIDKHTFENDIYSFINPCMSGFSVGVVSEAGCPGIADPGAEIVKLAHQKNIRVIPL
VGPSSILLAMMSSGLNGQNFAFNGYLPIEKSERRRTIKALERKVKEYKQTQIFIETPYRN
DKMLSDLVETLQNDTMLCIATEITLPTEYIKTQTVTQWKKMNISLQKRPTIFIIGS
>OBAHECAF_00983 Phosphatidylserine decarboxylase proenzyme
MFHREGFKIILGTFIVTAGIALLAHYFVDIFWLQKLIQGIALIFLILVLQFFRNPKRNTQ
RNENHIIAPVDGKVVVIEKVFEKEYFKDERLQVSIFMSPINVHVTRYAIGGEVVFSKYHP
GKYLVAWHPKASEENERTTVVVENHTFGKILYRQIAGALAKRIVNYAKEGDIAIQGADAG
FIKFGSRVDLYLPLDTQINVQLGQTVKGGIDIVAKKD
>OBAHECAF_00984 putative transcriptional regulatory protein
MGRAFEFRKARKFKRWAAMAKTFTRIGKDIVMAVKEGGPHPESNSRLRAVIQNAKAANMP
KENVERAIKKASEKDTANYKEVIFEGYAPHGIAILIETATDNNNRTVANIRSYFNKCNGA
LGTSGSVEFMFDHTCNFRINAEGLDVEELELEMIDFGAEEVFQDEDGIHIYAPFESFGAI
QKELEGRGIEILSSGFERIPQVTKELSPEEQADVEKLLEKIEEDEDVQNVYHTMKEAES
>OBAHECAF_00985 Catalase
MNNKLTTTTGAPVANNQDTMTAGKRGPALLQDIWFLEKLAHFDRQVIPERVMHAKGSGAY
GTFRVTHDITKYTKASIFAEIGKETPMFVRFSTVAGERGAADAERDIRGFAMKFYTDQGN
WDLVGNNTPVFFFRDPLKFPDLNHAVKRDPRTNMRSADNNWDFWTLLPEALHQVTIVMSD
RGIPKSYRTMHGFGSHTFSFINKEGVRHWVKFHLISQQGIENLTDEEAAKLVGMDRESHQ
KDLYEAIENGNFPKWKMFVQIMTEEQARNLDYNPFDLTKVWYKKDFPLIPVGEFELNRNP
ENYFAEVEQSAFSPANVVPGIGFSPDRMLQGRLFSYGDSHRYRLGVNHNQIPVNAPKCPV
HGYHRDGAMRVDGNYGSTKHYEPNSFGVWQEQKEFQEPALRIDGDAYNYDFREDDDDYFT
QPRKLFQLMNDEQKKALFENTARAIGPAQKFIQIRHIRNCYHADPAYAKGVADALGLTME
EVLKYEHPALNLGPVAHKKMECPFGHK
>OBAHECAF_00986 Dipeptidyl-peptidase 5
MKKRLIMLVAGLIANTMDAQQPLTPEKLWELGRVGTMGLTQDKNFVLFSVAYPNVKENSF
RRELFKLSVKGGVPIPISEEELKRETTKFNATKDKKLVHKPVKINKVFASDFYNDLDKST
GQNYKSLDHRHWDKWMDGAYNHVFIENMTDGKQVDIMEGLPYYCPQEPFGGTSDYIWSND
GKKVLYITKAKVGTDYVVSTNTDIYEYDLATQKTKNLSEGMMGYDTHPLYSSKDVLAWLS
MKNEGNEADKNDLVILENGQKRNITAHWDNTVADYIWSNDGKKIYFTAVVKGTTQLFEIN
PFEKHPMPKQLTKGMFDITGIVGQSANLLVVTRTDMNRAAEIYTIDLQVNKKKKNIKNFL
EVNQLTHVNDDAYKQIAKCEVKERIVKTTDGKDMLTWVIYPPNFDPNKKYPTLLYCQGGP
QSALSQFYSFRWNFQLMASQGYIVVAPNRRGMPGHGVEWNAQISGDWGGQVMRDYLSAID
DIAKEKYVDNNRLGAIGASYGGYSVFYLAGIHNKRFKSFIAHCGVFNLQSMYGTTEEIFF
TNNELGGAYWEKDNPKVQKSYTEFNPIEKVANWDTPILIIHGGKDYRVPKEQGFQAFTAA
QLLGIKSELLYFPDETHWVLRPQNGIFWQRNFFRWLDETLKN
>OBAHECAF_00987 Dihydroanticapsin 7-dehydrogenase
MKNVIVTGTSRGIGLEIAKQMADQGHQVLALSRNTLPLLKLNHKNIHFFPFDITLEEDLE
KVVDFVREEWGKVDILINNAGKLIKKPFEELTTTDFMEVYKVNVFGVAMLIQKVIPFMVK
KAHIVNISSMGGVQGSMKFAELSAYSSSKGALITLSELLAEEYKEKEIIFNVLALGAVQT
EMLAEAFPNYQANVTAEEMAIYISEFALQGYTFFNGKIIQVSNSTP
>OBAHECAF_00988 O-GlcNAcase
MKTKILFLACLLLSVTQMSANDSLLNPIPKKMIFTGKKISTKKSIPFRIILSEKDDKTFK
KHAHKAPNKKEGYYLRIEKNKVYIVGNDPRGVYYGLRTFQQLSKNSEIPLGEIIDYPDLE
YRGVVEGFYGTPWSHEKRLRQIEFYGENKLNTYIYGPKDDPYHSSPNWRKPYPTKEAEQL
QELVQKANKNYVDFVWAIHPGKDIQWNDTDRQHLLRKFEDMYQLGVRAFAVFFDDISGEG
TNPQKQAELLNFLHTEFVEKKKDVNPLIMCPTEYNKGWSNPEKRYLETLGEVLHPSIHIM
WTGNTVVADIDKATMEWINAKIKRKAYIWWNFPVSDYVRNHMLLGAAYGNTNDIKDDMSG
FVSNPMEHPEASMIAIYGVADYTWNVATYDSERAWHKAMARLMPQNKKALLTFAKHSSDL
GVNGHQYRRVESVEFAPVAKEFLKNLTKGKNPQIERVKKEFDDIISAAKQLLNTKENPLL
TEELHPWLLQLEVVGQQGKQAIELYEALHQKGYAKFKAGYARLQNLQKQQFNIDQTYNQN
PYQPGVRVATLVVEPLIAEILKYSVGKYNQETGEQLALTLNFNPNKLITNIQQIEYQPLL
QKGGGVRISPALEYISVKKDDFLGIELEKVASVKTISVDLGDAKHFEKGRIQISTNGIDW
KDISGSLRNSRWNSSENVHNVKYVRFINNADTPFQIRLKHFEIVAE
>OBAHECAF_00989 Glutamate dehydrogenase
MSNETEKKRTGMYENVMHEFNKAADKMNLDPGVRKILASTQNEIVVHFPVKMDDGSIEVF
TGYRVQHNNALGPYKGGLRYHPTVDIDAAKALATWMTWKSAIAGLPYGGGKGGIQIDPSK
YSKGELERITRRFTYALGDNIGPDYDIPAPDVNTNAQIMAWISDTYASAKSPANRSVNLH
VVTGKPVVSGGLAGRDRATGFGVVTAIKKWAKKNNVDLNGKTYIVQGFGNVGYWTAHFLH
KEGAKLIAVQDHTGSIANANGIDPEELSAYAKTNKGGVGGFEKAQKIENAEFWKTPCDIL
IPAALGNQITVDNANEIKATLIAEGANGPTDAAAEEIILKKGIHIIPDILCNSGGVIGSY
FEWLQNKRAEIWKIEEVLEKLNDKIETAFDNVVSCAERYKTDYRTAAYIVALEKLEQVYK
ERGVFP
>OBAHECAF_00990 hypothetical protein
MYIENAYHGKSPKWLYLIYSLGFLGFMGLNFLVLLFFDYQTLMQNQIEKKGELRYFAEDL
MSGFVLFLVALLVWVRYVHRQPLRAFHTSRPRVDWKRFFFAFTLWGGILVLTTFIDYWIN
PQDYVWNFQADKFFILLLLSVLLIPIQAGFEEYFFRGYLMQGIGIAVKNRWIPLLVTSIL
FGLMHSANPEIEKLGYGFIFYYIGIGLFLGMITLFDEGLELALGFHIANNLITGLLVTTN
WGVFRLPALFVNTADPTDGAYYQLLFLGVFILLCFYMFSKKYGWNLKDWKQKLFGKVMSE
KEFFNKITPETHAQSEREIMK
>OBAHECAF_00991 hypothetical protein
MKKMFLLLGLLASFTVASAQNDLGVGNLQLNAGFGLSSWGTPVYLGVDYGVAEDWTVGGE
ISYRSTNYGVADRNVKYTNVGVVGNVNYHFNRLFQLPSQFDLYAGGSLGYYSWTNNYKVE
GFNHHYTSGFGFALQLGGRYFFTNNFGVNLELGGGTVSGGKLGITYKF
>OBAHECAF_00992 Ribosomal RNA small subunit methyltransferase D
MRIISGKNKGKRLVAPQKLPVRPTTDFAKEALFNILNNLYYFNEISVLDLFSGTGNISYE
FASRGCEHLISVDSHSGCIQFINKISDELKFGINAIKSDVYTFLQKTTQTFDVIFADPPY
DFQQDKFNEIIQLVFNKNLLNENGILIIEHSKHVELETLPHFSYDKKYGGSVFSFFENTE
EDMN
>OBAHECAF_00993 Riboflavin biosynthesis protein RibBA
MDKIQLNTIEEAIEDIKKGKVIIVVDDENRENEGDFIAAAEKATPEMINFMVTHGRGLVC
VPLTEKRCEELDLPMMVQNNTVLHQTQFTVSVDLKGHGCTTGISTHDRAKTILSLVNPET
RPFDLGRPGHIFPLRAKEGGVLRRTGHTEAAIDLARLAGMQPAGILVEILNEDGTMARLP
QLAEVAKKFDLKLISIEDLIAYRMRKDTLIVKKEDFHLQTPYGEFRLRAYEQTTNKQIHL
AFTKGTWESDEAILTRVHASFISNDILEVLASEKENPLERIFKKINEEGKGAVIVINKEG
YSQNLLKRITEIKEKQSGSYAPVTSADTKDIGMGSQILHDLNIRKLRLLTNSKQSHYVGM
SGYGLEIVEQISY
>OBAHECAF_00994 hypothetical protein
MNPKKIVIFILGVLMTLFVITFFSERYLTLQGSVKEGIVLGNTMIKYPTSDILIRNNRSD
NSKAKDIIESVVSVEDTEVLAVKTKTTSDLTTPKKEKPELITNVEGKMYYPDNVTDFITL
LREKLNKSSCRIIHYGDSQIEGDRITKYVRNRFQNAFGGGGPGFIPIKVVYSQTSVNIST
SENWLRFASFDRNRKSKVPHEKYGLFATFSRFTSYDADTTSVKKAHFVVKPFGNVYKRLQ
TYTKFGLHYGNNTHEVKITVYENGKLLKEDFLKTDGKYHNFQLNFANTPKEIRVELEGKF
SPDFYGITLDRDTGVSMDNVAMRGEAGRVFTRLNRENFEQMSADRKADIFIFQYGGNTIP
YIRKDKQVTDYAHSLIQNIKWVKRSNPDAIFIVIGPSDMSTSENGKMVTYPFLPKLNEEM
KKKCLENGVAFWSIYEAMGGENSMPIWVSENLASSDYVHLKPKGTQRISELFFNSLYENI
LAIE
>OBAHECAF_00995 Peptidoglycan O-acetyltransferase
MDFIQNIFTFDENHPLNFVRIDFWIFFAIVYAIFTVIYRRRRMRNLFLLFASMYFYFKAS
GLFVLLLVFSTITDFYLGNYIYQQTEERKRKIAVTISIILNLFVLSYFKYAYFLTDTHNT
LFNTQYEVFNYLAYWANGFDSEGYFRVSTIILPVGISFYTFQTISYTVDIYRKKIAPLKY
ILDFGLYVSFFPQLVAGPIVRAENFVPQITKKTVITNEAFNRGIYLILKGLVKKMIFADF
IALHFLDQVFDNPTMYSGFTNIMAIIGYSLQIYGDFSGYTDIAIGVALLMGFQLPVNFNS
PYKAINCGDFWKRWHISLSTWLRDYLYIPLGGNRKSSVGTFIISLIFIVGVVVAMNSFWF
SIIMGVLLIGGSLLSFYSKSFERHVITNINIMLTMLIGGLWHGASWKYVIWGGLNGLGVV
AYKYWRKVSPYEQSTHWLATVWKIGFTFAFITFTRVFFRGKDMQSIGEWFSQVANDMQWG
MAFDVLWHYKSVFTVMLIGYIVHWLPNRWKDEIEHIFSESHIVVKAGIAVVTVIMCYQAY
SSDFQPFIYFQF
>OBAHECAF_00996 Putative TrmH family tRNA/rRNA methyltransferase
MMDKDYQIFGIRAVIEAITAGKTVDKVFVQKGLKGSLFQELQVLLQKEQIMISYVPVEKL
NRLTKKNHQGVVANVSPVEYHDFENLVINTIESGVTPLFLILDHLSDVRNFGAIIRTAEC
TGVSGIIIPKRGSVSVTADTVKTSAGAVFKVPICKVDNLRDAIYYLQGSGIKTVVATEKT
DQQIYDVTMTEPLAIIMGAEDVGVSPALLKLSDEKAKLPMLGDISSLNVSVACGVFLYEV
VRQRLTK
>OBAHECAF_00997 putative tRNA-dihydrouridine synthase
MVKIGNIELGEFPLLLAPMEDVSDPPFRRLCKIHGADMLYSEFISSEGLIRDAIKSRQKL
DIFDYERPVGIQIFGGDEEAMALSAKIVEAVEPDVLDINFGCPVKKVVSKGAGAGVLKDI
DLMVRLTKAVVNSTKLPVTVKTRLGWDEASINIDEVVERLQDVGVQAISIHARTRSQLYK
GHSDWTHIARIKENPRVKIPIFGNGDIDSPEKALEYRQKFGVDGIMIGRAAIGYPWIFNE
IKHYFSTGENLSAPTIIDRVQAVKKHLTWASEWKGERQGVLEMRRHYANYFRGIPNFKEY
RQKMVTLDSISEILAVLEEVAEKMG
>OBAHECAF_00998 Phosphopantetheine adenylyltransferase
MKRALFPGSFDPITLGHYDIVCRALDLFDEIVVAIGVNNDKNYMFSIEERKTFIEKAFAD
KPKVKVTTYQGLTVDYCKEIGASFILRGLRNPADFEFEKAIAHTNRKLSKIETVFLLTAS
STSYISSSIVRDVIRNNGDYTVLVPNSVVVNPK
>OBAHECAF_00999 D-alanine--D-alanine ligase
MKKKIAVVMGGYSGECGVSLKSGQLILQNLDKEKYEVFEVHILNEGWFLIDKSGDKSFSI
NKGDFSATKDGKKITFDLVVNTIHGTPGEDGQLQAYWKLIGIPYTGCDFYQSALTFNKRD
TLSVLAKFNIPKAKSIYASKKDKLDFNLISKELGLPLFVKANRSGSSLGVSKVRTSAEFE
EALLNAFQVDDEILIESFLSGREISVGVMRLNGKTTVMGHTEIISENDFFDYEAKYLGKS
KEITPALLSDELIERIDGLTIKIYEILNMKGFSRIDYIIMDNIPHFIEINTNPGLSPQSI
FPQQVAHKGLNFSDLLDSEINSALSN
>OBAHECAF_01000 Multidrug resistance protein NorM
MIFHKLSNYTKEFKQNLIIAYPVILGMLGHVFVGFIDNVMVGKVGVTELAAVALGNSAIF
IAMSFGIGFSTALTPLVAKADGEGDKEEVKSTLKHGILLNSVLCFFLFLLLFFAEPLMYL
TGQPENVVKLAVPYTFLVAFSLIPLGFFMAYKQFADGLSLTKYAMYVTLIGNIINIIFNY
IFIYGKLGMPALGVIGAGVGTLVSRFLMPILLWWMLKKIKQTKEYVVGLQWNTFDRKNIK
KIINIGIPSGLQMIFEVGIFTAAIWMSGILGEKELSANQIALNLASMTFMVANGLGVTAM
IRVGNQLGTKDFFNLRRIGLSVFVLVLFTQSFFALLLTVFRTWLPTLYLEMDNLEKLTEN
AFVIGEAAKLLLIAAIFQISDGLQVTALGALRGLQDVKVPMYITFVAYWILSFPVCYYLG
LKTELGTMGIWIGLLFGLTVAAVWLLWRFNIISKRMIQRTSPKDQE
>OBAHECAF_01001 hypothetical protein
MAQHNDFGKEAEQIAVDFLIENGHTILAQNFIYAHAEIDVISLKNNILHITEVKARTSVA
YGEPESFVNKSKINLVVKAANQYVLKNDLDTEVQFDIISIVKNQTGCSINYIEDAFYPF
>OBAHECAF_01002 Macrolide export ATP-binding/permease protein MacB
MGAKIVFLHKIIKHLYQKIMFIYLQLLKESFRFATKSLRDNKLRTFLSLLGVSVGIFLII
LVLSAVDSLNRNIQENLAGLDKNSMYVSKFSFGPTDVPRWQRLNFPQVTYQEYEFLKKDI
PNVEAMSYAIFGVSSSIKYEGKTIENVPARADTSEISEIEDIKVEKGRLMTESESRVGAP
VIVLGHQIAQQLFENEDPIGKEVRYLSKKMVVIGVLKKYGSVSDNDEKVFLLSTFVRSFM
NTGTQGVPSGIAIKPKKGVNMQEFEDILVQRFRKYRGLKPEEINNFFLNKMSSFTDMIDQ
TIGMMNLVGWIVGGFSILVGGFGIANIMFVSVRERTSLIGIQKSLGAKKHFILFQFLFEA
VLLALIGGFLGLLFVWLGTILASQLTDELTFVLSVQNVIIGLGVSFLVGLISGIIPALNA
SQLNPVEAIRTGM
>OBAHECAF_01003 Bifunctional purine biosynthesis protein PurH
MKPTKQAKSALISVFDKTGLEPIIHKMNSLGITMYSTGGTESFIRNLGVEVIPVETVTDY
PSIFGGRVKTLHPKIFGGILNRQDNDSDVAEMIQYAIPQIDIVIVDLYPFEKTVASGAIE
SDIIEKIDIGGISLIRAAAKNFKDVLCVASVEQYPDLLDILLNSHGATTLEQRKNFAAKA
FQVSSHYDTAIFNYFNQTEEIPVLKISENQGQVLRYGENPHQKGFFYGDFDALFEKLHGK
ELSYNNLLDVDAAVNLILEFKHEDPTFAILKHNNACGVATRKSIQEAYAAALAGDPVSAF
GGILISNTKIDSATANDMNSLFFEVIIAPSYSDDALEILEQKKNRIILVQKDITLPETSV
RSCLNGYLVQDKDLSTDSLADVKYATEQRPTDGALEDLFFASKICKHTKSNTIVLAKNKQ
LLASGTGQTSRVDALMQAIEKAKQFKFDLNGAVMASDAFFPFPDCVEIANKAGITDVIQP
GGSIKDQLSIDYCNNHQMAMVFTGIRHFKH
>OBAHECAF_01004 hypothetical protein
MKQICFLVCVLLFNSCQNTPEKTRYTQEQIASLQLEETKILTPKMDSIKKIDLNPFLGKK
HFEFGNLVSDVKIIPLETNNKSLIGGIYKIITTEEYIYIMDKFKGRNIIIFDKSGKFIKR
FSHGQGPGELSRLYDIDYDFKNDELVAFQHSFLLFFDKQGKFLRQERLPLGFNNLIVTDD
GYIFKTLSQQGGNTHLEEKEKYTLLVTDKKFELNFVSLPVDQETRALSAYTYLHKNDNLF
KITGEFTDSIYSYEPKTNKLTTEFVLDYDRKLPLKYVYGKTFKDFDRITQNNNYYFNIGD
YFETFSQNIFFLENYYIGSQTVIYRDKKTGNMVGGTDANYDPKEIPPIAFPKAVYKDYFV
STYIPGSKDYDFLKDSKIISVEDKEKIKLLEDDDNPVLVYFKLREF
>OBAHECAF_01005 hypothetical protein
MKNITYIGYLSFLLLSCQSSNVIGRYSEEQVVLLELENTKIITPKTETIKKIDLNPFLGK
KHFEFGNLVNEVKIIPLETNNKSLIDGIYKIITTEEYIYIMDNFKDGGILIFDRNGKFIK
RFSHGQGPGELSRLYDIDYDFKNDELVAYQHSFLLFFDKVGNFLRQKRLPLGFNNLVVTD
DGYIFKTLSKRGDPHLEDKRDYTLLLASKNFKLNFVALPERKKIKALSAYTYLYKNGDLI
SLTGQMTDTIYKYNSKTNELTTEFVLNYDKKVPRKYLYGETFETFTKATRNNDYYFNIGE
YFETFSQNVFFLHNNYTELKTVVYRDKKTGNMVGGNNANLKPKEIPPIAFPKAVYKDYFV
STYIPSSEDYEILKDSKTISAEDKEKIKHSKDDDNPVLVYFKLEEF
>OBAHECAF_01006 Phenylalanine--tRNA ligase alpha subunit
MIDKIKEHIAQVEAFVGATKEEVEQFRIQYLGKKGVLNDFFAVFKNVPNEEKKSFGQILN
ELKSKVESKVQALHDNLEQQNESQGVYGDLSRPATPIQIGARHPISLVKNQIIEIFSNIG
FNVSEGPEIEDDWHNFTALNLPEYHPARDMQDTFFIQTNPDILLRTHTSSVQVRYMENHQ
PPIRTISPGRVFRNEAISARSHCLFHQVEGLYIDKDVSFADLKQTLLYFTKEMFGKSKIR
LRPSYFPFTEPSAEVDIYWGLNNEIDYRITKGTGWLEIMGCGMVDPNVLKNCNINSEEYS
GFAFGMGVERIAMLLYQIGDIRMFYENDVRFLEQFKSSF
>OBAHECAF_01007 hypothetical protein
MKSNIIHFLVRFLGFFLVFFIIRYVFSEMDGIKMEKFLFLCLFLWSGISSLYLMAESYFL
LTKKRKTKGFISLGIGVMTIIYTLIGLNLLIEVYFMIA
>OBAHECAF_01008 hypothetical protein
MIPYLIKTLLCGMCFYTLYHLLLSREKMLTFNRFFLLSALVASFVFPLITIEMPFQPIFE
KTFEQTAVTQEVSTSSIYVNPTTEQFITENNNFTNLIIICLYGVIAFLMLFRFLRNLLKI
FNKIKKHPKQPYQGAYLVILEEECAPHSFWNYIFINKKDAYEQKVLLHELTHIRQKHSLD
LLFVEFLKIVFWFHPVVHLFGKAIRINHEFLADACVVSKHTNIAEYQILILKRAASANVA
FYNYFNFYNTKKRLIMLQTKVNHFRNLCKMALLIPTSILFLVVFAEKSYAQEVEKQKEVS
PLQVSTKYKIIKVQGVGLPNGKGEKTTVVLTDEAGNEIVEQITNKSEREAFTKKYGLQLP
PPPPPPPSAIRVKKAKELPPPPAPPTPVGKMKKSTELPPPPPPPVPVKEK
>OBAHECAF_01009 hypothetical protein
MKKLSNTEEQLMEYLWQKQTAYMKDLLEAYPDPKPASTTIATLLKRMIDKQMVGYHQRGN
SREYYPKVSKNSYFSRKMKTIISDYFGNSAFQFASFFAKEISMTPEQWEELKKIVDSNLK
KE
>OBAHECAF_01010 Carnitine transport ATP-binding protein OpuCA
MLKVNNISYTYDGFNAGFRDISFELQQGEHLSVMGESGSGKSTLLKAIYGLFDLQEGTIF
FNKKKVVGPSRQLVPGYEKMKYLAQDFGLSPYHTVAENIGKFLSNIDLDYKKQRVSELLS
LVEMERFSDRKAHLLSGGEKQRIGLAMALAQEPELLILDEPFSQIDTFRRNKLQRTLFAY
LKDKNISCIVATHDSREALAFADKVLIMKDGISIMFGNLLDVYLQNKDFYTASLFGDVTR
YSRENNVLLLKPYEIEVVEKSDWEAMILSSYYQGDMFLITAVSNAEPVYFYHKNPLKKDE
KVYLSKKN
>OBAHECAF_01011 hypothetical protein
MKAFFEAIQYFFEEILFAPLDFLRTLELESWWGANFMTWTFILIGFVFLFYWLGQLRKYN
KRNDERRDVVSHSFFK
>OBAHECAF_01012 GMP synthase [glutamine-hydrolyzing]
MNNSVLILDFGSQYTQLIARRVRELNFFCELHPFNHLPENLDDFSAVILSGSPYSVRSED
ALLPDLSKIKGKKPLLAVCYGAQYLAHFNGGNVAPSNIREYGRANLSFIKENEPLFDGIA
IDSQVWMSHSDTIKELPTRGVCLASTNDVVNAAYRIDGEQTYAIQFHPEVSHSIDGKKLL
ENFLTKIAKITPTWTPDNFVEMTIQSLKEQVGDEKVVLGLSGGVDSTVAAVLLNKAIGNQ
LHCIFVNNGLLRKNEFENVLKQYEGMGLNVKGVDASERFLTALAGKSDPEDKRKTIGRVF
IEVFDDESHKIEDAKWLGQGTIYPDVIESLSVKGPSATIKSHHNVGGLPDFMKLKVVEPL
RMLFKDEVRRVGKTLGIDEELLGRHPFPGPGLAIRILGDVTAEKVQILQEVDAIFINGLK
EHNLYDKVWQAGAILLPINSVGVMGDERTYEKVVALRAVESVDGMTADWVDLPYTFLQKI
SNAIINKVKGVNRVVYDISSKPPATIEWE
>OBAHECAF_01013 hypothetical protein
MTENTKNIQSQKQVNLQSYKELKRSKLDNSVHYNIIKYTKKYMDDYYLDGIIGLIPVVGD
FFTQFFSFSFLYVSIFKIRSYRLTVAILFNSLLDVLIGLIPYLGMVLDFVHRSHKENFEL
VIGFVNDDKEIIKKVNRRALWTTIGVIVLIVLIIIMIGFVLSLVKDLFDWIFR
>OBAHECAF_01014 hypothetical protein
MELFNSMDIFLKTFWYIAIPTSVIFLIQTVMTFIGMGSSDGIDADFDGDFEGEDTPFQLF
SFRNLINFLLGFSWTGISFYQLIENKILLTLLGVVIGCLFIYLFFLVIRALMKLTEDNSF
KINEIINKTAEVYLTIPPHKSGKGKITLSVKGSFRELEAMTDGDKIPSNSIVKIVGIENT
VAIVEKV
>OBAHECAF_01015 DNA repair protein RecN
MLKALSIKNFALIDDLHINFPEGFIIITGETGAGKSILLDALSLVLGKRADMSALRNKEE
KCVIEAEFSLEKYNFLTLFSDLEIDYEPQTFIRREILPSNKSRAFINDSPVTLDTLSRLG
EVLVDIHSQHQTLSIGNLDFQFDIIDAIAGNKHLISEYVSLWEKLKKKQKKLQELIDFQK
NANKEYDYNFHLLKELKSAPLQKGIQEELEETYEEASNSEEIKEYIKESLQLLSDENVGI
VNQLRELKRVFTKLTDYKQQYRDIFERIESAFIELDDLQNEVFDIDENIETDPETLEKVS
QQLHLIYDLQKKHKVSTVDELIAIQTQLEEAVSQTENIESSIEEQRNIVENQQIETIEKA
SELHKTRKKVIPELDTKLTNFMHELGMPNARFQIELQSTQTYQNNGMDQLTFLFSANKGG
NFGTLKKVASGGELSRIMLAVKAIMAEHTALPTIMFDEIDTGVSGEISLKMGEIMKNMSK
NRQVFAITHLPQVAAKGHYHFKVFKEDIEGKTTTQLKQLSENERIIELSEMLEGKNSGES
AKNHAIELLKKG
>OBAHECAF_01016 hypothetical protein
MLFSVLTSAQELNAVVTVNTQQVNLSNRNVFKTLEKSLHEFINNTTWTSIKTHDNERIRC
NFTFVITKYENNQMEGSLLVQSSRPVFNTAYQSPVVNLQDKDVSFSYQESETLSFTNNSF
ESNLTSIVAYYAYLILGFDANTFVESGGHPYFVQAQSVVTNAQSSGYAGWTDNGDNNRWM
LIKELLSENYTNYHKIWYTYHRLGLDIMNMDEKKAKEEMQNALLQIEKIPSLRLNSYAVN
ILFGAKTDEIVSIYSGGTMFSTKTLKESLLKVAPSQAIKWNMIK
>OBAHECAF_01017 Polyphosphate kinase
MAKNKYINRELSWLKFNERVLQEAADESVPLLERLRFAGIFSNNLDEFFKVRYATIKRIV
MNDSSDIHAKELLEEITKEVIQLQEQSLNIIGSVTKELEKEQIFIVNEKTLLPEHEKFVT
SYFLSKVRPALFTIILNDLEAFPELKDDVAYLAIKMILKEEGQTKGIQKFFSSKAYKEKI
QYALIELPTTIDRFVELPKVDGKHYIIMIDDIIRFCMHQIFYIFSYESLTAHMIKITRDA
ELDIDDDLSKSFVEKISSSVEGRRSGEPVRFVYDKGIDKDTLAFLFEKMDIVDTDSIIPG
GRYHNRRDYMNFPSMGRYDLTYEPIQPLPVKGLSSGESLLKKIAEKDYLQFTPYHTFSNI
VWFLREAALDPKVKSVKITVYRLAKNSQVVNSLINAVKNGKKVTVQIELQARFDEESNIK
YAELLKAEGVKLIFGVRGLKVHSKICVIEREEGKELKRYGFISTGNFNESTARIYTDYTL
FTANQDILKEVNKVFNFFDTNYIIQRYKHLIVSPHYTKKILTKLIEQEITNAKNGKEAFI
KLKMNSLTSYKMIDKLYEASRAGVKIQMIVRGICCLIPGVPGMSENIEVISIVDRFLEHP
RLFIFGNNGNPKVYISSADFMTRNISHRVEVGCPIYDAAIKKELMDTFEIGWSDNVKARI
ISQKQDNAYRRNDDLKVRSQVAMYDYYAQDRDL
>OBAHECAF_01018 hypothetical protein
MKLIFIILLFSSPLFSQSKYEGHVLDVKTNAPIYGVYISVNDKVVASTDDNGFFSFEGDE
ITTNDRICFSHISYKTLCLFGNEIGHQYHLELGVNELSEVNIYQGGEKVWNVLEKVKDFE
KKKSYYVTPDFWAKSHGTARFYNKKGTLVGYSEIVGQTMLLGDVRKNPFCIGFNIPQQIR
RSPEKMLLETDKTLKNNGILFKSPLYFYGFSMLKLTHPLFEKNTSKFVFEKVDDEYLTEN
AHTILEYKQVKEISTIMGKCSNMSGKIWLDENNKIFKETASFDEDNASRHILTVEYVIIG
EHHYPSKISYHKFALTREVISQKTHIQLTHITPVKNEYDGRHGFLSEMYLYPSLKYDSKF
WKKYPIENTITYDELKKMAEGMSLDAFFRKATDSPENLFNKQGENYKYIIDRVIPTMEYF
KKIRDRDMK
>OBAHECAF_01019 hypothetical protein
MSYKYFLIFLFLLISCQEKKTKTGSVKQASRSVEYEVSEGVLEPKRNRIKIQNVKKGERL
VQRFILSNTGTEMVRILGNDASCNCTEVLISKKEIQPTDTISVQMIIETSDKEVGNHNVN
TVLTTNGKQKFYNLEIDFTVVTND
>OBAHECAF_01020 hypothetical protein
MKYIYVISAVLLLFGCQSTSESNEPNSLEFYNTVDISKKEDIQYHSFTLDTLKMNPEGTS
YVGKFLMWKDTLYFVDERFSYIFQFTNEGEFVQRHAGKGRGPNEVFYIDYLTFGENEFAT
MNGNNWAIDIFDTQFQKKKFFRIDNNSTRTYEELWHEPMVTLADSYSFDCVRPNTFKRWD
EDRVVCSIFSKHAFLNGYSTSEKSELYYNYARCFGIINLRTGKFEKILGRHSPVYLSQQN
IPNFQYLNYDTYEKIDDVYINFWPDPDIYLYSKKEDKIKGKFGKAGRDMKTDYRRTNTSE
EGHRNWKSDYVTYGYYTFLKYFPEKQLIFRGYSKGKGATNHGLQIYKNHQLIADLDVPKG
FEIIGHSNGMFYGITPQDPDIDFLTVYKIKFL
>OBAHECAF_01021 hypothetical protein
MRYLLFLSLLLLFGCQSTSEGNEPNSREFYNTVDISKKEDIQYHSFALDTLKMNPEGTSY
VGKFLMWKDTLYFVDERFSYIFQFTNEGEFVQRHAGKGKGPNEVLNIDYLTFGKDEFVTL
NGNNNSFDVFDTRFEKKEFMRIDESITRSYEEMLNNPIPSLNDVYEYDYALPKILKKWGK
EHISIIITASHPKFNGYFDSDLYYNQARCFGIVNLKTGKLEKILGRRSPIYLSQQNIPNF
DHLNYDTYEKSDEVYLNFWADSDIYLYSKQEDKIKGIFGKAGRDMKTDYRRTNTFEDAEN
NWKSDYATYGYYTFLKYFPEKQLIFRGYSKGKGATNHGLQIYKNHQLIADLDVPKGFEII
GYSNGMFYGVTPQDPDVDFLTVYKIKFSQ
>OBAHECAF_01022 UvrABC system protein A
MEDKIEVKGARVHNLKNIDISIPREQLVVITGLSGSGKSSLAFDTIYAEGQRRYIETFSA
YARQFLGGLERPDVDKIDGLSPVIAIEQKTTSKSPRSTVGTITEIYDFLRLLFARASDAY
SYATGEKMVSYSDAQIQELIIEHYKGKKISILSPVVQSRKGHYRELFEQIAKQGFVKVRV
NGEILDLQKGMKLDRYKTHDIEIVIDRLYISNDETTEKRLQETIKTAMHYGDGVLMVLEH
QDNKIQYFSRNLMCPTTGVSYPMPEPNTFSFNSPKGMCPHCNGLGEVHEVNQRKIIPDPK
ISIKNGAIVAIGEQKNTWIFKQLELILQKFGAKMSDAVESLPQEAMDIILNGGKDKYAIK
SDVLGITREFEFDFEGIVKFIADQYENSDSVSIKRWAFEFMDTLPCGECNGTRIRKEALF
FKVNEKNIAELSAMDILELLAWFENLPKKLTKRQLQIASEIIKEISNRLQFLVDVGLTYL
SLNRSSKSLSGGESQRIRLATQIGSQLTGVLYILDEPSIGLHQRDNQRLINSLKSLRDIG
NSVIVVEHDEEMILEADYVVDIGPKAGKDGGQIIFEGTPQQMMDAKTTTADYISRRKQIH
VPEKRRKGNGKSLILSGCSGNNLKNITVTFPLGMMIGVTGVSGSGKSTLINETLYPILNA
HFFNAVKKPMPYKKIEGLEHIDKVIAIDQSPIGRTPRSNPATYTGVFSEIRTLFTQTPEA
MIRGYKPGRFSFNVKGGRCETCEGSGLKVIEMNFLPDVYVECETCKGKRFNRETLEVRYK
GKSIADVLDMTIAEAVIFFENIPKIYRKLKTIEEVGLGYITLGQQSTTLSGGEAQRVKLA
TELSKKDTGNTFYILDEPTTGLHFEDVNVLLQVLDKLVDKGNTVLVIEHNIDVIKKVDYI
IDIGYEGGKGGGQLVAFGTPEEVAKDTKSFTAQFLQDFAQKTS
>OBAHECAF_01023 hypothetical protein
MELPFQNDAIVLGVLMVCLGIVFYTSSLKTRFWKIFYTIFPALLMCYMLPAIVNSVGIIS
SKNSNLYFVSSRYLLPAALILMTLSVDLKSVFRLGSKALVMFFAGTIGVVIGGPIAILIV
SLIMPEAVGGAGFDAVWRGLSTLAGSWIGGGANQAAMLEIYQYNPEKYGAMVLVDIVVAN
IWMAFLLFFIARSQKIDKWLKADNSSIEELKQKVITFSEKTKKIPMLTDYKIMLGITFGG
VGLSHFGADFLTDFLKNKFHVIGDKTSALSFFGDKFFWMITFATLIGLALSFTKAKNYEG
AGASKLGSVFIYILVATIGMKMDLTKIFDNLGLLLVGIIWMAVHVGLMFIVAKIIRAPLF
FLAVGSKANIGGAASAPVVASAFHPSLATVGVLLAVLGYIVGTYAAMLSAFLMEYVSVTQ
GVMS
>OBAHECAF_01024 hypothetical protein
MKKIIFLIGVLLAIGCSNSGGNEKTMIVQGNVEGLKKGTIFLQQFDGEKLVNIDSVEAKG
SGEFTFKKEILSPEIFYIFLDLGKNQDQTFGDRLAFFGEPTTITINSKHELFDIHAKIEG
SESQKLWEEYSRNIRKFNIRNLELLEIQLKSIKEGYQPKADSLAKIIEKNQLRRHLYALN
FAITHGDSHVAPYIVLTDVPDTNVKYLDSVYNSLTPEITAAKYGKELKEYINKVKEKNQ
>OBAHECAF_01025 NAD-dependent protein deacylase
MKKKIVVLTGAGISEESGIRTFRDANGLWEGHDVMEVASPEGFSKNPSLVLEFYNQRRRQ
LKEVKPNKAHQLLVRLENEYDVVIITQNVDDLHERAGSSNVIHLHGELLKSRGVDNDAEI
FDCQDDILLGDLSPSGVQLRPHIVWFGEDVPLITKAIEQVETADIFLIVGTSLQVYPAAG
LIHYTQPKTPVYYVDPFPQIQSNKQLTVIAQKASSGVQKAIETIKSHII
>OBAHECAF_01026 DNA protection during starvation protein
MNYNVLGLEKSKAEKVANELNVLLANFQTYYQNLRGLHWNIKGKNFFVLHEKFEELYDGV
QSQIDEIAERILTLGFTPLHTLEAYVKHSTITVGKDVSDDVEAVKLVINNLAELLKFERG
LLETCNEAEDEGTIGLVGGFIPEQEKTIWMLRAYINA
>OBAHECAF_01027 Aerotaxis receptor
MSEQVNRPTPVNEEIAWDKTRTIVSTTDKFGTITDVNQTFLDVCEYTPSELLGKPHNIIR
HPDMPKIIFKITWDNINAGRNFHAIIKNLTKTGKYYWVITDFEVGRNILGEVVSIMARRR
SVPEHVIKEHIEPLYQTLLKLEKIGGMELSNRYFKGFLEKHGKSYIEFIMDIMDENNKDI
RFEHEGGDKSITTEEISDDIFSEERGELSKRKSFFARLFAAN
>OBAHECAF_01028 Putative K(+)-stimulated pyrophosphate-energized sodium pump
MEKYIIYLPLALAIVGLLFMISKSLWINKQTTGTERMKSISEKIQEGAMAFLNAEYRILA
IFVIIASVALFVVSRMVETSHWLIVVAFVFGALFSALAGNIGMRIATKSNVRTTEAARTS
LPKALKISFGGGTVMGLGVAGLAVLGLSLFFLIFINIFITEGGNFYNEMTIVLEALAGFS
LGAESIALFARVGGGIYTKAADVGADLVGKVEAGIPEDDPRNPATIADNVGDNVGDVAGM
GADLFGSYVATVLASMVLGNYIIKDISEATGIAYTDNFNGLGPILLPLVIAGVGIIASII
GTFFVSIKNNEAKEKQVQQSLNMGNYVALALTLISCWFLIDIMLPNTIQMKFFGEGVKEI
ASSNVFFATVVGLAVGLLISAFTEHFTALGKKPVLNIVQNSSTGAATNIIAGLATGMKST
FSSVLLFAVAIWGSYELAGFYGVAIAASAMMATTAMQLAIDAFGPIADNAGGIAEMSELP
KEVRQRTDILDSVGNTTAAVGKGFAIASAALTALALFAAYVTFTGIDGINIFKADVLAAL
FIGGMIPVVFSALAMQSVGKAAMDMVQEVRRQFREIPGIMEGTGTPEYGKCVDISTKAAL
REMMLPGAITIITPIVIGFVMGAEALGAYMAGVAVSGVLWAIFQNNAGGAWDNAKKSFEA
GVEINGKIEKKGSDAHKAAVTGDTVGDPFKDTSGPSMNILIKLTCLVGLVIAPILGGHTT
TVVAENKVMEKNVPVTEIENKQDVTTSNLDEGLLDAYGNYKYNVGEITPLQLSEISAINV
GINSSERKIVNLLLDENFDVERDSKQNWITLDRVFFKSGSDELIEESEEQLKNIAMIFNT
FHKAGLRIGGYTDNSGNNEKNIELSAKRAEVVKAKLIALGVNPSQLSSAGYGSEHPICPE
NDTPECKAKNRRVDVRLTSK
>OBAHECAF_01029 ATP-dependent DNA helicase RecG
MNNPEVLHTPIAYLKGVGSQRADLLSSELGIFQFQDLLNLFPYRYIDRTKFYKINELYVN
NTTEVQIIGKIVHIKTVSSNASKNADRLVATFVDDTGSIELVWFKGVKWIRDSLKINEPY
VIFGKTNVFNGAFSMPHPEMDLVTDYNKTMGNSIQPVYPSTEKLVKRGITNKVIRQLILH
IFEQVGDVFYENLPENILNSLNLISKKEALHNIHFPKNQELLSRATLRLKFEELFYIQIQ
LVQKNFLHKQKIKGFPFEKVGKYFMDFYNNHLPFPLTNAQKRVLKEIRKDMGSYSQMNRL
LQGDVGSGKTIVALMSMLLAVDNGFQACLVAPTEILANQHYLGISELLKKTNIKVALLTG
SSKTSERKTITETLRNGELSILIGTHAIFEDKVIFNNLGLAIIDEQHRFGVAQRSKVWQK
NYIPPHILVMTATPIPRTLAMSVYGDLDISVIDELPPGRKPIKTIHYYENKRAEVYEFIK
KEIDKGRQVYIVYPLIEESESVDFKNLTEGYELISSIFPLPKYKVSIVHGKLKPSEKDAE
MERFVRGETQLMVATTVIEVGVNVPNASVMVIESAERFGLSQLHQLRGRVGRGSEHSFCI
LMTGEKLSSDSKTRMQTMVNTNDGFEIAEVDLRLRGPGDLMGTQQSGVLNLKIADIVKDQ
SILKASRYQAIDLLRSDPYIQKNENRMVAYTLTQLHKYKNIWTHIS
>OBAHECAF_01030 Dihydroorotase
MNILLKSAVVIDPKSVFHQKTNDILITNGVITRIAPNLSTEKVDTVIENVYVSLGWADSS
VCFGEPGYEERETLTNGMQTAAKSGFTHVLINPATNPITDTKSAVLYLKNETKNELTTAH
PIGALTQGSKGEVLAELFDMKNGGAVAFGDYKKAISNNNLLKIALQYTQVFDGIVISFPN
DSKIMGKGVVNEHISATKLGLKGIPALAEELCVARDLAVLEYAGGKLHIPTISSKKSVVM
IREAKSKGLDVTCSVAIHNIHFDDSVLTSFDTNFKVLPPLRDMETVVALREALNDGTIDF
ITSDHFPLDIECKFKEFDHASYGTIGLETIFGILNQYVPLEKVVELLTAARQRFGIETQP
IAENQQADITIFRTDETYLFENKHILSSSHNSAFLGETLQGKVIGCIANGKAVINEVN
>OBAHECAF_01031 Signal transduction histidine-protein kinase BarA
MKSRIIFKIILGYVLLISVSFITGYIIYNQIQKLTFLEEEGIYERRKVLKISKILTLMNE
TESAGKIAIRTDDEEALNFFLDRNYALQDSIIKFKKEVKNSSYVSLFDSVQILLELKSEN
LQELKILQSSDSSSVIIRNAIEKLSSLEPTLGYFLLNDNAIAKKKRTASKSQQTLSTGTS
YASIIQKYKNIKIPPTRSQQKFDNTVLETLQLLNKVHEETIKYKDQQSEKIHTLWHTDNL
LSDKLHQLLSDIEDNILKSAQEFNEQRQAVFEKSRSFLTISYVIALLLMVVFSFIVINDF
WKIQRIRQKLEVANLKNKRLLKSREQLISMVSHDLRTPLSSIIGYTELLDNQSTNEKTKN
YLSNIKHASDYITKLVDELLDYSKIEAGKISLEKVPLNVSELIEEVATNIYSIHKSKPVE
LIFNFSENVQYQWFSSDPYRIKQILYNLISNAFKFTDKGQIRITTTEKQIDNSKFEISIS
VSDTGIGIKKEQQAHIFDEFTQANQEVSKQYGGSGLGLHISQKLAQLLKGNITLESQENK
GSTFTLTFVTSKISEQSLQADTVVEMSEKAIDDINIVIIDDDTNILSLMKELCKQKNIGV
FVFDNSKDAITNMETLNFDLVITDIQLPEMNGFHFVTLFNEKYGKSIPVLAITGRKDVPN
DFYVQSGFSGVLHKPFSPTQFYEKLQEFFPRINTQTSPSILTNDKTYKINSLEDFMGDDK
EQIITIYKNFCKDTFENIATLKSCSDTQDYEKTRAIAHKMLSMFGQIQATREVILLRQLE
EISEENPAEINLKIQEIERLFIHDCKPAIDQYCKQLLQDS
>OBAHECAF_01032 Bacterial leucyl aminopeptidase
MKKTCIAFISILAFGCTAQKEISNNLSKLSIDSQINEISERRLRETLEVIASDEMEGRMT
GSEGQKKAADYIVKYFEKEGINYPPKAKGWFQTVPKSFIKNRFGDSDNIWAFIEGSEKPE
EIIVVSAHYDHIGTQKGNIFNGADDNGSGTVAVMEIARVFNEAKKKGHAPKRSILFLLVT
AEEIGLFGSSYYAKNPLYPLENTVANINIDMIGRVDDLHTDNNYIYVIGADRLSSDLHKI
NEAVNKKYTQLNLDYKYDDRNDPWQIYYRSDHYNFAKNGIPSVFFFNGVHPDYHQPTDTV
DKIDFPAMTQRTKLIFALAWELANRSERIKVDRDGK
>OBAHECAF_01033 hypothetical protein
MKYIQHRYVKIILAVLIFAYAIYQFTQGNIGNGIALIFLATIPVLLYFRNEFLLLAFFRL
RKQDFQGTQKWLSKIVDPETALIRKQQGYYHYLHGIIYSQINLSQAEKYFRKALQLGLNM
SYDVAMAKLSLAGIMMQKRRKREAQELLTEAKKLDKQNMMTEQIKMMQQQLKKI
>OBAHECAF_01034 hypothetical protein
MKHFFKFSIASFLVIVGTSCSKNAPEPHPEGEHEATAKMEVIFTEGHTHHGNKFYGDEEI
KELKYLKKIQKITFILEENKLNMEGAPVRLKKGKHYGVEIIHYNAEGKRINSEFISDTEA
RIHQHFFMMEEAKTTDGRPTPTMNQVLEYTYRDTNPEDKYINEKGVKLLKRTWDAKNPTE
NDPIGLKGFFYVKENYMTFMLRITLAHFTGIGKTKLKEDGSLYAFNELPSGSRFYEADVN
VRIPVRIYTEEQSPDSVFKADAAKEFGVTEDEIQKDLDHIARHKHEEGHSHRGIHL
>OBAHECAF_01035 hypothetical protein
MKKIKNILSITTLIALQILFVSCQKDNKDLPVAEPKVENLEIGYENGKKAYTESDLHLEA
NITAEGTIKSVRVQITPKEAGGSWFVDRTYTKGFTGNKEANLHEHYDVPKRAKEGTYDVV
IIVTDAKGNKTVVEDVLTIERDPSLPIVTEKSSSYDNDVLNIKAKVSAPNKLASIHVRVR
GIEETYTDEDLVGKTSYDLNKDINVSSLAKGHYHFFVTITDQVGKKFTYEDHFDKK
>OBAHECAF_01036 hypothetical protein
MMKNIFRISFLATILIIMSSCTKDEQLQKPDLEKEFDITEHFIAGTIGDKNKSVYVINFL
EKGKAVFLNSSQELIGNYTLTKDSLIFEIKSDSNYRIAKFALNDKKQVTSAYYRALKKVY
PATATLVSIPEENQLVGKVFKGEEYKFGESFRPVFHYKFDEKGTHYGSGVDVNAVTPNKK
LELINNCVFRFKDTGISEIGYFVGNTLTVFRYQGLYYFGEYELQK
>OBAHECAF_01037 hypothetical protein
MKRFLKRMKYFPKGTKHFPKGTKHFPKGTKHFPKGTKHFPKGMKHFPKGMKHFPKGMKHF
PKGMKHFPKGMKHFPKGIKHLYNDLICFIY
>OBAHECAF_01038 putative TonB-dependent receptor
MRNILYLLTFSCMAIGFGQEKLHLKVEDSKEKQPLVGAVIHFLGKHYVTNLEGEVAILNL
KKGTFPIRVTYLGFEEYQGKVTFPTNNSLVVISMIESLNELSEVIISSSYQGVHRNTVTG
VLTKNDLEKQSGESLAKMLSSVQGVSMIQSGATIAKPVIHGLHSNRVLILNNGIRQEGQQ
WGADHAPEIDPSMANRITVVKGADAVRYGSDALGGVILLSSSKLPYGDNLHGEVSPSFSS
NGRRTTTSAKLEGTVPKVPLWAWRVQGTLKRAGDIKTADYYLNNTGVREENFSMETGWEK
ELWGIEAFYSQYNNESGVFYGSHIGNLEDLQTRFQVGRPLTTYPFSYEVNAPKQKVRHHL
AKAKAYVFLPFGGKLTAQYAFQDNIRHEYSVRRLERSRIPALDMHLATHSLDISWENMYG
KWKSQLGLTALSQENYNKPGTGITPVIPNFASVGYGAFAIQKYVEKRWEAETGVRYDYKT
LNADGYGLFGQRYGGNRTFNNLTYLIGGSYKPTDFWSVTSNIGVAWRSPHVSELYSNGLH
HGAGTFDIGDGSLTSERGGKWITSVKYQKEKFSTEVDLFVQLIQNYIYDAPTGKTRTLFS
GVFPIFQYQQSDAFFRGADLEIGYQFLPSWKYRLKASVVYANEIKTGRYFPFIPSERFSQ
EVSFELPDTGIWKNVYFSAKHQFVNKQTRFDSSQELVSSTPDAYNLFDIGFGVKLPLGNQ
SLDVHMSAENILNQLYKEYTNRFRYYAHDLGRNIQLRIVYSF
>OBAHECAF_01039 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MEKKSYKEFLKDVTTFVFDVDGVLTNAQVLVTNEGELLRSMSVKDGFVMKYAIEKGYNIC
IITGGNNQGTKKRFEDLGITDIFMKRHQKLDTFLEYQKNKGLKKEQILYMGDDLPDIPPM
KHAGLATCPQDAAPEVKAVADYISHLEGGKGCVRDVITQVLKVRGDWEF
>OBAHECAF_01040 hypothetical protein
MKKTLTITVIGGGNVAFHLVDTFLKLTDVEVKQLYNRSCFTSDFDKFQIKKTTHIAELKP
TDLTIIAVKDDAIADVSARLPYTNSLVVHTSGNTDIDLLNDKNRKGVFYPLQSFSKAKPV
DFRKIPLCLEAKRAEDLNILRHLAESISENIYEINSFQRKILHISAVFVNNFTNHLVGIG
QKLCDEHKIPFEILKPLLTETFEKLQNISAIEAQTGPARRDDQQTIKNHMAMLNGVEKEI
YKTITNSILTTYGKEKL
>OBAHECAF_01041 hypothetical protein
MRKIIGLTFIALSIIACNSENKTYLITKENVGVLQKNVAVQKLDSIYAKDSLVNSTYEGE
LRYANTERILIFEKGGKELLEITPAISGKTNEKVVESVRILDPRFTTEKGISLASTYKDI
KSKYTDFEIEQTFKSILITPKGENVYFTFDKSALKNKNFGLSSDVTKDDIEEDAKIDRMV
VDWSIY
>OBAHECAF_01042 hypothetical protein
MSKIESFKEHILSGYTCKGDYITLGGAIFDGEPIENLLVNLPLKTLNRHGLIAGATGTGK
TKTLQVIAENLSKNGVPVLLMDLKGDLSGLAEAGEEKSFITERHRKIGLPFENQSFPVEL
LTISEQKGVRLRATVSEFGSVLLSRILDLSDVQEGVLAVIFKYCDDHNYPLLDLKDLKKI
LQFATEEGKTDFEKEYGAIAKTSTSAILRKIVELEHQGGELFFGERSFEPSDLLRTNNKG
EGYVNIIRLTDIQDRPKMFSTFMLSLLAEIYSTFPEEGDLKKPKLVIFIDEAHLIFSEAS
KTLLNQLENIVKLIRSKGVGLIFCTQNPTDVPDAVLSQLGMKVQHALRAFTAKDRKAIKL
TAENYPITEYYNTAEVLTSLGTGEAFVTVLNEKGIPTPLVATMLRAPMSRMDILSDTEIN
SLINRSELAKKYNETIDRESAYELLNKKIAEIQASATKEKERELAEKQQSRQSQSPTTRK
TSRTTRSTAQNPLLKMVTSATFVRGVLGILNKVIKK
>OBAHECAF_01043 DNA gyrase subunit A
MAEGEKLIPVDIGDEMKSAYIDYSMSVIVSRALPDVRDGLKPVHRRVLFGMNELGVFSNS
QHKKSARIVGEVLGKYHPHGDSSVYDTMVRMAQDWSLRYMLVDGKGNYGSVDGDPPAAMR
YTEARMRKISEDMLVDIDKDTVDHQYNFDDTLLEPKVLPTRIPSLLVNGSSGIAVGMATN
MAPHNLTEVIDGTVAYIENPEIDIEELIKYVKAPDFPTGGIIYGYEGVREAFKTGRGRVV
VRAKTNIEEVNGKECIIVTEIPYQVNKAEMIKKTVDLINEKRIEGISEVRDESSGRGGMR
VVYVLKRDAVANVVLNNLFKHTALQTSFSVNNIALVDGRPQLLNLKDLIHYFVEHRYDVV
YRRTQFELKKAQERAHILEGLIIASDNIDEVIAIIRSSENANEARTRLMERFELSEIQSR
AIVEMRLRQLTGLEQDKLRIEYEEVMALIKDLEDIIARKERRTEIIKEELLEVKAKYGDE
RRSQIEYAGGEFSVEDMIPDETMVITITHAGYIKRTSLNEYKTQNRGGVGQKASNTRDQD
FLEHLFVSSNHQYMLFFTQKGKCFWMRVYEIPEGTKTSKGRAIQNLINIEQDDKVKAFIS
VKDLKDEEYINNNFLIMATKQGIVKKTLLEEYSRPRQNGINAITIKDGDELLEAKLTSGK
SQLMLAVKSGRAIRFEEEKVRAVGRNSQGVRGIDLDVETDEVVGMIAIENPQEETVLVVS
ENGYGKRSYIDEPETGEAVYRITNRGGKGVKTISITEKTGNLVAIKSVLSGEDLMIINKS
GIAIRLPIDDLRIMGRATQGVRLINIKGNDSIAAVAKVMKEDEQESSTDENQENGTEIES
TE
>OBAHECAF_01044 Beta-barrel assembly-enhancing protease
MKKPLVIAAALLVSATAFGQKKELREVEKLIKKGDLAGAKTMLFQVKSIASSGDFAAQYY
FLEGTVGLENAKKNANLLASLKDASQAFAKVREIEGGKGKFTAQLPALSEVAAKIASNKG
QEAYTKQDFKTATTAFEQVYRFSPKDTVNLYYAASMAVQDKDYDLALQYYKELKDMNYDG
SEVLYYAKDKQSGEEQLFGNKNQRDLMVKGGTHTNPRTEKTPSKRAEIVKNIAYIYVEQG
KNDEALQAFEEARKRFPNDANIVVQEAMIYFQLDNKDKFKELMQEAIRIEPNNPDLHYNI
GVINLQQNNVVEARKSFEEALRLKPDYAAAALNISTSYITQGNALIEEMNALGNSKADVK
KYEELRVKKDDFFKKGADVLEDYVKKQGNTKDILEQLKSIYGALGDHSNFQRIKSLLGE
>OBAHECAF_01045 hypothetical protein
MTDKNLASVVFTAEELQKLDEALQNIENVLKGKTFNLTPDERRQYGSIAEQNKLFVNKCK
EFMKQYPQFVPSFLDKEEFDRDYQARQQIETRLIRLKTITEQLSDTKVLLDNDNYFNSIT
FYRNVKFLSGQNVPGIKTLYEQLKQFFKGGRKKADV
>OBAHECAF_01046 hypothetical protein
MKKIIMYVMTLLIAVVIGGCTKEGPAGKDGRDGINGKDGSTIITGRGVPDASLGNVGDYY
FDRTTSNLYGAKTTNGWGMPVNLKGLQGDKGDKGDTGATGSTGANGVDGNRILYGTTAPT
AHLGNIGDWYIDTKNAKLYGAKTEQGWGSGISLSGGNSEGISASDYKLSADGKTLVLWMN
LNTRDIDMNADPNLSQVTTIGREAFVDCNNLNSIIISNSVKVIKPKAFTNLRRLSSVELG
RGVQNIASINKEYNFYEHDTIKSGVFHNCTSLKTITIPKQLKDISGAFRNCTDLTSVILE
EGVTDIEGAFVGCSKLSSITIPNSIVNIEGAFVKCKELKTAIIGNGVEYWKQAFQDCKNL
KDVTLSDGITNIGNDGGYDGIFEGCESLSTINIPNGVTRIADRTFDGSGLVSIVLPNSVT
ELGKGAFANCEKLTSVTLSNQMTIIKGAEDYYNQNATFYNCKALTTLTIPANITTIEKGA
FLESGLTSVTLEATTPPQIENYIGLFVDQYDENNYNSTTKLTKVKTIYVPASSLSAYQNA
EGWKDLATNGISLLPKP
>OBAHECAF_01047 Dipeptidyl aminopeptidase BI
MTKKINQKKFAIVAVSLIFATSCKNNTETMKKTEYPDIQPPVAKKVPHKLEKFGDVRIDD
YFWLNQRENQEVIDYLNAENEYYQKMTAHTKDFQNSLFEEMKSRIKEDDSSVPYFRNGYW
YITRYETGKDYPIYARKKGTLDAPEEIMFDCNEMAKGHAYFQLAGISVSDDNKWAAFGVD
TVSRRQYVLQIKNLETGEILSEKIENTTGSAAWASDNKTLFYTQKDPQTLRSDKIYRHEL
GTDTKKDVLVFHEKDDTFYTYVYREKSRKYIVIGSGSTLTSEYQILKADNPKGDFKVFQK
RTRGLEYDISHYGDAFYIVTNKDNATNFKLMKTAENATSAENWKELIPHREDVFLEGIEI
FKNFLVVEETFNGLNRIEIRPWSGGQSYYLPFESETYTAYTTQNIDFDTDVLRYGYQSMA
TPASVIDFNMVTKVKTVLKEQQVLGGKFDKNNYVEERIWATAQDGTKIPMSMVYRKGMKK
DGKNPLLLYAYGSYGHTVSPYFSSSRLSLLDRGFIYVIAHIRGGQYLGRKWYENGKMLHK
KNTFTDFVDCSKHLIAEKYTSNEHLYAEGGSAGGLLMGAVVNMAPELYNGVIAAVPFVDV
ITTMLDDTIPLTTGEYDEWGNPNEKEYYDYMLSYSPYDQVKAQNYPNMYVSTGLHDSQVQ
YWEPAKWVAKLRQMKTNNNLLFLDTNMDAGHGGASGRFEALKETAKEYAFMLDLEGITK
>OBAHECAF_01048 DNA polymerase III PolC-type
MKLKLSKPICFFDLETTGTDITKDRIVEISILKVFPNGNKESKTWLVNPTVPIPKEASDI
HGITDERVANEPTFKELAKTIHNMIKDSDLAGFNSDRFDIPLLAEEMLRAEIDFDLGNRV
TVDVQTIFHKMEQRTLSAAYKFYCDKILDDAHSAEADTNATYEIFKSQLERYDDLGTDIK
KISEFTTRKQSVDFAGFIVMNDKNEEIFSFGKHKGRRVEDILAEEPGYFGWILNADFPLY
TKKVLTAIKLRKFNL
>OBAHECAF_01049 hypothetical protein
MKRFFIGMLTAVILLLGLKYIFDKKEEKAVLEADTALIQTQIANVSKLIVTEGHFSEVIS
YTDSQKYFLDLFSFDKKILIVVNADVTVAYDLTKITYDIDEVNKIVNIKYIPEEEIKIYP
NLKYYDISQSQVNPFNADDVNKIQKKIQTELEKKVANSTLKSNAKNRLISELSNIIFLTR
SVGWTVVYNDKPIENTTDLRILENN
>OBAHECAF_01050 Fumarylpyruvate hydrolase
MKIICVGKNYIDHIKEFDGKHPESIVLFMKPDTAIHNTELPYYIPEFTSNLHHEVELILK
INQNGKFISEKFAHKYYDEIGLGIDFTARDIQSSLKKDGLSWEKAKSFDGSAIIGDFIQK
STLDLTNISFRLEKNGQTVQQGSSNQMLWNFDQIVSECSKYFTLRKGDLIFTGTPANVGQ
VLANDILEGFLGDKKMFSFAIKG
>OBAHECAF_01051 Lipid A biosynthesis lauroyltransferase
MNLLIFILAFPLIWLVSVLPFRLLYVLSDFFYIVIYKILKFRVKVVRKNLSIAFPFKSES
ERLSIEKKFYKHFCDIFLEMVKSYGMSEKEMKKRMIYSNLEILKKYETENRSIIFICGHY
ASYEWLLSLAYSLKHTSYALYSPLSNKYFDKLIQKIRMKHKSFLMSRYKASAEMKRHKDE
GLICCYGFAADQVPNSSKSYRRPFLGLRVPVFTGAERISKQLNTVVVFANIEKIKRGYYR
TTFEVLSENPIEMPDYQITDMFFERLNKQIYSQPEYYLWTHNRFKRM
>OBAHECAF_01052 hypothetical protein
MRDLHLITLIIIGANALFSMQGFKNYTLFEKYKFNVRDVQRGEYVRMFSSGFLHADWQHL
IFNMLTLFFFANVVIYNVGVLSFVITYLLALLLGNIFTLYFHKNEPYYSAVGASGAVTGI
LYASILFAPNMLIFVFFIPMPAYIFGIGYLLYSIYGMKTRSGNIGHSAHFGGAVGGLLYA
LILKPHLITTQPLLIIGMLVPIVLLLVFRKRLM
>OBAHECAF_01053 26 kDa periplasmic immunogenic protein
MKSFLLILFFIPLTMIAQSVPSVTVVGEGVVTVSPDIVYISLNVENEGDNVKHLKKVNEE
AVAKVLHTLADELPKSNFQTSHVSLRKHYNYEKHINKYYISQGINIKLEDISKYEWLMEC
LFEAGVNEINSVTFDVKDREKFIREAQSLAIYNARQKALFYAVSLEQNIGKALFISELNS
NAPRFENVAMFAKNDVMNSTIAVGVIEIRANVNISFELLKE
>OBAHECAF_01054 hypothetical protein
MFLYTATKRFFFKFAKVIKNMVQQNNKILTFYIRVNQGNIKDKKITLSVIQMKY
>OBAHECAF_01055 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNLGVVNVPDPRLQKLEELVNPER
VQPATVEIVDIAGLVKGASKGEGLGNQFLGNIRECNAIIHVLRCFENDNIVHVDGSVNPI
RDKGTIDVELQFKDLETVEKRLDKVNRAAKAGDKKAAKEQELLNRIKTTLESGNSARAVQ
VSDDERELMDSFQLLTAKPILYVCNVDEASAKSGNAYVEQVRDAIKNENAEVIVLAVATE
ADITELESYEERQMFLEDLGLDEPGASKLIRAAYKLLNLQTYFTAGVKEVRAWTIHKGDT
APQAAGVIHSDFERGFIRAEVIAYDDFIHYGSESKVKEAGKMRVEGKEYIVKDGDIMHFR
FNV
>OBAHECAF_01056 GTP cyclohydrolase 1 type 2 
MKVKHIIQRLEQLAPLDYAENFDNVGLLVGDAEMNVTGVLITLDTTEEVVDEAISRECNF
IVSFHPIIFNGLKSLTGKTYVERVVIKAIQHNIAIYSMHTALDNTLFGVNEAICEALGLR
NTRILIPQKHTIRKLITYVPKNQSDIVREALFDAGAGNIGNYSHCSFNLEGKGTFQGNDF
SKPTVGERNILHKEDETQIGVIFPKHLQSKVLNALRESHPYEEIAYEVYVLENAHQHIGL
GVVGEFSKPMTENDFLYHLKDKMQTSCVRYSELTGKMIQKVAVLGGSGAFAIDAAKAAKV
DAFVSADFKYHDFFKAEKQLLLADIGHFESEQYTKLLLFDYLTKKIPNFAIILSKINTNP
IKYY
>OBAHECAF_01057 hypothetical protein
MTKKAEITVEEKLRMLYDLQLIDSQIDELQNVRGQLPLEVSDLEDEVEGLKSRLVKFKEE
LEQLQSGITQKKNVIEEAKILIKKYVAQQKNVRNNREYNSITKEIEYQELEIQLAEKRIK
EFKAQVDLKKESIKQIENKKSERETHLKHKKEELNSILAETEKEEAILREKAVEFAEQIE
ERLLKAYQRIRGSVVNRLAVVPVERGASGGSFFTIPPQVQVEIATRKKIITDEHSGRILV
DAALAEEEKEKMNALFESIKQ
>OBAHECAF_01058 Inner membrane protein YqiK
METLTPITLIVIFAIVIFVTISSLVARYKRCPSDKILVIYGKTGGSSAKCIHGGGAFVWP
VIQDFAYLDLRPLSIEANLTNALSRQNIRVDVPCRFTIAISTETENMNAAAERLLGLLPE
QIQELAKDILFGQLRLVIATMTIEEINSDRDKFLDNISKNIDSELKKIGLKLINVNVTDI
KDESGYIEALGKEAAAKAINEAKISVAEQEKIGETGKAIADREKDTQIAETHRDRDVRIA
ITQKDKEISIAEAKKDESIGIAEAEKFESIGRAEAQRDSRIKISEANAVAIKGENEAKIA
IANSEALRREKEAESLRIAITAEKVQQAKALEEAYVAEQKAELARSERERSTQIANIIVP
TEIAKQQAIIEAQAEAERIREKAKGEADAIYAKMEAEAKGLFEILTKQAEGYRDVVGAAG
GDPTKAFQLLLIEKLPELVKTQVEAVKNIKIDKITVWDSGNNENGANSTANFVSGMMKTV
PPLNDLFNMAGLNLPTYLKGENPEDAKQIGGNETKEK
>OBAHECAF_01059 TPR repeat-containing protein YrrB
MHHFSEEENYSVSKFESMLKKNHISFFDVDEFEEIVEYYLELGKMTKAKHALQIGRNQHP
SASSLKLFEIEVMIFEDNLQQASHLLAELEAVEPYNSEVYVQKANLYSKLNDHEKAIELL
KFTLPLTDDLVDIYALIAMEYLFIENYEKAKKYFRKCLTEDIEDYMSLQQLLFCYDILEE
NDEAISFLNAYLDRNPYCEVAWHYLGKQHLIKENFTEALNCFNFAIASDDTFTGAYFEKA
KVLEKIQNYTQAIENYKITLTLDDASPLTYLHIGRCYEKMNDCSMAERYYLKAVHEDPQL
SKAWVTLSDFYYKQKNYEKALKYINKALLIEDDNFHYWRRMGEICVILNDSKSSEYAFKQ
AIHYGDNSMSTFAHLTNLLQSKK
>OBAHECAF_01060 Gamma-D-glutamyl-L-lysine endopeptidase
MICAIKFSFLTAQNSSENCEPIEGKTWGVVYNSVGKIHAESNHRSEIVTEVLLGMPVMVL
NRDKGWRKIKTSEGYVGWISESIVEMTHTELKEYNQKRKVIVTSLYTHSYKENSLKSAII
SDLVMGNILEVKGRKGNFFKVIYPDGREAYIKKNDAVHFDKWLNNIKLTEQSIASLAQQM
AGIPYVWGGTSSKGLDCSGFTKLIYFMHGVILLRDSSQQVKTGKLVDEKGDFSKLQVGDL
VFFGTKADESQPQERVTHVGIYLGNGRFIHASDYVKIASFYPHDPLYDAFNTNRYLRTKR
ILGSINSFGIEYVRENEFYTKN
>OBAHECAF_01061 Fructose-bisphosphate aldolase class 2
MAHNIKPGVIVGKQVQEVFQYAKEKGFALPAVNVVNSSTINAVMETAKEMNAPVIIQFSN
GGAIFMAGKSLSNENQKAAIAGAVAGAKHIHQLAEIYGVSVILHTDHCAKKLLPWIDGLL
DASEKHFAETGKPLFSSHMIDLSEEPLNENIEICKKYLERMSKMGMTLEIELGITGGEED
GVDNSDVESSKLYTQPEEVAFAYEELLKVSPQFTIAAAFGNVHGVYKPGNVKLTPKILKN
SQEYISKNYNVPHNTVDFVFHGGSGSSVEEIREAISYGVIKMNIDTDLQYAFTEGVRDYV
LAKKDYLMSQIGNPEGEEVPNKKYYDPRVWLREGEKTFVARLKKAFEDLNNVNTL
>OBAHECAF_01062 hypothetical protein
MKKNIFCFILGGMTFFLGTAQTQNPSPDLYTANNKGKFFIFWGGNRGYYSKSDIQFKGEN
YDFTIKDVAAIDRPKGWHIDYINPLRMTIPQTNARIGYFINNNYAISAGVDHMKYVMKQD
QTVKMNGYIRNSGTIHDGVYNNVDKQLTEDFLTFEHTDGLNYVTIEASRVDDISRWFGIR
NTDFFQANLTEGIGIGALYPRSNTKLMNKERYDQFHIAGVGVSAKAGLHLVFFKHFMIIG
ELKGGYINMYDIRTTYDIADKANQTFYFFETIIAFGGIFRL
>OBAHECAF_01063 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MNIAIVCYPTFGGSGVVATELGLVLARKGHQVHFITYSSPVRLDFLEANIHFHEVHVEEY
PLFLYQPYELALSSKMAYVIKNYNIDILHVHYAIPHAYAGYMAKQMLKKEGIDIPMVTTL
HGTDITLVGNHPNYKHAVTFSINASDVVTSVSESLKQDTLRLFEIEKDIVVIPNFISVEK
ETNIIPCKRSIMAKKEERIITHISNFRPVKRISDVVNVFYRIQRKIPAKLIMVGDGPEKE
HAEYQCKQLGIKDKVLFLGNTLDIDRILCMSDLFLLPSESESFGLSALEAMVSGVPVISS
NAGGLHEVNENGFSGFLSPIGDVDDMSKNAIYILEDEERLQRFKQQAKISASRFDERKII
PIYEELYEKTIRSRESQ
>OBAHECAF_01064 hypothetical protein
MKISVELTFSPLQNDFEQPIIHFIKKLRASGLTILENPLSTQVYGDYDQVMRVLMVEIKE
AMELVDIGLMYMKIVKTDRHDYEPHF
>OBAHECAF_01065 Nicotinamide riboside transporter PnuC
MTMNLIFDWFFSQYKGIDTHLIVLEIIGVIFGFLSVWFAKRGNIWVYPTGIISTLIFTYL
LAVFTLWGDMLINFYYTIMSIYGWILWTKSSKDHIHVDISKTTRYDVLVCSLLALFSFVL
VTTVYYLKPYIQNGFSTKNIVMGFQYFSWVECVDIFTTAIFLVGMWLMAKRKLENWIFWI
IGDVISVPVYAYKGLFFTSFQYLLFTVIAIFGYIEWKKNLNKQQRTSVELHS
>OBAHECAF_01066 Trifunctional NAD biosynthesis/regulator protein NadR
MEKKLKQTATNICRVTFVGPESTGKTTISQALAQKYQTEWVPEFMRTYLQQKWDEKREVC
DWEDLLPIAKGQMVMENELIKKANEFIFCDTNLFELMTYSYIYYGKCDPLIEKYAIDNQY
DFIFLTYIDVPWLPDDLRDKPNEREYMFQQFKQMLNQHKKSYILLEGNHEQRMKKVIDTI
DNYSCL
>OBAHECAF_01067 hypothetical protein
MRIVLSLFLFFINCTFTPKNMNISIENIQTIVDFPSGSGVTYINNKIYAIGDDSPYLYVI
NSDFKLDKKILLYEEDQENFKGNRIKKKRKMDFETLEVISEKELVIFGSGSKSPQRDMFF
RVLLDKNIIVEKYSISDFYDLIRNSDLLKNEELNIEATAFANGFLYLFNRSNNVIIKVFY
QDFLESLKTQEKPNLSYVRVPLPSIEGVEAGFSGATILRDQTFVFTASVEATDDAYNDGE
IMGSLIGLLDFSDFEKPKVLKFKNISNLEKNLKVESVAVISTSAKDSELVLITDDDQGNT
ELIKVKISE
>OBAHECAF_01068 hypothetical protein
MTKHIAVIRMSAMGDVAISVPVLTAFAEQYPQVELTVVTRPLFAPIFSHIPNCKIFTPDL
KGKHKGVVGLFRLYKDLKKQGINVVADIHNVLRTNILKLFFCLSGTPFEQIKKGRKEKKN
LIRSKNKIFKQLKPSYERYADVFAALGMPISLEKKYFAPQPKLSNSVKNILSNGKRIGIA
PFAAHLGKQYPFERMKKVIFELSQGYPNGKIYVFGGGNHEKEKINELIELKNVENTVGKY
NFSEELQLISRLDVMVAMDSGNAHLSAMYGVPTITLWGVTHPYAGFYPYQQPVENALLAD
RKLYPLLPTSIYGNKHPKGYENAITTIQIEDILRKVKEILEE
>OBAHECAF_01069 hypothetical protein
MRRFLFIFGFLFFVQSYSQSKSVFDFSKSLRIDFQLIGDAENLDVIVTQLKQEPFWGGSK
KNLIFPNYGTFRLQLIDVDTKKVVFSKGFNSLFSEWLHVEAAKTEKKIFSHAIQVPFPVK
NLKLHIDKRNSEGNFDKILEKTIKRTDYFIKKEKVATHPVIEILKNGEPSKKVDLVILAE
GYTADEMQKFYTDAKRMTDYMFTIPPFDVLKKDFNVYAIGVPSQESGTDIPGKHIFKKTA
FDASFYTFDMERYLTTNNMTAIADAASLVPYDQIYILVNTKTYGGGGFYNHLNLATSDHD
LSDKVFVHEFGHGFVGLADEYYTSTAFDSYYNLNVEPWEENITSMINFDKKWKDMVHEKT
PVPTPRTAEYRDVIGVFEGGGYVSKGIFSPVQDCRMKSNVPKGFCPVCERAIRRVVKFYT
N
>OBAHECAF_01070 hypothetical protein
MLKKFITASVLALALTSCSLTLPVNATSNSVGSKTGTSTATGYLGVLFFDADASIKTAAK
NAGITKISTVDIKQKNILGLIVTFETIVTGE
>OBAHECAF_01071 hypothetical protein
MKKIFVGLFLIFIGCKSTNKSSIDLFGIAQYSLEFNQRIVKNVPDNEIHRQVLSTYFKEE
QLPIFRTIESGTNKIYLTIPTGIVFDEKKLIGTPENCEILQTQETTDVKYIAYRCDKTYT
AIYLKKLQNNTFCIIVSGQEEESFRKEADKNNIDKKILINQ
>OBAHECAF_01072 hypothetical protein
MQRKKIILAIFSVILMVSCSSLGKGGKNLYASFFAEQGILYFIKPIELTGNEEKAFMDFT
FKSKQTLEGNTRVNISFHTDKPIHKIINCQIVVNGNNFSLTNKEFMFIEKKKDKFESRFS
FELETPHLKEIFTNNAWTLNITEENNTTHSFRTTSLSQKKINLLRDNLFTIFTQ
>OBAHECAF_01073 putative ABC transporter ATP-binding protein YbiT
MLTVSNLSVQFGKRVLFDEVNVTFTQGNCYGIIGANGAGKSTFLKILSGKIEPTSGRVIL
EPGKRMSVLEQDHYAYDEFTVLETVIMGNKVLSAIKKEMDELYADYSDENADRIGELQLQ
FDEMNGWNAESDAAALLSNLGISEDMHYTLMSEMDGKLKVRVLLAQALFGNPDVLIMDEP
TNDLDFETIGWLENFLANYDNTVIVVSHDRHFLDAVCTHISDIDFGKINHYSGNYTFWYE
SSQLAARQRAQQNKKAEEKAKELQEFIARFSANVAKSKQATSRKKMLEKLNIEEIRPSSR
RYPAIIFDKEREAGDQILHVENLSASIDGEILFLKVDINLAKDDKVAVISKDSRATTAFY
QILNEKQQPDSGKFQWGVTTSQSYLPVDNSEYFNNDYSLVDWLRQWAKTEEEREEVYIRG
FLGKMLFSGEEALKKSSVLSGGEKVRCMLSRMMMLRANVLMLNEPTNHLDLESITAFNNS
LKNFKGNVLFTTHDHEFAQTVANRIIELTPNGVIDRYMTFDEYMDDKNIQELRKTMYERK
>OBAHECAF_01074 hypothetical protein
MANKKLLNSFPFILLIFYYFFIYKSQIAWEYKMSALGAMILVSFWIYLKKGKNIKYSKNI
LPLALGASGVVMIIFYSI
>OBAHECAF_01075 Anhydro-N-acetylmuramic acid kinase
MEIYNVIGLMSGTSLDGLDIAYCQFSYNGQWRFKILKTKHVVYEDKQKNELKEAVKLSAI
DLLALHHSYGQWLGEQVKQFIDDEQLIVDFIASHGHTVHHQPQRGISCQIGCGQYLSNIS
GLPVVNDFRSGDLALGGQGAPLVPIGDRYLFGEYDFCLNLGGISNISFEDNGLRIAYDIG
IGNMLLNYLSQKIGKPYDKNGEIARHGTVNNVIFEQLNSLEYYELAYPKSTGYEWFQAKI
RPVIDSSDDSIENLLCTSVHHIAYSICQEVTSYSKNTDNQRLLVTGGGALNTFLIETMRD
YMNKSVRIVIPERAIIDYKEALIFGFLGVLRKRHEINILRSVTGATDDSCGGVFYFPNKK
>OBAHECAF_01076 hypothetical protein
MANQTDNTPPIFVDPNSTEMPNKTESFYGDEGEEPKKSSGIVSKVIIGILVVLAGGLGYF
SYNLNEEKKRNEAELNQQKEQIIKELSVLKTSYDKAVEDNKAVNQDLVDARDKITLYIDS
LQKMKVSISSLVKYKNQVITLKKERERLLSINDSLRRSNALMKQQRDSISVALQNVSSYL
DSLVQQNTKLKEVVESGEDLQISKLTTEGVKVRSSGKLVQTARARATDRIKICFTVVANK
IAKSGGRTFYVQVISPDGVTLGKNSTESNEQTTVNYSLATKFIYDNRNIDVCDFLSAPKN
DFDKGKYRVVVFDDKLSAVGETEFILK
>OBAHECAF_01077 tRNA (guanosine(18)-2'-O)-methyltransferase
MVTKNQIKLIQSLQQKKYRSKHQMFVVEGRKSILEFLMQNFQVESIFATDYFSELLPKSK
TILTTKDVLEKMSSFKNPDEGVAIFKIPLPQPIVDEGIIVATDDIRDPGNLGTIIRLCDW
FGVQHLVCSYQTVDCYNAKVVQSSMGSLGRVNIHYEDLHIFLKNSKLPILATAMDGENIY
QTSFPKEGILVLGNEANGISKLNLEIAHQILTIPKFGNLQQAESLNVATATAILLSELKR
NS
>OBAHECAF_01078 Outer membrane protein assembly factor BamA
MRLITLKIASIFCITILLSACNATKRVPDNAYLLDKTKVLVNDVKTEDAKIDNFILQKPN
GSLLGMPLGLYIYNLAKENPEQDFVDWLEEHPRTHKTLDRLLSQKQVGRLQKSFFVSGIH
NQLKKIGEAPVILDNSKTKSTVNYLKAYYRSIGYFNATVRDSVFLKDTKRKKQLADVSYI
IKTGEQYFIDDLKTSISSSQVDSVYHLHRHESLLKSQKPYLLADFNAERSRLTNLFRNNG
FYTFQQSSINFEITRDTIATNNDQKMDVVTVIDDLIERDGDEVTVKPYRVHRFNKIRIFT
DYEMGSDKSELDSIDYKNVTVFYKNKLRYRPRILEMATAFKKGAIYSDENRSLTYKQINN
LRIFKYPNIDLKYAENDSLQTKLDANIYLLPMDKFSLRLTNELKRSEIEQFGISLGTSVS
ARNLFRRSEVLELNLQGTIASQFDRDQGEPWFNMSELGADVRLIFPEIVFLFNTTNIIPY
SMTPQTMFQFGVSKQKNIGLDKQTLSGALRYTWNPKKNRVILDLFNLQYIHNLNVDNFFN
VYRSTYSRLNEISKKYSVDSSLLDNNGDLTIPEGTNQFMGLALWGGIPNITETDLRSTIS
VLERANRLTYDDFILSTSYTFILNNNFQFNQEDFYQFRVKLESAGSFLSLLSNAYKVVDS
NNKSTKFLDVEFAQYVKMELDYIKHFPLGRGNYLAFRSFFGLAVPYGNSKNIPFTQSYFA
GGSSDNRGWRAYSLGPGQSGSLLDFNEANMKLTLNLEYRFPISGAFKGALFADAGNIWNV
LDNTSFEQNKFKDISSLKDVGVSSGVGLRYDFGFFVFRLDLGNKIYNPAKAMSQRWFTDV
SFKNIIFNIGINYPF
>OBAHECAF_01079 hypothetical protein
MGTSRKETPKQVATRFDTISLKGYSPTLSKTEIMPGFPPYVRGYRTMGNIRQNPVYEPIM
FWGSYEIDEIFKQEIMFLFYDISELIKATDVKKKSLFIYKKSDFESIMYHQKDIQYLYVV
CIGKNYELNNLNFLNNLDKELLDKVRFFFNFSQTSMKVIEKIRQIRALSHLFVSENNLNF
YLPIVCYVNSVTEQIYSLSAHCDYIIYNAKNNHFNTSYNTFLIENSMISKTIDPFWNNDE
SIQF
>OBAHECAF_01080 hypothetical protein
MNNFHATSFKQWKQQVQFELEGADYNKTLVFKTLQEVDILPIYTSENNHLYYDINDKKTE
IMIPVECFSVIPVVKKINFFKKHHFSNFFLSIHPHIDIADLLNTLPKENTYFINNKHITD
EVINKLKKCIEECKLDIVVCNDYIHRYIEKGMWFRSQFNDFECFTKTFNIKKPVLFVDTT
LYQNAGASIIQQIAYGISHALEYSKHIEKTLNINRLTIYFKIAVGSHFLLEIAKLRAFHQ
IAMSIFDVFPFKIECMFMVEPSDRELSLSTSNYNEQYIKMAHESAILGGADFLFPKYPII
YHKKKEYQQEFKSIMTASDSLGNKASIINKSDCFQSLSYQFAKKSLLLLQNIEKNGGLLE
VFKNGSLQKSIREKALEEQEQFDALVISNNIDFKDIAQKELWEIYPFLKRNNTQTSVEPL
IPKRLWEHLEKKHLSK
>OBAHECAF_01081 Large-conductance mechanosensitive channel
MGFLKEFKEFAVKGNVVDLAVGVIIGGAFGAIVTSLVSDVITPLLLTPALEATGAKNLEG
LVWNGVAYGKFLAAVINFLCIAFVLFMLIKGINKMKKEKTVEPEAPAAPAGPTQEELLAE
IRDLLKK
>OBAHECAF_01082 Alanine racemase 1
MYFFCSKYVKMTYNTSQIGSTHLIIRLDNLEHNVRFLRSKLNENTLFMAVVKAFSYGNNH
CEIASFLQKKNLVDYFAVACVSEGVELREAGIRKPILVLHPQISDFEEIIKYELEPTLYS
KRILSHFIEFVENKGKTAYPVHLKCNSGMNRLGFLLDQITDVCQILGRQKTIFVKTAFSH
LFASEDKNASEFMEKQISLFIEFQNVIKKHFSHKILFHTCNTSGILNYPHAHFDMVRSGI
GMYGFANDSEYQSDFRPITILKSFISQINEIPVGGYVGYNFGFQADKVTRSATIAVGHAD
GLNRIYGKGIGFVYIKGKKAPILGNVCMDMLMVDVTDIDCQEGEEVTVFDEKYTAEILAE
NAQTISYELITSLSRRIKRIYVE
>OBAHECAF_01083 Guanylate kinase
MNKLIIFSAPSGSGKSTIVRHLLGKESLNLAFSISATSRAPRGEEQHGKEYYFLSVEEFR
KRIENNDFLEWEEVYAGNFYGTLKSEVERLWGLGKTVVFDIDVVGGLRIKEQFPEQSLAI
FVKPPSIKELEKRLRARQTETEEKIKMRLGKAAIELEAAPKFDVIIENDILEKALQDTEN
VIVNFINKQ
>OBAHECAF_01084 hypothetical protein
MIQSMTGFGKSTISLADKHINIEIKSLNSKSIDISTRIPLAYREKELEFRKIIAEQLQRG
KVDFNISMENTSMQTSVKINENAVKAYMEQMKSIVDGDPVELLKMAVRMPDALQTTSESI
SEDDFQLIVNLLHTAIDDLQKFRIEEGKVLEADFILRIHNIQSLLQEVEKLDPERLILVR
ERLEKAVAEVQNVDENRFEQELIFYLEKFDITEEKIRLKNHLDYFIETLNSSESNGRKLS
FIAQEIGREINTLGSKANFSPMQQIVVQMKDELEKIKEQVLNVL
>OBAHECAF_01085 Serine hydroxymethyltransferase
MQRDNEIFDLIDDEEARQIHGIELIASENFVSDQVLEAAGSILTNKYAEGYPGRRYYGGC
EVVDEIEQIAIDRAKTLFGAEYANVQPHSGSQANTAVYAACLKPGDKILGFDLSHGGHLT
HGSPVNFSGKLYTPVFYGVEKETGLLNYDKILEIAEKERPRLIIAGASAYSRDIDFKKFR
EIADKVGAILFADISHPAGLIAKGLLNDPIPHCHIVTTTTHKTLRGPRGGLILMGKDFEN
PFGLKTPKGEIRMMSSLIDSAVFPGNQGGPLEHIIAAKAVAFGEALSDEFLHYAIQVQKN
AKKLASLLIEKGYDIISKGTDNHMMLIDLRNKNISGKEAEEALGKADITVNKNMVPFDTR
SPFVTSGIRVGVAAITTRGLKEADMETIAGFIDEAITNHTNDEALEAIAERVYDFMEERP
LFAY
>OBAHECAF_01086 hypothetical protein
MTIKRGILLLLLTINSAIFAQEIIPFKLRKQENLRGGLRMIGNNVVNNQPSNMAYHGDET
NDRLRMSYIDVDNDATTFSSSAASLNLSSTCSKVKYAGLYWGGMYDTKDSTKNNIKIKIP
SKETYIDLEADTYIYDSFTATQTIAYNPYVCYKDITHILTDENPIGEYVVANVRATETLL
TEKFGGTSAGWLLVIIYEDPSQTTKNISTFDGYASIETNNNIPMEMTFTFSGFKTLPAPL
PVKARFGIAALEGDKQIKGDRLSILRPNGSYMGLSNDVNPTNNFFNSSISYENSYMNDRR
PASTNSLGWDIDLFSIENSNNSVIGNNQTSANFKASTTGDKFDVFFSAFEVEVIEPKMNL
LKTVEDVSQNVLNKQIIPLGTTVYYGLEFQNVGNDDAIDYSITDILPKNVTFDTTIPVEI
PVGVTYSLTTTTNGETQLIFTVPNALVTEGSAKQKIRFAVKLSNDCNDFSTICSETVVNK
AYSIYKGMKNSEIINDLGSYSEINPCNIGVPEETIFYVDISGCTPMQQTELFCGENKTLT
AESGYDSYVWTNGSGQVVSNSQKLIIAQGGQYTVAKTKKGCLPRKEIYDMNTTIRQEYNP
IVPYTTTNFKCEASKISFPQVFICGATVSITFDLNTVSNVTSIEWQKHTGETLKITENCP
PTDSNWQQIHIGKSIAIAEEGIYKVLLTFTNGCTAPYFFRVHTSPINPTVSTENISCNPG
KINVLGISNNYEFAVALSGTNPTNYQENPSFEITKNGNYTVYIRKKERLASDCTIEIPNV
IIKDVNLNLESEKVTNETCFEQNDASFSFQIKGGTASYTIILTNQNTGNTENRSVMTEGV
ITFDHLAPANYLLSVTDALSCVVTRSFTVTAAANLDFIVSQEQACEDNESISYLILDFVA
TNLDVNKLSYSLGESIATQTFDKLSKNRAYIHQRNLSNETNQQITIHYDGCSIVKNIDFE
KVTSLNITQVQPTKLLSAIEFNVNGGSGNHTIYYNGVPSDEHIYYFKSTDIGYTDANGNS
IKKVSVRIEDDLGCYFESQFEALFVDIELPNYFTPDGDGVNDTWGVRNASGYPKLRLDII
DRHGRTLKILRRNETWDGTYKGKKMPSGDYWYILKLNWFGTELYRGNLTLYR
>OBAHECAF_01087 hypothetical protein
MTKLTQKDQQLLTQKGITEEMLHKQIALFKEGVPPIELESAATIGNGIISFSKEETAKYA
AIYQKKKKGISILKFVPASGAATRMFKSLFAFKDNFDPEKESFKAYIKRKGDKEMEVFFN
GLEKFAFYPILMDYIAKNIPEFHSQNEDNQKHILVSTLLGENGLNYGNLPKGLLPFHKHS
EKIATAFEEHFRESVMYASGEELAHLHFTITEQHTDAFNKELSDIKPNLEERYNIKFDVN
FSYQKPSTDTVSVTESNEYFRDENGNLLFRPSGHGALLDNLNEVDADVIFIKNIDNVVVK
KYTDETVFYKEALAGKLREVQSDVFHILKRIENNKVKKKEVTKILNFLKEINIYVPDYLY
KFKRHYALEFIEEQLNRPIRVCGMVKNEGEPGGGPFWVRNSDGNLSLQIIESAQVDLNNP
QQKEIFQQATHFNPVDLVCGTKNFKGEKFDLHQFVDPKQAFITNKTYMGKPLKALERPGL
WNGSMANWITIFVEVPLITFNPVKTVNDLLKKTHQA
>OBAHECAF_01088 hypothetical protein
MYNMIAKFLKEKNIEISLKRYGIDALNAMALGLFGSLIIGLILKNIGTWTGFDWLVGAGN
QAQSAMGAAIGVCVAHRLSASILVIGATAVVGLSAASLGGPMGCFVAVLFAVEFGKLVDK
TTKIDIIVTPLTTICIGLGISQLIGEPIQLVMNKIAEFITWSVALHPVIMGVIISVVMGV
ILTLPISSAAVAISLSLSGLAAGAATVGCCAQMVGFAVMGYKENRMGGLLSIGLGTSMLQ
MPNIIRNWKIWLPPIITSAILGPVAILVFGMQNVPSGAGMGTSGLVGQIGTFDAMGSGWQ
VILAVVLLHFLFPALICWLLSVWFRKKGWIKEGDLLLR
>OBAHECAF_01089 tRNA dimethylallyltransferase
MFKEKKLITVVGPTAIGKTRLAIALAKHFNTEIISCDSRQFFKEMSIGTAVPNSFELEQA
PHHFIQHKSIHEPYSVGDFERDAIELLNQLFEKQNIVIMVGGSGLYVNAVTQGLDDFPEV
SSTIREELNQNYAQQGIGYLQELLKKLDFQQYQKMDIQNPQRMIRSLEVCLASGKPYSSF
LKQTEIKRNFSVIEIGLTADRDIVYDRINQRVELMLEQGLLCEAQNLYPYKHLNALQTVG
YRELFDFFDHKCSFDFAVEEIKKNTRRFAKRQYTWFRKNTNIQWFDYKVDIRDVFEYLLN
Y
>OBAHECAF_01090 Cyclic nucleotide-gated potassium channel
MRGVFKSKYDILKQKAYVIIYGTNTPLGKLFDIVLLILIFLSVIMVMLESVKDIDHQAHG
VLVFLEWVITVFFTLEYILRIISNKKPLQYIFSFYGIIDLISILPMYLSFFIPGSKALSV
VRALRLLRVFRILDLVSFTNQGNELKMALRTSRNKIIVFIYFVLVICVLLGSVMYVIESE
ESGFTSIPKSIYWCIVTLTTVGYGDIAPTTILGQMIASFVMILGYGVIAVPTGIVTAEFS
RTRTKFRATISEQKTDQVQKKCQSCGHTNHQRQAKFCCQCGTSLKNADV
>OBAHECAF_01091 Carboxylesterase 2
MMKMENQLPLEYVMREPLKKARRSPVIFMLHGYGSNEKDLFSFADELPEEYAIISIRAPY
ELSTFGYAWFSLYFDIENTPHADNEEAIKSRDLIMHFIEEACKLHKLDAKNVTLIGFSQG
SILSMAIAISYPRKIRNVIALSGYLNMDILKESYKKQKHFPINFYVSHGTSDQVIPIDWA
RKIPEFLKKIKADFVYEEFPVGHGVAPQNFYSFREWLKKRSAADN
>OBAHECAF_01092 UDP-3-O-acylglucosamine N-acyltransferase
MKFTALQIANILNGEVEGNPNVEVYKLAKIEEGEEGSITFLANPKYKHHIYTTKASIAIV
NKSFYPDSPLEVTLVKVEDAYSAFSKLLEYYNQIKLNKVGIENPSFISSSAILGENIYVG
AFVYIGENVQIGNNVKIYPNTYIGDNVTIDDNTTIFAGCKIYSETVIGKHCTLHAGVVLG
ADGFGFAPVQEGFYNKVPQIGNVIIKDYVDIGAGATVDRATLGSTVIGKGVKIDNLVQIA
HNVEIGKNTVIAAQTGVAGSTKIGESCMIGGQVGIAGHLTIGNHVKIQAQTGIGRNVKDE
ETLQGTPALSYAEYNKAYVVFRKLPDILKKIEQLESKIK
>OBAHECAF_01093 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MVNQNTLSKEVFLEGVGLHTGQNVKMTLKPAPIDNGFTFVRVDLEGNPVIEADVNYVTNT
ERGTVLEKKGVRIQTCEHVLAALVGMDLDNVIIELNASEPPIMDGSSRLFVEAIEKAGIE
AQDAPRQEYVVKEVISYVNEETGSEITLIPADEYQVTTMVDFGTKILGTQNAYLYRLSEF
KDTIANARTFSFLHELEMLIDHGLIKGGDLNNAIVYVDKEISEETIEKLKKVFNREDISV
TPNGILNNLTLHYSNEAARHKLLDVIGDLALVGTRIRGKVIATKPGHFTNTQFAKKMSKI
IKNERRNNVPTIDINQPPLLNINDISKLLPHRPPFLLVDKIYELSDKHVVGLKNVTMNEP
FFVGHFPGAPVMPGVLQIEAMAQAGGVLILSTVPDPENYLTYFMKIDNVKFKIQVMPGDT
LIFKLELLTPIRRGICHMQGYAYVNGKLATEAELMAQIVKVKES
>OBAHECAF_01094 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPGAKIAQNVVIEPFTTIHNNVEIGEGTWIGSNVTIMEGARIGKNCSIFPGA
VISAIPQDKKFQNEETVAIIGDGTTIRECVTINRGTSDKMKTVVGENCWIMAYSHIAHDC
FVGNHCIFSNNTTLAGHTTVGDFVVLAGMVAVQQFANIGNHAFVTGGSLVRKDVPPYVKA
AREPLSYVGINSVGLHRRGFTAEKIREIQNIYRIIFQKKYNIGQALSIVEAEMEATPERD
EILDFIRNSSRGIMKGYMGVSTL
>OBAHECAF_01095 Elongation factor P
MATTADIKKGLCIRFNHDIYKIIEFLHVKPGKGPAFVRTKLKSVTTGKILDNTFSAGHKI
EDVRVETRSFQYLYEEGDNFVFMNTEDYNQVHIRKDMLESPDLLKEGEIVMIIFNAEDES
PLSVEMPANVILTVTHVEPGVKGNTATNATKPATVETGAIVNVPLFINEGDRIKVETEKG
TYVERMKD
>OBAHECAF_01096 Triosephosphate isomerase
MRKKIVAGNWKMNNDLKKSTELIADLLKKLPKTEAEVMVAPTFVNLIPATETAKGTAVEV
IAQNMHFAENGAYTGEISAEMLKSIGVKTVILGHSERRAYFNETDESLAKKADTALKHNI
RMVFCIGEELADRKANNHFKVVENQIKNGLFHLSADAWKNIVLAYEPVWAIGTGETASPE
QAQEMHAFIRKTLADKYGKEVADSVSILYGGSVKPDNAKEIFAKADVDGGLIGGASLKAD
DFIAIINGI
>OBAHECAF_01097 Uroporphyrinogen decarboxylase
MGFEILIFWKAYCLLPIAYCLNMLQNDLFLRALNGETVERPPVWMMRQAGRYLPEFRALR
DKYDFFTRCRVPELAAEITVQPIDIVDTDAAILFSDILVVPQAMNIEVEMKSGVGPWLPN
PIRSAKDVENVIVPDIHETLGYVMEGIKLTKQMLDNRVPLIGFAGSPWTIFCYAVEGKGS
RDFNIAKELCFTDSQTAHKLLQKITDTTILYLKEKVKAGVDAVQIFDSWGGVLSPVDYQE
FSWKYINQIVEALAPLTKVIVFGKGCWFALPEMAKSKASALGVDWTCTPKIARELTGGKI
TLQGNFDPSRLLSPPSEIKRMVHQMIDDFGKDNYIVNLGHGILPNIPVENAKAFVEAVKS
YREK
>OBAHECAF_01098 hypothetical protein
MNLESPKVVVSKNPQELFTMLEDLRNFKKLMPESISKFEVIDENSFVFALKGMPEIALQK
KSKTPYTQIVMGAVGDKIPFTLITNIVQIAENQSEVQLLFEGSFNPMMAMMVKNPISKFI
ETLATKMQEL
>OBAHECAF_01099 Ribosomal RNA small subunit methyltransferase J
MYNLLYMNILDPKVQNFILTNQDINISELLLKKPIFESVTYKELAQQIVGRNVASRKFTF
LLHENIIFPPQLNLEQASSQQTAEFKSLNLRGKRFLDLTCGLGIDAFFLSKRFEEVHLVE
QNPELLSLVKHNWQILGRNANFYLQNATDFLAENQQKYDVIYIDPARRDIHNKKKFLLED
LSPNLLELQPQLWNISDKILVKLSPLIDLTYLIQTLPFVEQIDIIAVKNEVKEIFITQNR
YKIEAKTECRCINLGNEDPIFTFFFDEKYEKNVAFSKVKNFIYIPNNALLKSGAFSHIAV
HFGLKKLHPNTHLYTSDIKIPNFPGRRLKSEVISAKNIEKGAKYNIISKNYPLSVEEIKK
KYKIKEGGNRYLIFTESVTGKEIILGRLEEGNY
>OBAHECAF_01100 Thiol-disulfide oxidoreductase ResA
MKKLFIVSFATLGFVACGKKADHVILSGKIDGYMGMPVELIGGTERHTLNVKSDGTFADT
LTISTNYYNLLVQQTAMVPLYLQKGDELGINISPEKVTFSGKDTIIQVFLREKNKKINET
RQNLETILSEELDGFKTTVADIKKQNDEFLANYKGLPKEFVKLEEKSNHYFDLQLKALYP
RVKSQFSGRQIEMPAEFKAELDKVDYTNETDFELFETYKALVMENFFGKYMNQEPDWKAM
AEEIQAVKPAKIRSVFAEQLVFALNPQNGSETNEFIYKVIKDNVTKEDYLKHAEQLYAEL
EKLKSLKAGVISPKFEYENFKGGKTSLDDLKGKLVYIDIWATWCKPCLNEIPALQALEKE
FHGKDIAFVSISIDQDKDKWLGYMKENKLQGIQLYAEMTTEGQNFIQDYSVSSIPRFILL
DKEGKIISADAPRPSSPEIKELLVKNL
>OBAHECAF_01101 hypothetical protein
MNIAENLKGLQQSIPEWVTLVAVSKFKPIEDLQIAYDAGQRIFGESKIQEMTQKEALMPK
DVQWHFIGHVQRNKVKYMAPYVSLIHGVDSLKLLEEINKQALKHNRIIDCLLQIHIAQEE
SKFGFDPQEIFNLLENPTFDKLQNIRIKGIMGMATFTEDKKQIASEFQLLKSVFDVLKNK
QHPLLNVEILSMGMSDDYPIAIECGSTMIRVGSKIFGSR
>OBAHECAF_01102 Putative oxidoreductase YceM
MKLKAGVLGAGHLGKIHLRLLNQSEKYELMGFYDPDKENAQKVSQEFGYHCFDSIDSLIE
SCDMVDVVTPTLNHFECAERIITRGKHLFIEKPIANTVEEAEHIIALAKKHNVKGQVGHV
ERFNPAFLAVKNSINNPMFIEAHRLAEFNPRGTDVPVVLDLMIHDIDVILSIVQSKVKHI
SASGALVISQSPDIANARIEFENGCVANLTASRISMKNMRKSRFFQKDAYISVDFLEKKV
EVVKMKDAPEIAGDFDMILQNAEGEKKQIYFEVPEIKGNNAILNELEVFADAINNNTTPV
VTLEQGTEALRIAKQIIEKL
>OBAHECAF_01103 hypothetical protein
MKEDFLQYLWKHKIVPQVSTLASGQNLVIHSFGTPNRLSGADFFNAQLQIDGQLWAGNVE
LHVKSSYWYAHRHEQDPAYQNVILHVVWEHDVEVFDCNQRPIPTLELRHVIDQNIVKRYE
ILFSKSHSFINCDKNYKKVQEYISFSWNERLFVERLEQKSFLIDKLLTESHSDWEKVLFL
MLLKSFGGTVNGENFLNIGKTIDFSIIRKEKNNPLYVEALLFGQGQLLSKPTEGTYFQTI
LANYDYLKRKYNLKNNNLHLEFSKLRPQGFPTIRLSQLGQVYEKNEGLFSKIIETKDIQQ
LKIVLTVETSPFWETHYTFGKTSKKVKKKISNSLIELIWINVILPVKYIYFKYLGKDISE
ELMESLRQMKPEKNTIIDHFENIGAYPTSAFDTQILLQQYNQYCKEKKCLNCAVGISLLK
EEK
>OBAHECAF_01104 Diadenylate cyclase
MKLFEILDFSIADAIDILLVAMLLYYVYRLIRGTVAINIFLGIVIIYLIWKITEALQMQL
LSSILGQFIGVGVFALIVVFQQEIRKFLLTIGSTNITARNKFQKFFGFLRLTKKESALDV
KGLIAVCRKLGANNTGALIVLERNMSLEFVRETGDKMNIEFSQPIIESIFFKNSPLHDGA
IIIKGNFIVATRVILPVAGENKLPKHFGLRHRAAVSISEKTDASALIVSEETGRISYVKG
GDFIKYKNDEELFLLINKDLG
>OBAHECAF_01105 hypothetical protein
MNRLIILILALLLWSCNERSVQLPQLSQAQLPTEVTDYSPIYIFFNENSGLADLNRKNMI
STTHWVFNIDKRLPLSEVGKTMLTMQKKRATMSFHSNPDAKNYFTIADMHDHKYKFLEFT
TTQFEVITEIQNQDKILEISDLKNIKHLIETLKANPSETICMDGSISFQDFVIFLQKIQE
VGLFFKTITVLDIDKVK
>OBAHECAF_01106 Dihydropteroate synthase
MTINCKGILVSLERPKVMGILNATPDSFYENSRITGTEVLKKATQMLVDGADFLDVGGYS
SRPNADEVLEITESQRVVPIIRSLVKEFPNLPISVDTFRSEIARQCLLEGAAMVNDISAG
QLDEKMWDVVAEFQVPYIAMHLRGTPQTMNQFTDYENIVTEMIHYFSKIKAKAQLWGIND
CIIDPGFGFSKTLDQNYEVLQKMELFQSLDSPILVGFSRKSMLYNLLGVDSSKALNATTV
VNTIALMKGASILRVHDVKEAVECVNIFNKTSENE
>OBAHECAF_01107 Pyruvate dehydrogenase E1 component subunit beta
MTRKSKIQTTIHLSKEDILTDYRTAVISRECSLLGRREVLTGKAKFGIFGDGKEVPQLAM
ARAFQDGDFRSGYYRDQTFMMAIGAFTIENFFAGLYANPDIEADPTSAGRQMGGHFATHS
LDENGNWKNLLQQKNSSSDISPTAGQMPRLLGLAQASKIFREVPQTEKEKFSNNGNEVAW
GTIGNASTSEGHFFETLNAAGVLQVPMVISVWDDNYGISVPAKYQTTKENISEILKGFQR
DENNNGYEIFVVNGWDYPALLEVFEKAGKIAREEHVPVLIHVRELTQPQGHSTSGSHERY
KSTERLEWEREFDCNLKMRQWIVESGIATEEEVASIDAEAKKMVRDGKKRAWEAYQNPIF
RERNSLIEIIELSVNESFKNYNAVQSIKNHLASISTISRRDVASAARRVLRYVATETTTN
AETLRSWINDYFAENQPKYSSHLYIENEKNPTLITEVKPIYKENAELVDARVVLRENFDG
LFAKYPNLLIFGEDTGNIGDVNQGLEGLQKKYGELRVADTGIREATIIGQGIGLAMRGLR
PIAEIQYLDYILYGLQTMSDDLATVHYRTLGRQMAPLIVRTRGHRLEGIWHAGSHMGALL
HLLRGVHILVPRNMTKAAGFYNTLLECNQPAVVIECLNGYRLKEQLPSNLTEFKTPVGVV
ETVREGKDITIVSYGSTLRIVCQVAEELSEFGIDAEVIDIQSLLPFDLNHDIVKSIAKTN
RLLIIDEDVPGGASAYIMQKILEEQNAYQYLDSAPQTLCSKDHRPAYASDGDYFSKPNAE
DIFEKIYEIMRESNPAKFPKIL
>OBAHECAF_01108 Endolytic murein transglycosylase
MYFKKILIAISIIGLIILGFFSYSIYNLILAPNTNFEEREIEIFIPTGAYFSDVTHVLNP
YLSDIESFIQVAKQKKYVDNIKAGRYIIKKGSSNNDIINVLRSKNRPIKLTFNNQETLEN
LAGRVAQQIEADSISLLNAFLDPQFLTENEFTSKDVLGMYLPNTYEFFWNTSATQFRDRM
LKEYRRFWNSDRIEKAKNQNLTPKQVSVLASIVQKETAQVSEQSRVAGVYINRLRNNMLL
QADPTVIYAIKEHTGKHDTIIKRVLNRDLTIDSPYNTYKYAGLPPAPIAMSDISAIEAVL
SPENHDFFYFVADVEKPGFHKFASTYSQHLINSRAYHEWINAQGIRR
>OBAHECAF_01109 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MNLQQRDERHLWHPYTQHKTAMYPIGIVKGKDALLWDENGKQYIDAIASWWVNVFGHANP
HLAEAAFKQLSQLEHVLFGGFTHEPAVKLAEKLIELLPENQQKIFFSDNGSTAVEVAIKM
AIQYFFNKGQKKHVIVAFENAFHGDTFGAMAASGISFFTESFKNQLLEVVRIPIPEKGKE
QDSERKLAEVIKKYNPATFIFEPLVQGAAGMRMYAPEALDRLIQIAKNEKVITIADEVMT
GFGRTGKIFACDYLNEKPDIICLSKALTGGTIPLAVTSTTQAIFDAFCSDDVNKAFFHGH
TYMANPTGCAIALETIRILQTNDCSQNIQRISDLHKQFINKMKSNSKTSGWRSLGVILAF
EVNTNAGNEYYGSIRNQLYDFFISKGIILRPVGNTVYVFPSYVITNQQLMQVYDAIEEAI
EKFGIE
>OBAHECAF_01110 Aldose 1-epimerase
MKQIHKKTFGTYAGKNVTLITLENSKGMEVSIMNYGGIITSIKYPVNGKKIETVLGFDTF
EEYLSEAYRKEYPYFGAIIGRNAGRIKGGKTTLNGKELQLTVNHGVAQLHGGFQGFDSKV
WEIVEVGDSQNLFVVLKYISPDGEEGFPGEVVVTVTYSLNDDNELRVDYHGKTDKPTILN
LTQHTYFNFNSDSKNILNHLLQVNGNRYSPLNPDYSPTGELLLVENTHLDYRKPVTVHPD
IDNAFPRQVSENEVVGSLICEESNIRMDVRTNQPVLHIYGGYYVPELYPEGRKSTGQNAG
ICFECQGFADALNYPQFPSTQLNPEDEYSYFATFHFFENK
>OBAHECAF_01111 hypothetical protein
MINTPDFVKRLQEIMEHYDLNASSLADILDIQRSSISHLLSERNKPSLEFIMKLIEQFPE
VNFHWITQGKGNFPSKENSVTKIEEKKSIMQTNLFGDEPEQSATTKRKQNPPQNVVRVKE
PESEISYQQISPISKVVENTFVTKVNNKKQLKKIIFFYDDNSFEVFEN
>OBAHECAF_01112 Aspartate 1-decarboxylase
MQIEVLKSKIHRVTVTGADLNYVGSITIDEDLMEAANMIEGEKVAIVNVNNGERLETYII
KGKRGSGEVILNGPAARKVQRGDIIIIISYGILDFEEAKTFKPWIIFPNEKTNKIE
>OBAHECAF_01113 hypothetical protein
MKLIKTILPLFLGVFLCWYAYSQFTDEQLNEIKEKFLKADYFYIILSVLLGFLSNVSRAL
RWELLLNPMGYRTRSYNRIMAVFIGYLVNVTIPRSGEISRALVVNRYDGVPFDKSIGTII
SERVVDLILLLSFTLTAFLLQFNLISEFLLSIIPFQKLIFLLGIVLVLGVLFSIWVYKST
HFIALKVRNFVAGLKEGIFSILKLRRRGAFLLHTIFIWTMYVLMFYLPFLALPETSYVSI
GTVLTSFVVGSFAIAFTNGGFGSYPFFIAEILLLFGIPLVSGTAFGWIVWTAQFFMTLFF
GGISFILLPLLNRYQEDEKCFFLKMRKIPKTRNS
>OBAHECAF_01114 hypothetical protein
MNNSFLIFDGDCLFCNRIAYHLAKSDKRDSFKFVSSISETGQYFIVKYQLQKFVDKTVIV
RVGEVFYIKSKAIFMFLKESNMYPLLRFLIWITPTFIADFVYDIIAKHRKKLIKKECPIL
PPEIRKKFLN
>OBAHECAF_01115 Macrolide export ATP-binding/permease protein MacB
MAIRFTVIRENIKIALESIKSQLLRTILTVLIIAIGITALVGILSVITALRNTLEGNFSK
MGSNTFSITRYQYTQRVQGSGANEKINPPISYQNAIAFREQLQNPFAQISISLFSSASVE
IKYENQKTDPSSKVIGVDEFYIKNSGLELDSGRDFSKLDIENNAEVCIIGADFTKKLLKD
VNPIGKVISIKGHKFTIIGVLESKGSTFGNNEDMQVLIPLGIARSVFTIQNPNFAIKVKV
NDKGKLDVVMDDALIVMRNIRSLRPLDEDNFGMERSDDLLHRIESITQGIGIAGFVIGLI
TILGSSIALLNIMLVSVTERTKEIGIRKALGAHRKAITMQFFTETVIIAQLGAMAGIVLG
ITLGYFISLVADFDFIIPWRVIFVAILIAFVVAIISGLYPAMKASKLDPVEALRYE
>OBAHECAF_01116 hypothetical protein
MNKYLLILLVGFVLFQSCKNNSNPKELIDEIKSREVFENNKTISFSDTTEVSFERITVKD
KEVLAELKSFYSQNGYSTRWLYEKKPTNLFYGYMKVLEKSENYGLNPETYRYKALQHLVD
SLYSKTVDFMQLEQADKEITASFLLLTKHLGSGRVSKLSHGQHVWKKIKRNRNDLEILLK
LEDTDDLVTVIDALHPNHLLYKRMSEKYAELRADTQPDSIIKVAFENPKLFVDGYKHSAV
EAMRHNLKQKGYEVTPLVSTNVVDTVLLNALKKFQETKGITPDGVPGKTTLYHLNMTKVQ
KVELLKLNMERMRWLNNDLGDDYLIVNIPDFKLFVYHKDSMIHQMNVVVGREYTATPVFV
DSIRYVEFRPTWTVPQSIIHNEMIPQMVSENDAEKYQKRGYTIYENGEKIDPNNVDWTNP
EIRKRKFRFVEAPSARNSLGLVKFILTNDMSIYLHDTPSTRLFSREERAFSHGCVRVEQP
AELAYLLLKNQDEWTREKVDQAMQSGPNQNRITLKNRYLISLLYITAWVDENNQLIIKND
IYGFDQQQLKELKVYE
>OBAHECAF_01117 Histidine ammonia-lyase
MNHYISNDTLFLENIENLLIEDVKLKLSEEAKINIQKSQDFLSRWSLEHQKQNIPNENAD
FQCRLLKSYACGVGTAIPDEVVKLMLFLKIQSFCYGFSGIRLEIIERFLDFFNYNVLPVV
YSKDTPDDRISLAHLSLPLIGEGEVRIKGKIFSSCELEEKFGWKPLHLKEKEAEILLGGT
QLTTAYGAFNMIKALKLCELSDFIASVSSQVFGVSDLFFSEQVQIVRPHKGQIQTAESLR
KFLKNNEINVERSEFDTAPEAFRAIPQVHGAVKDTVAHVRKVIKTEINSVTDNLLVFSKE
NQLISSGNSHTLPLSLGLDFLAIALTSLGNMSERRIFHLISSREDEKEDFFLDLSVFQRI
TESILAENKRLSTPVSVESPIFTEKMTDIKGMGGSSAVKCLQVIENIEQILAVELLVAVL
WSINQKIAFTSSVLNEYIDYLELQTEKISLKKSIEKTIQFFKKEKRES
>OBAHECAF_01118 ATP-dependent Clp protease adapter protein ClpS
MLIFNHKEQTQTEVETLVEELLDREYHLVLYNDDVNTFDHVIDTLVRVCDHTYEQAEQCA
IIVHYKGKCDVKSGTYKTLEPMCTALLNADLSAEIE
>OBAHECAF_01119 Ribosomal protein L11 methyltransferase
MNYIEYDFKIEPQGVASEILVAELAEWGFESFVDTERGILAYIQESLWNEHILDEIYILK
SEEFLITYSFRTIEQVNWNEEWEKNFDPISVDGLCTVRAPFHPKTDTKYDIIIEPKMSFG
TGHHETTYMMLQFLLQTDFSGKSVLDMGCGTSVLAIMSEKRGATKITAIDIDDWCVENSI
ENIQRNDCKCIEVKLGDASLLKNEHFDVVIANINRNILLNDLSLYAATLSQNGMVLLSGF
YKSDMPVILEECSKHGLSFVENLERNEWVAVKCVKKD
>OBAHECAF_01120 Lipopolysaccharide export system ATP-binding protein LptB
MKLIVNDIIKIYKGRKVVKGVSLEVNQGEIVGLLGPNGAGKTTSFYMIVGLIKPNGGTIY
LDRENITDYPMYKRAQRGIGYLAQEASVFRKLSIEDNIKSVLQLTKLSKKEQQMKTDSLI
EEFGLGHIRKNRGDLLSGGERRRTEIARALATSPKFILLDEPFAGVDPVAVEDIQRIVAQ
LKNKNIGILITDHNVQETLAITDRTYLMFEGGILKAGVPEELAEDQMVRKVYLGQNFELR
RKKLF
>OBAHECAF_01121 hypothetical protein
MNCKTYLKQLPNVKTLKQICRGRAVMDWIICGYEFETYHTFYKSKQEEYDGTEAQWGLGF
EDEDGISLSFYFLDKACLIVPSASSEDSKDANSQLFEKKIPKIFHPYFRKNFSNSDIPFV
LWSLDGETWNAEENFEIEEIISKFDQITTNPAVYKQWAFDFFGDETYFKEDASEQTITDI
YEGKILTEAMVYSLVSEVHDWVDLEAELDEMPYRFEF
>OBAHECAF_01122 Sec-independent protein translocase protein TatCy
MSFLDHLEELRWHLIRSTVAVLVIAVVAFFLKDFIFDTIIFGPRKGDFITYEMFCKLGQF
FNYESDFCMEKLPFSIQNRTMAGQFSVHLWTSIWAGVILGFPYILYEIWRFISPGLYENE
RKIASGFIFIASLLFFMGVLFGYYMIAPLSINFLGTYTVSQEVANQIDLNSYISVVRSSV
ISCGLVFELPIIIYFLTKLGLITPTFMRKYRRHALVLVLILAAIITPPDVASQIIVAIPI
MLLYEISIFISVYVLKKEQKRKTKVE
>OBAHECAF_01123 RecBCD enzyme subunit RecD
MEELILTLINQTSQNIFLTGKAGTGKTTLLHKIIKTTHKNTIVVAPTGIAALNAGGVTIH
SMFQLPFASFLPTLSNPPVVYANSRFENRMTLRKHFKMRRNKQQLFHHLELLVIDEVSML
RADVLDAMDFMLQNIRKDKRPFGGVQVLFIGDLLQLPPVVKNEEWEVLKTYYSGIFFFQS
KVITENPLLYVELDKIYRQSDDDFISILNNLRDNKLNFSNMELLQGYVNPNFRSDRRNEY
ITLTTHNAKADAINNHEMRELHSKEYMFEAEIVGDFPEYMYPIDKYIYLKEGARVMFIKN
DLSPEKLFFNGKMGTVMRLSNGEIEVLLDGGKTINVEKHEWENIRYQINEQTKEIEEERL
GTFSQYPLRLAWAITVHKSQGLTFEKAILDLDHVFAPGQLYVAFSRLRSMEGMVLLSQVS
KYGIENSEEVVQYAVNKASPEQLSQACVSGEKAYLENAVLQCFQWDNLLGNWNLHKGSYV
GDMGNKNLYKDWALEQMNQVVEMVILTEKFTKQLKHILHTDYDFNFLYERFEKAYLYFFP
RLEVIWYEVLRVQKEIETHKKVKQFREELIDLESVTSEVIRSLFKTRQMMQLAKNQQPFN
NSSINLSQLVRIRENLILKAKEQLKEKRLFVEEQSHQATKIATKEKESTYDITYQLWEEM
RSVEAVAEKRMFTTATIYRHLMKLMEMDKVQISELLSEQALNELTTVFEQEEDLSLGYIY
DLLNERYTWDELRLFKSYFLKNMSSE
>OBAHECAF_01124 Tyrosine-protein kinase etk
MENNRQKEEDTIDLLELIRKLWDARKYILKVTILFFIIGILVALFSSKEYTATTLMIPQT
TDGKSIGGGLGGFAAIAGISLGGASSEEVPITVYPKVVQSVPFKKKLVQTPLNFENISEK
ITYKTYCEDHVKPGILDYVKKYTIGLPGLLFGSKEEENTSEEQKTVLQLSQKEREILNSV
DSQLSITINEKEGTIMLSYSMSEALAAAQMLQSAQNLLQESITEFKTQKAVEELDFIKER
YQEAEKDFKSKQFALAQFQDKNRNLFSSLPQTRLQQLQTDYNLAFSVYSELAKQLESKKI
KVKEDQPIFTIIEPVSVPNERSKPKRPMIVAIWTFLGIVIGIGGVFIKDFIKQIKQKKEA
>OBAHECAF_01125 Polysialic acid transport protein KpsD
MFYICAKYRSIMLKIKLFVVFLLFIGSFHVSIAQTEMDVQQISSVNVDNLSDEQIRAYWK
KAQDQGYSLEQLIVGVRTRGMSEIQANKLRQRILQLSTSTLSSNQKQISQRVDSEAIGFT
GQENKDSLAVKNDKNSIFGMNFFKNPKISFTPNSNMVTPETYQVGVGDELLIEVWGATET
SFKQVVDNQGNISVNGVGKINVLGLPLNQVKAKVNSQLKHIYSGISASEGSYNKIYTGVT
ITQVRTVSVNIIGEVIVPGTYSLSALSTVLNALYACGGPTESGSFREIKLIRGGKQVAIF
DVYDFLIKGSEKGNLTLQDQDVIIVPPYINRIWVEGRVKREGAYETKEGETLANLVTFFG
GFESDAFVNTLVVERIKDAKREVREVMFENIANFKMQNGDKLNIHPITDEYENRLSIGGA
VYQPGTYEFKEGMTAFDLLNRANGLKREASLERGLIFRTLNRVDYQTINFSVKDLIEQKH
NIALKDNDSIHIFFKDSLQMSRFVKVEGAVNKPKDLPFMENMTIKDVIVLTGGLAQGADA
STIDVFRETYDQNFKKLSQEFKVTEDDSDFILQPNDIVSVRYLKGYTPMQSVKIEGEVLY
PGVYSIQSKDERISDLIARAGGFSPHAYIEGATLIRKKLDESEVKQEQFLDELISIGSIG
DQDKSLKKIEKKVSEYRIGINLQKILEKKHSKYDLVLNESDVLLIPSEKQTVEIRGEVLA
PSLVRYQKGMTLRDYVNRAGGFSDRAKKRSVYVMYANGDIRSTDISLIFNNYPEIKPGAI
IIVPSKPERQRLSPGETIGIISAITTMGVLIYNVITK
>OBAHECAF_01126 hypothetical protein
MILIVDSGATKADWTALNDKGEQLFFTQTLGLNPEVLTEELIIERITTNNDLFSNKDKVT
GLYFYGAGCGTERMTSFMARTLQTIFRTAKIDVKEDTFAAVYATTRPEDKAIVCILGTGA
NCSYWNGEKLVQAVDSLGYILMDESSGNFYGKRLVTDYFFNKMPKELAQKFEKEYDLNSD
VIKNHLYKLPNPNSYLATFAKFIVENKEHDYCRNIVRNGVQLFVDHWISQYEARYEVPIN
FVGSIAFYLQDILKEVLTENNLKLGNVLRKPIDGLVAFHVNKVK
>OBAHECAF_01127 Glyceraldehyde-3-phosphate dehydrogenase A
MSTLKIGINGFGRIGRLVFRAVYERPNVEIVGINDLQDVEYIAYLLKYDSVHGTFKGNVE
VKDGNLVVDGKVVRITAEKDPANLKWNEVGATVVAECTGIFTTLEKAQAHINAGAKKVVI
SAPSADAPMFVMGVNHKSVKPTDNIVSNASCTTNCLAPIAKVINDAFGIEEALMTTVHAT
TATQLTVDGPSKKDWRGGRSALINIIPSSTGAAKAVGKVIPELNGKLTGMAFRVPTADVS
VVDLTVRTKKDTSLEEINAAMKKASEGELKGILGYTNELVVSQDFVGDKRTSIYDEKAGI
ALSKNFFKVVSWYDNEAGYSNKLVDLAEHVASL
>OBAHECAF_01128 hypothetical protein
MSKDIVTPQEWIANWQSNRRLTRKVIEAFPEKELFEFSIGGMRPFANIVDELVYLTDLSI
KQISENQVIEFCDFVGYAGKTKAEILAHWDKTTALIEKFGKETSQEKYREIFNMFGMYNY
ALIENLIYLLENEIHHRGQGYVYLRALGIEPPAFYGEY
>OBAHECAF_01129 hypothetical protein
MTIPKELKEAISHLSSAEKDKLIFRLLKKDLVLANRLLFELVSEESVEEKRQKTQEKIEK
IIERRAKHFYSCGVLNMEVRELSGMINEHVSITKDKFGEISLNLSMICKILETHKKDILE
QNFKKAQKFCTAVIARAFKLLILIKKMHEDYFMEFQEDLQKFGELIADNPYLIKSAIHNG
LDVRWLISGEIPDDISKIHREIRDKGLL
>OBAHECAF_01130 ATP-dependent 6-phosphofructokinase 1
MSVKKIAVLTSGGDAPGMNAAIRAVVRTCAYHNVEVLGVYRGYQGMIEGDFVELNARSVR
DTINKGGTFLKSARSKEFRTPEGRKKAYENLKKSGADALIVIGGDGSFTGALLFNEEFNF
PVMGIPGTIDNDIYGTSHTLGYDTALNTAVEAIDKIRDTASSHDRMFFIEVMGRDAGFIA
LNTGIGVGAERILIPEENTTAEELLADIEKGYAKGKTSNIIIVAEGDKSGKNVFQLKEYV
ESKHPGFDIRVAILGHMQRGGAPSCYDRVLASRMGVKAVETLLEGKSNYMVGVNNDVIDL
TPLEKAIKGGSKLDMELVRVAEIMSV
>OBAHECAF_01131 DNA polymerase III subunit beta
MKFIVSSSYLLKKLQVIGGVINSNNTMPILDNFLFELSPNLLTVSASDLETTVKGTLEVE
SDSEGSIAVPAKLLIESLKAFPEQPLTFIVKEGNQIEISTTNGNYQLTYFSAEDFPKPIS
LPEASKVSLLGDILATAIQKTIFAVGNDDLRPTMSGVFFEFNDEGLTFVATDAHKLVKYQ
RTDIKATESSDFIMPKKPLNLLKGILAGSESEVTIEYNESNAKFSFDDMEIICRLIDGKY
PNYDAVIPKENPNKLTVNRLQFLGSARRVSIFSNKTTHQIRLKVAGSDLQISAEDVDYSN
RAEERFACDYQGDDIEIGFNSRFLIEMLNNLESDEVMLEMSYPNRAGILTPLDGLDVGEK
VLMLAMPIMLNQQAQ
>OBAHECAF_01132 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKNSKIIVQGFTGSEGTFHAEQMIEYGTNVVGGITPNKGGQVHLGKPVFNTVREA
VKETGADVSIIFVPPAFAADAIMEAADAGIKVIITITEGIPVADMIKVSDYIKDKDCRLI
GPNCPGVITPEEAKVGIMPGFIFKKGKVGIVSKSGTLTYEAADQIVRQGLGITTAIGIGG
DPIIGTTTKEAVELLMNDPETECIVMIGEIGGQLESEAARWIKANGNKKPVVGFIAGETA
PKGRTMGHAGAIVGGADDTAEAKKRILKECGIHVVDSPAKIGEKVAEVLKK
>OBAHECAF_01133 hypothetical protein
MILLSKTNVEMRIKLIKTLLFFTFTAILTVGCKKEVEETPYFTLKDSIEVSREASFEFIE
VQTNVSNWRIVVPTEAASWLTAVKEKGGFKIATVSNKGGERSATLQLIGERVTHNFLVTQ
LGIYPNPDSIENDLKLKIVTGSASSFQKGSEIEKVFDGNLKGGSDAEIYHSAWDNRASNY
FPITIELTLESAKDVDYMMYYPRTNSSNGHFKEVEIWVSTEKKSEYTKVKDVDFGGTGAV
SRVNFGTTIVGARSFKLVVKSGQGNGAGFASAAEIEFYAKRTSNSDALSIFKDITCSELK
EGITEQEIQSISNTFYKNIAMQIKNNQYQSEFRIQEYRAWADPNVIKTKNRMQYAYSNLD
NPTGISVNEGEDLVVFVGETKGQKLQIKIMNLDKPGGDGFDQASYHPLYEGVNKIKAGSK
GLIYLQYQTPNYATAPRIKIHFATGNVNGYYDKTKHTAVNDWNRLISAATNKYFDVIGEH
AHLCYPTESYKAYATSKGKELIDIYDEIVRQTHIFAGTIGERAMTNRAYFQVMYHSYMYC
TAYRTSYHESTMSTVCNPDVLKTGNNIWGVAHEIGHAHQVPPVFQWIGMTEVSVNMNPMN
IQTAWNTPTRLEVESMQGEGGYNNRYEKAYNIGLIPDVPNCEIPDVFCRLIPFWQLNLYF
SRVKNDPTFYARFYEKMRTIDLKPTLKDGEYQVDFTKIASEMTGMNLISFFEKWGFYKPV
DKSIKDYATRQLTVTQEYVDQIRKEINVLGLPPITDKIEYICDSNWTYFRDQSSVIKGTA
TRRGTTVTTSGYKNVVAYEVYSNNDLIYATNKNSFDFKNTAATNVIVYAIAYDGTRTEVT
F
>OBAHECAF_01134 Fumarate hydratase class II
MNYRIEKDTMGEVKVPADKYWGAQTERSRNNFKIGAPASMPIEIVRGFAYLKKAAAYANC
DLGVLPIEKRDAIAQVCDEILEGKLDDQFPLVIWQTGSGTQSNMNVNEVIANRAQVLSGG
KIGEGDPVLKANDDVNKSQSSNDTFPTGMHIACYKMVVEKTIPGVEQLRNTLKTKAEAFK
DVVKIGRTHLMDATPLTLGQEISGYAAQLDYGLKALKNTLAHLSELALGGTAVGTGLNTP
KGYDVKVAEYIAKFTGHPFVTAPNKFEALASHDAIVEAHGALKQLAVSLNKIANDIRMLA
SGPRSGIGEILIPENEPGSSIMPGKVNPTQCEALTMVAAQVMGNDVAISVGGAQGHYELN
VFKPLMASNFLRSAELLGDACVSFDEHCAQGIEPNHRRIKELVDNSLMLVTALNTKIGYY
KAAEIAQTAHRNGTTLKEEAVRLGYVTPEDFDAWVKPEDMVGSLK
>OBAHECAF_01135 hypothetical protein
MKKIAISIVALLTFQLGMAQLKTPSASPKSSINQTIGLTEVQITYARPSVKNRVIFGDLV
PYGKIWRTGANAATVIEFSTPITFGNTEVKAGKYALYSVPDTNQWKVFLYADSELWGAPG
KNFDQGKVIAESVVKPLTINPKVETFTIGFDEIRNNDAMLTLAWDNILVKVPIKVNTRQA
VIESIGKTMNGPTASDYHRAAMFYFEENIDLDKALEWSSKAVELNPTAYWVQKLKSDIQA
AKKDYKNAIKTAEIALERAQKAGNDGYVRAIQENINAWKKK
>OBAHECAF_01136 GTPase Der
MSAIVAIVGRPNVGKSTFFNRLIKRREAIVDAVSGVTRDRHYGKTDWNGVEFSVIDTGGY
VLGSDDYFEKEIDKQVTLAIDEADAIIFMVNVEDGVTGMDETVADLLRKSKKPIFVAVNK
VDSNNRVADSHEFYAFGFENVYTLSSLNGSGSGELLDDLVKVLPIKESNEETEQLPRFAV
VGRPNAGKSSFINALIGEDRYIVTDIAGTTRDAIDTEYNRFGFKFNLVDTAGIRRKSKVK
EDLEFYSVMRSIRAIEHADVCILMIDATRGFEGQDSNIFWLAERNRKGIVILVNKWDLVE
KQNNTMKEYEAIIRKEIAPFTDVPIIFISALSKQRIFKAIEQAVEVYKNRSKRVQTSKLN
EIMLPLIESYPPPAIKGKYIKIKYCMQLPTPMPQFVFFANLPQYVKEPYKRFIENKLREN
FDFRGVPIDIYFRQK
>OBAHECAF_01137 GTP-binding protein TypA/BipA 
MTQIKNIAIIAHVDHGKTTLVDKILHHCALFRENQESGELILDNNDIERERGITILSKNV
SVNYKGTKINIIDTPGHADFGGEVERVLNMADGVLLLVDAFEGPMPQTRFVLQKAIEMKL
KPIVVVNKVDKENCTPDEVHEKVFDLMFELGAEEWQLDFPTVYGSAKNNWMSEDWKNQTD
SIDPLLDMVIKHIPSPKVEEGTTQMLITSLDYSSFTGRIAIGRLQRGVLKSGMNVSLVKR
DGTITKSKIKELHTFDGLGRKKIDEVQAGDICAIAGLEGFDIGDTIADFENPEALPTIAI
DEPTMSMLFTINDSPFFGKEGKFVTSRHIKERLEKELEKNLALRVEPTDSADKFMVFGRG
VLHLSVLIETMRREGYELQIGQPQVIIKEIDGVKCEPVEELTIDLPENLSGRAVEFVTLR
KGEMLSMTPKGERMVIEFIIPSRGIIGLRNQILTATAGEAIMAHRFLEYQPYKGEISGRI
NGSLISMENGKAIPYSIDKLQDRGKFFIDPNEDVYEGQVIGENSRGDDMVVNVTKTKKLT
NIRSAGADDKMRIAPAIKFSLEEALEYIQKDEYVEVTPKSIRLRKIYLNENDRKRYEKEF
K
>OBAHECAF_01138 Hyaluronan synthase
MNFGIIIPAHNEANYIAQTLESLFNQTLLPTQIIVVDDASTDETPLILDKIRRKNPILEV
IRKENTGKHLPGSKVVQTFNTGLPFLRKDIDIICKFDADLVFPTDYLATLQRHFLENSQL
GMCGGFCYIEKNGTWELENLTNRDHLRGALKAYRKDCFSNIGGLPPAMGWDTIDELLARY
FGWEVCTDSSLKVKHLKPTGTSYTLQARLLQGGVFYRLRYGFWLSLLASAKLASKKRKWQ
LFKDYLQGYFNAKREKQPYLVTYKQGQWIRNYRWKGVWKQLLKIKS
>OBAHECAF_01139 hypothetical protein
MKKTIFQYISFLKGYRLYVFILFCFFFWMAFFDSNSLLTHRELNKEIHKLNRQKQFLQKE
IEKDKEMLLILDTDEGRERLGREEYYLKHDNEDVYIIEHDTID
>OBAHECAF_01140 Uridine kinase
MLIIGIAGGTGCGKTTVVNQIVSELSQEVSVISQDSYYREMSHLPYTERVKTNFDHPDSI
DFDLLKQHLISLKSGIPVESPVYSFVEHNRTGETVLIKPTKVVIVEGILIFSRADIRELF
DIKIYVHADPDERLIRRIKRDITERGRDVEEVLNRYQTTLKPMHLKFIEPVKEYADIIIP
NNRRNFVAIDIIKTIVHNRILAN
>OBAHECAF_01141 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MGIFKIEGGHQLKGEITPQGAKNEALQILCAVLLTDEKVTIHNIPDILDINKLMSLLENL
GVKTQKLGKGSYSFQADEININYLESMAFHSEGQSLRGSIMIVGPLLTRFGVAYIPQPGG
DKIGRRRLDTHFEGFIKLGADFKYDSDNHIYSVKANGLTGTDMLLDEASVTGTSNIIMAA
VLAKGTTTIYNAACEPYVQQLCRMLNNMGADIQGIGSNFITINGVEKLSGCTHTILPDMI
EIGSWIGLAAMTQSEITIKNVGWEHLGLIPNVFRKLGIKLERQGDDIYIPAHKDGYEIQS
YIDGSILTVADAPWPGFTPDLLSIVLVVATQARGEVLIHQKMFESRLFFIDKLIDMGAKI
ILCDPHRATVIGNDFKSPLRATLMTSPDIRAGIALLIAALSAKGTSIIYNIEQIDRGYED
IDERLRSLGAKIIRVN
>OBAHECAF_01142 hypothetical protein
MESLEYNTERTPLIIPEYGRHIQKMIEKAIHIEDREERNNTAKGIIAVMGNLNPHLRDVP
DFQHKLWDQLFIMSGFQLDVDSPFERPTEAVLVRHPDRLNYPQSHPKYRFYGNNIKKMID
VCVRWEESDLKTALKFSIANHMKKSYLNWNKETVEDEVIFQHLYELSNGQIDLKQDKEDL
TTSQELIKTKQNLTRKNTSQNNKKGATNHKKTK
>OBAHECAF_01143 Ribosomal RNA small subunit methyltransferase B
MRLHRNLTEAVIEGLGFIFNEQQYADKVVERQLKKDKRWGARDRAFIAETMYDIVRWKRL
YAEIAEVKAPFSSHDLFRMFAVWAVLKGVHLPDWSCFENTPQRRIKGKFDELSKIRKFKD
SVPDWLDALGEVELGSDIWSKELTALNELAPVVLRVNTLKIAPAQLKNLLRNEGIETKLL
KSYPEALELIQRANIFTTKAFSSGMFEVQDASSQRVAPFLEVLPSMRVIDTCAGAGGKTL
HLASLMKNKGQIIAMDIYENKLQELKRRARRNEVFNIETKLIDNKHLKRMQNTADRVLID
APCSGLGVLKRNPDAKWKLQPEFLNKIRETQQQILQDYSKMVKPGGKMVYATCSILPSEN
QKQVKTFLESEAGKNFIFETEENIFAHQTGYDGFYMARMRKK
>OBAHECAF_01144 Ferric uptake regulation protein
MANTTEENLEIVRKVFTAYLEENGHRKTPERFAIVKEIYESGEHFDIETLYISMKNKKYR
VSRATLYNTIELLLECGLVRKHQFGQNQAHYEKSYFDRQHDHVILTDTGEVFEFCDPRIQ
SIKKTIEEVFNIEITNHSLYFYGKKNK
>OBAHECAF_01145 Adenylosuccinate synthetase
MAVNLLLGLQWGDEGKGKIVDVLTQEYDIIARFQGGPNAGHTLEFNGIKHVLHTIPSGIF
HESAINIVGNGVVIDPIIFKKEIEALKKFDIDLKKRLLISRKAHLILPTHRLLDAASETS
KGKAKIGSTLKGIGPTYMDKTGRNGLRVGDIELDDFKERYRNLTDKHEEMISHYNVEIQY
NLAELEAEFFEAIEVLKSLQFIDSEEYIHQAIRNNKKILAEGAQGSLLDIDFGTYPFVTS
SNTTAAGACTGLGVAPTQIGDVLGIFKAYTTRVGSGPFPTELFDETGETMGRVGKEFGAT
TGRKRRCGWLDLVALRYAVQINGVTQLMMMKADVLSGFDTLKVCTAYLYKGQEIKHLPYN
IEEQNVTPIYTEMKGWAQDLTTIKDHNKLPQELLNYIDFLEKELEVPITLVSVGPDRTQT
IHRK
>OBAHECAF_01146 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVAKKEYKRVTTKSLIDMKSRGEKISMLTAYDYTFSKLIDGAGIDVILVGDSASNVMAG
HETTLPITLDQMIYHASSVVRGANRALVVVDLPFGSYQSDPKEALRSAIRIMKESGGHAV
KLEGGKEIKESIKRILNAGIPVMGHLGLTPQSIYKFGSYTVRAKEDAEAEKLKQDALLLQ
KMGCFAIVLEKVPAKLAEEVAKSVSIPVIGIGAGSHVDGQVLVLHDVLGMTQGFHPRFLR
RYANLYEDINSAVSRYVEDVKNINFPNEEESY
>OBAHECAF_01147 Glucosamine-6-phosphate deaminase 1
MSTTIQKNTQSIKHQPAGLFEETRYEKIHNVIFSDANSASIAVAKEIAELIRTKQAEGKN
CVLGLATGSSPVKVYQELIRMHKEEGLSFKNVITFNLDEYFPMQKEDIQSYWHFMHKNLF
NHVDILPENINIPSGTLGKEEVRDYCYAYEEKIKQAGGIDFQLLGIGRTGHIGFNEPGSN
VNSITRMVTLNKVTKTDAAHAFGGYKNVPSKAITMGVGTVLAARRIVLLAWGASKASIIA
KTIEGEVSSQIPATFLQEHKNTTFVIDETAASELIRNKTPWLVGDYDFNNKNEEEIARAV
VWLCERLDKTILGLREEDYLENGLGVLLEDTSAYDLNIRIFNRIQRAITGWPGGKPNADD
SYRPERERPHKKRVIIFSPHPDDDVISMGGTFDRLVEQGHEVHIAYQTSGSTAVADTEAL
RFVEVAHDMLLGKTDVSHLEKVMQILKNKKQGDKETLDVWKLKGNIRRHECYGATRYYNV
PDENLHFLNLPFYETQAVEKQPIGEADIKIIEDLIREVKPHQIYAAGDLADPHGTHKVCL
DGIFAALERLKNEDYMKDCWVWLYRGAWHEWDVHEMEMIVPMTRDQVLRKRQAIFFHQSQ
KDGAMYMGSDMREFWQRAEERNSDTANRLHKLGLAKYQAMEAFKRHFF
>OBAHECAF_01148 putative RNA pseudouridine synthase
MKVISNEKNLDVLYEDNHLIIINKRAGDIVQGDKTGDTPLSEIVKSYLKEKYHKPGEVFL
GVVHRLDRPTTGIVVFAKTSKALSRLNILFANKTAVEKTYWTMTDNCPTESEGTLVHWLA
RNSEKNKSTAHSKEVKDSKKSILHYKVLEKLTNYYLLEIQLITGRHHQIRAQLAAVDCFI
KGDLKYGARRSNADGSIHLHARKLSFIHPVKKEKIEIIAPLPDEPLWQKLTVIR
>OBAHECAF_01149 L-serine dehydratase 1
MTANTMERISVFDMLKIGIGPSSSHTLGPWRASEAFVKELKDKNFLHKTFEVRVDLYGSL
SLTGKGHATDLAVMLGLSGADPEYVPIESLEVIINAINRNQELCLGNESIIKFSPSENIV
FNKNFLPFHANGISFTAKGNDFEYNSTFYSIGGGFIIKENEESDNNTGKVVRNFPFPIEK
ATELLEYCHRENKKISEIVFENEKSIRSEAEIDSELLRIWNTMLECAYIGCHTEGILPGG
LNVRRRAYDIHKNLIGVVTYHNPQDWLLSIKKTNVKFREILKWVSCFSLAVNEVNASLGR
VVTAPTNGSAGVIPAVLLYYLTIENHEASNEQIKQFLLVAGEIGSLFKKGATISAAMGGC
QAEIGVSSAMAAGALCELMGGTPDQVLIAAEIAMEHHLGLTCDPIGGLVQVPCIERNAMG
AIKAINAAELAIETDPKNAKVPIDKVISTMWETAKDMNHKYKETSEGGLAVAVSLADC
>OBAHECAF_01150 hypothetical protein
MNKLTFFLFFCSVVVFSQEKSVEDISSKKIDRGMINPFRRMYQEFATPNQYRTASGAPGV
AYYQQQADYVMKIEIDDQTQKLYGEQTITYHNNSPETLDYLWLQLDQNKRLPEAPTKKRN
SKFMDVAYEPQRFAETFMAVPFEGGYHIEWVKDATGKELAYTINETMMRVDLKQPLASGT
KVSFSVKWWYQINNYQKNGGRAGYEYFPKDDNCLYVIAQFFPRMAVYNDVEGWQNEQFWG
NAEFALNFGNYDVSITVPADHIVEATGELQNRKEVFSPKMLERYALAERSFEKPVVIVTQ
AEAEAKENKKETAKKTWRFKASNVRDFAFSSSRKFIYDAMAVKIGNKKVMALSLYPKEAN
PLWEQYSTKVVAHTLKTYSKFTFDYPYPKAVSISAEDQGMEYPMICWNYGRPNSEGSTSM
DTKFGMISVITHEVGHNFFPMVVNSDERQWGWMDEGMNTYLQYFAEQSYGEQYPEDIAPY
KRYPSKRGFAKQIVKYMSGDPTYLEPVMSNPEEVTRLGENAYGKPAAGFALLREVIMGPE
LFDFAFKTYANRWKFKHPTPEDFFRTMSDASGVELDWFWRTWFYSTEYVDLGIKSVKLYQ
VSDTPNDKLKTMLKERNMKITDLQPLVHVVSKGDAAYKKENFDKHPYELSIPLGDYVADN
RSLEQQSKAPQPTYFYEVTFEKKGGVPMPILLQVNYADGASEMMKFPVQVWRLNNREFTY
IITSNERITSFMIDPEELTADINTLNNHHTTEEL
>OBAHECAF_01151 Vitamin B12-dependent ribonucleoside-diphosphate reductase
MNEEQNIWWLNEESEQILNRGYLLKGETVEGAIDRITHAAARRLYKPELQPAFKEMITKG
WISFSSPIWANMGTERGLPISCFNVHVPDSIEGITHKLGEVIMQTKIGGGTSGYFGELRH
RGSAVTDNGKSSGAVSFMKLFDSAMDVVSQGGVRRGAFAAYLDIDHPDAEEFLQIKDVNF
PIQNLFFGICVPDYWMQEMIDGDLEKRKLWARVLESRQQKGLPYIFFTDNVNRNRPQVYK
DHNMLIRSSNLCSEIMLPSSFDESFICCLSSMNLELFDEWKDTKAVKLAIFFLDAVLSEF
IEKTEGNYYLQAARNFAIRHRALGLGVLGYHSYLQKNMIPFESFEATQFNARAFKHIKEE
ADKATRELAHIYGEPELLKGYGRRNTTTMAIAPTTSSSAILGQVSPGIEPYSSNYYKVGL
AKGNFMRKNKYLTALLDEKGLNNEDIWRSIRLNHGSVQHLQELTQHEKNVFKTFKEISPM
EIITQAAQRQAYIDQTQSLNLNIPAIMPIKDVNKVLIEAWKLGVKTLYYQRSQSVAKEMM
MNFVNCSSCEA
>OBAHECAF_01152 hypothetical protein
MHTRCKIIYFIRINIYFFEININKLFIKIEHKNILTLNKGQKILTY
>OBAHECAF_01153 Biosynthetic arginine decarboxylase
MKNKYIDLIDQTYYFPQEEFRLEGDELRFHDIDLMELVRTYGAPLKFMYLPRISENIQRA
KSWFQKAIKKHKYKGNYNYCYCTKSSHFKHVMVEALKNDIHMETSSAFDIDIINNLIQEG
RITKENHIICNGFKRNGYIDGIADLVNRGFDRCMPIIDNYEEINLFDKKINGKYNIGIRI
ASEEDPRSEFYTSRLGIGYKNIVPFYNREIKDNEKVTLKMLHFFINTGIKDNAYYWNELL
KCLKVYIQLKKVAPELDSLNIGGGFPIKSSLAFEYDYAYMVDEIIRQIKIACDQEKVPVP
NIFTEFGSFTVGEAGGAIYEIMYQKQQNDREKWNMINSSFITTLPDSWAINKRFVLLPIN
RWNDEYERVLLGGLTCDGDDYYNSEQNMNAIYLPKYNKNKPLYIGFFNTGAYQDTIGGVG
GLQHCLIPQPKIILIDKDEEGKISSRLFMEQQKAEDMLKILGY
>OBAHECAF_01154 DNA polymerase III subunit tau
MNNFIVSARKYRPQTFRDVVGQQAITDTLTNAIENNHLAQALLFTGPRGVGKTTCARILA
KKINEQYSGTQDDNDFAFNIFELDAASNNSVDDIRKLIEQVRIPPQVGKYKVYIIDEVHM
LSTAAFNAFLKTLEEPPKHAIFILATTEKHKIIPTILSRCQIFDFKRITVNDAREYLKYI
AGEQGIEAEDEALQIIAQKADGAMRDALSIFDRVVSFSGDRITRQATSEILNVLDYETYF
NVTDLILKNKLPDLLVTFNNIIAQGFDGHHFISGLASHFRDLMVCKNMSTISLMEMGEET
KRKYAQQTQQASVPFLMEAITIANDCDLKYRTSKNQRLLVEIALMQLASLTFEGDKKKMM
DAS
>OBAHECAF_01155 hypothetical protein
MSNYSIKSVVVKQEVLRNFKEEEIDEASLPREKFTEKEFFDSFNAYVETLKAQGERIQAS
TLEMGEPTLHGTVLDLQVPNKTIRDEVHREEAKLLGFLRKSLSNYGISLNIIENEEIIHK
IRVTPDEKFARLVELNPLLQDFKRTLDLKLVF
>OBAHECAF_01156 putative peptidyl-prolyl cis-trans isomerase
MQNGIYAKFKTTKGDILVKLTHDKTPGTVGNFVALAEGKQKNNSKPLGTPYYDGLKFHRV
IADFMIQGGCPLGTGTGNPGYQFDDEFRSDLKHDKPGILSMANAGPGTNGSQFFITHVPT
PWLDGKHTVFGEVVEGQDVVDAISKGDIINAIEIIRVGEEAQQWDAVQVFETFNAEKEER
IAKVREKAEKELATETAGFEKTESGLFYKIIEKGTGKQAEVGEEVAVHYTGMLLDKTVFD
SSYRRKQPLKFTVGVGQVIEGWDEGILLLQEGDKARLVIPSDLAYGSRGAGGVIPPNAPL
IFDVELVKVY
>OBAHECAF_01157 Putative O-methyltransferase/MSMEI_4947
MHFLPKEIEKYASEHTENEPLLLQELTRRTHLQVLQPRMISGHFQGRVLSLLSKLISPSA
ILEIGTYTGYATLCLAEGLQKNGVLHTIDIKEELQELQREFFDRSGKGKQIIQHLGKAKD
IIPTLETKFDLVFIDADKQNYAIYFDLIINKMNSGGIIVSDNVLWSGKVVQNVKSNDKQT
LALLEYNKKIKEDPRVETVLFPIRDGLTVSRVI
>OBAHECAF_01158 Dihydroorotate dehydrogenase (quinone)
MYKQFIQPILFSLDPEKAHHLTFSLLKIIHKIPGIPSLLRSIYQVEHPALEREVFGIKFK
NPVGLAAGLDKEAKLYKELSNLGFGFVEIGTITPKGQPGNPKKRLFRLKEDKAIINRMGF
NNQGVEEAIQRLKTNKNVLIGGNIGKNKITPNENAVNDYSYCFERLFPYVDYFVVNVSSP
NTPNLRTLQEKEPLKLLLNTLQQLNLAKEKQKPILLKIAPDLTDEQLLDIIDIVKETKIA
GVIATNTTISREGLQSANKNEVGGLSGKPLTKRSTEVIRFLSEKSGRAFPIIGVGGIHSA
DDAIEKLNAGASLVQLYTGFIYEGPNLIKEINKKLISTARQRS
>OBAHECAF_01160 hypothetical protein
MRKIFSVIFCLLSLSLSAQSKIKQAKNNLGTPQQTQLGSSSQSSGYSTSFGDSSVSFWDI
FFESFLYDLTLALAYNIAFETEAESEGRMSRATLNRYPFYGNSKGDYQYEAPWEDFVLWR
LEGSNYYFSEKGRFFTNDFNAKVRIGERFGINLQYLHFWEKLLQAEDEKLDIFVLTGEYY
RIRTQRVSTHWGIGAGYVGNELKQWGLAFELGNEIFFRPFSLHADLKYVYFKRNDVFSFS
VGPRFYYRNLHIGAKYQRMNLASVQTSGFSVGLGIVF
>OBAHECAF_01161 Beta-barrel assembly-enhancing protease
MIGRLIFRGLAVFGVFFISWLLLAQINWIRVFNFLPNNSKYLHKIEEKLGEVTLADFKRY
NSELENVFVSKTIDSIVAKICTANGIVKDSLNVYIFSNSEVNAFALPDNQMVIYTGLIQK
SENPEALAGVIAHELAHIQKDHVMQSLKKEIGLGVLFTVLTGQSDYTLISEISKMLVSSS
FSRKMEKEADLLGVEYLINAQVDPVPFADLTSNLNDMEFKALKWINSHPMSEERSKYIMK
VVDNKDFTFRKLVHTSTWEKIKEQINTDL
>OBAHECAF_01162 hypothetical protein
MIEISNFNKRLTESEKERASYSYLMSIVVLLVGLPLPIVNLISTFFFYIANRNNTFFVRW
HCIQSLISQLSVFFVNTVGFWWTISIIFGSNEVSNLYISYVLAAIIFNIWEFVVTFYTAT
KVRKGIHISWWFYGDITNLIVKNNDRKTDF
>OBAHECAF_01163 hypothetical protein
MEIKVDANKVDMFIVSNGKYFKSEAIPYIRKQLSEMNENQWVMLQTLQFKDPQTALLLSL
LTPIAAVSGIDRIFIGDVGLGVAKILTCGGLGIWTIVDWFLIMDATRDKNFEMLQNLLRF
>OBAHECAF_01164 Transcription termination factor Rho
MLDITDLKSMKLPELQGIAQAMKVPKFRSFNKEDLIYQILDHQAANPSQEQQESEKNEVK
TKKQTQKKTQRKTVTNKKKSNSASTTTPTVPQKEEKIQEENTQNNGKTNKEQLPKSDAKE
NVTTNNKENKQFQKVGFQKKNNQNTTNQSQQTSQNQQKTGQNQNTYRNGNGQNNNSENFD
KEKRNRYRSPDFEFDSIVECEGVLDIMQDGYGFLRSSDYNYLASPDDIYVSQSQIRLFGL
QTGDTVLGEVRPPKEGEKYFPLLKVLKINGLDPQIVRDRVLFEHLTPLFPNEKFKLADKG
STPSTRIIDLFSPIGKGQRAMIVAQPKTGKTMLLKDIANAISKNHPEVYLMVLLIDERPE
EVTDMQRSVRGEIIASTFDKEASEHVRIANIVLEKAKRLVECGHDVVILLDSITRLARAY
NTVQPASGKVLTGGVDANALHKPKRFFGAARNIENGGSLSIIATALTETGSKMDEVIFEE
FKGTGNMELQLDRRIANRRIFPAIDLISSSTRRDDLLLDEKTLQRMWILRKYLADMNPLE
AMEFMENRIKQTRDNEEFLLTMNQ
>OBAHECAF_01165 hypothetical protein
MDLFYAVDLAGVFVFAISGALAAREKKMDLFGIFIIAFVTGLGGGTLRDVLLGRTPVFWM
QAPIYVAMIFGGTLFAIIFRNKIHYLRKSLLLFDTIGIAFFTIIGTEIALSFSYELHPTI
VVSIGVMSACFGGVIRDILCNDIPVIFHKEIYATPCVVGSLMYLGLKELPFFHDYISLIT
IVFIIAFRIYAIKKSLELPKIG
>OBAHECAF_01167 hypothetical protein
MKQLFKFFICLFSISVFSQSIDNKLFTVESKYDFKQTIKLLKKGLTSENIQIFSVIDHSK
AAKKSALHLAPTTVLIIGNPKVGTVLMQENQLLAIELPLKILIREVNGKTFVTYKRLETL
YNDYTIEKTKPLLEKIDQAILKIIEKSIST
>OBAHECAF_01168 K(+)/H(+) antiporter NhaP
MNLTSENILLVGSLLLLVSIVAGRTSYKFGVPTLILFLGVGMLAGSDGILKIEFNNPGLA
QFIGILSLNFILFSGGLETRWKSVQPILGQGIMLSTVGVLLTAVFLGVFVWYVTDFTIFE
SLLLGSIVSSTDAAAVFSILRSKNLELKENLRPTLEFESGSNDPMAYVLTTTFLGLVQIP
DQDLLGVIFIFLKQIILGGILGFIFGRLSKIIFNRISLGFEGLYPVLAIALMYITFSGTE
ALGGNGFLAIYVAAVYLGNHSFIHKGSVIKMFDGLAWLMQIVMFLTLGLLVNPSETIPLM
GIGLLISVFLILVARPLSVFLGTLPFKMSFARRSYISWVGLRGAVPIVFATYPMLAGLEK
ANIIFNIVFFISVTSVLIQGTTLSMVAKWLNLASEQPAENEENPADAIKREHPRAVMQEI
FIPEDCYVVDKKIVDVDFPSNAIIAMIKRKDKYITPNGSTQIEGNDTLIVISDNTQVMDE
VRNALELES
>OBAHECAF_01169 hypothetical protein
MKFKLFSLPKNKKYNYTPRYYDGKEKGNIYDLDSRIRKDRETQTNHFTAQWRDVRANSRN
TKNVEINKTFLIVLAILLFLALYILDFDLSIFKRK
>OBAHECAF_01170 DNA mismatch repair protein MutL
MTDIIRLLPDHVANQIAAGEVIQRPASAVKELLENAIDAKATNIKLIVKDAGKTLIQVID
NGIGMSVTDARLAFERHATSKIQKAEDLFQLQTKGFRGEALASIAAIAHVELITKRPTDE
LGTELRIEGSKITYQEPCVTADGTSISMKNLFFNIPARRNFLKSDTVELRHILDEFHRVA
LAHPNIHFHFYNNGNELFNLPITNFRQRIVHLFGGKTNEKLVPIEEETPILKISGFVVKP
EYIAKTKSLQFLMVNNRFVKNRYLNHAITVAYEGLINSQQQAEYFIRLEVNPSTIDINIH
PTKTEVKFEDEHSIYALLKSAVKHSLGQFNIAPVLDFNRDTTFDIPYSYKDKEPVFPKIE
IDPNFNPFKEETQNNRNSGNGQNFSSHPKKQSSWESLYVGIESDLNSFEPQVIESKLFDV
EPLSPQIGKNILSIGKKYLVTTLHNELIIVNINRAHQRILYEDFLKTLKSTSTASQQLMF
PLELSFSREELDVVKRLKELFENIGFIIDIQEDKIQINGVPLHISDSDIPNVFQELIQQH
IENLPTNENSQKEAFAQSLSRSLAIKTGQNLTEQEQETLLNNLFACKESLISPLGKRVYS
HLSLNEIDKYF
>OBAHECAF_01171 Rhomboid protease AarA
MERITQIIKHLIIINVIVFFIAEYNLIPNINLTENAAIYFFENPNFKWWQYVTYMFMHGG
LMHLFFNMYALWAFGSPLEKIWGQQKFLFFYFSCGVGSALIHSGVNYYYFQEGLQALADN
GFTPEMVKSVLAEGKYNTAWEHIIPKSTFNDMMSSYFTPAVGASGAIYGILVAFGMMFPD
AKLMMIFIPYPIKAKYFIPILVGIDLFSGVTGFSIFGGNIAHFAHVGGALIGFLMMWYWK
KNSFDANGWKR
>OBAHECAF_01172 hypothetical protein
MKYKYLFSGVSILMSVVSHAQSMLPKMKIASQQNANPMELQELHTDIYVFGQTAITTMEM
AFYNPNDRVMEGEFEFPLGAGQVVSRFALDIDGKLREGVVVDKKQGRVAFENIVRRGVDP
GLLEKTEGNNFKARVYPIPAKGYRRILIAFEQELSHRNGKDFYFLPIKGDFTLKKFSLKA
EIVSREVKTEDDSVELSFKKWRNSYISELTKTDYRLNKNITLIFPKIEKQQIFASTENQK
TYFYGSILPEKEIINNKSFPKKIGLLWDISASSEERDFDKEYQLLDAYFKTIKNVDVELI
TFNIRANVPKKFSIKNGDWSALNSYLKKQTYDGATYVNPLEIKDSSDEYLVFTDGIFNFG
EEKDLKLLTAIIQKPVYVINSKSVANTDKMQYISNQTGGNFINLSQQTVENSLEKLLKPT
FRLIEAKVKSGKVSDLYPQVGSPITENYFSFAGQLQSDKAELEFSFGYGNKITESKIVTV
QKNMDSSEKEFKQLERFWAGKKIAQMRSEAENQEKIDAVGKEFGIVTEGTSLIVLELLSD
YVANRIVPPTELQKEYFEAIAGEDKYAKEEENRKKSQKKDKIEEVIAMSKAQSEWWNTSF
PINVEKKDGKGEIPPPPLPASAIEEVVVISATHSDRREVAVEEIAIMEEAEVASEMKEMV
VMTGAVSKKMTEKTNVNQTKNIGIQLNTWNPDTPYQKVLEYTDERKSYETYLKLKQEYGK
TPAFYVDAADYFFKKGKSETATLILSNLAELNLEEAQILRVLGYKLLEYKNPKLAILIFQ
KVLKMREEEPQSFRDLGLALAQDKQYNKAVETLYKVVTEVWNSRFYGIELIAMNEINNIV
NTQKNVKTSFIDKRLLKNEPVDVRVVLTWDTDSSDMDLWVTDPKKEKCYYSNDLTEYGGK
ISNDFTGGYGPEEFMIRKAIDGQYEIQVQYYGNYSQKQLFPVSLRLEFFTNYGSRNQKKQ
EVVIRLTNNKEVIDVGKFIYKK
>OBAHECAF_01173 Internalin-J
MNTKIGKWVVTSVVALVLLLACIKEEPIIHVTSVTLEKNELELTEGDNHKLSVIVLPEDA
TNASVSWESSNTDVATVDAKGLITALKPGTVEITVTTEDGEKTAVCKVTVAPRFIHVVSV
SISPEKLTLIEGDTHSLTTTILPAEATNPKVMWSSADSTIATVNEMGELTALKAGIVTIT
ATSEDGGKTALCEVTVEAKIIEVESVRLSEEQITLVEGNTYSLTATVLPADATNKNIHWT
SENEAVVTINEGGFLTAHKVGTATVVVTTESGKKTAICGVTVEAKVIAVESVSLSEEQIT
LVEGNTYSLTATVLPANATNKKVTWTSANTAIATVDDLGKVTGVASGTVYITATTEDSKK
TATCKVTVSKKVITVAYVSLDNETITLLEGDTKTLVATVSPTNATNKKITWTTTDKTIAT
VDANGKVTAITAGVVSITATTEDGGKKASCRVTVEKNIVAVTNVSIQPESIVLAIGNQRQ
LSATVSPTNATNKKVTWTSADPSIATVTANGKVTGVASGTVYITATTEDGGKKASCKVTV
ESVIAVTNVSIQPETITLPVGDELQLTATVSPTNATNKKVTWTTANAGIAKVDNHGKVTG
VASGTVYITATTEDGGKTATCKVSVTTPIIQVTSINIQPGTATVTVGGEQQLTANVLPTN
ATNKAVTWTSGNTSIATVSSSGKVTGVASGTVYITATTEDGSKTATCKVTVTASSVIPDG
ARISGSVLTGWDCTKIPADGKVIIPANVTIISSRAFANCQRLKEVVIHGNVYMIGEEAFI
NCTALNKVTMAEGMKHIEASAFEGCSSLQSIVLPATLENVGPRLFADTPSLVSITVKAPT
PPRTNAQYSLVLFGSSRNPFIYVPQAYIDTYKNDPNWFWSEYRDRIFPIPTGGDSTIVQV
TAVELSESNLTLSLGDTHNLSANVLPTNATNKAVTWTSGNTSIATVDANGKVTAVGTGTA
YITATSTDGGKTATCVVKVTDEETPKMVLKTTANSLNLVINAAPQNQNGVWIDLNNNGQK
DTGENVTSFSNNLYGTSTNYVINNQVTSEKTVTIYGKVTILNCSQNQLTNLDVTKNPYLN
DLDCYSNQLIDLDISKNTKLQGFDCADNQLTNLDISKNTELVSLWCINNQLTSLDISKNT
NLTILWCGANQLRDLDISKNTKLNWIYIVNNNLTPASKQKIIDDLPTRSASQKAKFNNYN
SQEFSQSQLNAIRAKGWTVVND
>OBAHECAF_01174 3-dehydroquinate dehydratase
MKIAIINGPNLNLLGKREPEIYGSETFEQFFEKLQKKYPSVQLTYYQSNIEGELIDKIHE
IGFEYDGIILNAGAYTHTSIAIADAIKAVTTPVLEVHISNTYARETFRHKSYISPVAKGV
ILGLGLKSYELALINFL
>OBAHECAF_01175 Protein translocase subunit SecA
MSIVNSLIKIFVGDKAKRDLKSIQPIVEKIKTYAQQLEAISNDELRAKTIEFKQKIRDAR
AEFDAKIFDLQQKANQTDDIDEKEDLYTEIDSLNAEAYEISEKTLDEILPEAFAVVKETA
RRLAGNPTLTVTATPYDRELSATKSYVTIEGDNAVWQNSWDAAGKQVTWDMVHYDVQLIG
GIALHQGKIAEMQTGEGKTLVATLPVYLNALTGNGVHLVTVNDYLARRDSAWMGPLFEFH
GMRVDCIDNHRPNSQERRNAYNADITYGTNNEFGFDYLRDNMAHTSEDLVQRVHNYAIVD
EVDSVLVDDARTPLIISGPTPKGELHEFNELKPLVSDLVSKQRQYLTKVLADARKLIAEG
NTKEGGFLLLRVYRGLPKNKALIKFLSEEGVKQLLQKTENFYMQDNNREMPKVDEELYFV
IDEKNNQIELTDKGFADISFDGDKNFFVLPDISIEIAKIEKQGLPIEEEAALKEKLFQDF
NIKSERIHSLNQLLKAYTLFEKDVEYVVIDNKVLIVDEQTGRIMDGRRYSDGLHQAIEAK
ENVKIEAATQTYATITLQNYFRMYNKLSGMTGTAITEAGEFWEIYKLDVMEIPTNRPIAR
KDKNDLIYKTKREKYNAVIEEVARISEAGRPVLIGTTSVEVSELLSRMLTMRKIKHNVLN
AKLHKKEAEIVAEAGQPGVVTIATNMAGRGTDIKLTPEVKAAGGLAIIGTERHDSRRVDR
QLRGRSGRQGDPGSSLFFVSLEDNLMRLFGSERIAKFMDKLGHKEGDVIEHSLMTKRIEA
AQKKVEENNFGIRKRLLEYDDVMNAQREVIYKRRRHALEGERLKVDLANMIYDTCKVIVE
QNKGGNNFKNFEYELIRFFSLKSQITESEFGKSSVNDLINTLYKEVLIHYQEKTERSAET
AFPVIKSVYENPSNTYERIVVPFTDGQKAMNIVTDLKEAYESNGKKLISDFEKNITLAII
DEEWKTHLRRMDELKQSVQLAVHEQKDPLLIYKFEAFELFSSMIDKVNKEIISFLFRAEL
PTQNTPIQEEQRVQRQPENYRTSREEVGDEVANQQREAGQAVSRRSQVVETIVREQPKIN
RNERIMVQNIRTGERKEMKYKQAIPLIEKGEWIVVPS
>OBAHECAF_01176 hypothetical protein
MYWTLELASYLSDAPWPATKDELIDYAIRTGAPMEVVENLQSLEDEGDMYESIEEIWPDY
PSEEDYLWNEDEY
>OBAHECAF_01177 2-iminobutanoate/2-iminopropanoate deaminase
MKQIIFTENAPAPIGPYNQAILAGNTLYVSGQIPVNPKTNEVVKGIEAATTQVMENLKAV
LEQAGATFENVVKTTIFLSDMEQFGQVNAIYGKYFDEKTAPARETVQVANLPKYVEVEIS
CVAVL
>OBAHECAF_01178 hypothetical protein
MKFSLTIFVLFISFFSYSQTKTDYISPLDIPLLLSGNFGELRGSHFHAGVDFKTQGKEGL
KIYAIEGGYVSRIKVGAYGYGKALYVTHPDGNTSVYAHLQKFSPDIEKYIKKRQYARKSF
EIEAYPKAIELPVKKGELIAYGGNTGSSGGPHLHFEIRDSSARAMNPLLFGYDILDEIPP
SVYQLVGYSLGGDSQIEKSQLPRQINMTKQSDGSYLADKITACGSIGLGIQSIDKQNDTY
HICGVYRVTLEINGIVHFQYVFDKLDFTEARYINVFSDYEQYVDKKTRIQLLYKKAGNRI
STIYRNIKNNGHIDVQDGMSYLATISVEDIKGNTTRIVLPIEGKQQEIIEPKPIAEGKLL
VAKRDQFYTFENGNVYFPENTFYNDFMIQIDSKNDTLSLHHPREAVHKQFTLNIENKKFT
EEETAQVFIAYLNEKNRPSAERTTYKNGVFTAKTRNLGRFTLMKDTIPPTVRPVNFKNNG
LLNASTLKVEIKDDLSGIGSYSASLNGEWILFEYDPKTRMLTFDFSDIEAKKTDTYKLEM
IVKDGVGNVQKLNVSFKKK
>OBAHECAF_01179 Cell division ATP-binding protein FtsE
MEAPIVHLKNTFIQQRSSVVLSDVNLTINKGELVYVIGKTGTGKSSLIKLLYGDLPLLKG
EGYVAGFNLKKMQESDIPLLRRKLGVVFQDFKLLSDRNVFNNLAFVLKATGWKDSNKIKQ
RIERVLAKVKMEDMILKFPHELSGGEQQRVAIARALLNNPELILADEPTGNLDPETSVEI
MQVLKEINASGRTILMATHDYALILKFPSKTLKCDESKLFEVIQRTV
>OBAHECAF_01180 UDP-3-O-acylglucosamine N-acyltransferase
MRFPQPYTLKQIATIIGTSFVGDDNFPVLGMNEIHVVQAGDIVFVDHPKYYDKALQSNAT
VVLINKEVECPKGKALLISDDPFRDFNKLTEFFKPFLKSTALVSPTAKIGKNTIIQHGAF
IGNNVQIGDNCVIHSNVSIYDDCIIGNNVTIHAGTVLGADAFYYKKRPEGFDKLKSGGRV
VIEDNVDLGALCTIDRGVTGDTTIRKGTKIDNQVHVGHDTVIGEKCLIASQTGIAGCVVI
ENEVTIWGQVGMTSGITIGAKAVILAQSGISKSLEGGLTYFGYPAEEARKKYKEMGALRR
LITQ
>OBAHECAF_01181 hypothetical protein
MLESVLLHPTYFPSIAQFYWILNRPCVLEVSDNYQKQTLRNRAYIYGANGKQALNLPIKH
VGGETGRQLFKDVKVENHFPWQRLHWKSLETAYRTSPFFEYYEDDLRPIFEKNYTFLLDV
NMDTIETVLACLQTDINFDKTVSYEATPKHLKDARILTNAKKELPVEMTEYHQIFSDKHG
FIPNLSILDLLFHEGPNTQDYLATQIYINI
>OBAHECAF_01182 Signal peptidase I
MAYFYILVIAQLVNGLFFWKGYEKAGYKGWQAFVPFYNTVIFLRIIERPWWWLFLVYLPV
IGNIMLIVMNYEWLHVFGYRKKRYTLLSVLTLGLFTAYVSYTAFYVKKDNQVIKKNVSSW
ISATLFAVVAASGIHTYFIQPYMIPTSSLEKTLLVGDFLFVSKFHYGVRVPMTPLALPMV
HDSVPVLGVKSYFSKPQLPYLRLPALQKIERNDITVFNWPTDTVRFFRDPSNIHVHKPID
KRSNYVKRTVALPGDVFEIKDGDVHINGKKEIYPVRAKLQSSYVVEVQPNKGVFDKYSMY
KQFGVTDYFFEIQPNVYVFSSLTEAVAETLRQNPNIVSVRKRVEEVGKYNPSVFPHSEKY
PWNEDQYGPITIPAEGATVVLSAENLPLYKRIIEEYEGNKLRIQGEDVYINDIKTNSYTF
KQNYYWMMGDNRHNSEDSRYWGFVPEDHVLGKPVLVWMSLDRNASGLDKIRWNRLFTTVN
GEGEPVSYRYYVLAALGLWLAYSLLRKKKKK
>OBAHECAF_01183 Alpha-galactosidase A
MVKKYFFLGILLLFAVIGVHGQKATAETPPMGFMTWNYFAENISESQLKEVVDAMVSTGL
RDAGYNFIFIDDGWQGGRDAKNNLIPDPKKFPSGMKAFADYVHSKGMKLGIYSNAAELTC
AGYTGSYGFEEKDAKTFAQWGIDYLKYDYCHAPSDWKVAIERYEKMAIALQNSGREITFA
ICEWGDREPWLWGKKAGGQLWRTTADVRDKWKSIEPYKNAKELHRVGAGILDIVNRNAEL
SSYAGINGWNDADMLVIGLYGKKGPSGDLGGVGCTDTEYRSQMSLWCLMAAPLMITCDVR
NMNETTHKILMNHDVIKINQDKLGKQATRIVNSNDWQIFLKPLQNGDIAIGILNTADNKR
SFNLKLDELGITNKKTSENLWTKTTSAVKNNQIKITADSHETILLRLSK
>OBAHECAF_01184 Integration host factor subunit alpha
MKYHLVQKANPQDRSKKKFYANAVISSKVEQKDIAKTISSKSSLTAGDIANVIQNLLEEL
PKELLKGNSVKLGDFGTFRISISSEGVENEKDFNASMIKDVRIIFTPGVEMKKAIEGISF
EKS
>OBAHECAF_01186 hypothetical protein
MKQNLQIKTFLGTSENAVKSQVYVALICYLLLELIKRFYSDKKTAFSNFCEKIKVCLMHY
LTLNYVCNELKPTVKKAKKPPENTLFDRDNSAQQTSLPL
>OBAHECAF_01187 hypothetical protein
MLITITLHCPNCQCTKIVKNGNKKNKKQNYLCKTCKRQFIGDHNLTYKGWASHIAAKILL
LLARNVGIRDIAEIEKVSIKKVLSVLVNFNREIKPKQNKYKSLQVDELWTFVGKKKNKKW
LIYAYSAETKEIVAWVWGKRNIKTAQKLREKLKKLSVSFDEICTDNWEAFASVFQEYTHK
VGKKYTTDIEGNNTLLRHRIRRAVRKTCCFSKKFENHIKAFEIVFFYINFGWI
>OBAHECAF_01188 Cellobiose 2-epimerase
MKHSELYKKTLLEDVIPFWEKHSLDHEFGGYFTCLDREGNVFDTDKFIWLQGRQAWTFAM
LYNQVEKNPKWLEISKLGVEFLKNHAMDSDGNFYFALTRDGKPLVQPYNIFSDCFVAMAF
SQYAKASGDETYKKLAISTYHNILKKQNNPKGKYEKTTDVRPLKGFSLPMILSNLVLELE
SVLSEEEINKTIDFSINEVMNVFLDAETGIIFENVRPDGSKEDSFNGRLLNPGHGIEAMW
FMIDIAVRRGDQSLIEKATQTILNILNYSWDEKHGGILYFMDSKGNPPQQLEWDQKLWWV
HLETLVALSKAYLHTKNSEIWTWYEKVHNYTWSHFSDPEYGEWFGYLNREGKPLLSLKGG
KWKGCFHVPRAMFQCWKTFEKIENQ
>OBAHECAF_01189 Sialidase
MNRIFYLLFAFVLLSACGSQKNVIGGGEFTQPEMPLVTGKENLLASFKLATKNLNAITEV
KVLLKSELKSSDLSEIAIYLSDKENFKEAQQFASTKSVQSTILLKGNYLPKTENTYVWVT
TKTTENPNLLNKIKVFQIEFLSNRSRYVYVNPKSPAQRFGITLRDKKQDGIECYRIPGLA
TTNKGTLIAVYDNRYNNCKDLQEDVNVGMSRSTDGGQTWEPMKEIMDLGEWGGLDNRLNG
IGDPAVLVDKTTGTIWVAALWLHGHDKDKMAWWASKPGMTPHETGQLMLVKSEDDGITWS
EPINITAQTKDPKWYLFFNGPGSGISLNDGKIMFAAQYKDENQVPHSTLIYSDDHGKTWH
CGTGAKSHTTEAQVVQLSDGSIMLNMRDDRNRQNYTLSDAFHGRSVAVTRDFGKTWTEHS
TSRKALTEPNCMASIISYLANNGKQYLFFSNPADAKNRINITIKASDDDGNTWNKLPQIK
LYANGNFGYSCMSLIDNKYIGILYEGVGDLIFQKIPISELIK
>OBAHECAF_01190 hypothetical protein
MGLSFFIGCSSKTEKKLPRIAIAGIAIESSTFSPAVSDEDAFPLRIGDSIFSYYNFFVPD
SSVVQRAEWVPTLRSHAMPGGIVKREVYEKMVNKTLEMLKESLPIDGLFFDIHGAMSVQG
LEDPEGDLIVRIREVIGDKVLVSSCMDLHGSVSPRLAQHVDMMTCYRLAPHEDAMISKKR
ALVNLIDRLESGKGKPAYKAWIPVPILLPGEKTSTRIEPAKSLYGQIPSLIDGDKVIDAS
IWMSYPWADEPRNHGVVLTYGDDKEAVGKAAETLAKHFWDVRDKFEFVAPTAYLPECLSQ
ALASTEKPFIISDMGDNPTAGGAGDVTWTLTELFKRPEFKSEKGKSVIYASIPDAEFVRQ
AQAIGVGGKIDALAGARVDDRYAPPVRVSGTITAIEKDDKNNTIVVVKSGAISVIITEKR
KAYHYERYFTEIGLNPRETDILVVKIGYLVPELYNMRKGWVMALTPGGVDQDLLRLPYKG
IQRPMYPLDADMPTPNLKARFVPLADEPPVTKL
>OBAHECAF_01191 hypothetical protein
MKKLYALVVGLFLIQISFAQTTVTTGTSTQTVPSNIELKTEKEALKAEQRAQKAQKEVLI
AEEKARRAEEKAQIQAKKAEEKAKRAEEKAKKAQEKAKKAEERAKKEAEKKQKNLAKAQQ
QVLKIEAQVKMKQNELAQEQNKFESKKAKGNLSSSDELKYKNRILKKEQEINKLNLKAIK
AKEQVNKYSK
>OBAHECAF_01192 Uracil-DNA glycosylase
MEVNIHSSWKPYLISEFQQDYFQKLVSFIKHEYTQGVCYPRGQQIFAAFDYCPFENVKVV
IIGQDPYHGVNQANGLCFSVQDGVDHPPSLINIFKELQRDLGVPYPSSGNLERWAKQGVL
LLNATLTVRANQAGSHQNQGWETFTDAVIRLVSEQKQQVVFMLWGGYAKKKASLIDASKH
YILTSGHPSPLSANRGYWFGNKHFSRANQYLVSVGKGEIQW
>OBAHECAF_01193 Endonuclease MutS2
MIHNKTLEDLEFGTVLTHISEICHTELGKKYALRLQPFEDKETLLFALQQTNEYLASFQN
NNTIPGHSCEKISSEIRLLQVENTTLELSAIRKLYLISQTVNTHIQFFRKFKELYSILHE
TAESIHYTTDITEAIDKIVDKFGEIKNDASQTLGNIRKEISILKGKINESFNRTLAEYNA
SDYLDDIRETVVDNRRVLAVKAMYRRKVLGTVLGSSKTGSIVYIEPRQTEMYSRELTNLI
YDEKEEIQRILKQLTTYLSQYVVLFKDYQRYITAIDIIYAKAKYALSMNGLLPEITEERV
LFLQEAYHPLLFLNNQKKGKPTYPQNIELTDDSRIIVISGPNAGGKSITLKTIGLLQLML
QSGMLVPVHHRSRMCLFERILTDIGDNQSIENHLSTYSYRLKNMNYFLRKCNERTLFLID
EFGTGSDPELGGALAETFLEEFYHRKAFGVITTHYANLKILANELPHATNANMLFNDKTL
EPIYKLIVGEAGSSFTFEVAQKNGIPFGLINRAKKKIEKGKVRFDATIAKLQKERSKMEK
TAENLKDEEAKAREEAKRLEELNERIKSKLVNYQELYDHNQRMIYLGNKIDEVAERYFYD
GKRRSLVSDILRIIESENAKRKQLSKVEKTQKKEQKKTIETEVNKEIEAIRIQKKAEKKA
KITQEEAAKERMQRMLKINDRVRIKDSRSVGVIDKIEKGKAIVNYGMFTTTVAISELELV
EKVKN
>OBAHECAF_01194 Aerotaxis receptor
MKNNSDETKTNTNSLKETEGGAKKNCVVRPTPIDEEVQWDKSKTLMSRTDKFGNIEYAND
DFIDVSGYEAYELMSQPHSIIRHPDMPKVVFKILWDNLKTRENFHAIIKNMSKSGKYYWV
ITNFEIKKDAEDKIIGFVSYRKALPKSIIEESIEPLYRRLLKIEQVNGLEVSEKYFMGYL
EDMGVSYYEFVANLLKTYKEEIESVISKEVSKEAEDDKSAEKGGFLSKIVS
>OBAHECAF_01195 hypothetical protein
MSTELNNSTISKQENKKVLAGVLALVLGSIGVHKFFLGYTKEGIIQIVLTVVTCGIASLV
PLIEGIIYLTKSDEEFYKIYQQGRKPWF
>OBAHECAF_01196 hypothetical protein
MKKIVLGLGVIASLIAVSCKSDAKKSETQTEQTEVVSTEKPVGSVAYTVAPSSVIEWVGS
KPAGKHNGTVNVSEGTVNVENKSIVSGEFVLDMNSIVVLDLAAGDGKEDLEGHLKGTGKE
DAEDHFFNVKKFPTAKFVFKSFDGTNVTGDLTVKEITKEVTFPATVSVTDSEVVIDSQSF
TINRTDFGVNYASKSIFDNLKDKFINDDIELVVKVKATK
>OBAHECAF_01197 RNA polymerase sigma-54 factor
MLKQNLQLKLSQKLSPQQIQLMKLVQLPTLAFEQRIKQELEENPALESGREESEYDEFAD
EFDNSSDEYNDSEVIDMEDINIDEYLSDDEIPEYRLHTNNYSDDDEEKEIPFSAEVSFHQ
SLLNQLNTFTLSDEDYFIAEFLVGSIDDSGYIRRSIQDLTDDLAFTQNIYTEEDKVKQIR
EQIIFQLDPAGVGAFDLQECLLIQLRRKKTTSSVDLAIEIIEKAFELFTKKHYAKLQQKF
SISEDELKEAIQEIERLNPKPGSSYSGSNVQVEQIIPDFTIRVNDSDLELSLNGRNAPEL
HVSREYSEMLDTYKKAKEKTSSQKEAVFFIKQKLDSAKWFIDAIKQRQQTLLVTMDAIMQ
HQREYFLTGDELKIKPLILKDIADKIGMDISTVSRVASSKYVTTPYGTRLIKDFFSESMK
NDQGEDVSTHEIKQILQRIIAKEDKSKPYPDDDLAQLLKEEGYPIARRTIAKYREQLDIP
VARLRREL
>OBAHECAF_01198 hypothetical protein
MTILGAIIIGAIAGWLGGLIYKGSGLGLLGNIVVGILGGAVGSWVLGHFGASLGEGWVGS
ILTGALGAIIILFLVNLIFKRKS
>OBAHECAF_01199 Vitamin B12 transporter BtuB
MFKSLHLYLFIITGYSVSLYGQNTETLKDTTVHTLSEVVVSATRTLRQLSSLPLQVQLVK
EKEIRSINSSRLSDILAEQNGLVTIPGHGRAGREGLQMQGLGAEYTLILIDEMPLIGRFV
GQIDLNRVSIGNVKQVEIVKGASSSLYGSEALAGVINIITQIPEDGLRANVGYKKSSFAT
HDASMNVGYRNKKWNISSFFNLYGSDGYSLSDPKTPTVPPYYNTTARTKVGYRFNDKTNL
NISGRYFLQDQQLHSGKFKGVSNITEWNFHSKLNNRYNNKWSSYFEFYLTNYKTAEYIPN
RPDIANRRFDQIFLRPEVRGKYSPKKNTDIIMGVGANLERAKNTIFISDPRMESYYTYGQ
LDTYLTPKMNLIGGFRYDLHSEYTSQFSPKIALKYDFTDRISSKISVGYGYKAPDFEKLY
YNFTNSNAGYSVLGYNAVITRLMEMEKNGEISTIYIDKDNFLKSKLAPESSLSFNFGIDL
KPFSNLKLQMNLFRNDIKNLIETRMIALKKSGQGVYSFHNVEKVYTQGLEANVLYYPINN
LSLSVGYQLLYAKNKTAERQFEEKKVYAKNASGEVFQLQTDDYFGLFNRSRHSANVKIFY
QVPRWDTDFNIRAIYRGKYGVVDTNSNKYLDSYDEFVEGYTMLNIAANKHFGERYSIGIG
VNNALDYTNPKYISNISGRIMYASMNINF
>OBAHECAF_01200 hypothetical protein
MFLLAGILATVMFVSCSKDEKKEEAPATSYQFKSTEKIEAKNIEAGKGRKKGERGTAFED
FLKFNFSENKIVEGDNWDIAFKGTTIIVNGGTPSDPKIKITGKGAIYVTDGTLESVTSAE
FEKLKQNSLNNFKEWATYTGHPTHLIKATPGKILVIRTHDEKFVKLRIDSYYQNKADLES
EASHLTTKDKDGYFTFTFIKG
>OBAHECAF_01201 Foldase protein PrsA 1
MAILEKIRNRTVFLIAIIGLALFAFVISDFIGSGRFGNWQTTEIGTVNGEDVSIDAFRFQ
VENAVQGAGGQASSLEAAKYVWEQNVRSILLKQQFEKLGLSIEKDQILSVLAKSPLAQSP
EFTNDLGVFDPSKFISYLATLKASNPQAYQEWKMQENALVETAKQQMYFNLIRAGLGVTN
AEAEIAYHQEQDKADIKFVALQYSSIPDSTVSVSDSDIKAYISKNKKQFEQEAFRNIQYI
VVNEKASAEDIEADKASLLRLLEPQVVYNSTTNSNDTIGGFANVKNIREFIEKNSDSPYD
SLYVTKSELPTVYADTLFALPVGKTFGPYDDNGVLKLSRMVDKETNGAVKASHILIAYAG
SRAANENTTRTKEEALAKANEILAKARKEGADFAELARENSEEPGANYSGGDLGFFTRGR
MVKPFEDFVFTNKVGHIGVVETDFGFHVVRVTEKANAVQIATITRNIEPSETTLNDLFTK
VSKFEMDALADVKNFGEVAKKSDLTVLRADNLKQNDEYIIGLGNNRQIVQWLFQEDTKVG
DIRKFTAGGSYIVAQLTKKGEKGVSSVQDAAPFVKPILIREKKAQILAEKAKGASLDAIA
SANNAEVRTATGLSMNNPTIIGEGREPKVVGTVFALKQGQTSKPIEGENAVYVVEVTAIS
PAQAPSDLKSQRKSLETLKVSRASQEVYNALKNAAEIKENLSSFY
>OBAHECAF_01202 Exodeoxyribonuclease
MKIISYNVNGVRAAMTKGLIEWLQSANPDVLCLQEIKALESQIEKEAFEALGYKYQYWHS
AEKKGYSGVAILSKTKPTHVEIGSGLDYMDKEGRILRADYGSLSVMSLYLPSGTNIDRLD
FKLTFMADFQKYIDNLKVSFPNLIICGDYNICHQAIDIHDPIRNANVSGFLPVEREWLDG
FMKSGFIDSFRYFNNEPHNYSWWSYRANARNNNKGWRIDYNLVAQPLENRLLRATILPEA
KHSDHCPILVEVAD
>OBAHECAF_01203 hypothetical protein
MNRLTFLIFFLFTTVVFAQTGTVSGRIVDAESKEVLPYTEVSLFSSDNKNRNFGVISDEN
GKFLLKNIPFGEYTLKISFVGYENVTKPLSINVSKTNLGDVLLHLSVQQIEEVVVEGRKA
AFSYQVDRKTINASAFPEANTAIDLLTNVPSLNVSVDGRITYREGGTFTVYINGIIAKDG
QERLRTLDASQIEKIDIITNPSAKYSASGTAGIIRVVLKKNKLEGYAINLSAEFNTLERK
SFSYSIDKKGKKGGWHVSGNIADHHWGDSRSQGISNVYAPDGKRFETLFNSEYKANMNNS
FIDFGFNYDITDRDFIDVSIDYVPFRKKEKKIDKTQISENTFDKEGNLLSSKDFLMDVDN
QFLYQNWGANLEYSHFFNKDKSHFLKLNSGYTFFIGSSDDFTKGHVISPKENTVFGNKSS
EKNEIFTKSILEYELPLTDATSIEAGVDIETDHIPEITTESGFFKGDRIVETSKDVSENQ
VINYKENIYAGYFSFKSSFGKFEYKLGLRSEHTARDIIYSFDNQQGVRKNDRFKKNFTDW
FPSVHLLYSFSQNSQISGNYSRRISRPEYWVLVPAFVWNDRYSFLTGNSRLLPSYTDSYE
LAYKNSWGKDFVSIEMFARNQHDIMSPYSRVYRDNMLLITRENVGSSWATGIELMAGVDV
FKWWNVNASFTAYHYRQDLEVDANSYPIEQWRFNAKLNHTLRLPRNFLLRVNMGYQSPTK
DLQNNVEAIFLTNASFTKTWKDNRWSLSLFGSNVFDSYRYTKTNVGENFSKQTKMTYRPY
VGFSLKYQFNNQK
>OBAHECAF_01204 hypothetical protein
MKKCLFYLAIGIGLASCSEKKQKPVTTNVKSSVENITQQNQEALDDALLTSFINDVGFDF
LNKCYYERNLNTYIRDEHDNLKEFIDPAIGLRRYHLPGAMVYLSGKDENYGFMDFDDFEF
EPTSQGESTLSVMDVNQDPCELDFNQGRTAYLHLVKELPEYFSQQTNEIEKVVLPYKDAK
IIVMYVMDKYERPKALFFIDTPKGMKLGFVDDAVCGNR
>OBAHECAF_01205 hypothetical protein
MKHKYFILWILVFWQLSFYAQEKKYMVRTIAFYNVENLFDTINDPRTFDDDRTPQGTDRW
TSKVYNDHVQKIAKVIADIGSDVSKQAPDIVGLCEIENEDVIVDLINTDYLKKYNYGIVH
YDSPDSRGVDVALIYKKGVFRPISTSKHVLKIFEPNGKRRYTRDQLLVSGMFDGEMMHFI
VNHWPSRSGGEAASRPKREAAAALNKKIIDSLLAKDPKAKIFSMGDFNDDPTNASFKKIL
KTEGKKNKVKAGGLYNPMEEMLKKGIGSLAYQDAWNLFDQIYFTQELLEEDKSTYRYWKA
GVFNKPYLANPKGKFKGYPFRSMSNGNYTWGYSDHFPVYLYLIKEMKL
>OBAHECAF_01206 Ribonuclease HII
MQLFYHTHKEAGTDEAGRGCLAGPVTAAAVILPENFKNELLTDSKQLTEKQRLILRTVIE
QQAVAFAVAHVFPVEIDELNILRASILAMHRALEQLSQTPDFIAVDGNKFVKYGTIPHAC
IVKGDAKIQTIAAASVLAKTYRDAYMERIADEYPMYQWKKNKGYPTVEHRRAIQEYGITP
YHRKSFQLLPVQMKLEF
>OBAHECAF_01207 Aminodeoxychorismate synthase component 1
MRIEKSFHITGNIKQQIVHWANNQGETMIWLDSNAYADVYHKFDAVLAFAPNAILRLDTP
LGAFDALRSFVDKTRDWIFGYLSYDLKNDVASLKSNNFDGLQFPELYFFQPQKLLFFREN
MVMFSYLSSVSSEIEADWKAMLTAEMFPFSEVSEPNAITARLSKADYMDRVRKMQEHIAR
GDIYEANFCQEFYVEDVQIDPISTYFRLNSISTPPFACYLRFDDCFVMSASPERYLQRTG
ETVISQPIKGTARRSSDVETDRKLRDELEQNPKERSENVMIVDLVRNDLSMYAQKGSVEV
RELCKPYTFKQVHQLISTIATKIKDGTHAVDVLKSTFPMGSMTGAPKLSAMQIIEKLEAS
KRGIYSGAIGYFTPTADFDFNVVIRSIFYNQKKKYVSFSVGSAITAVSDPEKEYEECLVK
ANAMKKVLEER
>OBAHECAF_01208 hypothetical protein
MKKSGLIPTPRIIERLQYENPWWSSQRIPDLYKNMSKRLYFDLFYPFVTEQDIRRAVVLM
GPRRVGKTVMMYHAIDQLIEEGINPQKIFFVGIDNPIYLHLGLQDILELCKEALKIEYLR
GCYVFFDEIQYLKDWERHLKVLVDTYPETKFVVSGSAAAALRWHSTESGAGRFTDFMLPP
LTFQEFIHLKNKNHLIREDVIQYGGQSIPYHLPLDINELNEEFQQYLNFGGYPEVVLSEK
IQKDMGRYVKNDIVDKVLLRDLPSLYGIKDVQELNRFFTYIAYNTGNEFSFEKMSKESGI
QKETLKRYLEYLEAAFLIKVLNKVDINAKRLKRITSFKIYLTNPSLRTALFSPIKAVDDE
MGNMVETAVLSQWMHRENLALTYARWKDGRKEGEVDLVLVDDVRFKPIWGVEIKWSNRYF
EKPQELQSLIQFCKSNGFKSALVTSIDKTGTKEIEDLYFTFVPASVYVYNIGNVTLKMKT
D
>OBAHECAF_01209 hypothetical protein
MKIKKLLLIAFTVPTLWITANAQEEQASKSNKFTFAATLGYNNYESADAPNGLGKSFTPV
QHATSWTNKGSMVGFEAGWFLNDDWRFVGSFGLSYSAYPGYYEVPGVEAEKDNKSEVFVP
AYETIPVQHNLSYAMSIGGDRYFNIEGTKLSWFAGGRMGLAYTQNSKRYNYAEEIEFGSS
VARTWNYRIAAVAGADYYFSDRFFVGAQIEGISYTYAVSSIKPQPGLANRSADHYNLSFF
GAPTIKIGFVLF
>OBAHECAF_01210 hypothetical protein
MKKRIIIPAILSAVLATGLTSCVKDNESDSVKNLREAKAEELRGSAEHKKAEAEREKAVA
AKRLAEAKKVEWEAKIQEHEAAIKEFAVKAAQRSETLAAAGHDDKVKEAQMKAEANRILA
QSAVASATAAYQMALANAEQAAASATVAAELAKTAVLEKKANEYNKALKEYYDVLKGIAT
NTLKATELNRDILRLKQGVVSATALRDKEIAKQKLIVKGLEVYIKELENILGDKDVVTKV
DAEKAQAKWKELLLKKEAFIAGDDLEKLQEAVVKLKKAFDEGDDKFYGKAKKLVEKVRSY
IDEYAISDFDGDGTYDFPYRNDLTFKKFKETVAVEDTDQVKGEVDGVSQTYSKTTVTLKE
LVIDPTESVGFYKAIYRAEQDLRTSIPLSKILFEQLDGTVDVSGSVKEAEKNRKEKLDAY
NTAVKDHGADSYQAKGAREEYLDAEELYRYRYATRAKAKSFYETAGERLDDCRKLIDLVT
NPENAEIVKLKADVEAYNKALEAEAKRWFEEENIAVPVTAAKKVYDALIAIHNKYASFDQ
ELKKAYSEKAEAQGIVDGAKEDVTAEQKVLNQQEELKLVEARIKALEAQAKILETKMANL
KP
>OBAHECAF_01211 hypothetical protein
MRSIKWSYVAEQEYVDVLQFWISHNSSNTYSQKIMKAVEEAEDMLMKNPFIAEEKEDHKD
GNVLRYRKLIILQNFSLIYIVRDMIEIVSFWDNRQNPKQLKSIL
>OBAHECAF_01212 hypothetical protein
MNTHTIQFKKALSFEQYQMAVRVLEAIGLEVYDETRLTEKQKENILRGIKQAEKGETKSY
LEVREKARKICGV
>OBAHECAF_01213 Aspartate-semialdehyde dehydrogenase
MGLQLTAYSLWFALSNFKLIFQYKKSMRVAVVGVTGMVGNVMLEVLEERNFPVTELIPVA
SEKSVGKKITFRGKEYAVVGMQQAVSLKPDIALFSAGGGTSLEWAPKFAQVGTTVIDNSS
AWRMDATKKLVIPEINADVLTIEDKIIANPNCSTIQMLVALAPLQQKYGIKRVVVSTYQS
ITGTGVKAVKQLENEYNGVEGEKAYHYQIHRNAIPQCDVFEDNGYTKEEMKLVRETKKIM
RDDSIAVTATAVRIPVVGGHSESLNIELRDDFNLEEVKQLLSTSAGIQVLDDTTTNSYPM
PLYAQGKDAVFVGRIRRDESQKNTLNMWVVADNLRKGAATNTIQIAEALIQKGLV
>OBAHECAF_01214 Dipeptide and tripeptide permease C
MEKARSNFFDTQVLGHPAGLFVLFFTEMWERFSFYGMRVLLINFLTMAMIGYNPGWQWTT
ENAGALFGTYVMLLYLTPIVGGIIADRFTGYRWAIVIGAVIMTLGHAAMAVETEFWLYVG
LGLLVVGTGFFKPNMTSIISHMYKDLPEKKDGAYTIFYMGVNAGAFFGMMLCGYIAEKVG
WSWGFGLAGVFMLLGTLQFWLARPLFGTVGDVPSKARKEVSEKQYVNKEINDLEKRNPFT
MLDKVLIAIAAIIGLGYAINDPLSRIGGIDLFKFLETQNMKGQYIAVVFGLFVFLFVVIS
RISRYTKIVRNRMITVIIFAFFTVFFWLSFEQGASSLIIFARDNVQRELLGSQAVIFNVV
NALLTVIPLLLITYVLYLLGKKTFSKIFASNIVLLVCFGLVWVVVGWMLKRDFNTVAYSV
SYDAFQVYDSDGKDLKINSEGDFVMKQIPLAIDDTKLASEVHITTKTQKMFKITEVDVSG
KAITKYVPFTDKNTPKGKYEIVEKAIPTIAVPRVNPETGAIVTDKKGEKLYDFYATENNT
YSLVSKETIIGETDARFEMGQDIFMLPRNNDFSSFGYVDAEKMAWAKERAASLHANSGVV
KAVVREEKSNWVEITTSWFSILNSFFIIALANLFSRWWDSRYNPPAAVKYGLGLIIMAIG
FGLLALGAHGVTEGVKVSMVWLVLAYLFHTMGELCMSPVGLSYVSKLVPARMIAFMFGVW
YLAIAIGNKVAAILGGQIENITNQYSLSTFFLIFTIVPVVAGLLIISLNPLIKKLMHGVK
>OBAHECAF_01215 hypothetical protein
MKNNTYQEQFFSWAGLFALSLRLVIGWTYFSAFWRRMVLEDKLSPEVAGYVGEKFNHFLP
NALGIKPLIEYLVSNPDKLEFAMIAFTIVEAIVGLFIMLGLFTRLMSVGVFSLAMGILLG
SGWLGTTCLDEWQIGVLGLAGGFTIFLTGGGFYSLDDFLMCKNYAFTSKKWFNYLGSGIL
TIKQLKPLVLVFSLLIFSITLFTNQYFHGGVFGKLHNKSVKPKVEISNVMLADNELTFEV
FRVEGADVYGSFLIEIQILNEKGEVSKSWNMNYLSKFPQEKINNYYVAKVKPGKHSLILP
LGAKADLSVSLEGLPKSEVKTLKLIDISGAEWTAEIH
>OBAHECAF_01216 hypothetical protein
MKTTLSFLCLLFATVLYSQEITLSGEVKNQQQKPAEFLNVILKKDEKPVHGALTDVSGKF
SVKIPKGDYTLILEQFGTELFSKNVSLSKNTDLGVIQIDESIQMEAVTVEGRKKLVEQKV
DRIVFNVENSVQASGGDALDALKSTPGVQVRNEDISIVGKNGLRVMVNDKIIQLSGEELT
NYLKSIASDNIQKIEVITTPPSKYDAEGNAGLINIVLKKAKEDHWNTTLRTSYQQGIVGK
LRNGINFSYRKNKFSALADLGYTDGKSKYENDIHFWYPQEYWVNRLDVEGKNKTWVPLVN
LNYDVTQKSTLGVQFMGSFSDIIGNGLTANRAYLYNNSKLMKEYITYQIEPGNTQNLSVN
VNFLQKIGEKGAKLTFDADYFHYKKDRNDNLNTIFHNYQLNTQPKSYVNSLSIQKIDNYS
FKTDAELPVSWGNLSFGAKISRTHTDNIAESDFRDENQIQTLAHKDHFLYTEDTQALYAD
WAKSLGKKWSVKAGLRGENTQTKGVSVLANNKTHKRNFFKLFPTLYIQYKIDENHNISAN
VNRRIHRPQFFSLNPGRLYMNPKSYVVGNPFLQPTYLLGATLNYSYKHWLTFQLTYSNVQ
DNGTQITYHNPALEETKMQWENFANSNEWSASVNINKSLFWWWEFSAYMVVTYENARPYV
AAFPDPMKSWGGYQYLGNTFMLNENKTLQASVSYEYQFPWDNDTSKSSEVSSLDLGIKYL
AFDKKLTIALNANDIFKTNIMTYTRKIKQQGITESYRQYYDTRYLRLSLTYKFGNSKISV
QKREGGNAEERGRS
>OBAHECAF_01217 hypothetical protein
MIRKYISSLALLGLMVTSCQEVKQPITEQETQQKPLTTYVDPFIGTGGHGHTYPGATVPF
GMLQVSPVNGISGWDWCSGYHHSDTLLIGFGHLSLSGTGIGDLNDILLMPVNKEYDLSQL
STGKKDQYPKAALDFRNQVSYKSRYSHQNEKAEPGYYQVFLEDPKVNAELTADQYVAYHK
YTYQKGDTQSVILNLGFAINWDSPTEMFIQQSNRKLDGQNDGNIITGHRFSTGWAKNQKV
FFAIAFSKPIKDLQLQNSGKQISSGQFFFDNSTGEELVVRVAVSSVSEENALANLDLYDK
RTFAEVRQKAHDTWEKHLSSIEIETPVDSLKTIFYTALYHTQVAPVTFSDKNGQFRQQND
EIYSTKDFTAYSTLSLWDTFRAENPLITLLQPKKSSDIISSMLAYSDAINKLPVWTLYGN
ETDCMTGYHSIPVIVEAYLKGVRSFDTEKAFEMMKKTMMGDERGLKFYKQYGYIPYDKWD
ESVTITLEYAYDDWCVAQMAKALGKTDDYEFFMKRSEAYKHLFDPTTGFMRGKSASGKWR
EPFDPKHSNHREATDYTEGNAWQHSWFVPQNPQGLIDAFGGKEKFTTHLEKLFTESSEIT
GDNVSADITGLIGQYAHGNEPSHHIAYLFNKAGEPHRTQYWVNEILKTQYNTTPNGYSGN
EDCGQMSAWYVWSSIGLYPMNPVSGEYEIGRPLFPKAKINLPNGKTFTIIAENVSAENMY
IQSATLNGKSLDRTFITDEELKNGGELKFVMGSAPTNN
>OBAHECAF_01218 Putative fluoride ion transporter CrcB
MYVGLGSAIGGMLRFLCYGLISIRIVKMFPFNTLFVNVLGSFLIGALFVLFQKKNFSAEW
LSFFITGVLGGFTTFSAFSLETFQLIEQNQIGKAFLYALLSVFLGLLACWGGYVVTSLLS
K
>OBAHECAF_01219 ATP synthase epsilon chain
MKVEIVTPEEILFNGEVNAVSVPGVNGEFQMLENHAPIVSVLTKGYVKLYGNIELRESVA
SRFEKGDKKNEFLLAINGGTLELNNNRVVILAD
>OBAHECAF_01220 ATP synthase subunit beta
MSQKGKVSQVIGPVVDVVFAAESELPRIYDSLEIIKADGSKLVLEVQSHIGEDVVRAISM
DSTEGLSRDTEVIATGNPIQMPIGKDIYGRLFNVIGDGIDGLGNLPKEGSNGLPIHREAP
KFEDLSTSTEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGGLS
VFAGVGERTREGNDLLREMLESGIIKYGDEFMHSMENGGWDLTKVDKKAMQDSKATFVFG
QMNEPPGARARVALSGLTIAEYFRDGAGDGQGKDVLFFVDNIFRFTQAGSEVSALLGRMP
SAVGYQPTLATEMGAMQERITSTKRGSITSVQAVYVPADDLTDPAPATTFAHLDATTVLS
RKIAELGIYPAVDPLDSTSRILTPEILGKEHYECAQRVKKLLQHYKELQDIIAILGMEEL
SEEDKLAVARARRVQRFLSQPFHVAEQFTGIPGVLVDIKDTIKGFNMIIDGELDHLPEAA
FNLKGTIEDAILAGEKMLAEVQ
>OBAHECAF_01221 hypothetical protein
MKQIGILLGILLLFSCKNSVDEIKVSEEALLNTQQAEALLQSSQNSSVFDKNLGLLNATS
ASQLPTTGSSGVTLNPPHGAPGHRCDIPVGAPLPNSSNMPQNISQHIPVSENEALPQVSS
EGFAVPQPASLSVDSRGVKLNPPHGEPDHRCDIPVGAPLDSKPMEQVVNQQNQSVEPQVA
PQQIVVDPQSTQQNVGVTAEGFSGKPNPPHGEPGHRCDIAVGAILP
>OBAHECAF_01222 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKMPIEYLPKHLEGKTLMQISDLHTGRWVSNDYLISTFEEMRKYDPDFVVYTGDYVTYKN
KKVLYDKLEEALQHCVKGRLGTIAVLGNHDYGVNWREPKVADSIVELMRSHQIVVLRNER
IQIEGLTFIGLDDLWAGEFNASKAFENYDAAQANVVLSHNPDTCDLEVWQNYQGWILSGH
THGGQCKPPFLTPPVLPVKNKEYASGKIELSNQRTLYVNRGIGHSIPVRFNVRPEITIFE
LEKRK
>OBAHECAF_01224 ATP synthase gamma chain
MANLKEIRSRISSVSSTMQITGAMKMVSAAKLKKAQDAIIAMKPYAYKLKQLLEQLSSAL
GNDSIYNERPQVAKNILIVPITSNRGLCGAFNSNIIKKTLELESTVYKNQKVEFYTVGKK
GNDVLKKTDKVFRYESHIFDNLNYADAAELASELMELYTSGRFDKVVLVYNSFKNAATQI
VIEETFLPIQTVAEEQESSVDYIYEPSKEEIVKELIPRSLKTQVFKALRDSVASEHGARM
TAMHKATDNASELRNQLKLTYNKARQAAITGEILEIVGGAEALN
>OBAHECAF_01225 hypothetical protein
MTSSYVYILVGVGAVLLIGLQIFISRKYSKNRLAKQTGHINQNPLNEEQKRLLTFGAILA
HYRGENLLNLMPNEILDVYQQGLRQQWEITNREQAIQTIGELLHLKSTFRFAPIFEQKPE
ELSKIQKAIAKGLDVEVEQVQEVNSVYGWDLCRAASLAKWCYWCNLITEDEMWTILQKVS
DIAHEHGKSWKEYTISFLLGRTIQGFDLDDIIIETDRVFNSKNPMLGKVEGIDVYKTYSF
>OBAHECAF_01226 ATP synthase subunit alpha
MAEIKAAEISAILKEQLANFDATASLEEVGTVLQVGDGIARIFGLSNAQYGELVKFDNGL
KGIVLNLEEDNVGITLLGPSTDIKEGDTVKRTGLIASINVGEGIVGRVVNTLGQPIDGKG
PITGQLYEMPLERKAPGVIFRQPVNEPLQTGIKSVDAMIPIGRGQRELVIGDRQTGKTTV
CIDTILNQKEFYDAGKPVYCIYVAIGQKASTVAAIAKTLEDNGALAYTTIVAANASDPAP
MQVYAPFAGAAIGEYFRDTGRPALIIYDDLSKQAVAYREVSLLLRRPPGREAYPGDVFYL
HSRLLERAAKVIADDSIARKMNDLPDSIKHLVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLESDLFNSGVRPAINVGISVSRVGGSAQIKSMKKVAGTLKLDQAQYRELEAF
AKFGSDLDAATMNVIEKGKRNVEILKQSQNDPYTVENQIAIIYVGSKNLLRQVPVNKVKE
FEKEYLDFLNLQHRNVLDELKAGQFNDKITATLEDVAKEIAERYTK
>OBAHECAF_01227 hypothetical protein
MRKSLFIIIMGALFFSCNKNNEKINNEENSEVGCCKHLSSSASFSVVDNQGNDLLSPFNE
KFDPKNIKIYYKDKNNKLELFDRPNLAEPKGFTFIAPEKEGQKYLINVFINSLYIEDKIS
HTVIDLGYKKYEIKSEFSVTTNAIVLQKIYVDNKLMNFQNNRIVTIVE
>OBAHECAF_01228 ATP synthase subunit delta
MYGFRAANRYAKALLEYALQQNAVESVFRDMSSIHKTIDENKELDNLLVSPVVKTVVKKN
VLDKVFVGVSPEVQRLFTLLIENRRLPILKQIAEKFVIHYNSYKNNETAEVTTAIPLTEE
MKKQVLQKVESLKQSRNITLVNKVDESIIGGFILRIGDIQYNASVAFKLNKLRQEFQ
>OBAHECAF_01229 ATP synthase subunit b
MNFTNPESFLFWGTLIFGVLLFLLAKFAWKPILSAVKQREESINNALEAAEEARKQMADL
KADNERLLAEAKAERDAMLKEAKELKDKIVAEAKEEAQKEGQKLIDQAKQAIDNEKKVAV
AQLKDKVASLSIEIAQKVIKNELSDKEKQTTLINEYLKGATLN
>OBAHECAF_01230 ATP synthase subunit c
MVLGGIGAAIAALAAGFGIGKIGAAAMEGIARQPEAASKIQTAMIIAAALIEGVALFAVV
VALIAK
>OBAHECAF_01231 ATP synthase subunit a
MVAKNIIQKFVLFLLFFIPFQGFSSDANKDKEEAFDPVSMIMHHISNSHEFHITDFQGKS
ISMPLPVILWTDNGLVTFMSSEFHHDNDGKVVVEKKGMKFARFHEVIHYTNPDGSLSFDK
DGHVTNTRPLNFSITKNVFSMILVSILLLAIFIPMAKSYKKNPKAPKGMAGFLEPLVLFV
RDDIAIPQIGEEKYARYMPYLLTIFFLIWFGNLFGLIPFFPFASTLTNDILFTGFLAIIT
FFVTVFSSNKNYWKHIFATPGVPFWLLPIMIPVEILGMFTKPFALMVRLFANITAGHIII
LSLISLIFIFKTVWVSPVSIAFALFINVLELLVAALQAYVFTLLSALFIGQAVEEHHH
>OBAHECAF_01232 hypothetical protein
MKKFLFLSVLLGALACSKEKDVKLCCSPPPIFNLYISKSSDSYKEFLDSEGKFDTKNVSL
YRMNGNVKKEYPVAEVSPLLKENYLSVGTHLDRINDVYTGKKEILYLKNASRTYKIEVEG
AMVSRNGCCPVAEVKEIRVDGVKIENDFLVK
>OBAHECAF_01233 4-hydroxythreonine-4-phosphate dehydrogenase
MKDELVRVGISIGDINGIGMEVILKTFEDPKILELCTPIIFGSNKTVSFQRKHFELNTNF
QGIDKIEDAIVGKLNVLNCWKDSPSIAFGQVTEEAGKYAFLSLKRAVEALKKGDVDVLVT
APINKNNIQSEEFTFPGHTDYLAKELNGKSLMFMVSEDLKVGLFTDHVPLKEVSSHITES
LIFEKIKAMNESLRKDFRLHRPKIAVLGLNPHCGDNGVIGNEDDEVIRPALKKLFKQGIL
VFGPFSADSFFATQNYRNYDAVIAPYHDQGLIPFKTLSFGSGVNYTAGLSRVRTSPDHGT
AYEIAGKGIADADSFRQAVFTAMDIFKNRIEYDELNHNPLKINDLEAEK
>OBAHECAF_01234 hypothetical protein
MIYKIILSLVVSIAVCGIFTVLFYQFLLWLNPPYVIVDGQIRYTMPLGTVIFSLLFGVIV
AIVTFILCLWKLKRQN
>OBAHECAF_01235 hypothetical protein
MKRILSFITLVFFVTASAQVQTISKPDYEKADFTNLTTLQNDLKNVRIVGLGESSHYMGE
TYVSKIKMVKYLHQHCGFDVIAIESPLYDLKKYYNETIKNNQVKTPWHFTEISGVWITDD
MYELFDYILETQKTDRPLIYTGFDEKLFYKFDYKLNDDYNEFLEKLNADTDSNIKTDSLF
KKALNFTAEKCYYFAKVPPKDTLVLHNTFNEVKKALNKLETKNGYYYFWERMTENIKSLY
RTNYKGLSHRDKQMAKNVSYLANYEFPDKKIILWAASIHLMDNITKINQYDEKRFAKDYT
MGHFLREKFKDQYYVIGFVPATGITGFKGYLGLGKLRAKAKKGSIERHILDNYNPDYAFI
SLRNEPSRKEITENNIKKSNLLGLTPYEMDMLSVVDAFFYLKEEHLVSFEKRKAYFKKER
EDLERTADTSNK
>OBAHECAF_01236 Glutamine--tRNA ligase
MSEEQKSNNFIENIIEEDLANGFSSSKLRFRFPPEPNGYLHIGHASSICLNFGLGLRYQS
PVNLRFDDTNPSKEEQEYVDAIKRDVEWLGFDWERECYASDYFQELYDWAVQLIKQGKAY
VDGQTSEEIAKQKGTPTQAGTESPYRNTSIEENLQLFERMKNGEFENGKYVLRAKIDMAS
PNMLMRDPIIYRIMHSSHHRTGNQWCIYPMYDWAHGESDYLEQISHSICTLEFLPHRELY
DWFLDQIIDKDKVRPKQREFARRNLSHTIVSKRKLLQLVNEKHVSGWDDPRMPTISGLRR
RGYTPESIRKFADTIGIAKRENLIDVSLLEFCIREDLNKKANRVMAVLEPVKVVITNYPE
GKEEWLDAENNPEEEVLTFRKVPFSREIYIEREDFREEANNKFFRLKLGGEVRLKNAYII
KAESVVKDENGNITEIHCTYDSDSRSGSGTEASKRKVKGTLHWVSVPHALEAEARIYDRL
FTVAEPDRQEKDFLEYVNPDSLKVTTAYVEPSLKDAKVGEGFQFQRLGYFSLDPDSTAQK
LVFNKTVGLKDTWAKVENADI
>OBAHECAF_01237 putative propionyl-CoA carboxylase beta chain 5
MDIQFNKNEDFNKLSVSDLHKRLAKVRKGGGEKSIQRLHDQGKLSARERIDYLLDKDRDF
IEIGAFVGEGMYVEHGGCPSGGVVVVVGYVSGKQCVVVANDASVKAGAWFPITGKKNLRA
QEIAIENRLPIIYLVDSAGVYLPMQDEIFPDKEHFGRIFRNNAVMSSMGITQIAVVMGSC
VAGGAYLPIMSDEAMIVDKTGSIFLAGSYLVKAAIGEDIDNETLGGATTHCEISGVTDYK
AKDDKDALDRVKRTMSKIGDYEKAGFNRETPQKPLKDPKEIYGILPISRTEQFDMKEIIL
RLVDNSEFDEYKEGYGQTLITGYARIDGWAVGIVANQRKVVKNKKGELQFGGVIYSDSAD
KATRFIANCNQKKIPLLFLQDVTGFMVGSKSEHGGIIKDGAKMVNAVGNSVVPKFTIVIG
NSYGAGNYAMCGKAYDPRFIVSWPSGNIAVMGGAQAAKVLLQIETASLKKKGEEISKEKE
EELFNQIKSKYDEQISPYYAAARLWTDAIIDPLETRKWISMGIEAANHAPIEKSFSLGVL
QV
>OBAHECAF_01238 hypothetical protein
MKTKDIFIALVVLFSVNSYAQLLKHTFDEKGETYIQAGIRGQFWGRYVATNPGTTINKEP
VSETFDFSVRRYRISFQAQIKKNLFFYMQLGNNNINQKTIRSSDVRLLDMLGEYTFSNKF
KLGVGKLSFTGAGRFVDIANGSMLNLDPSVHQLFTLNQLDDTGRNIGMYAKGQLGKFDYN
VSIHSMAIPTDAQVTDLNYSRKYTSLGYSTYVKYEFLEDESNRTPYSGGVGTYIGKKKIL
NIGVGYGYKSKMFERTVGANKTYDDHRNLGIDFFMDMPISAKNNAITAYLGYNNLFFGED
YVRNIGVNSIFDSSGTSFNGGGNAFPVIGTGNTLLLQLGYLLSKSEKNNTRYQPYFGWKL
ADFEGLNQSVNSYALGLNVYFNGHRSKLTFGYHNRPIFDATTKKVDSRKGTYIIQYQIEI
>OBAHECAF_01239 hypothetical protein
MTNVLDKFIQDMKNNVPGFIAVSVTEVRSGVSYGAETVNPNFDPTLASAYNLEVVKAKQN
ALQVLGLTPKERIEDILITLTDQIHIIDISASGAYFIYLAVDSTRANLGLTRALLSKYKK
DLAAIF
>OBAHECAF_01241 Dihydroneopterin aldolase
MGQIILKNIRVFANHGCLTEEGLIGSDYRVDLKVSLNLQKSIESDELADTINYVRLNSIV
MEEMAIRSKLLEHVAGRISDRIFLELADSEKITLKISKLNPPIGGDVESVSIKIKRKRVC
>OBAHECAF_01242 hypothetical protein
MKKILLFVFMVIATGGKILSQELHLPQMNQYLADSEFLVTSTYAGIGDFIKLRFSGVSQW
VGVKNAPDYQSLSGDLRIGERSGAGLILYNDKNGNTRQMGAKGSFAHHLTLDRYENHFIS
FGISYALNSFRIDIDKFDTASGIDPSVTNNRSRINHNFDVGVLYRYKGWFASLNALNILN
KDVDIFATNEPKGLRNYTVYAGYLYKMERNGSFEIEPSTFIQYYESDGRSSTDLNLKLRW
RNMEDYYWVGANYRFLNDQILAPLNVGPMAGLKRGYFYFAYSYQVTLNELIKYNSGTHVL
TIGLDLFQGISNCKCTHR
>OBAHECAF_01243 UDP-glucose 4-epimerase
MKIVVTGGLGFIGSHTVVELQNSGFEVVIIDNLSNSSEDVLPRIVNITGKKPIFEKFDLR
DKNAVIDFFKRHQDVSGMIHFAASKAVGESVENPLLYYENNLSTLVYLLQELTKLKKAHF
IFSSSCTVYGQADELPITENAPVKKAESPYGNTKQIGEEIISDTCKVTPNLHAISLRYFN
PIGAHPSAEIGELPIGVPQNLVPFITQTGIGLREKLSVFGDDYPTPDGTCIRDYIHVVDL
AKAHVVALQRLLEGKNTENYEVFNVGTGTGSSVLEVINSFERVSGEKLNYQIVGRRAGDI
TAAYANTDKANNILGWKSKSTLDEAMASAWKWEKKVRGKE
>OBAHECAF_01244 Small-conductance mechanosensitive channel
MEHFTAQDFEKLLKEWITSLIDFIPTLIGAIVFFIVGKYAIRLIMKLLKRVMERRELDSS
LQIFLTQLVRWVLYIALFLIIIQIIGIPATQFFAILASAGVAIGLALQGSLSNFAGGIMI
LILKPFRIGDNIEAKNERGTVKSIGLFYTTLNKFNNEEVIIPNGPLFGDSIINFSREDKR
RVKVMVGIGYDSDLQKAKEILLNIASQDKRAFDTPAPVVFVEELADSSVNISLRYWCNND
DYWNCYFETIEQIKLRFDEEGIEIPFPQRVLNIRNEGNGQNV
>OBAHECAF_01245 Aspartate--tRNA ligase
MYRTHTCGELRLSDVNKEITLSGWVQKIRNKGFMVWVDIRDRYGITQLIFDEERTSKNVL
ELATTLSREDVIQVTGKVIEREAKNNHIPTGEIEILVSELVVLNKSELPPFTIEDNTDGG
EDIRMKYRYLDIRRTPVRNNLIFRHEVAMQVRNYLSKEGFIEVETPVLIKSTPEGARDFV
VPSRMNEGEFYALPQSPQTFKQLLMVGGLDKYFQIVKCFRDEDLRADRQPEFTQIDCEMS
FVEQEDIINTFEGLTKHLLKEVKGISIEKFPRMTYAEAMKTYGNDKPDIRFGMKFGELND
IAQHKDFKVFNEAELVVGIAVPGANSYTRKEIDALIEWVKRPQVGASGMVYVKCNDDGSF
KSSVDKFYSEEDLQKWAERTEAKAGDLICILSGKADKVRGQLSALRMELAERLGLRKADE
FAPLWVVDFPLLEFNEEENRFFAMHHPFTSPKPEDIPLLNTNPAAVRANAYDLVLNGNEI
GGGSIRIFNKELQAKMFELLGFTSEQAEAQFGFLMNAFKYGAPPHGGLAFGFDRLVAILG
GQETIRDFIAFPKNNSGRDVMIDAPSPIDSTQLDELHIRLK
>OBAHECAF_01246 Thiol-disulfide oxidoreductase ResA
MRTLLFIVLTTLFSFKEMYAQKKLKLSGEVVGAETESILLAKPTQSVFTDAVIEIPVKNG
KFYYESQLEFPEAVELYFSEIRKKGSGSIMELFLENEEIHLTLYDEEEFNKNIVKGGKLN
AEHKKYTDDFNRKFEHLFQPIIDSLDVLYENDLYHSKEVEELYKQLDDKTGVEKKLIYEK
IEALTKADKHLSPEAKKLNDRLKPLNEEAKAYRQEYIEKNPNLIAYSFLLKDLMYKREQM
DISYSKRVAKKLVKANPNHPYNKLVVELVASLENIKVGQKFVDFTAPDLNGKQVQLSKVI
QGKITLLDFWATWCGPCIATTRMMIPIYEAYKDKGFTMVGVAGEFKNTDRLTQFLEKEKW
DWLQLVELDKQNKIWQKYGMQNKAGGVFLIDEKGTIIAIDPTAEEVRKELEKRLDKN
>OBAHECAF_01247 hypothetical protein
MKKYLLVLVILISSRCLGQDNIGIKFFGLSFHPLGERQNAHLMPNKLDRNAYFVLNLGAI
ISAEKFVYEGISIKFAQGIYADCAVQFGGFSHIGIRFRIFEIQRHKLSGGLGPTLVFRKN
WQKLEGYHNPNVFKGSKESRWQYLFLWYGGEFEYKYALNERFDLTMSFVPGYPDLISLSF
GVNYNL
>OBAHECAF_01248 D-aminoacyl-tRNA deacylase
MRAVIQRVSNASVSVSNQSVSSIGQGLLILVGIEDSDTLEDVQWLSAKIVNMRIFDDQNG
VMNLSVKDIDGEIITVSQFTLHASTKKGNRPSYIKAAKPIISVPLYEQFVEQLTSDLGKT
IGTGVFGADMQVSLCNDGPVTIIVDTKNKE
>OBAHECAF_01249 Tat-linked quality control protein TatD
MELLNSKTLNLLFDIHTHNESSSGNIVIRNEFPFSINKEGFFSVGIHPWYFSEDDWQSQW
ETVTKKVKYEHCAAIGECGLDRNVKYPLSLQQTIFERHIFLSEEVKKPLIIHCVKAYSEL
ISLKKKYQPQQAWILHGFNKNQAVATTLINENIKLSFGKSLLTNITVQEVFKSIPEGSYF
LETDDSGLDIAEIYQKAKQLRGLVQIQFDYPKIGIMM
>OBAHECAF_01251 Epimerase family protein
MSKELILITGGNGMFAKELCKVLKMSYEVRFLSRKANKPNHYRWDISSGFIDERAFDGVQ
HIVHLAGASIGEKRWTKSRKQEILDSRVQSAEILLNALKKHRIRLKTFISASAVGYYGTK
TTENIYTENSPKGNDFLSDVCQQWEAVADKFNILSDRVLKLRLGVIISKNGGILSKMLPI
TKIGLGAVLGNGKQYIPWIDIADLVDVTQFLLEEKNASGVFNIVAPEHVSNKNFTHSLAM
VVGRKIIFPPLPKYLIKCLFGEVSVLLLQGSRIHAERLEKLGYDFQFKTLLASLKHNLS
>OBAHECAF_01252 GTPase HflX
MLEQMNLNYEKVVLVGIINQTQDEEKSKEYLDELEFLTYTAGGEVLKRFTQRLDVPNPKT
FIGTGKMEEVQLFVEENGVGTVIFDDELSPAQQKNIERILKAKILDRTGLILDIFAQRAQ
TSYSRTQVELAQYQYLLPRLTGLWTHLERQRGGIGMRGPGETEIETDRRIVRDRIALLKK
KLSSIDRQMAVQRSNRGALVRVALIGYTNVGKSTLMNVISKSEVFAENKLFATLDTTVRK
VVIGNLPFLLSDTVGFIRKLPTQLIESFKSTLDEVREADLLLHIVDISHPNFEEHIQSVN
QILTEIKSADKPTIMVFNKIDAYTHESIADDDLTTEFTKKHFTLEDWKQTWMNKVGDDVL
FISALNKDNLAEFREKVYAKVREIHITRFPYNNFLYPEFVEISEDE
>OBAHECAF_01253 Methylglyoxal synthase
MKLAVIAHDGKKAEMVSFLMKNLTTLHSANIQIIATGTTGQHAQNAGLQVEKVLSGPKGG
DAQIAAQIVEGKVQGVFFFRDPLDKHPHEPDILMLMRICDVHNIPIATNPATAELVLKGL
AEKSE
>OBAHECAF_01254 SCO1 protein 
MKMRGIYALFLLLGMIACQTKEKPEIVTIGKAPSFTFTNQNNQTINNETYAGMVYVVDFF
FTDCPTICPVMTNNMVKIQNELKDKNVGFASFSINPEEDTPEVLKAYAQKKGATSANWHF
LTGEVDAIYDLSNKGFNLHVEEVAGDIHRFEHSGLFALIDQHGNIVSRKGKDGKPIIYYN
GLNDSQVKMLIEDIKSLIE
>OBAHECAF_01255 hypothetical protein
MKTLFYIFISILMISFSGCGQKKTQKQDTEEMSADENVTIEMKVVRVSNAKEFVNALASH
TEIIIAEGSHIDLTQYIEAVVDGSEQLNYREQESSYFEIEEIGDGHQLVIYDMENLIIRG
EGKTPIPVQVAPMYSFVFSFKGGTNIHIENLDAGHTEGGYCDGGVFQFVNCSNVTIHKTI
MYGSGTEGIQAIDSYDLKCTESVIKECTYSIMTLDNIFNAVFEDCKFHNNKEFTLVNVRN
SNNVQFNRCHFYDNEGTLFDLGNQITLKDCQIDHPKSKLGDMGSCIVE
>OBAHECAF_01256 hypothetical protein
MKRLLSIWIMVLFAVQPIFGQATAQKFKKTYKNQNESNVAWFATYVDDPDTNGTNLRETP
GGKVGKVIHPSLEESRVFTVSLLESWEGWFRIGQEIEILDEDTLVLGKSLWIHGSLLKAS
TTNYDGEVLSFYQKPDRKSKVVFTVNTEVSVSFVAIEQGWAKVKYVSPTQKVYVGWIPIE
QLCGNFVTNCS
>OBAHECAF_01257 hypothetical protein
MKQIVLKISIILFSVLLIACKNQSAKSKDTLSASEEQKVSLPELKAGEENVFENNLFRLV
DGGTVETSDGIYNTLKVQPKNSSIATFEIEGTVLTFEGVVGSTLLVSEGTGTVGLLTLFD
LTSGKEILQIENFTSDELSVENDNAFYYYAYDQDLPTVAWSEAKKVWEPVNKVPKTLLES
QELKDVAENNENLFEGMPMMAKQKIRVDIQQKKIIPLNEYKWLYIE
>OBAHECAF_01258 hypothetical protein
MKTISYFLVAVLLLGACKNTKSNNETESVSTDEQTLIQTLKEQLIASDNPLERIKINMQI
TDLQFKNASEEDRPKLYYDMTTFNWVELDRINEKESEYLENYYSYRFDDEGESREPHDSI
KQKEKPYLEAGLVFEELGEGLVQLVFSEDFYNKYEKQLSEDYQEYLRLERDATNIAPDAV
LILAWEDIADLIVRYEAYAEKYPQNIGLFKMLAGNYEFLQQAFVTGTDNTLIVDENGQLL
SELKTEWLRFSKAYPKSPTTKLIQIALAEKQYAEPHIYTLIEKINKAQSVSDDPYMSNKQ
>OBAHECAF_01259 hypothetical protein
MKNCIYSLTMVLLLGILVPAQAQVLDRLAKKVNSKIDNQASKTTDRNRTSTTPGKTYYVS
ATKGSVRADGLSKDKPLKDLQKAIDLAEEGDVILVAEGNYLGNMDRGYIECGKFGNGADN
GKFLKFYGGYSSDFSERNPVKYITKIQPNASIPKGIGSALFHITARRAYGDKRPAGEVVV
DGFTFDGGEYILYYKPDVKDPRTGTPNAEVETGMLVHPDALAGNAMGVNKHDWRALHLTV
EGNVKVQNCVFVNCRNFGLQGGMGAGHIEVSNNVFVANRYAACEIWGTLAAGREGEISFD
FHHNTVLFSWPITKEFETMGQGFRFMNGIRTINVYNNIFAFNSRCGVERCRYENKKELEK
LKQSNLYDNYFLGNMYDLEICDSSRPINVPASRIEEAEEIGPKYEGNKEMPFNEAFIAAI
DAPYLKGFTGLKISTTESYDANSSANQLNRFLGLNQQGTSTTRVTMFANRYPWQKARNLF
GVVKGYGAQEIK
>OBAHECAF_01260 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MNHTITTTQFNFPGQKSVYRGKVREVYHLENDLLVMIATDRLSAFDVVMPKGIPYKGQIL
NQIATKFMQQTEDIVPNWLIATPDPNVAIGHLCEPFKVEMVIRGYLAGHASREYKAGKRI
LCGVALPEGMKENDIFPHPIITPATKAENGEHDEDISKEEIIRRGIVSEEDYALLEKYTY
ALFARGSEIAAKRGLILVDTKYEFGKTKDGQIVLIDEIHTPDSSRYFYKEGYDERQEKGE
PQKQLSKEFVRQWLISNGFQGKEGQQVPEMTDAYVLSVSERYIELYENIIGEKFVKADVS
NIQERIFNNVMNYLSTNPLSK
>OBAHECAF_01261 Nitronate monooxygenase
MTNRITELFDIQHPIIQGGMVWASGWRLVSAVSNAGGLGLLGAGSMYPEVLREHIQKCRK
ATNKPFGVNIPIMYPDIDKLMEIILEEKVEIVFTSAGNPTLWTQILKKEGVKVAHVVSSS
KFAIKAQEAGVDAIVAEGFEAGGHNGREETTTMTLIPSVKQHIHIPIIAAGGIATGRGML
AAMALGAEGVQIGSRFIATDEASSHMNFKKMVLTADEGSTILTMKELAPVRLLKNKFYEQ
VKALYDRQEATPENLKVLLGKGRTKRGMFEGNLDEGELEIGQVASLIHEIKPVKAIFEEI
IDEYNKALKSLSQII
>OBAHECAF_01262 Sec-independent protein translocase protein TatA
MSFSEIFFILFIVLIVFGADKIPEIARGLGKGMRQLRDATNEIKSEIKRSAEQNNIDTSV
FEDTKNEIDKVKEEIQEATSSLTGSVKRQR
>OBAHECAF_01263 hypothetical protein
MTAKSKAFLFNFLCFGLIFITIRLGINYFFPELERLTASIISGVVTLFLSPRFAAIQTDS
GEKLFMKWIFIKGIKQL
>OBAHECAF_01264 hypothetical protein
MATNKHAQIRYQALDRCFRNTGRKYFIEDLVEACNQAIYEYSGIAEGVKKRQVQEDISFM
ESEAGWSIALERCREGRRVFYRYEDSRYSINNQLLNETEIRQLKETICMLNRFKGMPQFG
WMEEILTRFEDSFKLKGSVVSVVGFEHNPYLKGLHWFSHVFNAIINKQTVELHYRKFNDE
TKKYVFHPYFLKQYNNRWFLFGLCNHLKDKGMITNFAIDRIEHISMVSVPYVENTFIDFD
EHFENIIGVSVLDKEVETIILEVDNVLMPYVITKPLHGSQKIKQKNERTTRIELQLIINY
ELENLLLGYIDKIKIIAPNHLKEKILSRIKEAIDRNS
>OBAHECAF_01265 hypothetical protein
MAVSKFYTTFNIAGFTYWDGVDVIDELKVGTVLQLEAEPTNGYDANAVKILYGNTMLGYI
PRTDNKDITKFLQLGHTDLFSAKISRIDMNYNPENQIQVTVRINPKK
>OBAHECAF_01266 DNA replication and repair protein RecF
MNTNMYLKKIAVVNYRNISTKNLLFESGINCFVGNNGVGKTNLLDAIYHLGVGKSYFNPS
ASQNIRHGEEFYMIEGLFERENREEQIVCSIKKGQKKIIKCNGKNYDRITEHIGKYPMVI
ISPADTDLIVDGSEVRRRFLDNVISQSDTAYLDTLIRYNRVLLQRNTILKQFAVNQYVDL
LTLGIYDKQLAELGQHIYQKRTQFMEAFLPVFQYQYEYLSEGKEQVSLSYESALHTTSLS
ELLKQNLEKDRILQYTSQGIHKDDLLFEIDGFSMKKYGSQGQQKSFLIALKLSQFEVIKQ
QLRVTPIFLLDDIFDKLDDKRVEKLISLVTQQHFGQLFITDTHYDRTESVVKKRGVPYQI
FKI
>OBAHECAF_01267 putative epimerase/dehydratase
MAKTRILLTGAGGQLGSELTEALAEKFGAENIVATDINEKVAERFSYCTFEVLDIQDAQR
LEQLVDTYRITQVYHLAALLSAVGERNPLFTWNLNMNGLLNVLEVARKKNLDKVYWPSSI
AAFGVNTPKENTPQETVTEPNTVYGITKVAGELWCQYYFEKFGVDVRSLRYPGLIGYKSL
PGGGTTDYAVDIYHKAIAGETFSCFLNENTYLPMMYMPDAIKATINLMEAPKEQVKVRTS
YNVSSLSFSPKEIYDSIVKIIPDFKIKYEPDFRQNIADSWPDSIDDSAARNDWGWNHDFD
LDKMSEDIIKNLK
>OBAHECAF_01268 Endonuclease MutS2
MIPAYKKQLEKAKDLHQKYTKIYNIIGAVRLCVAISILFLGYLSFTNFSLLYLVGIFFFV
IFFLFLVVKHKKISYLRKIEKSKIDINQKEIDFLEKGVYFYDNGFDFQDKEHPYAYDLDI
FGEKSLFHYINRAVTFSGKKQLAAHFLRTDNKYIPEKQATIAELSEKLEWRQDFMAVASQ
APDNQHTAEKISTWKERKEVLFSFPLRVFIYLSPLLLLSFIILGYIFDYADMKMWANTLF
VINLMVFGWELRHILKNKQGFEGIYDTLYSVRKNIELIEKESFKSKQICELQQQLIQNNQ
RASELTRSLARLLDNMDNVLNIFSWVLNGFTLYHLHQYNKLILWKKINAEHVATWLDVIS
EMEALCSLANFKYNHPEFVFPELNAHFEVSFVGIGHPLIAENQRVTNSISFKENRFVILT
GSNMSGKSTFLRTLGVNVLLTSMGLPVCAKKANVHPMKILISMRLSDSLNDGKSYFFAEI
DRLKQIMQTLQQEPCFVLLDELLRGTNSEDKQSGTVKIIEKMVELNAIGIIATHDLEVCK
LESEYPHHLKNQCFEVEIINNELHFDYKLKEGVCQNKNATFLMKKMGII
>OBAHECAF_01269 Peptide methionine sulfoxide reductase MsrA/MsrB
MKSETMKEIYFAGGCFWGTDHFFKQVRGVITTEPGYVNGHTNKPIYEEVNTDTTGYAEAV
KVIYDPKEVRLELLIKLFFETIDPTSLNKQGNDVGTRYRTGVYYTNAKDKAVTDAFFNKI
ERMYFRPIVVERKPLEVFYPAEDWHRDYLIRNPNGYCHIEPHLFAYASKANPKKPRYKRE
SQSFLKKKLTPLQYAVTQKKATEQPFDNLYWNENRKGIYVDITTGEPLFLSSDKYDSGSG
WPSFTRPIDDSLIIEKPHKSGGKTRVEVRSKTGNSHLGHLFNDGPLHKGGLRYSINSASL
RFIAKEDMEKEGYGIYLFLFME
>OBAHECAF_01270 hypothetical protein
MNTFSDYHFRIATTDDFSAIWEIILFAKEIRKQEGSSQWQDGYPNGATIFADIQNKYGYV
VEFQSEIVGYFAFILGAEPAYESIDGKWVSEQPYAVVHRMAVSAKGKGKGLSKRMLQKAA
ELSVDNNTFSLRIDTNFDNIPMLRTIQTLGYVYCGEVYFRGSARKAFEKVLR
>OBAHECAF_01271 hypothetical protein
MSRQKFRHTILKMLGLFSSVRGYNILMVCIAQYLAAIFILSQRDSVREVVFDINLLILVA
AGALAIAGGYIINGFYDKEKDLINSPLKSMVDRLVGQNTKLTLYFLLNFISVIVASYVSF
RAVMFFSGYIFLMWFYSHRIKKIVFWGNLTSAILAIIPFFAVFVYYKNVHTVIFIHALLL
FLLILIKELIKDLENLKGDLVHNYQTIPVKYGENKSKIVISLVVCVCFSPIYVLLNHFDI
GCMYIYIIFVAISLLFFIIALWKSNKNRTYVLLHNLLRVILTIGIFSIMLVDMDKLTRIL
F
>OBAHECAF_01272 Iron-sulfur cluster carrier protein
MIKIEKKDVISALTKITTPGEGKNMVDSGAVQNIVIFGDEVVVDVVINNPSLQAKKRTEV
EIMKAIHSEVYEKAKVFVNVKVIAPEKPEIKGKPIPGIKNIIAVASGKGGVGKSTITANL
AVSLAKMGFSVGLLDADIYGPSMPIMFDVIDEKPKSVTVEGHSKMKPIENYGVKMLSIGF
FTNPNQAVIWRGPMAAKALNQMIFDADWGELDFLLLDLPPGTGDIHLSIMQAMPVTGAVV
VSTPQKIALADARKGVAMFQQDTINVPVLGIVENMAYFTPEELPNNKYYIFGREGAKNLA
EDLNVPFLGEIPLVQSIRESGDVGRPAALQENTPLALSFKQLSQNVVQSVVERNRSLPPS
EAIKITTMAGCSK
>OBAHECAF_01273 Fe/S biogenesis protein NfuA
MIHSEISKKMTTEQVRENVLRALDEIRPFLQSDGGDITLVDIEDDRIVKVRLEGNCLGCS
VNQMTLKSGVEMTVKKYVPQIESVVNIL
>OBAHECAF_01274 Murein DD-endopeptidase MepM
MSSQKKNKKEYIRRKLLSKYRLVFMDEETYEEKASLRLSRMNIFVVGTLFSLFLIIATTL
FIIYTPLRQYILGFSEVNNKQETINLAFKIDSLENQMRKNDLYLNSIKKVLTGDILYTQI
NKDSIYESNKIDPKTIDLSPSRQDSLLRQEVAEEDRYNVFEKALYQNKEILLFPPISKGV
ISNEFKPQERHFGIDIAAPEGTAVKSVADGTVIFAEWTVATGNVIIIEHKQNLVSVYKHN
ATLVKQQGDQVRTGEVIATIGNTGEFSTGTHLHFELWSNGYPANPRNYIEFK
>OBAHECAF_01275 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MNKKIILALLILSPIYFLIQIFFFDMKYINDEEIIFGWDRENMRFQINEKKPFELNGIDG
PYIINDTLYYVDENNTLVKSIEIKDSLRVQVPNKDKSTFYFSLNKQLEKDSVAYPMPEKL
IAISDIEGNFDAFCGFLEKNGIINQSFSWVFGKGHLVLNGDFVDRGEHVTPTLWLIYKLE
QEAKKQGGKVHFVLGNHEIMNFQGKYKYADHKYIKLAQLIAPNKSTKESYKILYSKKSEI
GKWLRSKNISVKIGNYLFVHAGLSPEIIPLRLTLGDINEITRENWDKDLHNKPENDSVAN
FLLGRKGPFWYRGLVTDYKYYSKATSEELEQLLEAYQVQKIVVGHSIVEAVSTDYKGKVI
HIDVKHGKEKYSPKTQGLLIEKGGAYKVDATGNKQQL
>OBAHECAF_01276 hypothetical protein
MYITKNRLFGIALLCKKSSFSMYYSTKENVLQIQTNCNTYYIYTNDTTHLFSVFYT
>OBAHECAF_01277 Undecaprenyl-phosphate alpha-N-acetylglucosaminyl 1-phosphate transferase
MDNPNERSSHTQRTPTMGGIAFFISIIFTIFFIRDYDVDHIGTNIISSVSILFFIGLKDD
LVGVQPKTKIIGQVLSTLILFYGTQLWVRSLDGFFFINEIDFWISVLLSCMVMMAIVNSF
NLIDGINGSAAMVGIVIFASFAYIFYLSGNHYYCLLSALCIGFLLAFLRYNLSEKKKIFM
GDTGSMIVGFIIGFLVLKFFSLSPEELVKAHIKPINKIWVVLAVIFIPFFDTTRVFVTRI
VRHGKPFLADRSHIHHVLIDYTGLTHGKASLFLAFINLVVLVVILYLNTIFSSTYVFLFL
SAIFVGLALLLFYFNRSYNTRKSKQKIRRILNKTGLSKHKK
>OBAHECAF_01278 DNA mismatch repair protein MutS
MSKKATKETPLMKQYNQIKSKYPDALLLFRVGDFYETFGEDAVKTAQVLDIVLTNRNNGS
ERTELAGFPHHSINTYLPKLVKAGYRVAICDQLEDPKTVKGIVKRGVTELVTPGVALNDD
ILHSKSNNFLASLWFGKTTNGVAFLDISTGEFLVAQGDRFYIDKLLQNFKPSEILIAKKQ
KKDFIDSFGEDFHLFFLEDWVYKQDYANQVLTQHFQTNSLKGFGVDELSEAILAAGSILF
YLSETQHNKLQHITSIQRIVEDAYVWLDKFTIRNLELYTGTSSQSVTLLDIIDKTTSAMG
SRTLKRWLALPLKKINQIEQRHEVVAHFMQHIDTLHKVKEQVAKISDIERLISKVATEKI
SPREVVQLRMSLEAIPPIKQLCVLSDNEHLKALGDRMHACEQLCLRIKNTLFDDAPVNIL
KGNVVAKGFSADLDELRNLSQSGKSYLDDMLKRETERTGIPSLKIDSNNVFGYYIEVRNT
HRDKVPTEWIRKQTLVNAERYITDELKEYEAKILGAEEKISQLEQRIFSELVSFTNEYIA
QIQTNASLIGQLDCLCGFAQLAIENNYSRPEMDASFVLNIKNGRHPVIEKQLPVGVPYIA
NDVYLDRDSQQIIMITGPNMSGKSAILRQSALIVLLAQIGSFVPAESAQIGIVDKIFTRV
GASDNISMGESTFMVEMNEAALILNNISERSLVLLDEIGRGTSTYDGISIAWAIAEYLHE
HPSKAKTLFATHYHELNEMTESFERIKNFNVSVKETKDSVLFLRKLVSGGSAHSFGIHVA
KMAGMPQFVIQKANKILKKLEESHSSSTTSETLKSTQKEMQLSFFNIEDPLLEELKNEIT
QIDINTITPVEALMKLNELKRIIGN
>OBAHECAF_01279 hypothetical protein
MKSYSKLYIVIPLLALSFLWITSCESDDLCDQKVNTPQLVIRFRDMSTQKEKKVSNLIVY
GEGKNTLLINASTDSIALPLKVAEPKTSYVMVSNANYNNTTGEITGGDMTTITFTYQVQE
EFVSRACGFKATYNTVSATIENPDDTWIQSINVTKTEVENEKNAHIQLYH
>OBAHECAF_01280 hypothetical protein
MKKTLTYSFIISFLFYQTTIAQEDTKETTYKQRYGLRVGMDVSKPIRSFFQKGYSGLEFV
GDYRWNYNYYLAAEVGFENRSKNEDFFSYKTTGQFIRLGIDYNAYNNWYGMENMIYMGGR
YAFSRFAQELTSYMIYTTNPYWEENTTGNNPNWLRSYEGRTAHWLEVILGMKVELFTNLF
AGASLRLGVMIANPTDSFPNYWIPGFNRVREGSRFGANFNYTITYLIPLYKKEKEKKKTD
KSTTQ
>OBAHECAF_01281 3-oxoacyl-[acyl-carrier-protein] synthase 3
MLYRSKIKGLGFYVPANIVTNDDLSKRMDTNDAWIRERTGIEERRHVIKGEDTTTSMGVK
ASLKAIENAGIDKNDIDFIIFATLSPDYYFPGSGVLVQKELGLKTVGALDVRNQCSGFIY
ALSIADQYIKTGMYKNILIIGAETQSPGLDFTTRGRNVSVIFGDGAGAAIISREENPQKG
ILSTHLHSEGIHAEELALIAPGIANRWVTDIIAENDSTDVSYFPYMNGQLVFKNAVIRFA
EVIQEGLQHNGLSKEDINMLIPHQANLRISQFIQQKFKLSDDQVFNNIMKYGNTTAASIP
IALTEAFEQGRIKDGDLVVLAAFGSGFTWASAIIRW
>OBAHECAF_01282 Regulatory protein Spx
MRKVYYLSSCDTCKRILNDLQLPTDFELQDIKKIPISETDLDFLKSKVGNYEVLCNKRSQ
LYKSRNLKAQNLTENEYKQLILEHYTFLARPVIVVDEQVFVGNATKTIQAVKQYLGNV
>OBAHECAF_01283 hypothetical protein
MKTIFSFLFLLWAISLSAQEVTLSGEVKNQQQKPAEFLNVILKKDEKPVHGTLTDASGKF
SVKIQKGDYTLILEQFGTEFLSKKISVSQNTDLGILQINQAIEVEAVTVEGRKKLVEQKV
DRIVFNVENSVQASGGDALDALKSTPGVQVRNEDISIVGKNGLRVMVNDKIIQLSGEGLT
NFLKSIASDNIQKIEVITTPPSKYDAEGNAGLINIVLKKAKEDHWSTTLRTSYQQGIEGN
LRNGANFSYRKNKFSALADLGYTNGKQHYENDIHFWYPKEYWVNRLESKSKVKIWSPLLN
LNYDVTPKSTLGVQFMGNFFNREINGSTANRAYLYNSPKLIKEYITHQNKPENTQNLSVN
VNFLQKIGKKGAKLTIDTDYFHYKKDRNDDLNTIFYNYQLNTQPKLFGNSLSMQQIDNYS
FKADMETPVSWGNLSFGAKLSRTQTDNIAQSDFRDENQIETLAHKDHFLYTEDTQALYAD
WAKSFGKKWSVKAGVRGENTQTKGVSVLANNETHKRNLFKLFPTLYIQYQINENHNISAN
VNRRIYRPQFFSLNPGRNYQNPKSYVVGNPFLQSSYSLGATLNYSYKHWLTLQLSYTDIE
DSRTQITYHNPDLEETQIRWENFANTNRWSASVNINKSLFWWWEVSAYMGATYEDARPYV
DLFPDKMISRGGYQNLQNTFMLNESKTLQANVSYFYQFPWDSGTRRVSESSSLDLGIKYL
AFDKKLTLALYVNDIFKTEAMTFTSHIEKQDIKESYRQYYDNRYVRLSLTYKFGNSKISV
RKREGGNAEERNRS
>OBAHECAF_01284 Glycogen phosphorylase
MPTKKMTLNPDYIFETSWEVCNKVGGIHTVISTKALSITKKFKNKYILIGPDIWQHAENK
EFIENKELFKSWKTKAGSEGLRVRVGNWNVAGNPIVILVDFSSYISNKNEILRYYWDTYK
LDSLNSSWDYIESVLFGYAAAKVIESFVKFNTASRENVLCHFHEWMTGSGLLYIEDKMPK
VGSVFTTHATVVGRSIAGNGYPLYDNMKGYNPEEMAYRFGVQHKHFLEKTAAKVTDCFTT
VSELTAQESLHFLGRKTDMITPNGFEDSIVPPSKTFDKKRKEAKKQLHKVAQALVGHTLS
EDTKMLAISGRYEFRNKGIDAFIDALGTLNRNPKNKKEVIAFLLVPTAHEGVNHGLQHNL
DYPQQAGNNDQKHLTHYLSDPNNDQILRRIYEQQLFNRKEDKVKVVFCPSYLNGNDGIFN
LSYYDVLIGIDGTVFPSYYEPWGYTPLESLAFNVPTITTSLAGFGKWVENYYPEKQKSIE
VIKRTDSNYGDVVSEITKNISSLLLMKDSDFELIREEAGKVAEIALWKNLSKNYFKAYEL
TLENIEERIISLPNIDTDAASVLEKSKIVNTPIWRNIIIHRAIPEALQPLEELAKNLWWC
WNDDASDLFHSIDPQKWLDSRKNPIELLDMISLSRYKELEKDSAFMKQLSNVYNKFQNYM
AKKVDMVSPSVAYFSMEYGLHSSLKIYSGGLGILAGDYLKEASDKATKITGVGLLYRYGY
FTQKLSSAGNQEADYEAQDFSKIPVTPVIDTNGKWMVVAVDLPGRTLYARVWRVDVGRIE
LYLLDTDFEDNREDDRFVTHHLYGGDWENRLKQEMLLGLGGIKMLRKLGIDAEVYHCNEG
HAAFIGLERLSEYIQNDNLSFSEAMEVVRASSLFTTHTPVPAGHDFFEEGMLRAHIENYT
DKLHVSWEQILSLGKINLNNPREKFSMSNLAANLSQEVNGVSWLHGEVSKDIFKNLWPGY
MPEESHISYVTNGVHKPTWTATLWKEIEDEVFGEDFKKNQFDPKGFEGIYKVSDKRIWEV
KTELRAKLLRRVEQKLRLEKNTPYFSPKQLIEIKENLRKDILTIGFARRFATYKRAHLLF
TNIERLDKIVNNPERPVQFIFAGKAHPADKAGQDLIKHIVEISKMPQFLGKILFIPNYDM
ELARHMVQGVDVWMNTPTRPQEASGTSGEKAAMNGVMHFSVLDGWWVEGYREDAGWALPM
ERAYENQEYQNEMDAEMIYNIIEDEIAPTFYEKDKDGISQSWCALIKNTIAKVAVNFTTT
RMLTDYENQYYFPMSERAASLKQDNFALAIQISDWKRKVNQEWDNVKIVSTEIPNKNKQL
ISIGNNYQAKITLDIGGLNMNDIGLELVIAREDKEGKTKVMDKKEFTPASQEGSNAVYTL
EVVTEYPGSLQLGLRVFPKNDLLPHRQDFALVKWF
>OBAHECAF_01285 Single-stranded-DNA-specific exonuclease RecJ
MNYNWVFKQSPQKEIVASLQKELNVSETIATLLAQRGITDFDKSKRFFRPSLDDLHSPYL
MKDMEKAVSRIHKAIENQENILIYGDYDVDGTTAVALIYLFLQQFTHNIDFYIPDRYSEG
YGISFQGIDYASDNDFSLIIALDCGIKAVDKVAYANEKGIDFIICDHHRPSDIVPDALAI
LNPKQVDCLYPYKELCGCGVGFKLIQALNEHWGYPFEEILPFLDLVATAIAADIVPITDE
NRVLMYFGLQVLNQNPRVGLKALLEVDKPVKTSNVVFRLAPRINAAGRIEHGKFAVKLLT
ENDENRAIEKAKIIEEFNTERRDLDQNIANEALAQIQENKEQHRFSTVVYAPSWHKGVIG
IVASRLIETYHRPTLVFTKSGEKYAASARSVSGFDVYEALEQCSEHIEQFGGHKYAAGLT
LLPEKYSLFKEKFEEIVSKTITKELLQPKITIDTMLPLEQITDNMFRIISQFEPFGPHNM
TPIFYAENVIDTGVAKAIGKNGEHLRLTLKECGGNRFFTATAFNMAHMLPTIKQGNVFKI
AYSLEENFWNGKRYLQLMIRDIKF
>OBAHECAF_01286 HTH-type transcriptional activator HxlR
MKENNENKYTEIQSVLDAIEVIGGKWKFPIIYSLCDHTKRFKELENELKGISPKALSNAL
KDLEMNGLIHREVFPTVPVTVEYSLTPYGKDLKPVLSALQEWGKKHREKIVESCKEE
>OBAHECAF_01287 hypothetical protein
MKKNVVLIVSKEETFIKELAKVYTSVVFEFAGNAEQAIEKLNLFAVGAILADTIIEEQEI
LKIKKIAGILDSEIIFEKADFKNMADLEKVVINLRNELFRRRMSNYTFEDNPNLNNPFLN
LDKTNVFKKND
>OBAHECAF_01288 Quercetin 2,3-dioxygenase
MNTKHIEKIIRPGTPHFVGDGFRVHNFIPGTSSMERMDPFIMMDYNAPYVFPPSEIPKGV
DVHPHKGFETVTIAYKGKVEHADSAGGGGVIGEGDVQWMTAGNGILHKEFHETEWSKSGG
LFHMMQLWVNLPAKYKTTPPKYQAIKNADIPKVPIADGEVAVIAGEYNGVKGAASTFSPI
HMYNVRLQKGAKTTLSFPKHYTTTLVTVEGSIRVNEQEEVTADHFVLFKNDGENFTVEAT
SDALILVLSGEPIAEPIAAYGPFVMNTRQELIQAFQDFEQGKFGKLK
>OBAHECAF_01289 Methicillin resistance regulatory protein MecI
MSQSIKTLTKAEEEIMQVLWQLGKGTVNDIIAQLNDPKPAYNTVSTVVRILENKGFVSHE
PQGRGFIYFPIVSKEIYSHKSLKDLAENYFKGSFKSMLSFFVEKKDIDLKDVEDLLQKLK
KEK
>OBAHECAF_01290 hypothetical protein
MENFLIYSVKTMFVQLLFLLLYEAFFKNEPYFRINRFFLLWGIALSLTLPFFPVSLANDN
ITAAIRLEEFVAYANTTSENMVIASNTNAINWYEMIYGIGAVCFGLLFIIKIIRLNRLLN
RSQRVVLNGTRIFLLEDLTQAFTFMNNIYVSKEQAKETCVIEHEKVHQKQWHSLDLLFLE
LMKIVFWFNPLLYFYQKRLVEAHEFEADRQTYPKFQNYYYQTLINQALGTKIDLLTSYWS
APKLIKRRLSMLQQKQKSTKGMSKYLLAIPTLAVSVLMLSAGNAPQNNLSENLPKISVAE
AQLTNNQVVNDTLPFTKVDKTPRFKECENVSESENLDCFRKKMDAHIARNFKYPEAALKN
NLQGKVTVVFVIGAEGKVVVKSLKGGDKLLQEEAKRLIEMLPELIPAKHKGKNIAVNFVY
PISFKLGK
>OBAHECAF_01291 Evolved beta-galactosidase subunit alpha
MGFVFFSLETVNFFITFVRIVFSTKIMIQHINKVSLIVGLVFSNFIFAQQQPLLGYAYGD
QQAPTGKEWESVEELSLNKEQPKAYFFSFADKQSARKVLPENSKYWQSLNGNWKFHWVKT
PDERPKDFFKPSYDVTAWEEIPVPSNWNIYGIQKDGTLKYGVPIYVNQPVIFYHERKVDD
WRKGVMRTPPTNWTTYEYRNEVGSYRREFTIPQDWKNREVFINFDGVDSFFYLWINGKYV
GFSKNSRNLASFNITKYLQKGKNTVAVEVYRNSDGSFLEAQDMFRLAGIFRTVALTSVPK
VQIRDLQVISDLDKNYLNGELNISAEIRNLDKKQAKGYKIEYSLYENKLYSDENKEVGKP
IFSASFDISSEKSSVIKTKFPLENPKKWSSEFPHRYVLVAQLKDAKGKVVETISTYTGFR
KVEIKDTKAEDDEFGKAGRYFYVNGKTVKFKGVNRHETNPSVGHAITRQQMEDEVKLMMK
ANINHVRNSHYPDDPYWYYLCDKYGIYLEDEANIESHQYYYGKESLSHPKEWEKAHVARV
LEMAHATVNSPSVVIWSLGNEAGPGENFVTAYNALKKFDASRPVQYERNNDIVDMGSDQY
PAVSKVKLRAEGKTNEKFPFHISEYAHSMGNAVGNLVDYWEAIESSNFICGGAIWDWIDQ
AMYNYTKDGKRYFAYGGDFGDYPNDGQFVMNGIIFADMTPKPQYYEVKKVYQYVGLKNIG
NEVEIFNKNYFKDLSDYNVEWFLFEDGKSIEKGNLAIGNIPARSRKSVKVPYNQSLLKPT
SEYFLKIQFKLKEDKPWAEKGYVQAEEQFLLKSPTQRPSILRIAKGEKIELSDEGNLKVL
KNSSFTAKFDTKTGSIFSLQYGNESIITDGNGPQINALRAFVNNDNWFYEKWFEKGLHNL
KHNATSNKVVENKNGSVSVYFIVVSQAPNAAKIHGGTSSGKNKIEELTDRKFGEKDFKFI
TNQIYTIYPDGSIELQSAITSNDLWLTLPRLGYVMTIPQKYENLTYYGRGKHDNYNDRKT
GAFIEQFSGKVKDEFVHFPKPQDMGNHEEVRWISLTDNQGNGAIFIPNEPMSASALQYTA
KDMILAGHPHELPKAKDTYLNLDIAVTGLGGNSCGQGAPLSKDRVLSGGSHITGFMIRPV
RSENIEAMVGVKASGEIPISISRDYFGNVSINSADEFAKIVYTIDGKGKPSKYNLPIPLR
KGGKVTAWFEGKPDSKVEMNFNRIENIPIRVISASSEESGEGDAQNLVDGNPNTIWHTMY
SVTVAKYPHWVDFDMSEIRTIKGFTYLPYDSWSSKVKEYSFSVSTDGKNWTEIQKGTFDS
SAELKRVLLEKPVKARYIRFTALTQLYNQDFASGAEFSVLEE
>OBAHECAF_01292 hypothetical protein
MKHLKKSLWGDLKNELLALSKKVFFAAQGVGENKINITRKTSLIFLICKINSFKHFDNLL
LRKCTFFVTFSSFICLKSRNQYYRRPYFFYHSRQVSGQ
>OBAHECAF_01293 Hemolysin C
MEPISIIIIIICLILSAFFSGFEIAYVSSNKVHIEIQKKQGGLLADVLTKITRKPSKLIT
TMLVGNNITLVLYGFEMGRVMTATLPPFFQNVLWHTVISTLIILITAEFMPKVFFQIYAN
QLLKILAIPAYFFYWLFSPISNFVIWISDFILKTFFKTKGDYVPLSFTKLELVDYISEQM
ENVPEKQEVDAEVQIFQNALEFSGVKAREIMVPRTEIVAVEINEKPEVLIDTFVSSGFSK
ILVYNENIDDIVGYVHTFDMFKKPKDIKSILIPIPYIPETMLINEILNMLTRKRKSMVVV
LDEYGGTSGMLTLEDIVEELFGEIEDEHDKDDFVEERISDNEFVFSARLEVEYINETYKL
NLPESEEYETLGGLIVSSNEGIPSQGEIVELAPFDFVIEECSANKIERVRVLIQER
>OBAHECAF_01294 hypothetical protein
MKYIVSLLITSVIIFLLGNVLPGAHITDYFSAVLVAFVLSILNVLVKPVLAIISIPITIL
TLGLFMFVINAVIILLAAQLVEGFKVNGFLGALLFSLCLSLVQSVAQNLLDKQEQRR
>OBAHECAF_01295 Serine/threonine-protein kinase PrkC
MKKHVKKLAIHVVLACILLVLLGFISLSILKVWTNHGEYVVVPDLSKKTLTEVDFMLKEI
DLRYEVLDSATYDPKFPKYSVISQNPEATEHVKEGRKIYLTINPSGYRKVTIPKVIQITR
RSAEAILKSVGLEIGKVTYVDDIGKDMVLELSHNGQKVEPGDQLIKTSKIDLTCGNGFTG
QPIDSTAVEEIVIPLEELE
>OBAHECAF_01296 Ribosomal large subunit pseudouridine synthase D
MVTFEEEDIEKGDELYEHYSFKAGKGQEPLRVDKFLMNFVENATRNKVQQAAKQGNIFVN
GIAVKSNYRVKANDEVKVMFAHPPHEELLTPENIPIDILFEDDQLLVVNKPAGMVVHPGH
GNYSGTLINALVYHFDNLPNNSSNRPGLVHRIDKDTSGLLVIAKTETAMVHLAQQFFHKT
TEREYVALVWGDVKDDEGTIEGHIGRHLKDRLQMAVFPDGNHGKEAITHYKVLERFGYVT
LISCRLETGRTHQIRVHLKHLGHTLFNDERYGGDKILKGTTFAKYKQFVENCFQVLPRQA
LHAKTLGFEHPVTGDMLRFDSELPQDMVDCIEKWRTYRQFVGE
>OBAHECAF_01297 hypothetical protein
MNKQTLLVILLLISLGINVFFLFRAERNEIEFAEVPKVDSEQVATADGDRQSLLDSIRSL
VIKNSDLQYFDLQHNNTAKDYFIEQGIDNPEELVMNQILKTNTVKGKHPLIRFAPKNESF
QTNKIKILNHKWAICDFSDGRLWGELLIKYYINEDKTVELTVMDDLLYPEEGRD
>OBAHECAF_01298 putative ATP-dependent helicase DinG 
MYAILDIETTGGKFNEEGITEIAIYRFDGHEVVDQFITLINPEREIQDFVVKLTGINNKM
LRNAPKFYEVAKRIIEITQDCVIVAHNASFDYRILQTEYRRLGYDFSRTTLCTVELAQRL
IPGKESYSLGKLARSLGIPVSERHRACGDALATVKLFKYLLEKDSKKEIITTYLKSNAPT
INVRHIRMLDELPERLGVYYMYNEAGEIIYIGKNKNIKKRVTQHFSSPLKRDVLLQKQTY
KITYEETGNELITRLKELHELEHNNPKYNKNNKSNTTKINYVLTSHFNRSGYLCFSTEMF
QTQKTSFITTFETIHQAQNFLYQITEEFGLCPKLQRLSEAKKNCHNYTIKKCNGACIDEE
AVEIYNQRAEQVIKKYGFVNQTIAIIDKGRTFDEKSVILVVNGIVKGYGFFNLNYQLSQV
EILENLITPLPNSLKNRHIIQSYVRNHKVKIIPINTQNSISYE
>OBAHECAF_01299 hypothetical protein
MKKTVSFIVLFCLAITAKAHTVWLETNTSGKLNKQHEVKIFFGELESPTFSEKWFSDIRD
IDVKVTYPSGKVESLQKTKRESHYVAFFTPTEKGTYTVSVAHLVKDVFREMKITYQSVAF
VNVNSKEKKDLQFGNLPVQLSAENTDFKVGQKNKIKILKEGNVAEKERVNISYENGWGQS
FRSNNKGEISFTLPWKGKYIVEYSYSKKETGTHNGADYKSDYQTITYVIYAK
>OBAHECAF_01300 Colicin I receptor
MKVFSTLILFLFSLIIYAQEGVLKGVVSSNRARLESVTVVLESANQKKWTTSDKNGAFKL
SVPNGDYTLKINSLGFVPFSEKIHIVSNKVVEKNIQLQEDVLGIEEVVVSATRTHLNRKE
APVLVSVTSQKDLVKVRATTLMEGLVFQPGLRTEVNCQNCGFSQVRINGMEGAYSQILID
SRPIFGSLNGVYGLEQIPTSMIERIEVIRGGGSALFGASAVAGTINIITKNPTENSMQAG
ITSSLIAGKSEDLVASFNASLVSDDLQRGISFYGVNRWRQPYDANDDGFSELTRLRNLNV
GAKFFNNISERKKLVGELNIGNEDRRGGNKFDMPEHMADIAESIRTNNIGGNATYDYYSP
TYNNKWSAFISGQRTRANNYYGAYDVENDAYDLEGLNYGITRENIWVLGGQHTAQFYVNE
NSLQWTSGAEYKYDEIAENRRNPEILGVNQDQHILGVYSQVDWKITPKFKVLAGLRLDNV
NSNLLKKSVSALNPRASLLYNITKEVIARGTYSRGFRAPLFYSEDVHSELITGDVRRVEL
ASDLKKETSDSFSASLEYNHSHDGHQIVAMLEAFYTNLDNPFHYVAIEGEDEDELLVKQK
QNGNRATVKGINVEFKYAPNSKFAFQLGSTFQSSRFSKSQVVAEEEDGTVIAETDKILRS
PSIYGNLTASYRPTEKWTLNLTSVYTGAMELFHEGENALKTSKGMFDFGLNTVYNLSFND
FFDMELSAGVKNIFNEYQKDFDKGVERDPTYIYGPALPRTIFAGVKIKM
>OBAHECAF_01301 hypothetical protein
MKKSKLYIFLVLIGFVACKKDSSLEEKKKRCSLPPVTFELIIQENENLPTYFSEVYNNVG
KDISIFLLKDSLLVKDIVDVALYKGNIAVFASDYSTKKYVYTEKEVRFLIKQAERVDTLK
IKGARVQKKCGFLGRLDEIYFNDVKLDFHEQRSYIVAFPKKDAI
>OBAHECAF_01302 hypothetical protein
MKVLKLYIFLVLIGFVACKKDSSLEEKKKRCSPPPADLRLIIQENENLPSSFYNLAHSNF
EKDISIFLQKDSLLIKDIAEVALYKGNIVVFAWEKNVVEYIYTGKEVRFLIRQAEKTDTL
RIKGYIENHCGFVGKLKEIYFNDVELAFREKGNYIVAFPKNDAI
>OBAHECAF_01303 hypothetical protein
MKKILFAVVILFFISCGDKKEREIAQIPMEFETIRFDSLFFLSPAGKLSELKKEYPYLFS
AYTEDEKWEEYQKDTLNQEIVREINKVFGDFSNEKTAIKHLFQHVKYYFPKFIAPKVITV
TSEVDYHSRVIYADSLLFIQLDNYLGEEHYFYENIQKYIRSELKKEHIVTDIAETFAEKL
VPRNQHLSFLDHMIYEGKKLYLLSQLLPKKSDGDLLKYDSEKTQWATENESQIWRYFIEN
ELLYQTNKQLLNRFIYPAPFSKFYLELDNESPGQIGRYIGLQIVKSYAQKNNGKSLIELL
AMDADEIFKQSFYKPKK
>OBAHECAF_01304 hypothetical protein
MANTSKIELTVALDENKIPEKLFWNAQDGGIYNEEAKAIFLSVWDSKNKEALRIDLWTKE
MPVDEMKLFFYQTLSSMVETFYRATEDEKMRDTMRDFCEYFAEKMELK
>OBAHECAF_01305 D-alanyl-D-alanine dipeptidase
MKHSKQKITVLLQLFFIGFGLVSCKNNQHPEKNTIVFEQKVLSAPEEVAKTEGIEDNRFD
IVEVKTTPEGVTAEKDSLEIEKQAIYDDFINIKSLSGDFVLDIKYATEDNFLGQAVYDCP
ECFLRRATAQALHNANEEFKTLGYRIKIFDCYRPLSVQKKMWNILPGTNYVANPAKGSKH
NRGAAVDLTLVDSEGNELDMGTPFDFFGKEAHHTYTKLPKEVLQNRNLLKTTLNKHNFKS
IYSEWWHYEYRPEMESKVEDFVWECN
>OBAHECAF_01306 Thiol-disulfide oxidoreductase ResA
MKRLFFTCAFFIYLLGSAQMTFSERVEYSELATSKDKQLFFVDFWATWCVPCIHVSTYLN
TVQEQFREELYIVSVTQENSDVVRPFLIKHPTKLAVSIDYDGQNFKKHNVRALPYGVLFD
AEGKILWKGNPADFTPKIIREQLAKNKKTTPIYDFLKYASYQNEVETTLDFNGDYKIQRA
NNPWGSSPVVERNGDITIIKGSITQIIGYLLKVSSRQVTMKGENAQYELLIKKTVNKARQ
ERQIAESIVKELGYKLRKEERSGQILEVRLPESTANYWKTDQIDWGTKNSKFLVDDNQFS
ADNISVHDFLYKLSEVVGKPISVKNSHYANDQLFDWQMHYWFRDLMVDNLSQLGIQAQEA
SGNFTRYFLE
>OBAHECAF_01307 Membrane-bound lytic murein transglycosylase D
MKRYSLSVLFGLLVGNLVAQTPQNVPNDTINKIEQKSDEIFDNSQETPIYIREETTTLKD
HPKAESYDKKWLKELSNSDLFFQMSEVIHNEPIEDVMFEELSTEVLKQRLEKLNQKTPFN
VEYNPILERVIKSFLKNRRSSLERLMSLSDYYFPMFEQEMSNHKIPLEMKYLAIVESALN
PKARSRMGATGLWQFMFTTGKAYGLEVSNYVDERSDPVRSTKAAARFLSELYKIFGDWDL
VLAAYNSGPGNVTKAMRRSGGKKNYWNLRPYLPQETAGYVPAFLATLYIFEYAKEHGFRP
QKRANHHFVTDTVRVKQAVPFKNIAELTGMDIQEIQFFNPSYQLDVVPYVEGRNYALRLP
IEEIGKFVANEDMIYSYISEEISKREKPLPALLKGDYVRGGKKTTYIVKKGDVLGKIASR
HGVTVSNLKNWNKIKGNNIRVGQKLVIYK
>OBAHECAF_01309 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MLFRQADISTIYSGKIRQVKGVFQSRERMELPDGDFLDLDWSYAIQKTNRCIVILHGLEG
SAKRPYVLATAKLFNQNGYDACAMNFRGCGGEPNRLFSTYHSGKTDDLEAVILKVLQLGY
SQVFIKGFSMGGNIALKYAGTHSLPTEVKAIVGVSVPCDLKGASLRLLSNRNWLYAKRFL
RTLIVKIKEKQQRFPTRITLDEIQSIRNLRDFDNVYTSKAHGFKDADDYYEQCSSLPNLG
NIQVPTLLLNAKNDSFLSLSCFPYDIAKNHQFLCLETPNYGGHVAFYDAQNIYYNEKKAL
QFCESHCS
>OBAHECAF_01310 Cytochrome c-552
MKNWVFFIVTIIVVFGLGWLISNITDRKAEAKFAYKPKVEIRTDKIEPRDSIWGLNYPRQ
YQSYMKTADTTYRSPFRSSGHLDALEHEPDLVILWAGYAFSKDYNQPRGHAYAIQDLRKT
LRTASPKFDGDGPMPSACWECKGPDVPRMMQELGLPEYYSKKWSDLGSEMVNSIGCADCH
DPKTMNLTITRPALVEAFKVQGFDINKQSHQEMRNLVCAQCHVEYYFDKNKVEGSMFVVF
PWHNGMTMEGAEEYYDKIGFYDWVHPLSKAKMLKAQHPDYEIYKTSVHAKRGVSCADCHM
PYKSEGGQKFTDHHIGSPLANVENSCFVCHRENANDLIGDVYERQAKVQEGTSQLARQVA
IAHIEAKKAWDLGATEAQMAPILANIRKAQWRWDYSVASHGGSFHAPVETQRIVNSGLGY
ARDARLGLSKVLSKLGFEGEVPLPEFKKEVLQAYIGLDMEKERANKKEFLNTLVPEWIKK
AKEREAKMSN
>OBAHECAF_01311 Cytochrome c-type protein NrfH
MATGSKEKKKFSLIPPPQWRLPALIVIGAMFGLGFYALYLSRATSYMSDDPKACINCHVM
TPHYMTWNKSSHREVASCNDCHVPQDNMFSKYYFKAKDGLWHSYVFTTRNEPEVIRAKDA
SVEVIHQNCVRCHIDQVTDAKLESDVANHIHSRTDRLCWECHREVPHGAVKSLSSIGFQI
EPTQFDNGRDSVRVMEWIKKSNESKSK
>OBAHECAF_01312 Ribosomal RNA small subunit methyltransferase I
MSKLYLIPTPIGNLEDITLRALRLLKGVDMILAEDTRTSSKLLKHYDIATPMQSYHMHNE
HKVVDYWVQRIKNGEIVGLITDAGTPGVSDPGFLLTRACLEQCIEVECLPGATAFVPALV
NSGLPNDRFIFEGFLPDKKGRQTRLQALIEEKRTMVFYVSPHKLLKTIEDFISVFGESRK
ASISRELTKLHEETQRGTLSELKSYYEKKSPKGEIVMIVQGK
>OBAHECAF_01313 hypothetical protein
MKEQLEREIRILAQNIVNSVGSWDLVFLKKEAEKLHEKITILSFVEKYYVTLGVTEGRMD
YTMRKVANFIEEHQDDEDIFAVPPQYSEPIATPASSKVERTQPTEDPVQVQSDSTVTEHA
IQPQENKFAEPVWSKNLEWAKPEPNEQPAENQSYATEIVQSSEKQEVLPEESVKDHYADW
TKRFQEDEPTNVQSHETETVQPVQTQEILPEEPVRDHYADWGKRFQEDEPTDAHPHETEV
VESVESQEVLPEEPVRDHYADWGKRFQEDEPTHVQSHVTEAPQPVEKQEFTPEEPVRDHY
ADWGKRFQEDESTDVQSHMTEAPQPVEKQEFTPEEPVRDHHIEWAPPPQLQQSVEEEEQY
TGFQSQFPETESVAETKEVSSEEPVRDHYSDWTKPVETAQQSDVQPNPTTMEQSTEVPFE
ESPQDYHIEWATPAQEEQQVDFQSYFVQQEQQERQEEIQQILETPVVQEPVLPTVNETNE
SKNESVIDSIFSQTQQLEFEKKEEKPRELIFETPSNQSFVVEKREDTEAKTPPSLNDHLG
KNMPIGLNDRLAFIRYLFLGSESEYNAVLQRLNEMNSMSEIVLYLEQNVKPIYNHWKGKD
EYEERFLKLILKRFEIQ
>OBAHECAF_01314 Endolytic peptidoglycan transglycosylase RlpA
MKNKRILVILGSLLLVAFLFQSCGGTKRAKHSSHASQRKTISHTPKSKTSVETGIYKRNV
VAAYYHDKFNGRKTASGAIFDNNKQTTAHRNLPFGTQLKVTNRVNGKWVYVVVNDRGPFT
KGRELDMSKKAWMSITHDTKIGLLDVDIEIVKN
>OBAHECAF_01315 Transcriptional regulatory protein ZraR
MSKILIIEDEAAIRRVLGKILMEESKDYEIEEAPDGLEGLEKIKKDDFDLVLCDIKMPKF
DGMEVLTEAKKIKPEIPFVMISGHGDLETAVNAMKLGAYDYISKPPDLNRLLNTVRNALD
KKELVIENKRLKKKINKNYEMIGKSDALEQIRQIIDKVAPTEARVLITGSNGTGKELVAH
ALHEKSERSEAPMVEVNCAAIPSELIESELFGHIKGAFTSAVKDRAGKFEAAHNGTIFLD
EIGDMSLSAQAKVLRALQENKISRVGSDKDINVDVRIIAATNKDLKKEIAEGRFREDLYH
RLAVILIRVPSLNERRDDIPLLVEHFSQKIAEEQGISPKKFSTKAINLLKEQDWTGNIRE
LRNVVERLIILGGKEISETDVKIFAGK
>OBAHECAF_01316 hypothetical protein
MKKTFSTYFSSFKIKKVLEWVVFSALLLFLGILMCNTTIVKRTKNMTYNNLDEIPHNKVG
LVLGTIPKLSNGAENPYFTYRIDATLALFEAKKIDYVLVSGDNNNSNYNEPQAFKEALIK
RGIPEERIFLDYAGFRTLDSVVRAKIIFGQEKITIISQKFHNERAIYIALKNNIDAIGFN
AKDLPTHLGFKTQIREYLARTKLFIDLLFGVTPKFLGEKIEIP
>OBAHECAF_01317 8-amino-7-oxononanoate synthase
MRIPEHIHKKIADRKADNAFRTLKNNLFTIDFFSNDYIGFASSKAIHAEVEKILAEQKWQ
HGATGSRLLSGNHSLYEVAENEITKFHNSESALLFNSGYDANVGFFSCIPQRNDIMLYDS
YIHASIRDGISLGLTKSYKFKHNDLSDLEKLLKKFSSSKQTTFVATESVFSMDGDSPDLL
KMTELCEQYGAFLIVDEAHALGVFGQFGCGLVQHLGLENRVFARIVTYGKALGCHGAAIL
SSGVVKDYLINFARSLIYTTAMPPQSVAHIVAGYRQLKKTTHIKKLQENISLFKNTLEKH
KKNYSFIHSNSSIQAMIVSGNDFVKSVAEQLQNKGFGVMPILSPTIPKGEERLRICLHSF
NTEEEILNLVNNILYLNELC
>OBAHECAF_01318 hypothetical protein
MKKLLLSVLCLSSLSIFAQNEESNWKRGGNASLMFNQAAFNNEWTGGGTSNVAANLAISY
AVNYKKDAWTWDNNFFIDYGITKLKNDEFARKINDRFEINSLLGRQASEFWYYSLFMNFK
TQLSNGYKYSASDKTLINRFLSPGYFQLGPGMLWKKSDNLKVNLAPATLKVTSARKQFTN
YVDSFYGVKRGKNFNYELGLAVGGYAKFNLMDNVSMENILNLYSNYLDKPQNIDIDYTAN
LVMTINKYLSANFTFQAIYDDNAVKGFQVREVLGLGVNYKL
>OBAHECAF_01319 hypothetical protein
MTQEIVNRVTKSALEIFDLEDYYPNERRLLLDIKEFLHEGFILREKEFREALDSYSWETY
ENAYVAIYCSTEAILPAWTFILIASKLQPYAKKIVQGDLQSLEVAIFQDIIAGVDISYLI
DKPVIVKGCSKKTIPEEAYVMAVQRIQPIARSVMFGEACSAVPIYKRKNM
>OBAHECAF_01320 hypothetical protein
MSNTINTEDLGEKIVDMLKTIYDPEIPVDIYELGLIYDVFVNENYDVKILMTLTTPNCPV
AEVLPQEVQEKVKSIDEINEVEVEITFDPPWHQDMMSEVAKLELGFL
>OBAHECAF_01321 Cysteine desulfuration protein SufE
MTIQQVQNEIIEEFSFFDDWMQRYEYMIELGKSLPLIDEKYKTDDYLIKGCQSKVWLFAD
FEDGKVKFTADSDAIITKGIIALLIRVLSNQKPKDIVEAPLDFIEKIGLKEHLSPTRANG
LVSMLEQMKRYAFVYQLKES
>OBAHECAF_01322 hypothetical protein
MATLNFILQSQGENIPIYLRMVLGRGKGKDIKRKTGLFVNSEYWNKTKGLPKANNPENKN
TIVTLEQLRAFIRESVNIAERDGNPINADWLQTQIDIFFKRIDDPNTGQSAFILDLIDYI
IQTAHTRKNGRGTLGLSQSRVKSYQTLKTIFNAYQSKTRKHYKAKDIDLKFERFFLDWLI
NTRQHKDSYALKLMDNLKAVCNEANTLGIETSPQLPKLAKGTPEKELLPIYLSIQELQQI
RDCKITNLQLHNARKWLLLGCHLGQRGGDLLKIDLSNFAYLDNGTPAVRIRQQKTGKIVI
VPIIEGLNSEILEIKNAGLPYPISIQRLNEYIKEVCKLAGIDIPITHTRSVLIDRNGNAI
EKDDKGNYEGKGNKRTIKVTLPKYEFITSHVCRRSFATNLYGKLPTTIIKNITGHSTEVM
LLKYIGKNEAETALQMVDFLTSKPELIQELNQLNDLNIK
>OBAHECAF_01323 Adenosine monophosphate-protein transferase SoFic
MNNFKIPFLPPATEIETASVLRQLAKSHRHLAELKGVVKTIPNEQILINTLALQEAKSSS
EIENIVTTHDDLYKENILIETKNPASKEVVNYAQGLKLGFQIVRTEKLLLNKHILQIQET
LEQNKAGFRTQAGTKLMNSLGETIYTPPQDKDEILNLMANLERFINDDEFSELDPLTKMA
VIHYQFESIHPFYDGNGRTGRIINILYLVLQGLLDLPVLYLSRYIIQNKTQYYQVLQGVR
TRNDWESLVMYLLKGVEVTAIQTIELVQEIKQVMQSTKQRLRTEFPKLYSQDLLNNLFKN
PYTKIEFLQNDLGVSKRTALNYLDTISQAGFMTKIKIGKSNYYINETLISVLMREKNNVE
KNTEFLPRS
>OBAHECAF_01324 hypothetical protein
MEKPEKIGVTYLSYKDFISNYNNDFKEWQKHYPDGVEVDYLDFLEDCLCYHMYHSGGSLF
PFSKYVKVNEVKIHISDFTFEIERCLEIYMGEEGNLKNEQDVKNTLNSWEIQWALNRGLY
GLDYQILKYYTPFLEISNIYEDRYTISFDDVKYKNFEISARRVIEFIETRREQLKNQPAP
VVSEEPQPENPKQSKTILINGRTPNLLERYLIADKTLNLEKALYALNVSEKERYKLLALV
LGCNETNARLIMTGQYKTKTNEEEIKDFVNKYPFK
>OBAHECAF_01325 hypothetical protein
MEAVQFIQITPEQLKEQFSQVVQSQINELKKHFQPKAPTEYLTRREVANLLGVNLTTLNN
WTRKGILKSYGIGGRVYYKRHEVESAVIELKA
>OBAHECAF_01326 hypothetical protein
MELVNVLRLREVLKEKNVTGKELAQMLNLTETSISRMLNGTQYPKLETLLGIANALQVDI
KDLFNSTSTATTPLYIKDDNGNLVEVGSLNKDKE
>OBAHECAF_01327 hypothetical protein
MQSFRTKVFKTAYKILKNFKDSITFGEALRTAWHLYRTEKERAKYIVKTEATPERIEQIA
RNINAFDTMYNYIDGYDNRNKWQFWNDLRKKLENILERLTDNAKAQIKVLCKLQQAEYFG
I
>OBAHECAF_01328 hypothetical protein
MEILERQTGNKQSYTPQIKDFRSVKVSINETNIYKNTYLQIDGYAELFTKIANIIDVCRV
ALLNETEKIDGFAVSETLEVAKNLIPYDEFYLLDKLHTQAIENLKKDTEQSPTPTK
>OBAHECAF_01329 hypothetical protein
MNNLNGANIHQFAKIETSDKYKEVTHFEKIHQTANSRHILDFANISVQRNFNRSENVAFW
YKPAPRKADGTRAKWGEVLTGLFRTAHPQIYYGDISSKDHYGRYKKHTLLFFVFNTDRTK
LAIVEYPNYYPMDVPLAITMIAIEIKRYFGLQ
>OBAHECAF_01330 hypothetical protein
MVDFIKISVSYPDNDKLHRILTSGAFLYVEQETDPYTGEVVKEVYKYHNMRLKPYNGGFI
LKGSIHKLHNELNGNTRPEWTAKYNGFNGDRFTLSEVENVIKHLCKLLDVQAGGCVLQNI
EIGLNNVIPFSAFDFLQGIQAHRNNFAPTIKHGRNYFEFGYSQYYLKLYNKGRQYGLYDE
VVRVEVKVIKMQKLHNAGVPIHTLADLSTDNLQKAFEVLTSEFEKVVNIDNSLRANELTE
KDLIRLNELRNPAFWQNMTRMQVQRAKEFLEELNTTFSDNQKGQIMRKMHHEKEAIFNNE
ITPKCYKITDPENDQNNISFSPSKNEKCYKITDPENTSKNGVMLQNYPLSKREDCNIEKT
DLEKKVVLSSENMSLEYEEKRDKKTSNFEVKKVEKNEVEKIKKSCPITGVELTHEKEGAR
YIRTATFLHLREHDPERYILLCSYLLPSTGYKPVREKNIIMHLCKQVRNLYRKLNNQPNK
PPLQKHFKNQLELF
>OBAHECAF_01331 hypothetical protein
MRKELGKLLLDIVKYVVTAVIVSDIFTDIKGSELYITASITTTILLIFGLLLVKDPTENK
TQKHNPKKRK
>OBAHECAF_01332 hypothetical protein
MNGAIYMMIYISVVAVVGYFYFYIRDKKQKHTPDNE
>OBAHECAF_01333 hypothetical protein
MNKIDRTKIDPEKIAKLTTGRELLAEMYGAVGTPTRKEFTAKAKAWYFAELLKEERKQLK
ITQRELAEKIGKKREYIASLERGETDMQLSTFISIAEALGLKFGLMTK
>OBAHECAF_01334 Bifunctional (p)ppGpp synthase/hydrolase RelA
METALQIVIKAHANQTDKAGRPYIFHLLRVSEKGQTQTEKICGLLHDLIEDTDWTFEQLQ
QEGFSDEIIQVLKCVTKQQGENYDDFINRIAQNSIAIRVKLNDLEDNMNITRLSHLTEKD
LQRLNKYLKAYHFLKSKTH
>OBAHECAF_01335 hypothetical protein
MKRTATKTDNLKERFLKHFEKCLGVISTACKQTKITRQTYYNWINSDDEFKEQVNDIQEE
QKDYVESKLIENIEKNDTTAIIFYLKTKAKNRGYTDKTEVEVSTNPQNMFLDLMKQATST
D
>OBAHECAF_01338 Arginine--tRNA ligase
MLDLQDILKQHTQKAVEQLFSVQLENIELQQTKKEFEGDITIVIFPMLRQIKGNPEQIGQ
QIGTFLQENVKEVESFNVIKGFLNLVISDSYYIDFLKSIENETHFGLAQLNSKKTIMVEY
SSPNTNKPLHLGHIRNNLLGYSVAEILKAAGHKVYKTQIINDRGIHICKSMIAWQRFGNG
ETPENSGLKGDKLVGNYYVAFDKAYKSEIEQLISEGKTKEEAEKQVPIFLEAQEMLRKWE
AGDEQVISLWKEMNQWVYNGFSTTYKNLGVDFDSYYYESDTYLLGKDIIEEGLQKGVFFK
KEDGSVWCDLTADGLDEKLVLRSDGTSVYITQDIGTATQRVKDYPDVKGMVYTVGNEQDY
HFKVLFLILKKLGFDWAENLYHLSYGMVDLPSGKMKSREGTVVDADDLIAEMEQTAEEIS
QELGKLDGYDDNQKKELYHTIGLGALKYYILKVDPKKRILFDPKESIDFQGNTGPFVQYT
YARIKSILRKYNEIEISKSESLSISELHPKEKTLLKNMALFPEVVQNAADSYSPAVIANY
VYDLVKDFNSFYQNVSILGEENVAKREFRVSLCKKISEIIALAFAMLGIQVPERM
>OBAHECAF_01339 Outer membrane porin F
MFFGALFFGFSQTKELIKAHKLYKNYDYVGAIKAYESIAKKGFVNQDLLQNLGNAYYYNA
DYESANIWYEQLFSKEEYKKSSEYYYRYAQTLKSVGKLEDSDKIMDKFVAMVGKSDARAV
IFNKNRSYRKDIELNSNRLELQPLKINSPNSEYGTAFYGKKIVFSKSSGLFKGKSTWTGD
AYYDLYEAKRDCMNVSKVSKMNKINTRFNESTAVFTKDGNTIYFTRNNFLNNKIKTNGDD
TVLLKIFKSTKDKNGKWSKEKEMPFNSNIHNVAHPALSPDEKYLYFASDMRGSFGASDIY
RVERLEKGGYGKPENLGNVVNTAGRESFPFVSKDNILYYSSDGYPGLGGLDIFAVKINED
GSFSKPVNIGAPANSSKDDFCFVIDSDTKVGFLTSNRVGGKGKDDIYAFQEHRPVSFSCT
KNISGIVRNATTREIIKDAGLVLRNADGKPIETKLSDVDGNFSFAYEIDCTNGSTFNINA
EKQGFIPKKQEVIIKEKDELFYEIALTPIERRKIEKGTDLAKVLKIDNIYFNYDKADIRP
DAAEQLAKIVDVMKEYPTMKIDVRLHTDSRGSDKYNLALSDRRAKSTIKWLVKHGIKKSR
ITGKGYGETQLTNHCGNGVKCSEEEHQANRRSEFIIISM
>OBAHECAF_01340 hypothetical protein
MLLGMLSVLLMTLTIIEVSTKKISIHKDFIVKEPLLVVIPPESELKEQITPPFIGRTFVG
FKEALAYRESRGNYFVVNPFGYMGKYQFGKSALRFYGVTDTYEFLNSPEQQERLFTLSIK
RNKWVLREEIDLFVGKKINGINITESGILAAAHLAGAQSVKQYFKRKGNYSFADANGTTL
QNYLRNFADYDVTDIIPEERPRF
>OBAHECAF_01341 Signal-transduction histidine kinase senX3
MLKKDSLRFRIFLSMTFLVVIAFATIAVVMVFQYRKQAEEYHIERLIDKENQIKTQIQYV
LSQTTYPVETAYVPLIFRESIYNIANILNVNFDLYDLNGSLLKSSRAVIDSKDTLIIPTP
VLKQLASTLNKRLSEHHYLEDGRGYQNSYTYVTDLQFKPIAVLSIPHFEDDTFNEKALQG
SLYNISLVYFSLLVLALGFAYFISSYITKSLKTIENRLEKTRLLERNEKIILKSPSTEIG
QLVGAYNSMIDEIERSKVLLAKSEREQAWREMAKQVAHEIKNPLTPMRLSVQSFQRRFDP
NDPEVRNKTNEFCESLVQQVDILSNISSAFSALTNMPAKQEEFFNAVPVVKRTLDIFDSK
HISFITTDEHISLLFDKDQLVRVVTNLVKNAIQATENKENPRIVVSLSKKEFQVELTVSD
NGVGIPTADQEKIFEPQFTTKTGGTGLGLAMVKSIITAANGSIKIQSQVGKGSTFIVHL
>OBAHECAF_01342 hypothetical protein
MNQKRNILGFVFAFFVSFAYSQVVVNQNGNITEIMELKKDVAKNEVLFQIQIYNGTISGA
NETMKSAKEQYKMPLFLVFETPNYKVRLGSFRTRLEAEKNLIEIRKVYPAAFVMSPKK
>OBAHECAF_01343 hypothetical protein
MKKITLLLVFLVNGIALALAQPKETHWQTAKLKGKVKSVISIERSIENSQASSSFKTSFT
NEGFVTEINAFDAQNKQMMRVEFDYDSKKNQTEIRSFSEEGKMYMKLVAVFDAKGNKIED
TTFEGEQPVQYGKYLYDEKRNLVEKNLCLTDEMCVEKQTYVYDSKGNKTEEIILNPEGDI
VYKTLFSYDKKGNVTEVRQFEGGSKFVAKINYTYDKYDNPTSSLSYDAENKLVEQTNSSY
IYDKKGNWIKKTISKEGREIYVSEQKIEYY
>OBAHECAF_01344 hypothetical protein
MKRIILYILFLFPVFGTQVIAQDNDLPFKGGEWLKFKVKYGIFNASEATLLLKEADYNGE
KVFHSVGKGATTGLARVFFKVDDTYESYFGISDGKPRHFIRNIYEGGYTKHLKMDFNHDV
NKVKIKNMENGELSEISVPIHIQDVISAFYQLRSNPKISNIQKGEEIAMDLIFDDDEVFK
FKLRYLGKEKIKTKFGTQNTMIFRPLVQDGRVFKEEESITMWISDDKNRVPLRIKATLRV
GSLVADLDSFNGLKHPHQLEK
>OBAHECAF_01345 1,4-alpha-glucan branching enzyme GlgB
MLPILKTDSLLQRFADKIQARHSYFLKICQKMQGNCVRLSDNINSHLFYGLHFTENEWIL
REWAPNATKIYLLFDKNDWQPTEKYAFTKIDHENWEIRLPKLELSHGDLYKLYVEWQGGG
AERLPSHAKRVVQDEYTKVFTAQVWQPEKFYQWKNTRPSQTNSPLIYEAHIGMSSEQRKV
TSFTEFRLFVLPRIASLGYNTIQLMAIQEHPYYGSFGYQVANFFAVSSRFGTPEELKELI
DTAHGLGIKVILDIVHSHSVSNEAEGLGYFDGTDYLYFHSGERGKHPQWDSRLFDYGKPQ
VLNFLLSNCKYWLEEFQFDGFRFDGVTSMIYLDHGLGKAFTNYSLYYDGNQDIDAITYLT
LANQLIHEIHPKAITIAEEMSGIPGLAFPIEGGGMGFDYKMHMGVPDYWIKLLEDYKDED
WHVGDIYYELTNKRLEEKTISYAESHDQALVGDKTIFFRLADKEIYSGMSVFDQNLVIDR
AIALHKMIRLVTIATAGNGYLAFMGNEWGHPEWIDFPREGNGWSYNHARRLWSLLDDENL
KFKYLNNFDRAMIHFVKKNNLLEEMPNILVRDNERQILAFERGGFLFVFNFNPSESFNNY
EFEVEAGKYTYVLNSDNPNFGGQNRIDENVEHFTQYKHEKNLISLYVPSRLAIVLKMNE
>OBAHECAF_01346 hypothetical protein
MINEIRIFTTDDKKISLQVSLEKETVWLTQSQMSFLFDTSTDNIGLHLKNIFLEEELDEF
STTEDFSVVRQEGKRQVKRTLKHYNLDAILSVGYRVSSKRATQFRKWATQTLKQHLVQGY
TINEQRLKERGIEFNEVLSLLSSTLENQTLISDEGVAVLKVVQKYAKSWSLLQAYDQQSL
PKSSLKNQEMNALPYEDVLKAIDQLKKSLVEKGEASELFGQIRSSGLESALATIEQGFGE
EYFYPNVASRAAHLLYFIIKNHPFADGNKRTGAFLFLWYLRINQHLLQKPVENLINDNTL
VALALLVAESKPEQKELIIRLTEHFINV
>OBAHECAF_01347 hypothetical protein
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAERQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKEFGEVMRTILETYKNGQHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYALALAEASKDKDFLKEWSDLPTMIAENFNQT
FWIADKKYLADYVNYAHQNRDVRPNQLIPCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYESVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKTYIPDAEAILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTMNYES
>OBAHECAF_01348 hypothetical protein
MKKDTKPLNKNLLSELSVLIENGQQQIVYYANSTLTLVFWQVGKRINEDVLNNERATYGK
RIVPMIANELESKYGRNFTEKNIRRMMQFAEVFPDFQIVVTLSRQLSWSQFLVLIPLKNH
EARMFYAELTANESLSVRDLRKQITTKAFERMQIANLQVQQSEIIPINTFKDPYLLDFLG
LRSDYLEKDIETAILHKLESFILELGRGFAFVERQKRMIIDGEDFYLDLLFFHRKLKRLI
AIELKIGKFQAKHKGQMELYLKWLNKYERQEGEEAPIGLILCAENSKEQVELLEIHKDGI
MVAEYWTELPPKKQLEKKLHEAFIEAREQFENKGLLNK
>OBAHECAF_01349 hypothetical protein
MRKRSFAEIITSAQLLVKALTERGENLPVGVTAQMRDKLNTAYQKAAEVNVEQEKLKAQL
KEKTAELEKHIAETEEVYAFLKKYIKMGEPQERWREFGFEDKR
>OBAHECAF_01350 hypothetical protein
MNKYLMFFVLLSYHCFSQQHQEEIIKTYLNDCAMKYNYNYQMKQWQDCLDLGLQRDSTIA
YLWQQKAMPYFKAQKYEVGMSYLDKAVIYNPKRWLPYRGFIKCIFSKSYKEAIDDFEKSI
LLLGNQYEMDHTYRFYIALSYLQLNEFEKAERLFEQDISEQEQKFKTAHYLDLFYFGICK
FELEKFDEAIIFFDKALEQYPQFSDVWYYKAVCFLRLGQSEKAVEPYEKAKDYAKQGYTI
NEDNVIYEKYPYQVRW
>OBAHECAF_01351 hypothetical protein
MKLLTDKIYRIEKFEGKGGWTFVRLPEIKPNKNAPFGWVRVFGTIDGHSIEKYNLQSMGN
GNLFLPLNAQIRKKIKKQVGDNVHIVLYEDNVPSEIANELRMCLQDEKYLLETFLSYSET
KRKKLIDWIYQSKNEDEKANRIVEIINRISSEKIRN
>OBAHECAF_01352 Endonuclease NucS
MKLFTDVKDIILQAREKAIRSVNNARTLMYWHIGKRIFEEEQQGKKRADYGSYLIKELSA
KLEPDFGSLCSFRQLNLYRQFYKTFPIVNALHSQLNWTQYKILMRIDDQHKREFYIAETT
KNNWTSRQLERQINASLYERLLLSNDKESVLAVARNERQPSDPKEIIKDPMVLEFLGLKQ
QSTYYEKDLETKMLSHLQEFLLELGNGFSFVARQKRIHIEGDEFFVDLVFYNRLLQSFVI
MEIKTDKLTHQDIGQLQMYVNYYDRTQKLSHENPTIGILLCADKNDAVVKYTLPENQKHI
ITSKYQLYLPTEKQLLDEIRKEIENFEINEEDEKPDEVQ
>OBAHECAF_01353 Glycogen synthase
MSVKVLMFGWEFPPHISGGLGTACYGIAKGLAKHNVNVLFVMPKAGGDEDSSVAQIINAS
DVEMLQNMENIEEFWKNINFMEIGSNLVPYLDPETFAREREAYLKTGENKETISFRNKFQ
FSGKYGANLMEEVYRYALVAGTVAKNHQFDVIHAHDWLTYSAGIVAKKLSGKPLVVHVHA
TEYDRGGEHNRNTLVYDIEKRGMEAADVVVTVSNWTRNIVVEKYGINPEKVITVHNAVDF
SAETTEKEERGVKEKIVTFLGRITLQKGPEYFVEAAAKVLKRTPNVRFVMAGSGEKMNPL
VRRVAQLGIGTKFHFTGFLKGGEVQRMFRYSDVYVMPSVSEPFGISPLEAMRSGVPTIIS
KQSGVAEVLDHAIKVDYWDIDALADAIHGILSYPTLAEYMSREGYDEVNQLKWENASLKL
KTIYEKLVE
>OBAHECAF_01354 hypothetical protein
MKYFLAILFLSCFSVMYSQNESLQKSKWKGEISFGLGSAELKREAFEITGNVNNVNTLLF
YKLSSKGGILTGVGVTHFNNGALLPDGYSRVKATFIEIPFKLRGYVWNFEQTNIKFTLSA
GFQFNKAIKYHQKINSVTFEPPKTDWYVDFPLEIGVEIPLGKDCSFGIYSQNNYFVGNKT
KKYIMKNYNLLKLSLIYNF
>OBAHECAF_01355 hypothetical protein
MDFVDFLREMLGITDDFAITSIVKDEENKIIKIHLKYLNTHFVKEGKRYKLYDTTPEREW
QHLNWFDYRCYLVCSLPRYLSEDGKPKVIDIHFAPKYKGYTHLFAAKVIETLHKVKVQNT
VAELMHTTPYMIRSIMESTVEKSLLERGEVNDLENVSLDEKAYAHGHKYATILIDSDKNC
VVEMTEGRKEKNVKALFFSVNSQEKQPSLKRVNMDMWKPYMNAIKDIAPQAMIVHDKFHL
FKKLSEAIDKTRRKEVKETELLKGQKYTVLKSEENRTEEQQRAFEQMLNENLLTAKAWQI
RENFKYLFSLKDCIAINYELWKNNAISQSITAVNEVIKTFDNHLQGIINAIVTQTSSAKH
ENMNGKIQSVISKARGFLNFERFRINTLFYFGNLKFSSQKI
>OBAHECAF_01356 hypothetical protein
MKKSICIYFQIHHPERLRKYHFFDIGKKHNYFDNYANRSELEELAENCYLPTNALLLDLI
KKYNGKFKVAFSISGSAIDQLNMHTPEVIRSFQELAETGNVEFLAETYSHSLASLSEDSD
EFEQQVKRHVNVVKSLFGKKPVTFRNTSLIYSDKIGERVAKLGFKTMLTDGAKHVLGWKS
PNFVYKNPIDENLNLLLKNSKLSDDIAIRFSDRQWSEYPLTSEKYVSWVKHSLAETEVLN
LFMNYDVIGHYNRKESGIFDFLEYFVKNMMEDDEYQFLLPKEVVKKHSAKDVLPVPFPIS
WTDEERDITSWLGNELQKEAFNQLFKIQSIVKKKKNAELSDDYGRLQASEHFYHMRTKLF
STSDYHKYFTPYDSPYEAFINYMNILSDFEVRLEEK
>OBAHECAF_01357 hypothetical protein
MIAIVILSLCYIVVAFLVTEKNAEQTLSGYNTMSEEERKRVDIRTYIPFFKRFHLFLGIS
SFIGGTMILYFINEHWGILFTIFYPLVIYPYFIWKGKKSDNNTGLFH
>OBAHECAF_01358 hypothetical protein
MKSNNLIFLGLIGLVLSFVGCKDNSKQQATQQNVQSNIASDFHKPDENIKKNAEGYKEYF
YEPSISVISGIIKIKTFFGPPGYGESPEVDAKEEVFILELRNPINLVADEEDDGFNPAQT
NILEVQLTSTSDIKFTNYIDKNVRLTGSFFGAHTGHHFTDVLMDVAQIKKE
>OBAHECAF_01359 Phosphoribosylformylglycinamidine synthase
MIHFFKNPKQNLYAVQTTENLSEQTISKLNWLFGGAKKIEQEVLKGFFVGPRAAMITPWS
TNAVEITQNMDIQGIIRIEEFSEVAEEFTDFDPMLFQKYNGLNQNIFTINITPEPVLEID
NIEEYNQKEGLSLSVEEVEYLNNLSKKLDRKLTDSEVFGFSQINSEHCRHKIFNGTFIID
GEEKPSSLFKLIKKTSETNPNEIVSAYKDNVAFIQGPVVEQFAPKTADKPDFFETKKFES
VISLKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGQGSLPLAGTAVYMTSYSRLEENRP
WEKAMDERKWLYQTPMDILIKASNGASDFGNKFGQPLIAGSLLTFEHEEDAKKLGFDKVI
MLAGGVGYGKKSQAIKHQPKEGDKIVILGGENYRIGMGGAAVSSADTGAFGSGIELNAIQ
RSNPEMQKRAANAIRAMVEADENPIVSIHDHGAGGHLNCLSELIEETGGKINLDKLPVGD
PTLSDKEIIGNESQERMGLVIGNKHIEKLKTIAERERSPMYEVGEVTSDKRFSITSKKKN
TKPLDFHLSDMFGSSPKTIMEDTSVKTEYEDLVYYQSNIKSYLEQVLQLEAVACKDWLTN
KVDRCVGGRVAKQQCVGALQLPLNNVGVMALDYQGKEGIATTIGHSPLTALIDPVAGSRN
AVAEALSNIVWAPLKNGIKGVSLSANWMWACKNKGEDARLYEAVKGCSDFAIELGINIPT
GKDSLSMKQKYPNGDVIAPGTVIISSVANCTGITKVVEPVLKRNGGAIYYINLSRDKFKL
GGSSFAQILNKIGKEAPTIKDAEYFKKAFSAIQYLVNQGKIQAGHDIGSGGLITTLLEMC
FAENDLGADFDFSVFKEEDTAKLLFNENIGVVFQADTEAENYLESEGIEVFKIGTVTNSD
ILNVKNFDTELTFNISELRDIWFLTSYLLDKKQTKNDKATERYQNYSEQPLNFVFPKYFT
GQKPKFSSGKRPKAAVIREKGSNSEREMANAMYLAGFDVKDVHMTDLISGRETLEDVQFI
GAVGGFSNSDVLGSAKGWAGAFLYNEKAKTALENFFKREDTLSVGICNGCQLFMELEVIN
PEHETHGKMIHNDSGKHESGFTSVTVQKNNSVMLSSLEGTTLGVWISHGEGKFHLPMAEN
EYNIIAKYAYEGYPANPNGSDYNTAMLCDKTGRHLVTMPHIERSIFQWNWANYPENRHDE
VSPWLEAFVNARKWIEERNK
>OBAHECAF_01360 Outer membrane porin F
MKKIKVTLIALAAVFSVGVQAQDESNPWQIGFGVNSVDIRTPSTFGELLKDWAGPSDINV
LPAVSRLSVGRYIGSGVSVEVSGSLNKIEKGFGYHKGGQKVDKSFWAIDARGKYHINTLW
EGARWFDPYAQVGVGYANIDKEGEFKFLGGAGANFWFTQNIGLNAQTTYNHMPKGEVGLD
YAQHSLGVTIKFGSKDTDGDGIIDEKDECPEVAGPKELNGCPDSDGDGIADKDDACPNDA
GSKDFNGCPDSDGDGIADKDDACPNQAGPRSLNGCPDSDGDGVADKDDACPKVAGPKENK
GCPWPDTDKDGVYDKDDECPQVAGPASNKGCPEVTEEVQKTLNEYAKTILFETGKASIKP
QSAAVLEQIVSVLNQYPNSKFTIEGHTDSTGNKAKNLTLSQERADSVKLYLVQRGISDTR
LSAKGYGVERPIASNKNAKGRALNRRVEINLVK
>OBAHECAF_01361 2-amino-3-ketobutyrate coenzyme A ligase
MYGEIKKHLQAEIESIKEAGLYKKERIITSKQGAEIKISTGEEVINFCANNYLGLSSHPE
VIQAAKDALDSHGFGMSSVRFICGTQDIHKELEKKIADFYGTEDTILYAAAFDANGGVFE
PLFTEEDAIISDALNHASIIDGVRLCKAKRFRYENSNMQDLEAKLQEANAAGARFKIIVT
DGVFSMDGVVAPLNEICDLADKYDALVMVDECHAAGFIGATGKGTMEAKNALGRVDIITG
TLGKALGGAMGGYTTGKKEIIEILRQRSRPYLFSNSLAPAIVGASIKVFDLISKDTSLRD
KLEWNTNYFKKGMKAAGFDIVEGDSAIVPVMLYDAQVSQIMADELLKKGIYVIGFFYPVV
PKGKARIRVQLSAAHSKSHLDKAIEAFTEVGKSLGVI
>OBAHECAF_01362 Beta-hexosaminidase
MKNIYIMKLFGLFFFVFMAGANAQQISVVPQPNEVFFRKEKCRLDRTVIFEIDKAFDSLQ
EELSLLFPTDDNSSKSTLKISVKQDHSINNQEGYILDIQPKVIIIKSKEKAGAFYAIQTL
KQLVAQSKYNRSNFITCMKINDAPRFAYRALMVDPARHYWKMEDLKKYIDAMAQYKFNFL
HLHLTDDQGWRIEIKKYPKLTEIGSKRTDFEGDKRNNEGYYTQDQMRELVQYALQRNVQI
IPEFDVPGHSDAAIAAYPELSCNDTIIKVRNVAGVSKNLLCVSKENVFRFIDDVITELSD
VFPCSYFHIGGDEAPLDKWIENPSVQDLKKRLQVTDNHQLVSYFFSRVNESLVKNGKQPL
MWLELETPEYPKNSIMYLWRYNTTPEVLERAKKDDFKVICSPGEYAYFDYPQWKNDLPNV
GWMPTLTLQRVYEFNPSFSLNKEEEKQYIFGVEATLWGESVKDLFRAFYMTFPRAFAMAE
AGWTEMPNRSWENFVKKLDFQLDYLLKQGVNYRPPVELYKDR
>OBAHECAF_01363 hypothetical protein
MKNFVRFFLTVCVVIALTQFLMDLLIKQYALNLFSSVEKICLFHLILSLGVLTIIYTVHR
LRPKYTSFAFLGTAFLRMGTMVVFVLPLAKAVEQTPITDVIFLMVPYFILTTIEAIFTVK
LIRNAT
>OBAHECAF_01364 hypothetical protein
MFKENKKVMAENTAASSNRIVTDTKFKGEIVSKTDFRIDGEVEGNFQTSGKLVVGKTGII
KGTVICENADVEGRIEGTLRVNSVLTLKSTAVIEGDVTVDKLSIEPGAVFNVSCTMKGSN
RPTSLNEKPTTDKAIK
>OBAHECAF_01365 Glycine oxidase
MFDFIIVGAGLAGVSFAHMLENENKTFCIINNHSQLASLVAAGVYNPVVLKRFTPIWKAD
EQVDLLHNFYDQMEQKLSKKIRIEQSILRKFNSIEEQNNWFHASDKPILSRYLNPSILPE
NNTHIKAPFGFGKVQYTGRLDVKTYLTESINRWRDENIYHHRNFFYEDLHIEDDVVYYQT
ILARHIVFCEGYGVLKNPFFQYLPMKPCKGETLTFYAPDLDLNEILKGDGVIIPIGEGVY
KIGATYEWDDLSDTITEKGRKELVDKLGKLISCSYEIIEQEASVRPTVSDRRPLVGKHPK
YDNMWILNGLGTRGVMNAPYVAKALYQTVFEQTELLKEMDVVRYRKFWK
>OBAHECAF_01366 hypothetical protein
MKFQSKNVVLFVAFVLIANLSSAQANLLNAKKVEDIGKKTEAQIDADNDKPLPYGYVDER
DILWSVETWEIIDLNERVNFPLLFPIDTLDVSTYRRPLFDVIMKNVKNGKLDIYRDSHFA
ERITLESIKASLTKEDLMDAGYDQLNAGEQVSEEYKIRRDLTAGDIAQYRVRGWWYFDKR
QGELKYRILAIAPVAPDVNFIDSEDAQASLIELFWIFYPQAREILHEAKTFNRKNDAKPI
SFDHLLNARMFSGVIYKEANVYGDRPINEYLPGNSLFQLLESDKIKEKIRSREHDMWAN
>OBAHECAF_01367 hypothetical protein
MAGGKLTPRQRMINLMYLVFIAMLALNMGKEVLNAFGLVNEKFEASNVRANAANIAAIET
LGNSARENPEQYGEVYEKAKQMRELSDELYSFVQEIKDGLNKEIGQEDKGVMEKDYQAMD
KSEYTDDLFFKGEGYNAKGQEFVDKIDSYREKALALLGDDPRYAELVAKIKANFNTESVK
KADGTIEKWLDYHYKGFPYIATLAKLSMMQSDIRSNGQEFYGMMLEGNLKAQISMTNYTT
LLEQGKGAYYQGETFDGAIVLGRKDASTKPNEVELSLDGRKLSANEFDIQDGKVKLKVNA
GNAGEHRITGNLHFDQDGKRISVPVDQTFSTIPKPNAAVISADKMNVVYRPLENPITISM
PGVADNKVTASAPGLSRKSGTSYVLKPGQGREVTINVVGEIDGQKFSSSRQFRIKDVPRA
VTVLAGQSGTVKMPKANLAAMPVGATIEDFDFELKYTVTSFKVSVPGQPSVQVNGDRMNE
QARAAIGRARKGDIIQIFDVKANIQGAAGYVPRPPAPISVEITN
>OBAHECAF_01368 hypothetical protein
MAKGNSTRKKIFNMVYSLGAAVVIIGALFKLTHWTIGPLNGTILLALGLGTEALIFFIAA
FEPVEEEVDWSLVYPELSGGAPRQNLATAQVVTKEDKALKESLSEKLDGILAEAKIDANL
MQSLGKSIENFAGAAKEIAPVTTSMTATHKYGEELSIAASHLESLNSLYKLQLERTENQV
AAQAGVVDNLNSLNQQMVSFQDNLKSLNRVYGGMLSAMGK
>OBAHECAF_01369 Serine/threonine-protein kinase pkn1
MFMARRLLIMLTILTLVYSCKRGGGDHKGELVGVKGKSWKQPRPYGMTLVPSGSFIMGSS
DDDKTGSLNAPVKTVSVGSFYMDETEITNSEYRQFVNWVRDSIIRTNLAELADQVGQTQG
NGGVGEYAYLNTNTENMNAYQQYMYNTYGDQQTKKLNRKVQLIWDTNKFPDEYYSEVMDK
MYLPIEESYNGKRIMDVEKFVFKYQWLDMEKSARAKGNRKDFVKEELVKVYPDTTVWIRD
FAYSYNEPMHNQYFWHEAYGEYPVVGVTWMQAKAFCEWRTLNKNSYLKAKGDDEINSFRL
PIESEWEYAARGGLEGATYPWGGPYTTDDRACFLANFKPLRGDYASDNALYTVEARSYEP
NGYNLYNMAGNVSEWTNTTYDPNSYEYMSTMNPNVIDEKNRRKVIRGGSWKDTAYMLQVN
TRDFEYQDSARSYIGFRTVQDFMGVSEGQQAKTARGFR
>OBAHECAF_01370 Prolyl endopeptidase
MYKRIIPLGCVLLAVSCSEKVKEQEVKINYPQTKKVDTVDVYFDTKIEDPYRWLEDDRSE
ETANWVKAQNEVTFGYLEKIPYRKTIKQRLEKLWNYEKVGAPFQEGDNIYYYKNDGLQNQ
SVLYRKDKDGKEEVFLNPNEFSKDGTTSLANLSFTEDGTLLAYQISEGGSDWRKLIVMNA
VTREIIGDTLVDVKFSGISWNGKEGFYYSSYDKPKGSELSAKTDTHKLFYHKLNTPQKED
KLIFGGTADQKYRYISGYVSDDGNYLFVSGANSTSGNKLFVKDLKNPKSTFVAITENFDN
DTQVINNKGSKLYLVTNLNAPNKRLVSVDISDPKPENWKDIIPQIDNVLSVSLAGDYIFA
RYIVDAVSKVKQYDYEGKLIREIKLPGVGSAGGFNAKKDEKETYFSFTNYNTPGKIYKMN
LDSGDYQLYWEPKIDFNSDNFESKQVFYISKDGTKVPMIITYKKGIKLDGKNPTILYGYG
GFNVSLTPNFNISNAVWLENGGVYAVANLRGGGEYGKKWHDAGTKMQKQNVFDDFIAAAN
YLITEQYTSANHLAISGGSNGGLLVGATMTQRPDLFRVALPAVGVLDMLRYHTFTAGAGW
AYDYGTANDSKEMFDYLRSYSPVHNVKSGVEYPATMVTTGDHDDRVVPAHSYKFAAELQA
KQKGTNPVLIRIETNAGHGAGTPVSKIIEQAADVQSFILWNVGVKDIKSVGN
>OBAHECAF_01371 hypothetical protein
MRTIKNIFIGVFVATILTGCLKDFQELNTNNEELTSVDPRNVFTGATENFNNSTRAHLLN
KYDGVLQIMQYIVSSSGGREGLYFQSSAANRPSIFTPYYNDYYRTIGLNLRYLTNTVIPN
NTEKTKYQNLAAIANILEVYEAWLVFDVNGAAPYHQAFMRSTHDIVKPKYDLYQKGIDGE
PMYKFFDKKVKENVAVLQSKLKDQHELGNNDYFYKGNIDNWIKFGNTLRIKMAQRVELAD
TEFYKKTIDDALASAGGIIANNDESCVYNHPNDHNNNTDDMQKLTSEYCASRAFVNFLKA
YDDPRLPLLIRRNGFGLGNNNKINDDNAKSLEKHFPDYPTKYPKFSERYFGISANPDSSS
TAWSRHSYFEFKYKNDAGVDVVLNIRHNSQIESRFYIKNGGKVSHSITARDKEDAKYDAP
QTSISLFTPLITYSETCFMMAEIAHKAGGAKGGKTDLDWFKEGIRASMQQYQTWATKMAV
PSAMNADSDNYNPITEDKINAYLARPEFQSVTLEKIISQQWVNLFMRPEEMWATWKRTGL
PAFKEDPVPTQGVAYFEKVTKAGSDLVIPRRGVLPTPNTENIDNFNATVEELKKDPAYGA
QENHTEGRIWWDKKQ
>OBAHECAF_01372 TonB-dependent receptor SusC
MKLKFLTLFAFVFSWCLTLSAQMVSVKGTVTDEGKVPLPGVSVLIKNTTRGVATDFDGKY
EIKANRGDVLVFSYLGFVTQEKIIGGGNSLTINVLLVEEAEQLGEVVVTALGVNKQARSV
GYATTKVATAEIERLNVINPVNALQGKVAGVAINTTGASGVTSSAGITIRGAKSLDKNNS
PIFVIDGMIIQETLTDAIGGTDWGSQLKNLNPADYESITVLKGAAATALYGSRGANGAIV
IVSKGGKFGKKGLGVEFSQSIEMANIYRSPMKLQNVYGAGHPRNGYEGGFLGDGSLGRSA
LSFGPKMEGQLINQHMPSGQQTPFVAHPDNWRALYQNPFNQTYNVAINGGGENSSFRLSY
SYMDNNGAFKRNNFNRNTVAFKGLMKLNDIFSMEAGVNYAFSKAQNGANQGGWNWGNNLS
MLSTLSTPRSFDMETYVNNYRDKETQALETETPWGTLRGYLHRRDLNLNQRNENSLLTNL
TLRANIAPWLTASVKGNYNYYGISKMEKQYGEGAFYGPTKTGGYSRGGEVYGSYNFLGML
QSNNNKINIAGEEITLDAIVAAELYGNLESHSWSKSTKGGLVVPGLFAFSNSAETIIPSF
GYTPANNKVFGVSGILNLGWRDQLFVEVTGRNDWLSSLTYPNYMIGGKNNYSVFYPSVNS
SWVFTETFKMPDWFSFGKIRASWAEVGMGTGAYATSKGYGIFKQESQFDAQRNSVLVARP
NLGTAWNNDLKPEIQRSIELGTDLRFFNERLNIDFAYYKTNTRNQILSVGAAIESGASTQ
LINAGNIQNQGIELQIEGTPIKTDNFRWTIGTNITKNKGKIIDLHPNVKEWRIWGQYDAG
PEIWAYEGGDYGVLTTSYNSPYGASIYRFNNPDDANDPRNGKPVIDYYGGLGSPHPVQWY
YYVTNNDKGIKDRIVLGKVEADFYLNINTSIAYKNFDLYALIDGRFGGNFHSNASVYATY
AGALESTLQGRDAEHGGLPRVNYKGETVYDAVNLDAVFDEGAKAPLVNDPTKTIDVGGLT
YREALDKGIIPMMATTHYERNMGWGSPNELHLQENTWLMLREISVGYRFDDEVCKKLGAN
YLRVGLTARNLGVLMSKLRDGLNPESISSNNPLTPMVLGGVPYSRTFSFNLTARF
>OBAHECAF_01373 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MNVNIKNISNNPLPNYQTEEAAGMDIHAFVTTPITILPLERVIVKTGLFLELPKGYEAQI
RPRSGLAAKHGITVLNAPGTIDSDYRGEIGIILVNLSNEPFVIENGERIAQMVFAKYEKA
TLTEVQELSETIRGTGGFGSTGKK
>OBAHECAF_01374 hypothetical protein
MRKIVFLVALGLLTFACKSKKSTVSAGEVDRKMKVGTLIQHHSNAFPKFVTVNGSISLAH
GSEGNMSSLPALSFRMQKDKAIWFSAPLGVAKVFVTPEKASYYNRLENTHFDGDFSNISD
LLGFEVNFENLQRLLLGQYIYDQDTSNTKIILIDSQNYILQSENINTLKTIYGITPKTYR
IGFLEITNTENPKEKSEVTYTYQKVDNVLFPDTIKINVQRMVDGELQKTEIELSFKSIRL
NEKVNFPFKIPSGTKSIL
>OBAHECAF_01375 Protein RecA
MAKKDTKELSAAEAKANALKLTLEKLDKTFGKGAVMQLGNAPIEEIETFSTGSVGLDVAL
GVGGYPKGRVIEIFGPESSGKTTLTLHAIAEVQKAGGTAAFIDAEHAFDRIYAQKLGVDI
NNLIVSQPDHGEQALEIADALIRSNAVDLIVVDSVAALTPKSEIEGDMGDSKMGVHARLM
SQALRKITGSINKANCIVIFINQLRDKIGITFGNPETTTGGNALKFYASVRLDIRKAGGG
SIKDSSGEVIGNRTRVKVVKNKVAPPFKSAEFDIIFGEGISKIGEIIDIGVDADIITKSG
SWFSYQGTKLGQGRDTVKALLKDNPELTEELENKIKEFLKNNDDDTTPKKGKKGKSKADI
ETQNSDDDSFDEDELNEEEE
>OBAHECAF_01376 Glucan 1,4-alpha-glucosidase SusB
MKKISIILCCLLGWQSQAQNTQISPDGNVKVTFELNPSGKPFYKIWYKNQEVIKQSYMGL
ELKNTTDLIADFKVIKEEKSTFDETWQPVWGEESHIRNHYNELLVSLHQKTSDRFMNIRF
RVYNDGVGFRYEFPEQKHLTYFTVVEEWTEFAMTGDHTAWWIVGDYDTQEYDYTESKLSQ
IRLLNQGAINHNASQTPFSRTGVQTSLMMKTDSGLYINLHEAALVDYSCMHLNLNDSNFV
FQSHLTPDATGDKAHLQAPCHTPWRTIMVSDDARNILASRLILNLNDPCAYEDTSWIKPV
KYIGVWWEMISGKSSWAYTDELPSIQLDKVDYTKLKTNGKHAANNQNVRKYIDFAAQHGF
DQVLVEGWNVGWEDWFGHKKDYVFDFVTPYPDFDLKALNEYAHSKGVKLMMHHETSSSVR
NYERHMHKAYQLMNDYGYNAVKSGYVGDIVPRGEHHYGQWLVNHYLYAVTEAAKYKIMVN
AHEAVRPTGLCRTYPNLIGNESARGTEFESFGGNKPFHTTVLPFTRLQGGPMDYTPGIFE
TQIWNVNPDNGSYARSTLAKQLALYLTMYSPLQMAADLPENYSKYLDAFQFIKDVPVDWQ
KSIYLEAEPGRYITVARKDKHSNDWYIGCTANENGHTSKLKLNFLDKNKKYEATIYADAK
NAHYKNNPKAYTITKRKVDANTTLTLVAKEGGGYAVSIKEIK
>OBAHECAF_01377 hypothetical protein
MRKDNIIQEKTFAFAVRIVNVYRYIVSEYNERVLSKQLLRCGTSIGANVEEAIGAQSDKD
FLSKISIAYKETRETIYWLRLLEATDFLTEEQSISLLNDAKEIAKIIGKIQITIKNKLKT
>OBAHECAF_01378 Cytoplasmic alpha-amylase
MKKNILTMVFVSLLLFQCGKKDNNDAPTPPQEVTPLNLSAMDNGNRVMMQTFYWDVEPRG
DWWNLTATKLTDWKANGVNRIWLPPATKGQSGGYSMGYDPSDYFDFGEYNQHGTVETRFG
SRAELENLIKKAHDNGLEVIADMVLGHNSGGGLEHNITRGKDTYTMFNEQHGNASGKFNR
SHLDFHPNDYHCCDEAADFFSEQDLCHHKEYVQNWLWKSDESVAKYYKNTMKFDGWRFDY
VKSFGAWVVKDWMASVGGFAVGEYWDGDAQKLKNWVDESGGVPAFDFACFYKLEQALDKN
DMRHLMGNQMLRTIYPDKAVTFVANHDTEKDKNLDNIISKERKLLAYAYMLTHSGYPTIF
ISDYENDEFKAKIQNLLLIHRSLAVGEEKFYLASDTEFIDFRLGDENSPGLMLFLNSGNA
PATRTIPTHWKNKTLIDYTQQSATRPVTDANGKVTITVRANSYGVWSISK
>OBAHECAF_01379 hypothetical protein
MISKHNLSRVRLMEFAQVMANVKNFLEKEDLANLELTAIKTDFDRDFNAFEASLKPVRKS
EYTQRITELDNQRDILLMGYIGHCKLFVNFPVKEKAEAAKKLVLINEKYGKSPQKQSFRE
ETAIIRNLLDDLAATQVKAMVTLIGAEQWIEQLAQVNEAFASIHTDRTQEQGAVEVGKTQ
TTRAQMQTTFTKLITLINGLTIVKGIQAYQNLVNSINEEIKKVTQ
>OBAHECAF_01380 hypothetical protein
MFLHPYKSGNLPDFIPLLAYNRVKPTDFVLLYPYKNANLSDFIDLYPYKKIKSQDLERHK
HYIQTPKLHIFKTQSKHLPDF
>OBAHECAF_01381 hypothetical protein
MKNIFKAGTLFGLLFVATSCEKDEEKAVLNAEAKIEMSLSANTLALDKEKGSETALSVSW
ETQQLNLNLGHSYSILLESNGKSKEVSVTKSPYSFSHVELNKILLANLELAAGTEAEVKV
TLKDAVSSTYSIPTQAKTIKITPYADLIEPTEWGIVGHATPNGWDGPDLPFWKNPTNSNE
RIAYVALKDGEIKFRKNNAWAENYGDDGKNGSLENGGANIPVTAGIYKIVWNINENTYTI
EKYSWSIIGDGAKGWGDNDDIPLEYDGATNTWKATGVTLKNGGIKFRFNKAWAVSWGDKN
ADGVLDQEDDNNIPVTAGTYTITVDFSVTPPTYSIK
>OBAHECAF_01382 Starch-binding protein SusD
MKRYTTYKIFGLALALSLTGCMKDLDQSPIDPDSFTQVQVFANPTEAKSALAKVYASYAL
TGQQGPQGQSDITGIDEGYSQFSRLYFAAQELTTETALVGWADQTIKDFHALSWSSSDMF
LNGLYNRLGQQISFANSFITNAEALSSDAQVRTFIAEARFLRAYSYYCLMDLFANVPLAT
KVQATLPTQSNRQEIFQFVESELKAIEGELKAAKSNEYGRVDAAAAQALLSRLYLNAKTW
VGTERYADCVAYAEKVINSGYALHNDYRQLFMADNDTNGAQNEFIFVLNYDGIKANTWGG
VTNLLLGSIGGSMKPENYGVVEGWDGYRTTKEFVSKFETKTTNVNGEPTAWNDQRAMFYT
DGQSYEINNISEFTEGYALPKFTNRTSTGGKGKDPSGKHPDTDLPIIRLAEIYLNYAEAV
VRGGGGSKATAVGYVNQLRTRAGATPITETELTADFILDERARELYWEGLRRTDLIRYGK
FTTADYLWTFKGGAITGVGTSEHRNIFPIPASVLLANPNLKQNTGY
>OBAHECAF_01383 TonB-dependent receptor SusC
MKSLKLRILLLFLFVSVGMYAQQIVKGTVKDATTGDPLLGVTVVVKGTSRGTATDFDGNY
ELKADRGEVLVFSSIGFRSQEITVNGTVLNVTLQEDAQQLDDVVVIGYGVAKKKDVTGSV
NLVNEKDFNKAPAVNADQLLQGKVAGVQMTSAGGAVGEGQTIRVRGNGSLSLSSNPLIVI
DGVPMNDGGVGGSRSIFNLVNPEDIESMTVLKDASSTAIFGSRAANGVIMITTKKGKAGQ
DMKINFNTSLSLQNVSDYVDVMSASQYRDLITSTGKANLIARLGAADTHWQKQIYQTAPM
SNSTLSVSAGGVVPYRVSVGHSYADGVLRTDNFQRTTAKVTLTPSLLDNHLKLELNANGT
FMKNRFAEKGAIGAAVGYDPTKPVYDPTSRYAGYSAWSDSATGLLGGLAPLNPMAMLFLT
DDNSKVYNFIGNLKADYKLPFFPEVIATVNVGLDHSNGKGDRIIDPRYPNSSSNFAGNHK
VYDNKTTNKLFDAYLNYNKEVNNHNIGLMVGHSYQSFEFDNHETFYETFVNPGDNKETPK
IDKSKNVLMSFFGRANYSYKDKYLLTATLRADASSKLAKEHRWGYFPSVALAWNIANENF
LKENETVNELKLRLGYGEVGNVNGLGDYIFLTNYTRSTNGASYQFGDNFYQTYRPSVVNT
DLRWEIGNTINAGIDFGFWQNRLTGTIDVYRKLTKDLIAPSTVDTFTNFGNEVNANIGNM
ENRGVEFGLSYTPFRTDDFRWTINYNVAYNENKLTKLPKVQDVGGIGGGTGNNIQRHQEG
QIPFAFFVFQQVYDANGKPIENVFVDRNSDGVINDDDRYFYKSPFAPVTMGLTMDFNYKN
WDLNIITRANIGNYVYNNTQSSLSQFEVATDREYLDNLMSNYNDTKFRELSGLGIKSDYF
VENASFFKLDNITLGYTFPTTKYNIRLYGTMQNVLTLTKYKGLDPEVLVPDVIGVKHGID
TNFYPRPKTYLVGLSVNF
>OBAHECAF_01384 hypothetical protein
MRATTVLQMSVRYAITEDTAQLFMHKVREAMKSNELHKMKGKVQVEEKKKANKDKATTQR
KRR
>OBAHECAF_01385 Thiol-disulfide oxidoreductase ResA
MKKFIVFISLIILISCSDQNNSIAEQIKTNSSSSVLILKKFHPTEKYYFSKYHYTLTLDA
PVEVINPNSFIRQKYTNFKGNSDTISITNESKVMIAKVTHSPFISNTYYLKAGDTLVVDF
SDLRNIKEYYQSKNALQGDIEPIYVKDSIDIQVMFSNDKQQRKANHLKDSLRLVENERKL
DSLFAQNLVTSFIYDARKLSYFYSRKTKNIDINDESHLKHDSIIGIRAYQSYVKSFTAKK
FTIKLTSSDYEVFYEPLSMFDAVYDSNFYGENVKEFLLYESLKNMQHKTSFTDVKLRLDK
FNKVTKDSLLITELKNSFLLDFDELITDKNNIHFIDYQKQTTTLSKLLEANQGKVVYVDF
WASWCVPCRKQMPFSKKLHHKYGDKVVFVYISIDTDFDKWQKAVAQEQLAIDGNNLFAVN
YPKANFYKELNLRSIPRYLLFDKQGKLVHKNAPQPDSQEIQKELEELLE
>OBAHECAF_01386 hypothetical protein
MKYILTIFLIAIFPNINAQTQVLDKENGQPIADTYVLLQVDGKNIATTKTDENGYFNLQI
PSSLSKTKLIFTHLGYIDFQTENVSEKKYFLERKVYKLDDVTVTHNEKKEWLPFGFSTNL
NMNSYAVTFIPATFKNKRKKITKLKYRLADFNGVKGLKYQPFKANLHSVDTLTCLPDKVI
FQSEVIRRKDNKKWTVIDISNENITMPKEGIYVVLETLDKSYYDKNLYYTRSGSVIEPVP
TLKMEPSKGGKKSFLSRNIHSKVRWEKQPYIFCMDIETEK
>OBAHECAF_01387 hypothetical protein
MKKIYLLFLIFVNISFSQEYTLLDKQGIAVSYAHLFLDDVIFAYSDEKGKFNIPQKPFEK
LEIQHISFQTKTIKRNELPENKQIVLEENTFELSEVEVSSPKKRKRKTLLPEKSLFNLIM
EKSDIQLIYTNGANRMQYALSPTVYESKAVYIPNEKPNKKAFIKKIILESRDKQIEGDTL
YIPFRVNLMSYDTIANLPNEKIRTEDWVVGKRVGERVEIEVDKSVILEFPKEGICVMVSV
YVPEFYINKRMTPPRFETVSIIKSSLFREYKLTHRRDLQFWEEMPYSKIREQCFNFGIEV
EYQD
>OBAHECAF_01388 hypothetical protein
MEKRRLSFWEIWNMSFGFLGIQFGFALQNANTSRIFETLGAKVEDIPILWIAAPVTGLII
QPIIGYMSDRTWTRLGRRRPYFLIGAILSSIALCVMPNSPSLWIAAGTLWIMDASINISM
EPFRAFVGDNLPDEQRTTGFAMQSFFIGVGAVVGSALPYIYTNYLGISNTAPDGVIPDSV
KWSFYAGAIVFLVAVLWTVFSSKEYSPAELEAFEKKDVNTYKNEVSSEEKAKKLNFYGAI
FAVVGVISTVFLYFFKMEKELYILAIGLAMLGFSFLFTSYLHKRKVKENGFISITTDMLY
MPKTMKQLALVQFFSWFSLFAMWIYTTATVTGRIYGTTDTSSPLYNEGADWVTLLFAVYN
GVAALVAFLLPVLAKATSRKVTHFICLLLGGLGLISVYFISDPNMLIVSMVGVGIAWASI
LSMPYAILSGALPSDKMGYYMGVFNFFIVLPQIVAATILGVIVHNLFNNEPVYALVVGGV
AMILSGFLTLGVKDSIK
>OBAHECAF_01389 Beta-phosphoglucomutase
MKAYIFDLDGVIVDTAKFHFIAWKKIGQEFGFELTHELNEQLKGVSRVDSLQKILNWAGV
SVSEEKFNELATRKNEDYLSYVTQMNENDILPGVKTFLEQAKQKNIKIALGSASKNARPI
LQKLGIISYFDAIVDGNDVSKAKPDPEVFVIAAQKLGVQNEDCVVFEDSEAGVQAAKTAG
MKAIGIGSADVLHQADEVFSGFDAVLNQ
>OBAHECAF_01390 hypothetical protein
MEEVINIREMFPSEYSLLQDFLYEAIFLPEGVTPPPRDIVFHPELRIYFADFGSQKGDVA
VVATVSERIIGAAWARIINDYGHIDDQTPSLSISLYSEYRNQGIGTKLFQKLLDQLAEEG
YEKASLSVQKANYAAKMYLKMGFYVVKENDEDYVMVIDLNSTNTH
>OBAHECAF_01391 hypothetical protein
MSELQLLMVLLPVVFMVHDFEEVVMFETWLSKNRDELRQRFPKLEKFLTRNNFFAYSTAD
FAVAVAHEFLLLSVVCYLSVWFGSYGWWFAGFMAFFIHLWMHIVQWLVYGKYVPVIITSL
LSLPYCFYTFWKFVDSDILSFEEMFWWTVGGIVVTIVSFPLAFFWASKFHKFCKKM
>OBAHECAF_01392 Maltose phosphorylase
MNQDYIVPDNWCIIEEGFEKDRVMQSESLFSLGNGAMGQRANFEEHYSGKTFQGSYIGGV
YYPDKTKVGWWKNGYPEYFAKVLNAPSWIGIRVKVNGEELDLNTCKLVKNFKRVLNMKEG
VYTRSFVATLPSGMEIQVNVTRFLSLQYDEVGVIRYEVTPLTEKATITFESYLDSSIENH
DTNWEEKFWNTLDVKQVGNRGFIVAETKKTAFRVCTFMENRLEVNGIISNIQKVNQKENY
IGFVYETSAEKNQTAQFEKYAGYVTSFNHPKEKLIEETEQLLLKITALGFNELLKKQKED
WAEVWQMADITIEGDVKAQQAIRFNIFQLNQTYSGKDARLNIGPKGFTGEKYGGSTYWDT
EAYCLPFYMVTKNAEVARNLLKYRYDQLGKAIENAEKLGFKNGAALYPMVTMNGEECHNE
WEITFEEIHRNGAIAFAIFNYVRYTNDFAYVPEMGLEVLIGIARFWHQRATFSKDKNKYV
ILGVTGPNEYENNINNNFYTNYIAQWCIKYAKECLDKVKISYSNDFERVWKKTNLSENEI
EQWLAVAENMYYPYSEELNIYLQQDGFLDKELITVAELDKKERPINQHWSWDRILRSPYI
KQADTLQGFYFFEDHFTKEELARHYDFYEPFTVHESSLSPCVHSILAASLGRMEHAYTFY
LRTSRLDLDDYNKEVHEGLHITSMAGTWMSIVEGFGGLRMRNGMLHLNPQIPSQWKSYSF
KVNFRGQILKVSVSPKETKLSLEGTSLQLSINGKEVVVNDELTISN
>OBAHECAF_01393 hypothetical protein
MALLVIGAISCVKDGIDGKDGRDGIDGKDGKDGRDGKDGRDGNMIISGNGSPAEDLGNLG
DFYFDRSTSNLYGAKTEHGWGVPLNLKGETGAKGDKGEPGVKGDKGDAGAKGDKGDPGVK
GDKGEQGADGAKGEPGAKGDPGPAGGPKGDKGDKGDTGATGATGAPGAKGDRGDKGDTGA
TGATGATGAKGDKGADGANILSGTVAPTAAVGNEGDWYIDLTTSRLYGPKTNTGWSVDYV
VLGGVGASGLPDFRLVNVYGKLQLKMWYNTMTRFIDMPAHPELKDVQVIHDYAFENCTAL
YSIKLANSIEYIGNKAFFAASRLRYINLEDTNIESIGYNTFANCKSLESITMPSTLTFIG
GEAFQNCISLTEVTLPDGLEYIYYNTFEDCHSLTHINLPSTLNEIGPYAFQNCHSLTSIT
IPGSVKNIHIQVFYNTGLESVTIENGVQKISSSAFRSTKLTSVTLPPSIQGLGAEVFAYC
RDLTTITVQATTPPTLDNGNLGNNLNSLTKIRVPAASVAAYQAAWSNYAHLIEGY
>OBAHECAF_01394 hypothetical protein
MKYFATVVSFLFHPIWFPAYGSIIFFLTTSIYQPADEIKSMWTMLVSVSLVAPTLVYAII
YMFNWIKSPFKIENENRKWMLYGYISILLVIALKITTLDSFPMLYFYMMQLSISCFLVVL
LHFLKFIISIFTTLIGGITGFTVFLSIFYQMDLTYLIILWVIISGFVASSRMYLTAQTLL
SSLIGWLIGFTSQMMLFLLLNNVHHID
>OBAHECAF_01395 Ribonuclease R
MSKQKKKTAKAKKHDLTKGIFSVLENNQNESFNYKQIAAKLNITDASGRNLLIKRLVQLK
EKKKILEVERGKYKAIPSQNYYTGIVDITSRGNAYVVVDELETDVFVPSNMLNKALHGDL
VEVYIFPRFRKGNKLEGEVTKIIERKKMRFVGVVQMQKNFAFVLPTDHRMYTDIFVSKND
INGAENGDKVIVRIEKWEGKSNSPFGVIEQILGKPGEQSTEMHSILAEYGLPYEFPHEVE
AFAKQLDTSITAEEIAKRRDMRNVLTFTIDPKDAKDFDDALSFQILENGNYEIGVHIADV
SHYVQEGTILDEEAYNRATSVYLVDRVVPMLPEVLSNFACSLRPNEEKYTFSAVFEMNKK
AEILNTWFGRTVTLSNHRFAYEEAQEIIENFAGVGEKQEKVEISDFQMPSEISIRKEGSY
SVPKEVVQAILFMDDLAKKLRTKRMRLGAISFDKIEVKFHLDENDNPTHVYFKESKDANK
LIEEFMLLANRKVAEFIAKQKKTFVYRVHDEPDDEKLMQLNGVISRFGYGINIKDRKSIT
YSLNSLLEEVKGKKEQNLVDTLAIRSMAKASYSTENIGHYGLAFDFYTHFTSPIRRYPDV
MVHRLLQKYLDNQPSEKQEVYETKCKHSSQMENLASSAERDSIKYMQVKFMENHKNQHFR
GVISGVTEWGIYVEIVENKCEGLVRARDIKDDYYIFDEKQYALVGEVTKNMYQLGDEVVV
RVKNTDLLKKQLDFELVGTN
>OBAHECAF_01396 Adenosine monophosphate-protein transferase SoFic
MLEKPPFFDVETTDIETIYLMLKAENEDILQKIQDDYLYWDKVKYKKTNLPAEKLWELVK
RHRFIKSKFVTFGNYQFSYVITDYIQKKLHFFDMYFGGILGSNIGIADTDKNKFIISSLI
EESISSSQMEGANTTRQKAKEMIQQQKKPKNKSEQMIFNNFLAMKYIVSNKEQEISLENF
LYLHKLLTNDTLDNELYEGKLRDTNDIYVVNYSNSEVVHTPPFFTEIPNLLDDLFTFFNK
EDKNFIHPILKACILHFMLGWIHPFVDGNGRTARAIFYWYMLKKGYWLTEYLTISKVIKN
TKNQYEKAYLYTEIDNNDLSYFITYHIKAMEKSFEELKQYIAKKQRQVMQSAQFLKIGGV
NERMAEILKIFNDDSDRIMTIKEVESRFQVSNYTARTDLKLLSEMGFLTVIQVNKKKQNF
IKSDNFDLILKELLSKK
>OBAHECAF_01397 hypothetical protein
MNDLVTINQIPDYEQIPLTNLHSDYKKIARMNAFIFGVIGFVFLLAIFFIFDTVEKYYVF
TAVFVIFLFLIIYISVSYKYKKYAFRQQDAIYKTGIIYQATHIVPYVRLQHITIKQGWYA
KRLGMATLCLYTASSNGDISIPGLSLQEAERWKSFLLNRIETTENEYDEL
>OBAHECAF_01398 hypothetical protein
MMNYDFSIPNKLSKKAFWLVLAKSFWSNFKIFWGAFALFLFKKGNNSDDKFQFFLIFLGI
FLVISVFIFIFQYIKYKYFSYQIIEDELIIREGWLNKSETVVKFDKIHEVHLNQKFIHKI
VGLYKVDIDTAGSDKVEISINGIDYHKALVIKDILTEKQIISEIKKNRITDENLEANDNF
TSLRISILTLFKIGITQNYLYTLSLMFAFSYQIIDFITDIFYEKRSDFVNQISEFSNTVS
TIFFWIFFLFILILFVIIFNLIRTLLTYYNYEIQIKNNRLLASYGLINSHIVAVPPKKVQ
MIHFQQNYFQKLMNLFEVRISQIDSSKSEEKKTQGLLIPGINALEMRKLFRFIYDKDFEE
VKEFYRPSSRKVIIRAMYLFFALFMIIISMYFIDLLQFVWIPIFLFFVVLSLIYISYRNE
KLFLKDDFIVLKSGIWDLTTTYLQVDKIQEVKIKQSYFQKRRGLASIKLYTASESLQLNF
YDEKLLKKLVNESVYKIEFVI
>OBAHECAF_01399 hypothetical protein
MYYYFRDIQLNFDNQSLFTMETKNQLIRKKFGLPFLVFYLVTFLIWFIFPHQLVGNIYVL
MGYLVGNLIFLYVLYKYKRSLNKVE
>OBAHECAF_01400 hypothetical protein
MFSDVLLALPLGVILAFTIGPVFFVLLETAITKGFRAAVAFDGGVILADIVFILVAYFTT
SGLLQRVKDDPLLFIIGGLIMISYGLISYIKLKKDFHQKNKIESTDNNLSIKRVNYLALF
MKGFLLNFINIGVLGFWLGIIIVFAPQLDMDTNRILVFFTSIVVIYFIIDILKILIAKQL
KNKLTAFHIYKIKRTISIILLVFGVFLLAQGIFPESKEKLNEIFTENQ
>OBAHECAF_01401 Ubiquinone biosynthesis O-methyltransferase
MNILKVKDYSVSEEEFQLIYNSELQLFKTSPTPENLAKYYESQEYISHTDSKKTWFDKLY
QYVKIINLRSKINVISNYKNENIRLLDIGAGTADFILACKKIKKWNVDGIEPNEKARKLA
MQKGINLFENYDSFEENSFDVVTLWHVLEHIPDLEKQINLINLLLKENGILIIAVPNFNS
WDAKHYKNFWAAYDVPRHLWHFSKTSIQKIFTAKGFELLKIKPMLFDSFYVSILSEKYKT
GKKNFIKGFLNGLYSNYYGMTKNEYSSHIYILKKCKKSF
>OBAHECAF_01402 hypothetical protein
MLITITLHCPNCQCTKIVKNGNKKNKKQNYLCKTCKRQFIGDHNLTYKGWASHITAKILL
LLARNVGIRDIAEIEKVSIKKVLSVLVNFNREIKPKQNKYKSLQVDELWTFVGKKKNKKW
LIYAYSAETKEIVAWVWGKRNIKTAQKLREKLKKLGVSFDEICTDNWEAFASVFQEYTHK
VGKKYTTDIEGNNTLLRHRIRRAVRKTCCFSKKFKNHIKAFEIVFFYINFGWI
>OBAHECAF_01404 hypothetical protein
MLRKLKQRWNVTSNTQFWLILITFTITGSLSARISRPFCDYIGLDFNNLHPILAWILRLI
VILPIYQITLLIVGTLLGQFRFFWAFEKKMLGIRPKKIENLQEQIEEKDSKKTTQIHN
>OBAHECAF_01405 Prolyl tripeptidyl peptidase
MKKHLLLWLFVSSLTTFGQQGITNQSNVGLKKITIEDAIFGYYKNPDAPQGYSLLYPENY
YDLQWIKNTNQWIHSSNGKFNIIDANGKTIRTLGDELMKNYPQLKRLPSIGYIDEKEFIF
EADNTYHIYNYQSDKKTGSIRIPQEADNKDFNRERDAVAYTIGNNLYLAIANNEKIVITN
HSDKNIVSGQSIHRQEFGIKKGTFWSPKGNFLAFYQKNESNVTDYPLVDINTHPAVPKII
KYPMVGQKSEQASIGIFNVDTQKTIYLDIDTTDEHYLTNLSWSPDEKYVLIAEINRDQNH
YWLNRYDVATGKKVNTLFEEKNDKWVEPENPAVFLPNKNNEFLWMSERDGFMNLYHYNTE
GKLIKKLTSFRWVVQDILGFDSKGKYVYISGTGTDPREKHTFRIDLTNPKKIQQLTKVNG
THKTQLSSDGKYLIDVYSSISIPNKIDIINTESTKSITILEAKNPLEGVAVGSTEFVEIK
ANDGTILYGKMHKPRDIDVTKKYPVLLYVYGGPHAQLVTNSWGVGSYLWMPFFAENEQYI
IFTIDNRGSANRGFAFESVIHRRLGDIEIQDQLTGVEYLKSLPYVDDSRIAVHGWSFGGF
MASSLMLRHPNVFTTSIAGGAVTDWKFYEVMYGERYMDTPISNPEGYEKSRVGKYLDNLS
GKLLFVHGSVDDVVVPQHVMSIIQESISKRKMVDLSIYPMHGHGVRGVDNANLVIRMLEY
IKQHNK
>OBAHECAF_01406 UvrABC system protein A
MKTQEIIIKGAKLHNLKNVTVGIPRNKLVVVTGLSGSGKSSLAFDTLYAEGQRRYVESLS
SYARQFLGRLDKPKVDNIVGIAPAIAIEQKVNTSNPRSTVGTSTEIYDYLKLLFARIGKT
FSPISGQEVKKHTVTDVVNAVLAYREREKLLLLAPIHIPSERTIYQVLQMLLQQGFLRIL
YQNEILRIDEIQEGQVTSDFSLVVDRVIVQHNEDFQHRLADAVEVAFFEGKGECFIQEVE
SGKRISFSNKFELDGIDFLESNVHLFSFNNPYGACPKCDGYGDVIGLDEDLIIPNTGLSV
YDNCIFPWRGETMSWFRDQLVNNSYKFDFPIHKPWFELTKEEKKLVWKGNKYFTGLDDFF
KELEEKSYKIQNRVLLARYRGKTKCSECEGKRLRKEAEYVKIQGKSISDLVDISIEELQI
FFKNLQLTEYEKNVAKRLLIEIENRLQFLSDVGLNYLTLNRKSNSLSGGESQRINLATSL
GSSLVGSMYILDEPSIGLHPKDTEKLIGVLKSLRDLGNTVIVVEHDEEIMKAADHIIDIG
PKAGTHGGEVVAQGSYEQILTADSLTGKYLSKKMSIELPKRRRTSPHYIKLIGCRENNLK
NIDVTLPLDMLTVVTGVSGSGKSTLIKKILYPAMLRELNINGDKAGQFTKLEGKYKHIQS
VEFVDQNPIGKSSRSNPITYLKVYDDIRNLYASQKLSKLRNFQAKHFSFNVDGGRCEVCK
GEGEVTIEMQFMADVHLPCEACGGKRFKKEVLEVSFEGKTIDDLLNTTIDDAIIFFDQHK
QHKISAKIKPLQDVGLGYVTLGQSSSTLSGGEAQRIKLASFLVKSESKEKVLFIFDEPTT
GLHFHDIHKLLSSFQALIEKGHSIVVIEHNLEMIKSADYVIDLGLDGGDKGGTVIAEGTP
EELIKNKISYTATYLKQVM
>OBAHECAF_01407 Inner membrane protein RclC
MKQLLTFLAGSQRNFVNYIRVAIFIVMAWIGGLKVYQYEADGIVPFVTNSPFMSFFYNNT
GKTAVNDKGETVPEYVLHKNPEGKMVAKNIEWHKQNGTYTFSYGLGAMICLIGLLTLLGI
WSPKIGLWGGLLTFGMSIVTLSFLITTPEVYVPNLGGDMPTPQHGFPYLSGAGRLVLKDI
IMSAGGLIAASDAAQRLLKKEK
>OBAHECAF_01408 HTH-type transcriptional activator Btr
MFNEILLRMNISIKNNTTQQLREGFSVENYCIFLFVGSGAFSVNSVDFEYDGHTILFLSP
YQKIEFLKEIPAEVEVLQFHGDFYCIEYHKEEVACNGLLFNNIYMQPHIQLSEEHFSEIK
SIFKRIKTELGEKTTYSQAVLRSYLQLILALSSKDKSLILKDLMLKVNNSIGLDFQKNLE
TYFLTERSVAFYADKAHLSVDTFSKKIKQLFEKSPAKLIQERIVLEAKKQLHLTCKSIKE
IAFEMNFEDEFYFSRFFKKAVGLSPKHFRETVGISVVAK
>OBAHECAF_01409 Thermophilic serine proteinase
MNTQKSLLMIATAFVLASCSSVSKVSKSSLDVAPSSYTSVGKLADDNLKTWPHESYSANL
PGMNLGGAYDLLKKMKPKQKVIVGVIDSGIDINHEDLRNVVWTNPNEIANNGIDDDKNGY
VDDIHGWNFLGDVNHENLEYVRIYKTKDKNNPLFEKAKKMYEKEHNETLEEKAYMEQLYQ
MILSADEVLAKELKKTNYTKSDLAQLKTSDDTIAQYVEFMQQMFNRVEDVNVLKSDFNNA
AKYYDSKLKHHLNLNFHPRKTILKDDENDFSKKGYGNNNVIGPDLEESLHGTHVAGIIAA
ERGNGIGIDGVANNVQIMALRAVPDGDEYDKDIAFAIRYAADNGAKVINTSFGKGLSPHK
DKVYEAIKYAASKDVLIVNAAGNDSKDIDIEDTYPNDEINGKEISDNFLTVGALNYMFNE
NLVASFSNFGKRNVDVFAPGVKIYAPAPDNNYKFLQGTSMASPEVAGIAALIRVYFPNLT
AAQVKQVIMQSGVKPNLEVKVGEGENKKKVPFSELSTSGTIVNARNAIILAAKMSLRK
>OBAHECAF_01410 hypothetical protein
MREKILLTIYGLGFVFFSHAYAQHDTIGKPHYQLIDTIRLSDVYVFERAERTFPNEEARK
QYLILRNRVRKVYPYAKMAADRLYVMEQTMDTMKNNRTKKTYVKRTQKYIEDRFTDELKQ
LSRSQGRILVKLIHRQTGRTAFNLVKELRNGWNAFWYNNTAWLYDISLKSEYNPAEVEED
YWIEEILLRAFAREELEEQDPAFLIDFEKISQERRNRRK
>OBAHECAF_01411 Sodium-dependent dicarboxylate transporter SdcS
MRSTKNHTISIFLLQNSFFFKCFFEIKLYICCRDLRKKCLRKCILLMDSLFSPMYLTLFI
LALASFFFMQGKVRSDLVAVCALLCLMFFKILSPEEALAGFSNSVVIMMVGLFVVGAGIF
RTGLAKMISSRILRLAGNNENLLFFLVMLVTASIGAFVSNTGTVAVMMPIVVSMAASANL
NPSRYLMPLAFASSMGLFTLISTPPNLVIQDVLTHGGYKPLSFFSFAPVGLICLVVGGIG
MFFLSKYLVDTKTDGATNSTKKGKTLQELVDEYRLNHQAFRFKIPKDTPLLNQSLAELKI
ATNYGITVTKITRKTSASGFGKKYLEIMATPNSLILHGDVVYCNGSEENIHRFATENGLT
IEEDKEGTFSDFQESGIAEVFVMPNSKLINHTIREARFREEYNVSVLGIKRQTTYQRDDF
QNIKLHSGDALLIQGTWKDIAEIGNLQDDLVLLGQPLKEAAKVTLDQKAPIAALIMLAMV
VAMVTNVIPTVTVVLVASVLMVVTGCLRNMEEAYNSINWETVVLIAAMLPMATAFKNTGA
ASLISNGLIHQLGSFGPYALLAGVYFSTSLLTLFISNTATAVLFAPIALNAAQGMGVSPY
PFLFAVAIAASLCFASPFSTPPNALVMQAGRYSFMDYVRIGTPLQIIMGIVFVFLLPLLF
PF
>OBAHECAF_01412 Ribosome maturation factor RimP
MKLIEKVKELVDNALSENPALFLIDLSVSNDNAVRIVIDGDNGVGIDDCITLSRSVEHNL
DREEIDFSIEVTSFGATEPFHLERQYQKNIGRTVEVLKNDGKKHEALLKGIVDGNVILET
ETREPKPVGKGKITVKRELQIALSDIKETKVIIKF
>OBAHECAF_01413 Transcription termination/antitermination protein NusA
MDNLELIESFSEFKDNKLINRETLMAILEEVFRNTLKKKYGSDDNFDIIINPDKGDLQIF
RNRVVVEDGEVKDPNQEIELSAAQKIEPDFEVGEDVSEEIKINDLGRRAILALRQNLISK
IHEYDSTTIYRKFKDLIGQIYIAEVHHIRHKAIILLDDEGNEIVLPKEKQIPSDFFKKGE
HVRGVIEGVELKGNKPSIIMSRTSPVFLERLFEQEIPEVADGLITISKVVRIPGDKAKVA
VDSYDDRIDAVGACVGVRGARIHGIVRELGNENIDVINYTSNPNLLIARSLAPAKVNSVT
VDEENKTAQVFLSPEEVSKAIGKAGYNIRLAGQLTGYDIDVYRDGIDDEEDIELEEFDDE
IEGWVIEEFKKAGLDTAKSILELDITELMKRTDLEEETIREVISVLQDEFE
>OBAHECAF_01414 Translation initiation factor IF-2
MSEGKNIRLSKVLREFNISLETAVDYLKKDKGIEVESNPNTKISEDAYKMLSDKFNADKN
KREASKEIVQDQRKEREAIRIEQEKEHEEKRKQQEQEVIKARGTVVGIKTVGKIDLEPKK
ENKSSEKVVDKIKQSTEKETVAQTENTPQPVEKKEENPQEIVATQEETVIEVTEKESVTF
KKNKNKQDSKKEFPQKNKSQNTQNDKYQSLNQHIIKDSKPQNDTAKNQEKEEPEVGVIET
QYQKLTGPKVVGEKIDLSQFDKKKKKKKKDKASKDKEKVNTDAPKEDESGDKKRKRKRIK
KDDVASSSPHKDKKDGKGKDKKQKTFAKVEPTEEEVQKQVRETLEKLQGKATKSKGAKYR
KEKRDLHRQKTESELAQLEQEEKILKVTEFVTVNEIATMMNVPINKVIGACMSLGIMVTM
NQRLDAETLTIVADEFGYEVEFVTADIEESIPVEEDEETDLIPRAPIVTVMGHVDHGKTS
LLDYIRKENVIAGESGGITQHIGAYSVKLESGERITFLDTPGHEAFTAMRARGTKVTDIA
IIVVAADDDVMPQTKEAISHAQAAGVPIIFAINKIDKPTANPEKIKERLAGMNLLVEDWG
GKIQSQDISAKQGIGVQELLEKVLLEAELLELKANPNKRALGTVVEASLDKGRGYVSTVL
VETGTLRVGDYVLAGTNSGKIRAMHDERGKKVKTAGPSTPISVLGLDGAPQAGDKFYVFE
DEREAKQIVAKRAQLQREQSVRTQRHITLDEIGRRIALGDFKQLNIILKGDVDGSVEALT
DSFQKLSTEEIQVSIIHKGVGAITESDVLLASASDAIIIGFNVRPMANARALADKEEIDI
RTYSIIYDAINDLKDAMEGMLSPVFKEEVTGTVEIRELFKISKVGTIAGCMVTDGKIYRN
SKIRIIREGVVIYTGELSSLKRFKDDVKEVSKGYDCGLQVKNYNDIKENDVLEAFQEVAV
KKKL
>OBAHECAF_01415 Ribosomal RNA small subunit methyltransferase A
MDTVKAKKHFGQHFLKDLNIAQKIADTLSLSGYEKVLEIGAGMGVLTQFLLQKNIDTHVV
EIDRESVAYLQKHFPELENKIIAADFLSYDIASYFNHKPFAIIGNFPYNISSQIIFKTLE
LRELIPEFSGMFQKEVAERICEKAGTKTYGILSVLVQAFYEAEYLFTVSEQVFNPPPKVK
SGVLRLVRKQKFHLDCDEKLFFTIVKTGFQQRRKTLRNSLKSFLRDESIKNNPIFDKRPE
QLSWEDFVYITQILT
>OBAHECAF_01416 Glycine betaine/carnitine/choline transport ATP-binding protein OpuCA
MIQVHNLSKTYNGITVLNIPELTINKGESFGLVGNNGAGKTTFFNLLLDLIEPSTGSITN
RGIQVNLNEEWKPFTTAFIDESFLIGYLTPEEYFYFVGELRGQNKADVNDFLTQYKEFFN
DEILGSRKYLRDLSKGNQKKVGIIAALIGNPEVVILDEPFANLDPTTQIRLKRIIKELSE
NKNITILISSHDLLHTVEVTSRIVALNKGIVVKDIQTSDQTLKELENFFGVE
>OBAHECAF_01417 hypothetical protein
MFKRFLFLEWKSFLRSASFSKNLAVKILLAFSTIYFIIIFFSLGIGLYPLLKEAFPEQKP
MLIVNMFVVYWFLAEFFVRFMWQSLPIINVKPLLINNINKKRIIRFLLTKTLFSPFNFFT
PLLIFPFGVWNIYVGDYSLVSILCWWIAILSLMFSANFLNFLLNRYFSDNIKKLFPYVAI
VLILVGLERFDIFKTSHFIGNLMDILLEQFYFVVIPIALCFLTYKLIFNHLRKSFYLDNV
LKSKNKTVSTANFGWVRLFGDIAPFLQLDLKLIWRNKRSKSVIWTMLFFVFYGLLFYPNP
EIGKSFLFSIFIGIFLSGVFLINFGQFIPAWDSTYYSMLMAQNIPMKQYVKSKAYLIYGS
ILLLTLLTIPYVYFGKHILLVNLATALYNLGVNVPILLYMGAFNKKRIDLDKSTMMNYQG
MGIVQWLLAIPFLVFPLLIGWLCKSIFDETWAIMILAGLGFIGFLCREYFFEFIANKYKS
RKYITINGFKQQA
>OBAHECAF_01418 hypothetical protein
MYKKLNFFEKILFLTNVFFVLWLLVSYLIPYLPPKRFSIISVLALLTPIVLIVNVLFSIY
WLVRRKKIFLLSTVILLFGYESLTRLFQIFNTSTEAGNSLSLMSFNVRLFNHYRWHPDRN
LKDKIIEFVQKQSADIIVFQEFYNHKKYDIAGYPHKKIITKTPKDNIGHAIFSRFPIINA
GSLNFPNTSNNGVFVDIRVQKDTLRIYSLHLESLHIKPENELINQDKERLIKNISRRFVL
QQEQMELFKTHQNTSPYKTIVCGDFNNTAYSYIYRNIRGENLNDAFEEKGVGFGKSFNFN
FFPFRIDYILLDKSLNIQDFNTFSEVLSDHRPMLVKFSME
>OBAHECAF_01419 Octanoyltransferase
MNKQIIFEDLGTKDYKETWDYQESLFESIIEKKRKNRANNTNEPTSNYFLFVEHPHVYTL
GKSGDISNLLIDEATLKKKGATFYKINRGGDITYHGPGQIVGYPILDLDNFFTDIHKYLR
LLEETIILVLKDYGIKGTRSEGETGVWIDVGTPFARKICAMGVRSSRWVTMHGFAFNVNA
DLGYFDNIIPCGIRGKAVTSLNLELGQKEVAIEEVKEKIIKYFQELFEAEMI
>OBAHECAF_01420 Cytochrome c biogenesis protein CcsA
MLKSFVNFVFSTRLMAILFIVFGIALGLGTFIENDYGIDTARIWIYNAWWFELIMLIFAI
NFIGNIKRYNLLKRENWAVLVLHLSWVFIIVGAGITRYMSDEGLMSIREGDTANFYVSDR
TYISVFVDGQHDGQPLRKSNQTEVLFSPYTRNSYHWNDDFKGKRFDVKYKKFIRGAKEGF
VESPEGALYLKLVESSGGTRHEHFLKDGEVTNVHNILFALNRPTEGAINLTINDKQQLIR
TPFEGKYMTMATQEFTPVAKDSLQPFMMRSLYSLEGIQFVVPEFMVRGYEGVVALDEKEI
TKESSNAVVLEINSGDESKEVTVMGSKGIIHPPKSISVNGLDFHLSYGSRRVEVPFSVKL
DDFIADKYPGTENSYAAFKSKVTVTNGNERFNYDIFMNNILNYKGYRLFQAQFHPDEKGT
VLSVNHDYWGTLITYIGYFLLYGGLIAFMFVGKSRFIKLAKQLRDVQLKRQKLSVLLFLL
GSSVMFGQHSVRPSDAEIDSILKATTVSKEHAEKFGELVIQDSGRMKPVHTFASELMRKM
TKFDDFRGMNPNQALLSMMLHPGVWTQVDFIFVKKQNDSLHSFLGVEKGTKYVRFADFFD
ENMSYKLSPYLHEIYSTNTPNQFQKDFKNADQRIGLINRALSGEMLKIFPLLNDPNNRWV
SGVEFRSDRSLEKDSLYANFISNAVPMYLSMLRESIQTGDYSNPDKLLEALKKNQQNHGA
EVLPSESKIKAEILYNKIDVFNLLFQWYLYVGGVMFILLVVDIFSKKPFLNIAVRICKYL
ILILFLLHTLGLICRWYISGHAPWSDAYESMIYVAWATMGMGLLFAKRSLLSLAATAFVT
SMILMIAHWNWMDPSIGTLQPVLNSYWLMIHVAIIVGSYGPFVLGAILGIISMYLMIFTT
DKNKERMSLATQELVIVNELSLTVGLVMLTIGNFLGGMWANESWGRYWGWDPKETWALVS
IMVYAFVIHMRLVPGLRGRWAFSFASTIALFSILMTYFGVNFYLSGLHSYASGDKIITPS
FVYYSVAFVLISGAISFWKYRQYYKK
>OBAHECAF_01421 hypothetical protein
MKRLIIVCLALFSGKAFSQDYPKNQINLNALNAIAIASVELGYERYVDFNQSIEVEMFFN
DRFSYFPKGDNRKYSATSIKVGYNYYFDLDNLSGPYINPFIKQRFGSFKETVLNADKKEV
VETTKLDSFIFGIGIGYIWNYNDTFVVAPYVNIGRNFGKKIVENKYFWAIEPNAGIKIGY
KF
>OBAHECAF_01422 DNA gyrase subunit B
MSEELNKSQYSADNIQSLEGMEHVRMRPSMYIGDVGTRGLHHLVYEVLDNSIDEALAGHC
DRITVSINEDNSITVEDNGRGIPVDIHKKEGVSALQVVMTKIGAGGKFDKGSYKVSGGLH
GVGVSCVNALSTHLIATVFRDGKVWEQEYSRGKALFPVKQIGNTDKRGTRVTFHPDEEIF
QQTTEYKYDTLATRIRELSYLNKGITITLTDFRNKDEKGEYISETFHSENGLSEFIKYLD
GNRVSIINRVISMEGEKNEIPVEVAMIYNDSFNENLHSYVNNINTTEGGTHLQGFRMGLT
RTLKNYADKSGLLEKASKDKKNPIEIVGDDFREGLTAIISVKVAEPQFEGQTKTKLGNRE
VTSAVSQAVSDMLESYLEENPNDAKTIVEKVILAAQARQAAKKAREMVQRKTAMSGGGLP
GKLSDCSEQDPEKCEIFLVEGDSAGGTAKLGRDRNYQAILPLKGKILNVEKTMQHKIFDN
DEIKNIYTALGVTIGTEEDAKALNLQKLRYHKVVIMCDADVDGSHITTLILTFFFRYMRE
LIEKGYVYIATPPLYSLKKGKKEVYAWNEKERDRVSEELGGGAHITRYKGLGEMDAPQLW
ETTMNPAQRTLRQVTIDNASEADRIFSMLMGDEVPPRREFIEKNAKYAKIDA
>OBAHECAF_01423 Outer membrane protein A
MKKTTLSLVALSFVGYVSAQDLPANPAPGKCYVKCITKDEFREETERIQIAPAYSKLEVI
PGTFKTIEERVLVKEASKKLVYVPAVYETVQVPYEKKEAGNILTVVPAAFGKDVKTLEVY
PKTSGWEYKHLDNCPSINKDACVTACFVERPARFESVDVVTLVKDAHTTEREIPSIEATF
KRQVVKTPARVEEIEIPAEYATIKREVVDREATTRKVEVPAEYKTITRQVLVKKGGVTVW
EEVDCKLLEPTMLPILYEYNSAKLTKASEKIIDEMLFPLLNGKNTSVEIMSHTDSRGNDD
YNMSLSQQRANAVVNYLASKGIQRSRMIAKGYGETRLINRCANGVQCSEQEHHKNRRTEF
RILGE
>OBAHECAF_01424 UDP-N-acetylmuramate--L-alanine ligase
MKVNFNNIQNVYFIGIGGIGMSALARYFKAIGKNVCGYDRTPTEITDTLENEGIKVHFTE
DEANIPSDFKNIENTLVVYTPAVPKMHVELVFFQKNGYQVFKRSEILGMITENSFCLAVA
GTHGKTTTSSILAHILVESGASVSAFLGGIAENFNSNLVLNGSKFTVVEADEFDRSFLRL
SPDIACITSMDADHLDIYGSKEEFEKGFRDFADKIKSDENRIICNGLKINGKTYGLEDNS
DFSFQNIRIENGLYHFDFHYANNVLKNYVFPKPGRHNLSNALAAVAMGVQAGFPAEKLLS
ALATFKGVKRRFSYIIKEKDFVFIDDYAHHPSEINALFQAVDEMYPKIEKTIVFQPHLFT
RTRDFMDEFAESLSKFDDVVLLDIYPARELPIEGITSEVLLEKIQSKQKVLVSKSDLIPL
LTKKQPKLLLTVGAGDIGAEVERIKNSFKM
>OBAHECAF_01425 hypothetical protein
MKTKQFGLETAVLTSFQNIFEKFENIEKVIIYGSRAKGNFRYNSDIDLSIIGEISYDDLL
KIELLIDELLLPYKVDLSVFNNIDNSELKAHIERVGIVLYKKNNK
>OBAHECAF_01426 hypothetical protein
MELDIRYKQRFTNYTKALEQLKKAIYYFEENAKNEKTDFLEIIGISVIKSFEFSFELAWN
LMKDYAIYQGITNISGSRDAIREAFAMGLINEKNQMVWREMIISRNQSSHTYNQSTATDI
LKKIKEDYLFAFQDFEEKMKPLSQ
>OBAHECAF_01427 hypothetical protein
MKEVIIKKLNSENLIAKGLRLSLEVFTKCNKMDYNDEGYRHFNSYIENKEQVSLLSMYGA
FINENLVGIIGVKENGQHISLFFVDKKYQGLKIGRKLFAFAQNDTKANHIIVNSSTSAVE
VYKKLGFNIIRERVTKNGLTSVLMEYKNNN
>OBAHECAF_01428 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKPKFIISGGGTGGHIYPAIAIANEIKRRLPDAEILFVGAENRMEMQKVPQSGYPIEGLW
ISGLQRKLTLDNLMFPLKLVSSLWKARKIIKKFRPDVVVGTGGYASAPTLKAAQWLGIPT
IIQEQNSYAGVTNKWVCQKAEKICVAYDDMEKFFPKEKIVKTGNPVRADLLNISEKRKEA
QIFFSLNPNKKTLLVLGGSLGARRINQLIESNLSLFEKLDIQVLWQCGKLYFEEYKKYNS
ENIKVLQFIDRMDFAYVSADAIISRAGASSVSELCIVGKPVIFIPSPNVAEDHQTKNAQA
VAKKQGCILIRESELDSQFETIFSQLILNENQQKNLSENIKKLAQPNATKDIVDIIFKLF
KD
>OBAHECAF_01429 Sodium/glucose cotransporter
MSIIDVLIVVLYILLTIGVGVWISKRASKGLDSYFLGGNSIKWYYLGLSNGSGMFDVAGT
AWMVGILFLYGVKSFMFMWIWPIWNQIFVMVFLAAWIRRSNIMTGSEWILTRFGNDKAGR
ASHLIIAIFAIITSVGFIAYFFEGVGKFMSIILPWDMTLAFGNSVLLTSEQSYSLLIIFL
TTIYTIKGGMFSVVATEVLQYGIMVLAGILVAGYAFFTISDAQITAIIPEEWKNIFFGTE
LTPFWDSKYQAFNDFIDTQGYKMFGAFIGMSLLKGFFASVAGPTPSYDMQRILSTRNVKE
ASYMSGFTNIILFIPRYLLIGGIVVIALVHIAPQMLTGITNNDLETILPKVVNFHVPVGI
KGLLLAGLLAAFMSTFSAFVNSGPAYIVNDIYKKYFKPEASMKHYIHASYWASFAIVILG
VIMGFFADSINGITLWITSALYGGYVAANFLKWVWWRFNGWGYFWGMLAGLLIATAQFIL
DINKANFTEGTWLYSLAHIPPIYLFPIFFVFSLLGCFLGTYLSKPTEMSVLVNFYKNIRP
WGLWHPVYVQLKQEDSTAVKNTDFWKDMGNCVIGIVWQSSQILIPIFLLIRDYPKMWWSI
AVFALTTAILKFTWLDVVKKYKD
>OBAHECAF_01430 Putative serine protease HtrA
MEQHKKYIFKIITSGGTGSGFAVKGYDFLITNYHVVEGAKTLAVEDQERNRYFARVVMAN
PELDLAFLHVEGISLADTSITINPDLQIHNTQKVFINGFPFGMPFTITEGIISSTNQPMN
NRHYVQTDAAVNPGNSGGPMLNQDGTLVGVTTSKFTEADNVGFAIHFNEVIKELRDFTFS
DNVFRVKCNSCDHFIETETKFCPQCGNKVNASVFEEFELSNFATFIESAIADMGANPILC
RAGRDVWEFHQGSALIRMFIFRSNYLIVTSPLVKLPKQNLAPLYEYMLSHPYSPYHFGIS
ENIIYLSYRVHLSDLFSEDSEKIKNHVRDIPKLADDLDNILVEQYHCEYSIDSKLA
>OBAHECAF_01431 hypothetical protein
MRNRIPKYHRPIKNINDPIAQVDSWYAAVDAFEEKRYSESLRKLLDYINPEVAKQVPASG
DFSVEYPQGSSRVTFGVRNDYFYIESPFVKITEKSNKIALLREVNELNFTHLTIPQIHLE
NQMLWFKFEAPLYVCQPNKIYEALREICETADDFDDEFIEKYNVEHVQSPVIEHLNEEEK
QQAWEKIQSILDEYKLFMDYFQEKRWSESQWDILMISLLQLGNMPCIQGVLRVDLQEYIQ
NISNNRIDFHYRIDRGRNFFKKLMEKSQEDLMKDIYYTKALMGLKWRSSSKIIQEYVTDF
EEQIRKYKNSNDHFNVAYYLNYIYLRLMYFYNLDQNYKDFIIGTLERASGEAYEKAATIY
LETFDHLLNETLPKNIKNGTTTKKGFLARLFG
>OBAHECAF_01432 hypothetical protein
MKKRFLLILGLSFLLSSCQCTLVRLLFVKKSAVKHKRVLVKGDQEFIFIPMVHLGKQQYY
DEVKEYITKKRSEGYKIYYEGVGISRDSISDEKKDTLERKQRKILGFHLTVYNDKDNQSL
PRCAKKYVGQTLTNTGIIPEIDTNADLSTEELIERFETKYGKILLNECDFTTPLKAPYEC
NKEMSRREFSNINFTYTHLLRDSHLAELLKTTKDKKVVIVFGKKHWIMGVYPTLRDEGFE
LIEGKI
>OBAHECAF_01433 hypothetical protein
MKTRFLLILGLSFLLSSCQCTLIKLFNVQRSALKHKKVFVRGDQSFIYIPMNHLGRQQYY
DEVKAYLEIKRSEGYTIYYEGMYLSRDTINQQRKDTLLLKRRKLMGFHLTPSYSDKNNHS
LPKCYKKYVGQTMENTGIIYGTDVNIDMTTEEVIEAYEAKYGEIPLNECDFTTPLNTPYK
CEQIKGVHPTNLLYRYSHTFRDEHLENFIKTVKDKKVILIFGRAHWHHGIRSTLIDENFE
MIEGKI
>OBAHECAF_01434 hypothetical protein
MKNNHFATFIRYFLQGILILGPLSATIWIIWSIFSSIDNLIPDISKKYPGLVFFMITIGT
TLVGFIGNKFLLGRILVNSLDYLLEHTPGIKFIYSSIKDVLTSFVGDKRKFNNPVWVKVQ
ESPETWRIGFLTQKNMDLANMPDMVSVYLPHSYAISGWVIVTNANNIKPAEGFSAHKAME
FALSGGMSGMTNTKNH
>OBAHECAF_01435 Endonuclease YhcR
MIMKSRKIISIFSMLLLSLVAIVACVKDTDYELPDYDKGQLTPFNGEIVSFTKANSSATA
EVTDYAKDEAIEGYIVSSDEGGNFYKKLYIQNEEKTAGVAVSIDKTALYTEFPVGSKVQL
RLKGLSTQINNGGLEIGYKTYTSSSGRVSVGSIPPAVYSSHLFVLKDQNKTVEELAKADA
SIETLKVNSNVNQLITLKNVSFQTAAIGKTYHLKANDAQQGTNYNLIDKQGQKIAFRTSR
YANFIDEKVPAGILDITGVLTKYGSSYQFMVSSTSDIKVIGEGNNEEETEQITISQFPFD
ESFSSGMPKGWKTIATKGDRLWEIKTFNKVNYVQMSAFKQNAVIDVTTWLITPKFNITTE
DLALKIKLADAHQNGNPLKIYYSSDYNGSNDVNGATWKELGKSAIDALINNSGKYDNNYE
ESAAIPLPKGEIYIAFVYESGGKISTTVQLQNVHIGQNQGETPDNPDTDATLKTVKEIRE
LLASETFVFEENVKIKVVITSDKDAKNVAGANAFAQDNTAGIALRFASAHSYALGTELEL
NLKGTKLKKYNGLLQIEGLKVSNVINQKADAGVPTPKTITIAEALTGNYESQLVRIENAQ
FTDVLKIYSGTQTITTDCTNHLAVYTRKEASFAGKDVSDKKGTITGVMGVHSSGIQLIMR
NINDVKFENDYTKCEGDTPDNPDTEATLKTVKEIRELLKAETFVFEENVKIKVVVTSDKD
AKNVAGANAFAQDDTAGIALRFASAHSYALGTELELNLKGTKLKKYNGLLQIEGLKASNV
INKKADAGVPTPKTVTIAEALTGNYEGQLVRIENAQFTDVLKIYSGTQTITTDCTNHLAV
YTRKEASFAGKDVSDKKGTITGVMAVHNSTIQLIMRNVTDVKFENDYTKCEGDTPDNPDT
EATLKTVKEIRELLKAETFVFEENVKIKVVITSDKDAKNVAGANAFAQDNTAGIALRFAS
AHSYALGTELELNLKGTKLKKYNGLLQIEGLKVSNVINQKADAGVPTPKTVTIAEALTGN
YESQLVRFENAQFTATSTTYNGAKEITTDCTNVLTIFTRKEATFAGENVNDKKGTITGVM
AVHNSTIQLIMRNVTDVNFTETRQDCGGSGDPSTPTYVEKTVSEIRAIHTSVDVDITEDF
KIKVVVTSDKGAKNVGVSNAFAQDNTAGIALRFASEHHHALGTELELNLKGTKLKKYNGL
LQIEGLKVGNIINVNTSAVAPTPKTITIADALTGNYESQLVRIENAQFTATSTTYNGAKE
ITTDCTNALTIFTRNQASFANENVSDKKGTITGIMAVHNSTIQLIMRNVTDVNFTETRQD
CGGSGDPSTPTYVEKTVSEVRAMHTLGDVDITEDLKIKVIITSDKDGKNIAGANAFAQDN
TAGIALRFASTHSYALGTELELNLKGTKLKRFNGLLQIEGLKASVNVLSVNNSATPITPK
TITIAEAITGNYESQLVRIENAQFKDVSKTYKGTQAITTDCNNALNVYTRNNAVFVNETV
SDKKGTITGVMGVHTSGVQLIMRNVSDVNFTGAYQVCP
>OBAHECAF_01436 hypothetical protein
MYKTLCFYLLCLVSVPIFSQSVIEGYVSDYQMKNALQDVKVRVEGTTIVGVTDINGFFSI
ELPEGSYILRFSKESYVEKRMLIELSGLKVTLPVVFMDADFVHESEQMAVITESELEDDE
SGADSMSGLLHSSQDIFMRRAAFDFSAVFFKPRGYDSKDVTVLMNGIPMNRIENGRAQWS
NWGGLNDVTRTQESQHGIAKSDYTFGGIAGANYINIRPSLNRPGFRFTTSAGNRSYAGRI
MYTYNSGLSKKGFAYSFSTSRRWAGNGSYIDGTLYNSYASFGAVEYHLNQHHNFTLLGMY
SLTRRGKTAPLTREVIDLAGYKYNPYWGNQAGDIRNSRNRIIDEPIFILSYDFHKNNTRL
NVDLGYQFGNMGNTRISYGNASNPEPNYYRNLPSYYINQRTGPNWEMANLQKDYFLKHQQ
LDWSSLYRANMNTRNDRSAFIISNDMNDERTFSANVNFSTPLQENIQWTSGLVYRNITSE
NYAQIDDLLGGSFFMNYDYFANKPYDENDTNLQKVKGDKWNYEYGLKSSLGEFFSQVDFN
FHKVDFFVTGRLHHAEYQREGKYNYALFADSFGKGDRKIFRGVSTKAGLTYALTGRHIFQ
LNTGYFNTPQSIRNSFANIRYSNRILPNLKNETAYTFDGSYILRVPYFKSRLTGYYTHVE
NTSETNFFFTEMALTDEISSDFISQTVDNIQKRHFGLEFGAEAQIFPTWKVTAAAAIGQH
TYINNPKMYVSSGEIGVIEVDKVSLKNYRVPSGPQQAYSIGIEHRNKKYWWVSATANLLT
DNYVSISAINRTRGFFINPDTRKTFTDIDEELARKLLKQERLQDVFLVNVVGGKSWRIKK
TYVSLIGSVNNLFGQNFVSGGFEQSRTANYGSMLRDNAHGVPSFGPRYFLGYGRTYMINL
AISI
>OBAHECAF_01437 Superoxide dismutase [Mn]
MKLRKLIPMTALIFSGAVFSSGELYAQKKKKETRQAKTEKVNYGSPSEVKANEGAFKIVP
LNYGYDAVSSYIDQETMFIHFSKHYVGYLNNLNKAVEGKAQANQSIEQVLKTLDMNNATL
RNNAGGYYNHNLYFDVISPKGGGMPTGTLATAINNEFGSFENFKKLFAEAGGKRFGSGWA
WLVVNNGKLQIGSTANQDNPLMPGLEISGTPILGMDVWEHAYYLKYQNKRGDYIQNFFNV
IDWNKVAELYNKAK
>OBAHECAF_01439 Bifunctional enzyme CysN/CysC
MDILRFLTAGSVDDGKSTLIGRLLYDSKNILIDQMEALERSSKNREDGSVDLALLTDGLR
AEREQGITIDVAYKYFSTPKRKFIIADAPGHIQYTRNMVTGASNADLIIILIDARNGVIE
QTKRHSIIASLLNIPHVIVAINKMDLVDFSQNRFEEIKQEYEKVAKTLELNGVEFIPISA
LNGDNIVEKSTKMDWYEGTSLLNRLETIELATSTNLTNARFPVQLVLRPQTEELHDYRGY
AGKIESGIFKKGDKVVVYPSKIEATISAVEVNNQEVVEAFAPQSAVLHLEEDVDVSRGSL
IAKDDELIKVSNELEATICWMDERPLHLGGRYLLQHNTQVVNAIVKEIRERIDVNTLERF
GGVSSVSLNEVVTVKIKTSSPLAYDSYKKIRETGSAILIDTTSYVTVAAVLLK
>OBAHECAF_01440 Superoxide dismutase [Mn]
MSFTLPKLPYAYDALEPHIDARTMEIHHTKHHNAYTTNLNTAIAGTDLEGKSIEEILKNL
DMNNGAVRNNGGGFYNHNLFWEVMSSKGGGQPTGELANAINEAFGSFEAFKEAFAKAAAT
RFGSGWAWLCVHKGGKVEVCSSANQDNPLMPNIGCGGLPILGLDVWEHAYYLNYQNRRPD
YIQAFFNVINWEKVAELYAKGK
>OBAHECAF_01441 Peptidyl-prolyl cis-trans isomerase A
MRTLIITFLLLISGISFAQKVVIKTSKGDIIVKLFPKKAPKTVANFLRYVDEERYDERSF
YRVVRLNNQGQSTTPIEVIQGGFYNDTLNVYPPIKIETTEQTGLSHKIGAVSMARNAPDS
ATTEFFIVLNQRQPQLDYGGKRNSDGYGFAVFGKVVKGMKIVKEIQKGKTVLWEGYGQEQ
LLKEPVKIISIRRLTN
>OBAHECAF_01442 hypothetical protein
MASGKGSLKEGGIRIPFLVSWKGKIIRNQTNNNIVSIEDIFPSLLEICNIEKENIIQTID
GKSFVNQLFTPTKNIPERNLYWHLPNNWFGYNRTLGLGASSAIRKGNYKLIYYHDSQDFE
LYNITTDISEKHNIATENQTKTEELAHDLANYLREAKAQMPTVQITGKQVPYPDEVINKK
P
>OBAHECAF_01443 Arylsulfatase
MYPCLLLFFMKKLYILSIIAFLPILFLRCNKTETPPNIVLFVVDDMGWQDTSVDFFEQTT
DFNHMYETPNMERLARQGMKFTQAYATPICSPSRVSLFTGTNASRHRVTNWTLLRDTSTD
QKDTLLTYPEWNVNGIATESGIPRTFVSTTLPQLLQKSGYHNIHIGKAHFAAKDTPCEDP
INMGFHVNVGGHAAGGLKSYEGVDNFGNDTIQKNIFAVPHLEEFHGKDIFVTEALTQKAI
EKLQKRPKEKPFFLYMSHYAIHVPIMGDKRFVNKYLDKGMHPVEAKYASLIEGMDKSLGD
LMNFLEQEELSENTIIIFISDNGGLDA
>OBAHECAF_01444 hypothetical protein
MIGLIILGVVVILIIWYVMTNNRLVALSNNRENAFADIDVQLKQRHDLIPQLLGAVKGYM
QHEADVLTRVTQARSKAMNATDVNSKIAAEKELGMAMSAFNIQVEAYPDLKANTNFMHLQ
QEIADIENKLASVRRYFNSTTRELNTAIQSIPTNIVAGMKKMTVQPFFDLGTEQRATLDK
APEISF
>OBAHECAF_01445 Protease HtpX 
MQYVGIQSQISRNNFKSILLIIAFPLLVLLEVYAFLYFTNEQNVTTTNSLFVGATPVVLV
VVGVWFLISYFFHTQMIQFATNSKPLERRNNMRVYNLTENLCMSVGMQMPKLYIIESEVL
NAYASGINEKTYAVTLTRGLINTLDDAELEGVIAHELMHIRNRDVRLLIVTIVFVGIFAV
LADLAFRMLLSNGLSSRKKSSNDKGGGGMIILIFLIIAFVVYILSMVFKFALSRKREYMA
DAGAAEMTRNPLGLASALRKISGNSELDIKNDEVKEMFIEHKSKGIMSLFATHPPIEKRI
QVLEQF
>OBAHECAF_01450 Elongation factor Tu
MAKETFDRSKPHLNIGTIGHVDHGKTTLTAAITKVLSDAGLSEARSFDSIDNAPEEKERG
ITINTSHVEYQTANRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRIVVFMNKVDMVDDPELLELVELEMRELLSSYDYDGDNGPIVQGSALGALN
GEPKWVDTVMKLMEAVDNWIELPTRDIDKPFLMPVEDVFTITGRGTVATGRIETGIAKTG
EAVEIIGMGAEKLTSTITGVEMFRKILDRGEAGDNVGLLLRGIDKKDIKRGMVICKPGSV
KPHAKFKAEVYILSKEEGGRHTPFKDKYRPQFYVRTTDVTGTISLPEGVEMVMPGDNVTI
TVELLQAIALNVGLRFAIREGGRTVGAGQVTEILD
>OBAHECAF_01452 Protein translocase subunit SecE
MVNYIKESYEELKNHVTWPTLAQAQKEMVIVVVFSVLFSLLIWGMDSFFEWLMAWYFNFM
K
>OBAHECAF_01453 Transcription termination/antitermination protein NusG
MSGILEKKWYVVKAVTGQENKVKNYIENETTRLGYADYVEEVLVPTEKVVQIRNGKKINK
EKVHMPGYVMVKANLAGEVIHIIKSIPGVVSFLSETKGGDPLPLRKSDVNRMLGQVDDLA
ENVEAVAIPYTVGETIKVIDGPFNGFNGTVEKVNEEKRKLEVMVKIFGRKTPLELSYMQV
EKV
>OBAHECAF_01454 50S ribosomal protein L11
MAKEISKVVKLQARGGQANPSPPIGPALGAAGVNIMEFCKQFNARTQDKQGKIIPVVITV
YKDKSFDFVTKTAPAAVQLLEAAKIKGGSGQPNRKKVGSITWDQVRAIAEDKMADLNAFT
IESAMSMVAGTARSMGITVTGDKPF
>OBAHECAF_01455 50S ribosomal protein L1
MAKLTKKHKEALSKVDYNKLYSLAEASALLKQITYTKFDASVDIAVRLGVDPRKANQMVR
GVVTLPHGTGKDVKVLALVTPDKEAEAKAAGADYVGLDEYLQKIKDGWTDVDVIVTMPSV
MGKLGPLGRVLGPRGLMPNPKTGTVTMEIGKAVQEVKAGKIDFRVDKTGIVHAAIGKVSF
SAEQIIDNAHELIQTLIKLKPTAAKGTYVKSIYLSSTMSPSVPVDTKSV
>OBAHECAF_01456 50S ribosomal protein L10
MTREEKSLVIEDLTARLAENNVIYVADLTGLNADETTNLRKACFKANIKLAVVKNTLLAK
AMEASEKEFGELPSVLKGNSTLMFSEVGNAPAKLIKEFRKKSDKLVLKGAFIEEAIFVGA
DQLETLVAIKSREELIGDIIGLLQSPAKNVVSALKSGGGKLAGIIKTLSEK
>OBAHECAF_01457 50S ribosomal protein L7/L12
MADLKNFAEQLVNLTVKEVNELAQILKDEYGIEPAAAAVAVAAGPAAAGEAVAEKTEFDV
FLKSAGANKLAVVKLVKELTGLGLKEAKEVVDGAPSKIKEGVSKDEAEGLKKSLEEAGAE
VELK
>OBAHECAF_01458 DNA-directed RNA polymerase subunit beta
MLTNQTARINFASVKHTPDYPDFLDIQIKSFQDFFQLETKSEERGNEGLYNTFKENFPIT
DTRNQFVLEFLDYFIDPPRYTIQECIERGLTYSVPLKARLKLYCTDPEHEDFETIVQDVY
LGTVPYMTASGTFVINGAERVIVSQLHRSPGVFFGQSFHANGTKLYSARIIPFKGSWIEF
ATDINNVMYAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEIKVSKTGLKKYIGRRL
AARVLNTWHEDFVDEDTGEVVSIERNEIILDRDTVLDKDNIEEIVEADVKTILLHKEDSQ
ATDYTIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIIDKLFFSDQRYNLGDV
GRYRINKKLGIDIPEDKQVLTKEDIITIVKYLIELINSKAEVDDIDHLSNRRVRTVGEQL
SAQFGVGLSRMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTNP
LAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLAVFSK
VNSMGFIETPYHKVTNGKVDLKDMTYLSAEEEEGLKIGMANISLDKEGNITEERVVVKED
GDFPVIEPNQVEFIDVAPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLLKPEAPI
VGTGLERRVASDARVLMNAEGDGVVEYVDAEKIIITYDRTENQKLVSFEEEQTVYDLIKF
QKTNQGTCINLKPIVRKGDRVTKGQVLCDGYATEQGELALGRNMKVAFMPWKGYNFEDAI
VISERVVREDIFTSIHIDEYSLEVRDTKLGAEELTNDIPNVSEEATKDLDENGMIRIGAE
VRPGDILIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLYGVVVDKKLFSR
VVKDKRKRGKEKEDVAVVEASYNSKFQALKDKLITKLFTLVEGKTSQGVTNDLGEEIIPK
GKKYSVKALEAVDDYAHIVSGGWTDDKEVNTLIDDLLHNYKIKLNDLQGALRREKFTISV
GDELPAGILKLAKVYIAKKRKLKVGDKMAGRHGNKGIVARIVRDEDMPFLEDGTPVDIVL
NPLGVPSRMNIGQIYETVLGWAGQKLGQKYATPIFDGASLEQINALTDEAGIPRFGHTYL
YDGGTGERFDQPATVGVIYMIKLGHMIDDKMHARSIGPYSLITQQPLGGKAQFGGQRFGE
MEVWALEAYGASSTLREILTVKSDDVIGRAKTYEAIVKGETMPEPGLPESFNVLMHELKG
LGLDIRLEE
>OBAHECAF_01459 hypothetical protein
MNIEELREFCLSLKASEESFPFDDNILVFSVKGKMFCLVNITKYEFINIKCDPEEAVELR
EQYAEVTPGWHMNKKHWNSVQINGKISDKLLRKWIFNSYELVVKRLPKKVQEELF
>OBAHECAF_01460 DNA-directed RNA polymerase subunit beta'
MARVKDKVTTTKFDKISIGLASPESILAVSRGEVIKPETINYRTHKPERDGLFCERIFGP
VKDYECACGKYKRIRYKGIVCDRCGVEVTEKKVRRDRVGHINLVVPIAHIWYFRSLPNKI
GYLLGLPSKKLDMIIYYERYVVIQPGIAKGPDGEDIQPMDFLTEEEYLNIMETLPVENQY
LEDTDPNKFVAKMGAECLLDLLQRLDLDELSYDLRHKANNESSKQRKTEALKRLQVVEAF
REAKNNRENKPEWMIMKVIPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLKRLM
EIKAPEVILRNEKRMLQESVDSLFDNTRKSSAVKTESNRPLKSLSDSLKGKQGRFRQNLL
GKRVDYSARSVIVVGPELKLYECGLPKNMAAELYKPFVIRKLIERGIVKTVKSAKKIIDK
KEPVVWDILDNVIKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLVCTAFNADFDG
DQMAVHLPLGPEAILEAQLLMLASHNILNPANGSPITVPSQDMVLGLYYMTKGRRSTPEY
PIKGEGLTFYSAEEVNIAYNERKLNLNAFIKVRVRDLGENGEEVYKVIETTTGRVLFNEV
VPREAGYINEVLTKKSLRDIIGHILKSTSIPTTAEFLDKIKNMGYKFAFQGGLSFSLGDI
IIPQEKEKMIAEANGLVEGIVANYNMGLITNNERYNQVIDVWTSTNAQLTELAMKRISSD
QQGFNSVYMMLDSGARGSKEQIRQLTGMRGLMAKPKKSTVGGGEIIENPILSNFKEGLSI
LEYFISTHGARKGLADTALKTADAGYLTRRLVDVSQDVIINTDDCGTLRGVEVRALKKNE
EVVETLGERILGRVSLHDVYNPLTEELLVKAGDEITEKAVAKITEAPIEMVEVRSALTCE
AKHGICAKCYGRNLSTGKMVQTGEAVGVVAAQSIGEPGTQLTLRTFHAGGTAGNISEESK
LEARFDGVVEIDDLRTVKGQDYEGNPVNVVISRTSELKVVEPKSGLVLHTHNIPYGAHIF
VKDKQEVNKGDVLCQWDPYNAVIISEFSGKIAYEGIEQGVTYQIEIDEQTGFQEKVIVES
RNKRLIPTLLIQDKDGETFRSYTLPVGAHLMVDDGSKIKEGKVLVKIPRRSAKSGDITGG
LPRVTELFEARNPSNPAIVSEIDGVVSFGKIKRGNREIVIESKTGEVRKYLVKLSNQILV
QENDFVRAGMPLSDGSVTPDDILNIKGPSAVQQYLVNEVQEVYRLQGVKINDKHFEVIVR
QMMRKVEIQDPGDTLFLEGQLVHKDDFIEENDKLFGQKIVEDAGDSENLKAGQIVSLRQL
RDENSLLKRADKNLVEARDVIPATATPVLQGITRASLQTKSFISAASFQETTKVLNEAAV
NGKVDFLDGLKENVIVGHRIPAGTGLKRYEKIIVGSKAEEEVVVEKKKSR
>OBAHECAF_01461 hypothetical protein
MSSINENAENQLSIELDEKVADGVYSNLAVINHSSTEFVVDFINVMPGMPKARVKSRIIL
TPQHAKRLLNALSENIQRFEQSHGSIHENEHHPVPLFGLKGEA
>OBAHECAF_01462 hypothetical protein
MKQILVALFLFSSIYSFGQNAKTVKVFENALVNFSEKGEAPADVIRLQSGRLLVKKIHIP
EYRKGTDVSVEITIRSNGDPWDKSGSCFVFKNEDLINVINVAQGSKQLPNESGTDNNYHG
IKAVSSYDLPVEILRFMTPFGVGHFSDEQKYPNMKYGRPVSVPKWEDKVVWQQDVSQLES
LLTGTFYIGIWIDTWTDKGYLADVSLTYSGRPRPKKVVTPLVNTIYYVNGQKIPDLFAKT
TLKHDITLKKDVKNAELYYITTGHGGHSGGDEFIKIKNSVFFNSKKVIDFIPWRDDCAAF
RRFNPSSGVWTRKDTAFAYNENYERVKKAVEERLASSDLSRSNWCPGSAVVPENVSLGTL
KKGKHTIEIVIPATANTGDQQNHWLVSSYLVSDK
>OBAHECAF_01463 Succinate semialdehyde dehydrogenase [NAD(P)+] Sad
MTHTTLENAFSGIETLQSSYKRWKEFDLKKRLTIVQEIRDKLLSNKSLYAHAITEDMNKP
ITQAIAEVNKCAYLCDYYITNAENFIAPRLVKTQWSESRVNFEPIGVLLGVMPWNFPFWQ
VFRFVIPNMILGNLFVIKHASNVPKSANLLETIFNSDKIDFPLYKNLFLDSKYVADIIAH
PHIKGVSLTGSENAGKAVAENAGKHLKKSVLELGGSAAFIVCKDADLELATSVAVMARMQ
NTGQSCIAAKRFLVDENIAETFINQYRSKIQALKTGDKFDPTTQIGAMAREDLAIELEKM
VTESIQEGAKLICGGNRKGAFYEPTIITEVTPSMAIFKEETFGPVAAITTFSTFDEAVEL
SNQSEFGLGVSIFSKNTEFVKSQAYRFEEGAVYINEMLISDPNLPFGGIKKSGYGRELSF
FGTYEFANIKTVVVK
>OBAHECAF_01464 hypothetical protein
MKTKNILLVALIMGSLSVWTQPNYKPSAENLKARSNFQDDKFGIFIHWGLYSMLSDGEWV
MHNKNLHWQEYEKLAGGFYPAKFNAAEWVSAIKASGAKYITITTRHHDGFSMFNTKHCDY
NIVKATPFKRDIIKEIADECKKQGIRLHLYYSHLDWRRNDYYPLGRTGKGTGRTTHGKWE
DYHKFMNNQLTELLTNYGEIGAIWFDGMWDKDIYPDGMTPETWNLHEQYQLIHNLQPACL
IGNNHHLVPFTGEDIQIFERDLPGENKAGLSGQDISKLPLETCETMNGMWGYKIIDQNYK
STETLIQYLVKAAGKNANLLMNVGPQPDGMLPAVAVQRLKEMGEWMKKYAPTIQGTRGGV
ITPRDWGVTTQRNKTLYVHVLDWKDKALFLPYAGNKLKKAIEFDSKKNIQFSQDKDGIWL
KFPKVPTAPDYVIELTFENKLTENQ
>OBAHECAF_01465 hypothetical protein
MRIQLLLQQQDNIDIIKQKLAEAPDEQYGIGIFIGNMLPFVVLVILAYLMYSYMKNKSNG
DENLLDD
>OBAHECAF_01466 Carnitinyl-CoA dehydratase
MGTNRINGSLYTKIENRVATIEFGHPHANSFPLELLERLAKEFDLLSENKDVSLIVVKSE
GDKAFCAGASFDELLTIDNETEGTRFFNGFANVFLAIRRCKKLIIGRVQGKTVGGGVGLV
AAMDYVFATEAATIKLSELSLGIGPFVIAPVILRKTGQATLNELFMAPDQWKNAYWAQQK
GLYARVFENIKEMDEALGHFLDRLLQANPMALTEMKRITWQHTEHWLEELPKNAEISGKL
VLSEQTKSMLSKFKNQ
>OBAHECAF_01468 hypothetical protein
MSKLKKLFKHTFVYGLATVLPRVLTLLLTNFYTHKLEKQDFGIYSGLFVYLILGNVLLSY
GMETAFFRFVNKETDKKKVQSTALTSVTVSSFLFLVGAILLQNHIAEWLNYKVEYIRLAI
YILVLDALVVIPFAWLRNEGKSVIYALIKIGNVVVNLLLNLYFFLVLSNHIDKTDEGVVF
IFMSNFIASLLTFLVLLPLYFRIKFSFSVALWKQMMRYGFPVLIAGIAFAVNEGFDRVFL
RMLLPVDTADATIGVYSACYKMGMFMTLFVTAYKLGVEPFFFSNAQDKNAPKTYALVTEY
FILFGAFILLFITVFIDVLKYIIVSNSEYWEALWIVPVILLANLCLGIYHSLSVWYKVTD
RTNFGAYVSVLGMFITVIVNFLLIPLISYKGSALATLATYFVMMSVSFWVGQKKYPIPYN
IKKIGMYLGFSIISSFIVFYVFDKNMYIGTVFLLLYVLLVVKQEKQLIRHLKR
>OBAHECAF_01469 Pyruvate formate-lyase-activating enzyme
METHPLRAAIHSVESFGNIDGPGIRYVVFFQGCMLRCKYCHNPDTWELHNDDAKMMTTDE
LVSDIVKYKTFFQASGGGVTLSGGEPLLQLDFVLELFTKLKSLGISTCVDTCGGFYANTP
IINEKILKLISLTDLFLVDIKHIDDTQHQRLTKRHNKNIITFIDFLSQNGAKMWVRHVLV
PKWTDDDVYLQKLRDYIDTLQGVERVEVLPYHDMAKFKYDELGIDYPLKDIERPSKERIE
NAIKILGARYDLD
>OBAHECAF_01470 TonB-dependent receptor SusC
MKRKFLVTFVLTMVFCFHWLYAQNRTVSGVVTDESGIPLSGVSVLVKGTTRGVSTDFDGK
YNIQAQAEEILIFSSMGFVTQEKKANVTKLNVMLKEDAEELEEVVVTALGIKRSEKALGY
ALQEIDGTKLLEARDANVTNALSGKVSGLQIVKGAGGMAGSSKIVLRGQNSLTGDNQPLI
VVDGVPIDNKASGAADIWGNSGMDMGNGLSDINPEDIESLTVLKGASAAALYGSRAGNGV
ILITTKSGKEKKGLGITFSTTLATEDIFVKPALQNTYAQGVDNLYDPKTARNWGPRIEGQ
TVTNWNNKQVKLEAYDNMNNFFRTGITATQALSFQQQINKTSVYGSVNYMDNTSMVPETD
MNRTSMALRTTTNLGASDRWKVDFKINYVNTQAHNRPIQGLNQSNVFKTLTIFPRTLDIR
EFNPPIVNGQQVWYDTQTLPDDNPWWTLKYNTNNDVRNRYISFGAVTYEFTNWLRGEVKG
GLDYYNTKMYQRKHSGSLSVPKNGQYAEASKEFSEKNLSFLLIAEKSDLLKDLNGTLTFG
GNLMSQHISEMNAKSGDLLIPNIFSLNNGKEKPTVTSLITQRKMNSLYGSAQIGWKNSLY
LDATFRNDWSSTMSKVNRSYFYPSLSFSGVISELIELPEWVTFAKVRASYAEVGNDLEPY
MLYNSYSVAKDYWGVPTISTNEILYDHSVRSELVKSYEAGLDLRLFNNRVRLDAAVYKTN
AMRQLLRLPMDETSGYKFKIINAGNIENKGVELSLGVGILQNPEGLNWDTTVNFSKNENQ
IIDLYPGVASYELLTVDEIMVLAEVGKEYGAIYGSAIRRVNDANSPHNGKMILTAEGLPQ
RDAVALHYLGNQQPDYLLGFSNSFSWKGINLDFLVDARVGGKMFSMTRNLLTGYGMAAET
AVDGKRDSFVVEGVIANSSGGYDVNAKQVTPQRYWGALAQNNIGITEANMYDATSVRLRT
LSLGYTFGKKHLESIGIQNLKCSFTANNLWLIHTNIPGIDPESVSGTGTNVTALEFGAPP
TSRTFTFNITIGL
>OBAHECAF_01471 hypothetical protein
MRKYILKFAIISIVAFSSYACSDFEEINKDPNAADRNSVLVEGLFNASVADAQLSWWNRD
ILFHRTWLWGARYTYRPIHGPQVLQDQNNYMSDYWNSAAKWITNVSQAIEIGEERIRTGK
ADAKTNNYVQMARVYRAYLLSEITDMFGPYPARKGFKGEVAEYDSVEDIYAYIEEELKLA
VSKFDESTEASNDAFDAFYAGKIGAWKKYANSLRLRCAMRFSNVGTVGKTRFENILQEVG
DISGFIINNVDNASVAQSSIADLEDPAGSIFALSYIGMEITSTLTNISFGLGGISVAEMA
QYPGTSAYGLPQEALTNHLRSPNEYLGVYMPDYLPTKTNIQSAGYLYDYIPKEIDPRILV
NYHIPGHHDGLVNFYVQRDLNAEKNNTNYQEIELPADSGQKFSTKYTFSSFTCGENAGKN
DLILRGFRRNLGRLPAIGKQYRGGDLRRVYFGCWETYFLLAEAAHYGWETGRTAKEWYEL
GVKASFDYHKIGRYADAYLESESYNRIGTSVKFDHTTEITSKQLTRKIYPSGTEETVTYN
YPKGVHPTNNDVLSKIMTQKYIAQNPWQPFEATNDYRRTGLPFFENPYLEGLLPFMPFYT
DHSAADIKNVYRRVRYPISLKTKNQAGYDRALQLLGGEDKPETPLIWHKR
>OBAHECAF_01472 hypothetical protein
MLNRIFIYFFYIRKNLPNTVQIYAEENKKSINITLSAQFSYKQISGI
>OBAHECAF_01473 hypothetical protein
MYRHNKHSVWLLLCFCLWLFVWHNASAQNKGLIGQITTLSVSDVPGSTYTWELYVPTPNL
DFAKTSGNCPSSKAVFVNGNNSSQAQVKWLEAGTYYYKVNINNGCSNNFKIGEIIITGEI
TPPKIQITYDCNKGIAQLKASEYTGTLLWNTGETTQSIEVSTKDIPQGESVTYSVYQTIN
GVQSKPTLVAIERNVPPNLPNTSNFPTRIYVGQSVSLTSVWCGNDKVQWFSDAALTQEIT
TSEINPTENTTYYVVCRTDKNCQSEAVSLLLEVVVKSPCEDLFDNMFIPNAISPNEDGAN
DTWEIEDLKKYYENCKQNNVVHIFNRWGVKVYEKENYMLDNNRFKGRSQHSRTVGKNHLP
NGTYFFVITFEDGKQKTGYLYVKGPDFGF
>OBAHECAF_01474 hypothetical protein
MRKLVLSMIIAFLSAGAYAQTTDCTANESNPAIGATYTYEVNTAQNGFTGNGKYHWYITK
ETDLLNGTKENATNDFFYVVGGNATYDDANNTNKRLKLTWKPDALTNGNPFYLVIRYTET
KDNCESSNMKAMKIKPLNNFKLKVTPVKDADGATFNAGEEKVCAAGISSAQVLANGKVKY
EYGKTTLYYKVEMSGYTGSWKPTISLPELQGKTGTDAEFIGRKYESVEWKAGGSTFETFS
DDFTEGASVTNLLAKTATTQNSFIVKVVVNNGTYEGLTNEDISLSTKGNMVLANNSLGAR
DVKDDCSDITNDSDNRKGTQVILARPEIQAQSGGFIIQIQ
>OBAHECAF_01475 hypothetical protein
MSCLEKINIAFICTFLFMVAPPLLAQCNTGTQVGDVVTPYWREQNGFDEGVPIPNISSGQ
YALVNVIKGVQYEINAFRIRICRNGGGEHSIDSSNWVPASTRFTADFSGQVRVYYTSPGT
GRNIVIKIIGGINSADNQETPPNQDNRWRTHFYREMNNFTNYLGYKDYDNHSFNEYRYPL
GDATPIEVRSQGTVRAGILRYFTARSLMQNTFFSGFYYVKLGADDGTRLFINNEKVYDRW
NPAGDYFIKIQVIKLSKGDQLKYEYFNNNIPLQYIFEIDPVADKIIENKTLTSSNGEKIC
IEETTTLDGDSFREVLPNIFTNPTYQWYYAKSLTGTKQPIGGNTRNYEVNTNTPPFNNPT
GGIYYFFREARITINNIGVAPKTESIMSDPIQLEIIRKLNINVNPNKKSFCQGGNDAYIR
VEITNHTQPPFTFRYKINGLEYSHVSNNRIFTIPINTSQAGTFKYDYVSITDGNGCTTKI
HRADNINIIAPPTAVFSQLNTNLCLIHSEVDVMNITSLTGGFPPFQVSVKITNLQNSQVK
TTVYNSVPPHQNIKIYHTPNEIGSFKYEIIALSNKRNCTTTYTDKSFIVTVTAPSIAPPE
NLTWCLPYVVSAVYNESNGHTDVSGNRYVLPIGNTDLDVTINPVPCCPTPNLKWTINNDL
SNVRTGQPSTFMGEIAFENDTSTDKTYNITYWLECNGQKYNYVTRQIRITPRPIIEFN
>OBAHECAF_01476 Aspartate/alanine antiporter
MDWIVNLFSNHESVAYTVIVYSFVIALGVALGKVRIWGISFGIACVLFAGIGVAHFGFTV
DGHIQHFIKEFGLILFVYTIGLQVGPGFFASFQQGGLKLNSLAILSVLTCVLTVIVLFYA
TDTSMADLVGIMSGAVTNTPGLGAAQQAITDIFRAEGQSQETINGALSNVSNGYAVAYPF
GVLGIILVMMILKSALKVNLDAEKRLNQWKVNKNNSSVDKVAVRVENPVLFEKHVAIIKE
TLGMDFVISRVYHTGKIHMVDKDTILKQGDILLLVANPKDFDKLSTLIGKKESIALFEGE
ANDIVSRRMNVTNKLAYSKKLGEINVREQYGVTVSRVYRAGIEFVPTKDTKLQFGDAITV
VGDEEHIKLVEKVFGNSKKRMQHPHIAELFFGIVLGVILGSIPIAIPGMSSPVKLGLAGG
PLIVAILISRYGGRFSVTHYVSHSANLMVREIGIVLFLASVGLGAGQNFIKTLSEGAGLQ
WMLMGVAITLVPLIVVALVARFYYKLNFLEICGLLSGSQTDPPALAFAHDVTGSDAPAVT
YAAVYPLTTFMRIMVAQLLIVMFL
>OBAHECAF_01477 hypothetical protein
MGIVFRQSLKNILTTYLGFGFGAVNTLFLFVYFLSKEEYGLVSYITSTATILSPLIAFGV
HNTFIRYYFSYADSKELSKFNTMLFVLPLLIIFPLGLIGVFTYEYMVQWLSGENEVVRDY
VFLIFITAIAMGYFEIFYSWARVQLKTVFGNFLKEVFHRICITLLLLGVYYKVFDFHEFV
WGVFVAYALRTLLMLISSFSIKLPTFSWGLPKNKREIFYYSLFIVVSGSVANLLMDIDKF
MINQYLPISEIAIYNVAIFTATVIAIPYRSMYQVVSPLVAKFISTNQTVGLHELYKKSTI
NIYLVSIIVFVLIIVNANQFYNLLPDKEYALGIKVLVFISLVKLSDSLVGVNNAILFNSK
YYRTVLYLGILLIICTIVLNMWLIPLYGIDGAGLSTLCAFLIYNALKISFVYRKFHLSPF
FKETQRITIFGVVSTLIFYFWDFSISPLSNIVLKSIILLIFSCFVLIRYKLSEEAIILIK
QIGSMKNRKR
>OBAHECAF_01478 Cysteine desulfurase IscS
MIYFDNASTTRPFPEVVEKIQQTLTSHYGNPSSTHSLGRSAKSLIENARKNIAKWLNVNA
SELIFTSGGTEANNMILRSAVRDLGVKTIITSKIEHHAVLHCVEHLQREYGIDILYVQLS
EVGDVDLHDLEYLLQRTENQKVLVSLMHVNNEIGNMLPITKVGELCKTYNAYFHSDTVQS
IGHFPLDLKAFPIDFITASAHKFHGTKGIGFAYVRKGIPLRGLIFGGEQEKGMRSGTENL
HNIVAMETALNESYKNLTTSTEHIKSIKKHFIESVRKYFPEAKFNGNSGNMESSSYTILN
VAFPFSADKGVTLLFTLDLKGVACSKGSACQSGSVQNSHVLSAFLSEEQLKMPSLRFSFS
VYNTKDEVDKVINILREIQK
>OBAHECAF_01479 N(1)-aminopropylagmatine ureohydrolase
MCRTYAGIPDENATFENSKVMLVTVPYDGTSTWGKGADKGPELFLNASENMELYDIETDS
EPFLQGVYLAGEVSENSSPEAMTEAVYQKTKELLKHDDKLFTLFGGEHSVSIGAIRAVGE
KYEKLTVLQLDAHTDLRPEFHGSTSNHACAVFEANEKHKLVQVGIRSMDAEEKKYLPKGR
VFFAHEIAKNKKWIDDVLDKVSGNVYITIDLDAFDPAIAPSTGTPEPGGLQWYPTLKLLR
KVFKKCNVVAFDIVELMDSPMAKPTAFLAAKLYYKMLAYNMKYGRKK
>OBAHECAF_01480 Putative esterase
MDKEVLQKIWSELPENELISYLGIEPVELGKDFITLKMPVTSRVTQIDGILHGGITFALA
ETVGSVGAYVLYRKQGESIRGIELSGNHLRAGKVGDTIFAKATCIHNGGTLQLWDIKATN
QHDKLISSFKFTTIKI
>OBAHECAF_01481 Isochorismate synthase EntC
MISYSEILKKAILLQESEVPFVIFRRPNEKQINLYNQIDNQVYIFEDSFANEGFVLAPFQ
NITHKKILLKSEEKYVANVEDFHFQFSDRKLPFDEGQKQNHIKLIKKAVQTMQNSELHKV
VLSRKIAVPYHKNPVEIFQKMIENYPTAFCYLFSHPKVGVWLAATPETLLKFSENQLYTM
ALAGTQPFKEGIITWQQKEREEQQIVTDDILDKIKFYTENKKVSEPKTVRAGGVVHLCTH
ITADLQADKNPFDVVTQLHPTPAVCGFPFEAAQRFILENESYDRIFYTGYCGVVEQQKFD
LYVNLRCMQLEENQAYIYVGGGVLKESIPDSEWDETQNKAQTMFRIL
>OBAHECAF_01482 hypothetical protein
MNTKQIIEQSLLNSITYPTYRSLHQQYVNEKRTSGANQSEEYIKHSTVNESRYKRLDKTI
VIPEEKATFFKNYDKQITLLVITEFWCGDAAQIIPVINKISELNPKIMLKLVFRDDNEEL
MNLFLTNGGKAIPIAVVLDLENNVLTHWGSRPSEATKMVEDYKAKHGALDAEFKENLQKW
YNQDKGNNIIDDFVKILSEI
>OBAHECAF_01483 hypothetical protein
MKDKERKLRYHKRMATTLFLIMVVLYVTMVFLQKKYPETSLIGYIKAFSEAAMVGALADW
FAVTALFHKPLGLPIPHTNLIENRKKSIGDNLGGFVVDNFLKPEGIRPYVEEVKITPFLA
EWLSKEKNINTLTNEISEKIVQLVNGIDEENATDFITQKSKELLHEIELKTLMSKSLDYI
MEEKEHQKLLSFILQKIETYIWENKSLVQEKVSSKSAFFIPKFVDDILADKITEGLANYV
AEIIKDPEHSVRKEVDSQLNAFSKDIQTSSAWSTKIENIKSQIINSKSIDKYALQMWKYL
KDYINNDLAKPTTDSTLKQYFYKYIQKLSLQLHTDVELQQKINRQIQKTAYQFILKNRHE
VGILISRTVGNWQGKELSRKLELEVGKDLQFIRINGTVVGGLAGVLIYAITQFL
>OBAHECAF_01484 Proton/glutamate-aspartate symporter
MKDKKKLALHWQIFIGMVAGGLLGLLMLQFSWGKDAVLDFVKPFGNMFIKSLKIIALPLI
LASLIKGIADLKDISKISSIGMRTIILYLSTTVLAVSIGLMVANIIKPGDMLTEETRTEL
TREYQTQANTSIEVAHNKQREARPLDPIENLIPDNLFLSATNNSNMLQIIFCAMLFGFAM
IMIPEEKTKPVKAFFDSLNDIILKIIDLIMKVAPFGVFALIASLIVEVPNAEMLSALLVY
ALAVVIGLTIMMGVYGLLVWTFTKKTPKFFFKNLAPVQLLAFSTSSSSATLPLTMETVEK
KLGVDEEVASFVIPLGATVNMDGTSLYLGIAALFIAQAFGMDLSFSAQLGIVATATLASI
GTAGVPGASIAMLVIILEQAGIPESGLALILAVDRPLDMLRTVANVTGDACVTMIVGKSV
GKLHEPEE
>OBAHECAF_01485 hypothetical protein
MNFLQNSSDSDEKYKIIFCCEGIGYITSKSLPGNGRTIPFISN
>OBAHECAF_01486 DNA processing protein DprA
MQEEELLYTIALKKIPMVGDITAKKLLAHFGSAKAIFSIKKHHLERVSGIGEKLLQNFSS
SADYLRQAETELEFILKNNIKVRHYNDTDYPTLLKQCVDSPLIFYQRGNINLANKRILSI
VGTRNITPYGIAFCEKIIEELSDLDIVIVSGYAYGVDILAHKTAMKHNLQTIACLAHGLN
TIYPNQHAKYMAEMEANGGFITDFGIDSRFDRKNFLSRNRIIAGLSEATIVIESGIKGGS
LVTADIAFSYNREVFAVPGRASDPYSLGCNMLIRNEKARILLSAQDLLYHLNWDKPKAKT
IQQELFVSLTPEEEKIHNHLKNNGKQLLDSIAIDCQLPIYKVSSLLFQLEMKGMVRPFPG
KLFEVI
>OBAHECAF_01487 Inosine-5'-monophosphate dehydrogenase
MKNTIANRVNDFLKKFPPFDIIDQENLLNLSKEVTIIYLEKGKIVFNEQDHPHDYFYIVK
EGAIEMRQTVNDNFEMVDICDEGDVFGVRPIITNTPYQMSAIAQEESIIYGIPSKDFRPL
IEKDTKIGLYLIEIFASKTRNPYSIDHTKYLYQNFDRNMLQKDFFELQPAVYVKKVVKAS
PEESIQQIATLMTEKRVSSIVIVDADKKPLGIVTDKDLRKQIATSYFSLDMQVSQVMSSP
VRTYPKQMTIAKAQFEMIKNNINHLIITEDGTNDTPTIGIMTQHDIETVKGDSIPELMKA
VKRSKKSKHLKSIRQQSINLLKGYVIQNIPLGLITDLFHQLFEAITSKAIELCIKRMPTP
PPVRFAWVSLGSLARKEQFLITDQDNAIVFEDVTEEHYEQTQTYFLQLANKINTMLNKIG
YDYCPANMMAKNPNWCLSLSKWEEQFKSWVSNANDADLLMFSIFYDMSFSFGEATLVNKL
SDKVFEFTQTNERFMALLAKSALENPSPLGFFRNFIVEHDGKYKDQFDLKARALTTISDI
ARLLALSHKIKNITNTAERFEKLAELEPQNKEIFLACAYAAKALLKFRIKSGLKNDDSGR
YLNIKNLNKEEKTKLKRCFKTISNAQELIKLRFKLNLTYV
>OBAHECAF_01488 Ribosome-recycling factor
MNEEINIILESTEEAMQNALAHLEKALVNIRAGKASPQMLGSVFVDYYGSQTPLSQVANV
STPDSRTITIQPWEKSMIQPIEKAILVANLGFNPMNNGDYVIISVPPLTEERRKDLVKQA
KGESEDAKISVRNARQEANKEIKKVETSEDIKKDAEERVQKLTDKYIKKVDEVLAVKESE
ILKV
>OBAHECAF_01489 Uridylate kinase
MNKNRFICFLQVCFALFNGQLKTGSKLITIILKNIYFMKYKRILLKLSGEALMGSRQYGI
DPARLKEYASEIKQVVKEGVEVAIVIGGGNIFRGVAGASNGMDRVQGDYMGMLATVINSL
ALQSALEDEGIYTRLQTAIKMEAIAEPFIKRRAVRHLEKGRVVIFGAGTGNPYFTTDSAA
VLRAIEINADVILKGTRVDGIYTADPEKDSTATKFERITFDDVMDKGLKVMDMTAFTLSQ
ENNLPIIVFDMNKKGNLMKVVTGENVGTTVDVK
>OBAHECAF_01490 hypothetical protein
MKYSFWFLYLSLTLVTACRGGGANLTEEEKEKIKQAKLDSIADLRLAEIDMNEVDTYPIF
KGLCSESASKEEQKQCFVQHFSKFLQERLENEKIEVTEPILDTIFVNIKIDNNGKAVLEN
TEAKAKTKELLPTLDEDLADNLDEIATINPIQPATKHGVNISVQFRVPIVMNVK
>OBAHECAF_01491 Crossover junction endodeoxyribonuclease RuvC
MEKIILGIDPGTTIMGFGIIKVENQQMELLQVNELHLQKYDNHYIKLRVIFDRTIELIDT
YHPDELAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSRQLPITEYEPKKVKMAITGNGNAS
KEQVAKMLQQLLKIKELPKYFDATDGLAVAVCHFFNNGKVTTQKSYNSWAAFVKQNENRI
R
>OBAHECAF_01492 Oxygen-independent coproporphyrinogen-III oxidase-like protein
MVDSLCKELIIRKKEAENSVIQTIYFGGGTPSILSDQELERILQTVFENYCVSDDAEITI
EANPDDFFKDGKTPEQRLCVFKSLKINRLSVGVQSFFEEDLRMMNRAHSTEQVHRLLSEA
PNFFDNITLDLIYGIPNMSDERWLQNLEKALSYNVPHISAYALTVEPQTALHKFIAIGKI
TQVDDNQSLSHFQKMIEVLIKAGFVHYEFSNFGKEGYFSRNNTAYWFGKKYMGIGPSAHS
FNGSERSWNIAHNIKYIQAIAKGELPAEKEVLSQNDRYNELIITRIRTMIGISITEVKQE
FGKKYYTYLLQQAQRHFAEATLRLEGDYLRVTPKGKFLSDGIASDLFMVE
>OBAHECAF_01493 Cytochrome c551 peroxidase
MRKIYFLLSLGVLVSCNNAPKKQVVNEVHPEETKSELLKTAETFFKSVSSVPKPEISEEK
IALGKKLYFDTRLSKDGNISCNSCHNLETFGVDNLAFSPGDTKELGGRNSPTVFHASLHA
MQFWDGRAKDVEEQAEGPILNPVEHNIPNAEFLENRLRKVAEYQTLFKKVYPDQEQPITF
KNIANAIGAFERTLNPVSRFDKFLDGDEHALTQQEKDGLQAFVDNSCITCHSGVAIGGQM
FQKFGLFGDYWEHTKSKKVDAGLFDLNKNEGEKYFFKVPGLRNIEKTAPYFHDGSVEKLE
DAVRIMAKLQSDKELTDKQVDDIVAFLKTLTADIDDTQKRL
>OBAHECAF_01494 hypothetical protein
MEQLIVIAIVLFSTFIFYKLHKASHKADNKLKKQEEIDELSFYKREGKHFRKAFDECFII
QEKVKEDVLDVEAKDFRDYMTRPGSKYRDEVFIESNKTRISCYAELLGKERLLYKIVDYD
YTVVQMKARMQGYIDLYIIEETYEDGDYVYGWFFDTTFLEKDLFE
>OBAHECAF_01495 Energy-dependent translational throttle protein EttA
MSDDKKVIFSMSKVSKTYASTNKQVLKDIYLSFFYGAKIGILGLNGSGKSSLLKIIAGVD
KNHQGEVVFAPGYTVGYLEQEPQLDENKTVIEVVREGAADVIAILDEFNKINDMFGLEEV
YSDPDKMQKLMDKQAELQDKIDACGGWEIDNKLEVAMDALRTPDPDTPIKVLSGGERRRV
ALCRLLLQQPDVLLLDEPTNHLDAESVLWLEQHLQQYAGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKAKRLAQEQKTESKRQKVLERELEWVRQGAKGRQAKQKARL
QNYDRLLNEDQKQLEEKLEIYIPNGPRLGTNVIEAKGVAKAFGDKLLYDNLNFVLPQAGI
VGVIGPNGAGKSTIFRMIMGEETPDSGEFIVGDTVKIAYVDQSHKNIDPEKSIWENFSDG
QDLIMMGGRQVNSRAYLSRFNFSGSEQNKKVATLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLENFAGCAVVISHDRWFLDRICTHILAFEGDSQVYFFEGSFSEYE
ENKRKRLGKEVTPTRIKYKKLVR
>OBAHECAF_01496 hypothetical protein
MKWEGRRQSGNVEDRRGSGAGKKVIAGGGILGIIILLLQVFGGETGQTIAPMLEQFNQSQ
QVQQADANVELTPEQKQIGAFAATVLADTEDVWDKIFKENSLGEYQKPTLVLFTDVVESA
CGRATASVGPFYCPADYKIYMDMSFFEELRTRFGAKGGDFAIAYVMAHEVGHHIQTLLGT
SKKVRQAQQGKSQAYANKLSVAQELQADFYAGVWAHHNRKYLEEGDIEEAMSAAHAVGDD
AIQKRVRGHVEPDSFTHGTSEQRVKWFMKGYNTGDIRQGNTFDEIN
>OBAHECAF_01497 1-pyrroline-5-carboxylate dehydrogenase
MGKGFFNVPKAVNEPVKSYAKGTPERDAVLKAYKELWNSQADVPLYIGSEEIRTGNTKNM
TAPHDHQHVVGKYHLAEKQHVEKAIKTALEAREKWAAMPWEERAAIFLKAAELIAGPYRA
KMNAATMIAQSKTIHQAEIDSACELIDFLRFNVEFMANIYNDQPISSEGIWNRVEYRPLE
GFIYAVTPFNFTAISGNLPASAALMGNVVVWKPSNAQVFSANVIMEVFKEAGLPDGVINF
INGDAAMITETLLASPDFAGIHFTGSTGVFQDIWRKIGTNIHNYKTYPKIVGETGGKDFI
VAHPSAISKQVATAITRGAFEYQGQKCSAASRVYLPKSKATEILNFVKEDVLSFKMGSPE
NMENFITAVIHESSFNKLAKYIDQAKQDSDAEVFVGGNYDKSKGYFIEPTVIVTTNPKYT
TMETELFGPVVTVYVYEDEKWTETLKLVDETSEYALTGAVFSQDRYALNEAIKALEDAAG
NFYINDKPTGAVVGQQPFGGARASGTNDKAGSAQNLLRWVSPRLIKETFVPPVDYRYPFL
G
>OBAHECAF_01498 Dipeptidyl carboxypeptidase
MKKNHLLTTALVLALVSCDDSKKQTIPMEENPLLVESKLEYFAPDFSKIKDEHFRPALLK
GMELQVERVEKIANSTEAPTFENTIIALEQSGQELSRARRVFSALASAHTNDTIKAIQKD
LSAKFAAHSDAIFLNDNLFHRIKELHGKRESLNLDAESKKLLEYYYENFEISGANLSKES
KEILKQYNAELASLQTEFNQTLLEGNLASAQTFDNKDALDGLSNETLESIANDGKWKVPT
FNTTQQPSLVDLKNRVTRRQIFEAAWSRTDGGKHNTNEIVKKIAVLRAKKANLLGFKNYA
EWSLQQTMVKTPENIYQFFKDLVPASVGKVKDEAKEIQAQIKATGGDFVLTPYDWNFYAE
QVRKAKYDLDENELKPYFELKNALEKGVFYAAERLYGIKFKERKDIPVYHPDVLVYELFE
EDGSKLGLFYGDFFARESKRGGAWMGNFVEQSKLLGKKPVIYNVCNYPKPADGLPALLTF
DELTTLYHEFGHALHGFFANQQYASLSGTAVARDFVELPSQFHENWALHPEILSNYAVHY
ETKQPIPQALVDKIMKASTFNQGYSFTEVLAAANLDLQWHTISADTHIEDVTAFEIEALK
KTGLFLNEVPPRYRSSYFAHIFGGGYGAGYYSYQWTEMLHHDAYMWFLENGGLTRSNGQR
FRDMILSRGNTLDYEKMYLDFRGKQPSIEPMLKARGFKK
>OBAHECAF_01499 Antiholin-like protein LrgA
MLIRYCAIIFGCLALGELVVYFTDIPFPSSIIGMLLLTLFLHLGWVKIHWVKAISDLLLA
NLGLFFVPPSVAILVYFDLIRNSFWPITIAVVVSTLIVIVGTGHVYQFLRKKIKQQ
>OBAHECAF_01500 Inner membrane protein YohK
MKNFLENPLWLLALTFAIYYGGQMLQRKYRSPLLSPVVITVSVLIGYLLVFNISYETYSA
SGGFIEFWLKPSIVALGVPLYLQTSKIKKQLVPLLISQLVGSVLGLLSVCFFAKILGADK
EVILSLAPKSVTTPIAIEVSHTLGGIPALTVASVIITGILGSLFGFKILQWFGVKSPMGR
GIALGTASHGLGVMAAFDVSEKHATYASLGMIFNGIFTAILAYPIILLIEPWL
>OBAHECAF_01501 TonB-dependent receptor SusC
MKVKILTLFIFVLGWCSSSLLAQTVSVKGVVTDENKIPLAGVSVSVKNTSRGVSTDFDGN
YEIKVNSGDVLVFSSLGFTSQEKIVTGGGKDLIINVLLKEEAEQLEEVVVTALGIKRQEK
SLSYATQTVSGKELTDVPSSNVLNTLAGKTAGMSVSGSGSGVGSSVKIVLRGNRSIQGNN
QPLYVVDGTPISSGAFSGSSIGDGYGGGIDAGDGMAGINPEDIESVNVLKGATAAALYGS
QAANGVILITTKRGNSEKIAVSVTSSVQADVPYLTYKFQDRYTMGVDGVSQSSMDAWGAP
RTNQDLSNDFVKNFFNTGFMSQNGVSVSGGNKVTKNFLSYQNTTATGIMPNNTFDKHNLS
LRSTTSLFDDFIEVDGSVALTHQDTGNAPAAPGQYFNPILGLYLFPAGTTAFNSYRDVYE
VPNPSRNGLMTMNWANQTDVYKNPYWLINRHNYSYNVEKAIVKLNTKFNFTSWLNLQLRG
SYDKTATLGERKVHAGMTTLTGKGGRYDHKTQNYALMYADALLTANKSYEKFSISATLGT
SISDTKETTNEIQIHNLAIANLFDLRNYIGIEGGSDNKRTHRQLQSVFGTVSLGYNEMLY
LDVTGRNDWSSTLPANNRSYFYPSVGTSFVFTEMLDQNEAKPEWLDFGKLRFSWTQVGND
MPWGLTEPYDKLQKGGVIEANTVKPFDDLKPERSNSLEAGVNLRFLGGRFTFDAAVYKTI
TENQYFKVDNTSGSGYSQYYINAGEVENKGFELTLGFTPIKTNDFQWNGYLNYSTNKNTV
LSLPSQYLDKGFEISSVGYRFRLKEGEEWGRMYEKRLKRDNQGNILLTQTIENGVDKGIQ
LQQSDDFEYIGNVNPKFLIGFKNEFSYKNFSLGLLIDGRFGGNVISSTQNILDRFGRSQR
SAEARDNGGIPLTGTLVTTTKVTGSPDVVTQTAFNQKIDAQTYYKVAPAGETSVYSATNV
RLRELSLSYTLPKSLVERVKYVESVRLSLIGRNLGFFYNEAPYDPEITLSTSSNGLSNAD
LFTIPASRSVGFSININF
>OBAHECAF_01502 hypothetical protein
MKKHIISVKSLAFLALATALGGCTDKFEDYNRDTFALTEELKKADWMHLKAFFPQMEQSI
YYNNSKGNWEFQIAQNLNADMFGGYLTPPTPFNGDKNNINYHMMEGWNQFAFGMYNNNIM
KPWFNVKAETLDKKESLNVYAISLILKVAGMHKSTDLYGPIPYSKYGLGGTTTPYDSQEA
IYNQFFTELDEAVSYLEAHLAGPNKDVNSLGDSDLIYGGVHTKWLKWANSLRLRLAMRVS
KVNPSLAQKEAEKAINNAYGVFTTNADNVLVPTINIGHPLIVVANDYNDSRMSADMESIL
TGLKDPRLSEYFSKATDKDENVNGKYKGIRQGINMKAKDLRSGYSTLGARFDMSKRNITP
ITLMTAAEVYFLRAEGVLRGWNMGDTAENLYKKGIELSIEQWGVSGANAYIENDTNKPAD
YTDPKEKLYDKPAVSTVTVKWDESASNEEKLEKIITQKWIAMFPDGAEAWAEFRRTGYPK
LFPIEVNNSGGEIDSNVMIRRLRFPENERTGTNKEEVAKAVQFLKGKDSPGTRLWWDTGT
PNF
>OBAHECAF_01503 Sodium/glucose cotransporter
MINKFQLCLVLLFLHCSSAIFSQENKKTATQFHQTTIFDTQSLEKLPQLHEGLAGTYFGK
HASYFILAGGSHFPTEKPWQGGKKQFSKTVFVFQVESDGNLTSIYQAEDLPEAIAEGAYV
TISDGLLCLGGQTPEGLSSKVFSISYNNGKIILKHYADLPIPVKSAVAEVVGNSVYLLGG
QTADNGSLNQFLRLDLQKTDATWETLPAYPQKVSGVAMVAQQNGTEIALFAFGGRNQNGR
NLTEFYHQAYTFKPSLNEWFPIKDIQKNKEVLPLAVANASKIGASSILLFGGDTGVIFNQ
VEQAIYDENIELRNQLWQTHKGFETDVLVYNTITDEWFNLGSTDKAVAVASVFYDAQKQE
VYVAGGEQKPGIRSPYITKLSFSKDSEFGWLNYAVLALYLIGMLMLGFFFMKNNKNTDDY
FKGGGRIPWWAAGISIFATMLSAITFISIPAKTYATDWRMLMFNMTIILAVPFIIRFFLP
FFLRFKLDTAYEYLEKRFNRPVRWVASALFSFFMISRIAIVLFLPSLALNAVTGFNIYYA
ILIMSIVTIIYSTSGGMEAVVWGDVIQGFILVGGAIVAFIVMVVGVDGGFGEFWNTTVTF
NKLDTFDFRFDFSQPVFWVVVFGGLANTLISYTSDQSVVQRYMSTVNEKATAKSIWLNGI
VSVPVSILFFLLGTGLFAFYKSNPEQMSITDPNIDSIFPQFIVSQMPVGMSGLLIASIFA
AAMSTLSSNINSVSAVITSDFYKTIFKNTSFKGQMNVARWSGVVIGLLGTAMAIVLATWN
IASLWDQFNTFLGLLTSGLGALFILGIFFPRVNGTVALIGLISGVLILYGVKSYTSFSFL
LYGLIGMVSSIIVAFIISMLIPNKKEVNGITWKYRNK
>OBAHECAF_01504 hypothetical protein
MRKIFYATIILLPFVIKAQEIGSAGRWLQNENRRSEATDRYIPSNLSYRWEMTYDLGYAE
VFIRIPESGRFTLQLGEQEITNSNGMFRFFDVPAVNQELSIYYGRRLVYRVTITPRDNTR
MVLDFFSRRGLFLLEEVNLNNVREIHYGRRWNDVWNHSYGRRNNILDFNDFLRMFEQQMF
DKDKLKFFRMENGNSSFTTAQVGELMKRLSFDENRLILAKEAYDCVIDRELYYQLYDMFQ
FRRTANEFSDFLTNRRSLRR
>OBAHECAF_01505 Ribulose-phosphate 3-epimerase
MILAPSILAADFGNLQRDVEMVNQSLADWFHIDIMDGVFVPNISYGMPVLEAINKHATKP
LDVHLMIVDPDRYISTFKKLGSHILTVHYEACTHLHRSVQAIKNEGMKAGVALNPHTPVN
VLEDIIQEVDLVLIMSVNPGFGGQSFIENTYKKIYQLKELILRNKSKALIEVDGGVTNKN
ARQLMDAGADALVAGSFVFNSSNPMQTIEGMKKL
>OBAHECAF_01506 hypothetical protein
MYKYLCSLLAFLGIQLMNAQGHEIGVFLGGSNPISDVGRTYYVFPNKLAYGGIYKWNFHD
RVSLRFQVTKTNLRANDIQSDIAAKVKRQFAFSNNLTETMLGLEYNFFKFNMDNLLEMPM
TPYFFTGASYVDGDELYFQNLTTRPLEAQKMPNRHRAWAIPVVMGFKMKIAIRWILAAEI
GTRFTFTNNLDGSLPSGGNLSFGNKTSNDWYTFSGFTLTYTFGRKPCYCRE
>OBAHECAF_01507 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MENKQIINYPKHLAIIMDGNGRWAKKKGMMRIFGHQNAVDAVRDSVEYCVEHRIEFLTLY
AFSTENWNRPKEEINGLMELLVKFLKKEFEKLNKNNVRLNAIGNLDRFPTKVKEELLTTI
AKLEHNTGLTLTLALGYGSREELQTAIKNIASDVKKGAILVENIDEKTIQKYLYTHDLPD
VDLLIRTSGECRISNFLLWQIAYAELYFTDVLWPDFSKKHLNEAVLNYQQRERRFGKTSE
QL
>OBAHECAF_01508 Outer membrane protein assembly factor BamA
MSLKKYIFIALSAIVGLVNAQEEERLTLKEGKKYIIGGVEVIGSQRYNPQTILVSSGLKV
GEEIVIPSEKFSAIIHKLWGYKLFNDIDIYIQRVEGDKAFLELVIKEIPSLVTAKVTGVR
TKKGETLLEDAKIKPGVKVTESLIADTKNYIITKYRKEGYFDTKVTIDTKVDTTDANGVN
MLIHVDRGNKVKIANVNFEGNEKFSDATLRRKMKKTKQRLFGRFWKRSKYVAKEYDQDLV
SLIDFYKENGYRDARITKDTVGYDADGKLQVNIALEEGRRYYFGDIRFLGNSIYSDHALH
QVLGVKKGDVYNGVVLKKRVRDNSKPDSDDIYNLYQNSGYLFADVFPVETSVVNDTIDFE
LRIKEGKPAYFDKVTIKGNLRTNDHVVYRELRTRPGYLYNKDAVIRTVRELGQLGIFDAQ
NISPNIKNPDEIQGTVDLEYDLTESGGSQVQLQGGYGGGSFIGTLILSFNNFSIRKLFDK
EAYMQKVPLPMGDGQSLSINLQASRFYRTYGFSFMEPWLGGKQPVQFSLSFNRTEQFGYD
YRTYDVDKSRRVYITGINLGIAKRLRVPDDYFQISHLFSFNNYDLKNYSLGLFSFQEGNS
NAFSYTISLSRNSSGPNPIYPMTGSNFSVSAKITPPYSIFNGVDYAALASQRVNAFANGD
MTAVAAIDQERFRWLEYYKLKASGTWYTNIVDKFVVKLGADFGYLGAYDKNRGIVPFERF
FMGGDGLGYYTMDGRENIQMRGYTNYSLSSDGGDNIYNKFSLELRYPITLKPMASIYGLA
FAEGGNTYTGFSNFNPFQLKRSAGLGLRLFMPMFGMLGIDFGYGFDKPLGSNTVGGWQTH
FIFGQQF
>OBAHECAF_01509 hypothetical protein
MNKIVKNIISLGLLIATTMLYAQKSSRIGYVDMDYVLSNLEEYQVASEQFALQVAQWQVE
IEKREADIQKEKQKLDAEKSLLTPELIKDKEQEIALLEYQLNAYKEQKFGKEGEYFTQKF
MLAKPIQDQVFNIVQEIGKLRNYDMVFEKSEVSMLYSANQHNLSNVVLRVLKRKDNAEDR
NRDFTELLKESYDFEFVDERTKRQREIEKERAKLQAERQKAYEQERKRKAEEKAQRDRER
EAKVKQQQQEREERIKKQQEEREARRKQQVTK
>OBAHECAF_01510 Outer membrane protein 26
MMRNIRTIMVVLALIFGATSMATAQVKVAHIDVQKLLEEMPERKAAEAQLKKLEQNYTAD
IQASIKELQTKAQTYQNEAASLSEAQLKARQAEFEKKGEEIQTMENNIRQAEQNARQTLL
KKQQELVEPILKKVKAAIEKVAKAQGIHYVLDSSAGSGVIVASGTDLYESVKKELKF
>OBAHECAF_01511 hypothetical protein
MENISTAHRTTISDLKKGERGVIKHIDIENVPLKLIELGCFVGSEVMVIEKSLFGNPIYV
NMNNSYLSIRKEMASLIEIEKI
>OBAHECAF_01512 Fe(2+) transporter FeoB
MTKDSIRVALIGNPNTGKTSIFNALTGLNQKVGNYPGITVEKKIGYCKLSDGTKAEIIDL
PGTYSLNANSMDERVAVNILLNKKGELYPDVVAVVTDVENLKQNMLIFTQIKDLNLPTIL
IVNMADRMEKRGISIDIQALEKELRTKVVLVSTRTKKGLNELKDVITNYAELSTDKFFNI
NSLDEGYFTRIADLFPKENPYKLWLIISHNVDIIDQYKEIDLSGVKSSKSESEIKRLKQR
ETILRYKHINEILKKTYSVNLADARGLRASLDKILIHKVFGYLIFALILLLVFQAVYDWS
SYPMDWIEKGFDWLSRKAEQILPEGALTNLLTQGILPGISGIVVFVPQISILFFFISLLE
ESGYMSRVVFLMDNLMKRFGLNGKSVVPLISGVACAIPAVMVARNIESWKERLITVLVTP
FMTCSARLPVYLIIIALVIPDGSVGFISYKALTLLALYVLGFVVALLSAFILDKILKINK
NKSFFIVEMPDYKMPLLRNVGTTVYEKTKSFVLGAGKIILAISIILWFLGSHGVGEKYEN
IEAEAEVLAQQNQWDKTEKAHFVESMQLEYSYLGYIGKAIEPVFKPLGYDWKISIGVLSS
FAAREVFVSTLSSIYSLGADLDTEEEEGERTILNKLRSEVRPDGTPVYTFATGISLLLFY
AFAMQCLSTMAIVKRETNSWKWTVIQWSFMTGIAYLSAMIAFVWLS
>OBAHECAF_01513 Dihydrolipoyl dehydrogenase
MKKYDVVVIGSGPGGYVAAIRSAQLGFKTAIVEKYNTLGGTCLNVGCIPSKALLDSSHHY
EDALKHFAAHGIEITGEVKISLEKMIDRKKTVVEQTCAGINFLMDKNKIDVFHGVGSFVN
NTQLKITNENQVEEIEAKYTIIATGSKPSTLPFITVDKERIITSTEALKLKEIPKHLIVI
GGGVIGLELGQVYRRLGAEVSVVEYMDSIIPTMDKGLGKELTKVLKKQGFKFYTSHQVKE
VSRSGEVVNVKATNSKGEEVSLQGDYCLVAVGRRPYTEGLNLEAVGVKKDERGRVEVNSH
LQTSVPNIYAIGDVVRGAMLAHKAEEEGVLVAEQLAGQKPHIDYNLIPGVVYTWPEVAAV
GKTEEQLKAEGIAFKVGQFPMRALGRARASMDIDGFVKILADATTDEILGVHMIGARAAD
MIAEAVTAMEFKASAEDISRISHAHPTFTEAIKEAALAATDNRALHV
>OBAHECAF_01514 Methylated-DNA--protein-cysteine methyltransferase
MIENTIYKSYITTPIGELLACVSSHGVCMLDFYDNEQTEIELDKLKKCFQASIVEEKTPL
FLELEKQIKAYFSKEITEFNLPLDLRGTDFQQRVWESLLNIPYGKTISYKEQAITLGNIK
GIRAVASANGMNPVAIIVPCHRVIGQNGSLIGYAGGLWRKKFLLELESNQLILY
>OBAHECAF_01515 hypothetical protein
MNKIIIFFTILFIANIALAQQESNVSFVTTQKHQVGIGISKFVNMAFPSDANAFLFEYKY
SPKEKLGYRLAGDYRIETTDDAIYDIGLKIGVETIFKQSGNWSFYYGIDLWGRHIDYTSR
KQRTKTLAINPFFGILYRISKHFSICTEPGFFIKYSVTKDNNTFDLKKTSAWFESRLAKI
GYIQFNFHF
>OBAHECAF_01516 hypothetical protein
MNFTRLTQKITIAFLVAITFVSCSKDGKEDDTTPLSREEAKQFIEQTTDNFYNCLKDLND
GGFSNFFYESFFTIAETVTTTHTYGNPPYEYVYTQVENHSWMSILSDAFEDQYGDVFDDS
FNYQLMKGVYTWDNTSKKWKKSNGNNITLHFPSKKDATTNNATLILDGYTDQTFTIEGKE
VKLPKRGNISVTVDSSKIFSIKVNDVAYMQTGESIMIEKADIEAYANPFTANLKWNKTSE
NIFRLDFVFSSPNACSTSLKGEVKLTHTDIENINPESDIEKITLEISHNELIIRVLADLK
RLYGSKKNIDDMSAEEINSFIKSEVFKNSKKIADLKLEKDNTEKLIPYLIFEDGSKEKAE
NFVSDFPERVEKIFKRFFEGRK
>OBAHECAF_01517 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MEKDLGNYRKIYDKKVLVENDIPENPLQLFQTWFYEVEESGGVDEPNAMTVSTIGLDGFP
KARVVLLKKYTHEGFIFFTNYSSEKGKAIEVHPNVCLSFFWANMERQVIIKGIAEKLPEN
LSDGYFESRPLGSKLGALVSPQSEVISSRHYLEETLENLEKEYINKEVLRPSYWGGYLVR
PQSIEFWQGRPNRLHDRIRYTLTDDYDWRIERLAP
>OBAHECAF_01518 Adenylosuccinate lyase
MSLQAISPIDGRYADKTTSLIPYFSEEALIRYRVLVEIEYFIALCELPLPQLEGFPTELF
PELRNLYINFDQEAAKEVKNIEKTTNHDVKAVEYFIKAAFDRLNISQFKEFIHFGLTSQD
INNTAVPLSLKEATSNVYYVELQGVIDKLAQLIDEWKDIPLLARTHGQPASPTRLGKEFE
VFKKRIEEQIKQLKAVPFAAKFGGATGNYNAHKVAYPAIDWKAFGTQFVEQKLGLHHSFP
TTQIEHYDHLAAMFDAFKRINTILIDFNRDVWTYISMDYFKQKIKAGEVGSSAMPHKVNP
IDFENSEGNLGIANAIFEHLSAKLPISRLQRDLTDSTVLRNIGVPFGHTLIGLKATLKGL
NKLLLNEEKIRWDLEQNWSVVAEAIQTILRREGYPNPYESLKGLTRTNEKINQQTIATFI
ETLEVSDVIKAELKAIKPENYTGI
>OBAHECAF_01519 hypothetical protein
MDAIIYILLIFFCLLVGFFIGNYINKLKTNSLLSTTLEREELQQRTIQELENRLTIEKSE
KEEIRKEKEELSLYLAKSDVEKDHLITKLREKDKESEQLQERFTKEFENLANRILEEKSS
KFTEQNRENLKNILNPLQEKIKDFEQKVEHSQKENISIHSALKQQLIDLQSQNLRITKEA
ENLTKALKGDSKIQGNWGELVLEKVLEKSNLEKGREYTVQESFVREDGTRAIPDVVIHLP
DGKKIIVDSKVSLTDYERFVNASEEERPIFLKQHTNSIRRHIEQLSSKKYEDLYTQSPDF
VLMFIPIEPAFAVALQEDESLYTKAFAQNIVIVTPTTLLATLRTIDSMWTNQKQQENAYE
ISRQAGALYDKFEGFVSDLIKIGKKMDEAKGEYSNAMNKLVEGKGNLVRSVERLRAMGVK
SKKSLPEAILKRALPTDEWNEE
>OBAHECAF_01520 Oxygen-independent coproporphyrinogen III oxidase
MTVSLIQKYNVAGPRYTSYPTVPYWDNESFSNDKWLNSLKRSFHESNKTEGISLYIHLPF
CESLCTFCGCHKRITKRHEMESPYIDAVLKEWKLYLDVLQEKPLIKEIHLGGGTPTFFKP
EELKRLLEGIFEYADIAKDKEFSFEGHPNNTTETHLRVLYSLGFERVSFGVQDYSLKVQK
AIHRIQPFENVKKVTEWARKIGYKSVSHDLVFGLPFQTLDDVLFTIDKTNSLHPDRIAFY
SYAHVPWIKGSGQRGFDESNLPSGEEKRLLYETGKKHLIDAGYVEIGMDHFALPTDSMYK
SFETNSLHRNFMGYTASKTQVMIGLGMSSISDSWYGFAQNEKDLEDYYARIQRNEIPVFR
GHILNEEDLIIRQHILNLMCHFNTSWEEDKMYTSEIESIKSKLNEMVSDGLIELREKSIR
VTNEGRPFVRNLCMAFDLRLQRNIPNTKIFSMTV
>OBAHECAF_01521 Biotin carboxylase
MFKKILIANRGEIALRIIRTCREMGIKSVAVYSTADADSLHVRFADEAVCIGPPASKDSY
LKIPNIIAAAEITNADAIHPGYGFLSENAKFSKICAEHGIKFIGASPEMIEKMGDKATAK
ATMKAAGVPTVPGSDGLIESLDHAKKVAKEMGYPVMLKATAGGGGRGMRAVWKEEDLEKA
LDSAKQEAGAAFGNDGMYMEKLIEEPRHIEIQIVGDQYGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDDLRKRMGEAAVKAAEYIKYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVIDYDLIREQILVAAGVPISGKNYLPKLHSIECRINAEDPYNDFRPSPGKITTLHAPG
GHGVRLDTHVYSGYVIPSNYDSMIAKLITTAQTREEAIAKMKRALDEFVVEGVKTTIPFH
LQLMDDPDYIAGNYTTKFMETFKMKTPRE
>OBAHECAF_01522 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDLRDIQNLIKFVAKSGASEVKLEMEDIKITIKTNPDESAREQVFVQQMPISAVPQIPVQ
QAVVTPTTSADPAESKPAANTDNDKYIVVKSPMIGTFYRRPGPDKPLFVEVGSTIAKGDV
LCIIEAMKLFNEIESEVSGKVVKILVDDSSPVEFDQPLFLVDPS
>OBAHECAF_01523 3-oxoacyl-[acyl-carrier-protein] synthase 3
MTKINAAITAIGGYVPDYVLSNEMLEQMVETNDEWIFTRTGIKERRILKDPDKGTSYLAI
KAAEDLINKKGIDPKEIDLVILATATPDMPVALTAPYVATEIGATNAFAFDLQAACSSFL
YGTSVAARYIESGRYKKVLLIGADKMSSIIDYTDRATCIIFGDGAGAALFEPNFEGFGVQ
DEILKSDGIGRNYLYTKAGGSLYPITEERLKNREHFVFQDGKTVFKYAVSGMSGVAEEIL
KRNNLTKDDVQWLAPHQANKRIIDATAQRIGLEENKVMVNIHKYGNTTSGTLPLVLNDYE
KQLKKGDNIVLAAFGGGFTWGAVYLKWAY
>OBAHECAF_01524 Deoxyadenosine/deoxycytidine kinase
MHIAIAGNIGAGKTTLTTLLAKHYHWEAHYEDVVDNPYLDDFYHQMERWSFNLQIYFLNS
RFRQILDFREKGNDIIQDRTIYEDAHIFAPNLHEMGLMSGRDFDNYSSLFQLMEKLVSAP
DLLIYLRSSISNLVKQIHKRGRDYESSISIDYLNRLNERYEQWIKGYDKGKLLIIDVDNV
DFVDNPEDLGVIINKIDAVLYGLF
>OBAHECAF_01525 Leucine-responsive regulatory protein
MYTLDYTDLMLLDELQQDSKQSIKKLAEKVGLSITPVHERIKKLESLGYISNYVAVVNGK
LLGKKLIAYCQVKLLRHQGELFEEFERYISTLDEVLEASYMAGGYDFLLKLVLNDMEEYQ
RFVVHKISKLEIISNIQSSFVIKEIKNTSMIKCLRDESEFNLKNQ
>OBAHECAF_01526 Mannose-1-phosphate guanylyltransferase RfbM
MQQNRYGVIMAGGVGSRFWPVSTENYPKQFHDMLGTGETLLQRTFSRLSKFIPKENILIL
TNERYEELIKDQIPDIATQNIVLEPAMRNTAPCILYAAMKIKTRNPNAVMIVAPSDHWIE
DEAEFTENVLECFGNSQSQDILMTLGIVPTFPNTGYGYIQYDKSDNNNIKKVCKFREKPN
YETAKDFLTQGNFLWNAGIFIWNVGSVLKAFETYQPTLYELFKEGEKFYNTEKEFDFIKV
NYPKATNISVDYAILEPSTNIFVLPARFDWNDLGTWGSLYEKLPKDNQQNVTVNAQVLFS
NSEKNIVRTETDKMVIIEGLDDYIIVDKKDILLIYPKEKEQNIKEIVAKVKNNFGEHWG
>OBAHECAF_01527 hypothetical protein
MKRFIIIASVFFGTLSTVQMYAQSIDLGVKAGLNLQKISDVKDIKNDLNTGFHAGAFLGI
GILDQLQVQGEVLYNRLSFEKSNLDYISVPVLFEVTPLKTLYIQAGPQFSFLANSNEKYQ
DLLKKSPIDLALGIEINIPAFVFYARYVMGLSDITIAGGRSNVIQIGAGFKLL
>OBAHECAF_01528 Modulator of FtsH protease HflK
MENLFSSLPLIIGILIVFFGMFFTVRQQTAVAIERFGKFQSIRHSGLQIKIPIIDKISAR
ISLKIQQLDVIVETKTLDDVFVKIKVSVQYVVIKDKVYDAIYKLEYPHDQITSYVFDVVR
AEVPKMRLDDVFVKKDDIAIAVKREVQEAMETYGYDIIKTLVTDIDPDAQVKSAMNRINA
AEREKVAAQYEGDAQRILIVEKAKAEAESKRLQGQGIADQRREIARGLVESVDVLNKVGI
SSQEASALIVVTQHYDTLQAVGQQTNSNLILLPNSPQAGSDMLNNMITSFTASNQIAEKM
KNQDSKSKS
>OBAHECAF_01529 hypothetical protein
MGKITNIFLLNEVLTSFFKRNPFYKMNLALVKSLTYNVNRNRIKFLNFSPSNFSLISIVA
TP
>OBAHECAF_01530 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MRLLEGKTAIITGASRGIGKGIAEVFASQGANVVFTYSASVEAAQQLEEELKAKGVKAKG
FQSNAADFESAQQLADAVLAEFGSIDILVNNAGITKDNLLLRMPEEDFDKVIEVNLKSVF
NMTKAVQRAMLKQRRGSIINISSVVGVKGNAGQANYAASKAGMLGFTKSVALELGSRNIR
CNAIAPGFIETEMTAVLDPKVVEGWRDAIPLKRGGTTVDVANACLFLASDMSAYVTGQVL
NVDGGMLT
>OBAHECAF_01531 Outer membrane protein assembly factor BamD
MQFKKYIIIGLLSVGFSSCGEYHKVLKSDDSARKYAMAEELYKTGKYRRATELFKQIANE
YAGRPQGERIFYMYGDAYYKLKQYTLAAYPFQRFQNLYPRSEKVAEVAFLEAKMFYIDTP
EYSVDQQPTNEALEKLQLFLDKYPDSEYAKEASDMVVDLLTRLQKKEFEIAKQYNTIRDY
QASMTSLDNFLANNPGSVFREEALYVRLNSAYEWAINSVEHKKKERLNTAKEAYEILLRS
FPETKYRKEADKMLEKIESTLKNFS
>OBAHECAF_01532 hypothetical protein
MDLKKIDAPISTITYSRADIEAETGNIYEAISIIAKRAVQINAEIKKELIDKLEEFATNN
DNLEEIFENKEQIEVSKFYERLPKPQAIAVKEWLDKKVYHRETT
>OBAHECAF_01533 Coenzyme A biosynthesis bifunctional protein CoaBC
MSLQGKNIVLGITGGIAAYKTAHLVRLFVKKGANVKVILTQSATEFITPLTLSTLSKNEV
YTSFSTTNARWNNHVELASWADFMIIAPATANTLAKMATGLCDNFLLATYLSANVPVFVA
PAMDLDMYAHPTLSKNLSQIAEHGNHVIPATFGELASGLVGQGRMAEPENIVSFIENTFD
NNLPMKGKRLLITAGPTYEAIDPVRFIGNFSTGKMGIALANEALQQGAIVDLVLGPSAEK
NIHKNIRLHRVITADEMYEKVASLFENTDVAILSAAVADYKPKNPASEKIKKNDNELHLE
LVKNRDILASLGANKKHQLLIGFALETENELANAKSKLKRKNLDAIVLNSLKDKGAGFGT
ETNKVTFITHDAEVSFPLKDKNEVAKDILREISDRFYK
>OBAHECAF_01534 hypothetical protein
MSKTNKKCPVCGSNHIIKKGKRNGKQRFQCGDCQANFTIKNIGVKRKNQFIWFRKWIMER
QVYKTLSRDSTMSQSTLQNLFKHYLSQVPTLSIKSKTKVHLLIDGTYFSNGLCLILYYDY
DIRYVQLYRQTNKEKLRDIKQDLENLKKLNVAVYSVTCDGHKSILGAVKKVFPEVIIQRC
LVHIKRQIKNYLSGSPKHFISQQLLCLSKEITHLKTNEQANDWVNRFYQWYVENQYFIEE
KSMNEESGFQWFKHKNLHLATYHIINALPNMFAYLKDSEIPYTTNRLEAYFTHLKEKLTL
HRGLRFEAKKNFIKWYLYFKNQGV
>OBAHECAF_01535 Succinate--CoA ligase [ADP-forming] subunit beta
MNLHEYQGKEILSSFGVRVQRGIVAQSPKEAVDAAKQLTAETGTQWYVVKAQIHAGGRGK
GGGVKLAKGLQDVEPLAEQIIGMNLVTPQTPPEGKKVHQVLIAEDVYYPGESQPEEFYMS
VLLDRSKGKNMIMYSTEGGMDIETVAEKTPHLIFTEEIDPAVGLLPFQARQVAFNLGVTG
DAFKEMVKFVTALYNCYVSSDASLFEINPVLKTSDNKILAVDAKVVLDDNALYRHKNYVD
LRDLREENPIEVEAKAVGLNYVALDGNVGCMVNGAGLAMATMDLIKQAGGSPANFLDVGG
TADAKRVETAFRIILKDPQVKAILVNIFGGIVRCDRVAQGIVDAYKNMGGDIAVPIIVRL
QGTNAELAKEIIDNSGLAVHSAIMFQEAADKVKEVLG
>OBAHECAF_01536 hypothetical protein
MKKHIPNLITLLNLLCGSIAVIYAVKGNFAITGLFVSLGIFFDFFDGFFARLLNVKSELG
LQLDSLADMVTAGVVPGIVMFQLIAKSDFVNENKTLLTDILPYFGLLITLASAYRLAKFN
IDTRQATGFIGLPTPANALFILSLPVILQFQPADFFEIILQNTWFLVCITLLSSYMLNAE
IPLFALKFKDFSFKNNKIKYIFLGICVLSLVILQFVAIPLIIVAYVFISLLQKRKN
>OBAHECAF_01537 hypothetical protein
MKVYGKNNIISYLAPLKKQKKYMLRKITLSISLLAILSIISCKKEEESKPITPPRDVTEV
RDENDAAITNYLKTHFHTFKNNEVVLDTIAGANANQTSLMDLVKTIEIDAYDANNKKVRH
KLYYLPVQEGTGMKSSIADSVYIAYRGQLLKGIEFDRSVGYTQSNWFDLLGDVTNPNAIN
VIRGFRHSIAELKDSASEIKVNVDGTIQTPTDGGVGVFFMPSRLAYFNTSKQSIPAYSPL
MFTIHLIKTKRADHDRDGKPSLEEIQVDDYGIITYTNCDNDSHPDYLDADTCK
>OBAHECAF_01538 Heat shock protein 15
MRIDKFLWCVRYYKTRNMATEACKKGHVRINGDIAKPSREVFNADKIALRKNQITYELKV
LDIPPSRVGAKLLDLYRQDLTPPEAFEHAELMKLSQEYYRKKGEGRPTKKDRRAIDSLLN
DADDDDWDI
>OBAHECAF_01539 hypothetical protein
MFSEKALAIFEESIQKYHILDDVYQPFSNPYPSSSMEHLLYRKNWIDTVQWHYEDIIRDP
NIDPVEALDLKRKIDASNQDRTDTVEYIDSYFLHTYKNVKPIENATINTESPAWAVDRLS
ILALKIYHMQEEVNRPDASDKHRAKCQEKLNVLIEQRKDLSDALDQLLADIEAGRKYMKV
YKQMKMYNDEELNPILRGK
>OBAHECAF_01540 putative ribonucleotide transport ATP-binding protein mkl
MIQVKNLHKSFNGVPVLKGISTTFEKGKTNLIIGQSGSGKTVFLKSLLGLFTPDEGDIIY
DGVSYAEMKRNERTKLRQKMGMVFQGSALFDSMTVLENVTFPLQMFSSKTPEEIRERADM
VLNRVKLVNAEHKLPSEISGGMQKRVAIARAIVNRPNFLFCDEPNSGLDPKTAIVIDNLI
QEITEEFNITTIINTHDMNSVMEIGAKIIFLKNGYKEWEGSKDTIFITDNEAVTDFVYSS
ELFKKVRRAYLDEHSTTLK
>OBAHECAF_01541 putative phospholipid ABC transporter permease protein MlaE
MKHIEAIGRYFIMLYDIFRKRTRWSITKKLIIKEIDDLIVNSLGIILFVSFFIGGVVAIQ
TALNLDSPLVMKSLIGFATRQSIILEFAPTFTSVILAGKVGSFITSSIGTMRVTEQIDAL
DVMGVNSLNYLVFPKIIALLFFPFLVAIGMFVGIVGGWVSTVASGAAFSGEFIEGVQMQF
KTYDLVYAFTKTLVFSFFLATVPAYHGYYMKGGALDVGKASTTSFVWTSIVIIIVNSVLT
QLFYA
>OBAHECAF_01542 hypothetical protein
MRKTLLLICSSIVGVTSAQNLTDALRYSVEDLNGTARYRAMSGAFGALGGDLSAISVNPA
GSAIFSTGEITFTLGGESFNSKNTLHNTTVTNKYSNFTFDQFGVVFSIPNTDDSDWKKFA
LSFNYQTSSDFNRDFIYGGSTTGKNLGDYFQHFANGIAQQDLMLDDYENKVIVRRNSLTD
IYDAMGRSPRAFTLRNALLGYTVGLVDPQIGFREIQPSDSDQLADNILAETNYINKVAGV
STKQNFDVATKGGIHKYNFSFATQYGDDIYLGLGFNAHTVDYSSVTRHYEGYDHSGDIKN
AYFRNELKTLGNGISFQLGAIAKATKDLRLGVSYTSPTWYTLQDETTQYIETNNRAFFAD
PRVVVVYDEYKFRTPGSWTASAAYIFGKNGLISFDYIYKGYGKTYFRTENLKSENTVIQN
ELGDTSTIRLGGEYRIKALSLRAGIRHEQSPYKTGIKYIGDLTGYSLGLGYALGGVRFDL
SYDVAKQDNYHRIYESVLTTPAKMTSTRSNILLTMSIKLF
>OBAHECAF_01543 hypothetical protein
MKKYNKIRVLAVRSFLVMLPLLLASCGSYYTYYDDGIYGERPSVRYVEVVEHRPAQQTIV
VRENKYSNYFRDKAQQFTPDDNYTVFTDVDNYSSNTYTENGRQAYAGWGDNPSQVTVNIY
DYNSYWYDPYYRYNSYWGYGAWYPTPYYGSYYPYYRNRGTWGFSIGWGWGYYERYYHPYH
YGYYPYYRGHYYGYPYYYGDRYYYRDRYYNNGGYYSNGNYYRYDGRRYSPTVGRRGDSSG
YYDDYNRGNSSRGYVPNRSNSDSRTYRTERNSNYGNSNNNRGTSSRSYSPSNSTQNRVNS
DSRSYQSRERSSNYNSNQERYNNSSRSYTPSNTNRGYDNSRNTSRSYDSGGSSSGNSNRS
SSGTTRRSY
>OBAHECAF_01544 Peptidase T
MQKLVERFITYIKTDTQSDPESQTTPSTEKQWNLARFLAEELKQIGMEEVTIDENSYVMA
TLPSNVDYEVPTIGFIAHFDTSPDFSGENVNPQFIENYDGSDIVLNKEKNIVLSPSYFED
LLLYKGQTIITTDGTTLLGADDKAGIAEIVTAMEYLIQHPEIKHGKIRVGFTPDEEIGRG
AHKFDVEKFGADWAYTMDGSQIGELEYESFNAAMAKVYFKGKSVHPGYAKNKMVNSLLIA
NKFMSMLPENEIPQETSGREGFFHVMDITGDIENTTVQLIIRDHDRQLFEKRKETIKQIV
EELNKTHKDAVTVEIKDQYFNMREKIEPVFHIVEVAEKAMKELGITPIIKPIRGGTDGSQ
LSFMGLPCPNIFAGGHNFHGKFEYVPVESLEKATQVIVNIAKLVAKK
>OBAHECAF_01545 hypothetical protein
MKKSFVCLAFFICYVVNAQKQDVSVVFNESAKHFTESLPIGNGRLGAMIFGKTDVERIVL
NEISLWSGGHQESDNPNANAYLKEIQQLLFEGKNLQAQELLQKHFVSEGRGSCHGNGMKC
HYGCYQILADLTLDWQNSSPVKNYKRILDLEKAIATTSFERDNNQIQQIAFADFKNDILW
IKISASNPLQLNVALSRKENASVSYQGNQIIMSGTLPNETEKGMRFASVVEVEADGVLEQ
NNDCLVVNNSKNIILKISASTNYDHNTGKLSSENVVEKAHSYLHKSASFEAALSDSQKKY
QEVFNRNRWYMPSSIPTENFTTHERLHRFYKGENDPLLPVLYYNFGRYLLICSSRPGLLP
ANLQGLWAEEYQTPWNGDYHLNINVQMNYWLAEQTNLSDLAEPLHRFTKNLMENGKKTAK
AYYNANGWVAHVISNPWFFTSPGEGASWGSTLTGGAWLCEHIWEHYKFTQDINFLREYYP
TLKESARFFEDILVKDPQTNFWVTSPSNSPEHGYVLPELKDGKKQVGFTCMGPTMDMQIL
RELFSNTLKASQLLGVDKEKHSQWRDIIKNTAPNTIGKDGDLNEWLDDWEDSDPKHRHVS
HLYGLYPYDEITPWDTPELAEASRKTLNIRGDAGTGWSKAWKINFWARLQDGDHALTLIR
QLLKPTEISSNNWRDGGTYANLFCAHPPFQIDGNFGGTAGISEMLLQSHGKDNVIRILPA
LPNHPDWKNGEMKGMKARNNFEVSFSWEDHNLKEAEIISLSGSTCYVMLPAGKSIYLKTN
NKLKRVVKSSKTNKKIGFKTKKNQIYIIK
>OBAHECAF_01546 Outer membrane porin F
MKKKIFTLGIFALAIVSVKAQEDYNKWSIDLQGGVNSPLIEMSEGYSTSTLSPWNVSGGV
RYMFNNKFGLRLGGGYDSFKNKNNTPKFESNLWNVNLQGIANIGRVLGFEEWTSDLGLLA
HAGVGYGQLKADAFSGKDQVAFGVVGLTPQLRISNRITLVVDGSFYFNGKQDRTFDGFTA
TQNKAVQGINFVTTVGLQFAIGKHGKHADWHSIATEKSDLNDRIAALEKDVAGLQKEVAK
KENKMNDANGNNIPDEIENYLNQNYATKNSVSHSGEINSDTASDLIRKGYINVYFDFNSS
KPQSYSIWAADFVAKFLKENPSSRVNVVGFADELGGTNYNQSLSKKRADTVKQLLIDSGI
NASRITSEGRGEDKSVNKNSAQARQIVRKATFELK
>OBAHECAF_01547 hypothetical protein
MKVHVHPVDFTIDQKLVDFIQKKLDKLDLFYDKIIEADVHLKLENTSAKENKIVEIKVHV
PGESLVVKKQFKSFEEGVDASVVPLERMLLKYKEKR
>OBAHECAF_01548 Tyrosine recombinase XerD
MSVSAFINYLTIERNYSTNTVEAYKHDLISFEKFLNELNPKENQNIENAQQEDLKKWIIH
LTEQNITFKTVNRKLAALRTYFSFLKKSSQIEVSPFEKGIPSLKTEKNIKLPFSEDEVKK
VLSLCEDKNCFEAIRNHAIIETLYSTGIRRFELINLQLKDIDFGSHQLKVLGKRNKERLI
PMLPELEKSLKEYLFVRQEVANSESENYLFLLKNGKKIYETLVYRIINSYFSTITTKKNL
SPHVLRHSFASHLLDGGADLNTVKELLGHSSLASTQVYTNSSLAELKKQYNGAHPRAIKN
E
>OBAHECAF_01549 Gamma-glutamyltranspeptidase
MKKSVFLLSLSLLFLQCNSPQITEKEKVYGLPAKNAMVVSAKEEASKIGVAIMQKGGNAF
DAMIAVELALAVAYPNAGNIGGGGFMVYRLADGKTGALDYREKAPAGATKDMYLDSKGEV
IEHKSTLGALAIGIPGTIDGLFEVHQKLGSLPFAELVQPAIDLARNGVVITELQANGYMN
KNIELIKKANNYPTPFDNGWTAGQVVKYEDLAKTLERIRDNGRDEFYKGETAKRIVDYVQ
ELGGIITHDDLANYKAQWRTPISFQYKDFNIISMTLPSSGGICLAQILKMIEPYHIGNYP
HNQTEYIQLLTEAERRAYADRAHYLGDIDFVRVSLDSLLNPNYLTYRMSDFSWDKASRSS
EISHGKLSSYESEETTHYSIVDSYGNAVAVTTTLNTNYGSKVYVKGAGFFLNNEMDDFSI
KPGVPNVYGLVGSEANAIAPNKRMLSSMTPTIVEHNGKLKMVIGTPGGSTIITSVLQNIL
NVIEFGMTMQEAVNQPRFHHQWLPDEVKLEPKGFDRKTVEELMGKGYLIKEEDNIIIGKV
DAILVHPNGELEGGADPRGDDTAIGF
>OBAHECAF_01550 Aminopeptidase S
MKYIALFFTLIIALNVNAQKPIQKGFQAIDRKNAEAHIEFLANDLLEGRESGFRGGRIAR
EYIVAQLKQYGIEPLLSSNSYLQHFTAYRPENSAREPKRYTVTDSIITRLQKTFHVRLEM
ANVLGMIRGKKENEYVIVGAHYDHLGMDANLFGDNIYNGADDNASGVSAVLQLAKAFKES
GEKPERTIIFAFWDGEERGLLGSQYFIDKCSFRDNIKSYLNYDMIGRNNRPAEPKHVVYF
YTASFPIFETWLKQDLKSYKLDLEPDYRAWDNPVGGSDNGSFAKYKIPIVWFHTDGHPDY
HKPTDHADRLNWDKIIEITRASYLIMWKLANDKY
>OBAHECAF_01551 Methionyl-tRNA formyltransferase
MGTPDFALETLKQLVENQYNVVGVVTIADKPTGRGQKLHSSPVKIYAESQQIPVLQPTNL
KDENFIKSLKDLEPDLQIVVAFRMLPKVVWQLPKCGTFNLHASLLPHYRGSAPINWAIIN
GEQKTGVTTFFIDEKIDTGAIIMQTETPISDRETAGSLHDKLMLQGAALVLKTVDAIQKG
NCLPKQQPMNETFTEAPKIFKETCKINWQTEGIAIERLIRGMSPYPTAWTLLRQNEIEMN
IKIYDAIFMEKAHDLPFGKVTTEKKEIHIAVKKGYINVLELQIPGKKRMKASDLLNGFSF
NEEAIFH
>OBAHECAF_01552 4-hydroxy-tetrahydrodipicolinate synthase
MEQLKGTGVALITPFTADNKVDTEALANIVDYVIDGGVEFIVALGTTSEAPTLTKEEKKL
VCKTIIEANKKRVPLVIGIGGNNTQEVIQQIKGTDLSDFVAILSVTPYYNKPSQNGLYAH
FAEIAKNAPLPLILYNVPGRTGVSMSAEVTVRLAKEFKNIVAVKEASGDLVLCMKILREK
LTNFTFLSGDDMTTLPSVYMGGSGVISVVAIAFPKEFSDMVRFGRTGNIQKANELQYKLI
EKIHLTFKEGNPAGIKAYLASKGLCKPHVRLPLVEASDSLKAEIQASLQ
>OBAHECAF_01553 hypothetical protein
MEFLKTYYVKKRIQRNIEELKSFSSRFDNGIVKIGCLIDMDVIKDIDPLLQLTKFYGVRP
ENYIFLGYKRKSDETHANGVPFLTDREINWQGKIRNYHADRLAEQEYDVLINYFNEPKLA
LLLLSSSIKAKLRIGFQGIDITYNDIIINCKLEEENIFIEETKKVLETILK
>OBAHECAF_01554 Mannosylglucosyl-3-phosphoglycerate phosphatase
MKISFMKNLFQYQRLFFVGFATFCFLSSCGDKKQQLTHIEAKSIEIDNQISEDTEIDSFI
SPFRKHIQKEMAVKLAYNLVALEKGKEENDANAAIANFMADVSYEMLNPTYFKRTGKNID
FVLLNWGGIRSDLPQGEVTIGTAYRLMPFENKFVCLEIKGNKVLEIVEYLHKGKRPHPIS
KQVNLKMTDKGDVKLFTINGKPLDLNATYIVATSDYLMHMGDGMLFFQDPVSVYETDYAI
RNVLIDYFTKVDTLHFRKDNRVERIKE
>OBAHECAF_01555 IMPACT family member YigZ
MNDVFKTIASPVEEVIFKEKSSKFLGYAFPIQTEEDVKRHLEAVKKLHHSARHWCYAWQL
GHGAQQHYRANDDGEPNNSAGIPIYGQIQSFDLTNVLIIVVRYFGGIKLGVGGLVQAYKT
SAQLTLQEAEIIKKIVTQTLQIVFDYKDMNKVMRVVKEKNLEVIDQKLGLDCRLFIEVRD
SEWDHIKAIFESIYGVQVIENERK
>OBAHECAF_01556 Riboflavin biosynthesis protein RibD
MTYYEKYMKRCIQLANNGLGATYPNPMVGSVVVFEDNILGEGWHQKAGKPHAEVNAIDSV
KNKNLLSKSTIFVSLEPCSHFGKTPPCADLIIKHGIPKVVIGTTDPFAKVCGNGIKKLKE
AGCEVIVGVLEDECQELNKRFFTFHQKKRPYIFLKWAETSNKFIAPEQKKEVNPHWITNL
FSRQYTHKIRSKEEAILVGTNTVLHDNPKLDTRHWQGKNPLRVIIDRELKTPKKFSVWDE
STDTIFITEKRENAKFKNTFFENICFSENIAEQICRILYKKGIQSLIVEGGRNVLQQFID
AKLWDEAFVFIGKSTFKNGIKAPALKDASLQKTMLFGEDHLFIYKNLQQ
>OBAHECAF_01557 DNA repair protein RadA
MKIKTSYFCQNCGTQYSKWQGQCYACKQWNTIVEEIIQKEAKKAWQDDTPKSKKTPKYVP
ISEISTQEETRLNSNNNELNNVLGGGIVPGSVTLLGGEPGIGKSTLLLQTALNLPYKTLY
VSGEESERQIKMRADRIVHKLDNCFILTETKTQNIFQQIKELQPEIVIIDSIQTLQSDYI
EASAGSVSQVRECASELIKFAKTTHTPVILIGHITKDGQIAGPKILEHMVDTVLQFEGDR
NHVYRILRSLKNRFGSTSELGIYEMLSNGLREVSNPSEILISKTEETISGTAIAATLEGM
RPLMIEIQALVSTAVYGTPQRSATGFNAKRLNMLLAVLEKRAGFRLGAKDVFLNITGGIN
IDDPATDLGVAMAILSSNEDIAIEKNICFAGEVGLGGEIRPVQRVEQRITEAEKLGFTTI
FVSKYSKVALKNTAINIVKVAKIEDAIQELFG
>OBAHECAF_01558 hypothetical protein
MKKIFSLGFLFLFLGTAYAQIISEEFSSRKLGEKRKLAIYLPEKYSDKEAYPLLVVLNAS
SLMEPVLANARYYEYFENMPKCIIVGVYNTLEDVKTGKNGELTRQSANFLDFMGGELIPY
IHGKYSVNNFKGIIAKDEGAYVSNYFFLGKEPLFNVVISLNPKTLPAISETISDKLNAVK
RTVFYYIATTNYDHETAYTNTKSLNSQIVNNLTTEDVKLFFDDFPKTSLHSVALSGIPRA
FDLIFSSYKPIDAKEFKENLQPLSEDIFYYLEDKYKKIESELGFKKTPVLNDIMATYDVI
IEKEDWDSLIKLSDYVKDNGYEKTAMPNFFLGEYYEHIGDNKRALRAYQKAYTELPIDFI
KKDIIDQRIVKLRK
>OBAHECAF_01559 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MKNISGFSKLTKQQKIQWLCDTYFPDDKDAFSNFKKYHNADETLQKLHDEFIENTVTNFY
LPFAVAPNFVINGKTYTVPMAIEESSIVAAASRAAKYWETRGGFKAEVISTEKNGQVHLM
FYGKKADLECFFEKIHSKMLTDAKHITSNMEKRGGGISTLRLVDKTSELANYYQLFASFE
TLDAMGANFINSCLEQFAETFRQEALKHPEIDGKYEIVMSILSNYVPECLVKVSTSSPVE
NLAVAGLSGKEFAEKFVRAIAIANSEVRRATTHNKGIMNGMDAVILATGNDFRAVEAGVH
AYAARSGKYQSLTKAHIKDEIFHFEIEVPLALGTVGGLTNLHPLVKTALQILEKPSASEL
MQIVATVGLAQNFAAVSSLITLGIQKGHMKMHLMNILNQLGASDRQKEQITEYFKDKTVT
HSEVVRIFEQTK
>OBAHECAF_01560 Thioredoxin-dependent 5'-adenylylsulfate reductase
MFMKEQIDLYLKEIADKSEIETLRYFAGQFPNQVVFSTSFGMEDQVITDLILKNRIPINI
FTLDTGRMFAETYATWDKTAMAYDTKITPYYPKAEFIENYVKTNGINAFYESAELRKECC
YIRKVEPLKRALTGNKVWITGLRAEQSSNREQMPMVEWDEGNQIIKFHPILHWKTTEVLD
FLRANGVPYNPLHDRGFISIGCQPCTRAVKDGEDFRAGRWWWEDKSKKECGLHSTK
>OBAHECAF_01561 Sulfate adenylyltransferase subunit 2
MDYLEQLEAEAIHIFREVGGQFEKPALLFSGGKDSIVLVHLALKAFRPCKFPFPLVHIDT
GHNFQEALDFRDNLVKKLGERLIVRKVEDTIKAKGLTEPKGKFASRNALQSYTLLDTIEE
FEFDACIGGARRDEEKARAKERIFSVRDDFGGWDPKLQRPELWHTYNGKIHKGENVRVFP
ISNWTELDVWNYIRREKIELPSVYFSHEREVIDHNGQLIAVSPYIQIDENDVIVKRKVRY
RTVGDMTCTAAVESEAYQIDDIINEITATRTSERGETRIDDRISEAAMEDRKKSGYF
>OBAHECAF_01562 hypothetical protein
MKNKIDSFVVLGQFLEQFSVFPYVKNVSLPQNEVFFDGFVEVLGLAEQQNGWFTSENLRF
ACKSWAEALQRNSIERWLSNYTFDGITPKDIAIIMAGNIPLVGFHDFLCVLISGHRAVVK
LSSDDQVLLPFLANYLQHIEPSWQGKFEFTNERMTHFDAVIATGSDNSARYFEYYFGNKP
HIIRKNRNSIAVLTGKETQEQLFQLGKDIFTYFGLGCRSVSKIFIPENYDLDIFFKAIFP
YSDIINGQKYANNYDYNKAVYLMSLYKLRENGFLILKEDERYASPIATLFYEYYTDINNL
KNKLLTDLDKIQCVVSDGFLHNEIHFGETQQPALWDYADGVDTVAFLTNIP
>OBAHECAF_01563 Phosphoserine aminotransferase
MKKHNFSAGPSILPQTVFEKASQAVIDFENTGLSILEISHRSSEFLNVIERARALALELA
GLDDSYEALFLHGGASTQFLSVPYNLLENKAAYIDTGTWANKALKEAQMFGKVEVIASSK
DTGYRHIPKEYSIPKDIDYLHITTNNTIYGTQYHSLPTTEVPLVADASSDIFSRTMDYSK
FSVIYAGSQKNIGPSGSTLVLIKKDVLGKVSRKIPSILSYENQIGNESMFNTPTTFSIYV
NLLVLEWIQAKGGLQGMEKLNQVKAELIYNEIDRNPLVLGYANTEDRSLMNVVFNLKDTS
AEILFDALCEEAGISGIKGHRSVGGYRASIYNAMPLESVQLLVEVLQLLERKS
>OBAHECAF_01564 hypothetical protein
MQNMYKIGVNIRKVRELRGYSQEYVANKLNISQASYARMESEDTKITVDRLFQIAKILET
NVSDFFDNSGINIHSQVYNGEAYCNGYIQNLVVENKDTVNKLIELYKAQLQDKDNQIQYL
KSLLAQFTP
>OBAHECAF_01565 hypothetical protein
MKIRLLFLLSSFFLYGCHHQEKPILEEQTPLIDYVNPLMGTDSKFELSNGNTYPAIALPW
GMNFWTPQTNKMGDGWTYQYQANKIRGFKQTHQPSPWINDYGAFALMPVVGDLKIEESER
ASWFSHKAEIVKPHYYKVYLADYDTTVEIAPTERAAQFKFTFPESQKAYILLDAYFKGSM
VKIIPEKRKIIGYARNHNGGVPDNFHNYFVAEFDTDFENVSTWGDQWRLLENNTESEGNH
VGAIVKFATKRGQEVRVKVASSFISWEQAERNLNAEIGNDSFEQTKNKALNRWEEELAKI
RVKDSNIDNIRTFYSCLYRVLLFPRTFYELDEKGEIVHYSPYNGKIEKGYMFTDNGFWDT
FRAVFPFFNLMYPEMNQKFMKGLVNTYLESGWLPEWASPGHRDCMIGSNSAPIIADAFLK
GNISNEDAEILLEAMLKNATQNEGRPVKSVGREGVDFYNKLGYVPYNVGINENVARTLEY
AYADFTIYQMAKAMGKNDIAQTYKQKSLNYHHMFDKESGWMRGKNEDGTFQSPFNPLKWG
DAFTEGNSLHYTWSVFHDIQGLANLMGGGAAFEKKLDEVFGMPPLFDHSYYGFTIHEIRE
MQIMDMGNYAHGNQPIQHMIYLYNYVGKPHKTQEKIREVMTKLYAPTPDGYCGDEDNGQT
SAWYVFSALGFYPVTPATDEYIIGSPVFEKVTVQLPNGKKLIINGVKNSLENKYIDHVVL
NGKPWDKPYIPFEFFKSNGRIDFHMTHMPSDSGIAGEKPYSISK
>OBAHECAF_01566 hypothetical protein
MNRNLLSLLFFIISLSAFSQNYQVIYKTEVNIDNLKNIKDPIIKNNVESKLKAKRSHRFQ
LLVAGDKAVYSFYEQMLPEGIQLPKVERFYYKGNQVVAEREGVFVKYDLNHHQWTITDDS
VTINGYVCYRAFTKRPHLIEALGDEEQEMEAWFCPDFPVKYGPEDFFGLPGLVLVARTKG
ATSSLVVEKIIPLKSAPQLKFPKIDKTLTPEEYKVFVNKEVNEFLEKLK
>OBAHECAF_01567 hypothetical protein
MRLLFFLLILCYFSGYSQKSVFEGTVRDSLAPLENANLLARPAQKGGRILFATTDKQGRY
KFNLLRDVEYVISVSYLGYTPQNITITATSERSEHHFVLKSTGIELTEVVISAERLPITV
KKDTTVYKVDAFVLGNERKMKEVLEKLPGVEVDDDGIIKVQGKQVTQMLVEGRSFFGGSS
KLAVENIPADALDKIEVIDNFNEVSFLKNVSSSNELAMNVLLKEDKKKFVFGDLEAGAGN
DRHHLAHTALFYYHPELNLNLIGDVNDFGKSAFSFQDLMHFQGGRSRFTKQRGVSVNLST
YSKNNQNMYRHNAQFLAFNFGYMPTSKLYLSGFSIFSKLLTDYKKDTSIEYLTNQTPLLE
WQQLTNEQQNLLGMGNIKVDYSPSSDEKWFYNAQFDANNNHISNDLVSKSPLRTRSVNSL
TDTDNVSFKQYVEWHKVYNRKETTTFVVNHSYDKISPNNQWITNQFTSLPSLLPLLTDTE
YHLVQTKQTKKHQVDAIFKHYWTINDLNHLYTNVGSNLEMSLLNGNEKQLLTDGSSNNFV
SAGFGNMYDYTLSDAFLGLEYRFKINKLVSKISTFLRYYRLKNNQLVNKRTSDLLAFEPA
FETTYEFSNSEEIKFHYAKRNIFPKEEMLLEKFSLLSYNAITKGNPMLDNELFHSFSLNY
RRNSFFKRITLSAHLSFNRKTKTIGSEYIFEDINRFSTWFLSHKPETSWSFMTTLERKIL
GMQWGLTYAGSWNNYVQKMNRIITENRRENHSVKAYTRVVYKKMNLNVSYTKNWNAHRGV
SSTKLVSDYWLTTGSYRFTNDFSMELQYAYFRNEQLNSSQLADFQYLNISLDYQRSKSPW
GFHLAGNNVLGTKTKINSSISNYYVVMQTTHVMPRTIVFSIRYKL
>OBAHECAF_01568 hypothetical protein
MSKYSYFSMTRNFFLLFFLGIFLTTSVYAQKKYTFSGHFVDASNGELLLGVNCIIKELGT
GTTSNEYGFFSITLPEGKYTISIESMGFMTITEELVLDKNIRKDYKLSAEAIELDGVEVF
ANTSSKVDIRKPEMSTVSIPISTIKKLPVLIGEVDIIKTLLQMPGVSNAGEVSSGFNVRG
GGADQNLVLLDEATIFNSSHLFGFLSVFNADAVRDMKLYKGGIPARYGGRTSSVLDIYQK
DGNRNDFGMTGGLGILSSRLLAEGPIVKEKSSFLIGGRASYAHLFLKFTDNKNSAYFYDL
NTKLSYKLNDNNTLYLSGYFGRDFFDLSDNLRNVYGNALFNLRWNHLFNDKLFSNLSLIF
SDYYYGFMFNYIGFQWDSGIKNFNLKYDFKNYISEKFKLSYGVQGLYYVFIQGKLSPSSP
DSNIKEQYLPNKYAFENGFYIDAEHSITSSLNLSYGIRLNSFYHLGSREINRYANDQPVT
FNPNRGVYQKGVPIGIDYYPNNKIIDLFSHLEPRLTLSYALNDNRSFKASYGRNAQYLHL
ISNTSSPSPLDVWTPSDQYLKPQVSDQFAVGFATNFAEDRYSFEAETYYKTTQNRLDYID
GADLIANKAIEQIVLSGRSRAYGLELLLRKNTGKLTGWIAYTLSKSEQQTPGRTPQETGI
NNGEWYSTPYDKPHDLSITATYALSPKWTFGAVFNLQTGLPANFPVGTYQYLNMIVPNYS
KRNEYRLPTYHRLDISATYTPQKQHKRWKSEWNFGIYNLYNRKNAVSISFRENSDTHLNE
AVKLSIFGIIPSVTYNFTF
>OBAHECAF_01569 hypothetical protein
MRKIYTIICMLSFALSSCEEVITLDIDNEKPQLVVDAYIDWKKGDTQAIPVVHLSYTTDY
YSNLPSPKATGAAVKITTYHSEEYILQEISHQQFANIFPPTEYPTVSNHLGGTIYAFPDG
ITPVLGRDYILHIEYEGEKYVAKARMKETAIVDSSRTQQNDNGGIFGNKTEARFFFNGFT
NEENAYLVRMKHKQKEDRYTLDDKFIADQKFFFTTNGFQEELKKGDQIYVSLYRISYEYK
QIIDFLADVAINDQGRGAGPPSNNIPARILGNVTHETNPKKNPLGAFRVGQYSEFQYIVK
>OBAHECAF_01570 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKIAVVVLNWNGKHLLEKFLPSLVKYSPQASLYLVDNASTDTSVEYVKNTFSDVHIVSLP
TNGGYARGYNQGLQQIEADVYCLLNSDIEVTENWLIPIEKLFKNPEIGVVQPKILDYKDK
NHFEYAGAAGGFIDKYGFPFCRGRIFDVVEQDLGQYDTEMDVFWASGACFFIRSDVFKQM
NGFDEDFFAHQEEIDLCWRIHRFGKRVFYTPQSKVFHVGAATLPTDNPKKTYLNFRNGLF
MLLKNLPQKRKYRILFLRMLLDGIAGGRFLFQGKISFTWAIFKAHMSFYRYFFKFKNKRK
GTDFLLYYEVESIVWEYFIKNKRTFNKLK
>OBAHECAF_01571 Outer membrane porin F
MPLYKPLKLNIMRKIFVAISLVSLVTVSCVSNKKYAELEQKYKQTDELLNTATVKLNACL
KDYEKLQYQVSSLKNENDLLRENNQQLINNMGNLTTLTQKGAENLEKSLESLREKDLTIR
NLRDAVTRRDSINLALVQSLKGAIGNLDDQDIEVKVEKGVVFVNISDKLLFSSGSYAVTN
RAKEVLGKVALVVKNKPDFEFMVEGHTDNVPYKANTVIKDNWDLSVLRATAIVRILQKDF
GVSPERMTAAGRSEYIPVTTNDTKEGKAQNRRTRIVVLPKLDQFYNMIEEGMKDPAINK
>OBAHECAF_01572 hypothetical protein
MKKKKRKYNKKPSVQPRKSDVTTPQLPKPKEDVSEESKPKVDTSQIPIVTDTNPKIHNSR
PRSKKKSRRGDWQTFLREVRRFIDMLSPIEKSVIITLSFIICILVLMLRVQLKAKEAEIM
LEMNFTPEVAQFDIPPEESKAEQGITEQTRITIKTYNEADRALKHADEPFKTLDEILAER
EMKEASESLLTDKISDVVVTTDVGIEQNQQGVKREEVVNKNTLIKYALVDREVRGDLPNP
VFTCEEEGKVVVDIKVNEEGKVVTASINREHSTTTNGCLVENALAYARQARFNVYLDRKM
QSGTITYFFQSKR
>OBAHECAF_01573 hypothetical protein
MIKNVIVFFTIVCVFFSCNGLGSQKTRNYNLKVQPQKKEYHLNDTVQLSVSDNDFGEAVA
SVSYKINGEELTSMEGSYLLKNIKLGKQIIEIEVVTESGKEYTFQKELTILADKAPKLYT
YRIINQYDHDKTAYTQGLEFVGDTLIESTGQYGKSILRKWNVFTGQEYKKINLASQYFGE
GVTVFDNKILQLTWQENLGIVYDLDLNQQQTFAYGKSKEGWGLCYDGKKIYKSDGTEKIW
ILNPNTYQEEDFIQISTDKSLFSNANELEWVNGKIYANTYQKDGIMIINPQNGAIEGIVD
MRGLKEKVEQIPELDVLNGIAYHHNRKTFFITGKNWNKIFEVVFEEK
>OBAHECAF_01574 Tail-specific protease
MKKISASLLLFFISFASCSFAKKFENPDKDKLLLEIVQYVLSNGHFSPMQINDEFSKKMY
KSYIEQLDSQKRYFLQSDINEFKKYETRLDDDLKRGDISFFNLTYSRLMQRMKESQEIAK
QIFKKPIDFNSKKTISTDFEEIQYVKTKTEMQNRWNQIITFSAISNYLTKEKEENTKLEK
DSTYKVKSAEELKKESVENAEKTLTEIFSIYDDMLEEEWFSIYVNAFAETFDPHTNYMAP
DIKKSFDQGMSGKFEGIGAQLQKKIDGIRVTTIILGGPVWKAKALEVGDLILKVAQGKEE
PVDVVGMRLDEAIKLIKGPKGTEVRLTVKRVDGTIETVGVIRDIVEMEETYAKSVIVDHN
GKKYGIIDLPKFYMDVENYNSKNAATDMAIEVEKLKKQGVAGIIVDLRNNGGGSLRSVVD
IAGLFIKSGPVVQVKSSQGRVDNLADTDSRTQWDGPLVIMTNELSASASEILAAAMQDYK
RAIVMGGKQTFGKGTVQTFADLNQYVRQNSFGDLGALKITIQKFYRINGGSTQLEGVKSD
IVMPDKYKYIDVGERDMSNAMVWDKIKSQQYVPLKNDELFARVIANSQRRIQENPNFKLI
DENAKWIKQQQDENIFPLNYEAYKKLMEKNEEESKRFKAISEYKSNLKFSSLPSDEAKIG
KNEDLKLRRDRWHENLQKDIYLEEAVNVLEDLAQK
>OBAHECAF_01575 Cytidylate kinase
MQKIIIAIDGYSSTGKSSTAKVVAKKLGYVYVDTGAMYRAVTYLAMQKGFVEKKTVENTD
KQQDEQIVYLKEQELLTALKNSDIKFKYNPELQFSEIYLNDVNIEKEIRSIEVANLVSEV
AKVASVRAYLVDLQRKFSEEKGIVMDGRDIGSVVFPNAELKIFMTASEQIRAERRYKELL
EKGEEVSFEEVLKNVQYRDFLDTTRKESPLLKAKDAVEIDNSNLTFDQQVQKILDLANQR
ISDETI
>OBAHECAF_01576 Lipoprotein-releasing system ATP-binding protein LolD
MIKATNIHKTYSGLEVLKGVDIHVHKGEIVSIVGASGAGKTTLLHILGTLDLANQQQDSS
LVINDVNVNELSSKSLSKFRNEHIGFIFQFHQLLPEFTALENVCIPAFIKGTAKKEAENR
AKELLSFLNLSDRIHHKPSALSGGEQQRVSVARALMNHPAVVLADEPSGNLDSESAENLH
HLFFELRKTFNQTFVIVTHNEDLANMADRKLTMLDGKFI
>OBAHECAF_01577 hypothetical protein
MIISDLKDFLDEKVLKYNRPEFVETDPLQIPKRYSAKEDVEISGFLVSVIAWGLRKSIIN
NGLKMMDLMGNAPYDFVMSHTQNDLKRLQNFVHRTFNGQDFEQFIISLKHIYTHYDGLEN
ALADSVENNDLQLGISNFKSLFFKDLKYNRSLKHLPDPRKGSVAKRINMYLRWMVRNDNS
GVDLGIWKRISPAMLSCPLDVHSGNVARSLGLITRPQNDIKALTELNGHLLRFDPNDPAK
YDFALFGLGIFEGFA
>OBAHECAF_01578 Hydroperoxy fatty acid reductase gpx1
MKKIFTILALLMFVLVKAQTGTEKNTIYQFTVKDISGKKFDFSKLKGKKIMIVNTASKCG
LTPQYEGLEALYKKYKDQNFIIIGFPANDFKSQEPGTNFEIAQFCKVNYGVTFPLMEKIT
VKGDDIHPIYQFLTQKSKNGVQDSEVQWNFQKYLIGTNGKLEKVISPRTQPDDQEIINWI
EN
>OBAHECAF_01579 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAFGAHPDDVELGCSGTIAKEVSLGRKVGIVDLTQGELGTRGNAQIRKQEAREGA
RILGVEIRENLKFADGFFVNDQAHQLEVIKMLRKYRPEIVLCNAIDDRHIDHGRGSKLVS
DACFLSGLRKIETVHEGVTQEAWRPKVVYHYIQWKNIEPDFVVDISGFMDKKLASVLAYK
TQFYDANNNEPNTPISDKNFLDSVTYRARDLGRLIGVDFAEGFTMERVVAVNTLYDLK
>OBAHECAF_01580 hypothetical protein
MKLILLTIGILALCIAGIAIKIWAKKGGKFSGTCASQNPHLNKTGEPCGFCGKMPEQQEC
GKE
>OBAHECAF_01581 tRNA (guanosine(18)-2'-O)-methyltransferase
MRKLANSELIRLDVDAFKKAPKTPLIVILDNVRSLNNIGSVFRTADAFLVEKIYLCGITA
TPPNKEIHKTALGATESVCWEYAEDTLSVVNSLKTQNVKVISIEQTENAVMLNEFQPQKE
QKYALIFGNEVKGVEQEVVSASDGVIEIPQYGTKHSLNISVSAGIVIWDLWQKIYGN
>OBAHECAF_01582 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MAHLRYVRKYFFKYRYHLILGIFITILARIFSLFMPEYVQNSIIAIEEYAKSSDKNGNIV
QLLIQYALIIIGATIISAILTFFMRQLIINVSRYIEFDLKNDIFVKYEELSLSFYKRNRT
GDLMNRISEDVSKVRMYVGPAIMYSVQTITLFACVIPLMLYTSVELTLYTLIPLPILSAL
IYVMSRKINRETLVVQQFLSDLSTFSQESFSGINVIKAYNNEPLVNQQLSDLAERGRQKN
IKLAKIQAIFFPTMILMIGLSLIFVIFMGGRLYYLGEITSIGVIAKFSIYVMMLTWPVAT
VGWVSSIVQQAEASQKRINEFLAEIPDIRNHNPNIEKINGNIRFENVSFTYADTGIEALK
NVSFDIPKGQTVAIIGKTGSGKTTIIDLIARMYDVSKGEIYIDSKPIREVNLHSLREAIA
VVPQESFLFSDTIKNNLLFANKQATDTQIVKATQEAAIHDNIMDFTHQYDSILGERGVSL
SGGQKQRISIARALLKDAEIYLLDDSLSAVDTETEEKILQNLHATLKNKTVVIVSHRVSV
AKNADKIFMLNEGELVESGTHESLLQQNGFYKAFYDSQV
>OBAHECAF_01583 Peptidase E
MKKILLASTSTIYGGTYLSYLQEELAVFFANVDEILFVPYAQPSGVSYDEYTQIAQKGFE
SIGKKIVGLHTFENPKEAIHQAKAIFTGGGNTFLLVTRLYQFDLMGTLREVVESGIPYFG
TSAGSNIAGLTMQTTNDMPIIYPPSFDTLGVVPFNLNPHYLDPDPDSKHKGETRETRIKE
FHKLNDTPVVGLREGSSILFESNRFILKGTLTARIFLKDKEPFEATNDDFSSLFKQMDR
>OBAHECAF_01584 Bifunctional protein PyrR
MTIILSHQDIENKIRRIAYQIYEKHLNESEIILAGIEGNGYLFAEKLNVYLSEICSLKVA
LCKVKMNKRNPLEGISTSIDSEDYKNKSVVLVDDVLNSGLTLIYGVKHFLEVPLKRLTTA
VLVNRNHKNFPIKADFKGISLSTSLQEHISVDFTEGNYVACLN
>OBAHECAF_01585 Protein GrpE
MSTEKHVQEEPLSNEEVKNEGITNEEIENIEDKSSIEEELAKEKDKFLRLFAEFENYKKR
TTRERVELFKTAGQDILSSMLPVIDDFDRALVEISKSEDKNMLKGVELIYNKFINTLKSK
GLEKVEVAPNDVFDSEIHDAITQIPALTEDMKGKIIDVVEKGYKLGDKIIRYPKVVVGQ
>OBAHECAF_01586 Chaperone protein DnaJ
MKKDYYEILEVEKTANAAEIKKAYRKQALKYHPDKNPGDKDAEEKFKLAAEAYEVLSDDT
KRAQYDRFGHAAFEGAGGGYHSSMEDIFSHFGDIFGGHFSGFSGFGGFGGGSQTRLRGEN
LRVRLKVTLEDIVKGAEKKIKVKRKVKAEGVTYKTCPSCNGSGQVVRQMQTMLGMMQTSA
PCSSCQGSGQIIENRPPESDSQGLKIFEETISVKIPAGVMDGVQLKVSGKGNEAMGKNSI
AGDLLVLIEEQEHETLKREGENLHYDLYISFPEAVLGASKEIETVTGKVRFKLDEGVQSG
KILRLKGKGVPSLNGYGTGDLIIHVNVWTPKNLTEKQKEFFREMRDNENFTPKVEKTDKS
FFEKVKDMFS
>OBAHECAF_01587 hypothetical protein
MTKKDIFVELKKRMKKVLFVMITLFTGMLSAQSTEVKGTVYSVQDNKGIANVHVLNLNNV
KGTTTNEQGDFSIKAAVNDTLYLSFLGYKSIKVLVTNDMIRFPDTKIGMTELAYALEEVV
ITPYKLTGYLDIDAKNAPVNENKRYSISGLEIGYESRANASMVGRILSSVMNPADMLYRL
FSSKGQEVRKLQKLKDDNKLSDALSQRYDRETLLELLQVDRAELENIIRSCNYSNEFIMS
ANDLQILDAISNCYEEYRVLNRKKK
>OBAHECAF_01588 TonB-dependent receptor SusC
MIKKWTLTIVCLLLGVVAYGQYEVRGEVVDAKTKKPLVGANVIVRGKLVGTATDIKGEFI
LPVSSKSGELVISYMGYISRRSSYRILTNKRGKVKVALQWDEKGQTLAGVMVSAHYNMFD
IAEERKTPTAATTIDRIEIKRRLGNRDFPELLRRVPSTYTVRGGGYGDSSVNIRGFSNEN
IAVMINGMPVNDMENGRVYWSNWTGLSDVTTAMQVQRGLGASKLAIPSVGGTVNIVMRSA
FMKQGGMVNAYVANGGEYKTSVTYNTGKNEKGFSSSFLFGNVGGSKYVDGTQFKGYNYFL
ALGYNPVEKHEFQLMLTGSPLQHDRSSSLVSIADALKYSTNGKPNRRYNADWGYLDGKEF
SIRKNVFHKPVFSLNWDWKATDRAEVNTTAYASFGRGYGTNDYGASRGLKINSFRSLETG
LYDFDRIVRNNQEATSPDDVLLRYARVNSHDWFGILTNYKQKIWDTVTLDVGFDGRYYQG
YHYGIVENFLGAKSIRDNSNKNIGENNVSTTVNNSSIYNAFKSIDPIENSIIYNNIGRVY
WLGVFGQFEYAEDDICMFVQGSISEKGYQRVDNFIKEGTYVPGTTIEMPRTTDYERMLGF
NGKAGINKNIDERHNVFVNIGFYSRQPIFDAVYRGDLNYASPDNVNEKVLGIELGYGYKT
DFFNAKANFYRTTWTDRFLRRVNLRDVDINQTSYFADISNLSEVHQGIELEASYIVNEYL
KVRGMLSVGDWFYNGNADAKTFRTEDSQPYILTNSISDRTSLLLDKSKIGGTAQTTFVLG
AEVTPIDRIIVNLDWRYVDRLYSNIDIYAFTDRSLAEKGALRLPSYNLVDFGVSYRLPLF
KSHVMNFRFNVDNIFDATYITESSDSVHATEHSQVYKGIDVKNRVRFGFGRTWNFSMRYS
F
>OBAHECAF_01589 hypothetical protein
MKVNKFFLWLCFCVSLPLIAQNDLVIKGKVIHNNQPLPGVHIQNIDKKKFVTTDTEGLFL
IHGEVGNVLKFTHVGKKDLYRSVNKEDLENELLIIELKEQVVELEGVEVKETTVTAKDFL
GYTPKKRTLEEKRSYANNNFWAGSGFPPINILAILNAISGKRKYYKQALKNETNLAVANY
IIDNMNRFLKKDLGLDDEKISVLAYYVMENPDIHNLVKSKNDKQLEFMLTDIWVTDLSEK
LKNKGK
>OBAHECAF_01590 hypothetical protein
MRKLYILIFILSFVQLFAQNKNIFHGRIVINDSIPVSDVHVQNLHNEKFTTTDKEGYFTI
SASENNALQFTHVSLQTTHRLLKATDFGTVVVIKMRTLIHELEGVEVQKAPDITAQSLGI
LQHTPTQRTYNEKQLYTSRAGGFGFIALLNKISGRTKMLRKVLMNEQNLKVANYIIDNMS
EFLKKELNLDEEEIRYLAYYLMENPEYHRVTQNKESKTLQFMLIDSWLQIQQEANNESE
>OBAHECAF_01591 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MYFSRNWRRILFENMYVILVLFIVVYLLLARYANQALKTLKISEKVRYVFGAVSVLVIVN
VVLQWLLRTKAVWTIFQQYSMGALITWFIILVVSSFILFLEDIQRIGVAIFRYKSAGDKS
IPSRRKFVSLLALGVASVPFLSVVYGVTKGKYNYKIWKYTLYFDDLPEAFDGYRITQISD
IHAGSLDNKSKIQYGIDLINQQQSDAIMITGDIVNNLASELLPWKDILKQLKAKDGVFSV
LGNHDYGDYSSWENPEAKAKNLEDLKEIQREMGFDLILNDHRYIEKNGERIAVLGVENWG
HGRFSKYGDLEKAMQNVSDEDFKILLSHDPTHWEYEVLPENKNIQLTLSGHTHGMQVGIE
IEGLVKWSPSKWTYKYWAGMYEEAGKKLNVNRGFGYHAFPGRVGIWPEITVIELRKKQ
>OBAHECAF_01592 Keratan-sulfate endo-1,4-beta-galactosidase
MRKILMLLCSVSLMVSCKTSSEVGSKKEKKWRLVWEDDFERDDIFSTGVWSKIPRGKSDW
NNTMSLDESLFEIKNGNLILIGKKNDIAPDDSSKFVTGGVFTKNGKYFEYGKVEIRCKLE
ATQGSWPAIWMLPKVGKWPYGGEIDILERLNFDNFVYQTVHTQYTRTNKENPKHYTTFPI
NPDDYNTYAVEIQPNELRFYVNDQFTFSYPRIEGNPEQFPFGKPFYLLIDMQLGGSWVGD
VPDFEKPIRMYVDWVRYYQK
>OBAHECAF_01593 Copper homeostasis protein CutC
MIYEICASSFESARNAQLAGANRIELCSELGVGGVTPSYGLIKKVMDELSIENCVLIRPR
SGNFTYTDEEFDVMLRDITFCRELGCKGVVTGVLNTDNTIDKERTQQLIEAAGDIDFIYH
RAFDCVPNPEEALNLLKTLGVKRILTSGGKKSAVEGLDVLKKLNQQAERKITIMPGGGIN
PQTILKIKEAGFNEVHFSGTVFEKSANEMPFSFNTASFLDESVRPISGIEQIKTIMNALK
>OBAHECAF_01594 putative 3-hydroxyacyl-CoA dehydrogenase
MRRIKKIAVIGSGVMGSSIACHFANIGVKVLLLDIVPTQLNHIEQKKGFSLSDKVVRNRI
TRENLEKILKSNPSPIYHPQFAKRIEIGNLADDLPKIADVDWIIEAVTENLEIKKSVFEK
LEQYRKQGTLITSNTSGLPVHFLSEGRSEDFRKHFAITHFFNPPRYLQLLEIIPSADCQS
DVVDFLFFYSDKFLGKTPVLAKNTPAFIGNRIGIFVMMHTLHQIKWLNLKISEIDALTGT
IIGRPKSATFRTADVVGLDTLVHVAKGVEKNSTDNQDKHLFQIPDYVLNMLKNNWLGAKS
GQGFYKKIDKEIFELDLRAMEYVPCQQVVFPLLNEVKKKELKDRFLLLIQGDDNVSLFYK
RTFAALFAYIQNRIPEISDTLYQIDDAVRAGFGWQIAPFEIWDAIGLAKGVELMQSMGYE
TADWIQDMLRNNQLSFYKLTKEATYFYDIKTKKYRKKVGQEGFIILDNFRSETLWKNDEA
SIINLGDGILNLEFHSKMNTIGGGILEGIHRAIDFAEEKFQGIVIGNQAENFSVGANIAM
IYAMATAKEYEKLNQTIAYFQNTMMRLRYSSIPTVAAIHGMTLGGGCELSLHTDKVVATA
ETYIGLVEFGVGLIPGGGGSKELTVKASDGLRKGDVILNRLQDYFLTIAMAKVSKSAYEA
FDWDILQKGKDIVVVNRLRLIAEAKKHALLLAEAGYTRPIERDDIKVFGRQSLGAFLVGT
DSMREGKYITDYDKRIADKLAYVMSGGDLSEPTLVSEQYLLDLEREAFLSLCTEPQTLER
IAKILK
>OBAHECAF_01595 DNA polymerase III PolC-type
MSIFRVFSKRQKDDLPLNKVKFVVFDTETTGFNFATDRILSIGAITILDNQMYVKESFEI
FLQQEKSNPESIPIHGIIKEHKYNKVPEKMAVTIFSDYAKDAVLVGHHVGYDIKMINTAL
ERHQLPTLKNEFIDTNYLFKKTKVINYLLKNDKNYSLDEVCQELNITTHDRHNAAGDAFL
TAIAFLKILHKLAESKKITTLSRLLKL
>OBAHECAF_01596 Non-canonical purine NTP pyrophosphatase
MLKIVFATNNLNKFNEIQALMPHSIQVLSLKDINFNDDIEETESTIEGNAVLKAQYIKKH
YGYDVFADDSGLEVVTLDNQPGVFSARYAGNHRSDTDNIALLLKNMQGQTNRKARFKTVI
ALCIGTEVHTFIGIVEGEITQIPKGTNGFGYDPIFKPEGYDQTFAELSASEKNGISHRGK
AVKQLVEFLSFGNKKS
>OBAHECAF_01597 hypothetical protein
MSELNNEQLPDVTKTPHSTNQEVNVTHNSDATQHILNEINRENAEDAEDLDNKKRHEIPM
LHYEAMSLDALKQEFKKLLHTEKVQAIKKHVDAIKNEFDKKYEELLEEKKEEYVADGGEE
YDFKYEHPLHREFYTLINEYRDKRNQYYKDLEVVHQENLIKRREIIEEIKNLINVEENIN
TTFKHFQQLQDRWRKAGAVSHSEYNDLWNNYYHHVENFYDFIDLSRDLRDIDFKRNLEEK
QKIVEKAEALAESDVDPIKAFHELQLLHKVWKEDIGPVAREYREEIWHRFSNATKAVHEK
RQYYFDNLDKMYEANAVKKNEIIEKLKTVAERKITTHGAWQKGIKEVENLREQFLNTGRV
PNTLTEEIWHKFKEVVREFNRKKNSYYKNLKKEQQENLEKKLALLEIAKNNKDSQDWEAV
TPVMKKIQEDWKAIGNVPKKNTDKIWKEFRKACNDYFDQYHKAVRNNQNKEFESLEKKKE
FLDKIKEYQLGDNREKELETLQGFVEQWDSFGKVPHAKKGIDLKFHKIIDSFYKKLDFDK
QEIELIKYNNKLERLANDDNEDLLTNEMMFVRRKIDEIKAEVLQLENNLQFFSNVDDKNP
LVRDVIRNINHQKETLETWKAKLRELRTLQNAQSKEEESTEE
>OBAHECAF_01598 L-fucose-proton symporter
MKKEKIVPSHYVVPFIIITSLFALWGFANDITNPMVAAFKTVMEIPNREAALVQFAFYGG
YGTMAIPAAIFASRFSYKKGILLGLILYTVGALLFYPAAKYEQFNYFLISLYILTFGLAF
LETTANPYILSMGSETTATRRLNLAQAFNPVGSLLGMFVASNFVLSHLESDKRDAAGNIV
FETLSASEKAIIRTQDLGVISKPYIILGFVVLLFFIIIALSKMPKTQNDNRLDVMGSFKR
LSKNVAYREGVIAQGFYVAVQIMCWTFIIQYAESIGINKSTAQNYNILAMVIFLSSRFVT
TFLMKYVKPSVLLTIFAIGGMLTTSMVIFVGGMFGLYCLILTSGFMSLMFPTIYGIALEN
TGKDATMGAAGLVMAIVGGALMPPLQGAIIDLGNVGSLPAINFSFILPFVCFVVIAIYGY
RVYKKLAKS
>OBAHECAF_01599 L-fucose isomerase
MNKERLIGRLPKVGIRPVIDGREQGVRESLEVQCMKMAQAAADLISKSLRFPNGEQVECV
IADTTIGGVAEAAHCADKFQREGVGVSLTVTPCWCYGTEVMDTDPLIPKAVWGFNGTERP
GAVYLAAALAGYTQKGLPAFGIYGSEVQDADDTSIPADVQAKILRFVKSGLAVAYMKGKS
YLSLGYSSMGIAGSMVDIHFLQDYLGVRTEFVDMSEIQRRIKEEIYDKDEYKKAMAWTRK
HCKEGKNWNNAHNIVDEKQKDYEWETVVKMTIIIRDLMIGNPKLRELGFGEESNGRNALI
SGFQGQRQWTDFMPNGDFPEAILNSSFDWNGIRQAFVVATENDCLNGVSMLFGHLLTGTA
QIFSDVRTYWSPEAVKRITGKTLEGRAKNGIIHLINSGSTTLDATGQMKDSEGNHLLKPY
WEVTEQDVQACLDNTLWPQAIREYFRGGGFSSQFKTVGEMPVTMSRINLVKGVGPVLQIA
EGWTVEIPEDIHKTLDERTNPTWPTTWFVPRLDASKDNFKDVYSVMSYWGANHGAISYGH
IGADLITLASMLRIPVMMHNVEDKDIFRPSAWAAFGMDKEGSDYRACDTYGALYGIKK
>OBAHECAF_01600 Competence protein ComM
MLVKIYGSAVFGVEATTITIEVNIDKGVGYHLVGLPDNAIKESNYRIAAALQNIGYKIPG
KKITINMAPADMRKEGSAYDMSFAIGILAANGQVESDRLSEYIIMGELSLDGSLQPIKGA
LPIAIQARKEKFKGFILPVQNAKEAAIVNDLDVYGVENIKDVIDFFNGEKELEKTVVNTR
EEFYKQIDSPEFDFADVKGQESIKRCMEIAAAGGHNIILIGPPGSGKTMLAKRLPSILPP
MTLHEALETTKIHSIVGRVKDSGLMYHRPFRSPHHTISDVALVGGGSYPQPGEISLAHNG
VLFLDELPEFKRTVLEVMRQPLEDREVTISRAKFTITYPASFMLVASMNPSPSGYFNDPN
APMTSTPAEMQRYLSKISGPLLDRIDIHIEVNPVPFEKLSSEHKSESSNTIRERVIAARN
IQTARFREYENIHYNAQMNTKQIRKFCKLDETSLSMLKDAMSRLNLSARAYDRILKVART
IADLDQSETINQNHIGEAIQYRSLDREGWLG
>OBAHECAF_01601 hypothetical protein
MINDFLLRVCTLKEIICGTNVHIYFLLTKFVPHEILTFSVQKKQFMHERSKNEPELFIF
>OBAHECAF_01602 hypothetical protein
MKNPVFRLYFIDVMRAFAICMMLQGHFVDGLLANEFRNSENIFYSTWLFFRGLTAPVFFT
VSGFIFMFLLAKEKTDEKIGWNHSRVIKGIRRGIVLIITAYLLRTHIRSLLVYGKIYPNT
YMIDVLHCIGLSLLFLISIYLFSYRKKIYVMPSILLGFTLISFVFAPIYSAMNYDFLPIA
LANYFTKANGSVFTIFPWFGYASFGAFMGVLFSIFRNNKYVYNYAIVFTSFFGLVLSFIF
SPFLLWINQLTNSDLALLLAKNEIFNRLGNVLLVFTVFMALRNVIMSEKIRSIGQNTLSI
YIIHYIILYGSFTGFGLYQYFHFSLNPYITIIGALLFVALNIWISFRYNHWKFIVFEKLQ
FVITEIKQAFIEGYRLSTRFFLRLKNQILLLLLAFTRK
>OBAHECAF_01603 Folylpolyglutamate synthase
MDYQQTLNWMFNRLPMFQQQGRSALNHKLDNIQKLVAELGYPQTKFKTIHVAGTNGKGSS
SHMLASVLQEAGYKVGLYTSPHLRDFRERIKINGFEIPQEEVVEFIANYRSFFEANNLSF
FEMTVGLAFDYFAKQQVDIAVIEVGLGGRFDSTNIIIPEVSLITNISKDHTDILGNTLPK
IASEKAGIIKRNTPVVISEYDEQTADVFIQKAKEENAPIVFANEIKTHLTTDLKGFYQEK
NIKGVIAVLDFLRNHFWDISEENIAIGLKSVVKNTNLKGRWQTLGENPKIICDTGHNEAG
LSYVLDQIAKQTYKNLHIVLGFVKEKDVETVLKMFPKTAHYYFCKPNIQRGLDVHLLKEL
ANKNNLKGDTYSSVELALTFAKKNATPEDFIFVGGSTFVVAEVV
>OBAHECAF_01604 hypothetical protein
MSIVDTKHKRKSLVITIFIMAITVFLLFFTGLKYLDPPPENGVDVIFGVDLMGSGQRTPP
PSASRSESTRVEQPSQPQETKIEEVKENLLAQENTDEEVVATTNEPKKEEKKKDEPKKEK
PKENPKPTASETPKETPKPSKEATDALSSILGAANAGGNATLGQGDDKVGGYKGDPNGDP
YANSYYGTGGSGTSGKGWGLKGRSIQAEGKEIQNCNEEGVVVVQIEVDQNGNVVKATPGA
RGTTSREPCLLEAARKTAFKHKWNADSNAPARQVGFIVVNFKLGE
>OBAHECAF_01605 hypothetical protein
MKIRGRNKVSAEFSMSSMTDIVFLLLVFFMITANSPNALDLLLPKAKGKSTNTQNVSVSI
NKKLDYFIDKKPVAVENLETELRNALKDVEKPTIILRVEESVPIENAVTVMDIANQNQYK
VILAVRPK
>OBAHECAF_01606 hypothetical protein
MALQTSIDSLGVASETALVEEKTLSVMDLIVNGGTSSIIIIAVLFAMLTVALFIYFERLF
AINAASKVDRNFMMKIRDSILAGKLDAARMFCLQSNSPVSRLIEKGISRIGKPLDDINKA
IENAGTLEVYKLEKNTAILATIAGAGPMIGFLGTVVGMILSFHEMASAGGQAEMGSLASG
IYTAMATTVAGLIVGIIAYIGYNHLVVRTDKVVHQMEANVVEFLDLLNEPL
>OBAHECAF_01607 DNA repair protein RecO
MYIKTDAIVISSMKYTDSSLIVKCFTKEYGMRSYLLQGVLSSKKTTLKMALFQPFTQLEL
IALNKDSGTLGRIKEAKLKCFYRSLHTNVLKSSVVMLLSEISAIVCNVEHKEPEFYRFLE
EKLHFFDENEFSANFHLKFLVDMTYYLGFYPNTFDDSHQFFNVEEGIFTTIDQSKYSISG
EALALFKRIIQTSYTDLESVKTNRIIRNSLLNSLLKYYEWHFPNFKRNKSLEVLQTLF
>OBAHECAF_01608 putative lipoprotein YfhM
MKNSFIILFIFFTALGCKKDGANFNSNPLIYKDYITGFSNGLVSAESHFKVTLNEAISQE
KLDKIDNLKLFDISPRVKGKVVALNNRHIEFVPEERLSQDTEYKISFQLKKLFDVSSDLE
VFNFTVKTFQQAYKIKQGDLQSYNENLCFLNAELLTNDALAYEEVQKLVTAKVGDKSISV
KVSPQTSENRYPIIFDSIPRTDKEQRLVVSWRNDQVAEENKEPFDYLIPEKGNFKVLSIV
VDDKTNKSFSVNFSEPLERNQNFNGLVSSVLGTEQKYSTNGNILKVFLDAPAEGDYKLSV
FQGVKSVYNKRLRTDYTTNISFLQQKPDLRFIKNGTILPSSENLKVNFQAINLRAVHVTV
YRIYENNVLQFLQENSLQSSNSIYRVGKPVARKVIELTESALYPLKEWNTYAVDLSSIIM
PEPGAIYRVELGMKKNYALYGCGKDDEPLDYSFEDEPLEKDNFYDDDYYYWEGSDDPCEE
SYYTYRSKTTNILASDLGVIAKKGQNNNYTIVVNNILTTEPVAGALVEVFDYQQQKINEA
KTDKKGIANFDLSSRAFFAAIKKDNSTTYIKMDDAIPQSVSKYDVDGMRLQKGLNGFVYT
ERGVWRPGDSIYVGFVLNDFAQKNPEKLPVKLTFTDPYGKVVAERMQNSNESNHYMFGLS
TSQDAPTGNWSVNIAAGASRYTKQIKIETIKPNRLKIENSLHGQQISARGSNAHLRVSWL
HGTPAGNTQVSMKAKFYPMETLFKGYEEYIFNNEAYQFENQEIDVYEGKTDETGNTSFFF
KTENLEAPGMLRVNLLTQASESGGDFSTDVSTASFSPYNNYVGLGLPEVNKYGYYGTEKK
HTFETIVVSEQGQPLRNKHVSVAIYKVGWNWWWDASNQNISTYNSSSSNSLYATTRLTTD
ASGKASFDIEIPDSDWGRYFVLLSNEDSGHKSGTSVYFDWDSWSGKSRNVSGDEAVMLTL
GSNKKEYNVGEKATISFPSDEGGRALISVENGSNVLETYWVETDKNETTYDISITDKMGP
NVYVYVTLLQPHANTVNDSPIRLYGILPISVIDKETQLTPEIKMPEVLRPEQKTTIKVSE
KLGKPMTYSLMIVEDGLLNLTRFSTPNPWKTFFSKTALGVKTWDVYNDVIGAYGGTINQA
FSIGGDEDLGGAEAQKANRFKPFVIVKGPFKLKKGGTNTHDIQIPNYIGSARVMIVASNV
EKNAYGFAEKKEVPVRSPLMLLGSLPRKAVPGERITLPVTVFTMENNIKNVSISVETNEQ
FKVVSDRSQSLYFEKPAEKMAYFELETTAAMGIGRVKITASSGNEKAVYEVEMDVYNPNP
MTYHISKEVISEGKTANFSMKAFGDKANAVLEISSFPGINLHQRLNYLISYPHGCAEQIT
SGAFPQLFLTDFMNLTSEKIEETKRNVTAAISKLHENQLTNGGFSYWKGSNYADDWATSY
IGQFFIEAEKRGYVLPSGSKNKWLTYQNNAVRQWKHEPRYSNDFAQAYRLYTLALAGNPN
IGAMNRLREMKEISVKTKRMLASAYAVAGQKKTAENLFQTMSTDNDGDYYYYGSELRNKA
MALETALLIGKKQEAAEWAFQIAEKLSSTDWLSTQTTAYSLYAMAKYVAVNKSGSDFSAA
YVLNGKTENIKSDEPMASITLPVKGEKQTVQVKNNSKQTLYAKLITSGVLPVGEELAMQN
GLAISTTFRTKGQNTDISQLQQSTEFTAIIEVRNLTQDYVNNIALTQLIPSGWEIVNTRF
TDYGGAEQNNLDYVDFRDDRANFYFSLRGQEVKVIQLKLNASYAGKYYLPGTYAEGMYDN
RYNTRTEGKWVEVIRK
>OBAHECAF_01609 Inorganic pyrophosphatase
MSKQEKLSFDVLIEIPKGSRNKYEYDFDLKKIRYDRMIFSSMMYPADYGFVPETLALDSD
PLDVLVLVSEPTFPGCVMEVKPLGVFHMADEKGPDEKMICVPVSDPVWSKLNTLEDVNPH
LIMEIEHFFQVYKDLEKKKVAVNGWGNLDEAIEIYHECRKRYETSEKKYSIR
>OBAHECAF_01610 Aminomethyltransferase
MKNTTLTDVHIALGAKMVPFAGYNMPVQYEGVNIEHETVRNGVGVFDVSHMGEFFLKGKH
ALDLIQKVTSNDASTLFDGRAQYSCLPNNEGGIVDDLIVYKIADEHYLLVVNASNIEKDW
DWISKHNTWGVDMENASDQYSLLAIQGPKAIEAMQKLTPVNLGDIKYYHFVIGEFAGVQD
VIISATGYTGSGGIEIYVKNEHIKHVWDKVFEAGASFGIKPIGLAARDTLRLEMGFCLYG
NDIDDTTSPIEAGLGWITKFNKEFVNCETIKAHKENGVSRKLVGFEMQEKAIPRHDYEIV
DAEGNIIGKVTSGTMAPSLGKGIGLGYVPTEFSKPGSQIFIQIRKNRVPATVVKLPFYKV
>OBAHECAF_01611 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MDCPSEEQMIRMKLDDLTNIQSLEFDIPNRLLHVFHIDNNEQIFQRLDTLKFDTSILSTV
SVDNFTATDNQNDERKTLWTVLIINFLFFAIEIVTGLISNSMGLVADSLDMLADSIVYGL
ALIAVGGTVVRKKNIAKFAGYFQILLAVIGFIEVVRRFIGVEKMPDFQTMIFVSIVALIA
NVICLYLLQKRKSKEAHMQASMIFTSNDIIINSGVITAGLLVNWLNSGYPDLIIGAIVFV
IVARGAYRILQLSK
>OBAHECAF_01612 hypothetical protein
MFLLSLQKENRAKIWLTLFPKKDRFVGYALSVFIRLLHSFQRNYYFCPYEVTPMTHNKTK
TAFFNRWWVNEHEPEEWEG
>OBAHECAF_01613 hypothetical protein
MTRKRTKKENSKISVIERWDKPFEYFGFLNLVLMAFYYGSLWFSATPLDADKVFKFSLLM
AFEFIMVHSGVFMVAFSARISLFIFFPVYGLFAYSFQSIMGFSDWTITTLYCVTVFNRMR
FAFFNTSEAVQQRVMAQSVVAVMLYFFLAMFVAFGQNIVPEFALDEGFRKSQSYLDAKKH
GGLFLDFPHTAIALGTLYFSFLALFDLSLIRKMK
>OBAHECAF_01614 hypothetical protein
MKKQNQTLLIILEESAFFSPEYYQIMTHQNVKYLKINCYSVIEVENVDEIYRELKAKNIP
IEIELRNEPWGDRHFAIKDPNGIGIDIVTYTEPE
>OBAHECAF_01615 hypothetical protein
MPKTTTITKEIIIETAFEMARKEGFAMLSARNIAKKIGCSTQPIYWTYKNMDDLKAEVCQ
KALIHLQNTMLGYSKTGNSFLDLGLGYVQMAHTEPALFKAFYMDNIMNIKLTDIFPESQQ
IVNIMKNSEEYRQLSDEGVKNIIAKSWMLAHGIASLVAVGMFVYDEEKILDILK
>OBAHECAF_01616 hypothetical protein
MNTKSKTFRNVALFSLVAITCGWVGVGVDKLLGLPSNLESLGALIFIATPLLCMLLLRLF
GGDGWKDIPLKPNFKQNARWYLFAFAVYPVVIGITLCIGQMLGWADVGKFSFIAYLTILA
TVFLPEFIKNIFEESVWRGYLTLKMEQLTKNEWLIYPVVALVWQTWHAPYYLVFLEDGYL
SQFFPYGGLWLFVYGFVVVGVWTIMYTEVFFLSSSLWVVILMHTMEDALNPLISEGFATI
PPDKTLLISPTFGAVPLLIYLCIGLYLRKIRKRKN
>OBAHECAF_01617 hypothetical protein
MNYQTFAPHKDLSDFIKCYWTLEVPAEPNPEKQRAIADGYIEMIFHLAEDVKSYTDEQGY
TLQPRAMILGHTIKPFFFEPTGNVDTFAVKFFPYGLANIIQCPLKDLTDKVLPLHQIFDK
NFSQKATLQINQATNTQQRISVIESLLFEMLSQKKISDCIVKNTIDMLFATKGNSSVSSL
LKETPNYQRQLQRKFSQKIGLTPKQLGKIIRLQTALRMLLNNPTDKLYHIAYDADYYDQA
HFIRDFKEFTGICPKTFWKDTSMEVASLMYAKE
>OBAHECAF_01618 hypothetical protein
MKNLISIVEIPTTDFSRAVTFYKALLNIDIEEIDMDGTQMGVLLSENEGVNVSLIKDENV
QPSINGTMVYFNAETDLQPILDKVEPNGGKIILPKTEISPEMGFFALFSDTEGNKIGLHS
QQ
>OBAHECAF_01619 hypothetical protein
MAQSKNNIVTHGLSGKVGDILVFSQRNGKTIVSKAPKKRTGEDSEKQKQQQAKFQQAVLY
GKAVLADDNQKALYETTGKKAYNVAVADLLNAPKIESINVSNYKGNAGDTIVIRATDDFK
VVSVKVIIQNADGSLVEEGEAVLQGIDWIYTATAQNPDLSGDKIIIQASDIPANVTEKTE
ILK
>OBAHECAF_01620 hypothetical protein
MKLKYILFFVIGGAISACSTSKEQIYWVNSVKVDCDAGAGKAECLQVSKNEDLDKAQWEY
FYAPIENFVFEEGFFKKIQVKETQLDSKNVPADASSVKYTMIKEIEKQKDMSFELNGNWT
LEKLNGNQVTQSLNPNLEFHLQEKKINGVGGCNNYFGTITELHQNKIQFGKIGATRKMCM
DDNIEMAYFDALSQVRTFKIDEGKLILSDASNKEILIFSPKKKVNERLHDIWGAVRIGGK
SIEKKEGIPMLEINLTEMSISGSDSCNNYFGQIEQLTDEKIVFAGIGVTAKLCPEMEISN
QYNQAMEKVTTYKLDGLNLMFYDIDGNELITFIKGD
>OBAHECAF_01621 hypothetical protein
MNYLLPFLSIVLGFAIVLIFKPKNQRNIKLLLAFSGAFLLAMTIFTLMPEVYHSLAHDHD
HDHHGEIGKQLGIWIVIGILLQIVLEFFSKGAEHGHTHHPHKDLKNAFPWTLFISLSIHS
ILEGFPLHHHHHMAYGIFVHHLPIAMVLTIFFLDSGIGFKRTFVFLTLFALMTPFGTFLA
EYIPQLGHYHVEISAIVIGIFLHISSVILFEASENHKFNHIKLITIILGFATAYFV
>OBAHECAF_01622 hypothetical protein
MATILIKELSSKKELTDFVKFPFSLYKNNPYWVPPIINDEVTSFDKTKNPVFENADAFFY
AAYDAQQKMVGRVVAIVNKHDLRQGVQKIRFGWLDMIDNIEVTKALLNKVAEKGREYNLQ
YMEGPMGFSNMDKVGVLTEGYDHIANMMTWYAYPYYKQHLEQMGLVKEKGYIETYFTLDS
VNPEVFNKTANAIKKRYGVRLVEANTKNEILKYVDAMFDLFNESYASLSSFVPITEKQRE
HFKKKYIPFINPEYIRFIEDNQGKMVCFAIVLPSFSKGLQKAQGKLFPFGFWHLLQAKRK
HDMVDFYLIGVSPEYQSKGIPSLLFDYYYPIFKKNGIKKCIITPELEDNIAIQQLWKNFN
PVIFAKRATYKKNI
>OBAHECAF_01623 hypothetical protein
MRKIIILLIINTLPIIARGQYTDIINSNQPGNSQSAYAVGRKVLQFEGGLWFEQRNHKYT
YTDMTLVGLNYSARYGVLSDKFEAVLNGTLAYDHTHYHYLGSQRSNNIGFINNTIGAKYL
IYNPYFNEKPNLYSWKANNKFQWKRLIPAIGVYAGMNFFPNKRFYYDNIPTLSPKAVVSL
QSHPMPRVVLVANLIANRFLDSNRELGYIATLTHNIDNGRFSIFLESEGIQSHYYSDHIL
RLGGAYLFTKDIQVNVDLGASWKDTPSRYMGLIGFSYRIDKHLDVIKKEILKGNEEEFKP
TKIKRKKKWLLF
>OBAHECAF_01624 ATP-dependent dethiobiotin synthetase BioD 1
MTFFITGISTNVGKTIASAILTEALQADYWKPIQAGDLDNSDTHKVQRLVTNQTSVFHKN
AYGLNTPASPHLAAEIDGVSIDLTQINRPNTENHLVIEGAGGLLVPLNDTQTIADLILPT
DKIIIVSRHYLGSINHTLLTYEALKNRGLSVFGIIFNGEENISTEEVILQKTQLSFLGRI
NEEPYFDRNVIAYYAEKFQERLTSLL
>OBAHECAF_01625 Thiol-disulfide oxidoreductase ResA
MSFLSDYKTAFRAENIKRKGTATFLMATIFGAFIPVVIFVFFLTRKENPPVTIPYNYFED
ITAGASEGLTSLFLPLLIVLTCAKITQIDHRNGGWQLMETLPISKIATYSSKLTIVLISN
LICILSFVVCAILFAWITYLFGKIPEGVEINIPWGFFFQFTVRMFVATLFFTILQFVLST
LFSSFIISILIGVALVIGTGILRGFDIEKVWNPITILAKTSKNTYGSDLNHWLLYTEKLS
LIAFITLFIVGFIWFKSKSLKRVFTKKTSAIATISALVIGCLTIYYLLTPNYLPKHHRTV
IAGEFDSDENISKLILSESFMRDTIAEIPVKDNKFHYIISEDLPLKQYTLLVPMKENNAQ
IHFPFQTNDSIFFKHKIAKNNIKIISIKGNQLADLQYNSEKVYNKLWTLEYWAEENNQPL
DKIDRFVEEAYSVWTNRMNTTNSFRTKDNYALSEDLLLIHKKLFTLKILNYWRAFEEKIK
HSRPDIVENLPKEIQEIKEFISFTDHSLLDFPEYLQYILNELTKKDTTEIALQTKQLNAI
ATLNDPIFKDQLLFYTLNESLQSSFDTNERSELIQNYASQIENTKIRNRIKTIYRQGEKV
SRGSQSFDFEAENSEKETVRLSDFKGKYVVIDVWTTWCGPCKYDYPYFEKYALKYKNNPN
FVFVGMNADSKREAWLQDVQNKSKSIVQLRPFDSEMNAFKENYNITKYPTYILLDKDGKF
ISAQMPRPTEDHFEQMLKDLEKQN
>OBAHECAF_01626 Fluoroquinolones export ATP-binding protein
MTQYAIQTKALNFGFSKSKKIIDNLSINVPKGSIYGFLGPNGAGKSTTMRLLTGILPDDT
NSIEIFGQSLKNQLPYIFDNIGCLVESPTLYLHLSGYDNMRYIALMRNVAEENIEKYLEI
VDLQRSKNMKAKKYSLGMKQRLAIAMALLSNPSLLLLDEPVNGLDPSGMLEIRNLLIKLN
KEFGTTIFVSSHLLSEIEKMCTHVGIISHGKLQFEGSMKELSDRYSDCKVQIFLRNLPEL
ANKIKEQFPEATFTDGKATFTLANKEAIPELVKQLVQLGAEIYELKSQEGLEESFMLLTK
>OBAHECAF_01627 hypothetical protein
MKILNELDELQEAGVITSEVAQNIRAYLHQRKPNTINSFLVIFGILGAVLIGLGLILILA
HNWDYLSRGVKTIVAFTPLVVGQSACFWVLFRPQKTWIYESFAIFTALSVGLCIAMVHQI
YNLPENNISNFIFTWILLGLPLVYVMKSKSVALFYMLGVSAYAISTQNAFNYDETDNYYF
LMQTGLVIAIIPFYYRLFKTEAKNNYTAVFHWFFVITLLISIFANAREQYVFALIIILLW
MFIYVGKYIQSSIYYNAYKLTAILGIVFLLFFPYYSYGFWSDFQFIAVLLFGLQLLYAYK
KYWVKKEEFDWLEVFPILIVAQAYWLSIPYMFDLLGLGFGIWYLIKGVKSHRFLLINFGL
IVLTYAIGQRFFDAYIPFLLKGIVFVILGMSFFVVNYLIIRKIRKNA
>OBAHECAF_01628 hypothetical protein
MRNYILFIAFGLMVLFQWLVPSVMIWNRENIIRQNQVYLFETEPVDPHDAFRGKYVVLGF
RDNKVQAYGFDSIPSFKVGQEAFVTVDRYAGIAYLSEISEQEPTEIANYFKTKVLHVDEY
GQITVDFPFNRYYMNEEKSLRAEQILNDENLKAYAQVAIYKGEVVLKDVLVEGVSLKDFV
ETYRGATTDASEEEPEIITQPMEEPSQVEEIIIETINEPNGDN
>OBAHECAF_01629 putative quorum-quenching lactonase YtnP
MKIYPIDTVNFKLDGGAMFGVVPKSIWQKTNPADANNQIDLSARCMLIEDNNRLILIDTG
MGNKQSDKFFGYYALWGDTNLDDSLKKAGFHRDDITDVFMTHLHFDHCGGSIQWNKERTG
YEPAFKNARFWTNESHWRWATQPNAREKASFLKENILPMQESGQLHFIDPKGNTFLEQSE
LGFGILFVDGHTEKQMLPYTHYKGKTIVFVADLLPTVGHIPLPYVMGYDTRPLLTLEEKD
KFLREAAEKEYYLFLEHDAHHQLCTVQRTEIGVRLKNTFRFEDVF
>OBAHECAF_01630 GTPase Obg
MTEGNFTDYVKVFATSGNGGKGSMHLHREKFVAKGGPDGGDGGRGGHVIVRGNKNLWTLI
HFKFQKHFRAGHGESGGASRSTGADGQDVYLEVPLGTIVKDAVTEEMLFEITEDKQEVIA
LRGGKGGLGNWHFRSATNQTPRYAQPGIPGEERELLLELKVLADVGFVGFPNAGKSTLLS
VITSAKPKIGDYPFTTLKPNLGIVEHRDFQSFVVADIPGIIEGAAEGKGLGHYFLRHIER
NSTLLFLIPADSKDIIEEYNILLNELKEYNPELLDKDRLIAISKSDMLDDELTLAIENEI
KSALEGVPFLFISSVSGKGIQNLKDTLWQMINR
>OBAHECAF_01631 Delta-aminolevulinic acid dehydratase
MYPLRRNRRLRTTEAIRSLVRETILSPNDFIVPLFVVEGKGIKEEIASMPNYFRYSLDLL
EQEVKELWNLGLKSVLLFVKVPDNMKDNSGKEAVNPNGLMQRAIKTVKNIVPEMVVMTDV
ALDPYSVYGHDGIIENGRIANDSTVEILCGMSLSHAKAGADFVAPSDMMDGRILNIRETL
ENEGFTDVGIMSYSAKYASSFYGPFRDALDSAPVDAQNIPKDKKTYQMDYHNRLEAIRET
RMDIEEGADIVMVKPGLCYLDIVREVKNMSEVPVAVYQVSGEYAMIKAASEKGWLNHDAV
MLEQTVAIKRAGADLIASYFAKDVAKLIGK
>OBAHECAF_01632 hypothetical protein
MTLQQLLISQRYVVIPLLITPTQHLQLSAKINGIEGRFILDTGASNTCVGMEHIVYFDLD
TKLSEIKATGAGSSDIETLLSVRNHLKIGTWEMKRTPLVLFDLTHVNAALIHHNAEPVHG
IIGADILKKGKAVINYPKKKLYLKL
>OBAHECAF_01633 hypothetical protein
MEQVYIFMLFVLFSLAILDLVVGVSNDAVNFLNSAVGSRAVTLRTIMIVASLGVAIGAIF
SSGMMEIARSGIFDPTEFYFSEIMVIFMTVMLADVLLLDLFNSLGLPTSTTVSIVFELLG
AAVCVGIIKTYNNDQSISAVLEYINTQKAGQIIYSIFLSVLIAFTVGTIVQYLARLVFSF
RYERNIHITGGLFGGLSLTALTYFIIFKGLKGVSFISSDTLEWLDENIKLILILCLVIFT
ILSQIFIQLRVNIFKIVIIVGTFGLSMAFAGNDLVNFIGVPIAAWQSFEMWQSSGLEPDQ
FTMEALSGKAQTPTLLLILAGTIMVLTLWFSKKARNVIETGVNLSRQSEGQERFSSNMLS
RFVVRISVFTANVIGYVIPQAVAQKIDERFQKPEEDPKIKDKDAPAFDLVRASTNLVVAS
SLIALGTSLKLPLSTTYVTFMVAMGSSLADRAWGRESAVYRVAGVFNVVGGWFLTAGAAF
LSAFVVAFVLYYGDVIGLIGMVLLVGFLLLRSAIAFKNKEKEKNKKRHFEYNDLVTINAI
AKESSEYISGTIERVNELYGKIINNLGTQDLGKLTKNKKNAKKIEKEIDELKGNIYYFIK
SLDDSSVVSSKFYIMIMDNLQDMAYSLSTIASHSYEHVNNNHKNLKFNQLRDLKGVSESM
EELFKGEVTVFRSEDYTNLHNVLGKGVELKKHVSNMVQKQIDRIRTSETSPKNSKLYFSL
LLETNALVRANNNLLLQFDEFQHELKKRNRNRK
>OBAHECAF_01634 hypothetical protein
MYKTFLTLILASGLMGGHQASNVFCQNRAVITQSKHLYDSEVHSLSLAQLQTIMLDYINS
IRKEHKLPPYRMIDLPLAQEHSKYLSESGEDKELDWNDHFDAEGRSIFMRMEATKILFTD
VGENIVTVPPGATVRQLVDAWMGSTMGHREALLSSIYKQVMIGHHPGSNNVVLDFVTLYE
KK
>OBAHECAF_01635 hypothetical protein
MYKFFLTLILASGLMGGHQASNVFCQNKKVLPQSKHLYDSEVHSLSLAQLQTIMIDYINS
IRKKHKLPPYTIFDHPLAQEHSKYLFESGKDKELDWNDHFDAEGKSIFWRMKATKIRFKD
VGENIVTVPPGATVRQLVDAWMESTMGHREALLSTEYKQVIIGHHPGSNNVVLDLVTLDD
EK
>OBAHECAF_01636 1-acyl-sn-glycerol-3-phosphate acyltransferase
MPFYFHKTRPLKMIFRYIFWFIWRTWFYVLVGTLTLLFAPLLLILTSHQKWYTQFYWVAR
NLWAKPILYGMGFYPQISRYETLEKGKSYMLIANHTSMTDIMLMFVCSKNPFVFVGKKEL
AKMPLFGFFYKRVAILVDRSNLQSRKQVYDSAMERLNAGLSICIFPEGGVPDESVMLDNF
KDGAFRLAIEYQIPIVPMTFFDNKKRFPFRFFAGSMGRMRVKIHPFVHTQGMQFEDRHAL
KNEIRSLILSDLEQVYNSN
>OBAHECAF_01637 hypothetical protein
MFWSLFFIYLFLIITFGYSAFEKIVNFKTSVNYYKNYFKGIFISGWIYPLLLIITVIEFV
TTLFLCIGIYELWTLPYPQYGFYGLVLSSSTLLCFLLGQRLAKDYDGARGIAIYFIICLI
GFISASL
>OBAHECAF_01638 DNA polymerase III subunit tau
MTFDDIIGYETIKKHLKDSVEAQRIPHAQLFVGNEGTGMLPMAIAYASHILCKGDTSCMT
KCNHLSHPDMHFVFPTATNNRVKKDPISSLFLEDWRVFIKEQPYGSLFDWYSQLGIENKQ
GNISVNEAKDITSKLTLKAFEGGFKVMIIWMAEKMNVESANKLLKLLEEPPQKTIFLLIT
EDESSILDTIRSRCQILRFPPLSENAIKQTLIQKGITESDATRYAVQAQGNFNKALQLSE
ETEEEDVFERWFITWVRSAYRAKGNKSAIHGLLQWSEEIATSGREKQKQFLFYCIEIFRQ
AMLLNYGSKELVYAVFKDPSFELQKFAPFVHGNNIEQIHQQLEEALLHVERNGNARIIFT
DLSIKLTRLLHKKP
>OBAHECAF_01639 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNSRGGNVPNLLKVATDIQNFGAEGITIHPRPDERHIRYQDAIDLL
DVVVTEYNIEGNPIRKFMDLVLKVKPTQVTLVPDADDAITSNAGWDTIKHRAYLTEVITE
FKRNGIRTSLFVDPVEAMVNAAAKTGTDRVELYTEAYATEFEKGNKNGIQPYVKAALEAQ
KVGLGLNAGHDLNLENIRFFKENIPNLLEVSIGHALISESLYLGLENVVNLYLNKLSR
>OBAHECAF_01640 hypothetical protein
MERVILSVFFGFITLLFSVLKAQTVFTHAKAERVQLYFNGAEIQQSANLALPKGTSEVVI
MNVANQLDESSIQIKSAKTATILSVQFSNQPVVGYDQQFVSDTARPIWDSIQNTEKEIKK
NALLRKSVQKSLEILDKNQQLTNQNMTTVELSKLLDYHKSKRFELEKQLNDLSEESDRLQ
KKLGLLKFRMGTASSQNVNNRGKIILQVMNETEGKVPFQLNYISYQARWSPFYEVRSEKI
NAPITLKYNAGVSQSTGVDWNNVKLSLSSGYVNQQTTAPVLSPWFINYDKPAQPAPMVRQ
RAAFSKNMETKQLNEVVEQDIMLEEKSLQDVVVVNETQFNTVFDIDLPYTILSNAKKHSV
ALRTIEIPATYKYYTVPKYDLGAYLVGEIQDYGKYNLLRGEANLIFEGMYVGKTIINPEN
ASKKLTLSLGKDRNIRIDRKLVSQNTENKSFSSKKVQTFTYEITMQNNKRELVEIEVEDQ
IPLSTNKEIKVHLVSSDNATFDASKGKLQWRIQLKPNENKKVKFTYQVESDKESNVSNL
>OBAHECAF_01641 Peptide deformylase
MVLPIVAYGDPVLRKMCTDISADYPNLKDLISNMFQTMEASRGVGLAAPQIGLPIRLFVV
DAAPFADDDELTKEEQTFLENFRKVFINAKIIEETGDKWSFNEGCLSIPGVRGDVSRHER
LTIEYLDENFQPQVLTVDGLAARIIQHEYDHIQGVLFTDKLSAFKKRILQGKLTDISKGK
VNVDYRMRFPDVRRK
>OBAHECAF_01642 hypothetical protein
MELNKILAISGKPGLYHLESQTRTGFLATSLLDGKRISIGIRDNVSLLSEIAIYTLEEEV
PLSQVFKNIKDKENSGKTPVTHKSSGAELEEYFFSVLPNYDEDRVYASDIKKVIQWYNLL
LEKGFLEETETEALSEEATEENK
>OBAHECAF_01643 Cytosol aminopeptidase
MKIYPTQNQQIGDVTAYIATEVEQTPDFLHTYLKKHTEKQQNIVVAFPLLERPLVVALLL
EKGKDTNAEREKARQLGNELLTTFKKEKYTEVYIHSSADKDLTMCVLEGMQLSDYQFNKY
KTKEDSQPEISVYVDLPVTELTQFNNLLASIAVARDLVNEPPLALTTTRLSEEIEVLSKH
FGFEVSVLRKQEIQDLKMGGLLGVNAGSEVPPTFNILTWKPKNAENQQPYVFVGKGVVYD
TGGYNIKPGNYMDTMKADMAGAAAVVGLLCAVAKNQLPLHVVGLIPATDNRINSNAIVSD
DVLTMMNGMTVEIKNTDAEGRLILADALTYAQRLNPELVIDLATLTGAAARVTGHYGSAF
MGNASDEIKKRLQRSGDKVFERLVELPFWDEFGEDLKSPIADIKNLGNPEGGASSAGKFL
EHFTNYPWVHIDIAGTAFLNAPFRYFKAGGTGVGIRLLYDFLSEVSTYND
>OBAHECAF_01644 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MNILCIETSGINCSVVVARDGVSIAEESENKGKFTHAETLHLFIEKVLADANLPMKEIDA
IAISGGPGSYTGLRIGVSAAKGLCFALDVPLISVPTLQVLAKQISDSQFVIPMLDARRME
VYSAVFDKNNNELEATQAKILDENSYQEWLNKGKVTFLGDGAMKFSAICNHPNAVFVSDK
YPQAKDMIPYAEERYRNACFEDIAYFEPNYLKPFHTTSSFVS
>OBAHECAF_01645 Dual-specificity RNA methyltransferase RlmN
MIEKKDIRALSKVELRDFFVTHGDKAFRGNQVYEWLWNKGVHSFEAMTNLPKQTREMLEN
HFSINHIQVDVMQRSADGTIKNAVRLHDGLLVESVLIPTDTRTTACVSSQVGCSLNCKFC
ATARLKRMRNLQPDEIFDQVKVIDNQSRIFFNRPLSNIVFMGMGEPLMNYNNVLSAIEKI
TSDEGLGMSPKRITLSTSGIPKLIRKMADDEVKFKLAVSLHSAIDEVRTSIMPFNENFPL
SELREALEYWYRKTKNKITYEYVVWKDINDKKKDVDALIKFCRFAPSKVNLIEYNPIDDG
DYQQADSSAIDMYQTMLENAGITVTVRRSRGKDIDAACGQLANKR
>OBAHECAF_01646 hypothetical protein
MRSLLFITLIFTILSCEETVLPKPKAALRLEYPQAEYKNYAKDYCPFEFETNTSAFVKTK
KDDSCDFDIEYPAMKATIYISYKKVKDNIRHLLRDAQKFTFEHTIKADNIASNQFVNDST
RVYGMFYQVYGNAASQAQFYATDSTTHFISGSVYFKVVPNYDSIQPASHYLEKDVRRIME
TLRWK
>OBAHECAF_01647 Magnesium and cobalt efflux protein CorC
MDSEPPLNLLWMPSMAVETIALQLNMLDWNIILQFVVFLILLGCSALISGSEVALFSLSP
TEVNNLNDGKSAVGSIIARLVENPKKLLATILISNNLVNISIILLFVDLGDFLFGNIESE
ILRMILDVGVVTFMILLCGEIVPKIYANRNNILFSKTVAYPIYVLDTLFTPLSIPMKGFT
SLIHNKLGKQSTHISVGQLSQALELASSDDTTKEEKKILESIVSFGNTETRQVMVPRIDI
FALSETLTFKEVITEIVRMGYSRIPVYNESLDDITGIIYIKDLLSHLENDNFDWLTVKRK
AFFVPENKKLDDLLSEFQEMKIHLAVVVDEYGGTCGIITLEDIIEEIVGNINDEFDDEDV
IYSQIDKDTYVFEGKTVLKDFYRIMQLTDEEELIFEEKEGEAETLAGFLLEIAGDFPQKG
VPIVFENYQFTVQEFDKKRIKQIKIHRENNA
>OBAHECAF_01648 Single-stranded DNA-binding protein
MSAGTLNKVMLIGRLGDKIKLTYFEGGNCVGRFSLATNEEYTNKTTNEKVVETEWHTVVV
RNKQAEIIDKYTSKGDLIYVEGRIKTRQWQGEDGSTRYVTEIYASDFTLLPNSRKEEKLE
KKSPADDMDKSLPF
>OBAHECAF_01649 Adenine DNA glycosylase
MNLSNSSSKVEAFDRFFSQRLLQWYNSEKRDLPWRQTTDPYKIWLSEIILQQTRVAQGLP
YYERFTNHFPSVFDLANASEEQVLKLWQGLGYYSRAKNLHHTAKTIAFDLNGIFPTTHEE
LLKLKGIGDYTASAIASICFSESCAVVDGNVYRVLARVFGIETPIDTTSGIIQFKKLATK
LLDPKNAGVYNQAIMEFGAIHCKPQLPMCESCVFSDKCVAKNQSKVERLPVKIGKTKIRK
RYFNYIVPIDNQKHTILNKRNNKDIWQGLYEFPLIETEKPYSEAEIKAEIDKIFDCITDI
YLHKYEKIHKLSHQHIHTQFWIISMEYSLKNSIDKEEVKNYPVSVLTANFLKEFWFFRN
>OBAHECAF_01650 Sec-independent protein translocase protein TatAy
MLANSIFLGIPGPWQIAVVVILILLLFGGKKIPELMRGLGSGIKEFKDATKEPNKDETNS
SIEKKQE
>OBAHECAF_01651 GTPase Era
MTHKAGFVNIIGNPNVGKSTLMNAFVGEKLSIITSKAQTTRHRIFGIVSGDDFQIIFSDT
PGIIKPAYELQHSMMDFVKSAFEDADVLIYMVEIGEKELKDEAFFEKINRMQVPVLLLIN
KIDKSSQETLENQVAYWKERVPKAEIFPISALEGFQTAEVFNRIVELLPESPAFFPKDQL
TDKPERFFVNEIIREKILINYKKEIPYAVEVETESFVDSEHIIHIRAVIMVERETQKGII
IGHKGEALKKVGTQARADLEKFFGKQIHIQIFVKVNKDWRSNSRQLRRFGYSQ
>OBAHECAF_01652 HTH-type transcriptional regulator IscR
MLSNPSKYAINAVIYLAINGSESNKIGTKEISKKLNIPSPFLAKILQTLAKRKVISSTKG
PKGGFWLADHEKQAPLITIIENLDDVENFSNCFMGLKACSEEFPCPIHYAMQPFKKGLIT
ELMENSIDYFSQKVINKEAFLFV
>OBAHECAF_01653 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MIFKFKQFSVSQSQSAMKIGTDNVLLGAWVPVDHFPHRILDIGAGTGVLSLMLAQRSEAM
TIDAVEIDESSFIECTENFENSPWSDRLFCYFASFQEFVEEMQGEEPYDLIISNPPFYTE
NYKTNSLARNKARFEDSLPFETLMDGVVQLLSDEGVFSVIIPFQEEERFISLAQSKGLFP
QKITRVKGNEQSELKRSLIAFIKNKGEYTSDLLVIEKGRGQYTEAYISLTKDFYLKM
>OBAHECAF_01654 hypothetical protein
MAILRYSEYNIVLQEVPNEISLCFTITGCPLACKGCHSEHIWNPNFGQPLTLSLLEKLIE
KYEGTISCVLFMGGEWNIDQLLKFIAIAKEKNLKTALYTGLNIKQVARKYPQLLERLDYI
KTGKWIPSLGGLGSKTTNQHLLEIKTGKILNHFFWKE
>OBAHECAF_01655 hypothetical protein
MSKFTKLTPEQLKTKCNFIENYLTSQNAASGSLFDSNANVSNKNIATMEAELNKDINIQV
NRMLVSRKIAQLFGQDLADEYIRQIEEHEIYVHDETSLKPYCVSVSMYPLLLDGLLKLGG
ESKAPKHLASFCGSFVNFLFSVSSQFAGAVATVEFLMYFDYFARKDYGNDYLKTHTKIVE
NEMQHVVYAINQPAAARGYQSVFWNISLYDKPYFDSMFGNFVFPDGSKPIYDSLDKIQKY
FMKWFNNERKKAILTFPVVTAAMLTKDKRVHDENFANFCAEELSEGNAFFIYQSDNADSL
ASCCRLRNEISDNTFSYSLGAGGVSTGSINVITINMNRLYQKGLSLEKMIDNIHKYQVAY
RAIIQDYKDAKMLPVYDAGFISLDKQFLTIGINGMVEAAEFLGLKISDNEEYKSFVNKNL
KLIYEKNKEAKAKYGYMFNTEFVPAENLGVKNANWDKSDGLFVPRDCYNSYFYVVEDESV
NIIDKFFMHGHEYIQFLDGGSAYHCNLEEYPTQEGFLKLLNVAAKTGCNYFCFNVKVTYC
NSCGYINKHTTNHCVKCQSTDVDYATRIIGYLKKVSNFSKDRQKEAQKRYYGNTAI
>OBAHECAF_01656 hypothetical protein
MQNIVSGSDSISEIFKKKRLSFVITKKIYNYLINRFMIFLIITLRSYANKRYINLKI
>OBAHECAF_01657 hypothetical protein
MKRPLFYSKILLFGEYGIIKDSKGLAIPYNFYNGALKTFDEADPNKLEEARKSNRALADF
SVYLEQLSTENPEIVTFDIAQLKSDIAEGMYFDSSIPQGYGVGSSGALVAAIYHQYAHDK
ITVLENLTREKLLKLKTIFGKMESFFHGTSSGLDPLNSYLSLPILIKSKDHIEPTGIPSQ
AINGKGAVFLLDSGVIGETAPMVRIFMEKMKNEGFQSMLKTEFIEYTNACIDDFLKGNIK
SLFSNVKKLSKVVLNNFKPMIPAEFHTLWKQGIDTGDYFLKLCGSGGGGYMLGFTEDLEK
AKKTLAGHKIEVVYQF
>OBAHECAF_01658 hypothetical protein
MKYQTQKGTVSAKAPSNIALVKYWGKRKNQLPANPSISLTLNNSYTETTIHFEQLTTPTD
DFQFEFFFEDKPKATFHPKITTFLERIYEYMPFLKDFHLEIHSRNSFPHSSGIASSASSM
AALSLCLMQMEKLLYPHLAEDETYWQKASVLARLGSGSACRSIQGKIVVWGKHTEIQGSS
HKYGVVYPYKVHEIFNNFQDTILLIDKGQKQVSSSLGHDLMHDHPFAERRFEQAHENISK
LIPIFENGDLDKFIEITESEALTLHAMMMTSTPYFILMKPNTLEVIQRIWRFREETKTPV
CFTLDAGANVHVLYPNYCKNEVIQFIQKELVVYCENKQYICDHN
>OBAHECAF_01659 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MSWFKRTAKGIQTSTEEKKDTPKGLWYKSPSGKIVETEELATNYFVSPEDEYHVRIGSKE
YFQILFDNNEFKELDANLSSKDPLEFVDTKSYATRLKEAEQKTGLKDAVRTAVGNSKGEK
LVVACMDFAFIGGSMGSVVGEKISRAIDYAIRKKLPFLMISKSGGARMMEAALSLMQMAK
TSVKLAQLDEAKLPYISLCTDPTTGGTTASYAMLGDINIAEPGALIGFAGPRVVKDTTGQ
DLPEGFQTAEFVLEHGFLDFIVNRKNLKNKVNLYIDLVMNRPLR
>OBAHECAF_01660 Vitamin B12 transporter BtuB
MKFLFLYILLFVSIQVFSQQVAGVVIDTHDDPLHGVVIVDEKSGRWTTSNKEGKFSITFH
QEYLLRFKMLGKEEESLVGSSPSSSIRIVLKDKTLRLDDVVVTASIPEKGVANSKIVLNK
YAISQFQSFSLADVLQQLPGQRIVASNFTSPKVLNMRTAINSGNNAFGVGYILDDMPLSN
DENMQTYKGTMATTSYSSNVNSGLDLRTIPTSNIEKIEVITGIADAKYGNATTGLVIIER
KAGIHPFLIDAKLQGGGQSISVGKGFQLSPKIGKLSLSLDYLNSNNQPVNNLNGFNRLTG
SAIWTTERDDFFHNSLSMTLRTNLDEVRKDKENEVNFQAKNEKKDYAITLSNRSRWQLNR
IWIDRLSLQGGFSYSYTEDYNSSWLNNGGLVVPTATETSLHTGVYTPPQYLGVMHTKGEP
FNANMQISAEKHYRVGSWNHDRFSAYFIIVSYA
>OBAHECAF_01661 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MNERLNYLSDFFIRLIIPTFVAYYIMMELKTILKAARLRTLPLSVSGIIMGSALAFRVGY
FQWNIFLLALLTTILFQILSNFANDYGDGVKGTDNINRVGPQRALQSGKISQSQMKKLII
ITALLSMLVAMVLIYVAFGKENWVYVLIFFVLGVSCVVAAIKYTVGKSAYGYRGFGDLFV
FIFFGLVSVVGTYFLYLHQLDWKIFLPATSVGLLSVAVLNINNMRDYENDKAMGKNTLVV
KMGSNLAKFYHYYLVVVAMLSMLVFSVLHLQTGWQLVYLLVFIPLALHLITVKNNKVLKN
LDKELKKVALSTFFMSLLFFIGQIL
>OBAHECAF_01662 hypothetical protein
MEITYYGHSCVGIKIGETYLLVDPFISENPLAKHIDINSIKADYILITSAHQDHTTDVEA
IAKRTNAKIISNFEIVEYFYDRGIDGHPLNLGGGNNFPFGVLKFVPALHSSTFQNGKAGG
CAGGFIIKTMDKTIYIAGNTALHFDMQLIPVRYKLDLAILPIGGNFTMDVEDAIMASDFV
KCNTIMGVNYDTFNLIKIDHELAKRSFKAKGKELLLPAIGSFITV
>OBAHECAF_01663 N5-carboxyaminoimidazole ribonucleotide synthase
MANYFSSDFTLGILGGGQLGKMLLTETRKYDIKTFVLDPSSDAPSRLACNRFFQGSLSDF
DTVYNFGKQVDVLTIEIENVNVEALEKLEEEGVKVYPSASSLKIIQNKGFQKQFYAQNNI
PTADFFRFPSIEELKKAIEDSHIRFPFVWKSTRFGYDGNGVKIVRSVTDLESLPKGECIA
ETMIPFKNELAVIVARNLQGEVRTYPVVEMEFHPEANQVEYVICPARISDTVAQKAREVA
LKTAEAFGIVGLLAVEMFQTQEDDILVNEVAPRTHNSGHYSIEAAYTSQFEQHLRAILNL
PLGKTESKLAGVMVNLVGAEGHTGEVVYQNIEKIMAMEGVTPHIYGKRETRPFRKMGHVT
IISENVVEARRIAQEVKETIKVISN
>OBAHECAF_01664 hypothetical protein
MRYNIVTLLFLFSLLGYAQFPITDWEKENLKGKVKSVKSITYQYINDNGKMQKGSPMTGF
NTLVSYNIKGYKVSGEQFSTDEKIIGSWVYIYEGNNLLRQVDVFNQKKQVQEIMKHTYNS
KTQKEDVNGYDANGVFTGKQIACYDEKGLKINELLLDSKENFLMKSEFIYDSKSNLSERY
IEDKEGKKVVLKYVYDEKNNVIEENYYGNGGQLYGQKKFTYKYDNQGNWIERIEEIYGMS
QVLTERKITYY
>OBAHECAF_01665 hypothetical protein
MKKFAVIIFIVFSFFCDFTFAQMVPPRKPTSQLKEIGLVGNVRSLRITSHMAVDSFGTIY
KGKKADYWRGDVVTNFDREGYKTDALYYDKEGKLNHKVVYRYSNTRKRTARETYGSDGKM
SKRSVYLYDQKGNKIAFRGYNSQGAIFEVYAYKNNDKGQEIEEVCVQTEQSTCGKYTHEY
DDAGRVSKLCRYVSTRSSKPDNCETYTYDAEGRMVEAILYQGDRLIYKVVFEYDSSGNIT
TQTKYDRLGLMLDEVAYVYTYDKRGNWIQRVEYVDGIARYMVLREVQYH
>OBAHECAF_01666 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDENEVVTEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIATVGQAIKYIEEAKQ
>OBAHECAF_01667 3-oxoacyl-[acyl-carrier-protein] synthase 2
MRNRRVVVTGLGALTPIGNTTQEYWENLIAGTSGAGMITHFDASKFKTRFACEVKNFKVE
DFIDRKEARKLDKFTQYAMVASDEAIKDAKIDLETIDKDRVGVIWGSGIGGLETFQDEML
NFGKGDGSPRFNPFFIPKMIVDIAPGMISIKYGFRGPNFATVSACASSANAIIDALNYIR
LGYADVIVSGGSEAAVTIPGIGGFNALHALSTRNDDYARASRPFDATRDGFVLGEGAGAL
VLEEYEHAIARGATIYCELAGGGLSADANHMTAPHPEGLGAKNVMLNCLRDAGVKPEEVD
AINLHGTSTPLGDVAESKAVLDVFGEHAYNINLNSTKSMTGHLLGAAGAVEAIASILAVK
HGIIPPTINFETADESIDPKLNFTFNKAQKRDVKVAMSNTFGFGGHNACVLFKKI
>OBAHECAF_01668 Ribonuclease 3
MINLKKILSFTRFKKKKDGVFYAKMEALLGYPPKTLSFYSEAFTHPSYQYDKTKRKSYER
LEFLGDAILGAVIADYIFKNAPEQDEGYLTKMRSKIVERRYLNELGKEMRLLDFLRTKLP
PKQLGNNITGNLFEALIGAIYLDKGYGECMRFIERKLIKPYINIKNLEDKILSHKSLLIE
WCQKHKLTFSFDTDEDKEDRSGAKYFVSKIYVEGFSVTKARATSKKKAEENAAKRACYKI
QGKHKNLIQ
>OBAHECAF_01669 hypothetical protein
MKLTSQTFNLHKATRAKLLNYLDSLTEQGLATIPNGFNNNVLWNIAHCVATQQILCYKLS
GLTPKVPESFIETYRKGTAPDGHTPTKEEVQQLKELLISTQKQLQEDYQQGFFENFNSYS
TSYGFELNSIEDAIQFNNTHESMHLGVVISLNYFVK
>OBAHECAF_01670 50S ribosomal protein L31 type B
MKKGIHPESYRLVAFKDMSNEEIFITKSTIDTKETIEVEGTEYPLVKLEISRTSHPFYTG
KSKLIDTAGRIDKFKSKYAKFKK
>OBAHECAF_01671 Chaperone protein DnaJ
MQWILSLLGYLLFKLPGAIIGYFLGYLLKSFTNNSGGSAQYGSQSNYRQQRTVSPADFEV
NLLSLCSLVIKANGQVSQSELDFVRLRFVEMYGKDRANAVFRTFNELVKGREISAQRVSM
FLRARTPYETRLQILHFLFGIAKADGIVSDSEERQIKEIAQYFAISQHDFESIKAMFVRS
QKESIRDAYTILEINRNATDAEVKKAYREMAKKYHPDKVITQDEAIRKGAEEKFKQVQQA
YEQIQKERGL
>OBAHECAF_01672 Nucleoside diphosphate kinase
MPTNRTFTMIKPDAVENGHIGAILNQITEAGFKIKAMKFTQLSRRDAELFYAIHKERPFF
QDLVVFMSRGPIVAAILEKDNAVEDFRKLIGATNPENAAEGTIRKRFAKSISENAIHGSD
SDENAAIESSFHFSGRETF
>OBAHECAF_01673 Adenine phosphoribosyltransferase
MDEITYLESKIRDICDFPKPGVVFKDITPLLADVQATKQVLDLFLKRLDGKKIDKVIGME
SRGFFFGTLLAQRLEAGFVPVRKPGKLPFETIAQTYDLEYGQDQLEIHSDSIKKGENVLI
HDDVLATGGTAEAAVKLVETLGGNIVQLNFLIELTFLKGVQKLGNHEVYSVLKY
>OBAHECAF_01674 Ribonuclease Y
METVILGIVVAGIVGIALGFAIAKVLEKKNASKIISGAKTEANTILKEAKSEGENIKKDK
ILQAKEKFLELKSEHEKVIASKDKKMAEAEKRIRDKESQVSNELAQNKRLKDELEEKNKE
AEHRLQSLNKKQEEIERLHKSQVKQLEVISGLSAEEAKTQLTDSLRSEAQADAMAYIQST
IEEAKLTARQEAKKIVINTIQRIGTEEAIDNCVSVFNLESDDVKGRIIGREGRNIRALEA
ATGVEIIVDDTPEAIILSCFDAVRREIARLSLHKLVTDGRIHPARIEEVVEKTTKQIEEE
IIDIGKRTVIDLGIHGLHPELVKCVGRMKYRSSYGQNLLQHSREVAKLCGVMAAELGLNV
KLAKRAGLLHDIGKVPQVETEVPHAILGMEWAEKYGEKPEVCNAIGAHHDEIEMTSLLSP
IVQVCDAISGARPGARRQVLDSYIQRLKDLEDAAFSFNGVKKAYAIQAGRELRVIVESEK
VSDDKAAELSFNLSQKIQTDMTYPGQVKITVIRETRAVNIAK
>OBAHECAF_01675 hypothetical protein
MDEILKIKVSIGDRVYPMNIEPHQEEGYRKAAKEINELIQKFESTYELKDKQDALALCAI
VLATNIEQKKLDESQIDSTVKDKLTSINELMDAML
>OBAHECAF_01676 hypothetical protein
MSATENIYDLARLLEEKAMQLKRKIEDLTSENQRLKEQTISLRNEKEILTKEIILWKEKY
EAIKVANGILGSKEEKTKAKQQINALIREIDTCIVQLSK
>OBAHECAF_01677 hypothetical protein
MKRNKLKIVNDPVHGFIHIPDAFIFDLMEHPYFQRLRRITQMGLSYLVYPGARHTRFQHA
LGCMHLMQKVVETLRYKGVEISDKEAQGLYAAILLHDIGHGPFSHAMEHSIVENISHEEI
SLLFMQELNREFKGKLDLAIEIFQGTYSRKFMNQLVASQLDMDRLDYLKRDSFYTGVAEG
NINPERIISMLNVRNDEVMVEEKGIYSVEKFLVARRLMYWQVYLHKTSVVAEQLLIKVLQ
RVKQLIQRGESVSMSSPLKYFIECRVNKDYFSKEILDTFAMLDDTDIIAAMKQWQFHSDF
VLSKLSKMLLYRDLPKVKMQNYPFETEKLESQRQKVMQHYNISKEEADFFVFSGVVSNTA
YNSERQRIQILTKKGKITDVIKASDQLNLEALSKPVVKHYVYYPK
>OBAHECAF_01678 Putative pre-16S rRNA nuclease
MYRILAIDYGVKRCGIAVTDPMQIIASGLTTVATNELLQFLKKYINEENVREIIVGKPKR
MNNEDSDIEALILNFIKNLITEFPELTILREDERFTSKMAFQTMIDSGMKKKQRQNKELI
DEISATIILQSYLNRRG
>OBAHECAF_01679 hypothetical protein
MGRIFLAILVVVLGFSACGRGKKPVKGDVLLFPENTQVIYRINDKNNFLSAIENNEFWKE
NNPKPLRTYETKLIQSLPADNNIWVAFTGYKNFFAIAKQETSDTLSIWKNANQHVQKQSQ
FGKEWFYTIIDNRLIVSNVFEIHSFFNTDKTNPTNKTESQSILEDLQRIATTACSANLFM
QNEQANQFFSPFFKKNITKEFDHWLALDLFLEENDIRFSGMAIVKDDYQNDVLIRSSPYE
NDLTKVFPAQILEATSFSFKEAENIVLRDSIHVPFKKRLNGIASVRTIDGLFVVASSFDV
DETLLQLPILTEVTQSDFAMYELTDDSSLDFFKSFEPNFKPRFVSVYDDYLLFSKSKELL
IAIMGDIDRKNTLSTNKSYEVLEKNTASTANLTYIANLRDNSEFNKKYPKIAENYRWAVF
QQTSQNDYCILNFASKKQTQKSLSEKIKERFQFSFDENMITPPTILLNHRTKRLEIAVQD
QNYDLHLIGNNGSLLWKKQLDGKIQSPIYQVDLFKNGFLQMAFTTEHSIWVVDRNGNNVA
PFPKKYKGKITPMEVFDYDRNREYRFLFAEGKNLHMLDKKGEVVSGFLRKTTNATPLFTP
KHYRANDKDFLVYLSDDGKCNILHRNGEIRIPIQGKYNFSNNPPLFFDNRFLFSTQRGEL
IRIDLNGNTIVNDREWAREHYLIGNQHTTSFLSGNTISIGTTRIDIPDGRYERQRLFRIR
GVNYVSVTDSYQKKVYLWNEKGELIQDFPLIGNTPIAIDVDLDKSIWIVVGKTNKQLHVY
EVRDLK
>OBAHECAF_01680 hypothetical protein
MSTNTHISIKNWSDDDKPREKMMAQGKNALSDAELLAILIGSGSRNESALELSRRILTSV
NNNLTQLGKLTLKQLQQFKGVGEAKAITILAATELGRRRSAELPEPQPVIKASKHVFQLM
QPIIGELAHEEFWGVFLNNANRVLHKTQLSKGGITQTVVDVRLLFKAAIEWGAVALILVH
NHPSGNLAPSQADRHITQKIKMAGESLDIKLLDHIILNEKTYFSFADEGEL
>OBAHECAF_01681 DNA polymerase I
MSKKRLFLLDAYALIFRGYYAFIKNPRVNSKGLNTSAILGFMNSLFDVIKKERPDHLAVA
FDKGGSVDRLELFTDYKANRDETPEAIRIAVPYIQQILRALHIPIIEKEGYEADDIIGTL
AKQAEKQDYQVFMVTPDKDYAQLVSENIFVYRPARMGNDVEIWGVDQVREKFEVERPDQV
IDFLGMMGDAVDNIPGLPGVGEKTAKKLLADFGSMENLLANTDKLKGKLRENIEKNAEKG
LLSKKLATIILDVPVQFDETDFELSQPDMEAVTKIFEELEFRQLLQNLIKTYQTTAPATK
QIEAPSDLFSLQTAPVVVQGNLFATEHISERKNIQNTPHFYQLVDTPMACKILIQNILQQ
KEVCFDTETTNLDSLEAELVGIAFSWSAGKGYYVPFPENQQQTSKQLEIFRPFFENEHIT
KVGQNLKYDIKVLHNYGVEVKGLIFDTMIAHYLINPDMRHNMDVLAETYLNYIPVSIESL
IGKKGKNQLSMRQVSLHDQKEYAVEDADITWQLKEVFEEKLKSSKVDELYYNLEAPLIQV
LTKMELEGIRLDTDFLKELSAGLDDDIATLEKAIATEAGEEFNLASPKQLGDILFEKLKI
AKNPKKTKTGQYATSEEVLSAFADKYLIVSNILEWRQLQKLKSTYVDSLPNEVNPKTGRV
HTTYMQSVAATGRLSSNNPNLQNIPIRTERGQQVRKAFVPRDEQHVLLAADYSQIELRII
AALSEEQNMIQAFLNKEDIHRSTAAKVFNVPIEAVTREQRSHAKTVNFGIIYGVSAFGLS
NQTDLSRTESKELIETYYATYPNLRAYINKQIFFAQQHGYVETVLGRRRYLPDIHSRNQV
VRGAAERNAINAPIQGSAADIIKIAMIRIQNRLEKEQFRTKMLLQVHDELVFDVPLDELE
TVKSAIQYEMENAFSLTVPLVVDLGVGKNWLEAH
>OBAHECAF_01682 hypothetical protein
MNLLQELKNRSGNCCELCGATENLHIYEVPPVGAGGVDGSLLVCETCKNQIENPAMMDTN
HWRCLNDSMWSEHRAVKVMAWRMLNRLKSEGWSLDLLNMMYLDDEELAFAKASDDHLDES
ERIVHRDSNGAILEAGDNVVLIKDLKVKGSSMVAKQGTIVRKISLDRENAQYIEGKVDGQ
QIVIVTQYVKKV
>OBAHECAF_01683 Ribonuclease P protein component
MNFCFSKEEKLCKLEHIQKLFSEGKSVQSFPLKFLYIPIEKRRENTQFQLLISVPKRNFK
KAVDRNRIKRLIRESYRLQKHQLATFTNEKYALAFIFTSKDMPTYDLIFNKVNRCFEKFA
QVLETQTKDCTLEK
>OBAHECAF_01684 hypothetical protein
MKKYGLIALLPFFFAYLNAQNTTYWQQKVHYEMEIDVDAENFQYKGKQKLTYFNNSPDTL
QVVFYHLYLNAFQPNSEMDFRLQSIADPDRRMVKNLGTAENPVYESRIAKLKPNEIGYIN
VKSLKQDGIAVEHTTEGTILKVKLNKPIPPKSKGVFTMEFDAQVPVMIRRTGRNNPDGVA
LSMAQWYPKIVAYDYRGWHPTEYIGREFYGVFGDFDVKITIDKNYVLGGSGTLINADEIG
FGYEKQGVILPKTKGRTKTWHFVASNVHDFTWAADPQFKHDKITLNDGKIFHFLYKTEVE
NWKKIQPKLIETFELFNNLVGKYPWERYSFIQGGDGGMEYAMCTLLVGGANYDDLLGTAV
HELAHAWFQHAINTDEGSYAWMDEGFTSFIEDLAMALVINPTKNETNPFEGSYKRYFRLI
KSGWEEPATTHADRFQRNFAYSVMAYSKGTLFLTQLGYIIGEQNLIKTLQQFYKEYALKS
PHPNDFVRVAEKVSGMQLGWFLNEFISTTHTVDYAIESVKAKGKKTEITLRRIGALPLSV
DLFVVDKSKKVTYCYIPLRMQFGEKSNPYQYERKVFPAWGWATPTYTFEIDVPFEELHGV
EIDPSEMTIDINRQNNSFTNQ
>OBAHECAF_01685 Regulatory protein PchR
MILELLTEYPATHFSIGSGGYFHHTQINTENFTLFQNQIFSGEKTIYLDGESSVPSLEIQ
INIGENDIPFYINPSQRKIAKKAHYNLLYINGEKSGISFQSQQEYKTFDVHMPVHRIFEY
YGNNAIIDNFIKQIENQEPAMLFDEYLPVSHTVYELIRGIKQCNLPDFLKEEYLNIKVQE
IFLSILSESERSFEPNGISLKDQKLLWKVKNLMEQNIEKPLTIIELSRLVGMNDNKLKIF
FKRYFGCTIFEYFQQYRMHKAKMYLEQKELTIKEIAYQLGYSNTANFSNAFKRFWGISPS
EK
>OBAHECAF_01686 hypothetical protein
MKNNIYILITLIGWTLVGCEPPFFSETQSFVTRFETSNGEESATYEEVIDFYKNLSAKYS
SINLKTMGLTDAGLPLHIVTYSTDAEFNFTKLQKDKVIILINNGIHPGETDGIDATMLLF
RNLAEKQIKTPEHVVVVAIPVYNIGGALNRNSTTRVNQNGPKEYGFRGNAKNLDLNRDFV
KSDSENALSFAKIFHLIQPDVFIDNHVTNGADYQHVLTYAISQPKKLGSFLGGYMQDTLI
PNLSEKLITHQNSVKNDSIEKPFLHLAPYVTVWNTTPDNGYREMLDTPRYSTGYTSLWGT
MSILIETHMLKPYKQRVEANYEMMKALLELLENDSKNIKQLRTKQREIALTEKSYPIQWQ
LDSSQVSSITFYGYKADTLISEVTGLPRLHYDRNQPYVKKIPYYNHYVPTKQVEVPQAYV
VPKAWTNIIDRLRANKVSMNEINRDTLMSIVYYRIENYKTVDTPFEGHYLHFDTEVSKHK
TEIQLSKGDWIIHLDQPAKRYLLEVLEPEAPDSFFNWNFFDAILQQKEHFSPYLFEKTAL
VFLEEHPQLRDSLELLKKNDPSFTKNSYEQLNWIYRQTPHYEKSHLRYPIFRVE
>OBAHECAF_01687 hypothetical protein
MSLLYLQPIDSTLASKTYKPQQLGSQIRKHTFELGVPDLDEIKVAFFSVETAERTLHEVR
KSLYALYRGNWNFPIADLGILYEGHSTSDTYFAVRELVNSLIKQNITPVVIGGKRDLTYP
IYRSFDTLEQMVNLVTVNPTFDFGDKYELFSETSYLSRILSEEPINLFDFTNLGYQSYYV
AQEELDLLEKMCFDTYRLGIIVNDLPMIEPTMRDADIVSITMNAIQARDIENTDGFVNGF
SNREICAISRYAGISSNVQVYGIFDIPDTGLAAQLTGQMFWYFCEGFNFRVKELPLVNDN
NYIKYIVPVDDIQIEFFKSVATGRWWMKAGSESFSERKPHLPLGLIPCNHKEYLDATQGV
IPERWWKAYRKSI
>OBAHECAF_01688 Sensor histidine kinase TodS
MKYIENKFFGFFVVFSFLIIYGCSSEKAQVVDNEAKSMYLKEAQKLSRKEDSLKIMVQKY
TDEKNNVALMMFYRQLGKTQRENTRFSDAITSHQTGLEIALKLNDTLEIVQALNDLSTDF
RRISAMTEAANYSYDALHYIEAFSDVKNSGRKLRVMTLNGIGNISERLGYSDDAERYFRE
ALKEETALDSKVGQAINYANLGSIFRNRQEYDSAKTYYNLSLQKNIEANSKLGIGLCHNH
LGNLYAVEKKYDLAEKEYRIAYDLMEKHSDKWHWLNACIALAKINLTTGKTEQYHEYISL
AEKTAQEINSTGHLAEIYLLKHDYSIKQGKYEAALEQYKFSKSMTDSILGVKNTNHFMDL
RVNYEREQNSRQLKMIEAENQIKEERRERVLYLMWLAAVVGAIIIGLLYYAYRQRTRSNQ
ILKQIEQTRSDFFTNLTHEFRTPLTVIQGLNRQLQQRKDLSEKEKTRFMLAIDRQSENLL
KLVNQLLDISKLKSGTDNPKWERGDIISYLRMTAETFGLFAQERNVNLVFYTDIAAQEMD
FVSFYMDKIISNLLSNAIKHTENGDKIEFIVLKGKNPNEIMIRVADNGDGIPKDELDRIF
ELFYQSPNVKNNSGTGIGLAFTKMLVEKMKGKIEVESELGKGSTFTVTLPLKNKKMQNLP
MLVLPKADHIVINTSQTQDNHDDDHGSDKITPMGTDVPIVLVVEDSKDVSLFVKSLLQSN
YNVITAKNGAEGLLMAEKYIPDIVITDVMMPVKNGYEFCTDMKDNVLLNHIPIIMLTAKT
SEEDQLEGLRHGVDAYMRKPFRSEELLIRIEKILENRKILKDKYLSVIESSGNNISEQKA
DNDEKMKFLCKVMDIINAEITNPNFNATFIADRMAMSTSQLSRKLNQIVGVSTVSYILQV
KLIKAKKMLQDSSISLGEVSDACGFYDLSYFSRTFKKEFGITPSAYQKNASMKGFLNT
>OBAHECAF_01689 Internalin-J
MKTRELIMFLAVLIFAACSTDEMEDYESLVEKSNKITFVTQKKKGESICLSLEAETSKQS
AVWIDWNNNKREDVGEKFNETLFGQYTIFEVDAPEVTIYGEVTALYIPRAKVERLEVSKN
PALEKLYCSENNIKELDLSKNVNLKELDCSENSISSLELGNNLKLEQLSMGVNPIRSVDV
SRNLILKRICVRGSQIENLNLKANANLEELNCSDTNLKSLDVSRNISLKTIFCYGNHIQG
ESMTAFMNSLPQRCDTTGFLYLTANKTPRGKTEKNVFTNGDINIGKNEKCWRVIVNFHKE
L
>OBAHECAF_01690 hypothetical protein
MKTNILKATLGLLVVFSLQINAQNDPELNNKTVEKGYTKSIGEIRKSYTQLDERLYHKPY
DNPAFKEFYLLDANSEQALISQEIYTHQQLNNRGLRESIQSKLFEVNLPNKGGKRYSFQD
DNVIHAYFAVFNADPEGIKPYSFYVSGKTLLEAHRYGDITFEAKYEDNEHTKVVTDSGIL
LLLYSHRARVADMGLEVVRLDQMVYDKTPFNTIGAAFFGMLNNIEKFEKAGKYDSCKMSF
RIATTMKEHFEKHPKKVQDDSYLFVLNKYEQIKQRVKGWDAHTAKGIDMPKTYNMTPATT
QKALADAKKQFEGAFKVDKLVFLEKDWKTFKSPNYPYEITHRSLLVGLLTNEGGVTYLRQ
YNLQQPGDGKKWQNKYQFTAPFDGTHNPRKISK
>OBAHECAF_01691 hypothetical protein
MKIKIILSIAVITLLWSCKSNSENDKVSVEAAEKWLYAIFQCPNGNGFCFPEWGGDDKLY
TKRFLEFYNEAIELYSFWAEDNYDSEEALEQARAQYKKKWASVYNPVKEDDLNVFGTGNG
DVDKLEDLKIKHLKDLSFNVFIDYGEVKTSSDVILVKNGDSFQIDYMNTNFID
>OBAHECAF_01692 hypothetical protein
MKFIYFIVVTCLLIVSCETTPKKQNTTEEQIPKEVSLPELSQGETVEFEDSFCRIVNRDD
ENEMFNKLKIQAKKEGIASFELASDNEYVSLEKVDNHFLLVSLGTGGTRDLEAYSLKTGE
KILEVSSSVWGIETGEESGVFYIYLYGEETPPGIYWEEATKTWKSNTEIPENLMNDQLEQ
QKKEFEKRGFLTDGFPIICLEKYKFDINQRKVSGTGEYRWDYAQ
>OBAHECAF_01693 hypothetical protein
MNKLIIFFAGIFISIGCNNQQPREPEFTYETYLNQDYEFQFEYPTKMDVVMNHLDGIRLG
YPEKDILLGGYHAFIINDESDWVNLKEAYDQDLKSENVKYSNTEFHDEDYYFLEGMIDGK
TSFMKYTINSERGFYIIEIQYTDEKDAQLCKAIVNHAKNTFKRIE
>OBAHECAF_01694 Polyamine aminopropyltransferase
MIKKILSYIIPISVHKQDSQVSTSLEVLLHNGRYILDTPNTNYSYGSLQRILRFGLKKIG
FARVREMERILVMGLAGGSVVRTLIDEIGYQGAMTAVELDSEVVDIANKYFIINDIDGLD
VVIDDAQNFVKTAKQTYDLIIVDIFQDNHMPDFLFSKVFINQTISLLNNNGIILFNTMKV
RKEDAIRNLRFVEYCKKYATVKVLPNVEGSNELLLIFKKDTTS
>OBAHECAF_01695 Isocitrate dehydrogenase [NADP]
MTQKATIIYTKTDEAPLLATHSLLPIIKRFTTSSNIDFQLKDISLAGRILANFPDFLTKE
QQVEDALKVLGELATQPEANIIKLPNISASVPQLIAAIKELQSKGYDLPDYPENPTTEGE
KQIKTRYDKIKGSAVNPVLREGNSDRRAPKAVKNYAKKHPHSMGAWSKDSLTEVATMSTG
DFYHSEKSVTTEKVDNVRIELTTAEGEKIVLKEKTSLQKGEIIDAAVMSKKALLTFLKEQ
VQVARDKNILFSLHMKATMMKVSDPIIFGHAVRTFFADIFEKHANILKKIGADANNGWGD
IIAKLSNLENTEREIIEKDIQTAIENAPALAMVNSDKGITNLHVPSDVIIDASMPAMIRN
SGKMWNAKGEAQDTLAVIPDSSYAGVYKEVIAFCKEHGAFDPTTMGTVPNVGLMAQKAEE
YGSHDKTFEIPATGIVNVIGEDGVVYLSHNVEVGDVWRMCQVKDAPIQDWVKLAVSRAKA
TQTPAVFWLDKNRAHDNELIKKVEEYLKNYDLNGLNIQILSPEEATVYTLKRLKKGEDTI
SVTGNVLRDYLTDLFPILELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVEQFLEENYL
RWDSLGEFLALEVSLEHLAETFNNPKALVLANALGEATEKVLENNKSPQRKLGQLDNRGS
HFYLALYWAEALANQDKDHQLAGEFASIAQALKDNETKIVEELVSVQGHPVSIEGYYAPN
EKRTYAAMQPSKTLNRILS
>OBAHECAF_01696 hypothetical protein
MKRVLHITNNQSTSEKLQQTYAKSEVITWNEMLCEGKTTTDVGSEHFWKNRYDFFKNEYN
TEKSSFIETVLKEYRNLCNQKTQDEIVLWFAEDLQSQFNMIGVISWIKQHRKNIQVSWVN
LLPSSQTTEKINLAYTQRHSLIQDDIEYADYIWQLYCSNSPLQLEKHTKNIQTRLTALPN
AIQLHLKRFPLVANGLNNVEINILETIYQLNGNRDAVLSHLVKNDQKMGYASAQYQNLIN
RLRPLLSSLNPLKINEDAEKALRQELNVYASLRNEHDYFGGSLKYNFLYYEPANKIMKL
>OBAHECAF_01698 hypothetical protein
MQLEDNVPIYSVLSLFRTELTEKKAFDSLLSEINHQLEKHRIIIHQGVKVDASITQSSFH
SKKPKTFEIAQDRKEDELSEKEVEKQDHFFKEVAEDGVDKEARWVKKGRF
>OBAHECAF_01699 hypothetical protein
MSFAAYDVERRTRKGSFYAQVDTIINWKTISAIIDQHYQKGLSASGEKPYDGLLLFKMLL
IGMGTTYRMSR
>OBAHECAF_01700 hypothetical protein
MEKFEGKNLLNFIKELPDDNACRAYLAKYKWSDGFKCPKCGHEKGCLKKNFSYYCYKCSH
VETATANTLFHKVKFGLHKAFCMVFEMVTSSKSLSSVQMGERYGVSQTSTWGFMHKVRTA
MESSKKYPLSDLVHVDEFTIGGMENDKPGRSYDTKKKKAVIAIELTDKQRVKRVYVKSID
DYSCKSLTPIFEEHISEKAQITTDKWNGYSPLKKKYNITQIESDKGKNFKKLHIVIHQIK
SWLRTIMVQVSKKYMSVILMNFAIG
>OBAHECAF_01701 Aminopeptidase YpdF
MKTSEKLLLLRKQMQTEGVDAFVVFSADPHLSEYLPKEWLERQWISGFTGSAGFVVITED
KAGLWTDSRYFVQAPIELEGSGIDLFKEGVEGTPDYTDWLLSELPEKSVVAVNALATSHV
AWEKLEKALATKHIELKDNPLLNKVWVNREKSPLHSIFVHPDKWAGQTVAEKLKAIREKM
KQQKANLHIITALDDVAWTLNLRGSDVAYNPVFLGYIVLSNEDAFLFVETQKVTDEVRAH
LTQANVTIRAYSDFFPYLTEIKDKQILIAPNTNQAIFRAIQGNVLIQSPVPGNLMKAVKN
ATELEGFRTVMVRDGVALAKFFYWLTHQVGKEPMTEYSIGVKLREFRAAGENFVGESFGS
IVGYQGNGAIVHYSAPETGSKEVFAEGSILVDSGGQYLEGTTDITRTIPLGKVSQEFIND
STLALKGMIQLSLVKFPKGTRGVQLDAFARMALWKNNKDYGHGTGHGVGSFMNVHEGPQN
IRKDMNPQELLPGMVCSNEPGFYLENKYGIRHENLVAVREVCKNEFGTFCDFETLTLCPF
MATGINPALLTDDEKQWLNAYHKTCQEKIAPHLEGEVKTWFLELVKPL
>OBAHECAF_01702 hypothetical protein
MYLLFFDFTFDADFSVYLPNAYIAQQKGKAWYFFKKATDSVLLGLPELSINLQQKEALVL
VNSLQRTVLLQKFVKKGSSLEIIYKNITQKQLIQRYIEEKTDVLLEIIAKNEFITTLEYS
SRDEIFKRRIQVSEKIIKPFLEFEKTNLGINYRLFLYDNDTKMIPSEQKIELLNNQKSWI
VINRELMRVNHIKALNIKPFLNKTEVHIPEKMVHEYFDKFLKEILKKVEINAIGFNVLQK
NSIQSSELRLVNDFFENRYKISVGFNYGGYVFFSNQGRISHSVLEVDENNAIQIITYKRD
TSSEEKIYDLFRKIGFEEENGLFFVQKEGLYASVYHLLGHSSAFISENINMNSIEIEGKK
LNKDNFELIFDNIYTENDWFDLKIHVKKGNNTFHFKELVKNIKENNPVYILPDGTVFLIP
EEWFARYGTIVKFSKVNEGKLQLPKSNYALLNDTPELQPKQLINSVVYVPSPNLKATLRP
YQKEGVQWLLDHHYNGLGACLADDMGLGKTLQTIALLVDIHDRLPMQENTTPTDLFDCVQ
QKEPLKALVILPSSLVFNWYDETKRFAPHLKCTQYVGNERKGKSNRLQNYDVIFTSYPIV
TRDAKLFHKHEFRYVILDESQRIKNKNSQIFKAIHDIKATHKISLSGTPIENSLSDLWSQ
MQFINPNILGSFSQFSKYFKQGIEKKKDPIVLEELKTIIRPFLLRRTKEQVLDDLPELTE
QITYCELSEAQEKWYEREKSAVRNQLLQVDGQISQLNALNMLMRLRQISNHPKLVEKNSD
IPSGKYEEVISYMELIANSSQKALVFSSFVSHLAIFEQWCIKNNLKYAKLTGSVPTDERK
KEVEAFQNQPEVTFFFISLKAGEVGLNLTKASHVLLLDPWWNPFSEKQAIARAHRLGQKN
KVNVIRFVSKNTIEEKIIRLQESKKELSQNIVDDTAIIHDVMQHIDEIL
>OBAHECAF_01703 hypothetical protein
MNQNITENINQIQARIENACQKVGRNPKEVKLLLATKTVNAERIKTALNAGYTLIAENKV
QEVKEKYDALKDIPHTSHFIGHLQTNKIKEILRYDIRCIQSLDRIELAQKLQQRLAYENK
NMDVFIQVNTSNEASKFGIAPEKAIALVQEVAQFDRLHIKGLMTIGLFSAKSEEVRPCFQ
LLKNLQLEINGLNITNVDVSELSMGMSNDLEIAIEEGATIIRVGTAIFGKRIYSDSYYWN
ENH
>OBAHECAF_01704 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MTEIKNTIEAAWENRELLKDESVQNAIRKVVDLLDSGKLRVAEPTENGWQVNEWVKKAVV
MYFPIQKMETLEAGIFEYHDKIPLKRGYEEKGIRVVPNAVARHGAYISKGVILMPSYVNI
GSYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIEDGAFIGSRCIV
VEGVRVEKEAVLGANVVLTASTKIIDVTGETPIELKGYVPERSVVIPGSYTKKFAAGEFQ
VPCALIIGKRKASTDKKTSLNDALREYNVSV
>OBAHECAF_01705 Tryptophan--tRNA ligase
MARILTGIQSTGTPHLGNILGAIMPAIEMAQNPENESFLFIADMHSLTQIKNGQELKANT
YSVAATWLAFGLDYNKITFYRQSDVPQTAELTWYLSCFFPYQRLTLAHSFKDKADRLEDV
NTGLFTYPMLMAADILLYDAQIVPVGKDQLQHLEITRDVASRFNHQMGETFVLPQAKIEE
RIMIIPGTDGEKMSKSRNNYINIFLPEKQLRKQVMSIQTDSIPLEEPKKPDTCKVFALYK
LLASDEQIQTMRNLYEGGNYGYGQAKQVLYELILEKFSEPRQKFHYYMENLDELEKILQE
GALKAQKVATDVLKRVREKIGY
>OBAHECAF_01706 hypothetical protein
MRPYILAETNWKTIQKTNFSIAVLPWGATEAHNYHLPYATDVIESECIASESARIAWEQG
CRIIVLPAIPFGVNTGQADITLDININPSTQLILLSDIVETLNRQNIHKLVVLNSHGGND
FKPILRELGLKFPKMHISVCNWFQNGEKKNYFDQIGDHADEMETSLLMYLRPELVLPLSE
AGEGKEKKHKIKEFTEGWMWSERKWSKITADTGVGNPKLATAEKGERYFKFITEKIANVF
IQLEKLDVEHPYE
>OBAHECAF_01707 Muramidase-2
MKKITSIVFFLLFGVIFAQQQTHTIKANESIDHIAKTYRVSPSDIFKQNPGLKDSMKKGM
VIVIPSGKVKYYSTQRPMGFIPHTVEAKETFFGLSQKYNITIDDIKRYNFDLYTRGLQEG
ELISIPIFSRATGTVEKGVQGQKKYVVKPQETLWRIAREHNISQAELEKMNRGVTASNLK
DGQEIWVPAVESVASKPNHRTDLVPYAVEKAEGFYSLQRKFGLSEAELIKLNPELKDGVK
ADTQIWIPKENYNRYRYSMTSFEEKSFPDSNQNVQSLSSIENVRQLSFVLPFRISDISEE
NKSAALRTRLGDNRATPMATDFYSGAMIALDSLQKMGYSFKVNVFDSENNNMKNIIADEN
LLNSQLIIGPFSAKSFNDLTKHITNVAVLAPLSNRNIDLNPNVFQTLPTDEVQQNKMITY
ISENHSDANILILADSKNTAIRERLASSFPNAKIVTEVTAKSIPNAIDYNRLNFVLIQSN
DIGYVSNAVRVLHGALSLKKNDISPKIILATIDRGSVFDSNNISNNQLSDLQFTYPTFNK
YSNGDDSFSQRYVKTYGVLPNRYAIRGFDITMDAVLRLGVTGNFEQSTSHVGETSYLENK
FAYQRNPYKGGGYENQGVFIVKYENMEVKEVK
>OBAHECAF_01708 50S ribosomal protein L19
MEPLLKYVQDNFVERKDFPEFSSGDTITVYYEIKEGDKKRTQFFKGVVIQRKGSGATETF
TIRKMSGTVGVERIFPFNLPALQKIEVNKRGKVRRARIYYFRGLTGKKARIKEVR
>OBAHECAF_01709 Alanine dehydrogenase
MIIGIPKEIKNNENRVGATPSGVNELVKFGHTVYVQKTAGEGSGFSDEEYVEAGAKLLPT
IEEIYAQSEMIYKVKEPIAVEYDLIRENQLIFTYFHFAAEEALTHAMIKQKAVCLAYETV
TENNTLPLLTPMSEVAGRMAAQQGARFLEKPQGGRGVLMGGVPGVHPARVLVLGGGVVGY
NAAIIAAGLGANVLIADISLPRLRLLDSILPKNIKTLFASQYNIKQELAHCDLVIGAVLV
PGAKAPYLITRDMLKLMKKGSVLVDVAIDQGGCFETSRVTTHSNPVYEVDGIVHYCVANI
PGAVPYTSTLALTNATLPYAIDLANKGWKRACQDNRGLAEGLNIIQGKVVYQAVANTFGL
EYTPVSEFLK
>OBAHECAF_01710 hypothetical protein
MKNLLLTFVFLCTVWVTQAQTPCIDSFTATPTPGSCFSDATLKVELPAGCTGNYLAVLTP
PEGTGNVEYQQLTGTPASYTFNALRAGTYTVTVMDQDSGTQTAPKIVNVTSSYVIMNIQE
IKQSPPTCLTQRNGKITFRIPTGGTGSFRVSVEDPNGNVLYAPEDFARPTGSNVISIEGS
GSNSIPLGNVVLVIEDLAGGAVQCGETRRIPMVMTGTIVQNYECLGVGVKPQSFERDPSG
VCKYRMTYSSHLLTGGGYIYSNLSGAERTVLDNLMKQSGTFVVENVTKGTITDFSSSFSG
GWYYTDYTFEENDEIKVRVRVNIPTVPPIFERDDHFKFEEVTQQAVPHLSYSISRTADCI
PVEKLYIYVNKYNGFRTYNHLMFPTDNNKRMSFHIRWAVKNNTDLMNHVDIYKFDEGTNT
WTGPLTTGIIKSNNHIDVTAHGAGKYKVKYRLNAHEGCYPDAEKEVEIKVPPLPKPPLEN
TINVLQPGLGIYEGTGYIYNYFYGNNMKLHLARTDGQTSVSFQTKLPLETDTYTRTVKFP
IEFTNNGGTRSIGDLPPGEYIVTVTDACGNIASKTLTVTGRLPIKYQETITKDCQLGTYT
YNFDRNDPLTRNMQATLQRKTVNASGVVTWVSMTTTHPRISGYTNTFVNIPTGEYRVEFY
NYYYTYIAPNGSKSSHSGYSFLEEALNGNPYFHGSTYAQNFRDYAYFEIKEQEIIDPDII
SSSCDASTPAYVAVNINNPHVISYPLTYSLINPITNAVVASQTYSSGGTSHVFSNIPTGK
YKVITAHRCGSVPKDVEVLANNFYPPRMIPLVNRPDVCSPANVILNFTGIESLYDIRWFK
LDEQDNRVGGVLHTGRVFLTTVTKTTTFEVEYNLKQSIICNQGEIKSLRRTITIPHDDEA
PVVAPMPDITQRLPLGRCLAPVSWTVSATDNCPPVTVSSTHTPGDEFPLGVTTVTYTFTD
LSGNTTTRTFLVTVLSNALDLSLTSRYVNGSNTPLSELSPTSDAFLYEIRYRNSGGEHIT
TATMTVVLPSNSNVTLDGSPMLTAASMGSFVPTYTYDTASRTYQFVIPGETLRQASAERI
IRIPLRITGGCEQAIKPCLDHLLANTSVVFGGGPASCSLAPQMRTHTATIKINTDSCQRQ
ELFCGEEVVLTSTEGFDSYQWYKNGVAIPGANTASLTSSGAGIYKVIKTNTCSGITVTNS
ETVNLVAPAVAIDPIRALANNIGMVCSNNGLWTSLFFLCESNSRVLTVSFQNTNFIWQRA
NGSCPAPFQGCPYSDESCWEDVSSNNSFTISSAGKYRLKIKDANCNTSYYFDVITNGLSG
DIPSNLVGHQSDYSQGYFSVVMSATGVNYNMKLYKDNALERDITTGSNSYQFTNLTAGNY
RIVVTSPQIQGCKYEDIIKIDKRTEMTMTASFLGWTQCNTARVRFSAEGGKPPYRFAIWS
INGIEQYASEELALQNAVIATLPENQTFIEAEIPNITHVGEYVFIAGDQRNGAFALSTPP
LLIEPPVPHNFKLNVNHIQCASAPNEGSILLNFASQQNRSVRLYRLNPDYTRNGVPIQQN
STGTFLNLPVGLYETEVIATISGTTCTYIKKPIEIKPSETTIKAFIGVVADKDCDTRIGI
SSKQYKIAVNNVSGGEAPYRYSFDGETNYSIDNIGYISNSMRIYVKDNKGCKQGFDIVVA
PAEIPTIEFSPISYRCDNGYGVVTVTMSATVTNSYEYRVGSTENYQTVSGTSFMLTLEPN
THLVQVRYVTQSNIASKNLLFQEDFGSGADICMPNINNLTCRENQTLFDGEYAITQQVAT
NANWVNPTPTDPTGGRYLAVMGNGNNEIIYKKRISGFVTNTSDAHLQFDVRSLLLNTGTN
ANLYVELRTTTGVVLSSQHVGNGNIPHGGNWETHKVTFPKNTIKENTLEVVIINKANSSV
GNLGNDVAIDNIEVWQDTQHCEAMVSKPITIEKNKQLYIEKIAETNVRCKGSSDGTLTIK
VNNPPASRVIEYAIGSQASWTTVTLTTTNNTFVATGLPVTTNGVIFVRDANQPSCMVDFT
PYTIGDAIPIVVKAEVVKKVTCGAISGATVLVTATGGNPSSYDYRLGPTAFTSNNQFVNI
SAGTYTVTVRDGNGCEESISLIIEDKKTLTITAETIYCYDGIGNGSVRISVTEGNGGYRF
QRVGDANMYTSVDDSYLFTGLSVGNHTFTVTDNAGCSATVIATVYPPMRLQVAENNQYIG
CTTGATVTFTLTAMGGDPLATKEFRVSNDGGATYTNFASATSNATYSTSTPGDYRFMVIY
FPNGEACDALTERKVIYDPPRFVNPSILTQEAFCGQNNGAIIVKPSDFYSSTASNTVNVF
KLDATGNRILPAVIPTALAIGSYLVEITDDRGCVVTTTVTVPGVEAMTATATQINSISCG
KTGGLKLAEWQVSVNRGGTPPFTVKVESTSNGYSRTQSLASHSAIGMFNGLDFGQYNAII
TDHNGCEVTIPFDVLANANFIITTAVATPTACATTGTVSVTAFNTMEGLEPATNGYWFAI
YQPGIENMLPRLFTGTTETVTYGTQQIVWYKHTNQTVSGTTTTSVERAFTGLLPGVEYTF
TMYNSGTNCYYTQRATIPVPTASTLTSTIGATKPTTCSSANDGSVTFSVAGWQAGTNSIN
AQVYNYIGNTIVPLATRVFAPATTPFTINNLPAGRYYIVFTEKDGSGNDTCVNASKDFII
EKATIELSVSATPMVNATCSNNGLVRLNFNGGKAPYHYDFVTGSSTPTYPVTNVTHATMV
MVPMGTNTWTVYVRDAYGCQKSTTVFVPKDTEPMVGTSHVMSCGTNPNTLETPVRISMNQ
LGIGNHFYTLETGSGVKPQEPITWDASGNAFSLNLEAGSYTITIRDGNNCTSTTTFVVNE
LIQYTANISSVATCRTTVPSVEIGVSTPTGGTGNYFYILERIEEKGTASETATVVLTGAY
TPTITILNPAYGNYRIAVYDNNTTACPIYKDLQIQEPVKPNIADATLVATPLTCDPNVGE
IIVSMPNSDPAGFTFAIVRMEDLTSGGMVTTTVTAPTTADNYTANFKDLRGTVAGVRYTI
RVVSNDNDCYAERYITLTAPEPLSLQNEALTASAYACAGNGRMNPATLTFDMTKVKGGTP
PYQATFYDATTNAALGNGNSYTLPDLNGGTFYMMITDQNGCTVSSTTPVTVTPTFSLEAI
TVTITQSITCSRDEQIGVEVSVLPSYLGTNLNYILRNIDTEAVVTQTTITSTSHTFVGLG
MGNYEIKVVNLSTGCELTSTHRVDNPNTFEVMAENIVRPTCYGDSGSVSLRFVDVALGNG
NQAVHGFTYTITSVINSTEVYTGTTTTDVTGTINLKAGMYEVTAKSLLNDCETLPIRMVI
PQSPPKIEVQATETYGVTCDNNKGEVLVTIKGGETPFEVTLTGSGAPITKTGVVQYALFT
GLSADNYTISVTDAVGCTMFTGTTSLTLLQPNSVSATVSVTHITCIGDQNGIITVNASGG
SGEGTYYYALYKDNVLHREPQTSNVFSGLGEATYFVEIIDAWNCGIRTSPVNIYEPSPMN
VEIIRGSSRFSVCHGEENAYVRVNVIGGGTAPYRVSVVHKDSFVEVGSYSNVNPGTELEF
KNNNIGPGNYEIRMTDANECLMQNTVSFTVVEFPDLTIRHIEQQGTCVDNQYSDYIEVGF
AIELDFSKLYYTLNGSSTKNTFSNTTRFAGRIYDFDRTIKKQQITVYYEDTVLGLTESCS
ITVDPFTVYNVLPLTLERVTDMRLNTIEVIAEQGTPQYTFYFNGKEQGENSVYVMNINDP
QRIEDGKIIKIIEVMVQDSAGCTRTMTIEQEYFDITIPNYFTPDGDGINDSWKPRNMENF
ANSNVHIYDRYGRRIKTLQFVNGVLDEWDGNYNHKPVPSGDYWYIIEINRQDDNRRFMGH
FTLYR
>OBAHECAF_01711 50S ribosomal protein L20
MPRSVNAVARRARRKKIMKQAKGFFGRRKNVWTVAKNAVEKAMQYAYRDRRNKKRTFRAL
WIVRINAGARLHGLSYSQFMGKLKANSIELNRKVLADLAMNHPEAFKAIVEKVK
>OBAHECAF_01712 50S ribosomal protein L35
MPKIKTKSGAKKRFQVTGSGKIKRKHAYKSHILTKKSTKRKLKLTHTTLVHPNDEASVKR
QLGLK
>OBAHECAF_01713 Translation initiation factor IF-3
MPEVRLVGENVEVGIYPTRKALEIADELELDLVEISPNATPPVCKVIDYKKFLYEQKKRE
KEIKAKATKVVIKEIRFGPQTDEHDYEFKKKHGEKFLKEGAKVKAYVFFKGRSIIYKDQG
EILLLRLATDLEEFGKVEQMPKLEGKRMTMFLAPLPKKK
>OBAHECAF_01714 Threonine--tRNA ligase
MIKVTLPDGSVKEFNKGITPYEVALSISEGLARNVLSASYDGKVVETTTPLTTDGSLILY
TWNDTEGKKTFWHSSAHILAQALEETYSDIKLTIGPAIDNGFYYDVDFGQHSFSEKDIPE
IEKKMLEIAKGKHLFSMRSVSKKEALDFYKNNPYKTELIENLEDGSITFCDHSTFTDLCR
GGHLPNTGFVKAVKILSIAGAYWRGDEKNKQLTRVYGISFPKQKDLTEYLTLLEEAKKRD
HRKLGKELELFTFSNKVGQGLPLWLPKGAALRERLEQFLRKAQKQAGYEQVVSPHIGHKD
LYVTSGHWEKYGKDSFQPIATPNEGEEYLLKPMNCPHHCEIYNSKPWSYRDLPKRFAEFG
TVYRYEQSGELHGLTRVRCFTQDDAHIFCTPEQLDQEFKNVIDLVLYVFGSLGFENFTAQ
VSLRDPENPTKYIGSDENWQKAEQAIINAAKEKGLNYVIETGEAAFYGPKLDFMVKDALG
RSWQLGTIQVDYNLPERFDLWYKGSDNELHRPVMIHRAPFGSMERFVAILLEHTAGNFPL
WLMPNQAIILSLSEKYENYAQKVLKLLENFDIRTLVDNRNETIGKKIREAETQKIPYMLI
VGENEEKEATVSVRKHGGESLGTLSVDAFVKIVETEIGKSIKSFK
>OBAHECAF_01715 hypothetical protein
MENNTTVDIRQINERIENESLFVDSLTREMNKVIVGQRHMVDALLIGLLGQGHILLEGVP
GLAKTLSINTLAKAVHGSFSRIQFTPDLLPADVVGTMTYNIKQNEFSIKKGPIFANFILA
DEINRAPAKVQSALLEAMQEKQVTIGDNTFVLDKPFMVMATQNPVEQEGTYPLPEAQVDR
FMLKAVIDYPKLDEEQFIMRNNLSGQQEVVNQVVSLDQIRRAQQVVREVYMDEKIEKYIL
DIIFATRYPEKYNLADLKPLIKFGASPRGSINLATAAKCHAFIKRRGYVIPEDVRAVIYD
VLRHRIGITYEAEAENVTSVEIINKIVNTVEVP
>OBAHECAF_01716 Arylesterase
MKRFVVLSFFAVFILNGYTQERKHSHFYEQRSDLFEKLPVTSEDIVFIGNSITNGGEWSE
LFPEKKVKNRGISADTTEGVYERLDYIVKAKPAKIFLMIGVNDIARGFEVKTIVDNMKKI
VQKIQQESPTTKIHIQSLLPVNPDFGIFKNHMKPEVIKHINQRYKLIAEEYGAMYIDLYP
YFVEKGTDKLAAKYTNDGLHLMAEGYFQWRDILHPYL
>OBAHECAF_01717 hypothetical protein
MDTKEILKKVRKVEIKTRRLSDNIFGGEYHSTFKGRGMTFSEVRPYQYGDDIRNIDWNVT
ARYNEPFVKVFEEERELTLMLMVDISGSELFGTMNQFKSEIITEIAATLAFSALQNNDKT
GLILFSDTVELYIPPKKGKSHVLRIIRELIEFQPKSKKTNISKALEFLSQVLKKKAIVFI
LSDFMDKGYEKPIQIAAKKHDVTGIRIYDQKETTLPNLGYITVKDAETGELILVNTASKS
ARMQYEKYYRENVAYYENLLQKSGAGTVSCRCDESYTQKLLGYFKRRG
>OBAHECAF_01718 hypothetical protein
MKDKFIIFCGLFWSIFSANSQEIKVETDTKNIKIGEQIRYKISVETTTEEPISFPEGQTF
MPLEMVRSSAIDTMRKQEKYRFIKEYFLTQFDSGSYTIPRQKIIINSKDFYTDSLLVEVR
SIPIDTLKQPLFDVKPIIGVNSTSKSRVYLWVLLGIIIIITIGFLVYYFFFHKKKLSEEE
LRRRLPPFERAIEDLKKLQNSKYLIESNHKAYYSKLTDIVREYLEDDVHILAKESTTDEL
LSKIKLMQENGSLNLSEETVKNLKSVLQTADLVKFAKSKPADSTAEYDRKMIEEVIIKTK
QAIPQVIETTEDLSEKIAEIQNKNKKRKLVVISGIACTVALLIGSLVYFYADSITQLFYN
SQYIKELYEKKWVTSDYGVPITELSTPEILKRKQIINLQEVGMPVKKQHFFEFGSIHSEL
YVMTSIITFHPQTNGQQAELNPELVNNLILSQIEAAKATNITTFTEEYTSTSGAKGMKVY
GKMVLVNEKTKSPFQAHYELYSFTENGALQQLLITHIDDPNAYKIAEKIVNSIHFKRE
>OBAHECAF_01719 hypothetical protein
MFKDITFANPIFFWLLAIIPLLVLWYVYTYKKSRPTLTLSSAAIFKQKSGWTTFGYHLLF
ALRILAITLIIIALARPQTRSESAKTKITEGIDIVMAIDVSSSMLSQDLKPNRFEALKKV
ASQFVRDRVSDRIGLVVYAGESYTQTPVTSDKSVIINAINALTYGQIEDGTAIGMGLATA
VNRLKDSKAKSRVIILLTDGVNNTGFIDPQTAAEMAAEFGIKVYTIGIGTNGMALSPYAL
NADGSFVYRMTQVNIDEPLMKKIAQTTEGKYFRATNNKKLEEIYEEINKMETTEIEEFKY
TKVEEKFRILALIGVFLLLLEFLLKHSIFRNEI
>OBAHECAF_01720 hypothetical protein
MIHIDEKIYLWLILSVGVLFLLFSISRIRMRRQQKQFSDENLLKRLAPDRSRFKPLLKLG
ILSVVIVALSVALANPKVGTKLETVKREGVDVFFVIDVSKSMLVEDVAPNRLEKAKRLVS
ETLNQLKGDRVGIVAYAASAYPLLPLTTDHSAAKMFLQSMDTDMLSSQGTAIQEAIRMTC
TYFDNTQETARILIIVSDGEDHEMGALEVSEEAVNQGVSIYTIGIGTEKGGPIPIKQGNV
TQSYKRDKNGEVVISRLNENLLKEIAENANGKYINGENTKETIDELITILDGTQKTEFET
QKFVDYQDQFQWFLAVALLLLVFDLFIFERKTLWVKKLNLFNEKK
>OBAHECAF_01721 Lipopolysaccharide assembly protein B
MRILLFVFLLTGFITFAQNREEQTKKTLEEAKNRSEKYTQKGNKAFNSDKPIQAEVEYRN
AIAENKENGIAQYNLGTMYYKQKSYDEAFYRLKNASTSAEVSHAEKHQIFHNLGNTFMKE
KAYEKAVQAYQEALRNNPNDEETRYNLAVAKEMLKKNPPQSQDNKDNKQDNNENKNDENK
DSQNKEENKDQNKDNKQDNKENEKEENKDNQDNKNNKDKEKDDNKEDKNQDKGNNQDRPN
NPEEGKNDKDKGEGKNTPASLSPQQMERILEAMNNEDRKVQEKINAKKVKGERIKSEKDW
>OBAHECAF_01722 hypothetical protein
MKHRILFIISLFFSVLHSQEVEFIAKVSKDKLGVNERLRIDFTMNKNGDNFTPPDFKGFT
VVMGPSQSVSDMWMNGVRTFSKSFSYTLQPTAEGKFTIQGASIDIGGKTYTTKPVEISVT
KAVETPSLDKPTTDLIKDNLFLVAEVSKGNPYLNEGISVIYKLYVGGQVALNDLRVVDVP
KFPNFWSQEIRMAMSQYEVDNCTYQGKKFRCVTIKKMVLYPQKTGKITLEPLSVDAVLAV
PTQQRDFFGRNIMQQSVQRVSSGNRVLNVRELPEEGKPDDFSGAVGDFTFEVNATRKELN
ASESTQIKVQVSGNGNLKLFDLPKLTFPSSLEVYNPEQKDNVNTTLSGMRGTVEQTYTIV
PQYGGKYPVGATSFSYFNPSTQKYHTVKTEDILLDIAGSPAKEIQSTGEIVKQSVQNLGN
QFRFLQLNPNLQPIDQPLFFSTSAYYWWLFLPLLAIPIALFWQRFQQKRQGDVEGNKIRK
ANRLAKKYLSEAKQRITDKDTFYEALERAFHNYLKAKLKIETYEMSKEKISSLLQEKQVK
ASTLETFISLLKNCELARYSQAHSVASLEKDYELSVQVLSELDKQIK
>OBAHECAF_01723 hypothetical protein
MKLRYILNISFFILGLGTSLAQDNEKLFSKATESYNTNDFKGAIESYMSILDSGYESSEL
YYNLGNAHYKLNQVGKSIYYYEKALKLNPDNEDARNNLVFANQMTVDVITPLPKTWYTQL
SNRITSLFSLSTWAIFPILSVFTFVICFLIYFFTPSTILKRIFFTLTLVCIVTAVGTYFI
ANFHYKNYVNEKYAILFEKTIRVFAEPNAYSSEVFILHEGTKVEIIETLNEWIKIRLADG
KIGWVKENVLRVL
>OBAHECAF_01724 hypothetical protein
MFSRAEAKKLREEFWISFGKSFPRKWVLYDTKIKDFSFKFYFDQKKAMVTLDIEDNNLEN
RCLYYNKILSLKQILLTEYLPDAIFEETHILPNQKEISRVYVQKYGVNIHNKESWRETME
FLYRTMSQFESFWFEYEDVIKE
>OBAHECAF_01725 Thioredoxin reductase
MANVEKVKCLIIGSGPAGYTAAIYASRANMSPVLYQGEQPGGQLTTTNEVENFPGYPKGI
TGPEMMIELQQQAERFGAEIRNGWVTKVDFSQTPHKVWVNETHEIHAKTVIIATGASAKY
LGLPSEQHYLKMGGGVSACAVCDGFFYRKQQVAIVGAGDSACEEALYLSNICEKVTMLVR
RDEFRASRIMKERVLKTQNIEVLFNTETEEVLGDGQVVTGIKVRNNQTNEISEIPVTGFF
VAIGHKPNTDVFKEFITLDEVGYIKNVPGTSETNVKGVFVAGDAADSRYRQAITAAGSGC
MAALDAERYLMTLE
>OBAHECAF_01726 ABC transporter ATP-binding protein YtrB
MIRIQNLDFSFHKKVVFQNLNLQIEAGQICGLFGKNGVGKTTLLYNLTGLLFPHKGKVEV
LGFEPKKRQTEFLQEIFLITDEVYLPDMSIRQYEKTIAPFYPKFDTVQFLEFLNRFEIPS
ESQINKLSLGQRKKVLISFALATNTAIVLMDEPTNGLDIMGKTQFQKILAEQMNDDRYFI
ISTHQAKDLENLIDRVIVLDNEKILFNQSVRTISEKLNFKISENKAELSKAFYAETNFFG
NVMVLPNHENTENRVDLELLYKAVTTNSEQINQWFNSK
>OBAHECAF_01727 hypothetical protein
MKQIGLLLRKEWTEKRTFFIFFTIVALLISIGVISYYCYVSWINSVDTGYFFFSTEAFMM
PYIVTIFVWAIISPYIAFRDFKKRKSAIYEWLIPATPTQKWLVKWFIYCVLFFIFFTILY
GILYYISAQIVDKLDFVNTYAPEDFGLPSFSHFIGIGTVICLMAQSIFFAGVLFFNKFSM
FFTTFSFFLWVFFMIALNSILGEYGSIFFDTVLGVEADEGMGYYAIHKNSENIKLLLTLL
FYIGIFMLYTLSYFKFKEKEIR
>OBAHECAF_01728 HTH-type transcriptional repressor YtrA
MEIRDTGRAIYLQIAEFVCKKILLDEWLPETKIPSVRELAVQLTVNPNTVARSYEVLKTN
GIIIDKRGIGYFVEKEGKQQAKNFRQADFLENELPTFFNTLHTLGIELNDLEPKFQVFKQ
QLKAKQDENQ
>OBAHECAF_01729 hypothetical protein
MKTSNKILMGLGVTLLLFPVFLTLLKNVENKKAPKVFNKYTYDYVPEKLLPFKHLKVVGS
YHNMQLAFASSDSAFAFVPQDKSAPRPKFIYHQDTLIVSYENIKTEKNLEYTYFFQVHTP
DLQSLTLDKSNFTLDAYPSVENASLDICMNESHITLQQERKTRDYKNITIEGTKSTILVD
TPTKVENMHITLSGKSFLMVKHLDMDNFSATVSSETTVKATESLNDFIQIKT
>OBAHECAF_01730 Lipoyl synthase
MSAETMTVENNVLPPKGKPKWIRVKLPTGKKYTELRGLVDKYSLNTICTSGSCPNMGECW
GEGTATFMILGNICTRSCGFCGVKTGRPDSLDWEEPEKVARSIKLMNITHAVITSVDRDD
LKDMGSILWAETVKAIRRMSPKTTLETLIPDFQGVEKNIDRIVAVAPEVISHNMETVRRL
TREVRIQAKYDRSLEVLKYLKSSGAHRTKSGIMLGLGETEEEVIETLHDLKAANVDIVTI
GQYLQPSKKHLPVKQFITPDQFAKFKQIGESLGFRHVESGALVRSSYRAHKHVL
>OBAHECAF_01731 Azurin
MKKVLLVALMGALAVSCGNTETKKKEESSVTHNHEHVAPETPSNSTAKHVENGTIVLEGT
DQMTFNLSEIKAKAGEKVTLTLKHVGKMPVTVMGHNFVLLKQGTDVAAFAAEALKAKDSD
YVPAGSDAVIAHTKVIGGGEETTITFDAPEAGTYDFICSFPAHAAMMKGKFIVE
>OBAHECAF_01732 hypothetical protein
MPIVILTICVVFIVYTLFDLIKNVQLDKRQKVTFAFLICAFPLLGSFVYVYSKFLFIKK
>OBAHECAF_01733 Sugar phosphatase YbiV
MMIKLIVSDIDGTLVNKFKEIPPLFWEVFKLIQQKDIRFCAASGRQIQSLEQLFAPIQQQ
IAFASDNGALVKYQDKVLHENSIEKTLLKPILETCESIEGIAVALCGKRKAYVKTENIRL
YEEIYLHYPAIEHVTDFNMVDDDILKVTVCDEKGSQQNSYPKLKIYECDFKVVISGDMWL
DITAKEVNKGVAVSILQKMWGILPEETLVFGDQMNDIEMMAQAKFSYAMKNAHEEVKKIA
SFITDYDNNDSGVPRKILELIS
>OBAHECAF_01734 Carbonic anhydrase 2
MLNSYDDVFKNNKKWVEKKLKENPSFFKELAETQNPDYLYIGCSDSRVTAEELMGMKPGE
VFVHRNVGNIVNNIDMNVAAVIQYAVEHLRVKHIIVCGHYECGGVKAAMIPQNMGLLNPW
LRNIRDVYRLHQVELDRIDDEQLRYDRLVELNVQEQCINVIKMACVQERYIIEEYPIVHG
WVFDLKNGNLIDLQIDYKRIMKDIQKIYDLTNCKWMMQHKK
>OBAHECAF_01735 Endonuclease MutS2
MNIGDHIEVLDDTIRGKIVKIKDQEATILTTDGFELIFLLSELVKINENNMIRVPISDMN
HDFLAKNIEKKKKIIPRKDKKFPPMEVDLHIHQLTNSTKNMTNHDMLTLQLETARRQLEF
AIEKRIQRVVFIHGVGEGVLRTELEYLLGRYPVKFYDAEYAKYGIGATEVYIFQNAN
>OBAHECAF_01736 hypothetical protein
MKNKWIYLLMALGATMAFTRSFFKGYEQLLLIGGMALLMFGIYNISRKLNSKTSDPYPMP
QKEKTIPYPHSKIESEVKTETQQQQEKK
>OBAHECAF_01737 Nicotinate phosphoribosyltransferase 2
MSQENYRVFNSILDNDFYKFTMQCAVVKLFPNTKGRYKFINRGKHEFPEGFAQAMQQSVN
QMSQLKLTKEEKAFLKASCPYLNPAYIDFLEGYRYDPSEVKITQNGSDFQMEVEGLWYRT
ILWEVPLLAMVSELYYKLTNATQWSDGQIIENTIEKVKFYENLGVVFAEFGTRRRHSYYV
HNLVMQTLTKSQKYNFSGSSNVHLAMKYQVKPIGTHAHEWFMFHAAEYGYKMSNALSLEH
WVDVFRGDLGIALSDTYTTDVFFKQFDKKFSKLFDGVRHDSGDPIVFAEKTIEHYKKFGI
NPLSKYIIFSDGLNPEKVKSIAEACKGKIGISFGIGTNLTNDVGLRPMNIVMKLTEVLTR
DNEWVSTVKLSDEPNKHTGDPRMIELAKELLQIK
>OBAHECAF_01738 hypothetical protein
MFQYYIIFMNRFLLTIVLLFTAFIAKSQELNDFTVTPELGDCYSDSKLKVSLGAGNYAPA
QLTVELQQPSVPGVPPTKTQEFTSSEHIFGSLQPGVYTVTVINENGWVRSQPKTVTIAVT
YTSTELIKWKITPPSCNNNNDAKVAFTIVRNTGKGPSFAVSITDLSGNVLVPAQIFTRTS
ANSDLNITVQGNATHPLAENQPVFVNVQDMTGTTPNCELRRERVTIPAVDLAVNCVKIVK
MDGQSRIQTNMDCKRRISFRIRREDDGNMAPVHKYIRENSGVAVVKRTKRDALGNIVEQA
EYDITSSFSAGYNIVAEYNSFVSDYVFEDGDEIEVTVNIGTEPIQEKFVLTPMDPMQIVA
ADKNQRPIGIANYSHLDELCQNRKLLYVAPYYQKVEFPNAANPADPAGYHKYEWYQNLGL
FLTDDELYNQGKEGYYFEIYKWEGTGSANIDATTGWRRKTQVAIPSTHPLYMPHDVESTL
VWNSRHDVVDVTNIGEGHYKVVYKKTGSQSCYAPQAMINFQPIPPQISQFFDGLYVGKGL
FENTVSFRKWISAVSFNYPLEVTIEPISVPGATPAIPPGGTYTMTFNTSLPLDNGVEHQR
SIVFPVKKTILNEAVVNNNVMYGDFPKGIYRITVKDKCGNTDSRDINFEVGMTLGENYVK
PVLGCEASEIEYSMGSNLRRGSVLWASIILEKKNADGTYRSITSQRLDMNAPKGKFTGLE
PGEYRVRAYSFSYDKHAVWKRSGSNYILEPLAPTNVMGVAGYTLIPEYRNVLRLNSPEFQ
RGSVLQVEIEKELKITKTEPLQVNASGTSCGTAAGTGMAIVYVQNREHIRYPLTFALYKQ
DGTEVASATYDADSEVDSHVFRNLPDGDYIVKLSHECTVSNYDVRVKADTYAPPRIIVAP
QSQNPCNGDVVKLTFSGSEVLFNIEWFKIKTDGSLESIGTGATITQTVMTSTQFQAGYTL
KDTSICGVAVGLTPPVTVAFIPDTTAPVISGCPTSPIVVNASANSCDAIVTWGTVTATDT
CGVTYTQTHQSGDRFTIGVHTVTYVFTDTSGNTSTCTFNVEVKSNALALDIQADYIDGNG
NVLNRDLALNEGFQYKIVYKNVGLDDLATATLTVDFSANPYINIGVPTYQPTTLPQTPTY
TNVGRVYTFVLPKEILKGNSGDRAIYIPLTMNATYAEIGAPCMNMFGAKYRIEYQRDNQL
CAAGIQTKTGVNPIEISTKNDIRSELFCVGSSLELKAKPGFTSYKWFKNGVEIPSATGSS
YIATEAAEYMVEKTTVCSDPTLGGNITVTCQEIIRFESFSSNLTADPIRALANGGATCGA
DGRWTSHFILCNEPSKVITVNFRDSNIQWQRFRATCSPPNDGRCQNYNNDCWESIPGATG
SSFTVNAAGRYRLKVSSANGCEAHYYFEVFMNGLSGEVIQPVGHITNYQPGHFNVKMATE
GVIYQYTIKDPNGQTYMDSSNAANIITYDQYNGGHDITVRGISVPGTYTIEVKSGSIANC
STTLRATVEERKNLTTTATVLSWSDCNNVKVRFGAQGGKAPYRFAIWKIDGVQRYPDYTS
IPDTAFIATIPEGSVQVDQDVHVTQLGRYIFVVKDANGAYAETVSPGEMIRPEGITDYAI
NVKNVACGDTSGVVSVTFTTAHPQDIITRLHRLQSGTRVQTFENASGIYAQGIVQGKYEL
EVIITQGSRVCTYVNPIEIGEDENTLKAFAGVVEDKSCDTTNSPKRYKVHINNVSGGTGT
GYMYKSEGGSYTTSNVVYLSGSGNVYVRDSAKCEIAIPVTITDIPSPEVNVSTVMYSCLG
KGTFTVTASPAGTYEYEVVGGGITERNTSGVFTLDAGNYSVYVYHQSGSSSATTPNVLFQ
EDFGTGNDTCNNSIIYMTCKPNEELQNSQYVITKQVTPRAEWTTPTDASGVVNGRYLAVN
ANSNQGNLGVIYTKNIKDIVAGQDVKVSVKLYNLLKSTYIGGVNPNLDFVLLTSGGVELK
RISLGQILADEKWHSRAVTFSSADIGTNTEVIFQIVSKEPVSTSVGSDVAVDDILIWQET
KVCNPRTDAKSVVIEAAKAFTVTGSAEDAACDGLGKLKLRIENRNGSDIVYSLDNANWTT
ITPTATSVSNVDTAVIPNLAAVTSGTVYVRKQNEPSCLVELTYTINALETVSITTQLLRV
ASCNPMNADVKVTATGGARPYQSVTAVPSGGISTVANMVNNEAVFDGARALAPGTYELRL
TDANGCVTTSTLKVDAPKTLTLEANSNNACLLPGEKAEVIIQVLDGNGNYRYSKDGVNFT
PPSATAEYTFEDLNPGVYVFKVIDGANCSTTITVDIPEPLTLNVQPTRALTCATGSNAVF
ELNASGGDPAQPKQFLWSNDGVSYVSTNAAGITMTASGNRATFTTNVEGIYYFKVVVGSC
ERIVSRQEVKISRPQFKTTLTKVDAVCHGSETGRINVSLNDIQGGTAPYQLLLFDGVSTT
TQAVGNIVNLKANTYRLTVRDANNCLSDSQTITIGDAPQLNVTVTTQDVRCIRGAGGGIS
NGEVEINLVSGGVASFSIELHYKDVPHGTALFNQSNVNIGDVIRIPNLIPHEYEYTITDA
NGCITKNTFHIHGTSDRIVAKADVVPGCDTASLVVSAYSSAAGSSIAAGSHWIAIYKQGM
QTPSGNPSSSSTWIVGGNTWYAGTVTNVTTVSGTTVSGTTATIPGLTPGTKYRFIVYDSS
TGCYVIEEVTEVPTPSSKLNIKLAPTTTTCRGSNDGKIDFEVKGMNSAIKSLEYQVYYYA
THELVLGAVGSVTITGPVTPATTQTGTITGLPAGKLYVVFTENTGGGGTYCRKASEPVVV
PQAPMELVIQDLSIINDNCQAGGQGSISVDVRHGVAPYKYYYHNESALGIPPVVGSPALT
TLINNSTDGHTVSGLDRGTWHVFVRDNNGCIKTQTVTVDEDKAPEISSVVLDNPCTSDKT
AYSVRLNLTKVGTGQHYYRVKLGGTPTADWMPMSVSPYATSVSLPVRLQPSTQTYTIELK
DANGCPTSGDIKLYSQVKYEVVTPLIHCGAVSADIVIKNLTGGSGKYAYTINKVETVLDP
INHTTSEIFVPITGVKTTTAGTVTVTISPAVLVGSYAIRLYDEATRSQTSVCPEVRNFSI
DLPEIPEMEVLSLTNPTCSTGTGSARVKVSPSVLAPYTFTIENPTTSTVLPATSSGVDYA
VFDGLSGSLTGETYIVSAVATNGCVVTKTVVVTTPAPLVLAPNALTMESYQCVGNTTSLP
TLTFDLSKVSGGTQSYTRVEFYEQSSITPVNIKVISQGTTSYTYTLTDHVAATQTYTVKV
FDANGCEVITPAVTVTPTLVLSSVTATRSVEIDCTTNQEVVSVTVTTSVYNGETLLYEVI
KRNANGTETTEFTRSVATTTQVFSLPIGNYTIRVTNPATNCFVTTAYDVHEPNSFLFTAS
NIVNVKCYGEATGAVTLNFSDMRLGDGNHAAAGFEFVISPVTGSAGSTVTGTVTGGTVTT
VTNLLAGNYQMIAKALSNQCSTEPVAFEILQSERPLAATATQTYGVTCLDNKGEILIKVT
GGEAPYQVILHGSSGYVSSPQIGGNIITNEGEFLFTGLTSNGSSQVYTVQVIDRNGSGCQ
DNSVTITLVHPTPITATATVIQNVTCKDAANGIIEIANVAGGSGSPTYFFELRQGTATVI
TQESPRFENLAPGEYEVWVMDAWNCDQKIGELNVTEPEELSLKVVSAELVVCHGEATAWI
NYEVHGGTAPYEVSIVKAVTGAVISTDTAFLGNVARGLSKGKYEVHITDAQGCTMSPVYE
FEVEETPNLEATATQIHDCQDNKYTTWIEVKFKHTVDPMKLSYKLGSKSERVFARFDTKR
NVAIINANGIDQTQPLQVLTIFHRDEIAATGQVVLCSYTLGDPVKIENLMQLDEVKRVAN
DEINTIQVAGKDGQYPYTYVFNGQNQGGNGVYKLKITDPEEVGEDGKRYKVIDVIIYDAV
GCTVTATIKELFHDITIPNYFTPDGDGNNDTWTPKYIDEYPYARTHIFDRYGRKIKTLKV
GESWDGIYNGKPLPSGDYWYLLELNSDIDPRKFKGNFTIYR
>OBAHECAF_01739 hypothetical protein
MILTTTPTLEGKPIKEYKGIVTGETIIGANAIKDFMAGLTDFFGGRSRTYEKVLVEAKNT
ALVELQQRAMAMGANAVVGIDLDYETLGNNGGMLMVTASGTAVVI
>OBAHECAF_01740 Cytochrome c biogenesis protein CcsA
MKRLVSIKMSVILLLLLALSMAVATFVENDFGTLVARAFVYEAWWFELIMIWLSINFLFH
IKRYRLFSKSKLPVGLLHLAFILIIIGAGVTRYFSKEGMVHIRENQTVTSYTTNEKYIQF
QTENAYFYKKSQPIPYFFSEETMQIADNDNHFECVLTEYLPKAVQKFVDGEESFLEIVML
ETDEESSYHLMKSGQSQKVDNYSLAFQSDEEHVFKIQKNENNWQLWSAIPLHTIHLESQQ
MSSFSPQQWTNIMPHTVYRWSGGSFMIEAIHDNKKLVYEPLGKNDKAEKEVSVVKLEVRN
EGKLITESYFSATKNIPEWQWFDYQGERYAYTYASKQIALPFALKLNKFHLKRYPGSESA
ESYTSYVEVIDGDKSFSYNIFMNNVLDYQSYRFYQSSYDKDEKGTLLSLNKDREGTIITY
LGYGVLFFAMFWLLFAYGSRFSFLNRNLKKIKTLDIGKLHSVLFMFFVLPSFAQSGGYLE
EHIIPQEKAQEYGRLIVQDFDGRMKPLTTLAYEITRKLTGKTSVDLNTHEGKKIEISPEQ
FLIALQKSPETFAEKPLIKINTDKGAIVFNILNINQKRMLQFTDFLDASGAYLLKDVVEE
TNRLKPAQRSESQKELLKVDERFNILYNVFTGNFLRLYPNTKSQNNKWLTADQFSEFEEQ
DADFVKNIHNFYIAGLEKGMQTNDFSEADQALSYLATYQKEAGKNVYPTKNEVEAEIFYT
RTRIGNYLFGICILLGGVLLIFNILSLFLSAKWLQNTLTVGSILACIIWVVFTFDLGLRW
YIAKHPPWSDGFEMLLFVSWGILLFGLLFVRKSSFTLPLGLLFSGTLLLVSFLDWLNPEI
TTLKPVLYSYWLKIHVTVIVGSYAPLGLSFVIALLSMILLIFKPLQPKKTWWRGMQEMIV
VQEMAVTIGLFLLTAGTFLGGIWANESWGRYWAWDPKETWALISIIVYSVVVHLRLIPKF
RNALVYYLVTMWAFSTIVMTSFGVNYYLVGLHSYATGDPIPIPKWVYFVVALLVVISVFA
WYSYKKMPQEERNKLYSN
>OBAHECAF_01741 Dipeptidyl-peptidase 7
MKKIIVAIVAAFTFVPSVIRADEGMWFLMFIERLNQRDMQKKGLQLTAKEIYDINNNSLK
DAIVQFNGGCTASIISPRGLVLTNHHCGYRQIAEVSTPENNYLRDGFWSKSDQDDIKPSS
LYVRFFVRMDNVTERMLAVVNDQMSEKDREAALNRETAKIIKENSENGKYVVSVRPFFQG
NEYYYFVYQDYKDVRLVGTPEESIGKFGGDTDNWEWPRQTGDFSLFRVYTDKNGNAAEYA
ADNIPMKSKRHLAVSIKGIKENDFAMILGYPGRTNRWVPSHWVDQNVKYAYPAWVESSKA
AMDGMKPFMDADPAVRLMYASKYAQIANYWKNRQGMIEALTLHKTADVKRSYEAKFAKWA
RKKANRATYGDVLQTIATYFERTNERSADRNYLQTLFRATNFSVLPFELNNQLGKLVEAP
HMARITMAASIDERLSAVYDNMHIPAEKAILAKTLKLYAMKGKNLADEVEKINREYRGDF
DRFVEEAFSVSVVASKERVQEFMDNPNAERLKNDPLILLSKSLIAKLRESSEELNALEDA
YSKAYRKYVDGLRKSGISRIQYPDANSTLRLTYGTVKSLPADPRNADASLNNYTTFKSMV
AKYKPNDSEFDMPKRLVEMYDKNDFGRYLDKDGTMHVNFLTDNDITGGNSGSPVMNGKGE
LIGLAFDGNIEAMAGDVIFDPKLQRTINVDIRYVLWVIDKYAGAKHIVDEMTIVE
>OBAHECAF_01742 Fe(3+) dicitrate transport protein FecA
MRKNNSISLAKNILIGSMSSFLLLNAENKLYAYSEKLNSKSIQTAQFQIEGQVTNDKGEA
MAGVSIFIKGNPHKGTLSDSNGHFSLTISPNEILVFKHLGYQTKEVSVGNNSSLNIVLLL
ETEQLSEVTVTSTGTKRNIKDFTGTVNVVSASQIKELAIPSVGDAVRFIPGANYQDEDGR
GLRPSIGLRGLDPSRSTSTLVLVDGKIPIGQSYTDMATYYMMPVGAIESVEVIKGASPVL
YGSGSIGGVLNIITKKGGQTPKSSVNLQYGNGNAINIGAETSGSVSDMTYYAGYHRKQGD
GLRTSRSKFAVNDLTLNLEGNFGEKHQWKIFLNAFTEDSDTPGGLNQKQWEENPKQSVNP
YDFFEARRFSGTFSYKRIFDENNSLTSAVYGSYLERDWWLDNRHSDPAKRKFTAALRNIP
SIGIFSDYERLNDLWGHKNKLLAGIRLHGDITNMISVAGDEFGVKSGKETSSSVNAISVM
EGYIFDEFFLNDQFSISPALRYTHADYGVKNYTAGSWRSATEKALTYSFGAFYKFSEQYR
IYATYSKGYQMPRFRDAMEASEDLNAESSNNYEIGFRTQPAEWIDLDLSAYILDFDNKIV
RESGLLKNGVKSLHQGIEGSGNIYLSKNIKLYGNASIQKATFSTGTYKGNRLPYAPKYMA
SAGIRHQIEIGTGVLSTNVYGNFVSTQFSDVANTEAGSANGNIGAIPRYYLLNATINYRI
GNWNFNANGLNLLNRTYFTSRHSSWGGIMPASTINVAVGASYSF
>OBAHECAF_01743 Na(+)-translocating NADH-quinone reductase subunit A
MSNDIRIRKGLDIRLEGEADKAIKQLPLAKTYGIKPDDFHRIIPKLIVREGSEVKAGEAL
FHSKSDERILFPSPVSGKVTEIVRGERRRILEIRIEANGQEFKDFGKKNVQELSAEQIKD
HLLASGCWPFIKQRPYDVIANPDDKPKAIFVSACKTNPLAPDYDYALKGKEVQLQVALSA
LAKLTTGKVHVSVFKDSSLSPFRNFKDIVLHNVSGPHPAGNVSTQIAKIDPINKGEVVWV
VTPQDLVVIGELFLSGHFNITRTLALTGSCVEKPQYVSVVAGAQVSSVVNGNVKSSGTRV
ISGDVLTGKKVSEDGFLGYYDDQITAIPEGDDYEFFGWNKPVFNKISTTRAMTFSWLNPK
KKYNLNTNTNGEHRAFVMTGMYEEVFPLDIYPMQLLKACLYKDLDELENLGAYEVAPEDF
ALTEFVCVSKQPHQKIIREGLDLMMQELG
>OBAHECAF_01744 hypothetical protein
MTKYYQPSGKYSPVAFVYFLLVSLFVLPLLGGIYAYATWYIPLVYINVLITIMFGFAIAG
VIANLVIKLGKVRNYALGVIFTLLGALVAYYAQWIVWADLALNTTDTIGNNRIGVAISNV
NFGELFHLLLNPSDLFSLIAEINSVGTWGVKGSTVNGIFLSIVWVAEIIVIFYAAFLGTK
NQAKRPFSEVADKWFKEEKLPLLSYIEDQESFKSDLESGDYERISELTLSDKKQSHSFFV
LYALEGVYYVSVINNKAQQDDKGKIKFETKNLIQYMRIDKTAYDALKLRVRA
>OBAHECAF_01745 Na(+)-translocating NADH-quinone reductase subunit B
MSLKSKLHTLKEKYKGTKLETTFNALHTFLYMPNETTHGGTHIKAADDLKRTMNTVIMAL
IPCLIFGIFNAGYQHYAATGEFAHAAGLSFFSPDFWTWKNFSLGAMKVLPLVVVSYAVGL
GIEFIFATLRGHEVEEGYLVTGMLVPLIVPVDLPLWMLAVAVAFGVIIGKEVFGGTGMNI
LNPALTIRAFLFFAYPTSMSGDKIWVHGATERAGEIAKGANLDAISGETILGHLAQQHNI
ADKFSVSDMFFGFTPGSIGETSTLLIILAGLFLIFTKIGSWRIMLSMVLGGLAMGYIFNA
FAPAMEGTKFFTLWSLPAWQHLLVGGFAFGTVFMATDPVTASQTNTGKYIYGFLAGFISI
MIRCFNPAYPEGVMLAILLMNVFAPTIDHYVVQANVARRKKRLKAKTA
>OBAHECAF_01746 Na(+)-translocating NADH-quinone reductase subunit C
MSNRTESNSYTVIFAIIMVIIVGALLAGVSSALSDKISENRKFEKQQNVLYAMGVNRNQN
TNLGEGDVTFVPTNEVTAEFKKYIKGQYFIKGNQAVEADLIEDPKWTAEKGLPLFVGEKD
SKTFYIIPVFGKGLWDAIWGYVAVDKDLIVQGVFFDHKGETAGLGSNIKERFFMDDFIGE
HLLDASGNFQSVEGSKSNGDPENKRKEDGKVDAIAGATLTVNGVNEMVKTGVGAYVDYIK
NLKN
>OBAHECAF_01747 Na(+)-translocating NADH-quinone reductase subunit D
MGLSKKDVKLVTDPLWDNNPITVQVLGICSALAITAQLKAAIVMGLSVIFVLSVGNVVIS
LIRNVIPGKIRIIVQLLVVAALVIIVDQVLKAFSYELSKQLSVFVGLIITNCIIMGRFEA
FALGNTPWKSFLDGIGNAGGYALALVIVAFFRELLGSGTLLGFQVLGDPIKKTGLYALGY
ENNGFMLLAPMALITYGIVIWIQRTRNKSLIEE
>OBAHECAF_01748 Na(+)-translocating NADH-quinone reductase subunit E
MEYIELIFKSIFVDNMVFATFLGMCSYLAVSKKVSTAVGLGAAVIFVLAVTVPMNWLLNE
YLLKEGALAWLGEEYASYDLSFLTYILFIATVATMVQLVEIIVEKFAPALYNSLGIFLPL
IAVNCAILGGSLFMQSREIPTIGLAATYGLASGIGWFLAIVAIAAIREKIRYSNVPPALR
GLGITFIITGLMAIGFMSFGGMLTGGEKKSDEDKKAVIEQKVDKTEKLANNTKEIK
>OBAHECAF_01749 Na(+)-translocating NADH-quinone reductase subunit F
MVLSSSIFVTVAVTVIALLVITLLLVALLLVVKQKLAPSGPVKIKINGEKVIEVPSGGSL
LSTLGNQKIFLPSACGGGGSCIQCECHVLSGGGEALPTETPHFTKKELKEGARLACQVKV
KQDMEISIPEEIFGIKKWEAVVVRNYNVASFIKEFVVEIPEDMDYKPGGYIQIEIPPCEI
KYSDIDITAHPAEHPGEPEKFKMEWDKFNLWPLVMKNGETVERAYSMASYPAEGREIMLN
VRIATPPWDRAKNGWMNVNPGVASSYIFSRKKGDKVVISGPYGEFFINESNAEMLYVGGG
AGMAPMRSHLYHLFKTLKTGRKVTYWYGGRSKRELFYLEHFWELEREFPNFKFFIVLSEP
LPEDNWKVKKDINDTEGDGFTGFVHNAVIDQYLSKHEAPEDIELYFCGPPMMNKAVQKMG
QDFGLPDENIRFDDFGG
>OBAHECAF_01750 HTH-type transcriptional regulator DegA
MKKKISIKDIARELNVSISTVSKALNNSGEISKEITERIKAFAKLHNYRPNSIALSLKNK
KSKTVGVIIPEIAHDFFSTVVSGIASVAEEKGYNIVTCFSNELFEQEVKNIETLMQTGID
GFIVALSKGSEAKKDYHHLREILNQELSLVLIDRVAQDIYCDKVIVDDAMASYRAVNHLI
QAGYHRIGLLTVPNYISVANLRTQGYKNALSDAQIPIDESLILAVEDVHSDTIISEFFDK
CKFDALLCNNEFLAVRAVREAHDRNIKIPQELGIITFADGSLAKYSYPKLTAIDQHGAEI
GKKAMELLVESIENTNQDRNFRTEIIKTSLQIRESTR
>OBAHECAF_01751 H(+)/Cl(-) exchange transporter ClcA
MGLKKRSLFVRFLFWKAKNLTNRQFILILCAVIGVVSGVFAVFIKKVTLLIQFVLQNGLV
ASYHRAFYFVFPTIGFLIVYFILRYVIRKRLEPGIPYTLYAMSKLKGIIPTYHTYGSLVT
APFTVGFGGSVGLEGPMVISGAGFSSYLSRLFHVNQSDRTLLIACACSATMAAMFKAPVA
AIVFAIEVFSLELTLMSLLPLMASSLLAVLTSYFFLGNEILMPINLDGEFTLADVPYYIV
LGILTGAVSIYFCTIFQRITAYFEEIDSLIKRLFFGGLMIGLVVFFIPPLYGEGFEVMNK
LISGNPKEVLQNAFNWEVDNPWSIIALMLGLVLFKVVAMATTVGAGGVGGVFAPALFTGG
ILGNLVARTINQLPFLGHSVPLASFTLVAMAGLVAGVLHAPLTAIFLIAELTGGHTLFVP
LMIVASVSFALSKYYLKHSLYTKRLAQEGNLITHDKDHKVLTLMDIDAVIEKNFIPVTAQ
MNLGELIEKAITKSNRNIFPVVNAQNQSFEGIILLDDIRQMMFNQALYDQIKVGDLMHQP
PAIICLGVDKMPDIMQKFQDTGAWNLPVVKEGAYIGFVSKSKLLTIYRRKLIYFSN
>OBAHECAF_01752 hypothetical protein
MNSKIIANGILRAVGIMVLVVLSLYALSLLKSILIYIVLALIITLLGKPFVFFFHRRLKI
RSKSVCVILTMTIFIILSLGVFSLFIPLLISQGKNLSGLNIDLLRTNLDNLLLHFFKLTG
VSKDEEETLLSVSDALNFIDIPNLINSFISFIGSFGAGLFSVLFITFFFMKDNTSLMKST
LSLLPNSQVKRTRTSIVKINSLLSRYFAGLILQLTILFVIYTIVLLIFGVQNPFIIAFLC
ALLNLIPYIGPIIAFVLMALLTMSSNIDNDFMSVTLPTTIYVLIGFLIGQFIDNVFSQPL
IFSNSVKSSPLEIFLIILICGTLFGVIGMVIAIPAYTVLKVILKEFLPNNKIVKILTKNF
>OBAHECAF_01753 Ribosomal RNA small subunit methyltransferase E
MQLFYNANIDENDHNFYFDKEESQHIVKVLRKKEGDQLYITNGKGYLFEGKITLATTKRC
EGNILNVKYKEKHFYNLHLVVAPTKMNERYEWFLEKAVEIGVDEITPVICQHSKRTVVKT
ERLEKIILSAMKQSLQFHLPKLNEPISALDFFHRYKDEKSSKYIAHCQEEKKVLFSKILH
PFPQKLIVLIGPEGDFSNEEIKTAFSTGFQAISLGENRLRTETAAIVACNVVATMATL
>OBAHECAF_01754 Chaperone SurA
MNRKIITAIGMLFFACGLFAQNEEITSSQKRIKVEGVAAVVGDYLILESDIDKAFAELQQ
QEVDIKNITRCELLGKLMEDRLFAHQAVQDSIPVTDSEVRESVNKRVAFLVERIGSMKKL
LEFYNKDNEQDMREELFNLFKLNMLSQRMKGEVVKNVEVTPEEVRLFFNAIPEEERPIFG
TELEIAQIVIDPVAPKSEVQKVIDRLNEIKADVEQTGSSFSMKAILYSQDRGTGGEMLTF
NRNSPYDKTFKDVAFTLQEGEISKPFESSFGWHIIEMVRIRGKEVSVRHILLVPDVPRTA
LVEAKEKIEKIKERIDNKEFTFSDAARNFSDEKETKGNGGQLVNPDDLSSRFELTRMEPV
LYNRVSKLGDNEVSIAYLDEDANGKKRYKIYQVTNRHEEHKADFVKDYVKIQDLTLKEKQ
LKTIAKWINEKVEKTHIVVKGTYKDCNFSNNWLKK
>OBAHECAF_01755 hypothetical protein
MKIKKYIWLFLGIFIVVSCDYFVKEKPKHAIARVGDIYLYKDEIKSIMPIDYTKEDSINI
VQKYINSWAIKELMLSNAERNISDDEKADFERLVNDYRADLYLNSYKQGLINSSIDTLIK
EEDLQFFYEANKETFLLNESLIKLRYIHLSSAEKQKRVSALEEKLKRFNAEDRHELDSIG
LQFNSIYLGDSIWVKTESVVKKLPFLEEKLKENRIFFTNHKDSTGVYLVQVRNVLRKNEQ
APMEYVKPTLRQIILNQRKLEFVKELEADIINRGIKKKQFEIIYE
>OBAHECAF_01756 hypothetical protein
MTENEQIKYFNILLYFRIIIKSKKNIKLQPFYGASYFLGIYL
>OBAHECAF_01757 Signal peptidase I
MWIMESVEFLKKTIYLCLRFNLKSKFTLISKLETFGRSEFIGGDHLENFGDSRYWGLVPE
EYIAGKAWFIWKSNDLYTGKLRMERILKKLTK
>OBAHECAF_01758 hypothetical protein
MRHIIPLFLLVLLSCQEKNKKITVITQEKKDTREHVCNLQENINLVGNIKDFSFYDNSSF
FVLADNNIIEYTVMGEQLNVFNRMGQGPGEYVTPTLINIYNESIYIWCSSTLKLIEYDRK
GRFIRENFNYRKAIKNFKLLDENSVCFYKSDGQKDAIIEIYSLKEDKIIKSIQGELTDED
LLLLSVASKPNMIVERGNLYFTKPSELSLYHVDLKTFSLSKDAFFEDDEFIVKKVQDAHS
MFNTDPQGVLTYMAENSIVDNLLKVGDNFYIKSEIGKYVIDFQKRKMEADQRFDKYYLCD
FRRPNVENIKAIKESKNRGTHRYALFGSDTYLLEVDNSNEDEQERMKVYKLNF
>OBAHECAF_01759 hypothetical protein
MKFYTILFVTLALFSCSSNQKNEIETKSPSPLIMESVETPKELFRPSKVIANEKYVIVFN
NVHEQMFNVFSPELKYLYSFGNIGQGPNDLNMVIQESFELEGNEFSMLDMRSFVTYQLGD
TTAVGKDKQHIISEESVFNKAKKLSNDSFIFLPYSYKENQSDIHKYDFKDGKITDFGEKI
SPKPEEIQEPYLLSSILSVNKNNQRVAQFYQHKPEFKIYDFQGKVLHKGAVSIEQTDDKR
LYFAEVYSTESFIYVLWVNSTKENVMKHMDKFRPELMVFDWEGNLLEQFKFNIPVISFAV
TPDEKMMVATSLKETDVNTLYKVKLPR
>OBAHECAF_01760 Small ribosomal subunit biogenesis GTPase RsgA
MNGVVYKSTGSWYSVKAEDGVFYQCRIKGRFRIKDIKNTNPIAVGDGVSFELEKSGNGVI
FDIHERKNYIIRKSVNLSKQTHIIASNIDIAFLVVTLNNPPTLTAFIDRFLVTAEAYSIR
TILLFNKIDTYTPEELDEVKYLAATYRQIGYECLGISAITHKNIDKLKELMQNNTCVISG
HSGVGKSTLINAIAPELNLKTASLSVQFQQGQHTTTFAQMYDLDFGGRIIDTPGIKGFGM
VDIEKEELTDYFPEFFRLKSECKFNNCLHIDEPKCAVKTALENDLISWSRYKNYLQILKG
EEEHYRTDEGEEES
>OBAHECAF_01761 hypothetical protein
MAKKTVATLQGKSKKLTKAIKMVKSPKTGAYTFVESVMAPELVDDFLKKK
>OBAHECAF_01762 50S ribosomal protein L33
MAKKGNRIQVIMECTEHKESGMPGTSRYITTKNKKNTPDRLELKKFNPILKRVTVHKEIK
>OBAHECAF_01763 50S ribosomal protein L28
MARVCELTGKKALVGNNVSHAMNKTKRKFNVNLRTKRFYIPEEDRWITLKVSTSAIKTIN
KKGISAVLREVERNGYI
>OBAHECAF_01764 Ycf48-like protein
MKRFLHAICCMILISCQNQNNDLQGIEIKERHTFSLEGKSVRAMVLLDKNIGFAGSGGVL
GFINTQNLTMEKTDFLDVEYRSVAATTNDFYMLSVGSPAMLFSTQSDGFKKMYEETHEKA
FYDSMLFLDNQFGIAVGDPTDDCMSVLTTHDGGKTWQKKSCDQAPKLAVGEALFAASNSN
IANVENLIWVITGGSKSRIFSSEDKGVTWKSTNLPIVQGNPSQGAFSVSFYDKNNGIVMG
GDYKNPTLKAKSGAITTDGGKTWQVIDETSSPGYISCVRYIPNSEGKGLVATSSSNGIWS
SVDSGKTWKKISEKGYHSLLFIDENTLVASGNEEIALFKYKKY
>OBAHECAF_01765 Porphobilinogen deaminase
MSKKIRIGSRDSELALWQARLVENKLNALNYETEIVAVKSEGDLILDKPLYEMGITGIFT
KTLDIAMLKKQVDIAVHSMKDVPTALPKGIVQKAVLKRANVHDILVFKENTLFLENPEAT
IATGSLRRKAQWLHRFPTHEVVNLRGNVNTRLQKLNDNNWNGAIFASAGLERIDKKPENH
VVLDWMIPAPAQGAMVVVVNEDDSFSCGAVAKLNDRETDICTHIERQFLRVLEGGCTAPI
GAFAHFEGNKIMFQGALFSLDGKQKISVSKAISETDFHEFGKQCAEEILSKGGAEIIKNI
TLKNK
>OBAHECAF_01766 2-oxoisovalerate dehydrogenase subunit beta
MRTIQFREAICEAMSEEMRRDESIYLMGEEVAEYNGAYKASKGMLDEFGPKRVIDTPIAE
AGFAGISVGAAMNGNRPIVEFMTFNFSLVAIDQIINNAAKMRQMSGGQFNIPIVFRGPTA
SAGQLGATHSQAFENWFANTPGLKVVVPSTPYDAKGLLKAAIRDNDPVIFMESEQMYGDK
GEVPEGEYVLPLGVADVKREGKDVTIVSFGKIIKEAFVAADILAKEGIECEIIDLRTVRP
MDKEAIFNSVKKTNRLVILEEAWPFASVASEITYQVQENVFDFLDAPIQRITTADAPAPY
SPALLKEWLPNANDVVKAVHKVMYK
>OBAHECAF_01767 Bifunctional ligase/repressor BirA
MKIIKLASVDSTNVFLKKMVNSGEGLSNFLTVWTPNQTQGVGQYGAKWMAEPYKNLTFSV
LYIHENFDLERYFVLNMLTSIAIVTTLKSLGVPNLHIKWPNDILSNKYKIGGVLIENIIR
GGKIEKSIIGIGLNVNQTNFEGLPKASSLKNETGKSFDIEEIINKIVVNLQQTFSQIDFS
FQELYPAYRSHLFRLNEVSAFRPQQGSDFSGIIRRVLPSGELVVETEEGEKHFSLKEVQL
LY
>OBAHECAF_01768 hypothetical protein
MNKLNTSIRTTEIDDVSDLLLVLYRKETALQEEAFLKSTFAEIETLSHQITEAIKRDVSL
SKQEEADLRRDNLVRSLNAALLGYCALPIPQLKENGEKLFAVFSKYGVKITKEAYAVESS
LIESLLKDLSAPELESAIASLQGIKEIISQLRNEQTAFTELRAEYEKSISEQKNTPSASS
LKKPLLEAINGKLIPYLIAMKIANPTQYSSLANAVEQVIDTTNSTIKRRNNQGKGDSETK
K
>OBAHECAF_01769 hypothetical protein
MDNNSREKILKKAKLESELSDLKQHADKMIRGFEKFNNKSSNRAIWELIQNACDLTSECE
VILDYTNGFSFTHNGKPFTPKSLISLIKQVSGKYGEESENPQVGKYGTGFLTTHTFGRKF
QINSILEAEDLYFEIKDFLIDRSPKEWEELSKNISNQQNEVYRIIESQTPISNPETKTTF
TFLPETEQERTYILESRKHLEDYIPIVLTINDRLKKVTIIQNDNKTLFERTSKEKIQNDK
GIELHKTIISVNGNPRTLYSIVENDSQIEVILPINEELDLFEFSKEIARLFLYYPLIGSE
DFGLNFIINCNKFSPTEPRDGIHLQSNKDQVKDQEEANRKIIKKVSQLIFDFLKSNVLEV
SNPHLYAKINFKRDTEDSELNKYFEILQKEWIKEYKLLSIVETTEGFKTIDEVRFFDEEL
LSSVEAFDDIYTLASKFYNNIPTKDNIILWSKFAKEWNDESIQFIGHKDLVDGISKKHLS
DFNKDCLINYYKNLIKENKKNYFSEYSLLPNLDGKFHSLSSLFKPQDLNETLIKIGRCLI
PDSIKCLIHEDFDFNYDLEKFNRRDFLISVKTKLDELEASKRIYFPENLNKESYNIQSIE
QLKELNQNLFKSLLDYCKLNNNINSKSKPTSLVKIISKYYSFDGNLIELSDLENSNENLD
IRSAMRILVQIFFNLLQCHNEDWVKNNIELLLEIAKCNEDSFKDVYSNSKIYPNQLNQLK
CISELKKEDNINSEIKDLYKKVVGKEIREELIYNGFNEFITEDRRVTTKQLTTEIEEIFF
NNDIANINQHPFKNDILDIIKSSKGSDDLSLELFPRLDDRKANIMLEVVTDENTKDDIFS
IVSLGESDLKKLGKLIQEDNFSTLLDKATNLLQQENQTKADFQHKYEIGTRIENLIRERL
SSELKNRVSFKNEKELKTTDQQGGQDIVIYFDNDPIYYIEVKSRWDSKNSVSMSKLQLQR
AVEENEHYALCVVDITRYEGGNDRYKLTIEEILPLTKFVTNIGDMIKPLIEVNLEAENQQ
TESIHLVDYRGIVPQEIIQSKGGNLNSIVNTIVGFISNNKS
>OBAHECAF_01770 Valine--tRNA ligase
MEIPSKYLPNSVEAKWYEYWMKHNFFHSTPDERTPYTIVIPPPNVTGILHMGHMLNNTIQ
DVLIRRARLKGFNACWVPGTDHASIATEAKVVAKLKEQGIDKANLTREEFLKHAWDWTHQ
YGGVILEQLKKLGCSCDWDRTKFTLDDDLYASVIKVFVDLYNKGYIYRGYRMVNWDPEAK
TTLSDEEVIYKEQNGKLFYLKYKIEGSEEYLLVATTRPETIFGDIAVCINPNDERYKHLK
GKKVIVPIVNRVVPIIEDEYVDIEFGTGALKITPAHDKNDYEIGERHKLEIIDAFTDDAK
LNHHGLHYEGKDRFVVRKEIVKELEAKDLLLKTEDYLNKVGTSERTGAVIEQRPLDQWFL
KMEDLVKPAISGVLESEEINFFPKRYENTYRHWMENIRDWNISRQLWWGQQIPAYYYGNG
KEDFVVAETKEKALELAKAKSNNYSLTINDLKQDEDALDTWFSSWLWPMSVFGGILDPEN
EEYNYYYPTSDLVTAPDIIFFWVARMIMAGYEFKGKKPFTNVYFTGLVRDKQGRKMSKSL
GNSPDALKLIDDFGADGVRVGLLLSSAAGNDLLFDEALCQQGSGFANKIWNAFRLVKGWE
ISEANQSENNRIAIEWYRNKFQKVLAETEDDFAKYRISDALMKIYKLVWDDFCSWLLEMV
KPAYGQPIDQKTFAEIIAIFEDNLKLLHPFMPFITEEIWQHITERKPQEALVVAKYPEIT
SFDEQILAEFETAAEVISGIRTVRKEKNIPFKEEMPLSVLNNEQTATTFDVIIAKLGNLS
ELKYVSQKVEGAISFRVKSNEYFIPMQGNINVEEEIKKLEEELKYTQGFLASVEKKLSNE
KFVSSAPEKVVEMERKKLSDALAKIETIQESLKNLRG
>OBAHECAF_01771 hypothetical protein
MKKFLTFLFVATFGLVTYAQEATAEITFTAEEIDYGTIKAGSDGVRVFEFTNTGKAPLVI
ANATSSCGCTVPSFPKGKPIMPGEKGKIEVKYDTNRVGPISKTVTITSNAKTKPVVALRI
KGTVQQ
>OBAHECAF_01772 N utilization substance protein B 
MLTRRHVRVKVMQSIYAMELSQSQNLDKEVKFLQRSTEDMYNLYLLTFALFKELHKMASQ
QIEIAQRKYLATAAEKNPNRKFIDNRLLTMIVSNELLDETIDNARMNRWDLDSEYVKIIY
KKILESKCYNEYMAEKTTNFDKDKEFLINIFKEIIACEDKLYEYINDFNLTWTDDFPIVN
TFILKLLKGVKGNESEKYFVPKLYKNDEDKLFAQDLLKKVVLNDEKYQNYIDDKTQNWDK
ERVAKLDNIIIKMAICEFLRFPTIPVKVTLNEYLEIAKEYSTDKSNVFINGILDSLAKEF
DEKKELKKVGRGLL
>OBAHECAF_01773 hypothetical protein
MDPNFSNLLIPVLMLAVVYFLMIRPQMNRQKQERKFIQDMKKGDKVVTKGGMHGKIVELT
DDSCVIETLAGKIKFERSAISLEMSKKANATPSTEAK
>OBAHECAF_01774 Capsule biosynthesis protein CapA
MKRKLFLIFLLHFFAIKAQESNNSVSLLFMGDIMGHSPQIEGAYDNEKKAYDYIPVFEKV
KHIFQKHDFVIGNLEVTLAGKPFKGYPQFSSPDELAVACKESGIGVLVTANNHSCDRGKQ
GIIRTLDVLDSLQIAHTGTFRNQEEFEKNNLLVLSKNHITIGILNYTYGTNGLPIPKPTV
VNLIDLEKMKVDIQKAKEQVLDQLIVVIHWGVEYQQIQHKEQEKIADFLFNNGVDIIIGG
HPHVLQPMHYYPKNALHNGRLLVYSLGNFVSNQRKPNTDGGAMFELTLLKDEQGTHIVDS
GYHLVWVNRSPKENKKYLYEVLPCREYENANFKDLDVKAIESMKTFIQNSRDLFKRNTFI
EEK
>OBAHECAF_01778 hypothetical protein
MKDLIKIAFFVLVAPYLVFAMIKVVAEDALIF
>OBAHECAF_01779 hypothetical protein
MKKRHWLLLFTVFWFSLLYFIDFETWIVLSLPFMIVTFFYLLFSLIVCFYYVIINKDPRD
L
>OBAHECAF_01780 hypothetical protein
MAYTETTRTGYGRRLGNSLKNIIVGLVLLVAGTFTLFWNEGNYVKTKKALNEAAAEVVAL
VDINTINPEFEGKFIHASGFASPQDSIYDDLLGVRELAIGLSRKVEYYQWVEHSETETVQ
NMGGSEETITTYHYKKEWSSSPINSLDFHDPEYRNENFVLAELPDKEILNTNVHFGAYKL
PEFILQLIQNSTPAKINLSKEQNEILEKEAEKVRLSAKKRVRKSIEPSDSDQEQEKPKMT
HVNDNVLYIGKSFNKPGVGDVRVTVEKTEPTVISLLASVEGNSFEMYKASNGRTVVEVAK
GEVSAQQMFEAAHADNEEMTWGLRMLGAILIITAIRTMFGFVSMLFKVVPFLGNIVEKGV
YVVAGVVGIAWSLIVIATAWLFYRPVIAILLILIIIGIFVLLKRRKSKEPPLEQV
>OBAHECAF_01781 hypothetical protein
MENSLFTFLLFCIPALIVGGIAYYFFYLHIKNEEKRRLFLLQKENQKISLPLRLQAYERM
TLFLERISPQQLLLRIPARNLPKKEYETLLVHSIDEEFEHNLAQQIYLSENLWNIIRAAK
MATIQIIRKATHDEELEDSKAMTEFIFKEFINKPTPSSNALSHLKNEVREIL
>OBAHECAF_01782 LPS-assembly protein LptD
MQKRRRQIVLLISLLFISTCCWYTSSFASKKTGYAYFQTFSIIDTLKKANRLLKDTTNQN
RRILLDSLKRTKDTLPKDSLSKDSMSKKSKSILEDVVRYKAKDSIVFNKTKNSIILYNET
QVQYTDIDITSGITNIKYDLAEVYAGRIKDSVGELVQHPVFKQGDDIIEPDSIRFNYKTQ
RAIIRNAYTKQDENNIKGQIIKKENDSTYFMQNAIITTAEDLDDPDYYIKVRKAKFVPGK
KVVAGLSNMYIVDIPTPLAIPFAYYPMVSGRSSGLIFPTFGEANNRGYFIQNGGYYFVIS
DYFDLAVTGDYFTNGSYGFKAQSTYKKRYKFSGNFNFSYENQIYSIRGLPDYSNSMFYNI
QWTHSKDSKSNPNSNFSASVNLGSSRFYQNSYNQINSPNVLNNTLSSSVSYSKTFPSYPS
MNLSLTASHSQNTNTQSIEMTLPALRLSMERIYPFAKQGESKKGLLKNLNFQYSSQGDNR
FSTTDSLFFSKQMFSEAKNGFRHSIPVSTTTKLFKYITLGLNSSLNETWQFKTIRRTDFN
AASGRSGMDTINGFDRFLTYNMGASLGTTVYGTFQFKKDRKIQAIRHVMRPSMSYGYTPA
FDQYYENYISDAFGKVSQYTRFEGGIYGTPGLNESQSIGLSLSNTLEAKVRSKDSTEVEP
KKISLLNSLNFNTNYNVITKQFSPVTMTGGTTLFNGKLPLNFGATFNPYAIDANGRQLET
FNINNGGSLFRLTNANISTNYSFSNRNKSDKKTTDNRASGGRSDDLFGSSRPVNDNQVEE
KKEEPEDKKTKFYHARIPWDLNIAYSLSYSNMSRERRISNNSLMFSGNVELSPKLQVGIS
SGYDFVNKGITYTQFRFERDLNSFRMSFQFTPIGQYNSWYFFIGIKASMLSDLKIDKNKE
PDRLLR
>OBAHECAF_01783 hypothetical protein
MKTAKFYTKMLFYVTATFILMGCQKSLNDLNEGQTADSGETKEVALLQKKVNTTKRLVSD
DLSLLSFNSSYRDKLYDYIPSEKNIFSRFDLSEINNDNLAGVVIYTQSEKDEVDFSDVNQ
MLLYVRKEDGFRTFLFENKEGKLELNPKYTFHSNFISSNDIYDLYKIISPKSKAHCYTLL
NGKLAKALSLKESSLQFFVSTAMERSVCRPPCSEGEGTCIVVGAGDDLDGNWICSQSFED
FQEAECAEEQVSEVLKEDTSYSTTDILLSSYNFKYLFLERSNKGKEYIEMYYELSKQMKK
KLFNVKFSIYVYQALKNDVIPICNKLMYHPDSNEILISDEKYKILYERIDYIEKQLNNAE
SSKILNRFKKDLRFYKNKTTAQVYNSFKNS
>OBAHECAF_01784 Demethylmenaquinone methyltransferase
MSDKITPYKNSTDGKKKQVAQMFDSISGTYDGLNRVISWGSDIKWRKFVVEKVAELRPQK
VLDVATGTGDLAIALTEIDGVKVVGLDISEGMLTVGREKIAKKQLSNRVELILGDSENLP
FADNYFDAVTVAFGVRNFENLEKGLSEIFRVIRPGGRLVVLETSVPEKFPFRQGYFAYTK
FVMPLIGKVFSKDRSAYTYLSKSASAFPYGKKFKTILEKIGFANTKYYPKTLGGVATIYV
GNKSK
>OBAHECAF_01785 hypothetical protein
MKKRIFLLFFLFNILIAFGQLKSPLTNLENFDEKPLQWGYYFGGNMFDLKFDYRDLQYTN
TSLLEVQTHKMFGFNVGLTGSARLMKYIDLRLEPGLVYNRKEIYFYNMTEKRDYLRDVKS
TYIYIPLLVKFSAERWYNFKPYVTAGGSMTINLSSNQNLTIDNYDLVFRTKTNVFFYELG
FGLDIYTPFFRLSPSIRGLFSVRNELVPDHKPDSPWTKNLNGLKSRGFLINLTLE
>OBAHECAF_01786 hypothetical protein
MYNEMKRMMLIALIFSVFFGYSQDFKYPMASPRQVVSQQFSVTKISVDYGRPSVRGRKVF
GELVPFGKVWRVGANEATNITFQQNVLFGGKATKVGRYAIFITPEEKEWTVVLNYDADAW
GAYSYDPNENAIEIKVPVEKLKELQESLEITFEGISETKINLVIKWEYSKIQIPIEADKI
DEVNKIIEFLKEIKQVERDMGG
>OBAHECAF_01787 Chaperone protein HtpG
MKGNINVSVENIFPLIKKFLYSDHEIFLRELISNATDATLKLKHLTQIGEAKVEYGNPII
EVKIDKENKTLHIIDQGIGMSGEEVEKYINQIAFSGAEEFLEKYKDTAKDAGVIGHFGLG
FYSAFMVANQVEIITKSYTDAPAVKWTCDGSPEYTLEPAEKSERGTEIILHIAEDSTEFL
EEYRIEELLRKYNKFMPIPIKFGTKQEPLPRPENADENYKTEYQTVDNIVNNPNPAWTKQ
PADLQDEDYKNFYRELYPMQFDDPLFHIHLNVDYPFNLTGILYFPKLSMDMQIQKDRIQL
YQNQVFVTDNVEGIVPEFLTMLKGVIDSPDIPLNVSRSYLQADGNVKKIANYITRKVSDK
LKSLFNANREDFQSKWNDIKIVLEYGMLSEPKFYEKAGDFVLYPTVDDQYYTLSELKEAL
KDQQTDKDGKLVVLYAQNKEVQHAAIEEAKEKGYQVLLLDSPIVSHLIQKLEHDNENLTF
ARVDSAPISKLIQKEDTTISKFSEEEKTSLKESIEKSIPSEGFVVQLEDLDSDSTPFSIN
QPEFMRRMKEMSATGGGGMFGMGNFPEMYHLVVNTNSPLATLILNTADENEKQSLIKQAF
DLARLSQGLLKGKELTDFIKRNFQELK
>OBAHECAF_01788 Aminopeptidase C
MKKIALFFAVGSFFGATAQDNLIRAVAGNQSENAGFKFTPVINLERMEVKDQGSSGTCWS
YAGASFLESEMSRMGKKPVDLAEIYTARNTYIEKAKQYVRFHGNLDYGDGGELHDIINMY
AKYGAVPQYIYSGLNYGTSRNDFSEMQAVLKGFLEGLVKREKIKKLTPNWEKAFTAAIDA
YLGQVPETFLHAGKKYTPQTFAKEVVGINPDHYVEMISYEDQPKYKNVLMAVPDNWSFDQ
AYNVQMTDFVKVIDNALKKGFTVAWASDVSERYFSWRNGVAFVPEKDLDQMTLDEQKMLF
NAPPTQERTITAEMRQKAFDNYETTDDHAMHIVGLAKDQNGREYYIVKNSWGVNNDHQGY
LYVTKAFVTYKTTAIMLHKDGVPADILKNWKK
>OBAHECAF_01789 Prolyl tripeptidyl peptidase
MRKILSLILVSSMSYLTAQENLTYQKPSEEILQLADFERAPSVMMNSQRTWMVFSYRSTY
RNLEELNQEEIRLGGLRMNPNINASSNLTYINNLKVQKVGNKQTQQVKNLPENAKIAYLG
FSPDEKKMSFTHTTDKGLELWVLDLETATAKRLSSNLLNANFGMPYTWSPDGSFLLVRTL
VTNRPALQSEAKSVPKGPIVSVGTGQVSQNRTYQDLLKNKIDEFNFEVLVTSELKKIDLN
GKESLFKGAGMYLSESFSPDGNYLMITELKKPFSYIVPFNRFPRESKVYDVQGKEVALVN
SLPLIENMPKGFSSTHKGKRSMSWRSDKPHTLFFVEALDGGDQNQKAEFRDEVFQWEAPF
NQSPVSLIKLKQRFNSIIWGDEENTLVYELWYDTRNQKAILLNLKNNTQKVIIDRNYQDV
YNDPGSPQTIKNQWNRYVLQIQNGKTYWLGAGHTKEGQFPFLDELDLKTLKKNRLYTSKL
KNQKENIIEVLDIKKGDMLVSLQSATDYPNYFVKNYKKGKTTQLTFFKNPFESLKGIHKE
VINYTRKDGVALSGTLYLPKNYDFKKKEKLPLLIWAYPREYKSKNTAGQSTANPNEFTYP
YYGSFIYWVTKGYAVLDDAAFPIVGEDKQEPNDTFIEQLVANGEAAIDALDKLGYIDRKR
VAVGGHSYGAFMTANLLTHSDLFVCGIARSGAYNRTLTPFGFQSEQRNYWDAPEVYNTMS
PFMNAHKMKKPLLLIHGAADNNAGTFTFQTERYFQALKNLGAPVRMVLLPLESHGYQAKE
SILHTLWEQDQFLEKHLKAKK
>OBAHECAF_01790 hypothetical protein
MRSIFFLFGIFIMGMGYSQNILLPQKSSSSTFNSDGKWIIGGNIGANIDSERLDIQIAPR
VGYRIIENLELGASVSYTFRNTKSVSMRTLGVGPYLSYVYQGFVFGTSYQHLMSSTKVKI
TENIAKRSENALFVSVGYRHQIGGKAYAELGMRYNLLYNKDSSVFASGFMPYAGISVSL
>OBAHECAF_01791 hypothetical protein
MTILKHVFIFCLSFISIDSIAQSEKEILVIENNILKKCDCEKIPANGHVVIPYFVKTIAK
EAFKGCHRLKSIEIPNTVEIVEERAFFDCYNLNKIDLSRVFEIKKSAFAYCTNLTEITLG
DGLKSIEDNAFESCFKLQSITLPNSLTTLGNEAFSQCKELANVTLSENLIHLPFKVFYEC
KSLKIIEIPKKTLHIRASAFAFCESLTSVYFLGNLESIGNDAFEHCVSLKEIELPDSVVH
LGASAFFNCSALEWIGLPAYLTQIKNDTFSGCNSLKEIHFPSGIEKIGMHAFRNCSSLIS
LDLPISLTDILFGAFNECTSLKIIKFAENVNYIGIFAFANCVSLEKVELPKSVVKIEDRV
FYDCKNLASVKLSSHTNSIGVQAFSGCEKLKKIDLPATLNYIGVEAFRNCSSLEEIICRA
STPPQVNLSLGYKGVVIVPKKSQEAYLQDDIWKQMIIK
>OBAHECAF_01792 hypothetical protein
MGLVNAKEVAKALNIDKYGFVGTFAGWLLMKILRLSKLNRIYDRNKHLQGIDFLNRLLDE
FEVQYDMPDEDLQNIPKEGAFITISNHPLGAMDGVLLLKLLGEKRPDFKVMANFLLQRIE
PLSNYVMPVNPFENRKDVKSSVLGFKQSIQHLKEGKPLGIFPAGEVSTQKEGKFIVDKQW
EEVAMRLAKKAQVPIIPIYFHAKNSKLFYSLAKINDSLRTAKLPSEMLSQRKRPIHVRIG
KPISVKTQNEHTDLESYTDFLRKKTYLLANTFDKTKKKNPLTSVLNKSNKSAEAPEEIIE
PIDIQLIEKEISLITEKDLRLFKSNNYEVFLAPYEDIPNIMTEIGRLREVTFREVGEGTN
ACIDIDDFDVYYHHMFLWDADAKKIAGAYRMGLGAYIFPKYGIDGFYTHNLFRFEPELYD
MMSKTIEMGRAFVISEYQQRPMPLFLLWKGIAHTTLRYPEHHYLLGGVSISNQFSNFSKS
LMIEFMKSNYYDPYIAQYVRPKKEFKVKLKDADKDFIFDETKADLNKFDKIIDELEPGTL
RLPVLIKKYIKQNARVVAFNVDPKFNNAIDGLMYIRIADLPESTMKPVIEEFQIEIEAKL
KENIT
>OBAHECAF_01793 hypothetical protein
MKNIFCALFFFPFVLIAQQDNSTLRWGVEGGLNLSIFRSQTENFHSSTGVKPDMYMGFFA
INQFLEETDLKLSASYSRQGSYIQEQNTTKHTITIDYISFGNVWKVGVWPSIYLDVGLVL
DVVINNPSVPFLNSSNLKGKIGGTFFLTDKIALELSVKESFSGIHNHLMKQIPPFDGYMS
NRVFQFGLIYFFKPYEQKAIFK
>OBAHECAF_01794 hypothetical protein
MNKLFKSIKKVVLPLFVLLNISFLFAQDEDNKIHWGIKGGLNYSRLAAVYPLQDGLQGKD
DIFFGGFATVKTSLPAVNSFLFEITYSGQGVYYEDMIENRYIHYNLPHLSIGYKARFKLH
EHIFYQFGFSTDFLLRKNDITSEFQNFDTTVSLFGFEFIFSKKISVFLDGKIGLRRSNIK
NDIIPFERNVTNRVVRFGVCYYIK
>OBAHECAF_01795 hypothetical protein
MRKLTLYFSALLLLLSINEANAQLFKSKKKKAQIEAEAKKKAEAAKPKGFDAVIPKTAKT
TQGLFTIHKVNDKYFYQIPDSLLGKEMLMVTRISKTATGIGFGGEEANNQVIRWEKKDKK
ILVRMVSHSIIANDSLPIYEAVINSNVEPILASFDIKTRGKDSISSVIEVNELFEKDTKP
FGLSERYRKQYKIGGIDTKRSFIERIKTFPKNIEVRSIKTYNASEPPAYTSRIAGIITVE
INNSMILLPENPMKRRYFDERVGWFTTSQTDYGLPVQRTKSVTYLDRWRLEVKDKDIEKF
KRGELVEPKKPIVYYIDRATPKEWAPYIKQGIEDWQKAFEAAGFKNAIIAKDPPTKEEDP
DWDPDDMRYSVVRYLASPIPNANGPHISDPRTGEILNANINWYHNVMTLLRNWFFVQTAA
INPDAQKPEFKTEIMGRLIRFVSSHEVGHTLGLPHNMGSSHAYPVDSLRSASFTKKHGTA
PSIMDYARFNYIAQPEDKGVALMPEIGIYDKYAIAWGYRPILDKSAEEEKETLNQWILKH
AGDPLYRFGHQQAGHIVDPSSQSEDLGDDAMKASAYGIANLKRIVPNLIKWTTKEGETYE
DLKSLYNQVLGQYRLYIGHVSANVGGVYEYYKTADQSGEVYVYVPKDIQKRAVQFLSKEV
FKTPSWLIDNAIIKRIEYAGTLERIKNTQAIGLSHLLDIARLHRVIENEALNGDKAYKIT
ELMSDIRKGVWTELTTGAKIDVYRRNLQRSHVEILGKILLETKALPPAPPSPYFKGTNAN
AHTSDIKAAVRAELSQIRTMARSASSADAMTQNHLKDIVARIDKLFETK
>OBAHECAF_01796 hypothetical protein
MLRLFKDFRFVTLLWFGLALATVIQNVFIRGKYNNYLIFEGVFRHTIGKLSLYAEYPTEY
FDVNHYGILFSAIIAPFAVLPNWLGCSLWIMSNVLFLYWAIRQLPLKQWQIIGILLIAAH
DLYTAAAMQQFNISIIAILVGAFVFIEKGKSHWATLLIVIGILTKIYGIVGLAFFFFSKD
KIRFIGSGLLWLVILFCLPMLYSSPEYVISQYQEWFERLAVKNNSNMNALQYNLQNLSLL
GFLQRTGVFNNNLVVIVTGLVLFTLPYLRFNQYENKDFRLMFLASVSMFLCLFSTGTENS
TYIIAYVGIGIWFVASPNQNKWLKISLLSLIILASLSPTDIFKPLKEPYIIKYSLRAIPV
AIVWLVMIWEMCFLNYKDRLLFENRND
>OBAHECAF_01797 putative glycosyltransferase
MIKEMQKKQIDIVVPCYNESGNIRVLYDSVQAIFQEKSLENYTFNLIFVNDGSTDDSLQI
LKEMCQRYKNVKYISFSRNFGHQLAVKAGLDNAFGDAVISMDADLQHPPSLIPELVRKWQ
EGNQVVATIRKYAPDAANKIKKSSTYFYKILNFITDIEIKDGAADFRLLDKSVVSVIRSM
SENEPFLRGMVPWTGFRQVYIPYIAQKRFSGKTKYTLKKMLHLAMVGATAFSVKPLHFAV
YLGFAFSLLSILYVPYVIFSFINGTEISGWASLIMTVVFFGGLQLIILGIIGIYIGKIFK
QTKDRPNYIIQERNF
>OBAHECAF_01798 Peptidoglycan-N-acetylmuramic acid deacetylase PdaA
MIYLSFDIEEFDMPKEYGYNIDFQRQIAISREGTIAILDLLKKYNAKATFFSTVVFAQNC
PDLIERLLMEGHELASHTYYHSNFEISHLKMSKEALEKQFQTEIKGLRMPRMAEIEANEV
KEAGYIYNSSVNPTILPGRYNKLHVSKRIFIEKGLLQIPAAVSPLFRIPLFWLSFHNFPQ
WFYHFLLKRTMKYRNYATLYFHPWEFTNLHQKEFNFPNYVMRNSGEKMISRFEELLKFIH
QNNWKTGLYQDLK
>OBAHECAF_01799 hypothetical protein
MKRIFLSIILAGTVLFTACKKDNEKTEPEIEKTEPVGEVKTVTNLNVTETNATSFVYFSF
DKNKEVIVKDPETNNEWDIAFNQYDVKTRGTLKTEQKVFEEVKEAPATGYIPDIQRTTFV
ERSVDQNVSSPVLSLGYSDGFWRFIESKGIVAKIPEAIRETVKTKW
>OBAHECAF_01800 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MEFTYSLSEIDETAKKILPLLTSKIVVFQGSMGMGKTTFIKALVKNLGIDNITASPTFGL
VNHYEGSENVVFHFDFYRIEHQEEAFDIGFEEYLYSGNWCFIEWAERVSSYIPDKHAVLS
FEWIDENTRKVRVA
>OBAHECAF_01801 Shikimate dehydrogenase (NADP(+))
MQKRLFGLVGRNISYSFSRKYFNEKFHKEHISDAQYVNFDIQTIAELPQKLAENPNIKGL
NVTIPYKKEIISLLTKLDETAETIGAVNTIKFTDSDIIGYNTDYVGFMESIRPLLKEHHQ
KALILGTGGASSAIAHAFKMLGISFKFVSRNPKMGQYTYADLGADILSEYKIIVNCTPLG
TFPNVNDSPPIPYHFITSEHLLYDLIYNPSKTAFLQEGENKNATIINGLRMLELQAEKAW
EIWNK
>OBAHECAF_01802 hypothetical protein
MKKLSTIIVLFVALLLSSCAMVQVATDYDRQANFSEYKTFGFFKEGIDKVPISDLDKRRI
LRAIEHNLTTKGMQTSETPDVLVNIFTQERENINVYNNNPYYWGWGVGYGPFWGHSNYSV
STNAEGTLFIEIIDAKKKELIWQGKGLGYIPRNMNAKEKAITRFVDKILEKYPPK
>OBAHECAF_01803 hypothetical protein
MKNLNKSIPLRPRFIVDSEKPVDELLHRVRECKEIFKEKYLLVISDRQVWIHIHKNQRKY
YSPHLQVEFQPKEEGGTRIRALFGPEPTLWTFFMFLHFAIATTFVIFLVLAYSHHILKDS
FSFDLIMMALMVALWFFLYIFARISRTKGFHKCMNSERSWTIFWNR
>OBAHECAF_01804 putative formate transporter 1
MINTPHEVIEITKGMALKKYNTTFGKLVILGILAGFYIGMGGVLSSLAGAGVGGIAQTNP
ILPKLISGATFPLGLMLIILVGGELFTGNNANLIPATIQGEIPKTYFLKNWIIIFISNFI
GLIIFDYIFVYHSGIMQSEPYASYITKLAEYKTHLPWHQVFIRGIGANWLVCLAVWLGLS
SQTMLGRLAGLWWPVMAFVVMGFEHSIANMFYIPTGIFHGANVTWTAFFVDNLIPATLGN
IVGGAIFVGGVYGFLYGSKKK
>OBAHECAF_01805 Alpha-1,3-galactosidase B
MNRTVLLLSFLCLACQHPQEERQVKISDFVSKNQNVENYSPIVEALINSLQQTDNTQPTT
IVLDKNIYHFHSDGAFEKELYISNHDQDNPKKVAFYLENMKNITIDGNGSELIFHGTMIP
FVMKSCENITLKNFSIDFELPHLRQLQILEVDAENNISVAEIHPAGNYKIENEKLLLLGE
NYQLQPTWVMAFDPNRRLSYKRADVDFKTQKITELRPNVLKIEGWSQNLLTKIGERFALR
TYNRPTPGIVIDYCKNTNVENVKVHYAWGMGLLAQMSENITLNKFSVCLKGDNDPRYFTT
QADATHFSACKGVIRSENGLYEGMADDAINVHGTYLKIIDRVDDKTIKAKYMHPQAWGFL
WGEVGDDVQFISSQSMDLVDGKTYKIASIKAVDRPTEFGAKIFEVSFTQDIPKELNGDQS
FGVENLTWVPEVVFSNNVIRNNRARGALFSTPKKVICENNLFDHTHGTAILLCGDCNGWY
ETGACRDVIIRNNTFINSLTANYQFTNAVISIYPEIPNLDQQQQFFHSGIVIENNEFQTF
DAPILYAKSVDNMIFKNNTIKKNNDFEPFHWNRHMFLLDRVNNVKINENNFDIPLSQSDV
KINLSEGNSIEIQRDSLKTQGK
>OBAHECAF_01806 Hydroxymethylglutaryl-CoA lyase YngG
MNHSKKHIKIIECPRDAMQGLKDFIATEKKVDYIQSLLNIGFDTIDFGSFVSPKAIPQMA
DTAQVLEKLDLSDTKSKLLAIIANERGADDATKYPQIDYLGYPFSISENFQMRNTHKTIA
ESLTTLDYVKNKTEKSGKELVVYVSMGFGNPYGDPWNEEIVEHWVEKLIEKDIRIISLSD
TIGSAEGETIKKLFTYLIPKYPTVEFGAHFHTSPNDWHEKVDNAYRSGCMRFDGAIRGYG
GCPMAKDELVGNMPTEKLISYFQKQQMPIGLNLLAFESSYNETMKIFQN
>OBAHECAF_01807 ComE operon protein 3
MKFTNLAILTILIGIVIGIAIPKGDFLSLQTSSISIAIAIFILGVHLFLSLQKSIFSKGF
VFTTFLTSIAVGIFVSILHDPTTKSTHYTNALKKQTPYLLKAKIIEQTSKSSFGITYKAD
LLSADHQPTSGSILCFFPENAIQNTDFQRNDVIIFASKLNDIPIPKNPYQFDYKQYMERQ
DVFGLANVSNYTLISGEKSSFSIISVAENIRRNSETILETYFSKETTSLLKTLLLGNRSD
LDEEVYQNYINAGAVHILAISGLHVGIITIILLYLLKKIPDKKHWKSIRFGILLVSLWSF
AFIAGLSPSVLRAVTMFSFMGVASLLNRRRGRFDSLMLSMLFLLLIRPNFLYEVGFQLSY
ASVFSILVFYPRMERWWQPKNKIVSYFWGLLLIGFAAQIIVLPISLYYFRQFPTLFFISN
LLIVPLLAPILIFGILSLICGFLNVVPLFLVSITEFLINCINTFAGLIANQEDFVIKHIY
FDNKILITSVLVLITVIYLVNKVQYKRIILFLISVIIFQGVLFYGKYQSETTEEFIVFQK
YKQNIFLKRKGNKITVYQPDTTQKFRLIENYQKAKGINDVKTKEIPSITDFQHKNILFVD
SLGIYPKDLGLVIDNLILMDAPKVNFERMLLEIKPKNVISNGTNPPYLLKKWRETCEKQN
IPFYATSEEGAFVLNSYGK
>OBAHECAF_01808 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKIKLLLLIFGLLLTSCAERYSTRKRTTTSYKSTTKKNKKAKNSTTKYVTSKQPIKTKQR
TNISKAENPIRDTNTEIPASSNAKGTTKKVIDTAFSYLGTPYRYGGTTRSGMDCSGFVCT
VYKTVGVPLSRSSTDMANQGNGVKLNNIRVGDLLFFATGKTNRISHVGIVVETGSEVKFI
HSSTSRGVIVSSLNEGYWSKAYRKAKRVM
>OBAHECAF_01809 Negative regulator of genetic competence ClpC/MecB
MNDNFSPRVKRILAYSNDEAIRLGQSVVGTEHLILALLQEGEGRAIDVLLSLNTDLERLR
QQIYGLTSMRGLNPGSHNTMHFTQQAERAMHASHLEARNSQDDTVNSGHLLLSILRNEND
PTTKIFNRLGVSYDIVKTKFQPTQGDHFLRANISNEFEEFDKSDKPIPDKGKGQQESGTQ
RGAKKLTVLDNFGRDLTLLAEQGQLDPVVGRDKEIERVSQILSRRKKNNPLLIGEPGVGK
SAIAEGLALRIIQKKVSRVLYNKRVVTLDIASLVAGTKYRGQFEERMKAIMNELEKNDDI
ILFIDEIHTMVGAGGAGGSLDASNMFKPALARGEIQCIGATTLDEYRQSIEKDGALERRF
QKVIVEPTSIDETIQILQNIKKKYEDHHNVIYTDEAIEACVKLTSRYLTDRFLPDKALDA
LDEAGARIHITQMKVPKKILELEEELEEVVKAKNNAVARQQFEEAARLRDDEKRIEATLK
EVHRKWEEDAKLNRDTVTEEHIADVVSMMSGIPVSRIAQTEMNKLSTLSDTIKEKIIGQD
VAVEKIIKSIKRNRTGLKDPNKPIGSFIFLGQTGVGKTQLAKVLARELFDSEDTMIRIDM
SEYMEKFSTTRLIGAPPGYVGYEEGGQLTEKVRRKPYSVVLLDEIEKAHPDVFNMLLQVL
DDGFLTDSLGRKIDFRNCIIIMTSNVGARQVKEFGQGIGFGTAAKTSQSDAHEKSIVENA
LKKVFAPEFLNRIDDVITFNPLSKEDIFRIIDIELKKLYLRIKDLGYTIELSEKAKEFIA
EKGYDKQYGARPLKRAIQKYVEDILAEEIVASHIKEGNTIYFDVDEQNENLKIVVN
>OBAHECAF_01810 Signal recognition particle protein
MFDNLSDKLEKALHNLKGHGKITEINVAETLKEVRRALLDADVNYKIAKDFTSKVKEKAL
GQSVLTSLQPGQLMVKIVKDELTELMGGDATGINLSGSPSVILMSGLQGSGKTTFSGKLA
NFLKKKKNKKPLLVACDVYRPAAIDQLHIVGEQVGVEVFSDRGNNNPVDIAQKGVQYAKS
NGYNVVIVDTAGRLAVDEQMMNEISNIHKALNPQETLFVVDSMTGQDAVNTAKAFNDVLN
FDGVILTKLDGDTRGGAAISIKSVVDKPIKFIGTGEKMDAIDVFYPERMADRILGMGDVV
SLVERAQEQFDEEQARKLQKKIAKNQFGFDDFLEQIQQIKRMGSMKDLLGMLPGVGKAVK
DLDINDDAFKHIEAIIYSMTPKERSNPSIIDTNRKRRIAKGSGRDIQEVNQLMKQFSQMS
KMMKMMQGGGGKKMMQMMQGMRR
>OBAHECAF_01811 Multifunctional CCA protein
MSIISTRISMYHEKALSNPIFTLISDISEEISLESYVIGGFVRDYILKRKLPKDIDIVSI
GSGISLAEKVAEKLPDNPKVSIFKNFGTAMIKCDGLDIEFVGARKESYSSNSRKPYVESG
TLKDDQNRRDFTINAMALSLSKSNFGELIDPFNGLSDLENKIIRTPLDPDITYSDDPLRM
MRAIRFATQLGFTIEEESLQAIARNKDRLRIISNERIVDEFNKILASPKPSIGLKLLYET
GLLHHILPELIDLKGVEEQDGQRHKDNFWHTLEVVDNIAENTDNLWLRWSALLHDVGKAP
TKRFDKKIGWTFHGHEFLGSKMVYQIFKRLRMPLNEKMKYVQKIVRMSSRPIIIAEDIVT
DSAVRRLVFDAGDDFEDLMTLCEADITTKNPKKIKKYRDNFQIVRQKVVEVEEKDHIRNF
QPPISGEEIMEVFNLKPSREIGILKDAIKEAILEGKIPNDYTAAKDFMFEKAKKMNLVK
>OBAHECAF_01812 2-dehydro-3-deoxyphosphooctonate aldolase
MAQLNSKENNFFLFAGPCAIEGEDMAMKIAEKIVSITEKLHIPYVFKGSFKKANRSRIDS
FTGIGDEKALRILEKVGKTFGIPTVTDIHEVSDAELAAQYVDVLQIPAFLVRQTDLVVAA
AKTGKVVNLKKGQFMSPESMKHAVQKVKDSGNNNALITDRGTMFGYQDLIVDFRGIPTMR
SYAPVIMDVTHSLQQPNQTSGVTGGRPDMIETIARAAIVNNVDGLFIETHFDPINAKSDG
ANMLHLDLLEGLLTRLTAIRKTINSFNE
>OBAHECAF_01813 hypothetical protein
MRILIYILLILSVISIGVNIYLIDFSNSLEGRSFIALISAGIALIAFLLLLIFLVAKRIR
K
>OBAHECAF_01814 hypothetical protein
MNFDIKEIISATMVLFAVIDIIGSIPIIINLRQKVGHIQSEKTAIVAGLLLILFLFLGKE
ILNLFGVTVESFAVAGAFILFFLALEMILGITLYRDEEPQTASIVPLAFPLVAGAGSLTT
VLSLRAEFQVENIIAGILINIIFVYFVLKSSKKIEKILGKQGISVIHKIFGVILLAIAVK
LFATNIKGLFATEGVASLF
>OBAHECAF_01815 hypothetical protein
MKTIKYAYIFLFFVFVSCQIQNNVDKIDVFSILEEKITSIQEIKSDSIIFPVEIYSFG
>OBAHECAF_01816 hypothetical protein
MELFIYVTIGLAVAFVLVVWNNKNNRKKLSSRKNRNFRQNYEQKKKKLESKS
>OBAHECAF_01817 putative ABC transporter ATP-binding protein YknY
MSLLRIKDIRRDFKLGSEILHVLKGIDLIIEKGEYVALMGPSGSGKSTLMNILGCLDTPT
SGEYILNGKDVSKMSDAELADIRNKEIGFVFQTFNLMPRTTALDNVALPMVYAGVGKEKR
SERAKEVLQLVGLGDRMMHKPNELSGGQRQRVAVARALVNSPSIILADEPTGNLDSKTSY
EIMALFDEIHSKGNTVILVTHEEDIAQHAHRIIRLRDGLIDNDTRK
>OBAHECAF_01818 hypothetical protein
MRKSFLTVVTLLFGMTAVYGQAYISVSGGYGFEANKKVVGREVTASGVSELKGSYGAGLQ
TQLRGGYFFTKRLGVELSVGYLHGEDVKTNKSPLVDMKARGRAFGASLSAVFNVTENIYL
RAGGVTKIGGKTESFTSLNATIPGIPHTPSSSFIPMVPLKVDFQTDFHGKVPFGFIGGLG
YRLKLSDNVSLFVEGEYLMVNVGRKTSKLDNFSATIAGKSISYEQFKKMATAMAQTPAGA
TFQSLLPLIEQEYDWSDKNPPVAPYSSIGVNFGLTYTL
>OBAHECAF_01819 Putative phosphatase
MDCKIIFSDVDGTLLNGERTISESTIYEVNRLKDTVPFILVSSRMPRQMRYLQNLLKTID
YPMIAYNGALVLSDDGQVLHSTEIDITLVEQIVQLNEQQFNGKIHISLYHNDLWYVPDYD
FWAQREENNTKTTPEIRSNSQVITDWKEQNIGAHKIMLMGDAMLIEEMFTILNSQFGQNL
HIYRAKDTYIEVSDLKVSKLTGIRVLLEHKYPFTLDESMAFGDNYNDLEMLQGVKYGIAV
GNARQEVKKIAYGVTFHHKEDGVARYLASFFHS
>OBAHECAF_01820 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGKMGKTIEKIALERGHEIVLKIDSADAVYDVSTVDVAIEFSTPDSAFNNISN
CIKHRVPVVAGTTGWLKDYDKAVAMCAENQGTFLYASNFSVGVNVFFALNKTLAKLMASR
KEYAVSIEEIHHTQKLDAPSGTAITLAEGIIEKSDKTGWKLDAAPKNEIPIKAKRIENVP
GTHTIIYESEVDTIEIKHTAHNRNGFALGAVLAAEWIVDKKGVFSMSDVLGV
>OBAHECAF_01821 hypothetical protein
MKKYFLIGLLSVSLCSLAQESLPLVVQQKNELDQNSWVKNVPFERIYTPEIGNQINHFDI
RKDNPLEWMVAPASGGLWLSKDAGVTYENIFQNQPTQQIKTFAVHWGKGIIWVATPYGLF
TSKDKGNSWFFGGLPEFKTIESVHINPRNTDEVVVAVLGNPFDADEKRGVFKTSDEGKTW
QHSLFVGNRAGVSQIIDTPNGQTLFASVWHDESTTWKSIPYGSMSAVYKSEDFGTSWSKV
STDGFLSGNFIGKIGLAAHSDEKVYAVVDNRGSKTRSVATRNLAKITNIHLLERDFEAMN
KTDFLNLDDNKLNAFLHAIGQDKKYTAQNLKDMISAEITSPARLMIFLGIRQQEVIGAEV
YVTSDGGKTWQKTHSQPLEDVFYQNGNQFGAITVDPNNDKHLFIGAYPLLESLDGGKSWQ
SKHNVSLDDSFEKIYYRNNTLYATSKKGLAISYTQGKDWIFRNVPQSVSFTKIGYDKHQK
SLFLASEQGVFMSKNNIWTKISSQRQLFGSENDIYVGSGNGIFYRYNVEKNTFLRLKSLY
TSENKAPLRFGKQTPLLVSQHNSDVLYVGSNKMRFSSDRGQNWRTISEDLTIGSKKGNDI
YATISAIAESPLSVGLLYVGSDDGTIHITSNGGTTWQSMYSNSNAFKVNNLVASKHHQKR
VFATFSHPDKTNPEPLIFMSEDQGVTWTELRSNLPDGRINIVKEDPKNEQIIYLGTDSGL
YVSFNLGESWHSFGSLPATGILDVFINDGTSEILVSTAGFGVFKSSLEVIQPLRVAIVAQ
DFFPLREKVRVEHSNRWGNTWSDWESAELPITHFEVFASKEMRLQIKIMKGKVTLQSFTY
KTSKGFNYIPYDMTISSVGKVMFERVAKRISLETASDGRVYLPKGEYTIVFSVEGGFDEE
RILEIY
>OBAHECAF_01822 hypothetical protein
MPSLISYHINNMQKKVKYEMEFVIQVSPQMLYQYISTPSGLSEWYADDVNSRGEIYTFIW
DDTQEKARLLRKKMDESIKFRWLDCGDDSYFELKIMVDELTQDVSLVVVDFAEPNDLEES
KMLWENQVTELRHALGTA
>OBAHECAF_01823 Aminodeoxychorismate lyase
MKINYNGTFLSSEELILSCENRGFKYGDAVFDTVKYTNQKLVFWEEHYLRLMAGMRILRM
EIPMNFTLEFLENEILKTLNINELNNTPTRVRMTVSRKNGGLYTPHTNDVDYLIEVHPIS
SIFYELHETPYEVELFKDFYLQPDLLANVKHTNRIINIIGSVFAKENDYQNCILLNSNKN
VAGALNGNLFMVEGNKLKTPPLTDGCINGITRKVLLNLLKKIPEFEVIETSISPFELQKA
DELFITNSIIGIQPITKYRKKTYTNLVAKSLIGKLNTAARFGVS
>OBAHECAF_01824 hypothetical protein
MKKIFAIVLLIVGIFGGYKGYQVIDDSSKGIELAGFEIKAEDKDSKTMGYVYLGLGVAAL
VGGIVLLSRKK
>OBAHECAF_01825 1-deoxy-D-xylulose-5-phosphate synthase
MKYTDTGKKDTRSGFGAGLAELGRTNPNVVALCADLIGSLKMEKFIEENPERFFQIGIAE
ANMMGIAAGLTIGGKIPFTGTFAAFSTGRVYDQIRQSIAYSGKNVKICASHAGLTLGEDG
ATHQILEDIGLMKMLPGMVVINPCDYNQTKAATIAIADYQGPVYLRFGRPTVANFTPEDQ
KFEIGKGILLTEGKDVTIVATGHLVWEALLAADELEKQGISAEVINIHTIKPLDEEIILN
SVKKTKCIVTCEEHNYYGGLGESVSRVLTQRFPIPQEFVAVNDTFGESGTPSELMKKYGL
DKDGILKAVEKVLKRK
>OBAHECAF_01826 hypothetical protein
MPKQVKKWLYDILTAIEEIESYFDENPKDFDYFSSNGMLKRAIERDLEIIGEAVNRILKV
APNTEITNARNIVGLRNQIIHAYDNIQDEIIWGIVIKNIPSLKEEIKLLIKNE
>OBAHECAF_01827 hypothetical protein
MKEIQKHQEDIVAACKKYKVSSLYAFGSVTREDFSKQSSDIDLLVVFQPIDLLDYSDNYF
DLLFVLQGIFNRKVDLVTEKSLKNPYFIEEINKTKQLIYAEAS
>OBAHECAF_01828 hypothetical protein
MKRLVFILLSIVMLSCNKESEPNRQEFLEVFKQERNIPQEISIERISLGKDFEIVVGKKD
FELFLYKIQNKKIVVSHKESIPKEVKKGEKTYLVKGFTPNISRLKEDGFIWIDITRDWAE
QGNTSVNPYYVLFSFVLHKDTFVKIDNSSYDWNGDIIDIRTWNETNFLVQVTGNSDRDFY
IYGDKWQFLFKSNSKFLINPDKIYTLNQEEAILFGDEKQLFKRINIKDNNTIWQVDSEKI
FPSKTVFLSRVTELNKSENIWTFTINYTLRYEDNEKQEQFEEGIKTIKIDINNGKIIE
>OBAHECAF_01829 hypothetical protein
MIKNELQNILSGKGKVKYGEPIQTIACYLRRSSETSTMVERKEQNKSKETEKLCQWIEEN
NFWIHTIDIDKFISQGAEQKVYLHQEEYVIKLNDGIYYLSWLDYFYNLLLNNYFFPDTAY
KLLGFYKDKNVLYAVVQQKFVKANELTSLENVREFMANNGFQLIRNNDYKNQELGIILED
LHDENVLTVDGVLAFIDTVFYLEDSFWE
>OBAHECAF_01830 hypothetical protein
MAVKYNIVERKNLLDKEAQPKFYASAKADGEISFRALAKEIATGSSTVSDTDVLAVLNDL
TKVLVKHLSEGRIVRLGDFGSFRITISSEGAETAEKFNPALIKSNKIQFTPGIDLKEMQR
VIKYEKYKK
>OBAHECAF_01831 Aspartate aminotransferase
MKVSKLAQNLIGSEIVKIGNEVNDLKAKGEKITNLTIGDLDSNIYPIPNELKKGIQQAYA
DNLTNYPPASGILSLRENVSKDLKQRYALEYSAKDILIAGGSRPLIYATFKTIVDEGDKV
IYPVPSWNNNHYSYLNSAQKIELEVKPENNFLPTAEELRPHLKDAVLLALCSPLNPTGTM
FSEHQLREICELIVEENRKRGADEKPLYLMYDQIYAMLTFGEKHFNPVSLVPEMKPYTIF
IDGSSKCFAATGVRVGWAFGPSEIIGKMAALLTHVGAWAPKPEQQAMAQFLTNTKAVDAF
VNDFKGKIKHSLETLHEGIQALKQKGYAVESIRPMGALYLTIQLGYVGKTTPKGDKINDT
TDLVFYLIKEAGMALVPFSAFGNSRTMPWFRASAGGCSLQDIKDVLPRLEKALSELK
>OBAHECAF_01832 Mechanosensitive channel MscK
MKETTFDFLEKLKGVMNFVIFDIKGSTFTLLTLVYLIVSSVLLVFLAKRLTHFLEYRFFA
TRIAERGNRSAIVTIIRYLILVFGFLFIFKSAGFELGAFSWLLGALGVGLGFGLQNITNN
FISGIIILFERPIKVGDRIQVGDISGDVVAISMRSTRIITNDNISVIVPNSQFINGNVTN
WSHNDRLVRFHYPIGVSYKENPQKVKDIVLKIANNHHGVLKEPAPALWFVEYGDNSLNFE
LVVWTSTYIQKPVVLKSELYYIIFEEFAKHDIEIPFPQRDIHIRSGLENSKQL
>OBAHECAF_01833 Transketolase 2
MSNIQQLTDLTTQVRRDILRMVHKVNSGHPGGSLGCTEFLVCLYNELMEINTNFEMDGKN
EDLFFLSNGHISPVFYSVLARRGYFPISELNTFRLLNSRLQGHPTPHEGLEGVRIASGSL
GQGLSVGIGAALTKKLDGDTHLVYTLHGDGELQEGQIWEAAMYAGGKGVDNLIATVDYNK
KQIDGSTDNVLPLGDLRAKFEAFGWQVIDIEKGNNIASVLEGMKKAKSLTGKGKPVCVLL
HTEMGNGVDFMMGTHAWHGKAPNDEQLAKALAQNPETLGDY
>OBAHECAF_01834 4-alpha-glucanotransferase
MIKIKHWEHSLVASLNLLQEESNQPQKQKLKSVSLPTKNLFMKKNTTAIAFATLIFLFFA
TACKSTIEEKATKEMKKNEKKVVYQVFTRLFGNTNTSNKPWGTKEENGVGKFSDFTDKAL
EEIRDLGVTHIWFTGVPHHALVNDYTAFGISNDDPEVVKGRAGSPYAVKDYYNVNPDLAE
NPENRLQEFKDLVERTHKHGLKVIIDIVPNHVARKYESVSKPKGVKGFGEDDDTSVAYHV
NNNFYYNPNETFELPNYATGYEPLGGEKHPLIDGKFHEFPAKWTGNGSRKSKPDFNDWYE
TVKLNFGVRPDGIKDFPELSDDFNDKNHEEHYQFWKDKTVPNTWIKFRDIALFWLDLGVD
GFRFDMAEMVPVEFWSYLNSNIKNKNPEAFLLAEIYNPKAYRDYIHKGKMDYLYDKVQLY
DTLRGIVSYGRSTDAIAPIQHELADIAKNMLHFLENHDEQRIASPEFAGYPEKAKPAMTV
STLISDTPIMIYFGQEVGEKGAEKGGFGSPSRTSIFDYVGVPAHQRWMNNKQFDGGQLSD
NEKHLRDFYKRLLHIPVTGFYADIHKYNRENTEFYNDKVYAFVRGDEENQWIIIVNFNES
DSFGFDLQIPQFIIGSWFLNDGNYSLTDDLYQTKQTTLNVANGFGKMRVDIAPLESLVFK
VKK
>OBAHECAF_01835 hypothetical protein
MEQHPRGHKKLLKAWIFYDWANSVYSLSIVSSIFPIFYGLLFKISNITHIDLFGFSVKNT
AAITFVTALAFLIVVVISPILSGIADYLGKKKTFMKFFCYLGAISCIGLYWFSLENIYFG
LLCYLFGVIGFWGSIVFYNSYLPDIALPEQYDEVSAKGFIMGYIGSCILLIFNLSMVMFP
SVFGIEGSEEEATLTAMKISFVTVGFWWIIFSQYSFRHLPNFETDRNKFSKRFLLNGYKE
LQNVQQQLKENKLLKTFLLAFFVYSMGVQTVMLVATYFGEQEIQWKDTEERTIGLIVSIL
IIQLIAIVGAKLTVWSVKKMGQILTLIVLNCIWICICLIAYYIYLPWHFYATATLVGLVM
GGIQTLSRSTYSTYLPKTKDTTSFFSFYDVSEKIGIVIGIGIYGMIDQMTNNMRNSVVFL
VLFFGIGALILFQIHKKKYFSKKSQF
>OBAHECAF_01836 hypothetical protein
MILNSIKYGGVILFLVFLSSCKEQTKGNLIRLEDFPKRHSLEINKIIKNEAIGVTAVYTT
NDYFLLLKRKSDYFFEVYSKKDTLKKMELCYRGQGPMDFIAPLYSAQFEDNTFFVFDRAK
ALFSKINIDKSILENKIVIDTMINFSSVLNVQARDMFVTEAGKYLYSEDFEDCTYYLIDE
NKQNRTEIGNNYKLELSADKHHLSQKLSTYNNNRFASVYFSFPKIDFASVESKKVYKSIH
FQGEIVIKDEKLEEYLQNTSFDAIDSTDEYVYCLYNDSRKEQDNSMILVFDWEANPVCVF
HLPKYYTHFSVDKQGKYMYLINWETEEIAVFTTDVPAN
>OBAHECAF_01837 hypothetical protein
MKSLLVIGIVSVGGYGISESVSKDTTELNELTLANLEALAQSENGEEDDSDTPPKECYRK
YQLSPGIFGQHSLTRFITCDGCKYVRGYNTQTNNYLSLISKRS
>OBAHECAF_01838 hypothetical protein
MKLIYAIVFLVFFSCQKKNDINRIDVFSISEEKITSIQEIKLDSIIFPTEIHSFGQWIVG
INLPNYSKNVFDFINKTTLQKDFSCMKFGNGVNEFQECNPYFFKCKDNLIQVNANVFDIK
TLRLKNGDLSVLSSKSLSVAPNKIIEIDTEKIAFKPLFEKPNYAIYNIGKQEFVSNFGNF
PNVELSEAGEDIDYANFFQETTVFDSEKDQFFSFYSNIPLIRIYKNFKLVKEIWTTDDFN
TNITDFYDEKTKIFYGKPLIRQRKIYVTYLNKNPEEFSKNSNVNLLIWDTEGELLKRYVI
RNTFQTYTISEDGTEFYAIDNSNTDYSTVFKFKL
>OBAHECAF_01839 hypothetical protein
MLIDSVLGVSGVANNSKHIFLRVNENPESKGMLKIFSKKGVLEATVLNRGGGPNDVTGFL
IINQKNEKNSLWLNDINARTLKSLNISESISDQSAKIDNVIRLNEASVHAFPLKDTLIVS
ETMKKNNYWLTFFNPITQTTVFDKPIYPNPSNHFSNLYQSVWAAKSDKTWIVGAMEALNQ
INFVSLVDAEKSFSVSLGSATDVEKAIDNEGVVKHAYYCDVATTSEYVFALKLDQVEEES
YEIAKPVTVEVLDWNGKPQYVLEIDEYLLDISVDEELKKIYGLSSDDTIYEYELNGIL
>OBAHECAF_01843 Aspartate aminotransferase
MQQFLSERIINMETSATLAMAAKTRELKAQGKDIIGLSLGEPDFNIPDFIKEAAIEAIHQ
NYSKYSPVDGYADLKEAICQKFKRDNNLIYKPSQISVATGAKQCLANVALVMINSGDEVI
FPAPYWVSYKDIVKIAEGVPVEVYTTIENDFKMTPEQLEAVITPKTKMVWFNSPCNPSGS
VYSREELEALAVVLRKHPNIFILSDEIYEYINFVGKHTSFAEIEGMYDRTITVNGVSKAY
AMTGWRIGYIGAPEWITKACTKMQGQITSGANSIAQRATIAALKAPVSNIQYMIDQFKNR
RDLVLRLLGEIEGFKLNVPEGAFYVFPDISYFFGKTLRGKEIKTASDFSLYLLEEAGVAT
VTGEAFGDERCIRISYAASEQELTEAIRRIKESLQ
>OBAHECAF_01844 Ribosomal RNA small subunit methyltransferase G
MEHILTYFKDLTLQQKEQFVALKSVYESWNTKINVISRKDMDSFYERHVLHSLAIAKVQV
FNPSSDIMDVGTGGGFPGIPLAILFPEVNFTLVDSIGKKIKVVKEVAKEIGLENVTAINS
RVELIDKKFDFIVSRAVTQMPEFVKWIKGKVKKDGKHELPNGILYLKGGDLSEELATFTN
VQLYNISDFFTEDFFETKKVVYLRIK
>OBAHECAF_01845 Inner membrane protein YiaA
MNQKPSSAFIGASWIALGIGFLGYMIGLWRAEMLLSEKGYYFTVLMYGLFAVISVQKSVR
DRLEGIPVTDIYYGISWFSTILSIVLLVVGLWNADTLLPSEKGFYAFSFILAIFSAIAVQ
KNTRDSKNFDLDFSSHSPKKEDDFHIKNESNS
>OBAHECAF_01846 Cysteine--tRNA ligase
MQKLNIYNSLTGEKENFIPLKEGHVGMYVCGPTVYSNVHLGNCRTFMSFDLIFRYLKHIG
YKVRYVRNITDAGHLTDDGNVENDRFVKQSRLEKLEPMEIVQKYTVDFHKVLEMFNNLPP
TIEPTATGHILEQIQLTEKLVKEGFAYESNGSVYFDVQEYNRRGLNYGELSRRNIEELFA
NTRDLDGQGEKKNPQDFALWKRASPAHIMRWASPWGDGFPGWHLECTVMSTKYLGEEFDI
HGGGMDLKFPHHECEIAQGKAGHGHSPVRYWLHANMLTMNGQRMSKSTGNYILPMQLISG
ENNFFEKPFKPSVVRFCFMQAHYRSVLDISNEAMLAAEKGFNRLMEAGKILSSLPVSKNS
SFDVQNWKQQCYNAMNDDFNSPILIAQLFEGVRIINLVKDGKETLTEADLRELEASFNAF
VFEVLGLKDEQQATENNDKLDGVMQMLIQMRMEARANKDWALSDKIRDELKVIGIQLKDG
KDGTTYSLE
>OBAHECAF_01847 Purine nucleoside phosphorylase 1
MDIYEKINETARIIQSYISEHTPEFAIILGSGLSRLENEVEVISEIKYSNIPNFPKSTVS
GHKGKLIYGKIEGRYVLMMAGRAHYYEGYSMQEVTFPIRIFKQLGINRLIVSNASGGVNP
NFEIGDVMIIRDHINMFPEHPLRGKNLDQFGTRFPDMSKPYSSAMITELENIAKENNIKV
QKGVYVGLQGPSFETPAEYGMVRILGGDAVGMSTVPEVIVARHQNMEVCALSVITDLGGP
EIAPNVSHEEVLNAANKAMPNVILLVKNLIKRYR
>OBAHECAF_01848 hypothetical protein
MNRIIYFLFLILLVSCHNTENQQLTYIKGFLPNTKEKVVVLYENDKAIDSITLDENKKFL
LEMDIKEETLYNIEIDHQYVYVYVEPKDSLVFTGNISNLSESLSFSGKGANINNFMLSQW
IENEKVTAFIKRNNALEPIEFKKKIDSIYEQKLQHYQLFVEENPSLSENAKKIALVSATY
PLFREVESYPFIYQRNSNNSVANSLPKDFYNHRNFIEFDNSSLEYYRPYYSYMVMLINNL
TFKKYNLTHNAPDINKDEEFHLKKIQIIDSLFPSGMMRDNLYRNAAYAYIFNIQNKQDCQ
CYMEEFYKYNEKNIHKAELEQVFIRTIDLQKGRTPPEFEIIDLDGNYYKLSNIVRPKVTV
VYFWSVNQREMSNLIFNRILQLKELFPNVEFIGIDVGQNVSEWCNTVFTSSNRLVGQQFH
STNFDDLSRKLLINNISKTLIISEDYSIISAFENIFSPNVERFLVLGE
>OBAHECAF_01849 hypothetical protein
MKRIVFSFVVVLLHTVMLQAQSIMGKWKTIDDETGNEKSIVEIFEENGKVYGKIIELFEE
KNKNAICSNCSGINKNKPYLGLIIINDLKKDGNEWSGGTILDPKTGKEYKCLIALESTNK
LKVRGYVGFSLIGRTQYWQRIK
>OBAHECAF_01850 Peptide chain release factor 2
MEILLEFQKEGIASADEVDEQYAKALHHIENLEFRNMLSDEGDSMSAVLQITAGAGGTES
CDWASMLLRMYTMWCNNQKYSVKTLNFQEGDVAGIKTVTIEIEGEYAFGYLKGENGVHRL
VRISPFDSNAKRHTSFASVYVYPLADDTIEIEINPSDISFETMRSSGAGGQNVNKVETAV
RLRHHPTGIIIENSETRSQLDNKNKALQLLKSQLYEIELKKRQAKRDEIEAGKMKIEWGS
QIRNYVMHPYKLVKDVRTAHESTDVDSVMNGEIDAFLKAYLMLMGQSEESN
>OBAHECAF_01851 hypothetical protein
MYKNFIEQIVKNQVVFALKNKKEVAVCPSAEFFVEETGEAIAVFPFWSEETMAKSCQEDE
WSDYQIEKIKLSEFMEFWCLGMYEDSVAVGINFDANLSGAEETPDQLLKDIIKEIERTNT
QIKFQNFVSLNQLRNFFL
>OBAHECAF_01852 Bifunctional protein FolD protein
MKLLDGKKTSEQIKQEIAEEVKQIKAKGGKVPHLAAILVGNDGASLTYVGSKVKACEQVG
FESTLITLPAEITEVELLQKINELNKNPEIDGYIVQLPLPKHIDSQKILLAVDPEKDVDG
FHPANFGKIALDMEAFIPATPFGIMELLKRYNVETKGKHVVVVGRSHIVGRPMSILLSQK
GNPGNATVTLTHSYTPNIKEITKQADIIVMALGIPEFLKGDMVKEGVTVIDVGITRLEDA
NAPKGYRIVGDVDFEQVKDKADYITPVPGGVGPMTIAMLLKNTLLARKWKDK
>OBAHECAF_01853 hypothetical protein
MIYKFRIILDVKEDVFRDIAIEGDATLEDLHNIIVQSFGFAGDEMASFYLTDEDWNQGEE
ITLFDLSESGEIRLMEETSIDSVVSEEEPKLLYVYDFFSMWTFFVELVEIADEYENGVSY
PALLFSHGTIPAEAPEKLFEAENFNEFDDEFNDFDMDEEDYENFREEDYY
>OBAHECAF_01854 hypothetical protein
MLNLYTTHIDSLSIHRVGNQSKNEPLFLSEQPYSLNDEIIGLLKEYFFKPFREKEENYFR
FSHEADVEFNELFQLVSKIFDNENTIHQVSKEIAQHLYRQSSHPHIKSGELYVSLLHDIY
LDNQKVTAVGIFKSEMKHSFLQFEENQNQLDIIIQEGVNIHKLDKGCIIFNVNKEEGYKV
LSVDSNRYDTKYWLENFLGVDALIDENFYTKKYLKFSQDFAKDVILPAEDKQQEVLFMNR
AINYFAKNDEFEESAFMNEVLDNPEFIPEFKHYKVEKGPKYNIEDVSNFPIANKAVTEAR
KKIKNVIDLDTNIQIRMDFVNPESAERFIEKGWDEEKQMYYYLVYFNKEQKN
>OBAHECAF_01855 hypothetical protein
MNADIQPITDSTLTQKTKHLQTVGVVICKIFLVDMPTYSKYKKHLEVARHTLLEIKKESD
AYYEKKALEKGGQRSDFFEIAIDLQRLEHSGTPITPAEFMGRQYDITTQKLLVRGQKYFL
NNYFFHDTIESSENIVKTFTHLPDGFAYAVLNPPHSLQVGKNIFEKGSYFLDLCQTLFTD
IERLEIYQWSDDTSNFFDAGKEWWGTFFYTVYNPIQNIYIGIVASSTD
>OBAHECAF_01856 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQRIKAGDTIALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAQRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKMYAYLEQAHERVPSAEEIAKELDMSVNDVKESMKNAGRHI
SMDAPLVEGEDSNLYDVLRSNESPNPDRELILDSLRTEIERALETLTPREADVIRLYFGL
GDQHAMTLEEIGETFELTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>OBAHECAF_01857 Ribonuclease H
MSKNKFYVVWEGREKGIFSSWDKCKKAVENYPKAKYKGFITKELAQQAFLMGYQVYKKST
LAKSTVSQVAMANVGKPKLPSISVDAACSGNPGVMEYRGVHTATKEEIFRLPPMEDGTNN
IGEFLAIVHALALMKKNNQTMPIYTDSQIAIKWIHQKKCKTKLKETPKNEKIFELIDRAE
CWLEQNTYLNPILKWETKFWGEIPADFGRKG
>OBAHECAF_01858 Demethylmenaquinone methyltransferase
MISWILNTIPRPWLIKMSYLVRPFLSLWYRGNRYKDPIDGKGFRKFLPYGYGVQRPNVLS
PSTLSLERHRLLWLYLTNETKLLEQKIRVLHVAPEQAFYRRFKKNPYWDYVTTDLYSPLA
DVKADLCNLPFEDNSFDLVLCNHVLEHIPDDIKAMNELFRIMKKGGMGIFQIPLDVNRTL
TFQDDSITDPVERTRIFGQYDHVRVYGIDYFDTLRKIGFQVEENRYAQRLSMSEIEKYRI
VKDEILPICRKL
>OBAHECAF_01859 hypothetical protein
MNENVKIQFLKDLSRNNNREWFAEHKSEYDAIAKDNKIFFQEILQRLRQHDDITDMHIFR
IYKDVRFSKDKSPYKTNFGASFTRRKPELRGGYYIHIEPNNSFVGGGFWNPNKEDTFRIR
KEFEMDDQPIREIIADMKFQKYFGNIQAFDTLKTAPKGFEKDLPAIDLIRMKHWVVKRNF
SDEDVENEYFLNEVIDTFLAMRPWFDYMSEVLTTDLNGESIL
>OBAHECAF_01860 hypothetical protein
MFLKNVITDVLEQYATVTERIIFVTSGKRPALFLKKYFAEQTTKVSIAPEFISIAELLQQ
ISGVQEVGNQQLLFELYETYRNTCQTTPDDFETFIGWGQTLLKDFSDIDHYLVQSEKIFP
YIHALKEAEHWSGFEKQTEMQQKYLDFWNTLGDYYFAFNEKLNDRNHGYAGFVAKKAVEK
LPKYIQENSHKIHIFVGFNALSKAEQQVVQSILMDTESEIYWDIDKYFMDNVHHDAGYFI
RKYKNNWRYYNQRKKEFKWLTSSYEESKNIEIIGVPKSVNQAHTVAGLLREIPHSNMERT
ALVIGDEHLLIPVLQSISSDIPVNVTMGYPLQQTPLNDLFVAFFRLHLSKSYRYKDVLHL
LTQPFLQEVFSGKGISKIIQHIKEKNLTYLSKAKLMEITPDEDKEIMEVLFPEKTDDYVT
DLINSALNIIYRIKNAVESDKNENILGLEYAYRFYQLFNQLQTLQGKYGYIDSVKTLYHF
YLDILQKSSLNFEGEPLEGLQVMGVLESRSLDFDNIIITSVNEGVMPMGKSGNSLIPYDV
KFHLEMPTYKDKDAIYSYNFYRMLQSAKNIYLIYDTENGSLKSKEKSRFILQLLSERNPN
HRIQYQVKAPEVYPAKGSMLQIPKTEAVFQRLREMADKGLSPSAITNYILNPRIFYQQNV
LQVYEERDVEETIEARTFGDIVHEVLETLYNPLLNTPLKQHHYIEMQSKLETLIEEKFVK
YYKNEDFKLGKNLLIFNVIHSYLKRFLDLEQQEVEKGTELVVLHLEEKIRVPFVSDKLPF
PVYIKGIIDRIDMRDGVLHIIDYKTGIVEENAVGIADWNLLVTDFKYSKAFQLLSYAYMY
QQRFGYQECMIVGNISFKRLNMGLIKFHTKEKVGRTYVKDYNINSFILDSYKEYTEALLA
EIFDISIPFTEKE
>OBAHECAF_01861 Arabinose 5-phosphate isomerase KdsD
MDTDKIIEIARVTIEEEAKSILKLYDFVDENFVKSVDYILKSKGRVVVTGIGKSAIIASK
IVATMNSTGTPAIFMHAADAIHGDLGIIQEDDVVICISKSGNTPEIKVLVPLLKRGKNKL
IAITSNKTSILAQQADAILYAHVEKEACPNNLAPTTSTTAQLVLGDALAVCLLKMKNFGS
SDFAKYHPGGALGKRLYLKVSDIVVNNQKPQVSPTTDIKKVIVEISEKMLGVTAVVENER
IMGIVTDGDIRRMLSKTDTVSGLTAQDVMTLNPKTIQADTLAIDALEIMESNKITQLLVT
EGNIYIGVVHLHNLIQEGII
>OBAHECAF_01862 ATP-dependent DNA helicase RecQ
MELAKNDLQSALKHYFGFDSFKGHQQEIIQSVINKENTFVIMPTGGGKSLCYQLPALVLE
GTAIVISPLIALMKNQVDAIRGVSSTDSVAHVLNSSLTKGEIREVMDDISSKKTKLLYVA
PESLIKDEYANFLKTIPISFVAVDEAHCISEWGHDFRPEYRNIRTIIDRLGNGIPVVALT
ATATPKVQEDILKNLGMSEANVFKSSFNRPNLYYEVRPKTKNVDTDIIRFVKQNSKKSGI
IYCLSRKKVEELAQMLQVNGITAVPYHAGLDAKTRAKHQDMFLMEEVEVVVATIAFGMGI
DKPDVRFVIHHDIPKSIESYYQETGRAGRDGGEGHCLAFYSYKDVEKLEKFMVGKPIAEQ
EIGQALLQDIVAYAETSSSRRKFILHYFGEEFDEVNGEGANMDDNVRYPKTKIEAKDDVV
KLLNIILSTKQKFKAKELVNVLVGKVSALIKSHKIDEQAFFGIGKEKDDLYWMALLRQVM
VNGLIYKDIESYGVMFVTEKGKDFLKNVPSFMMTEDHVYEEEPEENNNSSSGVADEVLLG
MLKDLRKKVAKKKGVPPFVVFQDPSLEDMALKYPITISELTNVHGVGDGKAKKYGAEFVE
LIARYVEDNDILRADDLIVRTTGSNSSLKLYIIQNVDRKLPLPDIAKAKGLEMDEFLKEL
EQIVYSGTKLDINYWVDEIFDEEQQEELHDYFMEAESDKISIASKEFDGDYEDDELRIYR
IKFISEVAN
>OBAHECAF_01863 SPBc2 prophage-derived glycosyltransferase SunS
MKISVVINTYNAEKHLQAVLETVKDFDEIVICDMYSTDKTIDIATEYNCKIVYHQNTGYA
EPARNFAISQAKNEWILVIDADETVPPKLKEYLYNIIEMPDLGGVYIPFKNYFINKWIRS
AYPDYKLRFFRKESAFWPPEVHSTVKVQGKIIKVPRNQTNLASEHLANDSITTILQKNNT
YSTAEIVRKKDKKITWFLLICSPLFWFIKFYFIKKGFLDGKRGFIFAVLKSQYKFSCLAK
VYEYQKNNE
>OBAHECAF_01864 hypothetical protein
MNIKKITSKVTSNNFALYTNVFLLLGAFIYYFIPSEFNLYASEKTLNIFFKIALVGIVLV
TFADIWLKRKVLFKNIDKIRVFFLLFASTIVMIYPYKHKMVLGLSIVLFSLMLLYGLHKR
QYIGFHIIMKSLLIFIFFVFASIFWATNTSEAFKHIDYFVLFLAVPLLSCFYRWKKEEIY
IFIYPVFTAFLSLLSLNVIAYVCLVKYHQKPVFSFLSFSKSYLAPATNHYEILRWSETFH
QSIIGWGLFIVGVLGYWLYKEKKQKLISIEHISLFAVLLACVSFMIQARVAMIGIVFFTG
LFIWVELMKKINSRGRIFIYTTIITILGILSCYWIFTETPYFNDEIRHTMNNAAIQFFPQ
HFWIGGGANYEIEVIQSVNYEFNKLHNIFLSAMVNQGIIGLILLLLFHFYAIYTGIKYEH
LLGIYVFLAFLIFNLTEDVLGYPICGLFFLFTLIPFEKEQINQIQK
>OBAHECAF_01865 hypothetical protein
MTNKTIIFGAPADFFNQKIIDNFKFLGFEVIDVSISLNYKYSSLKDKLKNTFRKAFFNDN
SHKKRVRFALIEQEINEKIDTLHRKADYVLLIRPDIYPEYFLQNLKTKSKKMVAYQWDGL
NVFPDVRKVVKYFDRFFIFDPKDVAESFLPTTNFYFDIPEQSLEVPKDEKRIFFIGTWKK
ERMKPTEKIVAKIKKNYIPDISLYTTKKSVLRKYKNSLVNITDKKISLEDNHKKIRESAV
LVDILNTVHNGLSFRVFESIKYKKKLITNNSHIKKYDFFDKNNILVIEKDSDYELIPSFL
ELPYLDLPQVIYEKYAFTNWIKYVLDIPTYQPIELPKANKLP
>OBAHECAF_01866 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKKIDKDVYLKWYEEMLFWRKFEDKLAAVYIQQKVRGFLHLYNGQEAIVAGCMHVIDPTK
DKMITTYRNHIQPIALGVDPRRVMAELFGKATGTSQGLGGSMHIFSKEHRFYGGHGIVGG
QIPLGAGLAFADKYFNRDAVTLTFMGDGAVRQGALHETFNLAMLWKLPVVFIVENNQYAM
GTSVERTANHTDIWKLGLGYEMPCAPVDGMDPVKVAEAVYEAVERARRGDGPTLLDIRTY
RYRGHSMSDAQLYRTKDEVEEYKKLDPITQVLNVIKENNYATEAEIEAINERVAKLVAEC
EKFADESPFPEKEVLYDVVYEQENYPFLPHKL
>OBAHECAF_01867 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAEIINMPRLSDTMEEGVVAKWLKKVGDKVQEGDILAEIETDKATMEFESFHAGTLLYIG
LQEGETAKVDTLLAVIGKEGEDISALISQDVASAQPVAESKPEPIETSEPLASIPAGVEI
VTMPRLSDTMTEGTVATWLKKVGDKVQEGDILAEIETDKATMEFESFYSGTLLHIGIKEG
ESASVDALLAIIGPAGTDVSAVIAGGGSAKPASTPTKSEVKKEQEKPVVSTPVVTTADNN
SDRVFASPLAKKIAQDKGINLSQVKGSGENGRIVKKDVENFTPSVQSQNAEKPTATSVTS
FVPAGVENVEEVKNSQMRKTIAKRLSESKFTAPHYYLTIEIDMENAINSRSEINKLPDTK
VSFNDMVVKACAMALKKHPQVNTSWKGDVTVYNQHVHIGVAVAVEDGLVVPVLKFTDSLS
LTQIGGQVKDLAGRARNKKLTPAEMEGSTFTVSNLGMFGIEEFTSIINQPNSAILSVGAI
VEKPVVKNGQIVVGNTMKVTLACDHRTIDGATGAQFLQTLKTYIENPVTMLA
>OBAHECAF_01868 hypothetical protein
MLKKYGYFIVLIISLSIFLRCARRGSPTGGPKDETPPVLLQVTPPSATTGFDKKKIRLVF
DELVTIKDLRKQLIVSPPMENFPIVSPMNASRNLEISILDTLKPNTTYVFNFGNSIQDYN
EGNVYKDFKYVFSTGKFIDSLKVTGKIKDALKSKPDKSIVVMLYEYNESYKDSVVYKNKP
LYIGYANDSLNTFEINHIREGKYMLMAMQDKNNNYLFNQKEDKIAFLEQPIFVKGDTVIS
YELTLFKEKWNYKAARPIQASENRFIFGFEGDTDNVKIEPISKQTNDFKYVISKEPKKDT
LNFWFSPKQDSLRFTITKGEKIDTFTTRLRKMKPDSLQISNLFSGDLPKGKYFGWKSNIP
IMKTDTTKVQVFEKDSIRIPFKTKLSEDRLEYLIVFDAKYGESYRVKAFPDAMIDFFGKT
NDTLEVKLRTKKQDEYSVLKLTLKGEVDYPILIQLTDEKGDVHRELYTEKPENQYIFEAV
PPKKYRLRIIEDKNGNKKWDTGNFLKRQQAEKIIHHPKEIELRANWDIEETFSW
>OBAHECAF_01869 5'-nucleotidase SurE
MTKKPLILITNDDGITAPGIRCLIKIMNEIGDVVVVAPDSPQSGMGHAVTLNSTLYCEPI
HIDDGVQKEYTCSGTPADCVKIAKYEVLKRKPDLCVSGINHGSNSSINVIYSGTMSAAVE
AGIEGIPAIGFSLLDFSWDANFEEARDFVKQIAINVLKNGLPKGVVLNVNIPKLKKEAIK
GIKICRQAQARWIEEFDKRTNPQGRNYYWMTGKFVNEDGGDDSDEWALANGYISVVPIQF
DLTAYHVIPHLEKWKMK
>OBAHECAF_01870 Inosine-5'-monophosphate dehydrogenase
MNFQEKIVGEGLTYDDVLLIPNYSEVLPREVVISTKFTKNITLNVPIISAAMDTVTEAAM
AIAMAREGGIGVLHKNMTIEEQAKQIRKVKRAESGMIIDPVTLNLEAKVSDAQRSMKENS
IGGIPIVDADGTLKGIVTNRDLRFEQNGNRPIVEVMTSENLITAAEGTSMKEAEKILQKH
KIEKLPVVDKNNKLVGLITFRDIANLQEKSISNKDLFGRLRVAAALGVTSDAVERAEALV
YAGVDAVIIDTAHGHTRGVVSVLKAVKEKFPELDVVVGNIATAEAALYLAENGADAVKVG
IGPGSICTTRVVAGVGYPQLSAVMNVANALKGTGVPVIADGGIRYTGDIVKAIAAGADCV
MLGSLLAGTKESPGETIIFEGRKYKSYRGMGSVEAMKQGSKDRYFQDVEDDIKKLVPEGI
VGRVAYKGELQESMHQFIGGLRAGMGYCGAKDIKTLKETARFVRITASGIAESHPHNITI
TKEAPNYSR
>OBAHECAF_01871 hypothetical protein
MSLKLKGYILALVSAITYGMIPLYMIPIKQSTLSLDDALFYRFAIGGVFILVFLIYRKER
LQVNFRELLIFKILGLLYALSSEFLFAAYDYLTPGIASTIFFMYPIVVALILGLFFKEKI
TLATVISLLIVVLGVGFLSVKDTDSFSINFFGLFIGLMGAVIYGIYMVVVNKSKLTASGI
KITFYSMLFSSIYFLVKSMIINGFVEIPTVDMGIHLTAFSLITTVLSILTLVYAIYYIGS
TPTAIIGAVEPIVAVGISVFLFGELLTKNLIFGVLLIITGVLISILFERKKGKSK
>OBAHECAF_01872 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MTDETERGYDIKSMGANKRILLVEDDPNFGTVLRDYLVMSGFDVSLAKNGMEGFEKFRKE
MFDLCILDVMMPYKDGFTLAKEIREKNEKIPIIFLTARTMREDIIKGYKVGGDDYLNKPF
DSEILLMKIRSMLQRKAVETVADSKKFEFEIGDFFFNSKLRFLKYKDEEPEKLSPKENEL
LRLLALHENDLMPRELALAKIWKDDNYFTSRSMDVYIAKLRKYLKKDEKVEVLNIHGEGF
RLLTNREEESFI
>OBAHECAF_01873 Sensor protein SrrB
MTISLIGIILIQGYWIKSAIDKQQEAFSHSIQQVLSSVTASLESQEVNKYIAQIIELREK
DSTLILKDSHLREFMYVQENKNTKETFIYKHGILQEDYNLPTNGFNGISSNDTVLVKNYI
SQQTEQKITYATELDNQIAPSIETYQKLSRLPQIEKLMLEESIKNISQKLSVVDRVSAEQ
IQNAVQQELDKRNLNMEFDFAIYNRNILSSIRSKYFDSTKGQEYRMPLFNTSSGDSRYEL
ALTFPQREHYMFSSVIVISSLSMVFMIIIIGVFTITLNQMLTHRRISQIKTDFINNITHE
FKTPIATTNLVLDAIKNPMTINNPEKILTYINMLREENKRMHSQVENILQISRIDKGELD
LSKEPLDVHLLLEIAIGHVQMMLHERSGMIRTHFEAENSDISANESHFTNVLINIIENAI
KYSPNPPDIDIYTENIKNKILIKVKDRGQGMSKQAVKQVFHKFYREHTGDLHNVKGHGLG
LAYVKRIVNHHGGTVYVESEKGKGSTFFIKMPTI
>OBAHECAF_01874 Dephospho-CoA kinase
MVVGLTGGIGSGKTTIARMFQDLGIPVYISDIEAQKVIETDPVVKRRIIKEFGELAYIDG
KYNRRYIADIVFNDKHKLQNLNNIVHPALALHFQRWKDMQKSLYIIKEAAILFESGAYKQ
CDYIITVTAPEQERIRRVVERDQVTEKLVRERMRNQWTDEERIKLSDEVVDNINIQVSLL
KVKEIHSKLIKKLRNRQ
>OBAHECAF_01875 hypothetical protein
MASTKKKIQLILVDRRTVTFVICLLVSIVLWSLIRLSKTLHREFSVDVAITNIPEDMFLN
TSQKYKIKIRAEGNGYALLKYYSQGQVLSVDFNDLEYIGNKRYKLSKNISNKLNVISKNN
FRIQNTYSDTIYIDLEKKYTKRLPLKVNLNASYHREYQLTDLEIMPDSVEVMGFKTAIDT
LQEVVVILDGRKEVKESFEAVHFLKKSDFLQYNTDKITVKAMVDKVSEQIIKLPIQVTNI
PEGSQVKTFPSEVDVLCSGDLNLLKNIKQDDIQIIADYLDVQDDSRIPLTIQTTLRRVKI
TFLAENKVEYLIKKI
>OBAHECAF_01876 5-methylcytosine-specific restriction enzyme B
MTNDLQNPISYLIEKYIRILKENGEPGEAYKYLAINTFQQNWNLDSEDFYQMFRNSFGKV
ANLLYQTSRGFIEKSAELFPEETRAMFRNLYDESVEVSKRITAFQTESENLLLKLQQALN
RTNIKAQQDERTISVYLAFRFPEKYTLYKADYYENFCEELQIKDKKAGNRFLHLQELADE
IIRKGLLENEKLMNNYRKFYPKPDWNDAYLVIQNILYITFKKRFIEMSEKFKLFYNEIKQ
YIETNELKYKLGRKGKEWVWVFDEQEYFNNDYVHYEFLLNENQVSIDLHFEKNKKIANEL
HSLCEPLPDFLEWKTWQKSVQSITHKNKIDLESPNRTKESIEALNELYNRTYPLLVEKAK
SLKVTTKNSDPIKSTEESMKNMNLTPNIPLNQILFGAPGTGKTYHTKKIAVEIINGKKER
TRKEINEEFETLTNAKQIVFTTFHQSLSYEDFIEGIKPETTDGKVTYEVKGGIFKRLCSR
AIEQKSKNNGIEIYDFDKAWNDLIAEAEQFFLSNSQLLLSILTPDKGLYVTEITDNGNLK
VKPKNSRLDIDYTVSYNRAKKLQEAFPDLSVVKNIDKEFRYVIGGSNSTAYWAVLNFINN
RIKENYKVTTIPKENKNYVLIVDEINRGNVSAIFGELITLLEEDKRKGNPEQTEVVLPYS
GNKFSVPNNVYIIGTMNTADRSVEALDTALRRRFSFVEMQPNPEILSEEEYKNVDLPRLL
ATINQRIEVLIDKDHQIGHSYFIGIQNLEDLKGVFRDKIIPLLEEYFYGDFGKIGLVLGG
KFIHQKENKALFPKNFTYENDFLEDKKIYRFAPFESWNEETFKSVYED
>OBAHECAF_01877 hypothetical protein
MQNKKFIQVFEHQKLRYDDSGDFQKHHFDAMVKFNEQHQNKYFTIIHKGIRFGSYVGVIQ
IGGLTIEILPKADHRADADKNLWQNVLLNMLKVCKYIQVDSVSETQLKKRYHSILDVYFE
LYLNEIERLVKKGLIKKYQKKQSNQNALKGKLLFAKNIQQNLVHKERFYCEHQVYDKNHL
LHQILYQGLRLLKTFVNDALKDKLNRLLFEFQEVENIEIGEKHFRKIVIDRKNNDYQKAI
DIAKVIILNYSPSLNYGSEHLLTLLFDMNALWEEYIFRIFQKHKTDEMQLSFQNSDKFWE
NKSIRPDIVLKTNQETFVIDTKWKIIEANNPSDEDLKQMFVYNLHWKAEKALLLYPKIQQ
TDSHFGLFHYNNLGKKCKLGFVDITCEGSIKNSKMVANEIFSKLTELSDDRMSYSN
>OBAHECAF_01878 hypothetical protein
MDIHFVIVQNYKTKKGQLPFLQIVILFYCGVGENRTLVQISNSKAFYILSFCLIFVALLT
KNRPQHA
>OBAHECAF_01880 hypothetical protein
MEKLNFNDYSFRIKEVDSKRFIFDEIRRKFVVLQPEEWVRQHVIRYLIQEKGYPISLINV
EKELKINDISKRYDIVVFSKNGDILLTVECKAPQVQITQKTFDQIARYNLILKSDFLMIT
NGLNHYFCTVDYVQKKYIFLKDLPAYSEIKG
>OBAHECAF_01881 Glutamate-1-semialdehyde 2,1-aminomutase
MIYKRSSELFAQAKKVLPGGVNSPVRAFNAVGGEPIFIKEGKGAYLYDEDGRKLIDYIAS
WGPLILGHAYPPVVEAVVEKAKKGTSFGIPTEIEIQIAELAVSMVPNIDKIRFVNSGTEA
CMSAIRLTRGYTKREKIIKFSGCYHGHSDSFLIQAGSGATTFGSPNSPGVTQGTAKDTLL
ARYNDIESVKSLFETNKDEIAGVIIEPVAGNMGCVPPKAGFMEALRKLCTENGALLIFDE
VMTGFRLAKGGAQEVLDIQADIVTFGKVIGGGLPVGAFASRNEIMNHLAPEGLVYQAGTL
SGNPLAMSAGLAMLTALNDNPQVFKSLEEKTAYLHRGFEEVMSKSDIPFQINRFGSMISL
HFNENPVVDFESSAKGNIDRFKKYFHGMLAEGIYLPPSAFESYFLNDALSYEDLDVTIEA
LNKLVINKKLD
>OBAHECAF_01882 Phosphorylated carbohydrates phosphatase
MDGVLVDSEPMHQQIIYEVFEQLGIPFSKEYIERDLTGMSAVPMWEKVKQDAKRTESANE
LLTFHREYFYKRFEQIEVNEIEGVKYVLQKLKDRGFLLSLASSSSRKLIDYFIKKVEIAH
FFDVIMSGDDVQYSKPFPDIFLKVAEAYNIDAQYFWVLEDSKNGVQAAKSAGMHCIGFKN
PNSGVQDLSKSDIVIEKMSDFTDDFITKISSIYRK
>OBAHECAF_01883 hypothetical protein
MKITESKYYRPIKILQLDSDERIELFDKHNILSFNNPFRTLLNSLMVSIYLADEDLVIHR
EKLKHFQKCTDYYTVEYASKQNELFESEQCYFHPDLEAFILIDKNLSNEYDNQIFEEGLF
KVSHVYYQNTNPKAKQNLDTLFSEYIEKHISKESKVSILLMTKFGFEIRTHIIKPYRIDF
ETMYNDDFMEVHHRVKNSLTNENKGIILFHGIAGSGKTNYIKWLTSQIPNKKFIFVPTTM
IGKLTDPSFIGLLMENNNSVLVLEDCENYIAERTTFNSNTDVVSSILNIADGILSDVLEC
QLIGTFNSDISKIDPALLRKGRLIAEYKFKELSVEKCNKYLESNDKNIKVNRPYSLAELT
NIDVKELKEDSNPTKIGFAK
>OBAHECAF_01884 Propionyl-CoA:succinate CoA transferase
MTKYTTAEEALKIVKSNDFIYIQGGAAVPNRLVDALVQRASELRNVTIGHIHVEGDAPYA
DPKYKDSFFVNSFFLSKNVRHTLEAGNGSYTPVFLSDLPLLFDRKHIPVDVALIQVSPPD
IHGHCSIGVSVEACKAAMRNAKRVVAQVNKWMPRVFGDAFVHIDNIDYLVQHDEPIFAVS
PTTPDEIEDQIGNHIIDLIENGSTLQLGIGNIPNAVLSKMGHLKNLGVHTELLTEGMLNL
IKQGVVDGSKKKSERGKVVASFMMGSRDFYDFVNDNPSVELLEASYTNNPAVIRQQPKMI
SINSAIEVDLTGQVCADSIGTRLYSGVGGQIDFVRGASLSEGGKSIIALPSMTKKGVSRI
TPFLKQGAGVVTTRSHVQYVVTEYGVAHLFGKNIHERIKAMINIAHPDHRETLERQYFEV
FKK
>OBAHECAF_01885 hypothetical protein
MDIQQIIAYTLVIIAVFFLIRTFFYKKKRKKGCGNDETNCKCG
>OBAHECAF_01886 Phosphoenolpyruvate carboxykinase (ATP)
MSKPNTISVENYGIKNANVRYQLSADELHKEAIAKGVAEEANSGALSIKTGKFTGRSPQD
RFIVKDDITKDRVWWGKVNIPFDSAKFDALYDKVMAYLSGKELFVHDGYVCADPNYRTNV
RTIAELPWSAQFVYNMFLRLEDSEVENFKEEWLVINAPGFLADPAVDGTRQSNFAILNFT
RKIALIGGTGYPGEMKKGIFSALNFVLPVFKNTMPMHCSANVGKDGDTAIFFGLSGTGKT
TLSADPNRHLIGDDEHGWTPENTVFNFEGGCYAKVVDLTPEKEPEIFAAIKKGAILENVI
MHNGEVDFADTSITENTRVSYPIHHIANIQPGSIGKNPKNIFFLTFDAYGVLPPISKLTP
EQAAYQFVSGYTSKVAGTEVGITTPQKTFSACFGAAFMPLHPAEYGKMLAEKIEKSGVNV
WLVNTGYNGKMKRCSLKDTRALITAALTGALDKVEYKELPIFGFGVPQSCEGVSDQAILN
PENTWDDKAQFAAKSKELAEAFLQNFKDKGFEEGADAQVLKGAPKL
>OBAHECAF_01889 30S ribosomal protein S20
MANHKSALKRIRRNEAARLRNRYQHKTARNAVRKLRAMENLEEAKEALPKVVSMIDKLAK
KNIIHANKASNLKSSLSKHINKLAK
>OBAHECAF_01890 hypothetical protein
MDISLALVFSFIFYMIMKIFSFTFAKTALKSLFLKGIKIYAIGFVLLISCDNSTEKEQLP
KEYQVKKVNFEEFRVTDISPKSTHDLQNWQSFQSLIQVIVSMAPTKIKNTENLVSTTPDS
LRIYQRLYPKNTNVILKNAFVERDWRSLENNTIDTIYRFEKDSESEFSFVQWDMFLVKNV
PYTLSVFVKGINQNEIALLFLDEQKELQKSNFELNTETHNKAGRKLNLSDDWKELQLQFT
PEQGATYSIQILFNEDAKKGENIIFYRPTLQVPPEYFSKIHQFSDKIVNQQTNVKSSYFS
LYLWLTQLDEELNQLLAEDKFPEPINSLAIKSRFRLFQTQIKELADNVKNNSDFEETAIN
QHIDKIKNTFNGLITRINSIYESDLDDQMKYIHSQIDTMESLFPMKDSLRFEHFTPIKE
>OBAHECAF_01891 DNA-binding protein HU-beta
MNKTELIDVIAADADITKAAAKKALESFFSNVEKALKKGDKVAIVGFGSWSIAKKEAREA
RNPRTGEMIKVAAKNVVKFKAGSELSDAVN
>OBAHECAF_01892 hypothetical protein
MNVGIIGCGWLGERLLSHLSDKHRMYVTIRTKRNLSTDNYYHCLEVDFDNFIPGKWQVLS
DLDSIIIAIPFGRRLSVEILQNRLKNICNFIEGFNKQLFFTSSVGIYPSVNGTIDENFPI
PDLQPELYFVEKYLKDKFPKINILRLGGLMGDDRYLSKYVVSEPHQMVNHIHYQDVCRVI
ERIMTFGLHSKTYNIVAPKHPTKQEIINHQTGIHLPLESAYGKIVTSEKVIRELDYDFLY
PNPLYF
>OBAHECAF_01893 Serine recombinase PinR
MIYGYIRVSTDKQTVENQRFEINQFCERQEMIVEKWIEETISGAKNIEDRKLGKLLKRMK
KGDILICSELSRLGRNLLMIMGILNECMNRDIQVWTIKDNYRLGSDINSKVLAFAFGLSA
EIERNLISQRTKEALARKKAEGVILGRPKGRKSSKTKLTGQEKQIKELLDKKVSYSAIGR
ILGVHRLTVSSFVRERIFAG
>OBAHECAF_01894 hypothetical protein
MEQRIKAKIEAVGVPLKDWDINIYRGILTGFNEAFIIDENKRNEILANCKTDKERQKTDE
LIRPLLRGRDIKRYSYDFADLYLICTFPSKSYNIDEFPAVKKFLEGFKSKLEQTGKKLTK
SEIYNVTEYAKSQGIEIKEKSLEKSRKKTNNKWFETQDSISYWEEFSKQKIVYSEIVREP
QFYLDNEGKFFPEATSFIMTGNDLEYLYHLLHSKIITYFFKTFYAGGGLGKDGYRYKKAF
LEKLPIPKNTSNITLNDANIEDFICEIFNLSTEEKNTIYEYLNDSDF
>OBAHECAF_01895 hypothetical protein
MIMNKLETLYTSIDNFKKLGVEINSEVIESIFNVEEGIIKNDILPIMRKAIIPIISQIQR
DLVLVIEYSPEKPIELKMTRKKSMKLTEEEEFIVTQRKEFKKEVKYTLPFHKKSPKTNLL
VTFSSGKTIKNKLAMDTFCEVIEIIGLEVVSNLNVRCCGSNLVSKIKNSDYRQKKMKKGF
YIITQTSTEQKKKYLDLISKKLNIGLEVTII
>OBAHECAF_01896 Type IIS restriction enzyme Eco57I
MSTLIDTFVEKFSIEALTDFFRKASKNFKKEQESFDYILKNKEEYASFSNLQKVGSIAFK
DADELIIFTCSYNGELSERSSKKRQYDIAKTILKNDFKDGAIFVFYDNTGKFRFSFIKKN
WGEKGANKYTSWKRFTFFVKPEETNKTFKKRLTECSFKDLKSVEEAFSVEALTKDFYNDL
FKWYTWVLTDKVGITFPNDTKTSDDDRVRLEEQIIRLITRMLFVWFIKQKHLVPNELFEI
EKLNTLLKDFEPQSVTSGNYYNAILQNLFFATLNKPILEREFAKLVDKRDIKARYRYAEM
FQISEEEILTLFRPVPFLNGGLFECLDKELSTDGVKYHLDGFSRNAEKAKNGNFKHRAFI
PNSVFFGDGTNEGLLPLLERYNFTVEENVPNEMEVALDPELLGNVFENLLGAFNPETKDS
ARKQSGSFYTPKEIVAYMADESLISYLENNLPEVDKLLIRSIFEEETLSVSLQNDFELCK
KIENELRKVKILDPACGSGAFPMGVLNRLVEILEKLDVQNKQSHYDLKLHLIQECIYGVD
IQTIASQISKLRFFISLIVEQEKVDYTKPEENYGVWTLPNLETKFVTANTLIGLEDKQEI
HLLDLKDEHLQKLQEQLLKIREEHFYAKSASKKVELRKQDEDLRAKIVDYLLQNATQPNQ
ECINEWKSDIQKLELEKEKYKNKKIVEKQTPNLFGEIDIIKEDVNQQKRKDLDIRIKNLK
TEIEKEERKSIKVGFEGVVQKVSQWNPYDQNASSPFFDMKWMFGVEEGFDIVIGNPPYIQ
LQKEGGKLAKLYENEKFETFAKTGDIYALFYEKGWQMLKSKGVLAYITSNKWMRAGYGES
LRKFFAEKTNPLQLIDFGGVQVFDSATVDTNILLFAKENNTFSTRACVIKEKELKKMSDY
FRQNTTICKFSSAESWVILSEMEQRIKAKIEAVGVPLKDWDIQINYGIKTGFNEAFIING
EKRKELIEADPKSAEIIRPILRGRDIKRYGYDFADLWLINTHNGVKEKAIKPINIEDYPA
IKSHLNLYYDKLKKRADKGDTPYNLRNCAYIEEFSKQKIVWKAVGRNLAFSILEENTFLT
APASFITSECNFYLLGFLCSSFAKYFIYNNSDTTGAGDIMLNIQSLIKIPIPQIENKTEI
ENLVSEIVISKKEKKNTEKLERELNNIIYLIFKFDNEEINFIENI
>OBAHECAF_01897 RNA polymerase-associated protein RapA
MQNNFITNAPNSTNLKSRLKTLISGSDELKFLVGFFYFGGWSEIYEELQKKPEVRIKILV
GLQVFNHLGNIIEYVDSNNRDKSTNEAFQEYLTSLHFALNNPELDSEAFYNQISFFVQML
QENRLKIRKTQHPNHAKLYLFKYNEKQAKFNDRLGEFITGSSNFTKAGLSGQEEFNVEIR
DYGFLEASAYFDELWENAYPITDDEENRQLIIQTIQTKTQVADITPFEAYCLVIKAYLDL
HNQNSEKVDLDELLKKVELKKFTYQTDAVSQAIQKINEHNGCIIADVVGLGKSVIASMIA
RQMNLRGIVICPPGLMGDAEKKDSGWWEYLEKFGLHNWQVFSRGILDRIADNIEGRNFDM
VIVDEAHYFRNSDTADYENLKLICQNKKVILLSATPFNNSPKDILALLELFLISGKSSIT
LNDNLKGLFESYNYQFKQLSKIRKNWNTSDDTKRRSAEQDYVALTGGELPIDLKKVDKLT
KKLSEKIRNTIDPVIIRRNRLDLLKDKVYSKEVGELSKVNDPVEGYYYLNEQQDEFYERI
IKKYFSEKGVFSGAIYQPFIYQKIVNENKLDEAGNRKFNQQKNLYDFMRRILVKRFESSF
GAFEKSIERFLEVHLLVRDFVKKTSKYILDRSLIQKINEFDLDGIEEVLLQFSQGSLERK
TPKNTEVYEIDTFQRKTDFLNDIDRDIELFQTIQEELKVLKLVENDPKQSEIISIIKEQL
TKEPNRKIILFSEYSDTIKHLEKGFREAFKNQVLVCDGKVNREFAKNLNEDFNAQYKGTQ
NNFFKILLTSDKLSEGFNLNRAGMIINYDIPWNPTRVIQRVGRINRIGTKVFDELYILNF
FPSVKGSNIIKSREIAQQKMFLIHNALGEDAKIFDKDEKPQASMLMDKVNTYTEGEDQEH
LITRIRNLYADLQEKYPEVFQKINQLPARVKTAKKHQQYELNVLKRKGNSLFVQHTNKDG
NVVEISFEELLPKIECKIDEPTLKLSSVFWELYKEVNNHKPNIRKVRSEISLEEKAMANL
KNARKIIPDLSIENIGFIEVLIKDLREYHTLANHTIRRIATIDFAKGKKAIDTFVEQVEW
IKKHLGTDYLHNIDKQLLTKRKEIIIAIENNDQTELFN
>OBAHECAF_01898 tRNA modification GTPase MnmE
MNETIIALATASGSGAIAIIRISGKDAISIADSVFKAHHGRSLANSDSHTVHLGYFFDNK
TIIDECLATIFKGNKSYTGEPTVEFSCHGSSYIIQQVIKVCLAKGCRLAKAGEFTLRAFL
NGKMDLSQAEAVADLIASDSEAAHTIAMKQMRGGFTSEIEELRTELLNFASLIELELDFS
EEDVEFADRNQFRSLLSRIQTTIKRLMDSFATGNVIKNGVPVAIVGKPNAGKSTLLNVLL
NEERAIVSDIAGTTRDTIEEVLHIGGTAFRFIDTAGIRETSDKIEEIGVKKAKEKITQAN
VLLYLYDELDNQPQEVIDFVKEVYRDDLKIILLHNKVDVSSGEFGDFDRKLKLELVPKYT
DTILGISAKENINIDILKSELTTYAESFTSSANNVIISNSRHYEALSNALAEIIKVQEGL
EMNLSGDLLAIDIREALYHLGTISGEVTNDEVLGNIFANFCIGK
>OBAHECAF_01899 Glucitol operon repressor
MKVLNERQIKIVEYLDAARHISVNDLSERLNVSVVTIRKDLTLLEQEGYLHRTHGGASKQ
MRYVFDQTISEKETLHVDEKIRITTKALEYIKEGDFIILSSGTTIHLLAQKLPDYKNLTV
LTPSLRVALDVCKHQNINTIHLGGEVRKNSTSTVGAFAEETLSNFLCTTLFLSVEGLDLD
FGISTTNAGEAHLNRKMVDHADKLIVLADSSKMHKRGFGFICYLEKIDILITDNKIDPEF
VEELEKRGVEVVIA
>OBAHECAF_01900 Peptide chain release factor 3
MSILQEIQKRRTFGVIAHPDAGKTTLTEKLLLFGGAIQEAGAVKSNKIKKGATSDFMEIE
RQRGISVATSVLAFNYKNYKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDVAKGVEEQT
EKLVEVCRMRNIPMIVFINKLDREGKDAFDLLDEVEQKLGLSVTPLSFPIGMGYDFKGIY
NIWEKNINLFSGDSRRNIEETIAFDNVNDPDLDKIIGEKSAENLRSELELVYEVYPPFDR
EAYLNGTQQPVFFGSALNNFGVRELLDCFVEIAPSPRAKASDERIVNPDENTFSGFVFKI
HANMDPNHRNRLAFVKIVSGTFERNKPYLHVRHGKKLKFSSPNAFFAEKKEVIDISYAGD
IVGLHDTGNFKIGDTLTEGETLQFKGIPSFSPEHFRYINNADPLKSKQLEKGIDQLMDEG
VAQLFRLDFNGRKVIGTVGALQYEVIQYRLEHEYGAKCSYESFPIHKACWVEEPENPKDT
EFQDFLRVKQKYMARDKQGNRVFLADSAFSIEMVKQKYPSVKLHFTSEF
>OBAHECAF_01901 hypothetical protein
MSKFTKKKSGELPPVSTASLPDIVFMLLFFFMTVTEMKNSDLMVQNKVPMADQVQKLDKK
DPVVYIYAGKPLPKYQEKFGVNAKIQINDKFADVSEIAPFILQYKDGIREELREMFITAL
KVDEETNMGVVSDIREKLQDINALKINYITKEGSVLK
>OBAHECAF_01902 hypothetical protein
MAKRGIPEVNAGSMADIAFLLLIFFLVTTTIETNAGITTKLPPKQPVDAPEPPAVKEKNV
LVVVVNKNNQLLVNNQVMELKDVRKAAVDFLDNGGDGSCTHCRGAKNQASSDNPEKAIIS
LRNDRETSYKTYISVQNELIAAYNDLRERERQRLFPNEVSYTEMDAEYNAARTPKKRKDD
LEVKIKKLQELFPRKLIESAPKKN
>OBAHECAF_01903 hypothetical protein
MYKISKIGVLVLGVLGAILWIMLITTADTQNVDNAPMEWMFIISYILLGLALVAAVFSGA
KNILSNPKALKKTLIYTGVFVVIMFLPFLFVTEKTTTETWVSAGLISFYILTIVAVGLLI
ISGVKGALTK
>OBAHECAF_01904 hypothetical protein
MKKMSSKLFFVAMLILNVATVSAQEVENAGASKGFHQVLKERFIEGGPEFMGVVLLCLIL
GLAVAIERIIYLNMATTNTKKLVAEVENALDKGGVEAAKEVCRNTKGPVASIFYQGLERS
NEGIEMVEKSVVAYGGVQMGQLEKNVSWVSLFIAIAPMLGFMGTVIGMIQAFDKISAAGG
LDASLIAGDIKVALLTTVFGLIVAIILQVFYNYIISKIDALINDMEDASISLIDMLVARQ
KR
>OBAHECAF_01906 L-asparaginase 1
MNTQNSKILLIYTGGTIGMIKDYETGVLRAFEFENIYHRIPELSHLDCVIDSVSFEKAID
SSDMNPRHWVNIAETIENNYHVYDGFVVLHGSDTMSYSASALSFMLENLAKPVIFTGSQL
PIGDLRTDAKENLITSIQLAALKENGQSVIQEVGLYFEYKLYRGNRTTKINAENFQAFVS
MNYPTLAESGVHLKVNKQHLLRSEGHHSLKVWKEFDQNVAVVKLFPGITEKILNGFFDIP
DLKAVILETYGSGNAPTEKWFLNSIEKAIQKGIHIVNVTQCSGGSVILGKYEASEHLRRM
GIINGKDITTEAAVTKMMILLKKIVSGNSLKIRFEENICGEI
>OBAHECAF_01907 hypothetical protein
MQQNTIVDYFKSIRPYYDKEVSEVLQKVKDHSKVQAMLAYGFPDLSVEERVGKLLSCESI
FDFQNKIMYGVVKKAMEKSIAQFTYEGFDKLTKEKSYLFISNHRDIILDTSLLNVTLHDH
NLKMTASAIGNNLIQKKFLKILSMLNRNFIIYRNLPPRESLEHSKIVSEYIHYCITKDNR
SVWIAQREGRTKNGDDRTQQGVLKMLSLAAPEGVSPLQYLKTLNIVPMSISYEFDPTDMM
KIPALMAQHYGVEYVKSKKEDFENILQGLIGQKGRVHISVGKPLNGELDKIEKEHAHVNK
QLQAIAETLDRSIHLQYKLFPANYIAYDLLNSTDTYKDFYTEKELRQFERRIHNRSKSDD
VLSQEKFLEMYANPVKNKMSQHV
>OBAHECAF_01908 putative metal-dependent hydrolase YcfH
MKQPLPIITDTHTHLYSKVFDEDRDQMMQRAMALGVTRFFIPAIDSSHTESMFALKRAYP
DNVFLMNGLHPCDVKENYLEELDHVEKLITEHSFCAIGETGIDLYWDKTFFKEQQEAFRR
QIGLAKKHKLPIVIHCREAFDEIFEILDSEKDDRLFGIFHCFSGNEQQAKQAISYNLKLG
IGGVVTFKNGKIDTFLKNIDLEHIVLETDSPYLAPVPYRGKRNESAYITEVLKKISSIYG
VSENEVADITTKNSIKVFGF
>OBAHECAF_01909 hypothetical protein
MKKIILFLALLVGTGVFAQKHKDEKNIYTDFLPYYNFGKGLGITAPDSIFQLNIRFRMKN
RLEVTEDTYSAKVRRLRLRFDGYVGDPKFTYAIQLAFAPEDIGTTRDGENLNIIRDAIVF
YKPNDQWSFGFGQTKLPGNRQRINSSGALNLTDRSINNQAYNIDRDFGLQAVYSKQKENA
FGYNIKVALTTGEGRNSTTKTKGLAYTGRIEFYPLGKFKKGGEFFEGDLQREEKPKLYFG
GTYHYNEKATLSRGQHGTKLLQQRDLQSFFLDFVCKYNGWSFTSAYMSRTADNPIVDAAK
ANFVQVGNGYDTQLSYVFPQKWEIIGRFSRNNSHSDLYAFVPKQNQFSLGITKYIWEHAF
KMQFEISKNDYIQSPKKDDWYARFQIEIGI
>OBAHECAF_01910 Peptidyl-prolyl cis-trans isomerase A
MRYSFLSMLCISIVLGCNDRSQKANNSLESVENNKEVTEENLVKEDKSEKEQEIFEPLTT
QSAIPFLFEYEKRHKERYVRIITDYGNIDIELFVETPYHRANFILLTKEKYFDGSVFHRV
VKNFVIQGGNSDSWAIHKKRHRIGQYLLPPDTKKGFKHHRGVVSMPSSDIENPHKFASPY
EFFIVVQDPGAYHLDGGYTAFGKVIQGMDVVDKISQVETDDQSEWPKRDIKMKVEILK
>OBAHECAF_01911 Lipase LipV
MKNIPFYTKKGSGKPLMLLHGFLESSEIWEHFAEILQSDFCVITTDLLGHGKTPVEAEIH
TMEMMAEAVNRILEIEKIDTCLFVGHSMGGYVSLAFAEKYPEKVNGLILMNSTTVADSEE
KKANRLRVLEVIDKDKSFFIRTAVNNLFSSENRIKMKQKVDKVIKIAMEIPNEGIKAASL
GMKDRPDRTHIFEGLQVPKHIIIGENDELIPAENLVELAQKTKASYSRLIGGHMSYIENE
TETVDIIKRIGYEI
>OBAHECAF_01912 Extracellular ribonuclease
MKYILFLLVSFFVACSTQNVPLPEKEENTEIPEEDPNFQNVKFNIPKELQAYYKNIDFSK
KSSDLYNDLATLTIQKHENILQYYDRHKYLYQADKSENDPQKVVLLYTGEIRFWKEYEGN
KGYKPQTFNTEHVYPRSKLGLVAIADLHHLRVCDSRVNTLRGNYPFTEGSGSARLINGSW
YPGDEWKGDVARMILYLNLRYNESLGKDISTGGVDLLLKWNAEDPVSTIEKNRNNVIEQA
QGNRNPFIDNPFLATLLWGKYKAENRWK
>OBAHECAF_01913 Lipoprotein-releasing system transmembrane protein LolE
MAITAIALGMVMMLIAIATGGGLQRKIREKIVTFQGHIQIYNYDNNASEVSIKPISIHQD
FYPQFTEIPSIVHLQAVATKGGIIRTETTYEAILAKGVGEDYHWEVMYEFLKEGRIPDFT
TDEISNEILISEYLANRLQLRLGDHCHTIFLKDETSQVPNQRNFKIVGIYNSGFQEFDAS
YVFVDIRQIQRINQWKKDEVGMFEVFVDDFDKIESVGDQVYDKTMATLDSQTIMQKYPFI
FEWLGMFDFNIYLIIGIMIVVGGFNMITAILVLILEKTPMIGILKSLGTSDRSIRSIFLY
NAAYIITQGLFWGNILGFLLLFLQQKYSIIKLDPATYYVTEVPIHIDVFSVIFLNIGVLI
LCLLMLLVPTYVVTKISPTKSMKFS
>OBAHECAF_01914 hypothetical protein
MKKGKFNGLFILRMVKNTFFLLFLITSCKNYSQKNTSNGISEKEIVLASNRIWLYINDLQ
NKKIGIVTNQTGIIKNKKGEYTHLVDSLISRKIDIHKIYVPEHGFRGEADAGEIVKDGKD
SKTGIPIISLYGKNKKPFPEHLKNIDVILFDLQDVGVRFYTYISTLHYVMEACAELNIPV
IVLDRPNPNAHYIDGPVLEMEQHSFVGMHPVPVVYGMTIGEYAQMINGEKWLKNQIVANL
KVIPLSNYTHQTPYSLPVRPSPNLPNDVAINLYPSLCFFEGTNVSMGRGTSSQFQIYGSP
YLEKTNFQFTPQPNLGDKNPKFKGKACYGENLTNHPRMSALNLSWLQKAFEQSKGVKIDF
FNNFFNKLAGNKKLKEQIIQGKSETEIRETWQKDLTKFKEIRNKYLIYRDK
>OBAHECAF_01915 Chondroitin synthase
MSYSFIIPVYNRPIEVDELLETIANQSFEGDFEVVVIEDGSTLQSKEICDKYADRLHITY
LYKPNSGPGDSRNYGMQKAHYDYFIILDSDCLLPEHYLESVDDFLKRQYVDCFGGADAAD
ESFTDIQKAINYAMTSLLTTGGIRGNKNGIGKFQPRSFNMGLSRKAFESSGGFGRIHPGE
DPDLVIRLWQKGYQTAFIEEAFVYHKRRISWKKFKEQVCKFGQTRAILNHWYPQTKKITF
WLPFLFSTGLIFSLSVAFIGRLEGLYIYCSYFIIVLLHSSRENKSTKIGFLTIWAILVQF
FSYGFGFFRATTKLFLYKKEPEKLFPHLFFRRK
>OBAHECAF_01916 Carbamoyl-phosphate synthase small chain
MKYQEKKKAVILLADGTAFYGKSVGNDGTVFGEVCFNTGMTGYQEIFTDPSYFGQIMVTA
NAHIGNYGINEDENESDGIKITGLVCRNFSYDHSRPSASGSLKDFFDKTNLVAICDVDTR
ALVAHIRDNGSMNAVISTQTDDLEFLKEKLKQIPDMKGLELASKVSVTEPYFFGNENATY
KVAALDFGIKKNILRNMAKRDMYVKVFPYDTPLEELKKWNPDGYFLSNGPGDPEPLTEVI
AKVKQMIAEDLPLFGICLGHQIIALANDVPTFKMHNGHRGINHPVKNLLTGKGEITSQNH
GFAVDRKQAEANKNIEITHVHLNDDTIMGIRVKGKKCFSVQYHPEAGPGPNDATYLFDQF
AEMMKNN
>OBAHECAF_01917 Enolase
MSIIVGVHARQILDSRGNPTVEVDVITENGHLGRAAVPSGASTGEYEAVELRDGGKDYMG
KGVLKAVANVNEIIAEEIIGMSVFEQNLIDRTMIELDGTPNKSKLGANAILGVSLAVAKA
AAAELDLPLYRYVGGVSAHTLPVPMMNIINGGSHSDAPIAFQEFMIMPVKAKNFSQAIQM
GAEVFHNLKKVLHDRGLSTAVGDEGGFAPTFEGTEDALDSIKKAVENAGYKWGEEIKIAL
DCASSEFYADGKYDYSKFEGASGKVRTRQEQVDYLAELVEKYPIISIEDGMDQNDWEGWK
MLTEKIGHKVQLVGDDLFVTNVSILERGIEKGVANSILIKVNQIGTLSETIAAVEMAHRA
GYTSVMSHRSGETEDNTIADLAVALNTGQIKTGSASRSDRMAKYNQLIRIEEELGLVAYF
PQEKAFNVK
>OBAHECAF_01918 hypothetical protein
MKKYIAIILGILLTACSSEPKFTEKVIEHTNENCMDNCLSVTINYLVCKKPTAFADFFNR
EIEEQVINFLLSNQIDSLVTNVSSVSEAVKLFVDDYNKLHEHFPDIPAFELNLSDSISFQ
NKKIISLVSDRYAYTGGAHELLTTIFLNFDIETKTLIANENLFSDIEKVSEIAEIHFNEQ
RKIVSATNPTENDFWFDDNKFTFPENIGFTKEYLILLYNPYEIASYVNGAFQVKIPIEEV
KPYLNIGDL
>OBAHECAF_01919 Iron-dependent repressor IdeR
MTLSEENYLKTIFHLFNEEEEEVSTNAIAEVMNTKASSVTDMLKKLADKKLINYKKYQGV
TLTTEGRNKAIYIVRKHRLWEVFLVEKLDFSWDEVHEIAEELEHIESEKLIERLDAFLGF
PEKDPHGDPIPNKHGFYEKTTKTLLSELDKNEKGICIAVKNTSKDFLRYLSKVSITLGDE
IIVKSKEKFDNSMIVSIHNKEINLSAMVCRNLYVQKEK
>OBAHECAF_01920 putative acyl-CoA thioester hydrolase
MQKKTPSQSRTILTDLVLTGETNHLNHMFGGELLARMDRAASIAAQRHSLRPTVTASVNH
VAFNHSIQLGSVVTVEASISRAFSTSMEVYIDVWVEDFDNGTRLKANEAIYTFVAIDDEG
RPTKVPEIQPETELEKVRYEGALRRRQLSLVLAGKIKPHDATELKALFMELENE
>OBAHECAF_01921 hypothetical protein
MKDLNIYVEELLYKHPCVIIPKFGAFISNRKSAKLFEDKTFSPPKRELTFNASLNSNDGL
LLKHISETSGVDYKLVEEYVNSTVESWKKALTRGENLSLKNIGLFRQTPEGKVSFEAFED
VNYLTDSFGMSPFVPHEINEMSNKKIAENQVSPTIDPVVPKPSIEPTVPENRDEAEDSEQ
QPVKKGKKRSFVKYTAVAVVGLILLTVGVITFFGEPLENNEEMMLAENQIEEKVQQKLSE
ATLNIPMSFSAIPVEVTKVDALKPKDNDVSQSSASQNVATSKPTNQNKTEVKTNKKETTP
VTTTTPKETTKKTNANSSAEVKKYQVIAGAFKEEKNANTKVAQLKKLGFKNAAVIGINAK
GLYQVSYAGFDSMVEAEALKQQIKAEKDTKKLEGGWILTNE
>OBAHECAF_01922 Putative cysteine ligase BshC
MIMIPIIFFTFAFIYVFIMIVDCIPFDQIRFFSSFISDYVSEKETLRTLYHRFPSVENFE
KQILEKQQQFSDEARVLLVNSLREQYASLKTSDKVQKNIAKLGDKNTFTITTGHQLSLFT
GPLYFIYKIISVINTCEILSKKYPDYHFVPIYWMATEDHDFEEINHFHFKQQTFRWNSSQ
TGMTGNFDTTTLDAVFSSFISNLGVGKNAEFLKQLFENSYLKNKDLASATRSLVNTLFEN
YGLVIIDGNDSKLKKSFASFMRNDILKNTAYQEVKKTIIQIQELDKIYPTQVNPREINLF
YLTEKGRNRIVITENGYGVHETEMYFTEKELLNELENHPERFSPNVIMRPLYQEVILPNL
AYIGGGGEIAYWLELKSFFDSEKIVFPILMLRNSAVFITDKQHNRIKKAEMKIADLFLKS
ENLKNIYVQKLSEFPIDFSEQRKTLQNQFANLYVLAEKTDKTFLNAVKSQEIKQLKGLNN
LEKRLLKAQKRQLSEKLERLTTLQSELFPNGSLQERFTNFSELYLEYGESFFEVLKNDFN
PFHFEFLAVK
>OBAHECAF_01923 hypothetical protein
MVRRIGTGRSSFEKKIKSTKKQTSQRKLVFLNSLSQEEDIISQLKIRNEKD
>OBAHECAF_01924 hypothetical protein
MIQIGETIISEDIIENEFVCNLNACKGACCIEGDAGAPIEDEELKILERIYPEVAPYLTE
KGRESIENQGVYIKGEDGEWETPLIDNADCAYVVRNEKGWALCAIEQAYNDGKIDWKKPI
SCHLYPIRLQKYTSFTAVNYNRWHICSDACSLGKELQVPVYKFVKNALIRKFGEAWYEEL
ELVVAHLKRK
>OBAHECAF_01925 Thiol-disulfide oxidoreductase ResA
MNNKHKILLVSILGSIFSCNNTMKQESDSFTLNGKLPTNVNEKVYLLEYKNREYTVVDSV
EAKNQTFTFKGKLQEPLVHAIRLGNSGKRANFFLENADISITLNDNWQISEAFGSENTEL
FKKYDDLNATKRINLDSLLQKDNSSPVIAYFLARNAYLYDYESLILLRKRINQNLSRNTY
IEELDGAITQLEKIQPGQVAPEIVMEDLEGNTICLSDLRGKVVLIDFWASWCPDCRKENP
ELVKLYNQYKDKNFTILGVSFDRKKDHWKTAIATDGLTWTHGFVEGAWKAEPIKTYAIRW
LPTAMLIDENGIIVARNIDHKKLIPNLENLLK
>OBAHECAF_01926 Ribosomal RNA small subunit methyltransferase C
MKDLFGQALLDYQQGNYTEDIKTETSISEEDVLPLPYLFRSFSEMPPLEKKALQLAKGKV
LDIGCGAGTHGLYLQNERGLEVHSVDISPKAIEVCKLRGLQNAYVGDIMTFEGQFDTILL
LMNGAGMCGRLRKMGTFFAKIKSLLAPKGQILTDSSDIIYMFDQNADGSYDVPLEFDYYG
ELMYLVKYKGEKEPPFPWLYVDYNTLQNVAHSVGLNCELIAEGENFDYLARLEHH
>OBAHECAF_01927 ABC transporter ATP-binding protein NatA
MIITENICKTYGSHIALNDVSLHVPKGSIFGLLGPNGAGKTSLIRILNQITFPDSGKVFF
DGEPLQNKHIYQIGYLPEERGLYKTMKVGEQVMYLAQLKGLSKIEAKQRLKFWFDRLNIG
DWWNKKVQELSKGMAQKIQFMVTVLHEPKLLIFDEPFSGFDPINANIIKDEILYLREKGA
TIIFSTHRMESVEEICDHIALINKSEKILEGKLIDVKRKFKNNTYEVGLKIDENRKKAVL
EDLKQYFSVSEANFKSLYDDLKINIHKKDEQSTGELLHFLQTKAEVTHFVESIPSMDEIF
IKSIKEREARISTPNFD
>OBAHECAF_01928 hypothetical protein
MKHIGIITKREYLNKIRNKSFIIMTFVSPLIVVVFGTLIGYLTTINSTSNVKKITILDES
GFFMDSFKDSETIKYTFLENITLSEAKLNVLTENSYGLLHIPSKTTPKWKENIEFFSEET
PNITLLNQLSNTLEDALFELNLTDKGMNKNEIDNARESIHISLSNFSGEKSSELSSIIKI
AIGGIAGYLIFMFIIIYGNMIMRSVIEEKSNRIVEIIISSVKPFELMLGKIFGTSLAGLT
QFLIWMIFGGLLMTITTNFLGISPSSTNEIVMTKSGMDRITSEILVAFFQFPFMEMFGAF
LLYFIGGYLLYSSIYATIGAMVDNETDTQQFLMPVLIPLILAVYIGFFSVIEEPHGTVSV
VFSYIPLTSPVVMLMRVPFGVSWWELLISVVILYATFFLFIGIAAKIYRIGILMYGKKPT
YKEILKWLKY
>OBAHECAF_01929 hypothetical protein
MNENLHQNEQNLNQNDQNLNQNEQTSTPKKRNVHISMEEWIQRMRLAFSNGKLPNIQEQM
GLLGYTTEKLDELLTKVVRLEELHQIQKTEYAQQYAETEKFDQKFSEINDLYTKHLAFCK
ILFKGDTLAGASLDFAGKRKTAYSDWLVQVGNFYSQLLKNSAFLTKLQSINIKEEDLKAV
QNKLTEVIALKESQKKETAEAQKATEVRDKFFDELYPQYSEFVAYAKVVFAHSQELEALG
IVTKKA
>OBAHECAF_01930 hypothetical protein
MSVWKRYSIEQRKEYIQFLQVYGALSNLFRQKQGDLIPYLDSKFQETVFARIFDSQNVDI
GNTPHDVLSVFGSDRIGIGLKTWMSSKPSFQKVMQLKRFQNEINQVRDDVEALAFKISEI
KNERMRIDYERLGLSEDKNIYHYITRDEGLFTINECAYPLINTNNLRDFDLTQTAFSWSD
GNKDYKFTFGDSQIWQKFDSSKKDTFLLDKFDVKIIEDPFEFLLKAYLQLIGTSKEVTQN
IVEAYLPLYSYRSKEVEEKSGLNAWNAAPKNRGSDAPRPLNEVYIPIPREFHQKHPDFFT
KNIFEFERARESYQGNKEYKPEVRFHLQLPNGKRIPALVTQSNMKGLQSGSNTEIDPQTG
KRYGQSALGQWLLVDVLGLKERNLVTREWLMKKGTDSVRLWRNKGDYSTIYIDFAPVGSF
EAFMNGNPIEEE
>OBAHECAF_01931 Modification methylase HpaII
MNSRVYKFIDLFAGVGGFRLAFQNLGADCVFSSEWDINAQKTYLANYGEIPKGDITLEET
KNLIPEKFDILCAGFPCQAFSIAGHQKGFDDTRGTLFFDIEQISKKHRPKVIFLENVKNL
VGHDKGKTFKVITSVLEEKLGYKIFYKVLNTMEYANIPQNRERIFIVAFDPQQVQNYSDF
RFPEKIQLTTVIHDFLEEGKQDDYFYYKAEHKYTPELIKTITKQDTLYQWRRVYVRENKN
NVCPTLTANMGTGGHNVPIIKDDYGIRKLTPRECFNFQGYPKDFILPNIANSKLYMQAGN
SVTMPLIQRIAEQILKVM
>OBAHECAF_01932 Carbamoyl-phosphate synthase large chain
MPKRKDLNCVLLIGSGPIIIGQACEFDYSGSQSLRSLREDGIETVLINSNPATIMTDPSM
ADHVYLKPLTTKSIVEILKKHPNIDAVLPTMGGQTALNLCIEAAEKGIWKDFGVEIIGVD
IDAIQITEDREKFRVLLDKIGIPMAPSETANSFLRGKEIAQKFGFPLVIRPSFTLGGTGA
SVVYKKEDFDTLLTRGLEASPIHEVLIDKALMGWKEYELELLRDKNDNVVIICTIENMDP
MGIHTGDSITVAPAMTLSDRTFQRMRDMAIKMMRSIGDFAGGCNVQFAVSPDEKEDIIAI
EINPRVSRSSALASKATGYPIAKIATKLAIGYNLDELSNQITKSTSALFEPTLDYVIVKI
PRWNFDKFEGSDRTIGLQMKSVGEVMGIGRSFQEALHKATQSLEIKRNGLGADGKGYKNY
EQIIDKLTNPSWDRVFVIYDAIAMGIPLSRIHEITKIDMWFLKQYEELYSIEKEISTYKI
ETLPKDLLLEAKQKGFADRQIAHMLGCWESEVYKKREELGINRVYKLVDTCAAEFKAQTP
YYYSTLEAPIRDANGNLFTANDSIVSDRKKVVVLGSGPNRIGQGIEFDYCCVHGVLSAAE
CGYETIMINCNPETVSTDFDTADKLYFEPVFWEHIYDIIRHEKPEGVIVQLGGQTALKLA
EKLHKYGIKIIGTSFDALDLAEDRGRFSTLLKELGIPYPKFGVAETADEALKLADELDFP
LLVRPSYVLGGQGMKIVINKHELEEHVVDLLRKIPNNKLLLDHYLDGAIEAEADAICDGE
NVYIIGIMEHIEPCGVHSGDSNATLPPFNIGEFVMQQIKDHTHKIAKALNTVGLINIQFA
IKDDTVYIIEANPRASRTVPFIAKAYGEPYVNYATKVMLGEKKVTDFDFQPKLDGFAIKQ
PVFSFNKFPNVDKRLGPEMKSTGESILFIDDLKDDQFYELYARRKMYLSK
>OBAHECAF_01933 50S ribosomal protein L34
MKRTFQPSKRKRRNKHGFRERMATANGRKVLARRRAKGRKKLTVSSEPRHKK
>OBAHECAF_01934 hypothetical protein
MKNISVKIVIYFGIFLLFLLGGFHLFFWVDRKQEVKLVKRNRQVARLTRQDIAKIKEGDI
ILRRGYGFFSDLIAERLNDSVYDVTHSGILYLKSNEWWVIHSLSADASDTDGMQEQPLRE
FLTYSMPEKMMIVRTKNTSEVQGKKIVERAKYYLAKRVPFDRVGEIDEPSKMYCTEMIWQ
ILDVDLKLIVLPKNPEERKRVFYSMVGMYDPTYFDIIINKYPVNSAD
>OBAHECAF_01935 hypothetical protein
MRKVFFIATLFVAFLVTSCSNNSPKSVAEKFLTSMENSDFEEAKKYADDSMQQMLGMLSG
MGKELPKGNEKKKVTITKVEEDGDNAKAFYKVEGEEEEKSIDLKKVDGKWKVTFNKENSN
KENMPNMDDVDLGESSLEEVNEEVQEAVGQ
>OBAHECAF_01936 N-acetylneuraminate lyase
MNSLIAATYAPMDSKGAVSTKIVPKYADFLKRNGVSGIFANGSTGDFASLSVEERKEIIE
AWAEQKSPDFFITNHVGDINLNHAVDLAKHSADKVDAIATLAPFYFKPNLEKLVTYCKTI
AEVAPNIPFYYYHIPDLTGANFDMCQFMEKAKQEIPNFAGLKFTQNNMIHFTQAKLCNNQ
EFNVLFGVDEAFLASLPLGATGWVGSTYNHLAKLYLTIKELFEKGNYQEVADLQHKAIEF
VNIVASYGGFNGGGKSFMRLLGVDCGVARYPHTTLTDAQLKEIESKLEKLGITSYLSK
>OBAHECAF_01937 NADH pyrophosphatase
MIFKHCPNCTSTNVEFPNNVRFFCHDCQFTYFHNIAAAVAVLFTYEQKILFTVRNVDPDK
GKLDLPGGFIDPKENAEEAACREIKEELGIDVLPSQLKYIGTHPNDYLYKNVPYRTMDIF
FECPLTNSQVSVAATDEIEALRWLSVHTINFDEIGFVSIRNMVRKYCQDLFSK
>OBAHECAF_01938 hypothetical protein
MKKLFIFVSFMMLTTSWIYAQCDSTHPINNFQLVTGDIQCENRGLITLNAPPVSAEHPAG
TEFSVYWIKPGATSASLRGTVLAGQSMTIPNLAAGTYTFTLENDVNMSCEKPVTINDLYP
PFEIKTLYAFPATIRRDPVTNTNVDEGNGIIVIGLKRFTVGQSKFQVRVVSADTGAVIVN
DRTFSSATADPLFFVHPEPGKRISHADHPNVSVFIREIPPGASDDDCRNYPSHPQQIPIP
ESVHLPGTYSLTLSDLTLSLHTQARTIAGVSVPQPTGKFNLRIPLRRGVDGKSVMAGFIG
GHANLDIPRNHFKGLGTSNAKATVQILNRTVPIADITSSFNGDAYSYNGADFQENDQVQI
VVDDGLGNIVTNTFTLTGLHDVHNETPTQGLGFSHNISPSTPVCPGAPLFLQIRTHLSRS
ERFMPVQEGGTLKINYNWYLSNLEDIWNATSSTSSLTYQYKVYKETAPNSYGPPLTQGTD
YTIVDYRTIDVHPSGAGRYKIRMEFLKSNGTVVSAFERTTNINYLPTPTDRFALMFNTLQ
SNYGIAEGTTSFRIIKRNELMYEDPANPGVSTVTISLGRADGQPSVSFETRLPFGQTKTE
TIIFPITATVTPTYMGDLNHHIGFGDLPPGNYILTIKDACGSASKTITLGNEIRYGVTEA
ERPFYKLVPRCGYYDLEFTHDALHANFPGFTQRMFTGLVGTYVDYSTVQLKRIQGRNGVF
TGLKPGETYKIYTHEFGGYTIHDNLSVATTVPWTLLSTFTNEIGPGKPHSVYYMNRHSSN
GSPDLLRYFTEIQVPSQTMDPVVTSIACGSDGTSMILVDLPHDTNVGIVGDVTYVLKSVS
GTTEAEVASVTMTGGQRNYEFKNLPDGTYKVYVKDECIAGSPVVSVQEIADSSVFPTPHI
INYDHPNGLCPGETTQMRLRGVSINSFDAEWYRINPDGSKVMVATNTQTFGEAVYTNTTY
EVRVKLKDRFGCATNVWLTATSTSVLAIDTGVPSVTDFPDDLVDYPSIGGCDVMVTWNEP
KVTDENVRCGVQLTVTSTVSIDTNFNGGTQHQGRFGVGVHSVVYTFTDVFGNAVSRTLIV
TVQDPKMEMQLTEGYSLNSLQVENEFYYILKYRNTGIVTLTSATLEVQLPSNANVQPDLS
KQIDFTNSGVSNVTYTYDSVAKKYTFTYPSAALPSTGGHEERSIGIPLKIVGGYGLAQQP
CMNQVNIIPTMVYTGGVAGCTLRTQTATIQTSTVVEIKTNENKRTEIYCVGNPMTLSVTP
GFDEYKWFLNGTPIGINTSTFVATTQGEYRVEKYKFDCGVATIVSYEIIDYHEPGSSADP
IKALAGNVGVTCRNDNKTWTSHFYLCGGTSKTIEVNFVNSTLTWEKLNPSASGLNCQPRH
ETCPVVIDGCWEEVSNNTNTFTLSQGGRYRLKVAGANCYDFYYFDVFDSNTPAATVTHGD
ETGYVDGYININMSTQGVNYNYTYKNLTTGATGAMTTNTTQYRFTGLKAGTYVVEVTSSE
ALLSCLAYTQTITIQKNTNLKFTAEFVEWESCNRAKIKFKGEGGNPPYQFAVWSVDGEVL
APGGSHMNIPDSEWVGNQGEFDAHYEGLMNLTRIGSYVFVMRHQQNGERAFSAPINILPV
GVHSVTFAVTDLDCATATGTGEIQLVFENSAVQREVSLYKLDDTGARILPARYQGNNLSL
FTNLEVGNYEVAYTAQVASQTCSFVKRPISINPPANPLRAFVGVTKDKTCDTNGKYTVSV
NNVIGGSGSYQYDFGTGYQNQPTAQVDGNVTVKIKDLSLSGCELTIPVTMQSPQAPTVNV
STPTYDCVGFGTVSVTAIAPPGQTHSYTYSVNTTTGAVQASIFTLSPGAHTIYVHYKPTG
ITPNILFKEDFGVGNDVCGSDLGYPTGANAINDLVCEQNVAVGAGKYAITKQAHPVGTWV
VPSDAQGVNNGRYMVVQASVQNAVVFRKHIKNVVPNEPLRVSVRHFNMLTTATPQFNVEL
VPVGASSGISKQIIVTSTGTPTWVQSSADFTDAEVTQSEYIVLIKNVPGNGVVALDAIGI
EQDIKLCDTTESVPVVIEDGKKLELEVLGTTAVSCHGGNDGSLRIFVHNPPTNVEYSTDN
GVTWTPTILAGGIFTVTNLEATQSRTIYVRDIDKKACKVETTYVITQPEAPLSLKVVEPI
NPVRCDAGNIASITFEAIGGNSEYTQFTYQSTTMPTPQVVGVYNGRYSQPMPLSPGVYTI
TVTDVKGCSTETSFEVEKKEIEFEVVYNPCHDGNGTDVTVNILNGNGGYVVNRSGETAWH
TVSNRVHTFEGLQVGTYTITLNDNSGCETSTVVNIYPPLTLTVSQTSVISCLGSPNSTFV
LTANGGVPGDRTFIIYTTDRANVYTEVTTVGSTYTFTSTNFGVTYLFDVKYTEKGHTCSY
QHSQPFRVASQPAFNATPLFNVKGAYCEDNGYINTSVPDIVNQSTGVAPFKVEVYANDGT
DNPTGAARNPIALATGNYVVVITDARGCKATRPVTVPSLPKATVVTVTTTPIACGVLAQA
NIEISAGGNANSNFSLIVKTASGTVYSTTNILSSQLPRTITVSNLHYDEYEVILQDMTSP
SCQDIRTFKTGLAPDAIVTASTTVVGCTPNSGELIVQSYRAGTGLTHTGNYVAIYKTTID
VNDPTSPGWYQFNPPVATTLPTTGQAGEKLEHTFTGLIPGAWYEFIIAAQTPSGACTLRG
GATIPVPTSSTLSMTTTQGTIACSGTSSGTILFTLKDWKSSTTGITWQVYTYPDYDPVAG
AGMSGNITVGSSMTSVSGNVNGLAPGRYVIVFEENNGGCVNATPPIAIRGPEPLIVHQVS
ITKEHVYCTTDIGDQAEITVDRVSGGVADYLFLVQPTSVTTTPAVGDFTNPQPGQFVSAL
GSQKIIVSTSGTYDLYVKDSGHCIVKYQGPTLTIEDAPQPKINSVQVQVCQAINNQYNVR
LNVTQSQSSLIHFYKLEPGGLTPVQQQYPYNVILLEGLNPGVYTLTYSNIRGCKTSTTFE
VKPPVQVGNANVTRALTCSTTSPAEVVIPNITGGTGTYTYEVVRVESDGSKNQIIPQTTT
TATTVTVTINMEGNYEFWLMDSDMVTMGCNSDAIKRPFVIEPRKVPQVVNGSLKVTNTSC
GSASEGSIELIATPIDIAPMTFTIISMRDLGTGVTTATSIPPTSVVSNQARFSGLLGSQA
GIVYEIKIEGTNGCSVTNNEAIIKSPPPLQVGATALTPQQFTCSTSAALIASLQFDATQI
TGGVPPYTWQFIDRTTNTVIGENSNSVSLSDVNGGTYYVRVKDSSGGCATDTTGVTINPA
FTLANMTVATVTPMTCAVDETIAVSVEATPIYIPGTEIRFTVKRLGDGFVTSAVYSSTIA
TTHITHTLPTTLGTGDYEITAENMATSCGRAKATHKVADLTNKYDITMSNQKQPTCYQGN
DGEITLTVVDRKPAIGGDTSASGFTYTVTYSVNGATTTGTIVAGSSSITLTGLKEGRYSI
EIQSFVNSCKATSSFVVPVSAEQISVNAYPAPIPQVSCLNDKGNIMVEVTGGQAPYEVTL
SSLATTFTKTVNRNRVLFDNLEVGVYSVTVRDALGCMDFIGTATAELVTPDPLTASITVE
DVHCKDEANGKITISNIQGGSGSTVFLFELDNGTTPAIEQSTPVFENLKAGIYTLKITDG
MGCWTQTTVEVWEPNYLYAAVDVSGSDRLICYGEADGRVAITAQGGVQPYKMDVYSKDGR
RVTPVSYVSGVPADPRIASPVSIVTDPILEAGEYYVTIIDVNGCSTQTVKFTVEEFPNIE
PREVYQEKSCDENVFTDAIKVRFPTPIDLTNVTYELKTQAGAITSGTLSRTTDVTTIGYI
HDYDRTSETQTLKVIYTYTHSDGSQTEQCEQVYVVTDIEDIKALTVTRVTNLGLNTIEVK
TTGGVEPYTYYFNGREQGSNSVYIMKINDPGRVDPDSGQIIKEVDVQVVDALGCTRTLTI
EEVYHDIRVPNFFTPDGDGINDTWKPINIENYPKAVIYIFDRNGRKITTLTPMDSWDGIY
DKKHMPSGDYWYILELNTLEDTRKFYGNFTLYR
>OBAHECAF_01939 Phenylalanine--tRNA ligase beta subunit
MKISYNWIKKFIKIDLPSEQTGALLTDLGLEVEGIESFESIKGGLKGVVVGHVLECQQHP
NADRLKVTKVDIGQGNIVQIVCGAPNVAKGQKVPVATIGTKLFDKDGNLWEIKKGKIRGE
ESFGMICAEDELGLGEGHEGIMVLDDKYEPGTLCSEIFEVENDEVFEIGLTPNRADAMSH
YGVARDLRAGLIQRGTSLELITPSVTKFHIDNRLSKIDVDVQNKELAPRYTGLTISNVKV
AESPMWLQNKLKAIGLTPKNNIVDITNYVLHGLGQPLHAFDADHIVGKKIIVKTAEAGTK
FKTLDGVERILDAEDLVICDAEKPLCIAGVLGGLNSGVTSSTRNIFLESAYFNPVSVRKS
AKRHAINSDASFRFERGIDISEVKHALMYAAILIENVAGGQISSDIIDLYPKKHEDFQVF
LAFERVHKVIGQTIPNDTIKSILHSLDIKINSVTERGLGLVVPSYRVDVQREADVIEEIL
RVYGYNNINFSEKINASMSHASKFDDHNVQNVIASQLAGQGFSEIMTNSLVSEKTITDFE
EDLTKVVKILNPLSSDLNFMRKNLLPSGLEIIEYNINRKRSDLKLFEFGKSYHKIGDNFV
ENKHLMIYITGNQLPENWNTIPQKTDFFFLKGIIESVFERLQLKNIHTQPLDNNLFIREG
FEWIINGKLLGSIGVVKGKILKKFGVKQEIFFADICWDIVLESIKNQKNTFKEIAKFPEV
RRDLALLLDEAVSFSDIHRIAFETEKSILKNVGLFDVYQGEKLPTGKKSYAISFTLQDDF
KTLTDKQIEKVMHNLQERFKEKLQASVRS
>OBAHECAF_01940 Branched-chain-amino-acid transaminase 1
MNNLAFNLRIQKAKESRINEVDFSNLQFGKIFSDHMFVCHYTDGMWQQPEIKPYSAITLE
PSASVFHYGQAIFEGMKAYKDDAGDIFLFRPQENYKRMNKSAVRLAIPEFPESWFDQGLR
ALLKIDSEWIQKGFGNSLYIRPFMISTTSGIKASPATDYMFIIITSPVQAYHSGDVKVKI
ADYYSRAANGGFGAAKAAGNYAGQFYPTQLAIEEGYQQVIWTDDATHEFLEEAGMMNLFF
RINDVLMTCPASERILDGVTRKSVLTIAEKMGIKTEVRPVRVKELIEAAENGTLQEIFGS
GTAAVISPISGFGYKDKKYTFTPPADLYASKIKEAILNIQYNKVEDPFGWRVKVD
>OBAHECAF_01941 hypothetical protein
MKLTKYIGVSITLLLLACNDLDKSPEGVLSTDAPFATASEMQNYINQFYESGVRHQGFAA
GGGGGIAGDDIHSDNMAASSASTRLAGELTLNNAQSLGNYTQIRNINFLLNNLDYSQEKG
SVAYNQCVGEAYYFRAWYYYQMFVNYGQLTWVEKPLDPDFEQMKLPRDSRTTIADNILSD
LDKAIELLSEQNSSATMRIHKDVARALKSEVALFEATWEKYHKAKGNAFYDPSVTDEKIK
SYLQQAVAAAKAVVDRGVWQIYSTGDVNNDYRKLFQTTNLSSNKEVLWFKLYDGDQVGNN
VNRYLNKGGGSVGVTASLVDDYLTISGTPFIGTEKQTAKKVFGNELLPTVRDPRLSQTVC
IPGQKLRPDEGSYVVPPLTGGAYHQNVTGYSLLKHVQIDYTGSLDAEYKGATPAIQFRYA
DVLLNYAEALAELDGAANAATIISLLKPLRDRVGMPSMDFDREYNQEMDYPFRNLDKYIQ
AVRRERRVEKACEGVRLIDILRWAAAEELIVGKLPTGALFVGSNLQGHPQYGNSLKYDQA
SGNNFFLTGSTNDTERYIYPYNPSGYSNGLRFNPNRDYLLPIQLRMLSLTGNNWKQNPGW
>OBAHECAF_01942 TonB-dependent receptor SusC
MNKKFLLAVLLMLSAITLTAQVKVTGKVTDETSSPLPGANVILKGTMKGVVTDFDGNYTL
EANQGDIIEFSYIGYQSQTKNVIADGSKSLIINISLREDAEKLEDVVVVGYGIQKKVNLT
GAVSSVKGETLETRPVANATQSLQGMVSGLFVNNSGSGRPGANGSLSLRGQGNLSNTANP
YVLVDGVEMNLADVNPNDIENISVLKDAAASAIYGARAAYGVILVTTKKGQEDKMRINYQ
GTMGFHSPTVLPDMVDSYSFAQYWNAGVKNAGSTRLYSDQKMALLQQYITDPNSVNPWFE
LPANSLMNPAFENSERGVGNVDYFDLHYKNNAVRINHNLSVSGGNKKAQYYLSGGYYEED
GILRYAKMDFKRHTLTANISSQMTDWLKIKLNTKFLSSQNNTPFGDGGLSEGFYHSLARF
RPTVSHIDPNGNFTELTMIPYLQSGTYTTLDRNSLNITAGAELQPLKNWFIFFDYTHRQG
NDEYEALSVAPNIYAADGVTTSKGVRSELSVTPDGRFTRYYAREGYKTMNLYTNYLLTLA
EKNNFTFMAGYQEEDLSYSYLKNSTTKLYSTINPNVGMGAGDKVITDSRYGWATRGIFGR
INYDYDGRYLLEINGRYDGSSRFAKANRWGFFPSLSMGWNISRESFMETTSNFLSNLKLR
ASYGLLGNQAGADLYTFAATMPLSNRLGGYIFSDGRHSYTQAPKVIDLNTTWEKVESKNI
GIDFGLFDNKLTGSFDVFQRDTKDMLGTALSFPDFFGADAPKTNNANMRNKGWELQINYR
GKITEDISFNVGGMLSDATSVVTKYTNPEGTAPANSWYEGRSVGEIWGYRSSGLIQTQAE
ADEYNKTYDMSYLSPKAWTPGDVKYIDLNNDKKIDRGDNKLSNMGDMTIIGNTTPRYQYT
INGGISWKGLALNVMLQGVGKRDWHPESGSYFWGSGPYAQVHVFKQHLDYWSETNPNAYY
PKPYIHTAGGVRTFQSKNKAVSDRYLQNAAYCRLKNVTLSYTLSEEIIKRFNFQKVQMFI
SGENLLTFTSLMDIYDPEAIFTGNTYTGEGGKNYPMNKVVSMGIIVNF
>OBAHECAF_01943 hypothetical protein
MSCNSCTTKNKKGGGCSGGCSSGGCNSGKLAVFDWLSNVRLPGGQDFFDCVEVRFKNSRK
EYFKNTEKLSLQIGDVVATEASSGHDVGVVTLTGELVRLQMKKRKIDWNGEGIPKVYRKA
NQRDIDIWQESRDKEIEVQKRSRELAIALGLEMKISDVEFQGDGSKATFYYTAEGRVDFR
QLIKDMARAFSVRIEMRQIGFRQEAARLGGIGSCGRELCCSTWLTDFRTVTTSAARYQQL
SLNPQKLAGQCGKLKCCLNFELDSYVDALQDFPRTETKLHTEKGKASCQKIDIFKRLMWY
SYDEDPINWHKLSVESVKEIIAKNGAGDKDVVLEDYAITAEADGIGSGIGMTMIKENTED
SLTRFDKPKRKKKKNDKRSKSNKAGNQNGNETGKSESKVEIPEKQADANIQHKNEQRKPN
QQVKIKKTQPQSQKHNIPIENEKDKQKNNIANQKNSKNPKHLKEKNPNAKRKSNHFNKNS
TDNNK
>OBAHECAF_01944 Gliding motility lipoprotein GldH
MRFLTLFLAVLMWSSCQSNIEYSEYVSLSDGEGWQKASPVSFQFQHSDSIAKKNIFIMLR
NNEKYEFSNLFLITHMELPDRRLIIDTLEYEMATPEGKWLGYGYSSVKENKLWYKENFVF
SANGTYTIKVEQAMRKIGETDGLEQLNGITEVGLQIENIQER
>OBAHECAF_01945 Penicillin-binding protein 1A
MKKNTTKEGSKNKLVKLFWLVFFGGIGFVCLLFAFGSWGFLGEMPDFKRLENPETNLATE
IVTADGKTLGKFYLDDNRTPVRYKDLPKHLVDALIATEDERFYDHSGIDVRGTLRAFAYL
GSKGGASTITQQLAKQLFHGTKARGLERYTQKIKEWIISTRLETQYTKEEILTMYFNIYD
FGYQADGIRSAARIFFDKEPMELSLEESAVLVGMFKNSSLYNPVRNPVGVTNRRNVVLAQ
MAKNNYITQKEKDSLQKLPLELRFTPESHNEGIATYFREYLRSFMKTWIDQNPKPDGTKH
NLYLDGLKVYTTIDSKMQTYAELAVEEHMQRLQKVFDAENNPKKNKTFPFVEVSKDEFNS
LINRAMKQSERWRKMKSLGYSEKEIEQSFKEKTEMRVFSWQGERDTIMTPLDSILYYKAF
LRTGMMSMEPQTGHIKAWVGGINYKHFQYDQVIQGARQTGSTFKPFVYATAIDQLHYSPC
HELPDIQTCIEAGKYQNLTAWCPRNSNGKFSGDMMTLKYALANSINSITVNLMDKVGPVP
VINLARELGISAEIPEMPSIALGTADITVYEMVGAYGTFANEGVYVKPTLVTRIEDKNGT
VLFENTPQTRDVVSAEVARAVVNLMEGVTQYGSGARLRTKGADSYNSMYKNVITGYPYAF
TNPIAGKTGTTQNNSDGWFMGMVPNLVTGVWVGGEDRAVHFKGITYGQGATMALPIWGNY
MKKCYADKDLNVSKSPFPAPQNIEIPMDCKKVEALENDKDDFGDIDF
>OBAHECAF_01946 hypothetical protein
MKKCYFLLWLFLILSLKAQENQGITHSKQLTGQVPFPKETFIELPNPVKANPQEWKNFKG
TTAGWGSTDVRYKKETPAKDLKLAQTLTAWKGERISGQIVVVNANKDAEISVDISDFRHT
KLKNNLKKEHISADFIRYVMTDELNKDGKGGCGYRTAINFDSTLVADAIDHYAKKLVIPA
QTSRGIWVKVQVPQNAASGSYKGFISVKNKGKVFQKLSLEIKVLDRVLPASKDWHFHLDL
WQNPYAVSRYHNLRPWSKEHFDKLRIEMQPYVEAGGKSITASIMHKPWGGQTYDAFGSMV
TWFKKLDGSWHFDFAVFDKWVEFMHEMGITKQINCYSMVPWKLSFQYFDQATNQVQKIET
QPGKPEYNEVWGAMLTAFAKHLKGKGWFEKTYISMDERPMKVMLETLKVIKQADPNFKVS
FAGDWHEEIEADLDDYCVALWKKFSDDVKNKRREQGKISTYYTCCTEPYPNTFTFSEPAE
SEWLAWFVAKENLDGYLRWALNSWTIEPLLDSRFVSWAAGDTYLTYPLARSSIRMERMIE
GIQNYEKVRILREEFKKSGNIQALEKIEEVLQTFDEYGIPKIPAKETVNKAKYIINSL
>OBAHECAF_01947 putative zinc protease
MMLSGSFAMAQQVAFEEYDLPNGLHVILHQDNSAPVVAVGVMYHVGAKDEDRSRTGFAHF
FEHLLFEGTENIERGKWFDIVSSHGGKNNAFTTQDKTYYYEIFPSNNLELGLWMESERLL
HPVINEIGVSTQNSVVKEEKKQRLDNAPYGKIMYRTGINPHLFKKHPYGESVIGQIEHLD
AAKLEEFIAFKKKFYNPNNAVLVVAGDFEKTQTKKWIHDYFASIPNTGDKIVRTKIEEEP
INQTIKVTDYDPNIQLPIKIYAYRTPGMNEKDAYVLDLISSILTGGKSSRLYKKMVDENK
SALQVLAFSDSQEDYGTYIMGALPMAGISLETVGKEMDEEIEKLQNGLISQREFEKLQNQ
IENRFVSTNSNMEGIALSLANFYTFYKDTNLINKQIDIYRSITREDIQRVAKKYLSANQR
LDLDYLPENAKQ
>OBAHECAF_01948 hypothetical protein
MATAQIDRSKIPTSGKTPVINLGTPYTYKLSNGMTLLVVENNKLPRVSISLSIDQPPVLE
GNKMGIADLTSSLLGNGTTSISKDAFNEEVDFLAANISLSAGGGYASSLSKYFPRVLELM
ADAALNPNFTQEEFEKEKAKLLQGIKFGENSAESIVGRVQGALVYGKNHPYGEFSTEESI
NSITLDDVKAFYKEHFVPTNAYIVVSGNIKVKEAKNLVTKYFKKWKPGKSTPKPITTPSD
VEFTQINFVDLPNAVQSEIRFNNLVDLKISDKDYFPVLIANYILGGGFGSYINMNLREKN
GFTYGASTSVGANKWTRGDFEGATKVGNDVLDKAIVEILKEIQRIRNEEVADDLIAQAKA
SYLGSFIMATENPQTIARYAINIKTQNLPADFYKNYVANINAVTKEDIKRVANKYFKNNN
LRFTVVSKGSEVADKLEAITFNGKSIPVYYFDKLGNPTAKAVYTKEIPAGVTAKTVLENY
LKSVGKTQSVKTIAIQAKGEMQGIALDFEIKRSGTDKFLQLITGMGMTLSKQIVNGKTVS
VEAQGQKIPVSDDEVVIAQMESGVFPEVNMLKNNNIKLVAIESFNGADAYVIALTDKKNL
YYDVVSGLKVGEKTTVEMGGQKIENIVIYDDYREVKGVKVPYAISVSSAGMTFEFKTSGV
KINEGVSDADFK
>OBAHECAF_01949 hypothetical protein
MKNNTLRKFLFLILAVFSLSPWVSSPIALALGIAFAFTLKTPFPLPKINPVIHRLLKFSI
IGLGFGLQLNEALKAGRNGFLITIISIGFVLILGGLLGKILKLDKILSYLIGVGTAICGG
SAIAAISPIIKANGKQISVALAVIFTLNSIALFIYPPVGHLLGLTQEQFGLWCAIGIHDT
SSVVGAANNYGEEALKIATTVKLARALWIIPLSLLTMWLFKGKSNRIKIPWFIGGFVLAI
LVNTYLPIPEVITNTITLTAKAGLHLTLFLIGSTLSYETLRNVGVKPLIFSVLLWIGISL
LGLLMVYEMM
>OBAHECAF_01950 Protein YceI
MSTVKWSLDTAHSELNFRVKHLMISNVKGSFKDFSVEILGEDFATSKVNAQVKTTSIFTN
NEDRDNHLRSADFFDVENFPEMKFEGTSLTKKSDDEYTLVGNLTIKGITKEIDLEVDFGG
ISKDPWGNEKLGFSVRGRINRKDFGLNWNAALETGGVLVSDEVRIEGELQFAKQN
>OBAHECAF_01951 Anaerobic regulatory protein
MMVSEYFSKLVELSTEEKNLIDNSFELKSFSKGDFPLRSGEVCESEFFVKKGCLKNYYID
FQGNEIILSFAIEHWWIGDFESFNRRTPSKMFVEALEDSEVYTISYNKKQQLLKDIPQLE
RAYRILLERHLQNYQERIYSVLALSAQERYERFLEKYAKLVQCVPQYSIASFLGVTPETL
SRIRAKQAKK
>OBAHECAF_01952 Quercetin 2,3-dioxygenase
MSNIGIILEEKAADIGNFLVGRLLPFREKRAVGPFVFIDHMGPADLKDYQNLDVAPHPHI
GLSTLTYLFEGSIFHRDSIGSQMEIQPGAVNWMTAGKGVVHSERTPDYLRNTEKKLHGLQ
IWVALPKHLEDCDPSFHHIEAEELPHWEENGVQVKLVAGEAFGKKSPVPVHSPLFFIELK
AKEKTKLHIGEDLYGEAAMYVLEGTVNIEGNDYGSKQLLVAKNSKLCEFEISENSVVYIF
GGEPFPEERFMFWNFVSSDKEKIEKAKQNWKEQNHEAFPKVIDDEDDFVPLPTYPLKSK
>OBAHECAF_01954 hypothetical protein
MDKYVKRTQRDYSMSFKLNIVKEIESGSLSTCGACKRYGIQSRSTVMNWLRKFGNFDWEN
QTPSNMPKSPEQRIMELEAEVKLLKKQKALLERQAYVSDKKSIIFDMMIDLAEQEYQIDI
RNVEHSVSPIEKNKIHELKNSPPRTVETFREKEQETVSFACQLFGVDRQVYYRNLKRRDT
RKNNAKQVVAMVAEIRKHSPKMGGRKLYFLLKEELKMLKIGRDKFFNVLRNNHLLIIPKR
SYHKTTNSLHRFRKHTNLIKDYQVKAPNRLWVADITYLGNRENPAYLSLITDAYSKKIVG
YDVSDSLASTSSLKALKSALKKEKIEGLIHHSDRGLQYCSDDYQKVLNQYNIRCSMTQES
DPYENAIAERINGILKQEYDIDKFNVNLQCRKKLVADVIKIYNEKRPHFSNHFLTPKQDA
YPTGISS
>OBAHECAF_01955 SusD-like protein
MKKIAFIIGLVFTFSSCELDLKPESSLRHSGYWTTEEAVNAAHIGIYPHLRGYDNTFWGM
GELRSDIWGGSTIESPFSAELIKNDVSVTRVHYGNWAGFYSLIHKINDFIKNAPTIPASN
QEQRNHMMGQMYGIRAYIYYTMLKAWGEVPIATDPLTKVESLEALKKKRSPKKEVLGLIK
SDIEKSLEFFASDNSKWLNKNIYWSKAATLTLKGDVYLWSGKVLEGGNADFQVAKTALES
VTGYSLVNYQDLWGQAKEGNKEFIFALDYQEDQSDNFYSLMTARQVDIKGRFDDEGNVLD
KFTLNGGSRYGASAKVFDYLKADLQDQRSKTFMGIYSDKTAKKLIGTVLNKFLGVVETGL
RRNWNNVPLYRYADVVLLLAEAKNHLGEDPSAEINKIRERAYGSDYNVTIHGYTNAGKSA
NAKAILDERLKEFVGEGKRWWDLVRAGDNYLFEEVSTIKASEAYKIYYSISESMIANDPE
LKQTEGY
>OBAHECAF_01956 TonB-dependent receptor SusC
MKGKFLKHILIMSLCFFLQGVFAQEKEVSGVVTSSDDGMPIPAVSVIVKGTNRGVATDFD
GKYTIKANEGEILQFISLGFTTVEKKVTGGGGKSLIINALMKEEANQLEEVVVTGYSVQT
RKTLATSISKVDTKVLESASRSNAATALQGTVSGLKVTQHSGQPGTTPDIILRGGTSFDG
SGTPLVLVDGVPSSFYALNSDDIESMEMLKDAASTAIYGARAANGVILVTTKKGKAGRSN
INFKSKLSFNGRIKDKMEYLNAADYVKFNRMAVRNTQMVQNNANAFSAFLNGQNGAATGN
NALNSIYTTMFLDDTNRYLLNHEGWQTIEDPVNPGRHLIFMDNSYLKDQYYQTSFSNDYT
LSFDGGNDKSTYYLSLGVLDDKGLVYNTGFKRYSGTFNASYKIFDNFKMSGNVIYTHSSK
IDSFDSIYDIFQRATGLAPTSRVYNNNPDGSLSNELQPGTYRGFGNPLYYRDKFVNDNLE
QRLTASGQFDWQFAKNFNLMARGSYFSINDVDESFNKAFLNSGNLNTERIAYAGYGRTLR
HQYTSVLSYNNTFLEKHNVNALLGTEYFREKRFGLSGATRKSPTDFIHTLNAGSEAQGKP
SSSRTEYAIASVFGQLNYDYDNRFLLGLTFRSDGTSRLANDKYGFFPGASLGWNIHNETF
YKDKSISTYISRIKPRVSYGVNGNIETLSDYGVHGVYDKTGIYDSQGGYANTALPVLDLR
WERSTTLNFGLDLGLFNNRVNVVADYFIRDVQDKLSTLTLPLWTGFSGITVNNGILQNKG
FELEVNAKVLKTENLNWDLGLVYYQVKNYAKKLPDNGITNNRQGGTEIYDVASGKNIYVG
GLQQGQRIENDLIVAYIPEGVYKTQAEIDADKDRSVEFAWQKKTRFLGDTRWKDVNGDNI
INHLDRQVIGRITPKFTGGFTNNLVYNNIGLYVKTDFAVGHHIINGRRVKGIAQTQGNQN
GPVEIRESWTPQNPNSNIPRFDLVDRQKNHLAGGGDQGSLHGSSATYWEKGDYLALREIT
LSYDLKGSLVKDVLKSARIYVTGANLFYFTAYGGSTPEDASANKENLGVVQGSERGRYPL
PRVITLGLNLTF
>OBAHECAF_01957 hypothetical protein
MKKIVLLLFLATTTIWGQDYSITGKVVEYDSKIPLEYATIVLEPIENPTKLTGGVTDEKG
EFHIKAPKGMYTLKVKFFSFKNYEVKNFNLKENTKLGTIALHSDVEQLEGVEVVAERTTV
ELHLDKKIYNVGQDMTVKGGSISDVLDNVPSVSVDTEGKVSFRGNESVQILINGKPSALS
GVNDEALRQLPAESIERIEVISNPSSRYDAQGTAGIINIILKKGSAIGLFGSVSASVGNP
EAYELGTNLSLRKEDWTFFGNLSYSNRKSPGKTLFNQENLDATGKTANFQDENRQTFRNR
KGLNFNLGAEYRFNERSSITNSVVVVSNDGKNIIDTDFLNYNASRVLTAQRYRNNTEKSD
DLRFQYAMNFEHKFDNQGHKLTADYQFSKSDQEGNGLITEHNLTSNTYLDVEQTINKEKV
NKHLAQIDYVLPFGANKKSQFEAGYRGTVDENDTDYTMGILDNTGKLIVNNNLSNRFIYD
QYVNAFYSQLGVKVDKWNFMGGLRFEHTKVQSLLVNTNENYSKEYAGLFPSVYVGREFEG
DQQVSVSYSRRLRRPWSRFMNPFVSRSSNTNLFGGNPDLDPTYTNAFEISHLKKWEKMTL
SSSVYYNYSTQVFDMISLETGDFVTVNGLLVPVMLRRPINLSDESRTGMEFTANYTPKRN
WRFSLNFNFYHYKSKGEYSYTNYLNTTTVQRFNTEANSWSSRFTARLPIVYGIDFQTNVN
YSAPRKSAQSDIEGSISANLALSKELFDRKASVSLNVSDIFNSRKMIADTRTERVISHSE
MQWRQRQIMLNFTYRFGNMKQQPKERRQRTTDDAGGDMEMM
>OBAHECAF_01958 hypothetical protein
MEVTSLFGMPVYTSFDKIDNALVSRSYPALVAKLDKGNGLAGGGEFIFRFNRWGIKLGTL
SANLSSSSNQDGHYYSGENEYTTFGVTYDVIANEIFTFTPYFGLGHQESEIYLDYEFKNS
VTPTSLHIQGKEADFTFGGKFYFRVYHWNDKRFKIYLNADIFYKISYSNKWRFDNMLIKS
KDFDLSTLGVLGGVTLRYDF
>OBAHECAF_01959 30S ribosomal protein S6
MHLKFLTQKNNFMNHYETVFILNPVLSETQIKEAVEKFENFLTAKGAEFVSKENWGLKKL
AYPIQNKKSGFYHLFEFKAAGEVISSFELEFKRDERVMRFLTVKLDKHAVAWAEKRRAKL
NIKKA
>OBAHECAF_01960 30S ribosomal protein S18
MSIEQQAKGKKDGEIKYLTPLNIDTSKQKKYCRFKKSGIKYIDYKDADFLLKFVNEQGKL
LPRRLTGTSLKYQRKVATAVKRARHLALMPYVADLLK
>OBAHECAF_01961 50S ribosomal protein L9
MEIILKQDVQNLGFKDDIVTVRNGYGRNYLIPQGLAILATPSAKKVLAENLKQRAYKEQH
IIDEAKKIAQALAGLAVKIVAKVGAGGKLFGSVNNADLAQELAKAGHEVDKKYVTIPGNS
LKRAGKYNASVRLHREVIVDLPFEIVAEIEKVAEKPVEKTETE
>OBAHECAF_01962 hypothetical protein
MKYVFILLLLSLKSFSQQISVSSQVIDYESGLPIYGAHILLNKEIIASTDDEGFFRILIH
PDKVQQLCISHISYETVCYNKLLDFPQKIEMKINVNTLAEVVVGNDIGNHKHFMKKLREV
YRKTSEGNFVSPFNLKKIAYNKEKISNYIESEGWVVVPSALNPRIFTDPMWIFCNTRFLE
NGEFGETSNVFYEGSEMYRYFVANHPFLLKSGYTFQMEESEYINGKEFWILSFQSKRKIK
NETRYFTNIKGKIWIDPANYMISKEMFSLNLENIISVVGNIFYSQVGGYNIMNKLTLDVF
SVEESMQRPYKPSYVLTFYIPQSREKYRNLNIRDFSDCYNKNIAYESTYWKNKPVTENNP
FYKELMILKGKRTFSEAFENSKKIELFSKQDLVNQHTKKSIERWLAKQEKKKK
>OBAHECAF_01963 hypothetical protein
MVSKTRKKEKMKHIVILSFILLLFGCNSIVNEQNSAVYYNTKDISKAENSMYRSFSLDTI
VISDIETSYVGQFSVFNDTLYFADERFAYVFRFDSNGKLISKGVGKGKGPNEINGLSGFV
VSKNDVISFNDSNGSIDIFDKNLQKQESFRKDWQINRSYDEVFNNPRADKGDCYEFDYGC
PNILKKWDENHVAFIITASHPKFNGYFDSDLYYNYARTFALVDIHSGKVVKLIGRRSPVY
LSLKNIPNFDHLNYDTYEDVDEVYLNFWADTDIYLYGKKEDRIKGKFGKAGRDMKIDYRR
TNSYEVAENNLSEDRERYGAYTFLKYFPKQNLVMRGYRKGENATTDGLQIYKDYQLVADL
DVPQGLQIIGETQGNAFYATTPQDVDQDYLCVFKIKFQ
>OBAHECAF_01964 ATP-dependent DNA helicase PcrA
MEKYLAQLNDAQRAPVLQKEGPLMVIAGAGSGKTRVLTYRIANLIHLGVDAFNILALTFT
NKAANEMKKRITEIVGNEAKNLWMGTFHSVFAKILRIEADKLGYPQNFTIYDTQDSQRLI
NSIIKEMELDKDVYKYKQIQSRISSFKNSLITVRAYFNNPELMEADAMSKRPRMGEIYQA
YVERCFKAGAMDFDDLLLKTNELLNLYPDVLAKYQHRFQYILVDEYQDTNHSQYLIVKAL
ADRFQNICVVGDDAQSIYAFRGANINNILNFQQDYQNARVYRLEQNYRSTKNIVEAANSV
IDHNKTKLEKVVWTANELGEPIKIHRSPTDSDEGRFVAGSIFENKMNLQLPNSAFAVLYR
TNSQSRAIEDALRKRDIPYRIYGGLSFYQRKEVKDMLAYLRLIINPNDEEALVRIINFPA
RGIGGTTLEKLTFAANHYKKSIFEIMYKINQIDGLNMNASTKQRLTDFVVMILNFQSLSK
TSNAFEIAEQVARKTGLLQELKKDGTPEGIAKMENIEEMLNGIKDFVEGQEDVADSTASL
AEYLEDVALVTDMDKDTGDDDRVALMTIHLAKGLEFPYVYIVGMEEDLFPSAMSVNSRAE
LEEERRLFYVALTRAEKQAYLTYAENRYRWGKLSDAEPSRFIDEINNQYVQYLTAPINNP
NYRYKPLINRDIFGEVDKSRLRLQKPTNSTPPPSHAPKGDELQRLRKLKPMNSSSIGNGS
NPNQGVALSEGMFVFHERFGKGKIISLEGVGSDRKASIDFESGGVRKILLKFAKLQVIEK
>OBAHECAF_01965 putative ABC transporter ATP-binding protein YheS
MLSVNGLAVEFGGTTLFSDVSFVINPKDRIALMGKNGAGKSTLLKILAGVREPSRGGISY
PKDFTIAYLPQHLMTNDGRTVFEETAQAFAHLHEMEKRIEELNNELTVRTDYESDEYMKL
IEEVSALSEKFYSIEDTNFEADIEKTLLGLGFTREDFQRKTEEFSGGWRMRIELAKLLLQ
NPDVLLLDEPTNHLDIDSIEWFEDFLINSAKAVVLISHDRAFVDNITNRTIEVTMGRIYD
YKAKYSHYLELRKERRAQQQKQFEDQQKMIAETKEFIERFKGTYSKTLQVQSRVKMLEKL
EIIEVDEEDTSALRLKFPPSPRSGNYPVIAEDIGKSYGDKKVFSHANFTIKRGEKVALVG
RNGEGKSTFVKCLMQEIEHEGTLTLGHNVQIGYFAQNQASLLDEELSVFQTIDDIAKGDI
RTKIRDILGAFMFDKEASEKKVKVLSGGERTRLAMIKLLLEPVNLLILDEPTNHLDMRTK
DILKQALKEFDGTLIVVSHDRDFLDGLVSKVYEFGGGRIIEHLEDIYGFLQKKKMENLKQ
IETKK
>OBAHECAF_01966 Dihydrolipoyl dehydrogenase
MSKYDIIVLGSGPGGYVTAIRASQLGFKTAVIEKENLGGVCLNWGCIPTKALLKSAQVFE
YLKHASDYGLSVKEFDKDFPAVVQRSRNVADGMSKGVQFLMKKNKIDVIEGYGKVKPGKK
VEVKDKDGKITEYSADHIIIATGARSRELPALPQDGKKVIGYRQALTLPAQPKKMIVVGS
GAIGIEFAYFYNSMGTEVTIVEFMPNIVPVEDEEVSKQLERSFKKLGIKILTSAEVTKVD
TSGEGVKAHVKTSKGEEVLEADVVLSAVGIKTNIENIGLEDVGIATDRDKILVDKYYQTN
VPGYYAIGDIVPGQALAHVASAEGILCVEKIKGLHVEPIDYGNVPGCTYCTPEIASVGLT
EKQAREKGYDIKVGKFPFSASGKAKAGGNSDGFVKVIFDAKYGEWLGCHMIGAGVTDMIA
EAVVARKLETTGHEVLKAIHPHPTMSEAVMEAVAAAYDEVIHI
>OBAHECAF_01967 putative NTE family protein
MRYKIYVLLICCIVNVLFSQEKKTDKDLKVGLVLSGGGAKGLAHIGVLKAIEEAGVRIDY
IGGTSMGAIVGAMYATGYSANELDSIFHRLDFDKLIYDKTSRRAKSLHERFIYDRYALAL
PFNNLKIGIPRSVSKGQNIYNEFVKLLYPIGDTFDFSKLSIPFLCIATDIEKGKQVVLES
GFLPKAIMASGAFPSLFDLVEIDGDLLTDGGALNNYPIDEVKAKGMDIIIGVDVQSPFQT
REEINSAFGVLSQVNAFAMYGNMPEKIAKTDVYIKPNIVGFNVISFDRGSAIIKRGEKAG
FDQIEKLKEIASQQKEKRTPEKIKKIDSIYVKAVHFHGNEHYSRSYLRGKLYLKELERKI
SFQDLNEGIDNLMATNKFHTVHHQIRYTDEGEHIDFLLRENPERTFVKFGLHYDNLFKTG
FIMNYTKHYLFQIDDFFSVDVVLGDNFRYQFDYFVDKGYYTSYGFRSKFNQFYRKIHPDR
ISKYSIEGSKLNRLHLDAYDWVNQFYFQTLLGNGFVAGIGIENRDISFKTEQVFFTEDFT
PLYKEKSNFGSAYSYIKYDSFDNSFFPRRGVYFDAMFHLYLLGKTPEKFNQFSMTKASLS
FAIPLFPRLSAKLAFDGGFTLGNAEGIHTLDYFFGGYNKNASNNYIPFYGYDFLSFGGKN
FLKTDITLDINHYRKHHILLHGNVAKVDNELFQSLNWQTSPDFSGYGIGYSLQSVLGPIE
LKFTYSPELKKPIWLLNIGYWF
>OBAHECAF_01968 Adenosyl-chloride synthase
MRIITLTTDFGERDYAVAAVKGKIYTEIPNVAVVDISHLIAPFDVMQTHYILKNAYHHFP
KGSVHIIGVDAEATRERKHLIMKLRGHYFIGADNGIFHLLSENESDVEVYELFNTTTKNQ
FPVLHFFPKVAKDLLEGIPLQVLGNRIEKCFEMTYFKPEVSDNKTFITGTVIYIDHYGNA
VSNIPKSLFHEVGQGRPFEVIFNMYSFTKIHENYSDIIDFSIPKQRRAIPDGERLILFNS
LDYLQVSVYKSNLHTVGGASSLLGIDYLDQVSIRFLDKKK
>OBAHECAF_01969 Phosphomannomutase/phosphoglucomutase
MTLIKSISGIRGTIGGKPEDNLTPIDAVKFAAAYGTWLKTTLNKENIRVVLGRDARISGE
MIQNLVAYTLVGLGIEVIDTGLSTTPTVEVAVPMENADGGIILTASHNPKQWNALKLLNS
KGEFLNGKDGEEILKIVEKSDFTFSQVDDLGKITKNDTYIDKHIESVLNLKLVDVSAIKS
KKFKVVVDAVNSTGGIAIPRLLEKLGVEVVKLYCEPNGHFPHNPEPLKEHLGDISAKVIA
EKAHFGIVVDPDVDRLALICEDGEMFGEEYTLVACADYVLSKTPGNTASNLSSSRALRDI
TEKYGANYFASAVGEVNVVEMMKKNNVIIGGEGNGGIIYPELHYGRDALVGVALFLSLLA
TRNITSVKELRESYPAYFMSKNKIELTPEVNVDMILTKMAQKYAHENVNTIDGVKIDFAE
SWAHLRKSNTEPIIRIYTEAKSFEEADALANRIIADIQDIIK
>OBAHECAF_01970 Zinc transporter ZupT
MYSTLVTYLENIDPILAAFYATLFTWLVTALGASVVFFFNKANKIVLDGMLGFTGGVMVA
ASIWSLLIPAIEMSEGEGFIKIIPATVGFLLGAFFLFLLDRLLPHFHANFKQTEGVKSPW
QKTTLLILAITLHNIPEGLAVGVLFGGVAANIPEASIAGAITLAIGIGLQNFPEGIAVSM
PLRRMGLSRRKSFFYGQLSAVVEPIAGVLGAVAVMFFTPILPYALAFAAGAMIYVVVEEV
IPESQQNKNTDVPTVGFLGGFIVMMVLDVVLG
>OBAHECAF_01971 hypothetical protein
MKKVLIITYYWKPAGGPGVQRWLTFVKYLRNFGVEPIVYTPENPSYPIVDEKIGEDVPSD
IQIIKHPIWEPYGLASFFSKNKTKKMSAGIIPRKKISFVEKMMLWLRGNFFIPDARKFWV
KPSVAFLSDFIEKNDIQTIITTSPPHSIHLIGYKLKKKYPDLKWISDFRDPWTTIGYYKD
LRLTKWADSKQKYWEKTILNTADTILVTSFKTQKEFSELTKRPIHVITNGYDDMNIQKIS
LSEKFLVSHIGSLLSDRNPKMLWQVFSELVTENEEFANDFQLCFAGKFSEDVEQEIRAFG
LGRYVINRGYITHNEAIELQRSSQILLLIEINSKETESIIPGKLFEYMVSGRPILAIGPK
GWDAVQIIRETNTGKSFSYDEHQQLKATIWEWYQLFKIRSLKTTPIGLAPYHRKKLTQKL
ADLI
>OBAHECAF_01972 N5-carboxyaminoimidazole ribonucleotide mutase
MKVAIVMGSKSDLPVMQEAVDILKEFGIETVVDIVSAHRTPEKLMDFSMNAHKRGINVII
AGAGGAAHLPGMVASMSPLPVIGVPVKSSNSIDGWDSVLSILQMPGGVPVATVALNGGKN
AGILAAQIIAAQHPQTLEKILQYKEGLKQAVLKSAETL
>OBAHECAF_01973 tRNA pseudouridine synthase B
MIITPEEFSNGKILLIDKPLHWSSFQAINKIKWSIIKNYKLKKIKIGHAGTLDPLASGLL
IVCTGKFTKKITEFQEATKTYTGTIRLGATTPSFDMETEIDQTFSIEHITPELIEKTRQQ
FVGEIVQYPPMFSALKKKGKRLYEFAREGDETIEIPSRTVCIEQFNLDTSEFPNIHFEVI
CGKGTYIRSLANDFGKALQCGGYLTALRRTKIGEFSVDEAISPDEFVINHILKSTK
>OBAHECAF_01974 hypothetical protein
MTLIREKLVLPNDGKKLLLHSCCAPCSGEVMEAIQASGIDFTIFFYNPNIHPLKEYELRK
EENIRFAEQCNIPIIDADYDVDNWYERAKGMEMEPERGIRCTMCFDMRFERTALYAYENG
FDVISSSLGISRWKNFDQINDCGERAAAKYDGITYWTYNWRKKGGSARMLEISKREKFYM
QEYCGCAYSLRDTNKWRIENGRERIKIGVKYYGNEEQNS
>OBAHECAF_01975 hypothetical protein
MKRIRHVFYAFVLFFSLQSVNAENNHTVSVTDSIRSKEYVSLALKKMENNIKELYDELEG
EYYDLNYEAFRYAYIGYQSLKNQQRLNEKEILSIIDFSKDSNTKRFYTIDLEEKQIIFHT
YVSHGKKSGDKLSTSFSNTKESNKSSIGFFITGSTYMGSKGFSLRLHGDEKGYNSNVATR
GVVIHTADYVSEDYIRRNGRLGRSLGCPVLPEHIYKDVIEAIKDKTVVFAYYNDKKYLKS
SKYLNLLKLIDYTVF
>OBAHECAF_01976 hypothetical protein
MEGNTKVLSSVIKQIIQQNKLEYGLHKVEVQEIWARIMGISIAKYTKSVELKGDVLYIEL
SSPALSEELTYGKETIVRSINEEIGKEVVKKIVFRS
>OBAHECAF_01977 DNA topoisomerase 1
MAKNIVIVESPAKAKTIEKFLGKDFKVVSSYGHIVDLPSKEIGVDIENGFKPKYLVSNDK
KEVVKELKALTQKAETVWLASDEDREGEAISWHLAETLKLNPEKTKRIVFNSITKTAIEK
AIQNPRSIDYNLVNAQQARRVLDRLVGYELSPVLWKKVKSGLSAGRVQSVSVRLIVERER
EIQEFKTHSSYKITAEFANSEGKTFKATLSKSFDTLEEAKAFLEKNIEATFKIASLETKP
AKKSPAPPFTTSTLQQEASRKLYFSVSKTMTVAQRLYESGFITYMRTDSTNLSQEALSTA
QNAIHQLYGTKYSQVRNFATKAKGAQEAHEAIRPTDMMRTNIPAESDQARLYELIWKRTI
ASQMADAQLERTNVKIEANKHKDLFAAHGEMIKFDGFLKVYLESTDEEEEEQEGILPILK
TGESVKNNDIIATQRFTRPQARYTEASLVKKLEELGIGRPSTYAPTISTIQNRGYVERSN
FEGEERNYQQLTLSNGIVKQKTLSEKVGADKGKLVPTDIGMVVNDFLVSNFETIMDYNFT
ATVEGSFDHIAEGTENWTEMLQNFYSHFHPVVEDVEKNAGRETGERVLGIDPKSGRPLSV
RLGRFGAMAQIGTSEDEEKPLFASLHSGMSIETITFEEALQLFELPRKLGIVDGKEVDVN
IGRFGPYVRHGDTFISLDRGEDVFSVTLDRAKEVIEKKNKADAPFAMYEGKGVSKGVGRF
GPYIKWNDMFINVSKKYDFNNLSQNDAEELIEAKLQKESEKVVKEWDDVRLEKARWGRYN
LIKGKTKIELPKETDVANFTLEQANALLDAKTKKTPAKAKTEKKTTTKKVTTTKATKNK
>OBAHECAF_01978 Thioredoxin-like protein
MDKFGNIVDVNVPVLFCFYADWHETSVQMNGVLKEIVTQLGNKVKVVKIDVDKNKELTKA
LKINGLPTIVIFNQRELVWRGEGFHSSNLLITELVKYLQ
>OBAHECAF_01979 hypothetical protein
MQKYYFFLTTKFLLNKKSKYTQKVTNKTFKDVINKV
>OBAHECAF_01980 Diaminopimelate decarboxylase
MNTTDLLSIANEFGNPVYVYDATKITSQYQRLTSAFNTILNLRVNYAVKALSNISVLRLL
RNLGSGLDTVSIQEVQLGLLAGFSPEQIIFTPNGVSLEEIEEATALGVQINIDNLSILEQ
FGSKYPQIPICIRINPHVMAGGNSNISVGHIDSKFGISIHQIPHILRIVENTKMQINGIH
MHTGSDILDIDVFLYAAEILFETAKHFEGLEFLDFGSGFKVPYKEGDIQTNIEELGERLS
SRFLAFCKEYGKDLALAFEPGKFLVSEAGFFLAKVNVVKQTTSTVFAGVDTGFNHLIRPM
LYGATHQIENISNPNGKKRFYSVVGYICETDTFASNRQIAEISEGDILCFRNAGAYCFSM
SSNYNSRLKPAEVLWHDGKAKLIRQAETFDDILRNQIQIF
>OBAHECAF_01981 tRNA pseudouridine synthase A
MRYFIEFSYNGKNYFGWQRQPHSVSVQEILENSLSTLLRTPIEVVGAGRTDSGVHAHQMF
AHFDIEKELDSQLIYRLNAFLPKDIAIHKLHRVTDQAHARFDALKRTYQYHISMKKDVFA
YESSMYLNLPLDLPKMEIATKKLFDYTDFQCFSKSNTDVRTYDCKIYDAFWQQQEHHLIF
TISADRFLRNMVRAIVGTLLDVGLGKISIVDFENIIKSKNRSKAGKSVPACGLFLVQVEY
PQSCFI
>OBAHECAF_01982 L-Ala-D/L-Glu epimerase
MKLSWFPYDLHLRHRFSVSGHSRSTTPVVLTKIEYDGLCGYGEASLPPYLGETKTSVIDF
LKKIDFTSFSSPMDIDEILEYVDSLAMKNTAAKASIDIALHDLVGKINNQSWHEYYHLDK
NNIPDTTFTIGIDTDTVVREKTREAVGRFNILKIKLGGRNDKQMLRAVRSVTDLPLAVDA
NQGWTDVHQAMDTIFWLQEQGVVMVEQPMQKDDLDNIALLTESSPLPIFADESVQRLEDI
SRLKGVFSGINIKLMKCTGMREAWKMRDLAKSLGMKTMMGCMTETSCAISAAAQLCADMD
FADLDGALLIANDCFDGAKLINGKIIPLDDSGIGVKILLSNF
>OBAHECAF_01983 Galactokinase
MKAYIQESFEQAYGKPADKIFFAPARVNLIGEHIDYNGGLVMPCALGNGTYLAVRKTEDN
MFTFRSLNFPDSVHQVPVNTKGYTKQDSLWINYPLGCIDYFTREGATLSGLELLFYGNIP
NGGGLSSSASIELVTTFALNTLFDLGKNQVELVKISQQVENKFVGVNCGIMDQFAIGMGK
EDHAIILDCQTLEYTYTPFVLKDDTLLIINTNKERKLADSKYNERRATCEAALEIFNKTE
NFKDLCSIPAEYFEANKHLLTPEMQQRVKHVIYENLRVKASEKALKLGDIEKFGELMSAS
HKSLMEDYEVTGKELDTIYLESVNFEGVTGVRMTGAGFGGCAIALVKNDRVNAYKKHIEK
VYTEKIGYAPSIYDVSIGDGTREI
>OBAHECAF_01984 Tyrosine--tRNA ligase
MKNFIQELQWRGMIQDMMPETEEHLLEGVRSAYVGIDPTADSLHIGHLVGVMMLKHFQNC
GHRPYALVGGATGMVGDPSGKSVERNLLTNEVLEHNIAGIKKQLAKFLDFESTAENKAVL
VNNYDWMKDFSFLNFIRDIGKHITVNYMMAKDSVKKRFDPKENTEGMSFTEFSYQLLQGY
DFLHLYRENGLTLQMGGSDQWGNITTGTELIRRIAGGKAYAMTCPLITKADGTKFGKSEG
GNIWLDPEKTSPYKFYQYWLNTSDVDAEKYIKIFTMLTQEEVAELTKQHQEAPHLRILQK
KLAEEITVMVHSREDYDNAVKASEILFGNSTSESLKSLDEKTFLDIFEGVPQKEIAKEEV
IGANIVELLADQSGFLKSRGEARRDLTANAISVNKEKVTEGFVASENDLIDGKFILLQKG
KKNYFVVVIK
>OBAHECAF_01985 Primosomal protein N'
MAYFIDVILPIPLRKLFTYNVTKEEAHFLKPGMRVAVPFGKSKVYAALVESVHTTEPSYE
TKDIEYILDETPIVNHSQLRLWKWISDYYMCWLGDVFKAAMPSAFLLESETIVERDETDL
EMTLFSDDEWMVYEALSYKTALTAKEINQIVGKRKALKVVKSLLEKGAIRISEKIFEKYV
PKLEKYIRLAEKYQSDEGMKAVFEDVGKSVKQKQLLVAYFNWMMRNKLPLKVEKLLSDSN
VSATVLKSMVGKGIFEEYYIQKDRINFKGELIGSKSLSEAQLTALKQINEQFNTNQVVLF
QGVTASGKTEIYIHLIQKCLDEGKQVLYLLPEIGLTEHLINRLKKHFGDKLGVYHSKYTT
NERVEVWNNVLNKNIKNQLIVGVRSSVFLPFSNLGLVIIDEEHDASYQQFDPAPRFQARD
TAIMLAKIQNAKVLLGSATPSIESLYNAKRKKYGFAYLLKRFGEFQYPDIELIDIRDKHF
RKQMTGHFSDKLIQEIQTTLSEGQQIILFQNQRGYAPEIQCKSCGTVAQCPACDVSLTYH
QGRKQLRCHYCGYAIPILDNCIACGSNELITKGFGTEQITKELAQLFPEVTIDRMDQDTT
SGKYGYQKILSKFEQQQTQILVGTQMISKGLDFENVGLVGVMNADSFIHFPDYKAYERSF
QLLIQVSGRAGRSTRKGKVLIQTYNPNHPVLKQVLEHNFRDMFNNQIAERREFLYPPMVR
LIKISFKHADFNKVTEGADWFGKSLRQGFEKHTDIHILGPESPLVSRIRNEYIKDILLKI
PFTHSAENVKKYILRTEISFQAIPNFRSIRVIYNVS
>OBAHECAF_01986 hypothetical protein
MSEKIEQKLAKIPVVKNLVALLKRVTISQNSFSLYDFLELYIVGIVKGALTYRASAISFS
FFLAIFPFLLFILNLIPYVPIDTFQIDVWSFIDGLLPPGTNELFSSIFFDIADNRRGGLL
SSVFLLSILLMTNGIVAIFGGFESSYHVRITRTYIRQYMVALMVAIIIALLILIVIAMFI
YYGIYIVPYLERTGLLYSTETIIQWSKIGFVTVIIYLATSILFFFGTKEGKKSKFFSIGS
ILTVLLFALTTYLFGIYIENFSQYNQLYGSIGALLIFLLYIWLNSNILLLGFELNASLLR
LKKIR
>OBAHECAF_01987 hypothetical protein
MYKNLYIWRNFKIMFEFDQYLGFLVFLGIATIGFWLMIFLLTFVVPYWVGGAIMEAIKEK
REARKAKKSA
>OBAHECAF_01988 putative adenylyltransferase/sulfurtransferase MoeZ
MKKSILILAMGLFSCSNIPSEKNIKIKDYEPKATDKLVDIRTAEEFADGHLKGAVNIDFF
EDDFLENFEKQYDKEDTVYIYCKSGGRSSKAYAILEKAGFKNLMHLDGGFMQWSGAGKPV
EK
>OBAHECAF_01989 Protein-L-isoaspartate O-methyltransferase
MLQLNDTLKHKGMRNQLVDLLRAKGIKDQDVLEAIRIIPRHLFMDSGFEMHAYQDKPFPI
GEGQTISQPYTVAFQTELLEVSAGQKVLEIGTGSGYQSCVLVFLGAKVYTIERQHKLFKQ
TQLLLPKLMSRLPKMYFGDGYKGLPNEAPFDRILVTAGAPEVPMTLLSQLAIGGRLVVPI
GIETQVMTLFERISDTEFHKTEYGDFQFVPMLKDKT
>OBAHECAF_01990 Beta-barrel assembly-enhancing protease
MPNSNLFPLSFSQYSSFLSENKVITGTKETEMVKKVGQRIAKAAQMWLEHNGYKDYLKDY
QWEYNLVQSDQVNAWCMPGGKIVVYTGILPITQTETGLAVVMGHEIAHALADHGARRMSV
GTTQQLVGMLGNVALHNSKYLDEFNMAYNVGSQVGVTLPFSRAHETEADEIGIQIMAIAG
YDPEEAPRLWERMDANSSGGTIELLSTHPSNASRIANLKSMVPKARAEAAKFGIRTFQYN
>OBAHECAF_01991 hypothetical protein
MKAVLSLLFILFFFFSFSQEKTMTLTLEQLVTMANSQSIASFKAKNMYLSNYWSFKSFKA
NRLPSLSLSMTPLRYNRDFVRRYDSQQNIDVYRPQQTLFSHGNLSLIQNFDWLGGTFFVD
SELGYHRNFSDNKFTQYSSVPIRIGYRQQLLGYNPFKWEKRIEPIKYEAAQKELLYNLEQ
TAEEATSYFFNLAMAQAEHKLAKEKIQSADTLYNIGKERFEIAAIRQSDLMTLRLDKINA
ENALQTAEISVKRAMFALVSYLNLEKDTKILLDIPQKVKNITINPEEALSYAKKNNPNFL
KQKIQLLELQKTVDKTKREARFNMGVSASVGFNQVAPSFDKVYNSPLQQDVFAITLSVPI
LDWGVNKGKYNVAKSNLSVAELSTKQEEIKIEEEILMTLGDFQVQQQIIVSAEEALELAS
QAYQQTQERFIIGKADINSLTLANDRHQQAQRNYISALRNYWLNYYKIRKYTLFDFEVGE
SIQIDFDSLR
>OBAHECAF_01992 Swarming motility protein SwrC
MYFNQPKISSFSIILVFLCISLAGIALVPLLPVKLAPSQNLPALTVSFSMPGSASRVVEM
EATSKIEAMLSRIKGIKKITSRSGNGWGSVSLEMDKHTSIDVARFEASTVIRQLWGDLPR
SVSYPQLQVRRPDENANRPFLNYTLNASAPPITIQNYCENSIKPRLSEIEGIYKVDVNGA
TPMEWQLQYDNDQLNRMGVSVDEIQRAIQLHYNTQFLGIGEIEDSGNVRKFARVVLGDAS
EKETFDASKISVTNKDGKILYLNQLVNVSRVEQAPRSYYRINGLNSIYISISAEENANQL
QLSSEIKKLMEDIRKNLPQGYELHQSYDATEYIKDELNKIYFRSGLTILILLAFVLLISR
NFKYLFLIVSSLFINLAIAVVLYYFLRLEIQLYSLAGITISLNLMIDNTIIMTDHLQTKN
NRKVFLPILAATLTTIGALCMIFFLDERLRLNLQDFAMVIVINLAVSLLVALFFVPAMME
RIKIANKTRKSRQKFRISKRFIVKTSLFYQKIILLLKKGKWAVYVFFILLFGLPVFLLPD
KIDKETRWAELYNSVFNTATYKEKIKPITDKVFGGTLRLFVQNVYERGYFDRNQEMVLTI
TSSMPNGTTLSQMNTLVQRMESYLSTFSEIKQFQTSINSPNRASISVYFTKEAERSGFPY
RLKNSVITKALELGGGSWGVFGLEDRGFSNDVKETAGSFSVKLLGYNYDELNTWADSLKN
NLLKHRRIQEVTIGSDMSYYKDDYQEFMFNLDKKQLAIQNMSPSRLFNSLSSMFGRDIWV
GRLFVDGQNEDIVLHSKQSKTYDIWALQHAGNHFDEQFHKLNQFAQITKGQAPQEIAKEN
QQYRLVVQFNYIGSSQQGNKVLEKEIEKLNNSLPSGYKAEKQGWNWNWGKDKKQYWLLGL
LIAIIFFTTSILFNSLKQPFIVILIIPISFIGVFLTFYSFDLNFDQGGFASFVLLSGITV
NANIYILNEYNGLRKKYPNLSSVRAYLKAWNSKIIPILLTIISTILGFIPFVIGLKREAF
WFPLAAGTMGGLLFSLVGIFILLPMLVVKRK
>OBAHECAF_01993 ECF RNA polymerase sigma factor SigM
MVDKTKDQQITQWIEMYSESLLNRALYLVSDKEDAADIVQEVFLVAYTSFESFQGKSSPL
TWLYNILRNKTADFYRNKYKNPVSTSLSDFFDEDGIWTDQSVLNFWEEISENSSEKEDFS
RALDECIEKLPQRWRFLVKLYYLEEKKTEVVCQEMEISTTNMWKILQRSRLQLRKCLEIN
WFGDV
>OBAHECAF_01994 hypothetical protein
MFSRIIHYFILPCSEISLLIEKKTARKISFFEKIRLFLHLRLCRLCKMYHKKVMFLDKSL
QNTEITEKKVVFNHSEIQLFKRKMKENLKK
>OBAHECAF_01995 Inner membrane protein RclC
MEKQISNCPLSDEKIYKIGYYVSLFGTAFILFWIGIFKFTTAEANAIKPLVENHFLTFWA
YDLMSVQAVSNLVGIVEITLALLLLLSPFFPKLRKYAAYGMIVTFLVTISYLFTTPNMWR
KVEWLPITDFFILKDLVLLGFSLMLVGKQVKK
>OBAHECAF_01996 Peptide methionine sulfoxide reductase MsrA/MsrB
MKNIITFMAVLPIMILLTSQCKISKESVKIQESVMKKQNMDIKTKNNKKDMKEIYFAGGC
FWGTEHFFKQIRGVIATQVGYANGNTQRPSYEEVYTDKTGFTEAVKVVYDPKEVDLQLLL
DLFYKTIDPTSLNKQGNDIGTRYRTGIYTVDDSDRKIIEKSLNELASKYNQPIVVENLPL
KNFYDAEENHQNYLDKNPDGYCHINPKLFQVAKEANSLPKNGKKMYEKPTDDVLKDKLTK
IQYEVTQKNATERPFHNEYWNEFREGIYVDITTGEPLFISTDKFESGCGWPSFSKPIDKK
LIAEKIDKSHGMTRVEVRSKTGDAHLGHVFTDGPLDKGGLRYCINSASLRFIPKEEMKKE
GYGDYLKLLKK
>OBAHECAF_01997 hypothetical protein
MKLIYTFLLFNLFTFSVFAQKEDNYERIKTLKIGYITEEVSLTAEEAKKFWPIYEKYNKI
LHDLHTEAKTCRRHGFSKKENLTEKEALEILKKDTELGDKISKISKDKDKELLKVISAQK
LVLLKNAERDFHRKLMTQYKNSK
>OBAHECAF_01998 hypothetical protein
MNEDNLHIQSGMQLPENYFDQFKKKLMNRVELEEYAPNKETFIVPEKYFEKSKQAILKAT
TKKTKTRMFSFVRYAVASVFTALILSSVWMYTSHNQNNNVHFSDLTSAEIQGYFSDIYIE
DKSYLIVEESEDVHLDNFLVGDIQSFGNIDSYLSEYDYRLDEY
>OBAHECAF_01999 ECF RNA polymerase sigma-E factor
MDEKELISQLQNEKKRGKAFEILVDLYQKRLYWHIRRIVISHDDADDVLQETFIKIFRSI
ENFRGDSSLFSWIYRIATNQALDFLKKKANEKNCTIEDLQYDRSSHLEADTYFEGDEIER
KFQQAISSLPEKQQIVFNMKYFEELKYEEISEILGTSVGALKSSYHHAVQKIKNYLESH
>OBAHECAF_02000 Lipid A export ATP-binding/permease protein MsbA
MNPNLKKFIPYIYPYKKYAFLNVLFNVLYALFSALSFVSLIPMLDILFGKKESRVYEVPT
FSGNVSDLVDYGKKWLNYKISNMVGEDSVSALTIVICLVILLFLLKNLFNYIAVFFITHL
RNGVLKDLRNKLYKKITNLPLSYFSEQRKGDIIARVAGDVGEVQHSFLSILELIVREPLT
IIFSIVMMLGISIKLTVFTFVFIPLSGWIISKIGKSLKKQSTKVQQEQGKFLSLIEETVG
GLRVVKAFNAEKTFQKRFEESTSRFFKLANNLGNRQNLASPMSEFLGILMIATLLWFGGT
MVLVEKSLDGAAFIAFMGLAYNILTPAKAISKASYDFRRGNAAAERVFEILEYDNPIKEK
ENATEIFDFSSAISLKNITFRYGEQNVLTDFSLEIPKGKTIALVGQSGSGKSTIANLITR
FYDVNEGTIEIDGIDIKQLKISHLRRLIGVVSQDSILFNDSIKNNLLIGNPTANDEAILD
ASKVANAYEFIKDLPEGFDTNIGDSGSKLSGGQKQRLSIARAVLKNPPIMILDEATSALD
TESERLVQSALENMMKNRTSIVIAHRLSTIQNADLIVVMQRGRIVEQGTHGELLAKDGVY
RKLVEMQSFET
>OBAHECAF_02001 2-succinylbenzoate--CoA ligase
MNEIDYTFIHRDFKIDNFPMDRERLLILATDYVKNGENHLKSVGDFLLNWLDNRDFIEAT
TSGSTGVPKVIHLKKQFMVNSALATGKYLNLSPKNTALFCLPADFIAGKMMIIRSIILGL
HLDIIQPSSMPLALTNRDYDFSAMIPLQASKSLYDLHRVKKLILGGASIDEDLENKLQNV
STHVYSSYGMTETISHIAMRRVNHTATHEESYKALPGVTFSQDDRKCLVINAPQIADHLV
VTNDIVELISQTEFIWVGRYDNVINSGGFKVFPESVERKMKKYIKNQYFLTSEPDEKLGE
KAVLYIEGNEKDYPTLSHDLFVDKDMLKLEVPRAIYFVPKFEYTDNGKVRRDETVKKHNK
>OBAHECAF_02002 hypothetical protein
MKQKLFDFRFFLEKHGFAVSSRIAEKLGVRAKDVRIFFIYSTFATLGAWFGIYLLLASLL
RIKDLFYTKRSSVFDL
>OBAHECAF_02003 hypothetical protein
MKKHFLTTLLFLVGFSTLVAQDFSVDANFRTRSEYRHGQGRLFQKEEKPAFFVNQRARLG
TSYQNEWLELRLTAQQIFTWGDAQQPQTELKNHLGFFEAWAKMQIDENWNVKLGRQVISY
DDERILGGLDWSQYGRFHDAAVVSYKNFLNVGLAFNQEGQPNVGNAYAIGNTSKNTYKTM
QFLRANKKWQDNSLSFLFINNGFQDFDSSGKQDGVSNMQTTGFYGIFPISSLMLEASAYY
QFGKFQKTSVSAYQLRAELIYKTQEFTAGLGMEMLSGRDYDDTSAKIKSFNPLYGTAHKF
NGHMDFYYLGQNLQGTTGLNDIYAKAIVKFNEKSNLLFMPHIFMSNAKRADNKSYLGTEL
DFMFTQQFRKDVALNVGYSHHLPSDAIKVATTHGMQNWFWVQLNIKPTLFTTKQ
>OBAHECAF_02004 hypothetical protein
MKTIQYTIIVLLISLSTSCKNKITEKELVLLNGYWEIEKVILADKSVKIYEINTTYDYID
LKDNSGFRKKVYPQLFGKYQTSEDAEFFSIVKKGNTWEMNYTSKDNKWVETLESLSEKSF
TVKNTAGIEYFYKKVERQE
>OBAHECAF_02005 hypothetical protein
MQLYLYLKNVYVRISEVKFTKNMRESFVISFFCCYFAFQRTLKMEDKSYLEDLQHIKQMM
RKSTQFLSLSGLSGVLAGVYALIGAYVVHLLLEKHYAYNQFVILESKTFKAILGVAATVL
ILSLVTAYILSQRKARRRGETLINATSKRAFWNFAIPMLTGGILIFLLLKNEYYGLLAPM
TLIFYGLACVNVSRYTFGDVRYLGITEVILGLLAVQFSGYGLLFWVIGFGVCHIFYGLLM
YFKYDRGRVE
>OBAHECAF_02006 hypothetical protein
MKELLQHINKAFDNRTRLGIMSILMVNESADFNTLKELLDVTDGNLASHTKSLENEEYIV
VEKRFIGRKTNTTYKATEKGRKAFQSHILALEKIIKGTEN
>OBAHECAF_02007 Inner membrane protein CreD
MESNQKSFIATLLQSSTARMVMVGILILVLLIPLELVKSLVRERKYRQEEVIGEINSKWG
EKVFFYGPILKVPYTSYEKNTVYDKKLGTTVIERKAQQNVAYFFPETLKNISNVMTETKK
RNNYESVVFTAEMEFEGKYVKPDFSSKNIPEEDIHWDKATILIRTTNLSSIKNGVSINLS
GKSYPFEPIYEESSSNYAEYDEYNGHTGTYFVVSSLETSFFNLKEHFDNGNFNFSIKYDG
SSSISIVPIGKITESTVKSNWKDPSFKGNFLPYQKEITNSGFSADWKVLHINRPFAQQSF
GVLPSIEKYTFDVDFVIPVDEYQQNERASKYGFLVIGLTFLIFFLIQTISKVKIHIFQYT
MIGLALIMFYTLLISITEHSSFSKAYLIASLMVILLISLYSVSILKNRKFPFFIGCSLSA
VYGFIYVIIQLENYALLVGSIGLFAILAIVMYVSRKIEW
>OBAHECAF_02009 GTP pyrophosphokinase
MGWNFDLEEENKIIAREYKELLSISYQTLTEDDKKLIRLAFDTAVDAHKEQRRKSGEPYI
LHPIAVAKIVASQIGLDAVSIAAALLHDVVEDTDHTVEDMERLFGKTVAHIVEGLTKISN
LSKEKDISLQAENFRKLLLTMNDDVRVIIIKIADRLHNMQTMDSMAEHKQAKIASETLYI
YAPLAHRIGLYNIKTELEDLGLKYTDPEYYYSILGKMEESKEEQKSYIESFTQIIESSLN
SQKIEYRIKGRPKSIYSIYKKMENQGVTFEEIYDKFAIRIIYKSTPEEEKFLAWKIYSIV
TDHFRPNPTRLRDWISAPKSTGYEALHITVMGPKGRWVEVQIRSERMHEIAEKGYAAHFK
YKHGNQEEAGIEVWLNRLQEVLENSEGNAVDFVEDFKLNLYAKEIFVFTPNGEIKSLPKG
ATPIDFAFYIHTGVGMKTRGAKVNNKLVPLSHVLKSGDQVEIITAENAKPNKNWLNYATT
AKARSKIKSALKEEVKTVAAEGRELLQRKLKQLKVSLTEDVVNDLVSHFKTKTSLDIFYQ
VGTGEITNQMLRDFASKRSSFFNFFKSKITSKKNVVEEVESSNEHYDSIVFGKEEESLDY
TFAKCCNPISGDPIFGFITINEGVKVHKKNCPNAISMQSNYAYRIMVAKWVKSAEQEFKV
AIRISGLDRDGLVADISQTIGSNKFVKMTNINIDTEGNMFNGKLSITVNNNATLKQLMLD
LKHIKGIDKVNRL
>OBAHECAF_02010 Heptaprenyl diphosphate synthase component 2
MSSIENYRKVFLTHLQENITKQEPENLYAPMHYILGLGGKRIRPILTLLGADIFQTDYKK
ALHAALAVEVFHNFSLVHDDVMDKAPLRRGQQTVHHKWDLNTAILSGDAMLIIAYQFFEN
YEPIVFQQLAKLFSKTALQVCEGQQWDMDFETRNDVSVEEYLLMIKYKTAVLVGAALQMG
AIVAKTTDENKQLIYDFGVQLGMAFQLQDDYLDSFGDASFGKKIGGDILENKKTMLYLKA
LELADNEQRNLLYNLYNTTEETPQKVEKVKKIFTDTKTTDFVKTQIEYYTQQAIQTLEKL
DIQQDKRNEIKQFALDLMHRKI
>OBAHECAF_02011 UDP-N-acetylenolpyruvoylglucosamine reductase
MIIEHHVSLKPFNTFGIDAQATTFVTIHSEKGLTEALSNYKNPFIFGGGSNMLLTKNIEN
PVFWIQLKGISIERETDDHVWITAAAGENWHEFVQFCLEKGYGGLENLSLIPGNVGATPI
QNIGAYGVEIKDVMAYCQAINIHSITQKQFSKDECKFSYRESIFKCEEKGNYIITSVTFK
LTKKNHILHTEYGAIREILEQKNIKNPQPIDISKAVISIRESKLPNPKEIGNSGSFFKNP
IVSKIHFEKLQKIYPQMPHYVVNEESTKIPAGWLIETCGLKGYRRGDAGVHQKQALVLVN
YGNATGQELVELSKFIQQTVYNKFQIHLESEVNIIQ
>OBAHECAF_02012 Sulfolipid-1 exporter MmpL8
MIKWFKAEFWTTVARLILRNRIAILVAIALITLFLALQWKNIRFTFTEANMLPDGHPINL
EYHEFLSKFGEEGNLILLAIENKNSYTPEILNQWKGLANEFKQFKEVEAVLSIGNLPVLT
KDVATESFTTKPLIDGIITSQNQVDSIKQLLSEKLPFYKGIVYNPETETLQTALYMNKKI
INTKERKDFIINILIPIIEKFEQQTQIKVRTSGMPYIRTLSAQNIIDEIGLFIGMALLIT
SFILFLFFRSYRAMFISMSVVSIGVMWSFGLLGLFNYEITILTGLIPPLVIVIGIPNCIF
LINKYQQEFNKHGNQAKSLQRVIRNVGNATLLTNLTTSIGFATFIFTESSLLQEFGTIAA
ISIMSIFFISLCIIPIIYSFMKIPKEKHLKHLHRTWIQKFIQLLERTVKHHRIAVFSIAV
MLLTLSIIGINQMKISGSLIEDMPKSAPFFDDILFFEKEFGGIMPLEITVDTKQKNGVMR
LPNLKKIDELCKYIEDIPEISKPISIVDLVKYAKQTYYNGNPEYYDLPTSQEQNFIMSYV
RNSKGNGQMLSSYVDSLGQTARITTFMKDIGTDKMQQIEENIYAKAKKLFPEEKYEVKVT
GKAFLFTKGTTYLAKNLIYSLGLAILLIALIMSYMFRSFKMILTSLVPNLLPLLVTAGMM
GYFGIPLKPSTILVFSIVFGISVDDTIHFLAKYRQELVARNWKISKSVYATLRETGVSMF
YTSVVLFFGFSVFMLSSFGGTKALGGLISLTLLFAMLTNLLLLPSLLLSLERTIANKETL
IEPKIDILPEEEEENKT
>OBAHECAF_02013 hypothetical protein
MRRTFLDYMLISLKGMAMGAADVVPGVSGGTIAFISGIYEELISSINNINLGAFKVLKNH
GIVNFWKHINGNFFFSLLVGIGISILSLAKGVKWLLENQPIAVWSFFFGLMLASILFLAK
DIKKWNLGTVLSMLFFGILAYLITIVPPLGSNDGLIYVFFSGALAICAMILPGISGAFIL
VLLGSYHIVLGALNDWNFKIIGVFGIGAIIGILSFSKVLKWLFANYRNTTIAGLTGVIIG
SLNKIWPWKEILQTRIDSHGNEVPVWEKSILPSTYESISGDSQFLTAVALALAGFFILYG
LERWAVNLKKS
>OBAHECAF_02014 Dihydroxy-acid dehydratase
MELNKYSKQVTQDDTQPAAQAMLHALGLTDDDLKKPLVGIASTGYEGNPCNMHLNDLALK
IKEGVQQSGSVGLIFNTIGVSDGISMGTYGMRYSLVSRDIIADSIETVIQAMCYDALVTV
VGCDKNMPGALMAMLRLNRPSILVYGGTIAAGCHNGKKLDVVSAFEAWGQKVAGIIDEKE
YKEVIHKACPGEGACGGMYTANTMASAIEALGMSLPYNSSTPASGDAKRQECLKVGKALR
YLQENDIKPRDIVTRKSIENAFRLVVALGGSTNAVLHFLAIAKAAQIPMTIDDFAKLSDS
TPFIADLKPSGKYVMEDLHHIGGIPAVMKYLLEKGLLHGDCLTVTGKTIAENLADVPSLP
ENQNIIHPLEKPIKETGHIRILYGNLATKGAVAKITGKEGLSFTGKAKVYEGEFLANEGI
AKGEVTEGTVVVIRYEGPKGGPGMPEMLKPTSAIMGAGLGKKVALITDGRFSGGSHGFVV
GHISPEAQNGGNIALVQDGDLITIDAVKNTIDVHLTEEELSQRRANFSLKPLKDTAKRGV
LYKYARTVSSASQGCVTDEF
>OBAHECAF_02015 hypothetical protein
MTYITEIKNILSQARQRAYTAINSVMVEAYWLIGRRIVEEEQNGENRAEYGKEVLQTLSI
ALTNEFGKGYSYRTLREIRQFYLTFPEIEKWRTLFAKLSWSHFQRVLKVSNEKARIYYLT
EAAENMWTVRTLDRNISTLYYDRLLASDNKLEVQEEMQNNTKLLQFEEFIKSPTVLEFLK
LPIGKSYTEMELEKALIDDLQEFMLELGKGFAFVARQQHIKTETSDFYIDLVFYNYILKC
FVIVELKTNKLTHQDIGQLDMYVRMYDDLKRQENDNPTIGLLLCTETDGVVARYSILNQN
SQLFATKYVHYLPTEEELVREITQQKWFFEQKNAK
>OBAHECAF_02016 Acetolactate synthase large subunit
MTGAEVLIKCLLAEGVDLAFGYPGGAIMPVYDELYKYQNQLKHILTRHEQGAIHAAQGYA
RATGKVGVVFATSGPGATNIITGIADAQIDSTPLVCITGQVAKHLLGTDAFQETDIIGIS
TPVTKWNFQITEVEEIPEAIAKAFYIARSGRPGPVLIDIVKSAQFDQVAQFDYKKCTRMR
SYNPVPEIDDSKLAEAAQIINQAQKPYVVFGQGIILGQAENELKSFLEKTDIPAAATILG
LSALPTEHPNYVGMVGMHGNYAPNVMTNTCDVLIALGMRFDDRVTGDLSRYAKQAKVLHF
DIDPAEINKNVKADVAILGNVKEALQKILPLVEQKKHTTWREEFKKYDKEEYDSVIKNEL
YPEKEGLTMGEVLELINKCSNHEAVIVSDVGQHQMMACRYAKFKNSRSKITSGGLGTMGF
ALPAAIGAKIGVPEKQVVAVIGDGGFQMTIQELGTIFQSQIPVKIVVLNNEFLGMVRQWQ
ELFFDRRYASTEMINPDFIKIAEGYHIQSRLVTKRSDLEEAVKEMLNSDKAYFLEVRVEK
ENNVFPMVPTGASVSEVRLK
>OBAHECAF_02017 Putative acetolactate synthase small subunit
MEQKTYTITIYSENQLGLLNRVTGIFLRRHIDMESINVSASEIDNVFRMIIVTHTTQKWV
EHLVQQIEKQIEIIKVFYHTDEEIISLENSLFKMPTASLFDEETPIQTIIQRYNANIVAV
YKHFYVISKTGSRESIAALYQELKPYGIMQFSGSARIAISKSEMKVSPLLNKYEVDNQK
>OBAHECAF_02018 hypothetical protein
MDCVLKNMMINFGVKPNKIKVLGIKDLILLNLKKLFSYIILYYFWLSTSYLLSKGDTFIS
DFEIAIRAEPENCIIP
>OBAHECAF_02019 Ketol-acid reductoisomerase (NADP(+))
MKNYFNTLNFREKLAQLGVCELLQKSDFSQGVEALKGKKIVIVGAGAQGLNQGLNMRDSG
LNVSYALRECAIAEKRPSYTNTIANGFQVGTFEELIPTADLVCNLTPDKQHTSVINRIMP
LMKQGATLSYSHGFNIVEEGIEIRKDITVIMVAPKSPGSEVREEYKRGFGVPTLIAVHPE
NDPENKGFEWAKAYAAALGSDTAGVLRSSFVAEVKSDLMGEQTILCGLLQTGSILAFNKM
KREGIAPEYAAKLIQYGWESITEALKHGGITNMMNRLSNPAKVRAFAISEDLKKMMRPLF
EKHMDDILSGHFSKTMMEDWANNDKNLLTWRSATAETDFEKTPITTETIEEQTYFDYGTL
LVAMVKSGVELAFEVMTESGIKAESAYYESLHELPLIANTIARKKLYEMNKTISDTAEYG
CYLFDHECRPLIAAYIDGLENNVIGRHFTASNQIDNIDLIQVNKSIASHPIEVIGVHLRA
YMTDMKRIK
>OBAHECAF_02020 L-threonine dehydratase biosynthetic IlvA
MEVTTYIPQVQEVQKAMLRIKSVINTTPLSKSVRLSNLFGAEIYFKREDLQQVRSYKIRG
AYNKISSLSEQDKQQGIVCASAGNHAQGVALSCQILNIKGDIYMPVTTPQQKIEQVQMFG
GENVTIVLEGDTFDDSNNAAIKFATENAKTFVPPFDDEKVIEGQATIGLEILDQANEPID
YVFVPIGGGGLSAGLSSVFKTLSPQTKIIGVEPLGAPSMKEALKAGKPVELTEIDKFVDG
ASVKKVGSLNFEICNRFLDDVVLVPEGKVCQTILDLYNRDAIVVEPAGALSISALDFYKE
KIRGKKVVCVISGSNNDITRTAEIKERALLYANLKHYFIVRFPQRAGALKEFVVEILGKT
DDITYFEYSKKHNRENGPAVVGIELKNESDLQPLINRMKQRNFYGDYLNNKPDLFQFLV
>OBAHECAF_02021 Regulatory protein AsnC
MGRFKLDEIDHQILDMLIENTRTPFTDIAKKLDISAGTVHVRVRKMEETGLIKGSTLTVD
YDRLGYTFVSYIGIYLEKNHQTQFVLERLEKIPYVTVAHVTTGKYNLFCKIRTRDPKHTK
EVIYMIDEIEGVARTESMISLEEVINDKRRLMHAVFKEL
>OBAHECAF_02022 hypothetical protein
MSLKPATKYIFIAIFLEFYFAFLTLFAFGIRSLDNQLILPIFIAIVTTYWVGYQLGEKFP
WERYDSIRILFGIVFQFLLLLTMLLAGWLCLVIVSVFDRTLDTNDVLTAILLLIIVTFIF
GGIQTFVIGLWLGYKLNTIEKIGELTFVNNLQMEYTNYKEPKLFGRYITSLMIEPLLEKH
TFENKILLGKSVQGNSISLYQKGNGRTKILIWSQMHGNESTTTKALFDVLNYMTQNPSEL
ENISMFFIPILNPDGAEVYNRMNANEIDLNRDAYDLSQPESQCLRKAYKLVQPDFCFNLH
DQRTIFSAGKTQNPATVSFLAPSYNGAREINHTRKKAMEVIGVMNAMLQTKIPNQVGRFD
DSFNLNCTGDMYTSLGTPTILFESGHYQNDYAREETRKYISLSILEALAYINQNEVTGKY
YKPYFTIPENDKLFFDILIRDDFYGDNNHIGILFKETLKNNEIHFEPYIAMIEDLSNHYG
HQERKLSDFFTKPVSKKDIEKELNLRDFGFKIA
>OBAHECAF_02023 Endonuclease III
MKKTEKVAFIIDTLEEIYPKVSIPLDHKDPYTLLIAVLLSAQSTDARVNTITPLLFQKAD
NPYDMIKLSVEEIREIIKPVGLSPAKSKGIYELSHILIDKHNGEVPQNFEDLEALPAVGH
KTASVVMSQAFGVPAFPVDTHIHRLMYRWGLSNGKNVTQTEKDAKRLFPEEKWNKLHIQI
ILYGREYSPARGWNIEKDIITKTIGRKSLFPK
>OBAHECAF_02024 hypothetical protein
MKNSYLLFLVLLCFYSCDNKPISQEQNINYQHLTDFVNPFIGTDGPGNTYPGATVPFGMV
QLSPDIGIPGWDRIAGYFYQDSIITGFSHTHLSGTGAGDLYDILVMPTNSRFDERIAENS
YKPFSKFSHQQEYATAGYYTVDLQSFGIKAELTSTERVGIHRYTFPKDKNTKITIDLGFA
MNWDAPTDTHINVVNDSIIEGYRKSTGWAKDQRIYFVMQFSKPFSKYILFNDEKKVENPT
KGKNTRIELHYSTEKDEQIVIKTALSTADITGAYASMNAEAFHFDFDQYRSEAQQKWEKQ
LRKIQIETDDINKKTIFYTMMYQSMLAPTLISDPNGNYKGADGNVQKANNYKRYDTFSLW
DTFRATHPLFTMIHTERMNDFIQSLLAHYQETGRLPVWSMQGNETNMMIGYHAVPVLVDA
YFKGFPMDKELLYKACYESAMVDERQIDLYKKYGYVPIDGHHENWSVSKTVEYAYDDWCI
AMLAKDLGKDYELFAKRAKSWKNHYDPKSTFLRPKDQKGKFVSDFIPKEYTPYFCESNAW
HYFWFVPQNIPELIKSVGSEERFEQKLDSMFSYYPLPEDKLPIFSTGMIGQYAHGNEPSH
HVGYLYNYVKKPSKTQEIIRQILKTQYKNEPAGHCGNEDCGQMSAWFVFSSLGFYPVNPA
QGVYLFGTPYFQESKIQVAENKYFDIKATNFSEENKYIKAIYLNGKPYKKLYISHKDIMA
GGELMFEMSNIPNDVGLGSYELPEVNKVY
>OBAHECAF_02025 hypothetical protein
MKRVIVDYKKLTSEILSMLVEKYPDGYGDDDVIRFKNAKNETVEALEVRTEDTIYLVKVS
TRLADSMENFDEDDDFDASSDDDLNTDGLEIPEDSLEED
>OBAHECAF_02026 Calcium-transporting ATPase 1
MLRGYPKKGTSFLFLNFTRQLTIFLTYKIYLCTQFNTEMTQKNHYQGLSDAQVLESRQKF
GNNTLTSVETEPLWKQFLEKFSDPIIMILLVALVASFGVSCYEFIAHDKGGHVFLEPIGI
LFAVFLATGVAFYFEVKANRQFKILNQVNDEILYKVIRNEKVTQVLKNDIVVGDIIILET
GEEVPADGELLEAISLQINESSLTGEPMVHKTTNPEEFESEATYPSNYVCRGTSVVDGHG
IFKVSQVGDRTEYGKVFEGVQIDNSIKTPLNEQLNKLAGIITKLSYGIALLVIIGRFVVF
FSNSANSQIEWIHFWGYALNTLMIAITIIVVAVPEGLPMSVTLSLAYSMRSMMKTNNLVR
KMHACETMGATTVICTDKTGTLTQNQMKIYDIFFNKFSSELEGKQLISESMAVNSTAYLD
FSDKEKPQVLGNPTEGALLLWLDGQGTNYLPIRENTPIVNQLTFSTERKYMATLVKSPVL
NKIILYVKGAPEIVMDFCYDSNNEFLSEIHRADFESKLEQYQSQAMRTIGFAYKVIDNEN
SIISENGKLTVKGLNFIGITAISDPVREDVPAAIEECMGAGIQVKIVTGDTPGTAKEIAR
QIGLWDETCNDQNHISGTDFATLSDDELSKKLPDIRVISRARPLDKARLVNLLQQRNEVV
AVTGDGTNDAPALKAAQVGLSMGDGTSVAKEASDITILDNSFTSIGKAVMWGRSLYLNIQ
RFILFQLTINVVACLIVLIGAFLGTESPLTVTQMLWVNLIMDTFAALALASLPPSSSVMK
EKPRERKSNIITPAMAKIIFGVGILFVLLLFGFVQYFKHTDIYTLTEFSVKDYFVNFFNF
NQVESGLSAYELSLFFSIFVMLQFWNMFNAKAHHTGKSAFNNLANNKGFLFIAVIIILGQ
VLITTFGGVMFNVTPLKLVDWIIIILSTSLVLWIGEVVRLFSKK
>OBAHECAF_02027 L-fucose-proton symporter
MQTNSSTKSFLVPLAFIGLMFFSIGFALGINGILIPVLKKITPEGQGYLIVAATFIPFLI
FGYPASILIKKIGYKKTMAFSFFLFALAFVLFIPSAKIESFMLFLIASFVSGTANAFLQA
SVNPYTTILGPIESAAKRISIMGICNKLAWPIPALFLVWIIGKEVDKIAIADLNTPFYIL
IAVFLFLGILSFFAPLPEVKAQGEEETVDTTQIRDNGKNSVFDFPYLLLGVLALFFYVGV
ETVALSSLIDFAKSLSIENAEIYAWISPIGMVIGYISGVILIPKYISQSTALKICSLIAI
IGSILVCITPTDIFFSFFGLQLNLTVSLIILIAIGCSLMWPAIWPLAMDGLGNFTKTGAS
LLTMAIAGGAVIPYVFGWLKDSYGMQNAYWICLPCFLFILYYGMAGHKIGKNKL
>OBAHECAF_02028 Lipoteichoic acid synthase
MKNIRLREYKVLFYRLFLVYLFYFIARVCFYLFNKDLISVDNVSEFFRLAFYGLLFDSAA
IIYINLLFLVLSLFPLWVNTSKKYQKFVFWVYFLTNIPPFLLNFIDIVFFQYNRSRLTLS
AWSLAASEDNKWSLLFGFLVRHWSVFVIFLVCVFTWIYLYKKNKINPQTYSNKWSYFIGS
TVFMFAITPLFLLGIRGMPFKKGTIPLTITDANKFANDLSQVNLILNTPFGIIRTLGKSD
SFRTYNFATEDYIAENIRPIKKYNRKVTKKPNIVLFILEGMGNEYFETFNKDKAITEFKS
YTPFLDSLAQNGLYFTNVYANASRSMEGISAITAGIPTFETPLAYSPHSQQEIASIANIY
REMSYKTAFFHGATNGSMGFSGFTKQIGFEHYFGRTEFNDESQHNGSWGIHDEPFLQYTK
KEIDKMKTPFLATVFTLSSHEPYTIPEKYKGVFNKGDVPMQNAVAYSDYSIRKFFESAKK
SDWFENTIFVFVADHPSTAYYDYYKQKIPYFNVPIIFYSPSKQLIQTGTSDELAQQIDIF
PTLVDLAGYQKPFRSWGRSLFAKEEPHRAYVTNRNFYQLIQGDYIYVADIKGEIVGIYAK
KDWDLKKNLKEILPEETTHKGITDLRAFMQDFMDRILHQKLK
>OBAHECAF_02029 Chorismate synthase
MAANTFGELFRLTTFGESHGTALGGVIDGCPAGITIDFQLIQQELDRRKPGQSSIVTQRK
EPDEVRFLSGIFEGKTTGTSIGFIIENTNQKSQDYNHIKDIFRPSHADYVYQQKYGHRDY
RGGGRSSARETACRVVAGAIAKQVLHQIRFTAFVSSVGELALQTPYTNLDLSLTETNAVR
CPDPELAQQMEDYIKQIRKEGDTVGGTVMCVIQNVPIGLGEPVFDRLDAQLAKAMLSINA
VKGFEYGSGFEGTKLRGSQHNDLFNPDGSTQTNRSGGIQGGISNGMDIYFKVAFKPVATL
MQEQEALDIRGNLIPVQGKGRHDPCVVPRAVPIVEAMAAMVLLDFYLINRGLQFK
>OBAHECAF_02030 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MNRQVITTSDGSTTIHIPEWNENFHSKHGALQEAMHVFIKNGLQLFENRQISILEIGFGT
GLNALVTYIEHQNLRLQVHYEGIEAYPLSWEEAQQMNYTQIIGNEKLDPIFEHIHQSDWE
TNIPITETFTLKKRRQRFETIDDINRFDLIYFDAFGARVQPELWEEIIFEKMHKALKNKA
VLVTYSAKGSVQRAMRQCGFQVEKLAGPPGKREMLRAKKSCR
>OBAHECAF_02031 hypothetical protein
MKIIIHILRLFLGITFIVSGLIKLNDPIGFSFKLEEYFSESVLNLPFFMPFALAIAIFVC
IAEVLLGVMILMGYLKKLTLWATLLMLIFFGFLTFYSAYYDKVTDCGCFGDAIKFTPWQS
FGKDILLLVVTLILFWKQKMIQPIGRKLPFVVTFVSLIGCIVFVYQVYNHLPIKDFRPYK
IGVNIPDAMRIPENAPKAVYDYLWKFNVNGEEKIVTTQGSYPTVDGEFISFETKLVDKGY
EPPIHDFYIEKEGENYLDEMMSKEKLLLVICYKIEKTDRNAFKNIKTITDKALKSGYTVI
GLAYDLNQSEQLIKEYELNFEFYYNDETTLKTMIRSNPGLITIKKGTIIDKKHYNDWEKL
VL
>OBAHECAF_02032 hypothetical protein
MNNTIEQYNQVISECKSLFINKMTDYGSAWRILRLPSLTDQIFIKAQRIRSLQENSVRKI
DEGEISEFIGIINYSVMALIQIEKGVVQQPDLSTQEAIQLYENKVEETRSLMEKKNHDYG
EAWRDMRVSSLTDLILQKLLRVKQIENNQGKTLVSEGIEANYQDMINYAVFALIHLKELK
K
>OBAHECAF_02033 30S ribosomal protein S1
MAEQQQTKEEFLQNFDWAKYQEGIDGVQEDKLKNFEDLVKNNFVDTQDNEVVEGTVVRIT
DREAIIDINAKSEGVISLNEFRYNPNLKVGDKVEVLIDIREDRTGQLVLSHRKARTIKAW
DRVNLAHENGEIVNGFVKSRTKGGMIVDVFGIEAFLPGSQIDVKPIRDYEQFVNKTMEFK
VVKVNHEFKNVVVSHKALIEADIEEQKKEIIGQLEKGQVLEGVVKNVTSYGVFVDLGGVD
GLIHITDLSWSRINHPSEVVELDQKLNVVILDFDDNKSRIQLGLKQLSKHPWDALTDDLK
VGDKVKGKVVVIADYGAFIEVAEGVEGLIHVSEMSWSTHLRSAQDFVNLGDEVEAVVITL
DKEERKMSLGIKQLTSDPWTNIASKYPVGSKHVGTVRNFTNFGVFVELEEGIDGLIYISD
LSWTKKIKHPSEFVNVGDKLDVVVLELDVEGRKLSLGHKQTTENPWDKYEVEFAVGTVHN
GTVSKIVDKGATVDFNEDIVAFIPTRHLEKEDGKKLGKGDVADFKIIEFNKEFKRVVASH
TAIFREEEEKIAKEAAVNTTTNVEKSTLGDLEALQELKDKMEKGK
>OBAHECAF_02034 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MQTFYGKIYSFIHHTMKLSNFNFELPKELLAEYPSENRDEARLMVVHRKTGLIEHKLFKD
VIDYFDDGDVFVLNNTKVFPARLYGNKEKTKAKIEVFLLRELNADQRLWDVLVDPARKIR
IGNKLYFGKDDSLVAEVIDNTTSRGRTLRFLYDGSYEEFRNKLTELGQTPLPKYISRAVE
PEDEERYQTIYAKHEGAVAAPTAGLHFSKHLMKRLEIKGINFAEVTLHVGLGTFSPVEVE
DLSKHKMDSEEMFILEDQTEIINKAKRGKNKVCAVGTTVMRALESSVSSENTVNPYVGWT
NKFIFPPHDFSIADAMITNFHTPKSTLLMMISAFAGHDLIMKAYKEAVQEKYKFYSYGDA
MLIL
>OBAHECAF_02035 Succinyl-diaminopimelate desuccinylase
METVKNYIEENKERFIDELIQLLKIPSISADSAYSQDVINTAEAVKNALEKAGCDTVEIC
DTPGYPIVYGEKIIDPALPTVLVYGHYDVQPADPIDLWHSDPFEPVIKTTEKHPQGAIFA
RGACDDKGQMYMHVKALEYMVKTGNLPCNVKFMIEGEEEVGSESLGWFVKRNHEKLKNDI
ILISDTGMIANDTPSITTGLRGISYVEVEVTGPNRDLHSGLYGGAVANPINILTKMIASL
HDENKRVTIPGFYDKVEELSQEERNEMAKAPFSLENYKKALDIEDVYGEEGYSTNERNSI
RPTLDVNGIWGGYIGEGAKTVIPSKAYAKISMRLVPNQNWEEITQLFKEHFESIAPAGVK
VTVKPHHGGQGYVTPTNSVGYQAAAKAYKQSFGKDPIPVRSGGSIPIVALFEKELGSKSI
LMGFGLDSDAIHSPNEHFGVFNFLKGIETIPWFYHFFAKPNE
>OBAHECAF_02036 Threonylcarbamoyl-AMP synthase
MAEFIRIYNDNPNEKEIAKVVEILREGGLVIYPTDTVYGLGCDITNTKALEKIARFKGIK
LEKANFSFVCADLSNLSDYVKQIDSSTFKILKKALPGPYTFILPGSNNLPKDFKKKKTVG
IRIPDNNIVRIIVERLGNPIVSTSIYDEDDLIEYTTDPELIFEKWQNRVDAVIDGGYGDN
VASTVIDLSGDEPVVVREGKGSVDIF
>OBAHECAF_02037 Trifunctional nucleotide phosphoesterase protein YfkN
MKRRVFIRNVGASSLFVGLGGLSLAMKPDNIKKITILHTNDTHSHIDPQPANAPKNPNRG
GVARRAYLVEQIRRENPNTLLFDAGDIFQGTPYFNFYGGELEFKLMSMMGYNASTIGNHD
FDNGIDGLYAQLPHAKFDFLISNYDFSNTLMDGHTNPYKVYVVDGIRIGVFGLGVKLENL
VSKQNYKETVYLDPLEIALDMERKLKEEEKCDLVICLSHLGYDYVDRKNQIYDLKIAEET
SHIDLIIGGHTHTFLTEPTLVTNKKGNTTLVNQVGCFGIQLGRIDFYFEEGKNTGNKSVS
IEV
>OBAHECAF_02038 hypothetical protein
MKRFTFLLCIAFLSITFGQEKIKVTSVYGSENKEVQVLLDFENIYIQTLTFHGTTIKGKH
YEVTISEYENGNLVRTETLFDGSESDYFRNQSNTLPLTFFFKMADGKFKGFLRGERFGSK
KVYFDLKSESDMYVLKDFFGSSNEWFFTSDTNKTTAIFAIITPKINPDGSGSYCEVAQSD
IAPERFGTHFLIPHYFLVSIRFKEK
>OBAHECAF_02039 Long-chain-fatty-acid--CoA ligase FadD15
MNEVTRLFDIPYYQLKNFPLEDAFVTKYDGKWEKTSTETYIQKINQVSRGLLRLGVEKDD
KIAVISSNNRTEWHVLDMGILQIGAQNVPVYPTISLEDYEYIFNHAECKYCFVSDKQLLD
KITSIQDKLPHLKGIYTFDTVPYAHSWKEILNLGVDESNQPEVENYKKQIHGTDLATIIY
TSGTTDRPKGVMLSHKNIISNVLNCEDRLPIKAGSRCLSFLPVCHIFERMLTYFYQYNFM
RIHFAESIEKMGENIKEVKPHLMTVVPRLLEKVYDKIYTKGTELSGIKKKLFFWALDLGF
AYKPYGANGFWYGFKLGIARKLIFKKWQEALGGELQLIVSGSAALQNRLNRVFCAAGLNI
VEGYGLTETSPVISVNRKSGKYLKIGTVGKPINNVEVKIAEDGEILCKGDNVMLGYFKDP
QMTAQAIVDGYFHTGDIGELDKEGFLKITDRKKEIFKTSGGKYITPQRIESLLKQSRFIE
QAMVVGEGEKMPAAIIQLNFPFVKEWAKRRGINLESSNEQIIANKKLFDRIRKEVERANE
NLGQWEKIKVFGLTPDEWSIDAGHLTPTLKLKRRIIKEKYSELYKSFYA
>OBAHECAF_02040 Riboflavin biosynthesis protein RibF
MKEITDISKFKASKGSVITIGTFDGVHLGHQKIIRKLVEEANQRDWYSTIFTFFPHPRMV
VQHCNDLKLIYTLEEKSQKLSTLGIDQLITHPFDEKFSQMSAREFVEEFLVKTLNMKKVV
IGYDHRFGRNRTADIDDMRQFGVQYGFEVEEISAKEINEVSVSSTKIREALAQGDVKKAW
DYLGSPFLITGQVVHGMKLGREIGFPTANIQVDFPYKLIPKDGIYIVYSIISGKKIYGMM
SIGKNPTIPGKEPSMEVFFFDFDKDIYGETLQIYFLQYHRTEQKFDSIEALKAQLQQDEI
ISRKFISTLKDF
>OBAHECAF_02041 3-ketoacyl-CoA thiolase
MKATYIVKAYRTAVGKAPRGLLRFKRPDELAAETIAYMISQMTDFDKTMIDDVIVGSAVP
EAEQGLNVGRIISLMGLQTDQVPGMTINRYCASGLESVAIAMAKIQSGMADCIIAGGVES
MSYIPFGGYRPSPDYKSVMQGNEDFYWGMGLTAEKVACQFNISREDQDMFAFQSHQKAVK
ALTEKRFEGQIAPIQVEEVLLRNGIRTARTYTFKTDEGPRSDTSLEALAKLKPVFAKGGS
VTAGNSSQTSDGAAFLLLMSEELVKKLNINPIARLITYAVAGVPPSIMGIGPVKAIPKAL
KQSGLQLSGIQMIELNEAFAAQTLAVIRELDLNPEIINVNGGAIALGHPLGCTGAKLSVQ
LFDEMKRRNQKYGMVSMCVGTGQGAAGIFEVF
>OBAHECAF_02042 D-cysteine desulfhydrase
MMDIFSDITIENQQVNLHLPNGISLYLKREDKNHPFVSGNKLRKLKYNILEAKKQQKNTL
LTFGGAYSNHIAATAAAGQLMGLKTIGVIRGEELCDKIHENPTLRFAQRCGMEFRFVTRT
EYRLKDSLEFLNNLLHNYGTDVYVLPEGGTNILAVQGCQEILISDDASFDVICTAVGTGG
TMAGLINSSFPHQKVLGFPALKGKFLEEVIKKYVSKNNWKLIHDYHFGGYAKINDDLIRF
LNNFNEKTNISLDPIYVGKMIFAIFALANQGYFEPNTKILAIHTGGLQGIAGFNERRLRK
SKEILNYV
>OBAHECAF_02043 Exo-glucosaminidase LytG
MFKKILFLLAFLSILASCSSRYYKNPKNPKKITHRGQRPMPKNIDKKTRELVNEKLKKYE
SSEEIYHEIPPAMPVTTAVTLKYIEDYKEISMVEMQRYRIPASITLAQGILESASGQGRL
ARYGNNHFGIKCHSAWKGKTITHDDDEKGECFRRYKYAFESFEDHSQFLVNRSRYASLFT
LAINDYEKWAHGLKKAGYATDPQYAQKLIAIIKRYKLYEYDNLVIKADNQGIAITDALRT
QQTQKDSVKAVEPVVEPVETFAKPSTEGSPVYYVVQAGDTLYKISREQKVPVNQIMKLNN
LNDITSNNLQVGQELRLN
>OBAHECAF_02044 Release factor glutamine methyltransferase
MNFRQLKEYLVYKLSEKYESRELQSLYFLLLEFYTNSSRTEVHLYPDKDFSVDEKQRILT
AIDELFIEKPIQYIFGETFFFGNRFFVNEDVLIPRQETEELVAWILDETSENQQYNILDI
GCGSGCISISIAKERPASKISALDISQKALSIAQKNAIENGVSVRFIHQDILQTDTLLHT
YDIIVSNPPYVRNLEKQEMKQNVLGYEPHLALFVSDENPLIFYEKIADLAQKSLAPQGKL
FFEINQYLGIETVNMLYAKGFSEVELRNDLHGNPRMIKAML
>OBAHECAF_02045 N-acetylmuramic acid 6-phosphate etherase
MSLYRKITEETSAYDNLEEMDVNSLLHNMNNEDRKVPEMVALAIPQIEKLVTALIPRFEQ
GGRLFYIGAGTSGRLGILDASEIPPTYGMPHDRIIGLIAGGDSAIRKAVEFAEDDPLQAW
KDIIPYSPTPNDCVIGIAASGSTPYVIGGVREARKNGLLTACIINNPNAPLSKEVDIPIE
INVGAEFVTGSTRMKSGTSQKLVLNMISTALMIKIGRVKGNKMVNMQLNNHKLVDRGIRF
VMDELQIDYPIAEQLLKENGSVKKAIDAYRKQLY
>OBAHECAF_02046 hypothetical protein
MAIRLTNGCVNCQNLQENNVCSVHHTKVEAKYTCDSFDMTVAAKDAISCGTCVRFKTAQC
AHPAKASAEMLCSSWAPGAKA
>OBAHECAF_02047 Methionine--tRNA ligase
MAKRITITAALPYTNGPIHIGHLAGVYVPSDIYARYQRLKNNDVAFICGSDEHGVAISIK
AKKEGITPQEVIDKYHAIIKQSFEDFGISFDNYSRTSLPIHHKTAADFFKKLYDQNDFIE
EVSQQLYDEKAQQFLADRFVIGTCPKCNNPEAYGDQCEKCGSSLNATDLINPKSSITGTT
PTMRETKHWFLPLNKYQKFIEEWILKGHKKDWKPNVYGQVKSWLDDELKPRAVTRDLDWG
IPVPVEGAEGKVLYVWFDAPIGYISSTIEWAEREGKDWKPYWKDKDTKLVHFIGKDNIVF
HCIIFPAMLKAEGSYILPENVPANEFLNLEGDKLSTSKNWAVWLHEYLQDFPNQQDVLRY
VLTANAPETKDNDFTWKDFQARNNNELVAIYGNFINRVMVLTQKYYNGNVPTPNEFSNTD
LQVLATLKEFPNIISNSLESYRFREASQELMNLARLGNKYLADEEPWKLIKENPERVKTQ
MYIALQVAGALAVLSEPFLPFTAEKLCNMLNFNNLQTKPTWNSIEIDQHIIPANHTLGKS
ALLFEKIEDDAVEKQLARLEATKSANKAQVVGNIEPQKELISYEDFAKMDIRIGTILEAE
KMPKADKLLILKVDTGIDVRTIVSGIATSFNPQDIIGKKVTVLVNLAPRKLRGIESQGMI
LMVENTTGQFVFLNPDADQISNGTPVK
>OBAHECAF_02048 Queuine tRNA-ribosyltransferase
MQFELLKTDEKTKARAGKITTDHGVIETPIFMPVGTVASVKGVHQRELKEDINPDIILGN
TYHLYLRPQTAILEKAGGLHKFMNWDRNILTDSGGYQVYSLAANRKIKEEGVKFKSHIDG
SYHFFSPENVMEIQRSIGADIIMAFDECTPYPCDYQYAKRSLAMTHRWLDRCISHLEKVP
PKYGYSQSLFPIVQGSVYKDLRQQSAEYIASKGADGNAIGGLSVGEPAEEMYAMTEVVCD
ILPKDKPRYLMGVGTPINILENISLGVDMFDCVMPTRNARNGMLFTSQGVINIKNKKWED
DFSPIDPDGHTFVDVQYTKAYLRHLFAANEYLGKQIASIHNLGFYLWLVREARRRILAGD
FSIWKEQMIRQMSTRL
>OBAHECAF_02049 Lipopolysaccharide export system permease protein LptG
MKILDWYILKRYLATFFTLIILFIPIGIVVDLSEKVDKMISRNAPIDEILIYYASFTIYF
ANILFPIFLFLSIIWFTSKLANNTEIIAILGSGISFNRFLKPYLIGATIISIIVFFMGMF
ITPAASKIYNEFYDKYLGSKNTTSVTDLYNQFSENDYLYVSSFNYETKTGYNFSVEHFDG
VHLKHKIMAQSIKWIENDSVKTYRLTDYVKRTLTEQGDILEKRYELDTLFAFTIDDLMPV
EYAAESKNIFELDKFIEREKMKGSPNINLYLLTKYRRWGLMFTAFILTFIGVAVSSVKRR
GGMGANLAFGIAIGFIFIFFDRVFGTLAETSGISPLTAVIIPNAIFLALALYLLRTIKH
>OBAHECAF_02050 Rod shape-determining protein MreB
MGFFDFLTEEIAIDLGTANTLIIHNDKVVVDSPSIVAQDRTTSKIIAVGKEARLMQGKTH
PNIKTIRPLKDGVIADFDASEQMISMLIRSIPALKKRFFSPSLRMVVCIPSGITEVETRA
VRESCERVNGKDIYLIHEPMAAAIGIGLDIMQPKGNMIIDIGGGTTEIAVIALGGIVCDK
SVKIAGDIFNSDIVHYMRTQHNLYVGESTAENIKITIGAATEDLESPPDDLSVQGRDLLT
GKPKQVQVSYREMVKALDKSILRIEDSIMETLSQTPPELAADIYNTGIYMAGGGAMLRGL
DKRISLKTDLPVYVAEDPLRAVVRGTGITLKNINKFRSILLK
>OBAHECAF_02051 Cell shape-determining protein MreC
MFLLLFSFSISLIFRDNFYPQSKFINSANAVSGTFYRFTNYWRQYFDLRTQNEMLSEENR
ELRRQLLAMQQYESRYVFMDSLQFFDSLKYEVRKANVIRNSFLHSKNYMTIDRGAKDGIT
QDMGVISSKGIVGIIENTGNRFSTVQSVLNTKSALNAMVKNSGHFGSLKWNGDRINVVQL
VDIPNIAPIQEGDTVITGGMSNIFPKGIPVGKIVAINRSQMDNSYVIDVELFTDMAKIDF
VYIIENKDKQEIHNLENQISYE
>OBAHECAF_02052 hypothetical protein
MNNIFIKNTVLFVVLLLLQVLIFNNISYWGYVNPMVYLLFIILSPYRENRVPFLFASFLL
GLCVDIFSNTGGLHAASSVFVAYFRSGILTLVFGKNLDYQEIKLQQHPFTKVLVYVVLLV
ILHHILFYFLEIFNFNHLLTTFARIGVASFFTTVVCLLFIYIFSNTKK
>OBAHECAF_02053 Peptidoglycan D,D-transpeptidase MrdA
MRKYLLFFAIILTGIIFSLRLIYLQVIAFNEDARPDADVAIEVVYDYPERGYIYDRNGEL
LVSNQPAYDVMVIPNEVRRIDTLELCNLLSINKEVFEERLKKAKKYSYRKPSVLVNQLSK
ADYAVLQEKLRKFDGFYIQKRALRHYLTHNAGNVLGYISEVNEWELKENSYYLSGELIGR
QGVEKQYETFLRGEKGVRYFQKDRHNRQISSYKNGALDTLPVMGQALQLTIDIHLQAYGE
QLMQNKRGGVVAIEPQTGEILALVSAPSFDPNLLVGRQRSKNYTALYQDSIAKPLYDRAL
LAEYPPASPFKVVNALIALQEGVIDPNTRFSCGGGYHYGNRVMRCHCGRSSNDLYHGIAF
SCNSYFANSYRRSIEKYPKTAIGMDAWANHLKSFGLGGFLGSDFPIGRPGKVPDASVYDR
AYGVGRWTSSNNVSNSIGQGELLTTPIQLANVMAIVANRGYFYTPHIVKKINGQVTPFEQ
FTKPKHTTIDEKHFEPIIQGMNMTYNYGTARGTVIEGVDVAAKTGTAENFIRINGVRTKL
EDHSIFVAFAPLENPKIAIAVFVENGSFGSRIAGPVASLMIEKYLNGEVKRTDLEKRMFE
RSLESEYAKQLKKD
>OBAHECAF_02054 hypothetical protein
MKGFPFFKRNQRIGIFLLLLLIVLIQIAYFVVDFSEKTSERSSQLFANIEKQVDSLRTVA
LRPQKDTIYPFNPNYITDYKGYILGMSTEEIDRLLAFRKQGKFVNSTQEFQNITKISDSL
LKKIAPAFKFPEWVNNKKSNDYQKVKTSLTSSHKEKQDINTATKEQLMEVKGVGNVLSDR
ILKYKERLQGFVEMDQLAEVYGLETDVVERLKIQFEVKTLPNIVKKDINLITLSELAKIP
YLKYEEAKKIIGLRSELGNFKKFDDLLEINEFDTLKIRKLQFYLFIED
>OBAHECAF_02055 Acyl-CoA dehydrogenase
MNFSYSETQKIVAETARDFSEKYIRPNVMKWDESQEFPVEVFRKAGEMGFMGILVPEVYG
GSGLDYHQYIAIVEEISKVDPSIGLSIAAHNSLCTNHILSFGNEEQKRKWLPKLASGEWI
GAWGITEHNTGSDAGGMSTTAVRDGDFWVLNGAKNFITHGKSGQIAVVIARTGEKGDKHG
ITAFVVERGTPGFSSGKKENKLGMRASETAEIIFQDCRIPDSNRLGEVGEGFIQAMKILD
GGRISIGALSLGIAKGAYEASVKYAKERMQFGQRLIDFQSIAFKIADMATEIEASELLLH
KAAYLKNTNQKVTQQGAMAKMYASEVCVKVSTEAIQIHGGYGYTKDFPVEKFFRDSKLCT
IGEGTTEIQKLVISRNIDKA
>OBAHECAF_02056 Mycothiol acetyltransferase
MIRFAIKNDADFVAPLMFQAMEEIVFKLIGKEDKTQAISFLKTLFLEERNQYSYTNTIVF
EENSQAIGSLVFYDGADLHELRKPVLTLSEQISGRKIIVEDETSEGEIYIDTVSVSPQGQ
GKGIGSQLITFLKEYVSKHKLGKIGLLVDEKNPQAEKLYTRLGFEYVNKQSLAGGSYKHL
VFETHK
>OBAHECAF_02057 UvrABC system protein B
MQFSIQSDFQPTGDQPQAIKQLTQSIEKGEKYQVLLGVTGSGKTFTVANVVQNVQRPTLV
LAHNKTLAAQLYSEFKAFFPNNAVEYFVSYYDYYQPEAYIPTTGTYIEKDLSINEEIEKL
RLSATSSLLSGRRDVLVVASVSCLYGIGNPIEFQKNVITIKRGEVLPRTKFMHRLVQSLY
ARTTADFIHGNFRVKGDVVDVYPGYSDTPFRIHFFGDEIEEIEVFDPQTNKVLERYDSLN
IYPANMFVTSPDVLQKAIWNIQQDLTKQVEYFKEIGKHLEAKRLEERTNFDLEMIRELGY
CSGIENYSRYLDGREPGSRPFCLLDYFPDDFLMVIDESHVTIPQVHAMYGGDRSRKENLV
EYGFRLPAALDNRPLKFEEFEALQNQVIYVSATPADYELQKTQGVYVEQIIRPTGLLDPE
IEIRPSENQIDDLAEEIQLRVEKDERVLVTTLTKRMAEELTKYLTKIGVRCRYIHSDVDT
LERVEIMQDLRRGLFDVLVGVNLLREGLDLPEVSLVAILDADKEGFLRSTRSLTQTVGRA
ARNVNGKAIMYADKITQSMQVTIDDTNYRREKQMNYNFRNGITPKPLNKKIENTLSKSPI
TEFHYDPSFKHVAEAENSYMTEKERTKKIKELKKQMESAAKELDFVKAAQLRDKIKELET
I
>OBAHECAF_02058 Orotate phosphoribosyltransferase
MVLNSNTAQKTAEFLLQIKAIKLNSENSFTWASGWKSPIYCDNRIILSYTEVRNFVASQM
AEQIKEKFPTTEVVAGVATGAIGIGMLVANLLGLPFIYVRPEPKKHGRQNQIEGLLEANQ
NVIVIEDLISTGMSSLNAVKALKDSQANVLGMIAIFSYGFDLAHTNFANEKVELYTLSDY
ENLLTQALKVGYITKDELHTLKEWRQNPSQWRQ
>OBAHECAF_02059 Diadenosine hexaphosphate hydrolase
MYEIFVNNKSIVLTSVEQTNVGENNKNVKYFSLKKEITIEFLISEINKEEVDKIYLYHPK
EEKLLKKFKKKVTTIKAGGGIVTNAKGEILFIKRQGKWDLPKGKKEKGENIVVCALREVE
EETGVKKMKIIRFNTITYHIFKHDGAYFMKETYWYDMFTKYKGKLKPQTEEDIEKVRWKA
LSEIPELLNNSYRSIQKIFEGIGENKE
>OBAHECAF_02060 Apolipoprotein N-acyltransferase
MKRNILLALLSGVLLAISWPTYGFAMLIFIAFVPLLFAEQHIRKNYKHTKRKLFFVSYLS
FLVWNVITTWWIWHSTQGGAVFAILANTLLMTIVFMLYHIVAKRMVRKVAYIFLVAIWLS
FEKFHLSWDISWTWLNLGNVFSEYPAWVQWYEYTGTFGGTLWVWLVNIILFLYVNAFFET
KNRKILAKGVGISVLCFAVPVIFSYFTYINYKEDENPIDVIVLQPNVDPYYEKYQISNPE
IANLLVKLSEDKIDHNVNFIVTPETVFGDNIGLNQLQQSWEISILRQMVAQYPKLNIVGG
VAMIDFIQDESLLTPQSNYLEKHNVWYNDYNSAFLLNKNADIPLYHKSKLVVGVENFPYQ
SVLKPIFGETLIDLGGTVALKTTQPHRSVFYGEQTKGKAAPIICYESIYGEFVTDYVKNG
ANFLAILTNDAWWQNTQGHKQLLSYARLRAIETRRSIARSANTGISAFINQRGDVLNSLP
YDTQGSLRGTINLNEKITFYTKTGDYLARISYFLSLFVFLYAIARKREVIFRN
>OBAHECAF_02061 hypothetical protein
MKKQNSALYKGSLSTIIMKLLQDNGRMYGYEITQKVKQLSQGEIAITEGALYPTLHKLEA
QGLLTPEIEQVDNRIRKYYKITESGIKETEKQVSEIQNFIACLQNIINPQGDTDLVPVVK
L
>OBAHECAF_02062 hypothetical protein
MKTITPKQIERLYEFTHQCQVKYFDVQTELVDHLANAIETHWQKFPDDDFEIVLIQEAQK
FGTFGFKEITEEKEKQLRKRYKNIIWKEIIAFFSFPKIIMTIILTMSLFILLNLSSDKGT
VVNVLFMSTYLTIISFFIQQYIRKKRQNQNDKKWILKDIIFNNSWCVSLLVIILNTLSMA
NIHHTEHIENKYFISIFSFVIVLIYIFCYLVLFHIPFKSEKYLTETYKEYKVAKLTS
>OBAHECAF_02063 hypothetical protein
MKTITPKQIERLYEFTRQHYVEYFDVQTELVDHLANAIETHWQEFPDDDFETALQKEFRK
FGVFGFNDIVEEKTKQMEKLYKRVLWKKKIEFFTFPKILLTLFISAVIYTLLSAFNTMWI
PFLGIIITFYIFKGIIYLKTKSIYKRKSNKQWLFKNIFLYQDNYPLLLHTSMYIILYYWL
FIQKQHIPILFIVVGFTLQFIYTYIISYHIPKNSDCYFLEMFPEYKFELSN
>OBAHECAF_02064 hypothetical protein
MKKVTPKQIERLYEFTRQHYVEYYDVQTELVDHLANAIETHWQEFPDDDFETALQKEFRK
FGVFGFMDVVEHKTKEMNKRYSKILWQKIKDFFTFPKIMMTLCIALVVYTVLYFFKDIAA
EIVGSMTLIILFFIYAFLLSKPKLYQNKTDKKWLFENVLLGYNNYVGALGLLAQLHFFIR
YLGENIAFMAVFSMLITFLGISVYLVFYYLPKNRDKYLMELYPEYKDFMITT
>OBAHECAF_02065 hypothetical protein
MKKVTPKQIERLYEFTRQHYVEYYDVQTELVDHLANAIETHWQEFPDDDFETALQKEFRK
FGVFGFMDVLEEKTKQMSKRYNRMLWKKTKELFVISKIILIFCIVISIFSLFTLFGNAKI
MVPALSLAIFIAAIVFMVKNRRTLKQKGDKKWLFEDIILRLNDYTFFFFFPCQMSLQFWR
DFPDSEMAYMIYSAVFTFLLVLMYVLMVYFPKHRDKYLQELYSEYKTQYIK
>OBAHECAF_02066 Signal recognition particle receptor FtsY
MAMNFFKKIFSSEKKETLDKGLEKSKVSFFDKLGRAIAGKSKVDDDVLDELEGILVSSDL
GVSTTLKVIERIEKRVARDKYLGTNELNRILREEIAGLLSGTNSGEDTDFVIPVDKKPYV
MMVVGVNGAGKTTTIGKLAYQFKKKGYKVMLGAADTFRAAAIDQLQVWADRVGVPIVKQQ
TGSDPASVAYDTLASAVAQDVDVVIIDTAGRLHNKINLMNELTKVKRVMQKVIADAPHDV
LLVLDGSTGQNAFEQAKQFTKATEVSALAVTKLDGTAKGGVVIGISDEFQIPVKYIGVGE
GIEHLQVFNKYEFVDSFFKD
>OBAHECAF_02067 ATP-dependent helicase/nuclease subunit A
MQSSYTIYNASAGSGKTYGLVKAYLKIILSDEKIDSFRRLLAITFTNKAVFEMKDRVIEM
LTEFSDIKSLTEANSMFEELRQELKIAPEKLRSRSESVLKHILHNYAAFNISTIDGFNHQ
LIRNFAFDLQLNQFFEVQLDQKTILRTAVDNLMSRAGEDAEITQLLIDFSEDKMKEDKNW
DTTKELLEVAEMLTKENHYTALKELKEKTLSDFIALKKILQQKLSQSIETIRQITTDFFT
LLNENDLDENIFSGKYMFNFFKKIQNDPKREPVWGANWQLNLETKPLYAESNKKGLNTAL
IDSLQPKFVRQFKTVQQQFGEYNFVKNALQYVVPLALLNRIQNEIELIKQEENILPIWEF
NSVISNEITKQTIPFIYERIGERFQHYFIDEFQDTSELQWNNLKELISNVVSSEDMNQQQ
GSVLLVGDAKQSIYRWRGSKAEQFMDLYLNKKQPFTIGGIVVNLEENYRSLETIIDFNNK
FFKFTSTFFESEEYQNLYVNATQNYPEYKRNNKNFPIGYVDIRFVDVEQEEENYEEENIA
DELGYTPRELTYCKEVWETVKHANESGAKDEDITILVRKKREGLALASYLSAQGKKIISP
DSLLLKNVPSIRFLISLLRAAQNPDSKELKVNMLFDFISVKNTADVHNFITEYIDQPIDS
FFEKYGFSLAQFNGYSLYEGMALAVNRFDLANDSDAYIASFLDIIFEFKNTNKGGISDFL
LYWEENQDALSISSPEGLDAISIMTVHKSKGLSAPVIIYAFADSELVDTKKDTLWYPVDA
EIFGGFSHLLVRFNKGIINFETQSQEIINQHNEQNKLDQINVLYVAMTRPESFLYVITAL
PKSPKKQTYGTLLKEFAGLHISLLNENEKIQCNVNENQSHYTFGSPIFPQRKKQKQIGSD
GFIKFQKDWKTPNYKIATGASLLWDTTRKEAIERGNLMHKLLAEIKYKSDIQKVLEKNLQ
NGTISQAQHELIEKQLIELLQRKEIQPYFTDRYTHYIEREFVDSNGNYFRPDRIAYSTEE
KIAVIIDYKTGKPNEKDIQQMSYYANNLSLLGWNITQKILVYLNTSEIIFG
>OBAHECAF_02068 Thymidylate synthase 2
MQQYHDLLRHILEHGHKKEDRTGTGTISVFGYQMRFDLSKGFPVVTTKKLHLKSIIHELL
WFLKGDTNIKYLSDNGVRIWNEWADENGDLGPVYGHQWRNWNNEDIDQIKQVIETIKKNP
DSRRIIVAAWNPSVLPDTSKSFCENVANGKAALPPCHAFFQFYVADGKLSCQLYQRSADV
FLGVPFNIASYALLTIMVAQVCKLEVGEFVHTFGDVHIYNNHLEQVKLQLSREPRPLPIM
KLNPEVTDLFSFKYEDFTLEGYDPYPAIKGEVSV
>OBAHECAF_02069 scyllo-inositol 2-dehydrogenase (NADP(+))
MNKIINVGLASFGMSGRLFHAPFVANHPLFRLQAVVERHKNNSREKYSQSKLYRSFDELL
HDEIIDLIVINTPVQTHYEYTKKALELGKNVLVEKPFTVTSDQAKELQQLADSNDCFLSV
YQNRRYDGDYLKVKEIIESGALGTIKEVEIRFDRFRTSISEKIHKEAPIAGSGALHDLGA
HLIDQALQLFGYPKFIYADLGFLREKTQTNDYFELILFYEKELRVRLKSSTISKEKGWEY
IAHGDRGSFLQQRFDAQEDMLSKGITPTTENWLPKVQYPNGILHTSTVYEQTVAQHGNYM
NFYQNVYESMVYGKSNPVPANQAVQTMSVIDKAIESFSQGRKISL
>OBAHECAF_02070 hypothetical protein
MFQGVLQKMMTEMANPVRYYLQLENDFLSVNSLLNQQIKIELSHFQCLSCGNNEPIFRQG
FCKKCFFEIPQAADWIMHPELSKAHLDIEDRDLDYEKQMQLQPHYVYLANSSKVKVGVTR
HSQVPTRWIDQGAHEALVIAELPNRYLAGITEVALKEHVSDKTDWRKMLTNTLEDIDLKE
IRNQLFTFFPKETKSYFIDNGEEVHIQFPVEQFPQKVHSLNLINTPVYNGVLKGIKGQYL
IFEDGTVFNVRGNEGYYVKFSM
>OBAHECAF_02071 hypothetical protein
MPLALFNSITSWFLRRRIDQIQQFVNNPHQTQERVLAELLNAAKDTEIGKKYGFSEIENY
QQFVQNTPLVTYEEFEPYIDRARKGERNVLWHSPIKWFAKSSGTTNAKSKFIPVSEEALQ
DCHYKSGKDMLCLYLNNNENSNLFTGKSLRLGGSKELYQENGTYFGDLSAILIENLPFWA
EFSSTPSNKVSLMSEWETKLQAIVKEAKNANVTSMAGVPSWMLVLLNRVLEETGKNNLLE
IWKNLEVYFHGGVSFVPYREQYKKIIPSDTFRYYEIYNASEGFFGIQDRNNSDELLLMLD
YGVFYEFIPMDTFGTNQQKVIPLSEVELGKNYAMVITTNAGLWRYIIGDTIRFTSVSPYR
IKITGRTKHFINVFGEELIIENTEKGLKKACELTNSHVKDYTVAPIFMKDKLKGGHEWII
EFDKEPLNIEKFTEILDEELKKVNSDYEAKRYNNMTLNMPTVHVARQNLFHDWLKNKGKL
GGQNKVPRLSNSREHLEELLKFM
>OBAHECAF_02072 Lipoprotein signal peptidase
MKLKHAIFIILAILIIDQVSKIYIKTNFILNESVDVFSWFKIYFIENNGAAWGAEIPGVY
GKLALTLFRIFAVFGIGYWLISSIKKQRHPILIISISMILAGALGNIIDSVFYGVIFDHS
YNNVATLFSEQPYGTWFHGKVVDMFYFPLIDTTLPEWLPIWGGNRFQFFEPVFNVADSAI
CVAVGLLLMFNKKAFPKEEKITEQT
>OBAHECAF_02073 hypothetical protein
MSIITNILKNNEHRPYPLPKGNWTYYQEWNRALFLHYKVPYELLRQIVPTGLQLDSYNND
CYISLVAFTMEKIRPKQLPAISFISDFHEINIRTYVEKDGKKGVYFLNIEAGKLLSAIVA
KCLSGLPYEFATIKRADNQYNSENKKKNFHLDVSFDIEEVILEKTPLDLWLTERYCLFLD
IKESLFRYDIHHQEWNLRGLKINKLNVNYHLKNISLSPNYHLCHYSDGTQVISWNRVKL
>OBAHECAF_02074 hypothetical protein
MKVKSILVSQPEPKAENSPYAHIIENQRVKIDFIPFIKVEGVSAKDIRLQKIDLTKFSAI
ILTSRKSVDHYFRIAEEMRFKVPDTMKYFCQSEAIAFYLQKYITYRKRKIYVGKKEFSDL
LPILKKYKEENFLFPGSDTCKAELATALNDLKIKWERAIFYRTVHSDLSGISNFNYDILA
FFSPAGIESLFKNFPNFTQNNTKIAVYGDSTLKAAQEAGLVIDIKAPSPETPSMTMALEQ
YISKVNGKK
>OBAHECAF_02075 hypothetical protein
MKMVYPNHFSEYVKLPLNDKYIVIYEKKERKIHLFTFFLFFLQWFSLSLFFYVCGQIYDL
QFPVSTGFLFLDIAVLLLLLLGLKLVVQTSIAQVFELRGFSKGYMFSRIAYSSYGAILVV
VVLFFILYAVSLEKKYIYLLFGILLIINVLGWISIVKSNQKMIKPYIIYFILYLCTLEIA
PYVFFIYGIRFL
>OBAHECAF_02076 hypothetical protein
MKIRLYILIILCFSVLSCGENIVKKPQKFLSEREMQNLMYDLILLDAIKSTDYTMMDTLN
ISFQELIYKKYEIDSLILAQNMEYYASFPQKYDTIIKNVELRLKRERDSIIPEIDATSVT
PLEVD
>OBAHECAF_02077 Allantoinase
MGFNFEYKTICNSTTQMKTLIKDVHIINENQVIRGDILIEGERIAKIAPNITAENGYTVI
EGKGHYLLPGVIDDQVHFREPGLTHKANIASESAAAVAGGVTTFFEQPNTVPQTTTIDLL
EEKFEIASKTSFANFSFFLGGTNDNLEELKRLDRKACVGIKLFLGSSTGNMLVDNEQTIE
RIFSNVDMVIATHCEDEQTIRHNMERYSQQFGYQIPIQVHPLIRSHEACYLSSSKAVSLA
QKTGARLHVFHLSTAKETHLFRNDIPLKDKKITAEVCVHHLWFSDADYDQKGSLIKWNPA
VKTANDRESLWEALLDDRLDVIATDHAPHTLEEKQNQEYHKIPSGGPLVQHSLVAMLEQY
HKGRISIQKIVEKMCHNPAILFEVKDRGFIREGYYADLVLVDLNSPWKVTSENILYKCGW
SPFTDSVFKSKIRTTFVNGKMVYNDGIIIGEAAGKRVTFNR
>OBAHECAF_02078 hypothetical protein
MKKIIYIFISLCLLTACNETDNNQKSAKNLHLPQSIGQLNSLAVVIDNTLWEGFVGDTIR
KYFASPLEGLPTEEPIFLLHQIPPQIFTDNTRNSRNVLIISQDSLNKSFVKENLYARPQK
VGVIKGKTKRDISCEIQEHFAKMIEEFRDNDIKEAQSRFQKSLNKETALQEKLGFSLTMP
SVYKIVKQENNFFWIERQIKGGTSNLIVYEMPINSIPKDNSRAETIVRMRDSIGERYIPG
RKEGMYMITETSFAPSITDMKIKNRNAMESRGLWEMKNFFLGGPYLNYIIEDVPNNRLVV
LEGFILAPRIEKRDYLFELEAIVKSIEFAK
>OBAHECAF_02079 Esterase YbfF
MNVLHSQIIGEGKPLFILHGFLGVSDNWRTLGIKYAEAGYEVHLIDQRNHGHSFHHQEFS
YSILTEDLRHYAQVKNIALFDLIGHSMGGKTAMLFATEYPNMVDSVIVADIAPKFYPPHH
QQILQGLASIDFEVVKSRSEADKQLSFYVSQADVRQFLLKNLFWKTKDQLDFRFNLEALM
ENEYEIGVELPKNNTFDGKILFLKGEFSEYVMPSDEPLIKQHFPNAKIEMVSKSGHWLHA
QNPDEFFQKTMAFLNQ
>OBAHECAF_02080 Lysine--tRNA ligase, heat inducible
MQLSEQEIIRREKLDKLKELGINPYPAELYPVDTTSADVKSGFQEGKKVTLAGRLMSVRI
QGKASFASLQDSQGRVQLYINRDEICPDEDKTLYNEVFKKLLDLGDFIGVEGELFLTQVG
EKSVRVKNFKLLSKVLRPLPLPKTDADGNTFDAFTDPELRYRMRYVDLVVNPQVKEVFIK
RTKLFNAMRQFFNERGYMEVETPVLQSIPGGAAARPFITHHNSLDIPLYMRIANELYLKR
LIVGGFDGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYHWMMEFTEQLLEHCAIAVN
GSTKATFGKHEIDFKAPYPRVTMTEAIQKFTGFDITGKTEKELFDFAKSIGIEVDDTMGK
GKLIDEIFGEKCEGNFIQPTFITDYPKEMSPLTKEHRNDPNLTERFELMVCGKEIANAYS
ELNDPIDQRERFEAQMALSERGDDEAMFIDQDFLRALEFGMPPTSGLGIGMDRLIMFLTN
NESIQEVLFFPQMKPEAKAAQTVELNEDEKMVFEILQKAEVLPLEELKAQSGLSNKKWDK
TIKGLTSKKVASVEKQGDNLLVKLV
>OBAHECAF_02081 hypothetical protein
MKHSILFCLLISFFIFGCEKKEDREEFCKILIDFDKIENVDLSQHIERKVCFEFSEESML
GNLDEIVLNGQGFLIRSLSNLFLFDEQGRFLSQIGSKGAAPDEYSNFNSFFIKGDDVFIY
DDQTKRMIIYDFQGRYKSTINLNDRYDSITPNFIYPLSDGKFISKNMYGGSHRKTPSYSI
LKEDYSIEKNIKNRWLAHSFFSLNNFNVGDGKNMLFWEILNDTIFTITEKQECFPKYIVD
FQEKSIPLDVKKKEFYELIQFTNQPENINKYASLVQNVYEDSDFLRFTFLFQRKIHYVKH
DRNNNKTKVYLLTYDNQNLGSRILFHKNHLYVPVNDLDSIESNGCLILIDESKL
>OBAHECAF_02082 Citrate synthase 1
MAETAKLVFDGKEYEFPVITGTENEKAIDIEKLRALTGLITLDSGYKNTGACKSAITFLD
GEKGILRYRGYNIEELAEKADFLEVAYLLIFGDLPTKAEYEKFITTIHKYTMIHEEMKGI
LDGFPKTAHPMGVLSSVISALVAFNPKAVDVSCEKDVYEAVCKVMAKIPVLASWVYRKRE
GLPLNYYNNDMEYIDNILNMMFAIPTNKYKVNPRVASALNKLLILHGDHEQNCSTSTVRL
VGSSHAGLFATISSGVSALWGPLHGGANQAVVEMLEDIKADGGDVEKYIRKAKDKDDPFR
LMGFGHRVYKNFDPRAKIIKAAADDVLNSLGIDDPIFDIAKHLEKVALEDEYFKSRNLYP
NVDFYSGIIYRALGMHVEMFTVLFAIGRLPGWIAQWKEMRQGGEPIGRPRQVYVGSTERP
FVEISKR
>OBAHECAF_02083 hypothetical protein
MKKITSSDFQLIKLTVWLILVIFSFDAIRMLFEFISPLIFSRENNTSSWGRKLMFFQNYP
IYYGIIVFFELIIAFSKIYMSLIAAKSVSKLNVNNSFFKEKLADNFLKISKIAISLSCFI
FIFQAISDFIFINIPSYQEFNRRTASDMGIILLLGSTMYVLAYIFKKGTDLQEENDLTI
>OBAHECAF_02084 hypothetical protein
MRKIFILKTILDLLFILSIFGVLSFISFFLEETIRVNGYDVTADTLFAKIVLWLWYIGYL
LFIYILYLFRKTAYLFLRVRIFNEKVVKNLNKIGILLIIITICTDISLMIYSVIERKNIG
FRLDTNPVLFKVAVGLLFMTLSEVLKISTKIKEENDLTI
>OBAHECAF_02085 hypothetical protein
MPIIVNLDVMMAKRKISLNELSEKVGLTLSNLSILKTGKAKAIRFSTLEAICKALDCQPA
DILEYKEDE
>OBAHECAF_02086 hypothetical protein
MKHIFQKALPHLVAVVLFIAIALAFFYPVMQGKTIFQSDIVQYTGMAKERNDFRLSQNEE
SYWTNSAFGGMPTYQLGANYSYDFIKKIDKAIRFLPRPADYLFLYFIGLYILLLTLKVDM
RTAFIGSIAFGLSTYLIIILGVGHNAKAHAIGYFAPVLAGILLVFRKKYLWGGLLTAFAL
ALEINANHLQMTYYLMLLVLVFGCFMLYKACKNKELNNFLKATATLVGAVILSVLTNATS
LLATQEYTQWSTRGKSELTISPDGNKKLNSGLSKDYITEYSYGLAESLNLIVPRLFGGSN
NEALGKDSKTYDFLVKQGVPPTQALEFTNGLPTYWGTQPIVAAPAYIGVIIFFFFVLSLF
LVKGYKKWWLLTGSIMALVLSWGKNFDILTNVMIDYFPLYNKFRAVSSIQVILELCVPIL
AMLGLYRFLKNTTEENKKPLLYTVCITFGIVILLLLGKGLFDFKGVSDTLYEQYYGREVV
AMIQEDRQSMYTSDLLRSTIFMLLTILFLNLYQYKKISEKGVQIALLLLIILDLGGVARR
YVDEKDFVSTHRMKQPFEATQADNMILEDKSVYRVYEPEVGINGARTSYFHHSIGGYHAA
KPKRLQELFEYQISNRNTEVLNMLNVKYILMRNENGQLQPMQNGGALGNAWFVNKIITKD
TNDEVMQGLSDFNPRTEAIVLTKEVGNLNFKSSTMDSTATIVLKNYKPNKLEYKTDNQQK
GFAVFSEMHYPHGWIATLDGIEVPHYRVNYLLRGMEVPAGKHTITFEFKPQVVATGTKIS
LAGNVLLILWLLGAGVVFYKNRRTKTDKK
>OBAHECAF_02087 hypothetical protein
MKTFTLLWGGIYGITSIILGAFGAHAFKKILSVERLASFEVGVKYQMYSALLLLIIGFFL
KFESSLEKWTSILVILGTFFFSVSIYFLSFQEHWGVSLRFLGPITPIGGTLMIIGWGLLI
TYFIKSKA
>OBAHECAF_02088 hypothetical protein
MDTNQNPTFNYNKNPIFDQRSELKQPISATVVYVLAIIGIVFSFCCGVGLIPAVIAVLIA
STRINQYNSNPEMYLGIDNLKTARTVAYISVIISVLMVLLSIYLIAIVGLEGIEQMTEEM
PYNHFD
>OBAHECAF_02089 Aminodeoxychorismate/anthranilate synthase component 2
MKVLVIDNYDSFVFNLVHYLEDLGCEVVVKRNDEISLTEVADFHKILLSPGPGIPDEAGL
MKVIIEKYAPSKSILGVCLGQQAIGEVFGGTLMNLPKVFHGVTSQVTVIEEDLLFKNMPK
QFTVGRYHSWVVSSVSDSLSVTSVDENGYIMSLRHKEYDIRGVQYHPESILTPFGKTILK
NWIEN
>OBAHECAF_02090 Deoxyguanosinetriphosphate triphosphohydrolase
MNWEDLLSLNRFGDTKKRLRKGQDENRLNFDVDYDRVVFSSAFRSLQDKTQVIPLSKTGF
VHTRLTHSIEVSVVGRSLGRSIGTHVLNRLPHMQELGYLANDFGAIVAAASVAHDIGNPP
FGHSGEKAIGEFFKYKKGATIKHLLSGKEYQDLCSFEGNANGFRILNESRPGVEGGLRLS
FATLGAFLKYPKESLPVRPTKNIEDKKYSVFQSESAFFKEVANELKMRSNSDDYTLRYAR
HPLAFLVEAADDICYTIIDFEDGINLGLIPEDLALEYLGKLINERINTQKYSKLCTREER
IAYLRAIAIGTLIHEATNIFIENEKTILAGEFHSSLLSKSVFRSQIEDIINISISHVYHS
KEVIEKEISGYTILQDLLEIFFTATLNDFNGKKNTFDELILKIIPETYKKDSSLYNRVMG
VTCYVASLTDSKAVELHSKIRG
>OBAHECAF_02091 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MYNLLKGKRGIIFGALDENSIAWKTAERVHAEGGKFVLTNAPIAMRMGQIKQLAEKTGSE
IIPADATNMDDLQNLVTKSMEILGGKIDFVLHSIGMSVNVRKNIPYTESNYDFTEKGWDV
SALSFHKVCQVLYKNDAMNEWGSIVALSYMAAQRTFPDYNDMADNKAYLESIARSFGYFF
GKEKKVRVNTISQSPTPTTAGQGVKGFDGFIAYAEKMSPLGNATAQDCADYTVSLFSDLT
RKVTMQNLFHDGGFSNTGVSQEVIEKFS
>OBAHECAF_02092 Glutamyl-tRNA reductase
MQIYNKKNKRVLKETKKVLLALFLYFTCDYFCERISEEYFMNQYHLSKSKSFYCIGLSYK
KADATMRGTFSLSSENKTLLLDEAKAQGIQELLVISTCNRTELYGYAEHPFQLIQLLCEF
SNGSVDDFQKIGYIYKNRDAVQHIFRVGTGLDSQILGDFEIIGQIKQSSSVSRQKGLLST
FLERLINSVINASKRIKNETNLSAGAASVSFAAVQYILQNVANISEKNILLYGVGKIGRN
TCENLIKHTQNNHITLINRTRKKAEQVAGKFNVLVKNENDLTSEIANADVLVVATGAPQP
TVHKQLIAENKKLLILDLSIPKNVNENVKELSGVTLVHMDALSKLTDETLERRKEAVPNA
LLIIEEVKNEFFEWMNSRKFAPTIKALKNKLENLKLAELDFQRKKINNFNEEQAEIISNR
IIQKITTQFVNHLKDSQTADETISWMQQVFQLDVEAV
>OBAHECAF_02093 Regulatory protein PchR
MKNLQYFFSKNTAGSTSEVVLISEDIILLKIGNDTAESLEIKKEIPQNFIQYHFNIKGLA
QFLFNNGNYKKPLHAECMLLLYNPQQALPLHQIVEPKSQIVSVFISIQKFHKLLSDEASY
VDFLSLENRDKKYYKEDKIAPAIMVVLHQIMNANFQKNLQPFYMKAKVYELLALYFNRSN
EADIEQCPFLADEESIAKIHKAKEIIIGRMIEPPTLQELSNEIGLNIKKLKEGFKQIYGD
SVYAFLFDYKMEIARKLLEGKDMNINEISSKIGYSTPSHFIAAFKKKYGVTPKKYLSNRD
>OBAHECAF_02094 hypothetical protein
MESLFLAANGQLHWTLAYGAVANGGYLWRNYKFLQIDNETLIKDRKRDINEEINYTAVQV
WNPWFLVYD
>OBAHECAF_02095 hypothetical protein
MKKIIVKFLLLLSIFVSFQGSCSKVGLEVETSNKSKTLKHNYIVLASVDGSAVEVEVSYS
VFVAGNSENIVKTETLTTPFVIGGEDVKVVYDSVVAASDKHFVYNELKRNYTPKGADYLE
IKNLSNVDLEYCVVGNQSLKYYTTKYIDEWINMSNRHLIDKSKVVKYSPTPIYKAVPVLF
LLKPELAPQIDVYIPKAIGRCNGISCSTSGMFAKLISLKAPILGEMTATAPFSIPQIMGI
YRQEYTKGYTLFRDYDRYTTGQISSVNESLISSRYNDVKHYGVIPSNQTLANSGQIWFIN
THQGFYGNKMFEEYGE
>OBAHECAF_02096 hypothetical protein
MKKIIIRSLVLLGISLNLQLRCTKPEVEVESPNKSKTLKHNYIVLASVDGSAVEVEVSYS
VFVAGNSENIVKTETLTTPFIIGGEDVKVVYDSLTYESHMGKRHLHNELKRNYTPKGADY
LEIKNLSNVDLEYCVVGNQSLKYYTTKYIDEWINMSNRHLIDKSKVVKYSPIPIYKAVPV
LYLLKPELAPQIDVYVPWVIGYCNGISCSISDMPAKLVSLKAPILGEMTATAPFSIPQIM
GIYRQEYTNGYTLFEDYDRYTTGQISSVNESLISSRYNDVKHYGVIPSNQTLSNSGQIWF
INTRQGFYGSKIFEQYGE
>OBAHECAF_02097 hypothetical protein
MKKIIVKFLLLLSIFVSFQGSCSKVGLEVETSNKSKTLKHNYIVLASVDGSAVEVEVSYS
VFVAGNSENIVKTETLTTPFVIGGEDVKVVYDSVVAASDKHFVYNELKRNYTPKGADYLE
IKNLSNVDLEYCVVGNQPLKYCTTECVESYGFFNANQIDKTKVLKSCPIPIYKDIPVLYL
IKPELAPQTDVYVRKSNPKLAERVSFKAPDFGGVVANTPFSASQIIDLYEREYIYKEILY
FAYYTQYVEKQSVGGKHKELEHYGVIPSNQTLSNSGQIWFINTRQGFYGSKIFEQYGE
>OBAHECAF_02098 hypothetical protein
MGSRFYIKTLVVLLQVFVLVGCNKDEITGLTSLQKDKALFVYMIADNDLDFYATANINEM
EAFIAENPDKGSIYVYIDRAKNRKTAHPLLYQISADTTAQINSKILKVYPEKDSSNEVVF
KEVLNEVITLTTTKNEKIRGLVLWSHGSAWLPKSSLLASNRATAVKSFGVDQTATEDTAI
NSEMDIRKLAKSLVNYHFDFLLFDACFMASIEVFYELKNSFDYIIASPTEVLATGFPYKD
ILIDMLENTVNYNNISKKYVSHFKQKQGILQSAAVTTIKTSELKNFAYLFNKCLSQQTEK
IDTTKWLQYDQEGSDYLFDMGDFLNHLQPNQTEIELSKQFEKLIVCYDHTSYFFNKIPLE
KSTGVSIFVPNKIDNTNEVYDFYKTLSWNNAVNMVNYIHD
>OBAHECAF_02099 hypothetical protein
MLLIWLITFMISCKKEEIFQENYNIGVKNNYFEAIDSIKIGSATFNKSLSVGETYFFKEK
FSVSSYSVKLYTTSNLIITTKFKAISHKNTILLTLISDGTILID
>OBAHECAF_02100 Vitamin B12 transporter BtuB
MKANTSNLILFLVLGLFSSVVWGQKKYTISGYITEKGSKELLIGANIYIPDLKVGTITNN
YGFYTISLPEGEHELYVSYVGYQLFTQKIELSGDMSLNVELEDAQLLEEVVVTGERTPML
SRSSQMSTIQVPIAQVQKIPALLGEKDVLKVLQLLPGVQSGSEGSSGLYVRGGGPDQNLL
ILDDAPVYNASHLFGFFSIFNGDAIKNVNLTKGGFPARYGGRLSSVLDMSMKDGNKERFA
GDMGIGLISSRLTLEAPIVKDKSSFIISGRRTYIDLLTRPLMPENAKLGYFFYDLNMKIN
YDFGQKDKLYLSGYFGRDKFYFRDKESSGEVFKGGLHWGNATATLRWNHLFTDKIFSNTS
LIFSDYLFEIFQEDTHKNNVFEMRYNSGIKDVGLKYDMQINLNPNYLIRTGFATTFHRFR
PSAIVIKDPAFNQFERKIQDIKTLESGIYIENELTLQEKLRLNAGLRLSHYLHKKTSYQD
LEPRFSVGCTLPNDWSVKASYTSMSQYVHLLSSSGISLPMDLWIPTTDEVKPQKSRQVAF
GVAKDIIDRNLSLSVEGYYKKMDNIIGYAPGANFLLLEDFESVSEYAWQESIIRGQGWSY
GAELLLQRKVGKLSGWLGYTLSWTQHQFDGDNGGRKFFPRYDRRHDVSLVAIYNLSEKVT
FSGTWVYGTGNAISLPVSSYQVDKGDVSEAIDGYTAYNYDEKNSFRMRAYHRLDLAVQFH
KNKGKNMKRTWEIGVYNAYSRRNPFFYSIRSEYSGSSSARKNVLEQYSIFPVIPSVTYNL
KF
>OBAHECAF_02101 hypothetical protein
MKKYFSILLLLGGFLLMSCENFFKSEVDPPQISTQPQLVVHSYISAGSPDVKVKVALSNP
IFGSRSESGMPSVSDARVTLRNDQYGSVTIPYETHSGYYIISTTNFPIEAGKTYYLEVQD
TKGNKATAHCTVPHDIVGDVQNLKLINTKSEGSDAYQVSFDFQDTANQRNYYIPVILVRQ
ELSNYDRRLEAKFFTDNNRDGHRITVRSEKEFGSAQYVKKVIVTLYNADVNFYEYARSVS
SQNEAQDAGPFAETVILNSNIKGGLGVFGAYTKKVVTLEL
>OBAHECAF_02102 Peptide chain release factor 1
MLERLNIVKQRFDEVSDLIIQPDVISDQKRYIQLNKEYKDLKELIDKREEYIIVTSNISE
AEEIIANETDAEMVEMAKMQLDEAKEKLPQLEEEIRFMLIPKDPEDAKNAVMEIRAGTGG
DEASIFAGDLYRMYTKYCQSKGWNTSVMDYNEGTSGGYKEIIFEVTGDNVYGTLKFEAGV
HRVQRVPQTETQGRVHTSAATVMVLPEAEEFDVELDMADVKIIRTTSTGPGGQSVNTTYS
AIQLQHIPTGIEVRCQDEKSQHKNLDKALKVLRSRLYEMELAKKMEEDSARRKSMVSSGD
RSAKIRTYNYPQGRVTDHRIGLTLYDLQNVINGDVQRLIDELQLAENTEKLKEGDIF
>OBAHECAF_02103 hypothetical protein
MVNTTFSSWNRSVHLSNGLHINLSPKKRYIRNFSENSANTDILLMLFSLSKSFVLILWEK
YQVIIIIYELKNISFFEFFGIFGKL
>OBAHECAF_02104 Na(+)/H(+) antiporter NhaA
MKATKLFKEFFESEKAGGLILIACTVISLLIANSSFGESYVQFFQTKTAGLSIEHWINDG
LMAIFFLLIGLELEREIYKGELSNVKDALLPIFAAIGGMLIPAGIFLALNFGTETQAGAG
IPMATDIAFALGILSLLGNRVPVSLKVFLTALAVIDDLGAIIIIAIFYTKELLWTNLLIA
LGIFAVLLVLNRLKVKSLIPYLLGGVAMWYFMLVSGVHATIAGVLLAFAIPFGDGGEEST
SYKLQHYLHKPVAFVILPIFALANTAIFFEGDISEILTQNNSLGIALGLIVGKPLGIFLL
SFLAVSFGLCKLPSDINWKSVLGVGFLAGIGFTMSIFITLLAFDNDIMVINNSKLVILLS
SLMAGLIGFVSLKLILKNTVVEEEA
>OBAHECAF_02105 hypothetical protein
MKQYEQVIQVMRENGGFATLGFLNHKVNVSDWATKTPFASIRRIVQDERFFFKIKPGLWA
LKEFQNEILNKFEIQLSTKKEQEFSHTYFQGLLLEIGNLKGYNTFIPAQDKNKLFLDRPL
RSISTLDKIFDFSYQNIVNRAKTIDVIWFNNRNLPHSFFEVEHSTDIQNSLLKFNDLQDF
YSKFYILSASERKKEFEQKIAYSAFKQIKNRVQFIDYDFVSDLHTKSFELYKIGDLE
>OBAHECAF_02106 hypothetical protein
MNIYKIEVKEILSRIVPVEAENEQEAVQKVEEMYKNEEIILDFDDFVTHEIIEYLE
>OBAHECAF_02107 hypothetical protein
MTIKKIYACWVYVSDLEVSKAFFQQLGFVLKFQQEDWVEFDLGATSFAILKRPAEKGKVK
PQKTRIMFEVDDMENLYETLKSQNVRFIGTIRYETYGKLLTFEDPDGNWFEFFEDKK
>OBAHECAF_02108 hypothetical protein
MASKIYFTNEEMLQNAKVLFETLENNSKIAEKLDDYGYSESEIAKGKALYEKAQAQYGSN
KKETEEERVAYLNFKQKMDETSKSYREHRNKAKLIFKNNEEAKVRLALKGSPSKSIVALL
EEMTLFYKNLAEQETLRTPLERVKITQQIITEKQSEISQTKDLYAIYSQEKNESEQATKD
KNKAFEALDKWTRELYSYAKYALADEPQFLQMFGRAIR
>OBAHECAF_02109 Orotidine 5'-phosphate decarboxylase
MTLQKLINQIRKKKSFLCVGLDVDLTKVPSHLLQTEDPIFEFNKAIIDATHSFAVAYKPN
TAFYEAYGMKGWQSLAKTIAYINENHPDIFTIADAKRGDIGNTSAMYAKAFFNDLQFDSV
TVAPYMGKDSVEPFLAFEDKITILLALTSNAGAFDFQTQMVNNEELYKKVLQTSLTWENS
QNLMYVVGATKAEYLKEIRKIVPNHFLLVPGVGAQGGSLDEVCKYGLNADNGLLINSSRG
IIYVSNGTDFAKKSREEAQKLQQRMEKWVL
>OBAHECAF_02110 D-alanyl-D-alanine carboxypeptidase
MIQTQMKLIFFIYFLSIPWVFPQNDSIKREKIAKVRSFADGKKEAEKIILSLIHKGTVPG
VAITITKKNKTLWQQGYGFADLQHKTPVSPQKTLFRIASVSKPMSATTLAKLQEKKKFDW
NKSIYTYLPNYPKKKHDFTIKQLGGHLAGIRSYKGREPFSNKPMTIEQGINMFKNESLLS
VPGTQYLYSSFNWNLISLAMQKYLKKSFENIVSDELLKPLQMKNTLPDKGKIIKNQAIPY
SNKNKGKGFVRSPDVNNFYKLAGGGYLSTSEDVAKFGNAVLSDKFISQKIKEEMLMPQQT
TAGSSTGCGIGWQSTKDWAGRTYYGHSGNGIGGYAWFFVYPEEQVVVVMLFNMTNPKISQ
QLRDVIDFILAGSKFIYM
>OBAHECAF_02111 Ribonuclease Z
MELTILGCHSATPRPNARPSSQVLELRGHLFLIDCGEGSQMALRNANVKFSRIKHIFISH
LHGDHFYGLPGLISTFQLLGRETELHIYGPKGIKEAILLLLKLGNAWTAFPLIFHELTSE
ESEILLDDEKVSVQTIPLKHRVYTNGFIFREKIGDRQLNLDAIYNYGIETCDYQNIKNGK
NITLPHGEVIANELLSFDPIEPQSYAYCSDTIYFEELASEIKGVRTIYHESTFLQQHTEL
AEKTMHSTALQAALTAKNAGAEVLIIGHYSSRYSDKNLFLKEAQTVFKNTLLSEDGKRIK
F
>OBAHECAF_02112 hypothetical protein
MSTKIITIKKSELSDFVNTFKDKEELKSTHIILDLSEIKDLETKDLIPFVEISKYHTKKN
KKSLVIVSEEITYGNIPNEINLTPTIQEAKDVIEIEDIQRDLGF
>OBAHECAF_02113 Aspartate carbamoyltransferase
MSELSVNHLLGIKYITEKDIQLIFETADHFKEVINRPIKKVPSLRDITIANLFFENSTRT
KLSFELAEKRLSADVINFSASQSSVAKGETLIDTVNNILAMKVDMVVMRHPNPGACVFLS
KHVNASIVNAGDGAHEHPTQALLDSYSIREKLGDLAGKKVVIVGDILHSRVALSNIFALQ
LQGAQVKVCGPKTLIPKYIHTLGVEVEHNLIKALEWCDVANMLRIQNERLDISYFPTTRE
YAQQYGVTKSILDNLPKEIVIMHPGPINRGVEITSEVADSKQSIILDQVENGVAIRMAVI
YLLASKINR
>OBAHECAF_02114 Bifunctional protein pyrR
MNQKDTHKKEIVSSSEMNVILNRLACQLIERHGDFSNTALIGIQPRGTFLAKRLVTLLSE
KYNIKNVPLGLLDITFFRDDFRRNNKPLEANSTDINFIVEDKKVVFVDDVLYTGRSIRSA
LTAIQSFGRPSEIELLVFIDRRFSRHLPIQPNYKGRQVDAINQERVIVHWKEKDGEDTVY
IINKDKI
>OBAHECAF_02115 hypothetical protein
MKTKKRNKTATISGSFSSHKKGNATLNLLTSILLIAYGYVTVLTPNWMAFDSNAPKFYTF
AILNLVVAILVFSIKDFREKNKVLFGFFTNKIGIAYTTIIFFALLSFAKVINVEEAVLHF
FKVFTAFSAAWMVSALVIYNPKNITVLAVSMTALLLYDSLETFRGVSKIIKGTGSDIDIK
SSYSNKNILASAMFIKIPFAIWLFFFKKDKLRIIGGIGTLVGTLAIFFMSARAFYLATFI
IMFVLIGYGILNYFILKNKKTAVSVGGHTLFVLIAFGIFSFVQGVMYPKAIKESTSFTAR
LATIADQENTSNNLRKTAWTTTLTEMIPNDPLLGVGIGNWKVRYLEYENSYSPHYIYMYK
AHNDFLELTSEAGIFAGLAFLSIFLLIAYYFLRATYKNKNSELEKWLFLPLFGLFAYSFD
AFFNFPQDRPEIQSLFAIYVGLAVGLLVVHLSKNNQIEENVITEENTDKKSIKANSGAFI
GMIAIVTIVVNLANVVVQKMYFDSSKIQRMVKEEQQGVRKTKSTSDFLIQNYPKIPNLTA
VAEPVDVEKARYLIDEKKFDEARKVLQSIEYNPWDGRADYFTAVSYFMEENKKYDSIYKY
AIWAKVAKPNFFGNVNLATYGLNGMGRENESIELWKDFLELSPPDTTSTKKPKKWKKILK
ERFHVDVDRDGRNAKRQEASAWNALAYLLEKNGMVEEAKAVLDTAIKYVPNDKTVVDNQM
KITSRLQMEQYLPIYGKALQLQQQRDYVEAVKLLSQFLEKVPAHVDALGQRAICYYNLQQ
YQNAIKDIVRMEELGATPSPAMDNYYASCYYMIGDRAKAKTLFERAVQKGNADAVNNLNK
LKF
>OBAHECAF_02116 hypothetical protein
MKKQITNTILMIRPVRFRMNEETAINNYFQEEIELKNEEINNKAQQEFDAFVQKLENIGV
NVIVVDDIYEQNTPDSVFPNNWISFHQNGNIALYPMFAENRRRERRDDVLDLLEEKGFSI
ENVYDYTDAEKEELFLEGTGSMILDRANEVAYCALSPRADEELFIEFCEDFEYTPVIFKA
YQTVNGKRELIYHTNVMMALGETFAVVCLDAVDDKSERKALTESLKRTGKEIISITEEQM
HRFAGNMLQVQGSDHTYLVMSQAAYDSLTEKQIKNIEKHCKILYSNLETIETCGGGSARC
MMAEVFLPTN
>OBAHECAF_02117 Arginine deiminase
MLQLNIKNETSRLKAVILGTAQSNGPTPTLEEAYDPKSAEHIKAGTYPIEKDMVSEMEAF
NAVLKKHGVTVYRPELIKDYNQIFSRDIGFVIEDIFIKANILPDRERELDAIQYVIDQID
PTKVVRPPEEVHIEGGDVMPWNDHIFIGTYKGGDYKNYITARTNTQGVEFIKNLFPNKIV
KEFDLVKSKIEPRDNALHLDCCFQPVGKNKGIIYKSGFREEADYMYLVELFGKENLFHIT
REEMYHMFSNIFSIAPDVVVSEQKFTRLNNWLKDHGFTVEEIPYYEISKQEGLLRCSTLP
LIRE
>OBAHECAF_02118 hypothetical protein
MLENFQTIIVIIASITLFVYGLHSFSKEIENLGTERLSRWIRRITVFPLGGFLLGGMFTA
VIQSSTLVSSITVSLVNAGAITFTDSILVLLGTNVGTTSTAWIVSLESTFLGPLFIVLGT
LISMIPAKVSVVGKSIFYFGFIFFSLAYIGEAMEPIKKDPMLIQVLSKASNPLLGILYGI
LITVIIQSSSVVVGLVIVLLSQGTITIDSAIPIVIGANIGTTSTALLISLRMSPISRLVA
LSASVFNIVGVLIIFPFFGLLESIATSFSQNPSLQVAIAFTISNSLTSLFFLFFLTPTIR
MLKRHRWYQKTEKQDE
>OBAHECAF_02119 Alkaline phosphatase 4
MKRRSFFKQGALATLGGMLTSSFDLRANTILEENKGKKAKNIIFMVSDGMSVGTLVMADI
YIRRKFDRPSNWMGLYETNLVQRGLMDMASASSIVTDSAAASSSWGGGVRVNNGSLNISP
DGKENLPILQKFKKAGKKVGCVTTVPITHATPAGFSVWSERRNDMEGIALKYTELGFDVM
MGGGNKVFNPSLREDGKDVYAILQQKGYTVVRNRADMQKASLKKPLFGVFADVALPYTVD
HMQDEVLKAEIPTLAEMTAKAIDVMKNHPQGFVIQVEAGKVDWAAHGNDLGGLIYDQVAF
DDAVKVAIDFAKKDGNTLVVLTSDHGNANPGLIYGKQCNGNFDRIQHFKHSNDWILQNIK
PTDGIAKVKESVYNNCGKMSITDDQARELLTYYAQAGQEDGIYNYNHLPYKLFSEIQKAH
TSVGWISMDHSSDFVELAMFGPGSEKLKPFMRNTDMHKFLLDVAEVEDKF
>OBAHECAF_02120 Ferrous-iron efflux pump FieF
MSNSLSFQKGIAIVGVVLFIGKLIAWQLTNSDAVFSDAMESIVNIISAFMGLYSLYLGAK
PRDDDHPYGHGKVEFITSGIEGTLIVIAGILIIAQSVHSLIMGVALHQLDWGIFIVGTTA
VANYVLGHISYQKGKRENSMVLMSSGQHLKSDTISTLGVVASLVLVYFTHLLWLDAIVAL
VFGGYIIIVGYRIIRKALSGIMDEQDEYLITEIVKVLQENRHSEWIDIHNMKVQQFGSHL
HIDAHITLPYYYSLREAHQEMEKVIQVLLKNTERTIDFNFHMDDCKSFSCEICDLDCPLR
KKPFVESIQWNSETIRQVQKHRFRGL
>OBAHECAF_02121 hypothetical protein
MKVKERTRAQESKRAIERMYVTMRHLFSRGFYKPMGISGEALREALLLLRPEIYGSIAEN
KSELAGLSYVLDRLPEGIEQCKYINLIADEGYRKSHFQSIIPPKRRRNCYRIDDQQMNIE
ITRGRSDIYDALTHLTFLFVESHKIARNVLLDDGKLTRDWEKLAQSVNKQKLSQAEREIT
LIHIGNILGRTFEEVLETYTYFSTETHPERFIHIIYWLGKLAIDEILHDDKRVITFSSVL
RERLGHHLYSEIWADAIKKILHTQGLLNRPLHIISANKHSVMNSLFAEKALKNEMKGKKT
MEIFELLSQKENEELRQKVNDYAHKNGMISLDDSSGTNIDVQIFDTAKIDFSNTSYSVVE
AEKPVIFVMDYAFGEQAYETIDELLKPYKTETEVHFMNVASISIMGKAGILEGEKGDLMI
PTAHIFEGTADNYPFKNELKKADFEGNGLRVFEGSMITVLGTSLQNKDVLNYFLRSTWNV
IGLEMEGIHYQKAIQSASKIRKSIREDVKVRYAYYASDNPLETGSTLASGGLGAMGVKPT
YLITLKILEQIFES
>OBAHECAF_02122 Asparagine--tRNA ligase
MYISVKKLLSEGKIAQDVTLKGWVRTFRSNRFIALNDGSTIENVQVVVDFENTSEELLKR
ITTGAAVEIHGSVVESQGKGQSIEVQASNVIVLGDSNPETYPIQPKKHSFEFLREHAHLR
VRTNVFGAIMRVRSVLSFAIHDYFQRNGFFYVHTPIITGSDAEGAGEMFRVTTLDAKNPP
LTEEGKVDYKKDFFGRETNLTVSGQLEGETFAMALGKIYTFGPTFRAENSNTSRHLAEFW
MIEPEVAFLDLDGNMDLAEDFIKYVLKYTLERCREDIEFLNARFLEEEKIKPQNERSTMS
LIEKLEFVINNNFKRVSYTEAIDILKNSNHNKKKKFQYIIDEWGADLQSEHERYLVEKHF
ECPVILYDYPAKIKAFYMRLNEDGKTVRAMDILFPGIGEIVGGSQREERYDVLIEKIKSV
GIEEKDLWWYLDLRKFGSAVHSGFGLGFERLVLFATGMSNIRDVIPFPRTPQNAEF
>OBAHECAF_02123 hypothetical protein
MLLHPYKNANLPDFILLSEYNSAKPADFMLLYPYKNTDLSDFMDLYPYKKIKFKI
>OBAHECAF_02124 hypothetical protein
MVSPMLWAQGNPPATLPTPSGDCDPYFDGLIKQTKASVFSPIESGSNAVIYLDNSRMATG
VTYFAINKTTGMWFAGSYDTTLFMVTIPVGVLTQNTTFEVHAIAGGCSFKVVDDVTFEVK
PTTEVHLQTRVRDEYCDNSGGIYYQMMGDSNDNYNFYHKLSTQTAFQTATADRNDLQTVQ
GGKTYVIRAELKTNPTTFYEKTINVGNLKVPNPPGIEYTVTAQPLLCAPNTGRAIVNITQ
GVAFPFTFEITSGPVTRPEQASNVFENLPAGNYVMYVKDACRQGRTLNFRIGGQPFHIGP
IGGFSYVSPTDECGRGLVRLQRGIKMSREHWYTDAIPYPMTVSYTLTSPSGTSYAMTRTF
NNRTELTTYAWYDHNQESIYFGHNLSGRQNFFGDGVQIPYEVGEWEHSIQVTTACGVRNL
GSLKENTSSRVQTFYQFSEIKQSYDPCGKNRISVRANYLFKDAYIVLDEAPAGFDPVAAG
FTKNHRFGGKYYKFVRLDHRYVPIVSYPHLLLGDYKFTYVYADCGSELQRQITVTDLQNP
VGVPNTSYFYSTYYCENQSYGIGFLETGGAGAPQKIRITSFTPAPGTSGTFAVPQEYDYD
QWTTIVNGRRVLHGLPFGTYTLSALDFECQQDVVDKVVTVQPPMPDPKVRFSMATGCKVQ
VELYDAVGDSYQRGYYLQGYDENQARWVNMVAPNANPYGDAISDKKQNIIKVLNHNNYKV
YTRYRVVELTGTVGLHSACPKVLGEYTPPSELPTLVDIVGATCGANQYEIMVVASGGTPP
FTYKILSRSVGGSLDPSFTPIINTTGKFTITETDPSASYKFAVEDVCNQETKDVEIRNMT
PFVITTDRTEYCQGTSATLSVPDLSLAYTYEWFREDDPSTILSHSPTLQVSNLQATDFVH
KYKLRVAPKDASFTLCIPAEYEVQLMGSTASAPVLTGDATNVVLCASELDGKTSYDIRTN
LFATVHNNATASGHTNAVIREISGMYPVSQDGLMALHKNMIPVLEGQTFTFTYTISNACG
LEATKTATLTVKRNIKPQDLIIPNYNAFRVCDADLTNWVIFGATNFNDLSEFIKNHNAAR
STDLIEFFSDPQGNTPVHQLDFTTESVKIIYYKINRADYCSSVARIRIDKLSTYKRPDGT
DDPRLVDLTYDTCANGVTVQDVRARLQQIFGHRSTPKVYLIRMVGGVETSSELPDNYALT
TSEVYRYRMEDGGCPSSWRNITLNFNQTNIVTQPVSHIVCSGEQVVLTALGASTSPPTAG
KMIYKWFESTYNGTIGATQVHAQTLNRGEASTYTPSTASVGAKYYFVEVTVENVCNVPMY
TNIVKVEVKGMTASVPTVTTLSSVQCGEDVKFTFTGVPNEEVHYTVNGVASTITLPTSGV
YTHTVSAATTTQVLRVVSVSNASGCPTTPTTGNVYTVTVNDLPTPTINVVNATCGNSGSA
TITNYDPTLTYTFSGSGVTRTGATITGFALGTTYTMTVSNGTCTKATSFVVNTTCTIDAV
EDDFGIVEANTTTTGSILDNDKLGTASATTADVDIKNVVSPHTGITINTTDGKVNVANNV
PSGVYTLTYTICEKVNGTPCDTATVSITVKNINADNDDFEVSAGGNTGSVLNNDKYDGEF
LSSMVSVTLTPIGTLPSGISLDPITGIVRVASGTPSGNYSFNYKICSKVVTSLCDDATVT
VTVQNGIVAADDDLGAVVSGGTTTQTVISNDKLNGTPVVIGTGTGQVTLTPIITPTGITL
DGDGKVSVGNNVPSGVYTLTYKICENGATPDNCDEATVTITVENSIVADNDDLGSVVSGG
TTTQTVISNDKLNGTPVVIGTGTGEVTLTPIITPTGITIDATNGKVTVGTNVSSGVYTLT
YKICENGATPDNCDDATVTITVENGIVAEDDDLGPVVSGGTTTQTVISNDKLNGTLVVIG
AGTGEVTLTPIITPTGITLNGDGKVSVGNNVPSGVYTLTYKICENGATPDNCDDATVTIT
VQNGIVADNDDLGPVVSGGTTTQTVISNDKLNGTPVVIGTGVGQVTLTPLITPTGITIDA
TNGKVTVGTNVSSGVYTLTYKICENGATPDNCDNATVTITVENSIVADNDDLGTVVSGGT
TTQTVISNDKLNGTPVVIGGNVGQVTLTPLITPTGITIDATNGKVSVGNNVPSGVYTLTY
KICENGATPDNCDDATVTITVENSIVADDDDLGPVVSGGTTTQTVISNDKLNGTPVVIGT
GVGQVTLTPLTTPTGITIDATNGKVTVGTNVSSGVYTLTYKICENGSNPLNCDDATVTIT
VQNGIVAEDDNLGTVVSGGTTTQTVISNDKLNGTSVVIGTEVGQVTLTPLITPTGITIDA
TNGKVTVGTNVSSGVYTLTYKICENGATPDNCDHATVTITVENSIVADEDDLGTVVSGGT
TTQTVITNDRLNGTPVVIGTGVGQVTLTPIITPTGITIDATNGKVTVGTNVSSGVYTLTY
KICENGATPDNCDDATVTVTVENSIVADEDDLGTVVSGGTTTQTVITNDRLNGTPVVIGT
GVGQVTLTPIITPTGITIDATNGKVTVGTNVSSGVYTLTYKICENGATPDNCDDATVTVT
VENGIVAEDDDLGAVVSGGTTTQTVTSNDKLNGTPVVIGTGVGQVTLTPLITPTGITIDA
TNGKVTVGTNVSSGVYTLTYKICENGSNPLNCDDATVTVTVIAPSVSTITANSDTFTSTI
AGGETVGSVFTNDDLNGLTPNSGTVSVTLLTDGGLTGVVINTDGKLLIPSTTATETKIYT
LTYSICEKDGVGNATSNCANSTIEIVIPVVPSVLNITANTDTFTVTTSTNTQTVGNVLDN
DRLGTKTPTTSDVTITVTSTPTGTIVPNLDPVTGNVTVPSGTPTGTYVIGYEICTKVGTI
TCDTATVVITVTAVTTPTVITATDDPVTVTTTQSGTVVNVLDNDKIGTNTPTTSDVTITV
TSTPTGTIVPNLDPSTGNVMVLSGTPTGTYTIGYSICTKSGTITCDTATVTVIVTAVTTP
TVIMATDDPVTVTTTQSGTVVNVLDNDRLGTNTPTTSDVTITVTSTPTGTIVPNLDAVTG
NVTVPSGTPTGTYTIGYSICTKSATITCDTATVTVVVTEVTTPTTPVVAKDDVEQTVVDT
PVTVKVVSNDEHVPTQGTLTIVTQPKNGTVVINNNGTTNDPSDDEVVYTPNRGYAGVDSF
EYELCDTMGNCSIAKVTITVLDEVIPYNAISVNGDGLNDYFHIQGIERYPNNTVRIYNRW
GVKVFETKGYDNVNRVFRAISNGRVTIEAPEKLPQGTYYYIIEYIDNNNKKHTKGSWLYI
KK
>OBAHECAF_02125 hypothetical protein
MEHLQPNDSLKIIQEIINQRKQKYEQNGFFFIFWGILIMLAGTIHFLMYQFDFHFSKSGL
VWLILMPLGFVFTFVAKMREGIKAEKQGKRIDWMGWLWLVAGIGAMVGGFTQSSKWIIIL
IYLPFVMASLATALQLKNRLWVSTSLISFALVYSTLFINYGYHSILMTVVLAALLFLIPG
IQLYSDYKKRKNV
>OBAHECAF_02126 hypothetical protein
MFKDLDPLLHSQLRLAIMSLLISEEKADFNRVKEVTQATSGNISVQIGKLEKAGYITVTK
SFKDNYPNTELALTAKGLQAFEEYVEALKGYLK
>OBAHECAF_02127 hypothetical protein
MNTTEQNAYRKAEKRVKKLKKFYHHLATYVVVNAFLVGLNLYQTPNNLWCLWVIFGWGLG
LVLNAVSVFLPNLFFSKQWEERKIKELMEKEKK
>OBAHECAF_02128 hypothetical protein
MNRNFKNIVFAVVCSFLAINTQAQSTQQSEIQTIENQSSLNGIQQQIETALGEAFTTKNG
LPLEKLEKQLSENKENNQWNLYWKSYLNFYQTIFYLKTDNKEKASEYNQKSIDILQDKKN
KNAEEYALLANNLSLSFVFMKNQMEAMQIDAKIRENLQKGFRLEKENPRLYYVEGNYDAN
IPKQYGGGKKVETSLLKAISLPEPNQNSGHLPTWGKREAYQSLLKWYSSENQKEKADELQ
KKFQSEFPEK
>OBAHECAF_02129 hypothetical protein
MKTLLFIFNLLIFSFVQAQQDSLQINQLEEVIIVKKDPISEKFAVKKLNSLDIYFNPASN
ADPLKAITTLPASTSTDESANPSLRGGSPDRSRVYLNGSPVLNPVRFSRNDGLGNFSLFN
TELIDKQYVYSSNPPLNFGNSSAGLVEIETNTQKISEFTQVSLALSNIGLMRNQKLGKNN
FTQIYANYQFSDAIIGLNRKSLDQLQHFSTFDLGANTHLKINKNLSFNTFNYFIDEKYSV
LNRSLNFSGDVEASKKRFFSVNNLDYFTQKTKIRWASMVDFSHSEFKFGNIDSKVKNIQF
FNGLSFKTQFSRAFSMQYGVDASVFRYHYNEVLPQFYFSLKPESPTFTNQKTTDFFYIEP
YVYANYSPDNQWNFSSALRKNIFLHKNTESFTSYQFSANYTPNNEHRLIFSAGKYHSYTT
PNYIIRNFNTLSSHQIALDYSFENEKFNISTSVYFKADKGDIVTNHYEQFDKTQIFGSEA
SVDFKLNHQFSFSISNTFLNQKYAIGNQKYNTPLNLKYFIKSQLIYKNPKWFTASLVFAT
RPGNRFTPVQSAVFNPQANDFQPIFGDWYSAEMPHYKRLDFSANRLFFIGKTAVIGFVSV
NNLLNFNNSASVYYNSNYTNLHYNHLQKRIFYFGTMVRF
>OBAHECAF_02130 Isoleucine--tRNA ligase
MKFTEHKNLDLSVVAKEILTYWQENNIFEKSIETREGKEPFVFFEGPPSANGLPGIHHVM
ARTIKDIFCRYKTQKGFQVKRKAGWDTHGLPVELGVEKELGITKEDIGKKISVEDYNKAC
KEAVMRYTNIWNDLTEKMGYWVDMENPYITYKSKYMESVWWLLKQIYNKGLLYKGYTIQP
YSPKAGTGLSSHELNQPGTYRDVSDTTIVAQFRVKKLSNKLKEKLSNPFDSCDIAGASCG
GALHWADYDEADYSKLPISILAWTTTPWTLPSNTALAVGKDIDYVLIKTFNQYTFEPINI
VLAKVLVSKQFGKKFFETSKEEDFKTPPSGAGGNIPYQILTEFKGSDLEGTTYEQLIPWF
SPAENTDQAFRVITGDFVTTEDGTGIVHIAPTFGADDARVAKENGIPPMLIKDENNNLVP
LVDLQGKFVKGENVPEIFSGKYIKNEYYDQNAPEKSWDVELAILLKTENKAFKVEKYVHS
YPHCWRTDKPVLYYPLDSWFIKITDVKDRLFDLNKDINWKPKATGEGRFGNWLQNANDWN
LSRSRYWGIPLPIWRTEDKKEEIIIGSVEELKAEIQKSIAAGLMKEDIFADFQVGNMSDE
NYEKIDLHKNVVDKIILVSASGKPMKRESDLIDVWFDSGAMPYAQWHYPFENKEMVENTW
KTADFIAEGVDQTRGWFYTLHAIAGLVFDGISYKNVVSNGLVLDKNGQKMSKRLGNAIDP
FTTLEEYGADATRWYMISNANPWDNLKFDLEGVAEVRRKFFGTLYNTYSFFALYANIDRF
TYKEEEIPLEKRPEIDRWILSELHTLIQKVDEAFADYEPTRATRLISDFVQENLSNWYVR
LCRRRFWKGEYEEDKISAYQTLYTCLLNVAKLMAPVAPFYAEVLYRDLVSGTQKETAESV
HLTIFPTTDKSFIDKSLESKMEKAQNISSLVLSLRKKEMIKVRQPLQKIMIPVSNEAERR
EIEAVADLIKSEVNVKEIELLEDASGILVKQIKPNFKTLGPRFGKDMKLVVAAVQQFTQE
DIQSIEKEGQIIVKLAEKDVTLSIEDVEITTQDIEGWLVASSGNLLVALDIHITDELRKE
GIARELVNRIQNIRKDSGFDVTDKINICIQKQKAVEEAVSDNLEYIKSETLTSELTFAEN
VSGEPIEFDDIVTKILVERV
>OBAHECAF_02131 hypothetical protein
MKKVILFLVLIFALYSCGTDKLTEAKVKDLVQACIEKEPQKDVIDTEITLGEGQLLATML
RKSDNEKNYLQLSDEKLIDFEKTNQMLFGQSKYNISLTEKGKQYVTRTEKNKTWVRCLSL
KLSEVEEIHENPSTNTAEVKLVFRKENKTPFHILLSDDLKSDEPIKRTMSFRKTNEGWKL
CD
>OBAHECAF_02132 hypothetical protein
MKELKIGSLLIGKKAYLGVILGFFLQEWYGVPSFLIKIMI
>OBAHECAF_02133 General stress protein 16O
MEENIRVRYSDKELEEFRALIEEKIKKAQHDLELLKSAYMNSATNGTEDTAPTFKAFEEG
SKVTSKEENTALAIRQEKFIRDLKNALIRIENKTYGVCRVTGKLIDKRRLLAVPHATLSI
EAKNMQ
>OBAHECAF_02134 hypothetical protein
MRKKEKYCNRHFTFFSFVFVLLVMTACTSEYGEIKNIKSGEITETVELRATDSVVYPLGS
SVSHIMTAFDYNLEKQIFSFYASDTVYRYKKDVLYDKIPVRKRHINSFSSKEGFLWAVDY
NGNRLFKVDSLGGIVKDLKIKETIKYFPLPITKTSPIIEDKNKVYFFGNISGEYSDESEE
NRRVMGVYDLETHKLSCFVAYPKEYEHNFGGGLFRWVYADYNSKERRIIISFPASHSLYV
YDIDNLEKEASFYAGSRFIESIKYLKSPKMFPIDTETKVRHFAETPSYSRLIFDPFREVY
YRIAEQGTVYEGMVGWSKEISVIVLDKTFKIIGETFVGKCLSNYRYAIYVDQEGLKVPVQ
SSEDVLIFKNYELCNIQK
>OBAHECAF_02135 hypothetical protein
MGTRFLINLCYFFLVIFVSCESHTEKQAEYEAVLDLKESMGVEKLSIKPLEATQMIPLEF
TKRSVLQSAYIEGVTDEYIVVRNGNSLIFFDTQGKFLSKISRMGNGPEEYIENTYSWIDF
DKKEAHVYDLHRKSVKRYDFSGNFIEEKKNVHLWSFTELSSDRFIAYNDMLSNFEFTIYD
KNWNVKDSIIERKDKFNIKDFNVIKSFQISKNNIFFYNAPIIYQSKNGGMFPKIFLEKGN
LQIPDEIHYDLSRKNEKQRYIWNDFVTLAGDYLFLSYYYDNKKYDDIWNVKNQKLLYRNT
ISSPDELPGVPISVNGEEVRGWIRYFENDMFYFVVSEGEQEKLNVDNEENPIIVVTDLKT
FEKSFSE
>OBAHECAF_02136 Beta-hexosaminidase
MMMLLSLVAVAQNQKPFVIPELREWTQSDGAFTLSEKTTLSGDEKSSEIVKIFAEDFETM
FGKQLKIKSNDANIHFEINPSILNDKGEEAYKIEIGQIVRVSANSPQGLFWATRTLLQLT
EQSAQLPCGTIVDYPDYPMRGFMLDVGRKFFTLDYLKSVVKTMAYYKMNVFQVHLNDNGF
KQFFNDDWNKTYSAFRLESTTFPGLAAKDGYYTKEEFRQFQIDALKQGVTVIPEIDAPAH
TLAFTHYLPEIGSDEYGKDHVDLFHPKTYEFFDKLFKEYLEGEKPVFVNPLVHIGTDEYS
NKDQKVVEKFRYFTDYYIKYVESFGKKVALWGALTHAKGETPVKVDDVLMLCWYNGYAEP
RDMIALGYDVLSVPDGWLYIVPAAGYYYDYLNIKNLYEKWTPAMIGKEVFEEKHPRIKGG
MFAVWNDHVGNGISQQDVYHRLFPAMQTLSVKMWDGKNTTVSFEEFDQKRHLLSEAPATN
LLARPAKSKKGVVFEVKKPKQNKNLNQSLTDIGYDYRVSFDILVKENPKNTPLFTSDHAT
FYLRDKDGKIGFSRDGYDYQFNYILPTNSLQKISIEGTNKSTSLFVNGKLVQTLGIIPHK
DDAHLKEKARKWIQTLVFPLKKLNKFNGKIQNLKVEYL
>OBAHECAF_02137 Magnesium transporter MgtE
MATFKLTDEIIEQIEMFIEEKRNRELISLFEEMHYADIAEIINELDVDQAIYIIRLIGKD
KTADIITELDEEFRDKIFEKLSAKEIADELIELDTDDAADIISDLPEERKTEIISYIEDV
EHAKDIVDLLRYDEDTAGGLMAKELVKVNENWNVLKCVKEMREQAEFVKRVHSIYVVDDN
DVLKGRLSLKDLLTTSTRSNVKDIYIPKVDYVYVTDSAEDVAHIMSKYDLEAIPVVDEMK
RLVGRITIDDVVDVIKEEAEKDYQLAAGITHDVEADDSIWKLTKARLPWLLIGMFGGLGA
ASIINGFQDAMNNFPILLIFIPLIQATAGNVGVQSSAIIVQGLANNSIDSQLWGRLLKEF
MLGLINGLAIAAIVILVSHFLFEADYMVSTTVAVALVTVIVNAAIIGTFIPIFLHKRGID
PAVATGPFITTSNDVLGILIYFSIAKIVLGF
>OBAHECAF_02138 hypothetical protein
MYVYNLTVVVSNEIFELWFNWLKTDYIPKVEASKKINNTRIFKVLNTPSDVTFALHHETQ
HPQDLLDFITKDIPHFQMLSHNLFGEKALMFGTELKEIFL
>OBAHECAF_02139 hypothetical protein
MPPQLRLHFIVFLWGFTAVLGKLIGLDAYHLVWYRMFFTSIILIGFVAVFQKQSIFIERS
LAVRLIGIGSLMAIHWLLFFQSIKVSNVSITLSCISTATLFAAFIEPLVFRRRIDWTEIV
LGIVITTCMLLIFKTEMRYKEGIIYGILCAIFGAVFSVFNGRVHGKTSSANIITYEIFGG
FFMLTIYYLFSGDLEGVSHISVNDFWWTLLLASVFTAYPMFESIRLMRHISPFTLILAVN
LEPVYGIILAYFIFGESENMNPIFYVASGVMILSIILNGIIKNRR
>OBAHECAF_02140 Neopullulanase
MKNNTASFIRKRFGALLFLFSLPIFAQIQKVEPPFWWADMHHSELQIMLYGKNIGQFSVE
SELPIVNVTKTENPNYIFVTVDTKNKPEGNYKITLLNSKRKITTFNYELKKRREDSALRK
GFDSSDVIYLLMPDRFANGNPQNDSNPKLNEKADRKLPGGRHGGDIQGIINHLDYIKSLG
ATAIWSTPMCEDNDETYSYHTYGQSDVYQIDARYGTNEDYKRLASEMHKRGMKLIKDYVT
NHWGWKHWMIDDLPTYDWIHQFPGYAQSNYRMSTQMDVNTSEFDKKYCVSGWFVKSMPDL
NQSNPLVLNYLIQNAIWWIEYADLDGLRVDTYSYNDKEPIARWTKAIMDEYPNFNIVGEV
WLHDQAQISYWQKDSPISAIQSYNTYLPSVMDFTLHDAIGEAFRATPSWDKGMIQIYDNF
VNDFLYKDINSLLIFAENHDTSRINEIYQDVKDYQLIMTLLATARGIPQLYYGSEIGMRG
DKSKGDAYIRQDFPGGWADDKQNAFTPAQRTEEQKQYFDFTSKLFNWRKTKPVIHYGKTK
QYLPQDEVYVYFRYTETESVMVIINQNKETQMLDLNRFDESLKGFYGGKDIISGKNITLQ
KDLQIAGKTAMVIELQ
>OBAHECAF_02141 hypothetical protein
MDFVRLYIKRISYSHSQNEAFVLILHELESDLKLPIVIGAFEAQAIALELERNVVPPRPL
THDLFKIFAKKFNVNITKVVINRLENGIFYSNMVCERDGEEHIIDARTSDAIALALRFNA
PIFTHRFILQKAGIYIPEPNEPQPQSPTLHIEDDEKIQEKRARFKRHSMSELKRMLEECI
ESEDYELAAELRDEITRRETDD
>OBAHECAF_02142 hypothetical protein
MSFYHYFNDYNHMLGQYDCYKVYENSLKRILKNLTNVE
>OBAHECAF_02143 Putative nucleoside permease NupX
MRTILILFLFLFPWIGKAQSSEVMSQTIPSQGFTFESLWRGVLGMVVLLAIAYLFSSNRK
KINWKTVGIGLALQLSLAVGVLKVDFVQAIFEKIGGVFVLILDFTKVGSEFLLGGLLDAS
TYGFIFIFQILPTIIFFSALTSLLFYLGVIQIVVRGMAWVLSKFLGISGAESLSVAGNIF
LGQTEAPLMIKAYLQKMTKSEVLLVMIGGMATVAGGVLAAYIGFLGGDDPQLRLIFAKHL
LAASVMAAPGAIVISKILYPQTENFSNESKVSVENVGSNVLDAIANGTTEGLKLAANVGA
MLLVFVAFIAMINYIFGWIGDITSLNTIISENTSYKSLSLEMILGVLFSPLMWLIGVAKE
DMMLMGQLLGVKLASSEFVAYTQLADLKNVASASHLMYDKSIIIATYMLCGFANFASIGI
QIGGIGSLAPTQRKTLSEFGLKAVLGGSLASLLSATIAGMIVG
>OBAHECAF_02144 tRNA-specific adenosine deaminase
MNILNTKQVRYDKAYMRMAMEWAKLSHCKRKQVGAIIVKDRMIISDGYNGTPTGFDNCCE
DNNGDTKWYVLHAEANAIMKVAASTQSSEGATLYITMSPCKECSKLIHQSGIKRVVYKEL
YKDDEGIDFLKKAGVELVHLSETEDV
>OBAHECAF_02145 Threonylcarbamoyl-AMP synthase
MEKDIKKTVETLTNGGTILYPTDTVWGIGCDATNEAAVTKIFSIKQRNESKSLIVLVDSE
QMLRDYTEDVADVVFDFIKKNPEPTTVIYPKAKNLAKNVIAVDNSIGIRLVQDDFCQKII
RQFGKPIVSTSANISGKPTPKIFKEIEAEIIHNCDYVVRYRQMDTKVKSPSRLVFFDSNG
NIEFLR
>OBAHECAF_02146 Inner membrane protein YccS
MYLGIISFFKSFSFFKGILKTIAVMVPIGIGWYFNALEVGLPIGLTIIAISPSDIPGNRK
HHIGGLLVATLLAMMSCLFVNLAFPYFYILLITIFLLTFFNAYISLYGHRASMVAFSGLF
SIASTLSHIEQGEGIFLHLLYIFIGGVWYILLVMFYLWIKPRQYSEQLLGKCFSLTADFF
SVRARLLLSEDRDEGFKKMIDLQTLLNENYEKLRDVILNSRSKSGKTDYLQRQFLMFIEL
VDIFELALANPVQYEKIDKEFAENKDILRFYSDFLEELSRQLQQMSVYIGSRKSVQLDNS
LQEKLLLIQQKNNEFKTQNNRDSDKEKVLTIRNFYIYIENQYNSIENIRVIFENYYQSNI
GKRDEESYRKFVSSQSYSWKRLKDHISLQSSFFRHSIRISITTLIAFLIGDYFSISNAYW
IVLTLFIIMRPGFGLTKERSLNRIYGTILGGVVAFAVIYLFPNPTLHLYVGVLCMPIAFG
LMQENYMYASIFITISAIFMFALASPDVYAVIHDRVLDTAIGVGLAFVANYLILPTWEYR
TYGDAIQKSIRANIGYLKQVKSVFNTDQVITNAYKISRKEAFLALSNLNATFQRMMQEPK
SKRNKTALTYGIIVIQQSFLSSVASLGVRLKAHKTTFPKEVFNQAIDDLITSLEMNLALL
TNEFTVNVQNYEIFVENFHKSVQNIIEKQELSKQSPISKRETQLYLEQFKYLFGLAKNLE
QELKKL
>OBAHECAF_02147 hypothetical protein
MEEKEFLENEEIFSKALRAGRRTYFFDVRATRAKDYYLTITESKKFTHEDGSFHYKKHKI
YLYKEDFEPFKDILNEMTGYVFEEKGEEVISERHQKNFKTRAFQGYSMDGYNSTINLNFE
DLQ
>OBAHECAF_02148 hypothetical protein
MKLLKRNPFGHILWIKRWVIRFFGFITHRRYNGINQLNIQGSDIIRQLPENNVLFISNHQ
TYFADVAAMLHVFNASLKGRKDSLKGFGYLWNPKLNIYYVAASETMKSGILPKILAYAGA
ITVDRTWREKGKDIQREVKQSDVENIGVALDDGWVITFPQGTTSPWKPIRKGTAHIIRQY
KPIVVPIVIDGFRRSFDKKGINFKKKGIQQSMVIKDPLQIDYENESVEQIVEKIELAIEQ
HETFKKINSVTLS
>OBAHECAF_02149 tRNA-specific 2-thiouridylase MnmA
MKKVVVGLSGGVDSSVAAYLLQQQGYEVIGLFMKNWHDDSVTISDECPWLEDSNDALLVA
EKLGIPFQTVDMSEPYKQRIVDYMFSEYENGRTPNPDVLCNREIKFDVFMNLALSLGADY
VATGHYCRKEEADVEGKKIYRLLAGKDSNKDQSYFLCQLSQNQLSKALFPIGELQKSEVR
AIASAQGLITAEKKDSQGLCFVGKIRLPEFLQQQLLPKEGKIIEIPNDWEGYTKRHQQLN
FESYESELEFRSKRFTYQPTDGKIKGKHQGAHFFTKGQRKGLNVGGTPEPLFVIETDVNQ
NIIYVGQGNTHQGLFRSALFIREEDVHWVRPDLALKTGDSKDFMVRIRYRQPLQKATLHK
VANGLYIDFKEPQSAITEGQFAAWYEDDELIGSGVIN
>OBAHECAF_02150 hypothetical protein
MKIISYPLSALHYLIFGSLLLIFHPIQWIAIHAFGRKTHKAVVDFLNFLLVHVMWMTGNR
SYLTFESPLPENTPLIFVANHQSVYDIPPLIWFLRKYAIRFVGKKELGNGTPSITINLRH
NGSVLIDRSKPQNAIPQLIEFGKSLQANNDAGFIFPEGTRRRDGKPKPFKTKGLEAIISQ
MPDGYVVPLTINNSWKVLKYGAFPMGLGNKITFYVHTPIKIDLNNINQQIVEVEKLVVSK
II
>OBAHECAF_02151 hypothetical protein
MYPPELVKPMIEELTNVGFQELKTVDAVKEALKQSGTTLVVVNSVCGCAARNARPAVIES
LQNAKKPDHLTTVFAGVDREATEEARNFMFPFPPSSPSIALFKDGELVHMLERHHIEGRY
AETISDNLKQAYDEFC
>OBAHECAF_02152 Acetyl-coenzyme A synthetase
MKYEKKSTGNLQNLENSSQKIHESLKALNERYYNINSLARYIDIYRLSQNDPIEFWETIA
NNNFQWRKKWDSVLEWDKEKSEVKWFSGATLNITENCIDRHLAHRGEQTAIIWEPNDPKA
PVRKLTYNDLARNVYRMANVLKSQGIKKGDRVCIYLPMIPELAIAVLACARIGAVHSVVF
AGFSSSSLASRINDANCKMVITADGGLRGEKTIPLKNIVDEALKECQCVEKVLVVEHTHQ
QVTMHSNRDMWLAPLFQEASEFCPAETMEAEDMLFILYTSGSTGKPKGIVHTTAGYMVYS
AFTFKNIFQYSDGDVYWCTADIGWITGHSYIVYGPLLNGATTVIFEGIPSYPDFGRFWEV
VEKHKVSQFYTAPTAIRSLAKQSLEFPQKYDLSSLKILGSVGEPINEEAWHWYNDHIGKK
RCPITDTWWQTETGGIMIAPIPFATPTKPTYATFPLPGIFPVLMQENKEEVTENSREGHL
CIAFPWPGMARTVYGDHQRYIDTYFSAYEGKYFTGDGAFRDEVGYYRITGRVDDVIIVSG
HNLGTAPIEDAINEHPAVAESAIVGFPHDIKGNALYGFVILKDETRVHDNVRREINQLIA
DKIGAIAKLDKIQFVTGLPRTRSGKIMRRILRKIASNDVSNLGDTTTLVNPEIIEDIIKN
AL
>OBAHECAF_02153 hypothetical protein
MLSAKDNFCHNCGQENHYNDFSIKELTSDFFGSFINFDNKIWNTLKTILRPGQITKQYVE
GKRIRFVPPFKLYLFFSFIFFVILSFSFQKASHSGFMQRMFTSINKSVTSTQLKITEAEY
MQLKDANSDQIKSFIDSILKHKNKWNNLNRKTFNNWADKNIFSDFRVGVWDNQFSIGSQK
IASSYAVFLNKKPEFDTIWVGKYQLTLKELKTVYENSFQTDSLITTKWKELDRFEHIRLR
NSIKQVGVFTFGTVTQMTEFTDTQIAKYLSITSYTMLLMMPFVSLLLLIFFRKKYKKMYI
HLIHSLHLHTVIYLFTSILMGIFLWSGLNTFFWILYVICMAGLVTYFTISNKILYEEPIS
KTIFKSLILTFLYFAISFFIGMLIGYVSVAYM
>OBAHECAF_02154 putative GTP-binding protein EngB
MIITKAEFVVSNSDVSKCPNEPLPEYAFIGRSNVGKSSLINMLTNNKNLAKTSGRPGKTQ
LINHFKINNNWFLVDLPGYGYARVSKSTKKVFQKFITQYFEKRHQLVCAFVLVDVRHEPQ
KIDLEFMNWLGENSIPFAIIFTKADKLKPNAIERNVEAYRQTLLETWEEFPPYFVTSSES
RLGKEELLQYIEDINKSLR
>OBAHECAF_02155 2-hydroxy-6-oxo-6-(2'-aminophenyl)hexa-2,4-dienoic acid hydrolase
MTTEVKQEGKFSYIEKGEGTPIILLHGLMGGLSNFEGVISFFSKANYKVVIPQLPLFSMS
LLTTSVKTLSKFLHKFIKHKNFEEVILLGNSLGGHVGLLYTKLHPNRVKALILTGSSGLY
ESAMGDGYPRRGDYEFIKKKCEEVFYDPAIATKEIVDEAFRDVNDRGKLIKTLALAKSAI
RHNMAKDLPKMTTPVCLIWGKNDIVTPPRVAEEFHELLPNSELFWIDKCGHAPMMEHPDK
FNELLNSWLIKQNIH
>OBAHECAF_02156 hypothetical protein
MKLKYVFYIFFVSIWIVFRNNSELTESIYSTGIYPYIAIIQHYTWGWLPFSFGDIFYTIS
IGYVFYFILRKGKNLWKRPLWFFDKLLFFVALVMFAFFFLWGFNYFRKPLSETLQIDTKY
TEEELYKATQLFVNEANNLHKILAKEDSVKVDFTLSHKEIYKIAYQSYPLGYEKITDFVS
IKSVKPSLYSAFLTYMGYSGYLNPFTNEAQVNGKLIGYSLPVTACHEIAHQMGYAAEDEA
NYLGYLSAQKSENQYFKYSASLFGLRYLLNEVYKVNPEKYDEFTSKVNKGIFKNYKEVRE
FWMQYENKAEPIFKASYDAFLKANKQQHGIKSYNLVVGLLIKNKINN
>OBAHECAF_02157 NAD(P)H-dependent FMN reductase
MKIVAFAGSTSSTSINKKLVEHTLTHFGESDINLLDLNDYSMPIFSSDEEKKGTPEQAHK
FLQCIEEADAIVCSFAEHNGNFAAAFKNVFDWASRINKSVFQNKPMLIMATSPGGYGGKN
VLDVAQKTLPHYGGNIKGVFSLPKFGQNFDANEGITNPELKQEHINTIENFKQQIAQ
>OBAHECAF_02158 hypothetical protein
MKPELEHLPLVKNDEKNRFELENNGHLAFIDFEERDSFIALTHTEAAAELAGTGTAAALV
EKTLHYIEESGKQLMPYCPYVFAFIQKHPEWKRIVSPKFPAYDKL
>OBAHECAF_02159 hypothetical protein
MMITKTYLDSLTYEIIGSAIEVHKIMGSGLLESVYHQCMREELKIRGIDFLTEMRIPIIY
KEKYLDIDFRCDLLVNQSIVVELKAVQELLPIHEAQLLTYMKLLKCPKGILINFNCSNIF
KEGQKTFVNEYFSRLPR
>OBAHECAF_02160 hypothetical protein
MVQNLRKMKASVKATLGKTNFYTEIVAGENKIITDEPVSLGGQNKGFNPLEVLASSLTSC
TAATLKMYIDRKEWEVESIEIDVDIENNTTERQAVFTRKIHFNGNLDEKQIERLHKVAES
CPIHKLLTNQIEIQTEIV
>OBAHECAF_02161 Quercetin 2,3-dioxygenase
MRKILFFLGVALLSSYSFGQKTKSNNKNNKQMKAVYHKADSRGHANHGWLNSYHTFSFAE
YYNPQRMNFGVLRVLNDDTVKGGMGFGTHPHRDMEIISIPLEGDLKHGDSMGNEGIIRKG
EIQVMSAGTGIMHSEMNGNQGETVKFLQIWVLPRQRGVKPRYDQINIEKDKKINDFQQIL
SPNPDDAGVWIHQDAWFNMANFTSGNSKTYKLNKEGNGVYVFVIKGKAKIGDQVLDQRDG
YGIYDTSEFNLQALEDSQVLLMEVPMQLP
>OBAHECAF_02162 hypothetical protein
MNIFQNKDLGLLILRLSVGLLMIPHGIHKLLNSGALGYIQSLLEAKGLPAFISYGVFVGE
IIAPLLIVIGFRTRISALVLAATGLMILFLGYDNLFALTQHGGWVAELAGLFLFGALALA
FTGGGKYAVSTNNQWD
>OBAHECAF_02163 Serine acetyltransferase
MKNNFLEYLKTGYCDRKYDLNKQKIEQFIDSFFRFIFFLEPQRCDSQTEIESRFVSFKNQ
FKDIINDIKQENTVQVCETFFNEIPSIYETLEKDAQFFLESDPAATHIEEIKVSYPGFYA
IAIYRFAHRLHLQKIPLIPRIWTELAHSKTGIDIHPGANIGEYFFIDHGTGIVIGETTQI
GNRVKIYQNVTLGALAVSKSIANTKRHPTIEDEVTIYAGATILGGKTTIGKGATIGGNVW
ITESIEPYSLVYYKDKTIIRSQGNSSEPINFSI
>OBAHECAF_02164 Cysteine synthase
MKFNNVLETIGKTPVVRLSKIFPKHNVWIKLERSNPGGSIKDRIALAMIETAEKEGKINR
NTQIIEPTSGNTGVGLAMVSAVKGYHLTLVMPESMSIERRKLMTAYGANIVLTPRELGMK
GAIEKAQELAQQNENTWIPQQFENISNPEIHRNTTAQEILNDFPEGIDYLITGVGTGGHI
TGISEIIKQKFSELKSFAVEPELSPVLSGGNPGAHPIQGIGAGFVPKVLNTEILDGTIQV
SKENAFAYTQRLAQEEGILAGISTGASLAAIAQKIDELPENTTILTINYDTGERYWSVEG
LF
>OBAHECAF_02165 hypothetical protein
MKKNILITALSLAALCSCNKTTTPKTETPQTASENIPQPFISSIEYSNLVDKASQEEVKK
ALSAAGIKEGNIQTFLDNVSTFNQTVGEVGMVKEGFATSQNLTPEYDKVKIQEKWEEKNP
LFVGYNCRITSFDMLRDFVHIENPILENAKNLFVDEDALENNPQKVFSSKERDLFMAFFS
QIPTVEGKDISKHIDMVQKDWQKKGISFIHNNDKTKASLISVFFHSFFSKEDNHLFIGHI
GVLVPSENGKLIFIEKLSFQEPYQALKFNNRTELNDYLMNRYDVEWNQPTAAPFIFENNQ
LIEGYRPNPNKKIEQSS
>OBAHECAF_02166 hypothetical protein
MATRINPYLNFNGNCEEAFNFYKKAFGGDFTMVVRSDETPMEVAENEKNRLMYIELPIGE
NDKLMGSDIFESLGQKLTTGNHNYVSIAVDSKAEADRLFHALSEGGEIEMPMEEQFFGYF
GDFKDKFGISWMIIFEG
>OBAHECAF_02167 hypothetical protein
MKNIGCPIFYGQPSFIDNVAKMELKNLINYCFFIDL
>OBAHECAF_02168 hypothetical protein
MKKIFFLLLMLSAFSIRAQQSFSGFRVSPYGGIYSIINNPAEAVGGMHKKGVNLLSFDGI
FSNNKVPLSLSGLSDSFEKFTKTGEGSVFSHNDLDADFNLDILGPSAFFNIGNKNAIAIT
SRVRAIADARGVDAKILESYFSDTNLMDLAAYPSIKIDNQHILVNAFSEVGVSWGSIVFS
NEKHTIKVGVTLKAIQGIISSRAGFDGFSGAIKLEQKKDDVILNVSGTGDFSINNGGINI
WGEDSDSKFRLQSSASTFVFDAGFAYEYRKEPCPDCEKTPYDFKFGLAFTDAGRLNYTTT
ENSKKYSINSSVTSVALNLDNLQRDLDRSNLVSQTSLKGKTFTSSLPVALRIYADARILR
KFFVDFSGQFASSDKKDKIYNAAYANSFVLTPRYESRWIGFYLPIANTQQVGTTIGTGLR
VGPLVVGSSSIISNLFSNNTKGINVFAGITYQWH
>OBAHECAF_02169 hypothetical protein
MKISIRQDLYWSFSYFLIIIGFGTFMRLTHAVPDLFSYNYRYVLHTHSHIAILGWIYTTL
TALLSYSFIPLEKAKQHRRIFYLTQISLLGMLFSFPFQGYGAISISFSVLFLLFSYYYSY
FFLKNSNTQEHKQLISYRFVRMGIFYLILSSVGIWMIPVAIATTGKDSNLYQASIFFFLD
FQYNGWVLTTLMGLFLKKNHADRITSPWINKILYGFQIGVFGAIAVSYISIFDSIFLHLI
ATISSLVWMLSIGAVIYFYIQKYPFKNVLSNGFLFLFITKVCMMFFASIPYFKEIIFYNN
DFIMSYLHFNFLGVINFGLLYLLKENNLLNLSRISILVYIAGFLTTEFLIAYKGICLWLG
WAFFENYFLLLSLASGLFLICVSEWLFRINRN
>OBAHECAF_02170 Chaperone protein ClpB 1
MNFNNYTIKSQEAIQRAQQIAQGYGHQDLQIEHIFKGIEEVDNNVLPFLLKKLNVNVSML
NQNVQKALDSYAKVSGGSMSLSRESAEMLNKASNIAKEMNDEYVSVEHLLLAILKTKNKL
SQAIKDQGITEKELEKAILELRKGERVTSASAEETYNSLNKYAKNLNQLADSGKLDPVIG
RDEEIRRVLQILSRRTKNNPMLVGEPGVGKTAIAEGLAHRIVQGDVPENLKDKIIFSLDM
GALIAGAKYKGEFEERLKSVVKEVTTSDGNIILFIDEIHTLVGAGGGEGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKVMVEEPDTESAISILRGIKEKYETHHK
VRIKDEAIIAAVELSERYITNRFLPDKAIDLMDEAASKLRMEINSKPEELDVLDRKIMQL
EIEIEAIKRENDVEKLQSLNADLANFKEERNHIFAQWQSEKTLVDEVQKAKTNIENYKLE
AEKAEREGNYGKVAELRYGKIKEEQDKLENLQKELDNQKDKALVKEEVTREDIAEVIAKW
TGIPVTKMMQGEREKLLHLEEELHKRVVGQEEAIEVVSDAIRRSRAGLQDVKKPIGSFLF
LGTTGIGKTELAKALAEYLFDDENAMTRIDMSEYQERHSVSRLIGAPPGYVGYDEGGQLT
EAVRRRPYSVVLLDEIEKAHPDTFNILLQVLDEGRLTDNKGRTADFKNTIIIMTSNIGSH
LIKESFENHSKDIEKATELAKNAVLQLLKQSVRPEFINRIDDIVMFTPLSKANIKEIVQL
QFRNIIRLVARENIVLDATPEAIDYLAEKGYDPEFGARPVKRVLQKELLNKLSKEILQGN
ITTNSVILVDSFNSQLVFRNIK
>OBAHECAF_02171 hypothetical protein
MNYLTKIKKIRLEKKISQEDIAFQLGISQSAYAKIETGKQKLSAEQLIKISKILSIDLKE
LSDSSS
>OBAHECAF_02172 hypothetical protein
MLTDNFNKNNMIRFTTKIQLKAIALTLSAILLKTSCSIKTCWVWRWRGFRSGLYREVTRM
TNTDALADEARHHLGKEYVKWYEFATAKWAAPRRFTCTTLVWWCSKKAYDVNVSSWYSPL
VSPSGLFTDSNTYLIREVR
>OBAHECAF_02173 hypothetical protein
MKKLYFLFALLGVFACSEDKDMTPEHFKAQQRDSRFFGKWAVINSKTFEEIVTVTFYSEY
TKIGELFLIHRDTEEKDKSVEYYYTKGDRLYVLNPGSGFKVSASVYEFRYEFSDSDNILV
LQEYTNGELSNYKRFLKRK
>OBAHECAF_02174 hypothetical protein
MKKFCFIFALLGIFACSEDEHMTADYFKAQQRDSRFFGKWMYVNPDTFEEEITTYYHNYT
KDGEFHLIYRETGEKNKRVEYYYTKGDRLYVLNPGSGFKVSASVYEFRYEFSNSDSILVL
QDYTNGELSNYKEFLKRK
>OBAHECAF_02175 hypothetical protein
MKKFYFILALLGVLSCSEDEHMTADYFKAQQRDSRFFGKWIFVDSNTLEELSDFTHNYIE
DGELQYFYLTGEPYYSRKEYYYTKGDRLYVLNPGSGFKVSASVKEFRYEFSNSDNILVLQ
GYTNGELSSYKESFKRK
>OBAHECAF_02176 hypothetical protein
MKKNYFLFALLGVFACSEDEHMTADYFKSQKRDSRFFGKWNVVDINTLEEVMTTVYREYA
ENGELSYIYRETGEKNKRVEYYYTKGDRLYVLNPGSGFKVSASVYEFRYEFSNSDSILVL
QDYTNGELSNYKEFFKRK
>OBAHECAF_02177 hypothetical protein
MKKFCFIFALLGVFACSEDEHMTADYFKSQQRDSRFFGKWKAVNPNTLEEKITSFYSEYT
EEGVFDLIDRETGEKDERKRYYYTKENTLYVLHPGAGFKVSASVSEYKYTFSDDNNILII
QTLEEYRKGDKGEFFKRK
>OBAHECAF_02178 hypothetical protein
MKKFYFIFALLGVFACSEDEHMTADYFKAQQRDSRFFGKWNDVDINTLEEVMTTVYPEYS
ENGELIHIYRETGEKNKRIEYYYTKGDRLYVLNPGSGFKVSASVYEFRYEFSDSDNILIL
QRYTNGELSNYKEFLKRK
>OBAHECAF_02179 hypothetical protein
MKKFYFLFALLGVFACSEDEHMTADYFKAQQRDSRFFGKWAVINSKTFEEVVTVTFYSEY
TETGEHFLIYRDTGEKNKRIEYYYTKGDRLYVLNPGSGFKVSASVNEYRYEFSDSDNILI
LQLYVNGELSNYKEFLKRK
>OBAHECAF_02180 hypothetical protein
MKKFCFIFALLGVFACSEDEHMTADYFKSQKRDSRFFGKWAVINSKTFEEVVTVTFYSEY
TKIGEHLRIDRETGESNQRVEYYYTKGDRLYVLNPGSGFKVSASVYEFRYEFSDSDNILI
LQEYTNGEPSNHKRFLKRK
>OBAHECAF_02181 hypothetical protein
MLTLRKSHTSIYAIFEKHINATTSEDIDFIFDLVDYYRQQYNKKTTIDLTELLSEIRNDK
EKTHFLKAKLISVFSDKKKTILLTDAGLLSSTSFFKELRRRVWHKLIPDQPLNNSIQYVL
NQLFYKSSDTNWLSTIPMDNWFEFLEILSLSTFYDDTKNRRVTKEILLAIMILSQRMGGF
ALQTDVMRMVPEYSSLESPFIALDDELNALHRAIMSQDKPYLSLEDHHLDLKQLDILVKQ
CEDFVEKAVNNTSKYGVSFNVNQTLLLIRQQVRRIRKLYNFLFISGEEEKKRKSIEFYLS
LVRVNSKKNNISKLIDDSVYNITYEITNYTGKTGEHYITSNAKEYFLMFNTAFWGGIIVS
FMCLVKLALSKTESSEFIHALNYSLNYAIGFVVIYLIGATLATKQPAMTASTIARTLENL
ESKDTKEKNKRYSEFSALFARLFRSQFVAFAGNVLAAFPMTLLLIWGLTFLLDGYNLAES
KHDKLLAELDFRQTPVFLHACIAGVFLFLSGIIAGNVASVNNFNNFYYRLSEHPVLKTIL
GKQRMIKISNWMKKKWPGVVSNIWFGFFMGCTGVIGTFLGLDLDIRHITFASGNLALGLF
GANFDIGLELLLWSIAGVFIIGFGNFIVSFSLSLFIALRSREIPVFELKNLTKSVWIRFK
QRPMSFFFPSRESKTVESV
>OBAHECAF_02182 Beta-hexosaminidase
MKKYILALTSLFFAISKAQTPNPLLAEDAENQKKWVEETYAKMTLEERIGQLFMVSVFSS
QINTRNTEVVKDFIKKYHIGGIIFSKGGPKRQAKLNNEYQSLSKVPLFMAMDAEWGLAMR
LDSTYAYPWNMTMGAVKDEKLIEKAAFRIGQHCRHMGMQFNFAPDIDVNTNPANPIIGNR
AFGEDKENVAIKGIAFTHGMQSAGVLGSAKHFPGHGDTAKDSHKTLPLIEFSAHRIDSID
LYPFRKLVDSGVASVMVGHLNIPALEPKKGLPSSLSYTIITELLKNKMGFQGLIFTDALG
MKGVAEYMPVGEVEVAAFLAGNDILLMPENMAVGFEAMKKAYQQNRITEERLAYSVKKIL
MAKYKVGLTSFTPLDEKTIYDNLHSLEDDLLTEQIFENALTVAKNNNKTLPIKDVDKKIA
YVKFGNDSGWTFYTTLQKYADISLIEPKSIEQLQKDIASFETVIIGLHRPNRTPWDAYQF
TKDELLWLENIAKKKKVILSIFTRPYALLDVKDISNIEAIIVSYQNHKVAQEKTAQLIFG
AIEGKGVLPVSAHPLLPVNTSIQTPKIGRLSYGLPESVGISSTKLNRIDSVAKEVLSKRM
APGMQILVAKQGKIIYRKNFGTLDYNDKNKVTDNTIYDLASLTKILVTVPQLMKMYSEDK
FNVNGTFSDILPYLKNTNKGKMKILDVLSHYAQFQSWIPFYIQTLDPDKKPLSEWYSTQK
TKDYNVQVAKDLFMKSEYVNIMYERIDSSDLIKKKRYLYSDLPYYYFKKYIEETYKKTLD
QVIDEHFYAKMGAYRLTYFPLKRFSLGSIAPSEVDTYFRHQEIRGYVHDQGAAMLGGVGG
HAGLFGTADDVAKMMQLFLQNGYYGGTWFLQPQALTLFNTCTFCSEKNRRGLGFDKPQLE
GEGPTCGCVPMSSFGHTGFTGTYAWADPENEVIIVFLSNRTFPTAENNLLIKENIRPKIQ
RIVYEALK
>OBAHECAF_02183 Ribosome maturation factor RimM
MTLKDCFYIGTIVSKFSFKGEVLVKLDSDDPELYENLESVFIALGNNLVPFFVEKCSLHK
TDLLRIKFEDVSSEADADALMKSKLYLPLSFLPKLTGNKFYFHEIIGFTMEDVNYGYVGK
IVGVNDITSQALFEVENDGKELLIPMNDEFIEKVDRQHKKIIVKTPEGLIDLYME
>OBAHECAF_02184 30S ribosomal protein S16
MPVKIRLQRHGKKGKPFYWVVAADSRAKRDGKFLEKIGTYNPVSNPAQIDLNVDAAVKWL
KNGAQPTDTARRILSYKGALLKYHLLGGVAKGALTLEQVEAKFNAWLEEKSGKITSKEEK
LAKDKAEAKAKSLAAEKEVSEKRKNAAVAEAQVEENAETPENNETEA
>OBAHECAF_02185 hypothetical protein
MKKILFLASIWLMIIGCSGSKIEDDPEGIIISNGKIVDMGNPASDGCGWLIEINGIYFVM
DGFDNQFQTNGLHVKISYLHTKFHYLCGRGGKPFSVIKIIRMDKM
>OBAHECAF_02186 hypothetical protein
MQNKGLIKLFALLFGLVSVYQLSFTFVANRVENKAKAFAEAKVLSSETDYVSKRERVESQ
YLDSMLGQSVYNIGVTKYTYGEVKEKELNRGLDLKGGINVILQISVKDILKGLANNSKDP
IFNKSLAEADELLVKTDRTYLDLFFEAYQNNGGKLASPEVFANKALSDEINIQMPDNEVR
PIIKRKVDESITSAFEVLRKRIDKFGVSQPNIQRLGTSGRILIELPGAKDVTRVKTLLQS
TAQLEFWETFKNVEVFPYLEALNQQLVATIKPQATETTSAIDSLLTDVKKDSVNQVNPLF
DLLKPVPTYEGSPVLFGASIKDTAKVNSYLKSTDAKRLLPPNLQFVKFVWGKPAKNTDVI
ELYALKGNRDNVASLTGNVITDASQTFDMRNQPAVSMQMDGKGARIWENLTDKAFKEQGN
IAIVLDDIVYSAPGVTNGAIAGGRSEITGNFTLNEAIDLANVLRAGKLPAGADIVQSEVV
GPSLGQEAIDSGFNSFLIATIFIFAWMIFYYGRAGVYADIALILNILLVFGVLASLGAVL
TLPGIAGIVLTIGMAIDANVLIFERAKEELAKGKGVAQAVQDGFNNALSSILDANITTGL
TAIILLFFGSGPIQGFATTLLIGIITSLFTAIFITRILIEYSLEKKHDLTFSTNLTKNLF
KNVNISFIGKRKIGYIVSGIAVLVSIISLSTRGLNQGIDFVGGRTYQIRFEHPVVASEVA
AELQQYLGTTEVKTFGAANQIKVSTKYKVEEESTQVDNEIQELLHKGLQKFLPAGYSYEE
FSNAETDAIGIVQSMKVGPTIAEDIKSSAYWSVIGSLIVIALYILFRFRRWQFSVGTVVS
SAHDVILVLGIFSLTYSFMPFNMEIDQAFIAAILTVVGYSLNDTVIIYDRIREYMKEPNF
TKEKINVALNSTLSRTLNTSITTLAVLVTIFIFGGESLRGFMFAMIVGVLVGTYSSLFIA
APMIYDTLEKDFDKKNTSES
>OBAHECAF_02187 hypothetical protein
MKTFILLPFCFLWLFSCTPKGELTAKDAQELIIDHLEQHPIFEQGKFDTSKQRIDSKKQR
ELLTSLEKLQEEGLIEINNEKIRKKWFTKDSIFVVTTNLTKKALPYVVQQNKNHTLVKTI
LYKLNESKEVVIEKKSEKNAVCTVFLDKEKTPFYYFGDDSTPKSDFISRKFKLKFSEQEG
WKVAK
>OBAHECAF_02188 hypothetical protein
MKNAIILTLFQAISSLVSGILISQMSFLGRVGISLKYREYLVFKTWWKTALLIFAVHLAI
ILLLYLLRKLIGFWGMKIVVALLFALGVAGVYLTYQDFTTTMHKVMKQKFHFGFYLFWLS
WFITCFYFLLMKKPKIKSYKENQQLHTSKERNHHTIVE
>OBAHECAF_02189 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MKLPAIKLAQHIIQACKTKNIQHIVISPGSRNAPLTIGFSNDPFFTCYSIVDERCAAFFA
LGIAQQKKHPVAVVCTSGSALLNYYPAVSEAFYSNIPMVVISADRPSDKIDIGDGQTIRQ
QNVLMNHSGYNANLSDKQHSDASNIYELNQALNTAIAERLPVHINAPFEEPLYTTTNEIF
PFENFSERERIYSTTPAQNKNFIQAWNQSKKKMVLVGVLSPNELENRYIEQLAEDPSVLV
LTETTSNLYHEKFIPYIDKLLTYTEKDESLKADLQPDFLLTFGGLVVSKKIKQFLRKYQP
KFHYHIDRYKGYDSYFCLTDHLKTDINSFFTDISLELKTISSNYQKRWTTVNTEIHKRHL
EYINQIPYSDLKVYKKIFENIPDNQMVQLSNSSTVRYAQLFRLNPSWQIFCNRGTSGIDG
STSTAIGAAIGSQRPTLLITGDLSFFYDSNGLWNHYVPKNFRIILINNQGGGIFRILPGD
KNDKHFETYFETPHQLTAMHLCKMYEWDYDQADNITDLTNKLHILFEKSDRPRLLEVHTP
RTENDKVLLNYFQILKK
>OBAHECAF_02190 hypothetical protein
MSKRDELIEVYAKDLKEKCGVTPDLDFLKKVTVGLGPSIYNADSSTVAGSDQMELDRVKQ
NFLIKKLGLSDGPELDKAIDSVIETYGRSNKTKHRAVVYYLLAKHFKKESVYNK
>OBAHECAF_02191 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLDFELPIKELEEQMEKCAIIGDKSDVDMTDACKKIEKKLNQVKKEIYGNLTPWQRVQ
ISRHLDRPYTLDYINALCGDSFLELHGDRTVKDDKAMIGGFGKIEDQSFLFIGQQKGVNT
KMRQYRNFGMANPEGYRKALRLMKSAEKFGIPIVCLVDTPGAFPGIEAEERGQGEAIARN
ILEMSRLKVPVIVFIIGEGASGGALGIGIGDRVYMLENTWYSVISPESCSSILWRSWEYK
KEAAEALKLTAPDMKKLKLVDEIIREPLGGAHRDRETTFLAVRKVILETYNELKKLPTDK
LVQKRMDKYLNMGVFKE
>OBAHECAF_02192 Replicative DNA helicase
MKDLQPYTTIQETSPVSSSIINLERGKIPPQDISIEQVVLGAMMIDKKGVDDVIDKLTPD
VFYKKQHQFIYQAIYDLFQQSEPIDLLTVVEQLRKNGNLEAVGGEYYLIQLTQRVSSSAH
IEFHARIIMQKFIQRRLIQISSEIIEEAYDETTDVFDLLDSAESKLYEVAQGNLKRSSES
AEELVIKALKKIQDISNKTDGFSGIPSGFTKLDQLTSGWQASDLIIVAARPGMGKTALTL
SMARNIAVGQGIPVAFFSLEMSSVQLITRLISSETSLPSEKLRTGKLEPHEWHVLSTRVK
DLEKAPLYIDDTPSISIFDLRAKARRLSSQYGIKLIIIDYLQLMTAGGGSKGVGNREQEI
STISRNLKALAKELDIPVIALSQLSRNVEARPGHKRPQLSDLRESGAIEQDADIVSFIYR
PEYYKIMEWDDEAQSSTKDQGEFIVAKHRNGGLENIRLKFLGQFGKFDNLDDFDTFGGGI
PQEISSRINDIDTSKLPSVEQAFGTPPQIPNDEDIPF
>OBAHECAF_02193 Aspartate--ammonia ligase
MSYLIKPTNYRPSLDLQQTELGIQKIKDFFQANLSAELRLRRVTAPLFVLRGTGLNDDLN
GVERAVNFPIKDMNEVRAEVVHSLAKWKRVMLADYGIEQGYGIYTDMNAIRADEELGNLH
SLYVDQWDWEMVISEGQRNTDFLRNIVRRIYATLLRTEYLVCESFSSIKPILPPEIHFIH
SEELLQKYPNLTPKEREAAIAKEYKAVFIMGIGNKLSHGEKHDGRAPDYDDWSTMENGLA
GLNGDIILWNPVLELPFEVSSMGIRVDKAALLHQLKLEGKEDRLELYFHKRLIEGSLPFS
IGGGIGQSRLCMFLLHKAHIGEIQASIWPESMREECLKHNIPLI
>OBAHECAF_02194 Endo-1,4-beta-xylanase Z
MIYLQLKKLLDMRYIYFVLLIFISVSCRKEQLVVEIDNDSKVDMSQSIFSTILGGQQPYS
VYLPPHYASNTTKKYPVLYLLHGMNQDYKHWVTYGDLKNIVDKAISEGLPEVIVICPNGY
NSLYYNTEQMRYEDFFMEEFIPVIEKKYRILDNKSNRHIAGLSMGGFGATYLGFKHHKKF
GGVYSMSGGFLLTAIPVIQSILDEKNSEELTKLPRYIMECGTEDTLVIDSNDLFHQMLTN
KGISHDYIRRKGKHNWQFWKESLPKALDFVSK
>OBAHECAF_02195 hypothetical protein
MFINMKNSSFFLMLLLTIVGGGRVFGQNHVDFNSLYRKTLQGDMIMVGNSILNVGDTRPA
NTPYVGSHDNNSRIGLQYADVDGDPSTFNSSSAFVSHPTSACLKVDKAYLYWSVAYTQER
VNNQVNPKFERNKFNSVKFKTPNSLYQSFTGIRIYDGNHELARKPNSEDSQRAYVYRADV
TNMLLTEGAARNGSFSGDYTVANIMAPYGTEWSGVGYAAGWTLVIIYEDKNQTSKMITLF
DGFSAITSTNQSLDISISGFQTIPSGSVKAKMGIAVLEGELGIQGDGLLIKSALKPAGVP
IDAPGGRTTSFYPNFFNSRITDTAPTPNTNRTPASTNLLGFDVAIFDIPNSANSLLDNNT
TSVILSPFTLQDSFYPFVVAFNVEVIAPAVVVEKKIYKVNGGTDVTGGTVNLGDKLRYEI
KFKNEGTDDAKKLVLTDLLPKNLVYNNIISSVRFGWKSNPVAGTDYVYNPTNHTLIFNIP
DHVVKKGGNWQKVSFEVKVPDTCDDLRDACSNVIDNVVTGTYFGVENTQITPFNVRSTDN
YSACGNVEGPSTFIADLKTCVSKRKETLCQKTLDLVAGADFDTYAWTKGGSSTIIGTSQT
LKVTETGTYKVLKKKTGCADMREEIEVVLHSDAQATNPINQYASLVLTCGNDGSDYPQIY
LCGTSATKLLQLNTAGAVSYNWQKRNNCTIPTTHPDTCPVLDNYGCTWNTVHTGSSYNVS
QGGDYRVEINYAGGCVQVFYFRVTKTELTPTVTTRDIICTKQGEITVTHPTSGYQYALRG
SDGNIVVNYQNSNKFTVTNPDSYTVLIRQALPAGSTYTPCIFELSASIIRKNPNLAVAAT
PLACQNSKGSLQISVSDMFPPYTYVVRNASASGAVVHQVNATNTTNITVPNLNDGNYYVQ
VTSPDGCALSHPITINKLPELKATATVKRHLMCGEAVIRVEAQGGTPGTSYGYSIDGGTT
YVYNYTGKFYEFTVTAAGTYNIQVTDGNNCSVSTSATVDALTHPTFTATSRLTDCGQKVA
LQINVTSNPSNFQIRYSVDGGLTSQIGNTFVGLTPGGTYTPSLLISSGSATCTLTSTLTL
PPINNAKITAAFAGVIELIGCGGTGVNSDKAKVRVTNVQGGSGNYEYSFDNKANWITSSE
AWLPAGTHNVFVRDKVNECEFGPMEVNVPNRPVAPNFTTSVAYDCQGLGSITVDSNQNGF
VYTYEYNGRTYTSSTISELPPGSHTIKIKYADPTAPTPSILIKEDFGYGGYTRNPNVHPN
YTYRDTSTIADGQYVVMPAGTVTNPTSGTLANNCWTAPTDHTSPSDPTGRYLAMNVGSVG
FNKPIYYKEVNDVIPEQEIRFEMYVYNLCHCTSCAPPIFAIRLVNSATGQIIGTQQDSGN
IPVNEMVRGAWHRFSGTLAAPGVTSLRIEVVSMSPETGGNDLAIDDILVYQVPKVCGFDA
EVTATVLPNKQFGANENTRIVENAKCHPTSTTTPNSRGKYQINLKNIANTGYYVSKDGGT
WTLETANPFVWDDVSVGNHTVKFRYSATSTDCEVTETFEIKAPPAITVTPIPTKYLGCNP
AEVTVTAVASGGTGALTYALESNIGTTPYQSNPSFVINNVGRYTIHVKDINECPASTSFD
VTPAPPVTIAVAPTSNYCVTTGGTGASITLNVTGTPPFVFRVNGAVHATTNNTSHTLTNL
QPNTYVVTVTDAHGCTTTETIRIEPPLRVSASSVQQDITCRPAPNHRGRIQVNLEGGYGS
NTYVVRGTTIVQPQTPVTGTSIIYESDQPGTYTIEITDAKGCKTQVTHTLTQPVPPTFTY
TQTNALCNGGRGSITVNVTSGIGGYTYILNGGTPQTSNIFNNLVAGIYTLTVRDAKHCDA
TVQTVTITEPVAIRGFAGVSQLIGCGTGANADKAKVRITNVTGGVPPYEYRFDGGWVSEN
EGWMPAGNNQSVWVRDANKCPFEMKVDVPQKLTPPVFTQTAVTYDCHGNGTVTINNDQST
YSYTYSVNGGTPTTTNTLTNLSPGNNIITIKYRQVTAPNPVILIHEDFGSGTPVPSPNVT
NAFLFIDTRIRCLNHNLYSITNKTDFSNASTCVNGWVAPNDHTPGGDPRGRYMAVDIGTQ
LAAGGVLYEKEVHDVLPNKPIKFKMYGFNLYSTLSGINPSMQIQVVAKDPLTGNETILQQ
ILSADVQPNGGNADAWAEFSSDAYGTIDPQNNTSLIIRIRTIHNATGGNDFALDDILVYQ
EPEMCDFTATQTVQVATDKEFRATAGTITQPSCHGGNDGSAQFFVENFAATGYRHRLNAG
AWSTATTNSPLTISNLTAGDHTLTLEYVGGGCTVTMPFKVTEPAVFTLTSTVITPQKCSN
TGATVRLTAGGGTPPYQYQLGTGTLQNSPEFVGVPHGTQIFTVIDDKGCPATTTVNLVAP
KTVSFTATTQNCYSGNNDASIQVNVTDGNGGYKFSINGGAWITPTNPTTHAFEGLSNGTY
TIRVLDSYDCTATQTLVIHPKLIMDVQTIDKSCNDGRITVTARGGNGNYEYGFAPVGDPM
PTLGTTNTFAVTTAGNYMVYLKSADCTISQTVSIGTAPAVGATVTANQPACFGSNGTVAL
TNVTGHAPYTFALKNTVTPTISQTFNNVIATNYTFANVVSGTYSVTVTDRYGCVVTYTAT
ITGKPQITGIIKSTATDCVKIGDEVPLELTVSPTTITAYTSSGYELYYSTNGGAWTTLSS
TNTIAGFRTGDQITVWFKTVPNGAGHGAPPVCIEKMPTETVPLPLHNLTISTNLTAFTAT
CDPAGMEVVVGASGGTGPYKFAILHSASDPIPLPVDPQWKTPTPANGLTHTFTGLVPGRS
YRFLVLDNTSCVKENTQELYDNYVPPIHITATKVKPACHGTTTGEIEFTVTRLASSTTTA
TTFDWKVYKIGQTAPVSTGSGVMMPAQGASVTLPPVTVQAPGTYYMLIKEAVTNCEWASA
NVEMRVLDPIGATARVITQDVTCDISGRILVENVLGGGGVYEYQLTSPAFVATITWTSNN
PIEISRSNIIAGTTGPINVTVHVRDQYGCGFTLTTPLTLNVPAPPPAPTGTANSCSEPLS
IQVTPAGANYEYALAGPTPRTWQTSNTFTNLQAGNYIVSIKDITTGCITTGTTTVTLHPM
MQATVQQTKLLGCTHLAEIKIDVTAGSGSYDYAITGAATVTRRALLTNTFTTSTAGTYNI
HLYDNDATTCPAKMFTVTVAPAIQPSFTTTTVSVTCHGGNDGKIFVHDQVVGSNYTYVIA
PAATFSSTIKAFEGLSAGVYSITMTDINNGCTTTTSVQVKQPAQITSAGGLTATAFKCTA
GNTSDAVVVTLDPTQVTGGTPPYSYQLVYDNGTPANSTDDITVNGTTMTITNRLGGDVKA
IITDTNGCTNLPATPITVTIAPYDELKTARVGIDDAITCVTRENVSVTVTSTSGDNTKWM
YIQSDTPPALTHPAWQSANTFTNLSVGTHRFWVKHIETGCMISAVHTVKDPNTFVINTPV
ITNPDCKGGTGSANITLTDATYTGAYQYTVQFGTTTLPVGTTAGGATTQNISLSNLLAGT
YTITVKQQAVPNCDKSYVFTVVEPTTALMASVTTEPITCVNGGVIEVTNATGGWGDYSYR
ITPQSTGTVGAWQPNPRFTGLVADTYKVEISDKAGTGCEETISATVVLTNPVPLTATMTI
ASQNCVAGSGVMSVTVSGGAGEGYTFELFRGGNSHAVLNTTTATTVTFTNLDAGAYHVKV
SDVWGCHTITTATLSTTLHTPITNVHATVMKEITCSTPTGGTVSITHSAGHSTNIRYAVT
PPGGGATVTQINSGLFTNLLTAGVYTVEVYDITTGCATESVTFELTPAVSPTFTTTRSDV
KCNGGADGWFTVDVPQTQQHLDYQVVVTSTATGFITQTRTVANVPTSLLFKDLSAGVYTV
VVTSVRGCVTTDTVTIGEPTVVGVTATTTTFACDPSNLPKPVIITAVGNGGTAPYHYSID
GTDFTNTSGVFTITDTGVTQTITVYVKDSHGCATTTTVVVQPFPAIQGVSVVGTNRITCA
NPETIAVTITGGANQGYTVEGNRISGVGVVSPTTRTIIAGSSTTTFEITEVGMYEFKIID
NHTGCYTVTTYTVHPYNNIEIKVSPKVNTSCYGASDGVITLETTGYLGSYAYRVIDDATS
LMVASGTATTTMASLPHRVDIGGLPTGMYKVELTENGIPFCTVTSTLVSVSGPTRALTAT
ATIIAPLTCEGNNAVIDVQAQYGWGNYEYQLWMNGIPHPTYGTYTTTSAFVGLGVGNYEV
KVRDMGGCELTASATATMTTITIAPPVPITLNLTSSVTQVSCYGDKSASITAVSVMGGSG
NYKYVLISTIGTEVYESGAQDSPTFTNLGAGVYQVKVIDGWGCDQVSTVHITITEPTPVR
LNATITKGLTCLTNAEITLVASGGSGTGYTFSTSPTETFTAADVLSVPMGTYTYYAKDSN
GCLSEVSNTIEILPIEPLTLTVDATDAYVKCNGESTAEIRATAQGGLGNYQYELKGTLAD
GSVVTRTTLDGIFVGLATGTYQVTLKSDDCVTSTIHPIIINEAPALVWGTATSTDETCFG
ENNGTIKVMATGGTGSITYAISPRLDRAVTAEFINQQEYAPGTYLVRASDENGCYVDFDV
TIQAATRLTAVLDVVTHEICFGAADATASITISGGKAPYHTAFNSNAVSGTWTQSNDGRV
YYDNLPAGENQVIFVKDANGCSTYVVIPSINTGVDLQLSATAKVECVSANTISSEVIVLV
NSNYASLVTYALDGGTPQRNNIFTNVSSGTHTITVAHPNGCTTQTTVFVPHYDPLTVVTS
TTQVSCNGESDASIVMQVTGGSASYTYRIAPNIGTFDVTTGTFRGLPAGTYEVSVRDNQL
GCVLTEIFTFAEPDVLYVETGSVTETCYQVNDGQLFFEIKGGRPQYAYTLTAPDGTLVES
ATGIVQGQVISKTGLVPGTYQLLYSDDASLCTKTATIQVGKAPNIEPINSKAIKVQYQCR
ESWDNTSVSENYIELFFDNTILTASNTFYALNSTNLVDAVPFSEFIGNKAIIRNIPAGKD
QYFTIFYKTCTYTIPVGQYFDVEEYDPLMLTDKTDPKSLNTIKVEATGGKAPYTYRFNGI
ISDDGNEYHIMPADKGYVTPGGKVIKQIDVEVLDDLGCTRTLTIEKEFIDIKIPNNFTPN
GDGNNDDWGPNDPRSYPNMTIAIYDRYGRLIAQLEKGQRWDGTYEGKHLPTGDYWYIIRL
NEDKDDSREFLGNMTLFR
>OBAHECAF_02196 hypothetical protein
MNRNTVTWVILMLLVQFSWAQQKNNYYLAHDLPGHTAVKYNTFLMNPAFPIFGYKESHVA
LYHRQQWMNFQNNFSIFMGTYGKKWSDNEVINVMAFQKNIGVFQNTGFLGNYVHQIGLGD
ESYLRLGINASFGMSGIAQGKIVANDSSDPFLANFSNTGIFNINPAFDINFGMIHFGLNA
ENLIDYALAGGEMAVPFSDKAFTGHVMYRNTMTAGSGVLEEATLSVLARGRKSADNFQMG
GHAMLDMPTLGWVHAGYDQKYGVSAGLGFNVNANLSAGFGYEQGIGTYVSNLGGTYEITL
AYNFGGERQARAKKLAKDRKAKEVELENKRKAAERAKEEKKKPAVVTPTTQTTPPPPKPE
EKPKTIMQRLEERLKVQEHKIANDKISEGFYVIVGVYRNPKGAYQYLQNVRGLGLTAYTF
VHPENGMTYVYLNKAYSSKGEAGVVMTETLRRPEFADRSIWILRVSR
>OBAHECAF_02197 hypothetical protein
MKIDISYKYLVLLILSLFVGYVHAQRIETISLGFSDACVSDSYNNFGVSFKWQPPLPNAT
NQYIIELSDANGDFSNPVTLATLTGQNTQFEYSVNVQFPNTMHGDAYRIRVSSTNPSSSI
TSNPFSAYYVNVNSPMELNGGVSNINLCPGHSQEISVNKKGEKAYKWYRNNTLIPGETKH
TLRVSEAGTYHAVVDYGNYCSGSSNSRSNNVTVVMGGSLGVVITNSISGNNICKGQPFTL
TASVNDSNYLYKWYRNGTVVQQGAGMHTYTAPTDDTAAGSYKLGISVPGSTCEELTNEIE
IKFRENFTVSATVQGDVLILPGGTKKLEATTTAESPSYQWKLNGAPIQGATEATYQARQP
GEYTVEVTQGGSCAGVLQTSNKVLLESPNEFKVEIRYKSSGYQPCMFDKATLGLAKIIAV
TPSGEVLLEASSYSAFTYQWYKDDQALDDDDDDNDDDDDDDDSGFELTLNKATQNGNYSL
KIATPGVTNIQRSNSLPVQLTDPNAVQLNGGQTSLEVCAGVVTLTASPLDVNATYTWYKD
GVKVSEGAGVYEYGATQMGTYYVAMSGTSEACPATSNSLVLVKREIRANWVLPQIPRAFI
PGKTYVLTITHNMNNPTIKWFRNGTEIQGVSAPTYSVTESGAYHAEVESSSSGCAGSKIV
LPLRSYIEIKELKPNIGFAEVQSQNCDGTATQTTLKLKKLEAVLEGGEVVLIGNEGDETD
YQYFSFQWLRNDAPIMGQSDPTGLVVTKEDALTGSYSLLAIYQTIIDPSNKLNVSFSTIP
DITLVSESDDDSPKICEGGSTIIKAPIDSEAFSYQWYKGAVPIEGAVEATYEATEVGDYY
LRISNGACTKQSTNIVKVSVFDPSSLKLVRVNSDGVEISEVPSGSRVTASKGEVIKVVGG
NNKAENYLWSTPSNSVFAQEIIIKETGDYVLTATIGGTCSPVELRFSAEVFEISKIPNVV
TPNGDGSNDFWEIPEDYLNKDNVKVSIYSQEGKAVFSGTRFTNKTWPNVETYKELGKRAL
IFMYIIEVDNKVDKQGTITLFR
>OBAHECAF_02198 Sulfite reductase [NADPH] flavoprotein alpha-component
MTLSIWRYAHLVLALVASFFVLIATLTGMILAFEPISNQLKPLKSSNFEDVELFETVLQL
KEKYTEVLSLEVDENRFVKTEVVDEQGDTMIFYIDPKTAATVGETYKRPELFSFTTTLHR
SLFMGKVGRIVMAVTAFLLFLIAVSGMILIVRKQKSWKRFFNKLVKERFFPHYHTFLGRL
LLFPITVITLTGIYLSLEGFSLITSPKIDFEDIDYEQITEKPHRSIADFEVFHIPLSNVK
KLTFPIFEDLEETYRLELIDSELIINQFTGEVLAQSPKSTVKAMTYYSMILHTGRGTVLW
AVILFLSCISILFFIYSGFVITLKRRKSKIRNPYTKDNCQYVILVGSEGGTTLGFANLVH
HELIRQGKKSYLAEMNSLSEYPKMEHLIVMTCTYGKGNEPVNATKFKSLWQKNTIQKPFT
YSVVGFGSLAYPDYCKYAYEVDELLAKTSIGKKIVDLQTINNQSVESFSLWANEWARQQG
FSLNLPFNKLAKKKGKQHTFKVIEKTTIQSDETFLVRLQTIENVRFTSGDLLGITSEVDG
RERLYSIGKTAFNEILLSVKRHEKGLISNVLNNLKSGDLLKSAIYKNPEFHFPKKGKPVV
CIATGTGIAPFLGMIADNEAHQPLTLFWGGKNDRSLAIYKSFLEEQLRVGKLTNLQIAYS
RMGAKKYVQDIVLEQSTFFANLLKSGGVVMICGSVAMQRGVAEILESICQEQLQKPLSYF
QNRQQYKVDCY
>OBAHECAF_02199 Transcriptional regulatory protein ZraR
MENIQTIKQRFGIIGNDPKLNRAVEKAAQVAPTNVSVLVTGESGVGKESIPKIIHSLSMR
KHGKYIAVNCGAIPEGTIDSELFGHEKGAFTGATSTRNGYFEEADGGTIFLDEVGELPLT
TQVRLLRVLENGEFIKVGSSVVQKTNVRIVAATNVKMFEAIKKGRFREDLYYRLSTVEIH
LPALRERKDDIHLLFRKFASDFAEKYKMPSIKLTDDGVHLLVNYRWSGNIRQLRNVAERI
SILEQKREISATILRNYLPDEGVNLPTVVGTTRSESDFSNERELLYKVLFDMKSDLNDLK
KLTLELLQKGNSQQVQEDNKGLIHRIYGENKKHTSEVTPEISFIPVEATIPTEVIDDAEE
YVYEEAPKDESLSLHDKELELIIKSLERNGGKRKETAKELGISERTLYRKIKQFDLDL
>OBAHECAF_02200 hypothetical protein
MTMISNIPLYNHTAGVFIIGVFVLVCIAFVVMTVMFFRSGKKK
>OBAHECAF_02201 Penicillin-binding protein 1C
MLRFFNYITQKIKQNPIKTSVFGVVLLLYYFSLPKALFPDDYSTVIESAEGNLLGAKIAN
DEQWRFPELDSVPYRFKKAIIYFEDEYFSYHWGVNPISMTKALVNNLQQGKIVRGGSTIT
QQVIRLSRENQQRTYFEKITELILATRLEFRHSKDKILRLYASHAPFGGNVVGLDMAAWR
YFGVSPHQLSWAECATLAVLPNAPSLIFPGKNQQLLLQKRNRLLKKLLDNQVIDNETYEL
ALAEPLPQKPHPLPQMAPHLLELIAKKNEGHRIKTTIDFYLQEKVNQIVRNYYHHYSQSE
VYNMSVLVTDVKTRNVLAYIGNTPTNVAHQKDVDIVHAPRSTGSVLKPLLYAAMLQEGDL
LPQMLIPDIPTHISGYSPQNFNNTFEGAVPADMALAKSLNIPFVWLLQRFGTYRFYDIIQ
KISLTDIKKHPDHYGLSIILGGAESNLWDLTRVYVNLASELNVFNKQRAYRSAEFQDLNY
DLSKNTIDFGHFTTEIPTLRAGAIWQMFEAMKEVNRPTSDVAWRYYESARKVAWKTGTSF
GNKDAWSIGITPEYVVSVWVGNATGEGRPSLTGASFAAPIMFSIFNTLPNSTWFQKPHED
LRELSVCEVSGFLAKEECPKKTIYSTISNSDNEQCKYHKIVHLDKNEQFQINASCESLDK
IVTKSWFVLPPVMEWFYKKQHVNYQTLPPFRADCQHSNTIKSLDFIYPKHGNIIYTTKGF
GGDLQPFTAKVAHNEGEVFWYLNSSYLGVTTHFHEMDIYAPKGKNILRIINTKGEERVIE
VTVK
>OBAHECAF_02202 1-deoxy-D-xylulose-5-phosphate synthase
MILPNIHTPHDLRQLPREQFSLLAKEIRDLIIDVVSRQGGHLGASLGVVELTIALHYVFN
TPDDKLVWDVGHQCYPHKILTDRKEAFENIRQFGGISGFPKIEESVFDAFGTGHSSTSIS
AVLGMAVASVLQGNRDRQHIAVIGDASIVSGMAFEALNHASTTDANVIIILNDNNIGIDP
SIGALKNYFEQQKKEKGKNESFFKSLNIKYKGIIDGHNISELITSFESAKKEKGIQLLHV
TTIKGKGLEKAENDQITYHSPRKFDKITGEQYSESVELPPKYQDVFGLTLKELAEQNPKI
VAITPAMPSGSSLTHMQQSFPNRVFDVGIAEQHAVTFSAGLSLQGMIPFCVVYSTFLQRA
YDQIVHDVALQNIPIIFCIDRAGLVGEDGATHHGVFDMAFLRSIPNLIIASPRNATELRN
LLYTAQLNVGQPFAIRYPRGRCSQTDWLQPFQKVEIGKGRRLKSGTKYAVLSIGSIADNV
TKALDLLKNSEEYAHFDIGFLKPLDESLLHTIFATYTTIFTVEEGIEKGGFGSSITEFAN
VYNYKNKLKIIGLPDIFITHGNVERLQKIVGLDSSTLAEKFSLL
>OBAHECAF_02203 hypothetical protein
MKKILLTTLLLINAVSFAQIRRAKGEIQPIKTYPIQIIKNQRAIEFAIDRFKKEQEKWFK
FNRINLSISEMAFSNWSAGGDNSVTALLNAQFRRRFSETTYFWDNELEINYGANAQKGRG
PRKTDDKFSITSSFGYRGNSKSRWYYTAKSQFLTQIYNGYAYPNTETAISKFMAPAHFTL
GIGLEFVPDAKRFNIFISPITHRTLFVLDKTLADQGAFGVDEAEYDANGNMIKPGKKTKS
QLGFYVSGNWRKEIAKNMQLENRFNFYGDYLKNVGNIDIDWESTLNLKVNTYVQARIGIH
LKYDDDIKFYSYKGANGAIHQYGARPQLKQMLAAGLSYTF
>OBAHECAF_02204 Thymidine kinase
MFLENTTNHSEKFGWIEVICGSMFSGKTEELIRRLRRAQFAKQKVEIFKPALDTRYDESK
VVSHNANEIHSTPVPTATHILLLADGCDVVGIDEAQFFDNEIVNVCNDLANRGVRVIVAG
LDMDFKGNPFGPMPALMATAEYVTKVHAVCTRTGNLAHFSFRTTDNDGLFVLGEKESYEP
LSRAAFFKAMKTKKDNRIENTEK
>OBAHECAF_02205 hypothetical protein
MEILFTADALIAFLTLTFLEIVLGIDNVIFISIVTGKLPEEKRKRATQIGLFLAMFMRIA
LLFAITWLTKMKSTLFTIDWGWFTAHINGQALILLSGGIFLIYKSTKEIHEKVNHIEHIT
DSKGAGQKRSVSFSSVIFQILMIDLIFSVDSILTAVGMTNGLYPAEVEIWGMRPELFIMI
AGVIVSVIVMMSFAVPVGKFVNRNPSIQILALSFLILIGFMLTTEALHLSDAVLAGETIG
AVPKGYLYFAIAFSLGVEFLNMRMRKKTS
>OBAHECAF_02206 hypothetical protein
MMGYKGVKMKCTITHKPKKPEKALKIRELQPKKPENGNKTKCTTITINYYLITI
>OBAHECAF_02207 hypothetical protein
MREFSVLKERILYFLDFKGISKYEFYQKTGASNGILSQKSGLSEENTLRFLSAYPEVNAE
WLLTGRGNMLKSDNENKESSIIIHHGDRKTRDKIIESQEIPLYDLEATAGLVELFKGGKA
AQVLETIKIPNLPSCDGALSVTGDSMYPLLKSGDIVLYKQIPVNPDSIFFGEMYLLGVMV
DEFEEMITVKYVQKSDKGDDYVKLVSLNQHHQSKDIQIKRVTAMAIIKASIRFNTMF
>OBAHECAF_02208 hypothetical protein
MDTKVQDFNEIVRFCEQKRQTGDYQTLANVLGVNTDAARMQIYRKTEKAVMILYKIIKQR
EELKKEYQNQ
>OBAHECAF_02209 hypothetical protein
MTNLINTTEQTMSSREIARLTGKRHQHVVRDIREITLQFADCQSQTKFGLAEYTFKRSNY
LDKQGKERVEYQLNQKEVLLLVSGYNVVLRAAVINRWVELEKQQGILKVPAPKTINGVQC
IAYNYWLLQNGYSLTSGQVRARIKKYPEQFIKTKDGWYMSEAIGRYFLDYRNPKEKIAKL
PFVSPKQLSMFND
>OBAHECAF_02210 hypothetical protein
MKKAFKPFKINVVIVYYADVKVKPVRHFVLSTLKNLAWLYRLDYNICENTPTFEAIEGGL
CQEADIVYFRSSKHTHLTLKEFQKLFDQVFAYKHTQYLGCDIFYQTQKGCREYPFPKHHF
YRPLNYPYMEEHKDNQAVVKLPYAVLAELFPEIQDS
>OBAHECAF_02211 hypothetical protein
MPYLWLHNKVAVEADELVPRFWNKLDTLRQEIHRYRNKPYGIKKLQSGGNGRKLLIDFDT
LSAEIQEELGDPRKAGHLLEKYYQTQDTTIRYYAEWKRGEKHLTDEEQRQYVINATTWQS
LLQLEADILNVRKGMNKRNPTRGLANDLLSHAQTFNESLKKKEKDKEKRKYTHNLPTNLR
RFKEALKAFKMNGLFSVIKDPHGKGKQGRRKVDERVLMVLQGLFVGQKFKPTPTEIYQQY
EAFLSGYVQIFNEETGELFEPKEFPKLSESTVTSYLMNWENKIASYKLRSGNRQTYKGTF
IPHGQMELPKFAGSLLSIDDRQPPFWYEKGKRLWFYIGLDVASDCITCFVYGKTKEGIIL
EFYRQLIRNYHDWGVELPYELECESSLNSSFTETFLQEGYMFQSVRMEANNAQGKIIERR
FGHLRNNIEKKANGWIARPHAKSESNQAGKGKTEIIPYKELVQARLADLEDWNNQPSRQD
KNQSRWEYFLNNQKSDLPKTNYRAILPHLGYKQTTSCQRGFISLQGKKRAIADNGKILTG
DALIEKMKQIEGKEFDVFWLDDNEGNVLKAIVYQNGRYVCEVQEMPKFQRAKAEQTEQDM
LNKALQDAYTMTVIRFAERQSKAIESIGIVSVAPKPKRMFQIKGLKRYETENEENEVEIL
GDFDEINEDDQHYMYNSSTGTEHVPQWKQRFNRQTTAV
>OBAHECAF_02212 hypothetical protein
MKIAIEFKEKIRKSILEDRENYGGSDSDYAKSINLKPAIFSRLKKGEIEKIISDTQWLVI
AHQLGVQVRDNAWKVARTKIYVEVEDALNFCQQYSKAMILVDDCGIGKTFCAKHISRKLK
NAFYVDCSQAKTKQQFIRLLAKTIGVDNTGKYADVKASLKMYLLYLELPLIVLDEAGDLD
YNAFLELKELWNATQGKCGWYMIGADGLRAKIESGIRNKKVGYAEIFDRFFDIISLVPKG
KDDREQFYARLIKDVADANAKDDEDTSVLVRQCMSEGKRLRYLETLIKMQ
>OBAHECAF_02213 hypothetical protein
MYERGQTPPLFGNPNQNAINMARIKGISGAKLLEKKYKTFAFDGVWFDTMGTPEVSGFWI
IYGAEKQGKTWFALKLAEYLSKFENVLYISAEQGTSYTFQEAYNRAGLDPKNEKIKFVPY
VELAELEKTLKRQRAPKVVFLDNITVYADELKNGKLRQLQMTYKNTLFVFVAHQEDGKSE
PYTATAKLCKKLAEIIVQVEGLACTISGRCPGGRLTIDEERATLYHNAILTENQTE
>OBAHECAF_02214 hypothetical protein
MTTVKQQTTFRHKLAYYTELSYLQYENLRHQYFLDWCGRIAKQKYIPLEWLSKNDYLKNW
FDDQWVALVEGGIKRQYNTELDAGIFDKDDVLLMLDTFYLDLQYFPKVLIQKIIQTHKQY
ENKVC
>OBAHECAF_02215 hypothetical protein
MRTKYVNRDYLEHRVNCINAELINSHHEAKERQRLEAARNYYVSKLVELDESGLNLIEIE
SYEQVN
>OBAHECAF_02216 hypothetical protein
MSRLIDYIEVLKLDNFIRELTFEERLQVSQYRAGRTDEVPPKVVALQQWIDKNNWQPPEF
KVSQYREILWYDLERQSFQPLKTHPMYNYKLRINN
>OBAHECAF_02217 hypothetical protein
MSNIDLSQLSAQELQAELQKRQDAQAENRQAYKDLVNNNLKNIIDVLKEFSNEVSKTKLF
VFQSLKTFLDIKNEVYEVKGEQQSHTFSDDHGNTITYGFRTVDGWDDTVNAGVEKVRDFI
SSLAKDDNSAKLVDVINRLLRKDAKGNLKASRVLELTKIAEEFNSPEFTDAVRIIAQAYK
PQKSAFFVDASYTDPQGKKVNIPLNISAVDFPEGTNIAELFPVHEKYDNI
>OBAHECAF_02218 hypothetical protein
MKKENKIKLLISADGDLNNENDFKIHLVAEGGMFEISCVLAGLIQREDWLKKVVEQALEM
AYEQ
>OBAHECAF_02219 hypothetical protein
MKPTHYYCDFQSGTQTKNKLQNEFYDFLKGFDHRIYRAEDIPKLQEVVQNKVKELNAKHP
RCKPLNASLDNSYLYNNDYSVWTDFAILKFKAGNIHEV
>OBAHECAF_02220 hypothetical protein
MITTDQIRIIQTLLNKRFSEREERLEFLSDFFGTEIKSTKDLTKTQATHLIRYLNGEKIT
PFQIYAYFDTQNPQHRALLARCHELGWVQEDNPNFVDLNRLGAWLISKRSPVKKALQDMG
HKEVSKVIYAIENMIKSKYK
>OBAHECAF_02221 hypothetical protein
MILPFKTKINGKPTYFVEKIWAGLENHCVDPFYHEGKTSGKYEFEDNWSFAPKIHTIRED
KHNRWQVGKMIDFYINNRTKKAFCFAPRVPVKNIQTIKLDYAPSFVYLYIDDECVEAARI
DDGGIEYLFRSLSTEGDCPIMHSLAINDGFNSISEFINYFYPYEKDGTTCFEGKIIHWTN
FKY
>OBAHECAF_02222 hypothetical protein
MEEQLNNEPDEDTTPVCTHENTHVLTLGWYATCEVTAVFCKDCGKQLGAEQWDC
>OBAHECAF_02223 hypothetical protein
MMIMTRSAYEFWSGKKAPPEVHSFEKNNLGQWTTTTWQEVFKERKEKQDKNLHFKRDFYE
KTVPCYVWVFHNQNQFLFGGWYIYIVTKNKEFALNFKPHLNYKDILLDIMKLFPCGVLPM
HENFELWCEAFCRQFPKKSKKRPTEGAKTCYAELDKYNRLKKVITK
>OBAHECAF_02224 hypothetical protein
MKISLKITKEATGVLCYYFSRAGEAQPRNRRQRVQLSIMKEVAVKMERYYANLQPNKKWR
KINFKAYEADMIEQYLSSFVDVVDDVYSRIIIQKVIAEINQQLA
>OBAHECAF_02225 hypothetical protein
METTYFMRGRNSPTEHIFKYDLNGDLISFENTGEPLNGAQKQWLFVSGNFPYDEEKMINM
QNNITLKKYFDIEKVPAKITFDDFWNAYGKIGTKSQAKKKFDKLKDSEVIKAFLGIKKEQ
QKKKLDGTAMPYAETYLNQKRWE
>OBAHECAF_02226 hypothetical protein
MFLFFLAMTLLTGCESQREKEERILREKVFESKYLKDAFSDLLRVETMSKVINSDSPMKE
ELILDYNTSLGIYMGLSKDVDEISRNIQSKKEWYKRYVIADTYLIYIKADDSIRIKEYTK
ERERFLELMK
>OBAHECAF_02227 hypothetical protein
MDTATVTYKRKAYRNEKLSARFYFYNSLVGLRYEVCVRLLEREFDISESRIYELLSQNNN
YIAFFERNKYSINDLRKRYPFMVWQYVHGMMSQNAEPLIVCPA
>OBAHECAF_02228 hypothetical protein
MKQLYITLIELLKEIPEIKWADLDMGQMQEEMPPVAFPCVLINIDLSKIETIDFDLQHVQ
ANFSITLHAKMLSETNANAPEKARLQGLAYLDLVDKITAKLQGYSDACFYEFERVSVQSQ
NIRQGIQSTVLRFETSFRERIAKP
>OBAHECAF_02229 hypothetical protein
MATFSGNLQIIKQRLAEKLRQLPPILGEEAVNFSLQSFEQQGWRGRTMQPWKLRKEVNKW
GKKDDRSRKILIQTGAGKRSIRVIKIDKYKVWIGAGGGDFSYMNAHNTGFRGRITQNVQP
FTRKIKKGKKAGTEQQVRGFQRTIAQNLPKRQFIGGEKDSPYLKARLQRIIKRNLNDLFR
>OBAHECAF_02230 hypothetical protein
MKVIQYVYRLKRLPDELINRDIVTLQAQTLIKPIDRILQDVDWNSPDYIMREILKKNMWH
FSVAKNYNDCVAINNLLIREDGSLRPWHDFKREAQKIAGNSARYLKTEYNTVVAGAQMSR
KWQEIQRDKHLFPYVMFDVVNDRHTSDICRPLHNVIVTVDDPMLMYYFPPNHFNCRTDVR
RLRYGKPTEKYRLPEIPEAFKNNVGMSGSIFTDKNKYIENTPAEVLKNADTLHKIDILSK
PREEQFKLLFEAENGGKVLEHLLLQKGKDYDSILTSAIEFAKQGKTAEILPVINQKELKE
YRKSVFLDYDLNKNPDLRVDGVYYDIKEVESLKKIQRNANKASIQGAVAIIQYNGEDLTQ
EAMEQQVRRIFGANNIDKNGIHNYPYQLVYFLHKGKLYKYNRG
>OBAHECAF_02231 hypothetical protein
MAKVKHDKPIKISQTLVVRPPERSPQDIQKWRSAMLQADRGRLHTLVDLFNDLLIDTVLS
GAVEKRIMAITNANLLFSVKNKEIEAMADFIDTPEFEELLREIMLAKFYPKTVLELDFTN
GFKAVSIDRRHLNTEQRAIVRSIGDTDGFPYENNDFLIHLGKEGDLGIFLKTAPHAIFKR
NGMSDFAQFAELFGIDMLVGYYDPDDENGREEMDRAFLKKGGGGVNMSMSNKSKVETVGN
KSSGTVDIHDRFLDKCDEQILIGILGQTMTTKDGASYSQGKVHADVEEDINKADRRYVQR
VLNKELLPRLEKRGYPVAGGWFHFAEKGEKLSKKDELEIAKGVNEIVPVDENYFYENFGL
PRAKSSPQIAPKEKEQEAEPNGAKENKEQNPSKGKTSPTRKVQAQNLSLWERFVDFFAQA
PR
>OBAHECAF_02232 hypothetical protein
MYLTPNELHTHIYEEELQAIIREDEAIVLSAIDTAVEYASSKLAKGYDIEAIFSAQGKER
NPLLLSIIKDITLWELVNLANPSVDYEKVKFRYERAVDWLTAVFKGMPANLPKRLEELQK
NNSVSLHSNPKRNNYF
>OBAHECAF_02233 hypothetical protein
MKLSADDKKALQQWEVFYKNLQREDSVDLNESPIAKAERIKKLEADPEAWFKYYFREYCT
AEPADFHKKSTKRVLGNSEWYEVRAWSRELAKSGRTMMEIAYLALTGKKKFVIYTSATKE
SAVRLLAPLKQAFEQNPRISNDYGEQANWGNWAEDNFLTNSGTLFLAIGAGQSPRGARNK
EARPDVIVVDDFDTDEDCRNPDIVDKKWDWFEKALYGARSIHKPLLVIFNGNIIADYCCI
KKAIERSTHHEIINIRDKHGKSTWASKNSEEHIDRALSKISQKAVQGEYFNNPLTIGKVF
KELNYGKVQPLNKYKFLVAYTDPSYKKNGDYKATALVGKYKDEYHVLWLRCRKTSISEMV
DWQFDVLNFVNGKTAVYLFIEYPWVDEPLKMEIKKGEQKHNLTLPLRADDRKKPEKFFRI
ESSLEPLNRNGKLIFDERLKDSKDMKEVEFQFLALSPKSRANDDAPDAVEGAVWKVNHKN
KQDVAPPQVWEKPINKKRF
>OBAHECAF_02234 hypothetical protein
MARLTNDEKQRLQEYAKLLYVRENITSQTELAQKVGVTVKTIAQWINDGNWERYKRNLVL
TRNEQMALLLEELEELNSVIQNKEEGKRYADYKESNIRRNLIKDIKELETKASVSEAINA
LTGFLNFMRSQNLEKAQEVSHWVDVYIKDKMK
>OBAHECAF_02235 hypothetical protein
MNKKVFILNDETQTNSYGFRVKTEGISLARFESNPVCLNNHKNDTKNVLGKWVNILKNGT
RLTASPEFDTEDTDGKEVVRKVEKGILKACSIGIMFKPEDVKLIDGVPVVEKCELMEASI
VAVPSNAQAITLYNDKGEALTHDEAKTFCLSFQSNTKNQNTMNKEILALLKLEDNANEDA
VKEAVKAIVANLLAVTSERDTLKTKLATIESQEQQKLQAEFNVELEKAVKDGRLDANNKT
PIEEIAKTNTAQAIAVLKAIPVRETVADKLKTETSALAKYDQLSWDELDKGGHLPYLKLN
HKAYYVERFKEEFGKEPN
>OBAHECAF_02236 hypothetical protein
MRNWKFKPLNLLLNIAILFVVLTTVFSLNPATALASSIPLGVVTGTALSFVDFKSVALEG
LQVEIWAKTIQEKLREDNTFLQHISDVDAGNILAGKVVHLPQAGAPSKVVKNRQTLPAEV
KQRKDAEVLYSIDEYTTDPVHIPYADTVELSYDKRRSILDQDIANLSDEVAEGMLTNIIV
SPVGNNKSLPQKNILLTESSVQVNPSLEGATGKRKAYNINDLQRMRAMFKRGQKSWSENN
MYALLTEEAMIQMFPADSVTTATYMQSVTEQERREGVVLKCQGWKILTRGTVYHMGNDKS
FKAFGAVVTATDTEGCLFWNKNMVEKAIGTTQIFERLNDPTYYGDIYSFLVRVGGRARRA
EFEGVGVLMQASAG
>OBAHECAF_02237 hypothetical protein
MRKPLLYLVIHCTATPEGREVSSDEIRKWHLSPQPQGRGWKQVGYTDMIHLNGAIERLVE
NNEDAFVDGWEITNGTKGINSVARHIVYVGGLSSQGGEMKPKDTRTPAQREALAKFVKDF
VRRNPNVKVAGHNQFANKACPSFDVPKWLRTIGIPEKNIYK
>OBAHECAF_02238 hypothetical protein
MIKLPQPFKINDIDKKTKAVVIALLMGFLLILSTVIGVLFNRMEDKANLCKQEKKELYDL
ILTERKERIQLYENMLFYKQKSQYLQAKTDSIVERTKPLVNQILNR
>OBAHECAF_02239 hypothetical protein
MRIRILLFTLIIALCVSLLWNVRQSRERKANETKITELIALNGKAQVVTQYVRDSITHTV
YRDVMVRDKTTEKQLAITKSYADSLEHALQVSIDKITSVTKTNARLISTVKMLQSEADKP
PNKHYSDRYLSLTYNPLTDSLWLKYDISLNIAKYSKRKWFLGEKQYFVDVFADDPRVTIQ
GLKTFTVAHESPRRWAIALQGGYGLHFTRPPLFAPYVGVGLSYNLIQF
>OBAHECAF_02240 hypothetical protein
MENIQETKSQLQQEADKLFDTHNHIDTLYMTSDGQGFTEQQYADDHARYLKENKVYEFKR
QGAFVQGKGADVLNGDPEREALFAEYEALTGQKPHHNIGTENLRAKIAEIKENNTNENTQ
>OBAHECAF_02241 hypothetical protein
MAEIKTYGLKSVKHADPKPDGTFPDSGLTELCRTYQNSCEFTEDDPQITEEYCDQADDPV
MTFMEKGGKNIKFSAFDYSPETLKALKGGTVLDSKWHEPTATAEIYRAIELTTDTGLKFM
FPKCRVFAKFNAKFVKNGMMLLEVTLKPVSPAPNKSAVIIG
>OBAHECAF_02242 hypothetical protein
MEAEKQVVDLLLKRGVQVQVTAPLFGFFRRKKTLILGVPTCETLLHIAGEFLQMEEIPNE
ITLNEAVKKVARDSRRLARIVALAVLNNPFSFRKTERLAKLLHKTLTQEQLSYLYSVIMT
QGGVGDFISTIRYIGQTRITKPMLSQQEKTS
>OBAHECAF_02243 hypothetical protein
MLSDAPRLVKNNKKSAFKDDEELKQWLMS
>OBAHECAF_02244 Chromosome partition protein Smc
MSQELEPIRLEVAMEVDGTISQADQLDVSMKKLDVSTEKTKKKFEQQTQKLIENGRQMNA
NTQAVKKYAETVQEQIQATQRQNESLTKSTQKFNSLGNSVNQITRELPAFTYSAQTGFMA
IANNIPILTDAMAKLRAENEALKASGQKTTPVWKQLIGSLFSWNSLLSVGITLLTVYGDD
IGSFIMSLFKGKESIDQAKMSIESLNKALNSTEYQKAKSDILSLRAEFDLAKKGIVAKEY
ALKQYNKTLGEVMGTTKDFAQAEDNLIKKGDAYIKMMFYKSAANAILQDEEANNKIIEAE
KRKIELTREWEKAIQDVKDEVARKQEATTSLNGLNFDGKGAGQQVEMVKKRVGELTGSYR
LLGAYWQTAQDKFKELQKVSEELDAETNQLDESRTQVYKRLTEKYHGIAGMFDLNLLGDD
TKKGSKKIQDEYKKLLERIAELDKEYSKQSFDKHDMEVQALKDKFAKVREAVKEYNKKNK
LKIGLGKLDALEDKAVATLKYRHETENLKKELSKQKELFEEYEAYKTKVGKQEADERFKH
DLNGIESYRKALEEAIAKTNADPDSPQRTERLRELQAMLLLANEEQSKRDRNKFADLLEE
YKGFNQKRITLETQYNNDVTLLEQQRNEANNDAVDEAIKVRKAKYEEDLANLQATILQSS
DFYQKLFSDLSKKGYKTLKDFSKDVVKTLQSAQTYNTTEGKTMVRIEYDQINEQGEIVKR
VSNITVAEFERIKAKAEELNNVLRDKNPFAEVVADFSQVVEKAKSGDLDELSTALNGLNT
SVKGSISTFKEWGESLSTIFGDGVGQAVDDIANLAGGVFDLGSGIARIASGDIVGGITSS
LSGIATIYKQVTGWREKAREQQVKMMIADIEALRLIQKQNLALKENVRELSVYNDNLELR
NRLIREGVISQDGIQNKFKYDLQMLKEYTDNLQKEQDNKAKLWENVGNSWFDTGKIKTGS
ASSRQFSAMIGANFEDTKRRMKQASELFGNEARDAYNMLNEAGSMENYVKMLDQRGWLKG
EAKEFYEQWKKSGESVTELEKKFADLKNEMRQVVMGENFDGFVNNFANALAQAQGNVAQF
AEFTHDKIKSSLFNAFKYQYLREQLKPLYEQMGDLLNEGVDALDKDKIEAISQQFESAFK
SANAKLEQLGQQFGTNLYDNKGAEASPNSLKGAVRGITEQQADLLAGQFGGLRLAQLETN
KINKQGFAETMAQTSKMIGIQLEIQHNTRRTADNTEAMKDYLKSIDTSVKSNKNDLKGNG
IKP
>OBAHECAF_02245 hypothetical protein
MFDDKLNNRNLYTDFGLIIQTGTAELLNFPERKESLSNDWREENGKEYDLSLPRFKDKEV
TLTCAFMADNDELFWENYNAFFAELTQAQWQQLYIADHSRTYEVFYQKMENAKKGNKRLK
NVEKVFVKFDLTLIVK
>OBAHECAF_02246 hypothetical protein
MNYQIKRNNNTIATICPEGQLQASVMGEEVVTMTFSLTNYVHFQTGDTVEVYGNIYYLST
EPQIEKISSREFRYSLEFQGIKYELGKVQYLFPDAQNVLNLSEFHIMGTARTMLELLVQN
ANRTGQGWSLGTVDDTEAKQLNFSAENCLAVLSKIAQEFKLEYWVDGDKSIHLTERKAVS
GYSFEYGKAKGLKSLTRQTLEGSNVVTRLYAFGSEKNIAGDYRGGQQKLRMPVPFLEKNT
DIYGIIEGSQTFDVFPHRLGTVTAINPSNPLQFSDSGMDFDLNERENGNTKYLINGVPVK
VTFNTGQLSGYTFEVKQYGYNTATKTFTLLKNQDEKAIEVPSETLRPAVGDRYVLTDLIM
PESYVTNAEQELQQKAQQYLDENSRQRVVYSLVTDPLYFKAQNVNIVLGSTIRAVDTDFN
LDDNLRVIRLTKDLQNPYNVQFEVAERAEIAYIVREYFEEEKSKVAMVQADKFNAEMARR
AYRFGKEISENVFDGEGYFNAEKIKPLSIETKLLSVGSRMQQFSLPDVVISVENATTVRN
TQGKIVHLTLEENPREWQIPANTQTGITEGFNYIYIKAQRIGSNASVFVSPEKIAVDSDV
AFYHFEAGYLGSVESGNRRIRMSHGFTQINPFEITTGRIAPPSGNHYIELTQDSINVVGN
LHITDGNVNQIKQSISPDLLNLENRLKQYTDNVQIGGRNLLRNSKYVKKRNEGGGIAYVG
EITEMIAGQTYIITAKKINGRINEADFYLNERTDWWNATPQYITMGVPFIATHNYKHLWV
TCPYNGTEAEYQFIMLEKGNKATDWSPAPEDLESQIQTEQQARQNAIDQAKSATEAYARA
QAELARTLAIANADGKITEAEQRQINNATQKLQEAKTFAEQKVNGLQIGGRNLVLKSKEM
RHYHSYMGHTWNFSEPMKVGEKYTFSCEAHVGGPLWCYFLDVVGQPRQGIKWLSEGRNEV
VVIPNYAWSGLRIYHETYHNVYSWAMALKMEKGEKATDWSPAPEDVEDNIKHGNLYVKGT
GYDRLEPLQIKLNDVNIEGSYGRGLKLMGLNRSTLQVVINENYDVFSSVNDINALANRLN
GLGSDHIIMIASYDAISCNEDLINAMHRCGASIEASRLTWRLPYALVGIPGIGKGAGIEV
YTSAGADAPFAEISTKIINGTPQGINTSAVGLVNSIASDLQTAINNAKALLEAEINNVNS
ITQKLSAKADFLSETKIDGNTVATGAMLVGNVLGGNAGVNGSGLASTDVRFFAGSSFANR
GNAPFRVLDDGSLYSTKGSIAGIAINQNGLGTDNSGFGFSLDNGKYFHINNERISIWSSY
NNTPHLNFPTHVIRETIIRPSEIVVEQNDNGGTTAMIIRNNGIYKKVGNTETKIL
>OBAHECAF_02247 hypothetical protein
MDTNLTIISRRENITAKAEVRGNTVTFAYDKNNNQVTAVAFSVQRGTQGSPEFTGAEAFR
GTMYGEAFNVENNSYHIGDSAMYEDIYTVCRQIMNPEPQEPEADDTSV
>OBAHECAF_02248 hypothetical protein
MIRVCKWLVPKGYSAITLYPFIFLRVRADKDNALLINHERIHLRQQAELLVVFFYLWYGI
DFLWKYAKYRNWGKAYYDNIFEREAYGNEHNLNYLQVRGWYWFIGWRVGSTDSNNLNNV
>OBAHECAF_02249 Modification methylase HaeIII
MKYYYNWKLSETKFAKNKGKVFSCFACGGGSTMGYKLAGFDVLGFNEIDPRMANLYIKNH
QPKYQFVEAMQDFVKWDEYPEELYHLDILDGSPPCSSFSVSGNREVDWGKEKIFKEGQKK
QVLDTLFFDFIALAKKLQPKIVIAENVKGILQGKAKAYTKRILQEFDQAGYKVNYYLLDA
SKMGVPQRRERVFFIAIRKDLAEKVSDLQLNFNLPTIPFGAIKTDENTASFTDHDRYVWG
NRKHSDRTYADVLQRIENRDSNFNAQFIYEDKTPPTLVASSGSKMVLFSEARKMNHTELI
RCQSFPQDYDFGTSAYSFVQYVLGMSVPPVMMANLVDEIYRQWRKIFENE
>OBAHECAF_02250 hypothetical protein
MNEIKRIVVQSSRMGNLVIKRISKEKAKSLIIKNHYSKKLGANHGLFNYGIFQENKESEN
ECLGVAVYGYMMHPKARHFTHPNPQALMLELNRMWISDELGKNAETILISRSLRLLREDS
PNCVAVQSFADGRLGCGTIYKAANFKYYGHHRTTFIKNKHTGEISHEMNFTRMDSKGMYL
RNNLAFLLGDVEVFQVDTYRYIFPLCKRFRYNKPSQPYPAYNRGVTPFEWQRNRKLIKER
LIKFISELE
>OBAHECAF_02251 hypothetical protein
MFLYTFLCLMMKSSKNVHFILNFGTFGFADYRYYLIIGALTLVSWLVSWQLKRKFKHYSQ
VHLRNNMSGAEIAEKMLHDNGIYDVKVISTPGMLTDHYNPMNKTVNLSEGVYNQRNAAAA
AVAAHEVGHAVQHAQAYKWLTMRSKLVPIASVSSNFSTFLIMGGLILSAMSSFGIYVAIA
GLVMSALATLFTIITLPVEYDASNRALAWLKNKNMLAPQEYAGAEDSLKWAARTYLVAAL
GSLAMLVYWALKIAAASRE
>OBAHECAF_02252 hypothetical protein
MKFRYIVVEDDTNVWENIRIRMQSYPQWEALEFSSELTDAIEKITQHLPEMIFSDWSIRG
GNAYQILNYISTIENYNPYVIFFTGYQSENPEIPQRIINDFPIVNKYIVKPIYENLTNHL
QSYVREAEKQAIKSVSKKGSSAESKESEGILIDTSLGKVRIFMSEFIAVLQQEGTRLKML
YLKNNCSYELKQTWEEIFTLLEESQIDYFVAHNRKSVINKVFIKTIVKPYVFMENDLSIK
VSREQWRKLETFS
